PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Duan, TY; Cil, O; Tse, CM; Sarker, R; Lin, RX; Donowitz, M; Verkman, AS				Duan, Tianying; Cil, Onur; Tse, C. Ming; Sarker, Rafiquel; Lin, Ruxian; Donowitz, Mark; Verkman, Alan S.			Inhibition of CFTR-mediated intestinal chloride secretion as potential therapy for bile acid diarrhea	FASEB JOURNAL			English	Article						chloride channel; BAD; intestinal fluid secretion; cystic fibrosis; CFTR inhibitor	IRRITABLE-BOWEL-SYNDROME; ION-TRANSPORT; CL-SECRETION; FLUID SECRETION; PHYSIOLOGY; PREVALENCE; MECHANISMS; (R)-BPO-27; MODEL; SALTS	Bile acid diarrhea (BAD) is common with ileal resection, Crohn's disease, and diarrhea-predominant irritable bowel syndrome. Here, we demonstrate the efficacy of cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor (R)-benzopyrimido-pyrrolo-oxazine-dione-27 (BPO-27) in reducing bile acid-induced fluid and electrolyte secretion in colon. Short-circuit current measurements in human T84 colonic epithelial cells and planar colonic enteroid cultures showed a robust secretory response following mucosal but not serosal addition of chenodeoxycholic acid (CDCA) or its taurine conjugate, which was fully blocked by CFTR inhibitors, including (R)-BPO-27. (R)-BPO-27 also fully blocked CDCA-induced secretory current in murine colon. CFTR activation by CDCA primarily involved Ca2+ signaling. In closed colonic loops in vivo, luminal CDCA produced a robust secretory response, which was reduced by similar to 70% by (R)-BPO-27 or in CFTR-deficient mice. In a rat model of BAD produced by intracolonic infusion of CDCA, (R)-BPO-27 reduced the elevation in stool water content by >55%. These results implicate CFTR activation in the colon as a major prosecretory mechanism of CDCA, a bile acid implicated in BAD, and support the potential therapeutic efficacy of CFTR inhibition in bile acid-associated diarrheas.-Duan, T., Cil, O., Tse, C. M., Sarker, R., Lin, R., Donowitz, M., Verkman, A. S. Inhibition of CFTR-mediated intestinal chloride secretion as potential therapy for bile acid diarrhea.	[Duan, Tianying; Cil, Onur; Verkman, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Duan, Tianying; Verkman, Alan S.] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA; [Cil, Onur] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Duan, Tianying] Cent S Univ, Xiangya Hosp 2, Dept Gastroenterol, Changsha, Hunan, Peoples R China; [Tse, C. Ming; Sarker, Rafiquel; Lin, Ruxian; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Gastroenterol Div, Baltimore, MD 21205 USA; [Lin, Ruxian; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Central South University; Johns Hopkins University; Johns Hopkins University	Verkman, AS (corresponding author), Univ Calif San Francisco, 1246 Hlth Sci E Tower,513 Parnassus Ave, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu	Cil, Onur/AAK-5166-2020	Cil, Onur/0000-0001-5178-0199	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK099803, DK72517, DK101373, DK089502]; NIH National Eye Institute [EY13574]; Cystic Fibrosis Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101373, P30DK072517, P30DK089502, R24DK099803] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Paul Dawson (Emory University, Atlanta, GA, USA), Stephen Keely (Royal College of Surgeons in Ireland, Dublin, Ireland), and Jerry Turner (Harvard Medical School, Boston, MA, USA) for helpful advice and suggestions. This study was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants DK099803, DK72517, DK101373, and DK089502, and NIH National Eye Institute Grant EY13574, and a research grant from the Cystic Fibrosis Foundation. A.S.V. is a named inventor on CFTR inhibitor patent applications owned by the University of California. The other authors declare no conflicts of interest.	Ahuja M, 2014, CELL CALCIUM, V55, P385, DOI 10.1016/j.ceca.2014.01.006; Alrefai WA, 2007, DIGEST DIS SCI, V52, P1270, DOI 10.1007/s10620-006-9090-8; Ao M, 2013, AM J PHYSIOL-CELL PH, V305, pC447, DOI 10.1152/ajpcell.00416.2012; Barcelo A, 2001, DIGEST DIS SCI, V46, P1223, DOI 10.1023/A:1010607127822; Barshop K, 2017, THER ADV CHRONIC DIS, V8, P153, DOI 10.1177/2040622317714389; Camilleri M, 2015, GUT LIVER, V9, P332, DOI 10.5009/gnl14397; Camilleri M, 2014, EXPERT REV GASTROENT, V8, P49, DOI 10.1586/17474124.2014.851599; Cil O, 2017, FASEB J, V31, P751, DOI 10.1096/fj.201600891R; CONLEY DR, 1976, AM J DIG DIS, V21, P453, DOI 10.1007/BF01072128; Dey I, 2018, CURR TOP MEMBR, V81, P337, DOI 10.1016/bs.ctm.2018.08.003; DHARMSATHAPHORN K, 1989, J CLIN INVEST, V84, P945, DOI 10.1172/JCI114257; Domingue JC, 2016, AM J PHYSIOL-CELL PH, V311, pC777, DOI 10.1152/ajpcell.00168.2016; Duan TY, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126444; Duboc H, 2012, NEUROGASTROENT MOTIL, V24, P513, DOI 10.1111/j.1365-2982.2012.01893.x; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Foulke-Abel J, 2016, GASTROENTEROLOGY, V150, P638, DOI 10.1053/j.gastro.2015.11.047; Gracie DJ, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01953.x; Haggie PM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121370; Halls ML, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004143; HOFMANN AF, 1969, NEW ENGL J MED, V281, P397, DOI 10.1056/NEJM196908212810801; Hoque KM, 2010, J GEN PHYSIOL, V135, P43, DOI 10.1085/jgp.200910339; In J, 2016, CELL MOL GASTROENTER, V2, P48, DOI 10.1016/j.jcmgh.2015.10.001; In JG, 2016, NAT REV GASTRO HEPAT, V13, P633, DOI 10.1038/nrgastro.2016.142; Khan S, 2010, NAT REV GASTRO HEPAT, V7, P565, DOI 10.1038/nrgastro.2010.137; Kim Y, 2015, MOL PHARMACOL, V88, P689, DOI 10.1124/mol.115.098368; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Lee JM, 2018, J LIPID RES, V59, P429, DOI 10.1194/jlr.M078279; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MASCOLO N, 1994, EUR J PHARMACOL, V264, P21, DOI 10.1016/0014-2999(94)90630-0; MEKHJIAN HS, 1971, J CLIN INVEST, V50, P1569, DOI 10.1172/JCI106644; Momen Mohammed Abdul, 2002, Journal of Medical Investigation, V49, P67; Mroz MS, 2014, GUT, V63, P808, DOI 10.1136/gutjnl-2013-305088; Nee Judy, 2015, Curr Treat Options Gastroenterol, V13, P432, DOI 10.1007/s11938-015-0068-5; Odunsi-Shiyanbade ST, 2010, CLIN GASTROENTEROL H, V8, P159, DOI 10.1016/j.cgh.2009.10.020; Pallagi-Kunstar E, 2015, PFLUG ARCH EUR J PHY, V467, P1277, DOI 10.1007/s00424-014-1560-9; Sarathy J, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13294; Shin A, 2013, CLIN GASTROENTEROL H, V11, P1270, DOI 10.1016/j.cgh.2013.04.020; Snyder DS, 2013, ACS MED CHEM LETT, V4, P456, DOI 10.1021/ml400069k; Snyder DS, 2011, J MED CHEM, V54, P5468, DOI 10.1021/jm200505e; Thiagarajah JR, 2015, NAT REV GASTRO HEPAT, V12, P446, DOI 10.1038/nrgastro.2015.111; Thiagarajah JR, 2004, GASTROENTEROLOGY, V126, P511, DOI 10.1053/j.gastro.2003.11.005; Venkatasubramanian J, 2010, CURR OPIN GASTROEN, V26, P123, DOI 10.1097/MOG.0b013e3283358a45; Walters Julian R F, 2010, Therap Adv Gastroenterol, V3, P349, DOI 10.1177/1756283X10377126; Wedlake L, 2009, ALIMENT PHARM THER, V30, P707, DOI 10.1111/j.1365-2036.2009.04081.x; Wong BS, 2012, CLIN GASTROENTEROL H, V10, P1009, DOI 10.1016/j.cgh.2012.05.006; Zachos NC, 2016, J BIOL CHEM, V291, P3759, DOI 10.1074/jbc.R114.635995; ZHANG R, 2017, JOVE J VIS EXP AUG, V126, DOI DOI 10.3791/55728	47	6	8	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10924	10934		10.1096/fj.201901166R	http://dx.doi.org/10.1096/fj.201901166R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31268738	Green Published, Bronze			2022-12-26	WOS:000489166300028
J	Santonocito, R; Venturella, F; Dal Piaz, F; Morando, MA; Provenzano, A; Rao, E; Costa, MA; Bulone, D; San Biagio, PL; Giacomazza, D; Sicorello, A; Alfano, C; Passantino, R; Pastore, A				Santonocito, Radha; Venturella, Francesca; Dal Piaz, Fabrizio; Morando, Maria Agnese; Provenzano, Alessia; Rao, Estella; Costa, Maria Assunta; Bulone, Donatella; San Biagio, Pier Luigi; Giacomazza, Daniela; Sicorello, Alessandro; Alfano, Caterina; Passantino, Rosa; Pastore, Annalisa			Recombinant mussel protein Pvfp-5 beta: A potential tissue bioadhesive	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; biomaterials; biophysics; epidermal growth factor (EGF); structural biology; adhesion proteins; EGF-like motifs; Marine proteins	ADHESIVE PROTEIN; DOPA; SURFACES	During their lifecycle, many marine organisms rely on natural adhesives to attach to wet surfaces for movement and self-defense in aqueous tidal environments. Adhesive proteins from mussels are biocompatible and elicit only minimal immune responses in humans. Therefore these proteins have received increased attention for their potential applications in medicine, biomaterials, and biotechnology. The Asian green mussel Perna viridis secretes several byssal plaque proteins, molecules that help anchoring the mussel to surfaces. Among these proteins, protein-5 beta (Pvfp-5 beta) initiates interactions with the substrate, displacing interfacial water molecules before binding to the surface. Here, we established the first recombinant expression in Escherichia coli of Pvfp-5 beta. We characterized recombinant Pvfp-5 beta, finding that despite displaying a CD spectrum consistent with features of a random coil, the protein is correctly folded as indicated by MS and NMR analyses. Pvfp-5 beta folds as a beta-sheet-rich protein as expected for an epidermal growth factor-like module. We examined the effects of Pvfp-5 beta on cell viability and adhesion capacity in NIH-3T3 and HeLa cell lines, revealing that Pvfp-5 beta has no cytotoxic effects at the protein concentrations used and provides good cell-adhesion strength on both glass and plastic plates. Our findings suggest that the adhesive properties of recombinant Pvfp-5 beta make it an efficient surface-coating material, potentially suitable for biomedical applications including regeneration of damaged tissues.	[Santonocito, Radha; Provenzano, Alessia; Rao, Estella; Costa, Maria Assunta; Bulone, Donatella; San Biagio, Pier Luigi; Giacomazza, Daniela; Passantino, Rosa] CNR, Ist Biofis, I-190146 Palermo, Italy; [Venturella, Francesca] Univ Palermo, I-190128 Palermo, Italy; [Dal Piaz, Fabrizio] Univ Salerno, I-184084 Salerno, Italy; [Venturella, Francesca; Morando, Maria Agnese; Alfano, Caterina] Fdn Ri MED, I-190133 Palermo, Italy; [Sicorello, Alessandro; Pastore, Annalisa] Kings Coll London, London SE5 9RT, England; [Sicorello, Alessandro; Pastore, Annalisa] Kings Coll London, UK Dementia Res Inst, London SE5 9RT, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Palermo; University of London; King's College London; University of London; King's College London	Passantino, R (corresponding author), CNR, Ist Biofis, I-190146 Palermo, Italy.; Alfano, C (corresponding author), Fdn Ri MED, I-190133 Palermo, Italy.	calfano@fondazionerimed.com; rosa.passantino@cnr.it	bulone, donatella/AAB-6116-2022; passantino, rosa/C-3993-2015; Giacomazza, Daniela/C-4280-2015	bulone, donatella/0000-0002-5841-9133; Costa, Maria Assunta/0000-0003-3377-6123; Alfano, Caterina/0000-0003-0374-5852; Rao, Estella/0000-0002-1202-5083; passantino, rosa/0000-0001-6598-2664; Giacomazza, Daniela/0000-0002-6667-0205; Sicorello, Alessandro/0000-0003-1407-8039	Cancer Research UK [FC001029]; UK Medical Research Council [FC001029]; Wellcome Trust [FC001029]; MRC [UKDRI-6002, MC_U117584256, MC_U117533887] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Francis Crick Institute through provision of access to the MRC Biomedical NMR Centre. The Francis Crick Institute receives its core funding from Cancer Research UK Grant FC001029, UK Medical Research Council Grant FC001029, and the Wellcome Trust Grant FC001029.	BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; Cho Hyung Joon, 2008, Biotechnology Journal, V3, P631, DOI 10.1002/biot.200700258; COOKE RM, 1987, NATURE, V327, P339, DOI 10.1038/327339a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0; DOVE J, 1986, J AM DENT ASSOC, V112, P879; Forooshani PK, 2017, J POLYM SCI POL CHEM, V55, P9, DOI 10.1002/pola.28368; George MN, 2018, BIOFOULING, V34, P388, DOI 10.1080/08927014.2018.1453927; GRANDE DA, 1988, B HOSP JOINT DIS ORT, V48, P140; Guerette PA, 2013, NAT BIOTECHNOL, V31, P908, DOI 10.1038/nbt.2671; He YH, 2018, SOFT MATTER, V14, P7145, DOI 10.1039/c8sm00509e; Hwang DS, 2012, SOFT MATTER, V8, P5640, DOI 10.1039/c2sm25173f; Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157; INOUE K, 1995, J BIOL CHEM, V270, P6698, DOI 10.1074/jbc.270.12.6698; Jeon EY, 2015, BIOMATERIALS, V67, P11, DOI 10.1016/j.biomaterials.2015.07.014; Jiang Z, 2012, COLLOID SURFACE B, V90, P227, DOI 10.1016/j.colsurfb.2011.10.037; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kershaw NJ, 2015, BIOCHEM J, V468, P159, DOI 10.1042/BJ20150010; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Lim S, 2009, J ADHESION, V85, P812, DOI 10.1080/00218460903291411; Maier GP, 2015, SCIENCE, V349, P628, DOI 10.1126/science.aab0556; Mirshafian R, 2016, BIOCHEMISTRY-US, V55, P743, DOI 10.1021/acs.biochem.5b01177; NARHI LO, 1992, INT J PEPT PROT RES, V39, P182; Ohkawa K, 2004, BIOFOULING, V20, P101, DOI 10.1080/08927010410001681246; Petrone L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9737; Priemel T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14539; Rahimnejad M, 2017, RSC ADV, V7, P47380, DOI 10.1039/c7ra06743g; Rodriguez NRM, 2015, BIOFOULING, V31, P221, DOI 10.1080/08927014.2015.1026337; RZEPECKI LM, 1992, BIOL BULL, V183, P123, DOI 10.2307/1542413; SAEZ C, 1991, COMP BIOCHEM PHYS B, V98, P569, DOI 10.1016/0305-0491(91)90255-C; Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x; Stewart RJ, 2011, J POLYM SCI POL PHYS, V49, P757, DOI 10.1002/polb.22256; Waite JH, 2017, J EXP BIOL, V220, P517, DOI 10.1242/jeb.134056; Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172; Weisshuhn PC, 2016, STRUCTURE, V24, P555, DOI 10.1016/j.str.2016.02.010; Wilker JJ, 2010, CURR OPIN CHEM BIOL, V14, P276, DOI 10.1016/j.cbpa.2009.11.009; Yu J, 2013, BIOMACROMOLECULES, V14, P1072, DOI 10.1021/bm301908y; Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z; Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y; Zhang W, 2017, RSC ADV, V7, P32518, DOI 10.1039/c7ra04228k; Zhang XY, 2017, APPL MATER TODAY, V7, P222, DOI 10.1016/j.apmt.2017.04.001; Zhu WZ, 2018, ACTA BIOMATER, V74, P1, DOI 10.1016/j.actbio.2018.04.034	43	11	13	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12826	12835		10.1074/jbc.RA119.009531	http://dx.doi.org/10.1074/jbc.RA119.009531			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31292195	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000484414600023
J	Duenas-Santero, E; Santos-Almeida, A; Rojo-Dominguez, P; del Rey, F; Correa-Bordes, J; de Aldana, CRV				Duenas-Santero, Encarnacion; Santos-Almeida, Ana; Rojo-Dominguez, Patricia; del Rey, Francisco; Correa-Bordes, Jaime; Vazquez de Aldana, Carlos R.			A new toolkit for gene tagging in Candida albicans containing recyclable markers	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; DISRUPTION; YEAST; TRANSFORMATION; CASSETTES; OVEREXPRESSION; CONSTRUCTION; MANIPULATION; RESISTANCE; DYNAMICS	Gene manipulation and epitope tagging are essential tools for understanding the molecular function of specific genes. The opportunistic human pathogen Candida albicans is a diploid fungus that utilizes a non-canonical genetic code. Since selection markers available in this organism are scarce, several tools based on recyclable markers have been developed for gene disruption, such as the C/oxsystem. This system relies on the Cre recombinase, which recycles selection markers flanked by loxP sites with high efficiency, facilitating single marker or multi-marker recycling. However, PCR-based modules for epitope tagging, such the pFA-modules, mainly use limited non-recyclable auxotrophic markers. To solve this problem, we have used a Gibson assembly strategy to construct a set of new plasmids where the auxotrophic markers of the pFA vectors were swapped with five recyclable marker modules of the C/oxsystem, enhancing the versatility of the pFA plasmids. This new toolkit, named pFA-C/ox, is composed of 36 new vectors for gene disruption and epitope tagging (GFP, 3xGFP, mCherry, 3xHA, 5xmyc and TAP). These plasmids contain the dominant NAT1 marker, as well as URA3, HIS1 and ARG4 cassettes, thereby permitting functional analysis of laboratory strains as well as clinical isolates of C. albicans. In summary, we have adapted the C/oxsystem to the pFA-backbone vectors. Thus, the set of primers used for the amplification of previously published pFA modules can also be utilized in this new pFA-C/oxsystem. Therefore, this new toolkit harbors the advantages of both systems, allowing accelerated gene modification strategies that could reduce time and costs in strain construction for C. albicans.	[Duenas-Santero, Encarnacion; Santos-Almeida, Ana; del Rey, Francisco; Vazquez de Aldana, Carlos R.] Univ Salamanca, CSIC, IBFG, Salamanca, Spain; [Rojo-Dominguez, Patricia; Correa-Bordes, Jaime] Univ Extremadura, Dept Ciencias Biomed, Badajoz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Universidad de Extremadura	de Aldana, CRV (corresponding author), Univ Salamanca, CSIC, IBFG, Salamanca, Spain.; Correa-Bordes, J (corresponding author), Univ Extremadura, Dept Ciencias Biomed, Badajoz, Spain.	jcorrea@unex.es; cvazquez@usal.es	de Aldana, Carlos Vazquez/B-7772-2008; del Rey, Francisco/L-7132-2014	de Aldana, Carlos Vazquez/0000-0002-4513-3654; del Rey, Francisco/0000-0002-6517-7400; Rojo Dominguez, Elvira Patricia/0000-0002-6149-3449	Spanish Ministry of Science and Innovation [BIO2015-70195-C2-1-R, BIO2015-70195-C2-2R]; Junta de Extremadura [GR15008]; European Union FEDER programme; Programa "Escalera de Excelencia" from Junta de Castilla y Leon [CLU-2017-03]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Extremadura; European Union FEDER programme; Programa "Escalera de Excelencia" from Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by grants from the Spanish Ministry of Science and Innovation to CRV (BIO2015-70195-C2-1-R) and to JC-B (BIO2015-70195-C2-2R), the Junta de Extremadura to JC-B (GR15008). All Spanish funding is co-sponsored by the European Union FEDER programme. The IBFG is supported by Programa "Escalera de Excelencia" from Junta de Castilla y Leon (CLU-2017-03, P.O. FEDER de Castilla y Leon 14-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta I, 2011, MOL BIOL CELL, V22, P3478, DOI 10.1091/mbc.E11-06-0482; Basso LR, 2010, YEAST, V27, P1039, DOI 10.1002/yea.1813; Bennett RJ, 2015, CURR OPIN MICROBIOL, V28, P10, DOI 10.1016/j.mib.2015.06.017; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Chang P, 2018, J MICROBIOL METH, V149, P14, DOI 10.1016/j.mimet.2018.04.016; De Backer MD, 2000, ANNU REV MICROBIOL, V54, P463, DOI 10.1146/annurev.micro.54.1.463; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Enloe B, 2000, J BACTERIOL, V182, P5730, DOI 10.1128/JB.182.20.5730-5736.2000; Finley KR, 2005, EUKARYOT CELL, V4, P1697, DOI 10.1128/EC.4.10.1697-1711.2005; FONZI WA, 1993, GENETICS, V134, P717; Gerami-Nejad M, 2004, YEAST, V21, P429, DOI 10.1002/yea.1080; Gerami-Nejad M, 2013, MICROBIOL-SGM, V159, P565, DOI 10.1099/mic.0.064097-0; Gerami-Nejad M, 2009, YEAST, V26, P399, DOI 10.1002/yea.1674; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; Gonzalez-Novo A, 2008, MOL BIOL CELL, V19, P1509, DOI 10.1091/mbc.E07-09-0876; Hernday AD, 2010, METHOD ENZYMOL, V470, P737, DOI 10.1016/S0076-6879(10)70031-8; Huang MNY, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00050-17, 10.1128/msphere.00050-17]; Kohler GA, 1997, J BACTERIOL, V179, P2331; Kumamoto CA, 2011, CURR OPIN MICROBIOL, V14, P386, DOI 10.1016/j.mib.2011.07.015; Lavoie H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-578; Lee HJ, 2015, EUKARYOT CELL, V14, P671, DOI 10.1128/EC.00016-15; Min K, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00130-16; Morschhauser J, 1999, MOL MICROBIOL, V32, P547, DOI 10.1046/j.1365-2958.1999.01393.x; Nguyen N, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00149-17, 10.1128/mspheredirect.00149-17]; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Reijnst P, 2011, YEAST, V28, P331, DOI 10.1002/yea.1841; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roman E, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00001-19; Samaranayake DP, 2011, FUNGAL GENET BIOL, V48, P858, DOI 10.1016/j.fgb.2011.04.003; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schaub Y, 2006, J BASIC MICROB, V46, P416, DOI 10.1002/jobm.200510133; Schmid J, 2016, CURR GENET, V62, P81, DOI 10.1007/s00294-015-0516-8; Shahana S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100390; Shapiro RS, 2018, NAT REV MICROBIOL, V16, P333, DOI 10.1038/s41579-018-0002-7; Shen JQ, 2005, INFECT IMMUN, V73, P1239, DOI 10.1128/IAI.73.2.1239-1242.2005; SMITH HA, 1988, GENE, V63, P53, DOI 10.1016/0378-1119(88)90545-8; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Walther A, 2008, NAT PROTOC, V3, P1414, DOI 10.1038/nprot.2008.137; Warenda AJ, 2002, MOL BIOL CELL, V13, P2732, DOI 10.1091/mbc.E02-01-0013; Wellington M, 2005, YEAST, V22, P57, DOI 10.1002/yea.1191; Wensing L, 2019, MSPHERE, V4, DOI [10.1128/msphere.00002-19, 10.1128/mSphere.00002-19]; Wilson RB, 2000, YEAST, V16, P65, DOI 10.1002/(SICI)1097-0061(20000115)16:1&lt;65::AID-YEA508&gt;3.0.CO;2-M; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Xu QR, 2014, VIRULENCE, V5, P507, DOI 10.4161/viru.28893; Zhang CD, 2010, EUKARYOT CELL, V9, P224, DOI 10.1128/EC.00327-09	50	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219715	10.1371/journal.pone.0219715	http://dx.doi.org/10.1371/journal.pone.0219715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295309	Green Submitted, gold, Green Published			2022-12-26	WOS:000484951800065
J	Farmer, R; Thomas, CM; Winn, PJ				Farmer, Rohit; Thomas, Christopher Morton; Winn, Peter James			Structure, function and dynamics in acyl carrier proteins	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; POLYKETIDE; DOMAIN; RECOGNITION; EFFICIENT; REVEAL; CHAIN; ACP	Carrier proteins are four-helix bundles that covalently hold metabolites and secondary metabolites, such as fatty acids, polyketides and non-ribosomal peptides. These proteins mediate the production of many pharmaceutically important compounds including antibiotics and anticancer agents. Acyl carrier proteins (ACPs) can be found as part of a multi-domain polypeptide (Type I ACPs), or as part of a multiprotein complex (Type II). Here, the main focus is on ACP2 and ACP3, domains from the type I trans-AT polyketide synthase MmpA, which is a core component of the biosynthetic pathway of the antibiotic mupirocin. During molecular dynamics simulations of their apo, holo and acyl forms ACP2 and ACP3 both form a substrate-binding surface-groove. The substrates bound to this surface-groove have polar groups on their acyl chain exposed and forming hydrogen bonds with the solvent. Bulky hydrophobic residues in the GXDS motif common to all ACPs, and similar residues on helix III, appear to prohibit the formation of a deep tunnel in type I ACPs and type II ACPs from polyketide synthases. In contrast, the equivalent positions in ACPs from type II fatty acid synthases, which do form a deep solvent-excluded substrate-binding tunnel, have the small residue alanine. During simulation, ACP3 with mutations I61A L36A W44L forms a deep tunnel that can fully bury a saturated substrate in the core of the ACP, in contrast to the surface groove of the wild type ACP3. Similarly, in the ACP from E. coli fatty acid synthase, a type II ACP, mutations can change ligand binding from being inside a deep tunnel to being in a surface groove, thus demonstrating how changing a few residues can modify the possibilities for ligand binding.	[Farmer, Rohit; Thomas, Christopher Morton; Winn, Peter James] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Farmer, Rohit] Sam Higginbottom Univ Agr Technol & Sci, Jacob Inst Biotechnol & Bioengn, Dept Computat Biol & Bioinformat, Allahabad, Uttar Pradesh, India; [Thomas, Christopher Morton; Winn, Peter James] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Winn, Peter James] Univ Birmingham, Ctr Computat Biol, Birmingham, W Midlands, England	University of Birmingham; Sam Higginbottom University of Agriculture, Technology & Sciences; University of Birmingham; University of Birmingham	Winn, PJ (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.; Winn, PJ (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.; Winn, PJ (corresponding author), Univ Birmingham, Ctr Computat Biol, Birmingham, W Midlands, England.	p.j.winn@bham.ac.uk		Winn, Peter/0000-0003-4706-723X; Farmer, Rohit/0000-0003-4197-3047	Darwin Trust of Edinburgh; BBSRC [BB/I014373/1] Funding Source: UKRI	Darwin Trust of Edinburgh; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	R.F. was supported by a scholarship from the Darwin Trust of Edinburgh and a study leave sanctioned by Sam Higginbottom University of Agriculture, Technology and Sciences. Computations were performed with BlueBEAR, University of Birmingham and BRAF, Centre for Development of Advanced Computing, India. Article publication charges were paid by the University of Birmingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Chan DI, 2008, J BIOL CHEM, V283, P33620, DOI 10.1074/jbc.M805323200; Charkoudian LK, 2011, PROTEIN SCI, V20, P1244, DOI 10.1002/pro.652; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Dong X, 2016, CHEM SCI, V7, P1779, DOI 10.1039/c5sc03864b; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Evans SE, 2009, J MOL BIOL, V389, P511, DOI 10.1016/j.jmb.2009.03.072; Haines AS, 2013, NAT CHEM BIOL, V9, P685, DOI [10.1038/NCHEMBIO.1342, 10.1038/nchembio.1342]; Helfrich EJN, 2016, NAT PROD REP, V33, P231, DOI 10.1039/c5np00125k; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang BD, 2009, OMICS, V13, P325, DOI 10.1089/omi.2009.0045; Jaremko MJ, 2015, J AM CHEM SOC, V137, P11546, DOI 10.1021/jacs.5b04525; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lai JR, 2006, BIOCHEMISTRY-US, V45, P14869, DOI 10.1021/bi061979p; Masoudi A, 2014, NATURE, V505, P422, DOI 10.1038/nature12679; Owen JG, 2016, CELL CHEM BIOL, V23, P1395, DOI 10.1016/j.chembiol.2016.09.014; Paramo T, 2014, J CHEM THEORY COMPUT, V10, P2151, DOI 10.1021/ct401098b; PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196; Perez DR, 2015, BIOCHEMISTRY-US, V54, P2205, DOI 10.1021/bi5014563; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; Ploskon E, 2010, CHEM BIOL, V17, P776, DOI 10.1016/j.chembiol.2010.05.024; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Tran L, 2010, CHEM BIOL, V17, P705, DOI 10.1016/j.chembiol.2010.05.017; Vance S, 2016, BIOCHEM J, V473, P1097, DOI 10.1042/BCJ20160041; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wattana-Amorn P, 2010, BIOCHEMISTRY-US, V49, P2186, DOI 10.1021/bi902176v; Wood DAV, 2018, PROTEINS, V86, P664, DOI 10.1002/prot.25493; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	33	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219435	10.1371/journal.pone.0219435	http://dx.doi.org/10.1371/journal.pone.0219435			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291335	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800083
J	Futse, JE; Buami, G; Kayang, BB; Koku, R; Palmer, GH; Graca, T; Noh, SM				Futse, James E.; Buami, Grace; Kayang, Boniface B.; Koku, Roberta; Palmer, Guy H.; Graca, Telmo; Noh, Susan M.			Sequence and immunologic conservation of Anaplasma marginale OmpA within strains from Ghana as compared to the predominant OmpA variant	PLOS ONE			English	Article							MAJOR SURFACE PROTEIN-2; PROTECTIVE IMMUNITY; SUPERINFECTION; IMMUNIZATION; DIVERSITY; ISOLATE	A primary challenge in developing effective vaccines against obligate, intracellular, bacterial tick-borne pathogens that establish persistent infection is the identification of antigens that cross protect against multiple strains. In the case of Anaplasma marginale, the most prevalent tick-borne pathogen of cattle found worldwide, OmpA is an adhesin and thus a promising vaccine candidate. We sequenced ompA from cattle throughout Ghana naturally infected with A. marginale in order to determine the degree of variation in this gene in an area of suspected high genetic diversity. We compared the Ghanaian sequences with those available from N. America, Mexico, Australia and Puerto Rico. When considering only amino acid changes, three unique Ghanaian OmpA variants were identified. In comparison, strains from all other geographic regions, except one, shared a single OmpA variant, Variant 1, which differed from the Ghanaian variants. Next, using recombinant OmpA based on Variant 1, we determined that amino acid differences in OmpA in Ghanaian cattle as compared to OmpA Variant 1 did not alter the binding capacity of antibody directed against OmpA Variant 1, supporting the value of OmpA as a highly conserved vaccine candidate.	[Futse, James E.; Buami, Grace; Kayang, Boniface B.; Koku, Roberta] Univ Ghana, Dept Anim Sci, Coll Basic & Appl Sci, Anim Dis Biotechnol Lab, Legon, Ghana; [Futse, James E.; Koku, Roberta; Palmer, Guy H.; Graca, Telmo; Noh, Susan M.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Koku, Roberta; Noh, Susan M.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Noh, Susan M.] ARS, Anim Dis Res Unit, USDA, Pullman, WA 99164 USA; [Graca, Telmo] CureVac AG, Tubingen, Germany	University of Ghana; Washington State University; Washington State University; United States Department of Agriculture (USDA); CureVac N.V.	Noh, SM (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.; Noh, SM (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.; Noh, SM (corresponding author), ARS, Anim Dis Res Unit, USDA, Pullman, WA 99164 USA.	smnoh@wsu.edu		Noh, Susan/0000-0002-8160-9074	Wellcome Trust [097171/Z/11/Z]; NIH [R37 AI44005]; USDA-ARS [2090-32000-038-00D]; Jan and Jack Creighton Endowment fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044005] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Jan and Jack Creighton Endowment fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Wellcome Trust (https://wellcome.ac.uk/) for the fellowship in Public Health and Tropical Medicine grant 097171/Z/11/Z (JEF), NIH (https://www.niaid.nih.gov/) Grant (R37 AI44005) (GHP), USDA-ARS 2090-32000-038-00D (https://www.ars.usda.gov/) (SMN), and the Jan and Jack Creighton Endowment fund (GHP). The funding agencies did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JR, 2004, INFECT IMMUN, V72, P7360, DOI 10.1128/IAI.72.12.7360-7366.2004; Beckley CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152560; Bock RE, 2003, VET PARASITOL, V118, P121, DOI 10.1016/j.vetpar.2003.08.011; Brayton KA, 2001, P NATL ACAD SCI USA, V98, P4130, DOI 10.1073/pnas.071056298; Brayton KA, 2006, EXPERT REV VACCINES, V5, P95, DOI 10.1586/14760584.5.1.95; Brayton Kelly A., 2009, P85, DOI 10.1007/978-3-540-74042-1_3; Brown WC, 1998, INFECT IMMUN, V66, P5406, DOI 10.1128/IAI.66.11.5406-5413.1998; Castaneda-Ortiz EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120748; Ducken DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129309; Esquerra EV, 2014, INFECT IMMUN, V82, P5286, DOI 10.1128/IAI.02537-14; Hebert KS, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00968-16; KUTTLER KL, 1984, VET MICROBIOL, V9, P181, DOI 10.1016/0378-1135(84)90033-6; Noh SM, 2008, INFECT IMMUN, V76, P2219, DOI 10.1128/IAI.00008-08; Noh SM, 2006, INFECT IMMUN, V74, P3471, DOI 10.1128/IAI.01843-05; Noh SM, 2012, INTERCELLULAR PATHOGENS II: RICKETTSIALES, P330, DOI 10.1128/9781555817336.ch11; Noh SM, 2010, VACCINE, V28, P3741, DOI 10.1016/j.vaccine.2010.02.067; Palmer GH, 1999, PARASITOL TODAY, V15, P281, DOI 10.1016/S0169-4758(99)01469-6; PALMER GH, 1984, J IMMUNOL, V133, P1010; PALMER GH, 1986, SCIENCE, V231, P1299, DOI 10.1126/science.3945825; Rodriguez JL, 2005, GENE, V361, P127, DOI 10.1016/j.gene.2005.06.038; TEBELE N, 1991, INFECT IMMUN, V59, P3199, DOI 10.1128/IAI.59.9.3199-3204.1991; Ueti MW, 2012, INFECT IMMUN, V80, P2354, DOI 10.1128/IAI.00341-12; VISSER ES, 1992, INFECT IMMUN, V60, P5139, DOI 10.1128/IAI.60.12.5139-5144.1992	23	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0217661	10.1371/journal.pone.0217661	http://dx.doi.org/10.1371/journal.pone.0217661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291256	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800015
J	Stepanova, EV; Kondrashin, AV; Sergiev, VP; Morozova, LF; Turbabina, NA; Maksimova, MS; Romanov, DV; Kinkulkina, MA; Lazareva, AV; Morozov, EN				Stepanova, Ekaterina V.; Kondrashin, Anatoly V.; Sergiev, Vladimir P.; Morozova, Lola F.; Turbabina, Natalia A.; Maksimova, Maria S.; Romanov, Dmitry V.; Kinkulkina, Marina A.; Lazareva, Alena V.; Morozov, Evgeny N.			Toxoplasmosis and mental disorders in the Russian Federation (with special reference to schizophrenia)	PLOS ONE			English	Article							GONDII INFECTION; LATENT TOXOPLASMOSIS; DECREASED LEVEL; NOVELTY SEEKING; RISK; DOPAMINE; SEROPREVALENCE; ANTIBODIES	The association of latent toxoplasmosis with mental disorders in general and with schizophrenia in particular was noticed in the mid-1950s. In subsequent years, the role of Toxoplasma gondii was established based on its ability to survive for long periods of time in the nerve cells of the brain. The acute manifestations of the infection include psychopathic symptoms resembling those of schizophrenia. In the former USSR, and in other parts of the world, a number of studies were performed with respect to the association of latent toxoplasmosis and schizophrenia. However, with the dissolution of the USSR at the beginning of the 1990s, studies on the subject were halted due to financial problems and have resumed only recently. The reasons for the resumption of such studies in contemporary Russia are related to the progressively increasing incidence of schizophrenia over the last 25-30 years in the country. According to official data, approximately 550 000 persons reported suffering from the disease in 2014. There are reasons to believe that this is only a fraction of the real burden of the disease. Economically, it cost the state no less than approximately US $10 billion. The purpose of the study was to identify the level of toxoplasmosis seroprevalence in patients with verified diagnoses of schizophrenia in comparison to healthy people in Moscow City and in the Moscow region. A total of 155 persons constituted the patients group and 152 healthy people were in the control group. An integrated approach to the diagnosis and comparison of data from the entire spectrum of serological markers of infection was used, including the detection of specific IgM and the determination of IgG concentrations. It was found that among persons with neuropsychiatric disorders, the incidence of cases with latent toxoplasmosis was higher than in the control group. The effect of toxoplasmosis was significant and similar for men and women. Further statistical analyses revealed that among patients with a diagnosis of schizophrenia, the incidence of latent toxoplasmosis was significantly higher than in the control group. These data are in agreement with the results of similar studies in other countries.	[Stepanova, Ekaterina V.; Kondrashin, Anatoly V.; Turbabina, Natalia A.; Maksimova, Maria S.] IM Sechenov First Moscow State Med Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia; [Sergiev, Vladimir P.; Morozova, Lola F.; Morozov, Evgeny N.] IM Sechenov First Moscow State Med Univ, Dept Trop Med & Parasit Dis, Moscow, Russia; [Romanov, Dmitry V.] IM Sechenov First Moscow State Med Univ, Dept Psychiat & Psychosomat, Moscow, Russia; [Romanov, Dmitry V.] Mental Hlth Res Ctr, Moscow, Russia; [Kinkulkina, Marina A.; Lazareva, Alena V.] IM Sechenov First Moscow State Med Univ, Dept Psychiat & Subst Addict, Moscow, Russia; [Morozov, Evgeny N.] Russian Med Acad Continuous Profess Educ, Dept Trop Parasit Dis & Disinfectol, Moscow, Russia	Sechenov First Moscow State Medical University; Sechenov First Moscow State Medical University; Sechenov First Moscow State Medical University; Sechenov First Moscow State Medical University	Morozov, EN (corresponding author), IM Sechenov First Moscow State Med Univ, Dept Trop Med & Parasit Dis, Moscow, Russia.; Morozov, EN (corresponding author), Russian Med Acad Continuous Profess Educ, Dept Trop Parasit Dis & Disinfectol, Moscow, Russia.	emorozov@mail.ru	Romanov, Dmitry/N-3459-2016; Morozov, Evgeny N./B-8483-2016; Morozova, Lola/C-7721-2014; Izyumina, Tatiana/N-3918-2014; Marina, Kinkulkina/U-8234-2017	Romanov, Dmitry/0000-0002-1822-8973; Morozov, Evgeny N./0000-0002-1324-9142; Morozova, Lola/0000-0003-3033-1401; Izyumina, Tatiana/0000-0001-7432-863X; Marina, Kinkulkina/0000-0001-8386-758X	Russian Academic Excellence Project 5-100	Russian Academic Excellence Project 5-100(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation)	This work was supported by the Russian Academic Excellence Project 5-100.	Anisimova AI, 1964, TOXOPLASMOSIS, P15; [Anonymous], 2017, MENTAL HLTH ATLAS 20; BETIN E M, 1970, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, V39, P416; Betin EM, 1969, KORSAKOV J NEUROLOGY, V69, P909; Centers for Disease Control and Prevention, EP INF WIND; Cetinkaya Z, 2007, SCHIZOPHRENIA BULL, V33, P789, DOI 10.1093/schbul/sbm021; Delgado Garcia G, 1979, Rev Cubana Med Trop, V31, P127; Dolgikh T. I., 2008, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P19; Fabiani S, 2015, J NEUROL SCI, V351, P3, DOI 10.1016/j.jns.2015.02.028; Flegr J, 2003, BIOL PSYCHOL, V63, P253, DOI 10.1016/S0301-0511(03)00075-9; Flegr J, 2016, PARASITOLOGY, V143, P1974, DOI 10.1017/S0031182016001785; Flegr J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-015-1290-7; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Fond G, 2013, ENCEPHALE, V39, P38, DOI 10.1016/j.encep.2012.06.014; Fuks JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003051; Hinze-Selch D, 2007, SCHIZOPHRENIA BULL, V33, P782, DOI 10.1093/schbul/sbm010; Hurley RA, 2012, J NEUROPSYCH CLIN N, V24, P376, DOI 10.1176/appi.neuropsych.12100234; Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357; Jones-Brando L, 2003, SCHIZOPHR RES, V62, P237, DOI 10.1016/S0920-9964(02)00357-2; KHALETSKII A M, 1956, Zh Nevropatol Psikhiatr Im S S Korsakova, V56, P405; Khodorkovsky AV, SCHIZOPHRENIA; Konovalov SI, 1972, THESIS; Korovitski LK, 1964, TOXOPLASMOSIS, P145, DOI [10.1016/j.parint.2017.10.014, DOI 10.1016/J.PARINT.2017.10.014]; Lubov EB, 2012, SOCIAL CLIN PSYCHIAT, V22, P3; Magnaval JF, 2016, VECTOR-BORNE ZOONOT, V16, P103, DOI 10.1089/vbz.2015.1828; Martin HL, 2015, NEUROSCIENCE, V306, P50, DOI 10.1016/j.neuroscience.2015.08.005; Mihalev PV, 1966, TOXOPLASMOSIS, P21; Moiseeva KV, 1964, TOXOPLASMOSIS, P18; MOTAVKINA N S, 1970, Zhurnal Nevropatologii i Psikhiatrii Imeni S. S. Korsakova, V70, P718; Nielbuhr DW, 2008, AM J PSYCHIAT, V165, P99, DOI 10.1176/appi.ajp.2007.06081254; Orestenko LP, 1966, TOXOPLASMOSIS, P21; Petrov VP, 1966, TOXOPLASMOSIS, P59; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Savonenko EA, 1966, TOXOPLASMOSIS, P45; Schwarcz R, 2007, SCHIZOPHRENIA BULL, V33, P652, DOI 10.1093/schbul/sbm030; Shuralev EA, 2018, PARASITOL INT, V67, P112, DOI 10.1016/j.parint.2017.10.014; Siim J.C., 1960, HUMAN TOXOPLASMOSIS, P53; Sivukha T A, 1969, Zh Nevropatol Psikhiatr Im S S Korsakova, V69, P1464; Skallova A, 2005, NEUROENDOCRINOL LETT, V26, P480; Stepanova EV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184930; Tedford E, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6020019; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; Xiao J, 2015, ACTA PHYSIOL, V213, P828, DOI 10.1111/apha.12458; Xiao J, 2014, NEUROSCIENCE, V268, P128, DOI 10.1016/j.neuroscience.2014.03.015; Xu XZ, 2005, RE DAI YI XUE, V3, P133; Yakovlev AA, 1980, THESIS; Yuksel P, 2010, FOLIA PARASIT, V57, P121, DOI 10.14411/fp.2010.015; ZASUKHIN D N, 1973, Zhurnal Nevropatologii i Psikhiatrii Imeni S. S. Korsakova, V73, P1083; ZASUKHIN D. N., 1967, MED PARA ZITOL PARA ZIT BOLEZ, V36, P695; ZHARIKOV NM, 1990, ZH NEVROPATOL PSIKH, V90, P70; Zhu S, 2003, ZHONGGUO MIN KANG YI, V15, P405; Ziryanov SK, 2013, QUALITATIVE CLIN PRA, V2, P18	53	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219454	10.1371/journal.pone.0219454	http://dx.doi.org/10.1371/journal.pone.0219454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4JZ	31291336	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800086
J	Rios-Kristjansson, JG; Rizo-Roca, D; Kristjansdottir, KM; Nunez-Espinosa, CA; Torrella, JR; Pages, T; Viscor, G				Gabriel Rios-Kristjansson, Juan; Rizo-Roca, David; Mist Kristjansdottir, Karen; Andres Nunez-Espinosa, Cristian; Ramon Torrella, Joan; Pages, Teresa; Viscor, Gines			A three-criteria performance score for rats exercising on a running treadmill	PLOS ONE			English	Article							INTERMITTENT HYPOXIA; ECCENTRIC EXERCISE; AEROBIC EXERCISE; STRAINS; WORK	In this study, we propose a novel three-criteria performance score to semiquantitatively classify the running style, the degree of involvement and compliance and the validity of electric shock count for rats exercising on a treadmill. Each score criterion has several style-marks that are based on the observational registry of male Sprague-Dawley rats running for 4-7 weeks. Each mark was given a score value that was averaged throughout a session-registry and resulting in a session score for each criterion, ranging from "0" score for a hypothetical "worst runner", to score "1" for a hypothetical "perfect runner" rat. We found significant differences throughout a training program, thus providing evidence of sufficient sensitivity of this score to reflect the individual evolution of performance improvement in exercise capacity due to training. We hypothesize that this score could be correlated with other physiological or metabolic parameters, thus refining research results and further helping researchers to reduce the number of experimental subjects.	[Gabriel Rios-Kristjansson, Juan; Rizo-Roca, David; Mist Kristjansdottir, Karen; Andres Nunez-Espinosa, Cristian; Ramon Torrella, Joan; Pages, Teresa; Viscor, Gines] Univ Barcelona, Fac Biol, Dept Cell Biol Physiol & Immunol, Barcelona, Spain; [Mist Kristjansdottir, Karen] Aarhus Univ, Sch Engn, Dept Biotechnol & Chem Engn, Aarhus N, Denmark; [Andres Nunez-Espinosa, Cristian] Univ Magallanes, Sch Med, Casilla, Punta Arenas, Chile	University of Barcelona; Aarhus University; Universidad de Magallanes	Viscor, G (corresponding author), Univ Barcelona, Fac Biol, Dept Cell Biol Physiol & Immunol, Barcelona, Spain.	gviscor@ub.edu	Viscor, Ginés/A-9519-2008; Rizo-Roca, David/AFJ-2125-2022; Torrella, Joan Ramon/D-4919-2014; Pages, Teresa/G-4244-2011; Rizo-Roca, David/F-5037-2019	Viscor, Ginés/0000-0003-4942-2346; Torrella, Joan Ramon/0000-0001-6314-6523; Pages, Teresa/0000-0002-4969-1522; Nunez Espinosa, Cristian Andres/0000-0002-9896-7062; Rizo-Roca, David/0000-0002-9379-7543	Plan Nacional I+ D+ i (The Spanish Ministry of Economy and Competitiveness) [DEP2010-22205-C02-01, DEP2013-48334-C2-1-P]; Spanish Ministry of Economy and Competitiveness [BES-2011-044293]	Plan Nacional I+ D+ i (The Spanish Ministry of Economy and Competitiveness); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was supported by DEP2010-22205-C02-01 (GV) and DEP2013-48334-C2-1-P (GV & JRT) grants from the Plan Nacional I+ D+ i (The Spanish Ministry of Economy and Competitiveness). JGRK was supported by a predoctoral grant (BES-2011-044293) from The Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by DEP2010-22205-C02-01 and DEP2013-48334-C2-1-P grants from the Plan Nacional I+ D+ i (The Spanish Ministry of Economy and Competitiveness). The authors are grateful to Elizabeth Radley, Ines Ferreira, Sergi Montero, Daniel Ramos, Maria Tsimpidi, Sara Martinez, Marien Espino, Carla Lopez-Grado, Alexandra Giraldo and Fernando Garzon for their technical cooperation. The authors declare no conflict of interest.	Silva MAAE, 2012, APPL PHYSIOL NUTR ME, V37, P1101, DOI [10.1139/H2012-129, 10.1139/h2012-129]; Arnold JC, 2014, JOVE-J VIS EXP, DOI 10.3791/51827; Barbato JC, 1998, J APPL PHYSIOL, V85, P530, DOI 10.1152/jappl.1998.85.2.530; Boldt KR, 2018, J APPL PHYSIOL, V125, P495, DOI 10.1152/japplphysiol.00631.2017; Borg E, 2006, SCAND J MED SCI SPOR, V16, P57, DOI 10.1111/j.1600-0838.2005.00448.x; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Chavanelle V, 2014, J SPORT SCI MED, V13, P689; European Union, 2010, COMM REG EU 37 2010; GERALD MC, 1978, NEUROPHARMACOLOGY, V17, P703, DOI 10.1016/0028-3908(78)90083-7; Griffiths WJ, 1954, ANN ANIMAL PSYCHOL J, V4, P1, DOI 10.2502/janip1944.4.1; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Koch LG, 2005, AM J PHYSIOL-REG I, V288, pR466, DOI 10.1152/ajpregu.00621.2004; Manchado-Gobatto F.B., 2010, J EXERC PHYSL ONLINE, V13, P40; Moraska A, 2000, AM J PHYSIOL-REG I, V279, pR1321, DOI 10.1152/ajpregu.2000.279.4.R1321; Nunez-Espinosa C, 2015, CURR STEM CELL RES T, V10, P132, DOI 10.2174/1574888X09666140930130048; Nunez-Espinosa C, 2014, RESP PHYSIOL NEUROBI, V192, P112, DOI 10.1016/j.resp.2013.12.011; Ferraresso RLP, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/935483; Real CC, 2015, BRAIN RES, V1624, P188, DOI 10.1016/j.brainres.2015.06.052; Rios JL, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0127-2; Rizo-Roca D, 2017, J APPL PHYSIOL, V122, P580, DOI 10.1152/japplphysiol.00501.2016; Rizo-Roca D, 2015, EUR J HISTOCHEM, V59, P310, DOI [10.4081/ejh.2015.2544, 10.4081/ejn.2015.2544]; Rizo-Roca D, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00481; Sakakima H, 2004, SCAND J MED SCI SPOR, V14, P186, DOI 10.1111/j.1600-0838.2004.382.x; SQUIBB RE, 1977, J NUTR, V107, P1981, DOI 10.1093/jn/107.11.1981; Tekin D, 2005, J EXERC PHYSL, V11, P44; Ways JA, 2007, PHYSIOL GENOMICS, V29, P91, DOI 10.1152/physiolgenomics.00027.2006	26	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219167	10.1371/journal.pone.0219167	http://dx.doi.org/10.1371/journal.pone.0219167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287828	gold, Green Published, Green Submitted			2022-12-26	WOS:000482328300010
J	Jiang, XJ; Keto-Timonen, R; Skurnik, M; Korkeala, H				Jiang, Xiaojie; Keto-Timonen, Riikka; Skurnik, Mikael; Korkeala, Hannu			Role of DEAD-box RNA helicase genes in the growth of Yersinia pseudotuberculosis IP32953 under cold, pH, osmotic, ethanol and oxidative stresses	PLOS ONE			English	Article							ESCHERICHIA-COLI; STRAINS LACKING; SHOCK; CSDA; TEMPERATURE; INDUCTION; RIBOSOME; INSIGHTS; BIOSYNTHESIS; DEGRADOSOME	Yersinia pseudotuberculosis is an important foodborne pathogen threatening modern food safety due to its ability to survive and grow at low temperatures. DEAD-box RNA helicase CsdA has been shown to play an important role in the low-temperature growth of psychrotrophic Y. pseudotuberculosis. A total of five DEAD-box RNA helicase genes (rhlB, csdA, rhlE, dbpA, srmB) have been identified in Y. pseudotuberculosis IP32953. However, their role in various stress conditions used in food production is unclear. We studied the involvement of the DEAD-box RNA helicase-encoding genes in the cold tolerance of Y. pseudotuberculosis IP32953 using quantitative real-time reverse transcription (RT-qPCR) and mutational analysis. Quantitative RT-PCR revealed that mRNA transcriptional levels of csdA, rhlE, dbpA and srmB were significantly higher after cold shock at 3 degrees C compared to non-shocked culture at 28 degrees C, suggesting the involvement of these four genes in cold shock response at the transcriptional level. The deletion of csdA ceased growth, while the deletion of dbpA or srmB significantly impaired growth at 3 degrees C, suggesting the requirement of these three genes in Y. pseudotuberculosis at low temperatures. Growth of each DEAD-box RNA helicase mutant was also investigated under pH, osmotic, ethanol and oxidative stress conditions. The five helicase-encoding genes did not play major roles in the growth of Y. pseudotuberculosis IP32953 under pH, osmotic, ethanol or oxidative stress.	[Jiang, Xiaojie; Keto-Timonen, Riikka; Korkeala, Hannu] Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland; [Skurnik, Mikael] Univ Helsinki, Dept Bacteriol & Immunol, Medicum, Helsinki, Finland; [Skurnik, Mikael] Univ Helsinki, Res Programs Unit, Immunobiol, Helsinki, Finland; [Skurnik, Mikael] Helsinki Univ Hosp, HUSLAB, Div Clin Microbiol, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Keto-Timonen, R (corresponding author), Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland.	riikka.keto-timonen@helsinki.fi		Keto-Timonen, Riikka/0000-0002-4823-9139; Skurnik, Mikael/0000-0001-8791-9260	Finnish Veterinary Foundation; Walter Ehrstrom Foundation; Chinese Scholarship Council	Finnish Veterinary Foundation; Walter Ehrstrom Foundation; Chinese Scholarship Council(China Scholarship Council)	This work was supported by the Finnish Veterinary Foundation (RK-T), the Walter Ehrstrom Foundation (RK-T) and the Chinese Scholarship Council (XJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; [Anonymous], 1908, BIOMETRIKA, V6, P1; Awano N, 2007, J BACTERIOL, V189, P5808, DOI 10.1128/JB.00655-07; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; Cairrao F, 2003, MOL MICROBIOL, V50, P1349, DOI 10.1046/j.1365-2958.2003.03766.x; Carty SM, 1999, J BIOL CHEM, V274, P9677, DOI 10.1074/jbc.274.14.9677; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Charollais J, 2004, NUCLEIC ACIDS RES, V32, P2751, DOI 10.1093/nar/gkh603; Charollais J, 2003, MOL MICROBIOL, V48, P1253, DOI 10.1046/j.1365-2958.2003.03513.x; CONCHAS RF, 1990, GENE, V87, P133, DOI 10.1016/0378-1119(90)90505-L; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fredriksson-Ahomaa M, 2010, PATHOGENS AND TOXINS IN FOODS: CHALLENGES AND INTERVENTIONS, P164; Henry A, 2012, FEMS MICROBIOL LETT, V336, P139, DOI 10.1111/j.1574-6968.12000.x; Huen J, 2017, STRUCTURE, V25, P469, DOI 10.1016/j.str.2017.01.012; Iost I, 2006, NUCLEIC ACIDS RES, V34, P4189, DOI 10.1093/nar/gkl500; Jagessar KL, 2010, RNA, V16, P1386, DOI 10.1261/rna.2015610; Jain C, 2008, RNA, V14, P381, DOI 10.1261/rna.800308; JONES PG, 1987, J BACTERIOL, V169, P2092, DOI 10.1128/jb.169.5.2092-2095.1987; Keto-Timonen R, 2018, J FOOD PROTECT, V81, P142, DOI 10.4315/0362-028X.JFP-17-223; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Lopez-Ramirez V, 2011, J MOL EVOL, V72, P413, DOI 10.1007/s00239-011-9441-8; Marintchev A, 2013, BBA-GENE REGUL MECH, V1829, P799, DOI 10.1016/j.bbagrm.2013.01.005; Markkula A, 2012, APPL ENVIRON MICROB, V78, P6875, DOI 10.1128/AEM.01526-12; Mastronicolis SK, 2005, FOOD MICROBIOL, V22, P213, DOI 10.1016/j.fm.2004.08.002; Najjar MB, 2007, APPL ENVIRON MICROB, V73, P6429, DOI 10.1128/AEM.00980-07; Palonen E, 2013, APPL ENVIRON MICROB, V79, P5970, DOI 10.1128/AEM.01891-13; Palonen E, 2012, APPL ENVIRON MICROB, V78, P1298, DOI 10.1128/AEM.07278-11; Pandiani F, 2011, APPL ENVIRON MICROB, V77, P5604, DOI 10.1128/AEM.02974-10; Peil L, 2008, FEBS J, V275, P3772, DOI 10.1111/j.1742-4658.2008.06523.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ranji A, 2010, RNA BIOL, V7, P775, DOI 10.4161/rna.7.6.14249; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Tsai YC, 2012, NUCLEIC ACIDS RES, V40, P10417, DOI 10.1093/nar/gks739; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14186, DOI 10.1074/jbc.M200408200; Xu L, 2017, STRUCTURE, V25, P1795, DOI 10.1016/j.str.2017.09.013; Yamanaka K, 2001, J BACTERIOL, V183, P2808, DOI 10.1128/JB.183.9.2808-2816.2001; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	39	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219422	10.1371/journal.pone.0219422	http://dx.doi.org/10.1371/journal.pone.0219422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287844	Green Published, gold			2022-12-26	WOS:000482328300020
J	Maric, V; Grgurevic, A; Cirkovic, A; Stankovic, S; Marjanovic, I; Milovanovic, J; Milovanovic, A; Bozic, M				Maric, Vesna; Grgurevic, Anita; Cirkovic, Andja; Stankovic, Sanja; Marjanovic, Ivan; Milovanovic, Jovica; Milovanovic, Andjela; Bozic, Marija			Nailfold capillary morphology and platelet function in patients with exfoliative glaucoma	PLOS ONE			English	Article							PRIMARY OPEN-ANGLE; RETINAL VEIN OCCLUSION; PSEUDOEXFOLIATION SYNDROME; FOLD CAPILLAROSCOPY; AQUEOUS-HUMOR; ABNORMALITIES; VOLUME; ASSOCIATION; LOXL1; IRIS	Purpose The purpose of the present study was to evaluate the nailfold capillary morphological features in patients with exfoliative glaucoma (XFG) and compare them with those pertaining to primary open-angle glaucoma (POAG), normal controls and subjects with exfoliation syndrome (XFS). The second purpose was to investigate all parameters related to platelet function on the hemogram, including the platelet count (PLT), the mean platelet volume (MPV), platelet distribution width (PDW), and plateletcrit (PCT) in patients with XFG. These parameters were subsequently compared with those belonging to normal controls, POAG and XFS subjects. Methods This case control study involved 152 consecutive patients that were examined at the Glaucoma Department of Clinic for Eye Diseases, Clinical Centre of Serbia, as the referral center for glaucoma in Serbia, between June 2016 and December 2017. Results Regarding capillaroscopic characteristics, statistically significant difference was found in capillary diameter and tortuosity between the XFG and POAG group (p = 0.050 and p = 0.035) and the XFG and NC group (p = 0.003 and p = 0.044), as well as in the distribution of capillary loops and avascular zones between the XFG and NC group (p = 0.014 and p = 0.004). The subjects with XFG had lower PLT values compared to POAG patients (p = 0.022). Conclusions In conclusion, to the best of our knowledge, this study marks the first attempt to evaluate capillary morphology as well as to investigate all parameters related to platelet function on the hemogram, in patients with newly diagnosed XFG. Our findings revealed nailfold capillary morphological vascular changes in XFG patients. The subjects with XFG had lower PLT values and a higher MPV serum parameter compared to normal controls and patients with POAG. Further research in this field should therefore aim to evaluate the consequences of the aforementioned microvascular abnormalities in patients with XFG.	[Maric, Vesna; Marjanovic, Ivan; Bozic, Marija] Clin Ctr Serbia, Clin Eye Dis, Belgrade, Serbia; [Maric, Vesna; Marjanovic, Ivan; Milovanovic, Jovica; Milovanovic, Andjela; Bozic, Marija] Univ Belgrade, Fac Med, Belgrade, Serbia; [Grgurevic, Anita] Univ Belgrade, Inst Epidemiol, Fac Med, Belgrade, Serbia; [Cirkovic, Andja] Univ Belgrade, Fac Med, Dept Med Stat & Informat, Belgrade, Serbia; [Stankovic, Sanja] Clin Ctr Serbia, Ctr Med Biochem, Belgrade, Serbia; [Milovanovic, Jovica] Clin Ctr Serbia, Clin Otorhinolaryngol & Maxilofacial Surg, Belgrade, Serbia; [Milovanovic, Andjela] Clin Ctr Serbia, Clin Med Rehabil, Belgrade, Serbia	Clinical Centre of Serbia; University of Belgrade; University of Belgrade; University of Belgrade; Clinical Centre of Serbia; Clinical Centre of Serbia; Clinical Centre of Serbia	Maric, V (corresponding author), Clin Ctr Serbia, Clin Eye Dis, Belgrade, Serbia.; Maric, V (corresponding author), Univ Belgrade, Fac Med, Belgrade, Serbia.	vesbabic@sezampro.rs	Stankovic, Sanja/AAQ-3433-2021	Stankovic, Sanja/0000-0003-0890-535X; Cirkovic, Andja/0000-0002-7542-5690; Maric, Vesna/0000-0003-3109-0531	Ministry of Education, Science and Technological Development of the Republic of Serbia [175042, 175087]	Ministry of Education, Science and Technological Development of the Republic of Serbia	This investigation was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant No. 175042 and No. 175087 to AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTOMONTE L, 1995, CLIN EXP RHEUMATOL, V13, P83; Andrikopoulos GK, 2014, WORLD J CARDIOL, V6, P847, DOI 10.4330/wjc.v6.i8.847; ASANO N, 1995, OPHTHALMOLOGY, V102, P1279, DOI 10.1016/S0161-6420(95)30873-1; Atalar PT, 2006, INT HEART J, V47, P77, DOI 10.1536/ihj.47.77; Barchetta I, 2011, DIABETIC MED, V28, P1039, DOI 10.1111/j.1464-5491.2011.03325.x; Bozic M, 2010, CURR EYE RES, V35, P1099, DOI 10.3109/02713683.2010.512113; BROOKS AMV, 1983, BRIT J OPHTHALMOL, V67, P249, DOI 10.1136/bjo.67.4.249; BROOKS AMV, 1987, OPHTHALMOLOGY, V94, P1090; Chen HY, 2010, MOL VIS, V16, P167; Chu SG, 2010, J THROMB HAEMOST, V8, P148, DOI 10.1111/j.1538-7836.2009.03584.x; Cortes S, 2007, ACTA REUMATOL PORT, V32, P31; Cousins CC, 2017, EYE, V31, P698, DOI 10.1038/eye.2016.312; Cousins CC, 2019, BRIT J OPHTHALMOL, V103, P203, DOI 10.1136/bjophthalmol-2018-311846; Cutolo M, 2008, BEST PRACT RES CL RH, V22, P1093, DOI 10.1016/j.berh.2008.09.001; Souza EJDE, 2015, REV BRAS REUMATOL, V55, P264, DOI [10.1016/j.rbre.2014.09.005, 10.1016/j.rbr.2014.09.003]; Gasparyan AY, 2011, CURR PHARM DESIGN, V17, P47; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Harju M, 2008, CLIN EXP OPHTHALMOL, V36, P738, DOI 10.1111/j.1442-9071.2008.01884.x; Hollo G, 1998, J GLAUCOMA, V7, P105; Hollo G, 2015, EXFOLIATION SYNDROME, P121; Hollo Gabor, 2018, J Glaucoma, V27 Suppl 1, pS72, DOI 10.1097/IJG.0000000000000905; Hollo G, 2014, J GLAUCOMA, V23, pE6, DOI 10.1097/IJG.0b013e31829e5635; Karagiannis D, 2015, CLIN INTERV AGING, V10, P879, DOI 10.2147/CIA.S77630; Lai WKC, 2015, ANN NUTR METAB, V67, P1, DOI 10.1159/000437098; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Manfredi A, 2015, CLIN RHEUMATOL, V34, P279, DOI 10.1007/s10067-014-2795-8; Mangalpally KKR, 2010, J THROMB THROMBOLYS, V30, P251, DOI 10.1007/s11239-010-0489-x; MARICQ HR, 1981, ARTHRITIS RHEUM, V24, P1159, DOI 10.1002/art.1780240907; Massberg Steffen, 2003, Semin Vasc Med, V3, P147; Mikropoulos DG, 2013, CURR EYE RES, V38, P266, DOI 10.3109/02713683.2012.757325; Muscari A, 2009, THROMB RES, V123, P587, DOI 10.1016/j.thromres.2008.03.025; Ohtsuka T, 1997, BRIT J DERMATOL, V136, P94, DOI 10.1111/j.1365-2133.1997.tb08753.x; Park HYL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1299, DOI 10.1001/archophthalmol.2011.249; Pasquale LR, 2016, ACTA OPHTHALMOL, V94, pE505, DOI 10.1111/aos.12918; Pasquale LR, 2015, INVEST OPHTH VIS SCI, V56, P7021, DOI 10.1167/iovs.15-17860; Pasquale LR, 2015, EXFOLIATION SYNDROME, P95; Philip S, 2019, JAMA OPHTHALMOL; Praveen MR, 2011, EYE, V25, P174, DOI 10.1038/eye.2010.175; Puska P., 2015, EXFOLIATION SYNDROME, P133; Ritch R, 2001, SURV OPHTHALMOL, V45, P265, DOI 10.1016/S0039-6257(00)00196-X; Ritch R, 2010, ACTA OPHTHALMOL, V88, P91, DOI 10.1111/j.1755-3768.2009.01578.x; Schlotzer-Schrehardt U, 2006, AM J OPHTHALMOL, V141, P921, DOI 10.1016/j.ajo.2006.01.047; Schlotzer-Schrehardt U, 2015, EXFOLIATION SYNDROME, V3rd, P57; Sekiyama JY, 2013, ARTHRIT CARE RES, V65, P1853, DOI 10.1002/acr.22054; Song Yumi, 2009, Korean J Ophthalmol, V23, P296, DOI 10.3341/kjo.2009.23.4.296; Terreri MTRA, 1999, SEMIN ARTHRITIS RHEU, V29, P36, DOI 10.1016/S0049-0172(99)80036-5; Teuchner B, 2004, ACTA OPHTHALMOL SCAN, V82, P738, DOI 10.1111/j.1600-0420.2004.00376.x; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Tosun M, 2012, BRIT J OPHTHALMOL, V96, P1137, DOI 10.1136/bjophthalmol-2012-301901; Turkcu FM, 2014, EUR J OPHTHALMOL, V24, P71, DOI 10.5301/ejo.5000340; Visontai Z, 2006, BRIT J OPHTHALMOL, V90, P563, DOI 10.1136/bjo.2005.087908; Visontai Z, 2008, J GLAUCOMA, V17, P133, DOI 10.1097/IJG.0b013e3181379d67; Xu F, 2012, GRAEF ARCH CLIN EXP, V250, P1067, DOI 10.1007/s00417-011-1877-4; Yang A, 2006, THROMB RES, V117, P371, DOI 10.1016/j.thromres.2005.04.004; Yazgan S, 2016, EYE CONTACT LENS, V42, P328, DOI 10.1097/ICL.0000000000000197; Zenkel M, 2011, INVEST OPHTH VIS SCI, V52, P8488, DOI 10.1167/iovs.11-8361	56	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219505	10.1371/journal.pone.0219505	http://dx.doi.org/10.1371/journal.pone.0219505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287835	Green Published, gold, Green Submitted			2022-12-26	WOS:000482328300025
J	Trachsel, Y; Herzig, D; Marcin, T; Zenger, N; Dysli, M; Trachsel, LD; Wilhelm, M; Eser, P				Trachsel, Y.; Herzig, D.; Marcin, T.; Zenger, N.; Dysli, M.; Trachsel, L. D.; Wilhelm, M.; Eser, P.			Response of peripheral arterial pulse wave velocity to acute exercise in patients after recent myocardial infarction and healthy controls	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; POSTEXERCISE HYPOTENSION; PRESSURE-DEPENDENCE; REACTIVE HYPEREMIA; AEROBIC EXERCISE; BRACHIAL-ARTERY; BLOOD-PRESSURE; STIFFNESS; DISTENSIBILITY; PREDICTION	Background Many studies found increased central arterial stiffness and poor endothelial function in patients with coronary artery disease (CAD). Acute exercise has been shown to decrease peripheral pulse wave velocity (pPWV) in young healthy volunteers. We hypothesized the response to acute exercise to be diminished in CAD patients compared to healthy young (HY) and age-matched (HAM) controls. Methods In 21 patients after recent myocardial infarction (CAD), 11 HAM and 10 HY pPWV was measured by applanation tonometry at the proximal femoral artery and the posterior tibial artery at rest and from 5 to 15 min after cessation of exhaustive exercise. Heart rate (HR) and blood pressure (BP) were monitored continuously. Resting central PWV (cPWV) was measured between the carotid and femoral arteries. Resting values and reponses to acute exercise were compared between the three groups and predictors for pPWV response were sought. Results The response in pPWV to acute exercise seen in HY (lowering in pPWV by 17%) was absent in both CAD and HAM. Resting pPWV was not statistically different between the three groups, while cPWV was comparable in CAD and HAM but 17% lower in HY. Predictors for response in pPWV to exercise were age (Spearman r = 0.48), cPWV (r = 0.34) and response in diastolic BP (r = 0.32). Conclusion The response in pPWV to acute exercise observed in HY was absent in CAD and HAM. In dilated peripheral arteries, PWV may reflect stiffness of passive vessel structures, which are likely to increase with age in healthy persons and CAD alike.	[Trachsel, Y.; Herzig, D.; Marcin, T.; Zenger, N.; Dysli, M.; Trachsel, L. D.; Wilhelm, M.; Eser, P.] Univ Bern, Univ Hosp Bern, Inselspital, Univ Clin Cardiol,Prevent Cardiol & Sports Med, Bern, Switzerland; [Zenger, N.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland	University of Bern; University Hospital of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Eser, P (corresponding author), Univ Bern, Univ Hosp Bern, Inselspital, Univ Clin Cardiol,Prevent Cardiol & Sports Med, Bern, Switzerland.	prisca.eser@insel.ch	Wilhelm, Matthias/AAS-9456-2020; Eser, Prisca/AAE-3758-2021; Stefanadis, Christodoulos/ABH-2232-2020	Wilhelm, Matthias/0000-0003-4541-3995; Stefanadis, Christodoulos/0000-0001-5974-6454; Marcin, Thimo/0000-0001-7229-5985	Swiss Heart Foundation - Swiss Heart Foundation	Swiss Heart Foundation - Swiss Heart Foundation	This study was funded by a grant from the Swiss Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by a grant from the Swiss Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank AJ, 1999, CIRCULATION, V100, P41, DOI 10.1161/01.CIR.100.1.41; Bilski J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/862968; Bortolotto LA, 1999, HYPERTENSION, V34, P889, DOI 10.1161/01.HYP.34.4.889; Bramwell JC, 1922, P R SOC LOND B-CONTA, V93, P298, DOI 10.1098/rspb.1922.0022; Campbell R, 2011, J HUM HYPERTENS, V25, P262, DOI 10.1038/jhh.2010.53; Chen YC, 2017, EUR J CARDIOVASC NUR, V16, P397, DOI 10.1177/1474515116684407; Ellins EA, 2017, OPEN HEART, V4, DOI 10.1136/openhrt-2017-000645; Fortin J, 2006, COMPUT BIOL MED, V36, P941, DOI 10.1016/j.compbiomed.2005.04.003; Gielen S, 2010, CIRCULATION, V122, P1221, DOI 10.1161/CIRCULATIONAHA.110.939959; Green DJ, 2010, ATHEROSCLEROSIS, V210, P525, DOI 10.1016/j.atherosclerosis.2010.01.048; Grillo A, 2018, AM J HYPERTENS, V31, P80, DOI 10.1093/ajh/hpx140; Halliwill JR, 2013, EXP PHYSIOL, V98, P7, DOI 10.1113/expphysiol.2011.058065; Heffernan KS, 2006, EUR J APPL PHYSIOL, V98, P185, DOI 10.1007/s00421-006-0259-9; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Hitosugi M, 2004, MED SCI LAW, V44, P197, DOI 10.1258/rsmmsl.44.3.197; Hofmann B, 2014, J CLIN HYPERTENS, V16, P629, DOI 10.1111/jch.12382; Janic M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/621437; Kamran H, 2011, ANGIOLOGY, V62, P409, DOI 10.1177/0003319710389022; Kamran H, 2010, ANGIOLOGY, V61, P100, DOI 10.1177/0003319709335028; Kingwell BA, 1997, AM J PHYSIOL-HEART C, V273, pH2186, DOI 10.1152/ajpheart.1997.273.5.H2186; Kobayashi Ryota, 2018, J Phys Ther Sci, V30, P181, DOI 10.1589/jpts.30.181; Lane AD, 2013, INT J SPORTS MED, V34, P770, DOI 10.1055/s-0032-1329990; Matsuzawa Y, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002270; Mutter AF, 2017, HYPERTENS RES, V40, P146, DOI 10.1038/hr.2016.111; Naka KK, 2006, EUR HEART J, V27, P302, DOI 10.1093/eurheartj/ehi619; Naka KK, 2003, AM J PHYSIOL-HEART C, V284, pH970, DOI 10.1152/ajpheart.00529.2002; Obata Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9640457; Pierce DR, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00073; Rakobowchuk M, 2009, EUR J APPL PHYSIOL, V105, P787, DOI 10.1007/s00421-008-0964-7; Rogoza AN, 2008, TERAPEVT ARKH, V80, P29; Spronck B, 2017, PULSE, V5, P106, DOI 10.1159/000479322; Spronck B, 2015, J HYPERTENS, V33, P330, DOI 10.1097/HJH.0000000000000407; Sugamata W, 2014, J CARDIOL, V64, P179, DOI 10.1016/j.jjcc.2014.01.004; Sung J, 2009, J KOREAN MED SCI, V24, P795, DOI 10.3346/jkms.2009.24.5.795; Tan I, 2016, HYPERTENSION, V68, P236, DOI 10.1161/HYPERTENSIONAHA.116.07462; Thijssen DHJ, 2016, J PHYSIOL-LONDON, V594, P2275, DOI 10.1113/JP270597; Tordi N, 2010, EUR J APPL PHYSIOL, V108, P801, DOI 10.1007/s00421-009-1285-1; Torrado J, 2011, IEEE ENG MED BIO, P6458, DOI 10.1109/IEMBS.2011.6091594; van der Heijden-Spek JJ, 2000, HYPERTENSION, V35, P637, DOI 10.1161/01.HYP.35.2.637; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Walsh J. H., 1985, J APPL PHYSIOL, V95, P2003; Williams JT, 2005, J APPL PHYSIOL, V98, P1463, DOI 10.1152/japplphysiol.01211.2004; Xu XL, 2017, AGING DIS, V8, P590, DOI 10.14336/AD.2017.0430; Yan H, 2014, AM J PHYSIOL-HEART C, V306, pH60, DOI 10.1152/ajpheart.00710.2013	45	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219146	10.1371/journal.pone.0219146	http://dx.doi.org/10.1371/journal.pone.0219146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287825	Green Published, Green Submitted, gold			2022-12-26	WOS:000482328300009
J	Galecki, R; Sokol, R				Galecki, Remigiusz; Sokol, Rajmund			A parasitological evaluation of edible insects and their role in the transmission of parasitic diseases to humans and animals	PLOS ONE			English	Article							NOSEMA-LOCUSTAE MICROSPORIDA; HYMENOLEPIS-DIMINUTA CESTODA; EXPERIMENTAL LIFE-CYCLE; INTERMEDIATE HOST; PERIPLANETA-AMERICANA; GRASSHOPPERS ORTHOPTERA; NEMATOMORPHA GORDIIDA; BLATTELLA-GERMANICA; GREGARINE PARASITES; TRIBOLIUM-CONFUSUM	From 1 January 2018 came into force Regulation (EU) 2015/2238 of the European Parliament and of the Council of 25 November 2015, introducing the concept of "novel foods", including insects and their parts. One of the most commonly used species of insects are: mealworms (Tenebrio molitor), house crickets (Acheta domesticus), cockroaches (Blattodea) and migratory locusts (Locusta migrans). In this context, the unfathomable issue is the role of edible insects in transmitting parasitic diseases that can cause significant losses in their breeding and may pose a threat to humans and animals. The aim of this study was to identify and evaluate the developmental forms of parasites colonizing edible insects in household farms and pet stores in Central Europe and to determine the potential risk of parasitic infections for humans and animals. The experimental material comprised samples of live insects (imagines) from 300 household farms and pet stores, including 75 mealworm farms, 75 house cricket farms, 75 Madagascar hissing cockroach farms and 75 migrating locust farms. Parasites were detected in 244 (81.33%) out of 300 (100%) examined insect farms. In 206 (68.67%) of the cases, the identified parasites were pathogenic for insects only; in 106 (35.33%) cases, parasites were potentially parasitic for animals; and in 91 (30.33%) cases, parasites were potentially pathogenic for humans. Edible insects are an underestimated reservoir of human and animal parasites. Our research indicates the important role of these insects in the epidemiology of parasites pathogenic to vertebrates. Conducted parasitological examination suggests that edible insects may be the most important parasite vector for domestic insectivorous animals. According to our studies the future research should focus on the need for constant monitoring of studied insect farms for pathogens, thus increasing food and feed safety.	[Galecki, Remigiusz] Univ Warmia & Mazury, Fac Vet Med, Dept Vet Prevent & Feed Hyg, Olsztyn, Poland; [Sokol, Rajmund] Univ Warmia & Mazury, Fac Vet Med, Dept Parasitol & Invas Dis, Olsztyn, Poland	University of Warmia & Mazury; University of Warmia & Mazury	Galecki, R (corresponding author), Univ Warmia & Mazury, Fac Vet Med, Dept Vet Prevent & Feed Hyg, Olsztyn, Poland.	remigiusz.galecki@uwm.edu.pl	Gałęcki, Remigiusz/GVR-7953-2022; Gałęcki, Remigiusz/X-3989-2019	Gałęcki, Remigiusz/0000-0002-1005-3945; 				Adeleke M. A., 2012, Munis Entomology & Zoology, V7, P1106; ALI JH, 1983, PARASITOLOGY, V86, P147, DOI 10.1017/S0031182000057255; ALICATA J. E., 1937, PAPERS ON HELMINTHOLOGY published in commemoration of the 30 year jubileum of K. J. Skrjabin and of 15th anniversary of the All-Union Institute of Helminthology., P11; ANANTARAMAN M., 1963, PROC INDIAN ACAD SCI SECT B, V58, P137; ANDERSON RC, 1993, CAN J ZOOL, V71, P1869, DOI 10.1139/z93-266; Ayinmode AB, 2010, GHANA MED J, V44, P116; Bakula T, 2016, INSECTA 2016 INT S I; Basir M. A., 1940, PROC INDIAN ACAD SCI SECT B, V12, P8; Basir M. A., 1948, Canadian Journal of Research Ottawa, V26D, P197; Belluco S, 2013, COMPR REV FOOD SCI F, V12, P296, DOI 10.1111/1541-4337.12014; Bodenheimer F.S., 1951, INSECTS HUMAN FOOD; Bolek MG, 2000, J FRESHWATER ECOL, V15, P421, DOI 10.1080/02705060.2000.9663760; Bollache L, 2002, J INVERTEBR PATHOL, V79, P102, DOI 10.1016/S0022-2011(02)00027-7; BOSCH H, 1986, Z PARASITENKD, V72, P673, DOI 10.1007/BF00925489; Bouamer S, 2002, SYST PARASITOL, V53, P121, DOI 10.1023/A:1020443905905; Boucias D.G., 2012, PRINCIPLES INSECT PA; Bowman D.D, 2014, GEORGIS PARASITOLOGY, V10th edition; Bowman D.D., 2009, INFECT DIS MANAGEMEN, V1, P209; CALENTINE RL, 1966, T AM MICROSC SOC, V85, P516, DOI 10.2307/3224475; Capinera J.L, 2008, ENCY ENTOMOLOGY; Carter GR., 2012, DIAGNOSTIC PROCEDURE; CAWTHORN RJ, 1977, CAN J ZOOL, V55, P368, DOI 10.1139/z77-050; CHABAUD ALAIN, 1954, ANN PARASITOL HUMAINE ET COMP, V29, P42; Chamavit P, 2011, EXCLI J, V10, P218; CHITWOOD B. G., 1932, ZEITSCHR WISS BIOL ABT F ZEITSCHR PARASITENK, V5, P14; Christoffersen M. L., 2013, Zoologische Mededelingen (Leiden), V87, P1; Colloff MJ, 1998, ALLERGY, V53, P7, DOI 10.1111/j.1398-9995.1998.tb04989.x; Conn DB, 2008, 10 INT WKSHPS OPP PR; Cranshaw WS, 2005, INSECT PARASITIC NEM; DEFOLIART GR, 1982, J ECON ENTOMOL, V75, P848, DOI 10.1093/jee/75.5.848; Dhakal S, 2015, VET PARASITOL, V207, P49, DOI 10.1016/j.vetpar.2014.11.006; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; ESSLINGER JH, 1962, J PARASITOL, V48, P452, DOI 10.2307/3275214; EWEN AB, 1980, J INVERTEBR PATHOL, V35, P295, DOI 10.1016/0022-2011(80)90165-2; Fayer R, 2000, INT J PARASITOL, V30, P1305, DOI 10.1016/S0020-7519(00)00135-1; Feng Y, 2018, INSECT SCI, V25, P184, DOI 10.1111/1744-7917.12449; FOTEDAR R, 1991, EPIDEMIOL INFECT, V107, P181, DOI 10.1017/S0950268800048809; Fries I., 2013, J APICULT RES, V52, P1, DOI [10.3896/ IBRA. 1.52.1.14, DOI 10.3896/IBRA.1.52.1.14]; GABRYELOW K, 1986, Wiadomosci Parazytologiczne, V32, P75; Galecki R, 2018, VET PARASITOL, V252, P17, DOI 10.1016/j.vetpar.2018.01.018; Galecki Remigiusz, 2016, Annals of Parasitology, V62, P363, DOI 10.17420/ap6204.76; Galecki Remigiusz, 2015, Polish Journal of Natural Sciences, V30, P203; Ghaly A.E., 2009, American Journal of Agricultural and Biological Sciences, V4, P319; GIJZEN HJ, 1994, APPL ENVIRON MICROB, V60, P1822, DOI 10.1128/AEM.60.6.1822-1826.1994; Golemansky Vassil G., 1998, Acta Zoologica Bulgarica, V50, P123; Goodwin Mark A, 1996, J Appl Poult Res, V5, P51, DOI 10.1093/japr/5.1.51; Gottlieb Y, 2011, VET PARASITOL, V180, P378, DOI 10.1016/j.vetpar.2011.03.008; Graczyk Thaddeus K., 2004, Wiadomosci Parazytologiczne, V50, P243; Graczyk TK, 2001, MICROBES INFECT, V3, P231, DOI 10.1016/S1286-4579(01)01371-5; Graczyk TK, 1999, AM J TROP MED HYG, V61, P500, DOI 10.4269/ajtmh.1999.61.500; Hamza H., 2010, J THI QAR SCI, V2, P1; Hanboonsong Y., 2013, 6 LEGGED LIVESTOCK E; Haruki K, 2005, HELMINTHOLOGIA, V42, P63; HENRY JE, 1971, J INVERTEBR PATHOL, V18, P389, DOI 10.1016/0022-2011(71)90043-7; HEYNEMAN D, 1971, J PARASITOL, V57, P881, DOI 10.2307/3277820; HEYNEMAN DONALD, 1958, EXPTL PARASITOL, V7, P374, DOI 10.1016/0014-4894(58)90033-X; Hong EJ, 2015, KOREAN J PARASITOL, V53, P719, DOI 10.3347/kjp.2015.53.6.719; HURD H, 1991, CAN J ZOOL, V69, P2291, DOI 10.1139/z91-321; Rodriguez-Mahillo AI, 2010, FOODBORNE PATHOG DIS, V7, P967, DOI 10.1089/fpd.2009.0517; JOHNSON DL, 1986, J INVERTEBR PATHOL, V48, P232, DOI 10.1016/0022-2011(86)90128-X; Johny Shajahan, 2007, Ann Clin Microbiol Antimicrob, V6, P15, DOI 10.1186/1476-0711-6-15; Khan A R, 1978, Bangladesh Med Res Counc Bull, V4, P86; King F.S., 2015, NUTR DEV COUNTRIES; Klunder HC, 2012, FOOD CONTROL, V26, P628, DOI 10.1016/j.foodcont.2012.02.013; Kobayashi M, 1999, AM J TROP MED HYG, V61, P625, DOI 10.4269/ajtmh.1999.61.625; Kudo R. R., 1936, Archiv fuer Protistenkunde Jena, V87, P10; Kudo R.R, 1954, PROTOZOOLOGY, P689; LACKIE AM, 1988, PARASITOL TODAY, V4, P98, DOI 10.1016/0169-4758(88)90035-X; LACKIE AM, 1989, PARASITOLOGY, V98, P307, DOI 10.1017/S0031182000062235; Lange CE, 1996, BIOL CONTROL, V7, P24, DOI 10.1006/bcon.1996.0059; Lockwood Jeffrey A., 1999, Insect Science and its Application, V19, P333; Lopes RB, 2005, J INVERTEBR PATHOL, V88, P261, DOI 10.1016/j.jip.2005.01.010; LUNDEN A, 1992, INT J FOOD MICROBIOL, V15, P357, DOI 10.1016/0168-1605(92)90069-F; LUTTERMOSER GEORGE W., 1940, POULTRY SCI, V19, P177, DOI 10.3382/ps.0190177; Marden JH, 2004, ANIM BEHAV, V68, P857, DOI 10.1016/j.anbehav.2003.09.019; Martinez MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184557; MCALLISTER CT, 1990, J WILDLIFE DIS, V26, P403, DOI 10.7589/0090-3558-26.3.403; MCCALLISTER GL, 1988, P HELM SOC WASH, V55, P12; McDonald ME, 1988, KEY ACANTHOCEPHALA R; MONTALI RJ, 1983, LAB ANIM SCI, V33, P194; NGUYEN KB, 1995, J NEMATOL, V27, P206; Palmer L. L., 2016, THESIS; PANCIERA RJ, 1971, VET PATHOL, V8, P479, DOI 10.1177/0300985871008005-00610; Park MiJeong, 2014, Journal of Clinical and Cellular Immunology, V5, P248; Plaistow SJ, 2001, INT J PARASITOL, V31, P346, DOI 10.1016/S0020-7519(01)00115-1; Pong WW, 2000, DO GREGARINES PARTIC; RAVINDRANATH MH, 1977, Z PARASITENKD, V53, P225, DOI 10.1007/BF00380467; ROBINSON ES, 1969, EXP PARASITOL, V26, P384, DOI 10.1016/0014-4894(69)90132-5; ROTHERAM S, 1972, PARASITOLOGY, V64, P15, DOI 10.1017/S0031182000044607; Rueckert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018163; Saehoong P, 1997, Southeast Asian J Trop Med Public Health, V28 Suppl 1, P184; Sanchez-Muros MJ, 2014, J CLEAN PROD, V65, P16, DOI 10.1016/j.jclepro.2013.11.068; Satbige Ajay S., 2017, Journal of Parasitic Diseases, V41, P590, DOI 10.1007/s12639-016-0817-y; Sayad W. Y., 1936, Journal of the American Medical Association Chicago, V106, P461; Schmidt-Rhaesa A, 2003, P ACAD NAT SCI PHILA, V153, P77, DOI 10.1635/0097-3157(2003)153[0077:RACONF]2.0.CO;2; Schutgens M, 2015, J HELMINTHOL, V89, P68, DOI 10.1017/S0022149X13000606; Sheiman IM, 2006, NATURWISSENSCHAFTEN, V93, P305, DOI 10.1007/s00114-006-0103-4; Shi WP, 2009, BIOCONTROL, V54, P77, DOI 10.1007/s10526-008-9153-1; Sianto Luciana, 2012, BMC Research Notes, V5, P586, DOI 10.1186/1756-0500-5-586; Siemianowska E., 2013, Agricultural Sciences, V4, P287; Smales LR, 2005, J PARASITOL, V91, P1459, DOI 10.1645/GE-550R1.1; Tanowitz Herbert B., 2001, Curr Infect Dis Rep, V3, P77, DOI 10.1007/s11908-001-0062-z; Tanyuksel M, 2003, CLIN MICROBIOL REV, V16, P713, DOI 10.1128/CMR.16.4.713-729.2003; Tatfeng Y. M., 2005, Journal of Vector Borne Diseases, V42, P129; TAYLOR RL, 1968, J INVERTEBR PATHOL, V11, P214, DOI 10.1016/0022-2011(68)90151-1; Thyssen Patricia Jacqueline, 2004, Cad. Saúde Pública, V20, P1096, DOI 10.1590/S0102-311X2004000400025; TSAI YH, 1970, J PARASITOL, V56, P375, DOI 10.2307/3277678; Van der Geest LPS, 2000, EXP APPL ACAROL, V24, P497, DOI 10.1023/A:1026518418163; Van Huis A., 2013, EDIBLE INSECTS FUTUR; VOGE M, 1961, J PARASITOL, V47, P839, DOI 10.2307/3275482; VOGE MARIETTA, 1960, PROC HELMINTHOL SOC WASHINGTON, V27, P32; VOLKMANN A, 1991, PARASITOL RES, V77, P616, DOI 10.1007/BF00931025; Wales AD, 2010, ZOONOSES PUBLIC HLTH, V57, P299, DOI 10.1111/j.1863-2378.2008.01222.x; WINCH JM, 1985, PARASITOLOGY, V91, P471, DOI 10.1017/S0031182000062715; Xie W, 2016, J HELMINTHOL, V91, P1; YOUNG P L, 1975, Proceedings of the Oklahoma Academy of Science, V55, P169; Zarchi AAK, 2009, VECTOR-BORNE ZOONOT, V9, P197, DOI 10.1089/vbz.2007.0230; Zhong A., 2017, PRODUCT DEV CONSIDER; ZUK M, 1987, ECOL ENTOMOL, V12, P349, DOI 10.1111/j.1365-2311.1987.tb01014.x; ZUK M, 1987, BEHAV ECOL SOCIOBIOL, V21, P65, DOI 10.1007/BF00324437	120	28	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219303	10.1371/journal.pone.0219303	http://dx.doi.org/10.1371/journal.pone.0219303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283777	Green Submitted, Green Published, gold			2022-12-26	WOS:000484939800029
J	Tod, E; McCartney, G; Fischbacher, C; Stockton, D; Lewsey, J; Grant, I; Wyper, GMA; Mesalles-Naranjo, O; McFadden, M; Dobbie, R				Tod, Elaine; McCartney, Gerry; Fischbacher, Colin; Stockton, Diane; Lewsey, James; Grant, Ian; Wyper, Grant M. A.; Mesalles-Naranjo, Oscar; McFadden, Mag; Dobbie, Richard			What causes the burden of stroke in Scotland? A comparative risk assessment approach linking the Scottish Health Survey to administrative health data	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; ECONOMIC BURDEN; ISCHEMIC-STROKE; GLOBAL BURDEN; MORTALITY; COUNTRIES; OBESITY; DISEASE; TRENDS	Background The availability of robust evidence to inform effective public health decision making is becoming increasingly important, particularly in a time of competing health demands and limited resources. Comparative Risk Assessments (CRA) are useful in this regard as they quantify the contribution of modifiable exposures to the disease burden in a population. The aim of this study is to assess the contribution of a range of modifiable exposures to the burden of disease due to stroke, an important public health problem in Scotland. Methods We used individual-level response data from eight waves (1995-2012) of the Scottish Health Survey linked to acute hospital discharge records from the Scottish Morbidity Record 01 (SMR01) and cause of death records from the death register. Stroke was defined using the International Classification of Disease (ICD) 9 codes 430-431, 433-4 and 436; and the ICD10 codes 160-61 and 163-64 and stroke incidence was defined as a composite of an individual's first hospitalisation or death from stroke. A literature review identified exposures causally linked to stroke. Exposures were mapped to the layers of the Dahlgren & Whitehead model of the determinants of health and Population Attributable Fractions were calculated for each exposure deemed a significant causal risk of stroke from a Cox Proportional Hazards Regression model. Population Attributable Fractions were not summed as they may add to more than 100% due to the possibility of a person being exposed to more than one exposure simultaneously. Results Overall, the results suggest that socioeconomic factors explain the largest proportion of incident stroke hospitalisations and deaths, after adjustment for confounding. After DAG adjustment, low education explained 38.8% (95% Confidence Interval 26.0% to 49.4%, area deprivation (as measured by the Scottish Index of Multiple Deprivation) 34.9% (95% CI 26.4 to 42.4%), occupational social class differences 30.3% (95% CI 19.4% to 39.8%), high systolic blood pressure 29.6% (95% CI 20.6% to 37.6%), smoking 25.6% (95% CI 17.9% to 32.6%) and area deprivation (as measured by the Carstairs area deprivation Index) 23.5% (95% CI 14.4% to 31.7%), of incident strokes in Scotland after adjustment. Conclusion This study provides evidence for prioritising interventions that tackle socioeconomic inequalities as a means of achieving the greatest reduction in avoidable strokes in Scotland. Future work to disentangle the proportion of the effect of deprivation transmitted through intermediate mediators on the pathway between socioeconomic inequalities and stroke may offer additional opportunities to reduce the incidence of stroke in Scotland.	[Tod, Elaine; McCartney, Gerry; Stockton, Diane; Wyper, Grant M. A.] NHS Hlth Scotland, Glasgow, Lanark, Scotland; [Fischbacher, Colin; Grant, Ian; Mesalles-Naranjo, Oscar; McFadden, Mag; Dobbie, Richard] NHS Natl Serv Scotland, ISD, Edinburgh, Midlothian, Scotland; [Lewsey, James] Univ Glasgow, Hlth Econ & Hlth Technol Assessment, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland	NHS National Services Scotland; University of Glasgow	McCartney, G (corresponding author), NHS Hlth Scotland, Glasgow, Lanark, Scotland.	gmccartney@nhs.net	Wyper, Grant/AAF-2382-2020	Wyper, Grant/0000-0003-2854-5822; McCartney, Gerry/0000-0001-6341-3521	Chief Scientist Office [CZH/4/756]	Chief Scientist Office	The National Burden of Disease, Injuries and Risk Factors Study in Scotland was funded by the Chief Scientist Office (grant number CZH/4/756) and is conducted by the Scottish Public Health Observatory (ScotPHO).	Avendano M, 2005, AM J EPIDEMIOL, V161, P52, DOI 10.1093/aje/kwi011; BHATNAGAR P, 2010, BMC PUBLIC HEALTH, V10, DOI DOI 10.1111/ENE.12560; Bos MJ, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001634; BROWN D, 2011, CARSTAIRS SCORES FOR, DOI DOI 10.1136/JECH-2014-204185; COUNTRIES A, 2015, LANCET; COUNTRIES A, 2016, LANCET, V15, P913, DOI DOI 10.1016/S0140-6736(10)60834-3; COUNTRIES A, LANCET; COUNTRIES A, 2015, LANCET, V10, P30, DOI DOI 10.1161/STROKEAHA.110.596429; Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9; Di Carlo A, 2009, AGE AGEING, V38, P4, DOI 10.1093/ageing/afn282; FAHIMFAR N, 2012, BMC NEUROL, V12, DOI DOI 10.1371/JOURNAL.PMED.1001634; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; FEIGIN VL, GLOBAL, V188, P1990, DOI DOI 10.1016/S0140-6736(13)61953-4; FISCHBACHER C, 2015, IDENTIFYING DEPRIVED, V1, P10, DOI DOI 10.1371/JOURNAL.PONE.0140533; Fischbacher C., 2014, USING SSCA DATA FOR; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Forouzanfar MH, 2013, J AM COLL CARDIOL, V61, pE786, DOI 10.1016/S0735-1097(13)60786-X; GBDMORTALITY, 2015, LANCET, V385, P117, DOI DOI 10.1016/S1474-4422(16)30073-4; Grant I, 2015, NATIONAL BURDEN OF D; Grant I, 2015, FARR CONFERENCE 2015; GRANT I, 2015, SCOTTISH BURDEN OF D, DOI DOI 10.1136/BMJOPEN-2013-002647; Gray L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002647; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Grimaud O, 2011, STROKE, V42, P1201, DOI 10.1161/STROKEAHA.110.596429; Information Services Division NHS Scotland, 2014, THE SICK MAN OF EURO; ISD Scotland, 2017, SCOTTISH HEALTH SURV; Jakovljevic D, 2001, STROKE, V32, P1492, DOI 10.1161/01.STR.32.7.1492; Lewsey JD, 2009, CIRC-CARDIOVASC QUAL, V2, P475, DOI 10.1161/CIRCOUTCOMES.108.825968; LIM SS, 2017, LANCET, V380, P2224, DOI DOI 10.1016/S0140-6736(14)61682-2; Lopez A, 2006, LANCET; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1; Malmivaara A, 2015, EUR J NEUROL, V22, P284, DOI 10.1111/ene.12560; McCartney G, 2015, J EPIDEMIOL COMMUN H, V69, P20, DOI 10.1136/jech-2014-204185; Mitchell AB, 2015, STROKE, V46, P1690, DOI 10.1161/STROKEAHA.115.008940; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; NHS Choices, 2014, STROKE SURVIVAL JANU; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; *PUBL HLTH INT, 2015, SCOTTISH STROKE CARE, V10, P1, DOI DOI 10.1093/AGEING/AFN282; Rodriguez G., 2010, MI IMPUTE CHAINED IM; RODRIGUEZ G, 2017, PARAMETRIC SURVIVAL, V2010, P9, DOI DOI 10.1186/1471-2288-8-70; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Sacco RL, 1997, STROKE, V28, P1507, DOI 10.1161/01.STR.28.7.1507; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; *SCOTT BURD DIS TE, 2017, SCOTTISH BURDEN OF D, V9, P2015, DOI DOI 10.1161/CIRCOUTCOMES.108.825968; Scottish Burden of Disease Team, 2017, COUNTR PROF; SHRIER I, 2008, BMC MED RES METHODOL, V8, DOI DOI 10.1097/EDE.0B013E318225C2BE; STATA.com, 2013, EDINBURGH; StataCorp, 2013, STAT STAT SOFTW REL, P13; StataCorp, 2013, THE SCOTTISH HEALTH; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Toivanen S, 2011, SCAND J PUBLIC HEALT, V39, P797, DOI 10.1177/1403494811418280; Turner M, 2014, STROKE STATISTICS UP; *UNESCO, 2015, ISCED MAPPINGS 1997, V1, P1997; UNESCO: Institute of Statistics, 2014, CONCEPTS AND PRINCIP; van Rossum CTM, 1999, STROKE, V30, P357, DOI 10.1161/01.STR.30.2.357; VOS T, GLOBAL, P301, DOI DOI 10.1016/S0140-6736(15)60692-4; Whitehead M, 1991, SMR01 GENERAL ACUTE; *WHO, 2003, RISK FACTORS, V1; Whyte B, 2012, CEREBROVASC DIS; WOODFIELD R, 2015, PLOS ONE, V10, P6350; Wright EO, 2010, ENVISIONING REAL UTO; EUROPEAN JOURNAL OF, P284, DOI DOI 10.1111/ENE.12560; 2014, STROKE, V9, P2, DOI DOI 10.1186/1471-2458-10-539	64	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0216350	10.1371/journal.pone.0216350	http://dx.doi.org/10.1371/journal.pone.0216350			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283778	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000484939800004
J	Li, ZX; Jiang, MF				Li, Zhixiong; Jiang, Mingfeng			Metabolomic profiles in yak mammary gland tissue during the lactation cycle	PLOS ONE			English	Article							CITRIC-ACID; DAIRY-COWS; GLYCINE; STIMULATION; BIOMARKERS; GENES	The yak is one of the most important domestic animals in Tibetan life for providing basic resources such as milk, meat and transportation. Although yak milk production is not elevated, yak milk is superior to dairy cow milk in nutrient composition (protein and fat). However, the understanding of the metabolic mechanisms of yak mammary gland tissue during the lactation cycle remains elusive. In this study, GC-MS-based metabolomics was employed to study the metabolic variations in the yak mammary gland during the lactation cycle (pregnancy, lactation and dry period). Twenty-nine metabolites were up or downregulated during the lactation period. Compared to the dry period, during the lactation period the levels of oxalic acid were upregulated, while glycine and uridine were downregulated. Thirty-seven pathways were obtained when the 29 differential metabolites were imported into the KEGG pathway analysis. The most impacted pathways during the lactation cycle were glycine, serine and threonine metabolism; alanine, aspartate and glutamate metabolism; TCA cycle; glyoxylate and dicarboxylate metabolism; and pyrimidine metabolism. Our results provide important insights into the metabolic events involved in yak mammary gland development, lactogenesis and lactation, which can guide further research to improve milk yield and enhance the constituents of yak milk.	[Li, Zhixiong; Jiang, Mingfeng] Southwest Minzu Univ, Coll Life Sci & Technol, Chengdu, Sichuan, Peoples R China; [Jiang, Mingfeng] Sichuan Prov Key Lab Qinghai Tibetan Plateau Anim, Chengdu, Sichuan, Peoples R China	Southwest Minzu University	Jiang, MF (corresponding author), Southwest Minzu Univ, Coll Life Sci & Technol, Chengdu, Sichuan, Peoples R China.; Jiang, MF (corresponding author), Sichuan Prov Key Lab Qinghai Tibetan Plateau Anim, Chengdu, Sichuan, Peoples R China.	mingfengjiang@vip.sina.com			Sichuan Youth Science and Technology Innovation Team (Chengdu, China) [2015TD0025]; National Natural Science Foundation of China (Beijing, China) [31172198]; National Sci-Tech Support Plan (Beijing, China) [2014BAD13B03]	Sichuan Youth Science and Technology Innovation Team (Chengdu, China); National Natural Science Foundation of China (Beijing, China)(National Natural Science Foundation of China (NSFC)); National Sci-Tech Support Plan (Beijing, China)	This project was jointly supported by the Sichuan Youth Science and Technology Innovation Team (Chengdu, China; 2015TD0025), the National Natural Science Foundation of China (Beijing, China; 31172198) and National Sci-Tech Support Plan (Beijing, China; 2014BAD13B03) to MJ.; This project was jointly financially supported through grants from the Sichuan Youth Science and Technology Innovation Team (Chengdu, China; 2015TD0025), the National Natural Science Foundation of China (Beijing, China; 31172198) and National Sci-Tech Support Plan (Beijing, China; 2014BAD13B03). We thank Assistant Professor Fernanda Batistel (Department of Animal, Dairy and Veterinary Sciences, Utah State University) for manuscript revision.	Abu Dawud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039896; Alarcon-Aguilar FJ, 2008, EUR J PHARMACOL, V599, P152, DOI 10.1016/j.ejphar.2008.09.047; ALLISON MJ, 1977, J ANIM SCI, V45, P1173, DOI 10.2527/jas1977.4551173x; Antunes-Fernandes EC, 2016, J DAIRY SCI, V99, P6251, DOI 10.3168/jds.2015-10248; Benjamini Y, 2001, ANN STAT, V29, P1165; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Caliskan M., 1998, TURK J ZOOL, V24, P103; Castellaro AM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1747-2; Dong SK, 2007, AFR J AGR RES, V2, P52; Garcia-Macedo R, 2008, EUR J PHARMACOL, V587, P317, DOI 10.1016/j.ejphar.2008.03.051; Grassian AR, 2014, CANCER RES, V74, P3317, DOI 10.1158/0008-5472.CAN-14-0772-T; Jiang MF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147705; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KREBS HA, 1980, FEBS LETT, V117, pK2, DOI 10.1016/0014-5793(80)80564-3; KUNJARA S, 1992, BIOCHEM MED METAB B, V48, P263, DOI 10.1016/0885-4505(92)90073-8; Loor JJ, 2013, ANNU REV ANIM BIOSCI, V1, P365, DOI 10.1146/annurev-animal-031412-103728; Neupaney Dhanapati, 2003, Animal Science Journal, V74, P391, DOI 10.1046/j.1344-3941.2003.00131.x; Nikkhah A., 2011, Food and Nutrition Sciences, V2, P667, DOI 10.4236/fns.2011.26092; Oakes SR, 2008, J MAMMARY GLAND BIOL, V13, P13, DOI 10.1007/s10911-008-9069-5; Palma M, 2016, MOL BIOSYST, V12, P2094, DOI 10.1039/c5mb00851d; Piccioli-Cappelli F, 2014, J DAIRY SCI, V97, P7788, DOI 10.3168/jds.2014-8336; RILLEMA JA, 1975, ENDOCRINOLOGY, V96, P1307, DOI 10.1210/endo-96-5-1307; Sejrsen K., 2006, RUMINANT PHYSL DIGES, DOI [10.3920/978-90-8686-566-6, DOI 10.3920/978-90-8686-566-6]; SHENNAN DB, 1994, EXP PHYSIOL, V79, P797, DOI 10.1113/expphysiol.1994.sp003808; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Sun HZ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4314-1; Sun HZ, 2015, J PROTEOME RES, V14, P1287, DOI 10.1021/pr501305g; Tang MingHui, 2014, Chinese Journal of Animal Nutrition, V26, P2162; Thelwall PE, 2012, NMR BIOMED, V25, P271, DOI 10.1002/nbm.1745; Vanholme R, 2012, PLANT CELL, V24, P3506, DOI 10.1105/tpc.112.102574; Wang YH, 2016, ITAL J ANIM SCI, V15, P545, DOI 10.1080/1828051X.2016.1180643; Wheeler MD, 1999, CELL MOL LIFE SCI, V56, P843, DOI 10.1007/s000180050030; Yang YX, 2016, J PROTEOMICS, V136, P174, DOI 10.1016/j.jprot.2015.12.031; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhong JC, 2004, P 4 INT C YAK, P32	35	13	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219220	10.1371/journal.pone.0219220	http://dx.doi.org/10.1371/journal.pone.0219220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276563	Green Published, gold, Green Submitted			2022-12-26	WOS:000484936300052
J	Kennedy, E; Arcadia, CE; Geiser, J; Weber, PM; Rose, C; Rubenstein, BM; Rosenstein, JK				Kennedy, Eamonn; Arcadia, Christopher E.; Geiser, Joseph; Weber, Peter M.; Rose, Christopher; Rubenstein, Brenda M.; Rosenstein, Jacob K.			Encoding information in synthetic metabolomes	PLOS ONE			English	Article							MASS-SPECTROMETRY; STORAGE	Biomolecular information systems offer exciting potential advantages and opportunities to complement conventional semiconductor technologies. Much attention has been paid to information-encoding polymers, but small molecules also play important roles in biochemical information systems. Downstream from DNA, the metabolome is an information-rich molecular system with diverse chemical dimensions which could be harnessed for information storage and processing. As a proof of principle of small-molecule postgenomic data storage, here we demonstrate a workflow for representing abstract data in synthetic mixtures of metabolites. Our approach leverages robotic liquid handling for writing digital information into chemical mixtures, and mass spectrometry for extracting the data. We present several kilobyte-scale image datasets stored in synthetic metabolomes, which can be decoded with accuracy exceeding 99% using multi-mass logistic regression. Cumulatively, >100,000 bits of digital image data was written into metabolomes. These early demonstrations provide insight into some of the benefits and limitations of small-molecule chemical information systems.	[Kennedy, Eamonn; Arcadia, Christopher E.; Rose, Christopher; Rosenstein, Jacob K.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Geiser, Joseph; Weber, Peter M.; Rubenstein, Brenda M.] Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University; Brown University	Rosenstein, JK (corresponding author), Brown Univ, Sch Engn, Providence, RI 02912 USA.	jacob_rosenstein@brown.edu	Arcadia, Christopher/AAQ-2593-2021	Arcadia, Christopher/0000-0003-4690-7065	Defense Advanced Research Projects Agency [DARPA W911NF-18-2-0031]	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This research was supported by funding from the Defense Advanced Research Projects Agency (DARPA W911NF-18-2-0031) to BMR and JKR. The views, opinions and/or findings expressed are those of the authors and should not be interpreted as representing the official views or policies of the Department of Defense or the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 13 14 CENTURY EGYPTI; [Anonymous], 1781, RHOD ISL HOP REG COL; Arcadia C. E., 2018, IEEE INT C REB COMP; Arcadia CE, 2017, ACS NANO, V11, P4907, DOI 10.1021/acsnano.7b01519; Belov ME, 2000, ANAL CHEM, V72, P2271, DOI 10.1021/ac991360b; Brown M, 2009, ANALYST, V134, P1322, DOI 10.1039/b901179j; Cartwright J. H. E., 2016, PHIL T ROY SOC LON A, V374; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Davis J, 1996, ART J, V55, P70, DOI 10.2307/777811; De Silva PY, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8072463; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Erlich Y, 2017, SCIENCE, V355, P950, DOI 10.1126/science.aaj2038; Galenkamp NS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06534-1; Gowda G A Nagana, 2014, Methods Mol Biol, V1198, P3, DOI 10.1007/978-1-4939-1258-2_1; Green JE, 2007, NATURE, V445, P414, DOI 10.1038/nature05462; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Kell DB, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1108-4; Kennedy E, 2016, NAT NANOTECHNOL, V11, P968, DOI 10.1038/nnano.2016.120; Kouskoumvekaki I, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/525497; Manzoni C, 2018, BRIEF BIOINFORM, V19, P286, DOI 10.1093/bib/bbw114; Martens S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06926-3; Matsuda Fumio, 2016, Mass Spectrom (Tokyo), V5, pS0052; Meiser J, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-34; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nikolaev EN, 2016, MASS SPECTROM REV, V35, P219, DOI 10.1002/mas.21422; Park BK, 2011, NAT REV DRUG DISCOV, V10, P292, DOI 10.1038/nrd3408; Peregrin-Alvarez JM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r63; Rose C, 2004, NATURE, V431, P47, DOI 10.1038/nature02884; Rosenstein J. K., ARXIV190502187; Roumpeka DD, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00023; Sarkar T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11374; Schmolz Lisa, 2016, World J Biol Chem, V7, P14, DOI 10.4331/wjbc.v7.i1.14; Sumner LW, 2015, NAT PROD REP, V32, P212, DOI 10.1039/c4np00072b; Sung J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15393; Tang Y, 2007, J BACTERIOL, V189, P940, DOI 10.1128/JB.00948-06; Wei PR, 2017, J MATER CHEM C, V5, P5780, DOI 10.1039/c7tc00929a; Wilkinson C. K., 1921, FACSIMILE MADE TEMPE; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Zampieri M, 2017, CURR OPIN CHEM BIOL, V36, P15, DOI 10.1016/j.cbpa.2016.12.006; Zhang AH, 2016, BIOMED CHROMATOGR, V30, P7, DOI 10.1002/bmc.3453	41	12	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0217364	10.1371/journal.pone.0217364	http://dx.doi.org/10.1371/journal.pone.0217364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IK4PT	31269053	gold, Green Submitted, Green Published			2022-12-26	WOS:000476569500001
J	Neves, PAR; Lourenco, BH; Pincelli, A; Malta, MB; Souza, RM; Ferreira, MU; Castro, MC; Cardoso, MA; da Silva, BP; de Souza, RM; de Castro, MC				Neves, Paulo A. R.; Lourenco, Barbara H.; Pincelli, Anaclara; Malta, Maira B.; Souza, Rodrigo M.; Ferreira, Marcelo U.; Castro, Marcia C.; Cardoso, Marly A.; da Silva, Bruno Pereira; de Souza, Rodrigo Medeiros; de Castro, Marcia Caldas		MINA-Brazil Study Grp	High prevalence of gestational night blindness and maternal anemia in a population-based survey of Brazilian Amazonian postpartum women	PLOS ONE			English	Article							RIO-DE-JANEIRO; PREGNANT-WOMEN; VITAMIN-A; SUPPLEMENTATION; TRIAL; RISK	Nutrition during pregnancy is one of the key elements to good maternal and child health, as well as to lifetime landmarks. However, many pregnant women go undernourished in less developed settings. The purpose of this study was to estimate the prevalence and factors associated with gestational night blindness (GXN) and maternal anemia in a cross-sectional population-based study in Cruzeiro do Sul, Acre State, Western Brazilian Amazon. All women living in the municipality admitted at the only maternity-hospital in the city to delivery of a singleton infant were eligible to this study (n = 1,525). Recruitment of participants took place between July 2015 to June 2016. GXN was assessed in the postpartum period by WHO standardized interview. Maternal anemia was defined as hemoglobin at delivery < 110.0 g/L. We estimated prevalence rates and adjusted prevalence ratios (aPR), alongside 95% confidence intervals (95% CI), of the factors associated with the outcomes through multiple Poisson regression models with robust variance. Alarming prevalence of GXN (11.5%; 95% CI, 9.97-13.25) and maternal anemia (39.4%; 95% CI, 36.84-41.95) were found. Factors associated with GXN were (aPR; 95% CI):. 5 residents in the household (2.06; 1.24-3.41), smoking during pregnancy (1.78; 1.15-2.78), and attending < 6 antenatal care visits (1.61; 1.08-2.40). Factors associated with maternal anemia were (aPR; 95% CI): maternal age < 19 years (1.18; 1.01-1.38), gestational malaria (1.22; 1.01-1.49), not taking micronutrient supplements during pregnancy (1.27; 1.01-1.62), and attending < 6 antenatal care visits (1.40; 1.15-1.70). High prevalence rates of GXN and maternal anemia in these postpartum women may reflect poor assistance during antenatal care, underlying the importance of rethinking current protocols related to nutrition in pregnancy.	[Neves, Paulo A. R.; Lourenco, Barbara H.; Malta, Maira B.; Cardoso, Marly A.] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, SP, Brazil; [Pincelli, Anaclara; Ferreira, Marcelo U.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, SP, Brazil; [Souza, Rodrigo M.] Univ Fed Acre, Multidisciplinary Ctr, Cruzeiro Do Sul, Brazil; [Castro, Marcia C.] Harvard TH Chan Sch Publ Hlth, Dept Global & Populat, Boston, MA USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Harvard University; Harvard T.H. Chan School of Public Health	Cardoso, MA (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, SP, Brazil.	marlyac@usp.br	Neves, Paulo Augusto Ribeiro/V-6160-2018; Lourenco, Barbara/H-8291-2012; Cardoso, Marly Augusto/B-8010-2013; Ferreira, Marcelo U/G-8289-2011; Medeiros de Souza, Rodrigo/F-4749-2014	Neves, Paulo Augusto Ribeiro/0000-0002-1200-4725; Lourenco, Barbara/0000-0002-2006-674X; Cardoso, Marly Augusto/0000-0003-0973-3908; Ferreira, Marcelo U/0000-0002-5293-9090; Pincelli Cintra, Anaclara/0000-0002-2071-1139; Medeiros de Souza, Rodrigo/0000-0002-7775-6901	Brazilian National Council for Scientific and Technological Development (CNPq) [407255/2013-3]; Maria Cecilia Souto Vidigal Foundation; Sao Paulo Research Foundation (FAPESP) [2016/00270-6]; Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES) [PDSE - 88881.133704/2016-01]	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Maria Cecilia Souto Vidigal Foundation; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial support for this study was provided by Brazilian National Council for Scientific and Technological Development (CNPq, 407255/2013-3), Maria Cecilia Souto Vidigal Foundation, and the Sao Paulo Research Foundation (FAPESP, 2016/00270-6). PARN received scholarships from Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES, PDSE - 88881.133704/2016-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GUIA PRAT TRAT MAL B; [Anonymous], 2009, WHO GLOBAL DATABASE; [Anonymous], 2012, GUID DAIL IR FOL AC; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Black RE, 2013, LANCET, V382, P372, DOI 10.1016/S0140-6736(13)60988-5; Cardoso MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036341; Christian P, 1998, INT J EPIDEMIOL, V27, P231, DOI 10.1093/ije/27.2.231; Christian P, 2011, AM J CLIN NUTR, V94, P1643, DOI 10.3945/ajcn.111.019059; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gomes LF, 2004, ANTIOXID REDOX SIGN, V6, P237, DOI 10.1089/152308604322899305; Instituto Brasileiro de Geografia e Estatistica, 2016, SINT IND SOC AN COND; Katz J, 2009, OPHTHAL EPIDEMIOL, V16, P193, DOI 10.1080/09286580902863080; Ministerio da Saude (Brasil), 2009, PESQ NAC DEM SAUD CR; Pincelli A, 2018, AM J TROP MED HYG, V99, P73, DOI 10.4269/ajtmh.18-0135; Programa das Nacoes Unidas para o Desenvolvimento, 2010, REL DES HUM 2010; Saunders C, 2005, NUTRITION, V21, P456, DOI 10.1016/j.nut.2004.07.015; Saunders C, 2016, PUBLIC HEALTH NUTR, V19, P851, DOI 10.1017/S1368980015001846; Smith ER, 2017, LANCET GLOB HEALTH, V5, pE1090, DOI 10.1016/S2214-109X(17)30371-6; Tanumihardjo SA, 2016, J NUTR, V146, P1816, DOI 10.3945/jn.115.229708; Taren D., 2012, HIST PRACTICAL USES; Tielsch JM, 2008, J NUTR, V138, P787, DOI 10.1093/jn/138.4.787; van den Broek NR, 2006, BJOG-INT J OBSTET GY, V113, P569, DOI 10.1111/j.1471-0528.2006.00891.x; WHO, 2017, NUTR AN TOOLS EFF PR; WHO,, 2014, C REACT PROT CONC MA; WHO, VIT MIN NUTR INF SYS; *WHO, 1996, IND ASS VIT A DEF TH; World Health O, 2014, XER NIGHT BLIN UNPUB, P1; World Health Organization, 2012, PRIOR ASS VIT A IR S; World Health Organization, 2015, GLOB PREV AN 2011	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219203	10.1371/journal.pone.0219203	http://dx.doi.org/10.1371/journal.pone.0219203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269067	Green Submitted, Green Published, gold			2022-12-26	WOS:000484927300051
J	Putman, SB; Brown, JL; Saffoe, C; Franklin, AD; Pukazhenthi, BS				Putman, Sarah B.; Brown, Janine L.; Saffoe, Craig; Franklin, Ashley D.; Pukazhenthi, Budhan S.			Linkage between fecal androgen and glucocorticoid metabolites, spermaturia, body weight and onset of puberty in male African lions (Panthera leo)	PLOS ONE			English	Article							STEROIDOGENIC ACTIVITY; TESTICULAR ACTIVITY; FEMALE LIONS; LYNX-LYNX; GROWTH; TESTOSTERONE; AGE; REPRODUCTION; DISPERSAL; FELIDS	There is limited physiological information on onset of puberty in male lions. The aim of this study was to use longitudinal non-invasive monitoring to: 1) assess changes in steroid metabolite excretory patterns as a function of age and body weight; 2) determine correlations between fecal androgen (FAM) and glucocorticoid (FGM) metabolite concentrations; and 3) confirm spermiogenesis non-invasively through urinalysis. Specifically, FAM and FGM metabolites were analyzed in samples collected twice weekly from 21 male lions at 17 institutions (0.9-16 years of age) for 3.8 months-2.5 years to assess longitudinal hormone patterns. In addition, body weights were obtained approximately monthly from 10 individuals at five zoos (0.0-3.0 years), and urine was collected from six males at two facilities (1.2-6.3 years) and evaluated for the presence of spermatozoa. An increase in overall mean FAM occurred at 2.0 years of age, at which point concentrations remained similar throughout adulthood. The onset of puberty occurred earlier in captive-born males (< 1.2 years of age) compared to wild-born counterparts (< 2.5 years of age). Additionally, males in captivity gained an average of 7.3 kg/month compared to 3.9 kg/month for wild males over the first 2-2.5 years of age. Sperm (spermaturia) was observed in males as young as 1.2 years in captivity compared to 2.5 years in the wild (ejaculates). There was no difference in FAM or FGM concentrations with regards to age or season. Overall, this study demonstrates that: 1) captive male lions attain puberty at an earlier age than wild counterparts; 2) onset of puberty is influenced by body weight (growth rate); and 3) spermiogenesis can be confirmed via urinalysis. Knowledge about the linkage between body weight and onset of puberty could facilitate improved reproductive management of ex situ populations via mitigating the risk of unintended breedings in young animals.	[Putman, Sarah B.; Brown, Janine L.; Pukazhenthi, Budhan S.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA 22630 USA; [Putman, Sarah B.] George Mason Univ, Fairfax, VA 22030 USA; [Saffoe, Craig] Natl Zool Pk, Washington, DC USA; [Franklin, Ashley D.] St Louis Zoo, AZA Reprod Management Ctr, St Louis, MO USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; George Mason University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Pukazhenthi, BS (corresponding author), Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA 22630 USA.	pukazhenthib@si.edu	Franklin, Ashley D/J-3069-2015	Franklin, Ashley D/0000-0002-0818-5156; Pukazhenthi, Budhan/0000-0003-4657-2023	20th Century Fox Corporation (Aslan Fund); 20th Century Fox Corporation; North American African lion SSP	20th Century Fox Corporation (Aslan Fund); 20th Century Fox Corporation; North American African lion SSP	This project was supported by funds from 20th Century Fox Corporation (Aslan Fund). The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For their support within the North American African lion SSP, we thank Tarren Wagener and Hollie Colahan and for her advice and assistance with the studbook records we thank Sue Pfaff. For technical assistance, we thank Courtney Lynd-Daigle, Kari Morfeld, Paola Mota, Jennifer Nagashima, Nicole Boisseau, Steven Paris and Emily Schneider. We thank the animal keeper and curatorial staff at the following institutions: Birmingham Zoo, Blank Park Zoo, Brookfield Zoological Park, Cheyenne Mountain Zoological Park, Denver Zoological Gardens, Henry Vilas Zoo, Indianapolis Zoo, Knoxville Zoological Gardens, Lee Richardson Zoo, Milwaukee County Zoological Gardens, North Carolina Zoo, Oklahoma City Zoo, Oregon Zoo, Potawatomi Zoo, Riverbanks Zoological Park, Smithsonian National Zoological Park, Virginia Zoological Park, and Wildlife Safari for their participation in the study. This project was supported by funds from 20 th Century Fox Corporation.	AZA Lion Species Survival Plan, 2012, LION CAR MAN; Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; Bertram B.C, 1978, PRIDE LIONS; BERTRAM BCR, 1975, J ZOOL, V177, P463; Boonstra R, 2001, ECOLOGY, V82, P1930, DOI 10.2307/2680058; BOULANOUAR B, 1995, ANIM REPROD SCI, V40, P229, DOI 10.1016/0378-4320(95)01420-5; Brown JL, 1996, ZOO BIOL, V15, P425, DOI 10.1002/(SICI)1098-2361(1996)15:4<425::AID-ZOO7>3.0.CO;2-D; BROWN JL, 1991, J REPROD FERTIL, V91, P29; Byrne CJ, 2018, J DAIRY SCI, V101, P3447, DOI 10.3168/jds.2017-13719; Conforti VA, 2012, ZOO BIOL, V31, P426, DOI 10.1002/zoo.20409; Cooper J., 1942, COMPAR PSYCHO MONOG, V17, P1; Derocher AE, 2002, J ZOOL, V256, P343, DOI 10.1017/S0952836902000377; Dloniak SM, 2004, GEN COMP ENDOCR, V135, P51, DOI 10.1016/j.ygcen.2003.08.011; Eaton R. L., 1971, INT ZOO YB, V11, P198; Eloff F.C., 1984, Koedoe, V27, P249; Fanson KV, 2010, GEN COMP ENDOCR, V169, P210, DOI 10.1016/j.ygcen.2010.09.001; Faya M, 2013, THERIOGENOLOGY, V80, P584, DOI 10.1016/j.theriogenology.2013.05.026; Fazio J., 2010, BEHAV ASSESSMENT CLO; Frisch RE., 1990, ADIPOSE TISSUE REPRO, V14, P1; Ganan N, 2009, REPRODUCTION, V139, P275, DOI DOI 10.1530/REP-09-0259; GARSHELIS DL, 1994, J MAMMAL, V75, P175, DOI 10.2307/1382249; HIRSCH M, 1985, J ADOLESCENT HEALTH, V6, P35, DOI 10.1016/S0197-0070(85)80103-0; Jewgenow K, 2006, GEN COMP ENDOCR, V149, P151, DOI 10.1016/j.ygcen.2006.05.015; Kenny DA, 2018, ANIMAL, V12, pS36, DOI [10.1017/S1751731118000514, 10.1017/s1751731118000514]; Klein TA, 1998, ENCY REPROD; KULIN HE, 1989, AM J DIS CHILD, V143, P190; Levasseur M., 1980, REPROD LIFE CYCLES, P130; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Macdonald KA, 2005, J DAIRY SCI, V88, P3363, DOI 10.3168/jds.S0022-0302(05)73020-4; Magni P, 2003, ENCY HORMONES; Malmsten A, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0236-1; Maly MA, 2018, GEN COMP ENDOCR, V268, P22, DOI 10.1016/j.ygcen.2018.07.011; MARKERKRAUS L, 1993, ZOO BIOL, V12, P5, DOI 10.1002/zoo.1430120104; MELLEN JD, 1991, ZOO BIOL, V10, P95, DOI 10.1002/zoo.1430100202; Morais RN, 2002, THERIOGENOLOGY, V57, P2027, DOI 10.1016/S0093-691X(02)00707-0; Moreira N, 2001, ZOO BIOL, V20, P103, DOI 10.1002/zoo.1010; Morse RW, 1973, INT S, P188; Newell-Fugate A, 2007, ZOO BIOL, V26, P187, DOI 10.1002/zoo.20127; Norris DO., 2007, VERTEBRATE ENDOCRINO, V4; OBRIEN SJ, 1987, NATL GEOGR RES, V3, P114; Okuyama MW, 2013, J REPROD DEVELOP, V59, P361, DOI 10.1262/jrd.2012-198; Onyango PO, 2013, HORM BEHAV, V64, P240, DOI 10.1016/j.yhbeh.2013.02.014; PACKER C, 1983, AM NAT, V121, P716, DOI 10.1086/284097; Pfaff SE, 2014, N AM REGIONAL AFRICA; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; Putman SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140373; Rudnai J, 1973, E AFR WILDL J, V11, P214; Sankhala K. S., 1967, International Zoo Yearbook, V7, P133, DOI 10.1111/j.1748-1090.1967.tb00354.x; Santymire RM, 2011, ANIM REPROD SCI, V128, P60, DOI 10.1016/j.anireprosci.2011.09.001; Schaller G. B., 1972, SERENGETI LION; Schook MW, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110122; Senger P.L., 2003, PATHWAYS PREGNANCY P, V2nd; Smuts G. L., 1982, LION; SMUTS GL, 1978, J ZOOL, V185, P115, DOI 10.1111/j.1469-7998.1978.tb03317.x; SMUTS GL, 1980, J ZOOL, V190, P365; Staley AM, 2007, J COMP PHYSIOL B, DOI [10.1007/s00360-007, DOI 10.1007/S00360-007]; Sugianto NA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0203910; Sunquist ME, 2002, WILD CATS WORLD; Tummers B, 2006, DATA THIEF 3 VERSION; VANORSDOL KG, 1985, J ZOOL, V206, P97; West PM, 2002, SCIENCE, V297, P1339, DOI 10.1126/science.1073257; Wildt D., 2010, BIOL CONSERVATION WI, P217; WILDT DE, 1986, BIOL REPROD, V34, P949, DOI 10.1095/biolreprod34.5.949; Young KM, 2004, GEN COMP ENDOCR, V137, P148, DOI 10.1016/j.ygcen.2004.02.016; Young KM, 2001, ZOO BIOL, V20, P517, DOI 10.1002/zoo.10001	65	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0217986	10.1371/journal.pone.0217986	http://dx.doi.org/10.1371/journal.pone.0217986			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269032	Green Published, gold, Green Submitted			2022-12-26	WOS:000484927300010
J	Liu, GQ; Xie, YH; Su, JW; Qin, HJ; Wu, HT; Li, KQ; Yu, B; Zhang, XR				Liu, Guanqiao; Xie, Yongheng; Su, Jianwen; Qin, Hanjun; Wu, Hangtian; Li, Kaiqun; Yu, Bin; Zhang, Xianrong			The role of EGFR signaling in age-related osteoporosis in mouse cortical bone	FASEB JOURNAL			English	Article						degeneration; senescence; Ezh2; aging; ERK1; 2	EPIDERMAL-GROWTH-FACTOR; PROLIFERATION; SENESCENCE; CELLS; MECHANISMS; POROSITY; SURFACE; MASS	So far, there has been no effective cure for osteoporotic cortical bone, the most significant change in long bone structure during aging and the main cause of bone fragility fractures, because its underlying molecular and cellular mechanisms remain largely unknown. We used 3- and 15-mo-old mice as well as 15-mo-old mice treated with vehicle and gefitinib to evaluate structural, cellular, and molecular changes in cortical bone. We found that the senescence of osteoprogenitors was increased, whereas the expression of phosphorylated epidermal growth factor receptor (EGFR) on the endosteal surface of cortical bone down-regulated in middle-aged 15-mo-old mice compared with young 3-mo-old mice. Further decreasing EGFR signaling by gefitinib treatment in middle-aged mice resulted in promoted senescence of osteoprogenitors and accelerated cortical bone degeneration. Moreover, inhibiting EGFR signaling suppressed the expression of enhancer of zeste homolog 2 (Ezh2), the repressor of cell senescence-inducer genes, through ERK1/2 pathway, thereby promoting senescence in osteoprogenitors. Down-regulated EGFR signaling plays a physiologically significant role during aging by reducing Ezh2 expression, leading to the senescence of osteoprogenitors and the decline in bone formation on the endosteal surface of cortical bone.-Liu, G., Xie, Y., Su, J., Qin, H., Wu, H., Li, K., Yu, B., Zhang, X. The role of EGFR signaling in age-related osteoporosis in mouse cortical bone.	[Liu, Guanqiao; Xie, Yongheng; Su, Jianwen; Qin, Hanjun; Wu, Hangtian; Li, Kaiqun; Yu, Bin; Zhang, Xianrong] Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Traumatol, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China; [Liu, Guanqiao; Xie, Yongheng; Su, Jianwen; Qin, Hanjun; Wu, Hangtian; Li, Kaiqun; Yu, Bin; Zhang, Xianrong] Southern Med Univ, Nanfang Hosp, Key Lab Bone & Cartilage Regenerat Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Yu, B; Zhang, XR (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Traumatol, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China.	yubinol@163.com; xianrongzh@smu.edu.cn		Qin, Hanjun/0000-0002-9982-6157; liu, guanqiao/0000-0003-4119-3796	Major Program of National Natural Science Foundation of China [81830079]; National Natural Science Foundation of China [81573515, 81572165]	Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Allen P. Liang (Nanfang Hospital, Southern Medical University) for English proofreading of this manuscript. This work was supported by The Major Program of National Natural Science Foundation of China (81830079) and the National Natural Science Foundation of China (81573515, 81572165). The authors declare no conflicts of interest.	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Alexander PB, 2015, CELL RES, V25, P135, DOI 10.1038/cr.2014.141; Anam K, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt323; Andreasen CM, 2018, BONE, V117, P70, DOI 10.1016/j.bone.2018.09.011; Andreasen CM, 2018, J BONE MINER RES, V33, P606, DOI 10.1002/jbmr.3354; Bai TT, 2017, STEM CELLS DEV, V26, P113, DOI 10.1089/scd.2016.0234; Bakalova LP, 2018, J BONE MINER RES, V33, P2177, DOI 10.1002/jbmr.3561; Birkhold AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep23480; Bjornerem A, 2018, J BONE MINER RES, V33, P598, DOI 10.1002/jbmr.3333; BROCKSTEDT H, 1993, BONE, V14, P681, DOI 10.1016/8756-3282(93)90092-O; Buenzli PR, 2013, INT J NUMER METH BIO, V29, P1307, DOI 10.1002/cnm.2567; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; Cooper DML, 2007, BONE, V40, P957, DOI 10.1016/j.bone.2006.11.011; Dai GD, 2013, BIOCHEM BIOPH RES CO, V440, P479, DOI 10.1016/j.bbrc.2013.08.070; Ding CY, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0781-9; Dong YP, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171589; Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385; Farr JN, 2016, J BONE MINER RES, V31, P1920, DOI 10.1002/jbmr.2892; Gerber PA, 2016, SUPPORT CARE CANCER, V24, P4241, DOI 10.1007/s00520-016-3254-7; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kim HN, 2017, AGING CELL, V16, P693, DOI 10.1111/acel.12597; Li CJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01509-0; McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092; Piemontese M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93771; Ramchand SK, 2018, CURR OSTEOPOROS REP, V16, P561, DOI 10.1007/s11914-018-0478-0; Savickiene J, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2019498; Schneider P, 2007, J BONE MINER RES, V22, P1557, DOI 10.1359/JBMR.070703; Seeman E, 2013, J GERONTOL A-BIOL, V68, P1218, DOI 10.1093/gerona/glt071; Siclari VA, 2013, BONE, V53, P575, DOI 10.1016/j.bone.2012.12.013; Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zebaze R, 2015, J BONE MINER RES, V30, P24, DOI 10.1002/jbmr.2419; Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295	36	11	11	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11137	11147		10.1096/fj.201900436RR	http://dx.doi.org/10.1096/fj.201900436RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31298955				2022-12-26	WOS:000489166300047
J	Vanacloig-Pedros, E; Lozano-Perez, C; Alarcon, B; Pascual-Ahuir, A; Proft, M				Vanacloig-Pedros, Elena; Lozano-Perez, Carlos; Alarcon, Benito; Pascual-Ahuir, Amparo; Proft, Markus			Live-cell assays reveal selectivity and sensitivity of the multidrug response in budding yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						stress response; multidrug transporter; xenobiotic; gene transcription; Saccharomyces cerevisiae; transcription factor; drug resistance; ABC transporter; chemical stress; efflux pump	TRANSCRIPTION FACTOR; DRUG-RESISTANCE; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; OXIDATIVE STRESS; ACTIVATION; PATHWAY; PDR1; YRR1; TRANSPORTERS	Pleiotropic drug resistance arises by the enhanced extrusion of bioactive molecules and is present in a wide range of organisms, ranging from fungi to human cells. A key feature of this adaptation is the sensitive detection of intracellular xenobiotics by transcriptional activators, activating expression of multiple drug exporters. Here, we investigated the selectivity and sensitivity of the budding yeast (Saccharomyces cerevisiae) multidrug response to better understand how differential drug recognition leads to specific activation of drug exporter genes and to drug resistance. Applying live-cell luciferase reporters, we demonstrate that the SNQ2, PDR5, PDR15, and YOR1 transporter genes respond to different mycotoxins, menadione, and hydrogen peroxide in a distinguishable manner and with characteristic amplitudes, dynamics, and sensitivities. These responses correlated with differential sensitivities of the respective transporter mutants to the specific xenobiotics. We further establish a binary vector system, enabling quantitative determination of xenobiotic-transcription factor (TF) interactions in real time. Applying this system we found that the TFs Pdr1, Pdr3, Yrr1, Stb5, and Pdr8 have largely different drug recognition patterns. We noted that Pdr1 is the most promiscuous activator, whereas Yrr1 and Stb5 are selective for ochratoxin A and hydrogen peroxide, respectively. We also show that Pdr1 is rapidly degraded after xenobiotic exposure, which leads to a desensitization of the Pdr1-specific response upon repeated activation. The findings of our work indicate that in the yeast multidrug system, several transcriptional activators with distinguishable selectivities trigger differential activation of the transporter genes.	[Vanacloig-Pedros, Elena; Pascual-Ahuir, Amparo] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, Dept Biotechnol, E-46022 Valencia, Spain; [Lozano-Perez, Carlos; Alarcon, Benito; Proft, Markus] CSIC, IBV, Dept Mol & Cellular Pathol & Therapy, Valencia 46010, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Pascual-Ahuir, A (corresponding author), Ingeniero Fausto Elio S-N, Valencia 46022, Spain.; Proft, M (corresponding author), CSIC, Inst Biomed, Jaime Roig 11, Valencia 46010, Spain.	apascual@ibmcp.upv.es; mproft@ibv.csic.es	Pascual-ahuir, Amparo/K-1338-2014	Proft, Markus/0000-0002-6788-5830; Alarcon Hernandis, Benito/0000-0002-9026-3247	Ministerio de Economia y Competitividad Grant [BFU2016-75792-R]	Ministerio de Economia y Competitividad Grant(Spanish Government)	This work was supported by Ministerio de Economia y Competitividad Grant BFU2016-75792-R. The authors declare that they have no conflicts of interest with the contents of this article.	Akache B, 2004, J BIOL CHEM, V279, P27855, DOI 10.1074/jbc.M403487200; Balzi E, 2019, YEAST, V36, P195, DOI 10.1002/yea.3354; Borecka-Melkusova S, 2008, FEMS YEAST RES, V8, P414, DOI 10.1111/j.1567-1364.2007.00352.x; Cadiere A, 2010, FEMS YEAST RES, V10, P819, DOI 10.1111/j.1567-1364.2010.00672.x; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Cavalheiro M, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00995-18; Colabufo NA, 2009, CURR TOP MED CHEM, V9, P119, DOI 10.2174/156802609787521553; Cui Z, 1998, MOL MICROBIOL, V29, P1307, DOI 10.1046/j.1365-2958.1998.01027.x; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; Dolz-Edo L, 2013, MOL CELL BIOL, V33, P2228, DOI 10.1128/MCB.00240-13; Fardeau V, 2007, J BIOL CHEM, V282, P5063, DOI 10.1074/jbc.M610197200; Gao C, 2004, J BIOL CHEM, V279, P42677, DOI 10.1074/jbc.M406363200; Healey KR, 2018, J FUNGI, V4, DOI 10.3390/jof4030105; Hikkel I, 2003, J BIOL CHEM, V278, P11427, DOI 10.1074/jbc.M208549200; Hong HY, 2000, ELECTROPHORESIS, V21, P841, DOI 10.1002/(SICI)1522-2683(20000301)21:5<841::AID-ELPS841>3.3.CO;2-W; Ito H, 2006, PLANT PHYSIOL, V142, P63, DOI 10.1104/pp.106.084533; Jungwirth H, 2006, FEBS LETT, V580, P1131, DOI 10.1016/j.febslet.2005.12.050; KATZMANN DJ, 1994, MOL CELL BIOL, V14, P4653, DOI 10.1128/MCB.14.7.4653; Keeven J, 2002, CURR GENET, V41, P11, DOI 10.1007/s00294-002-0274-2; Kim MS, 2019, NUCLEIC ACIDS RES, V47, P1211, DOI 10.1093/nar/gky1188; Kodo N, 2013, BIOCHEM BIOPH RES CO, V434, P42, DOI 10.1016/j.bbrc.2013.03.069; Kren A, 2003, MOL CELL BIOL, V23, P1775, DOI 10.1128/MCB.23.5.1775-1785.2003; Larochelle M, 2006, MOL CELL BIOL, V26, P6690, DOI 10.1128/MCB.02450-05; Le Crom S, 2002, MOL CELL BIOL, V22, P2642, DOI 10.1128/MCB.22.8.2642-2649.2002; Lucau-Danila A, 2003, J BIOL CHEM, V278, P52641, DOI 10.1074/jbc.M309580200; Moye-Rowley WS, 2019, CURR GENET, V65, P103, DOI 10.1007/s00294-018-0870-4; Naar AM, 2009, GENE DEV, V23, P419, DOI 10.1101/gad.1743009; Nishida-Aoki N, 2015, CURR GENET, V61, P153, DOI 10.1007/s00294-014-0463-9; Nishikawa JL, 2016, NATURE, V530, P485, DOI 10.1038/nature16963; Noel T, 2012, J MYCOL MED, V22, P173, DOI 10.1016/j.mycmed.2012.04.004; Onda M, 2004, GENE, V332, P51, DOI 10.1016/j.gene.2004.02.003; Ouyang LM, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy091; Pascual-Ahuir A, 2019, BBA-GENE REGUL MECH, V1862, P457, DOI 10.1016/j.bbagrm.2019.02.009; Paul S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00143; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Rienzo A, 2015, MOL CELL BIOL, V35, P3669, DOI 10.1128/MCB.00729-15; Rienzo A, 2012, YEAST, V29, P219, DOI 10.1002/yea.2905; Rong-Mullins X, 2018, G3-GENES GENOM GENET, V8, P607, DOI 10.1534/g3.117.300138; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Shahi P, 2010, MOL BIOL CELL, V21, P2469, DOI 10.1091/mbc.E09-10-0899; Stavrovskaya AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P592, DOI 10.1134/S0006297908050118; Teixeira MC, 2018, NUCLEIC ACIDS RES, V46, pD348, DOI 10.1093/nar/gkx842; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Vanacloig-Pedros E, 2016, TOXINS, V8, DOI 10.3390/toxins8100273; Voth WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084092; Zhang XT, 2001, J BIOL CHEM, V276, P8812, DOI 10.1074/jbc.M010686200	46	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12933	12946		10.1074/jbc.RA119.009291	http://dx.doi.org/10.1074/jbc.RA119.009291			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296662	hybrid, Green Published			2022-12-26	WOS:000486416000007
J	Li, LZ; Martin-Levilain, J; Jimenez-Sanchez, C; Karaca, M; Foti, M; Martinou, JC; Maechler, P				Li, Lingzi; Martin-Levilain, Juliette; Jimenez-Sanchez, Cecilia; Karaca, Melis; Foti, Michelangelo; Martinou, Jean-Claude; Maechler, Pierre			In vivo stabilization of OPA1 in hepatocytes potentiates mitochondrial respiration and gluconeogenesis in a prohibitin-dependent way	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver metabolism; mitochondria; hepatocyte; gluconeogenesis; mitochondrial metabolism; OPA1; prohibitins; liver	M-AAA PROTEASE; GLUCOSE-PRODUCTION; PHOSPHOENOLPYRUVATE CARBOXYKINASE; HEPATIC GLYCOGENOLYSIS; PROTEOLYTIC CLEAVAGE; TCA CYCLE; LIVER; DYSFUNCTION; APOPTOSIS; FUSION	Patients with fatty liver diseases present altered mitochondrial morphology and impaired metabolic function. Mitochondrial dynamics and related cell function require the uncleaved form of the dynamin-like GTPase OPA1. Stabilization of OPA1 might then confer a protective mechanism against stress-induced tissue damages. To study the putative role of hepatic mitochondrial morphology in a sick liver, we expressed a cleavage-resistant long form of OPA1 (L-OPA1 Delta) in the liver of a mouse model with mitochondrial liver dysfunction (i.e. the hepatocyte-specific prohibitin-2 knockout (Hep-Phb2(-/-)) mice). Liver prohibitin-2 deficiency caused excessive proteolytic cleavage of L-OPA1, mitochondrial fragmentation, and increased apoptosis. These molecular alterations were associated with lipid accumulation, abolished gluconeogenesis, and extensive liver damage. Such liver dysfunction was associated with severe hypoglycemia. In prohibitin-2 knockout mice, expression of L-OPA1 Delta by in vivo adenovirus delivery restored the morphology but not the function of mitochondria in hepatocytes. In prohibitin-competent mice, elongation of liver mitochondria by expression of L-OPA1 Delta resulted in excessive glucose production associated with increased mitochondrial respiration. In conclusion, mitochondrial dynamics participates in the control of hepatic glucose production.	[Li, Lingzi; Martin-Levilain, Juliette; Jimenez-Sanchez, Cecilia; Karaca, Melis; Foti, Michelangelo; Maechler, Pierre] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1206 Geneva, Switzerland; [Li, Lingzi; Martin-Levilain, Juliette; Jimenez-Sanchez, Cecilia; Karaca, Melis; Foti, Michelangelo; Maechler, Pierre] Univ Geneva, Fac Diabet Ctr, Med Ctr, CH-1206 Geneva, Switzerland; [Martinou, Jean-Claude] Univ Geneva, Fac Sci, Cell Biol Dept, CH-1205 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Maechler, P (corresponding author), CMU, Dept Cell Physiol & Metab, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.	Pierre.Maechler@unige.ch		Foti, Michelangelo/0000-0001-7199-4135; Maechler, Pierre/0000-0002-2005-1433; /0000-0002-6856-1299	Swiss National Science Foundation Sinergia [CRSII3_147637, 310030_172862]; Fundacion Alfonso Martin Escudero	Swiss National Science Foundation Sinergia(Swiss National Science Foundation (SNSF)); Fundacion Alfonso Martin Escudero	This work was supported by Swiss National Science Foundation Sinergia Grants CRSII3_147637 (to P. M. and J.-C. M.) and 310030_172862 (to M. F.) and by a fellowship from the Fundacion Alfonso Martin Escudero (to C. J. S). The authors declare that they have no conflicts of interest with the contents of this article.	Adam M, 2018, FASEB J, V32, P3434, DOI 10.1096/fj.201700914R; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; EXTON JH, 1972, METABOLISM, V21, P945, DOI 10.1016/0026-0495(72)90028-5; Farese RV, 2005, EXP BIOL MED, V230, P593; Foti M, 1997, MOL BIOL CELL, V8, P1377, DOI 10.1091/mbc.8.7.1377; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; Garcia-Ruiz I, 2010, J PROTEOME RES, V9, P2450, DOI 10.1021/pr9011427; Grimaldi M, 2017, HUM MOL GENET, V26, P3453, DOI 10.1093/hmg/ddx213; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Holmstrom MH, 2013, METABOLISM, V62, P1258, DOI 10.1016/j.metabol.2013.04.001; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Karaca M, 2018, DIABETES, V67, P1949, DOI 10.2337/db17-1561; Korwitz A, 2016, J CELL BIOL, V212, P157, DOI 10.1083/jcb.201507022; Landau BR, 1996, J CLIN INVEST, V98, P378, DOI 10.1172/JCI118803; Lane M, 2016, J INHERIT METAB DIS, V39, P427, DOI 10.1007/s10545-016-9927-z; Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; MCCLUNG JK, 1995, EXP GERONTOL, V30, P99, DOI 10.1016/0531-5565(94)00069-7; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Merkwirth C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003021; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Park M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030494; Park SE, 2005, MOL CELL BIOL, V25, P1989, DOI 10.1128/MCB.25.5.1989-1999.2005; Parvez S, 2006, TOXICOLOGY, V225, P109, DOI 10.1016/j.tox.2006.05.009; Petersen KF, 1996, AM J PHYSIOL-ENDOC M, V270, pE186, DOI 10.1152/ajpendo.1996.270.1.E186; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Ross JA, 2017, ONCOTARGET, V8, P65445, DOI 10.18632/oncotarget.18920; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Stark R, 2014, BBA-GEN SUBJECTS, V1840, P1313, DOI 10.1016/j.bbagen.2013.10.033; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Supale S, 2013, DIABETES, V62, P3488, DOI 10.2337/db13-0152; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tietge UJF, 1999, J LIPID RES, V40, P2134; von Wilamowitz-Moellendorff A, 2013, DIABETES, V62, P4070, DOI 10.2337/db13-0880; Wajngot A, 2001, METABOLISM, V50, P47, DOI 10.1053/meta.2001.19422; Wang LX, 2015, DIABETOLOGIA, V58, P2371, DOI 10.1007/s00125-015-3704-7; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103	64	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12581	12598		10.1074/jbc.RA119.007601	http://dx.doi.org/10.1074/jbc.RA119.007601			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31285263	Green Published, hybrid			2022-12-26	WOS:000484414600003
J	Hardy, LR; Pergande, MR; Esparza, K; Heath, KN; Onyuksel, H; Cologna, SM; Burdette, JE				Hardy, Laura R.; Pergande, Melissa R.; Esparza, Karina; Heath, Kimberly N.; Onyuksel, Hayat; Cologna, Stephanie M.; Burdette, Joanna E.			Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton	ONCOGENE			English	Article							GROWTH; FOXM1; EXPRESSION; CELLS; TRANSITION; TISSUES	High grade serous ovarian cancer (HGSOC) is the fifth leading cause of cancer deaths among women yet effective targeted therapies against this disease are limited. The heterogeneity of HGSOC, including few shared oncogenic drivers and origination from both the fallopian tube epithelium (FTE) and ovarian surface epithelium (OSE), has hampered development of targeted drug therapies. PAX8 is a lineage-specific transcription factor expressed in the FTE that is also ubiquitously expressed in HGSOC where it is an important driver of proliferation, migration, and cell survival. PAX8 is not normally expressed in the OSE, but it is turned on after malignant transformation. In this study, we use proteomic and transcriptomic analysis to examine the role of PAX8 leading to increased migratory capabilities in a human ovarian cancer model, as well as in tumor models derived from the OSE and FTE. We find that PAX8 is a master regulator of migration with unique downstream transcriptional targets that are dependent on the cell's site of origin. Importantly, we show that targeting PAX8, either through CRISPR genomic alteration or through drug treatment with micelle encapsulated thiostrepton, leads to a reduction in tumor burden. These findings suggest PAX8 is a unifying protein driving metastasis in ovarian tumors that could be developed as an effective drug target to treat HGSOC derived from both the OSE and FTE.	[Hardy, Laura R.; Heath, Kimberly N.; Burdette, Joanna E.] Univ Illinois, Dept Pharmaceut Sci, Chicago, IL 60607 USA; [Pergande, Melissa R.; Cologna, Stephanie M.] Univ Illinois, Dept Chem, Chicago, IL USA; [Esparza, Karina; Onyuksel, Hayat] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Burdette, JE (corresponding author), Univ Illinois, Dept Pharmaceut Sci, Chicago, IL 60607 USA.	joannab@uic.edu		Pergande, Melissa/0000-0003-1197-4057	Department of Defense Ovarian Cancer Fund [160076]; National Cancer Institute [F30CA224986]; National Cancer Center for Research Resources Facilities Improvement Program [C06RR15482]; University of Illinois-Chicago Department of Chemistry; Ara Parsegian Medical Research Foundation; Abraham Lincoln Fellowship; NATIONAL CANCER INSTITUTE [F30CA224986] Funding Source: NIH RePORTER	Department of Defense Ovarian Cancer Fund(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Center for Research Resources Facilities Improvement Program; University of Illinois-Chicago Department of Chemistry; Ara Parsegian Medical Research Foundation; Abraham Lincoln Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense Ovarian Cancer Fund 160076, the National Cancer Institute F30CA224986, the National Cancer Center for Research Resources Facilities Improvement Program C06RR15482, the University of Illinois-Chicago Department of Chemistry, the Ara Parsegian Medical Research Foundation, and the Abraham Lincoln Fellowship.	Adler EK, 2017, ONCOTARGET, V8, P108316, DOI 10.18632/oncotarget.22718; Adusumilli R, 2017, METHODS MOL BIOL, V1550, P339, DOI 10.1007/978-1-4939-6747-6_23; Ashok B, 2004, J PHARM SCI-US, V93, P2476, DOI 10.1002/jps.20150; Batth TS, 2014, J PROTEOME RES, V13, P6176, DOI 10.1021/pr500893m; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; de Cristofaro T, 2016, ONCOTARGET, V7, P41929, DOI 10.18632/oncotarget.9740; de Cristofaro T, 2009, J MOL ENDOCRINOL, V42, P35, DOI 10.1677/JME-08-0100; Di Palma T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-292; Eddie SL, 2015, ONCOTARGET, V6, P20500, DOI 10.18632/oncotarget.3985; Elias KM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87988; Endsley MP, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00154; Esparza K, 2019, INT J PHARMACEUT, V556, P21, DOI 10.1016/j.ijpharm.2018.12.001; Ghannam-Shahbari D, 2018, ONCOGENE, V37, P2213, DOI 10.1038/s41388-017-0040-z; Gokce E, 2011, J CHROMATOGR B, V879, P610, DOI 10.1016/j.jchromb.2011.01.032; Grassi ML, 2017, J PROTEOMICS, V151, P2, DOI 10.1016/j.jprot.2016.06.009; Haley J, 2016, ONCOTARGET, V7, P32810, DOI 10.18632/oncotarget.9053; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; Jiang LZ, 2015, J CANCER RES CLIN, V141, P971, DOI 10.1007/s00432-014-1872-3; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; King SM, 2013, CARCINOGENESIS, V34, P1125, DOI 10.1093/carcin/bgt003; King SM, 2011, ENDOCR-RELAT CANCER, V18, P627, DOI 10.1530/ERC-11-0107; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Labidi-Galy SI, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00962-1; Laury AR, 2010, AM J SURG PATHOL, V34, P627, DOI 10.1097/PAS.0b013e3181da7687; Li CG, 2011, ONCOGENE, V30, P4824, DOI 10.1038/onc.2011.190; Lim SB, 2012, J CONTROL RELEASE, V163, P34, DOI 10.1016/j.jconrel.2012.06.002; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McCloskey CW, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00053; Musrap N, 2015, J BIOL CHEM, V290, P17218, DOI 10.1074/jbc.M115.639773; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Ozcan A, 2011, MODERN PATHOL, V24, P751, DOI 10.1038/modpathol.2011.3; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodgers LH, 2016, ONCOTARGET, V7, P32785, DOI 10.18632/oncotarget.9051; Russo A, 2018, ONCOGENE, V37, P1976, DOI 10.1038/s41388-017-0097-8; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tanwar PS, 2014, CARCINOGENESIS, V35, P546, DOI 10.1093/carcin/bgt357; Waldemarson S, 2012, J PROTEOME RES, V11, P2876, DOI 10.1021/pr201258q; Wang LN, 2012, J CELL BIOCHEM, V113, P3762, DOI 10.1002/jcb.24250; Wang M, 2011, MOL CANCER THER, V10, P2287, DOI 10.1158/1535-7163.MCT-11-0536; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhang X, 2014, ONCOTARGET, V5, P11365, DOI 10.18632/oncotarget.2497	45	17	17	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 8	2019	38	32					6003	6016		10.1038/s41388-019-0842-2	http://dx.doi.org/10.1038/s41388-019-0842-2			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IP8XH	31296958	Green Accepted			2022-12-26	WOS:000480329900001
J	Gerhard, GS; Hanson, A; Wilhelmsen, D; Piras, IS; Still, CD; Chu, X; Petrick, AT; DiStefano, JK				Gerhard, Glenn S.; Hanson, Amanda; Wilhelmsen, Danielle; Piras, Ignazio S.; Still, Christopher D.; Chu, Xin; Petrick, Anthony T.; DiStefano, Johanna K.			AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p	PLOS ONE			English	Article							FATTY LIVER-DISEASE; CARBOXYPEPTIDASE-LIKE PROTEIN; ENHANCER-BINDING PROTEIN-1; TRANSCRIPTIONAL REGULATION; LUNG; GROWTH; HOMEOSTASIS; METASTASIS; METABOLISM; REPRESSION	Factors governing the development of liver fibrosis in nonalcoholic steatohepatitis (NASH) are only partially understood. We recently identified adipocyte enhancer binding protein 1 (AEBP1) as a member of a core set of dysregulated fibrosis-specific genes in human NASH. Here we sought to investigate the relationship between AEBP1 and hepatic fibrosis. We confirmed that hepatic AEBP1 expression is elevated in fibrosis compared to lobular inflammation, steatosis, and normal liver, and increases with worsening fibrosis in NASH patients. AEBP1 expression was upregulated 5.8-fold in activated hepatic stellate cells and downregulated during chemical and contact induction of biological quiescence. In LX-2 and HepG2 cells treated with high glucose (25 mM), AEBP1 expression increased over 7-fold compared to normal glucose conditions. In response to treatment with either fructose or palmitate, AEBP1 expression in primary human hepatocytes increased 2.4-fold or 9.6-fold, but was upregulated 55.8-fold in the presence of fructose and palmitate together. AEBP1 knockdown resulted in decreased expression of nine genes previously identified to be part of a predicted AEBP1-associated NASH co-regulatory network and confirmed to be upregulated in fibrotic tissue. We identified binding sites for two miRNAs known to be downregulated in NASH fibrosis, miR-372-3p and miR-373-3p in the AEBP1 3' untranslated region. Both miRNAs functionally interacted with AEBP1 to regulate its expression. These findings indicate a novel AEBP1-mediated pathway in the pathogenesis of hepatic fibrosis in NASH.	[Gerhard, Glenn S.] Temple Univ, Sch Med, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Hanson, Amanda; Wilhelmsen, Danielle; Piras, Ignazio S.; DiStefano, Johanna K.] Translat Genom Res Inst, Diabet & Fibrot Dis Unit, Phoenix, AZ 85004 USA; [Still, Christopher D.; Chu, Xin; Petrick, Anthony T.] Geisinger Obes Inst, Danville, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Translational Genomics Research Institute	DiStefano, JK (corresponding author), Translat Genom Res Inst, Diabet & Fibrot Dis Unit, Phoenix, AZ 85004 USA.	jdistefano@tgen.org	DiStefano, Johanna K/V-7801-2019	DiStefano, Johanna K/0000-0002-3286-0270; Piras, Ignazio/0000-0003-4024-3368	National Institute of Diabetes and Digestive and Kidney Diseases [DK088231]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded in part by the National Institute of Diabetes and Digestive and Kidney Diseases (http://www.niddk.nih.gov) to JKD (DK088231). The NIDDK did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano-Barrera A, 2017, ANN HEPATOL, V16, P48, DOI 10.5604/16652681.1226814; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Arrese M, 2016, DIGEST DIS SCI, V61, P1294, DOI 10.1007/s10620-016-4049-x; Jorge ASB, 2018, OBES RES CLIN PRACT, V12, P1, DOI 10.1016/j.orcp.2016.03.009; Bartolini D, 2017, J NUTR BIOCHEM, V47, P120, DOI 10.1016/j.jnutbio.2017.06.003; Blackburn PR, 2018, AM J HUM GENET, V102, P696, DOI 10.1016/j.ajhg.2018.02.018; Chu X, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1490-y; DiStefano JK, 2015, ACTA DIABETOL, V52, P373, DOI 10.1007/s00592-014-0654-3; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Fan XX, 2018, ONCOL LETT, V15, P1046, DOI 10.3892/ol.2017.7372; Gerhard GS, 2018, J ENDOCR SOC, V2, P710, DOI 10.1210/js.2018-00122; Gerhard GS, 2014, J OBES, V2014, DOI 10.1155/2014/368210; Ghouri Yezaz Ahmed, 2017, J Carcinog, V16, P1, DOI 10.4103/jcar.JCar_9_16; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; Heymann F, 2016, NAT REV GASTRO HEPAT, V13, P88, DOI 10.1038/nrgastro.2015.200; Jager M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197777; Jahn D, 2019, BBA-MOL BASIS DIS, V1865, P943, DOI 10.1016/j.bbadis.2018.06.023; Kim SW, 2001, J BIOL CHEM, V276, P10199, DOI 10.1074/jbc.M010640200; Koek GH, 2011, CLIN CHIM ACTA, V412, P1297, DOI 10.1016/j.cca.2011.04.013; Ladha J, 2012, MOL CANCER RES, V10, P1039, DOI 10.1158/1541-7786.MCR-11-0488; Latorre J, 2017, INT J OBESITY, V41, P620, DOI 10.1038/ijo.2017.21; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Layne MD, 1998, J BIOL CHEM, V273, P15654, DOI 10.1074/jbc.273.25.15654; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Leti F, 2015, TRANSL RES, V166, P304, DOI 10.1016/j.trsl.2015.04.014; Li SC, 2019, ONCOL LETT, V17, P55, DOI 10.3892/ol.2018.9623; Liu WS, 2016, CELL MOL LIFE SCI, V73, P1969, DOI 10.1007/s00018-016-2161-x; Lou Y, 2017, CELL PHYSIOL BIOCHEM, V41, P239, DOI 10.1159/000456061; Majdalawieh A, 2006, P NATL ACAD SCI USA, V103, P2346, DOI 10.1073/pnas.0508139103; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Park JG, 1999, EMBO J, V18, P4004, DOI 10.1093/emboj/18.14.4004; Qiu XF, 2015, ONCOTARGET, V6, P15397, DOI 10.18632/oncotarget.3778; Ro HS, 2007, OBESITY, V15, P288, DOI 10.1038/oby.2007.569; Schissel SL, 2009, AM J PATHOL, V174, P818, DOI 10.2353/ajpath.2009.080856; Sendi H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200847; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Teratani T, 2018, J CLIN INVEST, V128, P1581, DOI 10.1172/JCI92863; Teufel A, 2016, GASTROENTEROLOGY, V151, P513, DOI 10.1053/j.gastro.2016.05.051; Tumelty KE, 2014, J BIOL CHEM, V289, P2526, DOI 10.1074/jbc.M113.502617; Vejnar CE, 2012, NUCLEIC ACIDS RES, V40, P11673, DOI 10.1093/nar/gks901; Wang D, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/514206; Wang Q, 2017, CANCER MED-US, V6, P1323, DOI 10.1002/cam4.1026; Weng JQ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6010926; Wood GC, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-45; Wu YT, 2015, TOXICOL APPL PHARM, V289, P163, DOI 10.1016/j.taap.2015.09.028; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Xu SY, 2018, EUR REV MED PHARMACO, V22, P62, DOI 10.26355/eurrev_201801_14101; Zhu NL, 2010, J BIOL CHEM, V285, P30463, DOI 10.1074/jbc.M110.156703	48	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2019	14	7							e0219764	10.1371/journal.pone.0219764	http://dx.doi.org/10.1371/journal.pone.0219764			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4NB	31299062	gold, Green Published, Green Submitted			2022-12-26	WOS:000484955800012
J	Ceccato, I; Lecce, S; Cavallini, E; van Vugt, FT; Ruffman, T				Ceccato, Irene; Lecce, Serena; Cavallini, Elena; van Vugt, Floris T.; Ruffman, Ted			Motivation and social-cognitive abilities in older adults: Convergent evidence from self-report measures and cardiovascular reactivity	PLOS ONE			English	Article							SOCIOEMOTIONAL SELECTIVITY THEORY; AGE-RELATED DIFFERENCES; EMOTION RECOGNITION; EGO-INVOLVEMENT; MEMORY PERFORMANCE; EXECUTIVE FUNCTION; STEREOTYPE THREAT; TASK ENGAGEMENT; MENTAL STATES; MIND	Recently, some authors have suggested that age-related impairments in social-cognitive abilities-emotion recognition (ER) and theory of mind (ToM)-may be explained in terms of reduced motivation and effort mobilization in older adults. We examined performance on ER and ToM tasks, as well as corresponding control tasks, experimentally manipulating self-involvement. Sixty-one older adults and 57 young adults were randomly assigned to either a High or Low self-involvement condition. In the first condition, self-involvement was raised by telling participants were told that good task performance was associated with a number of positive, personally relevant social outcomes. Motivation was measured with both subjective (self-report questionnaire) and objective (systolic blood pressure reactivity-SBP-R) indices. Results showed that the self-involvement manipulation did not increase self-reported motivation, SBP-R, or task performance. Further correlation analyses focusing on individual differences in motivation did not reveal any association with performance, in either young or older adults. Notably, we found age-related decline in both ER and ToM, despite older adults having higher motivation than young adults. Overall, the present results were not consistent with previous claims that motivation affects older adults' social-cognitive performance, opening the route to potential alternative explanations.	[Ceccato, Irene; Lecce, Serena; Cavallini, Elena] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy; [van Vugt, Floris T.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [van Vugt, Floris T.] Haskins Labs Inc, New Haven, CT USA; [Ruffman, Ted] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Pavia; McGill University; Yale University; Haskins Laboratories; University of Otago	Ceccato, I (corresponding author), Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy.; Ruffman, T (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	irene.ceccato01@universitadipavia.it; tedr@psy.otago.ac.nz	Ceccato, Irene/AAC-1707-2019	Ceccato, Irene/0000-0003-4819-2120				Abell F, 2000, COGNITIVE DEV, V15, P1, DOI 10.1016/S0885-2014(00)00014-9; Adams RB, 2010, J COGNITIVE NEUROSCI, V22, P97, DOI 10.1162/jocn.2009.21187; Ahmed FS, 2011, J AUTISM DEV DISORD, V41, P667, DOI 10.1007/s10803-010-1087-7; Bailey PE, 2008, AGING MENT HEALTH, V12, P499, DOI 10.1080/13607860802224243; Beach K, 1996, CLIN PSYCHOL PSYCHOT, V3, P1, DOI 10.1002/(SICI)1099-0879(199603)3:1<1::AID-CPP74>3.0.CO;2-8; Bottiroli S, 2016, ARCH GERONTOL GERIAT, V62, P152, DOI 10.1016/j.archger.2015.09.009; Braver TS, 2014, COGN AFFECT BEHAV NE, V14, P443, DOI 10.3758/s13415-014-0300-0; BREHM JW, 1989, ANNU REV PSYCHOL, V40, P109, DOI 10.1146/annurev.ps.40.020189.000545; Brose A, 2010, RES HUM DEV, V7, P61, DOI 10.1080/15427600903578177; Brunstein JC, 1996, J PERS SOC PSYCHOL, V70, P395, DOI 10.1037/0022-3514.70.2.395; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Campbell A, 2014, NEUROBIOLOGY AGING, V35; Carstensen LL, 2006, SCIENCE, V312, P1913, DOI 10.1126/science.1127488; Carstensen LL, 2003, MOTIV EMOTION, V27, P103, DOI 10.1023/A:1024569803230; Cassidy BS, 2012, MEMORY, V20, P332, DOI 10.1080/09658211.2012.660956; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Charles ST, 2010, ANNU REV PSYCHOL, V61, P383, DOI 10.1146/annurev.psych.093008.100448; Charlton RA, 2009, PSYCHOL AGING, V24, P338, DOI 10.1037/a0015225; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Eich TS, 2014, SOC COGNITION, V32, P559, DOI 10.1521/soco.2014.32.6.559; Elliot A. J., 2008, HDB MOTIVATIONAL SCI, P235, DOI DOI 10.1007/S11031-007-9058-9; Elliot AJ, 2006, MOTIV EMOTION, V30, P111, DOI 10.1007/s11031-006-9028-7; Ennis GE, 2013, PSYCHOL AGING, V28, P495, DOI 10.1037/a0031255; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gaetano J., 2013, HOLM BONFERRONI SEQU; Gendolla GHE, 1999, MOTIV EMOTION, V23, P45, DOI 10.1023/A:1021331501833; Gendolla GHE, 2005, PSYCHOPHYSIOLOGY, V42, P595, DOI 10.1111/j.1469-8986.2005.00314.x; Gendolla GHE, 2008, MOTIV EMOTION, V32, P213, DOI 10.1007/s11031-008-9098-9; Gendolla GHE, 2006, PERS SOC PSYCHOL B, V32, P1188, DOI 10.1177/0146167206288945; Gendolla GHE, 2010, REV GEN PSYCHOL, V14, P212, DOI 10.1037/a0019742; Gonsalkorale K, 2009, J EXP SOC PSYCHOL, V45, P410, DOI 10.1016/j.jesp.2008.11.004; Halberstadt J, 2011, PSYCHOL AGING, V26, P133, DOI 10.1037/a0021366; Henry JD, 2013, PSYCHOL AGING, V28, P826, DOI 10.1037/a0030677; Hess TM, 2006, SOC COGNITION, V24, P279, DOI 10.1521/soco.2006.24.3.279; Hess TM, 2014, MOTIV EMOTION, V38, P844, DOI 10.1007/s11031-014-9433-2; Hess TM, 2014, PERSPECT PSYCHOL SCI, V9, P388, DOI 10.1177/1745691614527465; Hess TM, 2001, PSYCHOL AGING, V16, P629, DOI 10.1037//0882-7974.16.4.629; Hess TM, 2018, PSYCHOL AGING; Horton S, 2008, J APPL GERONTOL, V27, P446, DOI 10.1177/0733464808315291; JENNINGS JR, 1988, PSYCHOBIOLOGY, V16, P270; Klein GS, 1941, J ABNORM SOC PSYCH, V36, P249, DOI 10.1037/h0061777; Koenig AM, 2005, SEX ROLES, V52, P489, DOI 10.1007/s11199-005-3714-x; Lecce S, 2019, AGING MENT HEALTH, V23, P1105, DOI 10.1080/13607863.2018.1479832; Lecce S, 2017, AGING MENT HEALTH, V21, P253, DOI 10.1080/13607863.2015.1114586; Lerner JS, 1999, PSYCHOL BULL, V125, P255, DOI 10.1037/0033-2909.125.2.255; LLABRE MM, 1991, PSYCHOPHYSIOLOGY, V28, P701, DOI 10.1111/j.1469-8986.1991.tb01017.x; Lockenhoff CE, 2004, J PERS, V72, P1395, DOI 10.1111/j.1467-6494.2004.00301.x; Mioshi E, 2006, INT J GERIATR PSYCHI; Nolaker EJ, 2018, NEUROPSYCHOLOGY, V32, P754, DOI 10.1037/neu0000464; O'Keefe DJ, 2007, COMMUN METHODS MEAS, V1, P291, DOI 10.1080/19312450701641375; Oliva RV, 2012, J GERONTOL A-BIOL, V67, P1343, DOI 10.1093/gerona/gls148; Paal T, 2007, PERS INDIV DIFFER, V43, P541, DOI 10.1016/j.paid.2006.12.021; PELHAM BW, 1995, J PERS SOC PSYCHOL, V68, P581, DOI 10.1037/0022-3514.68.4.581; Perez-Zapata D, 2016, COGNITION, V146, P410, DOI 10.1016/j.cognition.2015.10.018; Richter M, 2013, SOC PERSONAL PSYCHOL, V7, P1, DOI 10.1111/spc3.12007; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Ruffman T, 2016, EXP AGING RES, V42, P279, DOI 10.1080/0361073X.2016.1156974; Ruffman T, 2016, EMOTION, V16, P226, DOI 10.1037/emo0000107; Ruffman T, 2012, PSYCHOL AGING, V27, P543, DOI 10.1037/a0023380; Ruffman T, 2010, PSYCHOL AGING, V25, P492, DOI 10.1037/a0018247; Ruffman T, 2009, PSYCHOL AGING, V24, P614, DOI 10.1037/a0016356; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037/0022-3514.43.3.450; Shipley WC, 1940, J PSYCHOL, V9, P371, DOI 10.1080/00223980.1940.9917704; Smith Brian T, 2015, Motiv Sci, V1, P22, DOI 10.1037/mot0000012; Stanley JT, 2015, PSYCHOL AGING, V30, P383, DOI 10.1037/pag0000028; Sullivan S, 2004, INT J NEUROSCI, V114, P403, DOI 10.1080/00207450490270901; Sullivan S, 2004, BRIT J PSYCHOL, V95, P1, DOI 10.1348/000712604322779424; Thibault P, 2006, J EXP SOC PSYCHOL, V42, P676, DOI 10.1016/j.jesp.2005.10.006; Tomioka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139065; Townsend SSM, 2014, SOC PSYCHOL PERS SCI, V5, P526, DOI 10.1177/1948550613511499; Vaes J, 2012, EUR REV SOC PSYCHOL, V23, P64, DOI 10.1080/10463283.2012.665250; Wechsler D, 2008, WAIS 4 NCS PEARSO WE; Weed E, 2010, BRAIN LANG, V113, P65, DOI 10.1016/j.bandl.2010.01.009; Wright R. A., 1996, PSYCHOL ACTION LINKI, P424; Wright RA, 2001, ADV EXP SOC PSYCHOL, V33, P255, DOI 10.1016/S0065-2601(01)80007-1; Yeh ZT, 2013, AGING MENT HEALTH, V17, P527, DOI 10.1080/13607863.2012.758235; Zhang XH, 2018, ACTA MECH SINICA-PRC, V34, P266, DOI 10.1007/s10409-017-0699-y; Zhang X, 2013, DEV PSYCHOL, V49, P1848, DOI 10.1037/a0031211	80	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218785	10.1371/journal.pone.0218785	http://dx.doi.org/10.1371/journal.pone.0218785			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4JZ	31291276	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800036
J	Surya, GS; Keitt, TH				Surya, Gautam S.; Keitt, Timothy H.			Altitudinal limits of Eastern Himalayan birds are created by competition past and present	PLOS ONE			English	Article							UNIFIED NEUTRAL THEORY; CLIMATE-CHANGE; SPECIES BORDERS; NICHE; EVOLUTION; PHYLLOSCOPUS; PLANKTON; PARADOX; IMPACTS; ECOLOGY	The degree to which interspecific competition structures diverse communities is an oft-debated topic. An approach to answering this question is to examine spatial patterns of coexistence among putatively competing species. The degree to which interspecies competition predominates in a community can have important effects on our ability predict the response of that community to perturbations, most notably climate change, when shifting species' ranges may result in novel species assemblages. We present a study on the avifauna of the Eastern Himalayas. We hypothesize that in a community where competitive interactions predominate, there will be a relationship between pairwise altitudinal overlaps and morphological differences between species. Moreover, we hypothesize that both morphological traits and altitudinal traits depart from a Brownian motion evolution model, resulting in species trait covariances having a phylogenetic component. We find a significant relationship between morphological dissimilarity and altitudinal overlaps of species pairs. We also find that closely related species are significantly more altitudinally stratified than a null model would predict. However, as more distantly related species pairs are included in the analysis, this pattern disappears, indicating that competitive interactions predominate only in closely related species. This is further suggested by the fact that altitudinal ranges themselves are phylogenetically overdispersed at the genus level, as are morphological traits. This effect disappears when the entire phylogeny is examined, with morphology and altitude being phylogenetically underdispersed. Model fitting suggests that individual clades have evolved towards local clade-specific fitness peaks, while within-clade results show evidence of niche partitioning. We interpret these results as a tension between competition on shorter time scales and selection on longer time scales, where competition forces closelyrelated species away from fitness peaks in order to allow for niche separation and hence coexistence, suggesting that this effect is partially responsible for the recent diversification of Eastern Himalayan avifauna.	[Surya, Gautam S.; Keitt, Timothy H.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Surya, Gautam S.] Wildlife Conservat Soc, Bronx, NY 10460 USA	University of Texas System; University of Texas Austin; Wildlife Conservation Society	Surya, GS (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.; Surya, GS (corresponding author), Wildlife Conservat Soc, Bronx, NY 10460 USA.	gsurya@wcs.org	Keitt, Timothy/AAF-9787-2021	Keitt, Timothy/0000-0002-4587-1083	Indo-US Science and Technology Forum - Research Internships in Science and Engineering fellowship; University of Texas, Department of Integrative Biology startup grant; Mohamed Bin Zayed Species Conservation Fund [140510101]; Indo-US Science and Technology Forum's RISE fellowships; University of Texas's Integrative Biology Department	Indo-US Science and Technology Forum - Research Internships in Science and Engineering fellowship; University of Texas, Department of Integrative Biology startup grant; Mohamed Bin Zayed Species Conservation Fund; Indo-US Science and Technology Forum's RISE fellowships; University of Texas's Integrative Biology Department	This work was funded by Indo-US Science and Technology Forum - Research Internships in Science and Engineering fellowship (no grant number available) - awarded to GSS, https://www.iusstf.org/program/research-internships-in-science-engineering; University of Texas, Department of Integrative Biology startup grant (no grant number available) - awarded to GSS; and Mohamed Bin Zayed Species Conservation Fund (Project 140510101) - awarded to GSS, https://www.speciesconservation.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was obtained from the Indo-US Science and Technology Forum's RISE fellowships and the University of Texas's Integrative Biology Department. All work was carried out with the permission of the Department of Environment and Forest, Government of Arunachal Pradesh, whom the authors would like to thank for their assistance and support.	Alstrom P, 2008, ZOOL J LINN SOC-LOND, V154, P291, DOI 10.1111/j.1096-3642.2008.00418.x; Alstrom Per, 1997, Bulletin of the British Ornithologists' Club, V117, P177; Anderson RP, 2013, ANN NY ACAD SCI, V1297, P8, DOI 10.1111/nyas.12264; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Cahill AE, 2014, J BIOGEOGR, V41, P429, DOI 10.1111/jbi.12231; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Chamberlain DE, 2013, BIOL CONSERV, V167, P127, DOI 10.1016/j.biocon.2013.07.036; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chesson PL, 1986, COMMUNITY ECOLOGY, P229; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; Diamond J.M., 1975, P342; DIAMOND JM, 1973, SCIENCE, V179, P759, DOI 10.1126/science.179.4075.759; Dingle C, 2010, EVOLUTION, V64, P3537, DOI 10.1111/j.1558-5646.2010.01089.x; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elsen PR, 2017, ECOLOGY, V98, P337, DOI 10.1002/ecy.1669; FAUTH JE, 1990, OIKOS, V58, P91, DOI 10.2307/3565364; Fitzpatrick BM, 2006, EVOLUTION, V60, P601; Gause G. F., 1934, STRUGGLE EXISTENCE; Gause GF, 1932, J EXP BIOL, V9, P389; GHILAROV AM, 1984, OIKOS, V43, P46, DOI 10.2307/3544244; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; GOLDBERG DE, 1983, AM J BOT, V70, P1098, DOI 10.2307/2442821; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Grimmett R., 2012, BIRDS INDIA; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Holt RD, 2005, OIKOS, V108, P18, DOI 10.1111/j.0030-1299.2005.13147.x; Holt RD, 2005, OIKOS, V108, P3, DOI 10.1111/j.0030-1299.2005.13145.x; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Irwin DE, 2001, IBIS, V143, P233, DOI 10.1111/j.1474-919X.2001.tb04479.x; Jankowski JE, 2008, ECOLOGY, V89, P3001, DOI [10.1002/ecy.2064, DOI 10.1002/ECY.2064]; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Johansson US, 2007, EVOLUTION, V61, P324, DOI 10.1111/j.1558-5646.2007.00024.x; Jombart T., 2008, ADEPHYLO EXPLORATORY; Josse J, 2016, J STAT SOFTW, V70; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; LANDMANN A, 1993, OECOLOGIA, V95, P506, DOI 10.1007/BF00317435; Langham GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135350; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; MARCHETTI K, 1995, J AVIAN BIOL, V26, P177, DOI 10.2307/3677316; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; Mendes L, 2005, OIKOS, V109, P396, DOI 10.1111/j.0030-1299.2005.13509.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Noble AE, 2011, J THEOR BIOL, V273, P1, DOI 10.1016/j.jtbi.2010.12.021; Packert M, 2012, J BIOGEOGR, V39, P556, DOI 10.1111/j.1365-2699.2011.02606.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pavoine S, 2008, THEOR POPUL BIOL, V73, P79, DOI 10.1016/j.tpb.2007.10.001; Price TD, 2014, NATURE, V509, P222, DOI 10.1038/nature13272; Price TD, 2010, PHILOS T R SOC B, V365, P1749, DOI 10.1098/rstb.2009.0269; QGIS Development Team, 2017, QGIS GEOGRAPHIC INFO; R Core Team, 2016, R LANG ENV STAT COMP; Rasmussen PC., 2005, BIRDS S ASIA RIPLEY; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; RICHMAN AD, 1992, NATURE, V355, P817, DOI 10.1038/355817a0; Ricklefs RE, 2006, ECOLOGY, V87, P1424, DOI 10.1890/0012-9658(2006)87[1424:TUNTOB]2.0.CO;2; ROBINSON SK, 1995, J ANIM ECOL, V64, P1, DOI 10.2307/5822; Roy S, 2007, ECOL COMPLEX, V4, P26, DOI 10.1016/j.ecocom.2007.02.016; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Siepielski AM, 2010, ECOLOGY, V91, P847, DOI 10.1890/09-0609.1; Srinivasan U, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2593; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Veech JA, 2014, J BIOGEOGR, V41, P1029, DOI 10.1111/jbi.12318; Warren DL, 2014, TRENDS ECOL EVOL, V29, P572, DOI 10.1016/j.tree.2014.08.003; WILSON JB, 1990, NEW ZEAL J ECOL, V13, P17; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	75	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0217549	10.1371/journal.pone.0217549	http://dx.doi.org/10.1371/journal.pone.0217549			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291248	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800012
J	Yalak, G; Shiu, JY; Schoen, I; Mitsi, M; Vogel, V				Yalak, Garif; Shiu, Jau-Ye; Schoen, Ingmar; Mitsi, Maria; Vogel, Viola			Phosphorylated fibronectin enhances cell attachment and upregulates mechanical cell functions	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; EXTRACELLULAR-MATRIX; ECTOPROTEIN KINASES; CANCER BIOMARKER; FRAGMENTS; PLASMA; MECHANOBIOLOGY; PROGRESSION; EXPRESSION; YAP	A large number of extracellular matrix proteins have been found in phosphorylated states, yet little is known about how the phosphorylation of extracellular matrix proteins might affect cell functions. We thus tested the hypothesis whether the phosphorylation of fibronectin, a major adhesion protein, affects cell behavior. Controlled in vitro phosphorylation of fibronectin by a casein kinase II (CKII) significantly upregulated cell traction forces and total strain energy generated by fibroblasts on nanopillar arrays, and consequently other elementary cell functions including cell spreading and metabolic activity. Mass spectrometry of plasma fibronectin from healthy human donors then identified a constitutively phosphorylated site in the C-terminus, and numerous other residues that became phosphorylated by the CKII kinase in vitro. Our findings open up novel strategies for translational applications including targeting diseased ECM, or to develop assays that probe the phosphorylation state of the ECM or blood as potential cancer markers.	[Yalak, Garif; Shiu, Jau-Ye; Schoen, Ingmar; Mitsi, Maria; Vogel, Viola] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Lab Appl Mechanobiol, Inst Translat Med, Zurich, Switzerland; [Schoen, Ingmar] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Irish Ctr Vasc Biol, Dublin, Ireland; [Mitsi, Maria] Swiss Fed Inst Technol, Lab Food & Soft Mat, Inst Food Nutr & Hlth, Dept Hlth Sci & Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Royal College of Surgeons - Ireland; Swiss Federal Institutes of Technology Domain; ETH Zurich	Vogel, V (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Lab Appl Mechanobiol, Inst Translat Med, Zurich, Switzerland.	viola.vogel@hest.ethz.ch	Vogel, Viola/O-8025-2015; Schoen, Ingmar/K-8312-2017; Mitsi, Maria/S-2519-2017	Vogel, Viola/0000-0003-2898-7671; Schoen, Ingmar/0000-0002-5699-1160; Mitsi, Maria/0000-0001-8983-1983	ERC Advanced Grant (European Research Council) [233157]; Swiss Initiative in Systems Biology (SystemsX.ch, "Phosphorylation Modulated Networks of the Cell" (PhosphoNetX)); Swiss National Science Foundation (SNF) [3100A0-116236]; ETH Zurich	ERC Advanced Grant (European Research Council); Swiss Initiative in Systems Biology (SystemsX.ch, "Phosphorylation Modulated Networks of the Cell" (PhosphoNetX)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); ETH Zurich(ETH Zurich)	This work was supported by funding from the ERC Advanced Grant (European Research Council, Contract Nr. 233157, to VV), the Swiss Initiative in Systems Biology (SystemsX. ch, "Phosphorylation Modulated Networks of the Cell" (PhosphoNetX), to VV), the Swiss National Science Foundation (SNF, Contract Nr. 3100A0-116236, to VV) and by the ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Rueda N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007581; Babiker AA, 2006, PROSTATE, V66, P675, DOI 10.1002/pros.20268; Babinska A, 1996, AM J PHYSIOL-HEART C, V271, pH2134, DOI 10.1152/ajpheart.1996.271.5.H2134; Bordoli MR, 2014, CELL, V158, P1033, DOI 10.1016/j.cell.2014.06.048; Boskey AL, 2008, BONE, V42, P1061, DOI 10.1016/j.bone.2008.01.016; CARSONS S, 1987, J RHEUMATOL, V14, P1052; Cho YS, 2000, P NATL ACAD SCI USA, V97, P835, DOI 10.1073/pnas.97.2.835; Chu LY, 2012, ARTERIOSCL THROM VAS, V32, P760, DOI 10.1161/ATVBAHA.111.242511; DeJager CA, 1996, SCAND J CLIN LAB INV, V56, P351, DOI 10.3109/00365519609090587; Discher DE, 2017, ANNU REV BIOPHYS, V46, P295, DOI 10.1146/annurev-biophys-062215-011206; Ek-Rylander B, 2010, EXP CELL RES, V316, P443, DOI 10.1016/j.yexcr.2009.10.019; Fernandez-Sanchez ME, 2015, ANNU REV CELL DEV BI, V31, P373, DOI 10.1146/annurev-cellbio-102314-112441; Hammarsten O., 1883, H-S Z PHYSIOL CHEM, V7, P227; He S, 2018, ANAL CHEM, V90, P6071, DOI 10.1021/acs.analchem.7b05417; Hertig S, 2012, NANO LETT, V12, P5162, DOI 10.1021/nl302153h; Hillen TJ, 2001, BIOCHEM BIOPH RES CO, V280, P259, DOI 10.1006/bbrc.2000.4083; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; IMADA S, 1988, EXP CELL RES, V179, P554, DOI 10.1016/0014-4827(88)90293-5; Kita T, 2004, CANCER LETT, V208, P187, DOI 10.1016/j.canlet.2004.02.018; Kuo CW, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/26/265302; LACELLE P, 1991, BLOOD, V77, P2037; Leeming DJ, 2011, BIOMARKERS, V16, P193, DOI 10.3109/1354750X.2011.557440; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045910; Nesterova MV, 2006, CANCER RES, V66, P8971, DOI 10.1158/0008-5472.CAN-06-1049; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rodriguez FA, 2008, P NATL ACAD SCI USA, V105, P5693, DOI 10.1073/pnas.0802065105; Rohwedder I, 2012, EMBO MOL MED, V4, P564, DOI 10.1002/emmm.201200237; Seger D, 2001, J BIOL CHEM, V276, P16998, DOI 10.1074/jbc.M003766200; Shintani Y, 2009, BIOCHEM BIOPH RES CO, V385, P618, DOI 10.1016/j.bbrc.2009.05.108; Shiu JY, 2018, NAT CELL BIOL, V20, P262, DOI 10.1038/s41556-017-0030-y; Song CJ, 2006, PLANT PHYSIOL, V140, P1222, DOI 10.1104/pp.105.073072; Stavenuiter F, 2013, FASEB J, V27, P2918, DOI 10.1096/fj.12-225961; Tagliabracci VS, 2015, CELL, V161, P1619, DOI 10.1016/j.cell.2015.05.028; Tagliabracci VS, 2013, TRENDS BIOCHEM SCI, V38, P121, DOI 10.1016/j.tibs.2012.11.008; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Trachana V, 2005, INT J BIOCHEM CELL B, V37, P478, DOI 10.1016/j.biocel.2004.08.001; VINCENT PA, 1988, EXP MOL PATHOL, V48, P403, DOI 10.1016/0014-4800(88)90074-3; Vogel V, 2018, ANNU REV PHYSIOL, V80, P353, DOI 10.1146/annurev-physiol-021317-121312; Wang H, 2007, CANCER EPIDEM BIOMAR, V16, P789, DOI 10.1158/1055-9965.EPI-06-0367; Yalak G, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0482-4; Yalak G, 2015, CANCER MED-US, V4, P404, DOI 10.1002/cam4.368; Yalak G, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003273; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	44	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218893	10.1371/journal.pone.0218893	http://dx.doi.org/10.1371/journal.pone.0218893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291285	gold, Green Published, Green Submitted			2022-12-26	WOS:000484947800039
J	Dong, H; Campbell, B; Rabinowitz, AN				Dong, Huan; Campbell, Benjamin; Rabinowitz, Adam N.			Factors impacting producer marketing through community supported agriculture	PLOS ONE			English	Article							UNITED-STATES; FOOD	Nowadays, consumers have become increasingly aware of their local food system as a result of concerning about health and nutrition, food safety and sustainability, and local economic development. This transitional shift from global to direct-to-consumer farm operations has increased the demand for locally produced foods. As an alternative, community supported agriculture (CSA), a direct and sustainable food channel, has gained tremendous popularity in the US. Despite the interest garnered by local agriculture and CSA, relatively few studies have empirically tested the determinants of why this marketing phenomenon has grown so rapidly. The purpose of this study is to explore the factors that drive producers to market their products through CSA by using a county-level data set from the US. Results using a Tobit model indicate that specific operator characteristics, such as young and female operators and those engaged in farming as primary occupation, play a strongly positive role in the likelihood of marketing through CSA; farms with small size, rented land, and engagement in growing vegetables, melons, fruits and tree nut crops are more interested in marketing via CSA; households with higher income and females significantly increase the share of farms marketing through CSA; presence of children and seniors and being married are negatively related to the demand for CSA foods. Moreover, counties with higher density of population, establishments-supermarket and other grocery stores, and legislation or active programs that encourage local food consumption tend to encourage more farms marketing through CSA.	[Dong, Huan] Sichuan Univ, Sch Publ Adm, Chengdu, Sichuan, Peoples R China; [Campbell, Benjamin] Univ Georgia, Dept Agr & Appl Econ, Athens, GA 30602 USA; [Rabinowitz, Adam N.] Univ Georgia, Dept Agr & Appl Econ, Tifton, GA USA	Sichuan University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Dong, H (corresponding author), Sichuan Univ, Sch Publ Adm, Chengdu, Sichuan, Peoples R China.	dhuan8844@126.com		Rabinowitz, Adam/0000-0002-3264-5327; dong, huan/0000-0002-1667-075X	National Social Science Fund of China [17CJY042]; China Postdoctoral Science Foundation [2018M633391]; China Scholarship Council [201406340144]	National Social Science Fund of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Scholarship Council(China Scholarship Council)	This work was financially supported by the National Social Science Fund of China (grant no. 17CJY042) and China Postdoctoral Science Foundation (grant no. 2018M633391). We also kindly thank the China Scholarship Council for their support (grant no. 201406340144).	[Anonymous], 2010, 97 USDA EC RES SERV; Berning J. P., 2012, Agricultural and Resource Economics Review, V41, P57; Bond J. K., 2009, Journal of Agricultural and Applied Economics, V41, P61; Borghans L, 2009, 14713 NBER; Brown C, 2008, AM J AGR ECON, V90, P1296, DOI 10.1111/j.1467-8276.2008.01220.x; Centers for Disease Control and Prevention, 2011 EST FOODB ILLN; Cicia G., 2011, International Journal on Food System Dynamics, V2, P326; Connolly C, 2014, AM J AGR ECON, V96, P1102, DOI 10.1093/ajae/aau030; Curtis K., 2013, Journal of Food Distribution Research, V44, P42; DeLind LB, 1999, HUM ORGAN, V58, P190, DOI 10.17730/humo.58.2.lpk17625008871x7; Devault G, 1991, NEW FARM, V13, P14; Dong DS, 2012, AM J AGR ECON, V94, P702, DOI 10.1093/ajae/aas013; Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S; Drewnowski Adam, 2010, Nutr Today, V44, P246; Groh T., 1997, FARMS TOMORROW REVIS; Haney JM, 2015, J AGRIC FOOD SYST CO, V5, P27, DOI 10.5304/jafscd.2015.053.009; Hayden J, 2012, GEOFORUM, V43, P332, DOI 10.1016/j.geoforum.2011.08.003; Jehle G. A., 2011, ADV MICROECONOMIC TH; Jekanowski M. D., 2000, Agricultural and Resource Economics Review, V29, P43; Jianakoplos NA, 1998, ECON INQ, V36, P620, DOI 10.1111/j.1465-7295.1998.tb01740.x; Kolodinsky JM, 1997, J SUSTAIN AGR, V10, P129, DOI 10.1300/J064v10n02_11; Lang KB, 2010, CULT AGRIC FOOD ENVI, V32, P17, DOI 10.1111/j.1556-486X.2010.01032.x; Lass D., 2003, COMMUNITY SUPPORTED; Liu P., 2014, CHINA RURAL SURVEY, V2, P73; Mas-colell A., 2004, MICROECONOMIC THEORY; Meyer J., 2012, COMMUNITY SUPP UNPUB; Monson J., 2008, Journal of Food Distribution Research, V39, P1; Moschini G., 2001, HDB AGR EC, V1, P88; Oberholter L., 2014, COMMUNITY SUPPORTED; Park T, 2014, AGR ECON-BLACKWELL, V45, P213, DOI 10.1111/agec.12042; Paul M, 2019, J AGRAR CHANGE, V19, P162, DOI 10.1111/joac.12280; Peterson HH, 2015, ECOL ECON, V119, P64, DOI 10.1016/j.ecolecon.2015.07.013; Pole A, 2013, AGR HUM VALUES, V30, P85, DOI 10.1007/s10460-012-9391-9; Schifferstein HNJ, 1988, FOOD QUAL PREFER, V9, P119; Strolling of the Heifers, 2015, WHICH STAT AR MOST C; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Uematsu H., 2011, Agricultural and Resource Economics Review, V40, P1; Underhill S. E., 1996, Journal of Food Distribution Research, V27, P56; Van der Ploeg JD, 2001, RURAL DEV STATE ART; Vassalos M, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9030478; Warner, 1996, J FOOD DISTRIB RES, V27, P90; Wells B. L., 2001, Agriculture and Human Values, V18, P107, DOI 10.1023/A:1007686617087; Zepeda L., 2004, Journal of Food Distribution Research, V35, P1; Zepeda L., 2006, Journal of Food Distribution Research, V37, P1; Zepeda L, 2013, AGR HUM VALUES, V30, P605, DOI 10.1007/s10460-013-9432-z	45	2	2	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219498	10.1371/journal.pone.0219498	http://dx.doi.org/10.1371/journal.pone.0219498			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS7KI	31287848	Green Published, gold, Green Submitted			2022-12-26	WOS:000482328300023
J	Radhakrishnan, S; Lee, YTT; Rachuri, S; Kamarthi, S				Radhakrishnan, Srinivasan; Lee, Yung-Tsun Tina; Rachuri, Sudarsan; Kamarthi, Sagar			Complexity and entropy representation for machine component diagnostics	PLOS ONE			English	Article							MULTISCALE PERMUTATION ENTROPY; EMPIRICAL MODE DECOMPOSITION; FRACTIONAL BROWNIAN-MOTION; SUPPORT VECTOR MACHINE; FAULT-DIAGNOSIS; APPROXIMATE ENTROPY; WAVELET TRANSFORM; CAUSALITY PLANE; BALL-BEARING; TIME-SERIES	The Complexity-entropy causality plane (CECP) is a parsimonious representation space for time series. It has only two dimensions: normalized permutation entropy (H-S) and Jensen-Shannon complexity (C-JS) of a time series. This two-dimensional representation allows for detection of slow or rapid drifts in the condition of mechanical components monitored through sensor measurements. The CECP representation can be used for both predictive analytics and visual monitoring of changes in component condition. This method requires minimal pre-processing of raw signals. Furthermore, it is insensitive to noise, stationarity, and trends. These desirable properties make CECP a good candidate for machine condition monitoring and fault diagnostics. In this work we study the effectiveness of CECP on three rotary component condition assessment applications. We use CECP representation of vibration signals to differentiate various machine component health conditions for rotary machine components, namely roller bearing and gears. The results confirm that the CECP representation is able to detect, with high accuracy, changes in underlying dynamics of machine component degradation states. From class separability perspective, the CECP representation is able to generate linearly separable classes for the classification of different fault states. This classification performance improves with increasing signal length. For signal length of 16,384 data points, the fault classification accuracy varies from 90% to 100% for bearing applications, and from 85% to 100% for gear applications. We observed that the optimum parameter for CECP representatino depends on the application. For bearing applications we found that embedding dimension D = 4, 5, 6, and embedding delay tau = 1, 2, 3 are suitable for good fault classification. For gear applications we find that embedding dimension D = 4, 5, and embedding delay tau = 1, 5 are suitable for fault classification.	[Radhakrishnan, Srinivasan; Kamarthi, Sagar] Northeastern Univ, Mech & Ind Engn, Boston, MA 02115 USA; [Lee, Yung-Tsun Tina] NIST, Syst Integrat Div, Gaithersburg, MD 20899 USA; [Rachuri, Sudarsan] US DOE, Adv Mfg Off, EERE, Washington, DC 20585 USA	Northeastern University; National Institute of Standards & Technology (NIST) - USA; United States Department of Energy (DOE)	Kamarthi, S (corresponding author), Northeastern Univ, Mech & Ind Engn, Boston, MA 02115 USA.	sagar@coe.neu.edu	Kamarthi, Sagar/P-7226-2014	Kamarthi, Sagar/0000-0001-5845-7714	National Institute of Standards and Technology [70NANB15H028]	National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA)	This work was supported by National Institute of Standards and Technology (https://www.nist.gov/), grant number: 70NANB15H028 (initials of the author who received award: SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this research was provided by the National Institute of Standards and Technology under sponsor award number 70NANB15H028.	[Anonymous], 2009, PHM GEAR DATASET; [Anonymous], 2013, MSFT BEARING DATASET; [Anonymous], 2015, CWRU BEARING DATASET; Antoni J, 2007, MECH SYST SIGNAL PR, V21, P108, DOI 10.1016/j.ymssp.2005.12.002; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Bandt C, 2007, J TIME SER ANAL, V28, P646, DOI 10.1111/j.1467-9892.2007.00528.x; Barszcz T, 2009, MECH SYST SIGNAL PR, V23, P1352, DOI 10.1016/j.ymssp.2008.07.019; Combet F, 2009, MECH SYST SIGNAL PR, V23, P652, DOI 10.1016/j.ymssp.2008.08.002; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Dunn J.C., 1974, J CYBERNETICS, V4, P95, DOI 10.1080/01969727408546059; El-Thalji I, 2015, MECH SYST SIGNAL PR, V60-61, P252, DOI 10.1016/j.ymssp.2015.02.008; El-Thalji I, 2014, ENG FAIL ANAL, V45, P204, DOI 10.1016/j.engfailanal.2014.06.004; Feldman DP, 1998, PHYS LETT A, V238, P244, DOI 10.1016/S0375-9601(97)00855-4; Gaber MM, 2005, SIGMOD REC, V34, P18, DOI 10.1145/1083784.1083789; Han MH, 2015, MEASUREMENT, V76, P7, DOI 10.1016/j.measurement.2015.08.019; Harvey TJ, 2007, WEAR, V263, P1492, DOI 10.1016/j.wear.2006.12.073; He X., 2005, ADV NEURAL INFORM PR, V18; Jantunen E., 2006, International Journal of COMADEM, V9, P24; Kowalski AM, 2007, PHYSICA D, V233, P21, DOI 10.1016/j.physd.2007.06.015; Lamberti PW, 2004, PHYSICA A, V334, P119, DOI 10.1016/j.physa.2003.11.005; Lee J, 2014, MECH SYST SIGNAL PR, V42, P314, DOI 10.1016/j.ymssp.2013.06.004; Lei YG, 2010, EXPERT SYST APPL, V37, P1419, DOI 10.1016/j.eswa.2009.06.060; Li YB, 2016, MEASUREMENT, V77, P80, DOI 10.1016/j.measurement.2015.08.034; Lopez-Ruiz R., 2011, STAT COMPLEXITY, P65; LopezRuiz R, 1995, PHYS LETT A, V209, P321, DOI 10.1016/0375-9601(95)00867-5; Loutas TH, 2009, APPL ACOUST, V70, P1148, DOI 10.1016/j.apacoust.2009.04.007; Ma H, 2015, ENG FAIL ANAL, V48, P105, DOI 10.1016/j.engfailanal.2014.11.018; Martin MT, 2006, PHYSICA A, V369, P439, DOI 10.1016/j.physa.2005.11.053; Mori K, 1996, WEAR, V195, P162, DOI 10.1016/0043-1648(95)06817-1; Ni Q., 2017, CASE STUD ENG FAI SC, V9, P99, DOI DOI 10.1016/j.csefa.2017.10.002; Parey A, 2007, MECH SYST SIGNAL PR, V21, P234, DOI 10.1016/j.ymssp.2005.12.011; Parey A, 2006, J SOUND VIB, V294, P547, DOI 10.1016/j.jsv.2005.11.021; Pennekamp F, 2019, ECOL MONOGR, V89, DOI 10.1002/ecm.1359; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; Ribeiro HV, 2012, PHYSICA A, V391, P2421, DOI 10.1016/j.physa.2011.12.009; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rosso OA, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061114; Rosso OA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154102; Rosso OA, 2013, EUR PHYS J B, V86, DOI [10.1140/epjb/e2013-30764-5, 10.1140/epjb/e2012-30307-8]; Ruqiang Yan, 2004, Proceedings of the 21st IEEE Instrumentation and Measurement Technology Conference (IEEE Cat. No.04CH37510), P2054, DOI 10.1109/IMTC.2004.1351493; Serinaldi F, 2014, STOCH ENV RES RISK A, V28, P1685, DOI 10.1007/s00477-013-0825-8; Shibata K, 2000, MECH SYST SIGNAL PR, V14, P229, DOI 10.1006/mssp.1999.1255; Smith WA, 2015, MECH SYST SIGNAL PR, V64-65, P100, DOI 10.1016/j.ymssp.2015.04.021; Thaxton CS, 2018, STOCH ENV RES RISK A, V32, P843, DOI 10.1007/s00477-017-1434-8; Traversaro F, 2018, COMMUN NONLINEAR SCI, V57, P388, DOI 10.1016/j.cnsns.2017.10.013; Wang WY, 2001, MECH SYST SIGNAL PR, V15, P887, DOI 10.1006/mssp.2001.1416; Wu SD, 2012, ENTROPY-SWITZ, V14, P1343, DOI 10.3390/e14081343; Yan RQ, 2007, MECH SYST SIGNAL PR, V21, P824, DOI 10.1016/j.ymssp.2006.02.009; Yan RQ, 2012, MECH SYST SIGNAL PR, V29, P474, DOI 10.1016/j.ymssp.2011.11.022; Yan RQ, 2009, INT J WAVELETS MULTI, V7, P411, DOI 10.1142/S0219691309002994; Yoshioka T, 2009, TRIBOL T, V52, P725, DOI 10.1080/10402000902913345; Zanin M, 2012, ENTROPY-SWITZ, V14, P1553, DOI 10.3390/e14081553; Zhang L, 2010, EXPERT SYST APPL, V37, P6077, DOI 10.1016/j.eswa.2010.02.118; Zhang XY, 2015, MEASUREMENT, V69, P164, DOI 10.1016/j.measurement.2015.03.017; Zhang X, 2015, J SOUND VIB, V339, P419, DOI 10.1016/j.jsv.2014.11.021; Zhang XH, 2014, INT J SYST ASSUR ENG, V5, P645, DOI 10.1007/s13198-014-0217-6; Zhang ZQ, 2012, TRIBOL INT, V47, P25, DOI 10.1016/j.triboint.2011.10.002; [赵志宏 Zhao Zhihong], 2012, [振动与冲击, Journal of Vibration and Shock], V31, P136; Zhu KH, 2014, MEASUREMENT, V47, P669, DOI 10.1016/j.measurement.2013.09.019; Zunino L, 2008, PHYSICA A, V387, P6057, DOI 10.1016/j.physa.2008.07.004; Zunino L, 2008, PHYS LETT A, V372, P4768, DOI 10.1016/j.physleta.2008.05.026; Zunino L, 2012, PHYSICA A, V391, P4342, DOI 10.1016/j.physa.2012.04.009; Zunino L, 2011, PHYSICA A, V390, P876, DOI 10.1016/j.physa.2010.11.020; Zunino L, 2010, PHYSICA A, V389, P1891, DOI 10.1016/j.physa.2010.01.007	67	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0217919	10.1371/journal.pone.0217919	http://dx.doi.org/10.1371/journal.pone.0217919			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287818	Green Published, Green Submitted, gold			2022-12-26	WOS:000482328300004
J	Dogan-Sander, E; Willenberg, A; Batmaz, I; Enzenbach, C; Wirkner, K; Kohls, E; Mergl, R; Thiery, J; Kratzsch, J; Hegerl, U; Sander, C				Dogan-Sander, Ezgi; Willenberg, Anja; Batmaz, Inci; Enzenbach, Cornelia; Wirkner, Kerstin; Kohls, Elisabeth; Mergl, Roland; Thiery, Joachim; Kratzsch, Juergen; Hegerl, Ulrich; Sander, Christian			Association of serum 25-hydroxyvitamin D concentrations with sleep phenotypes in a German community sample	PLOS ONE			English	Article							VITAMIN-D-METABOLISM; SOCIOECONOMIC-STATUS; DISORDERS; QUALITY; ADULTS; DURATION; HEALTH; POLYSOMNOGRAPHY; PREVALENCE; OBESITY	Background Sleep disorders and vitamin D deficiency are among the most common health problems. Few studies investigated the effect of vitamin D on objectively recorded sleep with sound methodological quality and reasonable temporal proximity. Objective To investigate the relationship between serum 25-hydroxyvitamin D (25(OH)D) concentrations and objective sleep parameters assessed within close temporal proximity in a population-based sample. It is expected that higher serum 25(OH)D concentrations are associated with 1) better objective sleep outcomes (longer sleep duration, higher sleep efficiency, earlier mid-sleep time) and 2) more positive subjective sleep evaluations. Methods A subset of participants (n = 1045) from the LIFE-Adult-Study was analysed. Measurement of serum 25(OH)D vitamin was performed using an electrochemiluminescence immunoassay. Actigraphic assessments were performed using SenseWear Pro 3 devices. The following objective sleep parameters were calculated: total sleep duration, night sleep duration, night sleep efficiency, midsleep time and wake after sleep onset (WASO). Subjective sleep evaluations were assessed via questionnaire (sleep quality (PSQI), daytime sleepiness (ESS)). Data were analysed applying a multiple linear regression model with a stepwise approach. Results The regression models revealed significant associations of serum 25(OH)D concentration with night sleep duration and midsleep time. No association was found for total sleep duration and night sleep efficiency. Higher serum 25(OH)D concentration was further associated with shorter WASO in males but longer WASO in females. Moreover, serum 25(OH)D concentration did not show any significant association with subjective sleep quality and daytime sleepiness. Conclusion The results indicate that a higher concentration of serum 25(OH)D is associated with longer and earlier night sleep. Although the present study was able to demonstrate an association between serum 25(OH)D concentration and objective sleep parameters, no conclusion about underlying mechanisms or causal inferences can be drawn.	[Dogan-Sander, Ezgi; Kohls, Elisabeth; Hegerl, Ulrich; Sander, Christian] Univ Leipzig, Med Ctr, Dept Psychiat & Psychotherapy, Leipzig, Germany; [Willenberg, Anja; Thiery, Joachim; Kratzsch, Juergen] Univ Leipzig, Med Ctr, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Willenberg, Anja; Enzenbach, Cornelia; Wirkner, Kerstin; Mergl, Roland; Thiery, Joachim; Kratzsch, Juergen; Hegerl, Ulrich; Sander, Christian] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, Leipzig, Germany; [Batmaz, Inci] Middle East Tech Fac, Dept Stat, Arts & Sci Fac, Ankara, Turkey; [Enzenbach, Cornelia] Univ Leipzig, IMISE, Leipzig, Germany; [Mergl, Roland] Bundeswehr Univ Munich, Inst Clin Psychol & Psychotherapy, Neubiberg, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Bundeswehr University Munich	Dogan-Sander, E (corresponding author), Univ Leipzig, Med Ctr, Dept Psychiat & Psychotherapy, Leipzig, Germany.	Ezgi.Dogan@medizin.uni-leipzig.de	Sander, Christian/AAB-8674-2022	Sander, Christian/0000-0002-5402-6631; Dogan-Sander, Ezgi/0000-0003-0148-2163	LIFE Leipzig Research Centre for Civilization Diseases; Medical Faculty of the University of Leipzig; European Regional Development Fund (ERDF); Free State of Saxony within the framework of the excellence initiative [713-241202, 14505/2470, 14575/2470]; German Research Foundation (DFG); Leipzig University within the program of Open Access Publishing; European Union	LIFE Leipzig Research Centre for Civilization Diseases; Medical Faculty of the University of Leipzig; European Regional Development Fund (ERDF)(European Commission); Free State of Saxony within the framework of the excellence initiative; German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University within the program of Open Access Publishing; European Union(European Commission)	This publication is supported by LIFE Leipzig Research Centre for Civilization Diseases, an organisational unit affiliated to the Medical Faculty of the University of Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by funds of the Free State of Saxony within the framework of the excellence initiative (project numbers 713-241202, 713-241202, 14505/2470, 14575/2470). We also acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing.	Alsaadi SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095824; Bansil P, 2011, J CLIN HYPERTENS, V13, P739, DOI 10.1111/j.1751-7176.2011.00500.x; Bertisch SM, 2015, SLEEP, V38, P1305, DOI 10.5665/sleep.4914; Beydoun MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103490; Budhiraja R, 2011, SLEEP, V34, P859, DOI 10.5665/SLEEP.1114; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Caprio M, 2017, EAT WEIGHT DISORD-ST, V22, P27, DOI 10.1007/s40519-016-0312-6; Carlander B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020433; Cashman KD, 2016, AM J CLIN NUTR, V103, P1033, DOI 10.3945/ajcn.115.120873; Centers for Disease Control and Prevention, SLEEP SLEEP DIS DAT; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Colten HR, 2006, SLEEP DISORDERS SLEE; Cui XY, 2017, MOL CELL ENDOCRINOL, V453, P131, DOI 10.1016/j.mce.2017.05.035; Evatt ML, 2015, SLEEP, V38, P171, DOI 10.5665/sleep.4386; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Gao Q, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101395; Gominak SC, 2012, MED HYPOTHESES, V79, P132, DOI 10.1016/j.mehy.2012.03.031; Grandner MA, 2010, SLEEP MED, V11, P180, DOI 10.1016/j.sleep.2009.07.014; Huang W, 2013, CLIN J PAIN, V29, P341, DOI 10.1097/AJP.0b013e318255655d; Imai CM, 2015, J NUTR SCI, V4, DOI 10.1017/jns.2015.27; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jung YS, 2017, ANN OCCUP ENVIRON ME, V29, DOI 10.1186/s40557-017-0187-7; Kaneko I, 2015, FASEB J, V29, P4023, DOI 10.1096/fj.14-269811; Kerkhof GA, 2017, SLEEP MED, V30, P229, DOI 10.1016/j.sleep.2016.09.015; Kim JH, 2014, J AM GERIATR SOC, V62, P2327, DOI 10.1111/jgs.13148; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Kutner M., 2004, APPL LINEAR REGRESSI, V4th; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P631, DOI 10.1007/s00103-012-1663-4; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P131, DOI 10.1007/s00103-012-1583-3; Lips P, 2004, J STEROID BIOCHEM, V89-90, P611, DOI 10.1016/j.jsbmb.2004.03.040; Loeffler M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1983-z; Mason C, 2016, PREV MED, V93, P166, DOI 10.1016/j.ypmed.2016.09.035; Massa J, 2015, SLEEP, V38, P251, DOI 10.5665/sleep.4408; McCarty DE, 2014, SLEEP MED REV, V18, P311, DOI 10.1016/j.smrv.2013.07.001; McCarty DE, 2012, J CLIN SLEEP MED, V8, P693, DOI 10.5664/jcsm.2266; Milaneschi Y, 2014, MOL PSYCHIATR, V19, P444, DOI 10.1038/mp.2013.36; Montgomery D.C., 2015, INTRO LINEAR REGRESS; Muscogiuri G, 2019, SLEEP MED, V54, P262, DOI 10.1016/j.sleep.2018.10.033; O'Driscoll DM, 2013, SLEEP BREATH, V17, P139, DOI 10.1007/s11325-012-0662-x; Ono D, 2017, NEUROSCI RES, V118, P74, DOI 10.1016/j.neures.2017.03.013; Papandreou D, 2015, DIS MARKERS, V2015, P1, DOI 10.1155/2015/580474; Peterson BT, 2012, SLEEP MED, V13, P419, DOI 10.1016/j.sleep.2011.12.003; Phinney KW, 2008, AM J CLIN NUTR, V88, p511S, DOI 10.1093/ajcn/88.2.511S; Piovezan RD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180901; SchmeiserRieder A, 1995, J EPIDEMIOL COMMUN H, V49, P645, DOI 10.1136/jech.49.6.645; Sharif MM, 2013, ANN THORAC MED, V8, P53, DOI 10.4103/1817-1737.105720; Shin M, 2015, SLEEP SCI, V8, P9, DOI 10.1016/j.slsci.2015.02.003; Shiue I, 2013, INT J CARDIOL, V168, P5074, DOI 10.1016/j.ijcard.2013.07.195; Spada J, 2016, J SLEEP RES, V25, P690, DOI 10.1111/jsr.12421; SUNSERI M, 2009, SENSEWEAR ARMBAND SL; Vogeser M, 2004, CLIN CHEM, V50, P1415, DOI 10.1373/clinchem.2004.031831; WHO, 2004, WHO TECHN M SLEEP HL; Wicherts IS, 2007, J CLIN ENDOCR METAB, V92, P2058, DOI 10.1210/jc.2006-1525; Zhang YL, 2016, ASIA PAC J CLIN NUTR, V25, P333, DOI 10.6133/apjcn.2016.25.2.15	55	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219318	10.1371/journal.pone.0219318	http://dx.doi.org/10.1371/journal.pone.0219318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276483	gold, Green Published, Green Submitted			2022-12-26	WOS:000484936300065
J	Orlova, NA; Kovnir, SV; Khodak, YA; Polzikov, MA; Nikitina, VA; Skryabin, KG; Vorobiev, II				Orlova, Nadezhda A.; Kovnir, Sergey V.; Khodak, Yulia A.; Polzikov, Mikhail A.; Nikitina, Victoria A.; Skryabin, Konstantin G.; Vorobiev, Ivan I.			High-level expression of biologically active human follicle stimulating hormone in the Chinese hamster ovary cell line by a pair of tricistronic and monocistronic vectors	PLOS ONE			English	Article							RECOMBINANT; GLYCOSYLATION; SEQUENCE; IRES	Recombinant human follicle stimulating hormone (FSH), produced in Chinese hamster ovary (CHO) cells, is widely used for treatment of fertility disorders and is subject to biosimilars development. Cell lines with high specific productivities may simplify the FSH production process. Here, we used our previously established expression system based on vector p1.1 to create new cell lines secreting heterodimeric FSH protein. To this end, we linked open reading frames of both FSH subunits by the wild-type internal ribosome entry site from the encephalomyocarditis virus (EMCV IRES). Intact and double-negative for the dihydrofolate reductase CHO cells were stably transfected by the FSH-coding plasmids. Stably transfected intact cells showed higher level of the FSH secretion and were utilized for subsequent methotrexate-driven transgene amplification, which doubled their productivity. The excess of the free alpha-subunit was corrected by transfecting the cells by the additional p1.1-based plasmid encoding the beta-subunit of the FSH. Clonal cell lines obtained secreted mostly the heterodimeric FSH and possessed specific productivities up to 12.3 +/- 1.7 pg/cell/day. Candidate clonal cell line C-P1.3-FSH-G4 maintained a constant specific productivity for at least 2 months of culturing without the section pressure. The resulting FSH protein conformed to the international pharmaceutical quality criteria as evidenced by the receptor binding kinetics, distribution pattern of hormone isoforms and biological activity. In conclusion, our expression system offers a simple and cost-effective approach to production of FSH.	[Orlova, Nadezhda A.; Kovnir, Sergey V.; Khodak, Yulia A.; Skryabin, Konstantin G.; Vorobiev, Ivan I.] Russian Acad Sci, Biotechnol Res Ctr, Inst Bioengn, Lab Mammalian Cell Bioengn, Moscow, Russia; [Polzikov, Mikhail A.] IVFarma LLC, Moscow, Russia; [Nikitina, Victoria A.] Fed Med Biol Agcy, Burnasyan Fed Med Biophys Ctr, State Res Ctr, Lab Radiat Hematol & Cytogenet, Moscow, Russia; [Vorobiev, Ivan I.] Russian Acad Sci, Inst Bioorgan Chem, Lab Biocatalysis, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Burnazyan Federal Medical Biophysical Center; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Vorobiev, II (corresponding author), Russian Acad Sci, Biotechnol Res Ctr, Inst Bioengn, Lab Mammalian Cell Bioengn, Moscow, Russia.; Vorobiev, II (corresponding author), Russian Acad Sci, Inst Bioorgan Chem, Lab Biocatalysis, Moscow, Russia.	ptichman@gmail.com	Orlova, Nadezhda/AAE-8279-2020; Vorobiev, Ivan/ABF-6809-2021; Nikitina, Victoria/D-3116-2012; Polzikov, Mikhail/GRY-3996-2022	Orlova, Nadezhda/0000-0001-9483-2892; Vorobiev, Ivan/0000-0003-0064-4458; Nikitina, Victoria/0000-0002-3150-7686; Polzikov, Mikhail/0000-0001-5345-0230	Russian Foundation for Basic Research (Moscow, Russia) [16-34-60242]; IVFarma LLC (Moscow, Russia) [105/12]; Institute of Bioengineering; Russian Foundation of Basic Research	Russian Foundation for Basic Research (Moscow, Russia); IVFarma LLC (Moscow, Russia); Institute of Bioengineering; Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR))	The project was supported by the grant 16-34-60242 of the Russian Foundation for Basic Research (Moscow, Russia; website https://www.rfbr.ru/rffi/eng) to NAO in a part of p1.1 derivative vectors comparison and investigation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The project was supported by IVFarma LLC (Moscow, Russia, website http://ivfarma.ru), having a contract. 105/12 dated by October, 15th, 2012 with the Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences. Contract was devoted to the creation of the FSHproducing cell-line, purification and characterization of the secreted product. According to the terms of the contract, the funding was received by the Institute of Bioengineering and it was spent in part on materials and reagents and employee (SVK, YAK, NAO, IIV) salaries. The funder also provided direct support in the form of the research materials and reagents. IVFarma LLC also provided support in the form of salary for VAN (short-term service contract) and to MAP (this company is his permanent job). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding organizations do not object and do not limit in any form of publication of articles on the topic of this study and/or sharing of data and/or materials included to our manuscript and supporting materials.; We would like to thank Oleg O. Glebov, Ph.D. and Prof. Alexandre G. Gabibov for the editing of the manuscript and valuable comments. DNA sequencing was carried out in the inter-institutional Center for collective use "GENOME" IMB RAS, organized with the support of the Russian Foundation of Basic Research.	BISHOP LA, 1995, ENDOCRINOLOGY, V136, P2635, DOI 10.1210/en.136.6.2635; Bochkov YA, 2006, BIOTECHNIQUES, V41, P283, DOI 10.2144/000112243; CHAPPEL SC, 1983, ENDOCR REV, V4, P179, DOI 10.1210/edrv-4-2-179; Gervais A, 2003, GLYCOBIOLOGY, V13, P179, DOI 10.1093/glycob/cwg020; Greenfield E. A., 2014, ANTIBODIES LAB MANUA; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Ho SCL, 2012, J BIOTECHNOL, V157, P130, DOI 10.1016/j.jbiotec.2011.09.023; Kelton CA, 1993, United States patent, Patent No. 5240832; Kim DJ, 2010, FERTIL STERIL, V93, P2652, DOI 10.1016/j.fertnstert.2009.05.009; Kirillova IV, 2013, CELL LINE HUFSHIK RE; Kovnir SV, 2018, ACTA NATURAE, V10, P51, DOI 10.32607/20758251-2018-10-151-65; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Li JD, 2007, J IMMUNOL METHODS, V318, P113, DOI 10.1016/j.jim.2006.10.010; Mastrangeli R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184139; Olijve W, 1996, MOL HUM REPROD, V2, P371, DOI 10.1093/molehr/2.5.371; Orlova NA, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0353-6; Orlova NA, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-56; Orvieto R, 2016, REPROD BIOL ENDOCRIN, V14, DOI 10.1186/s12958-016-0167-8; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; RATHNAM P, 1975, J BIOL CHEM, V250, P6735; Rohde J, 2012, DEV NEW CELL BASED A; Schlatter S, 2005, BIOTECHNOL PROGR, V21, P122, DOI 10.1021/bp049780w; Stefan A, 2012, FSH PRODUCING CELL C; Tyul'kina E. E., 2017, Eksperimental'naya i Klinicheskaya Farmakologiya, V80, P13; ULLOAAGUIRRE A, 1995, ENDOCR REV, V16, P765, DOI 10.1210/er.16.6.765; van Wely M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005354.pub2; Vorob'ev II, 2017, PHARM CHEM J+, V50, P753, DOI 10.1007/s11094-017-1525-3; Wang H, 2016, J PROTEOME RES, V15, P923, DOI 10.1021/acs.jproteome.5b00921	28	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219434	10.1371/journal.pone.0219434	http://dx.doi.org/10.1371/journal.pone.0219434			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276557	gold, Green Published			2022-12-26	WOS:000484936300078
J	Paaijmans, K; Brustollin, M; Aranda, C; Eritja, R; Talavera, S; Pages, N; Huijben, S				Paaijmans, Krijn; Brustollin, Marco; Aranda, Carles; Eritja, Roger; Talavera, Sandra; Pages, Nonito; Huijben, Silvie			Phenotypic insecticide resistance in arbovirus mosquito vectors in Catalonia and its capital Barcelona (Spain)	PLOS ONE			English	Article							WEST-NILE-VIRUS; AEDES-ALBOPICTUS; CULEX-PIPIENS; DIPTERA; INFECTION; CULICIDAE; FEVER; ANOPHELES; FRANCE	A range of mosquito species that belong to the Culicidae family are responsible for the worldwide transmission of infectious arboviral diseases such as dengue fever, Zika, West Nile fever and Chikungunya fever. Spain is at risk of arbovirus outbreaks, as various arboviral diseases are frequently introduced and it has established competent vector populations. Autochthonous human cases of West Nile virus have been reported infrequently since 2004, and since October 2018 three autochthonous human case of dengue fever have been confirmed. In response to an outbreak of any arboviral disease, space spraying or fogging will be implemented to control adult mosquito populations. To ensure adulticiding is cost-effective, the insecticide susceptibility status of vectors throughout Catalonia, an autonomous region in north-eastern Spain, was assessed through standardized WHO tube and CDC bottle bioassays. All Culex pipiens populations tested were resistant to at least one of the pyrethroids tested, whereas Aedes albopictus populations were susceptible to all pyrethroids tested. More detailed studies on the Cx. pipiens populations from the Barcelona area (the capital and largest city of Catalonia) revealed resistance to all four classes of public health insecticides available (pyrethroids, carbamates, organophosphates and organochlorides). All Ae. albopictus populations were susceptible to those classes, except for one of the tests performed with pirimiphos-methyl (an organophosphate). Pyrethroids are currently the first line chemical class to be used in space spray operations in response to an outbreak of an arboviral disease. While pyrethroids can be effective in reducing Ae. albopictus populations, this class may not be effective to control Cx. pipiens populations.	[Paaijmans, Krijn; Huijben, Silvie] ISGlobal, Barcelona, Spain; [Paaijmans, Krijn; Huijben, Silvie] Arizona State Univ, Ctr Evolut & Med, Sch Life Sci, Tempe, AZ 85281 USA; [Paaijmans, Krijn] Arizona State Univ, Biodesign Ctr Immunotherapy Vaccines & Virotherap, Tempe, AZ USA; [Brustollin, Marco; Aranda, Carles; Talavera, Sandra; Pages, Nonito] Ctr Recerca Sanitat Anim CReSA IRTA, Barcelona, Spain; [Brustollin, Marco] Penn State Univ, Ctr Infect Dis Dynam, Millennium Sci Complex, University Pk, PA 16802 USA; [Brustollin, Marco] Penn State Univ, Huck Inst Life Sci, Millennium Sci Complex, University Pk, PA 16802 USA; [Aranda, Carles; Eritja, Roger] Consell Comarcal Baix Llobregat, Serv Control Mosquits, Barcelona, Spain; [Eritja, Roger] CREAF, Cerdanyola Del Valles, Spain; [Pages, Nonito] CIRAD, UMR ASTRE, Petit Bourg, Guadeloupe, France; [Pages, Nonito] Montpellier Univ, INRA, CIRAD, ASTRE, Montpellier, France	ISGlobal; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; IRTA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); CIRAD; CIRAD; INRAE; Universite de Montpellier	Huijben, S (corresponding author), ISGlobal, Barcelona, Spain.; Huijben, S (corresponding author), Arizona State Univ, Ctr Evolut & Med, Sch Life Sci, Tempe, AZ 85281 USA.	silvie.huijben@asu.edu	Aranda, Carles/ABH-2778-2020; Paaijmans, Krijn/ABC-9928-2020; Talavera, Sandra/ABG-8759-2020; Pages, Nonito/Q-1274-2016	Aranda, Carles/0000-0003-1496-8306; Huijben, Silvie/0000-0002-3537-1915; Pages, Nonito/0000-0001-6020-7175	Programa Recercaixa 2011; Branco Weiss Fellowship	Programa Recercaixa 2011; Branco Weiss Fellowship	This work was financially supported by Programa Recercaixa 2011. Silvie Huijben was supported by a Branco Weiss Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alout H, 2014, J INFECT DIS, V210, P1464, DOI 10.1093/infdis/jiu276; Angelini R, 2007, Euro Surveill, V12; [Anonymous], 2016, WORLD HLTH ORG TECHN, DOI [10.1021/jp052915b, DOI 10.1021/JP052915B]; Aranda C, 2006, MED VET ENTOMOL, V20, P150, DOI 10.1111/j.1365-2915.2006.00605.x; Aranda C, 2018, EUROSURVEILLANCE, V23, P23, DOI 10.2807/1560-7917.ES.2018.23.47.1700837; Bagnarelli P, 2011, EUROSURVEILLANCE, V16, P5; Bahnck CM, 2006, AM J TROP MED HYG, V75, P251, DOI 10.4269/ajtmh.2006.75.2.0750251; Bahuon C, 2016, REV SCI TECH OIE, V35, P811, DOI 10.20506/rst.35.3.2571; Bengoa M, 2017, J AM MOSQUITO CONTR, V33, P246, DOI 10.2987/17-6636R.1; Bofill D, 2006, EMERG INFECT DIS, V12, P1163, DOI 10.3201/eid1207.060164; Brogdon W, 2010, GUIDELINE EVALUATING; Brustolin M, 2017, MED VET ENTOMOL, V31, P365, DOI 10.1111/mve.12254; Brustolin M, 2016, MED VET ENTOMOL, V30, P166, DOI 10.1111/mve.12164; Brustolin M., 2016, THESIS; Bueno-Mari R., 2012, European Mosquito Bulletin, P91; Busquets N, 2008, EMERG INFECT DIS, V14, P861, DOI 10.3201/eid1405.071577; Calba C, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.39.17-00647; Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058; Catalunya AdSPd, 2017, PROT VIG CONTR ARB T; Centro de Coordinacion de Alertas y Emergencias Sanitarias, 2016, EV RIESG VIR NIL OCC; Abramides GC, 2013, T ROY SOC TROP MED H, V107, P706, DOI 10.1093/trstmh/trt093; Chevillon C, 1999, BIOL J LINN SOC, V68, P147, DOI 10.1111/j.1095-8312.1999.tb01163.x; Collantes F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1262-y; Durand Jean-Paul, 2004, Rev Prat, V54, P703; ECDC, 2013, COMM DIS THREATS REP; ECDC, 2018, LOC TRANSM DENG FEV; Eritja R., 2000, European Mosquito Bulletin, V8, P10; Eritja R., 1998, ANALISI INTEGRADA DU; European Centre for Disease Prevention and Control, 2017, VECT CONTR FOC AED A; Ferraguti M, 2016, EPIDEMIOL INFECT, V144, P1907, DOI 10.1017/S0950268816000133; Fotakis EA, 2017, ACTA TROP, V174, P29, DOI 10.1016/j.actatropica.2017.06.005; Garcia-Bocanegra I, 2011, EMERG INFECT DIS, V17, P2397, DOI 10.3201/eid1712.110651; Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2; Glunt KD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003602; Gobierno de Canaries, 2017, SIST VIG ENT CAN DET; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Huijben S, 2018, EVOL APPL, V11, P415, DOI 10.1111/eva.12530; Junta de Andalucia, 2017, FIEBR NIL OCC; Kaptoul D, 2007, SCAND J INFECT DIS, V39, P70, DOI 10.1080/00365540600740553; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Alarcon-Elbal PM, 2014, MEM I OSWALDO CRUZ, V109, P782, DOI 10.1590/0074-0276140214; Neumayr A, 2017, EUROSURVEILLANCE, V22, P39, DOI 10.2807/1560-7917.ES.2017.22.1.30433; Observatori del Turisme a Barcelona: ciutat i regio, 2017, BARC TOUR ACT REP 20; Oliver SV, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-390; Owusu HF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03918-z; Padros J., 1997, CULICIDS BAIX LLOBRE; Pichler V, PEST MANAG SCI; Pichler V, 2018, PEST MANAG SCI, V74, P1319, DOI 10.1002/ps.4840; R Core Team, 2013, R LANG ENV STAT COMP; Rajatileka S, 2011, T ROY SOC TROP MED H, V105, P247, DOI 10.1016/j.trstmh.2011.01.009; Requena-Mendez A, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.28.20853; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Romi Roberto, 2001, Annali dell'Istituto Superiore di Sanita, V37, P241; Sanchez BS, 2017, ENFERM INFECC MICROB, V23; Suter T, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2364-5; Thomas MB, 2016, P NATL ACAD SCI USA, V113, P8900, DOI 10.1073/pnas.1609889113; Venturi G, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646; Viana M, 2016, P NATL ACAD SCI USA, V113, P8975, DOI 10.1073/pnas.1603431113; WHO, 2003, SPAC SPR APPL INS VE; WHO-World Health Organization, 1992, VECT RES PEST 15 REP; World Health Organization, 2017, GLOB VECT CONTR RESP; World Health Organization, 2012, WHO GLOB MAL PROGR G	62	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0217860	10.1371/journal.pone.0217860	http://dx.doi.org/10.1371/journal.pone.0217860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276554	gold, Green Published			2022-12-26	WOS:000484936300012
J	Gosser, F; Schartl, M; Garcia-De Leon, FJ; Tollrian, R; Lampert, KP				Goesser, Fabian; Schartl, Manfred; Garcia-De Leon, Francisco J.; Tollrian, Ralph; Lampert, Kathrin P.			Red Queen revisited: Immune gene diversity and parasite load in the asexual Poecilia formosa versus its sexual host species P. mexicana	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TOLL-LIKE RECEPTOR; TREMATODE UVULIFER-AMBLOPLITIS; CLASS-I; MOLLIES POECILIA; MHC GENES; SELECTION; FISH; REPRODUCTION; POPULATIONS	In accordance with the Red Queen hypothesis, the lower genotypic diversity in clonally reproducing species should make them easier targets for pathogen infection, especially when closely related sexually reproducing species occur in close proximity. We analyzed two populations of clonal P. formosa and their sexual parental species P. mexicana by correlating individual parasite infection with overall and immune genotype. Our study revealed lower levels of overall genotypic diversity and marginally fewer MHC class I alleles in P. formosa individuals compared to sexually reproducing P. mexicana. Parasite load, however, differed only between field sites but not between species. We hypothesize that this might be due to slightly higher genotypic diversity in P. formosa at the innate immune system (toll like receptor 8) which is likely due to the species' hybrid origin. In consequence, it appears that clonal individuals do not necessarily suffer a disadvantage compared to sexual individuals when fighting parasite infection.	[Goesser, Fabian; Tollrian, Ralph; Lampert, Kathrin P.] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Bochum, Germany; [Schartl, Manfred] Wuerzburg Univ, Dept Physiol Chem 1, Wurzburg, Germany; [Schartl, Manfred] Texas A&M Univ, Hagler Inst Adv Study, College Stn, TX USA; [Schartl, Manfred] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Garcia-De Leon, Francisco J.] Inst Politecn Nacl, Ctr Invest Biol Noroes SC CIBNOR SC, 195 Col Playa Palo de Santa Rita, La Paz, Bcs, Mexico; [Lampert, Kathrin P.] Univ Cologne, Inst Zool, Cologne, Germany	Ruhr University Bochum; University of Wurzburg; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Instituto Politecnico Nacional - Mexico; University of Cologne	Tollrian, R; Lampert, KP (corresponding author), Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Bochum, Germany.; Lampert, KP (corresponding author), Univ Cologne, Inst Zool, Cologne, Germany.	tollrian@rub.de; klampert@uni-koeln.de	León, Francisco García-De/AAH-9391-2019	León, Francisco García-De/0000-0003-2323-2560; Schartl, Manfred/0000-0001-9882-5948	German Research Foundation DFG [SFB 567, Scha408/10-1, Scha408/12-1]; University of Bochum; University of Cologne; University of Wurzburg; DFG Open Access Publication Funds of the Ruhr-Universitat Bochum; DFG [SFB 567]	German Research Foundation DFG(German Research Foundation (DFG)); University of Bochum; University of Cologne; University of Wurzburg; DFG Open Access Publication Funds of the Ruhr-Universitat Bochum; DFG(German Research Foundation (DFG))	This work was supported by grants to MS (German Research Foundation DFG projects SFB 567 'Mechanismen der interspezifischen Interaktion von Organismen,' Scha408/10-1 and Scha408/12-1), the University of Bochum, the University of Cologne and the University of Wurzburg. We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the National Commission of Aquaculture and Fisheries (CONAPESCA) of the Mexican government for the collection permits, nos. DGOPA/16986/191205/8101 and DGOPA/02232.230706-1079. We thank Peter Fischer and Matthias Stock for help in the field. Financial support for this study was granted by the DFG (SFB 567 'Mechanismen der interspezifischen Interaktion von Organismen'), the University of Wurzburg and the University of Bochum. We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum.	Altschmied J, 1997, BIOTECHNIQUES, V23, P228, DOI 10.2144/97232bm10; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; AVISE JC, 1991, EVOLUTION, V45, P1530, DOI 10.1111/j.1558-5646.1991.tb02657.x; Avise JC, 2015, P NATL ACAD SCI USA, V112, P8867, DOI 10.1073/pnas.1501820112; Bell G., 1982, THE MASTERPIECE OF N; BROWN SG, 1995, P ROY SOC B-BIOL SCI, V260, P317, DOI 10.1098/rspb.1995.0098; Campbell NA, 2016, CAMPBELL BIOLOGIE; Cheng TC, 1986, GEN PARASITOLOGY; DYBDAHL MF, 1995, J EVOLUTION BIOL, V8, P385, DOI 10.1046/j.1420-9101.1995.8030385.x; Eizaguirre C, 2012, ECOL LETT, V15, P723, DOI 10.1111/j.1461-0248.2012.01791.x; Facon B, 2005, J EVOLUTION BIOL, V18, P524, DOI 10.1111/j.1420-9101.2005.00887.x; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; Garcia-De Leon F, 2018, ENVIRON BIOL FISH, V101, P167, DOI 10.1007/s10641-017-0689-8; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hadany L, 2007, BMC EVOLUTIONARY BIO, V7, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hotz H, 1999, P NATL ACAD SCI USA, V96, P2171, DOI 10.1073/pnas.96.5.2171; Hubbs CL, 1932, SCIENCE, V76, P628, DOI 10.1126/science.76.1983.628; Janeway CA, 2005, IMMUNOBIOLOGY; Janse I, 2004, J MICROBIOL METH, V57, P279, DOI 10.1016/j.mimet.2003.12.006; Jault C, 2004, MOL IMMUNOL, V40, P759, DOI 10.1016/j.molimm.2003.10.001; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kropf P, 2004, INFECT IMMUN, V72, P1920, DOI 10.1128/IAI.72.4.1920-1928.2004; LADLE RJ, 1992, TRENDS ECOL EVOL, V7, P405, DOI 10.1016/0169-5347(92)90021-3; Lamatsch DK, 2009, EVOL ECOL, V23, P687, DOI 10.1007/s10682-008-9264-2; Lampert KP, 2009, MOL ECOL, V18, P1124, DOI 10.1111/j.1365-294X.2009.04097.x; Lampert KP, 2006, J GENET, V85, P67, DOI 10.1007/BF02728973; Lampert KP, 2005, EVOLUTION, V59, P881; Lehtonen J, 2012, TRENDS ECOL EVOL, V27, P172, DOI 10.1016/j.tree.2011.09.016; LEMLY AD, 1984, J PARASITOL, V70, P475, DOI 10.2307/3281395; Lighten J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01183-2; Lin JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15868-7; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Magnadottir B, 2006, FISH SHELLFISH IMMUN, V20, P137, DOI 10.1016/j.fsi.2004.09.006; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; Menken SBJ, 1995, EVOLUTION, V49, P1108, DOI 10.2307/2410435; Meyer H, 1938, J GENET, V36, P329, DOI 10.1007/BF02982453; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Monaco P.J., 1984, P311; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Murray BW, 2000, MAR BIOTECHNOL, V2, P437; Oshiumi H, 2003, IMMUNOGENETICS, V54, P791, DOI 10.1007/s00251-002-0519-8; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Persson AC, 1999, IMMUNOGENETICS, V50, P49, DOI 10.1007/s002510050685; Rauta PR, 2014, IMMUNOL LETT, V158, P14, DOI 10.1016/j.imlet.2013.11.013; Rebl A, 2010, VET IMMUNOL IMMUNOP, V134, P139, DOI 10.1016/j.vetimm.2009.09.021; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; Ridley M., 2004, EVOLUTION; Sambrook J., 2001, MOL CLONING LAB MANU; Sato A, 1998, MOL MAR BIOL BIOTECH, V7, P221; Sato A, 2000, IMMUNOGENETICS, V51, P108, DOI 10.1007/s002510050019; Sato A, 1996, IMMUNOGENETICS, V43, P38; Schaschl H, 2008, MOL ECOL, V17, P5220, DOI 10.1111/j.1365-294X.2008.03997.x; Schlupp I, 1996, ANIM BEHAV, V52, P885, DOI 10.1006/anbe.1996.0236; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SMITH JM, 1978, EVOLUTION SEX; SPELLMAN SJ, 1987, INT J PARASITOL, V17, P897, DOI 10.1016/0020-7519(87)90005-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobler M, 2005, J FISH BIOL, V67, P1072, DOI [10.1111/j.0022-1112.2005.00810.x, 10.1111/j.1095-8649.2005.00810.x]; Tobler M, 2005, BIOL LETTERS, V1, P166, DOI 10.1098/rsbl.2005.0305; Tobler M, 2014, J EVOLUTION BIOL, V27, P960, DOI 10.1111/jeb.12370; Tobler M, 2007, ACTA OECOL, V31, P270, DOI 10.1016/j.actao.2006.12.002; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Volff JN, 2013, GENETICS, V195, P1337, DOI 10.1534/genetics.113.155952; Warren WC, 2018, NAT ECOL EVOL, V2, P669, DOI 10.1038/s41559-018-0473-y; Wegner KM, 2008, J FISH BIOL, V73, P2110, DOI 10.1111/j.1095-8649.2008.02051.x; Wegner KM, 2003, SCIENCE, V301, P1343, DOI 10.1126/science.1088293	71	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219000	10.1371/journal.pone.0219000	http://dx.doi.org/10.1371/journal.pone.0219000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269085	gold, Green Submitted, Green Published			2022-12-26	WOS:000484927300035
J	Kothera, L; Phan, J; Ghallab, E; Delorey, M; Clark, R; Savage, HM				Kothera, Linda; Phan, John; Ghallab, Enas; Delorey, Mark; Clark, Rebecca; Savage, Harry M.			Using targeted next-generation sequencing to characterize genetic differences associated with insecticide resistance in Culex quinquefasciatus populations from the southern U.S	PLOS ONE			English	Article							WEST NILE VIRUS; DIPTERA-CULICIDAE POPULATIONS; PIPIENS COMPLEX MOSQUITOS; COPY NUMBER; PYRETHROID RESISTANCE; UNITED-STATES; AEDES-AEGYPTI; IDENTIFICATION; MECHANISMS; CALIFORNIA	Resistance to insecticides can hamper the control of mosquitoes such as Culex quinquefasciatus, known to vector arboviruses such as West Nile virus and others. The strong selective pressure exerted on a mosquito population by the use of insecticides can result in heritable genetic changes associated with resistance. We sought to characterize genetic differences between insecticide resistant and susceptible Culex quinquefasciatus mosquitoes using targeted DNA sequencing. To that end, we developed a panel of 122 genes known or hypothesized to be involved in insecticide resistance, and used an Ion Torrent PGM sequencer to sequence 125 unrelated individuals from seven populations in the southern U.S. whose resistance phenotypes to permethrin and malathion were known from previous CDC bottle bioassay testing. Data analysis consisted of discovering SNPs (Single Nucleotide Polymorphism) and genes with evidence of copy number variants (CNVs) statistically associated with resistance. Ten of the seventeen genes found to be present in higher copy numbers were experimentally validated with real-time PCR. Of those, six, including the gene with the knock-down resistance (kdr) mutation, showed evidence of a >= 1.5 fold increase compared to control DNA. The SNP analysis revealed 228 unique SNPs that had significant p-values for both a Fisher's Exact Test and the Cochran-Armitage Test for Trend. We calculated the population frequency for each of the 64 nonsynonymous SNPs in this group. Several genes not previously well characterized represent potential candidates for diagnostic assays when further validation is conducted.	[Kothera, Linda; Ghallab, Enas; Delorey, Mark; Clark, Rebecca; Savage, Harry M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA; [Phan, John] Ctr Dis Control & Prevent, Off Adv Mol Detect Sci Comp, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Kothera, L (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.	lkothera@cdc.gov		Kothera, Linda/0000-0002-8593-9134	CDC's office of Advanced Molecular Detection	CDC's office of Advanced Molecular Detection	Material support for this project came initially from a 2015 Incubator Grant from CDC's office of Advanced Molecular Detection. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alout H, 2016, HEREDITY, V116, P224, DOI 10.1038/hdy.2015.92; Alout H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29755; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Brogdon WG, GUIDELINE EVALUATING; Callaghan A, 1998, INSECT MOL BIOL, V7, P295, DOI 10.1111/j.1365-2583.1998.00077.x; Clarkson CS, 2018, CURR OPIN INSECT SCI, V27, P111, DOI 10.1016/j.cois.2018.05.017; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Corbel V, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2224-3; Dada N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20367-4; Darsie RFJ, 2005, IDENTIFICATION GEOGR; Davies TGE, 2007, INSECT MOL BIOL, V16, P361, DOI 10.1111/j.1365-2583.2007.00733.x; Delannay C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199615; Donnelly MJ, 2016, TRENDS PARASITOL, V32, P197, DOI 10.1016/j.pt.2015.12.001; Dudchenko O, 2017, SCIENCE, V356, P92, DOI 10.1126/science.aal3327; Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226; Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115; Feyereisen R., 2005, P1; Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895; Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Gong YH, 2013, INT J BIOL SCI, V9, P863, DOI 10.7150/ijbs.6744; Gricman L, 2015, PROTEINS, V83, P1593, DOI 10.1002/prot.24840; Hardstone MC, 2010, INSECT MOL BIOL, V19, P717, DOI 10.1111/j.1365-2583.2010.01030.x; He L, 2012, INT J BIOL SCI, V8, P1291, DOI 10.7150/ijbs.4966; HEMINGWAY J, 1990, MED VET ENTOMOL, V4, P275, DOI 10.1111/j.1365-2915.1990.tb00440.x; Hemingway J, 1998, PHILOS T ROY SOC B, V353, P1695, DOI 10.1098/rstb.1998.0320; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Hickner PV, 2013, J HERED, V104, P649, DOI 10.1093/jhered/est040; Huang J, 2005, IEEE T KNOWL DATA EN, V17, P299, DOI 10.1109/TKDE.2005.50; Huang SM, 2008, AM J TROP MED HYG, V79, P518, DOI 10.4269/ajtmh.2008.79.518; Huang SM, 2011, AM J TROP MED HYG, V85, P434, DOI 10.4269/ajtmh.2011.10-0679; Itokawa K, 2013, HEREDITY, V111, P216, DOI 10.1038/hdy.2013.40; Itokawa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24652; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Karunaratne SHPP, 2001, B WORLD HEALTH ORGAN, V79, P1060; Kasai S, 1998, INSECT MOL BIOL, V7, P185, DOI 10.1046/j.1365-2583.1998.72053.x; Kelvin AA, 2011, J INFECT DEV COUNTR, V5, P441, DOI 10.3855/jidc.2171; Kothera L, 2013, AM J TROP MED HYG, V89, P1154, DOI 10.4269/ajtmh.13-0040; Kothera L, 2010, J MED ENTOMOL, V47, P805, DOI 10.1603/ME10031; Kothera L, 2009, J MED ENTOMOL, V46, P236, DOI 10.1603/033.046.0208; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Lee Y, 2012, J MED ENTOMOL, V49, P299, DOI 10.1603/ME11108; Li CX, 2016, ACTA TROP, V157, P84, DOI 10.1016/j.actatropica.2016.01.019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00781; Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828; Liu NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023403; Lo CC, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0366-2; Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5; Martins WFS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06080-8; McAbee RD, 2008, AM J TROP MED HYG, V78, P303, DOI 10.4269/ajtmh.2008.78.303; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meuti ME, 2015, J MED ENTOMOL, V52, P131, DOI 10.1093/jme/tju016; Milani R., 1957, Rivista di Parassitologia Roma, V18, P199; Mori A, 2007, INSECT MOL BIOL, V16, P515, DOI 10.1111/j.1365-2583.2007.00746.x; Naumenko AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115737; Nelms BM, 2013, AM J TROP MED HYG, V89, P1168, DOI 10.4269/ajtmh.13-0219; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; Raymond M, 2001, GENETICA, V112, P287, DOI 10.1023/A:1013300108134; Reid WR, 2018, INSECT SCI, V25, P439, DOI 10.1111/1744-7917.12438; Reid WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047163; Rinker DC, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0966-4; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Rooker S, 1996, HEREDITY, V77, P555; ROZEBOOM L. E., 1951, The Culex pipiens Complex in North America., P343; Saavedra-Rodriguez K, 2008, GENETICS, V180, P1137, DOI 10.1534/genetics.108.087924; Sirim D, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-34; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; TOUTANT JP, 1989, PROG NEUROBIOL, V32, P423, DOI 10.1016/0301-0082(89)90031-2; Unger MF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0912-4; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wang WJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0709-5; Weetman D, 2018, CURR OPIN INSECT SCI, V27, P82, DOI 10.1016/j.cois.2018.04.005; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Wineinger Nathan E., 2008, International Journal of Computational Biology and Drug Design, V1, P368, DOI 10.1504/IJCBDD.2008.022208; Wirth MC, 1996, J AM MOSQUITO CONTR, V12, P112; Xu Q, 2005, PEST MANAG SCI, V61, P1096, DOI 10.1002/ps.1090; Xu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047609; Xu Q, 2011, BIOCHEM BIOPH RES CO, V407, P645, DOI 10.1016/j.bbrc.2011.03.060; Yan LZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-609; Yang T, 2013, J MED ENTOMOL, V50, P585, DOI 10.1603/ME12198; Yang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029418; Zhao MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095260; Zhou L, 2009, J MED ENTOMOL, V46, P321, DOI 10.1603/033.046.0217; Zhu PY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097507	91	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0218397	10.1371/journal.pone.0218397	http://dx.doi.org/10.1371/journal.pone.0218397			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269040	gold, Green Submitted, Green Published			2022-12-26	WOS:000484927300016
J	Kim, HY; Yoo, TH; Cho, JY; Kim, HC; Lee, WW				Kim, Hee Young; Yoo, Tae-Hyun; Cho, Joo-Youn; Kim, Hyeon Chang; Lee, Won-Woo			Indoxyl sulfate-induced TNF-alpha is regulated by crosstalk between the aryl hydrocarbon receptor, NF-kappa B, and SOCS2 in human macrophages	FASEB JOURNAL			English	Article						ESRD; HMDM; AhR; IS; CVD	CHRONIC KIDNEY-DISEASE; DOWN-REGULATION; UREMIC TOXINS; POTENTIAL MECHANISM; HEPATIC STEATOSIS; RENAL-DISEASE; AH RECEPTOR; ACTIVATION; INFLAMMATION; EXPRESSION	Indoxyl sulfate (IS) is a uremic toxin associated with increased prevalence of cardiovascular diseases (CVDs) in patients with chronic kidney disease. Despite the crucial role of uremia-related immune dysfunction, a majority of studies attempting to elucidate its pathogenic role in CVD have focused on IS-mediated endothelial dysfunction. Thus, we investigated the underlying molecular mechanisms involved in IS-induced production of TNF-alpha, a major cardiotoxic cytokine, by human macrophages. We found that crosstalk between the aryl hydrocarbon receptor (AhR), NF-kappa B, and the suppressor of cytokine signaling (SOCS)2 is important for TNF-alpha production in IS-stimulated human macrophages. IS-activated AhR rapidly associates with the p65 NF-kappa B subunit, resulting in mutual inhibition of AhR and NF-kappa B and inhibition of TNF-alpha production at an early time point. Later, this repression of TNF-alpha production is alleviated when SOCS2, a negative modulator of NF-kappa B, is directly induced by IS-activated AhR. In addition, once free of inhibition, activated AhR induces TNF-alpha expression by interacting with AhR binding sites in the TNF-alpha gene. Lastly, we confirmed decreased AhR and increased SOCS2 expression in monocytes of patients with end-stage renal disease, indicating the activation of AhR. Taken together, our results suggest that IS-induced TNF-alpha production in macrophages is regulated through a complicated mechanism involving interaction of AhR, NF-kappa B, and SOCS2.-Kim, H. Y., Yoo, T.-H., Cho, J.-Y., Kim, H. C., Lee, W.-W. Indoxyl sulfate-induced TNF-alpha is regulated by crosstalk between the aryl hydrocarbon receptor, NF-kappa B, and SOCS2 in human macrophages.	[Kim, Hee Young; Lee, Won-Woo] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea; [Kim, Hee Young; Lee, Won-Woo] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Lee, Won-Woo] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Lee, Won-Woo] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul, South Korea; [Yoo, Tae-Hyun] Yonsei Univ, Coll Med, Div Nephrol, Dept Internal Med, Seoul, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul, South Korea; [Kim, Hyeon Chang; Lee, Won-Woo] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Cho, Joo-Youn] Seoul Natl Univ, Dept Clin Pharmacol & Therapeut, Coll Med Hosp, Seoul, South Korea; [Lee, Won-Woo] Seoul Natl Univ, Seoul Natl Univ Hosp, Inst Infect Dis, Biomed Res Inst,Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Lee, WW (corresponding author), Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Dept Biomed Sci, 103 Daehak Ro, Seoul 03080, South Korea.	wonwoolee@snu.ac.kr	Cho, Joo-Youn/ABC-2044-2021; Cho, Joo-Youn/J-5672-2012; Kim, Hyeon Chang/F-8796-2019	Cho, Joo-Youn/0000-0001-9270-8273; Cho, Joo-Youn/0000-0001-9270-8273; Kim, Hyeon Chang/0000-0001-7867-1240	Ministry of Health and Welfare, Sejong City, South Korea [HI13C0715]; National Research Foundation (Daejeon, South Korea) - Korean government [Ministry of Science and Information and Communications Technology (MSIT) [NRF-2018R1A2B2006310, NRF-2013R1A1A2060080, NRF-2016R1A2B1009767]	Ministry of Health and Welfare, Sejong City, South Korea; National Research Foundation (Daejeon, South Korea) - Korean government [Ministry of Science and Information and Communications Technology (MSIT)	The authors thank Jiyeon Jang (Seoul National University College of Medicine) for assisting in the recruitment of human subjects. This study was supported partially by a grant (HI13C0715 to W.-W.L.) from the Korean Health Technology Research and Development Project (Ministry of Health and Welfare, Sejong City, South Korea), and grants (NRF-2018R1A2B2006310 to W.-W.L.; NRF-2013R1A1A2060080 and NRF-2016R1A2B1009767 to H.Y.K.) from the National Research Foundation (Daejeon, South Korea) funded by the Korean government [Ministry of Science and Information and Communications Technology (MSIT). The authors declare no conflicts of interest.	Adesso S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076778; Barisione C, 2015, CURR DRUG TARGETS, V16, P366, DOI 10.2174/1389450116666141230114500; Brito JS, 2017, NEPHRON, V137, P1, DOI 10.1159/000476074; Cheon H, 2007, EXP MOL MED, V39, P524, DOI 10.1038/emm.2007.58; Cohen G, 2007, NEPHROL DIAL TRANSPL, V22, P3381, DOI 10.1093/ndt/gfm210; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Di Meglio P, 2014, IMMUNITY, V40, P989, DOI 10.1016/j.immuni.2014.04.019; Dou L, 2018, KIDNEY INT, V93, P986, DOI 10.1016/j.kint.2017.11.010; Ellis RJ, 2016, NEPHROLOGY, V21, P170, DOI 10.1111/nep.12580; Enomoto A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022017.96399.B2; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; Gao HC, 2017, LIFE SCI, V185, P23, DOI 10.1016/j.lfs.2017.07.027; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gutierrez-Vazquez C, 2018, IMMUNITY, V48, P19, DOI 10.1016/j.immuni.2017.12.012; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Hidaka T, 2017, NAT IMMUNOL, V18, P64, DOI 10.1038/ni.3614; Hollingshead BD, 2008, CANCER RES, V68, P3609, DOI 10.1158/0008-5472.CAN-07-6168; Hung SC, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005022; Hung SC, 2016, KIDNEY INT, V89, P574, DOI 10.1016/j.kint.2015.11.020; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Ito S, 2016, J ATHEROSCLER THROMB, V23, P960, DOI 10.5551/jat.34462; Ito S, 2014, TOXINS, V6, P665, DOI 10.3390/toxins6020665; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Ke S, 2001, J BIOL CHEM, V276, P39638, DOI 10.1074/jbc.M106286200; Kim DW, 2000, ONCOGENE, V19, P5498, DOI 10.1038/sj.onc.1203945; Kim HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03130-z; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Koelwyn GJ, 2018, NAT IMMUNOL, V19, P526, DOI 10.1038/s41590-018-0113-3; Kolachalama VB, 2018, J AM SOC NEPHROL, V29, P1063, DOI 10.1681/ASN.2017080929; Leong SC, 2016, TOXINS, V8, DOI 10.3390/toxins8120358; Liu HT, 2000, J IMMUNOL, V164, P4277, DOI 10.4049/jimmunol.164.8.4277; Matsuo K, 2015, TOXINS, V7, P3155, DOI 10.3390/toxins7083155; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; Muteliefu G, 2009, J RENAL NUTR, V19, P29, DOI 10.1053/j.jrn.2008.10.014; Nakano T, 2019, CIRCULATION, V139, P78, DOI 10.1161/CIRCULATIONAHA.118.034588; Paul I, 2017, SCI REP-UK, V7, DOI 10.1038/srep42800; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Powe NR, 1999, KIDNEY INT, V55, P1081, DOI 10.1046/j.1523-1755.1999.0550031081.x; PROKIPCAK RD, 1991, CAN J PHYSIOL PHARM, V69, P1204, DOI 10.1139/y91-176; Rastmanesh MM, 2009, EUR J PHARMACOL, V602, P163, DOI 10.1016/j.ejphar.2008.11.014; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Rothschild DE, 2018, J LEUKOCYTE BIOL, V103, P1131, DOI 10.1002/JLB.3MIR0817-346RRR; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Sakai J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01600-y; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Sethi G, 2008, FRONT BIOSCI-LANDMRK, V13, P5094, DOI 10.2741/3066; Shi DD, 2012, CELL BIOCHEM FUNCT, V30, P664, DOI 10.1002/cbf.2846; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Tian Y, 1999, J BIOL CHEM, V274, P510, DOI 10.1074/jbc.274.1.510; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2001, INT J ARTIF ORGANS, V24, P695, DOI 10.1177/039139880102401004; Vanholder R, 2014, J AM SOC NEPHROL, V25, P1897, DOI 10.1681/ASN.2013101062; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; Vogel CFA, 2014, J BIOL CHEM, V289, P1866, DOI 10.1074/jbc.M113.505578; Vogel CFA, 2009, BIOCHEM PHARMACOL, V77, P734, DOI 10.1016/j.bcp.2008.09.036; Wada T, 2016, J BIOL CHEM, V291, P7004, DOI 10.1074/jbc.M115.693655; Wu DL, 2011, ARTERIOSCL THROM VAS, V31, P1260, DOI 10.1161/ATVBAHA.110.220202; Yeste A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0612; Zadjali F, 2012, FASEB J, V26, P3282, DOI 10.1096/fj.12-205583	63	22	23	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10844	10858		10.1096/fj.201900730R	http://dx.doi.org/10.1096/fj.201900730R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284759				2022-12-26	WOS:000489166300022
J	Su, YL; Chen, Z; Du, HX; Liu, RH; Wang, WZ; Li, HF; Ning, B				Su, Yanlin; Chen, Zhe; Du, Hongxia; Liu, Ronghan; Wang, Wenzhao; Li, Hongfei; Ning, Bin			Silencing miR-21 induces polarization of astrocytes to the A2 phenotype and improves the formation of synapses by targeting glypican 6 via the signal transducer and activator of transcription-3 pathway after acute ischemic spinal cord injury	FASEB JOURNAL			English	Article						microRNA-21; neurotrophic reactive astrocytes; neurotoxic reactive astrocytes; STAT3	REGENERATION; MICRORNAS	Ischemic spinal cord injury (ISCI) results in the motor sensory dysfunction of the limbs below the injury site. In response to the injury, astrocytes develop into neuroprotective astrocytes [(neurotrophic reactive astrocytes (A2s)] to mitigate the damage. MicroRNA (miR)-21 can promote the development of neuroinflammation in previous studies. Our aim was to investigate the effect of miR-21 on its polarization. We used the abdominal aortic occlusion model in vivo. Immunohistochemistry was used to detect the distribution of A2s in the spinal cord. We used an oxygen glucose deprivation method to model astrocytes ischemia in vitro and tested proliferation, migration, and excitability of A2s using an 5-ethynyl -2'-deoxyuridine kit, wound scratch assay, and calcium-ion probe. After adjustment, we detected the model and target genes of A2s using PCR, Western blot, immunofluorescence, and chromatin immunoprecipitation. We demonstrated in vivo that naive astrocytes were transformed into A2s by ischemia. And in vitro miR-21, which can regulate the signal transducer and activator of transcription-3 pathway, can transform neurotoxic reactive astrocyte into A2. Moreover, we also verified the mechanism of A2s promoting synaptic formation and nerve growth. miR-21 is a switch to regulate the polarization of reactive astrocyte, and it promoted synapsis formation and nerites growth after acute ISCI.-Su, Y., Chen, Z., Du, H., Liu, R., Wang, W., Li, H., Ning, B. Silencing miR-21 induces polarization of astrocytes to the A2 phenotype and improves the formation of synapses by targeting glypican 6 via the signal transducer and activator of transcription-3 pathway after acute ischemic spinal cord injury.	[Su, Yanlin; Du, Hongxia; Liu, Ronghan; Wang, Wenzhao; Li, Hongfei; Ning, Bin] Shandong Univ, Jinan Cent Hosp, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China; [Su, Yanlin] Shandong First Med Univ, Tai An, Shandong, Peoples R China; [Chen, Zhe] South China Normal Univ, Sch Phys Educ & Sports Sci, Guangzhou, Guangdong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; South China Normal University	Ning, B (corresponding author), Shandong Univ, Jinan Cent Hosp, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China.	ningbin@sdu.edu.cn	Liu, Ronghan/ABH-1619-2021	Liu, Ronghan/0000-0002-6897-0279; Wang, Wenzhao/0000-0001-5106-4862	National Natural Science Funds of China [81401014, 81771346]; Chinese Postdoctoral Science Foundation [2014M561935, 2015T80725]; Technology Research and Development Program of Jinan City [201704133]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Technology Research and Development Program of Jinan City	Grant support was provided by the National Natural Science Funds of China (81401014, 81771346), the Chinese Postdoctoral Science Foundation (2014M561935), the Chinese Postdoctoral Science Foundation (2015T80725), and Technology Research and Development Program of Jinan City (201704133). B.N. is a Taishan scholar, young expert, director, and founder of the Jinan Institute of Biomechanics who participated in the study design, decision to publish, and preparation of the manuscript. All applicable international, national, and institutional guidelines for the care and use of animals were followed. This article does not contain any studies with human participants performed by any of the authors. The authors declare no conflicts of interest.	Allen NJ, 2018, SCIENCE, V362, P181, DOI 10.1126/science.aat0473; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Bindocci E, 2017, SCIENCE, V356, DOI 10.1126/science.aai8185; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chivukula RR, 2008, TRENDS BIOCHEM SCI, V33, P474, DOI 10.1016/j.tibs.2008.06.008; El Fatimy R, 2018, ACTA NEUROPATHOL, V136, P537, DOI 10.1007/s00401-018-1880-5; Fujita A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1251-0; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Her LS, 2017, THERANOSTICS, V7, P2452, DOI 10.7150/thno.18813; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Karadimas SK, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6524; Kinoshita C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4823; Levine J, 2016, GLIA, V64, P668, DOI 10.1002/glia.22953; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Liu RH, 2018, AGING-US, V10, P1474, DOI 10.18632/aging.101484; Morizawa YM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00037-1; Ning B, 2014, INT J BIOL SCI, V10, P997, DOI 10.7150/ijbs.9058; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Renault-Mihara F, 2017, J CELL BIOL, V216, P2533, DOI 10.1083/jcb.201610102; Shi J, 2017, THERANOSTICS, V7, P664, DOI 10.7150/thno.15162; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tyzack GE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5294; Verma P, 2015, NAT NEUROSCI, V18, P379, DOI 10.1038/nn.3935; Xu XT, 2019, J CELL PHYSIOL, V234, P904, DOI 10.1002/jcp.26918; Yamashita T, 2005, J NEUROCHEM, V94, P459, DOI 10.1111/j.1471-4159.2005.03227.x; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang F, 2018, BIOMED PHARMACOTHER, V107, P1523, DOI 10.1016/j.biopha.2018.08.136	31	35	39	6	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10859	10871		10.1096/fj.201900743R	http://dx.doi.org/10.1096/fj.201900743R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31266356				2022-12-26	WOS:000489166300023
J	Ciccone, DN; Namiki, Y; Chen, CF; Morshead, KB; Wood, AL; Johnston, CM; Morris, JW; Wang, YQ; Sadreyev, R; Corcoran, AE; Matthews, AGW; Oettinger, MA				Ciccone, David N.; Namiki, Yuka; Chen, Changfeng; Morshead, Katrina B.; Wood, Andrew L.; Johnston, Colette M.; Morris, John W.; Wang, Yanqun; Sadreyev, Ruslan; Corcoran, Anne E.; Matthews, Adam G. W.; Oettinger, Marjorie A.			The murine IgH locus contains a distinct DNA sequence motif for the chromatin regulatory factor CTCF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA recombination; chromatin; cellular immune response; chromatin immunoprecipitation (ChIP); chromatin regulation; adaptive immunity; antigen receptor; CCTC-binding factor (CTCF); DNA binding; V(D)J	ENHANCER-BLOCKING ACTIVITY; INSULATOR PROTEIN CTCF; B-CELL DEVELOPMENT; V(D)J RECOMBINATION; BINDING SITES; ZINC FINGERS; H19 GENE; TRANSCRIPTION; ELEMENTS; GENOME	Antigen receptor assembly in lymphocytes involves stringently-regulated coordination of specific DNA rearrangement events across several large chromosomal domains. Previous studies indicate that transcription factors such as paired box 5 (PAX5), Yin Yang 1 (YY1), and CCCTC-binding factor (CTCF) play a role in regulating the accessibility of the antigen receptor loci to the V(D)J recombinase, which is required for these rearrangements. To gain clues about the role of CTCF binding at the murine immunoglobulin heavy chain (IgH) locus, we utilized a computational approach that identified 144 putative CTCF-binding sites within this locus. We found that these CTCF sites share a consensus motif distinct from other CTCF sites in the mouse genome. Additionally, we could divide these CTCF sites into three categories: intergenic sites remote from any coding element, upstream sites present within 8 kb of the V-H-leader exon, and recombination signal sequence (RSS)-associated sites characteristically located at a fixed distance (similar to 18 bp) downstream of the RSS. We noted that the intergenic and upstream sites are located in the distal portion of the V-H locus, whereas the RSS-associated sites are located in the D-H-proximal region. Computational analysis indicated that the prevalence of CTCF-binding sites at the IgH locus is evolutionarily conserved. In all species analyzed, these sites exhibit a striking strand-orientation bias, with >98% of the murine sites being present in one orientation with respect to V-H gene transcription. Electrophoretic mobility shift and enhancer-blocking assays and ChIP-chip analysis confirmed CTCF binding to these sites both in vitro and in vivo.	[Ciccone, David N.; Namiki, Yuka; Chen, Changfeng; Morshead, Katrina B.; Morris, John W.; Wang, Yanqun; Sadreyev, Ruslan; Matthews, Adam G. W.; Oettinger, Marjorie A.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Ciccone, David N.; Namiki, Yuka; Chen, Changfeng; Morshead, Katrina B.; Morris, John W.; Wang, Yanqun; Sadreyev, Ruslan; Matthews, Adam G. W.; Oettinger, Marjorie A.] Harvard Med Sch, Dept Genet, Boston, MA 02114 USA; [Wood, Andrew L.; Johnston, Colette M.; Corcoran, Anne E.] Babraham Inst, Lymphocyte Signalling & Dev, Babraham Res Campus, Cambridge CB22 3AT, England; [Matthews, Adam G. W.] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02481 USA; [Matthews, Adam G. W.] Wellesley Coll, Program Biochem, Wellesley, MA 02481 USA; [Ciccone, David N.] Merck, Boston, MA 02115 USA; [Chen, Changfeng] BioSciences Inc, Beijing 100053, Peoples R China; [Morshead, Katrina B.] Genentech Inc, San Francisco, CA 94080 USA; [Wood, Andrew L.] Kymab Ltd, Babraham Res Campus, Cambridge CB22 3AT, England; [Johnston, Colette M.] Crescendo Biol, Babraham Res Campus, Cambridge CB22 3AT, England; [Morris, John W.] Synopsys Inc, Burlington, MA 01803 USA; [Wang, Yanqun] Novartis Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wellesley College; Wellesley College; Merck & Company; Roche Holding; Genentech; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Synopsys Inc; Novartis	Oettinger, MA (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Oettinger, MA (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02114 USA.	Oettinger@molbio.mgh.harvard.edu		Morris, John W/0000-0001-9476-181X; Corcoran, Anne/0000-0002-9577-5313	Biotechnological and Biological Scientific Research Council [BB/F012217/1]; National Institutes of Health [GM48026]; BBSRC; BBSRC [BBS/E/B/000C0404, BB/F012217/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	Biotechnological and Biological Scientific Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Biotechnological and Biological Scientific Research Council Grant BB/F012217/1 (to A. E. C.) and National Institutes of Health Grant GM48026 (to M. A. O). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a BBSRC Ph.D. studentship. Present address: Kymab Ltd., Babraham Research Campus, Cambridge CB22 3AT, United Kingdom.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Benner C, 2015, P NATL ACAD SCI USA, V112, P12776, DOI 10.1073/pnas.1512995112; Bolland DJ, 2016, CELL REP, V15, P2475, DOI 10.1016/j.celrep.2016.05.020; Carico Z, 2015, ADV IMMUNOL, V128, P307, DOI 10.1016/bs.ai.2015.07.005; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Ciccone DN, 2004, METHOD ENZYMOL, V376, P334; Cuomo CA, 1996, MOL CELL BIOL, V16, P5683; de Almeida CR, 2011, IMMUNITY, V35, P501, DOI 10.1016/j.immuni.2011.07.014; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Featherstone K, 2010, J BIOL CHEM, V285, P9327, DOI 10.1074/jbc.M109.098251; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; Gerasimova T, 2015, GENE DEV, V29, P1683, DOI 10.1101/gad.263871.115; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grundy GJ, 2009, MOL CELL, V35, P217, DOI 10.1016/j.molcel.2009.06.022; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hu JZ, 2015, CELL, V163, P947, DOI 10.1016/j.cell.2015.10.016; Jhunjhunwala S, 2009, CELL, V138, P435, DOI 10.1016/j.cell.2009.07.016; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kleiman E, 2016, P NATL ACAD SCI USA, V113, pE3911, DOI 10.1073/pnas.1606297113; Kumari G, 2015, ADV IMMUNOL, V128, P41, DOI 10.1016/bs.ai.2015.08.001; Lin SG, 2015, P NATL ACAD SCI USA, V112, P1815, DOI 10.1073/pnas.1424936112; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Lucas JS, 2014, CELL, V158, P339, DOI 10.1016/j.cell.2014.05.036; Lucas JS, 2011, CURR OPIN CELL BIOL, V23, P318, DOI 10.1016/j.ceb.2010.11.007; Majumder K, 2015, ADV IMMUNOL, V128, P273, DOI 10.1016/bs.ai.2015.07.001; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Montefiori L, 2016, CELL REP, V14, P896, DOI 10.1016/j.celrep.2015.12.083; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Osipovich O, 2004, NAT IMMUNOL, V5, P309, DOI 10.1038/ni1042; Osipovich O, 2007, NAT IMMUNOL, V8, P809, DOI 10.1038/ni1481; Osipovich OA, 2009, J IMMUNOL, V183, P1509, DOI 10.4049/jimmunol.0900896; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Proudhon C, 2015, ADV IMMUNOL, V128, P123, DOI 10.1016/bs.ai.2015.07.003; Pulivarthy SR, 2016, P NATL ACAD SCI USA, V113, pE6427, DOI 10.1073/pnas.1605543113; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Shih HY, 2012, P NATL ACAD SCI USA, V109, pE3493, DOI 10.1073/pnas.1214131109; Stubbington MJT, 2013, CURR OPIN GENET DEV, V23, P81, DOI 10.1016/j.gde.2013.01.001; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; Volpi SA, 2012, J IMMUNOL, V188, P2556, DOI 10.4049/jimmunol.1102763; Xiao TJ, 2011, MOL CELL BIOL, V31, P2174, DOI 10.1128/MCB.05093-11; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhao LJ, 2016, J EXP MED, V213, P1921, DOI 10.1084/jem.20160670; Ziebarth JD, 2013, NUCLEIC ACIDS RES, V41, pD188, DOI 10.1093/nar/gks1165	64	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13580	13592		10.1074/jbc.RA118.007348	http://dx.doi.org/10.1074/jbc.RA118.007348			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31285261	hybrid, Green Published			2022-12-26	WOS:000486418600006
J	Varden, FA; Saitoh, H; Yoshino, K; Franceschetti, M; Kamoun, S; Terauchi, R; Banfield, MJ				Varden, Freya A.; Saitoh, Hiromasa; Yoshino, Kae; Franceschetti, Marina; Kamoun, Sophien; Terauchi, Ryohei; Banfield, Mark J.			Cross-reactivity of a rice NLR immune receptor to distinct effectors from the rice blast pathogen Magnaporthe oryzae provides partial disease resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plant defense; protein structure; plant biochemistry; host-pathogen interaction; Nod-like receptor (NLR); effector; plant immunity; rice; rice blast disease	AVR-PIA; AVIRULENCE PROTEIN; PLANT; FUNGAL; GENES; RECOGNITION; DOMAINS	Unconventional integrated domains in plant intracellular immune receptors of the nucleotide-binding leucine-rich repeat (NLRs) type can directly bind translocated effector proteins from pathogens and thereby initiate an immune response. The rice (Oryza sativa) immune receptor pairs Pik-1/Pik-2 and RGA5/RGA4 both use integrated heavy metal-associated (HMA) domains to bind the effectors AVR-Pik and AVR-Pia, respectively, from the rice blast fungal pathogen Magnaporthe oryzae. These effectors both belong to the MAX effector family and share a core structural fold, despite being divergent in sequence. How integrated domains in NLRs maintain specificity of effector recognition, even of structurally similar effectors, has implications for understanding plant immune receptor evolution and function. Here, using plant cell death and pathogenicity assays and protein-protein interaction analyses, we show that the rice NLR pair Pikp-1/Pikp-2 triggers an immune response leading to partial disease resistance toward the mis-matched effector AVR-Pia in planta and that the Pikp-HMA domain binds AVR-Pia in vitro. We observed that the HMA domain from another Pik-1 allele, Pikm, cannot bind AVR-Pia, and it does not trigger a plant response. The crystal structure of Pikp-HMA bound to AVR-Pia at 1.9 angstrom resolution revealed a binding interface different from those formed with AVR-Pik effectors, suggesting plasticity in integrated domain-effector interactions. The results of our work indicate that a single NLR immune receptor can bait multiple pathogen effectors via an integrated domain, insights that may enable engineering plant immune receptors with extended disease resistance profiles.	[Varden, Freya A.; Franceschetti, Marina; Banfield, Mark J.] Norwich Res Pk, John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Saitoh, Hiromasa; Yoshino, Kae] Tokyo Univ Agr, Fac Life Sci, Dept Mol Microbiol, Lab Plant Symbiot & Parasit Microbes, Tokyo 1568502, Japan; [Kamoun, Sophien] Univ East Anglia, Norwich Res Pk, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Div Genom & Breeding, Kitakami, Iwate 0240003, Japan; [Terauchi, Ryohei] Kyoto Univ, Grad Sch Agr, Lab Crop Evolut, Kyoto 6068501, Japan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Tokyo University of Agriculture; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; Iwate Biotechnology Research Center; Kyoto University	Banfield, MJ (corresponding author), Norwich Res Pk, John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England.	mark.banfield@jic.ac.uk	Kamoun, Sophien/B-3529-2009; Banfield, Mark/C-7453-2013; Terauchi, Ryohei/Y-2992-2019	Kamoun, Sophien/0000-0002-0290-0315; Banfield, Mark/0000-0001-8921-3835; Terauchi, Ryohei/0000-0002-0095-4651; Varden, Freya/0000-0003-4224-2326	Biotechnology and Biological Sciences Research Council (United Kingdom) [BB/P012574, BB/M02198X]; European Research Council [743165]; John Innes Foundation; Gatsby Charitable Foundation; JSPS KAKENHI [15H05779, 18K05657]; BBSRC [BBS/E/J/000PR9798, BB/M022315/1, BBS/E/J/000PR9795, BB/M02198X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); John Innes Foundation; Gatsby Charitable Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (United Kingdom) Grants BB/P012574 and BB/M02198X, European Research Council Proposal 743165, the John Innes Foundation, the Gatsby Charitable Foundation, and JSPS KAKENHI Grants 15H05779 and 18K05657. The authors declare that they have no conflicts of interest with the contents of this article.	Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Bebber DP, 2015, FUNGAL GENET BIOL, V74, P62, DOI 10.1016/j.fgb.2014.10.012; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bialas A, 2018, MOL PLANT MICROBE IN, V31, P34, DOI 10.1094/MPMI-08-17-0196-FI; Bonardi V, 2011, P NATL ACAD SCI USA, V108, P16463, DOI 10.1073/pnas.1113726108; Cesari S, 2018, NEW PHYTOL, V219, P17, DOI 10.1111/nph.14877; Cesari S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00606; Cesari S, 2014, EMBO J, V33, P1941, DOI 10.15252/embj.201487923; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; de Guillen K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005228; De la Concepcion JC, 2018, NAT PLANTS, V4, P576, DOI 10.1038/s41477-018-0194-x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fernandez J, 2018, TRENDS MICROBIOL, V26, P582, DOI 10.1016/j.tim.2017.12.007; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Franceschetti M, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00066-16, 10.1128/mmbr.00066-16]; Guo LW, 2018, P NATL ACAD SCI USA, V115, P11637, DOI 10.1073/pnas.1810705115; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Kanzaki H, 2002, THEOR APPL GENET, V105, P809, DOI 10.1007/s00122-001-0817-9; Kanzaki H, 2012, PLANT J, V72, P894, DOI 10.1111/j.1365-313X.2012.05110.x; Kourelis J, 2018, PLANT CELL, V30, P285, DOI 10.1105/tpc.17.00579; Krissinel E, 2015, NUCLEIC ACIDS RES, V43, pW314, DOI 10.1093/nar/gkv314; Kroj T, 2016, NEW PHYTOL, V210, P618, DOI 10.1111/nph.13869; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Maqbool A, 2015, ELIFE, V4, DOI 10.7554/eLife.08709; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Okuyama Y, 2011, PLANT J, V66, P467, DOI 10.1111/j.1365-313X.2011.04502.x; Ortiz D, 2017, PLANT CELL, V29, P156, DOI 10.1105/tpc.16.00435; Ose T, 2015, J BIOMOL NMR, V63, P229, DOI 10.1007/s10858-015-9979-7; R Core Team, 2019, R LANG ENV STAT COMP; Sarris PF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0228-7; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takano Y, 2001, MOL PLANT MICROBE IN, V14, P1149, DOI 10.1094/MPMI.2001.14.10.1149; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wu CH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00134; Yoshida K, 2009, PLANT CELL, V21, P1573, DOI 10.1105/tpc.109.066324; Yuan B, 2011, THEOR APPL GENET, V122, P1017, DOI 10.1007/s00122-010-1506-3; Zhang X, 2018, PLANT J, V96, P133, DOI 10.1111/tpj.14023; Zhang ZM, 2013, J BIOMOL NMR, V55, P219, DOI 10.1007/s10858-012-9695-5	46	13	13	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13006	13016		10.1074/jbc.RA119.007730	http://dx.doi.org/10.1074/jbc.RA119.007730			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296569	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-26	WOS:000486416000012
J	Gougoula, C; Bielfeld, AP; Pour, SJ; Sager, M; Krussel, JS; Benten, WPM; Baston-Bust, DM				Gougoula, Christina; Bielfeld, Alexandra Petra; Pour, Sarah Jean; Sager, Martin; Kruessel, Jan-Steffen; Benten, Wilhelm Peter M.; Baston-Buest, Dunja Maria			Metabolic and behavioral parameters of mice with reduced expression of Syndecan-1	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; HEPARAN-SULFATE; FOOD-INTAKE; GENE-EXPRESSION; BODY-WEIGHT; INSULIN; LEPTIN; SIGNALS; GLUCOCORTICOIDS; ACTIVATION	Energy balance is essential for all species. Ligand-receptor interactions mediate processes that regulate body activities like reproduction and metabolism based on the energy status. Such receptors are the heparan sulfate proteoglycans and specifically the family of syndecans. Therefore we investigated the differences of metabolic parameters of heterozygous Syndecan 1 mice (Sdc1(+/-)) with reduced expression of Sdc1 and the corresponding wild type mice. Sdc1(+/-) mice have a reduced body weight although they show increased leptin and decreased corticosterone levels. Furthermore, their food and water intake is increased. This is accompanied with less adipose tissue, smaller adipocytes and thus an increased density of adipocytes. For the detailed analysis of the metabolism the automated Pheno-Master system has been used, which allowed continuous and undisturbed recording of food and water intake, energy expenditure and movement. The reason for the lower body weight was the higher energy expenditure of these animals compared to controls. Additionally, female Sdc1(+/-) mice showed an increased locomotor activity. Referring to organs, the intestine in Sdc1(+/-) mice was heavier and longer, but no differences at the cellular level could be observed. These findings were independent of normal mating or vice versa embryo transfers of Sdc1(+/-) and wild type embryos in recipient females of the other genotype. Herein we showed that the reduced expression of Sdc1 led to an altered metabolism on fetal as well as on maternal side, which may play a role in the growth restriction observed in human pregnancy pathologies and in mice lacking Sdc1.	[Gougoula, Christina; Sager, Martin; Benten, Wilhelm Peter M.] Heinrich Heine Univ Dusseldorf, Cent Unit Anim Res & Anim Welf Affairs ZETT, Dusseldorf, Germany; [Bielfeld, Alexandra Petra; Pour, Sarah Jean; Kruessel, Jan-Steffen; Baston-Buest, Dunja Maria] Dusseldorf Univ Hosp, Dept OB GYN & REI UniKiD, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Baston-Bust, DM (corresponding author), Dusseldorf Univ Hosp, Dept OB GYN & REI UniKiD, Dusseldorf, Germany.	baston-buest@unikid.de			German Research Foundation (DFG) [HE 3544/2-2, 2-3]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) to AP Bielfeld (HE 3544/2-2 and 2-3). https://www.dfg.de/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Barash IA, 1996, ENDOCRINOLOGY, V137, P3144, DOI 10.1210/en.137.7.3144; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; Benoit SC, 2004, RECENT PROG HORM RES, V59, P267, DOI 10.1210/rp.59.1.267; Blum R, 2000, ABSTR SOC NEUROSCI; Blum RM, 2003, HORMONES BEHAV SOC B, P38; Bode L, 2008, J CLIN INVEST, V118, P229, DOI 10.1172/JCI32335; Bonaparte D, 2013, LAB ANIM-UK, V47, P134, DOI 10.1177/0023677212473918; Campfield LA, 1996, HORM METAB RES, V28, P619, DOI 10.1055/s-2007-979867; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CASTONGUAY TW, 1986, AM J PHYSIOL, V251, pR923, DOI 10.1152/ajpregu.1986.251.5.R923; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Chui A, 2012, AM J PATHOL, V180, P693, DOI 10.1016/j.ajpath.2011.10.023; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; De Luca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011286; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Evans MC, 2017, J MOL ENDOCRINOL, V58, pR107, DOI 10.1530/JME-16-0212; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Gougoula C, 2019, REPROD BIOL ENDOCRIN, V17, DOI 10.1186/s12958-019-0470-2; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Heyer-Chauhan N, 2014, J PERINAT MED, V42, P329, DOI 10.1515/jpm-2013-0097; HOGAN B, 1986, MANIPULATING MOUSE E; Huang XY, 2006, MOL CELL BIOL, V26, P6870, DOI 10.1128/MCB.00314-06; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Kasza I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004514; Klaus S, 2004, CURR DRUG TARGETS, V5, P241, DOI 10.2174/1389450043490523; Lim S, 2012, NAT PROTOC, V7, P606, DOI 10.1038/nprot.2012.013; Liu BY, 2003, ONCOGENE, V22, P9243, DOI 10.1038/sj.onc.1207217; McDermott SP, 2007, ONCOGENE, V26, P1407, DOI 10.1038/sj.onc.1209930; Michael B, 2007, TOXICOL PATHOL, V35, P742, DOI 10.1080/01926230701595292; Norwitz Errol R, 2007, Reprod Biomed Online, V14 Spec No 1, P101, DOI 10.1016/S1472-6483(10)61464-2; Ogus S, 2003, ENDOCRINOLOGY, V144, P2865, DOI 10.1210/en.2002-0178; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; REILLY RW, 1965, LAB INVEST, V14, P102; Reizes O, 2001, CELL, V106, P105, DOI 10.1016/S0092-8674(01)00415-9; Reizes O, 2008, INT J BIOCHEM CELL B, V40, P28, DOI 10.1016/j.biocel.2007.06.011; Reizes O, 2006, BIOCHEMISTRY-US, V45, P5703, DOI 10.1021/bi052263h; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; STRACK AM, 1995, AM J PHYSIOL-REG I, V268, pR142, DOI 10.1152/ajpregu.1995.268.1.R142; Strader AD, 2004, J CLIN INVEST, V114, P1354, DOI 10.1172/JCI200420631; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Westphal V, 2000, AM J PATHOL, V157, P1917, DOI 10.1016/S0002-9440(10)64830-4; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Zhang YY, 2002, AM J PHYSIOL-REG I, V282, pR226, DOI 10.1152/ajpregu.00392.2001	52	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2019	14	7							e0219604	10.1371/journal.pone.0219604	http://dx.doi.org/10.1371/journal.pone.0219604			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4NB	31299063	gold, Green Submitted, Green Published			2022-12-26	WOS:000484955800009
J	Moxon, SG; Blencowe, H; Bailey, P; Bradley, J; Day, LT; Ram, PK; Monet, JP; Moran, AC; Zeck, W; Lawn, JE				Moxon, Sarah G.; Blencowe, Hannah; Bailey, Patricia; Bradley, John; Day, Louise Tina; Ram, Pavani K.; Monet, Jean-Pierre; Moran, Allisyn C.; Zeck, Willibald; Lawn, Joy E.			Categorising interventions to levels of inpatient care for small and sick newborns: Findings from a global survey	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; PRETERM; IMPAIRMENT; COUNTRIES; RISK; REGIONALIZATION; PREMATURITY; RETINOPATHY; STRATEGIES; MORTALITY	Background In 2017, 2.5 million newborns died, mainly from prematurity, infections, and intrapartum events. Preventing these deaths requires health systems to provide routine and emergency care at birth, and quality inpatient care for small and sick newborns. Defined levels of emergency obstetric care (EmOC) and standardised measurement of "signal functions" has improved tracking of maternal care in low-and middle-income countries (LMICs). Levels of newborn care, particularly for small and sick newborns, and associated signal functions are still not consistently defined or tracked. Methods Between November 2016-November 2017, we conducted an online survey of professionals working in maternal and newborn health. We asked respondents to categorise 18 clinical care interventions that could act as potential signal functions for small and sick newborns to 3 levels of care they thought were appropriate for health systems in LMICs to provide: "routine care at birth", "special care" and "intensive care". We calculated the percentage of respondents that classified each intervention at each level of care and stratified responses to look at variation by respondent characteristics. Results Six interventions were classified to specific levels by more than 50% of respondents as "routine care at birth," three interventions as "special care" and one as "intensive care". Eight interventions were borderline between these care levels. Responses were more consistent for interventions with relevant WHO clinical care guidelines while more variation in respondents' classification was observed in complex interventions that lack standards or guidelines. Respondents with experience in lower-income settings were more likely to assign a higher level of care for more complex interventions. Conclusions Results were consistent with known challenges of scaling up inpatient care in lower-income settings and underline the importance of comprehensive guidelines and standards for inpatient care. Further work is needed to develop a shortlist of newborn signal functions aligned with emergency obstetric care levels to track universal health coverage for mothers and their newborns.	[Moxon, Sarah G.; Blencowe, Hannah; Bradley, John; Day, Louise Tina; Lawn, Joy E.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Bailey, Patricia] Columbia Univ, Mailman Sch Publ Hlth, Averting Maternal Death & Disabil, New York, NY USA; [Ram, Pavani K.] US Agcy Int Dev, Off Maternal & Child Hlth & Nutr, Washington, DC 20523 USA; [Monet, Jean-Pierre] United Nations Populat Fund UNFPA, Tech Div, New York, NY USA; [Moran, Allisyn C.] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland; [Zeck, Willibald] United Nations Childrens Fund UNICEF, UNICEF Hlth Sect, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine; Columbia University; United States Agency for International Development (USAID); United Nations Population Fund; World Health Organization; UNICEF	Moxon, SG (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.	sarah.moxon@lshtm.ac.uk	Lawn, Joy/ABE-6382-2020	Lawn, Joy/0000-0002-4573-1443; Moran, Allisyn C/0000-0002-4826-1475; Blencowe, Hannah/0000-0003-1556-3159; Bradley, John/0000-0002-9449-4608; Moxon, Sarah/0000-0001-6600-6147	Children's Investment Fund Foundation (CIFF) [EPDIZH6210]; MRC [MR/R010161/1] Funding Source: UKRI	Children's Investment Fund Foundation (CIFF); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Author time for SGM, HB and JEL was covered by a grant for the Every Newborn measurement improvement work, which is coordinated by the London School of Hygiene & Tropical Medicine (LSHTM) and is funded by the Children's Investment Fund Foundation (CIFF) grant code: EPDIZH6210. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other funding was received for this work.	Bailey P, 2006, INT J GYNECOL OBSTET, V93, P285, DOI 10.1016/j.ijgo.2006.01.028; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204; Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205; Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; British Association of Perinatal Medicine, 2010, SERV STAND HOSP PROV; Brown J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053622; Burgoine K, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000586; Campbell OMR, 2016, LANCET, V388, P2193, DOI 10.1016/S0140-6736(16)31528-8; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Committee on Perinatal Health, 1976, IMPR OUTC PREGN REC; Dickson KE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S1; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Enweronu-Laryea C, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S4; Gabrysch S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001340; Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009; Goncalves-Ferri WA, 2013, BRAZ J MED BIOL RES, V46, P892, DOI 10.1590/1414-431X20132849; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kawaza K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086327; Kenyon S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001058.pub2; Kinney MV, 2015, SEMIN PERINATOL, V39, P326, DOI 10.1053/j.semperi.2015.06.004; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lawn JE, 2013, PEDIATR RES, V74, P1, DOI 10.1038/pr.2013.202; Lee ACC, 2013, PEDIATR RES, V74, P50, DOI 10.1038/pr.2013.206; Liu G, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S3; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Lorch SA, 2010, PEDIATRICS, V126, P1182, DOI 10.1542/peds.2010-1119; Mason E, 2014, LANCET, V384, P455, DOI 10.1016/S0140-6736(14)60750-9; Menard MK, 2015, AM J OBSTET GYNECOL, V212, P259, DOI 10.1016/j.ajog.2014.12.030; Moxon S, 2018, J GLOBAL HLTH; Moxon SG, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S7; Moxon SG, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S8; NHS, 2009, TOOLK HIGH QUAL NEON; Paul Vinod K, 2004, Semin Neonatol, V9, P117, DOI 10.1016/j.siny.2003.08.010; Rashidian A, 2014, PUBLIC HEALTH, V128, P872, DOI 10.1016/j.puhe.2014.08.005; Slusher TM, 2017, EARLY HUM DEV, V114, P11, DOI 10.1016/j.earlhumdev.2017.09.008; TUNCALP, 2015, BJOG, V122, P1045, DOI DOI 10.1111/1471-0528.13451; UN IGME, 2018, LEV TRENDS CHILD MOR; Vesel L, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S5; WHO, 2010, ESS NEWB CAR TRAIN C; WHO; LSHTM, 2016, EVER NEWB ACT PLAN M; WHO UNFPA UNICEF, 2009, MON EM OBST CAR HDB; WHO; UNICEF, 2014, EVER NEW ACT PLAN EN; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization,, 2012, GUID BAS NEWB RES; World Health Organization, 2015, GUID MAN POSS SER BA; World Health Organization, 2018, PROT PROM SUPP BREAS; Zaka N, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0712-2	49	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0218748	10.1371/journal.pone.0218748	http://dx.doi.org/10.1371/journal.pone.0218748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295262	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000484951800008
J	Gunzler, DD; Perzynski, AT; Dawson, NV; Kauffman, K; Liu, JT; Dalton, JE				Gunzler, Douglas D.; Perzynski, Adam T.; Dawson, Neal V.; Kauffman, Kelley; Liu, Jintao; Dalton, Jarrod E.			Risk-period-cohort approach for averting identification problems in longitudinal models	PLOS ONE			English	Article							BODY-MASS-INDEX; INTRINSIC ESTIMATOR; BIOLOGICAL AGE; UNITED-STATES; DISPARITIES; MORTALITY; VALIDITY; OBESITY; RATES; YANG	In epidemiology, gerontology, human development and the social sciences, age-period-cohort (APC) models are used to study the variability in trajectories of change over time. A well-known issue exists in simultaneously identifying age, period and birth cohort effects, namely that the three characteristics comprise a perfectly collinear system. That is, since age = period-cohort, only two of these effects are estimable at a time. In this paper, we introduce an alternative framework for considering effects relating to age, period and birth cohort. In particular, instead of directly modeling age in the presence of period and cohort effects, we propose a risk modeling approach to characterize age-related risk (i.e., a hybrid of multiple biological and sociological influences to evaluate phenomena associated with growing older). The properties of this approach, termed risk-period-cohort (RPC), are described in this paper and studied by simulations. We show that, except for pathological circumstances where risk is uniquely determined by age, using such risk indices obviates the problem of collinearity. We also show that the size of the chronological age effect in the risk prediction model associates with the correlation between a risk index and chronological age and that the RPC approach can satisfactorily recover cohort and period effects in most cases. We illustrate the advantages of RPC compared to traditional APC analysis on 27496 individuals from NHANES survey data (2005-2016) to study the longitudinal variability in depression screening over time. Our RPC method has broad implications for examining processes of change over time in longitudinal studies.	[Gunzler, Douglas D.; Perzynski, Adam T.; Dawson, Neal V.] Case Western Reserve Univ, Ctr Hlth Care Res & Policy, MetroHlth Med Ctr, Cleveland, OH 44106 USA; [Gunzler, Douglas D.; Dawson, Neal V.; Liu, Jintao] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Kauffman, Kelley] Case Western Reserve Univ, Ctr Reducing Hlth Dispar, MetroHlth Med Ctr, Cleveland, OH 44106 USA; [Dalton, Jarrod E.] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; Case Western Reserve University; MetroHealth System; Cleveland Clinic Foundation	Gunzler, DD (corresponding author), Case Western Reserve Univ, Ctr Hlth Care Res & Policy, MetroHlth Med Ctr, Cleveland, OH 44106 USA.; Gunzler, DD (corresponding author), Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA.	dgunzler@metrohealth.org	Kauffman, Kelley/ABB-9908-2021; Perzynski, Adam/AAX-5730-2020	Kauffman, Kelley/0000-0002-7440-3481; Perzynski, Adam/0000-0002-1323-0353	National Institutes on Aging [5R01AG055480-01]; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK112905-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG055480] Funding Source: NIH RePORTER	National Institutes on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes on Aging (5R01AG055480-01) to JD, AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK112905-01A1) to DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Ananth CV, 2001, AM J EPIDEMIOL, V154, P657, DOI 10.1093/aje/154.7.657; Bell A, 2014, DEMOGR RES, V30, P333, DOI 10.4054/DemRes.2014.30.11; Bell A, 2014, SOC SCI MED, V101, P176, DOI 10.1016/j.socscimed.2013.09.004; Bell A, 2013, SOC SCI MED, V93, P163, DOI 10.1016/j.socscimed.2013.04.029; Brody Debra J, 2018, NCHS Data Brief, P1; Brown T.A., 2014, CONFIRMATORY FACTOR; Burke JF, 2014, CIRC-CARDIOVASC QUAL, V7, P163, DOI 10.1161/CIRCOUTCOMES.113.000497; Centers for Disease Control and Prevention, 2005, NAT HLTH NUTR EX SUR; Chang VW, 2009, J HEALTH SOC BEHAV, V50, P245, DOI 10.1177/002214650905000301; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Chernyavskiy P, 2019, STAT METHODS MED RES, V28, P20, DOI 10.1177/0962280217713033; Couoh LR, 2017, AM J PHYS ANTHROPOL, V163, P671, DOI 10.1002/ajpa.23236; Granizo JJ, 1996, INT J EPIDEMIOL, V25, P814, DOI 10.1093/ije/25.4.814; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Jylhava J, 2017, EBIOMEDICINE, V21, P29, DOI 10.1016/j.ebiom.2017.03.046; Kent DM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-30; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kwok MK, 2017, J EPIDEMIOL COMMUN H, V71, P1161, DOI 10.1136/jech-2017-209491; Levine ME, 2013, J GERONTOL A-BIOL, V68, P667, DOI 10.1093/gerona/gls233; Luo LY, 2013, DEMOGRAPHY, V50, P1985, DOI 10.1007/s13524-013-0263-8; Luo LY, 2013, DEMOGRAPHY, V50, P1945, DOI 10.1007/s13524-013-0243-z; MASON KO, 1973, AM SOCIOL REV, V38, P242, DOI 10.2307/2094398; O'Brien RM, 2000, SOC SCI RES, V29, P123, DOI 10.1006/ssre.1999.0656; Pelzer B, 2015, DEMOGRAPHY, V52, P315, DOI 10.1007/s13524-014-0360-3; Rosenberg PS, 2011, CANCER EPIDEM BIOMAR, V20, P1263, DOI 10.1158/1055-9965.EPI-11-0421; Rosenberg PS, 2010, STAT MED, V29, P1228, DOI 10.1002/sim.3865; Sussman JB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h454; Yang Y., 2013, CHAPMAN HALL CRC INT, V10	29	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219399	10.1371/journal.pone.0219399	http://dx.doi.org/10.1371/journal.pone.0219399			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4JZ	31291339	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800080
J	Lu, YT; He, JT; Zhu, HX; Wang, YX				Lu, Yongtao; He, Jintao; Zhu, Hanxing; Wang, Yongxuan			Effect of parathyroid hormone on the structural, densitometric and failure behaviors of mouse tibia in the spatiotemporal space	PLOS ONE			English	Article							MICRO-COMPUTED TOMOGRAPHY; FINITE-ELEMENT-ANALYSIS; BONE ARCHITECTURE; ALENDRONATE; REPRODUCIBILITY; COMBINATION; STRENGTH; FEMUR; PTH; ADAPTATION	Parathyroid hormone (PTH) is an anabolic bone drug approved by the US Food and Drug Administration (FDA) to treat osteoporosis. However, previous studies using cross-sectional designs have reported variable and sometimes contradictory results. The aim of the present study was to quantify the localized effect of PTH on the structural and densitometric behaviors of mouse tibia and their links with the global mechanical behavior of bone using a novel spatiotemporal image analysis approach and a finite element analysis technique. Twelve female C57BL/6J mice were divided into two groups: the control and PTH treated groups. The entire right tibiae were imaged using an in vivo micro-computed tomography (mu CT) system eight consecutive times. Next, the in vivo longitudinal tibial mu CT images were rigidly registered and divided into 10 compartments across the entire tibial space. The bone volume (BV), bone mineral content (BMC), bone tissue mineral density (TMD), and tibial endosteal and periosteal areas (TEA and TPA) were quantified in each compartment. Additionally, finite element models of all the tibiae were generated to analyze the failure behavior of the tibia. It was found that both the BMC and BV started to increase in the proximal tibial region, and then the increases extended to the entire tibial region after two weeks of treatment (p < 0.05). PTH intervention significantly reduced the TEA in most tibial compartments after two weeks of treatment, and the TPA increased in most tibial regions after four weeks of treatment (p < 0.05). Tibial failure loads significantly increased after three weeks of PTH treatment (p < 0.01). The present study provided the first evidence of the localized effect of PTH on bone structural and densitometric properties, as well as their links with the global mechanical behaviors of bone, which are important pieces of information for unveiling the mechanism of PTH intervention.	[Lu, Yongtao; He, Jintao] Dalian Univ Technol, Dept Engn Mech, Dalian, Peoples R China; [Lu, Yongtao] Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Dalian, Peoples R China; [Zhu, Hanxing] Cardiff Univ, Sch Engn, Cardiff, S Glam, Wales; [Wang, Yongxuan] Dalian Univ, Affiliated Zhongshan Hosp, Dalian, Liaoning, Peoples R China	Dalian University of Technology; Dalian University of Technology; Cardiff University; Dalian University	Wang, YX (corresponding author), Dalian Univ, Affiliated Zhongshan Hosp, Dalian, Liaoning, Peoples R China.	wangyongxuan@dlu.edu.cn	Lu, Yongtao/AAC-2394-2021	Lu, Yongtao/0000-0002-8511-6111	National Natural Science Foundation of China [11702057]; Chinese Fundamental Research Funds for the Central Universities [DUT18LK19]; State Key Laboratory of Structural Analysis for Industrial Equipment [GZ18104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Fundamental Research Funds for the Central Universities; State Key Laboratory of Structural Analysis for Industrial Equipment	Dr. Yongtao Lu received the funding from the National Natural Science Foundation of China (grant number: 11702057 to Dr. Yongtao Lu) and from the Chinese Fundamental Research Funds for the Central Universities (grant number: DUT18LK19). These fundings sponsored Dr. Yongtao Lu's research activities including study design, data analysis and preparation of the manuscript. Dr. Yongtao Lu and Dr. Hanxing Zhu jointly received the funding from the State Key Laboratory of Structural Analysis for Industrial Equipment (grant number: GZ18104). This funding sponsored Dr. Hanxing Zhu's research activities including the revision of the manuscript.	Altman AR, 2015, BONE, V81, P370, DOI 10.1016/j.bone.2015.07.037; Altman AR, 2014, BONE, V61, P149, DOI 10.1016/j.bone.2014.01.008; Ausk BJ, 2013, BONE, V57, P413, DOI 10.1016/j.bone.2013.09.009; Birkhold AI, 2015, BONE, V75, P210, DOI 10.1016/j.bone.2015.02.027; Birkhold AI, 2014, BIOMATERIALS, V35, P9290, DOI 10.1016/j.biomaterials.2014.07.051; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Boyd SK, 2006, BONE, V39, P854, DOI 10.1016/j.bone.2006.04.017; Brouwers JEM, 2009, OSTEOPOROSIS INT, V20, P1823, DOI 10.1007/s00198-009-0882-5; Buie HR, 2007, BONE, V41, P505, DOI 10.1016/j.bone.2007.07.007; Buie HR, 2008, J BONE MINER RES, V23, P2048, DOI 10.1359/JBMR.080808; Campbell GM, 2011, BONE, V49, P225, DOI 10.1016/j.bone.2011.04.008; Dall'Ara E, 2014, J BIOMECH, V47, P2956, DOI 10.1016/j.jbiomech.2014.07.019; de Bakker CMJ, 2015, BONE, V73, P198, DOI 10.1016/j.bone.2014.12.061; Ferrari SL, 2005, ENDOCRINOLOGY, V146, P1854, DOI 10.1210/en.2004-1282; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Johnell O, 2005, OSTEOPOROSIS INT, V16, pS3, DOI 10.1007/s00198-004-1702-6; Johnston S, 2007, ENDOCRINOLOGY, V148, P4466, DOI 10.1210/en.2007-0229; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P229, DOI 10.1007/s00198-004-1811-2; Keaveny TM, 2008, J BONE MINER RES, V23, P1974, DOI 10.1359/JBMR.080805; Klinck RJ, 2008, MED ENG PHYS, V30, P888, DOI 10.1016/j.medengphy.2007.11.004; Kohler T, 2005, CALCIFIED TISSUE INT, V77, P281, DOI 10.1007/s00223-005-0039-2; Lambers FM, 2012, CALCIFIED TISSUE INT, V90, P108, DOI 10.1007/s00223-011-9553-6; Lu YT, 2018, ANN BIOMED ENG, V46, P749, DOI 10.1007/s10439-018-1994-x; Lu YT, 2018, J MECH MED BIOL, V18, DOI 10.1142/S0219519418500112; Lu YT, 2017, J MECH BEHAV BIOMED, V75, P244, DOI 10.1016/j.jmbbm.2017.07.034; Lu YT, 2016, J BIOMECH, V49, P2095, DOI 10.1016/j.jbiomech.2016.05.022; Lu YT, 2015, MED ENG PHYS, V37, P1091, DOI 10.1016/j.medengphy.2015.08.017; Lu YT, 2014, J BIOMECH, V47, P2512, DOI 10.1016/j.jbiomech.2014.04.015; Nishiyama KK, 2010, BONE, V46, P155, DOI 10.1016/j.bone.2009.09.023; Pierroz DD, 2010, J BIOL CHEM, V285, P28164, DOI 10.1074/jbc.M110.101964; Pistoia W, 2002, BONE, V30, P842, DOI 10.1016/S8756-3282(02)00736-6; Qasim M, 2016, OSTEOPOROSIS INT, V27, P2815, DOI 10.1007/s00198-016-3597-4; Schulte FA, 2013, BONE, V52, P485, DOI 10.1016/j.bone.2012.09.008; Schulte FA, 2011, BONE, V48, P433, DOI 10.1016/j.bone.2010.10.007; Stadelmann VA, 2011, CLIN BIOMECH, V26, P101, DOI 10.1016/j.clinbiomech.2010.08.014; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; Wu XW, 2010, CELL STEM CELL, V7, P571, DOI 10.1016/j.stem.2010.09.012	38	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219575	10.1371/journal.pone.0219575	http://dx.doi.org/10.1371/journal.pone.0219575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291372	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000484947800119
J	Sheinerman, K; Djukic, A; Tsivinsky, VG; Umansky, SR				Sheinerman, Kira; Djukic, Aleksandra; Tsivinsky, Vladimir G.; Umansky, Samuil R.			Brain-enriched microRNAs circulating in plasma as novel biomarkers for Rett syndrome	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; NEURODEVELOPMENTAL DISORDERS; MOUSE MODEL; MECP2; EXPRESSION; MUTATIONS; NEURONS; MIRNAS	Rett syndrome (RTT) is a severe neurodevelopmental disorder caused by mutations in the X-linked gene MECP2 (methyl-CpG-binding protein 2). Minimally invasive and accurate biomarkers of disease progression and treatment response could facilitate screening of therapeutic compounds in animal models, enrollment of better-defined participants into clinical trials, and treatment monitoring. In this study, we used a targeted approach based on analysis of brain-enriched microRNAs (miRNAs) circulating in plasma to identify miRNA biomarkers of RTT using Mecp2-mutant mice as a model system and human plasma samples. An "miRNA pair" approach, i.e. the ratio between two miRNAs, was used for data normalization. Specific miRNA pairs and their combinations (classifiers) analyzed in plasma differentiated wild-type from Mecp2 male and female mice with >90% accuracy. Individual miRNA pairs were more effective in distinguishing male (homozygous) animals than female (heterozygous) animals, suggesting that disease severity correlated with the levels of the miRNA biomarkers. In the human study, 30 RTT patients were compared with age-matched controls. The results of this study showed that miRNA classifiers were able to differentiate RTT patients from controls with 85-100% sensitivity. In addition, a comparison of various age groups demonstrated that the dynamics in levels of miRNAs appear to be associated with disease development (involvement of liver, muscle and lipid metabolism in the pathology). Importantly, certain miRNA biomarker pairs were common to both the animal models and human subjects, indicating the similarity between the underlying pathological processes. The data generated in this feasibility study suggest that circulating miRNAs have the potential to be developed as markers of RTT progression and treatment response. Larger clinical studies are needed to further evaluate the findings presented here.	[Sheinerman, Kira; Tsivinsky, Vladimir G.; Umansky, Samuil R.] DiamiR LLC, Princeton, NJ 08540 USA; [Djukic, Aleksandra] Albert Einstein Coll Med, Montefiore Med Ctr, New York, NY USA	Montefiore Medical Center; Yeshiva University	Umansky, SR (corresponding author), DiamiR LLC, Princeton, NJ 08540 USA.	sumansky@diamirbio.com			Rett Syndrome Research Trust (RSRT)	Rett Syndrome Research Trust (RSRT)	SU, KS, and VT are employees of DiamiR, LLC. DiamiR received an award from the Rett Syndrome Research Trust (RSRT) for the animal work reported here. The RSRT (reverserett.org) contributed to the animal study design by participating in the initial discussions; introducing us to Dr. D. Katz, who provided the Mecp2tm1.1Jae animal model used in the studies described in this manuscript; and encouraging the making of the study results available to the research community. The RSRT had no role in data collection and analysis or in the preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Armstrong DD, 2001, BRAIN DEV-JPN, V23, pS72, DOI 10.1016/S0387-7604(01)00332-1; Backes C, 2016, ANAL CHEM, V88, P2088, DOI 10.1021/acs.analchem.5b03376; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cheng TL, 2014, DEV CELL, V28, P547, DOI 10.1016/j.devcel.2014.01.032; Della Sala G, 2014, DEV NEUROBIOL, V74, P178, DOI 10.1002/dneu.22114; Forbes-Lorman RM, 2014, BRAIN RES, V1543, P151, DOI 10.1016/j.brainres.2013.11.011; Gigek CO, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.56; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hansen KF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015497; Hicks SD, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00176; Hoffbuhr KC, 2002, MENT RETARD DEV D R, V8, P99, DOI 10.1002/mrdd.10026; Horvath PM, 2018, TRENDS NEUROSCI, V41, P72, DOI 10.1016/j.tins.2017.11.005; Jin XR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00316; Johnston M, 2015, F1000RES, V4; Johnston MV, 2001, BRAIN DEV-JPN, V23, pS206, DOI 10.1016/S0387-7604(01)00351-5; Jovicic A, 2013, J NEUROSCI, V33, P5127, DOI 10.1523/JNEUROSCI.0600-12.2013; Katz DM, 2016, TRENDS NEUROSCI, V39, P100, DOI 10.1016/j.tins.2015.12.008; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Li W, 2012, P NATL ACAD SCI USA, V109, P17087, DOI 10.1073/pnas.1205271109; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Lyst MJ, 2015, NAT REV GENET, V16, P261, DOI 10.1038/nrg3897; Martini P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089755; Mellios N, 2018, MOL PSYCHIATR, V23, P1051, DOI 10.1038/mp.2017.86; Nomura Y, 2001, BRAIN DEV-JPN, V23, pS50, DOI 10.1016/S0387-7604(01)00379-5; Obiols-Guardia A, 2017, ADV EXP MED BIOL, V978, P23, DOI 10.1007/978-3-319-53889-1_2; Sheinerman KS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00150; Panayotis N, 2011, NEUROBIOL DIS, V41, P385, DOI 10.1016/j.nbd.2010.10.006; Penso-Dolfin L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153453; Sceniak MP, 2016, CEREB CORTEX, V26, P1938, DOI 10.1093/cercor/bhv002; Shahbazian MD, 2001, CURR OPIN NEUROL, V14, P171, DOI 10.1097/00019052-200104000-00006; Sheinerman KS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0316-0; Sheinerman KS, 2015, EXPERT REV MOL DIAGN, V15, P329, DOI 10.1586/14737159.2014.973858; Sheinerman KS, 2012, AGING-US, V4, P590, DOI 10.18632/aging.100486; Shepherd GMG, 2011, CURR OPIN NEUROBIOL, V21, P827, DOI 10.1016/j.conb.2011.06.006; Tsujimura K, 2015, CELL REP, V12, P1887, DOI 10.1016/j.celrep.2015.08.028; Urdinguio RG, 2010, EPIGENETICS-US, V5, P656, DOI 10.4161/epi.5.7.13055; Vasu MM, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-40; Wu H, 2010, P NATL ACAD SCI USA, V107, P18161, DOI 10.1073/pnas.1005595107; Xu X, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00068; Yasui DH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-3; ZOGHBI HY, 1990, BRAIN DEV-JPN, V12, P131, DOI 10.1016/S0387-7604(12)80194-X	48	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218623	10.1371/journal.pone.0218623	http://dx.doi.org/10.1371/journal.pone.0218623			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291284	Green Published, gold			2022-12-26	WOS:000484947800029
J	Cardoso, AM; Resende, PC; Paixao, ES; Tavares, FG; Farias, YN; Barreto, CTG; Pantoja, LN; Ferreira, FL; Martins, AL; Lima, AB; Fernandes, DA; Sanches, PM; Almeida, WAF; Rodrigues, LC; Siqueira, MM				Cardoso, Andrey Moreira; Resende, Paola Cristina; Paixao, Enny S.; Tavares, Felipe G.; Farias, Yasmin N.; Barreto, Carla Tatiana G.; Pantoja, Lidia N.; Ferreira, Fernanda L.; Martins, Andre Luiz; Lima, Angela Barbosa; Fernandes, Daniella A.; Sanches, Patricia Machado; Almeida, Walquiria A. F.; Rodrigues, Laura C.; Siqueira, Marilda M.			Investigation of an outbreak of acute respiratory disease in an indigenous village in Brazil: Contribution of Influenza A(H1N1) pdm09 and human respiratory syncytial viruses	PLOS ONE			English	Article							PANDEMIC H1N1 INFLUENZA; A H1N1; AMERICAN-INDIANS; UNITED-STATES; RISK-FACTORS; CHILDREN; REMOTE; PREVALENCE; AUSTRALIA; PREGNANCY	Analyses of the 2009 H1N1 influenza pandemic and post-pandemic years showed high attack rates and severity among indigenous populations. This study presents the characteristics of the first documented influenza outbreak in indigenous peoples in Brazil, that occurred from 30th March to 14th April 2016 in a Guarani village in Southeast Region. Acute respiratory infections were prospectively investigated. The majority of the 73 cases were influenza-like illness (ILI) (63.0%) or severe acute respiratory infection (SARI) (20.5%). The ILI+SARI attack rate (35.9%) decreased with increasing age. There was a high influenza vaccination rate (86.3%), but no statistically significant difference in vaccination rates between severe and non-severe cases was seen (p = 0.334). Molecular analyses of 19.2% of the cases showed 100% positivity for influenza A(H1N1)pdm09 and/or hRSV. Influenza A (H1N1)pdm09 was included in the 6B.1 genetic group, a distinct cluster with 13 amino acid substitutions of A/California/07/2009-like. The hRSV were clustered in the BA-like genetic group. The early arrival of the influenza season overlapping usual hRSV season, the circulation of a drifted influenza virus not covered by vaccine and the high prevalence of risk factors for infection and severity in the village jointly can explain the high attack rate of ARI, even with a high rate of influenza vaccination. The results reinforce the importance of surveillance of respiratory viruses, timely vaccination and controlling risk factors for infection and severity of in the indigenous populations in order to preventing disease and related deaths, particularly in children.	[Cardoso, Andrey Moreira; Farias, Yasmin N.; Pantoja, Lidia N.] Fundacao Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Cardoso, Andrey Moreira; Paixao, Enny S.; Rodrigues, Laura C.] London Sch Hyg & Trop Med, London, England; [Resende, Paola Cristina; Siqueira, Marilda M.] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Tavares, Felipe G.] Univ Fed Fluminense, Niteroi, RJ, Brazil; [Barreto, Carla Tatiana G.] Univ Estado Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Ferreira, Fernanda L.; Martins, Andre Luiz; Lima, Angela Barbosa; Fernandes, Daniella A.] Secretaria Especial Saude Indigena, Curitiba, Parana, Brazil; [Sanches, Patricia Machado] Secretaria Municipal Saude Paraty, Paraty, RJ, Brazil; [Almeida, Walquiria A. F.] Secretaria Vigilancia Saude, Brasilia, DF, Brazil	Fundacao Oswaldo Cruz; University of London; London School of Hygiene & Tropical Medicine; Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Universidade do Estado do Rio de Janeiro	Cardoso, AM (corresponding author), Fundacao Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.; Cardoso, AM (corresponding author), London Sch Hyg & Trop Med, London, England.	andrey@ensp.fiocruz.br	RODRIGUES, LAURA CUNHA/AAO-4130-2021; Resende, Paola Cristina/P-5002-2015; Barreto, Carla/AAV-7384-2020; Cardoso, Andrey Moreira/H-8047-2012; Cardoso, Andrey/V-4074-2019; FARIAS, YASMIN N/H-7388-2015	Resende, Paola Cristina/0000-0002-2884-3662; Cardoso, Andrey/0000-0002-7591-7791; FARIAS, YASMIN/0000-0002-3413-0204	AMC - National Research Council (CNPq) [14/2011 - 47.4008/2011-8]; CNPq Universal [01/2016 - 428284/2016-7]; Oswaldo Cruz Foundation [25388.000556/2013-52]; PAPES VII - Young scientist 2014 [401789/2015-2]; ENSP [25388.000526/2017-70]; Research Foundation of the State of Rio de Janeiro (FAPERJ) PPSUS FAPERJ/SES-RJ/MS-DECIT/CNPq [35/2013-E-26/110.275/2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; MMS - CNPq Universal [431975/2016-7]	AMC - National Research Council (CNPq); CNPq Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Oswaldo Cruz Foundation; PAPES VII - Young scientist 2014; ENSP; Research Foundation of the State of Rio de Janeiro (FAPERJ) PPSUS FAPERJ/SES-RJ/MS-DECIT/CNPq(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); MMS - CNPq Universal	This project was funded by the following institutions: Received by AMC - National Research Council (CNPq - ww.cnpq.br) Universal 14/2011 - 47.4008/2011-8 and CNPq Universal 01/2016 - 428284/2016-7; Oswaldo Cruz Foundation (Fiocruz - www.fiocruz.br) - INOVA ENSP II 2013 -25388.000556/2013-52, PAPES VII - Young scientist 2014 -401789/2015-2 and ENSP 2016/2018 - 25388.000526/2017-70; Research Foundation of the State of Rio de Janeiro (FAPERJ - www.fapen.br) PPSUS FAPERJ/SES-RJ/MS-DECIT/CNPq 35/2013-E-26/110.275/2014; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES - www.capes.gov.br) - Finance Code 001; Received by MMS - CNPq Universal 431975/2016-7, used for the molecular analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, Wkly Epidemiol Rec, V90, P545; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P469; Baillie GJ, 2012, J VIROL, V86, P11, DOI 10.1128/JVI.05347-11; Brasil-Secretaria de Vigilancia em Saude/ Ministerio da Saude, 2010, B EP INV SURT SINDR, V43, P11; Brasil-Secretaria de Vigilancia em Saude/ Ministerio da Saude, 2015, PROT TRAT INFL 2015; Cardoso AM, 2015, INT HEALTH, V7, P412, DOI 10.1093/inthealth/ihv023; Cardoso AM, 2013, TROP MED INT HEALTH, V18, P596, DOI 10.1111/tmi.12081; Cebey-Lopez M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136526; Cheek JE, 2011, AM J EPIDEMIOL, V174, pS89, DOI 10.1093/aje/kwr311; Chidgzey PJ, 2015, AUST NZ J PUBL HEAL, V39, P15, DOI 10.1111/1753-6405.12295; Christian LM, 2014, VACCINE, V32, P2958, DOI 10.1016/j.vaccine.2014.03.075; Clark AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188267; Coimbra CEA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-52; Tran D, 2013, J PEDIAT-BRAZIL, V89, P421, DOI 10.1016/j.jped.2013.06.002; Davlin SL, 2016, MMWR-MORBID MORTAL W, V65, P567, DOI 10.15585/mmwr.mm6522a3; Freitas FTD, 2013, BRAZ J INFECT DIS, V17, P62, DOI 10.1016/j.bjid.2012.09.001; Santos KCD, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759009, 10.1590/s1678-9946201759009]; Flint SM, 2010, MED J AUSTRALIA, V192, P617, DOI 10.5694/j.1326-5377.2010.tb03654.x; Groom AV, 2009, AM J PUBLIC HEALTH, V99, pS271, DOI 10.2105/AJPH.2008.157453; Horta BL, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-23; Jacobson LM, 2012, PEDIATR INFECT DIS J, V31, P309, DOI 10.1097/INF.0b013e3182443eaf; Kool JL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-6; La Ruche G, 2009, EUROSURVEILLANCE, V14, P51; Marshall H, 2016, HUM VACC IMMUNOTHER, V12, P848, DOI 10.1080/21645515.2015.1127485; Ministerio da Saude, 2014, GUIA VIG SAUD; Pollock SL, 2012, CAN J PUBLIC HEALTH, V103, P90, DOI 10.1007/BF03404209; Quinones-Parra S, 2014, P NATL ACAD SCI USA, V111, P1049, DOI 10.1073/pnas.1322229111; [Secretary of Health Surveillance-Brazilian MoH. Surveillance SoH], 2017, INFL EP INFL MON AT, P1; Suryaprasad A, 2013, INFLUENZA OTHER RESP, V7, P1361, DOI 10.1111/irv.12123; Trauer JM, 2011, EMERG INFECT DIS, V17, P1615, DOI 10.3201/eid1709.101196; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Walter EB, 2010, VACCINE, V28, P4376, DOI 10.1016/j.vaccine.2010.04.058; Wenger JD, 2011, CLIN INFECT DIS, V52, pS189, DOI 10.1093/cid/ciq037; WHO Global Influenza Surveillance Network, 2011, MAN LAB DIAGN VIR SU; World Health Organization, 2017, GLOB EP SURV STAND I; Xiao YY, 2013, INFLUENZA OTHER RESP, V7, P1409, DOI 10.1111/irv.12141; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07	38	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0218925	10.1371/journal.pone.0218925	http://dx.doi.org/10.1371/journal.pone.0218925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283762	gold, Green Published, Green Submitted			2022-12-26	WOS:000484939800012
J	Kwon, JM; Kim, KH; Jeon, KH; Lee, SE; Lees, HY; Cho, HJ; Choi, JO; Jeon, ES; Kim, MS; Kim, JJ; Hwang, KK; Chae, SC; Baek, SH; Kang, SM; Choi, DJ; Yoo, BS; Kim, KH; Park, HY; Cho, MC; Oh, BH				Kwon, Joon-Myoung; Kim, Kyung-Hee; Jeon, Ki-Hyun; Lee, Sang Eun; Lees, Hae-Young; Cho, Hyun-Jai; Choi, Jin Oh; Jeon, Eun-Seok; Kim, Min-Seok; Kim, Jae-Joong; Hwang, Kyung-Kuk; Chae, Shung Chull; Baek, Sang Hong; Kang, Seok-Min; Choi, Dong-Ju; Yoo, Byung-Su; Kim, Kye Hun; Park, Hyun-Young; Cho, Myeong-Chan; Oh, Byung-Hee			Artificial intelligence algorithm for predicting mortality of patients with acute heart failure	PLOS ONE			English	Article							RISK SCORE; VALIDATION; SURVIVAL	Aims This study aimed to develop and validate deep-learning-based artificial intelligence algorithm for predicting mortality of AHF (DAHF). Methods and results 12,654 dataset from 2165 patients with AHF in two hospitals were used as train data for DAHF development, and 4759 dataset from 4759 patients with AHF in 10 hospitals enrolled to the Korean AHF registry were used as performance test data. The endpoints were in-hospital, 12-month, and 36-month mortality. We compared the DAHF performance with the Get with the Guidelines Heart Failure (GWTG-HF) score, Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) score, and other machine-learning models by using the test data. Area under the receiver operating characteristic curve of the DAHF were 0.880 (95% confidence interval, 0.876-0.884) for predicting in-hospital mortality; these results significantly outperformed those of the GWTG-HF (0.728 [0.720-0.737]) and other machine learning models. For predicting 12- and 36-month endpoints, DAHF (0.782 and 0.813) significantly outperformed MAGGIC score (0.718 and 0.729). During the 36-month follow-up, the high-risk group, defined by the DAHF, had a significantly higher mortality rate than the low-risk group(p<0.001). Conclusion DAHF predicted the in-hospital and long-term mortality of patients with AHF more accurately than the existing risk scores and other machine-learning models.	[Kwon, Joon-Myoung; Jeon, Ki-Hyun] Sejong Med Res Inst, Artificial Intelligence & Big Data Ctr, Gyunggi, South Korea; [Kwon, Joon-Myoung] Mediplex Sejong Hosp, Dept Emergency Med, Incheon, South Korea; [Kim, Kyung-Hee; Jeon, Ki-Hyun; Oh, Byung-Hee] Mediplex Sejong Hosp, Cardiovasc Ctr, Div Cardiol, Incheon, South Korea; [Lee, Sang Eun; Kim, Min-Seok; Kim, Jae-Joong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Lees, Hae-Young; Cho, Hyun-Jai] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Choi, Jin Oh; Jeon, Eun-Seok] Sungkyunkwan Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Hwang, Kyung-Kuk; Cho, Myeong-Chan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea; [Chae, Shung Chull] Kyungpook Natl Univ, Coll Med, Dept Internal Med, Daegu, South Korea; [Baek, Sang Hong] Catholica Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Seok-Min] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Choi, Dong-Ju] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Yoo, Byung-Su] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea; [Kim, Kye Hun] Chonnam Natl Univ, Heart Res Ctr, Dept Internal Med, Gwangju, South Korea; [Park, Hyun-Young] Korea Natl Inst Hlth, Div Cardiovasc & Rare Dis, Cheongju, South Korea	University of Ulsan; Asan Medical Center; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Chungbuk National University; Kyungpook National University; Catholic University of Korea; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Yonsei University; Chonnam National University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science	Kim, KH; Oh, BH (corresponding author), Mediplex Sejong Hosp, Cardiovasc Ctr, Div Cardiol, Incheon, South Korea.	leambylivinga@gmail.com; ohbhmed@seiongh.co.kr		Kang, Seok-Min/0000-0001-9856-9227; Kim, Kyung-Hee/0000-0003-0708-8685	Research of Korea Centers for Disease Control and Prevention [2010-E63003-00, 2011-E63002-00, 2012-E63005-00, 2013-E63003-00, 2013-E63003-01, 2013-E63003-02, 2016-ER6303-00, 2016ER6303-01]	Research of Korea Centers for Disease Control and Prevention	The KorAHF registry was supported by Research of Korea Centers for Disease Control and Prevention [2010-E63003-00, 2011-E63002-00, 2012-E63005-00, 2013-E63003-00, 2013-E6300301, 2013-E63003-02, 2016-ER6303-00, 2016ER6303-01]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 2016, P 12 USENIX S OP SYS, P21; Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Attia ZI, 2019, NAT MED, V25, P70, DOI 10.1038/s41591-018-0240-2; Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Cacciatore F, 2012, EUR J PREV CARDIOL, V19, P1401, DOI 10.1177/1741826711422991; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Chen X., 2016, ARXIV160603657, P2172; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Fong RC, 2017, IEEE I CONF COMP VIS, P3449, DOI 10.1109/ICCV.2017.371; Frizzell JD, 2017, JAMA CARDIOL, V2, P204, DOI 10.1001/jamacardio.2016.3956; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Khanam SS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206380; Kuhn M., 2013, PACKAGEAPPLIEDPREDIC, DOI DOI 10.1007/978-1-4614-6849-3; Kwon JM, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008678; Lagu T, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002912; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee SE, 2017, KOREAN CIRC J, V47, P341, DOI 10.4070/kcj.2016.0419; Mortazavi BJ, 2016, CIRC-CARDIOVASC QUAL, V9, P629, DOI 10.1161/CIRCOUTCOMES.116.003039; Peterson PN, 2010, CIRC-CARDIOVASC QUAL, V3, P25, DOI 10.1161/CIRCOUTCOMES.109.854877; Ponikowski P, 2014, ESC HEART FAIL, V1, P4, DOI 10.1002/ehf2.12005; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Sartipy U, 2014, EUR J HEART FAIL, V16, P173, DOI 10.1111/ejhf.32; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Shiraishi Y, 2016, AM HEART J, V171, P33, DOI 10.1016/j.ahj.2015.10.008; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Wolpert DH, 2002, SOFT COMPUTING AND INDUSTRY, P25; Zannad F, 2012, EUR HEART J, V33, P1049, DOI 10.1093/eurheartj/ehr437; Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25	31	30	34	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219302	10.1371/journal.pone.0219302	http://dx.doi.org/10.1371/journal.pone.0219302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283783	gold, Green Submitted, Green Published			2022-12-26	WOS:000484939800028
J	Hermassi, S; Ghaith, A; Schwesig, R; Shephard, RJ; Chelly, MS				Hermassi, Souhail; Ghaith, Aloui; Schwesig, Rene; Shephard, Roy J.; Chelly, Mohamed Souhaiel			Effects of short-term resistance training and tapering on maximal strength, peak power, throwing ball velocity, and sprint performance in handball players	PLOS ONE			English	Article							VERTICAL JUMP; PROGRAM; AGILITY; VS.; ADAPTATIONS; INTENSITY; SPEED	The purpose of this study was to assess the effect of short-term resistance training and two weeks of tapering on physical performances in handball players. Following a ten-week progressive resistance training program, subjects were divided between an experimental (n = 10) and a control group (n = 10). The experimental group completed a resistance training program, followed by a two-week period when the training intensity was tapered by 60%, while the control group maintained their typical pattern of training. Muscle power (force-velocity test and squat and counter-movement jump tests), sprinting ability (10m and 30m), ability to change direction (T-half test) and throwing velocity (a 3-step throw with a run, and a jump throw) were evaluated before training, at the end of training and after tapering. The experimental group showed significantly larger interaction effects for the 10-week training period (12/15, 80%), than for the following 2 weeks of tapering (10/15, 67%), with the largest gains being in 15 m sprint times (d = 3.78) and maximal muscular strength in the snatch (d = 3.48). Although the performance of the experimental group generally continued to increase over tapering, the mean effect size for the training period was markedly higher (d = 1.92, range: 0.95-3.78) than that seen during tapering (d = 1.02, range: -0.17-2.09). Nevertheless the ten weeks of progressive resistance training followed by two weeks of tapering was an effective overall tactic to increase muscle power, sprint performance and ball throwing velocity in handball players.	[Hermassi, Souhail] Qatar Univ, Coll Arts & Sci, Sport Sci Program, Doha, Qatar; [Ghaith, Aloui; Chelly, Mohamed Souhaiel] Univ La Manouba, Higher Inst Sport & Phys Educ Ksar Said, Res Unit UR17JS01 Sport Performance Hlth & Soc, Tunis, Tunisia; [Schwesig, Rene] Martin Luther Univ Halle Wittenberg, Dept Orthopaed & Trauma Surg, Halle, Germany; [Shephard, Roy J.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Chelly, Mohamed Souhaiel] Univ La Manouba, Higher Inst Sport & Phys Educ Ksar Said, Dept Biol Sci Appl Phys Act & Sport, Tunis, Tunisia	Qatar University; Universite de la Manouba; Martin Luther University Halle Wittenberg; University of Toronto; Universite de la Manouba	Hermassi, S (corresponding author), Qatar Univ, Coll Arts & Sci, Sport Sci Program, Doha, Qatar.	shermassi@qu.edu.qa	Hermassi, Souhail/AAF-1987-2019; Chelly, Souhaiel/I-6329-2019	Hermassi, Souhail/0000-0001-9389-8937; Chelly, Souhaiel/0000-0002-0713-1308				Arabatzi F, 2012, J STRENGTH COND RES, V26, P2192, DOI 10.1519/JSC.0b013e31823b087a; Arabatzi F, 2010, J STRENGTH COND RES, V24, P2440, DOI 10.1519/JSC.0b013e3181e274ab; Ayers JL, 2016, BIOL SPORT, V33, P251, DOI 10.5604/20831862.1201814; Banister EW, 1999, EUR J APPL PHYSIOL O, V79, P182, DOI 10.1007/s004210050493; Behm DG, 2008, APPL PHYSIOL NUTR ME, V33, P547, DOI 10.1139/H08-020; Bishop D, 2005, J SCI MED SPORT, V8, P200, DOI 10.1016/S1440-2440(05)80011-8; Bortz J., 1999, STAT SOZIALWISSENSCH; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF00422166; Bosquet L, 2007, MED SCI SPORT EXER, V39, P1358, DOI 10.1249/mss.0b013e31806010e0; Cavaco B, 2014, J HUM KINET, V43, P105, DOI 10.2478/hukin-2014-0095; Chelly MS, 2014, J STRENGTH COND RES, V28, P1401, DOI 10.1519/JSC.0000000000000279; Chelly MS, 2010, J STRENGTH COND RES, V24, P1480, DOI 10.1519/JSC.0b013e3181d32fbf; Chelly MS, 2009, J STRENGTH COND RES, V23, P2241, DOI 10.1519/JSC.0b013e3181b86c40; COSTILL D L, 1985, Physician and Sportsmedicine, V13, P94, DOI 10.1080/00913847.1985.11708748; de Lacey J, 2014, J STRENGTH COND RES, V28, P3567, DOI 10.1519/JSC.0000000000000572; Garcia-Pinillos F, 2014, J STRENGTH COND RES, V28, P2452, DOI 10.1519/JSC.0000000000000452; GIBALA MJ, 1994, INT J SPORTS MED, V15, P492, DOI 10.1055/s-2007-1021093; Gonzalez-Badillo JJ, 2006, J STRENGTH COND RES, V20, P73; HARTMANN A, 1992, J PSYCHOSOM RES, V36, P159, DOI 10.1016/0022-3999(92)90024-V; Helland C, 2017, MED SCI SPORT EXER, V49, P736, DOI 10.1249/MSS.0000000000001145; Hermassi S, 2015, J STRENGTH COND RES, V29, P2105, DOI 10.1519/JSC.0000000000000855; Hermassi S, 2011, J STRENGTH COND RES, V25, P2424, DOI 10.1519/JSC.0b013e3182030edb; Hoffman JR, 2003, J STRENGTH COND RES, V17, P109; HOUMARD JA, 1994, SPORTS MED, V17, P224, DOI 10.2165/00007256-199417040-00003; HOUMARD JA, 1991, SPORTS MED, V12, P380, DOI 10.2165/00007256-199112060-00004; JEUKENDRUP AE, 1992, INT J SPORTS MED, V13, P534, DOI 10.1055/s-2007-1021312; JOHNS RA, 1992, MED SCI SPORT EXER, V24, P1141; Kenitzer J.R, 1998, J SWIM RES, V13, P31; Maestu J, 2003, HORM METAB RES, V35, P109, DOI 10.1055/s-2003-39053; Margaritis I, 2003, J AM COLL NUTR, V22, P147, DOI 10.1080/07315724.2003.10719288; McArdle W.D., 2007, EXERCISE PHYSL ENERG; Moore EWG, 2005, J STRENGTH COND RES, V19, P791; Mujika I, 1996, MED SCI SPORT EXER, V28, P251, DOI 10.1097/00005768-199602000-00015; Mujika I, 1998, INT J SPORTS MED, V19, P439, DOI 10.1055/s-2007-971942; Mujika I, 2003, MED SCI SPORT EXER, V35, P1182, DOI 10.1249/01.MSS.0000074448.73931.11; Mujika I, 2002, INT J SPORTS MED, V23, P582, DOI 10.1055/s-2002-35526; Mujika I, 2010, SCAND J MED SCI SPOR, V20, P24, DOI 10.1111/j.1600-0838.2010.01189.x; Mujika Inigo, 2004, Sports Med, V34, P891, DOI 10.2165/00007256-200434130-00003; Neary JP, 2003, CAN J APPL PHYSIOL, V28, P576, DOI 10.1139/h03-044; NEUFER PD, 1989, SPORTS MED, V8, P302, DOI 10.2165/00007256-198908050-00004; Polla B, 2004, THORAX, V59, P808, DOI 10.1136/thx.2003.009894; Pritchard HJ, 2018, J STRENGTH COND RES, V32, P458, DOI 10.1519/JSC.0000000000001803; Rhibi F., 2016, SCI SPORT, P93; Sassi RH, 2009, J STRENGTH COND RES, V23, P1644, DOI 10.1519/JSC.0b013e3181b425d2; Tricoli V, 2005, J STRENGTH COND RES, V19, P433; WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004; WOMERSLEY J, 1973, HUM BIOL, V45, P281; Zaras ND, 2014, J STRENGTH COND RES, V28, P3484, DOI 10.1519/JSC.0000000000000566	48	10	10	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0214827	10.1371/journal.pone.0214827	http://dx.doi.org/10.1371/journal.pone.0214827			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276499	Green Published, gold, Green Submitted			2022-12-26	WOS:000484936300008
J	Kizewski, FR; Kaye, JP; Martinez, CE				Kizewski, Fiona R.; Kaye, Jason P.; Martinez, Carmen Enid			Nitrate transformation and immobilization in particulate organic matter incubations: Influence of redox, iron and (a) biotic conditions	PLOS ONE			English	Article							FOREST SOIL; NITROGEN MINERALIZATION; ABIOTIC IMMOBILIZATION; NITRITE; REDUCTION; RETENTION; PATHWAYS; AMMONIUM; CARBON; SEQUESTRATION	Nitrate can be reduced to other N inorganic species via denitrification and incorporated into organic matter by immobilization; however, the effect of biotic/abiotic and redox condition on immobilization and denitrification processes from a single system are not well documented. We hypothesize nitrate (NO3-) transformation pathways leading to the formation of dissolved- and solid-phase organic N are predominantly controlled by abiotic reactions, but the formation of soluble inorganic N species is controlled by redox condition. In this study, organic matter in the form of leaf compost (LC) was spiked with (NO3-)-N-15 and incubated under oxic/anoxic and biotic/abiotic conditions at pH 6.5. We seek to understand how variations in environmental conditions impact NO3- transformation pathways through laboratory incubations. We find production of NH4+ is predominantly controlled by redox whereas NO3- conversion to dissolved organic nitrogen (DON) and immobilization in solid-phase N are predominantly controlled by abiotic processes. Twenty% of added N-15-NO3- was incorporated into DON under oxic conditions, with abiotic processes accounting for 85% of the overall incorporation. Nitrogen immobilization processes resulted in N concentrations of 4.1-6.6 mu g N (g leaf compost)(-1), with abiotic processes accounting for 100% and 66% of the overall (biotic+abiotic) N immobilization under anoxic and oxic conditions, respectively. N-15-NMR spectroscopy suggests (NO3-)-N-15 was immobilized into amide/aminoquinones and nitro/oxime under anoxic conditions. A fraction of the NH4+ was produced abiotically under anoxic conditions (similar to 10% of the total NH4+ production) although biotic organic N mineralization contributed to most of NH4+ production. Our results also indicate Fe(II) did not act as an electron source in biotic-oxic incubations; however, Fe(II) provided electrons for NO3- reduction in biotic-anoxic incubations although it was not the sole electron source. It is clear that, under the experimental conditions of this investigation, abiotic and redox processes play important roles in NO3- transformations. As climatic conditions change (e.g., frequency/intensity of rainfall), abiotic reactions that shift transformation pathways and N species concentrations from those controlled by biota might become more prevalent.	[Kizewski, Fiona R.; Kaye, Jason P.] Penn State Univ, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA; [Martinez, Carmen Enid] Cornell Univ, Sch Integrat Plant Sci, Soil & Crop Sci, Ithaca, NY 14850 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cornell University	Martinez, CE (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Soil & Crop Sci, Ithaca, NY 14850 USA.	cem20@cornell.edu			NSF [0816668]; Agriculture and Food Research Initiative (AFRI) from the USDA National Institute of Food and Agriculture [201667019-25265, 1009565]	NSF(National Science Foundation (NSF)); Agriculture and Food Research Initiative (AFRI) from the USDA National Institute of Food and Agriculture	This project was funded by the NSF (Grant No. 0816668) and by the Agriculture and Food Research Initiative (AFRI, grant no. 201667019-25265/project accession no. 1009565) from the USDA National Institute of Food and Agriculture to CEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, SOIL SCI, V169, P35, DOI 10.1097/01.ss.0000112016.97541.28; Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; [Anonymous], 1996, SOIL MICROBIOLOGY BI; Bernal S, 2012, P NATL ACAD SCI USA, V109, P3406, DOI 10.1073/pnas.1121448109; Berntson GM, 2000, SOIL BIOL BIOCHEM, V32, P151, DOI 10.1016/S0038-0717(99)00132-7; Buchmann N, 1996, BIOGEOCHEMISTRY, V33, P1, DOI 10.1007/BF00000967; BURESH RJ, 1976, J ENVIRON QUAL, V5, P320, DOI 10.2134/jeq1976.00472425000500030021x; Colman BP, 2007, BIOGEOCHEMISTRY, V84, P161, DOI 10.1007/s10533-007-9111-5; Dail DB, 2001, BIOGEOCHEMISTRY, V54, P131, DOI 10.1023/A:1010627431722; DAVIDSON EA, 1991, J SOIL SCI, V42, P335, DOI 10.1111/j.1365-2389.1991.tb00413.x; Davidson EA, 2003, GLOBAL CHANGE BIOL, V9, P228, DOI 10.1046/j.1365-2486.2003.00592.x; DAVIDSON EA, 1992, ECOLOGY, V73, P1148, DOI 10.2307/1940665; Doane TA, 2017, ACS EARTH SPACE CHEM, V1, P411, DOI 10.1021/acsearthspacechem.7b00059; Fitzhugh RD, 2003, GLOBAL CHANGE BIOL, V9, P1591, DOI 10.1046/j.1365-2486.2003.00694.x; Fry B., 2006, STABLE ISOTOPE ECOLO; Geisseler D, 2010, SOIL BIOL BIOCHEM, V42, P2058, DOI 10.1016/j.soilbio.2010.08.021; Gundersen P, 1998, FOREST ECOL MANAG, V101, P1; Hardison AK, 2015, GEOCHIM COSMOCHIM AC, V164, P146, DOI 10.1016/j.gca.2015.04.049; Heil J, 2016, EUR J SOIL SCI, V67, P23, DOI 10.1111/ejss.12306; Huygens D, 2007, SOIL BIOL BIOCHEM, V39, P2448, DOI 10.1016/j.soilbio.2007.04.013; Huygens D, 2008, NAT GEOSCI, V1, P543, DOI 10.1038/ngeo252; Johnson DW, 2000, SOIL SCI SOC AM J, V64, P1503, DOI 10.2136/sssaj2000.6441503x; Jokic A, 2004, CAN J SOIL SCI, V84, P291, DOI 10.4141/S03-094; KOROM SF, 1992, WATER RESOUR RES, V28, P1657, DOI 10.1029/92WR00252; Leinweber P, 2013, ADV AGRON, V119, P83, DOI 10.1016/B978-0-12-407247-3.00002-0; Maie N, 2006, GEOCHIM COSMOCHIM AC, V70, P4491, DOI 10.1016/j.gca.2006.06.1554; Matus F, 2019, GEOCHIM COSMOCHIM AC, V245, P514, DOI 10.1016/j.gca.2018.11.020; Miyajima T, 2015, GEOCHEM J, V49, P453, DOI 10.2343/geochemj.2.0370; Morier I, 2008, EUR J SOIL SCI, V59, P467, DOI 10.1111/j.1365-2389.2007.00998.x; Myneni SCB, 2002, APPL SYNCHROTRON RAD, V49; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Nadelhoffer KJ, 1999, ECOL APPL, V9, P72, DOI 10.1890/1051-0761(1999)009[0072:SFNEAT]2.0.CO;2; NELSON D W, 1969, Soil Biology and Biochemistry, V1, P229, DOI 10.1016/0038-0717(69)90023-6; Olk DC, 2006, SOIL BIOL BIOCHEM, V38, P3303, DOI 10.1016/j.soilbio.2006.04.009; Ottley CJ, 1997, GEOCHIM COSMOCHIM AC, V61, P1819, DOI 10.1016/S0016-7037(97)00058-6; Pabich WJ, 2001, BIOGEOCHEMISTRY, V55, P247, DOI 10.1023/A:1011842918260; Perakis SS, 2002, NATURE, V415, P416, DOI 10.1038/415416a; Perakis SS, 2005, ECOLOGY, V86, P96, DOI 10.1890/04-0415; Phillips RL, 2016, SCI REP-UK, V6, DOI 10.1038/srep39077; Providoli I, 2006, SOIL BIOL BIOCHEM, V38, P1645, DOI 10.1016/j.soilbio.2005.11.019; Qin SP, 2017, SOIL BIOL BIOCHEM, V108, P36, DOI 10.1016/j.soilbio.2017.01.019; Sauve S, 2000, SOIL SCI SOC AM J, V64, P595, DOI 10.2136/sssaj2000.642595x; SCHIMEL DS, 1988, BIOGEOCHEMISTRY, V6, P239, DOI 10.1007/BF02182998; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; SCHIMEL JP, 1989, SOIL SCI SOC AM J, V53, P779, DOI 10.2136/sssaj1989.03615995005300030025x; Schmidt BHM, 2011, SOIL BIOL BIOCHEM, V43, P1742, DOI 10.1016/j.soilbio.2011.04.021; Schmidt BHM, 2009, BIOGEOCHEMISTRY, V93, P291, DOI 10.1007/s10533-009-9290-3; Schmidt-Rohr K, 2004, P NATL ACAD SCI USA, V101, P6351, DOI 10.1073/pnas.0401349101; SCHULTEN HR, 1992, PLANT SOIL, V142, P259, DOI 10.1007/BF00010971; Stark JM, 1996, SOIL SCI SOC AM J, V60, P1846, DOI 10.2136/sssaj1996.03615995006000060033x; Stevenson F. J., 1999, Cycles of soil: carbon, nitrogen, phosphorus, sulfur, micronutrients., ppp; Thorn KA, 2012, J ENVIRON QUAL, V41, P865, DOI 10.2134/jeq2011.0335; Vairavamurthy A, 2002, ENVIRON SCI TECHNOL, V36, P3050, DOI 10.1021/es0155478; Vega-Jarquin C, 2003, PLANT SOIL, V256, P379, DOI 10.1023/A:1026182211065; Wei J, 2017, BIOGEOCHEMISTRY, V132, P325, DOI 10.1007/s10533-017-0306-0; Zarnetske JP, 2011, J GEOPHYS RES-BIOGEO, V116, DOI [10.1029/2011JG001730, 10.1029/2011J0001730]; Zhang JB, 2010, SOIL SCI SOC AM J, V74, P1193, DOI 10.2136/sssaj2009.0368	57	5	5	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0218752	10.1371/journal.pone.0218752	http://dx.doi.org/10.1371/journal.pone.0218752			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276538	gold, Green Published, Green Submitted			2022-12-26	WOS:000484936300020
J	Du, Y; Li, WL; Lin, L; Lo, EH; Xing, CH				Du, Yang; Li, Wenlu; Lin, Li; Lo, Eng H.; Xing, Changhong			Effects of lipocalin-2 on brain endothelial adhesion and permeability	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; INFLAMMATORY MEDIATORS; ISCHEMIC BRAIN; NEUTROPHIL RECRUITMENT; BARRIER DISRUPTION; CEREBRAL-ISCHEMIA; CELL-DAMAGE; RAT-BRAIN; STROKE; INJURY	Lipocalin-2 (LCN2) is a stress protein, and can be hyper-produced by many kinds of cells after exposure to injury or disease conditions. In this study, we asked whether LCN2 may play a protective role in cerebral endothelium. After focal cerebral ischemia in rats, plasma levels of LCN2 were significantly elevated at 6, 12, and 24 hrs, and persisted until 3 days post-stroke. To assess the vascular mechanisms of LCN2, we used brain endothelial cell cultures to investigate its effects on neutrophil adhesion and endothelial barrier integrity. LCN2 did not affect neutrophil adhesion to endothelial cells either under normal conditions or after TNF alpha stimulation. TNF alpha significantly increased endothelial permeability, and LCN2 rescued endothelial permeability. Concomitantly, LCN2 restored the membrane distribution of the tight junction protein ZO-1 and the adherens junction protein VE-cadherin. Our findings suggest that elevated LCN2 in the blood after ischemic stroke might affect endothelial function, in part by reducing damage to endothelial junctional proteins and maintain blood-brain barrier integrity.	[Du, Yang] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Du, Yang; Li, Wenlu; Lin, Li; Lo, Eng H.; Xing, Changhong] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Lab, Charlestown, MA 02129 USA; [Du, Yang; Li, Wenlu; Lin, Li; Lo, Eng H.; Xing, Changhong] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Lab, Charlestown, MA 02129 USA; [Lin, Li] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou, Zhejiang, Peoples R China; [Xing, Changhong] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	Central South University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Wenzhou Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lo, EH; Xing, CH (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Lab, Charlestown, MA 02129 USA.; Lo, EH; Xing, CH (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Lab, Charlestown, MA 02129 USA.; Xing, CH (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA.	Lo@helix.mgh.harvard.edu; changhong.xing@phhs.org			AHA, NIH; Rappaport Foundation	AHA, NIH(American Heart AssociationUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rappaport Foundation	This study is supported by AHA, NIH, and the Rappaport Foundation.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Amantea D, 2014, CURR MED CHEM, V21, P2098, DOI 10.2174/0929867321666131227162634; An CR, 2014, PROG NEUROBIOL, V115, P6, DOI 10.1016/j.pneurobio.2013.12.002; Anwaar I, 1998, CEREBROVASC DIS, V8, P310, DOI 10.1159/000015873; Banks WA, 2018, J CEREBR BLOOD F MET, V38, P1104, DOI 10.1177/0271678X17740793; BEDNAR MM, 1991, STROKE, V22, P44, DOI 10.1161/01.STR.22.1.44; Benjelloun N, 1999, STROKE, V30, P1916, DOI 10.1161/01.STR.30.9.1916; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; Chia WJ, 2011, NEUROCHEM INT, V59, P591, DOI 10.1016/j.neuint.2011.04.007; Dimasi D, 2013, INT IMMUNOPHARMACOL, V17, P1167, DOI 10.1016/j.intimp.2013.05.034; Easton AS, 2013, INT IMMUNOPHARMACOL, V17, P1218, DOI 10.1016/j.intimp.2013.06.015; Egashira Y, 2016, ACTA NEUROCHIR SUPPL, V121, P131, DOI 10.1007/978-3-319-18497-5_23; Elneihoum AM, 1996, STROKE, V27, P1734, DOI 10.1161/01.STR.27.10.1734; Ferreira AC, 2015, PROG NEUROBIOL, V131, P120, DOI 10.1016/j.pneurobio.2015.06.005; Figueiredo-Pereira ME, 2015, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00104; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Flower DR, 1996, BIOCHEM J, V318, P1; Garcia-Bonilla L, 2014, J IMMUNOL, V193, P2531, DOI 10.4049/jimmunol.1400918; Garcia-Culebras A, 2018, J CEREBR BLOOD F MET, V38, P2150, DOI 10.1177/0271678X18795789; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ip JPK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-124; Cuartero MI, 2013, STROKE, V44, P3498, DOI 10.1161/STROKEAHA.113.002470; Jiang JX, 2019, NEUROPHARMACOLOGY, V149, P149, DOI 10.1016/j.neuropharm.2019.02.011; Jiang XY, 2018, PROG NEUROBIOL, V163, P144, DOI 10.1016/j.pneurobio.2017.10.001; Jung M, 2012, KIDNEY INT, V81, P969, DOI 10.1038/ki.2011.446; Keaney J, 2015, FEBS J, V282, P4067, DOI 10.1111/febs.13412; Keleshian VL, 2013, J NEUROCHEM, V125, P63, DOI 10.1111/jnc.12153; Kim BW, 2016, J NEUROSCI, V36, P5608, DOI 10.1523/JNEUROSCI.4261-15.2016; Kitagawa K, 1998, J CEREBR BLOOD F MET, V18, P1336, DOI 10.1097/00004647-199812000-00008; Kjeldsen L, 2000, BBA-PROTEIN STRUCT M, V1482, P272, DOI 10.1016/S0167-4838(00)00152-7; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Lin L, 2018, MOL NEUROBIOL, V55, P3131, DOI 10.1007/s12035-017-0544-0; Lv JJ, 2018, PROG NEUROBIOL, V161, P79, DOI 10.1016/j.pneurobio.2017.12.001; Mao SS, 2016, STROKE, V47, P1078, DOI 10.1161/STROKEAHA.115.012153; Marcos-Ramiro B, 2014, THROMB HAEMOSTASIS, V112, P1088, DOI 10.1160/TH14-04-0299; Marques F, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00033; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Moschen AR, 2017, TRENDS ENDOCRIN MET, V28, P388, DOI 10.1016/j.tem.2017.01.003; Naude PJW, 2012, FASEB J, V26, P2811, DOI 10.1096/fj.11-202457; Nico B, 2012, CURR DRUG METAB, V13, P50, DOI 10.2174/138920012798356970; Pagram H, 2017, INT J STROKE, V12, P123, DOI 10.1177/1747493016676622; Petrovic-Djergovic D, 2016, CIRC RES, V119, P142, DOI 10.1161/CIRCRESAHA.116.308022; Playford RJ, 2006, GASTROENTEROLOGY, V131, P809, DOI 10.1053/j.gastro.2006.05.051; Prestigiacomo CJ, 1999, STROKE, V30, P1110, DOI 10.1161/01.STR.30.5.1110; Price CJS, 2004, STROKE, V35, P1659, DOI 10.1161/01.STR.0000130592.71028.92; Rochfort KD, 2015, BIOCHEM SOC T, V43, P702, DOI 10.1042/BST20140319; SCHURER L, 1991, ACTA NEUROCHIR, V111, P54, DOI 10.1007/BF01402514; Stamatovic SM, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1154641; Strecker JK, 2017, NEUROCHEM INT, V107, P117, DOI 10.1016/j.neuint.2016.11.006; TAKESHIMA R, 1992, STROKE, V23, P247, DOI 10.1161/01.STR.23.2.247; Villasenor R, 2017, J CEREBR BLOOD F MET, V37, P3683, DOI 10.1177/0271678X17697340; Wu L, 2015, J NEUROCHEM, V132, P622, DOI 10.1111/jnc.13023; Wu LM, 2015, TRANSL STROKE RES, V6, P116, DOI 10.1007/s12975-014-0347-9; Xing CH, 2014, STROKE, V45, P2085, DOI 10.1161/STROKEAHA.114.005733; Yang J, 2013, FASEB J, V27, P45, DOI 10.1096/fj.12-211730; ZHANG RL, 1994, NEUROLOGY, V44, P1747, DOI 10.1212/WNL.44.9.1747; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	59	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0218965	10.1371/journal.pone.0218965	http://dx.doi.org/10.1371/journal.pone.0218965			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269059	Green Published, Green Submitted, gold			2022-12-26	WOS:000484927300032
J	Tokuda, M; Yamashita, S; Matsuo, S; Kato, M; Sato, H; Oseto, H; Okajima, E; Ikewaki, H; Yokoyama, M; Isogai, R; Tokutake, K; Yokoyama, K; Narui, R; Tanigawa, S; Yoshimura, M; Yamane, T				Tokuda, Michifumi; Yamashita, Seigo; Matsuo, Seiichiro; Kato, Mika; Sato, Hidenori; Oseto, Hirotsuna; Okajima, Eri; Ikewaki, Hidetsugu; Yokoyama, Masaaki; Isogai, Ryota; Tokutake, Kenichi; Yokoyama, Kenichi; Narui, Ryohsuke; Tanigawa, Shin-ichi; Yoshimura, Michihiro; Yamane, Teiichi			Clinical significance of early recurrence of atrial fibrillation after cryoballoon vs. radiofrequency ablation-A propensity score matched analysis	PLOS ONE			English	Article							PULMONARY VEIN ISOLATION; CATHETER ABLATION; ANTRUM ISOLATION; TACHYARRHYTHMIAS; PREDICTORS	Objectives One of the mechanisms of early recurrence of atrial fibrillation (ERAF) after AF ablation is considered to be the inflammatory reaction of the atrial tissue. The aim of this study is to compare the clinical significance of ERAF at each stage for true AF recurrence between cryoballoon (CB) and radiofrequency (RF) ablation. Methods Among 798 paroxysmal AF patients who underwent an initial ablation, 460 patients (CB, n = 230; RF, n = 230) were selected by propensity score matching. Very ERAF (VERAF), ERAF-1M, ERAF-3M and true AF recurrence were defined as AF recurrence at 0-2, 3-30, 31-90 days and more than 90 days after the procedure, respectively. Results The patient characteristics of the two groups were similar. ERAF was observed 21% and 27% in the CB and RF groups, respectively. In both the CB and RF group, VERAF, ERAF-1M and ERAF-3M were more frequently observed in patients with true AF recurrence than in those without. In a multivariable analysis, ERAF-1M and ERAF-3M were found to be independent predictors of true AF recurrence in both the CB (P = 0.04 and P< 0.001, respectively) and RF groups (P = 0.02 and P = 0.001, respectively). However, while VERAF was associated with true AF recurrence after RF ablation (P = 0.03), it was not associated with true AF recurrence after CB ablation (P = 0.19). Conclusion The relationship between ERAF and true AF recurrence differed between the RF and CB ablation groups. While VERAF was associated with true AF recurrence after RF ablation, it was not a predictor of true AF recurrence after CB ablation.	[Tokuda, Michifumi; Yamashita, Seigo; Matsuo, Seiichiro; Kato, Mika; Sato, Hidenori; Oseto, Hirotsuna; Okajima, Eri; Ikewaki, Hidetsugu; Yokoyama, Masaaki; Isogai, Ryota; Tokutake, Kenichi; Yokoyama, Kenichi; Narui, Ryohsuke; Tanigawa, Shin-ichi; Yoshimura, Michihiro; Yamane, Teiichi] Jikei Univ, Sch Med, Dept Cardiol, Tokyo, Japan	Jikei University	Tokuda, M (corresponding author), Jikei Univ, Sch Med, Dept Cardiol, Tokyo, Japan.	tokudam@gmail.com	Tokuda, Michifumi/AAS-7529-2020	Tokuda, Michifumi/0000-0003-1960-5627				Alipour Pouria, 2017, JACC Clin Electrophysiol, V3, P568, DOI 10.1016/j.jacep.2017.01.006; Andrade JG, 2014, CIRC-ARRHYTHMIA ELEC, V7, P69, DOI 10.1161/CIRCEP.113.000586; Andrade JG, 2012, J CARDIOVASC ELECTR, V23, P1295, DOI 10.1111/j.1540-8167.2012.02399.x; Andrade JG, 2012, PACE, V35, P106, DOI 10.1111/j.1540-8159.2011.03256.x; Bertaglia E, 2005, PACE, V28, P366, DOI 10.1111/j.1540-8159.2005.09516.x; Budzianowski J, 2019, HEART VESSELS, V34, P352, DOI 10.1007/s00380-018-1244-z; Calkins H, 2018, EUROPACE, V20, P157, DOI [10.1093/europace/eux275, 10.1016/j.hrthm.2017.05.012, 10.1093/europace/eux274]; Chang SL, 2011, J CARDIOVASC ELECTR, V22, P1193, DOI 10.1111/j.1540-8167.2011.02095.x; Ciconte G, 2015, EUROPACE, V17, P559, DOI 10.1093/europace/euu350; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Kuck KH, 2016, NEW ENGL J MED, V374, P2235, DOI 10.1056/NEJMoa1602014; Luik A, 2015, CIRCULATION, V132, P1311, DOI 10.1161/CIRCULATIONAHA.115.016871; Matsuo S, 2007, J CARDIOVASC ELECTR, V18, P704, DOI 10.1111/j.1540-8167.2007.00842.x; Miyazaki S, 2016, CIRC J, V80, P346, DOI 10.1253/circj.CJ-15-1051; Miyazaki S, 2015, CIRC J, V79, P2353, DOI 10.1253/circj.CJ-15-0475; Mugnai G, 2016, HEART RHYTHM, V13, P845, DOI 10.1016/j.hrthm.2015.12.034; O'Donnell D, 2003, AM J CARDIOL, V91, P83, DOI 10.1016/S0002-9149(02)03005-9; Pieragnoli P, 2017, J CARDIOVASC ELECTR, V28, P625, DOI 10.1111/jce.13190; Schmidt M, 2012, INT J CARDIOL, V158, P33, DOI 10.1016/j.ijcard.2010.12.084; Themistoclakis S, 2008, HEART RHYTHM, V5, P679, DOI 10.1016/j.hrthm.2008.01.031; Themistoclakis Sakis, 2017, JACC Clin Electrophysiol, V3, P577, DOI 10.1016/j.jacep.2017.03.012; Tokuda M, 2016, HEART RHYTHM, V13, P2128, DOI 10.1016/j.hrthm.2016.08.018; Yamane T, 2007, CIRC J, V71, P753, DOI 10.1253/circj.71.753	23	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2019	14	7							e0219269	10.1371/journal.pone.0219269	http://dx.doi.org/10.1371/journal.pone.0219269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3ZV	31265482	Green Published, gold, Green Submitted			2022-12-26	WOS:000484921200027
J	Cavey, T; Latour, C; Island, ML; Leroyer, P; Guggenbuhl, P; Coppin, H; Roth, MP; Bendavid, C; Brissot, P; Ropert, M; Loreal, O				Cavey, Thibault; Latour, Chloe; Island, Marie-Laure; Leroyer, Patricia; Guggenbuhl, Pascal; Coppin, Helene; Roth, Marie-Paule; Bendavid, Claude; Brissot, Pierre; Ropert, Martine; Loreal, Olivier			Spleen iron, molybdenum, and manganese concentrations are coregulated in hepcidin-deficient and secondary iron overload models in mice	FASEB JOURNAL			English	Article						metals; metabolism; hemochromatosis; disease	ANTIMICROBIAL PEPTIDE HEPCIDIN; GENE-EXPRESSION; MOUSE MODEL; METABOLISM; LIVER; FERROPORTIN; BMP6; ACERULOPLASMINEMIA; HEMOCHROMATOSIS; MEN	Iron excess increases the hepatic expression of hepcidin, the systemic iron metabolism regulator that favors iron sequestration in the spleen. Genetic iron overload related to hepcidin insufficiency decreases the spleen iron concentration and increases hepatic iron concentration, whereas during secondary iron overload, the hepcidin expression increases together with spleen iron concentration in addition to hepatic iron concentrations increase. Links between iron metabolism and other metals being suggested, our aim was to investigate, during iron overload, the relationships between the hepatic hepcidin expression level and the hepatic and splenic concentrations of iron, manganese, copper, zinc, and molybdenum, determined using inductively coupled plasma mass spectrometry. Hepcidin-deficient mice, secondary iron overload mice models, and their respective controls were studied. Spleen molybdenum and manganese concentrations paralleled the modulation of both spleen iron concentrations, increasing in secondary iron overload and decreasing in hepcidin deficiency related iron overload, as well as hepatic hepcidin mRNA expression. Our data suggest that iron, manganese, and molybdenum metabolisms could share mechanisms controlling their distribution that are associated to hepcidin modulation. In diseases with abnormal hepcidin levels, including chronic inflammation, special attention should be paid to those metals that can participate with the phenotype.-Cavey, T., Latour, C., Island, M.-L., Leroyer, P., Guggenbuhl, P., Coppin, H., Roth, M.-P., Bendavid, C., Brissot, P., Ropert, M., Loreal, O. Spleen iron, molybdenum, and manganese concentrations are coregulated in hepcidin-deficient and secondary iron overload models in mice.	[Cavey, Thibault; Island, Marie-Laure; Leroyer, Patricia; Guggenbuhl, Pascal; Bendavid, Claude; Brissot, Pierre; Ropert, Martine; Loreal, Olivier] Univ Rennes, INSERM, Anal Elementaire & Metab Metaux AEM2 Platform, CHU Pontchaillou,INRA,UMR 1241,Nutr Metab & Canc, Rennes, France; [Latour, Chloe; Coppin, Helene; Roth, Marie-Paule] Univ Toulouse, UPS, ENVT, INRA,IRSD,INSERM, Toulouse, France	CHU Rennes; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier	Loreal, O (corresponding author), CHU Pontchaillou, INSERM, UMR1241, 2 Rue Henri Le Guilloux, F-35033 Rennes, France.	olivier.loreal@univ-rennes1.fr	bendavid, claude/AAL-7345-2020; Coppin, Hélène/G-4326-2013; Roth, Marie-Paule/Q-2866-2018; Loreal, Olivier/G-3366-2013	bendavid, claude/0000-0003-2459-9567; Coppin, Hélène/0000-0001-7911-6353; Roth, Marie-Paule/0000-0001-9691-4234; Loreal, Olivier/0000-0002-7428-3766; Guggenbuhl, Pascal/0000-0002-8260-1824; Martine, Ropert/0000-0003-1227-9427	INSERM; Association Hemochromatose Ouest (AHO); University of Rennes 1; Region Bretagne; Afemers	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Hemochromatose Ouest (AHO); University of Rennes 1; Region Bretagne(Region Bretagne); Afemers	This work was supported by INSERM, University of Rennes 1, Region Bretagne, the Afemers, and the Association Hemochromatose Ouest (AHO). The authors declare no conflicts of interest.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Alsulimani HH, 2015, TOX RESEARCH, V31, P347, DOI 10.5487/TR.2015.31.4.347; AVAKYAN M A, 1978, Zhurnal Eksperimental'noi i Klinicheskoi Meditsiny, V18, P69; Balesaria S, 2010, FEBS LETT, V584, P719, DOI 10.1016/j.febslet.2009.12.023; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P293, DOI 10.1081/CLT-100102427; Bardou-Jacquet E, 2014, HEPATOLOGY, V59, P839, DOI 10.1002/hep.26570; Brissot P, 2016, J HEPATOL, V64, P505, DOI 10.1016/j.jhep.2015.11.009; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Camberlein E, 2010, BBA-MOL BASIS DIS, V1802, P339, DOI 10.1016/j.bbadis.2009.12.007; Cao HB, 2016, BIOL TRACE ELEM RES, V170, P237, DOI 10.1007/s12011-015-0442-0; CHESLEY R F, 1948, Bull Jersey City Margaret Hague Mat Hosp, V1, P68; Choi EK, 2019, FASEB J, V33, P2228, DOI 10.1096/fj.201800831R; Doyard M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148292; Flais J, 2017, JOINT BONE SPINE, V84, P293, DOI 10.1016/j.jbspin.2016.05.020; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Gehrke SG, 2003, BLOOD, V102, P371, DOI 10.1182/blood-2002-11-3610; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Henn BC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-97; Hosokawa S, 1994, ASAIO J, V40, pM445, DOI 10.1097/00002480-199407000-00039; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Joitihan HA, 2008, MOL MED, V14, P98, DOI 10.2119/2007-00114.Jouihan; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064944; Kono S, 2013, INT REV NEUROBIOL, V110, P125, DOI 10.1016/B978-0-12-410502-7.00007-7; Latour C, 2014, HEPATOLOGY, V59, P683, DOI 10.1002/hep.26648; Loreal O, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00128; Madejczyk MS, 2012, BBA-BIOMEMBRANES, V1818, P651, DOI 10.1016/j.bbamem.2011.12.002; Mendel RR, 2013, METAL IONS LIFE SCI, V12, P503, DOI 10.1007/978-94-007-5561-1_15; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Miyajima H, 2015, NEUROPATHOLOGY, V35, P83, DOI 10.1111/neup.12149; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Novotny JA, 2007, J NUTR, V137, P37, DOI 10.1093/jn/137.1.37; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Pfalzer Anna C, 2017, Curr Environ Health Rep, V4, P223, DOI 10.1007/s40572-017-0136-1; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Pigeon C, 2001, BBA-MOL BASIS DIS, V1535, P275, DOI 10.1016/S0925-4439(01)00024-2; Rivera-Mancia S, 2011, BIOMETALS, V24, P811, DOI 10.1007/s10534-011-9454-1; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; SEELIG MS, 1973, AM J CLIN NUTR, V26, P657, DOI 10.1093/ajcn/26.6.657; Seo YA, 2016, BIOMETALS, V29, P147, DOI 10.1007/s10534-015-9904-2; Seo YA, 2015, FASEB J, V29, P2726, DOI 10.1096/fj.14-262592; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.3.CO;2-7; Thompson KH, 1996, J APPL PHYSIOL, V81, P1404, DOI 10.1152/jappl.1996.81.3.1404; Troadec MB, 2010, BLOOD, V116, P4657, DOI 10.1182/blood-2010-04-278614; TURNLUND JR, 1995, AM J CLIN NUTR, V61, P1102, DOI 10.1093/ajcn/61.5.1102; Videt-Gibou D, 2009, BLOOD, V114, P2360, DOI 10.1182/blood-2009-06-226175; Vyskocil A, 1999, J APPL TOXICOL, V19, P185, DOI 10.1002/(SICI)1099-1263(199905/06)19:3<185::AID-JAT555>3.0.CO;2-Z; WALRAVENS PA, 1979, ARCH ENVIRON HEALTH, V34, P302, DOI 10.1080/00039896.1979.10667421; Yang F, 2011, BIOL TRACE ELEM RES, V140, P308, DOI 10.1007/s12011-010-8697-y; Zhang MM, 2017, J VET SCI, V18, P193, DOI 10.4142/jvs.2017.18.2.193	53	5	5	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11072	11081		10.1096/fj.201801381RR	http://dx.doi.org/10.1096/fj.201801381RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31298936	Green Submitted, Bronze			2022-12-26	WOS:000489166300042
J	Jia, Y; Reddy, MA; Das, S; Oh, HJ; Abdollahi, M; Yuan, H; Zhang, EL; Lanting, LD; Wang, M; Natarajan, R				Jia, Ye; Reddy, Marpadga A.; Das, Sadhan; Oh, Hyung Jung; Abdollahi, Maryam; Yuan, Hang; Zhang, Erli; Lanting, Linda; Wang, Mei; Natarajan, Rama			Dysregulation of histone H3 lysine 27 trimethylation in transforming growth factor-beta 1-induced gene expression in mesangial cells and diabetic kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibrosis; inflammation; diabetic nephropathy; epigenetics; microRNA (miRNA); transforming growth factor beta (TGF-beta); diabetic nephropathy; Ezh2; H3K27me3; histone modifications; mesangial cells; histone methylation; histone demethylases	TGF-BETA; EPIGENETIC CHANGES; RENAL FIBROSIS; MECHANISMS; EZH2; TRANSCRIPTION; NEPHROPATHY; METHYLATION; 12/15-LIPOXYGENASE; INHIBITION	Transforming growth factor-beta 1 (TGF-beta)-induced fibrotic and inflammatory genes in renal mesangial cells (MCs) play important roles in glomerular dysfunction associated with diabetic nephropathy (DN). TGF-beta regulates gene expression in MCs by altering key chromatin histone modifications at target gene promoters. However, the role of the repressive histone H3 lysine 27 trimethylation (H3K27me3) modification is unclear. Here we show that TGF-beta reduces H3K27me3 at the Ctgf, Serpine1, and Ccl2 gene promoters in rat MCs (RMCs) and reciprocally up-regulates the expression of these pro-fibrotic and inflammatory genes. In parallel, TGF-beta down-regulates Enhancer of Zeste homolog 2 (Ezh2), an H3K27me3 methyltransferase, and decreases its recruitment at Ctgf and Ccl2 but not Serpine1 promoters. Ezh2 knockdown with siRNAs enhances TGF-beta-induced expression of these genes, supporting its repressive function. Mechanistically, Ezh2 down-regulation is mediated by TGF-beta-induced microRNA, miR-101b, which targets Ezh2 3 '-UTR. TGF-beta also up-regulates Jmjd3 and Utx in RMCs, suggesting a key role for these H3K27me3 demethylases in H3K27me3 inhibition. In RMCs, Utx knockdown inhibits hypertrophy, a key event in glomerular dysfunction. The H3K27me3 regulators are similarly altered in human and mouse MCs. High glucose inhibits Ezh2 and increases miR-101b in a TGF-beta-dependent manner. Furthermore, in kidneys from rodent models of DN, fibrotic genes, miR-101b, and H3K27me3 demethylases are up-regulated, whereas Ezh2 protein levels as well as enrichment of Ezh2 and H3K27me3 at target genes are decreased, demonstrating in vivo relevance. These results suggest that H3K27me3 inhibition by TGF-beta via dysregulation of related histone-modifying enzymes and miRNAs augments pathological genes mediating glomerular mesangial dysfunction and DN.	[Jia, Ye; Reddy, Marpadga A.; Das, Sadhan; Oh, Hyung Jung; Abdollahi, Maryam; Yuan, Hang; Zhang, Erli; Lanting, Linda; Wang, Mei; Natarajan, Rama] City Hope Natl Med Ctr, Dept Diabet Complicat & Metab, Beckman Res Inst, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Jia, Ye; Yuan, Hang] Jilin Univ, Hosp 1, Div Nephrol, Changchun 130021, Jilin, Peoples R China; [Oh, Hyung Jung] Ewha Womans Univ, Ewha Inst Convergence Med, Mokdong Hosp, Seoul 07985, South Korea; [Zhang, Erli] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Dept Cardiol, Beijing 100037, Peoples R China	City of Hope; Beckman Research Institute of City of Hope; Jilin University; Ewha Womans University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Reddy, MA; Natarajan, R (corresponding author), City Hope Natl Med Ctr, Dept Diabet Complicat & Metab, Beckman Res Inst, 1500 E Duarte Rd, Duarte, CA 91010 USA.	mreddy@coh.org; rnatarajan@coh.org	Das, Sadhan/O-1423-2017	Das, Sadhan/0000-0002-7153-9519; Reddy, Marpadga A/0000-0001-9259-7243	NCI, National Institutes of Health [P30CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065073, R01DK081705, R01DK058191] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication included work performed in the DNA/RNA Synthesis Core supported by NCI, National Institutes of Health, under Grant P30CA33572.	Arcipowski KM, 2016, CURR OPIN GENET DEV, V36, P59, DOI 10.1016/j.gde.2016.03.010; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Chen H, 2019, J PHYSIOL-LONDON, V597, P1643, DOI 10.1113/JP277367; Chen JG, 2014, AM J PHYSIOL-RENAL, V306, pF916, DOI 10.1152/ajprenal.00697.2012; Chen S, 2003, SEMIN NEPHROL, V23, P532, DOI 10.1053/S0270-9295(03)00132-3; Chen Z, 2016, P NATL ACAD SCI USA, V113, pE3002, DOI 10.1073/pnas.1603712113; Das S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01629-7; Decleves AE, 2014, NAT REV NEPHROL, V10, P257, DOI 10.1038/nrneph.2014.31; Huntington disease, 2015, NAT REV DIS PRIMERS, V1, P15052, DOI [10.1038/nrdp.2015.52, DOI 10.1038/NRDP.2015.18]; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kato M, 2014, NAT REV NEPHROL, V10, P517, DOI 10.1038/nrneph.2014.116; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Khan S, 2015, BIOCHIMIE, V110, P1, DOI 10.1016/j.biochi.2014.12.015; Komers R, 2013, LAB INVEST, V93, P543, DOI 10.1038/labinvest.2013.47; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Majumder S, 2018, J CLIN INVEST, V128, P483, DOI 10.1172/JCI95946; McClelland AD, 2014, CLIN SCI, V126, P95, DOI 10.1042/CS20130079; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Naito M, 2009, J AM SOC NEPHROL, V20, P1787, DOI 10.1681/ASN.2009010118; Naito M, 2009, AM J PATHOL, V174, P54, DOI 10.2353/ajpath.2009.080602; Pirola L, 2010, NAT REV ENDOCRINOL, V6, P665, DOI 10.1038/nrendo.2010.188; Reddy MA, 2015, KIDNEY INT, V88, P250, DOI 10.1038/ki.2015.148; Reddy MA, 2015, DIABETOLOGIA, V58, P443, DOI 10.1007/s00125-014-3462-y; Reddy MA, 2014, KIDNEY INT, V85, P362, DOI 10.1038/ki.2013.387; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Sakurai T, 2012, BIOCHEM BIOPH RES CO, V422, P607, DOI 10.1016/j.bbrc.2012.05.035; Sanchez AP, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001057; Shanmugam N, 2008, J BIOL CHEM, V283, P36221, DOI 10.1074/jbc.M806322200; Siddiqi FS, 2016, J AM SOC NEPHROL, V27, P2021, DOI 10.1681/ASN.2014090898; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sun GD, 2010, J AM SOC NEPHROL, V21, P2069, DOI 10.1681/ASN.2010060633; Trionfini P, 2017, J AM SOC NEPHROL, V28, P1686, DOI 10.1681/ASN.2016101117; Van Beneden K, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-1; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang AB, 2013, J IMMUNOL, V191, P4908, DOI 10.4049/jimmunol.1300433; Xu HH, 2015, J AM SOC NEPHROL, V26, P1648, DOI 10.1681/ASN.2014070678; Yang Hai-Chun, 2010, Drug Discov Today Dis Models, V7, P13, DOI 10.1016/j.ddmod.2010.08.002; Yuan H, 2008, AM J PHYSIOL-RENAL, V295, pF605, DOI 10.1152/ajprenal.90268.2008; Yuan H, 2016, ANTIOXID REDOX SIGN, V24, P361, DOI 10.1089/ars.2015.6372; Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012; Zeybel M, 2017, MOL THER, V25, P218, DOI 10.1016/j.ymthe.2016.10.004; Zhou XX, 2016, J AM SOC NEPHROL, V27, P2092, DOI 10.1681/ASN.2015040457	45	34	37	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12695	12707		10.1074/jbc.RA119.007575	http://dx.doi.org/10.1074/jbc.RA119.007575			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31266808	hybrid, Green Published			2022-12-26	WOS:000484414600012
J	Charlebois, E; Fillebeen, C; Pantopoulos, K				Charlebois, Edouard; Fillebeen, Carine; Pantopoulos, Kostas			Hepatocellular heme oxygenase 1 deficiency does not affect inflammatory hepcidin regulation in mice	PLOS ONE			English	Article							CARBON-MONOXIDE; IRON; MOUSE; STRESS; INHIBITION; EXPRESSION; ANEMIA; STAT3; LIVER	Hepcidin is an iron regulatory peptide hormone that is secreted from hepatocytes and inhibits iron efflux from tissues to plasma. Under inflammatory conditions, hepcidin is transcriptionally induced by IL-6/STAT3 signaling and promotes hypoferremia, an innate immune response to infection. If this pathway remains unresolved, chronic overexpression of hepcidin contributes to the anemia of inflammation, a common medical condition. Previous work showed that carbon monoxide (CO) releasing drugs (CORMS) can attenuate inflammatory induction of hepcidin. Because CO is physiologically generated during heme degradation by heme oxygenase 1 (HO-1), an IL-6-inducible enzyme with anti-inflammatory properties, we hypothesized that hepatocellular HO-1 may operate as a physiological feedback regulator of hepcidin that resolves inflammatory signaling. To address this, we generated and analyzed hepatocyte-specific HO-1 knockout (Hmox1(Alb-Cre)) mice. We show that these animals mount appropriate hepcidin-mediated hypoferremic response to LPS-induced inflammation, with kinetics similar to those of control Hmox1(fl/fl) mice. Likewise, primary hepatocytes from Hmoxi(Alb-Cre) and Hmox1(fl/fl) mice exhibit similar degree and kinetics of hepcidin induction following IL-6 treatment. We conclude that hepatocellular HO-1 has no physiological function on hepcidin regulation by the inflammatory pathway.	[Charlebois, Edouard; Fillebeen, Carine; Pantopoulos, Kostas] McGill Univ, Lady Davis Inst Med Res, Jewish Gen Hosp, Montreal, PQ, Canada; [Charlebois, Edouard; Fillebeen, Carine; Pantopoulos, Kostas] McGill Univ, Dept Med, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University	Pantopoulos, K (corresponding author), McGill Univ, Lady Davis Inst Med Res, Jewish Gen Hosp, Montreal, PQ, Canada.	kostas.pantopoulos@mcgill.ca			Canadian Institutes of Health Research [PJT-159730]; Natural Sciences and Engineering Research Council of Canada; Fonds de recherche du Quebec -Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de recherche du Quebec -Sante(Fonds de la Recherche en Sante du Quebec)	KP received a grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), grant number PJT-159730. EC was funded by a fellowship from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) and is currently a recipient of a fellowship from the Fonds de recherche du Quebec -Sante (http://www.frqs.gouv.qc.ca).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhautdin B, 2014, J HEPATOL, V61, P1029, DOI 10.1016/j.jhep.2014.06.007; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Daba A, 2013, J MOL MED, V91, P95, DOI 10.1007/s00109-012-0937-5; Fillebeen C, 2018, BLOOD, V132, P1829, DOI 10.1182/blood-2018-03-841197; Fillebeen C, 2015, HAEMATOLOGICA, V100, pE334, DOI 10.3324/haematol.2015.126870; Ganz Tomas, 2012, Biochim Biophys Acta, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Garcia-Santos D, 2018, BLOOD, V131, P236, DOI 10.1182/blood-2017-07-798728; Gkouvatsos K, 2011, HEPATOLOGY, V54, P1800, DOI 10.1002/hep.24547; Goda N, 1998, J CLIN INVEST, V101, P604, DOI 10.1172/JCI1324; Jais A, 2014, CELL, V158, P25, DOI 10.1016/j.cell.2014.04.043; Kartikasari AER, 2009, J CELL MOL MED, V13, P3091, DOI 10.1111/j.1582-4934.2008.00494.x; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Munoz-Sanchez J, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/604981; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Shin DY, 2012, BLOOD, V119, P2523, DOI 10.1182/blood-2011-07-366690; Soares MP, 2016, IMMUNITY, V44, P492, DOI 10.1016/j.immuni.2016.02.016; Soares MP, 2016, CURR OPIN IMMUNOL, V38, P94, DOI 10.1016/j.coi.2015.11.006; Tron K, 2006, J HEPATOL, V45, P72, DOI 10.1016/j.jhep.2005.12.019; Tzima S, 2009, J EXP MED, V206, P1167, DOI 10.1084/jem.20081582; Vijayan V, 2018, BIOCHEM PHARMACOL, V153, P159, DOI 10.1016/j.bcp.2018.02.010; Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568; Weiss G, 2019, BLOOD, V133, P40, DOI 10.1182/blood-2018-06-856500	23	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219835	10.1371/journal.pone.0219835	http://dx.doi.org/10.1371/journal.pone.0219835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295319	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800074
J	Schwarz, R; Hoving, HJ; Noever, C; Piatkowski, U				Schwarz, Richard; Hoving, Henk-Jan; Noever, Christoph; Piatkowski, Uwe			Life histories of Antarctic incirrate octopods (Cephalopoda: Octopoda)	PLOS ONE			English	Article							AGE VALIDATION; REPRODUCTIVE-BIOLOGY; DEEP-SEA; LEPTONYCHOTES-WEDDELLII; SOUTHERN-OCEAN; GROWTH; ADELIELEDONE; TEMPERATURE; GRANELEDONE; PRECISION	As a general trend in the life history of marine organisms, species inhabiting cold waters have reduced growth rates and increased lifespans. Studies based on egg sizes and brooding times of deep-sea and polar octopods support this hypothesis, but empirical data on growth are still scarce. To test the hypothesis that octopods inhabiting cold waters (<3 degrees C) live longer than temperate and warm water species, this study investigated size -at -age, maturation and growth rates in incirrate Antarctic octopods. Octopod age was estimated via the interpretation and quantification of beak growth increments, which in shallow water octopods have been validated to be formed on a daily basis. Specimens from the families Megaleledonidae (Adelieledone spp., Pareledone spp. and Megaleledone setebos) and Enteroctopodidae (Muusoctopus rigbyae) were collected on the shelf and slope regions off the Antarctic Peninsula during a cruise in 2012. Examined specimens included early juveniles to animals in advanced maturity. The total number of growth increments ranged from 192-599 in Pareledone aequipapillae (body mass [BM] 2-109 g), 182-431 in Pareledone charcoti (BM 5-124 g), 98-906 in M. setebos (BM 10-6000 g) and 207-425 in M. rigbyae (BM 24-256 g). After the cruise, eleven specimens of P. charcoti were kept alive in captivity for more than 12 months and these animals had 219-364 growth increments, suggesting that increment formation in this species takes longer than one day. The complex population structure (size, age and maturity range) of the specimens that were captured during a relatively short time, the number of beak increments quantified, and the preliminary validation observations indicate that Antarctic octopods do not deposit increments daily, and may have lifespans exceeding 3 years. These findings corroborate the general trend that cold water molluscs have a longer lifespan than their warm water relatives.	[Schwarz, Richard; Hoving, Henk-Jan; Piatkowski, Uwe] GEOMAR Helmholtz Ctr Ocean Res Kiel, Evolutionary Ecol Marine Fishes, Kiel, Germany; [Noever, Christoph] Univ Bergen, Dept Biol Sci, Bergen, Norway	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Bergen	Schwarz, R (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Evolutionary Ecol Marine Fishes, Kiel, Germany.	ricschwarz@gmail.com	Piatkowski, Uwe/G-4161-2011; Hoving, Henk-Jan T./A-9267-2018	Piatkowski, Uwe/0000-0003-1558-5817; Hoving, Henk-Jan T./0000-0002-4330-6507; Noever, Christoph/0000-0002-1455-4966; Schwarz, Richard/0000-0002-0961-5998	National Council for Scientific and Technological Development (CNPq), Brazil [201585/2015-4]; Land Schleswig-Holstein within the funding program Open Access Publikationsfonds; German Research Foundation (DFG) [HO 5569/1-2]; Cluster of Excellence 80 "The Future Ocean" [CP1218]; DFG on behalf of the German federal government; DFG on behalf of the German state government	National Council for Scientific and Technological Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Land Schleswig-Holstein within the funding program Open Access Publikationsfonds; German Research Foundation (DFG)(German Research Foundation (DFG)); Cluster of Excellence 80 "The Future Ocean"; DFG on behalf of the German federal government; DFG on behalf of the German state government	R.S. was funded by the National Council for Scientific and Technological Development (CNPq), Brazil (grant 201585/2015-4). We acknowledge financial support by Land Schleswig-Holstein within the funding program Open Access Publikationsfonds. We also thank the German Research Foundation (DFG) for providing financial support to HJTH under grants HO 5569/1-2 and a grant CP1218 of the Cluster of Excellence 80 "The Future Ocean". "The Future Ocean" is funded within the framework of the Excellence Initiative by the DFG on behalf of the German federal and state governments.	Allcock AL, 2007, POLAR BIOL, V30, P883, DOI 10.1007/s00300-006-0248-9; Allcock AL, 2011, DEEP-SEA RES PT II, V58, P242, DOI 10.1016/j.dsr2.2010.05.016; Allcock AL, 2005, ZOOL J LINN SOC-LOND, V143, P75, DOI 10.1111/j.1096-3642.2004.00146.x; Allcock AL, 2003, ANTARCT SCI, V15, P415, DOI 10.1017/S0954102003001512; Allcock AL, 2003, J MAR BIOL ASSOC UK, V83, P319, DOI 10.1017/S0025315403007148h; Allcock AL, 2001, POLAR BIOL, V24, P832; Arkhipkin AI, 2018, J SHELLFISH RES, V37, P783, DOI 10.2983/035.037.0409; Arkhipkin AI, 2012, J MAR BIOL ASSOC UK, V92, P1389, DOI 10.1017/S0025315411001585; Arntz W, 1990, BERICHTE POLARFORSCH, P214, DOI [10.2312/BzP_0068_1990, DOI 10.2312/BZP_0068_1990]; Barratt IM, 2008, POLAR BIOL, V31, P583, DOI 10.1007/s00300-007-0392-x; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Barratt IM, 2009, THESIS; BEAMISH RJ, 1981, CAN J FISH AQUAT SCI, V38, P982, DOI 10.1139/f81-132; Boletzky S.v., 1987, P5; BOLETZKY SV, 1994, ANTARCT SCI, V6, P139, DOI 10.1017/S0954102094000210; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; CHANG WYB, 1982, CAN J FISH AQUAT SCI, V39, P1208, DOI 10.1139/f82-158; CLARKE A, 1988, COMP BIOCHEM PHYS B, V90, P461, DOI 10.1016/0305-0491(88)90285-4; Clarke A, 2003, ECOSY WORLD, V28, P239; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; CLARKE A, 1992, INVERTEBR REPROD DEV, V22, P175, DOI 10.1080/07924259.1992.9672270; Clarke M.R, 1986, HDB IDENTIFICATION C; Collins MA, 2006, ADV MAR BIOL, V50, P191, DOI 10.1016/S0065-2881(05)50003-8; Daly HI, 2000, J EXP MAR BIOL ECOL, V245, P197, DOI 10.1016/S0022-0981(99)00161-6; DALY HI, 1994, ANTARCT SCI, V6, P163, DOI 10.1017/S0954102094000258; Daly HI, 1996, THESIS; Daneri GA, 2012, POLAR BIOL, V35, P585, DOI 10.1007/s00300-011-1104-0; Daneri GA, 2000, ANTARCT SCI, V12, P16, DOI 10.1017/S0954102000000031; De Broyer C, 2004, DEEP-SEA RES PT II, V51, P1733, DOI 10.1016/j.dsr2.2004.06.032; DILLY PN, 1976, CELL TISSUE RES, V167, P229; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; HAIN S, 1992, POLAR BIOL, V12, P303; Hartwell AM, 2018, DEEP-SEA RES PT I, V135, P1, DOI 10.1016/j.dsr.2018.03.011; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Hernandez-Lopez JL, 2001, FISH B-NOAA, V99, P679; Hochberg FG., 1992, SMITHSON CONTRIB ZOO, P213; HOULIHAN DF, 1990, MAR BIOL, V106, P251, DOI 10.1007/BF01314808; Hu GY, 2016, FISHERIES SCI, V82, P597, DOI 10.1007/s12562-016-0991-y; Ibanez CM, 2018, EVOLUTION, V72, P1829, DOI 10.1111/evo.13559; JAZDZEWSKI K, 1991, HYDROBIOLOGIA, V223, P105, DOI 10.1007/BF00047632; Knust R, 2014, BERICHTE POLAR MEERE, V680; KUBODERA T, 1994, ANTARCT SCI, V6, P205, DOI 10.1017/S0954102094000325; KUEHL S, 1988, MALACOLOGIA, V29, P89; Laptikhovsky V, 2013, AQUAT BIOL, V18, P21, DOI 10.3354/ab00486; Lombarte A, 2006, J MAR BIOL ASSOC UK, V86, P767, DOI 10.1017/S0025315406013683; Lucassen M., 2012, REPORTS POLAR MARINE, DOI [10.2312/BzPM_0652_2012, DOI 10.2312/BZPM_0652_2012]; MANGOLD K, 1973, MAR BIOL, V19, P7, DOI 10.1007/BF00355414; MILEIKOVSKY SA, 1971, MAR BIOL, V10, P193, DOI 10.1007/BF00352809; Moles J, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3143-8; Moss DK, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1364; Negri A, 2016, POLAR BIOL, V39, P561, DOI 10.1007/s00300-015-1794-9; Nesis KN, 2003, SELECTED ENGLISH TRA, P11; Noever C, 2012, REPORTS POLAR MARINE, P89; O'Dor R.K., 1983, P401; Oellermann M., 2014, THESIS, DOI [10.13140/RG.2.1.1283.3442, DOI 10.13140/RG.2.1.1283.3442]; Oellermann M, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0097-x; Peck LS, 2006, BIOL REV, V81, P75, DOI 10.1017/S1464793105006871; Peck LS, 2002, POLAR BIOL, V25, P31, DOI 10.1007/s003000100308; Peck LS, 1998, COLD OCEAN PHYSL, P365, DOI DOI 10.1017/CBO9780511661723.015; Perales-Raya C, 2018, MAR ECOL PROG SER, V598, P247, DOI 10.3354/meps12218; Perales-Raya C, 2014, J SHELLFISH RES, V33, P481, DOI 10.2983/035.033.0217; Perales-Raya C, 2010, FISH RES, V106, P171, DOI 10.1016/j.fishres.2010.05.003; Piatkowski Uwe, 2003, Berichte zur Polar- und Meeresforschung, V470, P32; Regueira M, 2015, SCI MAR, V79, P71, DOI 10.3989/scimar.04137.23A; Robison B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103437; Robson, 1932, MONOGRAPH RECENT C 2; Rodriguez-Dominguez A, 2013, J EXP MAR BIOL ECOL, V449, P194, DOI 10.1016/j.jembe.2013.10.001; SCHRODER M, 2012, BERICHTE POLAR MEERE, V7, P88367, DOI DOI 10.2312/BZPM_0702_2016; Schwarz R, 2018, MAR ECOL PROG SER, V605, P151, DOI 10.3354/meps12749; Stearns S.C., 1992, pi; Stearns SC, 2000, NATURWISSENSCHAFTEN, V87, P476, DOI 10.1007/s001140050763; Stevens DW, 2014, ANTARCT SCI, V26, P502, DOI 10.1017/S095410201300093X; Strugnell JM, 2012, MOL ECOL, V21, P2775, DOI 10.1111/j.1365-294X.2012.05572.x; Strugnell JM, 2011, DEEP-SEA RES PT II, V58, P196, DOI 10.1016/j.dsr2.2010.05.015; Strugnell JM, 2017, ECOL EVOL, V7, P8087, DOI 10.1002/ece3.3327; Strugnell JM, 2014, HYDROBIOLOGIA, V725, P215, DOI 10.1007/s10750-013-1517-6; Team Rs, 2015, RSTUDIO INT DEV R, DOI [10.1007/978-81-322-2340-5, DOI 10.1007/978-81-322-2340-5]; Vecchione M, 2009, MALACOLOGIA, V51, P13, DOI 10.4002/040.051.0102; Barcenas GV, 2014, FISH RES, V152, P93, DOI 10.1016/j.fishres.2013.08.007; Vogt G, 2012, ZOOL ANZ, V251, P1, DOI 10.1016/j.jcz.2011.05.003; Voight JR, 2000, BIOL BULL, V198, P94, DOI 10.2307/1542807; VONBOLETZKY S, 1992, REV SUISSE ZOOL, V99, P755; Wood JB, 2000, THESIS; Xavier JC, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3352-9; Yau C, 2002, B MAR SCI, V71, P993	86	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219694	10.1371/journal.pone.0219694	http://dx.doi.org/10.1371/journal.pone.0219694			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295339	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800064
J	Brown, DA; Simmons, B; Boffito, M; Aubry, R; Nwokolo, N; Harding, R; O'Brien, KK				Brown, Darren A.; Simmons, Bryony; Boffito, Marta; Aubry, Rachel; Nwokolo, Nneka; Harding, Richard; O'Brien, Kelly K.			Evaluation of the psychometric properties of the HIV Disability Questionnaire among adults living with HIV in the United Kingdom: A cross-sectional self-report measurement study	PLOS ONE			English	Article							INFECTION; DISORDER; SCALE; CARE	Objective To evaluate the psychometric properties of the HIV Disability Questionnaire (HDQ) among people living with HIV (PLHIV) in London, United Kingdom (UK). Methods This is a cross-sectional measurement study. We recruited and administered the self-reported HDQ, seven criterion measures, and a demographic questionnaire with adults living with HIV accessing HIV care. We determined median and interquartile ranges (IQR) for disability presence, severity and episodic scores (range 0-100). We calculated Cronbachs alpha (alpha) Kuder-Richardson-20 (KR-20) statistics for disability and episodic scores respectively (internal consistency reliability), smallest detectable change (SDC) for each HDQ severity item and domain (precision), and tested 36 a priori hypotheses assessing correlations between HDQ and criterion scores (construct validity). Results Of N = 243 participants, all were male, median age 40 years, 94% currently taking antiretroviral therapy, and 22% living with >= 2 concurrent health conditions. Median HDQ domain scores ranged from 0 (IQR: 0,7) (difficulties with day-to-day activities domain) to 27 (IQR: 14, 41) (uncertainty domain). Cronbachs alpha for the HDQ severity scale ranged from 0.85 (95% Confidence Interval (CI): 0.80-0.90) in the cognitive domain to 0.93 (95%CI: 0.91-0.94) in the mental-emotional domain. The KR-20 statistic for the HDQ episodic scale ranged from 0.74 (95%CI: 0.66-0.83) in the cognitive domain to 0.91 (95%CI: 0.89-0.94) in the uncertainty domain. SDC ranged from 7.3-15.0 points on the HDQ severity scale for difficulties with day-to-day activities and cognitive symptoms domains, respectively. The majority of the construct validity hypotheses (n = 30/36, 83%) were confirmed. Conclusions The HDQ possesses internal consistency reliability and construct validity with varied precision when administered to males living with HIV in London, UK. Clinicians and researchers may use the HDQ to measure the nature and extent of disability experienced by PLHIV in the UK, and to inform HIV service provision to address the health-related challenges among PLHIV.	[Brown, Darren A.] Chelsea & Westminster Hosp NHS Fdn Trust, Therapies Dept, London, England; [Simmons, Bryony] Imperial Coll London, Dept Med, Fac Med, London, England; [Boffito, Marta] Chelsea & Westminster Hosp NHS Fdn Trust, Dept HIV Med, London, England; [Aubry, Rachel; O'Brien, Kelly K.] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Nwokolo, Nneka] Chelsea & Westminster Hosp NHS Fdn Trust, London, England; [Harding, Richard] Kings Coll London, Florence Nightingale Fac Nursing Midwifery & Pall, Dept Palliat Care Policy & Rehabil, London, England; [O'Brien, Kelly K.] Univ Toronto, IHPME, Toronto, ON, Canada; [O'Brien, Kelly K.] Univ Toronto, RSI, Toronto, ON, Canada	Imperial College London; Imperial College London; Imperial College London; University of Toronto; Imperial College London; University of London; King's College London; University of Toronto; University of Toronto	Brown, DA (corresponding author), Chelsea & Westminster Hosp NHS Fdn Trust, Therapies Dept, London, England.	Darren.Brown@chelwest.nhs.uk	O'Brien, Kelly/AFM-2205-2022	Simmons, Bryony/0000-0002-3207-9935; Brown, Darren A/0000-0002-4956-243X	British Academy Fellowship of Humanities and Social Sciences [VF1\102954]; Canada Research Chair in Episodic Disability and Rehabilitation; St Stephen's Clinical Research	British Academy Fellowship of Humanities and Social Sciences; Canada Research Chair in Episodic Disability and Rehabilitation; St Stephen's Clinical Research	We gratefully acknowledge the British Academy Fellowship of Humanities and Social Sciences awarded to RH and KKO'B, which supported this study (VF1\102954)(www.thebritishacademy.ac.uk).KKO'B is supported by a Canada Research Chair in Episodic Disability and Rehabilitation (www.chairs-chaires.gc.ca/chairholders-titulaires/profile-eng.aspx?profileId=4394). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the support of St Stephen's Clinical Research in managing the Dean Street Cohort Study. We also gratefully acknowledge the Dean Street Cohort Study participants, involved in this study.	Aaronson N, 2002, QUAL LIFE RES, V11, P193; Antiretroviral Therapy Cohort Collaboration, 2017, LANCET HIV; Auzenbergs M, 2018, POSITIVE VOICES NATL; Banks LM, 2015, TROP MED INT HEALTH, V20, P411, DOI 10.1111/tmi.12449; Baylis A., 2017, FUTURE HIV SERVICES; Brown D, 2016, AIDS CARE, V28, P1495, DOI 10.1080/09540121.2016.1191611; Cerrato E, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000174; Chuah FLH, 2017, HLTH POLICY PLAN; Compston J, 2016, J INTERN MED, V280, P350, DOI 10.1111/joim.12520; Croston Michelle, 2017, Nurs Stand, V31, P46, DOI 10.7748/ns.2017.e10411; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Engler K, 2017, PATIENT, V10, P187, DOI 10.1007/s40271-016-0195-7; Freiberg MS, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003411; Hanass-Hancock J, 2013, AJOD, V2, P1; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, DIS HIV; Kogan AC, 2016, J AM GERIATR SOC, V64, pE1, DOI 10.1111/jgs.13873; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Mactaggart I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164470; Mallon PWG, 2014, CURR OPIN HIV AIDS, V9, P428, DOI 10.1097/COH.0000000000000080; MILO. McMaster Industry Liaison Office (MILO), 2017, HIV DIS QUEST HDQ; Mont D., 2007, 76 WORLD BANK; Mossialos Elias, 2017, INT PROFILES HLTH CA; Nash S, 2018, PROGR ENDING HIV EPI; Nightingale S, 2014, LANCET NEUROL, V13, P1139, DOI 10.1016/S1474-4422(14)70137-1; Nixon SA, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-41; Nunnally J., 1978, PSYCHOMETRIC THEORY; O'Brien KK, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4203-0; O'Brien KK, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0310-9; O'Brien KK, 2014, PROG COMM HLTH PARTN, V8, P549, DOI 10.1353/cpr.2014.0071; O'Brien KK, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0724-8; O'Brien KK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004692; O'Brien KK, 2013, DISABIL REHABIL, V35, P566, DOI 10.3109/09638288.2012.702848; O'Brien KK, 2009, J INT AIDS SOC, V12, DOI [10.1186/1758-2652-12-30, 10.1186/1758-2652-2-5]; O'Brien KK, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-76; OBrien KK, 2017, 26TH ANNUAL CANADIAN; OBrien KK AR, 2009, ONT HIV TREATM NETW; Palmer M, 2012, HEALTH POLICY PLANN, V27, P357, DOI 10.1093/heapol/czr047; Royle J, 2008, DISABIL REHABIL, V30, P114, DOI 10.1080/09638280701223876; Sacktor NC, 2005, AIDS, V19, P1367; SAS Institute Inc, 2016, SAS 9 4 COMP SOFTW, V9, P4; Saylor D, 2016, NAT REV NEUROL, V12, P234, DOI [10.1038/nrneurol.2016.27, 10.1038/nrneurol.2016.53]; Shah ASV, 2018, CIRCULATION; Silverberg MJ, 2015, ANN INTERN MED, V163, P507, DOI 10.7326/M14-2768; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Solomon P, 2018, J INT ASS PROVID AID, V17, p2325958218759210; Solomon Patricia, 2014, J Int Assoc Provid AIDS Care, V13, P519, DOI 10.1177/2325957414547431; Solomon P, 2014, AIDS CARE, V26, P240, DOI 10.1080/09540121.2013.811209; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Thurn M, 2017, CURR HIV-AIDS REP, V14, P31, DOI 10.1007/s11904-017-0348-x; UNAIDS, 2018, 2017 GLOB HIV STAT J; UNAIDS, 2018, UNAIDS DAT 2018; Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organization, 2013, EXPOSURE DRAFT FOR C; Wyrwich Kathleen W, 2004, J Biopharm Stat, V14, P97, DOI 10.1081/BIP-120028508; Wyrwich KW, 1999, MED CARE, V37, P469, DOI 10.1097/00005650-199905000-00006; Yarchoan R, 2018, NEW ENGL J MED, V378, P1029, DOI 10.1056/NEJMra1615896; Yin Z., 2015, HALF PEOPLE HIV CARE	60	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0213222	10.1371/journal.pone.0213222	http://dx.doi.org/10.1371/journal.pone.0213222			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4JZ	31291243	Green Submitted, Green Published, gold			2022-12-26	WOS:000484947800004
J	Zhou, XL; Paushter, DH; Pagan, MD; Kim, DS; Santos, MN; Lieberman, RL; Overkleeft, HS; Sun, Y; Smolka, MB; Hu, FH				Zhou, Xiaolai; Paushter, Daniel H.; Pagan, Mitchell D.; Kim, Dongsung; Santos, Mariela Nunez; Lieberman, Raquel L.; Overkleeft, Herman S.; Sun, Ying; Smolka, Marcus B.; Hu, Fenghua			Progranulin deficiency leads to reduced glucocerebrosidase activity	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; ACID BETA-GLUCOSIDASE; SAPOSIN-C; EPITHELIN PRECURSOR; MUTATIONS; PROTEIN; GENE; DEMENTIA; DISEASE; STACK	Mutation in the GRN gene, encoding the progranulin (PGRN) protein, shows a dose-dependent disease correlation, wherein haploinsufficiency results in frontotemporal lobar degeneration (FTLD) and complete loss results in neuronal ceroid lipofuscinosis (NCL). Although the exact function of PGRN is unknown, it has been increasingly implicated in lysosomal physiology. Here we report that PGRN interacts with the lysosomal enzyme, glucocerebrosi-dase (GCase), and is essential for proper GCase activity. GCase activity is significantly reduced in tissue lysates from PGRN-deficient mice. This is further evidence that reduced lysosomal hydrolase activity may be a pathological mechanism in cases of GRN-related FTLD and NCL.	[Zhou, Xiaolai; Paushter, Daniel H.; Pagan, Mitchell D.; Kim, Dongsung; Santos, Mariela Nunez; Smolka, Marcus B.; Hu, Fenghua] Cornell Univ, Dept Mol Biol & Genet, Weill Inst Cell & Mol Biol, Ithaca, NY 14850 USA; [Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Overkleeft, Herman S.] Leiden Univ, Leiden Inst Chem, Gorlaeus Labs, Leiden, Netherlands; [Sun, Ying] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Sun, Ying] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	Cornell University; University System of Georgia; Georgia Institute of Technology; Leiden University; Leiden University - Excl LUMC; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hu, FH (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Weill Inst Cell & Mol Biol, Ithaca, NY 14850 USA.	fh87@cornell.edu	Zhou, Xiaolai/AAF-7227-2020	Hu, Fenghua/0000-0002-6447-9992	National Institute of Aging [R01NS095954, NS088448, R01NS088448]; National Institute of Neurological Disorders and Stroke [R01NS095954, NS088448, R01NS088448]; President's Council of Cornell Women Affinito-Stewart award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088448, R01NS095954] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); President's Council of Cornell Women Affinito-Stewart award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by funding to F. Hu from National Institute of Aging and National Institute of Neurological Disorders and Stroke (R01NS095954, NS088448) and President's Council of Cornell Women Affinito-Stewart award.; We would like to thank Dr. Haiyuan Yu for his gifts of cDNA; and Xiaochun Wu for technical assistance. This work is supported by funding to F. Hu from National Institute of Aging and National Institute of Neurological Disorders and Stroke (R01NS095954; R01NS088448) and President's Council of Cornell Women Affinito-Stewart award. The authors declare no additional competing financial interests.	Almeida MR, 2016, NEUROBIOL AGING, V41, DOI 10.1016/j.neurobiolaging.2016.02.019; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bdira FB, 2017, ACS CHEM BIOL, V12, P1830, DOI 10.1021/acschembio.7b00276; Beel S, 2017, HUM MOL GENET, DOI [10.1093/hmg/ddx1623768439, DOI 10.1093/HMG/DDX1623768439]; Belcastro V, 2011, NUCLEIC ACIDS RES, V39, P8677, DOI 10.1093/nar/gkr593; BEUTLER E, 1994, MOL MED, V1, P82, DOI 10.1007/bf03403534; Carecchio M, 2014, J ALZHEIMERS DIS, V38, P747, DOI 10.3233/JAD-131151; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Chang KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054448; Chao DHM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138107; Chen Y, 2015, J POLYM RES, V22, DOI 10.1007/s10965-015-0751-1; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Evers BM, 2017, CELL REP, V20, P2565, DOI 10.1016/j.celrep.2017.08.056; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Gegg ME, 2018, FEBS J, V285, P3591, DOI 10.1111/febs.14393; Gotzl JK, 2014, ACTA NEUROPATHOL, V127, P845, DOI 10.1007/s00401-014-1262-6; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Holler CJ, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0100-17.2017; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Jian JL, 2016, EBIOMEDICINE, V13, P212, DOI 10.1016/j.ebiom.2016.10.010; Jian JL, 2016, EBIOMEDICINE, V11, P127, DOI 10.1016/j.ebiom.2016.08.004; Jian JL, 2013, J LEUKOCYTE BIOL, V93, P199, DOI 10.1189/jlb.0812429; Lee CW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0196-6; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mateo I, 2013, EUR J NEUROL, V20, P1571, DOI 10.1111/ene.12090; MORIMOTO S, 1989, P NATL ACAD SCI USA, V86, P3389, DOI 10.1073/pnas.86.9.3389; Mukherjee O, 2006, ANN NEUROL, V60, P314, DOI 10.1002/ana.20963; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; OSIECKINEWMAN K, 1987, BIOCHIM BIOPHYS ACTA, V915, P87, DOI 10.1016/0167-4838(87)90128-2; Palfree RGE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133749; PLOWMAN GD, 1992, J BIOL CHEM, V267, P13073; Qi XY, 1996, J BIOL CHEM, V271, P6874, DOI 10.1074/jbc.271.12.6874; Rovelet-Lecrux A, 2008, NEUROBIOL DIS, V31, P41, DOI 10.1016/j.nbd.2008.03.004; SHOYAB M, 1990, P NATL ACAD SCI USA, V87, P7912, DOI 10.1073/pnas.87.20.7912; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Snowden JS, 2006, BRAIN, V129, P3091, DOI 10.1093/brain/awl267; Songsrirote K, 2010, J PROTEOMICS, V73, P1479, DOI 10.1016/j.jprot.2010.02.013; Sun Y, 2003, J BIOL CHEM, V278, P31918, DOI 10.1074/jbc.M302752200; Tamargo RJ, 2012, MOL GENET METAB, V106, P257, DOI 10.1016/j.ymgme.2012.04.024; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tanaka Y, 2017, HUM MOL GENET, V26, P969, DOI 10.1093/hmg/ddx011; Toh HS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075073, 10.1371/journal.pone.0064989]; Toh H, 2011, J MOL NEUROSCI, V45, P538, DOI 10.1007/s12031-011-9569-4; Tolkatchev D, 2000, BIOCHEMISTRY-US, V39, P2878, DOI 10.1021/bi992130u; Tolkatchev D, 2008, PROTEIN SCI, V17, P711, DOI 10.1110/ps.073295308; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; Valdez C, 2017, HUM MOL GENET, V26, P4861, DOI 10.1093/hmg/ddx364; Van Kampen JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097032; Van Mossevelde S, 2018, NAT REV NEUROL, V14, P363, DOI 10.1038/s41582-018-0009-8; Vancha AR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-23; Vranken WF, 1999, J PEPT RES, V53, P590, DOI 10.1034/j.1399-3011.1999.00048.x; Ward ME, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5642; Witte MD, 2010, NAT CHEM BIOL, V6, P907, DOI 10.1038/NCHEMBIO.466; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhou XL, 2017, J NEUROCHEM, V143, P236, DOI 10.1111/jnc.14110; Zhou XL, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0205-9; Zhou XL, 2017, ACTA NEUROPATHOL, V134, P151, DOI 10.1007/s00401-017-1719-5; Zhou XL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15277; Zhou XL, 2015, J CELL BIOL, V210, P991, DOI 10.1083/jcb.201502029	65	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0212382	10.1371/journal.pone.0212382	http://dx.doi.org/10.1371/journal.pone.0212382			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291241	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800003
J	Counotte, J; Bergink, V; Pot-Kolder, R; Drexhage, HA; Hoek, HW; Veling, W				Counotte, Jacqueline; Bergink, Veerle; Pot-Kolder, Roos; Drexhage, Hemmo A.; Hoek, Hans W.; Veling, Wim			Inflammatory cytokines and growth factors were not associated with psychosis liability or childhood trauma	PLOS ONE			English	Article							SCHIZOPHRENIA-PATIENTS; IMMUNE-SYSTEM; HIGH-RISK; METAANALYSIS; PSYCHOPATHOLOGY; MALTREATMENT; VALIDATION; BRAIN; MODEL	Psychosis is a multifactorial condition arising from an interaction between genetic liability and exposure to environmental risk factors, in particular childhood trauma. Furthermore, accumulating evidence supports a role for the immune system in the aetiology of psychosis. Increased peripheral levels of pro-inflammatory cytokines and reduced neurotrophic factors are found in patients with psychosis. Childhood trauma is highly prevalent in psychosis patients and is also associated with increased pro-inflammatory cytokines and reduced neurotrophic factors. Recent studies suggest the increase in pro-inflammatory cytokines and decrease in neurotrophic factors seen in psychosis may be attributable to the effects of child maltreatment. The aim of this study was to improve understanding of the relation between childhood trauma, inflammation and psychosis. We examined separate and interaction effects of psychosis liability and childhood trauma on serum levels of BDNF, CCL-2, CRP, IFN-gamma, IGFBP2, IL-6, PDGF, SCF and TNF-alpha in 40 patients with recent onset psychosis, 13 patients at Ultra-High Risk (UHR) for psychosis, 31 unaffected siblings of psychosis patients and 41 healthy controls. Childhood trauma was assessed retrospectively with the Childhood Trauma Questionnaire (CTQ). No statistically significant effects of psychosis liability or childhood trauma on concentrations of cytokines or growth factors in peripheral blood were found, nor were there any statistically significant interaction effects of psychosis liability with childhood trauma on serum levels of cytokines and growth factors.	[Counotte, Jacqueline; Pot-Kolder, Roos; Hoek, Hans W.] Parnassia Psychiat Inst, The Hague, Netherlands; [Bergink, Veerle] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands; [Pot-Kolder, Roos] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Drexhage, Hemmo A.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Hoek, Hans W.; Veling, Wim] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Hoek, Hans W.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Parnassia Psychiatric Institute; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Groningen; Columbia University	Counotte, J (corresponding author), Parnassia Psychiat Inst, The Hague, Netherlands.	j.counotte@parnassia.nl	Pot-Kolder, Roos/ABD-5685-2021	Veling, Wim/0000-0002-1364-9779	Veni laureate to dr. Veling from the Netherlands Organisation for Health Research and Development [916.12.013]	Veni laureate to dr. Veling from the Netherlands Organisation for Health Research and Development	This work was supported by a Veni laureate to dr. Veling from the Netherlands Organisation for Health Research and Development (916.12.013). The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Rodriguez L, 2012, CELL IMMUNOL, V273, P124, DOI 10.1016/j.cellimm.2012.01.001; Bergink V, 2014, BIOL PSYCHIAT, V75, P324, DOI 10.1016/j.biopsych.2013.09.037; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Beumer W, 2012, PSYCHONEUROENDOCRINO, V37, P1901, DOI 10.1016/j.psyneuen.2012.04.001; Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; Danese A, 2017, ANNU REV PSYCHOL, V68, P517, DOI 10.1146/annurev-psych-010416-044208; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2018, PHYSIOL REV, V98, P477, DOI 10.1152/physrev.00039.2016; de Witte L, 2014, SCHIZOPHR RES, V154, P23, DOI 10.1016/j.schres.2014.02.005; Dennison U, 2012, PSYCHOL MED, V42, P1865, DOI 10.1017/S0033291712000074; Elenkov IJ, 2002, ANN NY ACAD SCI, V966, P290, DOI 10.1111/j.1749-6632.2002.tb04229.x; Fagundes CP, 2013, BRAIN BEHAV IMMUN, V27, P8, DOI 10.1016/j.bbi.2012.06.014; Fisher HL, 2011, SCHIZOPHRENIA BULL, V37, P546, DOI 10.1093/schbul/sbp103; Franchimont D, 2004, ANN NY ACAD SCI, V1024, P124, DOI 10.1196/annals.1321.009; Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Green MJ, 2011, MOL PSYCHIATR, V16, P960, DOI 10.1038/mp.2010.88; Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531; Hepgul N, 2012, PSYCHOL MED, V42, P1893, DOI 10.1017/S0033291711002947; Juncal-Ruiz M, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1096-6; Kraan T, 2015, SCHIZOPHR RES, V161, P143, DOI 10.1016/j.schres.2014.11.026; Loewy RL, 2005, SCHIZOPHR RES, V79, P117, DOI 10.1016/j.schres.2005.03.007; McGorry PD, 2010, CAN J PSYCHIAT, V55, P486, DOI 10.1177/070674371005500803; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148; Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645; Rietdijk J, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-30; Schmidt FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121971; Thombs BD, 2009, CHILD ABUSE NEGLECT, V33, P518, DOI 10.1016/j.chiabu.2009.03.001; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os J, 2013, AM J PSYCHIAT, V170, P695, DOI 10.1176/appi.ajp.2013.13040474; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Veling W, 2016, PSYCHOL MED, V46, P3339, DOI 10.1017/S0033291716002208; Veling W, 2016, SCHIZOPHRENIA BULL, V42, P1363, DOI 10.1093/schbul/sbw031; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x	39	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219139	10.1371/journal.pone.0219139	http://dx.doi.org/10.1371/journal.pone.0219139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4FP	31276524	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300039
J	Khoshkhoo, A; Carrano, AL; Blersch, DM; Kardel, K				Khoshkhoo, Ali; Carrano, Andres L.; Blersch, David M.; Kardel, Kamran			Engineering of bio-mimetic substratum topographies for enhanced early colonization of filamentous algae	PLOS ONE			English	Article							SURFACE-ROUGHNESS; WATER; ATTACHMENT; FRICTION; PRODUCTIVITY; ADHESION; FLOW	This work reveals a set of surface topography parameters that are significant for algal attachment to natural rock substrata. Topography analysis of rock surfaces from a stream identifies three descriptive areal parameters (S-mr, S-v, and S-a) that correlate with the presence of natural periphyton community. A method was developed and validated to reverse engineer and manufacture artificial substrata with topographic complexity defined by these parameters, using computational modeling and additive manufacturing. Results from colonization experiments with filamentous algae show statistically significant increases in early biomass accrual rates on substrata with higher values of S-a and S-v parameters and lower values of S-mr parameter. These results suggest that manipulation of the level of roughness (peak-to-valley distance and material ratio above the mean) and the distribution of hill and dale sequences can control initial colonization locations and biomass accrual rates, presumably by enhancing growth and recruitment of cells from the overlying flow into protected refugia spaces. As such, these findings provide an approach for optimizing the design of substratum for increased early biomass productivity for attached growth algae cultivation systems.	[Khoshkhoo, Ali] SUNY Binghamton, Dept Syst Sci & Ind Engn, Binghamton, NY 13902 USA; [Carrano, Andres L.; Kardel, Kamran] Georgia Southern Univ, Dept Mfg Engn, Statesboro, GA 30460 USA; [Blersch, David M.] Auburn Univ, Dept Biosyst Engn, Auburn, AL 36849 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University System of Georgia; Georgia Southern University; Auburn University System; Auburn University	Khoshkhoo, A (corresponding author), SUNY Binghamton, Dept Syst Sci & Ind Engn, Binghamton, NY 13902 USA.	khoshkho@binghamton.edu	Carrano, Andres Leonardo/D-9090-2018; Kardel, Kamran/AAP-2806-2020; Blersch, David/L-7490-2015	Carrano, Andres Leonardo/0000-0003-0081-1973; Blersch, David/0000-0002-3239-7167; Khoshkhoo, Ali/0000-0002-1395-9400	U.S. Environmental Protection Agency [SU836122]; Alabama Agricultural Experiment Station of Auburn University; Alabama Agricultural Experiment Station; Hatch program of the National Institute of Food and Agriculture, U.S. Department of Agriculture	U.S. Environmental Protection Agency(United States Environmental Protection Agency); Alabama Agricultural Experiment Station of Auburn University; Alabama Agricultural Experiment Station; Hatch program of the National Institute of Food and Agriculture, U.S. Department of Agriculture	This work was partially supported by the U.S. Environmental Protection Agency Grant Number SU836122 to DMB. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the EPA. Material support provided by the Alabama Agricultural Experiment Station of Auburn University to DMB. Also, the Material for this project was supported by the Alabama Agricultural Experiment Station and the Hatch program of the National Institute of Food and Agriculture, U.S. Department of Agriculture to DMB.	Adey W., 1993, Restoration Ecology, V1, P29, DOI 10.1111/j.1526-100X.1993.tb00006.x; Adey WH, 2013, J PHYCOL, V49, P489, DOI 10.1111/jpy.12056; Adey WH, 2011, BIOSCIENCE, V61, P434, DOI 10.1525/bio.2011.61.6.5; Blersch DM, 2017, ALGAL RES, V21, P52, DOI 10.1016/j.algal.2016.10.027; Burkholder JM., 1996, INTERACTIONS BENTHIC; Cao J, 2009, J MANUF SCI E-T ASME, V131, DOI 10.1115/1.4000562; Carrano A.L., 2016, 5 INT C SURF METR IC, P4; Cui Y, 2014, INT J AGR BIOL ENG, V7, P82, DOI 10.3965/j.ijabe.20140702.010; Cui Y, 2013, INT J AGR BIOL ENG, V6, P44, DOI 10.3965/j.ijabe.20130604.006; Elderton WP, 1969, CERN DOCUMENT SERVER; Elliott O, 2017, J CONTEMP WAT RES ED, V160, P144, DOI 10.1111/j.1936-704X.2017.03246.x; Etsion I, 2005, J TRIBOL-T ASME, V127, P248, DOI 10.1115/1.1828070; Gross M, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0451-z; Hassan MF, 2012, WATER ENVIRON RES, V84, P744, DOI 10.1002/j.1554-7531.2012.tb00283.x; Hillebrand H, 2002, ECOLOGY, V83, P2205, DOI 10.1890/0012-9658(2002)083[2205:COMCBG]2.0.CO;2; ISO, 2009, GEOM PROD SPEC GPS 2; Kandlikar SG, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1896985; Kangas P, 2014, BIORESOURCE TECHNOL, V152, P484, DOI 10.1016/j.biortech.2013.11.027; Kardel K, 2018, ENVIRON ENG SCI, V35, P856, DOI 10.1089/ees.2017.0354; Kardel K, 2015, 3D PRINT ADDIT MANUF, V2, P12, DOI 10.1089/3dp.2014.0024; Khoshkhoo A., 2017, 28 INT SOL FREEF FAB, P2350; Kotwal CA, 1996, TRIBOL T, V39, P890, DOI 10.1080/10402009608983609; Margulis L, 2009, KINGDOMS AND DOMAINS: AN ILLUSTRATED GUIDE TO THE PHYLA OF LIFE ON EARTH, 4TH EDITION, P1, DOI 10.1016/B978-0-12-373621-5.00017-9; Mulbry W, 2010, ECOL ENG, V36, P536, DOI 10.1016/j.ecoleng.2009.11.026; Mulbry W, 2008, BIORESOURCE TECHNOL, V99, P8137, DOI 10.1016/j.biortech.2008.03.073; Ozkan A, 2013, BIOFOULING, V29, P469, DOI 10.1080/08927014.2013.782397; Praeger C, 2018, ALGAL RES, V36, P209, DOI 10.1016/j.algal.2018.10.014; Sandefur HN, 2014, ECOL ENG, V71, P527, DOI 10.1016/j.ecoleng.2014.07.070; Schnurr PJ, 2015, RENEW SUST ENERG REV, V52, P418, DOI 10.1016/j.rser.2015.07.090; Sekar R, 2004, HYDROBIOLOGIA, V512, P109, DOI 10.1023/B:HYDR.0000020315.40349.38; Sluiter A, 2008, LAB ANAL PROCED; SPEDDING TA, 1980, J LUBRIC TECH-T ASME, V102, P495, DOI 10.1115/1.3251585; Steinman Alan D., 2007, P357, DOI 10.1016/B978-012332908-0.50024-3; Tayebi N, 2004, TRIBOL INT, V37, P491, DOI 10.1016/j.triboint.2003.11.010; Taylor JB, 2006, INT J THERM SCI, V45, P962, DOI 10.1016/j.ijthermalsci.2006.01.004; TRANSEAU E. N., 1926, OHIO JOUR SCI, V26, P311; Wakuda M, 2003, WEAR, V254, P356, DOI 10.1016/S0043-1648(03)00004-8; Wang XL, 2003, TRIBOL LETT, V14, P275, DOI 10.1023/A:1022650813314	38	5	5	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219150	10.1371/journal.pone.0219150	http://dx.doi.org/10.1371/journal.pone.0219150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276527	Green Published, gold, Green Submitted			2022-12-26	WOS:000484936300041
J	Ettekal, I; Eiden, RD; Nickerson, AB; Schuetze, P				Ettekal, Idean; Eiden, Rina D.; Nickerson, Amanda B.; Schuetze, Pamela			Comparing alternative methods of measuring cumulative risk based on multiple risk indicators: Are there differential effects on children's externalizing problems?	PLOS ONE			English	Article							AFRICAN-AMERICAN CHILDREN; CAUSAL INDICATORS; BEHAVIOR PROBLEMS; RELIABILITY; ADJUSTMENT; PREDICTORS; ADVERSITY; COMPOSITE; PATHWAYS; MODELS	This study examined several alternative methods to measure cumulative risk (CR) based on multiple risk indicators. Several methods for measuring CR are presented and their conceptual and methodological assumptions are assessed. More specifically, at the individual risk level, we examined the implications of various measurement approaches (i.e., dichotomous, proportion- and z-scores). At the composite level, we measured CR as an observed score, and compared this approach with two variable-centered approaches (consisting of reflective and formative indicators) and two person-centered approaches (consisting of latent class analysis and latent profile analysis). A decision tree was proposed to aid researchers in comparing and choosing the alternative methods. Using a sample of 169 low-income families (children approximately 5 years old, 51% girls; 74% African American, and their primary caregiver), we specified models to represent each of the alternative methods. Across models, the multiple risk composite was based on a set of 12 individual risk indicators including low maternal education, hunger, meal and money unpredictability, maternal psychopathology, maternal substance use, harsh parenting, family stress, and family violence. For each model, we estimated the effect size of the composite CR variable on children's externalizing problems. Results indicated that the variable-centered CR composites had larger effects than the observed summary score CR indices and the person-centered methods.	[Ettekal, Idean] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA; [Ettekal, Idean; Eiden, Rina D.; Nickerson, Amanda B.; Schuetze, Pamela] SUNY Buffalo, Clin & Res Inst Addict, Buffalo, NY 14260 USA; [Eiden, Rina D.] SUNY Buffalo, Dept Psychol, Buffalo, NY USA; [Nickerson, Amanda B.] SUNY Buffalo, Alberti Ctr Bullying Abuse Prevent, Buffalo, NY USA; [Schuetze, Pamela] SUNY Buffalo, Dept Psychol, Buffalo, NY USA	Texas A&M University System; Texas A&M University College Station; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Ettekal, I (corresponding author), Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA.; Ettekal, I (corresponding author), SUNY Buffalo, Clin & Res Inst Addict, Buffalo, NY 14260 USA.	iettekal@tamu.edu		Eiden, Rina/0000-0002-5303-3661; Ettekal, Idean/0000-0003-3306-9330	National Institute on Drug Abuse of the National Institutes of Health (NIH) [R01DA013190, R01DA041231]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA041231] Funding Source: NIH RePORTER	National Institute on Drug Abuse of the National Institutes of Health (NIH); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the National Institute on Drug Abuse of the National Institutes of Health (NIH) under Awards R01DA013190 (awarded to RDE and PS) and R01DA041231 (awarded to RDE, PS, and ABN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.; The authors thank the families who participated in this study and the research staff responsible for data collection and coding of observational assessments. Special thanks go to Claire Coles for collaboration on the larger study, Amol Lele for collaboration on data collection at the Women and Children's Hospital of Buffalo, and Michael Ray for collaboration on data collection at Sisters of Charity Hospital of Buffalo. Research reported in this article was supported by the National Institute on Drug Abuse of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Achenbach TM, 1992, BURLINGTON; Bauer DJ, 2004, PSYCHOL METHODS, V9, P3, DOI 10.1037/1082-989X.9.1.3; Bollen KA, 2017, PSYCHOL METHODS, V22, P581, DOI 10.1037/met0000056; Bollen KA, 2011, PSYCHOL METHODS, V16, P265, DOI 10.1037/a0024448; Bollen KA, 2011, MIS QUART, V35, P359; Brown RA, 1998, PSYCHOL ADDICT BEHAV, V12, P101, DOI 10.1037/0893-164X.12.2.101; Brumley LD, 2018, CHILD ABUSE NEGLECT, DOI 10.1016/j.chiabu.2018.08.014; Burchinal M, 2008, PARENT-SCI PRACT, V8, P41, DOI 10.1080/15295190701830672; Clark R, 1997, CHILD DEV, V68, P364, DOI 10.1111/j.1467-8624.1997.tb01945.x; Clark R, 1999, EDUC PSYCHOL MEAS, V59, P821, DOI 10.1177/00131649921970161; Clark R, 1993, HDB INFANT MENTAL HL, P191; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; Cohen J, 2003, APPL MULTIPLE REGRES, P3; Collins LM, 2010, WILEY; Copeland W, 2009, J CHILD PSYCHOL PSYC, V50, P451, DOI 10.1111/j.1469-7610.2008.02005.x; Derogatis LR., 1993, COMPUTER SYSTEMS; Eiden RD, 2014, PSYCHOL ADDICT BEHAV, V28, P139, DOI 10.1037/a0032632; Evans GW, 2013, PSYCHOL BULL, V139, P1342, DOI 10.1037/a0031808; Evans GW, 2004, AM PSYCHOL, V59, P77, DOI 10.1037/0003-066X.59.2.77; Fanti KA, 2010, DEV PSYCHOL, V46, P1159, DOI 10.1037/a0020659; FERGUSSON DM, 1994, J CHILD PSYCHOL PSYC, V35, P1123, DOI 10.1111/j.1469-7610.1994.tb01813.x; Gach EJ, 2018, J FAM PSYCHOL, V32, P92, DOI 10.1037/fam0000360; Hall JE, 2010, BRIT J DEV PSYCHOL, V28, P219, DOI 10.1348/026151008X399925; Howell RD, 2007, PSYCHOL METHODS, V12, P205, DOI 10.1037/1082-989X.12.2.205; Jones DJ, 2002, J MARRIAGE FAM, V64, P105, DOI 10.1111/j.1741-3737.2002.00105.x; Kim S, 2005, J FAM PSYCHOL, V19, P305, DOI 10.1037/0893-3200.19.2.305; Kochanska G, 2000, CHILD DEV, V71, P417, DOI 10.1111/1467-8624.00154; Krishnakumar A, 2002, J APPL DEV PSYCHOL, V23, P237, DOI 10.1016/S0193-3973(02)00106-5; Lanza ST, 2010, DEV PSYCHOPATHOL, V22, P313, DOI 10.1017/S0954579410000088; Loeber R, 2001, CLIN CHILD FAM PSYCH, V4, P273, DOI 10.1023/A:1013574903810; Lucio R, 2012, DEV PSYCHOL, V48, P422, DOI 10.1037/a0025939; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; McLaughlin KA, 2016, CURR DIR PSYCHOL SCI, V25, P239, DOI 10.1177/0963721416655883; McLaughlin KA, 2014, NEUROSCI BIOBEHAV R, V47, P578, DOI 10.1016/j.neubiorev.2014.10.012; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Moran L, 2017, J RES PERS, V67, P61, DOI 10.1016/j.jrp.2016.03.003; Murphy JM, 1998, J AM ACAD CHILD PSY, V37, P163, DOI 10.1097/00004583-199802000-00008; Muthen L. K., 2017, LOS; PATTERSON GR, 1982, COERCIVE FAMILY PROC, P3; Patterson GR, 1992, CASTALIA; Ross LT, 2000, J MARRIAGE FAM, V62, P549, DOI 10.1111/j.1741-3737.2000.00549.x; Rouse HL, 2009, EARLY CHILD RES Q, V24, P1, DOI 10.1016/j.ecresq.2008.12.001; Rutter M, 1979, Ann Acad Med Singap, V8, P324; RUTTER M, 1981, J CHILD PSYCHOL PSYC, V22, P323, DOI 10.1111/j.1469-7610.1981.tb00560.x; SAMEROFF A, 1987, SCHIZOPHRENIA BULL, V13, P383, DOI 10.1093/schbul/13.3.383; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Shaw DS, 2014, ANNU REV CLIN PSYCHO, V10, P503, DOI 10.1146/annurev-clinpsy-032813-153650; Shaw DS, 2012, DEV PSYCHOPATHOL, V24, P871, DOI 10.1017/S0954579412000429; Shaw DS, 1998, J AM ACAD CHILD PSY, V37, P545, DOI 10.1097/00004583-199805000-00017; SOBELL MB, 1986, ADDICT BEHAV, V11, P149, DOI 10.1016/0306-4603(86)90040-7; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Wehler, 1991, COMMUNITY CHILDHOOD; Wehler C, 2004, AM J PUBLIC HEALTH, V94, P109, DOI 10.2105/AJPH.94.1.109; Wilson MN, 2009, PREV SCI, V10, P353, DOI 10.1007/s11121-009-0137-x	54	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219134	10.1371/journal.pone.0219134	http://dx.doi.org/10.1371/journal.pone.0219134			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4CE	31269048	gold, Green Published, Green Submitted			2022-12-26	WOS:000484927300043
J	Petrova, D; Mas, G; Navarrete, G; Rodriguez, TT; Ortiz, PJ; Garcia-Retamero, R				Petrova, Dafina; Mas, Guiliana; Navarrete, Gorka; Tello Rodriguez, Tania; Ortiz, Pedro J.; Garcia-Retamero, Rocio			Cancer screening risk literacy of physicians in training: An experimental study	PLOS ONE			English	Article							NUMERACY; COMPREHENSION; ENTHUSIASM; BENEFITS; HARMS	We investigated what factors may foster or hinder physicians' cancer screening risk literacy-specifically the ability to understand evidence regarding screening effectiveness and make evidence-based recommendations to patients. In an experiment, physicians in training (interns and residents) read statistical information about outcomes from screening for cancer, and had to decide whether to recommend it to a patient. We manipulated the effectiveness of the screening (effective vs. ineffective at reducing mortality) and the demand of the patient to get screened (demand vs. no demand). We assessed participants' comprehension of the presented evidence and recommendation to the patient, as well as a-priori screening beliefs (e.g., that screening is always a good choice), numeracy, science literacy, knowledge of screening statistics, statistical education, and demographics. Stronger positive a-priori screening beliefs, lower knowledge of screening statistics, and lower numeracy were related to worse comprehension of the evidence. Physicians recommended against the ineffective screening but only if they showed good comprehension of the evidence. Physicians' recommendations were further based on the perceived benefits from screening but not on perceived harms, nor the patient's demands. The current study demonstrates that comprehension of cancer screening statistics and the ability to infer the potential benefits for patients are essential for evidence-based recommendations. However, strong beliefs in favor of screening fostered by promotion campaigns may influence how physicians evaluate evidence about specific screenings. Fostering physician numeracy skills could help counteract such biases and provide evidence-based recommendations to patients.	[Petrova, Dafina] Andalusian Sch Publ Hlth, Canc Registry Granada, Granada, Spain; [Petrova, Dafina] Univ Granada, Inst Invest Biosanitaria Ibs Granada, Granada, Spain; [Petrova, Dafina] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Petrova, Dafina; Garcia-Retamero, Rocio] Univ Granada, Mind Brain & Behav Res Ctr, Granada, Spain; [Mas, Guiliana; Tello Rodriguez, Tania; Ortiz, Pedro J.] Univ Peruana Cayetano Heredia, Inst Gerontol, Sch Med, Lima, Peru; [Navarrete, Gorka] Univ Adolfo Ibanez, Sch Psychol, CSCN, Santiago, Chile; [Garcia-Retamero, Rocio] Harding Ctr Risk Literacy, Berlin, Germany	Escuela Andaluza de Salud Publica; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Granada; Universidad Peruana Cayetano Heredia; Universidad Adolfo Ibanez	Petrova, D (corresponding author), Andalusian Sch Publ Hlth, Canc Registry Granada, Granada, Spain.; Petrova, D (corresponding author), Univ Granada, Inst Invest Biosanitaria Ibs Granada, Granada, Spain.; Petrova, D (corresponding author), CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.; Petrova, D (corresponding author), Univ Granada, Mind Brain & Behav Res Ctr, Granada, Spain.	dafina.petrova.easp@juntadeandalucia.es	Petrova, Dafina/AAH-8970-2019; Navarrete, Gorka/H-5995-2011	Petrova, Dafina/0000-0002-0346-6776; Navarrete, Gorka/0000-0001-7678-8656; Garcia-Retamero, Rocio/0000-0001-9140-8519	Ministerio de Economia y Competitividad (Spain) [PSI2011-22954, PSI2014-51842-R]; Juan de la Cierva Fellowship from the Spanish Ministry of Economy, Industry, and Competitiveness [FJCI-2016-28279]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT/FONDECYT Regular) [1171035]	Ministerio de Economia y Competitividad (Spain); Juan de la Cierva Fellowship from the Spanish Ministry of Economy, Industry, and Competitiveness; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT/FONDECYT Regular)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Financial support was partially provided by the Ministerio de Economia y Competitividad (Spain) (PSI2011-22954 and PSI2014-51842-R to DP and RGR). Dafina Petrova is supported by a Juan de la Cierva Fellowship (FJCI-2016-28279) from the Spanish Ministry of Economy, Industry, and Competitiveness. Gorka Navarrete is supported by a grant from Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT/FONDECYT Regular 1171035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BL, 2014, NUMERICAL REASONING IN JUDGMENTS AND DECISION MAKING ABOUT HEALTH, P1, DOI 10.1017/CBO9781139644358; Anderson BL, 2014, NUMERICAL REASONING IN JUDGMENTS AND DECISION MAKING ABOUT HEALTH, P59; Anderson Britta L, 2013, J Grad Med Educ, V5, P272, DOI 10.4300/JGME-D-12-00161.1; Anderson BL, 2014, J HEALTHC QUAL, V36, P5, DOI 10.1111/j.1945-1474.2011.00194.x; Arkes HR, 2012, PSYCHOL SCI, V23, P547, DOI 10.1177/0956797612437428; Austin OJ, 1997, ARCH FAM MED, V6, P453, DOI 10.1001/archfami.6.5.453; Cokely D. E. T., 2018, CAMBRIDGE HDB EXPERT, P476, DOI [10.1017/9781316480748.026, DOI 10.1017/9781316480748.026]; Cokely ET, 2014, NUMERICAL REASONING IN JUDGMENTS AND DECISION MAKING ABOUT HEALTH, P11; Cokely ET, 2012, JUDGM DECIS MAK, V7, P25; Garcia-Retamero R, 2014, HEALTH EXPECT, V17, P664, DOI 10.1111/j.1369-7625.2012.00791.x; Garcia-Retamero R, 2017, HUM FACTORS, V59, P582, DOI 10.1177/0018720817690634; Garcia-Retamero R, 2016, PATIENT EDUC COUNS, V99, P1156, DOI 10.1016/j.pec.2016.01.013; Garcia-Retamero R, 2014, HEALTH PSYCHOL, V33, P920, DOI 10.1037/hea0000061; Garcia-Retamero R, 2013, SOC SCI MED, V83, P27, DOI 10.1016/j.socscimed.2013.01.034; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Gigerenzer G, 2009, JNCI-J NATL CANCER I, V101, P1216, DOI 10.1093/jnci/djp237; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Harris RP, 2014, JAMA INTERN MED, V174, P281, DOI 10.1001/jamainternmed.2013.12745; Hayes A., 2008, INTRO MEDIATION MODE; Hicks R J, 1995, Arch Fam Med, V4, P317, DOI 10.1001/archfami.4.4.317; Ilic D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004720.pub3; Jenny MA, 2018, BMJ OPEN, V8; Johnson TV, 2014, J SURG EDUC, V71, P211, DOI 10.1016/j.jsurg.2013.07.013; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Laugksch RC, 2000, SCI EDUC, V84, P71, DOI 10.1002/(SICI)1098-237X(200001)84:1<71::AID-SCE6>3.0.CO;2-C; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Mas G, 2018, GAC MED MEX, V154, P209, DOI 10.24875/GMM.17003024; National Science Foundation, 2014, SCIENCE AND ENGINEER; Nelson W, 2008, ANN BEHAV MED, V35, P261, DOI 10.1007/s12160-008-9037-8; Peters E, 2007, HEALTH AFFAIR, V26, P741, DOI 10.1377/hlthaff.26.3.741; Petrova D, 2018, MED DECIS MAKING, V38, P355, DOI 10.1177/0272989X17729359; Petrova D, 2016, J EXP PSYCHOL-APPL, V22, P247, DOI 10.1037/xap0000086; Petrova D, 2015, MED DECIS MAKING, V35, P847, DOI 10.1177/0272989X15587676; Rao G, 2008, FAM MED, V40, P354; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Sheridan SL, 2004, AM J PREV MED, V26, P56, DOI 10.1016/j.amepre.2003.09.011; Sheridan Stacey L, 2002, Eff Clin Pract, V5, P35; Sirota M, 2017, HEALTH PSYCHOL, V36, P402, DOI 10.1037/hea0000456; Voss JD, 2001, J GEN INTERN MED, V16, P831, DOI 10.1046/j.1525-1497.2001.10133.x; Waller J, 2015, BRIT J CANCER, V112, P562, DOI 10.1038/bjc.2014.643; Wegwarth O, 2012, ANN INTERN MED, V156, P340, DOI 10.7326/0003-4819-156-5-201203060-00005; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975; Woloshin S, 2012, NEW ENGL J MED, V367, P1677, DOI 10.1056/NEJMp1209407; Woloshin S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5132	47	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0218821	10.1371/journal.pone.0218821	http://dx.doi.org/10.1371/journal.pone.0218821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4CE	31269051	Green Published, gold			2022-12-26	WOS:000484927300027
J	Miettinen, H; Bomberg, M; Nyyssonen, M; Reunamo, A; Jorgensen, KS; Vikman, M				Miettinen, Hanna; Bomberg, Malin; Nyyssonen, Mari; Reunamo, Anna; Jorgensen, Kirsten S.; Vikman, Minna			Oil degradation potential of microbial communities in water and sediment of Baltic Sea coastal area	PLOS ONE			English	Article							DEGRADING BACTERIA; ARCHAEAL DIVERSITY; EXTRACELLULAR DNA; CRUDE-OIL; ABUNDANCE; FUNGI; SOIL; GRADIENT; FINLAND; GENES	Two long-term potentially oil exposed Baltic Sea coastal sites near old oil refineries and harbours were compared to nearby less exposed sites in terms of bacterial, archaeal and fungal microbiomes and oil degradation potential. The bacterial, archaeal and fungal diversities were similar in oil exposed and less exposed sampling sites based on bacterial and archaeal 16S rRNA gene and fungal 5.8S rRNA gene amplicon sequencing from both DNA and RNA fractions. The number of genes participating in alkane degradation (alkB) or PAH-ring hydroxylation (PAH-RHDa) were detected by qPCR in all water and sediment samples. These numbers correlated with the number of bacterial 16S rRNA gene copies in sediment samples but not with the concentration of petroleum hydrocarbons or PAHs. This indicates that both the clean and the more polluted sites at the Baltic Sea coastal areas have a potential for petroleum hydrocarbon degradation. The active community (based on RNA) of the coastal Baltic Sea water differed largely from the total community (based on DNA). The most noticeable difference was seen in the bacterial community in the water samples were the active community was dominated by Cyanobacteria and Proteobacteria whereas in total bacterial community Actinobacteria was the most abundant phylum. The abundance, richness and diversity of Fungi present in water and sediment samples was in general lower than that of Bacteria and Archaea. Furthermore, the sampling location influenced the fungal community composition, whereas the bacterial and archaeal communities were not influenced. This may indicate that the fungal species that are adapted to the Baltic Sea environments are few and that Fungi are potentially more vulnerable to or affected by the Baltic Sea conditions than Bacteria and Archaea.	[Miettinen, Hanna; Bomberg, Malin; Nyyssonen, Mari; Vikman, Minna] VTT Tech Res Ctr Finland Ltd, Solut Nat Resources & Environm, Espoo, Finland; [Reunamo, Anna; Jorgensen, Kirsten S.] Finnish Environm Inst SYKE, Ctr Marine Res, Helsinki, Finland	VTT Technical Research Center Finland; Finnish Environment Institute	Miettinen, H (corresponding author), VTT Tech Res Ctr Finland Ltd, Solut Nat Resources & Environm, Espoo, Finland.	hanna.miettinen@vtt.fi		Reunamo, Anna/0000-0003-2100-5006; Miettinen, Hanna/0000-0001-9257-9096; Jorgensen, Kirsten S./0000-0003-2092-676X; Nyyssonen, Mari/0000-0003-2989-0222	Academy of Finland; Finnish Environment Institute [289238]; VTT [289480]	Academy of Finland(Academy of Finland); Finnish Environment Institute; VTT	This work was funded by the Academy of Finland, by grant no 289480 to M.N. at VTT and by grant no 289238 to K.S.J. at the Finnish Environment Institute and by VTT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kymijoen vesi ja ymparistory and Lounais-Suomen vesi-ja ymparistotutkimus Oy for assistance in collecting the samples. Neste Ltd. is thanked for allowing the sampling in restricted area near the refineries. Mirva Pyrhonen, Viivi Norri and Amanda Raitosalo are acknowledged for skillful technical assistance in the laboratory. This work was funded by the Academy of Finland, by grant no 289480 to M.N. at VTT and the by grant no 289238 to K.S.J. at the Finnish Environment Institute and by VTT.	Adam PS, 2017, ISME J, V11, P2407, DOI 10.1038/ismej.2017.122; ALNASRAWI H, 2012, J BIOREMED BIODEGR, V3, P1, DOI DOI 10.4172/2155; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bano N, 2004, APPL ENVIRON MICROB, V70, P781, DOI 10.1128/AEM.70.2.781-789.2004; Bargiela R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11651; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Berg C, 2015, ISME J, V9, P1319, DOI 10.1038/ismej.2014.218; Broman E, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0311-5; Brunila OP, 2014, TRANSNAV, V8, P403, DOI 10.12716/1001.08.03.11; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cebron A, 2008, J MICROBIOL METH, V73, P148, DOI 10.1016/j.mimet.2008.01.009; Compte-Port S, 2017, MICROB ECOL, V74, P776, DOI 10.1007/s00248-017-0989-8; Dell'Anno A, 2002, LIMNOL OCEANOGR, V47, P899, DOI 10.4319/lo.2002.47.3.0899; Dupont CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089549; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edlund A, 2006, ENVIRON MICROBIOL, V8, P223, DOI 10.1111/j.1462-2920.2005.00887.x; Edlund A, 2008, FEMS MICROBIOL ECOL, V65, P513, DOI 10.1111/j.1574-6941.2008.00513.x; Eichorst SA, 2018, ENVIRON MICROBIOL, V20, P1041, DOI 10.1111/1462-2920.14043; Fillol M, 2016, ISME J, V10, P665, DOI 10.1038/ismej.2015.143; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Harper D, 2001, PAST PALEONTOLOGICAL; Hassanshahian M., 2013, BIODEGRAD ENG TECHNO, DOI [10.5772/55554, DOI 10.5772/55554]; Haugland R.A., 2002, U.S. Patent, Patent No. [6,387,652, 6387652]; HELCOM, BALT SEA ENV P, V152; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hu P, 2016, MBIO, V7, DOI 10.1128/mBio.01669-15; Izmalkova TY, 2018, MICROBIOLOGY+, V87, P261, DOI 10.1134/S0026261718020054; Jankowska E, 2015, ENVIRON SCI POLLUT R, V22, P14372, DOI 10.1007/s11356-015-5049-7; Jeanbille M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01303; Judger BE, 2016, FRONT MICROBIOL, V7, P249; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kohout P, 2012, FEMS MICROBIOL ECOL, V80, P216, DOI 10.1111/j.1574-6941.2011.01291.x; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Korhonen M, 2013, CHEMOSPHERE, V93, P1541, DOI 10.1016/j.chemosphere.2013.07.072; Koskinen K., 2010, MICROBIOLOGY ECOLOGY, V75, P99, DOI DOI 10.1111/J.1574-6941.2010.00987.X; Krzmarzick MJ, 2018, ARCHAEA, V2018, DOI 10.1155/2018/3194108; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Kummel S, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv006; Labrenz M, 2007, AQUAT MICROB ECOL, V46, P177, DOI 10.3354/ame046177; Lazarus KL, 2015, FUNGAL ECOL, V14, P62, DOI 10.1016/j.funeco.2014.11.004; Lennon JT, 2018, MBIO, V9, DOI 10.1128/mBio.00637-18; Lever MA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00476; Liang B, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0117-4; Lindroos A, 2011, AQUAT MICROB ECOL, V65, P29, DOI 10.3354/ame01532; Liu RY, 2009, J BIOSCI BIOENG, V108, P400, DOI 10.1016/j.jbiosc.2009.05.010; Llobet-Brossa E, 1998, APPL ENVIRON MICROB, V64, P2691; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Manttari V, 2016, PORVOON EDUSTAN MERI; McGenity Terry J, 2012, Aquat Biosyst, V8, P10, DOI 10.1186/2046-9063-8-10; McMurdie PJ, 2015, BIOINFORMATICS, V31, P282, DOI 10.1093/bioinformatics/btu616; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nie Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04968; Nubel U, 1996, J BACTERIOL, V178, P5636; Ortega-Retuerta E, 2012, BIOGEOSCIENCES, V9, P3679, DOI 10.5194/bg-9-3679-2012; Passarini MRZ, 2011, MAR POLLUT BULL, V62, P364, DOI 10.1016/j.marpolbul.2010.10.003; Payet J. P., 2010, MAN AQUAT VIRAL ECOL, P102, DOI [10.4319/mave.2010.978-0-9845591-0-7.102, DOI 10.4319/MAVE.2010.978-0-9845591-0-7.102]; Perez-de-Mora A, 2011, MICROB ECOL, V62, P959, DOI 10.1007/s00248-011-9858-z; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raisanen R., 2016, VUOSIRAPORTTI 2015; Rajtor M, 2016, CHEMOSPHERE, V162, P105, DOI 10.1016/j.chemosphere.2016.07.071; Rasigraf O, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.475; Reunamo A, 2017, GEOMICROBIOL J, V34, P385, DOI 10.1080/01490451.2016.1197987; Reunamo A, 2013, MAR POLLUT BULL, V72, P174, DOI 10.1016/j.marpolbul.2013.04.006; Richards TA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2243; Richards TA, 2012, ANNU REV MAR SCI, V4, P495, DOI 10.1146/annurev-marine-120710-100802; Riemann L, 2008, APPL ENVIRON MICROB, V74, P503, DOI 10.1128/AEM.01983-07; Rojo F, 2009, ENVIRON MICROBIOL, V11, P2477, DOI 10.1111/j.1462-2920.2009.01948.x; Sandaa RA, 2008, RES MICROBIOL, V159, P374, DOI 10.1016/j.resmic.2008.04.013; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Sinkko H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067061; Sinkko H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021555; Stern RF, 2015, PROG OCEANOGR, V137, P409, DOI 10.1016/j.pocean.2015.04.015; Sutton NB, 2013, APPL ENVIRON MICROB, V79, P619, DOI 10.1128/AEM.02747-12; Swarnakaran Hemalatha, 2011, Journal of Environmental Protection, V2, P243, DOI 10.4236/jep.2011.23028; Tamminen M, 2011, AQUACULTURE, V313, P15, DOI 10.1016/j.aquaculture.2011.01.020; Thureborn P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074983; Torti A, 2015, MAR GENOM, V24, P185, DOI 10.1016/j.margen.2015.08.007; Vieira GAL, 2018, BRAZ J MICROBIOL, V49, P749, DOI 10.1016/j.bjm.2018.04.007; Viggor S, 2015, MAR POLLUT BULL, V101, P507, DOI 10.1016/j.marpolbul.2015.10.064; Viggor S, 2013, MICROBIOL RES, V168, P415, DOI 10.1016/j.micres.2013.02.006; Wang XB, 2011, BIORESOURCE TECHNOL, V102, P7755, DOI 10.1016/j.biortech.2011.06.009; Wasmund K, 2014, ISME J, V8, P383, DOI 10.1038/ismej.2013.143; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wu YR, 2009, WORLD J MICROB BIOT, V25, P1395, DOI 10.1007/s11274-009-0026-2; Yamada T., 2018, BERGEYS MANUAL SYSTE, P1, DOI [10.1002/9781118960608.fbm00301, DOI 10.1002/9781118960608.CBM00064]; Yan LJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00015; Yli-Hemminki P, 2014, GEOMICROBIOL J, V31, P263, DOI 10.1080/01490451.2013.819050; Yu TT, 2018, P NATL ACAD SCI USA, V115, P6022, DOI 10.1073/pnas.1718854115; Zhang DC, 2012, SCI TOTAL ENVIRON, V421, P184, DOI 10.1016/j.scitotenv.2012.01.043	91	18	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2019	14	7							e0218834	10.1371/journal.pone.0218834	http://dx.doi.org/10.1371/journal.pone.0218834			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3ZV	31265451	Green Published, Green Submitted			2022-12-26	WOS:000484921200015
J	Gabrielsen, ISM; Helgeland, H; Akselsenl, H; Aass, HCD; Sundaraml, AYM; Snowhite, IV; Pugliese, A; Flam, ST; Lie, BA				Gabrielsen, Ingvild S. M.; Helgeland, Hanna; Akselsenl, Helle; Aass, Hans Christian D.; Sundaraml, Arvind Y. M.; Snowhite, Isaac V.; Pugliese, Alberto; Flam, Siri T.; Lie, Benedicte A.			Transcriptomes of antigen presenting cells in human thymus	PLOS ONE			English	Article							PROMISCUOUS GENE-EXPRESSION; B-CELLS; DENDRITIC CELLS; SELF-ANTIGENS; DIFFERENTIAL EXPRESSION; CENTRAL TOLERANCE; PROTEIN; AIRE; IDENTIFICATION; REPERTOIRE	Antigen presenting cells (APCs) in the thymus play an essential role in the establishment of central tolerance, i.e. the generation of a repertoire of functional and self-tolerant T cells to prevent autoimmunity. In this study, we have compared the transcriptomes of four primary APCs from human thymus (mTECs, CD19(+) B cells, CD141(+) and CD123(+) DCs). We investigated a set of genes including the HLA genes, genes encoding transcriptional regulators and finally, tissue-enriched genes, i.e, genes with a five-fold higher expression in a particular human tissue. We show that thymic CD141(+) DCs express the highest levels of all classical HLA genes and 67% (14/21) of the HLA class I and II pathway genes investigated in this study. CD141(+) DCs also expressed the highest levels of the transcriptional regulator DEAF1, whereas AIRE and FEZF2 expression were mainly found in primary human mTECs. We found expression of "tissue enriched genes" from the Human Protein Atlas (HPA) in all four APC types, but the mTECs were clearly dominating in the number of uniquely expressed tissue enriched genes (20% in mTECs, 7% in CD19(+) B cells, 4% in CD123(+) DCs and 2% in CD141(+) DCs). The tissue enriched genes also overlapped with reported human autoantigens. This is, to our knowledge, the first study that performs RNA sequencing of mTECs, CD19(+) B cells, CD141(+) and CD123(+) DCs isolated from the same individuals and provides insight into the transcriptomes of these human thymic APCs.	[Gabrielsen, Ingvild S. M.; Helgeland, Hanna; Akselsenl, Helle; Sundaraml, Arvind Y. M.; Flam, Siri T.; Lie, Benedicte A.] Univ Oslo, Dept Med Genet, Oslo, Norway; [Gabrielsen, Ingvild S. M.; Helgeland, Hanna; Akselsenl, Helle; Sundaraml, Arvind Y. M.; Flam, Siri T.; Lie, Benedicte A.] Oslo Univ Hosp, Oslo, Norway; [Gabrielsen, Ingvild S. M.; Helgeland, Hanna; Flam, Siri T.; Lie, Benedicte A.] Univ Oslo, KG Jebsen Inflammat Res Ctr, Oslo, Norway; [Aass, Hans Christian D.; Lie, Benedicte A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Aass, Hans Christian D.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Snowhite, Isaac V.; Pugliese, Alberto] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA; [Pugliese, Alberto] Univ Miami, Miller Sch Med, Dept Med, Div Endocrinol Diabet & Metab Microbiol & Immunol, Miami, FL 33136 USA	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Miami; University of Miami	Gabrielsen, ISM (corresponding author), Univ Oslo, Dept Med Genet, Oslo, Norway.; Gabrielsen, ISM (corresponding author), Oslo Univ Hosp, Oslo, Norway.; Gabrielsen, ISM (corresponding author), Univ Oslo, KG Jebsen Inflammat Res Ctr, Oslo, Norway.	ingvid.gabrielsen@gmail.com		Helgeland, Hanna/0000-0001-7209-7698; Sundaram, Arvind/0000-0002-3007-7784	Research Council of Norway [214280/F20]; Norwegian Diabetes Association	Research Council of Norway(Research Council of Norway); Norwegian Diabetes Association	This study was financed by the Research Council of Norway (214280/F20) (https./Agww.forskningsradetno/) and the Norwegian Diabetes Association (https/Amy) diabetesmienglishi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Harald Lindberg at Oslo University Hospital for providing the thymus tissues, the Norwegian Sequencing Center (NSC) for RNA sequencing our APC samples. This study was financed by the Research Council of Norway (214280/F20) and the Norwegian Diabetes Association.	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Adamopoulou E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3039; Alvarez I, 2015, J AUTOIMMUN, V60, P12, DOI 10.1016/j.jaut.2015.03.004; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cepeda S, 2018, CELL REP, V22, P1276, DOI 10.1016/j.celrep.2018.01.015; Chen H, 2011, CIRCULATION, V124; Chen Y., 2015, EDGER DIFFERENTIAL E; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fujihara C, 2014, J IMMUNOL, V193, P5534, DOI 10.4049/jimmunol.1401655; Gabrielsen IS, 2016, HUMAN MOL GENETICS; Gabrielsen IS, 2016, GENES IMMUN, DOI [10.1016/j.jim.2012.07.023, DOI 10.1016/J.JIM.2012.07.023]; Gies V, 2017, J ALLERGY CLIN IMMUN, V139, P1049, DOI 10.1016/j.jaci.2016.09.044; Ginestet C, 2011, J R STAT SOC A STAT, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x; Gurka S, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.21; Hadeiba H, 2012, IMMUNITY, V36, P438, DOI 10.1016/j.immuni.2012.01.017; Hanahan D, 1998, CURR OPIN IMMUNOL, V10, P656, DOI 10.1016/S0952-7915(98)80085-X; Heath VL, 1998, J AUTOIMMUN, V11, P309, DOI 10.1006/jaut.1998.0210; Klein L, 1998, J EXP MED, V188, P5, DOI 10.1084/jem.188.1.5; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Kojima K, 1997, INT IMMUNOL, V9, P897, DOI 10.1093/intimm/9.6.897; Li JC, 2009, J EXP MED, V206, P607, DOI 10.1084/jem.20082232; Liao Y, 2013, BIOINFORMATICS; Liu YW, 2014, BIOINFORMATICS, V30, P301, DOI 10.1093/bioinformatics/btt688; Moore Amanda J, 2013, Adv Hematol, V2013, P949513, DOI 10.1155/2013/949513; Perera J, 2013, P NATL ACAD SCI USA, V110, P17011, DOI 10.1073/pnas.1313001110; Perry JSA, 2018, IMMUNITY, V48, P1271, DOI 10.1016/j.immuni.2018.05.011; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROUSE RV, 1988, J HISTOCHEM CYTOCHEM, V36, P1511, DOI 10.1177/36.12.2461413; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Schwanhausser B, 2013, NATURE, V495, P126, DOI 10.1038/nature11848; Seach N, 2012, J IMMUNOL METHODS, V385, P23, DOI 10.1016/j.jim.2012.07.023; Sospedra M, 1998, J IMMUNOL, V161, P5918; St-Pierre C, 2015, J IMMUNOL, V195, P498, DOI 10.4049/jimmunol.1500558; Stoeckle C, 2013, JOVE-J VIS EXP, DOI 10.3791/50951; Takaba H, 2015, CELL, V163, P975, DOI 10.1016/j.cell.2015.10.013; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006; Vremec D, 2010, METHODS MOL BIOL, V595, P205, DOI 10.1007/978-1-60761-421-0_14; Yamano T, 2015, IMMUNITY, V42, P1048, DOI 10.1016/j.immuni.2015.05.013; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773	47	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0218858	10.1371/journal.pone.0218858	http://dx.doi.org/10.1371/journal.pone.0218858			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31261375	Green Published, gold, Green Submitted			2022-12-26	WOS:000484918700024
J	Conseil, G; Arama-Chayoth, M; Tsfadia, Y; Cole, SPC				Conseil, Gwenaelle; Arama-Chayoth, May; Tsfadia, Yossi; Cole, Susan P. C.			Structure-guided probing of the leukotriene C-4 binding site in human multidrug resistance protein 1 (MRP1; ABCC1)	FASEB JOURNAL			English	Article						ABC transporter; homology modeling; structure-function; bipartite binding site	ORGANIC ANION TRANSPORTER; AMINO-ACID-RESIDUES; ALTERS SUBSTRATE-SPECIFICITY; DRUG-RESISTANCE; ATP-BINDING; PHARMACOLOGICAL CHARACTERIZATION; TRANSMEMBRANE HELICES; FUNCTIONAL IMPORTANCE; POLYMORPHIC VARIANTS; MUTATIONAL ANALYSIS	The human multidrug resistance protein 1 (hMRP1) transporter is implicated in cancer multidrug resistance as well as immune responses involving its physiologic substrate, glutathione (GSH)-conjugated leukotriene C-4 (LTC4). LTC4 binds a bipartite site on hMRP1, which a recent cryoelectron microscopy structure of LTC4-bound bovine Mrp1 depicts as composed of a positively charged pocket and a hydrophobic (H) pocket that binds the GSH moiety and surrounds the fatty acid moiety, respectively, of LTC4. Here, we show that single Ala and Leu substitutions of H-pocket hMRP1-Met(1093) have no effect on LTC4 binding or transport. Estrone 3-sulfate transport is also unaffected, but both hMRP1-Met(1093) mutations eliminate estradiol glucuronide transport, demonstrating that these steroid conjugates have binding sites distinct from each other and from LTC4. To eliminate LTC4 transport by hMRP1, mutation of 3 H-pocket residues was required (W553/M1093/W1246A), indicating that H-pocket amino acids are key to the vastly different affinities of hMRP1 for LTC4 vs. GSH alone. Unlike organic anion transport, hMRP1-mediated drug resistance was more diminished by Ala than Leu substitution of Met(1093). Although our findings generally support a structure in which H-pocket residues bind the lipid tail of LTC4, their critical and differential role in the transport of conjugated estrogens and anticancer drugs remains unexplained.-Conseil, G., Arama-Chayoth, M., Tsfadia, Y., Cole, S. P. C. Structure-guided probing of the leukotriene C-4 binding site in human multidrug resistance protein 1 (MRP1; ABCC1).	[Conseil, Gwenaelle; Cole, Susan P. C.] Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Dept Pathol & Mol Med, 10 Stuart St, Kingston, ON K7L 3N6, Canada; [Arama-Chayoth, May; Tsfadia, Yossi] Tel Aviv Univ, Dept Biochem & Mol Biol, Tel Aviv, Israel	McMaster University; Queens University - Canada; Tel Aviv University	Cole, SPC (corresponding author), Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Dept Pathol & Mol Med, 10 Stuart St, Kingston, ON K7L 3N6, Canada.	spc.cole@queensu.ca	Cole, Susan/I-6389-2017	Cole, Susan/0000-0001-6571-6884	Canadian Institutes for Health Research [133584]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Dr. Richard Callaghan (Australia National University, Canberra, ACT, Australia) for advice on sulforhodamine B assays, and Robyn Millott (Cole Laboratory, Queen's University) for establishing some of the stable FlpIN293 cell lines. This work was supported by Grant 133584 from the Canadian Institutes for Health Research. The authors declare no conflicts of interest.	Banerjee M, 2016, BIOCHEM PHARMACOL, V120, P72, DOI 10.1016/j.bcp.2016.09.016; Bao XY, 2005, J BIOL CHEM, V280, P8647, DOI 10.1074/jbc.M413536200; Blokzijl H, 2008, J BIOL CHEM, V283, P35630, DOI 10.1074/jbc.M804374200; Budulac SE, 2012, EUR J PHARMACOL, V696, P136, DOI 10.1016/j.ejphar.2012.08.015; Campbell JD, 2004, J BIOL CHEM, V279, P463, DOI 10.1074/jbc.M310711200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole SPC, 2014, J BIOL CHEM, V289, P30880, DOI 10.1074/jbc.R114.609248; Cole SPC, 2014, ANNU REV PHARMACOL, V54, P95, DOI 10.1146/annurev-pharmtox-011613-135959; Conseil G, 2009, MOL PHARMACOL, V75, P397, DOI 10.1124/mol.108.052860; Conseil G, 2013, DRUG METAB DISPOS, V41, P2187, DOI 10.1124/dmd.113.054213; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; DeGorter MK, 2008, BIOCHEM BIOPH RES CO, V365, P29, DOI 10.1016/j.bbrc.2007.10.141; Esser L, 2017, J BIOL CHEM, V292, P446, DOI 10.1074/jbc.M116.755884; Gordillo GM, 2016, J BIOL CHEM, V291, P10089, DOI 10.1074/jbc.M115.688879; Grant CE, 2008, DRUG METAB DISPOS, V36, P2571, DOI 10.1124/dmd.108.022491; Haimeur A, 2004, MOL PHARMACOL, V65, P1375, DOI 10.1124/mol.65.6.1375; Haimeur A, 2002, J BIOL CHEM, V277, P41326, DOI 10.1074/jbc.M206228200; HEISTERKAMP N, 1991, P NATL ACAD SCI USA, V88, P6303, DOI 10.1073/pnas.88.14.6303; Hipfner DR, 1996, CANCER RES, V56, P3307; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Ito K, 2001, J BIOL CHEM, V276, P38108; Jedlitschky G, 1996, CANCER RES, V56, P988; Jehle J, 2017, ARCH MED SCI, V13, P930, DOI 10.5114/aoms.2017.68239; Johnson ZL, 2018, CELL, V172, P81, DOI 10.1016/j.cell.2017.12.005; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Koike K, 2004, J BIOL CHEM, V279, P12325, DOI 10.1074/jbc.M311435200; Koike K, 2002, J BIOL CHEM, V277, P49495, DOI 10.1074/jbc.M206896200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee KPK, 2017, ELIFE, V6, DOI 10.7554/eLife.32481; LEIER I, 1994, J BIOL CHEM, V269, P27807; Li MS, 2018, J BIOL CHEM, V293, P5649, DOI 10.1074/jbc.RA117.001373; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Loe DW, 1996, J BIOL CHEM, V271, P9683, DOI 10.1074/jbc.271.16.9683; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Maeno K, 2009, DRUG METAB DISPOS, V37, P1411, DOI 10.1124/dmd.109.026633; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.31054; Neuser J, 2016, J DIABETES COMPLICAT, V30, P623, DOI 10.1016/j.jdiacomp.2016.02.002; Nunoya K, 2003, DRUG METAB DISPOS, V31, P1016, DOI 10.1124/dmd.31.8.1016; Oleschuk CJ, 2003, AM J PHYSIOL-GASTR L, V284, pG280, DOI 10.1152/ajpgi.00331.2002; Petrova SS, 1997, HIST MATH, V24, P361, DOI 10.1006/hmat.1996.2146; Robey RW, 2018, NAT REV CANCER, V18, P452, DOI 10.1038/s41568-018-0005-8; Salerno M, 2001, EUR J PHARMACOL, V421, P1, DOI 10.1016/S0014-2999(01)00992-X; Shukalek CB, 2016, MOL PHARMACOL, V90, P127, DOI 10.1124/mol.116.103648; Situ D, 2004, J BIOL CHEM, V279, P38871, DOI 10.1074/jbc.M403832200; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Stride BD, 1997, MOL PHARMACOL, V52, P344, DOI 10.1124/mol.52.3.344; Tabas LB, 2002, ANAL BIOCHEM, V310, P61, DOI 10.1016/S0003-2697(02)00282-8; Taguchi Y, 2002, FEBS LETT, V521, P211, DOI 10.1016/S0014-5793(02)02816-8; Taylor NMI, 2017, NATURE, V546, P504, DOI 10.1038/nature22345; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Weigl KE, 2018, MOL PHARMACOL, V94, P1069, DOI 10.1124/mol.118.112615; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; Wu P, 2005, MOL PHARMACOL, V68, P1455, DOI 10.1124/mol.105.016576; Zelcer N, 2001, J BIOL CHEM, V276, P46400, DOI 10.1074/jbc.M107041200; Zhang DW, 2006, DRUG METAB DISPOS, V34, P539, DOI 10.1124/dmd.105.007740; Zhang DW, 2003, J BIOL CHEM, V278, P46052, DOI 10.1074/jbc.M308403200; Zhang DW, 2002, J BIOL CHEM, V277, P20934, DOI 10.1074/jbc.M201311200; Zhang DW, 2001, J BIOL CHEM, V276, P34966, DOI 10.1074/jbc.M105063200	61	13	13	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10692	10704		10.1096/fj.201900140R	http://dx.doi.org/10.1096/fj.201900140R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31268744	Bronze			2022-12-26	WOS:000489166300010
J	Sengupta, R; Coppo, L; Mishra, P; Holmgren, A				Sengupta, Rajib; Coppo, Lucia; Mishra, Pradeep; Holmgren, Arne			Glutathione-glutaredoxin is an efficient electron donor system for mammalian p53R2-R1-dependent ribonucleotide reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						thioredoxin; ribonucleotide reductase; DNA replication; DNA repair; enzyme kinetics; antioxidant system; cell cycle; deoxyribonucleotide; glutaredoxin; Glutathione	ESCHERICHIA-COLI; ALLOSTERIC REGULATION; RECOMBINANT MOUSE; DNA-DAMAGE; THIOREDOXIN; MITOCHONDRIAL; SUBUNIT; DEOXYRIBONUCLEOTIDES; PURIFICATION; RESIDUES	Deoxyribonucleotides are DNA building blocks and are produced de novo by reduction of ribose to deoxyribose. This reduction is catalyzed by ribonucleotide reductase (RNR), a heterodimeric tetramer enzyme in mammalian cells, having one of two free radical-containing subunits called R2 and p53R2. R2 is S-phase specific and used for DNA replication, whereas p53R2 functions in DNA repair and mitochondrial DNA synthesis. The larger RNR subunit, R1, has catalytically active cysteine thiols in its buried active site and a C-terminal swinging arm, with a Cys-Leu-Met-Cys sequence suggested to act as a shuttle dithiol/disulfide for electron transport. After each catalytic cycle the active site contains a disulfide, which has to be reduced for turnover. Thioredoxin (Trx) and glutaredoxin (Grx) systems have been implicated as electron donors for the RNR disulfide reduction via the swinging arm. Using mouse R1-R2 and R1-p53R2 complexes, we found here that the catalytic efficiency of the GSH-Grx system is 4-6 times higher than that of the Trx1 system. For both complexes, the V-max values for Grx are strongly depended on GSH concentrations. The GSH disulfide resulting from the Grx reaction was reduced by NADPH and GSH reductase and this enzyme was essential because reaction with GSH alone yielded only little activity. These results indicate that C-terminal shuttle dithiols of mammalian R1 have a crucial catalytic role and that the GSH-Grx system favors the R1-p53R2 enzyme for DNA replication in hypoxic conditions, mitochondrial DNA synthesis, and in DNA repair outside the S-phase.	[Sengupta, Rajib; Coppo, Lucia; Mishra, Pradeep; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden	Karolinska Institutet	Holmgren, A (corresponding author), Karolinska Inst, SE-17177 Stockholm, Sweden.	arne.holmgren@ki.se	SENGUPTA, RAJIB/AGY-3587-2022	SENGUPTA, RAJIB/0000-0002-9665-8784; Holmgren, Arne/0000-0001-5046-1815; COPPO, LUCIA/0000-0001-6902-6346	Swedish Cancer Society [961]; Swedish Research Council Medicine Grant [13X-3529]; K& A Wallenberg Foundation; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council Medicine Grant; K& A Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet(Karolinska Institutet)	This work was supported by Swedish Cancer Society Grant 961, Swedish Research Council Medicine Grant 13X-3529, the K& A Wallenberg Foundation, and grants from Karolinska Institutet. The authors declare that they have no conflicts of interest with the contents of this article.	ABERG A, 1989, J BIOL CHEM, V264, P12249; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Bucurenci N, 1996, J BIOL CHEM, V271, P2856, DOI 10.1074/jbc.271.5.2856; Coppo L, 2016, ANAL BIOCHEM, V499, P24, DOI 10.1016/j.ab.2016.01.012; DAVIS R, 1994, J BIOL CHEM, V269, P23171; DETHLEFSEN LA, 1988, RADIAT RES, V114, P215, DOI 10.2307/3577219; Du YT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392225; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Foskolou IP, 2017, MOL CELL, V66, P206, DOI 10.1016/j.molcel.2017.03.005; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; Holmgren A, 2010, FREE RADICAL BIO MED, V49, P1617, DOI 10.1016/j.freeradbiomed.2010.09.005; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Johansson C, 2011, BIOCHEM J, V433, P303, DOI 10.1042/BJ20101286; Kashlan OB, 2002, BIOCHEMISTRY-US, V41, P462, DOI 10.1021/bi011653a; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; LIN ANI, 1987, BIOCHEMISTRY-US, V26, P6905, DOI 10.1021/bi00396a006; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Mandal PK, 2010, CANCER RES, V70, P9505, DOI 10.1158/0008-5472.CAN-10-1509; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; Markovic J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006413; Montano SJ, 2014, ANAL BIOCHEM, V449, P139, DOI 10.1016/j.ab.2013.12.025; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; Prigge JR, 2017, CELL REP, V19, P2771, DOI 10.1016/j.celrep.2017.06.019; REN XL, 1993, BIOCHEMISTRY-US, V32, P9701, DOI 10.1021/bi00088a023; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Rollins MF, 2010, J CELL SCI, V123, P2402, DOI 10.1242/jcs.068106; Sengupta Rajib, 2014, World J Biol Chem, V5, P68, DOI 10.4331/wjbc.v5.i1.68; Stubbe J, 2000, CURR OPIN STRUC BIOL, V10, P731, DOI 10.1016/S0959-440X(00)00153-6; SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; Thelander L, 2007, NAT GENET, V39, P703, DOI 10.1038/ng0607-703; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; Yang F, 2018, J PROTEOME RES, V17, P1091, DOI 10.1021/acs.jproteome.7b00761; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P2217, DOI 10.1073/pnas.0611095104	45	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12708	12716		10.1074/jbc.RA119.008752	http://dx.doi.org/10.1074/jbc.RA119.008752			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31266802	Green Published, hybrid			2022-12-26	WOS:000484414600013
J	Gad, HA; Ayoub, IM; Wink, M				Gad, Haidy A.; Ayoub, Iriny M.; Wink, Michael			Phytochemical profiling and seasonal variation of essential oils of three Callistemon species cultivated in Egypt	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; ANTIINFLAMMATORY ACTIVITY; CITRINUS LEAVES; ANTIFUNGAL; EXTRACTS; RIGIDUS	The genus Callistemon comprises evergreen shrubs or small trees, widely cultivated as ornamentals and for essential oil production. Callistemon is well-recognized in folk medicine for its anti-cough, anti-bronchitis, and insecticidal activities. In the current study, we profiled the essential oil composition of the leaves of C. citrinus, C. rigidus and C. viminalis (Myrtaceae) collected during different seasons by GLC-MS coupled to multivariate data analysis. Antioxidant, anti-inflammatory and anti-proliferative activities of Callistemon essential oils were evaluated. A total of 29 compounds were tentatively identified. Oxygenated monoterpenes dominated in essential oils, where eucalyptol represented the major constituent in the three Callistemon species in all seasons. Multivariate data analysis including Principal Component Analysis (PCA) and Hierarchical Cluster Analysis (HCA) were applied to discriminate between different Callistemon species in each season and to investigate any correlation between the metabolic profile of each species within different seasons. As expected, PCA plot could discriminate the three Callistemon species in the four seasons. The dendrogram from HCA confirmed the results of PCA as it showed the same segregation pattern regarding the discrimination of different Callistemon species. C. viminalis showed more pronounced antioxidant activity than C. citrinus, exhibiting IC50 values of 1.40 mg/mL and 1.77 mg/mL, respectively. Meanwhile, C. rigidus showed very weak antioxidant activity. All oils showed membrane stabilization activity in hypotonic solution induced haemolysis assay, where C. viminalis showed potent membrane stabilizing activity exhibiting IC50 value of 25.6 pg/mL comparable to that of the standard drug, indomethacin (17.02 mu g/mL). Nevertheless, Callistemon essential oils were not cytotoxic in HCT-116 and Hela human cancer cell lines.	[Gad, Haidy A.; Ayoub, Iriny M.] Ain Shams Univ, Pharmacognosy Dept, Fac Pharm, Cairo, Egypt; [Wink, Michael] Heidelberg Univ, INF, Inst Pharm & Mol Biotechnol, Heidelberg, Germany	Egyptian Knowledge Bank (EKB); Ain Shams University; Ruprecht Karls University Heidelberg	Wink, M (corresponding author), Heidelberg Univ, INF, Inst Pharm & Mol Biotechnol, Heidelberg, Germany.	wink@uni-heidelberg.de	Ayoub, Iriny/AAH-3014-2019; Wink, Michael/E-3803-2012	Ayoub, Iriny/0000-0003-2382-8241; Wink, Michael/0000-0002-7875-4510	Science and Technology Development Fund in Egypt (STDF) [25448]	Science and Technology Development Fund in Egypt (STDF)(Science and Technology Development Fund (STDF))	Iriny M. Ayoub is thankful to the Science and Technology Development Fund in Egypt (STDF, project ID 25448) for funding her postdoctoral fellowship in Germany.	Abdelhady MI, 2012, FREE RADIC ANTIOXIDA, V2, P37; Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Ahmad K, 2017, NAT PROD J, V7, P166, DOI 10.2174/2210315507666161216100323; Ahmed F, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1239-1; Ashour ML, 2009, J PHARM PHARMACOL, V61, P1079, DOI [10.1211/jpp/61.08.0012, 10.1211/jpp.61.08.0012]; Ayoub IM, 2015, Z NATURFORSCH C, V70, P217, DOI 10.1515/znc-2015-0164; Brereton R., 1990, CHEMOMETRICS APPL MA; Brereton R.G., 2007, APPL CHEMOMETRICS SC; Brophy J. J., 1998, Journal of Essential Oil Research, V10, P595; Carson CF, 2006, CLIN MICROBIOL REV, V19, P50, DOI 10.1128/CMR.19.1.50-62.2006; Chane-Ming J., 1998, Journal of Essential Oil Research, V10, P429; Sa RDDE, 2013, MOLECULES, V18, P1227, DOI 10.3390/molecules18011227; Dhifi Wissal, 2016, Medicines (Basel), V3, DOI 10.3390/medicines3040025; Elkady WM, 2018, IND CROP PROD, V118, P188, DOI 10.1016/j.indcrop.2018.03.051; Gad HA, 2013, PHYTOCHEM ANALYSIS, V24, P1, DOI 10.1002/pca.2378; Goyal Praveen Kumar, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS1906; Jazet PM, 2009, J MED PLANTS RES, V3, P9; Ji T, 2009, Traditional Chinese medicine pills for treating hemorrhoid, Patent No. [CN 101352524 A, 101352524]; Kumar D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133823; Lumely P, 1991, CALLISTEMON FLORA NE, P168; Oliveira C. M. de, 2015, American Journal of Plant Sciences, V6, P2664, DOI 10.4236/ajps.2015.616268; Oyedeji OO, 2009, MOLECULES, V14, P1990, DOI 10.3390/molecules14061990; Pierre DYS, 2014, J VECTOR DIS, V51, P216; Russo R, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/397821; Salem MZM, 2017, ASIAN PAC J TROP MED, V10, P219, DOI 10.1016/j.apjtm.2017.03.015; Sharma RK, 2006, FLAVOUR FRAG J, V21, P239, DOI 10.1002/ffj.1564; Shinde UA, 1999, FITOTERAPIA, V70, P251, DOI 10.1016/S0367-326X(99)00030-1; Shukla R, 2012, FOOD CONTROL, V25, P27, DOI 10.1016/j.foodcont.2011.10.010; Silva CJ, 2010, QUIM NOVA, V33, P104, DOI 10.1590/S0100-40422010000100019; Srivastava SK, 2001, J ESSENT OIL RES, V13, P359, DOI 10.1080/10412905.2001.9712233; Sudhakar M., 2004, East and Central African Journal of Pharmaceutical Sciences, V7, P10; YEN GC, 1994, J AGR FOOD CHEM, V42, P629, DOI 10.1021/jf00039a005; Zandi-Sohani N, 2012, J ESSENT OIL BEAR PL, V15, P703, DOI 10.1080/0972060X.2012.10644109; Zubair M, 2013, SCI WORLD J, DOI 10.1155/2013/489071	34	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219571	10.1371/journal.pone.0219571	http://dx.doi.org/10.1371/journal.pone.0219571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295290	Green Published, gold			2022-12-26	WOS:000484951800047
J	Kugler, A; Dong, HL				Kugler, Alex; Dong, Hailiang			Phyllosilicates as protective habitats of filamentous cyanobacteria Leptolyngbya against ultraviolet radiation	PLOS ONE			English	Article							FATTY-ACIDS; UV-B; PHYSIOLOGICAL-RESPONSES; OXIDATIVE STRESS; MARS; DESERT; LIGHT; DAMAGE; GROWTH; REPAIR	Phototrophic cyanobacteria are limited in growth locations by their need for visible light and must also cope with intermittent ultraviolet radiation (UVR), especially in extreme environments such as deserts and on early Earth. One survival method for cyanobacteria is growing endolithically within minerals such as micas, gypsum, and quartz minerals. However, the capability of different mica minerals to protect cyanobacteria from UVR, while at the same time allowing transmission of photosynthetically active radiation (PAR), has only been minimally examined. In this study, we performed laboratory incubation experiments to demonstrate that a model filamentous cyanobacterium, Leptolyngbya sp., can colonize micas, such as muscovite, phlogopite, and biotite. After inoculation experiments confirmed that these cyanobacteria grew between the sheets of mica, Leptolyngbya sp. colonies were exposed to UVB and UVC for up to 24 hrs, and the level of survival was determined using chlorophyll a and carotenoid assays. Of the three micas investigated, muscovite, being an Fe-poor and Al-rich mica, provided the least attenuation of UVR, however it transmitted the most visible light. Fe-rich biotite provided the best UVR shielding. Phlogopite, apparently because of its intermediate amount of Fe, showed the greatest ability to shield UVR while still transmitting an adequate amount of visible light, making it the ideal habitat for the cyanobacterium. Upon exposure to UVR, significant shifts in several important fatty acids of the cyanobacterium were detected such as linolenic acid and oleic acid, 18:3w3 and 18:1w9c, respectively. These cellular changes are interpreted to be a consequence of UVR and other accessory stress (such as O-3).	[Kugler, Alex; Dong, Hailiang] Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA; [Dong, Hailiang] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing, Peoples R China	University System of Ohio; Miami University; China University of Geosciences	Dong, HL (corresponding author), Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA.; Dong, HL (corresponding author), China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing, Peoples R China.	dongh@miamioh.edu		Kugler, Alex/0000-0003-4504-3488				AGRAWAL R, 1996, BIOTRONICS, P25; AGUSTI S, 1992, LIMNOL OCEANOGR, V37, P434, DOI 10.4319/lo.1992.37.2.0434; Albertano P, 2000, MICRON, V31, P27, DOI 10.1016/S0968-4328(99)00063-3; Amonette JE, 1998, CLAY CLAY MINER, V46, P51, DOI 10.1346/CCMN.1998.0460106; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Bahl J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1167; Ballottari M, 2013, J PHYS CHEM B, V117, P11337, DOI 10.1021/jp402977y; BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; Billi D., 2013, ADV MICROBIOL, V3, P80, DOI DOI 10.4236/AIM.2013.36A010; BJORKUM PA, 1988, J SEDIMENT PETROL, V58, P506; Bonaccorsi R, 2010, PHILOS MAG, V90, P2309, DOI 10.1080/14786435.2010.486374; Bridges JC, 2006, J GEOL SOC LONDON, V163, P229, DOI 10.1144/0016-764904-501; Bridges JC, 1998, METEORIT PLANET SCI, V33, pA23; Cavalier-Smith T, 2006, PHILOS T R SOC B, V361, P969, DOI 10.1098/rstb.2006.1842; Cheloni G, 2018, ENVIRONMENTS, V5, DOI 10.3390/environments5070081; Chintalapati S, 2004, CELL MOL BIOL, V50, P631; Cockell CS, 2008, J PHOTOCH PHOTOBIO B, V90, P79, DOI 10.1016/j.jphotobiol.2007.11.009; Conconi A, 1996, NATURE, V383, P826, DOI 10.1038/383826a0; Cordeiro RS, 2017, AN ACAD BRAS CIENC, V89, P2021, DOI 10.1590/0001-3765201720150707; Couradeau E, 2017, BIOGEOSCIENCES, V14, P311, DOI 10.5194/bg-14-311-2017; de la Torre R, 2010, ICARUS, V208, P735, DOI 10.1016/j.icarus.2010.03.010; De Los Rios A, 2014, ANTARCT SCI, V26, P459, DOI 10.1017/S0954102014000194; de Vera JP, 2010, ASTROBIOLOGY, V10, P215, DOI 10.1089/ast.2009.0362; Dong HL, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000385; Edge R, 1997, J PHOTOCH PHOTOBIO B, V41, P189, DOI 10.1016/S1011-1344(97)00092-4; Essene EJ, 1995, CLAY CLAY MINER, V43, P540, DOI 10.1346/CCMN.1995.0430504; FRANKEL EN, 1984, J AM OIL CHEM SOC, V61, P1908, DOI 10.1007/BF02540830; FRIEDMANN EI, 1982, SCIENCE, V215, P1045, DOI 10.1126/science.215.4536.1045; Gan F, 2014, SCIENCE, V345, P1312, DOI 10.1126/science.1256963; Gao Y, 2009, Z NATURFORSCH C, V64, P117; GARCIAPICHEL F, 1991, J PHYCOL, V27, P395, DOI 10.1111/j.0022-3646.1991.00395.x; Gauger T, 2015, GEOLOGY, V43, P1067, DOI 10.1130/G37095.1; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; GOLUBIC S, 1981, J SEDIMENT PETROL, V51, P475; GRIFFIN PS, 1991, INT BIODETERIOR, V28, P187, DOI 10.1016/0265-3036(91)90042-P; Halldal P., 1970, PHOTOBIOLOGY MICROOR, Vx; Hazen RM, 2008, AM MINERAL, V93, P1693, DOI 10.2138/am.2008.2955; He YY, 2002, PHOTOCH PHOTOBIO SCI, V1, P729, DOI 10.1039/b110365m; He YY, 2002, J PHOTOCH PHOTOBIO B, V66, P115, DOI 10.1016/S1011-1344(02)00231-2; Herrera A, 2009, ASTROBIOLOGY, V9, P369, DOI 10.1089/ast.2008.0278; Iliev I, 2011, Z NATURFORSCH C, V66, P267, DOI 10.5560/ZNC.2011.66c0267; Jain S, 2017, J BASIC MICROB, V57, P715, DOI 10.1002/jobm.201700044; Jeong GY, 2014, ATMOS CHEM PHYS, V14, P505, DOI 10.5194/acp-14-505-2014; JOHNSON FS, 1965, SCIENCE, V150, P1445, DOI 10.1126/science.150.3702.1445; Kannaujiya VK, 2015, PROTOPLASMA, V252, P1551, DOI 10.1007/s00709-015-0786-5; Kapitulcinova D, 2008, MINERAL MAG, V72, P71, DOI 10.1180/minmag.2008.072.1.71; Kapitulcinova D, 2015, GEOMICROBIOL J, V32, P530, DOI 10.1080/01490451.2014.973124; KIPENOLT JA, 1978, J BACTERIOL, V135, P286, DOI 10.1128/JB.135.1.286-288.1978; Kumar A, 2004, BIOCHEM BIOPH RES CO, V318, P1025, DOI 10.1016/j.bbrc.2004.04.129; Laity J., 2008, DESERTDESERT ENV, Vxiii; Lao KQ, 1996, P NATL ACAD SCI USA, V93, P5258, DOI 10.1073/pnas.93.11.5258; LEVINE E, 1987, J BACTERIOL, V169, P3988, DOI 10.1128/jb.169.9.3988-3993.1987; Li ZK, 2017, J PHYCOL, V53, P425, DOI 10.1111/jpy.12517; Makhalanyane TP, 2015, FEMS MICROBIOL REV, V39, P203, DOI 10.1093/femsre/fuu011; McKay CP, 2012, ANTARCT SCI, V24, P243, DOI 10.1017/S0954102011000915; Mloszewska AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05520-x; MOLITOR V, 1990, ARCH MICROBIOL, V154, P112, DOI 10.1007/BF00423319; Moraes CC, 2011, BRAZ J CHEM ENG, V28, P45, DOI 10.1590/S0104-66322011000100006; MURATA N, 1992, PLANT CELL PHYSIOL, V33, P933; Myers JA, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-4; OBRIEN PA, 1982, PHOTOCHEM PHOTOBIOL, V35, P359; OLSON JM, 1986, PHOTOSYNTH RES, V9, P251, DOI 10.1007/BF00029748; PFUNDEL EE, 1992, PLANT PHYSIOL, V98, P1372, DOI 10.1104/pp.98.4.1372; Pointing SB, 2012, NAT REV MICROBIOL, V10, P551, DOI 10.1038/nrmicro2831; Rastogi RP, 2010, J IND MICROBIOL BIOT, V37, P537, DOI 10.1007/s10295-010-0718-5; Rastogi RP, 2015, PHOTOCHEM PHOTOBIOL, V91, P837, DOI 10.1111/php.12449; Rastogi RP, 2014, J PHOTOCH PHOTOBIO B, V141, P154, DOI 10.1016/j.jphotobiol.2014.09.020; Rath J, 2007, J APPL PHYCOL, V19, P529, DOI 10.1007/s10811-007-9166-7; Richa, 2015, MICROBIOLOGY+, V84, P398, DOI 10.1134/S0026261715030169; RINGELBERG DB, 1994, FEMS MICROBIOL ECOL, V14, P9, DOI 10.1111/j.1574-6941.1994.tb00085.x; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rubin AE, 2014, METEORIT PLANET SCI, V49, P1057, DOI 10.1111/maps.12315; Sasso S, 2016, INT BIODETER BIODEGR, V107, P102, DOI 10.1016/j.ibiod.2015.11.017; Shen SG, 2018, RSC ADV, V8, P21065, DOI 10.1039/c8ra04024a; Shilpi G, 2014, INT J PHARM PHARM SC, P8; Singh SC, 2002, ACTA PROTOZOOL, V41, P297; Singh SP, 2010, AGEING RES REV, V9, P79, DOI 10.1016/j.arr.2009.05.004; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Smith HD, 2014, INT J ASTROBIOL, V13, P271, DOI 10.1017/S1473550414000056; Smith HL, 2009, J AM CHEM SOC, V131, P3631, DOI 10.1021/ja807680m; Smith ML, 2014, ICARUS, V231, P51, DOI 10.1016/j.icarus.2013.11.031; Stoker CR, 2011, INT J ASTROBIOL, V10, P269, DOI 10.1017/S1473550411000115; Takeuchi N, 2008, ARCT ANTARCT ALP RES, V40, P744, DOI 10.1657/1523-0430(07-094)[TAKEUCHI]2.0.CO;2; Tribollet A, 2002, CORAL REEFS, V21, P424, DOI 10.1007/s00338-002-0267-0; Verseux C, 2016, INT J ASTROBIOL, V15, P65, DOI 10.1017/S147355041500021X; VILES H, 1995, GEOMORPHOLOGY, V13, P21, DOI 10.1016/0169-555X(95)00024-Y; Vincent Warwick F., 1993, Environmental Reviews, V1, P1; Walker JJ, 2007, ANNU REV MICROBIOL, V61, P331, DOI 10.1146/annurev.micro.61.080706.093302; WATSON LL, 1994, SCIENCE, V265, P86, DOI 10.1126/science.265.5168.86; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810; Whitton BA, 2000, ECOLOGY CYANOBACTERI, Vxvii; Wierzchos J, 2012, INT MICROBIOL, V15, P172, DOI 10.2436/20.1501.01.170; Yee N, 2003, CHEM GEOL, V199, P83, DOI 10.1016/S0009-2541(03)00120-7; Yokawa K, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01162; YUAN C, 1961, J BIOL CHEM, V236, P1277; Zavrel T., 2015, BIOPROTOCOL, V5, P1, DOI [10.21769/BioProtoc.1467, DOI 10.21769/BIOPROTOC.1467, DOI 10.21769/BioProtoc.1467]; Zyszka B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177631	99	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219616	10.1371/journal.pone.0219616	http://dx.doi.org/10.1371/journal.pone.0219616			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295311	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800055
J	Megha; Wegener, C; Hasan, G				Megha; Wegener, Christian; Hasan, Gaiti			ER-Ca2+ sensor STIM regulates neuropeptides required for development under nutrient restriction in Drosophila	PLOS ONE			English	Article							OPERATED CALCIUM-ENTRY; CA2+ ENTRY; NEURONS; CELLS; EXPRESSION; CORAZONIN; CIRCUIT; ORAI; TRANSMISSION; HOMEOSTASIS	Neuroendocrine cells communicate via neuropeptides to regulate behaviour and physiology. This study examines how STIM (Stromal Interacting Molecule), an ER-Ca2+ sensor required for Store-operated Ca2+ entry, regulates neuropeptides required for Drosophila development under nutrient restriction (NR). We find two STIM-regulated peptides, Corazonin and short Neuropeptide F, to be required for NR larvae to complete development. Further, a set of secretory DLP (Dorso lateral peptidergic) neurons which co -express both peptides was identified. Partial loss of dSTIM caused peptide accumulation in the DLPs, and reduced systemic Corazonin signalling. Upon NR, larval development correlated with increased peptide levels in the DLPs, which failed to occur when dSTIM was reduced. Comparison of systemic and cellular phenotypes associated with reduced dSTIM, with other cellular perturbations, along with genetic rescue experiments, suggested that dSTIM primarily compromises neuroendocrine function by interfering with neuropeptide release. Under chronic stimulation, dSTIM also appears to regulate neuropeptide synthesis.	[Megha; Hasan, Gaiti] Natl Ctr Biol Sci, Tata Inst Fundamental Res, Bangalore, Karnataka, India; [Wegener, Christian] Bioctr, Theodor Boveri Inst, Dept Neurobiol & Genet, Wurzburg, Germany	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Wurzburg	Megha (corresponding author), Natl Ctr Biol Sci, Tata Inst Fundamental Res, Bangalore, Karnataka, India.	meghaphd@ncbs.res.in	Hasan, Gaiti/P-4107-2019	Hasan, Gaiti/0000-0001-7194-383X; , Megha/0000-0002-2968-8211; Wegener, Christian/0000-0003-4481-3567	Wellcome Trust/ DBT India Alliance [IA/E/12/1/500742]; NCBS	Wellcome Trust/ DBT India Alliance(Wellcome TrustWellcome Trust DBT India Alliance); NCBS	This work was supported by Wellcome Trust/ DBT India Alliance (Early Career Award IA/E/12/1/500742 to M; www.wellcomedbt.org) and NCBS (www.ncbs.res.in) core funding (GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006652; Agrawal N, 2010, J NEUROSCI, V30, P1301, DOI 10.1523/JNEUROSCI.3668-09.2010; Agrawal T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003849; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Brini M, 2014, CELL MOL LIFE SCI, V71, P2787, DOI 10.1007/s00018-013-1550-7; Chakraborty S, 2016, J CELL SCI, V129, P3903, DOI 10.1242/jcs.191585; Chakraborty S, 2012, BIOCHEM SOC T, V40, P279, DOI 10.1042/BST20110618; Chen WF, 2013, INSECT BIOCHEM MOLEC, V43, P809, DOI 10.1016/j.ibmb.2013.06.003; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Choi YJ, 2005, J COMP NEUROL, V482, P372, DOI 10.1002/cne.20419; Dawydow A, 2014, P NATL ACAD SCI USA, V111, P13972, DOI 10.1073/pnas.1408269111; Elphick MR, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.151092; Fosque BF, 2015, SCIENCE, V347, P755, DOI 10.1126/science.1260922; Gopurappilly R, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00178; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hartenstein V, 2006, J ENDOCRINOL, V190, P555, DOI 10.1677/joe.1.06964; Hartmann J, 2014, NEURON, V82, P635, DOI 10.1016/j.neuron.2014.03.027; Jayakumar S, 2018, J NEUROSCI, V38, P10202, DOI 10.1523/JNEUROSCI.1163-18.2018; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; Johnson EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012799; Kapan N, 2012, CELL MOL LIFE SCI, V69, P4051, DOI 10.1007/s00018-012-1097-z; Klose M, 2016, NEURON, V90, P781, DOI 10.1016/j.neuron.2016.04.002; Kubrak OI, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160152; Lalonde J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005242; Lee G, 2008, CELL TISSUE RES, V331, P659, DOI 10.1007/s00441-007-0549-5; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Luo JN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004052; McClure KD, 2013, J NEUROSCI, V33, P4044, DOI 10.1523/JNEUROSCI.3413-12.2013; McNabb SL, 2008, J EXP BIOL, V211, P2263, DOI 10.1242/jeb.015818; Megha, 2017, DEVELOPMENT, V144, P1484, DOI 10.1242/dev.145235; Mishra D, 2013, CURR BIOL, V23, P1466, DOI 10.1016/j.cub.2013.06.028; Miyamoto T, 2014, FLY, V8, P19, DOI 10.4161/fly.27241; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Nassel DR, 2009, INVERTEBR NEUROSCI, V9, P57, DOI 10.1007/s10158-009-0090-1; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; Nguyen N, 2013, BBA-MOL CELL RES, V1833, P1294, DOI 10.1016/j.bbamcr.2013.02.027; Onaka T, 2010, TRENDS ENDOCRIN MET, V21, P287, DOI 10.1016/j.tem.2010.01.005; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Pathak T, 2015, J NEUROSCI, V35, P13784, DOI 10.1523/JNEUROSCI.1680-15.2015; Popugaeva E, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00029; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Putney JW, 2017, BBA-MOL CELL RES, V1864, P900, DOI 10.1016/j.bbamcr.2016.11.028; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Rhea JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000967; Richhariya S, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0455-17.2018; Richhariya S, 2017, SCI REP-UK, V7, DOI 10.1038/srep42586; Secondo A, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00087; Selcho M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15563; Sha K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087062; Shakiryanova D, 2011, P NATL ACAD SCI USA, V108, P4477, DOI 10.1073/pnas.1017837108; Shang YH, 2013, NEURON, V80, P171, DOI 10.1016/j.neuron.2013.07.029; Subramanian M, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-157; Sun SY, 2014, NEURON, V82, P79, DOI 10.1016/j.neuron.2014.02.019; Taghert PH, 2012, NEURON, V76, P82, DOI 10.1016/j.neuron.2012.08.035; Tayler TD, 2012, P NATL ACAD SCI USA, V109, P20697, DOI 10.1073/pnas.1218246109; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Veenstra JA, 2009, INSECT BIOCHEM MOLEC, V39, P755, DOI 10.1016/j.ibmb.2009.09.008; Veenstra JA, 2009, CELL TISSUE RES, V336, P309, DOI 10.1007/s00441-009-0769-y; Venkiteswaran G, 2009, P NATL ACAD SCI USA, V106, P10326, DOI 10.1073/pnas.0902982106; Wang YS, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal1683; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wegener C, 2011, J NEUROCHEM, V118, P581, DOI 10.1111/j.1471-4159.2010.07130.x; Wegener C, 2010, METHODS MOL BIOL, V615, P117, DOI 10.1007/978-1-60761-535-4_9; Wong MY, 2015, MOL BIOL CELL, V26, P2466, DOI 10.1091/mbc.E15-01-0002; Zhou QD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10332	67	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219719	10.1371/journal.pone.0219719	http://dx.doi.org/10.1371/journal.pone.0219719			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295329	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800067
J	Sarkar, S; Rivas-Santiago, CE; Ibironke, OA; Carranza, C; Meng, QY; Osornio-Vargas, A; Zhang, JF; Torres, M; Chow, JC; Watson, JG; Ohman-Strickland, P; Schwander, S				Sarkar, Srijata; Rivas-Santiago, Cesar E.; Ibironke, Olufunmilola A.; Carranza, Claudia; Meng, Qingyu; Osornio-Vargas, Alvaro; Zhang, Junfeng; Torres, Martha; Chow, Judith C.; Watson, John G.; Ohman-Strickland, Pamela; Schwander, Stephan			Season and size of urban particulate matter differentially affect cytotoxicity and human immune responses to Mycobacterium tuberculosis	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBON; AIR-POLLUTION; IN-VITRO; PULMONARY TUBERCULOSIS; BIOMASS FUEL; RISK-FACTOR; AMBIENT; ASSOCIATION; SMOKING; MACROPHAGES	Exposure to air pollution particulate matter (PM) and tuberculosis (TB) are two of the leading global public health challenges affecting low and middle income countries. An estimated 4.26 million premature deaths are attributable to household air pollution and an additional 4.1 million to outdoor air pollution annually. Mycobacterium tuberculosis (M.tb) infects a large proportion of the world's population with the risk for TB development increasing during immunosuppressing conditions. There is strong evidence that such immunosuppressive conditions develop during household air pollution exposure, which increases rates of TB development. Exposure to urban air pollution has been shown to alter the outcome of TB therapy. Here we examined whether in vitro exposure to urban air pollution PM alters human immune responses to M.tb. PM2.5 and PM10 (aerodynamic diameters <2.5 mu m, <10 mu m) were collected monthly from rainy, cold-dry and warm-dry seasons in Iztapalapa, a highly populated TB-endemic municipality of Mexico City with elevated outdoor air pollution levels. We evaluated the effects of seasonality and size of PM on cytotoxicity and antimycobacterial host immunity in human peripheral blood mononuclear cells (PBMC) from interferon gamma (IFN-gamma) release assay (IGRA)+ and IGRA- healthy study subjects. PM10 from cold-dry and warm-dry seasons induced the highest cytotoxicity in PBMC. With the exception of PM2.5 from the cold-dry season, pre-exposure to all seasonal PM reduced M.tb phagocytosis by PBMC. Furthermore, M.tb-induced IFN-gamma production was suppressed in PM2.5 and PM10-pre-exposed PBMC from IGRA+ subjects. This observation coincides with the reduced expression of M.tb-induced T-bet, a transcription factor regulating IFN-gamma expression in T cells. Pre-exposure to PM10 compared to PM2.5 led to greater loss of M.tb growth control. Exposure to PM2.5 and PM10 collected in different seasons differentially impairs M.tb-induced human host immunity, suggesting biological mechanisms underlying altered M.tb infection and TB treatment outcomes during air pollution exposures.	[Sarkar, Srijata; Rivas-Santiago, Cesar E.; Ibironke, Olufunmilola A.; Meng, Qingyu; Schwander, Stephan] Rutgers State Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Piscataway, NJ 08854 USA; [Carranza, Claudia; Torres, Martha] Inst Nacl Enfermedades Resp, Dept Microbiol, Mexico City, DF, Mexico; [Osornio-Vargas, Alvaro] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Zhang, Junfeng] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Zhang, Junfeng] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Chow, Judith C.; Watson, John G.] Desert Res Inst, Div Atmospher Sci, Reno, NV USA; [Ohman-Strickland, Pamela] Rutgers State Univ, Sch Publ Hlth, Dept Biostat, Piscataway, NJ USA; [Schwander, Stephan] Rutgers State Univ, Sch Publ Hlth, Dept Urban Global Publ Hlth, Newark, NJ 07102 USA; [Rivas-Santiago, Cesar E.] Univ Autonomous Zacatecas, Catedras CONACyT, Natl Council Sci & Technol CONACyT, Zacatecas, Mexico	Rutgers State University New Brunswick; University of Alberta; Duke University; Duke University; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick	Schwander, S (corresponding author), Rutgers State Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Piscataway, NJ 08854 USA.; Schwander, S (corresponding author), Rutgers State Univ, Sch Publ Hlth, Dept Urban Global Publ Hlth, Newark, NJ 07102 USA.	schwansk@sph.rutgers.edu	Osornio Vargas, Alvaro Roman/B-4645-2010; Meng, Qingyu/Y-2802-2019; Watson, John G/E-6869-2010; Zhang, Junfeng/AAJ-9183-2020	Osornio Vargas, Alvaro Roman/0000-0001-8287-7102; Watson, John G/0000-0002-1752-6899; Zhang, Junfeng/0000-0003-3759-6672; Torres, Martha/0000-0003-3217-9407; Rivas-Santiago, Cesar/0000-0002-0504-2299; Ibironke, Olufunmilola/0000-0002-0227-0122; Ohman Strickland, Pamela/0000-0001-7877-7125	National Institute of Environmental Health Sciences [R01ES020382, P30 ES005022, 3R01ES020382-05S1]; United States Environmental Protection Agency [FP-91782501-0]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020382, P30ES005022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055145] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); United States Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by: S.S. (last), Grant R01ES020382, National Institute of Environmental Health Sciences, https://www.niehs.nih.gov/; S.S. (last), Grant P30 ES005022, National Institute of Environmental Health Sciences, https://www.niehs.nih.gov/; O.A.I., Grant 3R01ES020382-05S1, National Institute of Environmental Health Sciences, https://www.niehs.nih.gov/; O.A.I., EPA Star Award FP-91782501-0, United States Environmental Protection Agency, https://www.epa.gov/research-fellowships.	Alcaide J, 1996, TUBERCLE LUNG DIS, V77, P112, DOI 10.1016/S0962-8479(96)90024-6; Alfaro-Moreno E, 2002, ENVIRON HEALTH PERSP, V110, P715, DOI 10.1289/ehp.02110715; Alfaro-Moreno E, 2009, ENVIRON RES, V109, P528, DOI 10.1016/j.envres.2009.02.010; Altet-Gomez MN, 2005, INT J TUBERC LUNG D, V9, P430; Blount RJ, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1699; Garcia-Sancho MC, 2009, REV INVEST CLIN, V61, P392; Chen RJ, 2013, SCI TOTAL ENVIRON, V450, P259, DOI 10.1016/j.scitotenv.2013.02.040; Chow J, 2017, ENHANCED ION CHROMAT; Chow J.C., 1999, ELEMENTAL ANAL AIRBO, VVolume 1, P97; den Boon S, 2007, PEDIATRICS, V119, P734, DOI 10.1542/peds.2006-1796; du Preez K, 2011, INT J TUBERC LUNG D, V15, P1490, DOI 10.5588/ijtld.10.0759; Fares A, 2011, J GLOB INFECT DIS, V3, P46, DOI 10.4103/0974-777X.77296; Farraj AK, 2015, PART FIBRE TOXICOL, V12, DOI 10.1186/s12989-015-0087-3; Feng SL, 2016, ECOTOX ENVIRON SAFE, V128, P67, DOI 10.1016/j.ecoenv.2016.01.030; Haque M A, 2016, Mymensingh Med J, V25, P31; Hetland RB, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-4; Ho SSH, 2008, J CHROMATOGR A, V1200, P217, DOI 10.1016/j.chroma.2008.05.056; Huang KS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171365; Jalava PI, 2009, INHAL TOXICOL, V21, P994, DOI 10.1080/08958370802695710; Jassal MS, 2013, PUBLIC HEALTH, V127, P268, DOI 10.1016/j.puhe.2012.12.030; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Kolappan C, 2009, THORAX, V64, P705, DOI 10.1136/thx.2008.109405; Kumar RK, 2015, RESPIROLOGY, V20, P73, DOI 10.1111/resp.12381; Lai TC, 2016, OCCUP ENVIRON MED, V73, P56, DOI 10.1136/oemed-2015-102995; Lakshmi PVM, 2012, J EPIDEMIOL COMMUN H, V66, P457, DOI 10.1136/jech.2010.115840; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lindsay R. P., 2014, PLoS ONE, V9, pe93137, DOI 10.1371/journal.pone.0093137; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Manzano-Leon N, 2016, ENVIRON HEALTH PERSP, V124, P406, DOI 10.1289/ehp.1409287; Mauderly JL, 2009, ENVIRON HEALTH PERSP, V117, P1, DOI 10.1289/ehp.11654; Mirowsky J, 2013, INHAL TOXICOL, V25, P747, DOI 10.3109/08958378.2013.846443; Mishra V K, 1999, Natl Fam Health Surv Bull, P1; Mugica V, 2010, J AIR WASTE MANAGE, V60, P548, DOI 10.3155/1047-3289.60.5.548; Qian ZM, 2010, J AIR WASTE MANAGE, V60, P481, DOI 10.3155/1047-3289.60.4.481; Rivas-Santiago CE, 2015, INFECT IMMUN, V83, P2507, DOI 10.1128/IAI.03018-14; Salonen RO, 2004, SCAND J WORK ENV HEA, V30, P80; Sarkar S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143077; Sarkar S, 2012, J IMMUNOL, V188, P2778, DOI 10.4049/jimmunol.1101380; Secretaria del Medio Ambiente de la Ciudad de Mexico, 2016, CAL AIR CIUD MEX IM; Shoenfelt J, 2009, J LEUKOCYTE BIOL, V86, P303, DOI 10.1189/jlb.1008587; Smith GS, 2014, INT J ENVIRON HEAL R, V24, P103, DOI 10.1080/09603123.2013.800959; Tedijanto C, 2018, EPIDEMIOLOGY, V29, P857, DOI [10.1097/ede.0000000000000877, 10.1097/EDE.0000000000000877]; Torres M, URBAN AIRBORNE PARTI, DOI [10.1139/APNM-2016-0271, DOI 10.1139/APNM-2016-0271]; Watanabe M, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13100983; WHO, FACT SHEET AMB OUTD; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Xu Dongqun, 2008, Wei Sheng Yan Jiu, V37, P423; You SM, 2016, ENVIRON POLLUT, V218, P1170, DOI 10.1016/j.envpol.2016.08.071; Zanobetti A, 2009, ENVIRON HEALTH PERSP, V117, P898, DOI 10.1289/ehp.0800108	49	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219122	10.1371/journal.pone.0219122	http://dx.doi.org/10.1371/journal.pone.0219122			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4LN	31295271	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800015
J	Serrien, DJ; O'Regan, L				Serrien, Deborah J.; O'Regan, Louise			Stability and flexibility in cognitive control: Interindividual dynamics and task context processing	PLOS ONE			English	Article							ATTENTIONAL CAPTURE; FRONTAL-CORTEX; HANDEDNESS; PATTERNS; RECONFIGURATION; CONNECTIVITY; INTERFERENCE; COORDINATION; MODULATION; MECHANISMS	Adaptive behaviour requires cognitive control for shielding current goals from distractors (stability) but at the same time for switching between alternative goals (flexibility). In this behavioural study, we examine the stability-flexibility balance in left- and right-handers during two types of decision-making, instructed (sensory cued) and voluntary (own choice), by means of distractor inhibition and hand/task switching. The data revealed that both groups showed opposite tendencies for instructed decision-making. Moreover, right-handers resisted distracting information more efficiently whereas left-handers showed superior switching abilities. When participants were involved in voluntary decision-making, no effects of handedness were noted, which suggests that free-choice processing alters the balance between stability and flexibility. These data illustrate that handedness is an index of individual variation during instructed decision-making, biasing the proficiency of cognitive control towards stability and flexibility of information processing. These biases can however be overruled by top-down strategies that dominate during voluntary decision-making. Overall, the research underlines the antagonistic functions of stability and flexibility in decision-making, and offers an approach for examining cognitive control and the role of internal and external factors in balancing the stability-flexibility trade-off.	[Serrien, Deborah J.; O'Regan, Louise] Univ Nottingham, Sch Psychol, Nottingham, England	University of Nottingham	Serrien, DJ (corresponding author), Univ Nottingham, Sch Psychol, Nottingham, England.	deborah.serrien@nottingham.ac.uk		serrien, deborah/0000-0002-5987-0567	BIAL foundation [376/14]	BIAL foundation(Bial Foundation)	The work was supported by a research grant from the BIAL foundation to DJS (no. 376/14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann EM, 2004, PSYCHOL SCI, V15, P616, DOI 10.1111/j.0956-7976.2004.00729.x; Annett M, 2002, HANDEDNESS BRAIN ASY; Armbruster-Genc DJN, 2016, J NEUROSCI, V36, P3978, DOI 10.1523/JNEUROSCI.2517-14.2016; Arrington CM, 2004, PSYCHOL SCI, V15, P610, DOI 10.1111/j.0956-7976.2004.00728.x; Bledowski C, 2004, NEUROIMAGE, V22, P530, DOI 10.1016/j.neuroimage.2003.12.034; Boogert NJ, 2018, PHILOS T R SOC B, V373, P1756; Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Burnham BR, 2010, J EXP PSYCHOL HUMAN, V36, P317, DOI 10.1037/a0015871; Capizzi M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00545; Cherbuin N, 2006, NEUROPSYCHOLOGY, V20, P700, DOI 10.1037/0894-4105.20.6.700; COREN S, 1977, SCIENCE, V198, P631, DOI 10.1126/science.335510; Cowell P, 2018, NEUROSCIENCE, V388, P57, DOI 10.1016/j.neuroscience.2018.06.017; de Fockert JW, 2012, BRAIN COGNITION, V80, P367, DOI 10.1016/j.bandc.2012.07.006; Demeter E, 2011, NEUROIMAGE, V54, P1518, DOI 10.1016/j.neuroimage.2010.09.026; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Derrfuss J, 2004, NEUROIMAGE, V23, P604, DOI 10.1016/j.neuroimage.2004.06.007; Dodds CM, 2011, CEREB CORTEX, V21, P1155, DOI 10.1093/cercor/bhq187; Dreher JC, 2002, NEUROIMAGE, V17, P95, DOI 10.1006/nimg.2002.1169; Dreisbach G, 2019, CURR DIR PSYCHOL SCI, V28, P3, DOI 10.1177/0963721418800030; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; Frober K, 2017, COGNITION, V162, P48, DOI 10.1016/j.cognition.2017.01.024; Goschke T, 2014, NEUROPSYCHOLOGIA, V62, P403, DOI 10.1016/j.neuropsychologia.2014.07.015; Goschke T, 2014, INT J METH PSYCH RES, V23, P41, DOI 10.1002/mpr.1410; Hedden T, 2010, NEUROIMAGE, V51, P421, DOI 10.1016/j.neuroimage.2010.01.089; Herve PV, 2005, NEUROIMAGE, V25, P1133, DOI 10.1016/j.neuroimage.2004.12.062; Hommel B, 2007, NEUROSCI BIOBEHAV R, V81, P43; Kang MS, 2014, PSYCHON B REV, V21, P454, DOI 10.3758/s13423-013-0499-8; Kelso JAS, 2002, J EXP PSYCHOL HUMAN, V28, P776, DOI 10.1037//0096-1523.28.4.776; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Kloppel S, 2007, NEUROIMAGE, V34, P274, DOI 10.1016/j.neuroimage.2006.08.038; Koch I, 2018, PSYCHOL BULL, V144, P557, DOI 10.1037/bul0000144; Leonard CJ, 2015, J EXP PSYCHOL HUMAN, V41, P11, DOI 10.1037/xhp0000011; Mayr U, 2006, PSYCHOL SCI, V17, P774, DOI 10.1111/j.1467-9280.2006.01781.x; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; Mittelstadt V, 2018, PSYCHOL RES-PSYCH FO, V82, P78, DOI 10.1007/s00426-017-0911-5; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Monsell S, 2003, MEM COGNITION, V31, P327, DOI 10.3758/BF03194391; O'Regan L, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00380; Park H, 2001, J EXP PSYCHOL HUMAN, V27, P32, DOI 10.1037/0096-1523.27.1.32; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Perelle IB, 2005, BEHAV GENET, V35, P343, DOI 10.1007/s10519-005-3226-z; Perri RL, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00251; Pool EM, 2014, NEUROIMAGE, V99, P451, DOI 10.1016/j.neuroimage.2014.05.048; Reid CS, 2014, NEUROSCIENCE, V270, P20, DOI 10.1016/j.neuroscience.2014.04.005; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rosch RE, 2018, CEREBELLUM, V17, P191, DOI 10.1007/s12311-017-0889-y; Samuelson W, 1988, J RISK UNCERTAINTY, V1, P7, DOI 10.1007/BF00055564; Schmitz J, 2017, PROG NEUROBIOL, V159, P69, DOI 10.1016/j.pneurobio.2017.10.005; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Seibold VC, 2014, ACTA PSYCHOL, V151, P51, DOI 10.1016/j.actpsy.2014.05.012; Serrien DJ, 2016, BRAIN COGNITION, V108, P42, DOI 10.1016/j.bandc.2016.07.005; Serrien DJ, 1999, J EXP PSYCHOL HUMAN, V25, P1253, DOI 10.1037/0096-1523.25.5.1253; Somers M, 2015, NEUROSCI BIOBEHAV R, V51, P48, DOI 10.1016/j.neubiorev.2015.01.003; Wylie G, 2000, PSYCHOL RES-PSYCH FO, V63, P212, DOI 10.1007/s004269900003	55	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219397	10.1371/journal.pone.0219397	http://dx.doi.org/10.1371/journal.pone.0219397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4JZ	31291325	Green Submitted, Green Published, gold			2022-12-26	WOS:000484947800079
J	Wei, X; Liang, WJ				Wei, Xi; Liang, Wenjun			Multifactor relationships between stand structure and soil and water conservation functions of Robinia pseudoacacia L. in the Loess Region	PLOS ONE			English	Article							SPECIES-DIVERSITY; CANOPY STRUCTURE; FOREST; VEGETATION; MANAGEMENT; NUTRIENTS; PATTERNS; REVEALS; EROSION; TRAITS	Ninety-six sample plots were established for a tree census to explore the multifactor relationships between the soil and water conservation functions and the stand structure in a typical black locust (Robinia pseudoacacia L.) plantation in the Caijiachuan watershed of the Loess Plateau, Western Shanxi Province, China. Based on the observational and experimental data, a topography-structure-function model was built using a structural equation modeling (SEM) approach. The latent variables were the topographical factors, horizontal structure, vertical structure, soil and water conservation, and sediment reduction. The results indicated that the horizontal structure of the Robinia pseudoacacia L. forest was the most obvious latent variable, which was expressed in the path coefficient (pc = 0.85) corresponding to the sediment reduction; the stand density and tree competition index were the major drivers of the structure, with path coefficients of -0.96 and -0.92 and influence coefficients of -0.997 and -0.998. These factors are easily regulated. Among these factors the stand density of the arbor layer is recommended to be kept stable within the range from 1600 to 1700 trees/hm(2). These relationships showed that reducing the tree competition index and changing the microtopography could effectively enhance the soil and water conservation functions in this ecologically significant loess area.	[Wei, Xi; Liang, Wenjun] Shanxi Agr Univ, Coll Forestry, Taigu, Peoples R China; [Wei, Xi] CNERN, Ji Cty Stn, Beijing, Peoples R China	Shanxi Agricultural University	Liang, WJ (corresponding author), Shanxi Agr Univ, Coll Forestry, Taigu, Peoples R China.	liangwenjun123@163.com			National Natural Science Foundation of China [31500523]; National Key R&D Program of China [2016YFC0501704]; Shanxi Province Excellent Doctoral Award Fund [SXYBKY2018032]; Fund for Introduced Talents for Shanxi Agricultural University [2014YJ19]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Shanxi Province Excellent Doctoral Award Fund; Fund for Introduced Talents for Shanxi Agricultural University	This research was funded by the National Natural Science Foundation of China (grant no. 31500523), the National Key R&D Program of China (grant no. 2016YFC0501704), the Shanxi Province Excellent Doctoral Award Fund (grant no. SXYBKY2018032), and the Fund for Introduced Talents for Shanxi Agricultural University (grant no. 2014YJ19).	Ahmad B, 2018, LAND DEGRAD DEV, V29, P2998, DOI 10.1002/ldr.3070; Batjes NH, 2014, LAND DEGRAD DEV, V25, P278, DOI 10.1002/ldr.2141; Bollen KA, 1989, STRUCTURAL EQUATIONS; Brzostek ER, 2014, GLOBAL CHANGE BIOL, V20, P2531, DOI 10.1111/gcb.12528; Cao Xiao-yu, 2015, Shengtaixue Zazhi, V34, P589; Capmourteres V, 2016, ECOL INDIC, V71, P258, DOI 10.1016/j.ecolind.2016.07.006; Deng HZ, 2017, CHEMOSPHERE, V182, P617, DOI 10.1016/j.chemosphere.2017.02.156; Eisenhauer N, 2015, PEDOBIOLOGIA, V58, P65, DOI 10.1016/j.pedobi.2015.03.002; ELLSWORTH DS, 1993, OECOLOGIA, V96, P169, DOI 10.1007/BF00317729; Gao T, 2014, FOREST ECOL MANAG, V330, P82, DOI 10.1016/j.foreco.2014.07.007; Grace JB, 2007, ECOL LETT, V10, P680, DOI 10.1111/j.1461-0248.2007.01058.x; Grace James B., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P1, DOI 10.1078/1433-8319-00063; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; Graham RT, 1999, NATURAL RESOURCES; Hacisalihoglu S., 2018, Turkish Journal of Agriculture - Food Science and Technology, V6, P500, DOI 10.24925/turjaf.v6i4.500-507.1857; Hau K.T., 1999, EXPLOR PSYCHOL, V19, P54; Hegyi F., 1974, GROWTH MODELS TREE S, P74, DOI DOI 10.1111/1365-2435.12428; Hui GangYing, 1999, Scientia Silvae Sinicae, V35, P37; Hui Gangying, 1999, Forest Research, V12, P1; Jonsson M, 2010, BIOL LETTERS, V6, P116, DOI 10.1098/rsbl.2009.0613; Jukes MR, 2001, FOREST ECOL MANAG, V148, P271, DOI 10.1016/S0378-1127(00)00530-2; Jû┬reskog KG., 1993, LISREL 8 USERS REFER; Labree W, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0123672, 10.1371/journal.pone.0138822]; Laliberte E, 2012, ECOLOGY, V93, P145, DOI 10.1890/11-0338.1; Lamb EG, 2011, CAN J PLANT SCI, V91, P603, DOI [10.4141/CJPS2010-035, 10.4141/cjps2010-035]; Li S, 2016, SCI TOTAL ENVIRON, V569, P1032, DOI 10.1016/j.scitotenv.2016.06.141; Lucas-Borja ME, 2016, SCI TOTAL ENVIRON, V562, P145, DOI 10.1016/j.scitotenv.2016.03.160; McCune B, 2002, ANAL ECOLOGICAL COMM; Montgomery RA, 2001, ECOLOGY, V82, P2707, DOI 10.1890/0012-9658(2001)082[2707:FSCAAL]2.0.CO;2; Naidu Maradana Tarakeswara, 2016, Journal of Asia-Pacific Biodiversity, V9, P328; Ou ZY, 2015, POL J ENVIRON STUD, V24, P2559; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Quinn G.P., 2002, EXPT DESIGN DATA ANA; Ruiz MA, 2010, PAPEL PSICOL, V31, P34; Santibanez-Andrade G, 2015, ECOL INDIC, V54, P124, DOI 10.1016/j.ecolind.2015.02.022; Saremi H, 2014, TREES-STRUCT FUNCT, V28, P733, DOI 10.1007/s00468-014-0985-2; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Schumacker R.E., 2004, BEGINNERS GUIDE STRU, V2nd ed.; Shen YY, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102168; Shi WY, 2017, AGR FOREST METEOROL, V247, P1, DOI 10.1016/j.agrformet.2017.07.006; Sutton-Grier AE, 2010, ECOL MODEL, V221, P761, DOI 10.1016/j.ecolmodel.2009.11.015; Takahashi K, 2017, PLANT SPEC BIOL, V32, P238, DOI 10.1111/1442-1984.12148; Do TV, 2015, GLOB ECOL CONSERV, V4, P185, DOI 10.1016/j.gecco.2015.06.010; Trivino M, 2017, J APPL ECOL, V54, P61, DOI 10.1111/1365-2664.12790; Valdes A, 2011, J APPL ECOL, V48, P1422, DOI 10.1111/j.1365-2664.2011.02047.x; Valipour A, 2014, FOREST ECOL MANAG, V327, P221, DOI 10.1016/j.foreco.2014.05.004; Venema HD, 2005, EUR J OPER RES, V164, P423, DOI 10.1016/j.ejor.2003.11.011; Wei X, 2018, FORESTS, V9, DOI 10.3390/f9030124; Wu M., 2010, 3 INT I STAT MAN ENG, V2; Yirdaw E, 2015, J FORESTRY RES, V26, P919, DOI 10.1007/s11676-015-0155-4; [王力 Yu Li], 2004, [自然资源学报, Journal of Natural Resources], V19, P263; [张超 Zhang Chao], 2016, [中国水土保持科学, Science of Soil and Water Conservation], V14, P90; Zhang L, 2015, CATENA, V128, P44, DOI 10.1016/j.catena.2015.01.016; Zhou MM, 2017, WATER SCI TECHNOL, V76, P2526, DOI 10.2166/wst.2017.405	54	5	6	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219499	10.1371/journal.pone.0219499	http://dx.doi.org/10.1371/journal.pone.0219499			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291341	Green Submitted, gold, Green Published			2022-12-26	WOS:000484947800098
J	Frasca, D; Diaz, A; Romero, M; Thaller, S; Blomberg, BB				Frasca, Daniela; Diaz, Alain; Romero, Maria; Thaller, Seth; Blomberg, Bonnie B.			Metabolic requirements of human pro-inflammatory B cells in aging and obesity	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; T-BET; PROTEIN-KINASE; ACTIVATION; SENESCENCE; MEMORY; HYPERGLYCEMIA; EXPRESSION; PHENOTYPE; RESPONSES	The subset of pro-inflammatory B cells, called late memory, tissue-like or double negative (DN), accumulates in the blood of elderly individuals. Here we show that DN B cells do not proliferate and do not make antibodies to influenza antigens, but they secrete antibodies with autoimmune reactivity, in agreement with their membrane phenotype (CD95+CD21-CD11c+) and their spontaneous expression of the transcription factor T-bet. These cells also increase in the blood of individuals with obesity and autoimmune diseases, but causative mechanisms and signaling pathways involved are known only in part. In the present paper we compare frequencies and metabolic requirements of these cells in the blood of healthy individuals of different ages and in the blood and the subcutaneous adipose tissue (SAT) of individuals with obesity. Results show that DN B cells from young individuals have minimal metabolic requirements, DN B cells from elderly and obese individuals utilize higher amounts of glucose to perform autoimmune antibody production and enroll in aerobic glycolysis to support their function. DN B cells from the SAT have the highest metabolic requirements as they activate oxidative phosphorylation, aerobic glycolysis and fatty acid oxidation. DN B cells from the SAT also show the highest levels of ROS and the highest levels of phosphorylated AMPK (5'-AMP activated kinase) and Sestrin 1, both able to mitigate stress and cell death. This metabolic advantage drives DN B cell survival and function (secretion of autoimmune antibodies).	[Frasca, Daniela; Diaz, Alain; Romero, Maria; Blomberg, Bonnie B.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Thaller, Seth] Univ Miami, Miller Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Miami, FL 33136 USA; [Blomberg, Bonnie B.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Frasca, D (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.	dfrasca@med.miami.edu	Thaller, Seth/AAO-1801-2020		National Institutes of Health [R56 AG059719, R56 AG32576]; NATIONAL INSTITUTE ON AGING [R56AG059719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by R56 AG059719, National Institutes of Health, to DF; R56 AG32576, National Institutes of Health, to DF/BBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by NIH R56 AG32576 (DF/BBB) and by NIH R56 AG059719 (DF). We thank the nurses and staff of the Family Medicine Department and of the Ambulatory Surgery. We are deeply thankful to all individuals who have agreed to participate in this study.	Adlowitz DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128269; Akkaya M, 2018, NAT IMMUNOL, V19, P871, DOI 10.1038/s41590-018-0156-5; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Bulati M, 2014, EXP GERONTOL, V54, P123, DOI 10.1016/j.exger.2013.12.011; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Chang LY, 2017, J VIRAL HEPATITIS, V24, P389, DOI 10.1111/jvh.12659; Claes N, 2016, J IMMUNOL, V197, P4576, DOI 10.4049/jimmunol.1502448; Colonna-Romano G, 2009, MECH AGEING DEV, V130, P681, DOI 10.1016/j.mad.2009.08.003; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cui JJ, 2018, MOL IMMUNOL, V101, P221, DOI 10.1016/j.molimm.2018.05.028; Eid AA, 2013, MOL CELL BIOL, V33, P3439, DOI 10.1128/MCB.00217-13; Frasca D, 2008, J IMMUNOL, V180, P5283, DOI 10.4049/jimmunol.180.8.5283; Frasca D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197472; Frasca D, 2018, EXP GERONTOL, V107, P55, DOI 10.1016/j.exger.2017.07.002; Frasca D, 2017, CELL IMMUNOL, V321, P68, DOI 10.1016/j.cellimm.2017.04.007; Frasca D, 2016, CRIT REV IMMUNOL, V36, P523, DOI 10.1615/CritRevImmunol.2017020113; Frasca D, 2017, EXP GERONTOL, V87, P113, DOI 10.1016/j.exger.2016.12.001; Frasca D, 2016, OBESITY, V24, P615, DOI 10.1002/oby.21383; Frasca D, 2016, BIOGERONTOLOGY, V17, P7, DOI 10.1007/s10522-015-9578-8; Frasca D, 2014, EXP GERONTOL, V54, P116, DOI 10.1016/j.exger.2014.01.004; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Hardt U, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1530-2; Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Illingworth J, 2013, J IMMUNOL, V190, P1038, DOI 10.4049/jimmunol.1202438; Isaacs JD, 2009, EXPERT OPIN BIOL TH, V9, P1463, DOI 10.1517/14712590903379494; Kim DY, 2012, INT J MOL SCI, V13, P994, DOI 10.3390/ijms13010994; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Lewis ED, 2019, IUBMB LIFE, V71, P487, DOI 10.1002/iub.1976; Lindholm E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002546; Martorana A, 2014, IMMUNOL LETT, V162, P303, DOI 10.1016/j.imlet.2014.06.003; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Muller-Durovic B, 2016, J IMMUNOL, V197, P2891, DOI 10.4049/jimmunol.1600590; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Naradikian MS, 2016, J IMMUNOL, V197, P1023, DOI 10.4049/jimmunol.1600522; Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200; Olivieri F, 2013, AGE, V35, P1157, DOI 10.1007/s11357-012-9440-8; Osler ME, 2008, ENDOCRINOLOGY, V149, P935, DOI 10.1210/en.2007-1441; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Rubtsova K, 2013, P NATL ACAD SCI USA, V110, pE3216, DOI 10.1073/pnas.1312348110; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Saadoun D, 2013, ARTHRITIS RHEUM-US, V65, P1085, DOI 10.1002/art.37828; Sarzi-Puttini P, 2005, LUPUS, V14, P780, DOI 10.1191/0961203305lu2220oa; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Surh YJ, 2010, CANCER PREV RES, V3, P1379, DOI 10.1158/1940-6207.CAPR-10-0251; Wehr C, 2004, CLIN IMMUNOL, V113, P161, DOI 10.1016/j.clim.2004.05.010; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Zamboni M, 2014, MECH AGEING DEV, V136, P129, DOI 10.1016/j.mad.2013.11.008	54	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219545	10.1371/journal.pone.0219545	http://dx.doi.org/10.1371/journal.pone.0219545			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287846	Green Published, gold, Green Submitted			2022-12-26	WOS:000482328300028
J	Hardy, LL; MacNiven, R; Esgin, T; Mihrshahi, S				Hardy, Louise L.; MacNiven, Rona; Esgin, Tuguy; Mihrshahi, Seema			Cross-sectional changes in weight status and weight related behaviors among Australian children and Australian Indigenous children between 2010 and 2015	PLOS ONE			English	Article							BODY-MASS INDEX; TO-HEIGHT RATIO; PHYSICAL-ACTIVITY; OBESITY; ADOLESCENTS; OVERWEIGHT; ADIPOSITY; BREAKFAST; POLICIES; WALKING	Background Since 2006 there has been substantial long-term investment in school-based child obesity prevention programs in New South Wales (Australia). Whether these programs have led to population level improvements in children's weight status and weight-related behaviors are yet to be determined. The purpose of this study was to describe changes in children's weight status and weight-related behaviors, including Indigenous children, who are at greater risk of poorer health outcomes than non-Indigenous children. Methods Representative cross-sectional population surveys conducted in 2010 and 2015 among children age 5-16 years (n = 15,613). Objective measurements included height, weight, waist circumference, cardiorespiratory fitness, and fundamental movement skills. Indigenous status and indicators of weight-related behavior (i.e., diet, physical activity, school travel, screen-time) were measured by questionnaire with parents responding for children age <10 years and self-report by children age >= 10 years. Results The prevalences of overweight/obesity, obesity and abdominal obesity were higher in 2015, than 2010, and higher among Indigenous than non-Indigenous children at both timepoints. There were some small positive changes towards healthier weight-related behaviors between surveys among all children, but many unhealthy weight-related behaviors remain highly prevalent. The magnitude of changes and the 2015 prevalences of weight-related behaviors were generally similar for Indigenous and non-Indigenous children. Conclusions Schools play an important role in health promotion, but our findings suggest the current approaches need re-thinking. Upstream factors that shape weight-related behaviors such as the regulation of the food industry and food environment, urban, neighborhood and public transport planning must be including in solutions to ensure populations can eat healthily and be physical active.	[Hardy, Louise L.; MacNiven, Rona; Mihrshahi, Seema] Univ Sydney, Sydney Sch Publ Hlth, Sydney Med Sch, Prevent Res Collaborat, Sydney, NSW, Australia; [MacNiven, Rona] Univ New South Wales, Sch Publ Hlth & Community Med, Fac Med, Sydney, NSW, Australia; [Esgin, Tuguy] Univ Sydney, Discipline Exercise & Sport Sci, Fac Hlth Sci, Sydney, NSW, Australia; [Esgin, Tuguy] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia	University of Sydney; University of New South Wales Sydney; University of Sydney; Edith Cowan University	Hardy, LL (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney Med Sch, Prevent Res Collaborat, Sydney, NSW, Australia.	louise.hardy@sydney.edu.au	Esgin, tuguy/ABC-6610-2020; Mihrshahi, Seema/AAW-1854-2020; Mihrshahi, Seema/A-9877-2009	Mihrshahi, Seema/0000-0002-2394-5432; Esgin, Tuguy/0000-0003-0277-4950; Macniven, Rona/0000-0002-2967-7977; Mihrshahi, Seema/0000-0001-6567-9884; Hardy, Louise L/0000-0001-8656-6758	NSW Ministry of Health	NSW Ministry of Health	This work was funded by NSW Ministry of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Active Healthy Kids Australia, 2018, MUSC FITN ITS TIM JU; [Anonymous], 1996, ANTHROPOMETRICA TXB; [Anonymous], 2011, NSW SCH PHYS ACTIVIT; [Anonymous], 2009, BUILT KIDS CHILD FRI; [Anonymous], 2013, NSW HLTH EAT ACT LIV; [Anonymous], 2011, EST AB TORR STRAIT I; [Anonymous], 2008, FITNESSGRAM ACTIVITY; Australian Government Department of Health and Ageing, 2007, EV NAT GO 2 5 CAMP 2; Blondin SA, 2016, PEDIATR OBES, V11, P333, DOI 10.1111/ijpo.12082; Booth M L, 1999, J Sci Med Sport, V2, P93; Boylan S, 2017, BMC PUBLIC HEALTH, V17, P1, DOI [10.1186/s12889-016-3954-4, DOI 10.1186/S12889-016-3954-4]; Brambilla P, 2013, INT J OBESITY, V37, P943, DOI 10.1038/ijo.2013.32; Bravo A, 2015, LIVE LIFE WELL SCH E; Browne J, 2017, AUST HLTH REV; Browne J, 2009, ACTING FOOD INSECURI; Carver A, 2013, J TRANSP GEOGR, V26, P72, DOI 10.1016/j.jtrangeo.2012.08.017; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cooksey-Stowers K, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111366; Department of Health, 2014, PHYS ACT SED BEH GUI; Diaz PE, 2016, NSW SCH PHYS ACTIVIT; Flood V., 2005, RECOMMENDATIONS SHOR; Hardy LL, 2017, INT J OBESITY, V41, P76, DOI 10.1038/ijo.2016.204; Hardy LL, 2007, PREV MED, V45, P71, DOI 10.1016/j.ypmed.2007.03.014; Hardy LL, 2019, INT J OBESITY, V43, P116, DOI 10.1038/s41366-018-0139-5; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; Hector D, 2017, HLTH PROMOT J AUSTR; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; Lubans DR, 2010, SPORTS MED, V40, P1019, DOI 10.2165/11536850-000000000-00000; Macniven R, 2019, RURAL REMOTE HLTH; Magarey AM, 2001, MED J AUSTRALIA, V174, P561, DOI 10.5694/j.1326-5377.2001.tb143435.x; Maitland C, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-99; Martin A, 2016, PEDIATR EXERC SCI, V28, P353, DOI 10.1123/pes.2015-0207; Nathan N, 2015, HEALTH EDUC RES, V30, P262, DOI 10.1093/her/cyu068; National Health and Medical Research Council, 2013, AUSTR DIET GUID; NSW Department of Health & NSW Department of Education and Training, 2006, FRESH TAST SCH NSW H; NSW Office of Preventive Health, 2008, MUNCH MOV 2008; NSW Office of Preventive Health, 2012, HLTH CHILDR IN 2012; Price Waterhouse Coopers, 2015, WEIGH COST OB CAS AC; Ramsay SA, 2018, EUR J CLIN NUTR, V72, P548, DOI 10.1038/s41430-018-0084-3; Ryde NSW., 2000, GET SKILL GET ACT K, P7; Schoeppe S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2789-3; Shan LC, 2018, APPETITE, V130, P228, DOI 10.1016/j.appet.2018.08.022; Sigman A, 2012, ARCH DIS CHILD, V97, P935, DOI 10.1136/archdischild-2012-302196; Stodden DF, 2008, QUEST, V60, P290, DOI 10.1080/00336297.2008.10483582; Stone J, 2014, SUSTAINABLE URBAN MO; The Australian Institute of Aboriginal and Torres Strait Islander Studies, 2019, IND AUSTR AB TORR ST; Trapp GSA, 2012, HEALTH EDUC BEHAV, V39, P172, DOI 10.1177/1090198111423272; Vik FN, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-58	48	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0211249	10.1371/journal.pone.0211249	http://dx.doi.org/10.1371/journal.pone.0211249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287823	Green Published, gold			2022-12-26	WOS:000482328300001
J	Miyashita, Y; Ishikawa, K; Fukushima, Y; Kouwaki, T; Nakamura, K; Oshiumi, H				Miyashita, Yusuke; Ishikawa, Kana; Fukushima, Yoshimi; Kouwaki, Takahisa; Nakamura, Kimitoshi; Oshiumi, Hiroyuki			Immune-regulatory microRNA expression levels within circulating extracellular vesicles correspond with the appearance of local symptoms after seasonal flu vaccination	PLOS ONE			English	Article							CYTOKINE RESPONSES; CELLS; EXOSOMES; MIR-451; BINDING	Extracellular vesicles (EVs) contain microRNAs (miRNAs) that regulate the innate immune responses, such as the production of pro-inflammatory cytokines. The excessive production of pro-inflammatory cytokines after vaccination can cause local adverse reactions, such as pain, itching, swelling, and redness. Previous studies have shown that circulating EV miR-451a regulates innate immune responses, and miR-451a levels in serum EVs are negatively correlated with the pro-inflammatory cytokine expression levels in response to the influenza vaccine. Since excessive pro-inflammatory cytokine production is a cause of the local adverse reactions to vaccination, we investigated whether miR-451a levels in serum EVs correlate with local symptoms at the vaccination site, such as pain, itching, swelling, and redness. Interestingly, miR-451a levels in serum EVs were inversely correlated with the number of symptoms after vaccination. We determined the level of several other immuneregulatory miRNAs in serum EVs. Using the immune-regulatory miRNA levels of miR-22, miR-29a, miR-451a, and miR-107, we calculated a normalized miRNA level for each healthy donor and found that the normalized miRNA levels were significantly correlated with the number of local symptoms after vaccination. Our data indicated that immune-regulatory miRNA levels in serum EVs can be used as biomarkers to assess local symptoms after influenza vaccination.	[Miyashita, Yusuke; Ishikawa, Kana; Fukushima, Yoshimi; Kouwaki, Takahisa; Oshiumi, Hiroyuki] Kumamoto Univ, Grad Sch Med Sci, Fac Life Sci, Dept Immunol,Chuo Ku, Kumamoto, Japan; [Miyashita, Yusuke; Nakamura, Kimitoshi] Kumamoto Univ, Fac Life Sci, Dept Pediat, Chuo Ku, Kumamoto, Japan	Kumamoto University; Kumamoto University	Oshiumi, H (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Fac Life Sci, Dept Immunol,Chuo Ku, Kumamoto, Japan.	oshiumi@kumamoto-u.ac.jp		, Kimitoshi/0000-0003-4903-2428; Oshiumi, Hiroyuki/0000-0003-1567-8722	Japan Agency for Medical Research and Development (AMED); Ministry of Education, Science, and Technology (MEXT); PRESTO JST; Waksman Foundation of Japan; Shinnihon Foundation of Advanced Medical Treatment Research; Naito Foundation; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Care; Cosmetology Research Foundation	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Science, and Technology (MEXT); PRESTO JST(Japan Science & Technology Agency (JST)); Waksman Foundation of Japan(Waksman Foundation of Japan Inc.); Shinnihon Foundation of Advanced Medical Treatment Research; Naito Foundation(Naito Memorial Foundation); Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Care; Cosmetology Research Foundation	This work was funded by the Japan Agency for Medical Research and Development (AMED), the Ministry of Education, Science, and Technology (MEXT), PRESTO JST, the Waksman Foundation of Japan, the Shinnihon Foundation of Advanced Medical Treatment Research, the Naito Foundation, the Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Care, and the Cosmetology Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all members of our laboratory for their helpful discussions and technical assistance. This work was supported in part by Grants-in-Aid from the Japan Agency for Medical Research and Development (AMED), a grant-in-aid from the Ministry of Education, Science, and Technology (MEXT), PRESTO JST, the Waksman Foundation of Japan, the Shinnihon Foundation of Advanced Medical Treatment Research, the Naito Foundation, the Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Care, and the Cosmetology Research Foundation.	Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Cha DJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07197; Chen T, 2011, FEBS LETT, V585, P657, DOI 10.1016/j.febslet.2011.01.027; Christian LM, 2015, VACCINE, V33, P3360, DOI 10.1016/j.vaccine.2015.05.008; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Dinarello CA, 2004, J ENDOTOXIN RES, V10, P201, DOI 10.1179/096805104225006129; Dinarello CA, 1999, J INFECT DIS, V179, pS294, DOI 10.1086/513856; Gu W, 2017, FEBS LETT, V591, P513, DOI 10.1002/1873-3468.12565; Kawabata A, 2011, BIOL PHARM BULL, V34, P1170, DOI 10.1248/bpb.34.1170; Koppers-Lalic D, 2014, CELL REP, V8, P1649, DOI 10.1016/j.celrep.2014.08.027; Kouwaki T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030666; Kouwaki T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00335; Okamoto M, 2018, J BIOL CHEM, V293, P18585, DOI 10.1074/jbc.RA118.003862; Pan X, 2013, MOL CANCER THER, V12, P1153, DOI 10.1158/1535-7163.MCT-12-0802; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Rosenberger CM, 2012, J IMMUNOL, V189, P5965, DOI 10.4049/jimmunol.1201437; Santangelo L, 2016, CELL REP, V17, P799, DOI 10.1016/j.celrep.2016.09.031; Shurtleff MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19276; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Smyth LA, 2015, IMMUNOLOGY, V144, P197, DOI 10.1111/imm.12390; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Xue XC, 2014, EUR J IMMUNOL, V44, P673, DOI 10.1002/eji.201343717	25	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219510	10.1371/journal.pone.0219510	http://dx.doi.org/10.1371/journal.pone.0219510			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287847	Green Published, Green Submitted, gold			2022-12-26	WOS:000482328300026
J	Sorel, A; Plantard, P; Bideau, N; Pontonnier, C				Sorel, Anthony; Plantard, Pierre; Bideau, Nicolas; Pontonnier, Charles			Studying fencing lunge accuracy and response time in uncertain conditions with an innovative simulator	PLOS ONE			English	Article							TARGET CHANGE; PERFORMANCE; ELITE; MOVEMENT; LEVEL; DETERMINANTS; PERCEPTION; STRENGTH; FENCERS	Lunge motion is one of the fundamental attacks used in modern fencing, asking for a high level of coordination, speed and accuracy to be efficient. The aim of the current paper was the assessment of fencer's performance and response time in lunge attacks under uncertain conditions. For this study, an innovative fencing lunge simulator was designed. The performance of 11 regional to national-level fencers performing lunges in Fixed, Moving and Uncertain conditions was assessed. The results highlighted notably that i) Accuracy and success decreased significantly in Moving and Uncertain conditions with regard to Fixed ones ii) Movement and Reaction times were also affected by the experimental conditions iii) Different fencer profiles were distinguishable among subjects. In conclusion, the hypothesis that fencers may privilege an adaptation to the attack conditions and preserve accuracy instead of privileging quickness was supported by the results. Such simulators may be further used to analyze in more detail the motor control strategies of fencers through the measure and processing of biomechanical quantities and a wider range of fencing levels. It has also a great potential to be used as training device to improve fencer's performance to adapt his attack to controlled opponent's motion.	[Sorel, Anthony; Plantard, Pierre; Bideau, Nicolas; Pontonnier, Charles] Univ Rennes, INRIA, M2S EA7470, F-35000 Rennes, France; [Pontonnier, Charles] Univ Rennes, CNRS, INRIA, IRISA UMR 6074, F-35000 Rennes, France; [Sorel, Anthony] Univ Rennes, M2S Lab, Ave R Schuman, F-35170 Bruz, France	Inria; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); Inria; Universite de Rennes	Sorel, A (corresponding author), Univ Rennes, INRIA, M2S EA7470, F-35000 Rennes, France.	anthony.sorel@univ-rennes2.fr		Sorel, Anthony/0000-0003-3246-6123	French Agence Nationale de la Recherche project ENTRACTE [ANR 13-CORD002-01]; French ANR project ENTRACTE [ANR 13CORD-002-01]	French Agence Nationale de la Recherche project ENTRACTE(French National Research Agency (ANR)); French ANR project ENTRACTE(French National Research Agency (ANR))	This study was funded by the French Agence Nationale de la Recherche project ENTRACTE awarded to Charles Pontonnier and Nicolas Bideau (grant agreement: ANR 13-CORD002-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the French ANR project ENTRACTE (Grant agreement: ANR 13CORD-002-01). The authors also thank Patrice Dherbilly (regional technical advisor of the French fencing federation) and Sylvain Guyomard (fencing master).	Borysiuk Z, 2008, J HUM KINET, V19, P63, DOI 10.2478/v10078-008-0005-y; Bottoms L, 2013, ACTA BIOENG BIOMECH, V15, P109, DOI 10.5277/abb130414; Brunet R., 1995, Science and Sports, V10, P215, DOI 10.1016/0765-1597(96)89373-7; Chen TLW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171578; Cronin J, 2003, J SPORT SCI, V21, P49, DOI 10.1080/0264041031000070958; Di Russo F, 2006, NEUROSCI LETT, V408, P113, DOI 10.1016/j.neulet.2006.08.085; Do MC, 1999, EXP BRAIN RES, V129, P462, DOI 10.1007/s002210050914; Duque J, 2010, J NEUROSCI, V30, P3793, DOI 10.1523/JNEUROSCI.5722-09.2010; Frere J, 2011, INT J SPORTS MED, V32, P28, DOI 10.1055/s-0030-1267199; Gutierrez-Cruz C, 2016, J SPORT SCI, V34, P651, DOI 10.1080/02640414.2015.1068434; Gutierrez-Davila M, 2006, J APPL BIOMECH, V22, P194, DOI 10.1123/jab.22.3.194; Gutierrez-Davila M, 2014, J SPORT SCI MED, V13, P66; Gutierrez-Davila M, 2013, EUR J SPORT SCI, V13, P364, DOI 10.1080/17461391.2011.635704; Gutierrez-Davila M, 2013, J SPORT SCI, V31, P1100, DOI 10.1080/02640414.2013.770908; Gutierrez-Davila M, 2013, RES Q EXERCISE SPORT, V84, P16, DOI 10.1080/02701367.2013.762286; Hagemann N, 2010, ATTEN PERCEPT PSYCHO, V72, P2204, DOI 10.3758/APP.72.8.2204; Hassan SEA, 1998, ISBS C P ARCH, V1, P170; Hudson TE, 2007, J NEUROPHYSIOL, V98, P3034, DOI 10.1152/jn.00858.2007; Ivanoff J, 2009, HUM BRAIN MAPP, V30, P4167, DOI 10.1002/hbm.20837; Kerby D.S., 2014, INNOVATIVE TEACHING, V3, DOI [10.2466/11.IT.3.1, DOI 10.2466/11.IT.3.1]; Morris N, 2011, PORT J SPORT SCI, V11, P343; NOUGIER V, 1990, J HUM MOVEMENT STUD, V19, P251; Pain MTG, 2007, J SPORT SCI, V25, P79, DOI 10.1080/02640410600718004; PIERSON WR, 1956, RES QUART, V27, P90, DOI 10.1080/10671188.1956.10612855; Plantard P, 2017, COMPUT METHOD BIOMEC, V20, P161, DOI 10.1080/10255842.2017.1382912; Roi GS, 2008, SPORTS MED, V38, P465, DOI 10.2165/00007256-200838060-00003; Ruiz ALC, 2017, APPL BIONICS BIOMECH, V2017, DOI 10.1155/2017/3050917; Sanderson FH, 1983, J SPORT SCI, V1, P105, DOI 10.1080/02640418308729667; Schmidt R. A., 2018, MOTOR CONTROL LEARNI; Stewart SI, 2005, J SPORT SCI, V23, P105; Tsolakis C, 2010, PERCEPT MOTOR SKILL, V110, P1015, DOI 10.2466/05.25.26.PMS.110.C.1015-1028; Tsolakis C, 2010, J HUM KINET, V23, P89, DOI 10.2478/v10078-010-0011-8; Turner A, 2014, J STRENGTH COND RES, V28, P3001, DOI 10.1519/JSC.0000000000000478; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Vignais N, 2009, J SPORT SCI MED, V8, P501; Wang CH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055773, 10.1371/journal.pone.0073985]; Williams L R, 2000, J Sci Med Sport, V3, P460, DOI 10.1016/S1440-2440(00)80011-0; Williams LRT, 2000, PERCEPT MOTOR SKILL, V91, P131, DOI 10.2466/PMS.91.5.131-142; Yiou E, 2001, EXP BRAIN RES, V137, P197, DOI 10.1007/s002210000624	39	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0218959	10.1371/journal.pone.0218959	http://dx.doi.org/10.1371/journal.pone.0218959			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287814	Green Submitted, gold, Green Published			2022-12-26	WOS:000482328300007
J	Wepprich, T; Adrion, JR; Ries, L; Wiedmann, J; Haddad, NM				Wepprich, Tyson; Adrion, Jeffrey R.; Ries, Leslie; Wiedmann, Jerome; Haddad, Nick M.			Butterfly abundance declines over 20 years of systematic monitoring in Ohio, USA	PLOS ONE			English	Article							MONARCH BUTTERFLIES; PRAIRIE BUTTERFLIES; POPULATION TRENDS; CLIMATE-CHANGE; MANAGEMENT; COMMON; INDEX; INDICATORS; PATTERNS; HABITAT	Severe insect declines make headlines, but they are rarely based on systematic monitoring outside of Europe. We estimate the rate of change in total butterfly abundance and the population trends for 81 species using 21 years of systematic monitoring in Ohio, USA. Total abundance is declining at 2% per year, resulting in a cumulative 33% reduction in butterfly abundance. Three times as many species have negative population trends compared to positive trends. The rate of total decline and the proportion of species in decline mirror those documented in three comparable long-term European monitoring programs. Multiple environmental changes such as climate change, habitat degradation, and agricultural practices may contribute to these declines in Ohio and shift the makeup of the butterfly community by benefiting some species over others. Our analysis of life-history traits associated with population trends shows an impact of climate change, as species with northern distributions and fewer annual generations declined more rapidly. However, even common and invasive species associated with human-dominated landscapes are declining, suggesting widespread environmental causes for these trends. Declines in common species, although they may not be close to extinction, will have an outsized impact on the ecosystem services provided by insects. These results from the most extensive, systematic insect monitoring program in North America demonstrate an ongoing defaunation in butterflies that on an annual scale might be imperceptible, but cumulatively has reduced butterfly numbers by a third over 20 years.	[Wepprich, Tyson] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Adrion, Jeffrey R.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Ries, Leslie] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Wiedmann, Jerome] Ohio Lepidopterists, Columbus, OH USA; [Haddad, Nick M.] Michigan State Univ, Dept Integrat Biol, Hickory Corners, MI USA; [Haddad, Nick M.] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA	Oregon State University; University of Oregon; Georgetown University; Michigan State University; Michigan State University	Wepprich, T (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	yyson.wepprich@oregonstate.edu		Wepprich, Tyson/0000-0002-6875-092X; Ries, Leslie/0000-0002-5953-9284	Ohio Department of Natural Resources; Department of the Interior Southeast Climate Adaptation Science Center; North Carolina State University	Ohio Department of Natural Resources; Department of the Interior Southeast Climate Adaptation Science Center; North Carolina State University	We thank the volunteers and directors who contribute their time and expertise to the Ohio butterfly monitoring program. The Ohio Department of Natural Resources provides support, the Cleveland Museum of Natural History provides data entry and archiving, and the Ohio Lepidopterists provides training and coordination for the Ohio butterfly monitoring program. We thank Marjorie Weber for advice on our phylogenetic analysis. The Department of the Interior Southeast Climate Adaptation Science Center and North Carolina State University supported TW during earlier work with Ohio butterflies that grew into this analysis.	Agrawal AA, 2018, SCIENCE, V360, P1294, DOI 10.1126/science.aat5066; Baker NT, 2017, US GEOLOGICAL SURVEY, V907, P9; Basley K, 2018, ENVIRON SCI TECHNOL, V52, P3990, DOI 10.1021/acs.est.8b00609; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Belitz MW, 2018, BIODIVERS DATA J, V6, DOI 10.3897/BDJ.6.e29081; Bigelow D. P., 2017, Economic Information Bulletin - USDA Economic Research Service; Breed GA, 2013, NAT CLIM CHANGE, V3, P142, DOI [10.1038/nclimate1663, 10.1038/NCLIMATE1663]; Brereton T, 2011, J INSECT CONSERV, V15, P139, DOI 10.1007/s10841-010-9333-z; Brereton TM., 2018, UK BUTTERFLY MONITOR; Cayton HL, 2015, ECOLOGY, V96, P1473, DOI 10.1890/15-0131.1; Cech R, 2005, BUTTERFLIES E COAST; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Conrad K. F., 2007, Insect conservation biology, P203, DOI 10.1079/9781845932541.0203; Conrad KF, 2004, J INSECT CONSERV, V8, P119; Curtis RJ, 2015, J APPL ECOL, V52, P1676, DOI 10.1111/1365-2664.12523; Dennis EB, 2017, CONSERV BIOL, V31, P1350, DOI 10.1111/cobi.12956; Dennis EB, 2017, ECOL INDIC, V76, P184, DOI 10.1016/j.ecolind.2017.01.009; Dennis EB, 2016, BIOMETRICS, V72, P1305, DOI 10.1111/biom.12506; Dennis EB, 2013, METHODS ECOL EVOL, V4, P637, DOI 10.1111/2041-210X.12053; Dennis RLH, 2003, OIKOS, V102, P417, DOI 10.1034/j.1600-0706.2003.12387.x; Diamond SE, 2014, ECOLOGY, V95, P2613, DOI 10.1890/13-1848.1; Diamond SE, 2011, SPECIES TRAITS PREDI, V92, P8; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Douglas MR, 2015, ENVIRON SCI TECHNOL, V49, P5088, DOI 10.1021/es506141g; Espeland M, 2018, CURR BIOL, V28, P770, DOI 10.1016/j.cub.2018.01.061; Forister ML, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0475; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Fox R, 2013, INSECT CONSERV DIVER, V6, P5, DOI 10.1111/j.1752-4598.2012.00186.x; Gilburn AS, 2015, PEERJ, V3, DOI 10.7717/peerj.1402; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Habel JC, 2018, BIOL CONSERV, V218, P211, DOI 10.1016/j.biocon.2017.12.018; Haddad NM, 2008, CONSERV BIOL, V22, P929, DOI 10.1111/j.1523-1739.2008.00932.x; Haddad NM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003488; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Hellerstein Daniel, 2017, LAND USE LAND COVER, P47; Henry EH, 2016, J INSECT CONSERV, V20, P505, DOI 10.1007/s10841-016-9883-9; Herrera CM, 2019, ECOL MONOGR, V89, DOI 10.1002/ecm.1338; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Hunter MD, 2014, GLOBAL CHANGE BIOL, V20, P1723, DOI 10.1111/gcb.12529; Iftner DC., 1992, BUTTERFLIES SKIPPERS; Isaac NJB, 2011, METHODS ECOL EVOL, V2, P585, DOI 10.1111/j.2041-210X.2011.00109.x; Kleijn D, 1997, J APPL ECOL, V34, P1413, DOI 10.2307/2405258; Knape J, 2016, J APPL ECOL, V53, P1852, DOI 10.1111/1365-2664.12720; Kraemer HC, 2004, INT J METH PSYCH RES, V13, P141, DOI 10.1002/mpr.170; Krupke CH, 2017, J APPL ECOL, V54, P1449, DOI 10.1111/1365-2664.12924; Kurze S, 2018, OECOLOGIA, V188, P1227, DOI 10.1007/s00442-018-4266-4; Link WA, 1998, ECOL APPL, V8, P258, DOI 10.1890/1051-0761(1998)008[0258:EPCFCD]2.0.CO;2; Lister BC, 2018, P NATL ACAD SCI USA, V115, pE10397, DOI 10.1073/pnas.1722477115; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Melero Y, 2016, BIOL CONSERV, V201, P336, DOI 10.1016/j.biocon.2016.07.029; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Ockinger E, 2006, BIOL CONSERV, V128, P564, DOI 10.1016/j.biocon.2005.10.024; Oliver TH, 2015, BIOL J LINN SOC, V115, P767, DOI 10.1111/bij.12579; Opler P. A., 1984, BUTTERFLIES E GREAT; Orme D, 2013, CAPER PACKAGE COMP A, V5; Pagel J, 2014, METHODS ECOL EVOL, V5, P751, DOI 10.1111/2041-210X.12221; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pannekoek J, 2001, TRIM 3 MANUAL TRENDS; Paradis E, 2018, BIOINFORMATICS, pxxx; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pellet J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041396; Pisa L, 2017, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-017-0341-3, DOI 10.1007/S11356-017-0341-329124633]; Pleasants JM, 2016, ANN ENTOMOL SOC AM, V109, P169, DOI 10.1093/aesa/sav115; Pleasants JM, 2013, INSECT CONSERV DIVER, V6, P135, DOI 10.1111/j.1752-4598.2012.00196.x; POLLARD E, 1994, MONITORING BUTTERFLI; R Core Team, 2021, R LANGUAGE ENV STAT; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ries L., 2015, MONARCHS CHANGING WO, P268; Rohatgi A., 2019, WEBPLOTDIGITIZER; Roy DB, 2015, J INSECT CONSERV, V19, P313, DOI 10.1007/s10841-014-9739-0; Ryan SF, 2018, BIORXIV; Saunders SP, 2019, P NATL ACAD SCI USA, V116, P8609, DOI 10.1073/pnas.1805114116; Saunders SP, 2018, ECOGRAPHY, V41, P278, DOI 10.1111/ecog.02719; Schlicht D, 2009, J INSECT CONSERV, V13, P429, DOI 10.1007/s10841-008-9192-z; Schmucki R, 2016, J APPL ECOL, V53, P501, DOI 10.1111/1365-2664.12561; Schultz CB, 2017, BIOL CONSERV, V214, P343, DOI 10.1016/j.biocon.2017.08.019; Shuey JA, 1987, BUTTERFLIES ARE ENDA; Soykan CU, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1351; Stefanescu C, 2018, CYNTHIA BUTLLETI BUT, V14; Stone WW, 2013, ESTIMATED ANN AGR PE; Swengel SR, 2011, J INSECT CONSERV, V15, P327, DOI 10.1007/s10841-010-9323-1; Szabo JK, 2010, ECOL APPL, V20, P2157, DOI 10.1890/09-0877.1; Taron D, 2015, BUTTERFLY CONSERVATI, P35, DOI DOI 10.1007/978-94-017-9852-5_3; Thomas JA, 2005, PHILOS T R SOC B, V360, P339, DOI 10.1098/rstb.2004.1585; Thomas JA, 2016, SCIENCE, V353, P216, DOI 10.1126/science.aaf8838; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; van Strien AJ, 2013, J APPL ECOL, V50, P1450, DOI 10.1111/1365-2664.12158; Van Swaay C., 2015, EUROPEAN BUTTERFLY I; Van Swaay CAM, 2018, VS2018006 VLIND; WallisDeVries MF, 2017, BIOL CONSERV, V212, P448, DOI 10.1016/j.biocon.2016.11.029; Warren MS, 2001, RAPID RESPONSES BRIT, V414, P5; Weiss SB, 1999, CONSERV BIOL, V13, P1476, DOI 10.1046/j.1523-1739.1999.98468.x; Wepprich TM, 2017, EFFECTS CLIMATIC VAR; Winfree R, 2015, ECOL LETT, V18, P626, DOI 10.1111/ele.12424; Wong MKL, 2018, BIOL REV, DOI [10.1111/brv.1248830548743, DOI 10.1111/BRV.1248830548743]; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]	102	84	89	12	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0216270	10.1371/journal.pone.0216270	http://dx.doi.org/10.1371/journal.pone.0216270			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IN4XF	31287815	Green Submitted, Green Published, gold			2022-12-26	WOS:000478679800001
J	Alrubaye, B; Abraha, M; Almansour, A; Bansal, M; Wang, H; Kwon, YM; Huang, Y; Hargis, B; Sun, XL				Alrubaye, Bilal; Abraha, Mussie; Almansour, Ayidh; Bansal, Mohit; Wang, Hong; Kwon, Young Min; Huang, Yan; Hargis, Billy; Sun, Xiaolun			Microbial metabolite deoxycholic acid shapes microbiota against Campylobacter jejuni chicken colonization	PLOS ONE			English	Article							BILE-ACIDS; ANTIBIOTIC-RESISTANCE; INFECTION; BACTERIA; COLITIS	Despite reducing the prevalent foodborne pathogen Campylobacter jejuni in chickens decreases campylobacteriosis, few effective approaches are available. The aim of this study was to use microbial metabolic product bile acids to reduce C. jejuni chicken colonization. Broiler chicks were fed with deoxycholic acid (DCA), lithocholic acid (LCA), or ursodeoxycholic acid (UDCA). The birds were also transplanted with DCA modulated anaerobes (DCA-Anaero) or aerobes (DCA-Aero). The birds were infected with human clinical isolate C. jejuni 81-176 or chicken isolate C. jejuni AR101. Notably, C. jejuni 81-176 was readily colonized intestinal tract at d16 and reached an almost plateau at d21. Remarkably, DCA excluded C. jejuni cecal colonization below the limit of detection at 16 and 28 days of age. Neither chicken ages of infection nor LCA or UDCA altered C. jejuni AR101 chicken colonization level, while DCA reduced 91% of the bacterium in chickens at d28. Notably, DCA diet reduced phylum Firmicutes but increased Bacteroidetes compared to infected control birds. Importantly, DCA-Anaero attenuated 93% of C. jejuni colonization at d28 compared to control infected birds. In conclusion, DCA shapes microbiota composition against C. jejuni colonization in chickens, suggesting a bidirectional interaction between microbiota and microbial metabolites.	[Alrubaye, Bilal; Abraha, Mussie; Almansour, Ayidh; Bansal, Mohit; Wang, Hong; Kwon, Young Min; Hargis, Billy; Sun, Xiaolun] Univ Arkansas, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA; [Huang, Yan] Univ Arkansas, Dept Anim Sci, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Sun, XL (corresponding author), Univ Arkansas, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA.	xiaoluns@uark.edu	Bansal, Mohit/AAG-1260-2019; Bansal, Mohit/AAJ-7196-2020	Alrubaye, Bilal/0000-0003-0702-6556; Sun, Xiaolun/0000-0001-5601-0812; Bansal, Mohit/0000-0001-8777-1980	USDA National Institute of Food and Agriculture (NIFA) [1012366]; USDA NIFA Hatch/Multi State project [1018699]; USDA NIFA project [2018-06686]; Arkansas Biosciences Institute	USDA National Institute of Food and Agriculture (NIFA); USDA NIFA Hatch/Multi State project; USDA NIFA project; Arkansas Biosciences Institute	This research was supported grants of Arkansas Biosciences Institute, USDA National Institute of Food and Agriculture (NIFA) Hatch project 1012366, USDA NIFA Hatch/Multi State project 1018699, USDA NIFA project 2018-06686 to X. Sun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar VF, 2013, FOODBORNE PATHOG DIS, V10, P435, DOI 10.1089/fpd.2012.1302; ARCHER RH, 1982, EUR J APPL MICROBIOL, V14, P41, DOI 10.1007/BF00508002; Bae J, 2014, ANTIMICROB AGENTS CH, V58, P7573, DOI 10.1128/AAC.04066-14; Baffoni L, 2017, INT J FOOD MICROBIOL, V251, P41, DOI 10.1016/j.ijfoodmicro.2017.04.001; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Cawthraw SA, 2010, AVIAN DIS, V54, P86, DOI 10.1637/9004-072709-Reg.1; CDC, 2018, FOODB DIS ACT SURV N; CDC, 2010, CAMP GEN INF; CDC, 2016, MORBIDITY MORTALITY; CDC, 2014, CAMP GEN INFL 2014; Chiang JYL, 2004, J HEPATOL, V40, P539, DOI 10.1016/j.jhep.2003.11.006; Darkoh C, 2010, ANTIMICROB AGENTS CH, V54, P3618, DOI 10.1128/AAC.00161-10; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Evans SJ, 2000, PREV VET MED, V46, P209, DOI 10.1016/S0167-5877(00)00143-4; Galarza-Seeber R, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00010; Gibbens JC, 2001, PREV VET MED, V48, P85, DOI 10.1016/S0167-5877(00)00189-6; GILLILAND SE, 1977, APPL ENVIRON MICROB, V33, P15, DOI 10.1128/AEM.33.1.15-18.1977; Han ZF, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00380-17, 10.1128/iai.00380-17]; Han ZF, 2016, DEV COMP IMMUNOL, V62, P58, DOI 10.1016/j.dci.2016.04.020; Hertwig S, 2013, BERL MUNCH TIERARZTL, V126, P357, DOI 10.2376/0005-9366-126-357; Hodgins Douglas C, 2015, BMC Res Notes, V8, P204, DOI 10.1186/s13104-015-1203-z; Hou FQ, 2012, SCAND J INFECT DIS, V44, P439, DOI 10.3109/00365548.2011.652163; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Kampmann C, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.09.004; Kittler S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094782; Lertpiriyapong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042842; Lippert E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007413; Luethy PM, 2017, MBIO, V8, DOI [10.1128/mBio.00407-17, 10.1128/mbio.00407-17]; Ma HJ, 2014, BEST PRACT RES CL GA, V28, P573, DOI 10.1016/j.bpg.2014.07.004; Negretti NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15379-5; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Pham NTK, 2016, JPN J INFECT DIS, V69, P77, DOI 10.7883/yoken.JJID.2014.582; Pielsticker C, 2012, EUR J MICROBIOL IMMU, V2, P61, DOI 10.1556/EuJMI.2.2012.1.9; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; Sakaridis I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00927; Silverman MS, 2010, CLIN GASTROENTEROL H, V8, P471, DOI 10.1016/j.cgh.2010.01.007; Sun XL, 2018, GASTROENTEROLOGY, V154, P1751, DOI 10.1053/j.gastro.2018.01.042; Szczepanska B, 2015, FOODBORNE PATHOG DIS, V12, P24, DOI 10.1089/fpd.2014.1793; Ternhag A, 2007, CLIN INFECT DIS, V44, P696, DOI 10.1086/509924; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; Vlasova AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076962; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Zhao SH, 2015, J ANTIMICROB CHEMOTH, V70, P1314, DOI 10.1093/jac/dkv001	50	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0214705	10.1371/journal.pone.0214705	http://dx.doi.org/10.1371/journal.pone.0214705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276498	Green Published, gold, Green Submitted			2022-12-26	WOS:000484936300007
J	Kim, KN; Hernandez, D; Seo, JH; Noh, Y; Han, Y; Ryu, YC; Chung, JY				Kim, Kyoung-Nam; Hernandez, Daniel; Seo, Jeung-Hoon; Noh, Young; Han, Yeji; Ryu, Yeun Chul; Chung, Jun-Young			Quantitative assessment of phased array coils with different numbers of receiving channels in terms of signal-to-noise ratio and spatial noise variation in magnetic resonance imaging	PLOS ONE			English	Article							FIELD-STRENGTH; MR-IMAGES; PARALLEL	The neuroimaging of humans using 7T magnetic resonance imaging (MRI) has been conducted using phased array (PA) coils with different numbers of receiving channels. PA coils with a high number of channels may offer parallel imaging (PI) with a high reduction (R)-factor, which is enabled via under-sampling and coil geometry (g) factor, increasing the radio-frequency signal sensitivity provided by a small coil. The goals of this study were to assess and validate the coil performance of PA coils with different numbers of receiver (Rx)-channels in and to propose the coil selection guidelines by visualizing 7T brain images. The combined magnetic flux density (parallel to B-1 parallel to) distributions of four configurations of PA coils-4-, 8-, 12, and 16-channel Rx-only mode under the local transmit (Tx) mode of birdcage coils-were evaluated using electromagnetic (EM) calculations. These four configurations of PA coils and a local Tx coil were designed and built for a 7T MRI experiment. For 7T brain imaging experiments, all PA coils with (w/) and without (w/o) R-factors were compared in terms of signal-to-noise ratio (SNR) and spatial noise variation (SNV). EM simulation results clearly demonstrated that PA coils with a high number of Rx channels showed more homogeneously distributed parallel to B-1 parallel to fields than a PA coils with a low number of Rx coils. The results of this study demonstrate that a collection of smaller surface coils can contribute to high RF signal sensitivity in terms of the anatomical coverage of the brain and may facilitate PI. With further improvement in coil technology, researchers and clinicians will be provided with PA coils with different numbers of channels, which can ensure the optimum SNR and PI benefits for 7T brain MR imaging.	[Kim, Kyoung-Nam; Hernandez, Daniel; Han, Yeji] Gachon Univ, Dept Biomed Engn, Incheon, South Korea; [Seo, Jeung-Hoon; Ryu, Yeun Chul] Gachon Univ, Neurosci Res Inst, Incheon, South Korea; [Noh, Young] Gachon Univ, Gil Med Ctr, Dept Neurol, Incheon, South Korea; [Chung, Jun-Young] Gachon Univ, Coll Med, Dept Neurosci, Incheon, South Korea	Gachon University; Gachon University; Gachon University; Gachon University	Chung, JY (corresponding author), Gachon Univ, Coll Med, Dept Neurosci, Incheon, South Korea.	jychung@gachon.ac.kr	Seo, Jeung-hoon/GXZ-6854-2022; Seo, Jeung-hoon/AAJ-9028-2020	Hernandez, Daniel/0000-0003-0993-1373; Ryu, Yeunchul/0000-0001-9114-463X	Osong innovation center - ministry of health & welfare, the republic of Korea [HO16C0004]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea [HI14C1135]	Osong innovation center - ministry of health & welfare, the republic of Korea; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant (HO16C0004) from Osong innovation center funded by the ministry of health & welfare, the republic of Korea and supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1135).	Adriany G, 2010, MAGN RESON MED, V63, P1478, DOI 10.1002/mrm.22413; Breuer FA, 2005, MAGN RESON MED, V53, P981, DOI 10.1002/mrm.20430; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Lee RF, 2002, MAGNET RESON MED, V48, P203, DOI 10.1002/mrm.10186; Maubon AJ, 1999, RADIOGRAPHICS, V19, P1057, DOI 10.1148/radiographics.19.4.g99jl281057; Mori Harushi, 2002, Radiat Med, V20, P223; Perez Marlon, 2014, Investigative Magnetic Resonance Imaging, V18, P107, DOI 10.13104/jksmrm.2014.18.2.107; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Scott GC, 2008, P 16 ISMRM; Sobol WT, 2012, SAUDI J OPHTHALMOL, V26, P393, DOI 10.1016/j.sjopt.2012.07.005; Sodickson DK, 1997, MAGNET RESON MED, V38, P591, DOI 10.1002/mrm.1910380414; van der Kolk AG, 2013, EUR J RADIOL, V82, P708, DOI 10.1016/j.ejrad.2011.07.007; Wiesinger F, 2004, MAGN RESON MED, V52, P953, DOI 10.1002/mrm.20281; Wu B, 2007, CONCEPT MAGN RESON B, V31B, P116, DOI 10.1002/cmr.b.20087	15	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219407	10.1371/journal.pone.0219407	http://dx.doi.org/10.1371/journal.pone.0219407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276549	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300075
J	Ricardo, CZ; Azeredo, CM; de Rezende, LFM; Levy, RB				Ricardo, Camila Zancheta; Azeredo, Catarina Machado; Machado de Rezende, Leandro Fornias; Levy, Renata Bertazzi			Co-occurrence and clustering of the four major non-communicable disease risk factors in Brazilian adolescents: Analysis of a national school-based survey	PLOS ONE			English	Article							ULTRA-PROCESSED FOODS; RIO-DE-JANEIRO; PHYSICAL-ACTIVITY; HEALTH-SURVEY; UNHEALTHY BEHAVIORS; CONSUMPTION; ALCOHOL; INDICATORS; MORTALITY; CHILDREN	Background The major non-communicable chronic diseases (NCD) are associated with a small group of modifiable lifestyle-related risk factors, including smoking, insufficient physical activity, unhealthy eating, and alcohol abuse. In this study, we evaluated the co-occurrence and clustering of the major NCD risk factors among Brazilian adolescents. Methods This cross-sectional study analyzed data of 101,607 adolescents from the Brazilian National Survey of School Health (PeNSE) 2015. The risk factors included were: regular consumption of ultra-processed foods, irregular consumption of fruits and vegetables, insufficient physical activity, smoking, and alcohol consumption. Clustering was defined through the ratio between observed and expected prevalences of combination of risk factors greater than 1. Expected prevalence of the co-occurrence of risk factors was calculated from the joint probability of the behaviors. Additionally, we examined the presence of at least four risk factors according to socioeconomic characteristics. Results Of the 32 combinations of risk factors, 13 corresponded to clustering. We observed a strong correlation between alcohol consumption and smoking, which were found together in 8 of the 13 clusters identified. The most frequent combinations of risk factors involved unhealthy eating and insufficient physical activity. Only 2.9% of the adolescents did not present any risk behaviors, while 38.0%, 32.9%, 9.4% and 1.8% accumulated two, three, four and five risk factors, respectively. The accumulation of risk factors was higher in girls, older adolescents, those who did not live with both parents, children of less-educated mothers, students attending public school, and residents of cities in more developed urban areas of the country. Conclusions The main risk factors for NCD are frequent and not randomly distributed among Brazilian adolescents. Our results provide information for policymakers to target specific groups and joint behavioral risk factors for health improvement in adolescents.	[Ricardo, Camila Zancheta; Machado de Rezende, Leandro Fornias; Levy, Renata Bertazzi] Univ Sao Paulo, Fac Med FMUSP, Dept Prevent Med, Sao Paulo, SP, Brazil; [Azeredo, Catarina Machado] Univ Fed Uberlandia, Fac Med, Uberlandia, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Uberlandia	Ricardo, CZ (corresponding author), Univ Sao Paulo, Fac Med FMUSP, Dept Prevent Med, Sao Paulo, SP, Brazil.	ca.zancheta@gmail.com	Azeredo, Catarina Machado/B-2308-2015; Azeredo, Catarina Machado/AAG-7216-2019; Levy, Renata Bertazzi/F-8931-2012; Rezende, Leandro F. M./C-1724-2012	Azeredo, Catarina Machado/0000-0002-6189-4429; Azeredo, Catarina Machado/0000-0002-6189-4429; Levy, Renata Bertazzi/0000-0001-5388-7002; Rezende, Leandro F. M./0000-0002-7469-1399; Zancheta Ricardo, Camila/0000-0003-3643-302X	Coordination for the Improvement of Higher Education Personnel (CAPES); Sao Paulo Research Foundation (FAPESP) [2014/26711-3]	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	C.Z.R. received a master's scholarship from the Coordination for the Improvement of Higher Education Personnel (CAPES) and from the Sao Paulo Research Foundation (FAPESP; grant number 2014/26711-3). https://bv.fapesp.br/pt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamian A, 2009, PREV MED, V48, P493, DOI 10.1016/j.ypmed.2009.02.015; [Anonymous], 2012, PESQ NAC AM DOM SINT; [Anonymous], 2003, DIET NUTR PREV CHRON; Azeredo CM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025338; Azeredo CM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011571; Benzies KM, 2008, HEALTH CARE WOMEN IN, V29, P997, DOI 10.1080/07399330802269675; Bryant J, 2013, AUST NZ J PUBL HEAL, V37, P118, DOI 10.1111/1753-6405.12028; Busch V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1118; Caleyachetty R, 2015, LANCET DIABETES ENDO, V3, P535, DOI 10.1016/S2213-8587(15)00076-5; Louzada MLD, 2018, PUBLIC HEALTH NUTR, V21, P94, DOI 10.1017/S1368980017001434; Louzada MLD, 2015, PREV MED, V81, P9, DOI 10.1016/j.ypmed.2015.07.018; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; de Oliveira MM, 2017, EPIDEMIOL SERV SAUDE, V26, P605, DOI 10.5123/S1679-49742017000300017; Del Duca GF, 2012, PREV MED, V54, P254, DOI 10.1016/j.ypmed.2012.02.005; Santos SLD, 2016, REV BRAS GINECOL OBS, V38, P482, DOI 10.1055/s-0036-1584686; Dodd LJ, 2010, PREV MED, V51, P73, DOI 10.1016/j.ypmed.2010.04.005; Antunes JLF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068132; Nunes HEG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159037; Hardy LL, 2012, J ADOLESCENT HEALTH, V51, P265, DOI 10.1016/j.jadohealth.2011.12.017; Idowu A., 2018, INT J ADOLESCENT MED, V30, P1438, DOI [10.1515/ijamh-2016-0008, DOI 10.1515/IJAMH-2016-0008]; Instituto Brasileiro de Geografia e Estatistica, 2014, SINT IND SOC AN COND; Instituto Brasileiro de Geografia e Estatistica, 2013, PESQ NAC SAUD ESC 20; Levy RB, 2010, CIENC SAUDE COLETIVA, V15, P3085, DOI 10.1590/S1413-81232010000800013; Luoto R, 1998, PREV MED, V27, P93, DOI 10.1006/pmed.1997.0249; Maia EG, 2018, INT J PUBLIC HEALTH, V63, P481, DOI 10.1007/s00038-017-1053-7; Malta Deborah Carvalho, 2014, Rev Bras Epidemiol, V17 Suppl 1, P77; Marinho F, 2018, LANCET, V392, P760, DOI 10.1016/S0140-6736(18)31221-2; Matias TS, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6203-1; McAloney K, 2013, PREV MED, V56, P365, DOI 10.1016/j.ypmed.2013.03.002; Ministry of Health of Brazil, 2015, DIET GUID BRAZ POP; Monteiro CA, 2018, PUBLIC HEALTH NUTR, V21, P5, DOI 10.1017/S1368980017000234; Monteiro CA, 2009, REV SAUDE PUBL, V43, P35, DOI 10.1590/S0034-89102009000100005; Muthuri S, 2016, PLOS ONE, V11, P8; Nimptsch K, 2014, INT J CANCER, V134, P2458, DOI 10.1002/ijc.28578; Noble N, 2015, PREV MED, V81, P16, DOI 10.1016/j.ypmed.2015.07.003; Ortigão Maria Isabel Ramalho, 2013, Rev. Bras. Estud. Pedagog., V94, P364; Paavola M, 2004, J ADOLESCENT HEALTH, V35, P238, DOI 10.1016/j.jadohealth.2003.12.004; Perrin JM, 2007, JAMA-J AM MED ASSOC, V297, P2755, DOI 10.1001/jama.297.24.2755; Rezende L, 2019, BRIT J CANC; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Camargos MCS, 2015, CAD SAUDE PUBLICA, V31, P1460, DOI 10.1590/0102-311X00128914; Schlecht NF, 1999, AM J EPIDEMIOL, V150, P1129, DOI 10.1093/oxfordjournals.aje.a009938; Schuit AJ, 2002, PREV MED, V35, P219, DOI 10.1006/pmed.2002.1064; Slattery ML, 2002, MED SCI SPORT EXER, V34, P913, DOI 10.1097/00005768-200206000-00002; StataCorp, 2015, STAT 14 BAS REF MAN; Steele EM, 2014, PUBLIC HEALTH NUTR, V17, P369, DOI 10.1017/S1368980012005472; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Tassitano Rafael Miranda, 2014, Rev. bras. epidemiol., V17, P465, DOI 10.1590/1809-4503201400020014ENG; Tavares LF, 2014, CAD SAUDE PUBLICA, V30, P1861, DOI 10.1590/0102-311X00151913; Tavares LF, 2014, CAD SAUDE PUBLICA, V30, P1029, DOI 10.1590/0102-311X00000413; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2014, HLTH WORLDS AD 2 CHA; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Yuan ML, 2015, J PHYSIOL-LONDON, V593, P3397, DOI 10.1113/JP270492; 2014, GLOB STAT REP VIOL, P1	56	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219370	10.1371/journal.pone.0219370	http://dx.doi.org/10.1371/journal.pone.0219370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4CE	31269084	Green Submitted, Green Published, gold			2022-12-26	WOS:000484927300062
J	Rzepecka, A; Zmigrodzka, M; Witkowska-Pilaszewicz, O; Cywinska, A; Winnicka, A				Rzepecka, Alicja; Zmigrodzka, Magdalena; Witkowska-Pilaszewicz, Olga; Cywinska, Anna; Winnicka, Anna			CD4 and MHCII phenotypic variability of peripheral blood monocytes in dogs	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; EXPRESSION; CELLS; SUBSETS; ANTIGEN; IDENTIFICATION; MACROPHAGE; RECEPTOR	In humans and mice, the detailed phenotypic and functional characterization of peripheral blood monocytes allows for identification of three monocyte subsets. There are also evidences of monocyte phenotypic heterogeneity in other species, including cattle, sheep, pig and horse. However, little is known about such variability in dogs. The aim of the study was to determine whether and how peripheral blood monocytes of healthy dogs differ in the presence of MHCII and CD4 and in the basal production of reactive oxygen species (ROS). Three distinct subsets of CD11b(+) CD14(+) monocytes were found in peripheral blood samples of healthy dogs, based on the variations in the density of MHCII and CD4 surface molecules: MHCII+ CD4(-) (Mo1), MHCII+ CD4(+) (Mo2) and MHCII(-)CD4(+) (Mo3). The Mo2 and Mo3 were significantly lower in percentage than Mo1 but their basal ROS production was higher. Within the Mo2 and Mo3 subsets, the percentage of cells producing ROS was significantly higher comparing to cells lacking this activity. Canine peripheral blood monocytes vary in the expression of MHCII and CD4 and in the activity suggesting that cells within the three identified subsets carry out different functions. The higher production of ROS in non-activated cells within small subsets of Mo2 and Mo3 monocytes might indicate their immunomodulatory potential.	[Rzepecka, Alicja; Zmigrodzka, Magdalena; Witkowska-Pilaszewicz, Olga; Cywinska, Anna; Winnicka, Anna] Warsaw Univ Life Sci, Div Anim Pathophysiol, Dept Pathol & Vet Diagnost, Warsaw, Poland; [Witkowska-Pilaszewicz, Olga] Poznan Univ Life Sci, Fac Vet Med & Anim Sci, Dept Internal Dis & Vet Diagnost, Poznan, Poland	Warsaw University of Life Sciences; Poznan University of Life Sciences	Rzepecka, A (corresponding author), Warsaw Univ Life Sci, Div Anim Pathophysiol, Dept Pathol & Vet Diagnost, Warsaw, Poland.	airzepecka@gmail.com	Cywinska, Anna/AAD-2890-2020; Witkowska-Piłaszewicz, Olga/AGF-3131-2022; Witkowska-Piłaszewicz, Olga/AAI-8080-2021	Cywinska, Anna/0000-0002-5365-9218; Witkowska-Piłaszewicz, Olga/0000-0002-3541-5914; Witkowska-Piłaszewicz, Olga/0000-0002-3541-5914; Zmigrodzka, Magdalena/0000-0003-0880-9093; Winnicka, Anna/0000-0001-9918-3430	NCN (National Science Centre, Poland) [2015/17/N/NZ5/00663]; Faculty of Veterinary Medicine, Warsaw University of Life Sciences	NCN (National Science Centre, Poland); Faculty of Veterinary Medicine, Warsaw University of Life Sciences	This work was supported by NCN (National Science Centre, Poland) grant number 2015/17/N/NZ5/00663, https://www.ncn.gov.pl, and Faculty of Veterinary Medicine, Warsaw University of Life Sciences, http://www.sggw.pl/en/(both to A.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NCN (National Science Centre, Poland) grant number 2015/17/N/NZ5/00663 and Faculty of Veterinary Medicine, Warsaw University of Life Sciences (both to A.R.).	AHUJA V, 1995, CELL IMMUNOL, V163, P59, DOI 10.1006/cimm.1995.1099; ANEGON I, 1988, J EXP MED, V167, P452, DOI 10.1084/jem.167.2.452; Bui VC, 2016, J BIOMED MATER RES A, V104, P239, DOI 10.1002/jbm.a.35559; Castano D, 2011, TUBERCULOSIS, V91, P348, DOI 10.1016/j.tube.2011.04.002; COBBOLD S, 1994, TISSUE ANTIGENS, V43, P137, DOI 10.1111/j.1399-0039.1994.tb02315.x; Corripio-Miyar Y, 2015, VET RES, V46, DOI 10.1186/s13567-015-0246-4; de Carvalho CM, 2004, VET IMMUNOL IMMUNOP, V101, P171, DOI 10.1016/j.vetimm.2004.04.012; Degasperi GR, 2009, METABOLISM, V58, P1087, DOI 10.1016/j.metabol.2009.04.002; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; Duran MC, 2013, EQUINE VET J, V45, P249, DOI 10.1111/j.2042-3306.2012.00616.x; Fairbairn L, 2013, J IMMUNOL, V190, P6389, DOI 10.4049/jimmunol.1300365; Gibbons N, 2017, VET IMMUNOL IMMUNOP, V190, P26, DOI 10.1016/j.vetimm.2017.06.007; Goldman S J, 1988, Princess Takamatsu Symp, V19, P149; GROH V, 1986, J INVEST DERMATOL, V86, P115, DOI 10.1111/1523-1747.ep12284090; Hussen J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01875; Hussen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071502; Ikeda A, 1997, J VET MED SCI, V59, P715, DOI 10.1292/jvms.59.715; Javeed N, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1252013; JEFFERIES WA, 1985, J EXP MED, V162, P117, DOI 10.1084/jem.162.1.117; KAZAZI F, 1989, J GEN VIROL, V70, P2661, DOI 10.1099/0022-1317-70-10-2661; Koretzky GA, 2010, J IMMUNOL, V185, P2643, DOI 10.4049/jimmunol.1090076; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Mates JM, 2008, ARCH TOXICOL, V82, P273, DOI 10.1007/s00204-008-0304-z; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; MOORE PF, 1992, TISSUE ANTIGENS, V40, P75, DOI 10.1111/j.1399-0039.1992.tb01963.x; Noronha LE, 2012, VET IMMUNOL IMMUNOP, V146, P135, DOI 10.1016/j.vetimm.2012.02.006; Ohl K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02499; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Restaino RM, 2017, EXP PHYSIOL, V102, P139, DOI 10.1113/EP085794; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Santos Sidneia S, 2016, Intensive Care Med Exp, V4, P5, DOI 10.1186/s40635-016-0078-1; Tallone T, 2011, J CARDIOVASC TRANSL, V4, P211, DOI 10.1007/s12265-011-9256-4; Tian Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01728-5; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Vignali DAA, 2010, J IMMUNOL, V184, P5933, DOI 10.4049/jimmunol.1090037; VIVIER E, 1992, INT J CANCER, P11; Watanabe T, 2006, J HUM HYPERTENS, V20, P336, DOI 10.1038/sj.jhh.1001990; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; WOOD GS, 1983, J IMMUNOL, V131, P212; Yeap WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep34310; Zhen A, 2014, J VIROL, V88, P9934, DOI 10.1128/JVI.00616-14; Ziegler-Heitbrock L, 2014, CELL IMMUNOL, V289, P135, DOI 10.1016/j.cellimm.2014.03.019; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	43	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219214	10.1371/journal.pone.0219214	http://dx.doi.org/10.1371/journal.pone.0219214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269060	Green Published, gold, Green Submitted			2022-12-26	WOS:000484927300053
J	Nicoletti, M; Loppini, A; Chiodo, L; Folli, V; Ruocco, G; Filippi, S				Nicoletti, Martina; Loppini, Alessandro; Chiodo, Letizia; Folli, Viola; Ruocco, Giancarlo; Filippi, Simonetta			Biophysical modeling of C. elegans neurons: Single ion currents and whole-cell dynamics of AWC(on) and RMD	PLOS ONE			English	Article							GATED CALCIUM-CHANNEL; POTASSIUM CHANNELS; ACTION-POTENTIALS; K+-CHANNEL; VOLTAGE-DEPENDENCE; CA2+ CHANNEL; CONDUCTANCE; BISTABILITY; TEMPERATURE; SENSITIVITY	C. elegans neuronal system constitutes the ideal framework for studying simple, yet realistic, neuronal activity, since the whole nervous system is fully characterized with respect to the exact number of neurons and the neuronal connections. Most recent efforts are devoted to investigate and clarify the signal processing and functional connectivity, which are at the basis of sensing mechanisms, signal transmission, and motor control. In this framework, a refined model of whole neuron dynamics constitutes a key ingredient to describe the electrophysiological processes, both at the cellular and at the network scale. In this work, we present Hodgkin-Huxley-based models of ion channels dynamics black, built on data available both from C. elegans and from other organisms, expressing homologous channels. We combine these channel models to simulate the electrical activity of two among the most studied neurons in C. elegans, which display prototypical dynamics of neuronal activation, the chemosensory AWC(ON) and the motor neuron RMD. Our model properly describes the regenerative responses of the two cells. We analyze in detail the role of ion currents, both in wild type and in in silico knockout neurons. Moreover, we specifically investigate the behavior of RMD, identifying a heterogeneous dynamical response which includes bistable regimes and sustained oscillations. We are able to assess the critical role of T-type calcium currents, carried by CCA-1 channels, and leakage currents in the regulation of RMD response. Overall, our results provide new insights in the activity of key C. elegans neurons. The developed mathematical framework constitute a basis for single-cell and neuronal networks analyses, opening new scenarios in the in silico modeling of C. elegans neuronal system.	[Nicoletti, Martina; Loppini, Alessandro; Chiodo, Letizia; Filippi, Simonetta] Campus Biomed Univ, Dept Engn, Rome, Italy; [Nicoletti, Martina; Folli, Viola; Ruocco, Giancarlo] IIT, Ctr Life Nano Sci CLNS Sapienza, Rome, Italy	University Campus Bio-Medico - Rome Italy	Loppini, A; Chiodo, L (corresponding author), Campus Biomed Univ, Dept Engn, Rome, Italy.	a.loppini@unicampus.it; l.chiodo@unicampus.it	folli, viola/ABE-7803-2020; Ruocco, Giancarlo/A-6245-2010; Filippi, Simonetta/G-1261-2014; Chiodo, Letizia/G-9609-2012; Nicoletti, Martina/ABE-3130-2021	Ruocco, Giancarlo/0000-0002-2762-9533; Chiodo, Letizia/0000-0002-8278-7075; Nicoletti, Martina/0000-0003-0154-0482; FILIPPI, Simonetta/0000-0003-1952-0834; Loppini, Alessandro/0000-0002-8986-2365				Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Adelman JP, 1995, NEURON, V15, P1449, DOI 10.1016/0896-6273(95)90022-5; Alqadah A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005654; [Anonymous], 2005, POTASSIUM CHANNELS C; [Anonymous], 2006, CHEMOSENSATION C ELE; [Anonymous], 2018, CELL, DOI DOI 10.1016/HCELL.2018.08.018; [Anonymous], 2010, MATH FDN NEUROSCIENC; [Anonymous], 1952, J PHYSL, DOI DOI 10.1113/JPHYSIOL.1952.SP004764; [Anonymous], 2015, NATURE COMMUNICATION, DOI DOI 10.1038/NOMMS8191; Biron D, 2008, P NATL ACAD SCI USA, V105, P11002, DOI 10.1073/pnas.0805004105; Brenner S, 2009, GENETICS, V182, P413, DOI 10.1534/genetics.109.104976; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cai SQ, 2007, J BIOL CHEM, V282, P18597, DOI 10.1074/jbc.M702079200; Cai SQ, 2009, NAT NEUROSCI, V12, P611, DOI 10.1038/nn.2291; Cain SM, 2010, CHANNELS, V4, P475, DOI 10.4161/chan.4.6.14106; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chotoo CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075869; Chrisman SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151320; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cox DH, 2014, BIOPHYS J, V107, P2797, DOI 10.1016/j.bpj.2014.10.069; Crunelli V, 2005, J PHYSIOL-LONDON, V562, P121, DOI 10.1113/jphysiol.2004.076273; Dovzhenok A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042811; Emtage L, 2012, J NEUROSCI, V32, P16285, DOI 10.1523/JNEUROSCI.2667-12.2012; Ermentrout B, 2002, SIMULATING ANAL ANIM, V14; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Faumont S, 2006, J NEUROPHYSIOL, V95, P3665, DOI 10.1152/jn.00052.2006; Fawcett GL, 2006, J BIOL CHEM, V281, P30725, DOI 10.1074/jbc.M605814200; Frokjaer-Jensen C, 2006, J NEUROBIOL, V66, P1125, DOI 10.1002/neu.20261; Fuentealba P, 2005, J NEUROPHYSIOL, V93, P294, DOI 10.1152/jn.00552.2004; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Griffith T, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004949; HAYASHI H, 1988, BIOPHYS J, V53, P747, DOI 10.1016/S0006-3495(88)83155-2; Hobert O., 2013, NEURONAL GENOME CAEN; HOUNSGAARD J, 1984, EXP BRAIN RES, V55, P391; Huang SLB, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-24; Huang X, 2010, J EXP BIOL, V213, P2094, DOI 10.1242/jeb.042242; Itskovits E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05151-2; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Jeong K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17893; Johnstone DB, 1997, NEURON, V19, P151, DOI 10.1016/S0896-6273(00)80355-4; Jospin M, 2002, J CELL BIOL, V159, P337, DOI 10.1083/jcb.200203055; Kim H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000780; Kuramochi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168415; Laine V, 2011, J BIOL CHEM, V286, P36180, DOI 10.1074/jbc.M111.256149; Li LY, 2007, J NEUROSCI, V27, P13420, DOI 10.1523/JNEUROSCI.1709-07.2007; Liu P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6155; Liu P, 2011, J PHYSIOL-LONDON, V589, P101, DOI 10.1113/jphysiol.2010.200683; Lockery SR, 2009, NAT NEUROSCI, V12, P377, DOI 10.1038/nn0409-377; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Loppini A, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.032403; Loppini A, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/6/066002; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Mathews EA, 2003, J NEUROSCI, V23, P6537; Mellem JE, 2008, NAT NEUROSCI, V11, P865, DOI 10.1038/nn.2131; Mirzakhalili E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201302; Montefusco F, 2017, BIOPHYS J, V112, P2387, DOI 10.1016/j.bpj.2017.04.035; Oh KH, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0166-2; Pospischil M, 2008, BIOL CYBERN, V99, P427, DOI 10.1007/s00422-008-0263-8; Press W. H., 1992, ART SCI COMPUTING; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Riz M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003389; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Salkoff L, 2001, NEUROSCIENCE, V103, P853, DOI 10.1016/S0306-4522(01)00079-3; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Santi CM, 2003, P NATL ACAD SCI USA, V100, P14391, DOI 10.1073/pnas.1935976100; Senatore A., 2012, WIRES MEMBR TRANSP S, V1, P467, DOI DOI 10.1002/WMTS.41; Sengupta P, 2009, CURR OPIN NEUROBIOL, V19, P637, DOI 10.1016/j.conb.2009.09.009; SHERMAN A, 1988, BIOPHYS J, V54, P411, DOI 10.1016/S0006-3495(88)82975-8; Shtonda B, 2005, J EXP BIOL, V208, P2177, DOI 10.1242/jeb.01615; Smith GD, 2001, METH NE FRO NEUROSCI, P49; Steger KA, 2005, J EXP BIOL, V208, P2191, DOI 10.1242/jeb.01616; Sun L, 2000, J PHYSIOL-LONDON, V529, P139, DOI 10.1111/j.1469-7793.2000.00139.x; Tong WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114034; Topalidou I, 2017, GENETICS, V206, P265, DOI 10.1534/genetics.116.198820; Usuyama M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042907; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Wei AD, 2005, J BIOL CHEM, V280, P21337, DOI 10.1074/jbc.M502734200; Weinshenker D, 1999, J NEUROSCI, V19, P9831; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wolf JA, 2005, J NEUROSCI, V25, P9080, DOI 10.1523/JNEUROSCI.2220-05.2005; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Zhang Z, 2013, CHANNELS, V7, P194, DOI 10.4161/chan.24492	89	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0218738	10.1371/journal.pone.0218738	http://dx.doi.org/10.1371/journal.pone.0218738			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260485	Green Submitted, Green Published, gold			2022-12-26	WOS:000484918700021
J	De Oliveira, DMP; Everest-Dass, A; Hartley-Tassell, L; Day, CJ; Indraratna, A; Brouwer, S; Cleary, A; Kautto, L; Gorman, J; Packer, NH; Jennings, MP; Walker, MJ; Sanderson-Smith, ML				De Oliveira, David M. P.; Everest-Dass, Arun; Hartley-Tassell, Lauren; Day, Christopher J.; Indraratna, Anuk; Brouwer, Stephan; Cleary, Ailish; Kautto, Liisa; Gorman, Jody; Packer, Nicolle H.; Jennings, Michael P.; Walker, Mark J.; Sanderson-Smith, Martina L.			Human glycan expression patterns influence Group A streptococcal colonization of epithelial cells	FASEB JOURNAL			English	Article						glycosylation; M protein; pathogenesis; blood group antigens	ABO BLOOD-GROUPS; STRUCTURAL-ANALYSIS; TISSUE TROPISMS; BINDING; INFECTION; PYOGENES; PROTEIN; ENDOGLYCOSIDASE; INHIBITORS; PHENOTYPE	Colonization of the oropharynx is the initial step in Group A Streptococcus (GAS) pharyngeal infection. We have previously reported that the highly virulent M1T1 GAS clone attaches to oral epithelial cells via M1 protein interaction with blood group antigen carbohydrate structures. Here, we have identified that colonization of human oral epithelial cells by GAS serotypes M3 and M12 is mediated by human blood group antigens [ABO(H)] and Lewis (Le) antigen expression. Removal of linkage-specific fucose, galactose, N-acetylgalactosamine, and sialic acid modulated GAS colonization, dependent on host ABO(H) blood group and Le expression profile. Furthermore, N-linked glycans from human salivary glycoproteins, when released and purified, were potent inhibitors of M1, M3, and M12 GAS colonization ex vivo. These data highlight the important role played by human protein glycosylation patterns in GAS attachment to oral epithelial cell surfaces.-De Oliveira, D. M. P., Everest-Dass, A., Hartley-Tassell, L., Day, C. J., Indraratna, A., Brouwer, S., Cleary, A., Kautto, L., Gorman, J., Packer, N. H., Jennings, M. P., Walker, M. J., Sanderson-Smith, M. L. Human glycan expression patterns influence Group A streptococcal colonization of epithelial cells.	[De Oliveira, David M. P.; Indraratna, Anuk; Cleary, Ailish; Gorman, Jody; Sanderson-Smith, Martina L.] Univ Wollongong, Sch Chem & Mol Biosci, Mol Horizons & Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [De Oliveira, David M. P.; Brouwer, Stephan; Walker, Mark J.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Everest-Dass, Arun; Kautto, Liisa; Packer, Nicolle H.] Macquarie Univ, Dept Mol Sci, Sydney, NSW, Australia; [Everest-Dass, Arun; Hartley-Tassell, Lauren; Day, Christopher J.; Packer, Nicolle H.; Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia	University of Wollongong; University of Queensland; Macquarie University; Griffith University	Sanderson-Smith, ML (corresponding author), Univ Wollongong, Northfields Ave, Wollongong, NSW 2522, Australia.	martina@uow.edu.au	Dass, Arun/C-1290-2014; Jennings, Michael P/G-4822-2013; Everest-Dass, Arun/AAF-3322-2019; Sanderson-Smith, Martina/H-9614-2013	Jennings, Michael P/0000-0002-1027-4684; Packer, Nicolle/0000-0002-7532-4021; Sanderson-Smith, Martina/0000-0002-6366-4993; Walker, Mark/0000-0001-7423-2769; Everest-Dass, Arun/0000-0002-3795-0291; Indraratna, Anuk Dulanta/0000-0003-0003-4860; Kautto, Liisa/0000-0002-4724-8818; De Oliveira, David/0000-0002-5085-7163; Brouwer, Stephan/0000-0002-9777-2992	National Health and Medical Research Council of Australia (NHMRC) [1143266]; NHMRC [1071659, 1138466]; Illawarra Health and Medical Research Institute (IHMRI)	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Illawarra Health and Medical Research Institute (IHMRI)	This work was funded by the National Health and Medical Research Council of Australia (NHMRC) Project Grant 1143266 to M.S-S, A.E-D and N.H.P; NHMRC Program Grant 1071659 to M.P.J and M.J.W; the Illawarra Health and Medical Research Institute (IHMRI) Career Development Grant (to D.M.P.D) and NHMRC Principal Research Fellowship 1138466 (to M.P.J).	[Anonymous], [No title captured]; Armah GE, 2010, J INFECT DIS, V202, pS64, DOI 10.1086/653571; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; Bessen DE, 2016, CURR OPIN INFECT DIS, V29, P295, DOI 10.1097/QCO.0000000000000262; Bessen DE, 2010, FUTURE MICROBIOL, V5, P623, DOI [10.2217/fmb.10.28, 10.2217/FMB.10.28]; Brouwer S, 2016, FEBS LETT, V590, P3739, DOI 10.1002/1873-3468.12254; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chang JS, 2010, BLOOD, V116, P1779, DOI 10.1182/blood-2009-12-260513; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14; Day CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004927; De Oliveira DMP, 2017, MBIO, V8, DOI 10.1128/mBio.02237-16; Dean L., 2005, BLOOD CELLS IT CONTA; Everest-Dass AV, 2012, GLYCOBIOLOGY, V22, P1465, DOI 10.1093/glycob/cws112; Gallegos KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030368; Goodfellow JJ, 2012, J AM CHEM SOC, V134, P8030, DOI 10.1021/ja301334b; HASTY DL, 1992, INFECT IMMUN, V60, P2147, DOI 10.1128/IAI.60.6.2147-2152.1992; HAVERKORN MJ, 1969, AM J HUM GENET, V21, P360; Hong YJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/573652; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Jaff MS, 2011, CLIN EXP GASTROENTER, V4, P221, DOI 10.2147/CEG.S23019; Jaff MS, 2010, INT J NANOMED, V5, P901, DOI 10.2147/IJN.S13980; Kautto L, 2016, EXP EYE RES, V145, P278, DOI 10.1016/j.exer.2016.01.013; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Kouki A, 2011, J BIOL CHEM, V286, P38854, DOI 10.1074/jbc.M111.260992; Lee JL, 2009, AUTOIMMUN REV, V9, P117, DOI 10.1016/j.autrev.2009.04.002; MCCORKLE LP, 1955, NEW ENGL J MED, V252, P1066, DOI 10.1056/NEJM195506232522502; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; Murakami J, 2012, J BIOL CHEM, V287, P22266, DOI 10.1074/jbc.M112.350082; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Ryan PA, 2001, INFECT IMMUN, V69, P7402, DOI 10.1128/IAI.69.12.7402-7412.2001; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; Shewell LK, 2014, P NATL ACAD SCI USA, V111, pE5312, DOI 10.1073/pnas.1412703111; Sims Sanyahumbi A, 2016, STREPTOCOCCUS PYOGEN; Tse H, 2012, J INFECT DIS, V206, P341, DOI 10.1093/infdis/jis362; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13; WANG JR, 1994, INFECT IMMUN, V62, P1268, DOI 10.1128/IAI.62.4.1268-1274.1994; Ziegler T, 2004, INT J ANTIMICROB AG, V24, pS70, DOI 10.1016/j.ijantimicag.2004.03.002	41	5	5	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10808	10818		10.1096/fj.201900559R	http://dx.doi.org/10.1096/fj.201900559R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31262188				2022-12-26	WOS:000489166300019
J	Choi, SH; Koh, DI; Cho, SY; Kim, MK; Kim, KS; Hur, MW				Choi, Seo-Hyun; Koh, Dong-In; Cho, Su-Yeon; Kim, Min-Kyeong; Kim, Kyung-Sup; Hur, Man-Wook			Temporal and differential regulation of KAISO-controlled transcription by phosphorylated and acetylated p53 highlights a crucial regulatory role of apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p53; apoptosis; gene transcription; transcription factor; DNA damage; post-translational modification (PTM); DNA damage response; KAISO; mutant p53; p53QRQ; transcriptional regulation; DNA damage response (DDR); zinc finger and BTB domain-containing 33 (ZBTB33); stress response	DAMAGE-INDUCED PHOSPHORYLATION; POSTTRANSLATIONAL MODIFICATIONS; BINDING-PROTEIN; DNA-BINDING; ACTIVATION; ATM; DEACETYLATION; CANCER; UBIQUITINATION; INHIBITION	Transcriptional regulator KAISO plays a critical role in cell cycle arrest and apoptosis through modulation of p53 acetylation by histone acetyltransferase p300. KAISO potently stimulates apoptosis in cells expressing WT p53, but not in p53-mutant or p53-null cells. Here, we investigated how KAISO transcription is regulated by p53, finding four potential p53-binding sites (p53-responsive DNA elements; p53REs) located in a distal 5'-upstream regulatory element, intron 1, exon 2 coding sequence, and a 3'-UTR region. Transient transcription assays of pG5-p53RE-Luc constructs with various p53REs revealed that p53 activates KAISO (ZBTB33) transcription by acting on p53RE1 (-4326 to -4227) of the 5'-upstream region and on p53RE3 (+2929 to +2959) of the exon 2 coding region during early DNA damage responses (DDRs). ChIP and oligonucleotide pulldown assays further disclosed that p53 binds to the p53RE1 and p53RE3 sites. Moreover, ataxia telangiectasia mutated (ATM) or ATM-Rad3-related (ATR) kinase-mediated p53 phosphorylation at Ser-15 or Ser-37 residues activated KAISO transcription by binding its p53RE1 or p53RE3 sites during early DDR. p53RE1 uniquely contained three p53-binding half-sites, a structural feature important for transcriptional activation by phosphorylated p53 Ser-15.Ser-37. During the later DDR phase, a KAISO-mediated acetylated p53 form (represented by a p53QRQ acetyl-mimic) robustly activated transcription by acting on p53RE1 in which this structural feature is not significant, but it provided sufficient KAISO levels to confer a p53 "apoptotic code." These results suggest that the critical apoptosis regulator KAISO is a p53 target gene that is differently regulated by phosphorylated p53 or acetylated p53, depending on DDR stage.	[Choi, Seo-Hyun; Koh, Dong-In; Cho, Su-Yeon; Kim, Min-Kyeong; Kim, Kyung-Sup; Hur, Man-Wook] Yonsei Univ, Brain Korea 21 Plus Project Med Sci, Dept Biochem & Mol Biol, Severance Biomed Res Inst,Sch Med, 50-1 Yonsei Ro, Seoul 03722, South Korea	Yonsei University	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, 134 ShinChon Dong, Seoul 120752, South Korea.	mwhur2@yuhs.ac		Hur, Man-Wook/0000-0002-3416-1334; Kim, Kyung-sup/0000-0001-8483-8537	National Research Foundation of Korea (NRF) of the Korean Government (MSIP) [2016R1E1A1A02921938, 2011-0028817, 2011-0030086]	National Research Foundation of Korea (NRF) of the Korean Government (MSIP)	This work was supported by JeonRack-HooSok Grant 2016R1E1A1A02921938 (to M.-W. H.), Do-Yak Research Grant 2011-0028817 (to M.-W. H.), and Medical Research Center Grant 2011-0030086 (to M.-W. H.) from the National Research Foundation of Korea (NRF) of the Korean Government (MSIP). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Berglind H, 2008, CANCER BIOL THER, V7, P699, DOI 10.4161/cbt.7.5.5712; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen JJ, 2017, J CELL PHYSIOL, V232, P2308, DOI 10.1002/jcp.25669; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Dohoney KM, 2004, ONCOGENE, V23, P49, DOI 10.1038/sj.onc.1207005; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Koh DI, 2015, BBA-GENE REGUL MECH, V1849, P1170, DOI 10.1016/j.bbagrm.2015.07.008; Koh DI, 2014, P NATL ACAD SCI USA, V111, P15078, DOI 10.1073/pnas.1318780111; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lopes EC, 2008, CANCER RES, V68, P7258, DOI 10.1158/0008-5472.CAN-08-0344; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Rozan LM, 2007, CELL DEATH DIFFER, V14, P3, DOI 10.1038/sj.cdd.4402058; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang H, 2008, J BIOL CHEM, V283, P2564, DOI 10.1074/jbc.M702454200; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; ZAMBETTI GP, 1993, FASEB J, V7, P855, DOI 10.1096/fasebj.7.10.8344485; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	49	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12957	12974		10.1074/jbc.RA119.008100	http://dx.doi.org/10.1074/jbc.RA119.008100			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296660	Green Published, hybrid			2022-12-26	WOS:000486416000009
J	Malfatti, MC; Henneke, G; Balachander, S; Koh, KD; Newnam, G; Uehara, R; Crouch, RJ; Storici, F; Tell, G				Malfatti, Matilde Clarissa; Henneke, Ghislaine; Balachander, Sathya; Koh, Kyung Duk; Newnam, Gary; Uehara, Ryo; Crouch, Robert J.; Storici, Francesca; Tell, Gianluca			Unlike the Escherichia coli counterpart, archaeal RNase HII cannot process ribose monophosphate abasic sites and oxidized ribonucleotides embedded in DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribonuclease; bacteria; Escherichia coli (E coli); archaea; oxidative stress; abasic-ribose; oxidized-ribonucleotides; Pyrococcus abyssi; Type 2 RNase H	CRYSTAL-STRUCTURES; REPAIR; H2; MECHANISM; GENOME; IMPACT	The presence of ribonucleoside monophosphates (rNMPs) in nuclear DNA decreases genome stability. To ensure survival despite rNMP insertions, cells have evolved a complex network of DNA repair mechanisms, in which the ribonucleotide excision repair pathway, initiated by type 2 RNase H (RNase HII/2), plays a major role. We recently demonstrated that eukaryotic RNase H2 cannot repair damage, that is, ribose monophosphate abasic (both apurinic or apyrimidinic) site (rAP) or oxidized rNMP embedded in DNA. Currently, it remains unclear why RNase H2 is unable to repair these modified nucleic acids having either only a sugar moiety or an oxidized base. Here, we compared the endoribonuclease specificity of the RNase HII enzymes from the archaeon Pyrococcus abyssi and the bacterium Escherichia coli, examining their ability to process damaged rNMPs embedded in DNA in vitro. We found that E. coli RNase HII cleaves both rAP and oxidized rNMP sites. In contrast, like the eukaryotic RNase H2, P. abyssi RNase HII did not display any rAP or oxidized rNMP incision activities, even though it recognized them. Notably, the archaeal enzyme was also inactive on a mismatched rNMP, whereas the E. coli enzyme displayed a strong preference for the mispaired rNMP over the paired rNMP in DNA. On the basis of our biochemical findings and also structural modeling analyses of RNase HII/2 proteins from organisms belonging to all three domains of life, we propose that RNases HII/2's dual roles in ribonucleotide excision repair and RNA/DNA hydrolysis result in limited acceptance of modified rNMPs embedded in DNA.	[Malfatti, Matilde Clarissa; Tell, Gianluca] Univ Udine, Dept Med, Lab Mol Biol & DNA Repair, Piazzale M Kolbe 4, I-33100 Udine, Italy; [Henneke, Ghislaine] Univ Brest, CNRS, IFREMER, Lab Microbiol Environm Extremes, F-29280 Plouzane, France; [Balachander, Sathya; Koh, Kyung Duk; Newnam, Gary; Storici, Francesca] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Uehara, Ryo] Ritsumeikan Univ, Ritsumeikan Global Innovat Res Org, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan; [Crouch, Robert J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Koh, Kyung Duk] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA	University of Udine; Centre National de la Recherche Scientifique (CNRS); Ifremer; Universite de Bretagne Occidentale; University System of Georgia; Georgia Institute of Technology; Ritsumeikan University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Francisco	Tell, G (corresponding author), Univ Udine, Dept Med, Lab Mol Biol & DNA Repair, Piazzale M Kolbe 4, I-33100 Udine, Italy.	gianluca.tell@uniud.it		Henneke, Ghislaine/0000-0002-2985-5526; Uehara, Ryo/0000-0002-7534-599X; Tell, Gianluca/0000-0001-8845-6448; MALFATTI, MATILDE CLARISSA/0000-0002-8101-568X	Associazione Italiana per la Ricerca sul Cancro Grant [IG19862]; NIEHS, National Institutes of Health [1R01ES026243-01]; Howard Hughes Medical Institute Faculty Scholar Grant [55108574]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026243] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro Grant(Fondazione AIRC per la ricerca sul cancro); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Howard Hughes Medical Institute Faculty Scholar Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Associazione Italiana per la Ricerca sul Cancro Grant IG19862 (to G. T.), by NIEHS, National Institutes of Health Grant 1R01ES026243-01 (to F. S.), and Howard Hughes Medical Institute Faculty Scholar Grant 55108574 (to F. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Caldecott KW, 2014, SCIENCE, V343, P260, DOI 10.1126/science.1248234; Cerritelli SM, 2016, TRENDS BIOCHEM SCI, V41, P434, DOI 10.1016/j.tibs.2016.02.005; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chiu HC, 2014, NANOSCALE, V6, P10009, DOI 10.1039/c4nr01794c; Chon H, 2013, NUCLEIC ACIDS RES, V41, P3130, DOI 10.1093/nar/gkt027; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Cilli P, 2015, J BIOL CHEM, V290, P26259, DOI 10.1074/jbc.M115.679209; Clausen AR, 2013, DNA REPAIR, V12, P121, DOI 10.1016/j.dnarep.2012.11.006; Cohen GN, 2003, MOL MICROBIOL, V47, P1495, DOI 10.1046/j.1365-2958.2003.03381.x; Crespan E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10805; Dalgaard JZ, 2012, TRENDS GENET, V28, P592, DOI 10.1016/j.tig.2012.07.008; EGLI M, 1993, BIOCHEMISTRY-US, V32, P3221, DOI 10.1021/bi00064a004; El Hage A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004716; Eme L, 2017, NAT REV MICROBIOL, V15, P711, DOI 10.1038/nrmicro.2017.133; Evich M, 2016, CHEMBIOCHEM, V17, P1968, DOI 10.1002/cbic.201600385; Figiel M, 2011, J BIOL CHEM, V286, P10540, DOI 10.1074/jbc.M110.181974; GASPARUTTO D, 1992, NUCLEIC ACIDS RES, V20, P5159, DOI 10.1093/nar/20.19.5159; Heider MR, 2017, J BIOL CHEM, V292, P8835, DOI 10.1074/jbc.M117.783472; Henneke G, 2012, BIOCHEM J, V447, P271, DOI 10.1042/BJ20120959; Huang SYN, 2015, J BIOL CHEM, V290, P14068, DOI 10.1074/jbc.M115.653345; Koh KD, 2015, NAT METHODS, V12, P251, DOI [10.1038/NMETH.3259, 10.1038/nmeth.3259]; Le Laz S, 2010, J BACTERIOL, V192, P3689, DOI 10.1128/JB.00268-10; Lemor M, 2018, J MOL BIOL, V430, P4908, DOI 10.1016/j.jmb.2018.10.004; Lindsey-Boltz LA, 2015, J BIOL CHEM, V290, P29801, DOI 10.1074/jbc.M115.695254; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Malfatti MC, 2017, NUCLEIC ACIDS RES, V45, P11193, DOI 10.1093/nar/gkx723; Morelra PI, 2008, FREE RADICAL BIO MED, V44, P1493, DOI 10.1016/j.freeradbiomed.2008.01.002; Muroya A, 2001, PROTEIN SCI, V10, P707, DOI 10.1110/ps.48001; Ohtani N, 1999, BIOCHEMISTRY-US, V38, P605, DOI 10.1021/bi982207z; Potenski CJ, 2014, NUCLEIC ACIDS RES, V42, P10226, DOI 10.1093/nar/gku773; RANDERATH K, 1992, MUTAT RES, V275, P355, DOI 10.1016/0921-8734(92)90038-Q; Reijns MAM, 2011, J BIOL CHEM, V286, P10530, DOI 10.1074/jbc.M110.177394; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; Sassa A, 2019, GENES ENVIRON, V41, DOI 10.1186/s41021-019-0118-7; Sassa A, 2016, J BIOL CHEM, V291, P24314, DOI 10.1074/jbc.M116.738732; Shen Y, 2012, NAT STRUCT MOL BIOL, V19, P98, DOI 10.1038/nsmb.2176; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Tadokoro T, 2009, FEBS J, V276, P1482, DOI 10.1111/j.1742-4658.2009.06907.x; Williams JS, 2016, NAT REV MOL CELL BIO, V17, P350, DOI 10.1038/nrm.2016.37	40	9	9	4	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13061	13072		10.1074/jbc.RA119.009493	http://dx.doi.org/10.1074/jbc.RA119.009493			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31300556	Green Published, hybrid			2022-12-26	WOS:000486416000017
J	Wittenborn, EC; Cohen, SE; Merrouch, M; Leger, C; Fourmond, V; Dementin, S; Drennan, CL				Wittenborn, Elizabeth C.; Cohen, Steven E.; Merrouch, Meriem; Leger, Christophe; Fourmond, Vincent; Dementin, Sebastien; Drennan, Catherine L.			Structural insight into metallocofactor maturation in carbon monoxide dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nickel; iron-sulfur protein; metalloenzyme; one-carbon metabolism; oxidation-reduction (redox); X-ray crystallography; bioremediation catalyst; carbon monoxide dehydrogenase (CODH); heterometallic cofactor	RHODOSPIRILLUM-RUBRUM; CO-DEHYDROGENASE; ACETYL-COA; CLOSTRIDIUM-THERMOACETICUM; NICKEL INSERTION; ACTIVE-SITE; CLUSTER; PROTEIN; MECHANISM; INTERCONVERSIONS	The nickel-dependent carbon monoxide dehydrogenase (CODH) employs a unique heterometallic nickel-iron-sulfur cluster, termed the C-cluster, to catalyze the interconversion of CO and CO2. Like other complex metalloenzymes, CODH requires dedicated assembly machinery to form the fully intact and functional C-cluster. In particular, nickel incorporation into the C-cluster depends on the maturation factor CooC; however, the mechanism of nickel insertion remains poorly understood. Here, we compare X-ray structures (1.50-2.48 angstrom resolution) of CODH from Desulfovibrio vulgaris (DvCODH) heterologously expressed in either the absence (DvCODH(-CooC)) or presence (DvCODH(+CooC)) of co-expressed CooC. We find that the C-cluster of DvCODH(-CooC) is fully loaded with iron but does not contain any nickel. Interestingly, the so-called unique iron ion (Fe-u) occupies both its canonical site (80% occupancy) and the nickel site (20% occupancy), with addition of reductant causing further mismetallation of the nickel site (60% iron occupancy). We also demonstrate that a DvCODH variant that lacks a surface-accessible iron-sulfur cluster (the D-cluster) has a C-cluster that is also replete in iron but lacks nickel, despite co-expression with CooC. In this variant, all Fe-u is in its canonical location, and the nickel site is empty. This D-cluster-deficient CODH is inactive despite attempts to reconstitute it with nickel. Taken together, these results suggest that an empty nickel site is not sufficient for nickel incorporation. Based on our findings, we propose a model for C-cluster assembly that requires both CooC and a functioning D-cluster, involves precise redox-state control, and includes a two-step nickel-binding process.	[Wittenborn, Elizabeth C.; Cohen, Steven E.; Drennan, Catherine L.] MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Merrouch, Meriem; Leger, Christophe; Fourmond, Vincent; Dementin, Sebastien] Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee, Lab Bioenerget & Ingn Prot, Marseille, France; [Drennan, Catherine L.] Canadian Inst Adv Res, Bioinspired Solar Energy Program, Toronto, ON M5G 1M1, Canada; [Wittenborn, Elizabeth C.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Canadian Institute for Advanced Research (CIFAR); University of California System; University of California Berkeley	Drennan, CL (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Dementin, S (corresponding author), Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee, Lab Bioenerget & Ingn Prot, Marseille, France.	dementin@imm.cnrs.fr; cdrennan@mit.edu	Fourmond, Vincent/K-1706-2014; Leger, Christophe/C-7230-2016	Fourmond, Vincent/0000-0001-9837-6214; Cohen, Steven/0000-0002-3193-0740; Leger, Christophe/0000-0002-8871-6059; Merrouch, Meriem/0000-0001-6948-0135; Dementin, Sebastien/0000-0001-6168-5371; Drennan, Catherine/0000-0001-5486-2755	National Institutes of Health [T32 GM008334, R01 GM069857, R35 GM126982]; French Agence Nationale de la Recherche [ANR-15-CE05-0020, ANR-17-CE11-0027]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069857, T32GM008334, R35GM126982, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants T32 GM008334 (to E.C.W. and S.E.C.) and R01 GM069857 and R35 GM126982 (to C.L.D.) and the work in Marseille was funded by the French Agence Nationale de la Recherche (ANR-15-CE05-0020 and ANR-17-CE11-0027). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alfano M, 2018, J BIOL INORG CHEM, V23, P809, DOI 10.1007/s00775-018-1576-2; Alfano M., 2019, J BIOL CHEM; ANDERSON ME, 1994, BIOCHEMISTRY-US, V33, P8702, DOI 10.1021/bi00195a011; BARTHOLOMEW GW, 1979, APPL ENVIRON MICROB, V37, P932, DOI 10.1128/AEM.37.5.932-937.1979; Can M, 2014, CHEM REV, V114, P4149, DOI 10.1021/cr400461p; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CONOVER RC, 1990, J AM CHEM SOC, V112, P4562, DOI 10.1021/ja00167a074; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; DeRose VJ, 1998, J AM CHEM SOC, V120, P8767, DOI 10.1021/ja9731480; Dobbek H, 2001, SCIENCE, V293, P1281, DOI 10.1126/science.1061500; Drennan CL, 2001, P NATL ACAD SCI USA, V98, P11973, DOI 10.1073/pnas.211429998; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENSIGN SA, 1990, BIOCHEMISTRY-US, V29, P2162, DOI 10.1021/bi00460a029; Hadj-Said J, 2015, BBA-BIOENERGETICS, V1847, P1574, DOI 10.1016/j.bbabio.2015.08.002; Hu ZG, 1996, J AM CHEM SOC, V118, P830, DOI 10.1021/ja9528386; Inoue T, 2013, BIOCHEM BIOPH RES CO, V441, P13, DOI 10.1016/j.bbrc.2013.09.143; Jeon WB, 2005, J BIOL INORG CHEM, V10, P903, DOI 10.1007/s00775-005-0043-z; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; Jeoung JH, 2007, SCIENCE, V318, P1461, DOI 10.1126/science.1148481; Jeoung JH, 2014, BIOL CHEM, V395, P545, DOI 10.1515/hsz-2013-0290; Jeoung JH, 2010, J MOL BIOL, V396, P1165, DOI 10.1016/j.jmb.2009.12.062; Jeoung JH, 2009, BIOCHEMISTRY-US, V48, P11505, DOI 10.1021/bi901443z; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KENT TA, 1982, P NATL ACAD SCI-BIOL, V79, P1096, DOI 10.1073/pnas.79.4.1096; Kerby RL, 1997, J BACTERIOL, V179, P2259, DOI 10.1128/jb.179.7.2259-2266.1997; Kim EJ, 2004, BIOCHEMISTRY-US, V43, P5728, DOI 10.1021/bi036062u; KUMAR M, 1993, J AM CHEM SOC, V115, P11646, DOI 10.1021/ja00077a093; Kung Y, 2009, BIOCHEMISTRY-US, V48, P7432, DOI 10.1021/bi900574h; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merrouch M, 2018, J BIOL INORG CHEM, V23, P613, DOI 10.1007/s00775-018-1541-0; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; MOURA JJG, 1982, J BIOL CHEM, V257, P6259; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; ROBBINS AH, 1989, P NATL ACAD SCI USA, V86, P3639, DOI 10.1073/pnas.86.10.3639; Shepard EM, 2011, CURR OPIN CHEM BIOL, V15, P319, DOI 10.1016/j.cbpa.2011.02.012; Spangler NJ, 1998, J BIOL CHEM, V273, P4059, DOI 10.1074/jbc.273.7.4059; Staples CR, 1999, J AM CHEM SOC, V121, P11034, DOI 10.1021/ja990396i; SVETLICHNY VA, 1991, SYST APPL MICROBIOL, V14, P254, DOI 10.1016/S0723-2020(11)80377-2; Svetlitchnyi V, 2001, J BACTERIOL, V183, P5134, DOI 10.1128/JB.183.17.5134-5144.2001; Timm J, 2017, METALLOMICS, V9, P575, DOI 10.1039/c7mt00063d; UFFEN RL, 1976, P NATL ACAD SCI USA, V73, P3298, DOI 10.1073/pnas.73.9.3298; Watt RK, 1998, J BIOL CHEM, V273, P10019, DOI 10.1074/jbc.273.16.10019; Wittenborn EC, 2018, ELIFE, V7, DOI 10.7554/eLife.39451; Zhou J, 1997, J AM CHEM SOC, V119, P6242, DOI 10.1021/ja9704186	46	11	11	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13017	13026		10.1074/jbc.RA119.009610	http://dx.doi.org/10.1074/jbc.RA119.009610			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296570	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000486416000013
J	Aye, SKK; Hlaing, HH; Htay, SS; Cumming, R				Aye, San Kyu Kyu; Hlaing, Hlaing Hlaing; Htay, San San; Cumming, Robert			Multimorbidity and health seeking behaviours among older people in Myanmar: A community survey	PLOS ONE			English	Article							ELDERLY-PEOPLE; PATTERNS; PREVALENCE; ADULTS; CARE	Background The world population is aging very rapidly and the impact is more severe in developing countries because of insufficient resources and low awareness of the challenges faced by older people. This study aimed to explore multimorbidity of older people in Myanmar and their health seeking behaviours. Methods A community-based cross-sectional study was conducted in both urban and rural areas of Bago Region and Mon State during October 2016. A multistage sampling method was used to select 4,859 people aged 60 years and older. Participants were interviewed face-to-face using a questionnaire. Multinominal logistic regression was used to analyse data. Results More than half of the study participants (57.9%) reported at least one chronic condition in the last year and 33.2% reported two or more conditions (multimorbidity). The common conditions were hypertension (67.3%), arthritis (24.7%), arrhythmia (14.7%), coronary heart disease (13.8%) and diabetes (13.7%). A majority (61.7%) of participants with a chronic condition took western medicine. Older people usually saw a doctor (60.2%) or health assistant (21.9%) at a nearby clinic or rural health center; 1.6% reported seeing uncredentialed medical persons. Factors associated with multimorbidity were being female (adjusted Prevalence Ratio (aPR) = 2.14, 95% confidence interval (CI) 1.63-2.82) and having fair (aPR = 2.20, 95% CI 1.59-3.04) or poor self-reported health (aPR = 3.93, 95% CI 2.79-5.52). Those with less than middle school education (aPR = 0.50, 95% CI 0.25-0.99) and those living in rural areas (aPR = 0.78, 95% CI 0.62-0.98) were less likely to have multimorbidity. Older people in rural areas had less access to health care than their urban counterparts. Conclusion Chronic conditions are common among older people in Myanmar, with higher prevalence in women and in urban areas. The lower prevalence of chronic conditions in those who live in rural areas may be related to living a more traditional lifestyle.	[Aye, San Kyu Kyu; Hlaing, Hlaing Hlaing] Univ Med Mandalay, Dept Prevent & Social Med, Mandalay, Myanmar; [Htay, San San] Univ Med 2, Dept Prevent & Social Med, Yangon, Myanmar; [Cumming, Robert] Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia	University of Sydney	Aye, SKK (corresponding author), Univ Med Mandalay, Dept Prevent & Social Med, Mandalay, Myanmar.	sankyukyuaye@gmail.com		Aye, San Kyu Kyu/0000-0001-7545-2608				[Anonymous], 2012, LANCET; Department of Population & United Nations Population Fund, 2005, ELD POP MYANM TRENDS; Diederichs C, 2011, J GERONTOL A-BIOL, V66, P301, DOI 10.1093/gerona/glq208; Garin N, 2016, J GERONTOL A-BIOL, V71, P205, DOI 10.1093/gerona/glv128; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th; Han M, 2012, REGIONAL HLTH FORUM; He W, 2012, SHADES GRAY CROSS CO; Hussain MA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009810; Jabeen s, 2013, J DHAKA MED COLL, V22, P129, DOI DOI 10.3329/JDMC.V22I2.21522; Khanam MA, 2011, J HEALTH POPUL NUTR, V29, P406, DOI 10.3329/jhpn.v29i4.8458; Knodel J., 2014, BOLD, V24, P9; Knodel J, 2017, GERONTOLOGIST, V57, P599, DOI 10.1093/geront/gnw211; Knodel J, 2015, J CROSS-CULT GERONTO, V30, P1, DOI 10.1007/s10823-014-9254-5; Kubinger K., 2003, PSYCHOL SCI, V45, P106, DOI DOI 10.1177/014662169101500105; Li J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3335-z; Lujic S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183817; Marengoni A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7029027; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Mini GK, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013529; Ministry of Health, 2014, REP UN MYANM, P61; Ministry of Immigration and Population (2015a), 2015, 2014 MYANM POP HOUS; Moe S, 2012, INT J COLLAB RES INT, V4, P1538; Mwangi J, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0266-8; Nunes BP, 2016, ARCH GERONTOL GERIAT, V67, P130, DOI 10.1016/j.archger.2016.07.008; Palladino R, 2016, AGE AGEING, V45, P431, DOI 10.1093/ageing/afw044; Pati S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183966; Pati S, 2015, ANN FAM MED, V13, P446, DOI 10.1370/afm.1843; Pengpid S, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091019; Piramanayagam A, 2013, INT J MED RES HEALTH, V2, P372, DOI 10.5958/j.2319-5886.2.3.066; Poblador-Plou B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100375; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Rajan SI, 2017, STUDY ACCESSING HEAL; Rzewuska M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171813; Shrestha LB, 2000, HEALTH AFFAIR, V19, P204, DOI 10.1377/hlthaff.19.3.204; Stubbs B, 2018, MATURITAS, V107, P84, DOI 10.1016/j.maturitas.2017.10.007; Teerawichitchainan B, 2018, J CROSS-CULT GERONTO, V33, P143, DOI 10.1007/s10823-017-9336-2; United Nations, 2015, WORLD POP AG 2015; Wang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138521; Woo EK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-10	41	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219543	10.1371/journal.pone.0219543	http://dx.doi.org/10.1371/journal.pone.0219543			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4LN	31295287	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800044
J	Nasir, MSM; Ab-Kadir, MZA; Radzi, MAM; Izadi, M; Ahmad, NI; Zaini, NH				Nasir, M. S. M.; Ab-Kadir, M. Z. A.; Radzi, M. A. M.; Izadi, M.; Ahmad, N. I.; Zaini, N. H.			Lightning performance analysis of a rooftop grid-connected solar photovoltaic without external lightning protection system	PLOS ONE			English	Article							ENERGY	The Sustainable Energy Development Authority of Malaysia (SEDA) regularly receives complaints about damaged components and distribution boards of PV systems due to lightning strikes. Permanent and momentary interruptions of distribution circuits may also occur from the disturbance. In this paper, a solar PV Rooftop system (3.91 kWp) provided by SEDA was modelled in the PSCAD/EMTDC. The Heidler function was used as a lightning current waveform model to analyse the transient current and voltage at two different points susceptible to the influence of lightning events such as different lightning current wave shape, standard lightning current and non-standard lightning current. This study examines the effect on the system components when lightning directly strikes at two different points of the installation. The two points lie between the inverter and the solar PV array and between inverter and grid. Exceptionally high current and voltage due to the direct lightning strike on a certain point of a PV Rooftop system was also studied. The result of this case study is observed with and without the inclusion of surge protective devices (SPDs). The parameters used were 31 kA of peak current, 10 metres cable length and lightning impulse current wave shape of 8/20 mu s. The high current and voltage at P1 striking point were 31 kA and 2397 kV, respectively. As for the AC part, the current and voltage values were found to be 5.97 kA and 5392 kV, respectively. Therefore, SPDs with suitable rating provided by SEDA were deployed. Results showed that high transient current voltage is expected to clamp sharply at the values of 1.915 kV and 0 A at the P1 striking point. As for the AC part, the current and voltage values were found to be 0 kA and 0.751 V, respectively. Varying lightning impulse current wave shapes at striking point P2 showed that the highest voltage was obtained at waveshape 10/350 mu s at 11277 kV followed by wave shapes of 2/70 mu s, 8/20 mu s and 0.7/6 mu s. The high value of transient voltage was clamped at a lower level of 2.029 kV. Different lightning amplitudes were also applied, ranging from 2-200 kA selected based on the CIGRE distribution. It showed that the current and voltage at P1 and P2 were directly proportional. Therefore, the SPD will be designed at an acceptable rating and proper position of SPD installation at solar PV Rooftop will be proposed. The results obtained in this study can then be utilised to appropriately assign a SPD to protect the PV systems that are connected to the grid. Installing SPDs without considering the needs of lightning protection zones would expose the expensive equipment to potential damage even though the proper energy coordination of SPDs is in place. As such, the simulation results provide a basis for controlling the impacts of direct lightning strikes on electrical equipment and power grids and thus justify SPD coordination to ensure the reliability of the system.	[Nasir, M. S. M.; Ab-Kadir, M. Z. A.] Univ Putra Malaysia, Fac Engn, Adv Lightning Power & Energy Res Ctr, Ctr Electromagnet & Lightning Protect Res CELP, Serdang, Selangor, Malaysia; [Nasir, M. S. M.] UPNM, Fac Engn, Kuala Lumpur, Malaysia; [Ab-Kadir, M. Z. A.; Izadi, M.; Ahmad, N. I.; Zaini, N. H.] Univ Tenaga Nas, Inst Power Engn, Kajang, Selangor, Malaysia; [Radzi, M. A. M.] Univ Putra Malaysia, Adv Lightning Power & Energy Res Ctr, CAPER, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Pertahanan Nasional Malaysia; Universiti Tenaga Nasional; Universiti Putra Malaysia	Nasir, MSM (corresponding author), Univ Putra Malaysia, Fac Engn, Adv Lightning Power & Energy Res Ctr, Ctr Electromagnet & Lightning Protect Res CELP, Serdang, Selangor, Malaysia.; Nasir, MSM (corresponding author), UPNM, Fac Engn, Kuala Lumpur, Malaysia.	solehin@upnm.edu.my	Kadir, Zainal/B-6629-2009; Radzi, Mohd Amran Mohd/I-7637-2013	Kadir, Zainal/0000-0001-7263-2953; Radzi, Mohd Amran Mohd/0000-0003-3785-1573; Izadi, Mahdi/0000-0002-8348-4404; MOHD NASIR, MOHD SOLEHIN/0000-0002-6112-589X; Zaini, Nur Hazirah/0000-0002-1253-2915				Ab Kadir MZA, 2010, RENEW SUST ENERG REV, V14, P3023, DOI 10.1016/j.rser.2010.07.062; Ahmad N. I., 2017, RENEWABLE SUSTAINABL; Akikur RK, 2013, RENEW SUST ENERG REV, V27, P738, DOI 10.1016/j.rser.2013.06.043; Asuhaimi A., 2007, APPL FAULT SIGNATURE, V22, P2047; Belik Milan, 2014, 2014 15th International Scientific Conference on Electric Power Engineering (EPE). Proceedings, P367, DOI 10.1109/EPE.2014.6839446; Delfino F, 2012, IEEE T ELECTROMAGN C, V54, P308, DOI 10.1109/TEMC.2011.2161636; Heidler F, 1999, IEEE T POWER DELIVER, V14, P399, DOI 10.1109/61.754080; Hidayu N., 2014, INVESTIGATION WAVE P, V12, P47; Jiang T., 2014, ICHVE 2014 2014 INT; JONES RA, 1992, IEEE T POWER DELIVER, V7, P302, DOI 10.1109/61.108922; Kahlane A.E.W.H., 2014, 3 INT SEMIN NEW RENE, P227; Mastromauro RA, 2012, IEEE T IND INFORM, V8, P241, DOI 10.1109/TII.2012.2186973; Mekhilef S, 2012, RENEW SUST ENERG REV, V16, P386, DOI 10.1016/j.rser.2011.08.003; Naxakis I, 2017, SOL ENERGY, V144, P721, DOI 10.1016/j.solener.2017.01.072; Perera B. K., 2012, PROC IEEE INT C POWE, P1; Rajapakse A., 2009, EL POW EN C EPEC 200, P1; Riyadi Slamet, 2013, IAES International Journal of Power Electronics and Drive Systems, V3, P9; Ruan X, 2018, CONTROL TECHNIQUES FOR LCL-TYPE GRID-CONNECTED INVERTERS, P1, DOI 10.1007/978-981-10-4277-5; Sastry J, 2014, RENEW ENERG, V69, P208, DOI 10.1016/j.renene.2014.03.049; Sekioka S., 2012, 2012 31 INT C LIGHTN; Tu YP, 2013, ELECTR POW SYST RES, V94, P10, DOI 10.1016/j.epsr.2012.06.012; Wang J, 2006, CEEM' 2006: ASIA-PACIFIC CONFERENCE ON ENVIRONMENTAL ELECTROMAGNETICS, VOLS 1 AND 2, PROCEEDINGS, P320; Wong SL, 2015, RENEW SUST ENERG REV, V41, P42, DOI 10.1016/j.rser.2014.08.006; Xue J., 2009, AS PAC POW EN ENG C, V102206	24	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219326	10.1371/journal.pone.0219326	http://dx.doi.org/10.1371/journal.pone.0219326			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295278	Green Submitted, Green Published, gold			2022-12-26	WOS:000484951800026
J	Spence, KL; O'Sullivan, TL; Poljak, Z; Greer, AL				Spence, Kelsey L.; O'Sullivan, Terri L.; Poljak, Zvonimir; Greer, Amy L.			Descriptive analysis of horse movement networks during the 2015 equestrian season in Ontario, Canada	PLOS ONE			English	Article							CATTLE MOVEMENTS; DISEASE-CONTROL; EQUINE INFLUENZA; RISK; SPREAD; PATTERNS; EVENTS; IMPACT; FARMS; SHEEP	Horses are a highly mobile population, with many travelling locally, nationally, and internationally to participate in shows and sporting events. However, the nature and extent of these movements, as well as the potential impact they may have on disease introduction and spread, is not well documented. The objective of this study was to characterise the movement network of a sample of horses in Ontario, Canada, over a 7-month equestrian season. Horse owners (n = 141) documented their travel patterns with their horse(s) (n = 330) by completing monthly online questionnaires between May and November 2015. Directed networks were constructed to represent horse movements in 1-month time periods. A total of 1754 horse movements met the inclusion criteria for analysis. A variety of location types were included in each monthly network, with many including non-facilities such as parks, trails, and private farms. Only 34.3% of competitions attended by participants during the study period were regulated by an official equestrian organisation. Comparisons of the similarity between monthly networks indicated that participants did not travel to the same locations each month, and the most connected locations varied between consecutive months. While the findings should not be generalized to the wider horse population, they have provided greater insight into the nature and extent of observed horse movement patterns. The results support the need to better understand the variety of locations to which horses can travel in Ontario, as different types of locations may have different associated risks of disease introduction and spread.	[Spence, Kelsey L.; O'Sullivan, Terri L.; Poljak, Zvonimir; Greer, Amy L.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada; [Spence, Kelsey L.] Royal Vet Coll, Dept Pathobiol & Populat Sci, Vet Epidemiol Econ & Publ Hlth Grp, Hatfield, Herts, England	University of Guelph; University of London; University of London Royal Veterinary College	Greer, AL (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada.	agreer@uoguelph.ca		Spence, Kelsey L/0000-0002-3948-8598	Equine Guelph; Ontario Ministry of Food, Agriculture and Rural Affairs (OMAFRA); Canada Research Chairs program; Ontario Veterinary College Scholarship; Ontario Graduate Scholarship	Equine Guelph; Ontario Ministry of Food, Agriculture and Rural Affairs (OMAFRA); Canada Research Chairs program(Canada Research Chairs); Ontario Veterinary College Scholarship; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This study was supported by grants awarded to ALG from Equine Guelph, the Ontario Ministry of Food, Agriculture and Rural Affairs (OMAFRA), and the Canada Research Chairs program. Graduate funding for KLS was provided by the Ontario Veterinary College Scholarship and the Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda AG, 2016, PREV VET MED, V128, P41, DOI 10.1016/j.prevetmed.2016.03.010; Bell IG, 2011, AUST VET J, V89, P63, DOI 10.1111/j.1751-0813.2011.00775.x; Bigras-Poulin M, 2006, PREV VET MED, V76, P11, DOI 10.1016/j.prevetmed.2006.04.004; Boden LA, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-188; Canada Equine, 2010, CAN HORS IND PROF ST; Cardenas NC, 2019, TRANSBOUND EMERG DIS, V66, P715, DOI 10.1111/tbed.13071; Christley RM, 2003, EQUINE VET J, V35, P586, DOI 10.2746/042516403775467298; Csardi G, 2006, INTERJOURNAL; Dominguez M, 2016, EQUINE VET J, V48, P641, DOI 10.1111/evj.12523; Dube C, 2009, TRANSBOUND EMERG DIS, V56, P73, DOI 10.1111/j.1865-1682.2008.01064.x; Dutta BL, 2014, PREV VET MED, V117, P79, DOI 10.1016/j.prevetmed.2014.09.005; Ensoy C, 2014, PREV VET MED, V116, P89, DOI 10.1016/j.prevetmed.2014.05.003; Equestrian Canada, 2015, EV RES; Firestone SM, 2012, PREV VET MED, V106, P123, DOI 10.1016/j.prevetmed.2012.01.020; Firestone SM, 2011, PREV VET MED, V102, P185, DOI 10.1016/j.prevetmed.2011.07.006; Gates MC, 2013, PREV VET MED, V108, P125, DOI 10.1016/j.prevetmed.2012.07.016; Guinat C, 2016, SCI REP-UK, V6, DOI 10.1038/srep28429; Hayama Y, 2010, J VET MED SCI, V72, P839, DOI 10.1292/jvms.09-0447; Hijmans, 2019, GEOSPHERE SPHERICAL; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Liebenberg D, 2016, ACTA TROP, V158, P201, DOI 10.1016/j.actatropica.2016.03.005; Marquetoux N, 2016, PREV VET MED, V126, P94, DOI 10.1016/j.prevetmed.2016.01.022; Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x; Natural Resources Canada, 2015, N AM ATL POP PLAC DA; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; R Core Team, 2018, R LANG ENV STAT COMP; Reynolds JJH, 2015, J ANIM ECOL, V84, P1720, DOI 10.1111/1365-2656.12422; Robin CA, 2013, EQUINE VET J, V45, P302, DOI 10.1111/evj.12018; Rosanowski SM, 2013, NEW ZEAL VET J, V61, P245, DOI 10.1080/00480169.2012.750571; Rosanowski SM, 2013, PREV VET MED, V108, P178, DOI 10.1016/j.prevetmed.2012.08.003; Rossi G, 2019, TRANSBOUND EMERG DIS, V66, P562, DOI 10.1111/tbed.13066; Sanchez-Matamoros A, 2013, TRANSBOUND EMERG DIS, V60, P448, DOI 10.1111/j.1865-1682.2012.01365.x; Schulz J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179915; Sergeant ESG, 2011, AUST VET J, V89, P103, DOI 10.1111/j.1751-0813.2011.00761.x; Silk MJ, 2017, ECOL EVOL, V7, P9006, DOI 10.1002/ece3.3402; Smith RP, 2013, PREV VET MED, V108, P167, DOI 10.1016/j.prevetmed.2012.08.011; Spence KL, 2018, CAN VET J, V59, P783; Spence KL, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1103-7; Statistics Canada, 2016, CENS AGR FARMS CLASS; Traub-Dargatz JL, 2013, J VET INTERN MED, V27, P339, DOI 10.1111/jvim.12051; Valdano E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004152; Vernon MC, 2012, PREV VET MED, V105, P110, DOI 10.1016/j.prevetmed.2011.12.016; Volkova VV, 2010, EPIDEMICS-NETH, V2, P116, DOI 10.1016/j.epidem.2010.05.004; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Webb CR, 2006, EPIDEMIOL INFECT, V134, P31, DOI 10.1017/S095026880500467X	46	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219771	10.1371/journal.pone.0219771	http://dx.doi.org/10.1371/journal.pone.0219771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295312	Green Published, Green Submitted, gold			2022-12-26	WOS:000484951800069
J	Nazmi, A; Hoek, KL; Greer, MJ; Piazuelo, MB; Minato, N; Olivares-Villagomez, D				Nazmi, Ali; Hoek, Kristen L.; Greer, Michael J.; Piazuelo, Maria B.; Minato, Nagahiro; Olivares-Villagomez, Danyvid			Innate CD8 alpha alpha(+) cells promote ILC1-like intraepithelial lymphocyte homeostasis and intestinal inflammation	PLOS ONE			English	Article							OSTEOPONTIN EXPRESSION; T-CELLS; GENE-EXPRESSION; CROHNS-DISEASE; IFN-GAMMA; MUCOSAL; COLITIS; PROGRESSION; ETA-1; IL-12	Innate CD8 alpha alpha(+) cells, also referred to as iCD8 alpha cells, are TCR-negative intraepithelial lymphocytes (IEL) possessing cytokine and chemokine profiles and functions related to innate immune cells. iCD8 alpha cells constitute an important source of osteopontin in the intestinal epithelium. Osteopontin is a pleiotropic cytokine with diverse roles in bone and tissue remodeling, but also has relevant functions in the homeostasis of immune cells. In this report, we present evidence for the role of iCD8 alpha cells in the homeostasis of TCR-negative NKp46(+)NK1.1(+)IEL (ILC1-like). We also show that the effect of iCD8 alpha cells on ILC1-like IEL is enhanced in vitro by osteopontin. We show that in the absence of iCD8 alpha cells, the number of NKp46(+)NK1.1(+)IEL is significantly reduced. These ILC1-like cells are involved in intestinal pathogenesis in the anti-CD40 mouse model of intestinal inflammation. Reduced iCD8 alpha cell numbers results in a milder form of intestinal inflammation in this disease model, whereas treatment with osteopontin increases disease severity. Collectively, our results suggest that iCD8 alpha cells promote survival of NKp46(+)NK1.1(+)IEL, which significantly impacts the development of intestinal inflammation.	[Nazmi, Ali; Hoek, Kristen L.; Olivares-Villagomez, Danyvid] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Greer, Michael J.] Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Piazuelo, Maria B.] Vanderbilt Univ, Dept Med, Med Ctr, Nashville, TN USA; [Minato, Nagahiro] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan; [Olivares-Villagomez, Danyvid] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Infect Immunol & Inflammat, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Kyoto University; Vanderbilt University	Olivares-Villagomez, D (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Olivares-Villagomez, D (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Inst Infect Immunol & Inflammat, Nashville, TN 37232 USA.	danyvid.olivares-villagomez@vumc.edu			NIH/NIDDK [R01DK111671]; American Association of Immunologists; National Library of Medicine [T15 LM00745]; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK111671] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Association of Immunologists; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by (D.O-V.) NIH/NIDDK grant R01DK111671. (D.O-V. and A.N.) Careers in Immunology Fellowship Program from the American Association of Immunologists. (M.J.G) National Library of Medicine T15 LM00745. The funders had no role in the study, design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Translational Pathology Shared Resource for tissue processing. We thank the Flow Cytometry Shared Resource, which is supported by the Vanderbilt Ingram Cancer Center (P30 CA68485) and the Vanderbilt Digestive Disease Research Center (DK058404).	Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bhagat G, 2008, J CLIN INVEST, V118, P281, DOI 10.1172/JCI30989; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Cheroutre H, 2004, ANNU REV IMMUNOL, V22, P217, DOI 10.1146/annurev.immunol.22.012703.104522; Das G, 2003, P NATL ACAD SCI USA, V100, P5324, DOI 10.1073/pnas.0831037100; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Ettersperger J, 2016, IMMUNITY, V45, P610, DOI 10.1016/j.immuni.2016.07.018; FRANZEN A, 1985, BIOCHEM J, V232, P715, DOI 10.1042/bj2320715; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gassler N, 2002, SCAND J GASTROENTERO, V37, P1286, DOI 10.1080/003655202761020560; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Guy-Grand D, 1998, EUR J IMMUNOL, V28, P730, DOI 10.1002/(SICI)1521-4141(199802)28:02<730::AID-IMMU730>3.0.CO;2-U; Heilmann K, 2009, J CELL MOL MED, V13, P1162, DOI 10.1111/j.1582-4934.2008.00428.x; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Inagaki-Ohara K, 2004, J IMMUNOL, V173, P1390, DOI 10.4049/jimmunol.173.2.1390; Ito K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173629; Kanayama M, 2017, NAT IMMUNOL, V18, P973, DOI 10.1038/ni.3791; Kourepini E, 2014, P NATL ACAD SCI USA, V111, pE856, DOI 10.1073/pnas.1316447111; Kumar AA, 2017, IMMUN INFLAMM DIS, V5, P109, DOI 10.1002/iid3.146; Leavenworth JW, 2015, P NATL ACAD SCI USA, V112, P494, DOI 10.1073/pnas.1423011112; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; Lepage AC, 1998, J IMMUNOL, V161, P4902; Masopust D, 2001, J IMMUNOL, V166, P2348, DOI 10.4049/jimmunol.166.4.2348; Masuda H, 2005, J GASTROENTEROL, V40, P409, DOI 10.1007/s00535-005-1567-2; Masuda H, 2003, J SURG RES, V111, P85, DOI 10.1016/S0022-4804(03)00046-5; Mishima R, 2007, J CLIN GASTROENTEROL, V41, P167, DOI 10.1097/MCG.0b013e31802d6268; Murugaiyan G, 2008, J IMMUNOL, V181, P7480, DOI 10.4049/jimmunol.181.11.7480; Olivares-Villagomez D, 2018, TRENDS IMMUNOL, V39, P264, DOI 10.1016/j.it.2017.11.003; Olivares-Villagomez D, 2008, P NATL ACAD SCI USA, V105, P17931, DOI 10.1073/pnas.0808242105; Oz HS, 2012, DIGEST DIS SCI, V57, P1554, DOI 10.1007/s10620-011-2009-z; PRINCE CW, 1987, J BIOL CHEM, V262, P2900; Sato T, 2005, GUT, V54, P1254, DOI 10.1136/gut.2004.048298; Staines KA, 2012, J ENDOCRINOL, V214, P241, DOI 10.1530/JOE-12-0143; Talayero P, 2016, AM J TRANSPLANT, V16, P72, DOI 10.1111/ajt.13435; Taniuchi I, 2004, ADV IMMUNOL, V83, P55; TEITELL M, 1991, J EXP MED, V174, P1131, DOI 10.1084/jem.174.5.1131; Toyonaga T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135552; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Van Acker A, 2017, CELL REP, V19, P1431, DOI 10.1016/j.celrep.2017.04.068; Van Kaer L, 2018, J IMMUNOL, V200, P2235, DOI 10.4049/jimmunol.1701704; Van Kaer L, 2014, IMMUNITY, V41, P451, DOI 10.1016/j.immuni.2014.08.010; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Zhong J, 2006, INFLAMM BOWEL DIS, V12, P790, DOI 10.1097/00054725-200608000-00015	43	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0215883	10.1371/journal.pone.0215883	http://dx.doi.org/10.1371/journal.pone.0215883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291255	Green Submitted, Green Published, gold			2022-12-26	WOS:000484947800009
J	Morawetz, L; Koglberger, H; Griesbacher, A; Derakhshifar, I; Crailsheim, K; Brodschneider, R; Moosbeckhofer, R				Morawetz, Linde; Koeglberger, Hemma; Griesbacher, Antonia; Derakhshifar, Irmgard; Crailsheim, Karl; Brodschneider, Robert; Moosbeckhofer, Rudolf			Health status of honey bee colonies (Apis mellifera) and disease-related risk factors for colony losses in Austria	PLOS ONE			English	Article							VARROA-DESTRUCTOR; NOSEMA-CERANAE; MELISSOCOCCUS-PLUTONIUS; PESTICIDE-RESIDUES; WINTER MORTALITY; BACILLUS-LARVAE; LOSS RATES; QUEEN AGE; VIRUSES; PATHOGENS	Austrian beekeepers frequently suffered severe colony losses during the last decade similar to trends all over Europe. This first surveillance study aimed to describe the health status of Austrian bee colonies and to analyze the reasons for losses for both the summer and winter season in Austria. In this study 189 apiaries all over Austria were selected using a stratified random sampling approach and inspected three times between July 2015 and spring 2016 by trained bee inspectors. The inspectors made interviews with the beekeepers about their beekeeping practice and the history of the involved colonies. They inspected a total of 1596 colonies for symptoms of nine bee pests and diseases (four of them notifiable diseases) and took bee samples for varroa mite infestation analysis. The most frequently detected diseases were three brood diseases: Varroosis, Chalkbrood and Sacbrood. The notifiable bee pests Aethina tumida and Tropilaelaps spp. were not detected. During the study period 10.8% of the 1596 observed colonies died. Winter proved to be the most critical season, in which 75% of the reported colony losses happened. Risks for suffering summer losses increased significantly, when colonies were weak in July, had queen problems or a high varroa mite infestation level on bees in July. Risks for suffering winter losses increased significantly, when the colonies had a high varroa mite infestation level on bees in September, were weak in September, had a queen older than one year or the beekeeper had few years of beekeeping experience. However, the effect of a high varroa mite infestation level in September had by far the greatest potential to raise the winter losses compared to the other significant factors.	[Morawetz, Linde; Koeglberger, Hemma; Derakhshifar, Irmgard; Moosbeckhofer, Rudolf] Austrian Agcy Hlth & Food Safety Ltd, Div Food Secur, Dept Apiculture & Bee Protect, Inst Seed & Propagating Mat Phytosanit Serv & Api, Vienna, Austria; [Griesbacher, Antonia] Austrian Agcy Hlth & Food Safety Ltd, Div Data Stat & Risk Assessment, Dept Stat & Analyt Epidemiol, Graz, Styria, Austria; [Crailsheim, Karl; Brodschneider, Robert] Karl Franzens Univ Graz, Inst Biol, Graz, Styria, Austria	University of Graz	Morawetz, L (corresponding author), Austrian Agcy Hlth & Food Safety Ltd, Div Food Secur, Dept Apiculture & Bee Protect, Inst Seed & Propagating Mat Phytosanit Serv & Api, Vienna, Austria.	linde.morawetz@ages.at		Griesbacher, Antonia/0000-0002-0544-3893; Brodschneider, Robert/0000-0002-2535-0280	Austrian Federal Ministry of Sustainability and Tourism [100972]; federal provinces of Austria	Austrian Federal Ministry of Sustainability and Tourism; federal provinces of Austria	This research was conducted within the project "Zukunft Biene" (DaFNE grant number: 100972, www.dafne.at/) funded by the Austrian Federal Ministry of Sustainability and Tourism (www.bmnt.gv.at), the federal provinces of Austria, the beekeeping umbrella organisation 'Biene Osterreich' (www.biene-oesterreich.at) and in kind contributions of AGES (Austrian Agency of Health and Food Safety Ltd.) and the University of Graz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol E, 2008, ITAL J ANIM SCI, V7, P19, DOI 10.4081/ijas.2008.19; Akyol E, 2007, ITAL J ANIM SCI, V6, P143; Al-Lawati H, 2009, ANN ENTOMOL SOC AM, V102, P881, DOI 10.1603/008.102.0514; Alaux C, 2017, SCI REP-UK, V7, DOI 10.1038/srep40568; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Aupperle H., 2016, DIAGNOSTIC COLOUR AT; BAILEY L, 1963, VIROLOGY, V21, P390, DOI 10.1016/0042-6822(63)90200-9; BAILEY L, 1974, J GEN VIROL, V25, P175, DOI 10.1099/0022-1317-25-2-175; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; Blanchard P, 2008, J INVERTEBR PATHOL, V97, P182, DOI 10.1016/j.jip.2007.07.003; Blanchard P, 2014, J VIROL METHODS, V197, P7, DOI 10.1016/j.jviromet.2013.09.012; BMGF AGES, 2017, VET 2016; Botias C, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-25; Brodschneider R., 2013, Entomologica Austriaca, V20, P195; Brodschneider R, 2010, 6 COLOSS C ANK TURK; Brodschneider R, 2019, AGR ECOSYST ENVIRON, V274, P24, DOI 10.1016/j.agee.2019.01.002; Brodschneider R, 2018, J APICULT RES, V57, P452, DOI 10.1080/00218839.2018.1460911; Brodschneider R, 2016, J APICULT RES, V55, P375, DOI 10.1080/00218839.2016.1260240; Brodschneider R, 2010, J APICULT RES, V49, P23, DOI 10.3896/IBRA.1.49.1.04; Budge GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133228; Buchler R, 2014, J APICULT RES, V53, P205, DOI 10.3896/IBRA.1.53.2.03; Chauzat MP, 2016, APIDOLOGIE, V47, P348, DOI 10.1007/s13592-016-0440-z; Chauzat MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079018; Chauzat MP, 2010, J APICULT RES, V49, P31, DOI 10.3896/IBRA.1.49.1.05; Chauzat MP, 2010, J APICULT RES, V49, P40, DOI 10.3896/IBRA.1.49.1.06; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Cornelissen B., 2018, Bee World, V95, P99, DOI 10.1080/0005772X.2018.1465374; DA SILVA M. J. V., 2014, BEE WORLD, V91, P90, DOI DOI 10.1080/0005772X.2014.11417619; Dahle B, 2010, J APICULT RES, V49, P124, DOI 10.3896/IBRA.1.49.1.26; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; de Graaf DC, 2006, LETT APPL MICROBIOL, V43, P583, DOI 10.1111/j.1472-765X.2006.02057.x; De Smet L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171529; DEJONG D, 1983, J ECON ENTOMOL, V76, P766, DOI 10.1093/jee/76.4.766; Delaplane KS, 1999, APIDOLOGIE, V30, P383, DOI 10.1051/apido:19990504; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Donkersley P, 2014, ECOL EVOL, V4, P4195, DOI 10.1002/ece3.1293; Dooremalen C, 2018, ECOSPHERE, V9; Forsgren E, 2005, MICROB ECOL, V50, P369, DOI 10.1007/s00248-004-0188-2; Forsgren E, 2010, J INVERTEBR PATHOL, V103, pS5, DOI 10.1016/j.jip.2009.06.016; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Frey E, 2011, J APICULT RES, V50, P138, DOI 10.3896/IBRA.1.50.2.05; Fries I, 2003, APIDOLOGIE, V34, P389, DOI 10.1051/apido:2003032; Fries I, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.14; Garrido-Bailon E, 2013, MICROB BIOTECHNOL, V6, P731, DOI 10.1111/1751-7915.12070; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Giacobino A, 2014, PREV VET MED, V115, P280, DOI 10.1016/j.prevetmed.2014.04.002; Giacobino A, 2016, J APICULT RES, V55, P335, DOI 10.1080/00218839.2016.1238595; Granato A, 2017, APIDOLOGIE, V48, P194, DOI 10.1007/s13592-016-0465-3; Guler A, 2018, J ECON ENTOMOL, V111, P2003, DOI 10.1093/jee/toy189; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Hatjina F, 2014, J APICULT RES, V53, P233, DOI 10.3896/IBRA.1.53.2.05; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; HORNITZKY MAZ, 1991, J APICULT RES, V30, P13, DOI 10.1080/00218839.1991.11101228; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; Jacques A, 2016, EFSA SUPPORTING PUBL; Jacques A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172591; Johnson BR, 2014, J APICULT RES, V53, P165, DOI 10.3896/IBRA.1.53.1.18; Jovani R, 2006, TRENDS PARASITOL, V22, P214, DOI 10.1016/j.pt.2006.02.011; Kasiotis KM, 2014, SCI TOTAL ENVIRON, V485, P633, DOI 10.1016/j.scitotenv.2014.03.042; Khongphinitbunjong K, 2019, INSECTS, V10, DOI 10.3390/insects10020036; Koglberger H, 2014, BIENEN AKTUELL, V2014, P28; Koglberger H, 2009, BIENEN AKTUELL, V2009, P15; Kuchling S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30891-y; Laurent M, 2016, EPILOBEE PAN EUROPEA; Le Conte Y, 2008, REV SCI TECH OIE, V27, P485, DOI 10.20506/rst.27.2.1819; Lee KV, 2015, APIDOLOGIE, V46, P292, DOI 10.1007/s13592-015-0356-z; Liebig G., 2001, APIDOLOGIE, V32, P484, DOI [10.1051/apido:2001156, DOI 10.1051/APIDO:2001156]; Martin S, 1998, ECOL MODEL, V109, P267, DOI 10.1016/S0304-3800(98)00059-3; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Martinello M, 2017, J APICULT RES, V56, P239, DOI 10.1080/00218839.2017.1304878; Meixner MD, 2014, J APICULT RES, V53, P215, DOI 10.3896/IBRA.1.53.2.04; Molineri A, 2018, J APICULT RES, V57, P551, DOI 10.1080/00218839.2018.1475697; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Mutinelli F, 2011, REV SCI TECH OIE, V30, P257; Natsopoulou ME, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05596-3; OIE, 2013, OIE MANUAL DIAGNOSTI; OIE, 2008, OIE MANUAL DIAGNOSTI; OIE, 2016, OIE MANUAL DIAGNOSTI; OIE Manual of Standards for Diagnostic Tests and Vaccines, 2017, OIE MANUAL DIAGNOSTI; PLAGEMANN O, 1985, BERL MUNCH TIERARZTL, V98, P61; Porrini C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155411; Ravoet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072443; Requier F, 2017, J APPL ECOL, V54, P1161, DOI 10.1111/1365-2664.12836; Ribiere M, 2010, J INVERTEBR PATHOL, V103, pS120, DOI 10.1016/j.jip.2009.06.013; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; RINDERER TE, 1994, J APICULT RES, V33, P171, DOI 10.1080/00218839.1994.11100866; Ritter W., 1994, BIENENKRANKHEITEN; Ritter W., 1996, DIAGNOSTIK BEKAMPFUN; Ruttner F., BIOGEOGRAPHY TAXONOM; SAKOFSKI F, 1990, APIDOLOGIE, V21, P547, DOI 10.1051/apido:19900608; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Seitz N, 2016, J APICULT RES, V54, P292, DOI 10.1080/00218839.2016.1153294; Simeunovic P, 2014, J APICULT RES, V53, P545, DOI 10.3896/IBRA.1.53.5.09; Smart M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152685; Strange JP, 2001, J ECON ENTOMOL, V94, P1324, DOI 10.1603/0022-0493-94.6.1324; Switanek M, 2017, SCI TOTAL ENVIRON, V579, P1581, DOI 10.1016/j.scitotenv.2016.11.178; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Traynor KS, 2016, APIDOLOGIE, V47, P325, DOI 10.1007/s13592-016-0431-0; Tsvetkov N, 2017, SCIENCE, V356, P1395, DOI 10.1126/science.aam7470; van der Zee R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131611; van der Zee R, 2014, J APICULT RES, V53, P19, DOI 10.3896/IBRA.1.53.1.02; van der Zee R, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.18; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; White G. F, 1917, USDA B, V431, P1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	113	30	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219293	10.1371/journal.pone.0219293	http://dx.doi.org/10.1371/journal.pone.0219293			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287830	gold, Green Submitted, Green Published			2022-12-26	WOS:000482328300016
J	Alonso, B; Perez-Granda, MJ; Latorre, MC; Rodriguez, C; Sanchez-Carrillo, C; Munoz, P; Guembe, M				Alonso, Beatriz; Jesus Perez-Granda, Maria; Consuelo Latorre, Maria; Rodriguez, Carmen; Sanchez-Carrillo, Carlos; Munoz, Patricia; Guembe, Maria			Is heparinized 40% ethanol lock solution efficient for reducing bacterial and fungal biofilms in an in vitro model?	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; CENTRAL VENOUS CATHETERS; THERAPY; EFFICACY; ERADICATION; PREVENTION; GUIDELINES; DIAGNOSIS; SOCIETY	Background We applied an in vitro model to evaluate the efficacy of a heparinized 40% ethanol-based lock solution in a wide variety of clinical isolates causing C-RBSI. Methods A total of 100 clinical strains were collected retrospectively from the blood of patients with C-RBSI. The reduction in biomass and metabolic activity of biofilms was measured using the crystal violet (CV) assay and XTT assay, respectively. Regrowth inhibition (RI) was measured within 24 hours and 72 hours of ethanol lock therapy. Percentage reduction of >= 85% in RI was considered to be successful. Results Ethanol lock was more effective in reducing metabolic activity than in reducing biomass (83% vs. 50%, respectively). Percentages of RI diminished as regrowth was prolonged (57% for 24 hours and 17% for 72 hours of regrowth). No statistically significant intraspecies differences were found in biofilm reduction or in RI (p>0.05). Conclusions The use of heparinized 40% ethanol lock solution for 72 hours significantly reduced biomass and metabolic activity in clinical isolates from patients with C-RBSI. However, as biofilm has an important regrowth rate, 40% ethanol solution was not able to fully eradicate biofilm in vitro.	[Alonso, Beatriz; Jesus Perez-Granda, Maria; Consuelo Latorre, Maria; Rodriguez, Carmen; Munoz, Patricia; Guembe, Maria] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Alonso, Beatriz; Consuelo Latorre, Maria; Sanchez-Carrillo, Carlos; Munoz, Patricia; Guembe, Maria] Hosp Gen Univ Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain; [Jesus Perez-Granda, Maria] Hosp Gen Univ Gregorio Maranon, Cardiac Surg Postoperat Care Unit, Madrid, Spain; [Jesus Perez-Granda, Maria; Munoz, Patricia] CIBER Enfermedades Resp CIBERES CB06 06 0058, Madrid, Spain; [Rodriguez, Carmen] Hosp Gen Univ Gregorio Maranon, Pharm Dept, Madrid, Spain; [Munoz, Patricia] Univ Complutense Madrid, Sch Med, Med Dept, Madrid, Spain	General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; General University Gregorio Maranon Hospital; Complutense University of Madrid	Alonso, B; Guembe, M (corresponding author), Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain.; Alonso, B; Guembe, M (corresponding author), Hosp Gen Univ Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain.	beaafm@hotmail.com; mariaguembe@hotmail.com	Guembe, María/J-1897-2015; Muñoz, Patricia/E-9431-2017; GRANDA, MARIA JESUS mjpg PEREZ/L-3040-2015	Guembe, María/0000-0002-7607-5848; Muñoz, Patricia/0000-0001-5706-5583; GRANDA, MARIA JESUS mjpg PEREZ/0000-0002-0613-2122; , Maria Consuelo/0000-0002-2731-9826; Alonso, Beatriz/0000-0002-0062-2999	Miguel Servet Program (ISCIIIMICINN) from the Health Research Fund (FIS) of the Carlos III Health Institute (ISCIII), Madrid, Spain [MS13/00268]; European Regional Development Fund (FEDER) "A way of making Europe"	Miguel Servet Program (ISCIIIMICINN) from the Health Research Fund (FIS) of the Carlos III Health Institute (ISCIII), Madrid, Spain; European Regional Development Fund (FEDER) "A way of making Europe"	M. Guembe is supported by the Miguel Servet Program (ISCIIIMICINN, MS13/00268) from the Health Research Fund (FIS) of the Carlos III Health Institute (ISCIII), Madrid, Spain. The study has been partially financed by the European Regional Development Fund (FEDER) "A way of making Europe".	Alnuaimi AD, 2013, FEMS YEAST RES, V13, P689, DOI 10.1111/1567-1364.12068; Alonso B, 2016, J MICROBIOL METHODS; Alonso B, 2018, J HOSP INFECT; Bhatt S, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00744-18;e00744-18; Blackwood RA, 2017, J PEDIAT INF DIS SOC, V6, P94, DOI 10.1093/jpids/piv060; Bookstaver PB, 2010, CLIN PHARMACOL-ADV A, V2, P123, DOI 10.2147/CPAA.S11262; Broom J, 2008, SCAND J INFECT DIS, V40, P399, DOI 10.1080/00365540701756953; Broom JK, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-146; Chaftari AM, 2017, ANTIMICROB AGENTS CH, V61; Chambers ST, 2006, J HOSP INFECT, V63, P193, DOI 10.1016/j.jhin.2006.01.009; Chaudhury A, 2012, FEMS IMMUNOL MED MIC, V65, P305, DOI 10.1111/j.1574-695X.2012.00950.x; Chaves F, 2018, ENFERM INFEC MICR CL, V36, P112, DOI 10.1016/j.eimc.2017.10.019; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; Dibb MJ, 2016, JPEN-PARENTER ENTER, V40, P699, DOI 10.1177/0148607114549999; Freire MP, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00569-18, 10.1128/aac.00569-18]; Gahlot Rupam, 2014, Int J Crit Illn Inj Sci, V4, P162, DOI 10.4103/2229-5151.134184; Gominet M, 2017, APMIS, V125, P365, DOI 10.1111/apm.12665; Perez-Granda MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091838; Li L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00258; Lleo MM, 2001, J APPL MICROBIOL, V91, P1095, DOI 10.1046/j.1365-2672.2001.01476.x; Mermel LA, 2014, J ANTIMICROB CHEMOTH, V69, P2611, DOI 10.1093/jac/dku182; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Metcalf SCL, 2004, J INFECTION, V49, P20, DOI 10.1016/j.jinf.2003.08.010; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; Oncu S, 2014, CLIN NUTR, V33, P360, DOI 10.1016/j.clnu.2013.04.014; Parasuraman P, 2019, BIOFOULING, V35, P89, DOI 10.1080/08927014.2019.1570501; Peters BM, 2013, ANTIMICROB AGENTS CH, V57, P74, DOI 10.1128/AAC.01599-12; Qu Y, 2009, J MED MICROBIOL, V58, P442, DOI 10.1099/jmm.0.006387-0; Rajpurkar M, 2014, HAEMOPHILIA, V20, P52, DOI 10.1111/hae.12241; Ramamurthy T, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00103; Riu M, 2012, ENFERM INFEC MICR CL, V30, P137, DOI 10.1016/j.eimc.2011.11.006; Rodriguez-Creixems M, 2013, CLIN MICROBIOL INFEC, V19, P845, DOI 10.1111/1469-0691.12050; Salonen BR, 2018, CLIN NUTR, V37, P1181, DOI 10.1016/j.clnu.2017.05.009; Tan M, 2014, ANN PHARMACOTHER, V48, P607, DOI 10.1177/1060028014524049; Vassallo M, 2015, INFECTION, V43, P389, DOI 10.1007/s15010-015-0738-1; Worth LJ, 2014, J HOSP INFECT, V88, P48, DOI 10.1016/j.jhin.2014.06.007; Zandri G, 2012, CLIN MICROBIOL INFEC, V18, pE259, DOI 10.1111/j.1469-0691.2012.03893.x	37	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219098	10.1371/journal.pone.0219098	http://dx.doi.org/10.1371/journal.pone.0219098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283786	gold, Green Submitted, Green Published			2022-12-26	WOS:000484939800019
J	Lamattina, D; Berrozpe, PE; Casas, N; Moya, SL; Giuliani, MG; Costa, SA; Arrabal, JP; Martinez, MF; Rivero, MR; Salas, M; Humeres, CA; Liotta, DJ; Meichtry, MB; Salomon, OD				Lamattina, Daniela; Eduardo Berrozpe, Pablo; Casas, Natalia; Lorian Moya, Sofia; Gabriela Giuliani, Magali; Andres Costa, Sebastian; Pablo Arrabal, Juan; Florencia Martinez, Mariela; Romina Rivero, Maria; Salas, Martin; Alejandro Humeres, Cristian; Javier Liotta, Domingo; Belen Meichtry, Maria; Daniel Salomon, Oscar			Twice upon a time: The progression of canine visceral leishmaniasis in an Argentinean city	PLOS ONE			English	Article							LUTZOMYIA-LONGIPALPIS; RHIPICEPHALUS-SANGUINEUS; EPIDEMIOLOGIC ASPECTS; ECO-EPIDEMIOLOGY; PUERTO IGUAZU; PARANA STATE; RISK-FACTORS; MATO-GROSSO; DOGS; TRANSMISSION	Canine Visceral Leishmaniasis (CVL) prevalence, spatial distribution and associated factors were assessed in four locations in Iguazu department in 2014 and in Puerto Iguazu city again in 2018. The city areas were divided into a grid of 400x400m cells. All cells were sampled in 2014 and a random subsampling was developed in 2018. In each cell, five dogs clustered in a 'critical scenario' (prone to have vectors) were sampled. A rapid immunochromatographic dipstick was used to detect antibodies against Leishmania infantum, confirming by lymph node smears observation and PCR. For Puerto Iguazu, Generalized Linear Models (GLMs) were constructed considering environmental, dog and clinical variables. Pearson's Chi square and Fisher's exact tests were employed to evaluate the association between CVL, dog clinical signs and infestation with other parasites. Cartographic outputs were made and Moran's I indices were calculated as spatial autocorrelation indicators. CVL prevalence rates were 26.18% in 2014 and 17.50% in 2018. No associations were established in environmental models, but dog age and repellent use were significant when running 2014 dog models. Clinical models showed significant associations between seropositive dogs and ophthalmological, dermal signs and onychogryphosis in 2014. In 2018, only adenomegaly was associated. The results of global Moran's I were not significant but regarding local analysis, six sites in 2014 and one in 2018 presented autocorrelation with neighboring sites. The decrease in CVL prevalence may be associated to transmission stabilization, which could explain the lack of associations with dog-related variables. Further, spatial distribution of CVL is a poor evidence for design of transmission control measures but could be important in case of intensive parasite circulation or when the first autochthonous cases appear. For control success, sensitivity of diagnostic methods, political will and adequate material resources remain critical. Modeling of multiple variables will be required to identify factors that drive disease stabilization/destabilization.	[Lamattina, Daniela; Eduardo Berrozpe, Pablo; Lorian Moya, Sofia; Gabriela Giuliani, Magali; Pablo Arrabal, Juan; Florencia Martinez, Mariela; Romina Rivero, Maria; Salas, Martin; Alejandro Humeres, Cristian; Javier Liotta, Domingo; Belen Meichtry, Maria; Daniel Salomon, Oscar] Minist Salud & Desarrollo Social Nac, INMeT, Puerto Iguazu, Misiones, Argentina; [Eduardo Berrozpe, Pablo; Lorian Moya, Sofia; Romina Rivero, Maria; Daniel Salomon, Oscar] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Casas, Natalia] Minist Salud & Desarrollo Social Nac, Direcc Nacl Epidemiol & Anal Situac Salud, Buenos Aires, DF, Argentina; [Andres Costa, Sebastian] Univ Nacl Misiones, Fac Ciencias Forestales, Inst Biol Subtrop, Puerto Iguazu, Misiones, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Lamattina, D (corresponding author), Minist Salud & Desarrollo Social Nac, INMeT, Puerto Iguazu, Misiones, Argentina.	daniela.lamattina@gmail.com		Moya, Sofia Lorian/0000-0001-7255-748X; Berrozpe, Pablo/0000-0002-3981-2669; Salomon, Oscar/0000-0002-6206-3862; Lamattina, Daniela/0000-0002-5926-8234	International Development Research Centre - IDRC-Canada [107577-001]; Instituto Nacional de Medicina Tropical - Ministerio de Salud de la Nacion	International Development Research Centre - IDRC-Canada(CGIAR); Instituto Nacional de Medicina Tropical - Ministerio de Salud de la Nacion	This work received support from the International Development Research Centre - IDRC-Canada project -grant number 107577-001 - https://www.idrc.ca/en/project/addressing-emergence-and-spread-leishmaniasis-borders-argentina-brazil-and-paraguay; Instituto Nacional de Medicina Tropical - Ministerio de Salud de la Nacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRANCHES P, 1991, J PARASITOL, V77, P557, DOI 10.2307/3283159; Acosta L, 2015, REV INST MED TROP SP, V57, P175, DOI 10.1590/S0036-46652015000200013; Anselin L., 2002, P CSISS WORKSH NEW T; Baneth G, 2008, TRENDS PARASITOL, V24, P324, DOI 10.1016/j.pt.2008.04.001; Benitez AD, 2018, PREV VET MED, V154, P47, DOI 10.1016/j.prevetmed.2018.02.011; Berrozpe P, 2017, MEM I OSWALDO CRUZ, V112, P674, DOI 10.1590/0074-02760170056; Berrozpe PE, 2018, MED VET ENTOMOL; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Campos R, 2017, GEOSPATIAL HEALTH, V12, P67, DOI 10.4081/gh.2017.503; Antonialli SAC, 2007, J INFECTION, V54, P509, DOI 10.1016/j.jinf.2006.08.004; Costa DNCC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002355; Costa Danielle Nunes Carneiro Castro, 2018, BMC Vet Res, V14, P229, DOI 10.1186/s12917-018-1550-9; Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; Curi NHA, 2017, BRAZ J BIOL, V77, P388, DOI 10.1590/1519-6984.19515; Salomon OD, 2016, REV PANAM SALUD PUBL, V40, P29; Salomon OD, 2015, MEM I OSWALDO CRUZ, V110, P831, DOI 10.1590/0074-02760150207; Dantas-Torres F, 2011, TRENDS PARASITOL, V27, P155, DOI 10.1016/j.pt.2010.12.006; de Carvalho AG, 2018, PATHOG GLOB HEALTH, V112, P29, DOI 10.1080/20477724.2018.1438229; deAlmeida Curi NH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104003, DOI 10.1371/journal.pone.0104003]; dos Santos DR, 2012, REV SOC BRAS MED TRO, V45, P643, DOI 10.1590/S0037-86822012000500019; Figueiredo ABF, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311x00093516, 10.1590/0102-311X00093516]; Gimenez-Ayala A, 2018, J PUBLIC HLTH, P1, DOI [10.1007/s10389-017-0850-z, DOI 10.1007/S10389-017-0850-Z]; Gomez-Bravo A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2296-0; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; HENRIKSEN SA, 1981, ACTA VET SCAND, V22, P594; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Pangrazio KK, 2009, VET PARASITOL, V165, P327, DOI 10.1016/j.vetpar.2009.07.013; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Lamattina D, 2018, MED VET ENTOMOL, V32, P271, DOI 10.1111/mve.12295; Lemos EM, 2008, ACTA TROP, V107, P205, DOI 10.1016/j.actatropica.2008.04.023; Leite BMM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006496; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Brazuna JCM, 2012, REV SOC BRAS MED TRO, V45, P601, DOI 10.1590/S0037-86822012000500012; Martins-Melo FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093770; Meireles P, 2008, VET PARASITOL, V152, P242, DOI 10.1016/j.vetpar.2007.12.025; Mettler M, 2005, J CLIN MICROBIOL, V43, P5515, DOI 10.1128/JCM.43.11.5515-5519.2005; de Araujo VEM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002540; Moraes Marcela Figueredo Duarte, 2017, Vet Parasitol Reg Stud Reports, V8, P1, DOI [10.1016/j.vprsr.2017.01.003, 10.1016/j.vp]; NEWTON WL, 1956, J PARASITOL, V42, P246, DOI 10.2307/3274849; Nunes CM, 2010, VET PARASITOL, V170, P131, DOI 10.1016/j.vetpar.2010.01.044; Oliveira AM, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3084-1; Orellano P, 2018, VACCINE, V36, P979, DOI 10.1016/j.vaccine.2018.01.007; Otranto D, 2010, VET PARASITOL, V172, P323, DOI 10.1016/j.vetpar.2010.05.017; Ozbel Y, 2000, ACTA TROP, V74, P1, DOI 10.1016/S0001-706X(99)00047-9; Palatnik-de-Sousa CB, 2001, AM J TROP MED HYG, V65, P510, DOI 10.4269/ajtmh.2001.65.510; Bruhn FRP, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2877-6; Paz GF, 2010, PREV VET MED, V97, P131, DOI 10.1016/j.prevetmed.2010.08.006; Paz GF, 2010, PARASITOL RES, V106, P523, DOI 10.1007/s00436-009-1697-1; Pech-May A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006614; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Peters N, 2006, IMMUNOL REV, V213, P159, DOI 10.1111/j.1600-065X.2006.00432.x; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; R Core Team, 2013, R LANG ENV STAT COMP; Rakhshanpour A, 2017, IRAN J PARASITOL, V12, P482; Reifur L, 2004, VET PARASITOL, V122, P273, DOI 10.1016/j.vetpar.2004.05.017; Reithinger R, 2004, INT J PARASITOL, V34, P55, DOI 10.1016/j.ijpara.2003.09.006; Rocha MAN, 2018, BRAZ J BIOL, V78, P609, DOI 10.1590/1519-6984.166622; Rivero MR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006098; Rynkiewicz EC, 2015, TRENDS PARASITOL, V31, P212, DOI 10.1016/j.pt.2015.02.005; Salomon OD, 2008, MEM I OSWALDO CRUZ, V103, P109, DOI 10.1590/S0074-02762008000100018; Salomon OD, 2005, MEM I OSWALDO CRUZ, V100, P475, DOI 10.1590/S0074-02762005000500005; Salomon OD, 2011, MEDICINA-BUENOS AIRE, V71, P22; Santini MS, 2018, MED VET ENTOMOL, V32, P197, DOI 10.1111/mve.12283; Saridomichelakis MN, 2005, AM J TROP MED HYG, V73, P82, DOI 10.4269/ajtmh.2005.73.82; Satragno D, 2017, EMERG INFECT DIS, V23, P536, DOI 10.3201/eid2303.160377; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Shang LM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-173; Silva FL, 2009, VET PARASITOL, V160, P55, DOI 10.1016/j.vetpar.2008.10.079; Fernandez MS, 2013, MEM I OSWALDO CRUZ, V108, P817, DOI 10.1590/0074-0276130047; Santini MS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003951; Silva RBS, 2018, REV SOC BRAS MED TRO, V51, P683, DOI 10.1590/0037-8682-0429-2017; Supali T, 2010, INT J PARASITOL, V40, P1171, DOI 10.1016/j.ijpara.2010.05.003; Teixeira-Neto RG, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0485-7; Thomaz Soccol Vanete, 2017, PLoS One, V12, pe0189182, DOI 10.1371/journal.pone.0189182; THOMAZSOCCOL V, 2018, PLOS NEGLECT TROP D, V12, DOI DOI 10.1371/journal.pntd.0006336; Bezerra JMT, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006697; Ulrich Y, 2012, P ROY SOC LOND B BIO; Ursine RL, 2016, MEM I OSWALDO CRUZ, V111, P505, DOI 10.1590/0074-02760160133; Mastrangelo AV, 2018, VIGIL SANIT DEBATE, V6, P64, DOI 10.22239/2317-269x.01090; World Health Organization, 1991, BAS LAB METH MED PAR; Zuur Alain F., 2009, P1	82	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219395	10.1371/journal.pone.0219395	http://dx.doi.org/10.1371/journal.pone.0219395			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276573	gold, Green Published, Green Submitted			2022-12-26	WOS:000484936300073
J	Yoon, SY; Kim, ES; Han, GS; Suh, LH; Jung, HS; Tchah, H; Kim, JY				Yoon, Sam Young; Kim, Eun-Soon; Han, Gill Sang; Suh, Leejee H.; Jung, Hyun Suk; Tchah, Hungwon; Kim, Jae Yong			Safety and efficacy of tacrolimus-coated silicone plates as an alternative to mitomycin C in a rabbit model of conjunctival fibrosis	PLOS ONE			English	Article							SIROLIMUS-ELUTING STENTS; CORONARY-ARTERIES; TRABECULECTOMY; FIBROBLASTS; BEVACIZUMAB; SCLERITIS; RAPAMYCIN; TOXICITY; OINTMENT; SURGERY	Purpose To find safer and more effective drugs than mitomycin C to prevent conjunctival fibrosis in a rabbit model. Methods Twenty-four rabbits were involved and randomly divided into four groups. Limbus-based peritomy was performed at the superior cornea, and normal saline (NS group), mitomycin C (MMC group), SR (SR group), or TC (TC group)-coated silicone plate was inserted at the sub-Tenon's space in each group. Conjunctival congestion was evaluated at 1 and 4 weeks postoperatively. At 4 weeks, the numbers of inflammatory cells, fibroblasts, myofibroblasts, blood vessels, and goblet cells were counted in the conjunctiva and Tenon's capsule around the silicone plate. Results At 4 weeks, conjunctival congestion was significantly less than that observed at 1 week in the SR and TC groups (p < 0.05), whereas the number of myofibroblasts was significantly lower in the MMC and TC groups (p < 0.05). The conjunctiva was significantly less congested in the TC group versus the other groups at 1 week and 4 weeks (p < 0.05). The TC group had the lowest number of inflammatory cells and MMC group had the lowest number of goblet cells among all groups (p < 0.05). Conclusions The TC-coated silicone plate was more effective in inhibiting inflammation and fibrosis versus the MMC-coated silicone plate and was associated with fewer adverse effects in the rabbit model.	[Yoon, Sam Young] Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Dept Ophthalmol, Seoul, South Korea; [Yoon, Sam Young; Suh, Leejee H.] Columbia Univ, Med Ctr, Edward S Harkness Eye Inst, New York, NY USA; [Kim, Eun-Soon; Tchah, Hungwon; Kim, Jae Yong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Han, Gill Sang; Jung, Hyun Suk] Sungkyunkwan Univ, Sch Adv Mat Sci & Engn, Suwon, South Korea	Hallym University; Columbia University; University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU)	Kim, JY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, Seoul, South Korea.	jykim2311@amc.seoul.kr	Han, Gill Sang/P-8395-2015	Han, Gill Sang/0000-0002-3974-2138; Kim, Jae Yong/0000-0001-8571-8350	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST) [KNRF-2018043010]; Asan Institute for Life Sciences, Seoul, Korea [2014-464]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST); Asan Institute for Life Sciences, Seoul, Korea	JK received the following award. This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (KNRF-2018043010) and a grant (2014-464) from the Asan Institute for Life Sciences, Seoul, Korea.	Altmann S, 2011, J INFECT DIS, V203, P683, DOI 10.1093/infdis/jiq103; Arslan S, 2012, CURR EYE RES, V37, P228, DOI 10.3109/02713683.2011.635404; Bae Kunho, 2012, Korean J Ophthalmol, V26, P265, DOI 10.3341/kjo.2012.26.4.265; Silva MRBD, 2009, ARQ BRAS OFTALMOL, V72, P152, DOI 10.1590/S0004-27492009000200004; Bhatt N, 2015, AM J OPHTHALMOL, V159, P601, DOI 10.1016/j.ajo.2014.12.009; Brugaletta S, 2008, Minerva Cardioangiol, V56, P35; Chang SW, 2004, J CATARACT REFR SURG, V30, P1742, DOI 10.1016/j.jcrs.2003.12.044; Coolong A, 2007, AM J CARDIOL, V100, p17K, DOI 10.1016/j.amjcard.2007.06.004; Earla R, 2012, J CHROMATOGR B, V908, P76, DOI 10.1016/j.jchromb.2012.09.014; FOURMAN S, 1995, OPHTHALMOLOGY, V102, P1569; Francis BA, 2005, ARCH OPHTHALMOL-CHIC, V123, P166, DOI 10.1001/archopht.123.2.166; Fuller JR, 2002, BRIT J OPHTHALMOL, V86, P1352, DOI 10.1136/bjo.86.12.1352; Gomes WJ, 2005, ANN THORAC SURG, V80, P1903, DOI 10.1016/j.athoracsur.2004.05.079; Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008; Kelbaek H, 2006, J AM COLL CARDIOL, V47, P449, DOI 10.1016/j.jacc.2005.10.045; KERN W, 1990, J ELECTROCHEM SOC, V137, P1887, DOI 10.1149/1.2086825; Kim TI, 2004, INVEST OPHTH VIS SCI, V45, P2978, DOI 10.1167/iovs.04-0070; Lee YJ, 2013, AM J OPHTHALMOL, V155, P804, DOI 10.1016/j.ajo.2012.12.009; Li J, 2011, CORNEA, V30, P1286, DOI 10.1097/ICO.0b013e31820ce270; Lubbe J, 2004, BRIT J DERMATOL, V151, P1275, DOI 10.1111/j.1365-2133.2004.06289.x; MAHDAVIAN DB, 2011, IMMUNOBIOLOGY, V216, P753, DOI DOI 10.1016/J.IMBI0.2011.01.001; Mai SY, 2014, J OCUL PHARMACOL TH, V30, P670, DOI 10.1089/jop.2014.0001; Memarzadeh F, 2009, INVEST OPHTH VIS SCI, V50, P3233, DOI 10.1167/iovs.08-2441; Miwa Y, 2008, MOD RHEUMATOL, V18, P208, DOI 10.1007/s10165-008-0034-3; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Niel ORP, 2009, TRANSPL P, V41, P3329, DOI 10.1016/j.transproceed.2009.09.034; O'Neill EC, 2010, INVEST OPHTH VIS SCI, V51, P6524, DOI 10.1167/iovs.10-5669; Ohgo T, 2008, INT J CARDIOL, V128, pE89, DOI 10.1016/j.ijcard.2007.04.175; ORAM O, 1995, ARCH OPHTHALMOL-CHIC, V113, P19, DOI 10.1001/archopht.1995.01100010021008; Nguyen QD, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-32; Rikkers SM, 2003, AM J OPHTHALMOL, V135, P297, DOI 10.1016/S0002-9394(02)01982-7; Rodriguez-Agirretxe I, 2013, INVEST OPHTH VIS SCI, V54, P5227, DOI 10.1167/iovs.13-11777; Ryu Eun Hye, 2012, Korean J Ophthalmol, V26, P241, DOI 10.3341/kjo.2012.26.4.241; Sahiner N, 2009, ARCH OPHTHALMOL-CHIC, V127, P448, DOI 10.1001/archophthalmol.2009.19; SalasPrato M, 1996, J GLAUCOMA, V5, P54; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Sieb JP, 2014, CLIN EXP IMMUNOL, V175, P408, DOI 10.1111/cei.12217; SKUTA GL, 1987, SURV OPHTHALMOL, V32, P149, DOI 10.1016/0039-6257(87)90091-9; Sun SJ, 2018, J MATER SCI-MATER M, V29, DOI 10.1007/s10856-018-6138-1; Tempest-Roe S, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-39; Vigil EM, 2015, J OPHTHALMIC INFLAMM, V5, DOI 10.1186/s12348-015-0044-1; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wessely R, 2010, NAT REV CARDIOL, V7, P194, DOI 10.1038/nrcardio.2010.14; Yagi Y, 2013, EUR NEUROL, V69, P344, DOI 10.1159/000347068	45	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219194	10.1371/journal.pone.0219194	http://dx.doi.org/10.1371/journal.pone.0219194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276522	Green Published, gold, Green Submitted			2022-12-26	WOS:000484936300049
J	Stefan, L; Paradzik, P; Sporis, G				Stefan, Lovro; Paradzik, Petar; Sporis, Goran			Sex and age correlations of reported and estimated physical fitness in adolescents	PLOS ONE			English	Article							HEALTH	The main purpose of the study was to explore sex and age specific correlations between self-reported and estimated physical fitness. In this cross-sectional study, we recruited 1 036 secondary-school students (55.3% girls). Self-reported physical fitness was assessed on a 10-point scale, with a higher score indicating better physical fitness. We measured waist circumference, sit-ups in 1 minute, standing long jump and sit-and-reach test and calculated z-scores to obtain objective physical fitness index. Boys performed better in sit-ups in 1 minute and standing long jump tests and had higher waist circumference values. Girls performed better in sit-and-reach test. Overall, boys had higher physical fitness z-score values, compared to girls. Younger boys had better physical fitness perception (r(1st) (grade) = 0.61, p<0.001), compared to older ones (r = 0.40-0.50, p<0.001). In girls, correlation coefficient was the highest in the 3rd grade (r = 0.46, p<0.001), followed by the 2nd grade (r = 0.43, p<0.001), the 1st grade (r = 0.41, p<0.001) and the 4th grade (r = 0.37, p<0.001). Our study shows moderate sex and age specific correlation between self-reported and estimated physical fitness in a large sample of adolescents.	[Stefan, Lovro; Sporis, Goran] Univ Zagreb, Fac Kinesiol, Dept Gen & Appl Kinesiol, Zagreb, Croatia; [Paradzik, Petar] VII High Sch, Zagreb, Croatia	University of Zagreb; University of Zagreb, Faculty of Kinesiology	Stefan, L (corresponding author), Univ Zagreb, Fac Kinesiol, Dept Gen & Appl Kinesiol, Zagreb, Croatia.	lovro.stefan1510@gmail.com	Sporiš, Goran/AAB-6582-2020					Aadahl M, 2007, EUR J CARDIOV PREV R, V14, P422, DOI 10.1097/HJR.0b013e3280128d00; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Chen JL, 2008, INT NURS REV, V55, P81, DOI 10.1111/j.1466-7657.2007.00588.x; Clarys J. P., 2006, Morphologie, V90, P189, DOI 10.1016/S1286-0115(06)74505-2; Croatian Bureau of Statistics, 1 REL UPP SEC SCH EN; Garcia-Hermoso A, 2019, SPORTS MED, V49, P1079, DOI 10.1007/s40279-019-01098-6; Gerber M, 2010, MED SCI SPORT EXER, V42, P893, DOI 10.1249/MSS.0b013e3181c0ea8c; Keith NR, 2012, MED SCI SPORT EXER, V44, P1388, DOI 10.1249/MSS.0b013e31824bdc35; LAMB KL, 1992, PERCEPT MOTOR SKILL, V74, P907, DOI 10.2466/PMS.74.3.907-914; Lovecchio N, 2019, J SPORT MED PHYS FIT, V59, P1389, DOI 10.23736/S0022-4707.18.08926-0; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Mikkelsson L, 2005, SCAND J MED SCI SPOR, V15, P329, DOI 10.1111/j.1600-0838.2004.00429.x; Obling Kirstine H, 2015, Prev Med Rep, V2, P462, DOI 10.1016/j.pmedr.2015.05.010; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Ortega FB, 2013, SCAND J MED SCI SPOR, V23, P749, DOI 10.1111/j.1600-0838.2012.01454.x; Ortega FB, 2011, INT J EPIDEMIOL, V40, P701, DOI 10.1093/ije/dyr039; PCPFS (Presidents Council on Physical Fitness and Sports), 2012, PRES CHALL PHYS FITN; Plante TG, 2000, INT J STRESS MANAGE, V7, P181, DOI 10.1023/A:1009514214782; Plante TG, 1998, INT J STRESS MANAGE, V5, P141, DOI 10.1023/A:1022936930992; Ruiz JR, 2009, BRIT J SPORT MED, V43, P909, DOI 10.1136/bjsm.2008.056499; Ruiz JR, 2011, BRIT J SPORT MED, V45, P518, DOI 10.1136/bjsm.2010.075341; Sauka M, 2011, SCAND J PUBLIC HEALT, V39, P35, DOI 10.1177/1403494810380298; Stroyer J, 2007, PERCEPT MOTOR SKILL, V104, P519, DOI 10.2466/PMS.104.2.519-533; YOUNG ML, 1985, J SPORT MED PHYS FIT, V25, P144	24	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219217	10.1371/journal.pone.0219217	http://dx.doi.org/10.1371/journal.pone.0219217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269061	Green Published, Green Submitted, gold			2022-12-26	WOS:000484927300054
J	Lee, H; Lee, Y; Tae, J; Kwon, Y				Lee, Hyeonjin; Lee, Yoonhyoung; Tae, Jini; Kwon, Youan			Advantage of the go/no-go task over the yes/no lexical decision task: ERP indexes of parameters in the diffusion model	PLOS ONE			English	Article							VISUAL-WORD RECOGNITION; SYLLABLE-FREQUENCY; COMPUTATIONAL MODELS; ACCOUNT; P300; COMPONENTS; SURPRISE; ACCESS; YOUNG; TIME	Previous research findings supporting the advantages of the go/no-go choice over the yes/no choice in lexical decision task (LDT) have suggested that the go/no-go choice might require less cognitive resources in the non-decisional processes. This study aims to test such an idea using the event-related potential method. In this study, the tasks (yes/no LDT and go/no-go LDT) and word frequency (high and low) were manipulated, and the difference between the go/no-go choice and yes/no choice were examined with BP, pN, pN1, P200, N400, and P3 components that were assumed to be closely related with the various parameters in the diffusion model. The results showed that BP, pN and pN1 amplitudes reflecting the preparation stage were not differently affected by word frequency and the task type. However, ERPs after stimulus onset showed differences. The P200 amplitudes were smaller in the go/no-go task than in the yes/no task only for low-frequency words. N400 and P3 amplitudes were only affected by word frequency. The results suggest that the go/no-go task and the yes/no task differ in sub-lexical processes, which is indicated in the T-encoding parameter in the diffusion model. This study is important as it offers the first electrophysiological evidence supporting the assumption in the diffusion model that explains the advantage of the go/no-go choice over the yes/no choice.	[Lee, Hyeonjin] Yeungnam Univ, Dept Early Childhood Educ, Gyongsan, South Korea; [Lee, Yoonhyoung; Tae, Jini] Yeungnam Univ, Dept Psychol, Gyongsan, South Korea; [Kwon, Youan] Konkuk Univ, Multilingualism & Multiculturalism Res Ctr, Seoul, South Korea; [Kwon, Youan] Daegu Catholic Univ, Dept Psychol, Gyongsan, South Korea	Yeungnam University; Yeungnam University; Konkuk University; Catholic University of Daegu	Kwon, Y (corresponding author), Konkuk Univ, Multilingualism & Multiculturalism Res Ctr, Seoul, South Korea.; Kwon, Y (corresponding author), Daegu Catholic Univ, Dept Psychol, Gyongsan, South Korea.	yakwon213@cu.ac.kr			Yeungnam University	Yeungnam University	This work was supported by the 2015 Yeungnam University research grant to Hyeonjin Lee. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN PA, 1993, PSYCHOL AGING, V8, P274, DOI 10.1037/0882-7974.8.2.274; Barber H, 2004, NEUROREPORT, V15, P545, DOI 10.1097/00001756-200403010-00032; Barber HA, 2007, BRAIN RES REV, V53, P98, DOI 10.1016/j.brainresrev.2006.07.002; Bartholow BD, 2001, PSYCHOL SCI, V12, P197, DOI 10.1111/1467-9280.00336; Berchicci M, 2016, BIOL PSYCHOL, V117, P202, DOI 10.1016/j.biopsycho.2016.04.007; Carreiras M, 2005, J COGNITIVE NEUROSCI, V17, P1803, DOI 10.1162/089892905774589217; Carreiras M, 2014, TRENDS COGN SCI, V18, P90, DOI 10.1016/j.tics.2013.11.005; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Conrad M, 2004, LANG COGNITIVE PROC, V19, P369, DOI 10.1080/01690960344000224; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Di Russo F, 2017, NEUROSCI BIOBEHAV R, V78, P57, DOI 10.1016/j.neubiorev.2017.04.019; Di Russo F, 2016, NEUROIMAGE, V126, P1, DOI 10.1016/j.neuroimage.2015.11.036; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Gibbs P, 1998, J EXP PSYCHOL HUMAN, V24, P1162, DOI 10.1037/0096-1523.24.4.1162; Gomez P, 2007, J EXP PSYCHOL GEN, V136, P389, DOI 10.1037/0096-3445.136.3.389; Gomez P, 2014, Q J EXP PSYCHOL, V67, P2455, DOI 10.1080/17470218.2014.937447; GORDON B, 1983, J VERB LEARN VERB BE, V22, P24, DOI 10.1016/S0022-5371(83)80004-8; GORDON B, 1982, BRAIN LANG, V15, P143, DOI 10.1016/0093-934X(82)90053-0; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hino Y, 2000, J EXP PSYCHOL HUMAN, V26, P166, DOI 10.1037/0096-1523.26.1.166; Kida T, 2003, EUR J APPL PHYSIOL, V89, P326, DOI 10.1007/s00421-003-0801-y; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Kwon Y, 2012, NEUROPSYCHOLOGIA, V50, P3385, DOI 10.1016/j.neuropsychologia.2012.09.041; Kwon Y, 2011, NEUROSCI LETT, V501, P117, DOI 10.1016/j.neulet.2011.06.060; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P147; Moret-Tatay C, 2011, J EXP CHILD PSYCHOL, V110, P125, DOI 10.1016/j.jecp.2011.04.005; Naatanen R., 1979, ORIENTING REFLEX HUM, P61; National Institute of the Korean Language, 2001, KOR WORD DAT 21 CENT; Navarro-Pardo E, 2013, J GEN PSYCHOL, V140, P251, DOI 10.1080/00221309.2013.817964; Perea M, 2005, PERCEPT PSYCHOPHYS, V67, P301, DOI 10.3758/BF03206493; Perea M, 2016, J COGN PSYCHOL, V28, P147, DOI 10.1080/20445911.2015.1107077; Perea M, 2015, J EXP CHILD PSYCHOL, V129, P140, DOI 10.1016/j.jecp.2014.09.005; Perea M, 2010, PSYCHON B REV, V17, P369, DOI 10.3758/PBR.17.3.369; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ratcliff R, 2004, PSYCHOL REV, V111, P159, DOI 10.1037/0033-295X.111.1.159; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; Ratcliff R, 2000, J EXP PSYCHOL HUMAN, V26, P127, DOI 10.1037/0096-1523.26.1.127; RATCLIFF R, 1981, PSYCHOL REV, V88, P552, DOI 10.1037/0033-295X.88.6.552; Ratcliff R, 2002, PSYCHON B REV, V9, P278, DOI 10.3758/BF03196283; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2016, TRENDS COGN SCI, V20, P260, DOI 10.1016/j.tics.2016.01.007; Salisbury DF, 2001, CLIN NEUROPHYSIOL, V112, P1676, DOI 10.1016/S1388-2457(01)00607-1; Voss A, 2004, MEM COGNITION, V32, P1206, DOI 10.3758/BF03196893; Wagenmakers EJ, 2008, J MEM LANG, V58, P140, DOI 10.1016/j.jml.2007.04.006; Wessel JR, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.12871	48	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0218451	10.1371/journal.pone.0218451	http://dx.doi.org/10.1371/journal.pone.0218451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3YW	31260472	Green Submitted, Green Published, gold			2022-12-26	WOS:000484918700016
J	Sha, Z; Blyszcz, T; Gonzalez-Prieto, R; Vertegaal, ACO; Goldberg, AL				Sha, Zhe; Blyszcz, Tamara; Gonzalez-Prieto, Roman; Vertegaal, Alfred C. O.; Goldberg, Alfred L.			Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; proteasome; ubiquitylation (ubiquitination); small ubiquitin-like modifier (SUMO); sumoylation; nuclear body; promyelocytic leukemia (PML); SUMO-conjugating enzyme UBC9; TAK243; ubiquitin-activating enzyme (UAE; E1))	ACUTE PROMYELOCYTIC LEUKEMIA; NF-KAPPA-B; TRANSCRIPTIONAL ACTIVITY; HEAT-SHOCK; E3 LIGASE; COMPUTATIONAL PLATFORM; SUMO-1 MODIFICATION; STRUCTURAL BASIS; REVEALS; DEGRADATION	Protein ubiquitination and SUMOylation are required for the maintenance of cellular protein homeostasis, and both increase in proteotoxic conditions (e.g. heat shock or proteasome inhibition). However, we found that when ubiquitination was blocked in several human cell lines by inhibiting the ubiquitin-activating enzyme with TAK243, there was an unexpected, large accumulation of proteins modified by SUMO2/3 chains or SUMO1, but not by several other ubiquitin-like proteins. This buildup of SUMOylated proteins was evident within 3?4 h. It required the small ubiquitin-like modifier (SUMO)-conjugating enzyme, UBC9, and the promyelocytic leukemia protein (PML) and thus was not due to nonspecific SUMO conjugation by ubiquitination enzymes. The SUMOylated proteins accumulated predominantly bound to chromatin and were localized to PML nuclear bodies. Because blocking protein synthesis with cycloheximide prevented the buildup of SUMOylated proteins, they appeared to be newly-synthesized proteins. The proteins SUMOylated after inhibition of ubiquitination were purified and analyzed by MS. In HeLa and U2OS cells, there was a cycloheximide-sensitive increase in a similar set of SUMOylated proteins (including transcription factors and proteins involved in DNA damage repair). Surprisingly, the inhibition of ubiquitination also caused a cycloheximide-sensitive decrease in a distinct set of SUMOylated proteins (including proteins for chromosome modification and mRNA splicing). More than 80% of the SUMOylated proteins whose levels rose or fell upon inhibiting ubiquitination inhibition underwent similar cycloheximide-sensitive increases or decreases upon proteasome inhibition. Thus, when nuclear substrates of the ubiquitin?proteasome pathway are not efficiently degraded, many become SUMO-modified and accumulate in PML bodies.	[Sha, Zhe; Goldberg, Alfred L.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Blyszcz, Tamara; Gonzalez-Prieto, Roman; Vertegaal, Alfred C. O.] Leiden Univ, Dept Cell & Chem Biol, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Sha, Zhe] 3 Preston Ct, Bedford, MA 01730 USA	Harvard University; Harvard Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Goldberg, AL (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; Vertegaal, ACO (corresponding author), Leiden Univ, Dept Cell & Chem Biol, Med Ctr, NL-2333 ZA Leiden, Netherlands.	vertegaal@lumc.nl; alfred_goldberg@hms.harvard.edu	Gonzalez Prieto, Roman/O-4132-2014; Vertegaal, Alfred/ABG-8141-2021	Gonzalez Prieto, Roman/0000-0001-8997-2321; Vertegaal, Alfred/0000-0002-7989-0493	National Institutes of Health Grant from NIGMS [RO1 GM51923-23]; Muscular Dystrophy Association; Cure Alzheimers Foundation, Project ALS; European Research Council (ERC) [310913]; Netherlands Organisation for Scientific Research (NWO) VICI Grant [724.016.003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Muscular Dystrophy Association(Muscular Dystrophy Association); Cure Alzheimers Foundation, Project ALS; European Research Council (ERC)(European Research Council (ERC)); Netherlands Organisation for Scientific Research (NWO) VICI Grant(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1 GM51923-23 from NIGMS (to A. L. G.); the Muscular Dystrophy Association; the Cure Alzheimers Foundation, Project ALS (to A. L. G.); the European Research Council (ERC) Grant 310913 (to A. C. O. V.), and Netherlands Organisation for Scientific Research (NWO) VICI Grant 724.016.003 (to A. C. O. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ablain J, 2014, NAT MED, V20, P167, DOI 10.1038/nm.3441; Bailey D, 2005, BIOCHEM J, V392, P271, DOI 10.1042/BJ20050873; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Barghout SH, 2019, LEUKEMIA, V33, P37, DOI 10.1038/s41375-018-0167-0; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Cappadocia L, 2015, NAT STRUCT MOL BIOL, V22, P968, DOI 10.1038/nsmb.3116; Chen H, 2010, BIOCHEM J, V429, P95, DOI 10.1042/BJ20100193; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; de The H, 2017, CANCER CELL, V32, P552, DOI 10.1016/j.ccell.2017.10.002; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dundr M, 2012, CURR OPIN CELL BIOL, V24, P415, DOI 10.1016/j.ceb.2012.03.010; Eisenhardt N, 2015, NAT STRUCT MOL BIOL, V22, P959, DOI 10.1038/nsmb.3114; Erker Y, 2013, MOL CELL BIOL, V33, P2163, DOI 10.1128/MCB.01019-12; Ferbeyre G, 2000, GENE DEV, V14, P2015; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Guo LL, 2014, MOL CELL, V55, P15, DOI 10.1016/j.molcel.2014.04.030; He XY, 2017, NAT CHEM BIOL, V13, P1164, DOI [10.1038/nchembio.2463, 10.1038/NCHEMBIO.2463]; Hendriks IA, 2017, NAT STRUCT MOL BIOL, V24, P325, DOI 10.1038/nsmb.3366; Hendriks IA, 2016, METHODS MOL BIOL, V1475, P171, DOI 10.1007/978-1-4939-6358-4_13; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Hendriks IA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8289; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Hou X, 2017, BIOCHEM BIOPH RES CO, V494, P446, DOI 10.1016/j.bbrc.2017.10.103; Hsu KS, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0204-8; Hyer ML, 2018, NAT MED, V24, P186, DOI 10.1038/nm.4474; Imoto S, 2008, BIOCHEM BIOPH RES CO, V370, P359, DOI 10.1016/j.bbrc.2008.03.116; Kumar R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01900-x; Lallemand-Breitenbach V, 2018, CURR OPIN CELL BIOL, V52, P154, DOI 10.1016/j.ceb.2018.03.011; Liebelt F, 2019, CELL REP, V26, P236, DOI 10.1016/j.celrep.2018.12.027; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Lomonte P, 2016, MICROB CELL, V3, P438, DOI 10.15698/mic2016.11.541; Long JY, 2004, BIOCHEM J, V379, P23, DOI 10.1042/BJ20031867; Maghames CM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06365-0; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Myatt SS, 2014, ONCOGENE, V33, P4316, DOI 10.1038/onc.2013.546; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Rao HBDP, 2017, SCIENCE, V355, P403, DOI 10.1126/science.aaf6407; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Rott R, 2017, P NATL ACAD SCI USA, V114, P13176, DOI 10.1073/pnas.1704351114; Sahin U, 2014, J PATHOL, V234, P289, DOI 10.1002/path.4426; Sahin U, 2014, J CELL BIOL, V204, P931, DOI 10.1083/jcb.201305148; Schimmel J, 2014, MOL CELL, V53, P1053, DOI 10.1016/j.molcel.2014.02.001; Seeler JS, 2017, NAT REV CANCER, V17, P184, DOI 10.1038/nrc.2016.143; Sha Z, 2018, J CELL BIOL, V217, P1757, DOI 10.1083/jcb.201708168; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tatham MH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001484; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Xiao ZY, 2015, MOL CELL PROTEOMICS, V14, P1419, DOI 10.1074/mcp.O114.044792; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112; Zilio N, 2017, ADV EXP MED BIOL, V963, P51, DOI 10.1007/978-3-319-50044-7_4	74	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2019	294	42					15218	15234		10.1074/jbc.RA119.009147	http://dx.doi.org/10.1074/jbc.RA119.009147			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HM	31285264	Green Published, hybrid			2022-12-26	WOS:000499248700003
J	Green, NH; Galvan, DL; Badal, SS; Chang, BH; LeBleu, VS; Long, JY; Jonasch, E; Danesh, FR				Green, Nathanael H.; Galvan, Daniel L.; Badal, Shawn S.; Chang, Benny H.; LeBleu, Valerie S.; Long, Jianyin; Jonasch, Eric; Danesh, Farhad R.			MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma	ONCOGENE			English	Article							ONE-CARBON METABOLISM; CANCER; SERINE; TRANSLATION; GLYCINE; HIF-2; N-6-METHYLADENOSINE	One-carbon metabolism plays a central role in a broad array of metabolic processes required for the survival and growth of tumor cells. However, the molecular basis of how one-carbon metabolism may influence RNA methylation and tumorigenesis remains largely unknown. Here we show MTHFD2, a mitochondrial enzyme involved in one-carbon metabolism, contributes to the progression of renal cell carcinoma (RCC) via a novel epitranscriptomic mechanism that involves HIF-2 alpha. We found that expression of MTHFD2 was significantly elevated in human RCC tissues, and MTHFD2 knockdown strongly reduced xenograft tumor growth. Mechanistically, using an unbiased methylated RNA immunoprecipitation sequencing (meRIP-Seq) approach, we found that MTHFD2 plays a critical role in controlling global N-6-methyladenosine (m(6)A) methylation levels, including the m(6)A methylation of HIF-2 alpha mRNA, which results in enhanced translation of HIF-2 alpha. Enhanced HIF-2 alpha translation, in turn, promotes the aerobic glycolysis, linking one-carbon metabolism to HIF-2 alpha-dependent metabolic reprogramming through RNA methylation. Our findings also suggest that MTHFD2 and HIF-2 alpha form a positive feedforward loop in RCC, promoting metabolic reprograming and tumor growth. Taken together, our results suggest that MTHFD2 links RNA methylation status to the metabolic state of tumor cells in RCC.	[Green, Nathanael H.; Danesh, Farhad R.] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA; [Green, Nathanael H.; Galvan, Daniel L.; Badal, Shawn S.; Long, Jianyin; Danesh, Farhad R.] Univ Texas MD Anderson Canc Ctr, Sect Nephrol, Houston, TX 77030 USA; [Chang, Benny H.] Baylor Coll Med, Dept Med & Mol & Cellular Biol, Houston, TX 77030 USA; [LeBleu, Valerie S.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Jonasch, Eric] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Oncol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Danesh, FR (corresponding author), Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA.; Danesh, FR (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Nephrol, Houston, TX 77030 USA.	fdanesh@mdanderson.org	Galvan, Daniel L./L-2768-2019	Galvan, Daniel L./0000-0001-7541-6252; Danesh, Farhad/0000-0001-6849-5239	 [R01-DK078900];  [R01-DK091310]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078900, R01DK091310] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	FRD: R01-DK078900; R01-DK091310	American Cancer Society, 2018, CANC FACTS FIG 2018; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Chen WF, 2016, NATURE, V539, P112, DOI 10.1038/nature19796; Cho H, 2016, NATURE, V539, P107, DOI 10.1038/nature19795; Choueiri TK, 2017, NEW ENGL J MED, V376, P354, DOI 10.1056/NEJMra1601333; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Di Pietro E, 2002, MOL CELL BIOL, V22, P4158, DOI 10.1128/MCB.22.12.4158-4166.2002; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; GEBHARD RL, 1987, J LIPID RES, V28, P1177; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Hakimi AA, 2016, CANCER CELL, V29, P104, DOI 10.1016/j.ccell.2015.12.004; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsieh JJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.9; Kaelin WG, 2007, CLIN CANCER RES, V13, p680S, DOI 10.1158/1078-0432.CCR-06-1865; Komata M, 2014, METHODS MOL BIOL, V1164, P33, DOI 10.1007/978-1-4939-0805-9_4; Koufaris C, 2016, J PROTEOME RES, V15, P2618, DOI 10.1021/acs.jproteome.6b00188; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Mack FA, 2003, CANCER CELL, V3, P75, DOI 10.1016/S1535-6108(02)00240-4; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Martinez-Saez O, 2017, CRIT REV ONCOL HEMAT, V111, P117, DOI 10.1016/j.critrevonc.2017.01.013; Massari F, 2015, CANCER TREAT REV, V41, P767, DOI 10.1016/j.ctrv.2015.07.002; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Moore LE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002312; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morscher RJ, 2018, NATURE, V554, P128, DOI 10.1038/nature25460; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Noone AM, 2018, SEER CANC STAT REV 1; Pikman Y, 2016, J EXP MED, V213, P1285, DOI 10.1084/jem.20151574; Qiu B, 2015, CANCER DISCOV, V5, P652, DOI 10.1158/2159-8290.CD-14-1507; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Sheppard NG, 2015, SCI REP-UK, V5, DOI 10.1038/srep15029; Shimba S, 2004, J BIOL CHEM, V279, P40946, DOI 10.1074/jbc.M400840200; Tedeschi PM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.393; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wettersten HI, 2017, NAT REV NEPHROL, V13, P410, DOI 10.1038/nrneph.2017.59; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Ye JB, 2014, CANCER DISCOV, V4, P1406, DOI 10.1158/2159-8290.CD-14-0250; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	51	50	50	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 22	2019	38	34					6211	6225		10.1038/s41388-019-0869-4	http://dx.doi.org/10.1038/s41388-019-0869-4			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IS5RM	31289360	Green Accepted			2022-12-26	WOS:000482210100005
J	Scalia, P; Pandini, G; Carnevale, V; Giordano, A; Williams, SJ				Scalia, Pierluigi; Pandini, Giuseppe; Carnevale, Vincenzo; Giordano, Antonio; Williams, Stephen J.			Identification of a novel EphB4 phosphodegron regulated by the autocrine IGFII/IRA axis in malignant mesothelioma	ONCOGENE			English	Article							GROWTH-FACTOR-II; INSULIN-RECEPTOR ISOFORM; IGF-II; TYROSINE-KINASE; BIOLOGICAL SIGNIFICANCE; VASCULAR MORPHOGENESIS; BREAST CANCERS; CELL MIGRATION; MELANOMA-CELLS; EXPRESSION	Malignant mesothelioma is a deadly disease with limited therapeutic options. EphB4 is an oncogenic tyrosine kinase receptor expressed in malignant mesothelioma as well as in a variety of cancers. It is involved in tumor microenvironment mediating angiogenesis and invasive cellular effects via both EphrinB2 ligand-dependent and independent mechanisms. The molecular network underlying EphB4 oncogenic effects is still unclear. Here we show that EphB4 expression in malignant mesothelioma cells is markedly decreased upon neutralization of cancer-secreted IGF-II. In particular, we demonstrate that EphB4 protein expression in malignant mesothelioma cells depend upon a degradation rescue mechanism controlled by the autocrine IGF-II-insulin receptor-A specific signaling axis. We show that the regulation of EphB4 expression is linked to a competing post-translational modification of its carboxy-terminal tail via phosphorylation of its tyrosine 987 by the Insulin receptor isoform-A kinase-associated activity in response to the autocrine IGF-II stimuli. Neutralization of this autocrine-induced EphB4-phosphorylation by IGF-II associates with the increased ubiquitination of EphB4 carboxy-terminal tail and with its rapid degradation. We also describe a novel Ubiquitin binding motif in the targeted region as part of the identified EphB4 phosphodegron and provide 3D modeling data supporting a possible model for the acute EphB4 PTM-driven regulation by IGF-II. Altogether, these findings disclose a novel molecular mechanism for the maintenance of EphB4-expression in malignant mesothelioma cells and other IGF-II-secreting cancers (IGF2omas).	[Scalia, Pierluigi; Giordano, Antonio; Williams, Stephen J.] Temple Univ, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA; [Scalia, Pierluigi; Giordano, Antonio; Williams, Stephen J.] Temple Univ, Ctr Biotechnol, Biol Dept, Philadelphia, PA 19122 USA; [Scalia, Pierluigi; Williams, Stephen J.] ISOPROG, Ist Somatogene Ric Oncogenom, I-93100 Caltanissetta, Italy; [Scalia, Pierluigi; Williams, Stephen J.] Somatolink Res Fdn, Philadelphia, PA 19102 USA; [Pandini, Giuseppe] Univ Catania, Garibaldi Nesima Med Ctr, Dept Clin & Expt Med, Endocrinol, I-95122 Catania, Italy; [Carnevale, Vincenzo] Temple Univ, Coll Sci & Technol, Inst Computat Mol Sci, Philadelphia, PA 19122 USA; [Giordano, Antonio] Univ Siena, Dept Med Biotechnol, I-53100 Siena, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Presidio Ospedaliero Garibaldi-Nesima; University of Catania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Siena	Scalia, P (corresponding author), Temple Univ, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA.; Scalia, P (corresponding author), Temple Univ, Ctr Biotechnol, Biol Dept, Philadelphia, PA 19122 USA.; Scalia, P (corresponding author), ISOPROG, Ist Somatogene Ric Oncogenom, I-93100 Caltanissetta, Italy.; Scalia, P (corresponding author), Somatolink Res Fdn, Philadelphia, PA 19102 USA.	pscalia@isoprog.org	Scalia, Pierluigi/AAH-8443-2019; Pandini, Giuseppe/AAB-9650-2019; Giordano, Antonio/F-1927-2010	Scalia, Pierluigi/0000-0002-5911-1640; Pandini, Giuseppe/0000-0003-3747-7649; Giordano, Antonio/0000-0002-5959-016X	ASEM srl (Treviso, Italy); GianAmico Alessandrini Family	ASEM srl (Treviso, Italy); GianAmico Alessandrini Family	We thank Dr. Steven Albelda (University of Pennsylvania, USA) for providing the MSTO211H cell line and his constructive criticism during the manuscript preparation; Dr Veronica Vella (University of Catania, Italy) for IR system expression data in colorectal cancer cell lines; Dr Parkash S Gill (USC, Los Angeles, CA) for critical insights in manuscript revision. We also thank ASEM srl (Treviso, Italy) and the GianAmico Alessandrini Family for supporting PS research.	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Atapattu L, 2014, CELL ADHES MIGR, V8, P294, DOI 10.4161/19336918.2014.970026; Baserga R, 2013, J CELL PHYSIOL, V228, P675, DOI 10.1002/jcp.24217; Becerikli M, 2015, INT J CANCER, V136, P1781, DOI 10.1002/ijc.29244; BENNETT BD, 1994, J BIOL CHEM, V269, P14211; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen T, 2013, TUMOR BIOL, V34, P379, DOI 10.1007/s13277-012-0560-7; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; DAUGHADAY WH, 1993, P NATL ACAD SCI USA, V90, P5823, DOI 10.1073/pnas.90.12.5823; Dynkevich Y, 2013, ENDOCR REV, V34, P798, DOI 10.1210/er.2012-1033; ELBADRY OM, 1990, CELL GROWTH DIFFER, V1, P325; Erber R, 2006, EMBO J, V25, P628, DOI 10.1038/sj.emboj.7600949; Ferguson BD, 2015, SCI REP-UK, V5, DOI 10.1038/srep10641; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Greenall SA, 2018, TRANSL ONCOL, V11, P971, DOI 10.1016/j.tranon.2018.05.011; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang X, 2007, CANCER RES, V67, P9800, DOI 10.1158/0008-5472.CAN-07-0531; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kim KW, 1998, CANCER RES, V58, P348; Kumar SR, 2009, CANCER RES, V69, P3736, DOI 10.1158/0008-5472.CAN-08-3232; Liu R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-269; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Marks AG, 2011, ENDOCRINOLOGY, V152, P922, DOI 10.1210/en.2010-0784; Martiny-Baron G, 2010, ANGIOGENESIS, V13, P259, DOI 10.1007/s10456-010-9183-z; Morcavallo A, 2011, MOL ENDOCRINOL, V25, P1456, DOI 10.1210/me.2010-0484; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Noren NK, 2009, BIOCHEM J, V422, P433, DOI 10.1042/BJ20090014; Nussbaum T, 2008, HEPATOLOGY, V48, P146, DOI 10.1002/hep.22297; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pundir S, 2017, METHODS MOL BIOL, V1558, P41, DOI 10.1007/978-1-4939-6783-4_2; Ritter MR, 2002, P NATL ACAD SCI USA, V99, P7455, DOI 10.1073/pnas.102185799; ROGLER CE, 1994, J BIOL CHEM, V269, P13779; Rutkowski R, 2012, INT J CANCER, V131, pE614, DOI 10.1002/ijc.27392; RUTTEN AAJJL, 1995, CANCER RES, V55, P3634; Salgia R, 2018, BBA-REV CANCER, V1869, P128, DOI 10.1016/j.bbcan.2018.01.003; Scalia P, 2001, J CELL BIOCHEM, V82, P610, DOI 10.1002/jcb.1196; Sciacca L, 1999, ONCOGENE, V18, P2471, DOI 10.1038/sj.onc.1202600; Sciacca L, 2002, ONCOGENE, V21, P8240, DOI 10.1038/sj.onc.1206058; SINHA UK, 2003, ENT-EAR NOSE THROAT, V82, P887; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Steinle JJ, 2002, J BIOL CHEM, V277, P43830, DOI 10.1074/jbc.M207221200; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tawo R, 2017, CELL, V169, P470, DOI 10.1016/j.cell.2017.04.003; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Xia GB, 2005, CLIN CANCER RES, V11, P4305, DOI 10.1158/1078-0432.CCR-04-2109; Xia GB, 2005, CANCER RES, V65, P4623, DOI 10.1158/0008-5472.CAN-04-2667; Xu WW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14399; Yang NY, 2006, J BIOL CHEM, V281, P32574, DOI 10.1074/jbc.M604338200; Zhao SK, 2010, P NATL ACAD SCI USA, V107, P7704, DOI 10.1073/pnas.0908764107	55	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 1	2019	38	31					5987	6001		10.1038/s41388-019-0854-y	http://dx.doi.org/10.1038/s41388-019-0854-y			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IT3GE	31270394	hybrid, Green Published			2022-12-26	WOS:000482740000006
J	Lind, AP; Anderson, PC				Lind, Alex P.; Anderson, Peter C.			Predicting drug activity against cancer cells by random forest models based on minimal genomic information and chemical properties	PLOS ONE			English	Article							PRECISION MEDICINE; SENSITIVITY; MUTATIONS; IDENTIFICATION; BIOMARKERS; RESPONSES; SURVIVAL	A key goal of precision medicine is predicting the best drug therapy for a specific patient from genomic information. In oncology, cancers that appear similar pathologically can vary greatly in how they respond to the same drug. Fortunately, data from high-throughput screening programs often reveal important relationships between genomic variability of cancer cells and their response to drugs. Nevertheless, many current computational methods to predict compound activity against cancer cells require large quantities of genomic, epigenomic, and additional cellular data to develop and to apply. Here we integrate recent screening data and machine learning to train classification models that predict the activity/inactivity of compounds against cancer cells based on the mutational status of only 145 oncogenes and a set of compound structural descriptors. Using IC50 values of 1 mu M as activity cutoffs, our predictive models have sensitivities of 87%, specificities of 87%, and yield an area under the receiver operating characteristic curve equal to 0.94. We also develop regression models to predict log(IC50) values of compounds for cancer cells; the models achieve a Pearson correlation coefficient of 0.86 for cross-validation and up to 0.65-0.73 against blind test sets. Predictive performance remains strong when as few as 50 oncogenes are included. Finally, even when 40% of experimental IC50 values are missing from screening data, they can be imputed with sufficient reliability that classification accuracy is not diminished. The presented models are fast to generate and may serve as easily implemented screening tools for personalized oncology medicine, drug repurposing, and drug discovery.	[Lind, Alex P.; Anderson, Peter C.] Univ Washington, Phys Sci Div, Bothell, WA 98011 USA	University of Washington; University of Washington Bothell	Anderson, PC (corresponding author), Univ Washington, Phys Sci Div, Bothell, WA 98011 USA.	pca4@uw.edu						Ali Mehreen, 2019, Biophys Rev, V11, P31, DOI 10.1007/s12551-018-0446-z; Amnnad-ud-din M, 2014, J CHEM INF MODEL, V54, P2347, DOI 10.1021/ci500152b; Arisholm E, 2010, J SYST SOFTWARE, V83, P2, DOI 10.1016/j.jss.2009.06.055; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Bresler SC, 2014, CANCER CELL, V26, P682, DOI 10.1016/j.ccell.2014.09.019; Camacho DM, 2018, CELL, V173, P1581, DOI 10.1016/j.cell.2018.05.015; Chang Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27214-6; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Cichonska A, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005678; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Cortes-Ciriano I, 2016, CURR PHARM DESIGN, V22, P6918, DOI [10.1174/1381611811666161016154430, 10.2174/1381612822666161026154430]; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; De Ferrari L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-61; Friedman AA, 2015, NAT REV CANCER, V15, P747, DOI 10.1038/nrc4015; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Goldstein BA, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1691; Gutlein M, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-7; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Haider S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144490; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hejase HA, 2015, CPT-PHARMACOMET SYST, V4, P98, DOI 10.1002/psp4.2; Hermeking H, 2003, CURR CANCER DRUG TAR, V3, P163, DOI 10.2174/1568009033481949; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jameson JL, 2015, NEW ENGL J MED, V372, P2229, DOI 10.1056/NEJMsb1503104; Kelloff GJ, 2012, NAT REV DRUG DISCOV, V11, P201, DOI 10.1038/nrd3651; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; La Thangue NB, 2011, NAT REV CLIN ONCOL, V8, P587, DOI 10.1038/nrclinonc.2011.121; Lee SI, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02465-5; Li Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04250-2; Lievre A, 2010, ONCOGENE, V29, P3033, DOI 10.1038/onc.2010.89; Martins MM, 2015, CANCER DISCOV, V5, P154, DOI 10.1158/2159-8290.CD-14-0552; Menden MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061318; Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866; Naulaerts S, 2017, ONCOTARGET, V8, P97025, DOI 10.18632/oncotarget.20923; Nayak DR, 2016, NEUROCOMPUTING, V177, P188, DOI 10.1016/j.neucom.2015.11.034; Qi YJ, 2012, ENSEMBLE MACHINE LEARNING: METHODS AND APPLICATIONS, P307, DOI 10.1007/978-1-4419-9326-7_11; Riddick G, 2011, BIOINFORMATICS, V27, P220, DOI 10.1093/bioinformatics/btq628; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Rucker C, 2007, J CHEM INF MODEL, V47, P2345, DOI 10.1021/ci700157b; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Sherwood Ben, 2016, Alzheimers Dement (Amst), V2, P12, DOI 10.1016/j.dadm.2015.11.005; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Souglakos J, 2009, BRIT J CANCER, V101, P465, DOI 10.1038/sj.bjc.6605164; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tsimberidou A-M, 2012, CLIN CANCER RES, V18, P1; Wan Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101183; Willighagen EL, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0220-4; Wright MN, 2017, J STAT SOFTW, V77, P1, DOI 10.18637/jss.v077.i01; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111	56	33	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219774	10.1371/journal.pone.0219774	http://dx.doi.org/10.1371/journal.pone.0219774			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295321	gold, Green Submitted, Green Published			2022-12-26	WOS:000484951800070
J	Wutzl, B; Leibnitz, K; Rattay, F; Kronbichler, M; Murata, M; Golaszewski, SM				Wutzl, Betty; Leibnitz, Kenji; Rattay, Frank; Kronbichler, Martin; Murata, Masayuki; Golaszewski, Stefan Martin			Genetic algorithms for feature selection when classifying severe chronic disorders of consciousness	PLOS ONE			English	Article							VEGETATIVE STATE; UNRESPONSIVE WAKEFULNESS; FEATURE-EXTRACTION; DIAGNOSIS; RECOVERY; MISDIAGNOSIS; SLEEP	The diagnosis and prognosis of patients with severe chronic disorders of consciousness are still challenging issues and a high rate of misdiagnosis is evident. Hence, new tools are needed for an accurate diagnosis, which will also have an impact on the prognosis. In recent years, functional Magnetic Resonance Imaging (fMRI) has been gaining more and more importance when diagnosing this patient group. Especially resting state scans, i.e., an examination when the patient does not perform any task in particular, seems to be promising for these patient groups. After preprocessing the resting state fMRI data with a standard pipeline, we extracted the correlation matrices of 132 regions of interest. The aim was to find the regions of interest which contributed most to the distinction between the different patient groups and healthy controls. We performed feature selection using a genetic algorithm and a support vector machine. Moreover, we show by using only those regions of interest for classification that are most often selected by our algorithm, we get a much better performance of the classifier.	[Wutzl, Betty; Leibnitz, Kenji; Murata, Masayuki] Osaka Univ, Grad Sch Informat Sci & Technol, Osaka, Japan; [Wutzl, Betty; Leibnitz, Kenji; Murata, Masayuki] Ctr Informat & Neural Networks, Natl Inst Informat & Commun Technol, Osaka, Japan; [Wutzl, Betty; Leibnitz, Kenji; Murata, Masayuki] Osaka Univ, Osaka, Japan; [Wutzl, Betty; Rattay, Frank] TU Wien, Inst Anal & Sci Comp, Vienna, Austria; [Wutzl, Betty; Golaszewski, Stefan Martin] Paracelsus Med Univ, Dept Neurol, Salzburg, Austria; [Kronbichler, Martin; Golaszewski, Stefan Martin] Paracelsus Med Univ, Christian Doppler Med Ctr, Neurosci Inst, Salzburg, Austria; [Kronbichler, Martin] Univ Salzburg, Ctr Cognit Neurosci, Salzburg, Austria; [Kronbichler, Martin] Univ Salzburg, Dept Psychol, Salzburg, Austria; [Golaszewski, Stefan Martin] Karl Landsteiner Inst Neurorehabil & Space Neurol, Vienna, Austria	Osaka University; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; Technische Universitat Wien; Paracelsus Private Medical University; Paracelsus Private Medical University; Salzburg University; Salzburg University	Wutzl, B (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, Osaka, Japan.; Wutzl, B (corresponding author), Ctr Informat & Neural Networks, Natl Inst Informat & Commun Technol, Osaka, Japan.; Wutzl, B (corresponding author), Osaka Univ, Osaka, Japan.; Wutzl, B (corresponding author), TU Wien, Inst Anal & Sci Comp, Vienna, Austria.; Wutzl, B (corresponding author), Paracelsus Med Univ, Dept Neurol, Salzburg, Austria.	b-wutzl@ist.osaka-u.ac.jp	Kronbichler, Martin/A-5599-2008; Kronbichler, Martin/AAY-1519-2021; Leibnitz, Kenji/M-3841-2013; Rattay, Frank/A-2231-2015	Kronbichler, Martin/0000-0003-2240-2812; Kronbichler, Martin/0000-0003-2240-2812; Leibnitz, Kenji/0000-0002-3691-3675; Rattay, Frank/0000-0002-2819-8827; Wutzl, Betty/0000-0003-0183-7067				Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Blum AL, 1997, ARTIF INTELL, V97, P245, DOI 10.1016/S0004-3702(97)00063-5; Bodien YG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00688; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Cologan V, 2013, J NEUROTRAUM, V30, P339, DOI 10.1089/neu.2012.2654; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Fischer DB, 2016, NEUROLOGY, V87, P2427, DOI 10.1212/WNL.0000000000003404; Frohlich H, 2003, PROC INT C TOOLS ART, P142, DOI 10.1109/TAI.2003.1250182; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gosseries Olivia, 2016, Open Neuroimag J, V10, P52, DOI 10.2174/1874440001610010052; Gosseries O, 2014, BRAIN INJURY, V28, P1141, DOI 10.3109/02699052.2014.920522; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hannawi Y, 2015, NEUROLOGY, V84, P1272, DOI 10.1212/WNL.0000000000001404; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; Holler Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080479; Holland, 1975, ADAPTATION NATURAL A; Huang CL, 2006, EXPERT SYST APPL, V31, P231, DOI 10.1016/j.eswa.2005.09.024; Jox RJ, 2012, LANCET NEUROL, V11, P732, DOI 10.1016/S1474-4422(12)70154-0; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Karamzadeh N, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.335; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Landsness E, 2011, BRAIN, V134, P2222, DOI 10.1093/brain/awr152; Laureys S, 2006, J CLIN INVEST, V116, P1823, DOI 10.1172/JCI29172; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Legostaeva L, 2017, J NEUROL SCI, V381, P756, DOI 10.1016/j.jns.2017.08.2134; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Noe E, 2012, ARCH PHYS MED REHAB, V93, P428, DOI 10.1016/j.apmr.2011.08.048; Olaolu AM, FEATURE SELECTION BA; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Pavlov YG, 2017, J SLEEP RES, V26, P629, DOI 10.1111/jsr.12524; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Plum F, 1972, Contemp Neurol Ser, V10, P1; Pugin D, 2018, CLIN NEUROPHYSIOL, V129, pe46; Richiardi J, 2013, IEEE SIGNAL PROC MAG, V30, P58, DOI 10.1109/MSP.2012.2233865; Riganello F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00769; Sachdeva J, 2013, J DIGIT IMAGING, V26, P1141, DOI 10.1007/s10278-013-9600-0; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; Salcedo-Sanz S, 2002, LECT NOTES COMPUT SC, V2415, P547; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Sebastiano DR, 2018, CLIN NEUROPHYSIOL, V129, P687, DOI 10.1016/j.clinph.2017.12.012; Segovia F, 2016, CURR ALZHEIMER RES, V13, P831, DOI 10.2174/1567205013666151116141906; Seidl M, 2013, J NEUROL SCI, V333, pe263; Sladky R, 2011, NEUROIMAGE, V58, P588, DOI 10.1016/j.neuroimage.2011.06.078; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Weston J, 2000, P 13 INT C NEUR INF, V13, P647; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Zheng Zhemin, 2016, Entomotaxonomia, V38, P1, DOI 10.11680/entomotax.2016001	55	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219683	10.1371/journal.pone.0219683	http://dx.doi.org/10.1371/journal.pone.0219683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295332	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800063
J	Beh, CY; Rasedee, A; Selvarajah, GT; Yazan, LS; Omar, AR; Foong, JN; How, CW; Foo, JB				Beh, Chaw Yee; Rasedee, Abdullah; Selvarajah, Gayathri Thevi; Yazan, Latifah Saiful; Omar, Abdul Rahman; Foong, Jia Ning; How, Chee Wun; Foo, Jhi Biau			Enhanced anti-mammary gland cancer activities of tamoxifen-loaded erythropoietin-coated drug delivery system	PLOS ONE			English	Article							TRANSLATION; EXPRESSION	Nanomedicine is an emerging area in the medical field, particularly in the treatment of cancers. Nanostructured lipid carrier (NLC) was shown to be a good nanoparticulated carrier for the delivery of tamoxifen (TAM). In this study, the tamoxifen-loaded erythropoietin-coated nanostructured lipid carriers (EPO-TAMNLC) were developed to enhance the anti-cancer properties and targetability of TAM, using EPO as the homing ligand for EPO receptors (EpoRs) on breast cancer tissue cells. Tamoxifen-loaded NLC (TAMNLC) was used for comparison. The LA7 cells and LA7 cell-induced rat mammary gland tumor were used as models in the study. Immunocytochemistry staining showed that LA7 cells express estrogen receptors (ERs) and EpoRs. EPO-TAMNLC and TAMNLC significantly (p<0.05) inhibited proliferation of LA7 in dose-and time-dependent manner. EPO-TAMNLC induced apoptosis and G(0)/G(1) cell cycle arrest of LA7 cells. Both drug delivery systems showed anti-mammary gland tumor properties. At an intravenous dose of 5 mg kg(-1) body weight, EPO-TAMNLC and TAMNLC were not toxic to rats, suggesting that both are safe therapeutic compounds. In conclusion, EPO-TAMNLC is not only a unique drug delivery system because of the dual drug-loading feature, but also potentially highly specific in the targeting of breast cancer tissues positive for ERs and EpoRs. The incorporation of TAM into NLC with and without EPO coat had significantly (p<0.05) improved specificity and safety of the drug carriers in the treatment of mammary gland tumors.	[Beh, Chaw Yee; Rasedee, Abdullah; Omar, Abdul Rahman; Foong, Jia Ning] Univ Putra Malaysia, Inst Biosci, Upm Serdang, Selangor, Malaysia; [Rasedee, Abdullah; Selvarajah, Gayathri Thevi; Omar, Abdul Rahman] Univ Putra Malaysia, Fac Vet Med, Upm Serdang, Selangor, Malaysia; [Yazan, Latifah Saiful] Univ Putra Malaysia, Fac Med, Upm Serdang, Selangor, Malaysia; [How, Chee Wun] MAHSA Univ, Fac Pharm, Ctr Preuniv Studies, Kuala Langat, Selangor, Malaysia; [How, Chee Wun] Monash Univ Malaysia, Sch Pharm, Bandar Sunway, Selangor, Malaysia; [Foo, Jhi Biau] Taylors Univ, Fac Hlth & Med Sci, Sch Pharm, Subang Jaya, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Mahsa University; Monash University; Monash University Sunway; Taylor's University	Beh, CY; Rasedee, A (corresponding author), Univ Putra Malaysia, Inst Biosci, Upm Serdang, Selangor, Malaysia.; Rasedee, A (corresponding author), Univ Putra Malaysia, Fac Vet Med, Upm Serdang, Selangor, Malaysia.	chawyee1015@gmail.com; rasedee@upm.edu.my	Rasedee, Abdullah/E-9119-2013; Foo, Jhi Biau/J-2844-2019; HOW, CHEE WUN/AAE-2256-2019	Rasedee, Abdullah/0000-0001-6625-508X; HOW, CHEE WUN/0000-0002-5910-6542; Foo, Jhi Biau/0000-0002-5880-2220; Chaw Yee, Beh/0000-0003-1392-0589; Selvarajah, Gayathri Thevi/0000-0001-7240-9882	Graduate Research Fellowship University Putra Malaysia [GP-IPS/2017/9537700]	Graduate Research Fellowship University Putra Malaysia	Chaw Yee Beh has received the funding from Graduate Research Fellowship University Putra Malaysia with grant numbers GP-IPS/2017/9537700. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Institute of Bioscience (IBS) and the Faculty of Veterinary Medicine (FVM), Universiti Putra Malaysia for the facilities provided and the staffs of Laboratory of Vaccines and Immunotherapeutics, IBS and Haematology and Clinical Biochemistry Laboratory, FVM, for their assistance. This work was funded by Graduate Research Fellowship, University Putra Malaysia with grant number GP-IPS/2017/9537700.	Abbasalipourkabir R, 2010, AFR J BIOTECHNOL, V9, P4491; Acharya S, 2009, BIOMATERIALS, V30, P5737, DOI 10.1016/j.biomaterials.2009.07.008; Al-Janabi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082576; Beh CY, 2017, DRUG DES DEV THER, V11, P771, DOI 10.2147/DDDT.S123939; Beloqui A, 2013, EUR J PHARM BIOPHARM, V84, P309, DOI 10.1016/j.ejpb.2013.01.029; Beloqui A, 2016, NANOMED-NANOTECHNOL, V12, P143, DOI 10.1016/j.nano.2015.09.004; Dalvai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011011; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; DiFrancesco T, 2012, CLIN INVEST MED, V35, pE114; Fabbrocini G, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-50; Fasehee H, 2016, J NANOBIOTECHNOL, V14, DOI 10.1186/s12951-016-0183-z; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Gargiulo S, 2012, ILAR J, V53, pE55, DOI 10.1093/ilar.53.1.55; Gewirtz DA, 2006, CLIN CANCER RES, V12, P2232, DOI 10.1158/1078-0432.CCR-05-2287; Harrington SE, 2008, JAMA-J AM MED ASSOC, V299, P2667, DOI 10.1001/jama.299.22.2667; He QL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189837; Housman G, 2014, CANCERS, V6, P1769, DOI 10.3390/cancers6031769; How CW, 2013, COLLOID SURFACE B, V112, P393, DOI 10.1016/j.colsurfb.2013.08.009; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Laugsch M, 2008, INT J CANCER, V122, P1005, DOI 10.1002/ijc.23201; Lazzeroni M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3233; Lee SH, 2008, INT J LAB HEMATOL, V30, P349, DOI 10.1111/j.1751-553X.2008.01100.x; Manshadi SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084635; Martins NM, 2008, J APPL TOXICOL, V28, P337, DOI 10.1002/jat.1284; Narvekar M, 2014, AAPS PHARMSCITECH, V15, P822, DOI 10.1208/s12249-014-0107-x; Nounou MI, 2015, BREAST CANCER-BASIC, V9, P17, DOI 10.4137/BCBCR.S29420; Poonia N, 2016, FUTUR SCI OA, V2, DOI 10.4155/fsoa-2016-0030; Radwan EM, 2016, MOL MED REP, V13, P3945, DOI 10.3892/mmr.2016.4989; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Roger E, 2012, MOL PHARMACEUT, V9, P2103, DOI 10.1021/mp2005388; Sairah AK, 2009, AM J PHARM TOXICOL, V4, P12; Sanad R., 2014, J DRUG RES EGYPT, V35, P73; Savjani K. T., 2012, ISRN PHARM, V2012; Sulahian R, 2009, BLOOD, V113, P5287, DOI 10.1182/blood-2008-09-179572; Syahida M., 2012, International Food Research Journal, V19, P955; Talluri SV, 2016, DRUG DELIV, V23, P1291, DOI 10.3109/10717544.2015.1092183; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; Trost N, 2013, INT J MOL MED, V31, P717, DOI 10.3892/ijmm.2013.1231; Wang Y, 2006, CURR CANCER THER REV, V2, P271, DOI 10.2174/157339406777934717; Xiao G, 2013, INTERNATIONAL JOURNA, V2013	40	8	9	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219285	10.1371/journal.pone.0219285	http://dx.doi.org/10.1371/journal.pone.0219285			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291309	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000484947800065
J	Dussourd, DE; Van Valkenburg, M; Rajan, K; Wagner, DL				Dussourd, David E.; Van Valkenburg, Madalyn; Rajan, Kalavathy; Wagner, David L.			A notodontid novelty: Theroa zethus caterpillars use behavior and anti-predator weaponry to disarm host plants	PLOS ONE			English	Article							SECRETORY DUCTS; ACID-GROWTH; DEFENSE; EUPHORBIA; LEPIDOPTERA; MORPHOLOGY; LATICIFERS; SABOTAGE; LATEX; LEAF	Unlike most notodontids, Theroa zethus larvae feed on plants that emit copious latex when damaged. To determine how the larvae overcome this defense, we filmed final instars on poinsettia, Euphorbia pulcherrima, then simulated their behaviors and tested how the behaviors individually and combined affect latex exudation. Larvae initially scraped the stem, petiole, or midrib with their mandibles, then secreted acid from their ventral eversible gland (VEG) onto the abraded surface. Scraping facilitated acid penetration by disrupting the waxy cuticle. As the acid softened tissues, the larvae used their mandibles to compress the plant repeatedly, thereby rupturing the latex canals. Scraping, acid application, and compression created withered furrows that greatly diminished latex exudation distal to the furrows where the larvae invariably fed. The VEG in notodontids ordinarily serves to deter predators; when attacked, larvae spray acid aimed directly at the assailant. Using HPLC, we documented that the VEG secretion of T. zethus contains 30% formic acid (6.53M) with small amounts of butyric acid (0.05M). When applied to poinsettia petioles, the acids caused a similar reduction in latex outflow as VEG secretion milked from larvae. VEG acid could disrupt latex canals in part by stimulating the normal acid-growth mechanism employed by plants to loosen walls for cell elongation. Histological examination of cross sections in poinsettia midribs confirmed that cell walls within furrows were often highly distorted as expected if VEG acids weaken walls. Theroa zethus is the only notodontid caterpillar known to use mandibular scraping and VEG acid to disable plant defenses. However, we document that mandibular constriction of petioles occurs also in other notodontids including species that feed on hardwood trees. This capability may represent a pre-adaptation that facilitated the host shift in the Theroa lineage onto latex-bearing plants by enabling larvae to deactivate laticifers with minimal latex contact.	[Dussourd, David E.; Van Valkenburg, Madalyn] Univ Cent Arkansas, Dept Biol, Conway, AR 72035 USA; [Rajan, Kalavathy] Univ Arkansas, Dept Biol & Agr Engn, Fayetteville, AR 72701 USA; [Wagner, David L.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Van Valkenburg, Madalyn] GV Sonny Montgomery VA Med Ctr, Jackson, MS USA; [Rajan, Kalavathy] Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN USA	University of Central Arkansas; University of Arkansas System; University of Arkansas Fayetteville; University of Connecticut; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Dussourd, DE (corresponding author), Univ Cent Arkansas, Dept Biol, Conway, AR 72035 USA.	dussourd@uca.edu	Rajan, Kalavathy/I-1345-2019	Rajan, Kalavathy/0000-0002-1837-1235; Dussourd, David/0000-0003-1182-1886; Van Valkenburg, Madalyn/0000-0002-3887-9933	University of Central Arkansas; Arkansas SURF program; USFS [14-CA-11420004-138]; Richard P. Garmany Fund; Arkansas Center for Plant-Powered Production; RII: Arkansas ASSET Initiatives (AR EPSCoR), National Science Foundation [EPS-0701890, EPS-1003970]; Arkansas Science and Technology Authority	University of Central Arkansas; Arkansas SURF program; USFS; Richard P. Garmany Fund; Arkansas Center for Plant-Powered Production; RII: Arkansas ASSET Initiatives (AR EPSCoR), National Science Foundation; Arkansas Science and Technology Authority	Support was provided by various sources at the University of Central Arkansas (to DED and MV), the Arkansas SURF program at https://scholarships.adhe.edu/scholarships/detail/student-undergraduate-research-fellowship-surf (to MV), USFS Co-op Agreement 14-CA-11420004-138 (https://www.fs.fed.us/working-with-us/grants) (to DLW), Richard P. Garmany Fund (Hartford Foundation for Public Giving at http://www.hfpg.org/index.php/donate/view-fund/richard-pgarmany-fund) (to DLW), and the Arkansas Center for Plant-Powered Production that provided funds to DED. The P3 Center was funded through the RII: Arkansas ASSET Initiatives (AR EPSCoR) I (EPS-0701890) and II (EPS-1003970) by the National Science Foundation (https://www.nsf.gov/) and the Arkansas Science and Technology Authority (https://portal.arkansas.gov/agency/arkansasscience-technology-authority/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2006, OIKOS, V114, P556, DOI 10.1111/j.2006.0030-1299.15025.x; Agrawal A.A., 2015, MONARCHS CHANGING WO, P47; Agrawal AA, 2017, MONARCHS AND MILKWEE; Agrawal AA, 2012, NEW PHYTOL, V194, P28, DOI 10.1111/j.1469-8137.2011.04049.x; Agrawal AA, 2009, ANNU REV ECOL EVOL S, V40, P311, DOI 10.1146/annurev.ecolsys.110308.120307; Akino T, 2005, APPL ENTOMOL ZOOL, V40, P497, DOI 10.1303/aez.2005.497; Arsuffi G, 2018, J EXP BOT, V69, P137, DOI 10.1093/jxb/erx390; ATTYGALLE AB, 1993, J CHEM ECOL, V19, P2089, DOI 10.1007/BF00979649; Bauer G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113336; Bowers M. Deane, 1993, P331; BUTTERY BR, 1976, WATER DEFICITS PLANT, V4, P233; Castelblanque L, 2016, PLANT PHYSIOL, V172, P1032, DOI 10.1104/pp.16.00954; COVELL CV, 1984, FIELD GUIDE MOTHS E; Demarco D, 2013, BOTANY, V91, P545, DOI 10.1139/cjb-2012-0277; Detwiler J. D., 1922, Canadian Entomologist, V54, P176; DILLON PM, 1983, BIOTROPICA, V15, P112, DOI 10.2307/2387953; Dussourd David E., 1993, P92; Dussourd DE, 2017, ANNU REV ENTOMOL, V62, P15, DOI 10.1146/annurev-ento-031616-035030; Dussourd DE, 2016, ARTHROPOD-PLANT INTE, V10, P143, DOI 10.1007/s11829-016-9416-1; Dussourd DE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141924; Dussourd DE, 2009, BIOL J LINN SOC, V96, P715, DOI 10.1111/j.1095-8312.2008.01168.x; Dussourd DE, 1999, J INSECT BEHAV, V12, P501, DOI 10.1023/A:1020966807633; DUSSOURD DE, 1991, ECOLOGY, V72, P1383, DOI 10.2307/1941110; DUSSOURD DE, 1995, ANN ENTOMOL SOC AM, V88, P163, DOI 10.1093/aesa/88.2.163; Edger PP, 2015, P NATL ACAD SCI USA, V112, P8362, DOI 10.1073/pnas.1503926112; EDWARDS PB, 1989, OIKOS, V54, P246, DOI 10.2307/3565274; EISNER T, 1972, ANN ENTOMOL SOC AM, V65, P765, DOI 10.1093/aesa/65.3.765; FAHN A, 1974, AM J BOT, V61, P1, DOI 10.2307/2441239; FINERAN BA, 1982, ANN BOT-LONDON, V50, P207, DOI 10.1093/oxfordjournals.aob.a086358; Forister ML, 2015, P NATL ACAD SCI USA, V112, P442, DOI 10.1073/pnas.1423042112; Frantz JM, 2004, J AM SOC HORTIC SCI, V129, P331, DOI 10.21273/JASHS.129.3.0331; Ganong CN, 2012, ARTHROPOD-PLANT INTE, V6, P621, DOI 10.1007/s11829-012-9214-3; Gillespie M, 2011, ECOL ENTOMOL, V36, P616, DOI 10.1111/j.1365-2311.2011.01305.x; Gomez de Aizpurua C, 1988, BIOL MORFOLOGIA ORUG, VVI; Hagel JM, 2008, TRENDS PLANT SCI, V13, P631, DOI 10.1016/j.tplants.2008.09.005; Hager A, 2003, J PLANT RES, V116, P483, DOI 10.1007/s10265-003-0110-x; Heckel DG, 2014, ANNU PLANT REV, V47, P77, DOI 10.1002/9781118472507.ch3; HEINRICH B, 1983, ECOLOGY, V64, P592, DOI 10.2307/1939978; Herrick G. W., 1919, Annals of the Entomological Society of America, V12; Hua J, 2017, PHYTOCHEMISTRY, V136, P56, DOI 10.1016/j.phytochem.2016.12.021; HULLEY PE, 1988, ECOL ENTOMOL, V13, P239, DOI 10.1111/j.1365-2311.1988.tb00351.x; Jeffree CE, 1986, INSECTS PLANT SURFAC, P23; JOEL DM, 1980, ANN BOT-LONDON, V46, P225, DOI 10.1093/oxfordjournals.aob.a085911; Kant MR, 2015, ANN BOT-LONDON, V115, P1015, DOI 10.1093/aob/mcv054; Karban R, 2002, ANNU REV ECOL SYST, V33, P641, DOI 10.1146/annurev.ecolsys.33.010802.150443; Kitajima S, 2016, PLANT PHYSIOL BIOCH, V108, P434, DOI 10.1016/j.plaphy.2016.08.008; Konno K, 2011, PHYTOCHEMISTRY, V72, P1510, DOI 10.1016/j.phytochem.2011.02.016; KUTSCHERA U, 1994, NEW PHYTOL, V126, P549, DOI 10.1111/j.1469-8137.1994.tb02951.x; MARTI OG, 1988, ANN ENTOMOL SOC AM, V81, P308, DOI 10.1093/aesa/81.2.308; McDonald J.H., 2014, HDB BIOL STAT; Metcalfe C.R., 1983, NORD J BOT, V4, P668; MILLER JS, 1991, B AM MUS NAT HIST, P1; MILLER JS, 1992, BIOSCIENCE, V42, P50, DOI 10.2307/1311628; Miller JS., 2018, MOTHS AM N MEXICO; NAVON A, 1992, J ECON ENTOMOL, V85, P2138, DOI 10.1093/jee/85.6.2138; O'Donovan A., 2013, BIOFUEL TECHNOLOGIES, P97, DOI [10.1007/978-3-642-34519-7_4, DOI 10.1007/978-3-642-34519-7_4]; OLSON KC, 1967, P AM SOC HORTIC SCI, V91, P377; Pickard WF, 2008, NEW PHYTOL, V177, P877, DOI 10.1111/j.1469-8137.2007.02323.x; PORTER J., 1997, COLOUR IDENTIFICATIO; Poulton EB, 1887, REP BR ASS ADV SCI, V57, P765; Prado E, 2018, ECOSYSTEM SERVICES G, DOI [10.1002/ecy.2154, DOI 10.1002/ECY.2154]; RAYLE D, 1970, PLANT PHYSIOL, V46, P250, DOI 10.1104/pp.46.2.250; RAYLE DL, 1980, PLANT PHYSIOL, V66, P433, DOI 10.1104/pp.66.3.433; RISLEY LS, 1988, ECOLOGY, V69, P1118, DOI 10.2307/1941266; Robinson G. S., 2010, HOSTS A DATABASE WOR; ROSOWSKI JR, 1968, BOT GAZ, V129, P113, DOI 10.1086/336422; Rotter MC, 2018, EVOL ECOL RES, V19, P423; RUDALL PJ, 1987, BOT J LINN SOC, V94, P143, DOI 10.1111/j.1095-8339.1987.tb01043.x; SANDBERG SL, 1989, J CHEM ECOL, V15, P875, DOI 10.1007/BF01015183; Schintlmeister A., 2013, NOTODONTIDAE OENOSAN, V11; Schreiber L, 2006, ANNU PLANT REV, V23, P280; Scriber J. Mark, 1996, American Entomologist, V42, P19; Sohn JC, 2019, ZOOL ANZ, V279, P52, DOI 10.1016/j.jcz.2019.01.001; SPILATRO SR, 1986, AM J BOT, V73, P1312, DOI 10.2307/2444065; Sugi S., 1987, LARVAE LARGER MOTHS; Sytwala S, 2015, PLANT PHYSIOL BIOCH, V95, P35, DOI 10.1016/j.plaphy.2015.07.004; Van Valkenburg M, 2014, THESIS U CENTRAL ARK; Vegliante F, 2012, ANNU REV ENTOMOL, V57, P187, DOI 10.1146/annurev-ento-120710-100646; Wagner D.L, 2005, CATERPILLARS E N AM, DOI [DOI 10.1515/9781400834143, DOI 10.1515/9781400838295], Patent No. [2203.04766, 220304766]; WEATHERSTON J, 1979, J CHEM ECOL, V5, P165, DOI 10.1007/BF00988232; Weiblen GD, 2006, ECOLOGY, V87, pS62, DOI 10.1890/0012-9658(2006)87[62:PDOHUI]2.0.CO;2; WEINSTEIN P, 1990, OIKOS, V58, P231, DOI 10.2307/3545430; WELLER S J, 1987, Journal of the Lepidopterists' Society, V41, P187; Wilkens RT, 1996, OECOLOGIA, V106, P181, DOI 10.1007/BF00328597; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Zalucki M.P., 1992, Chemoecology, V3, P81, DOI 10.1007/BF01245886; Zebelo S, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-140	87	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218994	10.1371/journal.pone.0218994	http://dx.doi.org/10.1371/journal.pone.0218994			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IK4PZ	31291279	Green Published, gold, Green Submitted			2022-12-26	WOS:000476570100001
J	Kar, S; Paglialunga, S; Jaycox, SH; Islam, R; Paredes, AH				Kar, Sumit; Paglialunga, Sabina; Jaycox, Sharon H.; Islam, Rafiqul; Paredes, Angelo H.			Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; ADHESION MOLECULES; DISEASE; STEATOHEPATITIS; CYTOKINES; ADIPOKINES; DIAGNOSIS; FEATURES; CELLS	Nonalcoholic steatohepatitis (NASH) is a chronic liver disease that can lead to cirrhosis, liver transplant, and even hepatocellular carcinoma. While liver biopsy remains the reference standard for disease diagnosis, analytical and clinical development of non-invasive soluble biomarkers of NASH are of great importance to advance the field. To this end, we performed analytical and clinical validation on a series of pro-inflammatory cytokines and chemokines implicated hepatic inflammation; IL-6, CRP, TNF alpha, MCP-1, MIP-1 beta, eotaxin, VCAM-1. Biomarker assays were validated for accuracy and precision. Clinical performance was evaluated in a random sample of 52 patients with biopsy-proven NAFLD/NASH. Patients were categorized into three groups according to their fibrosis stage; advanced (F3-F4), mild (F1-2) and no (F0) fibrosis. Serum IL-6 was increased in patients with advanced fibrosis (2.71 pg/mL; 1.26 pg/mL; 1.39 pg/mL p<0.01) compared to patients with mild or no fibrosis respectively. While, there was no significant difference noted in CRP, TNF alpha, MCP-1, MIP-1 beta, eotaxin among the three groups, VCAM-1 levels were increased by 55% (p<0.01) and 40% (p<0.05) in the advanced cohort compared to the mild and no fibrosis groups respectively. VCAM-1 also displayed good clinical performance as a biomarker of advanced fibrosis with an area under the receiver operating curve of 0.87. The VCAM-1 assay demonstrated robust accuracy and precision, and VCAM-1 outperformed IL-6, CRP, TNF alpha, and the chemokines MCP-1, MIP-1 beta, and eotaxin as a biomarker of advanced fibrosis in NASH. Addition of biomarkers such as IL-6 and VCAM-1 to panels may yield increased sensitivity and specificity for staging of NASH.	[Kar, Sumit; Islam, Rafiqul] Celerion, Bioanalyt Serv, Lincoln, NE USA; [Paglialunga, Sabina] Celerion, Sci Affairs, Tempe, AZ 85283 USA; [Jaycox, Sharon H.] Celerion, Early Clin Res, Tempe, AZ USA; [Paredes, Angelo H.] Brooke Army Med Ctr, Internal Med Serv, San Antonio, TX USA; [Paredes, Angelo H.] Brooke Army Med Ctr, Gastroenterol Serv, San Antonio, TX USA; [Paredes, Angelo H.] Brooke Army Med Ctr, Serv Hepatol, San Antonio, TX USA	San Antonio Military Medical Center; United States Department of Defense; United States Army; San Antonio Military Medical Center; United States Department of Defense; United States Army; San Antonio Military Medical Center; United States Department of Defense; United States Army	Paglialunga, S (corresponding author), Celerion, Sci Affairs, Tempe, AZ 85283 USA.	sabina.paglialunga@celerion.com			commercial company Celerion Inc.	commercial company Celerion Inc.	The commercial company Celerion Inc. (https://www.celerion.com) provided funding for this study in the form of reagent supplies and salary to authors SK, SP, SHJ, and RI. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdel-Razik A, 2018, EUR J GASTROEN HEPAT, V30, P1237, DOI 10.1097/MEG.0000000000001232; Ajmera V, 2017, HEPATOLOGY, V65, P65, DOI 10.1002/hep.28776; Amur S, 2015, CLIN PHARMACOL THER, V98, P34, DOI 10.1002/cpt.136; Andrys C, 2000, Acta Medica (Hradec Kralove), V43, P103; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; [Anonymous], [No title captured]; [Anonymous], 2018, BIOAN METH VAL GUID; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Carulli L, 2009, DIGEST LIVER DIS, V41, P823, DOI 10.1016/j.dld.2009.03.005; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Fitzpatrick E, 2012, PEDIATR OBES, V7, P471, DOI 10.1111/j.2047-6310.2012.00082.x; Fleet SE, 2017, GASTROENTEROL CLIN N, V46, P217, DOI 10.1016/j.gtc.2017.01.002; Friedman SL, 2018, HEPATOLOGY, V67, P1754, DOI 10.1002/hep.29477; Giron-Gonzalez JA, 2005, SCAND J GASTROENTERO, V40, P217, DOI 10.1080/00365520510011470; Grigorescu M, 2012, J PHYSIOL PHARMACOL, V63, P347; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hui JM, 2004, HEPATOLOGY, V39, P1458, DOI 10.1002/hep.20223; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Itoh Y, 2018, HEPATOL RES; Jarrar MH, 2008, ALIMENT PHARM THER, V27, P412, DOI 10.1111/j.1365-2036.2007.03586.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kong DH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041057; Kugelmas M, 2003, HEPATOLOGY, V38, P413, DOI 10.1053/jhep.2003.50316; Lee JW, 2006, PHARM RES, V23, P312, DOI 10.1007/s11095-005-9045-3; Lefere S, 2017, INT J OBESITY, V41, P1207, DOI 10.1038/ijo.2017.102; Lo Iacono O, 1998, ALIMENT PHARM THERAP, V12, P1091; Nati M, 2016, REV ENDOCR METAB DIS, V17, P29, DOI 10.1007/s11154-016-9339-2; Okanoue T, 2018, J GASTROENTEROL, V53, P129, DOI 10.1007/s00535-017-1355-9; Page S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056009; Paredes AH, 2012, CLIN LIVER DIS, V16, P397, DOI 10.1016/j.cld.2012.03.005; Piccoli S., POINTS CONSIDER DOCU; Piccoli SP, 2018, BIOANALYSIS, V10, P893, DOI 10.4155/bio-2018-0125; Sanyal AJ, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1149-9; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Sharma M, 2015, J CLIN EXP HEPATOL, V5, P147, DOI 10.1016/j.jceh.2015.02.002; Stojsavljevic S, 2014, WORLD J GASTROENTERO, V20, P18070, DOI 10.3748/wjg.v20.i48.18070; Tarantino G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105610; Ustyol A, 2017, SCAND J CLIN LAB INV, V77, P205, DOI 10.1080/00365513.2017.1292363; VANOOSTEN N, 1995, HEPATOLOGY, V22, P1538; Vilar-Gomez E, 2018, J HEPATOL, V68, P305, DOI 10.1016/j.jhep.2017.11.013; VOLPES R, 1990, HEPATOLOGY, V12, P59, DOI 10.1002/hep.1840120110; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Wyczalkowska-Tomasik A, 2016, ARCH IMMUNOL THER EX, V64, P249, DOI 10.1007/s00005-015-0357-7; Yoshimura K, 2016, HEPATOLOGY, V63, P462, DOI 10.1002/hep.28226; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zimmermann E, 2011, J HEPATOL, V55, P660, DOI 10.1016/j.jhep.2010.12.017	49	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0217263	10.1371/journal.pone.0217263	http://dx.doi.org/10.1371/journal.pone.0217263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291245	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800011
J	Kurano, M; Yatomi, Y				Kurano, Makoto; Yatomi, Yutaka			Use of gas chromatography mass spectrometry to elucidate metabolites predicting the phenotypes of IgA nephropathy in hyper IgA mice	PLOS ONE			English	Article							PROGRESSION; APOPTOSIS	IgA nephropathy, a common chronic kidney disease, has various possible outcomes. Therefore, the identification of novel prognostic biomarkers is needed. To this purpose, we used gas chromatography mass spectrometry to search for metabolites capable of predicting the phenotypes of IgA nephropathy in hyper IgA (HIGA) mice, an established model mice for IgA nephropathy. We measured the plasma metabolite levels in 12- and 22-week-old mice, prior to the manifestation of IgA nephropathy phenotypes, and statistically investigated the associations between these metabolites and the phenotypes of IgA nephropathy, such as the urine protein levels and histological phenotypes of the kidney at 32 weeks. We observed that in plasma samples collected from 12- and 22-week-old HIGA mice, the urinary protein levels were significantly associated with 8 and 10 metabolites, the glomerular cellular component levels were significantly associated with 8 and 7 metabolites, and the mesangial substrate levels were significantly associated with 8 and 8 metabolites, respectively. Among the candidate metabolites associated with the phenotypes of IgA nephropathy, coniferyl alcohol levels were significantly higher in HIGA mice at all of the 12, 22, and 32 weeks of age. Since this study was an observational study, we could not elucidate the underlying mechanisms; however, we were able to identify new candidate metabolites, such as coniferyl alcohol, as being potentially involved in the pathogenesis of IgA nephropathy. These results might help to develop novel laboratory tests and therapeutic reagents for IgA nephropathy in the future.	[Kurano, Makoto; Yatomi, Yutaka] Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan	University of Tokyo	Kurano, M (corresponding author), Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan.	kurano-tky@umin.ac.jp		Yatomi, Yutaka/0000-0003-1719-4297	Japanese Society of Laboratory Medicine (Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research); Japan Society for the Promotion of Science (JSPS KAKENHI) [16H06236]	Japanese Society of Laboratory Medicine (Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research); Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by the Japanese Society of Laboratory Medicine (Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research, awarded to MK) and the Japan Society for the Promotion of Science (JSPS KAKENHI grant number 16H06236 awarded to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2008, AM J NEPHROL, V28, P1014, DOI 10.1159/000148209; Coppo R, 2017, J NEPHROL, V30, P339, DOI 10.1007/s40620-016-0360-z; Coppo R, 2017, PEDIATR NEPHROL, V32, P725, DOI 10.1007/s00467-016-3390-9; Hastings Margaret Colleen, 2013, Expert Opin Med Diagn, V7, P615, DOI 10.1517/17530059.2013.856878; Iwanami N, 2008, J NEPHROL, V21, P118; Kim KM, 2016, ENVIRON TOXICOL PHAR, V48, P85, DOI 10.1016/j.etap.2016.10.016; Kurano M, 2019, FASEB J; Lai KN, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.1; Maixnerova D, 2016, J NEPHROL, V29, P535, DOI 10.1007/s40620-016-0299-0; Marek-Bukowiec K, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/5205831; McGrogan A, 2011, NEPHROL DIAL TRANSPL, V26, P414, DOI 10.1093/ndt/gfq665; Muso E, 1996, KIDNEY INT, V50, P1946, DOI 10.1038/ki.1996.517; Stacchiotti A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060689	13	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219403	10.1371/journal.pone.0219403	http://dx.doi.org/10.1371/journal.pone.0219403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291349	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800081
J	Rebourcet, D; Monteiro, A; Cruickshanks, L; Jeffery, N; Smith, S; Milne, L; O'Shaughnessy, PJ; Smith, LB				Rebourcet, Diane; Monteiro, Ana; Cruickshanks, Lyndsey; Jeffery, Nathan; Smith, Sarah; Milne, Laura; O'Shaughnessy, Peter J.; Smith, Lee B.			Relationship of transcriptional markers to Leydig cell number in the mouse testis	PLOS ONE			English	Article							SERTOLI-CELLS; METABOLIC SYNDROME; FETAL; TESTOSTERONE; FATE; ABLATION; GENE; STEROIDOGENESIS; ASSOCIATION; EXPRESSION	Objectives The current study aims to identify markers that would reflect the number of Leydig cells present in the testis, to help determine whether labour-intensive methods such as stereology are necessary. We used our well-characterised Sertoli cell ablation model in which we have empirically established the size of the Leydig cell population, to try to identify transcriptional biomarkers indicative of population size. Results Following characterisation of the Leydig cell population after Sertoli cell ablation in neonatal life or adulthood, we identified Hsd3b1 transcript levels as a potential indicator of Leydig cell number with utility for informing decision-making on whether to engage in time-consuming stereological cell counting analysis.	[Rebourcet, Diane; Smith, Lee B.] Univ Newcastle, Fac Sci, Callaghan, NSW, Australia; [Monteiro, Ana; O'Shaughnessy, Peter J.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Cruickshanks, Lyndsey; Jeffery, Nathan; Smith, Sarah; Milne, Laura; Smith, Lee B.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Newcastle; University of Glasgow; University of Edinburgh	Smith, LB (corresponding author), Univ Newcastle, Fac Sci, Callaghan, NSW, Australia.; Smith, LB (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	Lee.Smith@ed.ac.uk		Smith, Lee/0000-0002-4103-3074	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J015105/1]; Medical Research Council (MRC) [G1100354/1, MR/N002970/1]; BBSRC [BB/J015105/1] Funding Source: UKRI; MRC [MR/N002970/1, G1100354] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Biotechnology and Biological Sciences Research Council (BBSRC) Project grant (BB/J015105/1) (to LBS and PJO), and Medical Research Council (MRC) Programme Grant (G1100354/1 and MR/N002970/1) (to LBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyaratne HBS, 2000, BIOL REPROD, V62, P680, DOI 10.1095/biolreprod62.3.680; Baker P J, 2003, Reprod Biol Endocrinol, V1, P4, DOI 10.1186/1477-7827-1-4; Baker PJ, 1999, EUR J BIOCHEM, V260, P911, DOI 10.1046/j.1432-1327.1999.00245.x; Baker PJ, 2001, REPRODUCTION, V122, P227, DOI 10.1530/rep.0.1220227; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; Clark AM, 2000, BIOL REPROD, V63, P1825, DOI 10.1095/biolreprod63.6.1825; De Gendt K, 2005, ENDOCRINOLOGY, V146, P4117, DOI 10.1210/en.2005-0300; Farrell JB, 2008, DIABETES EDUCATOR, V34, P799, DOI 10.1177/0145721708323100; Fouchecourt S, 2016, CELL DEATH DIFFER, V23, P521, DOI 10.1038/cdd.2015.120; Gnessi L, 2000, J CELL BIOL, V149, P1019, DOI 10.1083/jcb.149.5.1019; Hazra R, 2013, ENDOCRINOLOGY, V154, P3410, DOI 10.1210/en.2012-2273; Kaftanovskaya EM, 2015, FASEB J, V29, P2327, DOI 10.1096/fj.14-263632; KERR JB, 1988, DEVELOPMENT, V103, P535; Kupelian V, 2006, J CLIN ENDOCR METAB, V91, P843, DOI 10.1210/jc.2005-1326; Kupelian V, 2008, J CLIN ENDOCR METAB, V93, P3403, DOI 10.1210/jc.2008-0054; Nef S, 2000, DEV BIOL, V224, P354, DOI 10.1006/dbio.2000.9785; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P839, DOI 10.1530/REP-08-0012; O'Shaughnessy PJ, 2011, MOL HUM REPROD, V17, P620, DOI 10.1093/molehr/gar032; Park SY, 2007, ENDOCRINOLOGY, V148, P3704, DOI 10.1210/en.2006-1731; Rebourcet D, 2017, ENDOCRINOLOGY, V158, P2955, DOI 10.1210/en.2017-00196; Rebourcet D, 2016, ENDOCRINOLOGY, V157, P2479, DOI 10.1210/en.2016-1156; Rebourcet D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105687; Rebourcet D, 2014, DEVELOPMENT, V141, P2139, DOI 10.1242/dev.107029; Saad F, 2011, J OBES, V2011, DOI 10.1155/2011/471584; SCOTT IS, 1990, J ENDOCRINOL, V125, P131, DOI 10.1677/joe.0.1250131; Shima Y, 2015, MOL ENDOCRINOL, V29, P1581, DOI 10.1210/me.2015-1200; Teerds KJ, 2015, HUM REPROD UPDATE, V21, P310, DOI 10.1093/humupd/dmv008; Tremblay JJ, 2015, STEROIDS, V103, P3, DOI 10.1016/j.steroids.2015.08.001; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; Wen Q, 2014, AM J PHYSIOL-ENDOC M, V307, pE1131, DOI 10.1152/ajpendo.00425.2014; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202; Zhang YF, 2015, ASIAN J ANDROL, V17, P253, DOI 10.4103/1008-682X.136447	32	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219524	10.1371/journal.pone.0219524	http://dx.doi.org/10.1371/journal.pone.0219524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291327	gold, Green Accepted, Green Published			2022-12-26	WOS:000484947800105
J	Schiffino, FL; Siemian, JN; Petrella, M; Laing, BT; Sarsfield, S; Borja, CB; Gajendiran, A; Zuccoli, ML; Aponte, Y				Schiffino, Felipe L.; Siemian, Justin N.; Petrella, Michele; Laing, Brenton T.; Sarsfield, Sarah; Borja, Cara B.; Gajendiran, Anjali; Zuccoli, Maria Laura; Aponte, Yeka			Activation of a lateral hypothalamic-ventral tegmental circuit gates motivation	PLOS ONE			English	Article							MESOLIMBIC DOPAMINE SYSTEM; LEPTIN RECEPTOR NEURONS; DISTINCT POPULATIONS; NEUROTENSIN NEURONS; AREA; OREXIN; REWARD; GALANIN; STIMULATION; DISRUPTS	Across species, motivated states such as food-seeking and consumption are essential for survival. The lateral hypothalamus (LH) is known to play a fundamental role in regulating feeding and reward-related behaviors. However, the contributions of neuronal subpopulations in the LH have not been thoroughly identified. Here we examine how lateral hypothalamic leptin receptor-expressing (LHLEPR) neurons, a subset of GABAergic cells, regulate motivation in mice. We find that LHLEPR neuronal activation significantly increases progressive ratio (PR) performance, while inhibition decreases responding. Moreover, we mapped LHLEPR axonal projections and demonstrated that they target the ventral tegmental area (VTA), form functional inhibitory synapses with non-dopaminergic VTA neurons, and their activation promotes motivation for food. Finally, we find that LHLEPR neurons also regulate motivation to obtain water, suggesting that they may play a generalized role in motivation. Together, these results identify LHLEPR neurons as modulators within a hypothalamic-ventral tegmental circuit that gates motivation.	[Schiffino, Felipe L.; Siemian, Justin N.; Petrella, Michele; Laing, Brenton T.; Sarsfield, Sarah; Borja, Cara B.; Gajendiran, Anjali; Zuccoli, Maria Laura; Aponte, Yeka] NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Petrella, Michele] Univ Camerino, Sch Pharm, Pharmacol Unit, Camerino, MC, Italy; [Aponte, Yeka] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Schiffino, Felipe L.] VA Boston Healthcare Syst, Dept Psychiat, West Roxbury, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); University of Camerino; Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Aponte, Y (corresponding author), NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA.; Aponte, Y (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	yeka.aponte@nih.gov	Sarsfield, Sarah/Y-5113-2019; Aponte, Yeka/AAL-4643-2020; Schiffino, Felipe/AAR-4766-2021; Core, Vector/CAF-4832-2022	Aponte, Yeka/0000-0002-5967-2579; Schiffino, Felipe/0000-0002-2877-3406	National Institute on Drug Abuse Intramural Research Program, National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000595] Funding Source: NIH RePORTER	National Institute on Drug Abuse Intramural Research Program, National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute on Drug Abuse Intramural Research Program, National Institutes of Health (https://irp.drugabuse.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis A, 2008, CELL MOL LIFE SCI, V65, P1475, DOI 10.1007/s00018-008-7521-8; ALLEN GV, 1995, NEUROSCIENCE, V69, P533, DOI 10.1016/0306-4522(95)00261-G; Aponte Y, 2008, J PHYSIOL-LONDON, V586, P2061, DOI 10.1113/jphysiol.2007.147298; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Baroncini M, 2012, NEUROIMAGE, V59, P168, DOI 10.1016/j.neuroimage.2011.07.013; Bonnavion P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7266; Broberger C, 1998, J COMP NEUROL, V402, P460; Brown JA, 2017, ENDOCRINOLOGY, V158, P1271, DOI 10.1210/en.2017-00122; Cason AM, 2010, PHYSIOL BEHAV, V100, P419, DOI 10.1016/j.physbeh.2010.03.009; de Vrind VAJ, 2019, OBESITY, V27, P1123, DOI 10.1002/oby.22495; Franklin KBJ, 2013, PAXINOS AND FRANKLIN; GLICKMAN SE, 1967, PSYCHOL REV, V74, P81, DOI 10.1037/h0024290; Goforth PB, 2014, J NEUROSCI, V34, P11405, DOI 10.1523/JNEUROSCI.5167-13.2014; Gomez JL, 2017, SCIENCE, V357, P503, DOI 10.1126/science.aan2475; Griffond B, 2009, PEPTIDES, V30, P2045, DOI 10.1016/j.peptides.2009.07.008; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Karnani MM, 2013, J PHYSIOL-LONDON, V591, P933, DOI 10.1113/jphysiol.2012.243493; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Laque A, 2015, MOL METAB, V4, P706, DOI 10.1016/j.molmet.2015.07.002; Laque A, 2013, AM J PHYSIOL-ENDOC M, V304, pE999, DOI 10.1152/ajpendo.00643.2012; Lee H, 2014, NATURE, V509, P627, DOI 10.1038/nature13169; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Leshan RL, 2006, OBESITY, V14, P208, DOI 10.1038/oby.2006.310; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mickelsen LE, 2019, NAT NEUROSCI, V22, P642, DOI 10.1038/s41593-019-0349-8; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Nieh EH, 2016, NEURON, V90, P1286, DOI 10.1016/j.neuron.2016.04.035; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; Opland D, 2013, MOL METAB, V2, P423, DOI 10.1016/j.molmet.2013.07.008; Patterson CM, 2015, ENDOCRINOLOGY, V156, P1692, DOI 10.1210/en.2014-1986; Patterson CM, 2011, BRAIN RES, V1378, P18, DOI 10.1016/j.brainres.2011.01.010; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Qualls-Creekmore E, 2017, J NEUROSCI, V37, P6053, DOI 10.1523/JNEUROSCI.0155-17.2017; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Sharpe MJ, 2017, CURR BIOL, V27, P2089, DOI 10.1016/j.cub.2017.06.024; Singh J, 1996, BRAIN RES BULL, V41, P399, DOI 10.1016/S0361-9230(96)00217-1; Stuber GD, 2016, NAT NEUROSCI, V19, P198, DOI 10.1038/nn.4220; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14; WISE RA, 1974, BRAIN RES, V67, P187, DOI 10.1016/0006-8993(74)90272-8; Wise RA, 2013, BIOL PSYCHIAT, V73, P819, DOI 10.1016/j.biopsych.2012.09.001; Ziegler DR, 2002, J COMP NEUROL, V448, P217, DOI 10.1002/cne.10257	50	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219522	10.1371/journal.pone.0219522	http://dx.doi.org/10.1371/journal.pone.0219522			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291348	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800104
J	Tanikawa, C; Takata, S; Takano, R; Yamanami, H; Edlira, Z; Takada, K				Tanikawa, Chihiro; Takata, Sadaki; Takano, Ruriko; Yamanami, Haruna; Edlira, Zere; Takada, Kenji			Functional decline in facial expression generation in older women: A cross-sectional study using three-dimensional morphometry	PLOS ONE			English	Article							AGE-RELATED-CHANGES; NASOLABIAL FOLD; SEX; MORPHOLOGY; SKELETAL; MUSCLE; REJUVENATION; SMILE; SKIN	Elderly people show a decline in the ability to decode facial expressions, but also experience age-related facial structure changes that may render their facial expressions harder to decode. However, to date there is no empirical evidence to support the latter mechanism. The objective of this study was to assess the effects of age on facial morphology at rest and during smiling, in younger (n = 100; age range, 18-32 years) and older (n = 30; age range, 55-65 years) Japanese women. Three-dimensional images of each subject's face at rest and during smiling were obtained and wire mesh fitting was performed on each image to quantify the facial surface morphology. The mean node coordinates in each facial posture were compared between the groups using t-tests. Further, the node coordinates of the fitted mesh were entered into a principal component analysis (PCA) and a multifactor analysis of variance (MANOVA) to examine the direct interactions of aging and facial postures on the 3D facial morphology. The results indicated that there were significant age-related 3D facial changes in facial expression generation and the transition from resting to smiling produced a smaller amount of soft tissue movement in the older group than in the younger group. Further, 185 surface configuration variables were extracted and the variables were used to create four discriminant functions: the age-group discrimination for each facial expression, and the facial expression discrimination for each age group. For facial expression discrimination, the older group showed 80% accuracy with 2 of 66 significant variables, whereas the younger group showed 99% accuracy with 15 of 144 significant variables. These results indicate that in both facial expressions, the facial morphology was distinctly different in the younger and older subjects, and that in the older group, the facial morphology during smiling could not be as easily discriminated from the morphology at rest as in the younger group. These results may help to explain one aspect of the communication dysfunction observed in older people.	[Tanikawa, Chihiro; Edlira, Zere] Osaka Univ, Grad Sch Dent, Dept Orthodont & Dentofacial Orthoped, Suita, Osaka, Japan; [Tanikawa, Chihiro; Takada, Kenji] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka, Japan; [Takata, Sadaki] Osaka Shoin Womens Univ, Dept Fash & Beauty Sci, Higashiosaka, Osaka, Japan; [Takano, Ruriko] Shiseido Co Ltd, Corp Culture Dept, Tokyo, Japan; [Yamanami, Haruna] Shiseido Co Ltd, Shiseido Global Innovat Ctr, Yokohama, Kanagawa, Japan; [Takada, Kenji] Natl Univ Singapore, Fac Dent, Singapore, Singapore	Osaka University; Osaka University; Shiseido Company, Limited; Shiseido Company, Limited; National University of Singapore	Takada, K (corresponding author), Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka, Japan.; Takada, K (corresponding author), Natl Univ Singapore, Fac Dent, Singapore, Singapore.	denkt@nus.edu.sg		Zere, Edlira/0000-0002-2768-9632	JSPS KAKENHI [22792048, 25862008]; JST COI [R1WD07]; Shiseido Co., ltd.	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST COI; Shiseido Co., ltd.(Shiseido Company, Limited)	This work was partially supported by Shiseido Co., ltd., JSPS KAKENHI (grant no. 22792048 and 25862008), and JST COI (grant no. R1WD07). The funder (Shiseido Co., ltd.) provided support in the form of salaries for authors [ST, RT, HY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2016, WORLD HLTH STAT; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Chen WY, 2015, CELL RES, V25, P574, DOI 10.1038/cr.2015.36; De Menezes M, 2011, INT J ORAL MAX SURG, V40, P856, DOI 10.1016/j.ijom.2011.03.004; Dindaroglu F, 2016, ANGLE ORTHOD, V86, P448, DOI 10.2319/040915-236.1; Donofrio L., 2015, SURG SKIN; Elson ML, 2012, EVALUATION MANAGEMEN; Farkas L G, 1987, ANTHROPOMETRIC FACIA; Fischbein NJ, 2001, AM J NEURORADIOL, V22, P880; Gosain AK, 1996, PLAST RECONSTR SURG, V98, P622, DOI 10.1097/00006534-199609001-00005; Gueugneau M, 2015, J GERONTOL A-BIOL, V70, P566, DOI 10.1093/gerona/glu086; Hamrick MW, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00069; Henry F, 1997, J AM GERIATR SOC, V45, P220, DOI 10.1111/j.1532-5415.1997.tb04512.x; Hess U, 2012, J EXP SOC PSYCHOL, V48, P1377, DOI 10.1016/j.jesp.2012.05.018; Iblher N, 2008, J PLAST RECONSTR AES, V61, P1170, DOI 10.1016/j.bjps.2008.06.001; Jang SI, 2015, SKIN RES TECHNOL, V21, P201, DOI 10.1111/srt.12177; Klecka W. R., 1980, DISCRIMINANT ANAL; Kono K, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00567; LaFrance M, 2003, PSYCHOL BULL, V129, P305, DOI 10.1037/0033-2909.129.2.305; Marcus RL, 2010, J NUTR HEALTH AGING, V14, P362, DOI 10.1007/s12603-010-0081-2; Mendelson B, 2012, AESTHET PLAST SURG, V36, P753, DOI 10.1007/s00266-012-9904-3; Okuda I, 2012, AESTHET PLAST SURG, V36, P290, DOI 10.1007/s00266-011-9829-2; Pessa JE, 1998, PLAST RECONSTR SURG, V102, P205, DOI 10.1097/00006534-199807000-00034; Rosati R, 2012, INT J ORAL MAX SURG, V41, P1344, DOI 10.1016/j.ijom.2012.04.002; Saito N, 2008, SKIN RES TECHNOL, V14, P287, DOI 10.1111/j.1600-0846.2008.00292.x; Sarver TR, 1997, 25 INT EL PROP C CLE; See MS, 2008, J ORAL MAXIL SURG, V66, P1410, DOI 10.1016/j.joms.2007.12.041; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Sforza C, 2010, INT J ORAL MAX SURG, V39, P990, DOI 10.1016/j.ijom.2010.05.011; Spangenburg EE, 2012, MED SCI SPORT EXER, V44, P1653, DOI 10.1249/MSS.0b013e31825871fa; Tanikawa C, 2016, HOMO, V67, P23, DOI 10.1016/j.jchb.2015.10.001; Tanikawa C, 2018, ANGLE ORTHOD, V88, P319, DOI 10.2319/062617-425.1; Uthaikhup S, 2017, MUSCULOSKEL SCI PRAC, V29, P1, DOI 10.1016/j.msksp.2017.02.002; WARREN R, 1991, J AM ACAD DERMATOL, V25, P751, DOI 10.1016/S0190-9622(08)80964-4; Weeden JC, 2001, ANGLE ORTHOD, V71, P132; YOUSIF NJ, 1994, PLAST RECONSTR SURG, V93, P70, DOI 10.1097/00006534-199401000-00010	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219451	10.1371/journal.pone.0219451	http://dx.doi.org/10.1371/journal.pone.0219451			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4JZ	31291323	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800084
J	Tsai, JJ; Liu, WL; Lin, PC; Huang, BY; Tsai, CY; Lee, PYA; Tsai, YL; Chou, PH; Chung, S; Liu, LT; Chen, CH				Tsai, Jih-Jin; Liu, Wei-Liang; Lin, Ping-Chang; Huang, Bo-Yi; Tsai, Ching-Yi; Lee, Pei-Yu Alison; Tsai, Yun-Long; Chou, Pin-Hsing; Chung, Simon; Liu, Li-Teh; Chen, Chun-Hong			A fully automated sample-to-answer PCR system for easy and sensitive detection of dengue virus in human serum and mosquitos	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; TIME RT-PCR; AEDES-AEGYPTI; HEMORRHAGIC-FEVER; RAPID DETECTION; ASSAY; MULTIPLEX; DIAGNOSIS	Background The insulated isothermal PCR (iiPCR) technology enables consistent PCR amplification and detection in a simple heating device. A pan-dengue virus (DENV) RT-iiPCR, targeting the 5 untranslated region, was validated previously on the semi-automated POCKIT combo system (involving separate devices for nucleic acid extraction and PCR amplification/detection) to offer performance comparable to a laboratory real-time PCR. Working on the same technologies, a compact automated sample-in-answer-out system (POCKIT Central Nucleic Acid Analyser) has been available commercially for iiPCR, minimizing human error risks and allowing easy molecular bio-detection near points of need. Here, we evaluated the analytical and clinical performance of the pan-DENV RT-iiPCR on the fully automated system by comparison to those on the semi-automated system. Methodology/Principal findings Testing sera containing serial diluted DENV-1, -2, -3, or -4 cell culture stock, the pan-DENV RT-iiPCR system had similar 100% detection endpoints on the two systems; i.e. at 1, 10, 1 and 10 PFU/ml, respectively, on the fully automated system, and at 10, 1, 10 and 10 PFU/ml, respectively, on the semi-automated system. Furthermore, both fully automated and semi-automated PCR system can detect all four DENV serotypes in mosquitos. Clinical performance of the reagent on the two systems was evaluated by testing 60 human serum samples. Both systems detected the same 40 samples (ten DENV-1, -2, -3, and -4 positive each) and did not detect the other 20; 100% agreement (kappa = 1) was found between the two systems. Conclusions/Significance With performance comparable to a previously validated system, the fully-automated PCR system allows applications of the pan-DENV reagent as a useful tool near points of need to facilitate easy, fast and effective detection of dengue virus and help mitigate versatile public health challenges in the control and management of dengue disease.	[Tsai, Jih-Jin; Lin, Ping-Chang; Huang, Bo-Yi; Tsai, Ching-Yi; Liu, Li-Teh] Kaohsiung Med Univ, Ctr Dengue Fever Control & Res, Kaohsiung, Taiwan; [Tsai, Jih-Jin] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan; [Tsai, Jih-Jin; Lin, Ping-Chang; Huang, Bo-Yi; Tsai, Ching-Yi] Kaohsiung Med Univ Hosp, Trop Med Ctr, Kaohsiung, Taiwan; [Tsai, Jih-Jin] Kaohsing Med Univ, Div Infect Dis, Dept Internal Med, Kaohsiung, Taiwan; [Liu, Wei-Liang; Chen, Chun-Hong] Natl Hlth Res Inst, Natl Mosquitoborne Dis Control Res Ctr, Zhunan, Taiwan; [Lee, Pei-Yu Alison; Tsai, Yun-Long; Chou, Pin-Hsing; Chung, Simon] GeneReach Biotechnol, Taichung, Taiwan; [Liu, Li-Teh] Chung Hwa Univ Med Technol, Dept Med Lab Sci & Biotechnol, Coll Med Technol, Tainan, Taiwan; [Chen, Chun-Hong] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Health Research Institutes - Taiwan; Chung Hua University; National Health Research Institutes - Taiwan	Tsai, JJ (corresponding author), Kaohsiung Med Univ, Ctr Dengue Fever Control & Res, Kaohsiung, Taiwan.; Tsai, JJ (corresponding author), Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan.; Tsai, JJ (corresponding author), Kaohsiung Med Univ Hosp, Trop Med Ctr, Kaohsiung, Taiwan.; Tsai, JJ (corresponding author), Kaohsing Med Univ, Div Infect Dis, Dept Internal Med, Kaohsiung, Taiwan.; Chen, CH (corresponding author), Natl Hlth Res Inst, Natl Mosquitoborne Dis Control Res Ctr, Zhunan, Taiwan.; Chen, CH (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan.	jijits@cc.kmu.edu.tw; chunhong@nhri.org.tw	TSAI, JIH-JIN/GOP-2776-2022	TSAI, JIH-JIN/0000-0003-2226-8916; CHEN, CHUN-HONG/0000-0002-3028-5508; Liu, Li-Teh/0000-0002-7993-7263; LIU, WEI-LIANG/0000-0002-1159-1286	Ministry of Health and Welfare, Taiwan [MOHW108-TDU-B-212-133006, M08L6030]; NHRI (National Health Research Institutes, Taiwan) [NHRI-108A1-MRCO-0419191]	Ministry of Health and Welfare, Taiwan; NHRI (National Health Research Institutes, Taiwan)(National Health Research Institutes - Taiwan)	This study was supported partly by the Ministry of Health and Welfare, Taiwan (https://www.mohw.gov.tw/mp-2.html) MOHW108-TDU-B-212-133006 and M08L6030 to JJT), and in part by NHRI (National Health Research Institutes, Taiwan)(grant no. NHRI-108A1-MRCO-0419191, http://english.nhri.org.tw/NHRI_WEB/nhriw001Action. do, to JJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GeneReach Biotechnology provided support in the form of salaries for authors P.-H.C., Y.-L.T., S.C., and P.-Y.A.L., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065; Boonyasuppayakorn S, 2016, J VIROL METHODS, V237, P25, DOI 10.1016/j.jviromet.2016.08.009; Britton S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1158-0; Chang HFG, 2012, BIOTECHNOL J, V7, P662, DOI 10.1002/biot.201100453; Chao DY, 2004, EMERG INFECT DIS, V10, P552, DOI 10.3201/eid1003.020518; Chua KH, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1183-z; Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112; Ferguson T., 2014, PAN STANFORD, P409, DOI [10.1201/b15537-20, DOI 10.1201/B15537-20]; Gaikwad Seema, 2017, J Lab Physicians, V9, P177, DOI 10.4103/0974-2727.208265; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; Go YY, 2017, J MOL DIAGN, V19, P817, DOI 10.1016/j.jmoldx.2017.06.007; Go YY, 2016, J CLIN MICROBIOL, V54, P1528, DOI 10.1128/JCM.00225-16; Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296; Huang JH, 2007, AM J TROP MED HYG, V77, P903, DOI 10.4269/ajtmh.2007.77.903; Kurane I, 2001, REV MED VIROL, V11, P301, DOI 10.1002/rmv.324; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lau SM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2091-y; Lauterbach SE, 2018, VECTOR BORNE ZOONOTI; Low JGH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001191; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Neeraja M, 2015, J VIROL METHODS, V211, P22, DOI 10.1016/j.jviromet.2014.10.005; Oriero EC, 2015, J ANTIMICROB CHEMOTH, V70, P2, DOI 10.1093/jac/dku343; Pang J, 2017, J CLIN MICROBIOL; Rojas A, 2018, AM J TROP MED HYG, V98, P1833, DOI 10.4269/ajtmh.18-0024; Sa-ngamuang C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006573; Salles TS, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2830-8; Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311; Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142; Tsai CH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2493-x; Tsai JJ, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01865-17, 10.1128/jcm.01865-17]; Tsai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045278; Tsen HY, 2013, J FOOD PROTECT, V76, P1322, DOI 10.4315/0362-028X.JFP-12-553; Voge NV, 2013, AM J TROP MED HYG, V88, P260, DOI 10.4269/ajtmh.2012.12-0477; Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P3418, DOI 10.1128/JCM.01359-13; Waggoner JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002116; Wang WK, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00203-18; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2012, GLOB STRAT DENG PREV; Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730	40	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218139	10.1371/journal.pone.0218139	http://dx.doi.org/10.1371/journal.pone.0218139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291289	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800017
J	Wu, PPY; Sterkenburg, N; Everett, K; Chapman, DW; White, N; Mengersen, K				Wu, Paul Pao-Yen; Sterkenburg, Nicholas; Everett, Kirsten; Chapman, Dale W.; White, Nicole; Mengersen, Kerrie			Predicting fatigue using countermovement jump force-time signatures: PCA can distinguish neuromuscular versus metabolic fatigue	PLOS ONE			English	Article							ENDOCRINE RESPONSES; ELITE PLAYERS; PERFORMANCE; VARIABILITY; INTENSITY; IMPACT	Purpose This study investigated the relationship between the ground reaction force-time profile of a countermovement jump (CMJ) and fatigue, specifically focusing on predicting the onset of neuromuscular versus metabolic fatigue using the CMJ. Method Ten recreational athletes performed 5 CMJs at time points prior to, immediately following, and at 0.5, 1, 3, 6, 24 and 48 h after training, which comprised repeated sprint sessions of low, moderate, or high workloads. Features of the concentric portion of the CMJ force-time signature at the measurement time points were analysed using Principal Components Analysis (PCA) and functional PCA (fPCA) to better understand fatigue onset given training workload. In addition, Linear Mixed Effects (LME) models were developed to predict the onset of fatigue. Results The first two Principal Components (PCs) using PCA explained 68% of the variation in CMJ features, capturing variation between athletes through weighted combinations of force, concentric time and power. The next two PCs explained 9.9% of the variation and revealed fatigue effects between 6 to 48 h after training for PC3, and contrasting neuromuscular and metabolic fatigue effects in PC4. fPCA supported these findings and further revealed contrasts between metabolic and neuromuscular fatigue effects in the first and second half of the force-time curve in PC3, and a double peak effect in PC4. Subsequently, CMJ measurements up to 0.5 h after training were used to predict relative peak CMJ force, with mean squared errors of 0.013 and 0.015 at 6 and 48 h corresponding to metabolic and neuromuscular fatigue. Conclusion The CMJ was found to provide a strong predictor of neuromuscular and metabolic fatigue, after accounting for force, concentric time and power. This method can be used to assist coaches to individualise future training based on CMJ response to the immediate session.	[Wu, Paul Pao-Yen; Sterkenburg, Nicholas; White, Nicole; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Australian Res Council Ctr Excellence Math & Stat, Brisbane, Qld, Australia; [Everett, Kirsten] Australian Inst Sport, Strength & Conditioning, Bruce, ACT, Australia; [Everett, Kirsten; Chapman, Dale W.] Univ Canberra, Res Inst Sport & Exercise, Bruce, ACT, Australia; [Chapman, Dale W.] Australian Inst Sport, Physiol, Bruce, ACT, Australia	Queensland University of Technology (QUT); Australian Institute of Sport; University of Canberra; Australian Institute of Sport	Wu, PPY (corresponding author), Queensland Univ Technol, Sch Math Sci, Australian Res Council Ctr Excellence Math & Stat, Brisbane, Qld, Australia.	p.wu@qut.edu.au	Chapman, Dale Wilson/I-3125-2019; Mengersen, Kerrie/AHC-4096-2022	Chapman, Dale Wilson/0000-0002-3393-1261; White, Nicole/0000-0002-9292-0773; Wu, Paul Pao-Yen/0000-0001-5960-8203				Abbiss CR, 2005, SPORTS MED, V35, P865, DOI 10.2165/00007256-200535100-00004; Abdel-Aty M, 2007, J AIR TRANSP MANAG, V13, P355, DOI 10.1016/j.jairtraman.2007.06.002; Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Anderberg M. R., 1973, CLUSTER ANAL APPL; Bro R, 2014, ANAL METHODS-UK, V6, P2812, DOI 10.1039/c3ay41907j; Carling C, 2012, J SPORT SCI, V30, P325, DOI 10.1080/02640414.2011.652655; Casella G., 2002, STAT INFERENCE, V2nd; Cormack SJ, 2008, INTJ SPORT PHYSIOL, V3, P439, DOI 10.1123/ijspp.3.4.439; Cormack SJ, 2008, INTJ SPORT PHYSIOL, V3, P359, DOI 10.1123/ijspp.3.3.359; Cormack SJ, 2008, INTJ SPORT PHYSIOL, V3, P131, DOI 10.1123/ijspp.3.2.131; Cormie P, 2010, MED SCI SPORT EXER, V42, P1731, DOI 10.1249/MSS.0b013e3181d392e8; Cormie P, 2009, J STRENGTH COND RES, V23, P177, DOI 10.1519/JSC.0b013e3181889324; Drew MK, 2016, BRIT J SPORT MED, V50, P1423, DOI 10.1136/bjsports-2015-095543; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Gathercole R, 2015, INT J SPORT PHYSIOL, V10, P84, DOI 10.1123/ijspp.2013-0413; Gathercole RJ, 2015, J STRENGTH COND RES, V29, P37, DOI 10.1519/JSC.0000000000000622; Gatterer H, 2014, J SPORT SCI MED, V13, P731; Halson Shona L, 2014, Sports Med, V44 Suppl 2, pS139, DOI 10.1007/s40279-014-0253-z; Jordan MJ, 2015, SCAND J MED SCI SPOR, V25, pe301, DOI 10.1111/sms.12314; Kennedy RA, 2017, J SPORT MED PHYS FIT, V57, P1261, DOI 10.23736/S0022-4707.17.06848-7; LAYZER RB, 1990, BAILLIERE CLIN ENDOC, V4, P441, DOI 10.1016/S0950-351X(05)80064-3; Lehmann E. L., 1998, THEORY POINT ESTIMAT; Mooney MG, 2013, J STRENGTH COND RES, V27, P166, DOI 10.1519/JSC.0b013e3182514683; Nimphius S, 2016, HUM MOVEMENT SCI, V47, P151, DOI 10.1016/j.humov.2016.03.005; Overton AJ, 2013, NEUROMUSCULAR FATIGU; Pinheiro J, R PACKAGE VERSION; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsay JO, 2009, USE R, P1, DOI 10.1007/978-0-387-98185-7_1; Ronglan LT, 2006, SCAND J MED SCI SPOR, V16, P267, DOI 10.1111/j.1600-0838.2005.00474.x; Taylor K., 2012, J AUST STRENGTH COND, V20, P12; Taylor K-L, 2012, MONITORING NEUROMUSC; Taylor KL, 2010, INT J SPORT PHYSIOL, V5, P546, DOI 10.1123/ijspp.5.4.546	32	22	22	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219295	10.1371/journal.pone.0219295	http://dx.doi.org/10.1371/journal.pone.0219295			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291303	Green Submitted, Green Published, gold			2022-12-26	WOS:000484947800067
J	Zhao, T; Chen, YD; Yu, Q; Shi, DZ; Chai, HX; Li, L; Ai, HN; Gu, L; He, Q				Zhao, Ting; Chen, Yongdong; Yu, Qing; Shi, Dezhi; Chai, Hongxiang; Li, Li; Ai, Hainan; Gu, Li; He, Qiang			Enhancement of performance and stability of anaerobic co-digestion of waste activated sludge and kitchen waste by using bentonite	PLOS ONE			English	Article							SEWAGE-SLUDGE; METHANE PRODUCTION; FOOD WASTE; RESIDUAL SLUDGE; PIG MANURE; PRETREATMENT; PARTICIPATION; COMMUNITIES; INHIBITION; ADSORPTION	There are large amounts of waste activated sludge (WAS) and kitchen waste (KW) produced every year in China. It has been confirmed that anaerobic co-digestion is an effective method to solve this problem. The targets of the present study were optimizing the digestive performances and clearing of the mechanism of bentonite addition by adding bentonite into digestive system. Group M (WAS: KW = 1:2, based on VS) presented higher cumulative methane yield (CMY), where the CMY increased from 19.8 to 36.3 mL/g VS with the bentonite dosage from 0 to 2 g/g VS. After bentonite addition, the lag phase of every digester presented an obvious decrease from 15.1 to 1.4 d. Furthermore, and the moderating effects on microbial community by bentonite. The addition of bentonite improved methane production, and it can also reduce the lag phase of methane production in co-digestion. What's more, bentonite addition increased the speed of pH recovery from 4.2-4.8 to normal level (7.0-8.0) and thus enhanced the system stability. The conclusion of this study can be used to guide practical engineering.	[Zhao, Ting; Chen, Yongdong; Yu, Qing; Shi, Dezhi; Chai, Hongxiang; Li, Li; Ai, Hainan; Gu, Li; He, Qiang] Chongqing Univ, Key Lab Three Gorges Reservoir Regions Ecoenviron, Minist Educ, Inst Urban Construct & Environm Engn, Chongqing, Peoples R China	Chongqing University	Gu, L (corresponding author), Chongqing Univ, Key Lab Three Gorges Reservoir Regions Ecoenviron, Minist Educ, Inst Urban Construct & Environm Engn, Chongqing, Peoples R China.	guli@cqu.edu.cn	chai, hongxiang/AAF-7240-2019; Shi, DeZhi/L-3374-2016	chai, hongxiang/0000-0001-7163-6055; Shi, DeZhi/0000-0003-4452-1855; Gu, Li/0000-0003-2731-0458	National Nature Science Foundation of China [51208531]; National Key Technology Support Program [2014BAC29B001]; Chongqing science and Technology Commission Project [cstc2017jcyjAX0173]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program(National Key Technology R&D Program); Chongqing science and Technology Commission Project	The authors would like to acknowledge the financial support for this work provided by the National Nature Science Foundation of China (NO. 51208531), National Key Technology Support Program (2014BAC29B001) and Chongqing science and Technology Commission Project (cstc2017jcyjAX0173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APHA, 1995, PUBL HEAL ASS STAND; Ariunbaatar J, 2014, APPL ENERG, V123, P143, DOI 10.1016/j.apenergy.2014.02.035; Bhattacharyya KG, 2008, ADV COLLOID INTERFAC, V140, P114, DOI 10.1016/j.cis.2007.12.008; Buswell A.M., 1930, LAB STUDIES SLUDGE D; Chen YQ, 2014, WASTE MANAGE, V34, P2014, DOI 10.1016/j.wasman.2014.06.029; Chen YD, 2019, SCI TOTAL ENVIRON, V671, P838, DOI 10.1016/j.scitotenv.2019.03.339; Dang Y, 2017, BIORESOURCE TECHNOL, V238, P30, DOI 10.1016/j.biortech.2017.04.021; El-Mashad H. M., 2008, Biological Engineering, V1, P235; Fagbohungbe MO, 2016, BIORESOURCE TECHNOL, V216, P142, DOI 10.1016/j.biortech.2016.04.106; GOSSETT JM, 1982, J ENV ENG DIV-ASCE, V108, P1101; Guo XH, 2014, BIORESOURCE TECHNOL, V152, P420, DOI 10.1016/j.biortech.2013.11.012; HANAKI K, 1994, WATER RES, V28, P877, DOI 10.1016/0043-1354(94)90094-9; Hiraishi A, 2000, J BIOSCI BIOENG, V90, P148, DOI 10.1263/jbb.90.148; Jin H., 2018, CHINA BIOGAS, V36, P47; Kim SH, 2004, INT J HYDROGEN ENERG, V29, P1607, DOI 10.1016/j.ijhydene.2004.02.018; Lee DH, 2009, WASTE MANAGE, V29, P876, DOI 10.1016/j.wasman.2008.06.033; Li WW, 2018, APPL ENERG, V226, P1219, DOI 10.1016/j.apenergy.2018.05.055; Lim JW, 2014, BIORESOURCE TECHNOL, V171, P132, DOI 10.1016/j.biortech.2014.08.050; Lu L, 2012, WATER RES, V46, P2425, DOI 10.1016/j.watres.2012.02.005; Luo G, 2012, BIOTECHNOL BIOENG, V109, P2729, DOI 10.1002/bit.24557; Ma JY, 2018, J CLEAN PROD, V183, P11, DOI 10.1016/j.jclepro.2018.02.121; Ma S, 2018, WATER RES; Maqueda C, 1998, ENVIRON TECHNOL, V19, P811, DOI 10.1080/09593331908616737; Milan Z, 2016, BIORESOURCE TECHNOL, V80, P37; Naseem R, 2001, WATER RES, V35, P3982, DOI 10.1016/S0043-1354(01)00130-0; Pan JunTing, 2016, Transactions of the Chinese Society of Agricultural Engineering, V32, P246; Pilli S, 2015, CRIT REV ENV SCI TEC, V45, P669, DOI 10.1080/10643389.2013.876527; Pilli S, 2011, ULTRASON SONOCHEM, V18, P1, DOI 10.1016/j.ultsonch.2010.02.014; Prabhu MS, 2016, WASTE MANAGE RES, V34, P307, DOI 10.1177/0734242X16628976; Sasaki K, 2011, APPL MICROBIOL BIOT, V90, P1555, DOI 10.1007/s00253-011-3215-5; Siddiqui Z, 2011, INT J CHEM REACT ENG, V9, DOI 10.1515/1542-6580.2327; Silvestre G, 2014, APPL ENERG, V117, P87, DOI 10.1016/j.apenergy.2013.11.075; Toor M, 2012, CHEM ENG J, V187, P79, DOI 10.1016/j.cej.2012.01.089; [王星 WANG Xing], 2007, [农业环境科学学报, Journal of Agro-environment science], V26, P330; Wang YY, 2018, BIORESOURCE TECHNOL, V250, P328, DOI 10.1016/j.biortech.2017.11.055; Wu LJ, 2015, INT BIODETER BIODEGR, V104, P315, DOI 10.1016/j.ibiod.2015.06.020; Xie SH, 2017, INT BIODETER BIODEGR, V116, P191, DOI 10.1016/j.ibiod.2016.10.037; Yang G, 2015, WATER RES, V78, P60, DOI 10.1016/j.watres.2015.04.002; Yi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102548; Yu HQ, 1999, ENVIRON TECHNOL, V20, P1095, DOI 10.1080/09593332008616906; Yu SY, 2013, BIORESOURCE TECHNOL, V146, P758, DOI 10.1016/j.biortech.2013.07.087; Zhang DJ, 2018, PROCESS SAF ENVIRON, V115, P116, DOI 10.1016/j.psep.2017.09.011; Zhang WQ, 2014, APPL ENERG, V128, P175, DOI 10.1016/j.apenergy.2014.04.071; Zhen GY, 2015, APPL ENERG, V148, P78, DOI 10.1016/j.apenergy.2015.03.038; Zhou Y, 2019, SCI TOTAL ENVIRON, V649, P1307, DOI 10.1016/j.scitotenv.2018.08.411; Zou HJ, 2018, BIORESOURCE TECHNOL, V268, P371, DOI 10.1016/j.biortech.2018.07.129	46	19	19	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218856	10.1371/journal.pone.0218856	http://dx.doi.org/10.1371/journal.pone.0218856			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291286	Green Submitted, gold, Green Published			2022-12-26	WOS:000484947800038
J	Feria, B; Abreu, FV				Feria, Bruno; de Abreu, Fernao Vistulo			Cellular frustration algorithms for anomaly detection applications	PLOS ONE			English	Article							SUPPORT-VECTOR; AUTOENCODER; CLASSIFICATION; RECOGNITION; SYSTEM; MODEL	Cellular frustrated models have been developed to describe how the adaptive immune system works. They are composed by independent agents that continuously pair and unpair depending on the information that one sub-set of these agents display. The emergent dynamics is sensitive to changes in the displayed information and can be used to detect anomalies, which can be important to accomplish the immune system main function of protecting the host. Therefore, it has been hypothesized that these models could be adequate to model the immune system activation. Likewise it has been hypothesized that these models could provide inspiration to develop new artificial intelligence algorithms for data mining applications. However, computational algorithms do not need to follow strictly the immunological reality. Here, we investigate efficient implementation strategies of these immune inspired ideas for anomaly detection applications and use real data to compare the performance of cellular frustration algorithms with standard implementations of one-class support vector machines and deep autoencoders. Our results demonstrate that more efficient implementations of cellular frustration algorithms are possible and also that cellular frustration algorithms can be advantageous for semi-supervised anomaly detection applications given their robustness and accuracy.	[Feria, Bruno; de Abreu, Fernao Vistulo] Univ Aveiro, Dept Phys, Aveiro, Portugal; [Feria, Bruno; de Abreu, Fernao Vistulo] I3N, Aveiro, Portugal	Universidade de Aveiro	Abreu, FV (corresponding author), Univ Aveiro, Dept Phys, Aveiro, Portugal.; Abreu, FV (corresponding author), I3N, Aveiro, Portugal.	fva@ua.pt	Vistulo de Abreu, Fernao/J-4989-2013	Vistulo de Abreu, Fernao/0000-0003-0452-3493	FEDER funds through the COMPETE 2020 Programme; FCT - Portuguese Foundation for Science and Technology [UID/CTM/50025/2013]; FCT [SFRH/BD/79865/2011]	FEDER funds through the COMPETE 2020 Programme; FCT - Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work is funded by FEDER funds through the COMPETE 2020 Programme and National Funds through FCT - Portuguese Foundation for Science and Technology under the project UID/CTM/50025/2013. BFF acknowledges FCT for grant SFRH/BD/79865/2011.	Almeida CR, 2003, EVOL ECOL RES, V5, P739; Amer M., 2013, P ACM SIGKDD WORKSHO, P8, DOI [10.1145/2500853.2500857, DOI 10.1145/2500853.2500857]; [Anonymous], 2017, AI H R INTERFACE H2O; Boughorbel S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177678; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Candia J, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224015; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chu MX, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212361; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cortez P, 2009, DECIS SUPPORT SYST, V47, P547, DOI 10.1016/j.dss.2009.05.016; Creech G, 2014, IEEE T COMPUT, V63, P807, DOI 10.1109/TC.2013.13; de Abreu FV, 2009, J R SOC INTERFACE, V6, P321, DOI 10.1098/rsif.2008.0280; Douat LR, 2010, IEEE INT C INT ROBOT, P6175, DOI 10.1109/IROS.2010.5649161; Edgeworth F.Y., 1887, PHILOS MAGAZINE J SC, V23, P364, DOI [10.1080/14786448708628471, DOI 10.1080/14786448708628471]; Erfani SM, 2016, PATTERN RECOGN, V58, P121, DOI 10.1016/j.patcog.2016.03.028; Faria BF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169464; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; GALE D, 1962, AM MATH MON, V69, P9, DOI 10.2307/2312726; Gogna A, 2017, IEEE T BIO-MED ENG, V64, P2196, DOI 10.1109/TBME.2016.2631620; Goldstein M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152173; GORMAN RP, 1988, NEURAL NETWORKS, V1, P75, DOI 10.1016/0893-6080(88)90023-8; Hawkins S., 2002, INT C DAT WAR KNOWL, P170, DOI [10.1007/3-540-46145-0_17, DOI 10.1007/3-540-46145-0_17]; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; He WP, 2015, MECH SYST SIGNAL PR, V54-55, P457, DOI 10.1016/j.ymssp.2014.09.007; Dau HA, 2014, LECT NOTES COMPUT SC, V8886, P311, DOI 10.1007/978-3-319-13563-2_27; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Katzman SD, 2010, P NATL ACAD SCI USA, V107, P18085, DOI 10.1073/pnas.1010560107; Lee YJ, 2013, IEEE T KNOWL DATA EN, V25, P1460, DOI 10.1109/TKDE.2012.99; Li DG, 2017, NANOSCALE RES LETT, V12, DOI 10.1186/s11671-016-1803-0; Lindo AM, 2012, THEOR BIOSCI, V131, P77, DOI 10.1007/s12064-011-0134-z; Marsland S., 2003, NEURAL COMPUTATION S; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Mostardinha P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00769; Mostardinha P, 2012, NEGATIVE SELECTION A, P178; Munoz MA, 2018, MACH LEARN, V107, P109, DOI 10.1007/s10994-017-5629-5; Ning XJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201280; Patcha A, 2007, COMPUT NETW, V51, P3448, DOI 10.1016/j.comnet.2007.02.001; Popoola OP, 2012, IEEE T SYST MAN CY C, V42, P865, DOI 10.1109/TSMCC.2011.2178594; Prasad NR, 2009, CMC-COMPUT MATER CON, V14, P1, DOI 10.1145/1541880.1541882; Rajeswari AM, 2018, PROCEEDINGS OF THE 2018 SECOND INTERNATIONAL CONFERENCE ON INVENTIVE COMMUNICATION AND COMPUTATIONAL TECHNOLOGIES (ICICCT), P1068; Schallmo MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068090; Scholkopf B, 2000, ADV NEUR IN, V12, P582; Shao HD, 2017, MECH SYST SIGNAL PR, V95, P187, DOI 10.1016/j.ymssp.2017.03.034; Smola AJ, 1999, ADV NEUR IN, V11, P585; Staniford-Chen S, 1996, P 19 NAT INF SYST SE, P361; Steinwart I, 2005, J MACH LEARN RES, V6, P211; Sun YM, 2009, INT J PATTERN RECOGN, V23, P687, DOI 10.1142/S0218001409007326; Tax DMJ, 1999, PATTERN RECOGN LETT, V20, P1191, DOI 10.1016/S0167-8655(99)00087-2; Van Hulse J., 2007, P 24 INT C MACH LEAR, P935, DOI [10.1145/1273496.1273614, DOI 10.1145/1273496.1273614]; Vapnik V, 1963, AUTOMATION REMOTE CO, V24; de Abreu FV, 2006, LECT NOTES COMPUT SC, V4163, P37; Xiong YH, 2016, COMPUT GEOSCI-UK, V86, P75, DOI 10.1016/j.cageo.2015.10.006; Zhao J, 2014, INFORM SCIENCES, V259, P335, DOI 10.1016/j.ins.2013.05.018; Zoppi T, 2018, IEEE PAC RIM INT SYM, P279, DOI 10.1109/PRDC.2018.00050	56	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0218930	10.1371/journal.pone.0218930	http://dx.doi.org/10.1371/journal.pone.0218930			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283758	Green Published, Green Submitted, gold			2022-12-26	WOS:000484939800013
J	Palstam, A; Sjodin, A; Sunnerhagen, KS				Palstam, Annie; Sjodin, Astrid; Sunnerhagen, Katharina Stibrant			Participation and autonomy five years after stroke: A longitudinal observational study	PLOS ONE			English	Article							PERCEIVED PARTICIPATION; SOCIAL-PARTICIPATION; LIFE SATISFACTION; IMPACT; DISABILITY; PREDICTORS; DEPRESSION; HANDICAP; DETERMINANTS; RECOVERY	Objective Stroke is the second most common cause of disability in the world. The purpose of this study was to evaluate the participation and autonomy of persons with stroke, five years after a stroke, and to explore potential associations between factors and perceived restrictions in participation and autonomy. Methods This five-year follow-up survey study included individuals diagnosed with a first-time stroke during 2009-2010, in Gothenburg. The survey included the Impact of Participation and Autonomy-questionnaire (IPA-E), which comprised five domains: Autonomy Indoor, Family Role, Autonomy Outdoor, Work & Education, and Social Life & Relationships. Logistic regression analyses were used to analyze factors associated with participation restrictions. Results At 5 years after a stroke, 457 patients were alive; of these, 281 responded to the follow-up survey. Participation restrictions were most pronounced in the IPA-E domains of Autonomy Outdoors, Work/Education, and Social Life and Relationships. In contrast, restrictions were less pronounced in the IPA-E domains of Autonomy Indoors and Family Role. Severe stroke, older age, and female sex predicted participation restrictions at five years after a stroke. Participation restrictions were partly explained by feelings of depression at five years after stroke. Problems associated with participation restrictions were most frequently observed in the areas of mobility, leisure, and help/support from other people. Conclusion This study showed that participation and autonomy were restricted among persons with stroke at five years after the stroke. The domains perceived as most restricted were those that required high levels of physical, social, and cognitive abilities.	[Palstam, Annie; Sjodin, Astrid; Sunnerhagen, Katharina Stibrant] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden	University of Gothenburg	Palstam, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden.	anme.palstam@gu.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400	Swedish Research Council [VR 2012-70X-22122-01-3, VR2017-00946]; Swedish Heart Lung Foundation; Swedish Brain Foundation; Promobilia; Swedish Stroke Association; Swedish government; county councils, the ALF agreement [ALFGBG-718711]; Norrbacka-Eugenia foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Brain Foundation; Promobilia; Swedish Stroke Association; Swedish government; county councils, the ALF agreement; Norrbacka-Eugenia foundation	The study was supported by grants from the Swedish Research Council (VR 2012-70X-22122-01-3, VR2017-00946), The Swedish Heart Lung Foundation, The Swedish Brain Foundation, Promobilia, Norrbacka-Eugenia foundation, The Swedish Stroke Association as well as by grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF agreement (ALFGBG-718711) to KSS.	ALLEN SM, 1993, J GERONTOL, V48, pS204, DOI 10.1093/geronj/48.4.S204; Amosun SL, 2013, AFR HEALTH SCI, V13, P24, DOI 10.4314/ahs.v13i1.4; Andrenelli E, 2015, EUR J PHYS REHAB MED, V51, P575; Bergstrom AL, 2015, J REHABIL MED, V47, P508, DOI 10.2340/16501977-1964; Blomgren C, 2018, SCAND J OCCUP THER, V25, P119, DOI 10.1080/11038128.2017.1329343; Boosman H, 2011, CLIN REHABIL, V25, P460, DOI 10.1177/0269215510388314; Burton CR, 2000, J ADV NURS, V32, P301, DOI 10.1046/j.1365-2648.2000.01477.x; Cardol M, 2002, CLIN REHABIL, V16, P27, DOI 10.1191/0269215502cr464oa; Cardol M, 2002, DISABIL REHABIL, V24, P970, DOI 10.1080/09638280210151996; Cardol M, 2001, ARCH PHYS MED REHAB, V82, P210, DOI 10.1053/apmr.2001.18218; Chau JPC, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-49; Chen XM, 2017, CLIN REHABIL, V31, P1257, DOI 10.1177/0269215516684178; D'Alisa S, 2005, ACTA NEUROL SCAND, V112, P157, DOI 10.1111/j.1600-0404.2005.00466.x; de Graaf JA., 2017, DISABIL REHABIL, V5, P1; Desrosiers J, 2006, DISABIL REHABIL, V28, P221, DOI 10.1080/09638280500158372; Desrosiers J, 2004, AGING CLIN EXP RES, V16, P406; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Duncan PW, 2003, ARCH PHYS MED REHAB, V84, P950, DOI 10.1016/S0003-9993(03)00035-2; Edwards Dorothy F, 2006, J Stroke Cerebrovasc Dis, V15, P151, DOI 10.1016/j.jstrokecerebrovasdis.2006.04.001; Erikson A, 2010, J REHABIL MED, V42, P831, DOI 10.2340/16501977-0608; Eriksson Gunilla, 2013, Am J Occup Ther, V67, pe131, DOI 10.5014/ajot.2013.008292; Fallahpour M, 2011, J REHABIL MED, V43, P388, DOI 10.2340/16501977-0789; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P161, DOI 10.1159/000441085; Gadidi V, 2011, ARCH PHYS MED REHAB, V92, P1802, DOI 10.1016/j.apmr.2011.06.014; Hadidi N, 2009, HEART LUNG, V38, P151, DOI 10.1016/j.hrtlng.2008.05.002; Hankey GJ, 2002, STROKE, V33, P1034, DOI 10.1161/01.STR.0000012515.66889.24; Harwood RH, 1997, DISABIL REHABIL, V19, P205, DOI 10.3109/09638289709166528; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Kirkevold M, 2002, DISABIL REHABIL, V24, P887, DOI 10.1080/09638280210142239; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; Lund ML, 2007, J REHABIL MED, V39, P156, DOI 10.2340/16501977-0031; Pallesen H, 2014, DISABIL REHABIL, V36, P232, DOI 10.3109/09638288.2013.788217; Parker CJ, 1997, DISABIL REHABIL, V19, P1, DOI 10.3109/09638289709166438; Persson HC, 2018, ACTA NEUROL SCAND, V137, P99, DOI 10.1111/ane.12815; Persson HC, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-162; Reinhardt JD, 2007, J RHEUMATOL, V34, P1214; Schepers VP, 2005, ARCH PHYS MED REHAB, V86, P1472, DOI 10.1016/j.apmr.2004.11.039; Shi Y, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00218; Silva SM, 2016, DISABIL REHABIL, V38, P1830, DOI 10.3109/09638288.2015.1107774; Singam A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144344; Sturm JW, 2004, STROKE, V35, P715, DOI 10.1161/01.STR.0000117573.19022.66; Sturm JW, 2002, STROKE, V33, P762, DOI 10.1161/hs0302.103815; Tellier M, 2009, TOP STROKE REHABIL, V16, P454, DOI 10.1310/tsr1606-454; Tornbom K, 2017, ACTA NEUROL SCAND, V135, P649, DOI 10.1111/ane.12661; Tornbom K, 2017, J STROKE CEREBROVASC, V26, P57, DOI 10.1016/j.jstrokecerebrovasdis.2016.08.029; Turner-Stokes L, 2002, CLIN REHABIL, V16, P231, DOI 10.1191/0269215502cr487oa; Venna VR, 2015, METAB BRAIN DIS, V30, P497, DOI 10.1007/s11011-014-9544-1; Vikholmen K, 2015, ACTA NEUROL SCAND, V132, P329, DOI 10.1111/ane.12404; Wesali S, 2015, CLIN NEUROL NEUROSUR, V138, P52, DOI 10.1016/j.clineuro.2015.07.020; Woodman P, 2014, DISABIL REHABIL, V36, P2031, DOI 10.3109/09638288.2014.887796; Ytterberg C, 2017, J REHABIL MED, V49, P637, DOI 10.2340/16501977-2258	51	22	23	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219513	10.1371/journal.pone.0219513	http://dx.doi.org/10.1371/journal.pone.0219513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4GX	31283800	Green Submitted, Green Published, gold			2022-12-26	WOS:000484939800039
J	Feneant, L; Szymanska-de Wijs, KM; Nelson, EA; White, JM				Feneant, Lucie; Szymanska-de Wijs, Katarzyna M.; Nelson, Elizabeth A.; White, Judith M.			An exploration of conditions proposed to trigger the Ebola virus glycoprotein for fusion	PLOS ONE			English	Article							RESPIRATORY SYNDROME-CORONAVIRUS; NIEMANN-PICK C1; HOST-CELL ENTRY; MEMBRANE-FUSION; CONFORMATIONAL-CHANGES; ENVELOPE PROTEIN; DOMAIN RESIDUES; ACIDIC PH; REQUIRES; CHANNELS	Ebolaviruses continue to inflict horrific disease and instill fear. The 2013-2016 outbreak in Western Africa caused unfathomable morbidity and mortality (over 11,000 deaths), and the second largest outbreak is on-going in the Democratic Republic of the Congo. The first stage of an Ebolavirus infection is entry, culminating in delivery of the viral genome into the cytoplasm to initiate replication. Among enveloped viruses, Ebolaviruses use a complex entry pathway: they bind to attachment factors on cell surfaces, are engulfed by macropinocytosis, and traffic through the endosomal system. En route, the receptor binding subunit of the glycoprotein (GP) is reduced from similar to 130 to similar to 19 kDa by cathepsins. This event allows cleaved GP (GP(cl)) to bind to Niemann-Pick C1 (NPC1), its endosomal receptor. The virus then fuses with a late endosomal membrane, but how this occurs remains a subject of debate. An early, but standing, observation is that entry of particles bearing GP(cl) is inhibited by agents that raise endosomal pH or inhibit cysteine proteases, suggesting the need for an additional factor(s). Yet, some have concluded that NPC1 is sufficient to trigger the fusion activity of GP(cl). Here, we re-examined this question using sensitive cell-cell and pseudovirus-cell fusion assays. We did not observe detectable GP(cl)-mediated fusion with NPC1 or its GP(cl) binding domain at any pH tested, while robust fusion was consistently observed with GP from lymphocytic choriomeningitis virus at low pH. Addition of proposed fusion-enhancing factors-cations (Ca++ and K+), a reducing agent, the anionic lipid Bis(Monoacylglycero)Phosphate, and a mixture of cathepsins B and L-did not induce detectable fusion. Our findings are in line with the earlier proposal that an additional factor is required to trigger the full fusion activity of GP(cl) after binding to NPC1. We discuss caveats to our study and what the missing factor(s) might be.	[Feneant, Lucie; Szymanska-de Wijs, Katarzyna M.; Nelson, Elizabeth A.; White, Judith M.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22904 USA; [White, Judith M.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Feneant, Lucie] Friedrich Loeffler Inst, Greifswald, Insel Riems, Germany; [Szymanska-de Wijs, Katarzyna M.] Hannover Med Sch, Inst Virol, Hannover, Germany	University of Virginia; University of Virginia; Friedrich Loeffler Institute; Hannover Medical School	White, JM (corresponding author), Univ Virginia, Dept Cell Biol, Charlottesville, VA 22904 USA.; White, JM (corresponding author), Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.	jw7g@virginia.edu			NIH [AI114776]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by a grant from the NIH to JMW (AI114776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, ALZHEIMERS DEMENTI S, V11, pP121; Bale S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001395; Bitto D, 2016, J BIOL CHEM, V291, P6412, DOI 10.1074/jbc.M115.691113; Brecher M, 2012, J VIROL, V86, P364, DOI 10.1128/JVI.05708-11; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Coevoets R, 2009, EUR J HUM GENET, V17, P301, DOI 10.1038/ejhg.2008.184; Cohen-Dvashi H, 2016, J VIROL, V90, P10329, DOI 10.1128/JVI.01624-16; COLLINS DS, 1991, J IMMUNOL, V147, P4054; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; DISIMONE C, 1994, VIROLOGY, V198, P455, DOI 10.1006/viro.1994.1057; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Dube M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004530; Flint M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08135-4; Goldstein T, 2018, NAT MICROBIOL, V3, P1084, DOI 10.1038/s41564-018-0227-2; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Gregory SM, 2014, J VIROL, V88, P6636, DOI 10.1128/JVI.00396-14; Gregory SM, 2011, P NATL ACAD SCI USA, V108, P11211, DOI 10.1073/pnas.1104760108; Gunaratne GS, 2018, CELL CALCIUM, V75, P30, DOI 10.1016/j.ceca.2018.08.003; Haines KM, 2012, VIROLOGY, V432, P20, DOI 10.1016/j.virol.2012.05.018; Harrison JS, 2011, PROTEIN SCI, V20, P1587, DOI 10.1002/pro.688; Hover S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006845; Hullin-Matsuda F, 2014, SEMIN CELL DEV BIOL, V31, P48, DOI 10.1016/j.semcdb.2014.04.010; Hulseberg CE, 2018, MBIO, V9, DOI 10.1128/mBio.01818-17; Jae LT, 2014, SCIENCE, V344, P1506, DOI 10.1126/science.1252480; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kondo N, 2010, J BIOL CHEM, V285, P14681, DOI 10.1074/jbc.M109.067090; Krishnan A, 2012, VIRUSES-BASEL, V4, P2471, DOI 10.3390/v4112471; Lai AL, 2017, J MOL BIOL, V429, P3875, DOI 10.1016/j.jmb.2017.10.017; Lee J, 2017, P NATL ACAD SCI USA, V114, pE7987, DOI 10.1073/pnas.1708052114; Markosyan RM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005373; Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102; Matsuyama S, 2018, J VIROL, V92, DOI 10.1128/JVI.00683-18; Miller EH, 2016, EMBO J, V31, P1; Millet JK, 2018, VIROLOGY, V517, P3, DOI 10.1016/j.virol.2017.12.015; Millet JK, 2014, P NATL ACAD SCI USA, V111, P15214, DOI 10.1073/pnas.1407087111; Mingo RM, 2015, J VIROL, V89, P2931, DOI 10.1128/JVI.03398-14; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Ng M, 2014, VIROLOGY, V468, P637, DOI 10.1016/j.virol.2014.08.019; Paterson RG, 2000, VIROLOGY, V270, P17, DOI 10.1006/viro.2000.0267; Rhein BA, 2016, J VIROL, V90, P6097, DOI 10.1128/JVI.00100-16; Ruedas JB, 2018, J VIROL, V92, DOI [10.1128/JVI.00820-18, 10.1128/jvi.00820-18]; RUIGROK RWH, 1986, VIROLOGY, V155, P484, DOI 10.1016/0042-6822(86)90210-2; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; SHEN WC, 1985, J BIOL CHEM, V260, P905; Simmons JA, 2016, J VIROL, V90, P605, DOI 10.1128/JVI.01828-15; Spence JS, 2016, MBIO, V7, DOI 10.1128/mBio.01857-15; Stauffer S, 2014, J VIROL, V88, P13029, DOI 10.1128/JVI.01430-14; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Wharton SA, 2000, VIROLOGY, V271, P71, DOI 10.1006/viro.2000.0280; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389; Wong AC, 2010, J VIROL, V84, P163, DOI 10.1128/JVI.01832-09; Yang X, 2020, NAT PROD RES, V34, P2001, DOI 10.1080/14786419.2019.1569661; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131	60	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219312	10.1371/journal.pone.0219312	http://dx.doi.org/10.1371/journal.pone.0219312			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IK4PY	31276481	gold, Green Submitted, Green Published			2022-12-26	WOS:000476570000001
J	Nishio, A; Horita, R; Sado, T; Watanabe, T; Uehara, R; Mizutani, S; Yamamoto, M				Nishio, Akihiro; Horita, Ryo; Sado, Tadahiro; Watanabe, Takahiro; Uehara, Ryosuke; Mizutani, Seiko; Yamamoto, Mayumi			Relationship between non-communicable diseases and background characteristics among homeless people in Nagoya City, Japan	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; RISK-FACTORS; HEALTH-RISK; PREVALENCE; OBESITY; HYPERTENSION; SOCIETY; ADULTS	Background There are few reports that objectively show actual health conditions among the homeless or diagnoses of non-communicable diseases based on blood tests. This report discloses the actual data from blood tests and non-communicable diseases among the participants. Furthermore, associations between the test values for lifestyle-related disease and mental disorder/intellectual disability, as well as personal backgrounds of homeless people, were analyzed from the data gathered in the survey. Methods This study was performed in a rented meeting room close to Nagoya Station on November 2, 2014. Blood samples, physical measurements, blood pressure measurements intellectual faculties were measured. Physical/mental diseases were diagnosed by doctors. Fisher's exact test was performed to compare between subgroups (by participants' socio-demographic data or the presence of mental illness/cognitive disability) according to non-communicable disease test values, and to calculate the odds ratio. Results Abnormalities among participants in test values for non-communicable disease were as follows: hypoalbuminemia in one participant (0.9%), abnormalities in liver function in 22 participants (19.3%), decreased renal function in two participants (1.8%), dyslipidemia in 67 participants (58.8%), "a person whose impaired glucose tolerance cannot be ruled out" in 20 participants (17.5%), obesity in 33 participants (28.9%), thinness in five participants (4.3%), and hypertension in 60 participants (52.6%). Compared to the National health and nutrition survey 2015, non-communicable diseases of the homeless people were similar or slightly better than in the general population in Japan. Participants aged 20-39 years had a significant positive tendency of having liver function abnormality compared to. 60 years old participants. There was no significant tendency with socio-demographic characteristics in dyslipidemia and "impaired glucose tolerance". Conclusion It was found that the percentage of homeless people in Nagoya who showed abnormalities of lifestyle-related disease was similar or better than that of general population in Japan.	[Nishio, Akihiro; Horita, Ryo; Sado, Tadahiro; Yamamoto, Mayumi] Gifu Univ, Hlth Adm Ctr, Gifu, Japan; [Nishio, Akihiro] Gifu Univ, Grad Sch Med, Div Neurosci, Dept Psychopathol, Gifu, Japan; [Sado, Tadahiro] Tokoha Univ, Fac Hlth Promot Sci, Hamamatsu, Shizuoka, Japan; [Watanabe, Takahiro] Midori Hosp, Gifu, Japan; [Uehara, Ryosuke] Yoshida Hosp, Nara, Japan; [Mizutani, Seiko] Nihon Fukushi Univ, Fac Nursing, Miyahama Okuda, Aichi, Japan; [Yamamoto, Mayumi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan	Gifu University; Gifu University; Gifu University	Nishio, A (corresponding author), Gifu Univ, Hlth Adm Ctr, Gifu, Japan.; Nishio, A (corresponding author), Gifu Univ, Grad Sch Med, Div Neurosci, Dept Psychopathol, Gifu, Japan.	a_nishio@gifu-u.ac.jp			Gifu Pref. Medical Association	Gifu Pref. Medical Association	Our survey was financed by the Gifu Pref. Medical Association.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arnaud A, 2010, EUR J PUBLIC HEALTH, V20, P601, DOI 10.1093/eurpub/ckp197; Bernstein RS, 2015, AM J PUBLIC HEALTH, V105, pE46, DOI 10.2105/AJPH.2014.302330; Dairoku H, 2008, JPN PSYCH ASS M MEM, V433; Kario K, 2015, PULSE, V3, P35, DOI 10.1159/000381300; Kuroda K., 2006, RES MED NEEDS HOMELE; Kuwahara K, 2016, IND HEALTH, V54, P505, DOI 10.2486/indhealth.2016-0082; Lee TC, 2005, CIRCULATION, V111, P2629, DOI 10.1161/CIRCULATIONAHA.104.510826; Martins DC, 2015, PUBLIC HEALTH NURS, V32, P453, DOI 10.1111/phn.12180; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Ministry of Health Labour and Welfare, NAT HLTH NUTR SURV 2; Nielssen O, 2017, AUSTRALAS PSYCHIATRY, V25, P270, DOI 10.1177/1039856217695705; Nishio A, 2015, ENV HLTH INT, P147; Nishio A, 2017, PSYCHIAT CLIN NEUROS, V71, P180, DOI 10.1111/pcn.12469; Nishio A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138052; Nishio A, 2015, PSYCHIAT CLIN NEUROS, V69, P534, DOI 10.1111/pcn.12265; Ohsaka Takako, 2003, Nihon Koshu Eisei Zasshi, V50, P686; Romaszko J, 2017, CENT EUR J PUBL HEAL, V25, P29, DOI 10.21101/cejph.a4464; Scott J, 2013, QJM-INT J MED, V106, P547, DOI 10.1093/qjmed/hct063; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Suzuki W, 2007, MONTHLY J JAPAN I LA, V6, P61; Tahara E, 2011, JAPANESE J NUTR DIET, V69, P29; Tahara E, 2011, THE JAPANESE JOURNAL, V69, P29; Teramoto T, 2007, J ATHEROSCLER THROMB, V14, P155, DOI 10.5551/jat.E537; Tsai J, 2013, PUBLIC HEALTH REP, V128, P29, DOI 10.1177/003335491312800105; Vandentorren S, 2016, EUR J PUBLIC HEALTH, V26, P71, DOI 10.1093/eurpub/ckv187	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219049	10.1371/journal.pone.0219049	http://dx.doi.org/10.1371/journal.pone.0219049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4FP	31276474	Green Published, gold, Green Submitted			2022-12-26	WOS:000484936300034
J	Thobani, R; Jessani, S; Azam, I; Reza, S; Sami, N; Rozi, S; Abrejo, F; Saleem, S				Thobani, Rozina; Jessani, Saleem; Azam, Iqbal; Reza, Sayyeda; Sami, Neelofar; Rozi, Shafquat; Abrejo, Farina; Saleem, Sarah			Factors associated with the discontinuation of modern methods of contraception in the low income areas of Sukh Initiative Karachi: A community-based case control study	PLOS ONE			English	Article								Introduction Discontinuation of a contraceptive method soon after its initiation is becoming a public health problem in Low middle income countries and may result in unintended pregnancy and related unwanted consequences. A better understanding of factors behind discontinuation of a modern method would help in designing interventions to continue its use till desired spacing goals are achieved. Objective To determine factors associated with the discontinuation of modern contraceptive methods within six months of its use compared to continued use of modern method for at least six months in low-income areas of Karachi, Pakistan. Methods A community-based case-control study was conducted in low-income areas of Karachi. Cases were 137 users who discontinued a modern contraceptive method within 6 months of initiation and were not using any method at the time of interview, while controls were 276 continuous users of modern method for at least last six months from the time of interview. Information was collected by using a structured questionnaire. Applied logistic regression was used to identify the associated factors for discontinuation. Results The mean ages of discontinued and continued users were 29.3 +/- 5.3 years and 29.2 +/- 5.4 years respectively. A larger proportion of the discontinued users had no formal education (43.8%) as compared to the continued users (27.9%). The factors associated with discontinuation of a modern method of contraception were belonging to Sindhi ethnicity [OR: 2.54, 95% CI 1.16-5.57], experiencing side effects [OR: 15.12; 95% CI 7.50-30.51], difficulty in accessing contraceptives by themselves [OR: 0.40, 95% CI 0.19-0.83] and difficulty in reaching clinics for management of the side effects [OR: 4.10, 95% CI 2.38-7.05]. Moreover, women having support from the husband for contraceptive use were less likely to discontinue the method [OR: 0.58, 95% CI 0.34-0.98]. Conclusions Sindhi ethnicity and side effects of modern methods of contraception were identified as major factors for discontinuation in low-income populations. Similarly, women who had difficulty in travelling to reach clinics for treatment also contributed to discontinuation. Furthermore, women using long acting methods and those supported by their husbands were less likely to discontinue the contraceptive methods. Findings emphasize a need to focus on Sindhi ethnicity and trainings of service providers on management of side effects and provision of high quality of services.	[Thobani, Rozina; Jessani, Saleem; Azam, Iqbal; Reza, Sayyeda; Sami, Neelofar; Rozi, Shafquat; Abrejo, Farina; Saleem, Sarah] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	Aga Khan University	Saleem, S (corresponding author), Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan.	sarah.saleem@aku.edu	; , Rozi/AAB-6281-2021	Saleem, Sarah/0000-0002-6797-8631; , Rozi/0000-0003-4117-1335	Aman Foundation	Aman Foundation	Funding for this research was recieved from Aman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aga Khan University, 2013, INT ADV SEM FAM PLAN; Aga Khan University, 2015, SUKH IN BAS ASS; Ali M, 1999, J BIOSOC SCI, V31, P343, DOI 10.1017/S0021932099003430; Ali M., 2012, CAUSES CONSEQUENCES; Ali MM, 2011, LONG TERM CONTRACEPT; Ali MM, 2010, CONTRACEPTION, V81, P22, DOI 10.1016/j.contraception.2009.06.009; [Anonymous], 2013, POSTABORTION CARE PA; [Anonymous], 2016, WHY DO WOMEN GIRLS S; Barden-O'Fallon J, 2011, INT PERSPECT SEX R H, V37, P16, DOI 10.1363/3701611; Blanc, 1997, DHS ANAL REPORTS, V6; Blanc AK, 2002, STUD FAMILY PLANN, V33, P127, DOI 10.1111/j.1728-4465.2002.00127.x; Bracher M, 1992, FAMILY PLANNING PERS, P58; Bradley S.E.K., 2009, DHS ANAL STUDIES; Choe MK, 1991, CONTRACEPTIVE USE DI; Khan MA, 2001, CONTRACEPTION, V64, P161, DOI 10.1016/S0010-7824(01)00238-4; Laguna EP, 2000, CONTRACEPTIVE USE DY; Littlejohn KE, 2012, DEMOGRAPHY, V49, P1433, DOI 10.1007/s13524-012-0127-7; Mumah JN, 2015, STUD FAMILY PLANN, V46, P369, DOI 10.1111/j.1728-4465.2015.00038.x; National Institute of Population Studies, 2012, PAK DEM HLTH SURV 20; Parveen T, 2015, INVESTIGATING LOW MO; Rizvi Farwa, 2012, J Ayub Med Coll Abbottabad, V24, P101; Sathar Z, 2014, STUD FAMILY PLANN, V45, P471, DOI 10.1111/j.1728-4465.2014.00004.x; Tolesa Bekele, 2015, Epidemiology: Open Access, V5, P179; UNDESA, 2015, TRENDS CONTR US WORL; Vadnais D, 2006, RES FINDINGS DEMOGRA; World Health Organization, 2013, SEX REPR HLTH CONTR	26	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0218952	10.1371/journal.pone.0218952	http://dx.doi.org/10.1371/journal.pone.0218952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4CE	31269086	Green Published, gold, Green Submitted			2022-12-26	WOS:000484927300031
J	Tian, XR; Li, SD; Zeng, Q; Huang, W; Liu, XM; Song, SQ				Tian, Xiangrong; Li, Sidi; Zeng, Qing; Huang, Wei; Liu, Xuanming; Song, Songquan			Relationship between loss of desiccation tolerance and programmed cell death (PCD) in mung bean (Vigna radiata) seeds	PLOS ONE			English	Article							MAIZE ENDOSPERM; FRAGMENTATION	Mung bean (Vigna radiata), an important legume crop, has the property of desiccation tolerance (DT), which is lost in the final stage of germination (preimbibition, 18 h-24 h). We compared parameters related to the programmed cell death (PCD) of mung bean seeds before and after dehydration at different imbibition stages through various detection methods. The results of Evans blue and TTC staining methods showed that the dehydration process could lead to cell death. The results of optical and subcellular morphology showed that PCD occurred after dehydration. The destruction of DNA integrity and the activity changes in caspase and total nuclease in mung bean seeds after dehydration treatment indicated that the loss of desiccation tolerance was related to PCD. Dehydration resulted in the destruction of the mitochondrial structure, reversal of the membrane potential, and the entrance of cytochrome C into the cytoplasm. These processes all indicate that the mitochondrial apoptosis pathway was the main form of dehydration-induced PCD. The results of cytoplasmic Ca2+ concentration showed that Ca2+ signaling also played a role in inducing PCD, with the upstream signal being dehydration-induced changes in water potential and the downstream signal being the ROS and mitochondrial PT channel, according to the order in which these signals happened. The mitochondrial apoptosis pathway can be considered the main mechanism of dehydration-induced PCD based on our analysis of the sequence of major events in PCD. The main processes include dehydration induction, changes in Ca2+ and mitochondrial respiratory electron transport, the reversal of mitochondrial membrane potential induced by ROS and Ca2+, and the transmission and execution of PCD downstream signals induced by cytochrome C release.	[Tian, Xiangrong; Li, Sidi; Huang, Wei] Jishou Univ, Hunan Prov Univ Key Lab Plant Resources Protect &, Jishou, Hunan, Peoples R China; [Tian, Xiangrong; Song, Songquan] Huaihua Univ, Hunan Prov Key Lab Med Plants & Plant Med, Huaihua, Hunan, Peoples R China; [Tian, Xiangrong; Liu, Xuanming] Hunan Univ, Coll Biol, Changsha, Hunan, Peoples R China; [Zeng, Qing] Chinese Acad Sci, Southern China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Song, Songquan] Chinese Acad Sci, Inst Plant Res, Beijing, Peoples R China	Jishou University; Huaihua University; Hunan University; Chinese Academy of Sciences; Chinese Academy of Sciences	Tian, XR (corresponding author), Jishou Univ, Hunan Prov Univ Key Lab Plant Resources Protect &, Jishou, Hunan, Peoples R China.; Tian, XR; Song, SQ (corresponding author), Huaihua Univ, Hunan Prov Key Lab Med Plants & Plant Med, Huaihua, Hunan, Peoples R China.; Tian, XR; Liu, XM (corresponding author), Hunan Univ, Coll Biol, Changsha, Hunan, Peoples R China.; Song, SQ (corresponding author), Chinese Acad Sci, Inst Plant Res, Beijing, Peoples R China.	dan_ran_pro@126.com; xmliu105@sina.com; sqsong105@sina.com	Tian, Xiangrong/HGE-2877-2022		Natural Science Foundation of China [31360062, 31660119]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Grant No. 31360062, 31660119).	Balk J, 2001, PLANT CELL, V13, P1803, DOI 10.1105/tpc.13.8.1803; Feng HT, 2012, AFR J MICROBIOL RES, V6, P3222, DOI 10.5897/AJMR11.1592; Golovina EA, 2000, SEED SCI RES, V10, P365, DOI 10.1017/S0960258500000404; He X, 2003, PLANT MOL BIOL, V51, P509, DOI 10.1023/A:1022319821591; Jones A, 2000, TRENDS PLANT SCI, V5, P225, DOI 10.1016/S1360-1385(00)01605-8; Leprince O, 2015, PLANTA, V242, P369, DOI 10.1007/s00425-015-2357-6; Li X, 2011, J PLANT PHYSIOL, V168, P1761, DOI 10.1016/j.jplph.2011.04.006; Merk Co, 2002, PROT TDT FRAGEL DNA; Merk Co, 2002, PROTOCOL NUCLEOSOME; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Pennell RI, 1997, PLANT CELL, V9, P1157, DOI 10.1105/tpc.9.7.1157; Perveen S, 2014, KOREAN J PHYSIOL PHA, V18, P297, DOI 10.4196/kjpp.2014.18.4.297; Qiao A, 1999, CHIN B BOT, V16, P701; van Doorn WG, 2011, J EXP BOT, V62, P4749, DOI 10.1093/jxb/err196; Wacker R., 2006, MIKROKOSMOS, V4, P210; Wang Z, 1999, SHENGWU WULI XUEBAO, V15, P655; Yamada T, 2006, PLANTA, V224, P1279, DOI 10.1007/s00425-006-0307-z; Young TE, 1997, PLANT PHYSIOL, V115, P737, DOI 10.1104/pp.115.2.737; Young TE, 2000, PLANT MOL BIOL, V42, P397, DOI 10.1023/A:1006333103342; Zhang JT, 1991, CHI PHARM J, V26, P655	20	4	5	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2019	14	7							e0218513	10.1371/journal.pone.0218513	http://dx.doi.org/10.1371/journal.pone.0218513			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3ZV	31265452	Green Submitted, gold, Green Published			2022-12-26	WOS:000484921200012
J	Davey, DLJ; Nyemba, DC; Gomba, Y; Bekker, LG; Taleghani, S; DiTullio, DJ; Shabsovich, D; Gorbach, PM; Coates, TJ; Klausner, JD; Myer, L				Davey, Dvora L. Joseph; Nyemba, Dorothy C.; Gomba, Yolanda; Bekker, Linda-Gail; Taleghani, Sophia; DiTullio, David J.; Shabsovich, David; Gorbach, Pamina M.; Coates, Thomas J.; Klausner, Jeffrey D.; Myer, Landon			Prevalence and correlates of sexually transmitted infections in pregnancy in HIV-infected and- uninfected women in Cape Town, South Africa	PLOS ONE			English	Article							NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS; CHILD TRANSMISSION; RISK-FACTORS; DISEASES; ACQUISITION; THERAPY; RAKAI; CARE	Objectives Sexually transmitted infections (STIs) are associated with adverse outcomes in pregnancy, including mother-to-child HIV transmission. Yet there are limited data on the prevalence and correlates of STI in pregnant women by HIV status in low- and middle-income countries, where syndromic STI management is routine. Methods Between November 2017 and July 2018, we conducted a cross-sectional study of consecutive pregnant women making their first visit to a public sector antenatal clinic (ANC) in Cape Town. We interviewed women >= 18 years and tested them for Chlamydia trachomatis (CT), Neisseria gonorrhoea (NG) and Trichomonas vaginalis (TV) using Xpert assays (Cepheid, USA); results of syphilis serology came from routine testing records. We used multivariable logistic regression to identify correlates of STI in pregnancy. Results In 242 women (median age 29 years [IQR = 24-34], median gestation 19 weeks [IQR = 14-24]) 44% were HIV-infected. Almost all reported vaginal sex during pregnancy (93%). Prevalence of any STI was 32%: 39% in HIV-infected women vs. 28% in HIV-uninfected women (p = 0.036). The most common infection was CT (20%) followed by TV (15%), then NG (5.8%). Of the 78 women diagnosed with a STI, 7 (9%) were identified and treated syndromically in ANC. Adjusting for age and gestational age, HIV-infection (aOR = 1.89; 95% CI = 1.02-3.67), being unmarried or not cohabiting with the fetus' father (aOR = 2.19; 95% CI = 1.16-4.12), and having STI symptoms in the past three days (aOR = 6.60; 95% CI = 2.08-20.95) were associated with STI diagnosis. Conclusion We found a high prevalence of treatable STIs in pregnancy among pregnant women, especially in HIV-infected women. Few women were identified and treated in pregnancy.	[Davey, Dvora L. Joseph; Gorbach, Pamina M.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90032 USA; [Davey, Dvora L. Joseph; Nyemba, Dorothy C.; Gomba, Yolanda; Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa; [Bekker, Linda-Gail] Desmond Tutu HIV Fdn, Cape Town, South Africa; [Taleghani, Sophia; DiTullio, David J.; Shabsovich, David; Gorbach, Pamina M.; Coates, Thomas J.; Klausner, Jeffrey D.] UCLA, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of Cape Town; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Davey, DLJ (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90032 USA.; Davey, DLJ (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa.	dvoradavey@ucla.edu	Bekker, Linda-Gail/AAZ-8929-2020	Joseph-Davey, Dvora/0000-0001-6290-9293; BEKKER, LINDA-GAIL/0000-0002-0755-4386	NIH; Fogarty International Center [K01TW011187]; NIMH [R01MH116771]; FOGARTY INTERNATIONAL CENTER [K01TW011187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH116771, P30MH058107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors received funding from the following NIH grants: Fogarty International Center K01TW011187 (DJD), NIMH R01MH116771 (TC and LM). Authors received STI test kits and related supplies from Cepheid (Sunnyvale, CA). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ADACHI K, 2016, BIOMED RES INT, V2016, DOI DOI 10.1155/2016/9315757; Adachi K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189851; Adachi K, 2016, PEDIATR INFECT DIS J, V35, P894, DOI 10.1097/INF.0000000000001199; Adachi K, 2015, SEX TRANSM DIS, V42, P554, DOI 10.1097/OLQ.0000000000000340; Allan-Blitz LT, 2018, SEX TRANSM DIS, V45, P87, DOI 10.1097/OLQ.0000000000000698; Badman SG, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1573-4; Brittain K, 2017, AIDS BEHAV, V21, P274, DOI 10.1007/s10461-016-1389-7; Cepheid, 2018, XPERT CT NG TV BROCH; Davey DLJ, 2016, SEX TRANSM DIS, V43, P450, DOI 10.1097/OLQ.0000000000000460; Davey DJ, 2018, SEX TRANSM DIS, V45, P754, DOI 10.1097/OLQ.0000000000000847; Davey DJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192982; Davey DLJ, 2017, JAIDS-J ACQ IMM DEF, V76, P123, DOI 10.1097/QAI.0000000000001494; Fawzi W, 2001, AIDS, V15, P1157, DOI 10.1097/00002030-200106150-00011; Ghys PD, 1997, AIDS, V11, pF85, DOI 10.1097/00002030-199712000-00001; Gray RH, 1999, AIDS, V13, P2113, DOI 10.1097/00002030-199910220-00015; Gray RH, 2001, AM J OBSTET GYNECOL, V185, P1209, DOI 10.1067/mob.2001.118158; Health SANDo, 2015, SEX TRANSM INF MAN G; Johnson LF, 2012, JAIDS-J ACQ IMM DEF, V59, P417, DOI 10.1097/QAI.0b013e3182432f27; Johnson RV, 1994, MAYO CLIN COMPLETE B; Joseph Davey Dvora L, 2017, AIDS, V31, P2193, DOI 10.1097/QAD.0000000000001604; King CC, 2013, CURR HIV RES, V11, P10; Kinuthia J, 2015, AIDS, V29, P2025, DOI 10.1097/QAD.0000000000000793; Liebenberg LJP, 2017, JAIDS-J ACQ IMM DEF, V74, P318, DOI 10.1097/QAI.0000000000001218; Lunny C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132776; Maina Anne Njeri, 2016, BMC Res Notes, V9, P193, DOI 10.1186/s13104-016-1990-x; Marx G, 2010, INT J STD AIDS, V21, P549, DOI 10.1258/ijsa.2010.010005; McClelland RS, 2001, AIDS, V15, P105, DOI 10.1097/00002030-200101050-00015; Mofenson LM, 2018, J INFECT DIS, V218, P1, DOI 10.1093/infdis/jiy118; Moodley D, 2015, SEX TRANSM DIS, V42, P43, DOI 10.1097/OLQ.0000000000000219; Moodley P, 2000, Semin Neonatol, V5, P255, DOI 10.1053/siny.2000.0026; Mudau M, 2018, INT J STD AIDS, V29, P324, DOI 10.1177/0956462417724908; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Sonkar SC, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0133-x; Vallely LM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018630; Wangnapi RA, 2015, SEX TRANSM INFECT, V91, P194, DOI 10.1136/sextrans-2014-051670; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; World Health Organization, 2015, GUID START ANT THER; World Health Organization, GLOB STRAT WOM CHILD; World Health Organization (WHO), GLOB HLTH SECT STRAT; Wynn A, 2018, SEX TRANSM INFECT, V94, P230, DOI 10.1136/sextrans-2017-053134	40	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0218349	10.1371/journal.pone.0218349	http://dx.doi.org/10.1371/journal.pone.0218349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260486	Green Published, Green Submitted, gold			2022-12-26	WOS:000484918700014
J	Marini, E; Di Giulio, M; Ginestra, G; Magi, G; Di Lodovico, S; Marino, A; Facinellil, B; Cellini, L; Nostro, A				Marini, Emanuela; Di Giulio, Mara; Ginestra, Giovanna; Magi, Gloria; Di Lodovico, Silvia; Marino, Andreana; Facinellil, Bruna; Cellini, Luigina; Nostro, Antonia			Efficacy of carvacrol against resistant rapidly growing mycobacteria in the planktonic and biofilm growth mode	PLOS ONE			English	Article							ESSENTIAL OILS; BROTH MICRODILUTION; OTITIS-MEDIA; SUSCEPTIBILITY; ABSCESSUS; STAPHYLOCOCCI; CONSTITUENTS; ANTIBIOTICS; INFECTIONS; OREGANO	Rapidly growing mycobacteria (RGM) are environmental bacteria found worldwide with a propensity to produce skin and soft-tissue infections. Among them, the most clinically relevant species is Mycobacterium abscessus. Multiple resistance to antibiotics and the ability to form biofilm contributes considerably to the treatment failure. The search of novel anti-mycobacterial agents for the control of biofilm growth mode is crucial. The aim of the present study was to evaluate the activity of carvacrol (CAR) against planktonic and biofilm cells of resistant RGM strains. The susceptibility of RGM strains (n = 11) to antibiotics and CAR was assessed by MIC/MBC evaluation. The CAR activity was estimated by also vapour contact assay. The effect on biofilm formation and preformed biofilm was measured by evaluation of bacterial growth, biofilm biomass and biofilm metabolic activity. MIC values were equal to 64 mu g/mL for most of RGM isolates (32-512 mu g/mL), MBCs were 2-4 times higher than MICs, and MICs of vapours were lower (16 mu g/mL for most RGM isolates) than MICs in liquid phase. Regarding the biofilm, CAR at concentrations of 1/2 x MIC and 1/4 x MIC showed a strong inhibition of biofilm formation (61-77%) and at concentration above the MIC (2-8 x MIC) produced significant inhibition of 4- and 8-day preformed biofilms. In conclusion, CAR could have a potential use, also in vapour phase, for the control of RGM.	[Marini, Emanuela; Magi, Gloria; Facinellil, Bruna] Polytech Univ Marche, Dept Biomed Sci & Publ Hlth, Unit Microbiol, Ancona, Italy; [Di Giulio, Mara; Di Lodovico, Silvia; Cellini, Luigina] Univ G dAnnunzio, Dept Pharm, Chieti, Italy; [Ginestra, Giovanna; Marino, Andreana; Nostro, Antonia] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy	Marche Polytechnic University; G d'Annunzio University of Chieti-Pescara; University of Messina	Nostro, A (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy.	anostro@unime.it	Nostro, Antonia/AAE-6161-2020; Di Lodovico, Silvia/ABI-5050-2020	Di Lodovico, Silvia/0000-0001-9281-5028; Marino, Andreana/0000-0001-8751-8811				Akram SM, 2018, MYCOBACTERIUM CHELON; Al-Ani I, 2015, PHYTOMEDICINE, V22, P245, DOI 10.1016/j.phymed.2014.11.019; Alokam R, 2014, J ENZYM INHIB MED CH, V29, P547, DOI 10.3109/14756366.2013.823958; Ananta P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208053; Brown-Elliott BA, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TNMI7-0027-2016; Burgess W, 2017, INFECT CONT HOSP EP, V38, P784, DOI 10.1017/ice.2017.75; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Cacciatore I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120937; Chihara S, 2010, J CLIN MICROBIOL, V48, P579, DOI 10.1128/JCM.01930-09; Ciandrini E, 2014, CLIN ORAL INVEST, V18, P2001, DOI 10.1007/s00784-013-1179-9; Clinical and Laboratory Standards Institute, 2007, LAB DET ID MYC PROP; Clinical and Laboratory Standards Institute, 2011, M24 A2; De Groote MA, 2006, CLIN INFECT DIS, V42, P1756, DOI 10.1086/504381; Doke SK, 2014, J GEN APPL MICROBIOL, V60, P163, DOI 10.2323/jgam.60.163; Espina L, 2015, MOLECULES, V20, P11357, DOI 10.3390/molecules200611357; Esteban J, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02651; Esteban J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-184; Gaio V, 2017, FUTURE MICROBIOL, V12, P1487, DOI 10.2217/fmb-2017-0122; Houdkova M, 2017, FITOTERAPIA, V118, P56, DOI 10.1016/j.fitote.2017.02.008; Hyldgaard M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00012; Inouye S, 2000, MYCOSES, V43, P17, DOI 10.1046/j.1439-0507.2000.00538.x; Inouye Shigeharu, 2001, Journal of Antimicrobial Chemotherapy, V47, P565, DOI 10.1093/jac/47.5.565; Kristinsson KG, 2005, J INFECT DIS, V191, P1876, DOI 10.1086/430003; Langeveld WT, 2014, CRIT REV MICROBIOL, V40, P76, DOI 10.3109/1040841X.2013.763219; Lee MR, 2015, EMERG INFECT DIS, V21, P1638, DOI [10.3201/eid2109.141634, 10.3201/2109.141634]; Lemos M, 2014, INT BIODETER BIODEGR, V86, P42, DOI 10.1016/j.ibiod.2013.06.011; Magi G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00165; Mandras N., 2016, ALTERNATIVE MED, V16, P330, DOI DOI 10.1186/S12906-016-1316-5; Marchese A, 2018, BIOFOULING, V34, P630, DOI 10.1080/08927014.2018.1480756; Marini E, 2018, PHYTOTHER RES, V32, P488, DOI 10.1002/ptr.5994; de Vasconcelos SSN, 2018, FUTURE MICROBIOL, V13, P877, DOI 10.2217/fmb-2017-0232; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Nostro A, 2013, APPL MICROBIOL BIOT, V97, P9515, DOI 10.1007/s00253-013-5196-z; Nostro A, 2004, FEMS MICROBIOL LETT, V230, P191, DOI 10.1016/S0378-1097(03)00890-5; Nostro A., 2012, DRUG DISCOVERY, V7, P28, DOI DOI 10.2174/157489112799829684; Nostro A, 2007, J MED MICROBIOL, V56, P519, DOI 10.1099/jmm.0.46804-0; Nostro A, 2009, J MED MICROBIOL, V58, P791, DOI 10.1099/jmm.0.009274-0; Scaffaro R, 2018, APPL MICROBIOL BIOT, V102, P4171, DOI 10.1007/s00253-018-8879-7; Soni KA, 2013, J FOOD PROTECT, V76, P205, DOI 10.4315/0362-028X.JFP-12-196; Sugimoto H, 2010, AURIS NASUS LARYNX, V37, P636, DOI 10.1016/j.anl.2010.01.010; Tang IP, 2014, ENT-EAR NOSE THROAT, V93, P390; Tullio V, 2007, J APPL MICROBIOL, V102, P1544, DOI 10.1111/j.1365-2672.2006.03191.x; Upadhyay A, 2013, FOOD MICROBIOL, V36, P79, DOI 10.1016/j.fm.2013.04.010; van Ingen J, 2012, DRUG RESIST UPDATE, V15, P149, DOI 10.1016/j.drup.2012.04.001; Williams MM, 2009, APPL ENVIRON MICROB, V75, P2091, DOI 10.1128/AEM.00166-09; Wong SYY, 2008, APPL ENVIRON MICROB, V74, P5986, DOI 10.1128/AEM.00981-08	46	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219038	10.1371/journal.pone.0219038	http://dx.doi.org/10.1371/journal.pone.0219038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260476	Green Published, Green Submitted, gold			2022-12-26	WOS:000484918700026
J	Wu, HH; Chang, YY; Kuo, SC; Chen, YT				Wu, Hao-Hsin; Chang, Yea-Yuan; Kuo, Shu-Chen; Chen, Yung-Tai			Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders-A propensity score-matched follow-up study	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; INSURANCE RESEARCH DATABASE; ACUTE CORONARY SYNDROMES; ARTERY-DISEASE; RISK; EVENTS; STROKE; DEATH; ASSOCIATION; VALIDATION	The present study aimed to evaluate the association between influenza vaccination and the secondary prevention of cardiovascular disease (CVD) among elderly persons. This retrospective cohort study used the Geriatric Dataset of Taiwan's National Health Insurance Research Database (2000-2013). Patients aged >= 65 years who had been hospitalized for the first episodes of myocardial infarction were eligible. The vaccinated cohort comprised patients who received one dose of influenza vaccine within 180 days after discharge. The unvaccinated cohort included those who did not receive influenza vaccination and was propensity score matched (1:1) for known CVD risk factors. All-cause death, acute myocardial infarction or cardiovascular death, and hospitalization for heart failure were assessed 1 year after the 181St day after hospital discharge. Compared with the matched cohort (n = 4,350), the vaccinated cohort (n = 4,350) had significantly lower incidences of all-cause death (hazard ratios [HR] 0.82, 95% CI [confidence interval] 0.73-0.92), myocardial infarction or cardiovascular death (HR 0.84, 95% CI 0.74-0.96), and hospitalization for heart failure (HR 0.83, 95% CI 0.74-0.92). The association between influenza vaccination and reduction of CVDs was similar across different subgroups. Cumulative incidence curves of the CVDs of interest for the two cohorts separated within the initial 3 months of follow-up (P < 0.05). Influenza vaccination was associated with a reduced risk of CVD in the elderly population with previous myocardial infarction.	[Wu, Hao-Hsin] Ctr Dis Control, Div Infect Control & Biosafety, Taipei, Taiwan; [Chang, Yea-Yuan] Natl Yang Ming Univ Hosp, Dept Internal Med, Div Infect Dis, Taipei, Yilan County, Taiwan; [Kuo, Shu-Chen] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan Township, Miaoli County, Taiwan; [Chen, Yung-Tai] Taipei Vet Gen Hosp, Div Nephrol, Taipei, Taiwan; [Chen, Yung-Tai] Taipei City Hosp, Heping Fuyou Branch, Dept Med, Taipei, Taiwan	Centers For Disease Control - Taiwan; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; Taipei City Hospital	Kuo, SC (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan Township, Miaoli County, Taiwan.; Chen, YT (corresponding author), Taipei Vet Gen Hosp, Div Nephrol, Taipei, Taiwan.; Chen, YT (corresponding author), Taipei City Hosp, Heping Fuyou Branch, Dept Med, Taipei, Taiwan.	sckuo@nhri.edu.tw; ytchen0117@gmail.com	Kuo, Shu-Chen/U-6115-2019	Kuo, Shu-Chen/0000-0002-6940-6450	National Health Research Institutes [IV-106-PP-09]; National Science Council [105-2628-B-400 -002 -MY2]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan)	Funder: National Health Research Institutes. Website: http://english.nhriorg.tw/NHRI_WEB/nhriw001Action.do. Grant Number: IV-106-PP-09. Recipient: SCK. Funder: National Science Council. Website: https.//www.preventionweb net/organizations/6407. Grant number: 105-2628-B-400 -002 -MY2. Recipient: SCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agac MT, 2013, ANGIOLOGY, V64, P604, DOI 10.1177/0003319713479155; Burden A, 2017, PRAGMAT OBS RES, V8, P15, DOI 10.2147/POR.S122563; Chang YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158075; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Ciszewski A, 2008, EUR HEART J, V29, P1350, DOI 10.1093/eurheartj/ehm581; Clar C, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005050.pub3; Dai XM, 2016, J GERIATR CARDIOL, V13, P101, DOI 10.11909/j.issn.1671-5411.2016.02.012; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Frobert O, 2017, AM HEART J, V189, P94, DOI 10.1016/j.ahj.2017.04.003; Gurfinkel EP, 2004, EUR HEART J, V25, P25, DOI 10.1016/j.ehj.2003.10.018; Hasdai D, 2003, EUR HEART J, V24, P623, DOI 10.1016/S0195-668X(02)00742-X; Hsiao AJ, 2015, J FORMOS MED ASSOC, V114, P679, DOI 10.1016/j.jfma.2013.12.003; Jackson LA, 2002, AM J EPIDEMIOL, V156, P634, DOI 10.1093/aje/kwf073; Law MR, 2002, ARCH INTERN MED, V162, P2405, DOI 10.1001/archinte.162.21.2405; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Madjid M, 2005, EXPERT OPIN BIOL TH, V5, P91, DOI 10.1517/14712598.5.1.91; Naghavi M, 2003, CIRCULATION, V107, P762, DOI 10.1161/01.CIR.0000048190.68071.2B; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; O'Connor AD, 2005, MED CLIN N AM, V89, P1343, DOI 10.1016/j.mcna.2005.06.010; Phrommintikul A, 2011, EUR HEART J, V32, P1730, DOI 10.1093/eurheartj/ehr004; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Sachdev M, 2004, J AM COLL CARDIOL, V43, P576, DOI 10.1016/j.jacc.2003.10.031; Sato APS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123840; Shih CJ, 2014, CIRCULATION, V130, P1684, DOI 10.1161/CIRCULATIONAHA.114.012717; Siriwardena AN, 2010, CAN MED ASSOC J, V182, P1617, DOI 10.1503/cmaj.091891; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Udell JA, 2013, JAMA-J AM MED ASSOC, V310, P1711, DOI 10.1001/jama.2013.279206; Vardeny O, 2018, AM HEART J, V202, P97, DOI 10.1016/j.ahj.2018.05.007; Veljkovic V, 2014, VACCINE, V32, P6569, DOI 10.1016/j.vaccine.2014.07.007; Wang YP, 2014, AM J PSYCHIAT, V171, P54, DOI 10.1176/appi.ajp.2013.12111467; Warren-Gash C, 2011, J INFECT DIS, V203, P1710, DOI 10.1093/infdis/jir171; Warren-Gash C, 2009, LANCET INFECT DIS, V9, P601, DOI 10.1016/S1473-3099(09)70233-6; Woodward M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006408	36	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219172	10.1371/journal.pone.0219172	http://dx.doi.org/10.1371/journal.pone.0219172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260487	gold, Green Published, Green Submitted			2022-12-26	WOS:000484918700038
J	Bruen, R; Curley, S; Kajani, S; Lynch, G; O'Reilly, ME; Dillon, ET; Fitzsimons, S; Mthunzi, L; McGillicuddy, FC; Belton, O				Bruen, Robyn; Curley, Sean; Kajani, Sarina; Lynch, Gina; O'Reilly, Marcella E.; Dillon, Eugene T.; Fitzsimons, Stephen; Mthunzi, Liberty; McGillicuddy, Fiona C.; Belton, Orina			Different monocyte phenotypes result in proresolving macrophages in conjugated linoleic acid-induced attenuated progression and regression of atherosclerosis	FASEB JOURNAL			English	Article						inflammation; ApoE-; -mouse model; plaque microenvironment	CHOLESTEROL; CELLS; OMEGA-3-FATTY-ACIDS; PATHOGENESIS; INFLAMMATION; LIPOPROTEIN; ACTIVATION; EXPRESSION; RESOLUTION; DIVERGENT	Monocytes/macrophages drive progression and regression of atherosclerosis. Conjugated linoleic acid (CLA), an anti-inflammatory lipid, mediates atheroprotective effects. We investigated how CLA alters monocyte/macrophage phenotype during attenuated progression and regression of atherosclerosis. Apolipoprotein E knockout (ApoE(-/-)) mice were fed a high-fat (60%) high-cholesterol (1%) diet (HFHCD) for 2 wk, followed by 6-wk 1% CLA 80:20 supplementation to investigate disease progression. Simultaneously, ApoE(-/-) mice were fed a 12-wk HFHCD with/without CLA for the final 4 wk to investigate regression. Aortic lesions were quantified by en face staining. Proteomic analysis, real-time quantitative PCR and flow cytometry were used to interrogate monocyte/macrophage phenotypes. CLA supplementation inhibited atherosclerosis progression coincident with decreased proinflammatory and increased anti-inflammatory macrophages. However, CLA-induced regression was associated with increased proinflammatory monocytes resulting in increased proresolving M2 bone marrow-derived macrophages, splenic macrophages, and dendritic cells in lesion-draining lymph nodes. Proteomic analysis confirmed regulation of a proinflammatory bone marrow response, which was abolished upon macrophage differentiation. Thus, in attenuation and regression of atherosclerosis, regardless of the monocyte signature, during monocyte to macrophage differentiation, proresolving macrophages prevail, mediating vascular repair. This study provides novel mechanistic insight into the monocyte/macrophage phenotypes in halted atherosclerosis progression and regression of atherosclerosis.-Bruen, R., Curley, S., Kajani, S., Lynch, G., O'Reilly, M. E., Dillon, E. T., Fitzsimons, S., Mthunzi, L., McGillicuddy, F. C., Belton, O. Different monocyte phenotypes result in proresolving macrophages in conjugated linoleic acid-induced attenuated progression and regression of atherosclerosis.	[Bruen, Robyn; Fitzsimons, Stephen; Belton, Orina] Univ Coll Dublin, UCD Conway Inst, Sch Biomol & Biomed Sci, Diabet Complicat Res Ctr, Dublin 4, Ireland; [Curley, Sean; Kajani, Sarina; Mthunzi, Liberty; McGillicuddy, Fiona C.] Univ Coll Dublin, UCD Conway Inst, Sch Med, Diabet Complicat Res Ctr, Dublin, Ireland; [Lynch, Gina; O'Reilly, Marcella E.] Univ Coll Dublin, UCD Conway Inst, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland; [Dillon, Eugene T.] Univ Coll Dublin, UCD Conway Inst, Mass Spectrometry Resource, Dublin, Ireland	University College Dublin; University College Dublin; University College Dublin; University College Dublin	Belton, O (corresponding author), Univ Coll Dublin, UCD Conway Inst, Sch Biomol & Biomed Sci, Diabet Complicat Res Ctr, Dublin 4, Ireland.	orina.belton@ucd.ie	Kajani, Sarina/GPX-8306-2022	Belton, Orina/0000-0002-7701-6540; Fitzsimons, Stephen/0000-0002-1576-8632; O'Reilly, Marcella/0000-0001-6346-1881; McGillicuddy, Fiona/0000-0003-3623-3503; Mthunzi, Liberty/0000-0002-4636-4884	AstraZeneca	AstraZeneca(AstraZeneca)	The authors thank the University College Dublin (UCD) Biomedical Facility for their assistance with animal husbandry and breeding; without their help and advice this study would not have been possible. The authors also acknowledge the UCD Core Facilities, specifically Dr. Dimitri Scholz (UCD Imaging Core), Catherine Moss (UCD Genomics Core), and Dr. Alfonso Blanco (UCD Flow Cytometry Core). The European Foundation for the Study of Diabetes (EFSD) awarded an "EFSD Clinical Diabetes Research Program in Macrovascular Complications of Diabetes" grant supported by AstraZeneca to O.B. and F.C.M. for all work carried out by all authors. The authors declare no conflicts of interest.	Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Angerer P, 2002, CARDIOVASC RES, V54, P183, DOI 10.1016/S0008-6363(02)00229-8; [Anonymous], 2007, NURSING, V37, P34; Arbones-Mainar JM, 2006, ATHEROSCLEROSIS, V189, P318, DOI 10.1016/j.atherosclerosis.2006.01.015; Boyle JJ, 2012, CIRC RES, V110, P20, DOI 10.1161/CIRCRESAHA.111.247577; Boyle JJ, 2011, ARTERIOSCL THROM VAS, V31, P2685, DOI 10.1161/ATVBAHA.111.225813; Brown AL, 2012, ARTERIOSCL THROM VAS, V32, P2122, DOI 10.1161/ATVBAHA.112.253435; Bruen R, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0626-3; Bruen R, 2017, BRIT J CLIN PHARMACO, V83, P46, DOI 10.1111/bcp.12948; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Cooper MH, 2008, ATHEROSCLEROSIS, V200, P294, DOI 10.1016/j.atherosclerosis.2007.12.040; de Gaetano M, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0060-9; de Gaetano M, 2013, J IMMUNOL, V191, P4326, DOI 10.4049/jimmunol.1300990; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; El Hadri K, 2012, ARTERIOSCL THROM VAS, V32, P1445, DOI 10.1161/ATVBAHA.112.249334; Erbel C, 2015, INNATE IMMUN-LONDON, V21, P255, DOI 10.1177/1753425914526461; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Gleissner CA, 2007, THROMB HAEMOSTASIS, V98, P917, DOI 10.1160/TH07-09-0567; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Holm S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028785; Kadl A, 2011, FREE RADICAL BIO MED, V51, P1903, DOI 10.1016/j.freeradbiomed.2011.08.026; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Kostogrys RB, 2010, J PRECLINICAL CLIN R, V4, P87; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Libby P, 2000, BBA-MOL CELL BIOL L, V1529, P299, DOI 10.1016/S1388-1981(00)00161-X; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; McCarthy C, 2013, EMBO MOL MED, V5, P1443, DOI 10.1002/emmm.201302587; McCarthy C, 2013, FASEB J, V27, P499, DOI 10.1096/fj.12-215442; McCarthy C, 2010, ATHEROSCLEROSIS, V213, P400, DOI 10.1016/j.atherosclerosis.2010.09.025; McClelland S, 2010, ATHEROSCLEROSIS, V211, P96, DOI 10.1016/j.atherosclerosis.2010.02.003; Mitchell PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052634; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nelson JR, 2017, VASC PHARMACOL, V91, P1, DOI 10.1016/j.vph.2017.02.004; Pitsilos S, 2003, THROMB HAEMOSTASIS, V90, P1112, DOI 10.1160/TH03-02-0069; Rahman K, 2017, J CLIN INVEST, V127, P2904, DOI 10.1172/JCI75005; Randolph GJ, 2008, CURR OPIN LIPIDOL, V19, P462, DOI 10.1097/MOL.0b013e32830d5f09; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reynolds CM, 2013, J NUTR BIOCHEM, V24, P401, DOI 10.1016/j.jnutbio.2011.12.006; Scott J, 2002, J NEURAL TRANSM-SUPP, P1; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Toomey S, 2006, ATHEROSCLEROSIS, V187, P40, DOI 10.1016/j.atherosclerosis.2005.08.024; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; Viola JR, 2016, CIRC RES, V119, P1030, DOI 10.1161/CIRCRESAHA.116.309492; Yeganeh A, 2017, J NUTR BIOCHEM, V49, P123, DOI 10.1016/j.jnutbio.2017.08.003; Zaromitidou M, 2016, CARDIOVASCULAR DISEASES: GENETIC SUSCEPTIBILITY, ENVIRONMENTAL FACTORS AND THEIR INTERACTION, P3, DOI 10.1016/B978-0-12-803312-8.00002-1; Zhao JY, 2013, ATHEROSCLEROSIS, V226, P238, DOI 10.1016/j.atherosclerosis.2012.10.048	50	5	5	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11006	11020		10.1096/fj.201900922R	http://dx.doi.org/10.1096/fj.201900922R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284764				2022-12-26	WOS:000489166300036
J	Aguilera, G; Teran, GE; Mirande, JM; Alonso, F; Rometsch, S; Meyer, A; Torres-Dowdall, J				Aguilera, Gaston; Enrique Teran, Guillermo; Marcos Mirande, Juan; Alonso, Felipe; Rometsch, Sina; Meyer, Axel; Torres-Dowdall, Julian			Molecular and morphological convergence to sulfide-tolerant fishes in a new species of Jenynsia (Cyprinodontiformes: Anablepidae), the first extremophile member of the family	PLOS ONE			English	Article							FRESH-WATER FISHES; HYDROGEN-SULFIDE; DIFFERENTIATION; ENVIRONMENTS; ADAPTATIONS; EVOLUTION; GENUS; PHYLOGENY; TELEOSTEI; SELECTION	Freshwater sulfide springs have extreme environmental conditions that only few vertebrate species can tolerate. These species often develop a series of morphological and molecular adaptations to cope with the challenges of life under the toxic and hypoxic conditions of sulfide springs. In this paper, we described a new fish species of the genus Jenynsia, Anablepidae, from a sulfide spring in Northwestern Argentina, the first in the family known from such extreme environment. Jenynsia sulfurica n. sp. is diagnosable by the lack of scales on the pre-pelvic area or the presence of a single row of scales, continuous or not, from the isthmus to the bases of the pelvic fins. Additionally, it presents a series of morphological and molecular characteristics that appear convergent with those seen in other fish species (e.g., Poeciliids) inhabiting sulfide springs. Most notably, J. sulfurica has an enlarged head and postorbital area compared to other fish of the genus and a prognathous lower jaw with a hypertrophied lip, thought to facilitate respiration at the air-water interface. Analyses of cox1 sequence showed that J. sulfurica has two unique mutations resulting in amino acid substitutions convergent to those seen in Poeciliids from sulfide springs and known to provide a physiological mechanism related to living in sulfide environments. A phylogenetic analysis, including molecular and morphological characters, placed J. sulfurica as sister taxa to J. alternimaculata, a species found in nearby, non-sulfide habitats directly connected to the sulfide springs. Thus, it can be inferred that the selection imposed by the presence of H2S has resulted in the divergence between these two species and has potentially served as a barrier to gene flow.	[Aguilera, Gaston; Enrique Teran, Guillermo; Marcos Mirande, Juan] Consejo Nacl Invest Cient & Tecn, Fdn Miguel Lillo, Unidad Ejecutora Lillo, San Miguel De Tucuman, Argentina; [Alonso, Felipe] Consejo Nacl Invest Cient & Tecn, IBIGEO, Inst Bio & Geociencias, Rosario De Lerma, Salta, Argentina; [Rometsch, Sina; Meyer, Axel; Torres-Dowdall, Julian] Univ Konstanz, Dept Biol, Chair Zool & Evolutionary Biol, Constance, Germany; [Rometsch, Sina; Meyer, Axel] Hector Fellow Acad, Karlsruhe, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Miguel Lillo Foundation; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Konstanz	Torres-Dowdall, J (corresponding author), Univ Konstanz, Dept Biol, Chair Zool & Evolutionary Biol, Constance, Germany.	julian.torres-dowdall@uni-konstanz.de	Meyer, Axel/C-9826-2009; Alonso, Felipe/AAA-5717-2020; Rometsch, Sina J./AAT-6686-2020	Meyer, Axel/0000-0002-0888-8193; Alonso, Felipe/0000-0001-7227-2732; Rometsch, Sina J./0000-0001-5029-1748; Teran, Guillermo/0000-0002-3795-3345; Aguilera, Gaston/0000-0002-5486-2787	Deutsche Forschungsgemeinschaft [TO 914/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	JTD, TO 914/2-1, Deutsche Forschungsgemeinschaft, www.dfg.de.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; To Horacio Baltazar Bugeau and Diego Delgado for field trip help; to Wilson Sebastian Serra Alanis for the help on preparing the plates of live specimens, and Jorge Salas from Fundacion Miguel Lillo for the logistical help during trip. To Mayra Varela and Luciana Cristobal for they valuable help in the confection of map. To Ministerio de Ambiente of Jujuy province for collecting permits. To Fundacion Miguel Lillo and CONICET for permanent support. This work was partially supported by a Deutsche Forschungsgemeinschaft Grant (TO 914/2-1 to JTD).	Aguilera G, 2005, ZOOTAXA, P29, DOI 10.11646/zootaxa.1096.1.3; Aguilera G, 2013, NEOTROP ICHTHYOL, V11, P565, DOI 10.1590/S1679-62252013000300009; Amils R., 2007, LIFE EXTREME ENV, DOI [10.1007/978-1-4020-6285-8, DOI 10.1007/978-1-4020-6285-8]; Amorim PF, 2018, J FISH BIOL, V92, P1312, DOI 10.1111/jfb.13587; Amorim PF, 2019, SYST BIODIVERS, P1; Azua-Bustos A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00426; BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; Beitinger TL, 2000, ENVIRON BIOL FISH, V58, P237, DOI 10.1023/A:1007676325825; Betito R., 2006, REV DIDATICA SISTEMI, V3, P71; Bogan S, 2018, J S AM EARTH SCI, V88, P374, DOI 10.1016/j.jsames.2018.09.009; BRAUNER CJ, 1995, CAN J ZOOL, V73, P739, DOI 10.1139/z95-086; Buti Cristina, 1998, Acta Zoologica Lilloana, V44, P309; Calvino P, 2016, J FISH BIOL, V88, P1236, DOI 10.1111/jfb.12895; Chapman LJ., 2015, EXTREMOPHILE FISHES, P9, DOI DOI 10.1007/978-3-319-13362-1_2; Cochrane P.V., 2019, J COMP PHYSIOL B, P1; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; Martinez JD, 2016, NEOTROP ICHTHYOL, V14, DOI 10.1590/1982-0224-20150171; Ghedotti Michael J., 2013, Fieldiana-Life and Earth Sciences, V7, P1; Ghedotti Michael J., 1998, P561; Ghedotti MJ, 1995, COPEIA, P939, DOI 10.2307/1447043; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gosline WA., 1949, OCCASIONAL PAPERS MU, V519, P1; Grieshaber MK, 1998, ANNU REV PHYSIOL, V60, P33, DOI 10.1146/annurev.physiol.60.1.33; Gunther A, 1866, CATALOG FISHES BRIT; Hued AC, 2005, HYDROBIOLOGIA, V543, P279, DOI 10.1007/s10750-004-7893-1; Iglesias C, 2008, FRESHWATER BIOL, V53, P1797, DOI 10.1111/j.1365-2427.2008.02007.x; Karr J. R., 1986, SPECIAL PUBLICATION, V5; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kimura H, 2002, MOL NEUROBIOL, V26, P13, DOI 10.1385/MN:26:1:013; Losos JB., 2017, IMPROBABLE DESTINIES; McMullin ER, 2007, GRAVITATIONAL SPACE, V13; Menni RC, 1996, HYDROBIOLOGIA, V328, P173, DOI 10.1007/BF00017629; Miranda F., 2000, P WORLD GEOTHERMAL C, P1437; Nordlie FG, 2006, REV FISH BIOL FISHER, V16, P51, DOI 10.1007/s11160-006-9003-0; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Oke KB, 2017, AM NAT, V190, P1, DOI 10.1086/691989; Orgogozo V, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2015.0057; Palacios M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071069; Pesce A, 2003, CATALOGO MANIFESTACI, V36, P1666; Pfenninger M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4873; Plath M, 2007, NATURWISSENSCHAFTEN, V94, P991, DOI 10.1007/s00114-007-0279-2; Plath M, 2013, EVOLUTION, V67, P2647, DOI 10.1111/evo.12133; Riesch R., 2015, EXTREMOPHILE FISHES, P137; Riesch R., 2015, EXTREMOPHILE FISHES, DOI [10.1007/978-3-319-13362-1, DOI 10.1007/978-3-319-13362-1]; Riesch R, 2014, ECOL LETT, V17, P65, DOI 10.1111/ele.12209; Sferco E, 2018, PAP PALAEONTOL, V4, P177, DOI 10.1002/spp2.1102; Soares D, 2013, BIOSCIENCE, V63, P274, DOI 10.1525/bio.2013.63.4.7; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; TAYLOR W R, 1985, Cybium, V9, P107; Thomas DN, 2002, SCIENCE, V295, P641, DOI 10.1126/science.1063391; Thormahlen de Gil AL, 1949, REV MUSEO LA PLATA, V5; Tobler M, 2009, J EVOLUTION BIOL, V22, P2298, DOI 10.1111/j.1420-9101.2009.01844.x; Tobler M, 2011, EVOL BIOL, V38, P412, DOI 10.1007/s11692-011-9129-4; Tobler M, 2011, EVOLUTION, V65, P2213, DOI 10.1111/j.1558-5646.2011.01298.x; Torres-Dowdall J, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0197	57	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218810	10.1371/journal.pone.0218810	http://dx.doi.org/10.1371/journal.pone.0218810			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291282	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800037
J	Cammarota, S; Citarella, A; Guida, A; Conti, V; Iannaccone, T; Flacco, ME; Bravi, F; Naccarato, C; Piscitelli, A; Piscitelli, R; Valente, A; Calella, G; Coppola, N; Parruti, G				Cammarota, Simona; Citarella, Anna; Guida, Antonella; Conti, Valeria; Iannaccone, Teresa; Flacco, Maria Elena; Bravi, Francesca; Naccarato, Cristina; Piscitelli, Antonella; Piscitelli, Raffaele; Valente, Alfredo; Calella, Giulio; Coppola, Nicola; Parruti, Giustino			The inpatient hospital burden of comorbidities in HCV-infected patients: A population-based study in two Italian regions with high HCV endemicity (The BaCH study)	PLOS ONE			English	Article							HEPATITIS-C VIRUS; CHRONIC VIRAL-HEPATITIS; ECONOMIC BURDEN; EXTRAHEPATIC MANIFESTATIONS; RESOURCE UTILIZATION; COST-EFFECTIVENESS; MORTALITY; PREVALENCE; CARE; EPIDEMIOLOGY	Background & aims Hepatitis C (HCV) is associated with several extrahepatic manifestations, and estimates of the hospitalization burden related to these comorbidities are still limited. The aim of this study is to quantify the hospitalization risk associated with comorbidities in an Italian cohort of HCV-infected patients and to assess which of these comorbidities are associated with high hospitalization resource utilization. Methods Individuals aged 18 years and older with HCV-infection were identified in the Abruzzo's and Campania's hospital discharge abstracts during 2011-2014 with 1-year follow-up. Cardio- and cerebrovascular disease, diabetes and renal disease were grouped as HCV-related comorbidities. Negative binomial models were used to compare the hospitalization risk in patients with and without each comorbidity. Logistic regression model was used to identify the characteristics of being in the top 20% of patients with the highest hospitalization costs (high-cost patients). Results 15,985 patients were included; 19.9% had a liver complication and 48.6% had one or more HCV-related comorbidities. During follow-up, 36.0% of patients underwent at least one hospitalization. Liver complications and the presence of two or more HCV-related comorbidities were the major predictors of hospitalization and highest inpatient costs. Among those, patients with cardiovascular disease had the highest risk of hospitalization (Incidence Rate Ratios = 1.42; 95% CI: 1.33-1.51) and the highest likelihood of becoming high-cost patients (Odd Ratio = 1.37; 95% CI: 1.20-1.57). Conclusion Beyond advanced liver disease, HCV-related comorbidities (especially cardiovascular disease) are the strongest predictors of high hospitalization rates and costs. Our findings highlight the potential benefit that early identification and treatment of HCV might have on the reduction of hospitalization costs driven by extrahepatic conditions.	[Cammarota, Simona; Citarella, Anna; Valente, Alfredo] LinkHlth Hlth Econ Outcomes & Epidemiol SRL, Naples, Italy; [Guida, Antonella] Directorate Gen Protect Hlth, Naples, Italy; [Conti, Valeria; Iannaccone, Teresa] Univ Salerno, Dept Med Surg & Dent, Scuola Med Salernitana, Baronissi, SA, Italy; [Flacco, Maria Elena] Reg Healthcare Agcy Abruzzo, Pescara, Italy; [Bravi, Francesca] St Anna Univ Hosp Ferrara, Ferrara, Italy; [Naccarato, Cristina] Italian Natl Agcy New Technol Energy & Sustainabl, Bologna, Italy; [Piscitelli, Antonella] Univ Salerno, Specialisat Sch, Dept Pharm, Fisciano, Italy; [Piscitelli, Raffaele] Univ Naples Federico II, Specialisat Sch, Dept Pharm, Naples, Italy; [Calella, Giulio; Parruti, Giustino] Pescara Gen Hosp, Infect Dis Unit, Pescara, Italy; [Coppola, Nicola] Univ Campania Luigi Vanvitelli, AORN Caserta, Infect Dis Unit, Caserta, Italy	University of Salerno; University of Ferrara; Arcispedale Sant'Anna; Italian National Agency New Technical Energy & Sustainable Economics Development; University of Salerno; University of Naples Federico II; Universita della Campania Vanvitelli	Cammarota, S (corresponding author), LinkHlth Hlth Econ Outcomes & Epidemiol SRL, Naples, Italy.	simona.cammarota@linkhealth.it	Conti, Valeria/AAV-8824-2021; Flacco, Maria Elena/E-3306-2017	Conti, Valeria/0000-0001-6964-2739; Flacco, Maria Elena/0000-0003-1404-4314; Piscitelli, Antonella/0000-0002-9552-9665	Gilead Sciences	Gilead Sciences(Gilead Sciences)	The study was supported by research funding from Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi LE, 2014, WORLD J GASTROENTERO, V20, P3410, DOI 10.3748/wjg.v20.i13.3410; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Bucci L, 2017, LIVER INT, V37, P259, DOI 10.1111/liv.13204; Chung RT, 2018, CLIN INFECT DIS, V67, P1477, DOI 10.1093/cid/ciy585; Coward S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011821; El Khoury Antoine C, 2012, J Med Econ, V15, P887, DOI 10.3111/13696998.2012.681332; Essa M, 2018, EUR J GASTROENTEROL; European Assoc Study Liver, 2018, J HEPATOL, V69, P461, DOI 10.1016/j.jhep.2018.03.026; Fattore Giovanni, 2006, Health Care Manag Sci, V9, P251, DOI 10.1007/s10729-006-9092-2; Fusco M, 2008, EUR J CANCER, V44, P847, DOI 10.1016/j.ejca.2008.01.025; Galbraith JW, 2014, CLIN INFECT DIS, V59, P755, DOI 10.1093/cid/ciu427; Goh GBB, 2017, LIVER INT, V37, P251, DOI 10.1111/liv.13241; Grimaldi E, 2017, INTERVIROLOGY, V60, P82, DOI 10.1159/000481821; Hartmann J, 2016, EUR J PUBLIC HEALTH, V26, P549, DOI 10.1093/eurpub/ckv248; Heo YA, 2018, DRUGS, V78, P577, DOI 10.1007/s40265-018-0895-5; Hill Andrew, GCSHCCBCG WHAT COST; Juanbeltz R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205277; Julicher P, 2018, J MED ECON, V21, P1, DOI 10.1080/13696998.2017.1369983; Kieran JA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1208-1; Kondili LA, 2018, LIVER INT; LaMori J, 2016, J MED ECON, V19, P364, DOI 10.3111/13696998.2015.1127252; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lee MH, 2014, WORLD J GASTROENTERO, V20, P9270, DOI 10.3748/wjg.v20.i28.9270; Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385; Leone N, 2005, Minerva Gastroenterol Dietol, V51, P31; Lin YJ, 2017, LIVER INT, V37, P179, DOI 10.1111/liv.13194; Marcellusi A, 2015, EUR REV MED PHARMACO, V19, P1610; Marshall AD, 2018, J HEPATOL; McDonald SA, 2018, LIVER INT, V38, P1402, DOI 10.1111/liv.13681; Moorman AC, 2016, DIGEST DIS SCI, V61, P2087, DOI 10.1007/s10620-016-4199-x; Moorman AC, 2013, CLIN INFECT DIS, V56, P40, DOI 10.1093/cid/cis815; Negro F, 2015, GASTROENTEROLOGY, V149, P1345, DOI 10.1053/j.gastro.2015.08.035; Solinis RN, 2016, INFECT DIS THER, V5, P491, DOI 10.1007/s40121-016-0134-x; Papatheodoridis GV, 2018, J VIRAL HEPATITIS, V25, P6, DOI 10.1111/jvh.12875; Petta S, 2018, J HEPATOL, V69, P18, DOI [10.1016/j.jhep.2018.02.015, 10.1016/j.jhep.2018.05.019]; Polilli E, 2016, AIDS PATIENT CARE ST, V30, P471, DOI 10.1089/apc.2016.0082; Polilli E, 2016, INFECTION, V44, P85, DOI 10.1007/s15010-015-0841-3; Rattay T, 2017, GASTROENTEROLOGY, V153, P1531, DOI 10.1053/j.gastro.2017.10.016; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Reau N, 2017, HEPATOL COMMUN, V1, P439, DOI 10.1002/hep4.1049; Soriano V, 2016, ANTIVIR THER, V21, P1, DOI 10.3851/IMP2975; Stasi C, 2019, CURR MED RES OPIN, V35, P661, DOI 10.1080/03007995.2018.1482264; The Italian Data Protection Authority, GENERAL AUTHORISATIO; Thrift AP, 2017, NAT REV GASTRO HEPAT, V14, P122, DOI 10.1038/nrgastro.2016.176; Udompap P, 2016, J HEPATOL, V64, P1027, DOI 10.1016/j.jhep.2016.01.009; Wong WWL, 2015, CAN MED ASSOC J, V187, pE110, DOI 10.1503/cmaj.140711; Xu FJ, 2014, HEALTH AFFAIR, V33, P1728, DOI 10.1377/hlthaff.2014.0096; Younossi ZM, 2015, J VIRAL HEPATITIS, V22, P137, DOI 10.1111/jvh.12262; Younossi ZM, 2017, LIVER INT, V37, P159, DOI 10.1111/liv.13272; Zignego AL, 2007, DIGEST LIVER DIS, V39, P2, DOI 10.1016/j.dld.2006.06.008	50	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219396	10.1371/journal.pone.0219396	http://dx.doi.org/10.1371/journal.pone.0219396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4JZ	31291351	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800078
J	Cheng, KC; Cheng, XM; Wang, YQ; Bi, HS; Benfield, MC				Cheng, Kaichang; Cheng, Xuemin; Wang, Yuqi; Bi, Hongsheng; Benfield, Mark C.			Enhanced convolutional neural network for plankton identification and enumeration	PLOS ONE			English	Article							IMAGING-SYSTEM; CLASSIFICATION; ZOOPLANKTON; ABUNDANCE	Despite the rapid increase in the number and applications of plankton imaging systems in marine science, processing large numbers of images remains a major challenge due to large variations in image content and quality in different marine environments. We constructed an automatic plankton image recognition and enumeration system using an enhanced Convolutional Neural Network (CNN) and examined the performance of different network structures on automatic plankton image classification. The procedure started with an adaptive thresholding approach to extract Region of Interest (ROIs) from in situ plankton images, followed by a procedure to suppress the background noise and enhance target features for each extracted ROI. The enhanced ROIs were classified into seven categories by a pre-trained classifier which was a combination of a CNN and a Support Vector Machine (SVM). The CNN was selected to improve feature description and the SVM was utilized to improve classification accuracy. A series of comparison experiments were then conducted to test the effectiveness of the pre-trained classifier including the combination of CNN and SVM versus CNN alone, and the performance of different CNN models. Compared to CNN model alone, the combination of CNN and SVM increased classification accuracy and recall rate by 7.13% and 6.41%, respectively. Among the selected CNN models, the ResNet50 performed the best with accuracy and recall at 94.52% and 94.13% respectively. The present study demonstrates that deep learning technique can improve plankton image recognition and that the results can provide useful information on the selection of different CNN models for plankton recognition. The proposed algorithm could be generally applied to images acquired from different imaging systems.	[Cheng, Kaichang; Cheng, Xuemin; Wang, Yuqi] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen, Guangdong, Peoples R China; [Bi, Hongsheng] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [Benfield, Mark C.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; University System of Maryland; University of Maryland Center for Environmental Science; Louisiana State University System; Louisiana State University	Cheng, XM (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Shenzhen, Guangdong, Peoples R China.; Bi, HS (corresponding author), Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA.	chengxm@sz.tsinghua.edu.cn; hbi@umces.edu	Bi, Hongsheng/B-9409-2012	Bi, Hongsheng/0000-0003-2595-6271; Cheng, Xuemin/0000-0003-2150-776X; CHENG, Kaichang/0000-0003-0972-3099	National Key Research and Development Program of China [2017YFC1403602]; Shenzhen Science and Technology Innovation Program [JCYJ20160428182026575, JCYJ20170412171011187]; National Science Foundation (NSF) [1602488]	National Key Research and Development Program of China; Shenzhen Science and Technology Innovation Program; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	This work was supported by The National Key Research and Development Program of China (2017YFC1403602), the Shenzhen Science and Technology Innovation Program (Nos. JCYJ20160428182026575, Nos. JCYJ20170412171011187). Bi was supported by the National Science Foundation (NSF #1602488).; This work was supported by The National Key Research and Development Program of China (2017YFC1403602), the Shenzhen Science and Technology Innovation Program (Nos. JCYJ20160428182026575, Nos. JCYJ20170412171011187). Bi was supported by the National Science Foundation (NSF #1602488).	A Krizhevsky, 2012, 25 INT C NEUR INF PR; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; BANSE K, 1995, ICES J MAR SCI, V52, P265, DOI 10.1016/1054-3139(95)80043-3; Benfield MC, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.63; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Bi HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127121; Bi HS, 2013, J PLANKTON RES, V35, P270, DOI 10.1093/plankt/fbs094; Chen Z, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18010196; Corgnati L, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16122124; Cowen RK, 2008, LIMNOL OCEANOGR-METH, V6, P126, DOI 10.4319/lom.2008.6.126; CRIMMINS TR, 1985, APPL OPTICS, V24, P1438, DOI 10.1364/AO.24.001438; Culverhouse PF, 1996, MAR ECOL PROG SER, V139, P281, DOI 10.3354/meps139281; Davis CS, 1996, DEEP-SEA RES PT II, V43, P1947, DOI 10.1016/S0967-0645(96)00051-3; Galdran A, 2015, J VIS COMMUN IMAGE R, V26, P132, DOI 10.1016/j.jvcir.2014.11.006; Glorot Xavier, 2010, P MACHINE LEARNING R, P249; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; Haury L.R., 1978, SPATIAL PATTERN PLAN, V3, DOI DOI 10.1007/978-1-4899-2195-6_12; HE K, 2015, CVPR, DOI [10.1109/CVPR.2015.7299173, DOI 10.1109/CVPR.2015.7299173]; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hu Q, 2006, MAR ECOL PROG SER, V306, P51, DOI 10.3354/meps306051; Hu Q, 2005, MAR ECOL PROG SER, V295, P21, DOI 10.3354/meps295021; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Li X, 2016, OCEANS-IEEE; Li ZF, 2014, IEEE J OCEANIC ENG, V39, P695, DOI 10.1109/JOE.2013.2280035; Ling HB, 2007, IEEE T PATTERN ANAL, V29, P286, DOI 10.1109/TPAMI.2007.41; Lu HY, 2015, PROC CVPR IEEE, P806, DOI 10.1109/CVPR.2015.7298681; Luo JY, 2018, LIMNOL OCEANOGR-METH, V16, P814, DOI 10.1002/lom3.10285; Luo T, 2004, IEEE T SYST MAN CY B, V34, P1753, DOI 10.1109/TSMCB.2004.830340; MacLeod N, 2010, NATURE, V467, P154, DOI 10.1038/467154a; Matas J, 2004, IMAGE VISION COMPUT, V22, P761, DOI 10.1016/j.imavis.2004.02.006; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ouyang P, 2016, 2016 IEEE INFORMATION TECHNOLOGY, NETWORKING, ELECTRONIC AND AUTOMATION CONTROL CONFERENCE (ITNEC), P132, DOI 10.1109/ITNEC.2016.7560334; Picheral M, 2010, LIMNOL OCEANOGR-METH, V8, P462, DOI 10.4319/lom.2010.8.462; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Sauvola J, 2000, PATTERN RECOGN, V33, P225, DOI 10.1016/S0031-3203(99)00055-2; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Tang XO, 2006, IEEE J OCEANIC ENG, V31, P728, DOI 10.1109/JOE.2004.836995; Trevorrow MV, 2005, J ACOUST SOC AM, V117, P3574, DOI 10.1121/1.1920087; Tsechpenakis G, 2007, OCEANS 2007 - EUROPE, VOLS 1-3, P438; Wiebe PH, 2003, PROG OCEANOGR, V56, P7, DOI 10.1016/S0079-6611(02)00140-4; Xuan L, 2017, OPT ENG, V56, DOI 10.1117/1.OE.56.2.023101; Ye L, 2011, MAR ECOL PROG SER, V441, P185, DOI 10.3354/meps09387; Zhang S, 2017, NEUROCOMPUTING, V245, P1, DOI 10.1016/j.neucom.2017.03.029; Zheng HY, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1954-8	45	23	23	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219570	10.1371/journal.pone.0219570	http://dx.doi.org/10.1371/journal.pone.0219570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291356	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800117
J	Godini, R; Pocock, R; Fallahi, H				Godini, Rasoul; Pocock, Roger; Fallahi, Hossein			Caenorhabditis elegans hub genes that respond to amyloid beta are homologs of genes involved in human Alzheimer's disease	PLOS ONE			English	Article							ENDOCYTIC TRAFFICKING; MOUSE MODELS; RISK-FACTORS; PROTEIN; EXPRESSION; NEURODEGENERATION; PROGRESSION; NETWORKS; ONSET	The prominent characteristic of Alzheimer's disease (AD) is the accumulation of amyloid beta (Abeta) proteins in the form of plaques that cause molecular and cellular alterations in the brain. Due to the paucity of brain samples of early-stage Abeta aggregation, animal models have been developed to study early events in AD. Caenorhabditis elegans is a genetically tractable animal model for AD. Here, we used transcriptomic data, network-based protein-protein interactions and weighted gene co-expression network analysis (WGCNA), to detect modules and their gene ontology in response to Abeta aggregation in C. elegans. Additionally, hub genes and their orthologues in human and mouse were identified to study their relation to AD. We also found several transcription factors (TFs) responding to Abeta accumulation. Our results show that Abeta expression in C. elegans relates to general processes such as molting cycle, locomotion, and larval development plus AD-associated processes, including protein phosphorylation, and G-protein coupled receptor-regulated pathways. We reveal that many hub genes and TFs including ttbk-2, daf-16, and unc-49 have human and mouse orthologues that are directly or potentially associated with AD and neural development. In conclusion, using systems biology we identified important genes and biological processes in C. elegans that respond to Abeta aggregation, which could be used as potential diagnostic or therapeutic targets. In addition, because of evolutionary relationship to AD in human, we suggest that C. elegans is a useful model for studying early molecular events in AD.	[Godini, Rasoul; Fallahi, Hossein] Razi Univ, Sch Sci, Dept Biol, Kermanshah, Iran; [Godini, Rasoul; Pocock, Roger] Monash Univ, Dev & Stem Cells Program, Monash Biomed Discovery Inst, Melbourne, Vic, Australia; [Godini, Rasoul; Pocock, Roger] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic, Australia	Razi University; Monash University; Monash University	Fallahi, H (corresponding author), Razi Univ, Sch Sci, Dept Biol, Kermanshah, Iran.	h.fallahi@razi.ac.ir	Pocock, Roger/AAQ-8526-2020	Pocock, Roger/0000-0002-5515-3608; Fallahi, Hossein/0000-0002-8754-3491	Monash Biomedicine Discovery Fellowship; NHMRC [GNT1105374, GNT1137645]; Victorian Endowment for Science, Knowledge and Innovation Fellowship [VIF23]	Monash Biomedicine Discovery Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Endowment for Science, Knowledge and Innovation Fellowship	R.P. is supported by a grant from a Monash Biomedicine Discovery Fellowship, NHMRC Project Grant (GNT1105374), NHMRC Senior Research Fellowship (GNT1137645), and a Victorian Endowment for Science, Knowledge and Innovation Fellowship (VIF23).	Acquaah-Mensah GK, 2015, J ALZHEIMERS DIS, V44, P827, DOI 10.3233/JAD-141731; Alkallas R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00867-z; Baruch-Suchodolsky R, 2009, BIOCHEMISTRY-US, V48, P4354, DOI 10.1021/bi802361k; Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Blalock EM, 2011, J CHEM NEUROANAT, V42, P118, DOI 10.1016/j.jchemneu.2011.06.007; Boyle AP, 2014, NATURE, V512, P453, DOI 10.1038/nature13668; Cai H, 2012, CURR ALZHEIMER RES, V9, P5, DOI 10.2174/156720512799015064; Cavallini A, 2013, J BIOL CHEM; Chen XF, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-44; Chiocco MJ, 2010, SUBST USE MISUSE, V45, P1809, DOI 10.3109/10826084.2010.482449; Do Carmo S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-37; Donev R, 2007, MOL PSYCHIATR, V12, P681, DOI 10.1038/sj.mp.4001971; Ewald CY, 2012, J NEUROSCI, V32, P10156, DOI 10.1523/JNEUROSCI.0495-12.2012; Ewald CY, 2012, EXP BRAIN RES, V217, P397, DOI 10.1007/s00221-011-2905-7; Ewald CY, 2010, BRAIN STRUCT FUNCT, V214, P263, DOI 10.1007/s00429-009-0235-3; Hall AM, 2012, BRAIN RES BULL, V88, P3, DOI 10.1016/j.brainresbull.2011.11.017; Hassan WM, 2015, NEUROBIOL AGING, V36, P857, DOI 10.1016/j.neurobiolaging.2014.10.016; Hersi M, 2017, NEUROTOXICOLOGY, V61, P143, DOI 10.1016/j.neuro.2017.03.006; Hesp K, 2015, EXP GERONTOL, V72, P1, DOI 10.1016/j.exger.2015.09.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikiz B, 2015, CELL REP, V12, P335, DOI 10.1016/j.celrep.2015.06.019; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kiddle SJ, 2014, J ALZHEIMERS DIS, V38, P515, DOI 10.3233/JAD-130380; Kim JR, 2003, EXP MOL MED, V35, P403, DOI 10.1038/emm.2003.53; Knight AL, 2014, CELL METAB, V20, P145, DOI 10.1016/j.cmet.2014.04.017; Kummer MP, 2014, J NEUROSCI, V34, P8845, DOI 10.1523/JNEUROSCI.4027-13.2014; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lin H, 2014, AM J ALZHEIMERS DIS, V29, P90, DOI 10.1177/1533317513506774; Link CD, 2006, EXP GERONTOL, V41, P1007, DOI 10.1016/j.exger.2006.06.059; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Ni H, 2018, J ALZHEIMERS DIS, V64, P1149, DOI [10.3233/JAD-180276, 10.3233/jad-180276]; Niwa R, 2008, DEV BIOL, V315, P418, DOI 10.1016/j.ydbio.2007.12.044; Oliveira J, 2017, J ALZHEIMERS DIS, V58, P953, DOI 10.3233/JAD-170176; Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934; Pearson HA, 2006, J PHYSL, V575; Potter H, 2005, NEUROSCI INTELL UNIT, P55; Prussing K, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-35; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Sagi D., 2017, BIOL OPEN; Schobel S, 2008, J BIOL CHEM, V283, P14257, DOI 10.1074/jbc.M801531200; Sekar S, 2015, NEUROBIOL AGING, V36, P583, DOI 10.1016/j.neurobiolaging.2014.09.027; Sevimoglu T, 2014, COMPUT STRUCT BIOTEC, V11, P22, DOI 10.1016/j.csbj.2014.08.008; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen PY, 2018, ANNU REV FOOD SCI T, V9, P1, DOI 10.1146/annurev-food-030117-012709; Sun XJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00548; Szklarczyk D., 2016, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKW937; Tabaton M, 2010, EXP NEUROL, V221, P18, DOI 10.1016/j.expneurol.2009.09.002; Thathiah A, 2011, NAT REV NEUROSCI, V12, P73, DOI 10.1038/nrn2977; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Tseveleki V, 2010, GENOMICS, V96, P82, DOI 10.1016/j.ygeno.2010.04.004; van Dam S, 2017, BRIEFINGS BIOINFORMA; Wang XX, 2016, ONCOTARGET, V7, P54183, DOI 10.18632/oncotarget.10857; Williams C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004936; Xu X, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003108; Zhang X, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00427; Zhu L, 2013, J BIOL CHEM, V288, P32050, DOI 10.1074/jbc.M113.504365	58	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219486	10.1371/journal.pone.0219486	http://dx.doi.org/10.1371/journal.pone.0219486			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291334	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800096
J	Liu, A; Kline, DM; Brock, GN; Bonsu, BK				Liu, Anqi; Kline, David M.; Brock, Guy N.; Bonsu, Bema K.			Multistate model of the patient flow process in the pediatric emergency department	PLOS ONE			English	Article							LENGTH-OF-STAY; WAITING-TIMES; PREDICTION; VARIABLES; TRIAGE	Objectives The main purpose of this paper was to model the process by which patients enter the ED, are seen by physicians, and discharged from the Emergency Department at Nationwide Children's Hospital, as well as identify modifiable factors that are associated with ED lengths of stay through use of multistate modeling. Methods In this study, 75,591 patients admitted to the ED from March 1st, 2016 to February 28th, 2017 were analyzed using a multistate model of the ED process. Cox proportional hazards models with transition-specific covariates were used to model each transition in the multistate model and the Aalen-Johansen estimator was used to obtain transition probabilities and state occupation probabilities in the ED process. Results Acuity level, season, time of day and number of ED physicians had significant and varying associations with the six transitions in the multistate model. Race and ethnicity were significantly associated with transition to left without being seen, but not with the other transitions. Conversely, age and gender were significantly associated with registration to room and subsequent transitions in the model, though the magnitude of association was not strong. Conclusions The multistate model presented in this paper decomposes the overall ED length of stay into constituent transitions for modeling covariate-specific effects on each transition. This allows physicians to understand the ED process and identify which potentially modifiable covariates would have the greatest impact on reducing the waiting times in each state in the model.	[Liu, Anqi; Kline, David M.; Brock, Guy N.] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA; [Liu, Anqi; Kline, David M.; Brock, Guy N.] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA; [Liu, Anqi; Kline, David M.; Brock, Guy N.] Ohio State Univ, Wexner Med Ctr, Ctr Biostat, Columbus, OH 43210 USA; [Brock, Guy N.; Bonsu, Bema K.] NCH, Dept Pediat, Columbus, OH 43205 USA; [Brock, Guy N.; Bonsu, Bema K.] Ohio State Univ, Columbus, OH 43210 USA; [Brock, Guy N.] Nationwide Childrens Hosp, Biostat Resource NCH BRANCH, Columbus, OH 43205 USA; [Bonsu, Bema K.] Nationwide Childrens Hosp, Div Emergency Med, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Kline, DM; Brock, GN (corresponding author), Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA.; Kline, DM; Brock, GN (corresponding author), Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA.; Kline, DM; Brock, GN (corresponding author), Ohio State Univ, Wexner Med Ctr, Ctr Biostat, Columbus, OH 43210 USA.; Brock, GN (corresponding author), NCH, Dept Pediat, Columbus, OH 43205 USA.; Brock, GN (corresponding author), Ohio State Univ, Columbus, OH 43210 USA.; Brock, GN (corresponding author), Nationwide Childrens Hosp, Biostat Resource NCH BRANCH, Columbus, OH 43205 USA.	david.kline@osumc.edu; guy.brock@osumc.edu	Kline, David/K-8372-2019	Kline, David/0000-0001-6183-3303	National Institutes of Health/National Center for Advancing Translational Sciences [UL1TR002733]; Nationwide Children's Hospital; National Institutes of Health (NIH)/National Center for Advancing Translational Science (NCATS) [UL1TR002733]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002733] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Advancing Translational Sciences; Nationwide Children's Hospital(Ohio State University); National Institutes of Health (NIH)/National Center for Advancing Translational Science (NCATS); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	GNB was partially supported by National Institutes of Health/National Center for Advancing Translational Sciences grant UL1TR002733. AL was partially supported by funding from Nationwide Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by funding from Nationwide Children's Hospital and by National Institutes of Health (NIH)/National Center for Advancing Translational Science (NCATS) grant UL1TR002733.	AALEN OO, 1978, SCAND J STAT, V5, P141; Alver SK, 2016, LIVER TRANSPLANT, V22, P1343, DOI 10.1002/lt.24503; Bobrovitz N, 2017, BMC EMERG MED, V17, DOI 10.1186/s12873-017-0145-2; Boudreaux ED, 2000, AM J EMERG MED, V18, P394, DOI 10.1053/ajem.2000.7316; Bruijns SR, 2008, EMERG MED J, V25, P395, DOI 10.1136/emj.2007.049411; Chang AM, 2018, ANN EMERG MED, V71, P497, DOI 10.1016/j.annemergmed.2017.07.022; Choi YF, 2006, EMERG MED J, V23, P262, DOI 10.1136/emj.2005.025254; Clark DE, 2016, HEALTH SERV RES, V51, P1074, DOI 10.1111/1475-6773.12400; Cross KP, 2010, ACAD EMERG MED, V17, P1197, DOI 10.1111/j.1553-2712.2010.00908.x; de Wreede LC, 2011, J STAT SOFTW, V38, P1; Doan Q, 2014, JAAPA-J AM ACAD PHYS, V27, P35, DOI 10.1097/01.JAA.0000451860.95151.e1; Georgio G, 2017, J EMERG MED, V53, P418, DOI 10.1016/j.jemermed.2017.05.004; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gran JM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2408-8; Hosmer DW, 2002, STATA J, V2, P331, DOI 10.1177/1536867X0200200401; James CA, 2005, PEDIATRICS, V115, pE310, DOI 10.1542/peds.2004-1541; Jouriles N, 2013, ACAD EMERG MED, V20, P421, DOI 10.1111/acem.12107; Keiding N, 2001, STAT MED, V20, P1871, DOI 10.1002/sim.810; Lambe S, 2003, ANN EMERG MED, V41, P35, DOI 10.1067/mem.2003.2; Lateef A, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2491-x; Liu SW, 2009, ANN EMERG MED, V54, P381, DOI 10.1016/j.annemergmed.2009.02.001; Mason S, 2017, EMERG MED J, V34, P46, DOI 10.1136/emermed-2015-205201; Michelson KA, 2016, PEDIATR EMERG CARE, V32, P599, DOI 10.1097/PEC.0000000000000892; Newton AS, 2014, EMERG MED INT, V2014, P10; Park CY, 2009, HEALTH SERV RES, V44, P2022, DOI 10.1111/j.1475-6773.2009.01020.x; Qiu SS, 2015, HEALTH CARE MANAG SC, V18, P67, DOI 10.1007/s10729-014-9283-1; Rathlev NK, 2007, ANN EMERG MED, V49, P265, DOI 10.1016/j.annemergmed.2006.11.007; Schull MJ, 2007, ANN EMERG MED, V49, P257, DOI 10.1016/j.annemergmed.2006.06.027; Sethuraman U, 2011, PEDIATR EMERG CARE, V27, P295, DOI 10.1097/PEC.0b013e318217b503; Smith CJ, 2015, J HOSP MED, V10, P711, DOI 10.1002/jhm.2431; Sun Y, 2012, ANN EMERG MED, V60, P299, DOI 10.1016/j.annemergmed.2012.03.011; Vashi AA, 2019, MIL MED, V184, pE169, DOI 10.1093/milmed/usy165; Yiadom MYAB, 2018, ACAD EMERG MED, V25, P65, DOI 10.1111/acem.13319	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219514	10.1371/journal.pone.0219514	http://dx.doi.org/10.1371/journal.pone.0219514			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291345	gold, Green Published, Green Submitted			2022-12-26	WOS:000484947800101
J	Popov, P; Bizin, I; Gromiha, M; Kulandaisamy, A; Frishman, D				Popov, Petr; Bizin, Ilya; Gromiha, Michael; Kulandaisamy, A.; Frishman, Dmitrij			Prediction of disease-associated mutations in the transmembrane regions of proteins with known 3D structure	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; STABILITY CHANGES; SERVER; PERFORMANCE; VARIANTS; SEQUENCE; DATABASE; TOOL	Being able to assess the phenotypic effects of mutations is a much required capability in precision medicine. However, most of the currently available structure-based methods actually predict stability changes caused by mutations rather than their pathogenic potential. There are also no dedicated methods to predict damaging mutations specifically in transmembrane proteins. In this study we developed and applied a machine-learning approach to discriminate between disease-associated and benign point mutations in the transmembrane regions of proteins with known 3D structure. The method, called BorodaTM (BOosted RegressiOn trees for Disease-Associated mutations in TransMembrane proteins), was trained on sequence-, structure-, and energy-derived descriptors. When compared with the state-of-the-art methods, BorodaTM is superior in classifying point mutations in transmembrane regions. Using BorodaTM we have conducted a large-scale mutation analysis in the transmembrane regions of human proteins with known 3D structures. For each protein we generated structural models for all point mutations by replacing each residue to 19 possible residue types. We classified similar to 1.8 millions point mutations as benign or diseased-associated and made all predictions available as a Web-server at https://www.iitm.ac.in/bioinfo/MutHTP/boroda.php.	[Popov, Petr] Skolkovo Inst Sci & Technol, Moscow, Russia; [Popov, Petr] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Bizin, Ilya; Frishman, Dmitrij] St Petersburg State Polytech Univ, St Petersburg, Russia; [Gromiha, Michael; Kulandaisamy, A.] Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Chennai, Tamil Nadu, India; [Frishman, Dmitrij] Tech Univ Munich, Wissensch Zentrum Weihenstephan, Dept Bioinformat, Freising Weihenstephan, Germany	Skolkovo Institute of Science & Technology; Moscow Institute of Physics & Technology; Peter the Great St. Petersburg Polytechnic University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Technical University of Munich	Frishman, D (corresponding author), St Petersburg State Polytech Univ, St Petersburg, Russia.; Frishman, D (corresponding author), Tech Univ Munich, Wissensch Zentrum Weihenstephan, Dept Bioinformat, Freising Weihenstephan, Germany.	d.frishman@wzw.tum.de	arulsamy, kulandaisamy/AAX-2889-2021; Frishman, Dmitrij/AAT-7815-2020; Bizin, Ilya/AAD-9017-2019; Bizin, Ilya/Q-7135-2017; Solodushenkova, Anastasia/H-1732-2019; Popov, Petr A/G-9638-2016; Popov, Petr A/O-8970-2015	arulsamy, kulandaisamy/0000-0002-3367-2669; Bizin, Ilya/0000-0002-2216-4845; Bizin, Ilya/0000-0002-2216-4845; 	Deutsche Forschungsgemeinschaft [FR 1411/14-1]; Department of Science and Technology, Government of India [INT/RUS/RSF/P-09]; Russian Science Foundation [18-74-00117, 16-44-02002]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Deutsche Forschungsgemeinschaft grant FR 1411/14-1 (D.F.), the Russian Science Foundation grant (18-74-00117) (P.P.), Department of Science and Technology, Government of India (INT/RUS/RSF/P-09) (M.G.), and the Russian Science Foundation grant (16-44-02002) (I.B., M.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bendl J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004962; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Dobson L, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0061-x; Famiglietti ML, 2014, HUM MUTAT, V35, P927, DOI 10.1002/humu.22594; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Frishman D, 1997, NAT STRUCT BIOL, V4, P626, DOI 10.1038/nsb0897-626; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Kozma D, 2012, NUCLEIC ACIDS RES, V40, pW329, DOI 10.1093/nar/gks488; Kulandaisamy A, 2018, BIOINFORMATICS, V34, P2325, DOI 10.1093/bioinformatics/bty054; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Martelli PL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2726-y; Molnar J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151760; Muller T, 2001, Bioinformatics, V17 Suppl 1, pS182; Ng PC, 2000, BIOINFORMATICS, V16, P760, DOI 10.1093/bioinformatics/16.9.760; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Niroula A, 2016, HUM MUTAT, V37, P579, DOI 10.1002/humu.22987; Oberai A, 2009, P NATL ACAD SCI USA, V106, P17747, DOI 10.1073/pnas.0906390106; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Popov P, 2019, CURR OPIN STRUC BIOL, V55, P25, DOI 10.1016/j.sbi.2019.02.010; Popov P, 2018, ELIFE, V7, DOI 10.7554/eLife.34729; Quan LJ, 2016, BIOINFORMATICS, V32, P2936, DOI 10.1093/bioinformatics/btw361; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150965	38	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219452	10.1371/journal.pone.0219452	http://dx.doi.org/10.1371/journal.pone.0219452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291347	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800085
J	Shlezinger, M; Friedman, M; Houri-Haddad, Y; Hazan, R; Beyth, N				Shlezinger, Mor; Friedman, Michael; Houri-Haddad, Yael; Hazan, Ronen; Beyth, Nurit			Phages in a thermoreversible sustained-release formulation targeting E. faecalis in vitro and in vivo	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS; CALCIUM HYDROXIDE; BACTERIOPHAGES; TEETH; CHLORHEXIDINE; THERAPY; ENCAPSULATION; COCKTAIL	Introduction Enterococcus faecalis is a key pathogen recovered from root canals when conventional treatment fails. Phage therapy has generated new interest in combating pathogens. A sustained-release formulation using specific phages against E. faecalis may offer an alternative approach. Objectives To evaluate the efficacy of anti-E. faecalis phages formulated in a thermo-sustained-release system against E. faecalis in vitro and in vivo. Methods EFDG1 and EFLK1 phages were formulated with poloxamer P407. Gelation time, phage survival, activity and toxicity were evaluated. Lytic activity was evaluated in vitro against E. faecalis at various growth phases, including anti-biofilm activity. Methods included viable bacterial count (CFU/mL), biofilm biomass determination and electron microscopy (live/dead staining). Further evaluation included infected incisors in an in vivo rat model. Anti-E. faecalis phage-cocktail suspension and sustained-release phage formulation were evaluated by viable bacterial count (CFU/mL), histology, scanning electron microscopy (SEM) and 16S genome sequencing of the microbiota of the root canal. Results Gelation time for clinical use was established. Low toxicity and a high phage survival rate were recorded. Sustained-release phages reduced E. faecalis in logarithmic (4 logs), stationary (3 logs) and biofilm (4 logs) growth phases. Prolonged anti-biofilm activity of 88% and 95% reduction in biomass and viable counts, respectively, was recorded. Reduction of intracanal viable bacterial counts was observed (99% of enterococci) also seen in SEM. Phage treatment increased Proteobacteria and decreased Firmicutes. Histology showed reduced periapical inflammation and improved healing following phage treatment. Conclusion Poloxamer P407 formulated with phages has an effective and long-lasting effect in vitro and in vivo targeting E. faecalis.	[Shlezinger, Mor; Houri-Haddad, Yael; Beyth, Nurit] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Prosthodont, Jerusalem, Israel; [Shlezinger, Mor; Hazan, Ronen] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Fac Dent Sci, Jerusalem, Israel; [Friedman, Michael] Hebrew Univ Jerusalem, Inst Drug Res, Dept Pharmaceut, Fac Med, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Beyth, N (corresponding author), Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Prosthodont, Jerusalem, Israel.	nuritb@ekmd.huji.ac.il			Kamin grant [55328]; Isidor Kabakoff grant [0365076]	Kamin grant; Isidor Kabakoff grant	This work was supported by Kamin grant (grant number 55328) and Isidor Kabakoff grant (grant number 0365076). MS is a fellow of the "Ariane de Rothschild Women Doctoral Program". The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Andrew AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051301; Azizian R, 2013, J PARAMEDICAL SCI, V4, P92; Ban E, 2017, MOLECULES, V22, DOI 10.3390/molecules22020246; Brynolf I., 1967, ODONTOLOGISK REVY; Cheng WL, 2018, J BIOMED MATER RES B, V106, P2588, DOI 10.1002/jbm.b.34075; Donovan David M, 2007, Recent Pat Biotechnol, V1, P113, DOI 10.2174/187220807780809463; El-Mal EOA, 2019, SAUDI DENT J, V31, P219, DOI 10.1016/j.sdentj.2018.09.004; Gandi Padma, 2013, J Int Oral Health, V5, P14; Gelman D, 2018, RES MICROBIOL, V169, P531, DOI 10.1016/j.resmic.2018.04.008; Gill JJ, 2007, EXPERT OPIN THER PAT, V17, P1341, DOI 10.1517/13543776.17.11.1341; Hanlon GW, 2007, INT J ANTIMICROB AG, V30, P118, DOI 10.1016/j.ijantimicag.2007.04.006; Heithersay G S, 1975, J Br Endod Soc, V8, P74; Holland R, 2003, J ENDODONT, V29, P121, DOI 10.1097/00004770-200302000-00009; Holland R, 2017, J APPL ORAL SCI, V25, P465, DOI 10.1590/1678-7757-2016-0464; Jikia D, 2005, CLIN EXP DERMATOL, V30, P23, DOI 10.1111/j.1365-2230.2004.01600.x; Karpinski TM, 2015, EUR REV MED PHARMACO, V19, P1321; Khalifa L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00326; Khalifa L, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.32157; Khalifa L, 2015, APPL ENVIRON MICROB, V81, P2696, DOI 10.1128/AEM.00096-15; Kolasinac N, 2012, INT J PHARMACEUT, V436, P161, DOI 10.1016/j.ijpharm.2012.06.060; Korehei R, 2014, CARBOHYD POLYM, V100, P150, DOI 10.1016/j.carbpol.2013.03.079; Kudiyirickal Marina George, 2008, Acta Medica (Hradec Kralove), V51, P3; Lacevic Amela, 2003, Bosn J Basic Med Sci, V3, P26; Malik DJ, 2017, ADV COLLOID INTERFAC, V249, P100, DOI 10.1016/j.cis.2017.05.014; Markoishvili K, 2002, INT J DERMATOL, V41, P453, DOI 10.1046/j.1365-4362.2002.01451.x; Mohammadi Zahed, 2014, Iran Endod J, V9, P89; Olszak T, 2015, APPL MICROBIOL BIOT, V99, P6021, DOI 10.1007/s00253-015-6492-6; ORSTAVIK D, 1986, Endodontics and Dental Traumatology, V2, P20; Paisano AF, 2004, ORAL MICROBIOL IMMUN, V19, P327, DOI 10.1111/j.1399-302x.2004.00166.x; Paule Armelle, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6040086; Pereira TC, 2019, CLIN ORAL INVEST, V23, P1253, DOI 10.1007/s00784-018-2549-0; Petel R, 2013, ARCH ORAL BIOL, V58, P75, DOI 10.1016/j.archoralbio.2012.06.014; Pirisi A, 2000, LANCET, V356, P1418, DOI 10.1016/S0140-6736(05)74059-9; Ponce JB, 2019, ACTA ODONTOL SCAND, V77, P158, DOI 10.1080/00016357.2018.1533142; Pourhajibagher M, 2017, PHOTODIAGN PHOTODYN, V18, P198, DOI 10.1016/j.pdpdt.2017.02.013; Rodrigues CT, 2018, INT ENDOD J, V51, P901, DOI 10.1111/iej.12904; Saatchi M, 2014, J APPL ORAL SCI, V22, P356, DOI 10.1590/1678-775720140032; Sanchez-Sanhueza G, 2018, INT ENDOD J, V51, P1336, DOI 10.1111/iej.12953; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shlezinger M, 2017, CURR TOP MED CHEM, V17, P1199, DOI 10.2174/1568026616666160930145649; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Siqueira JF, 1999, INT ENDOD J, V32, P361, DOI 10.1046/j.1365-2591.1999.00275.x; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Sundqvist G, 1998, ORAL SURG ORAL MED O, V85, P86, DOI 10.1016/S1079-2104(98)90404-8; Tanji Y, 2005, J BIOSCI BIOENG, V100, P280, DOI 10.1263/jbb.100.280; Vivacqua-Gomes N, 2005, INT ENDOD J, V38, P697, DOI 10.1111/j.1365-2591.2005.00992.x; Yuanita Tamara, 2018, Iran Endod J, V13, P42, DOI 10.22037/iej.v13i1.18781; Zandi H, 2018, J ENDODONT, V44, P372, DOI 10.1016/j.joen.2017.11.019; Zheng TY, 2018, BIOMATER SCI-UK, V6, P596, DOI 10.1039/c7bm00764g	49	19	20	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219599	10.1371/journal.pone.0219599	http://dx.doi.org/10.1371/journal.pone.0219599			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291645	Green Submitted, gold, Green Published			2022-12-26	WOS:000484947800122
J	Reis, JHD; Barreto, GD; Cerqueira, JC; dos Anjos, JP; Andrade, LN; Padilha, FF; Druzian, JI; Machado, BAS				de Oliveira Reis, Joao Henrique; Barreto, Gabriele de Abreu; Cerqueira, Jamile Costa; dos Anjos, Jeancarlo Pereira; Andrade, Luciana Nalone; Padilha, Francine Ferreira; Druzian, Janice Izabel; Souza Machado, Bruna Aparecida			Evaluation of the antioxidant profile and cytotoxic activity of red propolis extracts from different regions of northeastern Brazil obtained by conventional and ultrasound-assisted extraction	PLOS ONE			English	Article							SUPERCRITICAL CARBON-DIOXIDE; CHEMICAL-COMPOSITION; IN-VITRO; PHENOLIC-COMPOUNDS; ANTIBACTERIAL ACTIVITY; BIOLOGICAL-ACTIVITY; BOTANICAL ORIGIN; RAW PROPOLIS; INDUCED APOPTOSIS; CHILEAN PROPOLIS	Propolis is a complex mixture of resinous and balsamic material collected from the exudates of plants, shoots, and leaves by bees. This study evaluated red propolis extracts obtained by conventional (ethanolic) extraction and ultrasound-assisted extraction of six samples from different regions of northeastern Brazil. The total phenolic compounds and flavonoids, in vitro antioxidant activity, concentration of formononetin and kaempferol and the cytotoxicity against four human tumor cell lines were determined for all twelve obtained extracts. Significant variations in the levels of the investigated compounds were identified in the red propolis extracts, confirming that the chemical composition varied according to the sampling region. The extraction method used also influenced the resulting propolis compounds. The highest concentration of the compounds of interest and the highest in vitro antioxidant activity were exhibited by the extracts obtained from samples from state of Alagoas. Formononetin and kaempferol were identified in all samples. The highest formononetin concentrations were identified in extracts obtained by ultrasound, thus indicating a greater selectivity for the extraction of this compound by this method. Regarding cytotoxic activity, for the HCT-116 line, all of the extracts showed an inhibition of greater than 90%, whereas for the HL-60 and PC3 lines, the minimum identified was 80%. In general, there was no significant difference (p>0.05) in the antiproliferative potential when comparing the extraction methods. The results showed that the composition of Brazilian red propolis varies significantly depending on the geographical origin and that the method used influences the resulting compounds that are present in propolis. However, regardless of the geographical origin and the extraction method used, all the red propolis samples studied presented great biological potential and high antioxidant activity. Furthermore, the ultrasound-assisted method can be efficiently applied to obtain extracts of red propolis more quickly and with high concentration of biomarkers of interest.	[de Oliveira Reis, Joao Henrique; Druzian, Janice Izabel] Univ Fed Bahia, Fac Pharm, Salvador, BA, Brazil; [Barreto, Gabriele de Abreu; Cerqueira, Jamile Costa; dos Anjos, Jeancarlo Pereira; Souza Machado, Bruna Aparecida] Univ Ctr SENAI CIMATEC, Natl Serv Ind Learning SENAI, Heath Inst Technol ITS CIMATEC, Salvador, BA, Brazil; [Andrade, Luciana Nalone] Univ Fed Sergipe, Lagarto, Sergipe, Brazil; [Padilha, Francine Ferreira] Univ Tiradentes, Inst Res & Technol ITP, Aracaju, Sergipe, Brazil	Universidade Federal da Bahia; Universidade Federal de Sergipe; Universidade Tiradentes	Machado, BAS (corresponding author), Univ Ctr SENAI CIMATEC, Natl Serv Ind Learning SENAI, Heath Inst Technol ITS CIMATEC, Salvador, BA, Brazil.	brunamachado17@hotmail.com	dos Anjos, Jeancarlo Pereira/L-7499-2016; Andrade, Luciana/P-4604-2017; Machado, Bruna/AAP-6877-2021; Anjos, Jeancarlo dos/AAV-1086-2020; DE OLIVEIRA REIS, JOÃO HENRIQUE/ABB-6843-2021; MACHADO, BRUNA/C-3130-2016	dos Anjos, Jeancarlo Pereira/0000-0001-8353-1066; Andrade, Luciana/0000-0002-5481-4355; Anjos, Jeancarlo dos/0000-0001-8353-1066; MACHADO, BRUNA/0000-0003-1655-0325; Barreto, Gabriele/0000-0002-0180-281X; Druzian, Janice Izabel/0000-0001-8940-6098				Albu S, 2004, ULTRASON SONOCHEM, V11, P261, DOI 10.1016/j.ultsonch.2004.01.015; Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005; Amaral RG, 2015, J PHARM PHARMACOL, V67, P1100, DOI 10.1111/jphp.12409; Andelkovic B, 2017, J PHARMACEUT BIOMED, V135, P217, DOI 10.1016/j.jpba.2016.12.003; Awale S, 2008, BIOORGAN MED CHEM, V16, P181, DOI 10.1016/j.bmc.2007.10.004; Bandyopadhyay S, 2008, MOL CELL ENDOCRINOL, V287, P57, DOI 10.1016/j.mce.2008.01.015; Bankova V, 2005, J ETHNOPHARMACOL, V100, P114, DOI 10.1016/j.jep.2005.05.004; Bankova VS, 2000, APIDOLOGIE, V31, P3, DOI 10.1051/apido:2000102; Banzato TP, 2014, PLANTA MED, V80, P1441; Barba FJ, 2015, FOOD BIOPROCESS TECH, V8, P1139, DOI 10.1007/s11947-015-1482-3; Begnini KR, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/639856; Bestwick CS, 2005, BBA-MOL BASIS DIS, V1740, P340, DOI 10.1016/j.bbadis.2004.10.005; Biscaia D, 2009, J SUPERCRIT FLUID, V51, P17, DOI 10.1016/j.supflu.2009.07.011; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Brazil. National Institute of Metrology Standardization and Industrial Quality (INMETRO), 2011, GUID CHEM TEST METH; Briones-Labarca V, 2015, LWT-FOOD SCI TECHNOL, V60, P525, DOI 10.1016/j.lwt.2014.07.057; Bueno-Silva B, 2013, J AGR FOOD CHEM, V61, P4546, DOI 10.1021/jf305468f; Cao J, 2017, ANAL CHIM ACTA, V963, P24, DOI 10.1016/j.aca.2017.01.063; Catchpole OJ, 2004, J SUPERCRIT FLUID, V29, P97, DOI 10.1016/S0896-8446(03)00033-0; Catlin NR, 2018, FOOD CHEM TOXICOL, V118, P328, DOI 10.1016/j.fct.2018.05.013; Cavendish RL, 2015, J ETHNOPHARMACOL, V173, P127, DOI 10.1016/j.jep.2015.07.022; Chen AY, 2013, FOOD CHEM, V138, P2099, DOI 10.1016/j.foodchem.2012.11.139; Chen J, 2012, HORM METAB RES, V44, P943, DOI 10.1055/s-0032-1321818; Chen MS, 2015, FOOD CHEM, V172, P543, DOI 10.1016/j.foodchem.2014.09.110; Christov R, 2005, NAT PROD RES, V19, P673, DOI 10.1080/14786410512331328159; Cottica SM, 2015, LWT-FOOD SCI TECHNOL, V60, P609, DOI 10.1016/j.lwt.2014.08.045; Cottica SM, 2011, J BRAZIL CHEM SOC, V22, P929, DOI 10.1590/S0103-50532011000500016; Cuesta-Rubio O, 2007, J AGR FOOD CHEM, V55, P7502, DOI 10.1021/jf071296w; Almeida ETD, 2017, J PHARM ANAL, V7, P280, DOI 10.1016/j.jpha.2017.03.004; Frozza COD, 2017, BIOMED PHARMACOTHER, V91, P951, DOI 10.1016/j.biopha.2017.05.027; Frozza COD, 2013, FOOD CHEM TOXICOL, V52, P137, DOI 10.1016/j.fct.2012.11.013; Silva RPD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172585; Darendelioglu E, 2016, ACTA HISTOCHEM, V118, P369, DOI 10.1016/j.acthis.2016.03.007; Pierini GD, 2016, MICROCHEM J, V128, P62, DOI 10.1016/j.microc.2016.04.015; Daugsch A, 2008, EVID-BASED COMPL ALT, V5, P435, DOI 10.1093/ecam/nem057; de Figueiredo LC, 2018, FOOD CHEM, V240, P441, DOI 10.1016/j.foodchem.2017.07.140; De Zordi N, 2014, J SUPERCRIT FLUID, V95, P491, DOI 10.1016/j.supflu.2014.10.006; Dent M, 2015, CHEM BIOCHEM ENG Q, V29, P475, DOI 10.15255/CABEQ.2015.2168; Devequi-Nunes D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207676; Devi KP, 2015, PHARMACOL RES, V99, P1, DOI 10.1016/j.phrs.2015.05.002; Di Capua A, 2018, CHEM ENG RES DES, V136, P776, DOI 10.1016/j.cherd.2018.06.037; Ding QZ, 2018, ULTRASON SONOCHEM, V42, P704, DOI 10.1016/j.ultsonch.2017.11.027; do Nascimento TG, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1517-3; Doi K, 2017, IN VIVO, V31, P187, DOI 10.21873/invivo.11044; Escriche I, 2018, FOOD RES INT, V106, P834, DOI 10.1016/j.foodres.2018.01.055; Falcao SI, 2013, IND CROP PROD, V49, P805, DOI 10.1016/j.indcrop.2013.07.021; Filomeni G, 2012, NEUROBIOL AGING, V33, P767, DOI 10.1016/j.neurobiolaging.2010.05.021; Franchi GC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/918956; Freires IA, 2016, EUR J MED CHEM, V110, P267, DOI 10.1016/j.ejmech.2016.01.033; Freitas AS, 2019, FOOD RES INT, V119, P622, DOI 10.1016/j.foodres.2018.10.040; GHISALBERTI EL, 1979, BEE WORLD, V60, P59, DOI 10.1080/0005772X.1979.11097738; de Mendonca ICG, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0888-9; Graikou K, 2016, LWT-FOOD SCI TECHNOL, V65, P261, DOI 10.1016/j.lwt.2015.08.025; Hatano A, 2012, FOOD SCI TECHNOL RES, V18, P577, DOI 10.3136/fstr.18.577; Hossain MB, 2012, ULTRASON SONOCHEM, V19, P582, DOI 10.1016/j.ultsonch.2011.11.001; Huang SA, 2014, MOLECULES, V19, P19610, DOI 10.3390/molecules191219610; Inui S, 2014, NAT PROD RES, V28, P1293, DOI 10.1080/14786419.2014.898146; Jansen-Alves C, 2019, FOOD HYDROCOLLOID, V87, P703, DOI 10.1016/j.foodhyd.2018.09.004; Jug M, 2014, LWT-FOOD SCI TECHNOL, V57, P530, DOI 10.1016/j.lwt.2014.02.006; Kabala-Dzik A, 2018, CELL MOL BIOL, V64, P1, DOI 10.14715/cmb/2018.64.8.1; Kakehashi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158654; Kamiya T, 2012, J AGR FOOD CHEM, V60, P11065, DOI 10.1021/jf303004n; Kole L, 2011, EUR J PHARMACOL, V653, P8, DOI 10.1016/j.ejphar.2010.11.026; Kurek-Gorecka A, 2014, MOLECULES, V19, P78, DOI 10.3390/molecules19010078; Li F, 2008, BIOORGAN MED CHEM, V16, P5434, DOI 10.1016/j.bmc.2008.04.016; Li ZZ, 2014, J NEUROL SCI, V338, P112, DOI 10.1016/j.jns.2013.12.027; Lo YL, 2013, CHEM-BIOL INTERACT, V205, P188, DOI 10.1016/j.cbi.2013.07.003; Lopez BGC, 2014, FOOD CHEM, V146, P174, DOI 10.1016/j.foodchem.2013.09.063; Lopez-Sanchez C, 2007, BRAIN RES, V1182, P123, DOI 10.1016/j.brainres.2007.08.087; Lotti C, 2010, J AGR FOOD CHEM, V58, P2209, DOI 10.1021/jf100070w; Ma ZQ, 2013, INFLAMMATION, V36, P1560, DOI 10.1007/s10753-013-9700-5; Machado CS, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/6057650; Marcucci MC, 1998, Z NATURFORSCH C, V53, P117; das Nevesa MVM, 2016, BRAZ J MICROBIOL, V47, P159, DOI 10.1016/j.bjm.2015.11.009; MARQUEZHERNANDE.I, 2010, ANAL CHEM, V58, P4725, DOI DOI 10.1021/JF904527N; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Medina-Torres N, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7030047; Mello BCBS, 2012, INT J FOOD SCI TECH, V47, P2510, DOI 10.1111/j.1365-2621.2012.03129.x; Metherel AH, 2009, PROSTAG LEUKOTR ESS, V81, P417, DOI 10.1016/j.plefa.2009.07.003; Miguel MG, 2010, FOOD CHEM TOXICOL, V48, P3418, DOI 10.1016/j.fct.2010.09.014; Molyneux P., 2004, SONGKLANAKARIN J SCI, V26, P211, DOI DOI 10.1287/ISRE.6.2.144; Monroy YM, 2018, J SUPERCRIT FLUID, V138, P167, DOI 10.1016/j.supflu.2018.04.016; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nani BD, 2018, PHYTOTHER RES, V32, P750, DOI 10.1002/ptr.6016; Novak EM, 2014, J FUNCT FOODS, V11, P91, DOI 10.1016/j.jff.2014.09.008; Omar RMK, 2016, PHYTOCHEM ANALYSIS, V27, P107, DOI 10.1002/pca.2605; Park KW, 2009, NUTR RES, V29, P819, DOI 10.1016/j.nutres.2009.09.014; Pasupuleti VR, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1259510; Paviani LC, 2012, BRAZ J CHEM ENG, V29, P243, DOI 10.1590/S0104-66322012000200005; Pellati F, 2013, J PHARMACEUT BIOMED, V81-82, P126, DOI 10.1016/j.jpba.2013.04.003; Pellati F, 2011, J PHARMACEUT BIOMED, V55, P934, DOI 10.1016/j.jpba.2011.03.024; Piccinelli AL, 2005, J AGR FOOD CHEM, V53, P9010, DOI 10.1021/jf0518756; Piccinelli AL, 2011, J AGR FOOD CHEM, V59, P6484, DOI 10.1021/jf201280z; Rajendran P, 2014, EUR J MED CHEM, V86, P103, DOI 10.1016/j.ejmech.2014.08.011; Neto MSR, 2017, FOOD CHEM TOXICOL, V107, P572, DOI 10.1016/j.fct.2017.03.052; Regueira-Neto MD, 2018, FOOD CHEM TOXICOL, V119, P215, DOI 10.1016/j.fct.2018.04.029; Ren J, 2012, EUR J MED CHEM, V54, P175, DOI 10.1016/j.ejmech.2012.04.039; Cabral ISR, 2009, QUIM NOVA, V32, P1523, DOI 10.1590/S0100-40422009000600031; Ribeiro DR, 2015, BASIC CLIN PHARMACOL, V117, P85, DOI 10.1111/bcpt.12374; Righi AA, 2011, J SCI FOOD AGR, V91, P2363, DOI 10.1002/jsfa.4468; Ristivojevic P, 2018, LWT-FOOD SCI TECHNOL, V95, P367, DOI 10.1016/j.lwt.2018.04.063; Rufatto LC, 2018, MICROBIOL RES, V214, P74, DOI 10.1016/j.micres.2018.05.003; Rufatto LC, 2017, ASIAN PAC J TROP BIO, V7, P591, DOI 10.1016/j.apjtb.2017.06.009; Russo A, 2004, LIFE SCI, V76, P545, DOI 10.1016/j.lfs.2004.07.019; Sadhana N, 2017, J INTEGR MED-JIM, V15, P483, DOI 10.1016/S2095-4964(17)60360-1; Salatino A, 2005, EVID-BASED COMPL ALT, V2, P33, DOI 10.1093/ecam/neh060; Salatino A., 2018, MOJ FOOD PROCESS TEC, V6, P21, DOI DOI 10.15406/MOJFPT.2018.06.00139; Salgueiro FB, 2016, QUIM NOVA, V39, P1192, DOI 10.21577/0100-4042.20160136; Sallet D, 2019, J FOOD ENG, V242, P1, DOI 10.1016/j.jfoodeng.2018.08.015; Sampaio BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29265; Andrade JKS, 2018, FOOD RES INT, V109, P278, DOI 10.1016/j.foodres.2018.04.048; Andrade JKS, 2017, FOOD RES INT, V101, P129, DOI 10.1016/j.foodres.2017.08.066; Sati P, 2019, J TRADIT COMPL MED, V9, P15, DOI 10.1016/j.jtcme.2017.10.003; Sawaya ACHF, 2004, ANALYST, V129, P739, DOI 10.1039/b403873h; Sawaya ACHF, 2010, TALANTA, V81, P100, DOI 10.1016/j.talanta.2009.11.043; Sena-Lopes A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191797; Sforcin JM, 2000, J ETHNOPHARMACOL, V73, P243, DOI 10.1016/S0378-8741(00)00320-2; Sharma V, 2007, MOL CANCER THER, V6, P2544, DOI 10.1158/1535-7163.MCT-06-0788; Silici S, 2005, J ETHNOPHARMACOL, V99, P69, DOI 10.1016/j.jep.2005.01.046; Silva BB, 2008, EVID-BASED COMPL ALT, V5, P313, DOI 10.1093/ecam/nem059; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; Machado BAS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145954; Machado BAS, 2013, SEP SCI TECHNOL, V48, P2741, DOI 10.1080/01496395.2013.811422; Stanisavljevic I, 2009, CHINESE J CHEM ENG, V17, P478, DOI 10.1016/S1004-9541(08)60234-7; Sun CL, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/595393; Szliszka E, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/757628; Taddeo VA, 2016, J PHARMACEUT BIOMED, V129, P219, DOI 10.1016/j.jpba.2016.07.006; Tan CX, 2018, J SUPERCRIT FLUID, V135, P45, DOI 10.1016/j.supflu.2017.12.036; Teles F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116535; Trusheva B, 2006, EVID-BASED COMPL ALT, V3, P249, DOI 10.1093/ecam/nel006; Trusheva B, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-13; Tsai MS, 2018, TOXICOL LETT, V290, P97, DOI 10.1016/j.toxlet.2018.03.024; Valencia D, 2012, FOOD CHEM, V131, P645, DOI 10.1016/j.foodchem.2011.08.086; Vieira GS, 2013, J FOOD ENG, V119, P196, DOI 10.1016/j.jfoodeng.2013.05.030; Vilkhu K, 2008, INNOV FOOD SCI EMERG, V9, P161, DOI 10.1016/j.ifset.2007.04.014; Virot M, 2010, ULTRASON SONOCHEM, V17, P1066, DOI 10.1016/j.ultsonch.2009.10.015; Vukovic NL, 2018, FOOD RES INT, V106, P71, DOI 10.1016/j.foodres.2017.12.056; Wang X, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1043-y; Wang Y, 2012, MOLECULES, V17, P10052, DOI 10.3390/molecules170910052; Wang ZB, 2014, J CHROMATOGR B, V969, P205, DOI 10.1016/j.jchromb.2014.08.022; Watson DG, 2006, PHYTOCHEM ANALYSIS, V17, P323, DOI 10.1002/pca.921; Wiktor A, 2016, APPL ACOUST, V103, P136, DOI 10.1016/j.apacoust.2015.05.001; Wilkinson J, 2017, WORLD DEV, V98, P82, DOI 10.1016/j.worlddev.2015.05.003; Yang J, 2018, IND CROP PROD, V124, P363, DOI 10.1016/j.indcrop.2018.08.003; Yang WY, 2015, BIOORG MED CHEM LETT, V25, P1394, DOI 10.1016/j.bmcl.2015.02.051; Yen CH, 2017, LWT-FOOD SCI TECHNOL, V84, P281, DOI 10.1016/j.lwt.2017.05.074; Zabaiou N, 2019, J STEROID BIOCHEM, V189, P108, DOI 10.1016/j.jsbmb.2019.02.016; Zabaiou N, 2017, CHEM PHYS LIPIDS, V207, P214, DOI 10.1016/j.chemphyslip.2017.04.005; Zang YQ, 2015, FOOD FUNCT, V6, P834, DOI [10.1039/c4fo00844h, 10.1039/C4FO00844H]; Zhang H, 2018, FOOD HYDROCOLLOID, V81, P104, DOI 10.1016/j.foodhyd.2018.02.019; Zhong JF, 2018, IND CROP PROD, V120, P1, DOI 10.1016/j.indcrop.2018.04.028; Zhou JH, 2009, FOOD CHEM, V115, P1074, DOI 10.1016/j.foodchem.2008.12.031	153	27	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219063	10.1371/journal.pone.0219063	http://dx.doi.org/10.1371/journal.pone.0219063			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276476	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300035
J	Jankowski, M; Danalache, BA; Plante, E; Menaouar, A; Florian, M; Tan, JJ; Grygorczyk, R; Broderick, TL; Gutkowska, J				Jankowski, Marek; Danalache, Bogdan A.; Plante, Eric; Menaouar, Ahmed; Florian, Maria; Tan, Ju Jing; Grygorczyk, Ryszard; Broderick, Tom L.; Gutkowska, Jolanta			Dissociation of natriuresis and diuresis by oxytocin molecular forms in rats	PLOS ONE			English	Article							VASOPRESSIN RECEPTOR; EXTENDED FORMS; BINDING-SITES; PEPTIDE; HORMONE; RELEASE; PLASMA; SYSTEM; CAMP	In the rat, oxytocin (OT) produces dose-dependent diuretic and natriuretic responses. Posttranslational enzymatic conversion of the OT biosynthetic precursor forms both mature and C-terminally extended peptides. The plasma concentrations of these C-terminally extended peptides (OT-G; OT-GK and OT-GKR) are elevated in newborns and pregnant rats. Intravenous injection of OT-GKR to rats inhibits diuresis, whereas injection of amidated OT stimulates diuresis. Since OT and OT-GKR show different effects on the urine flow, we investigated whether OT-GKR modulates renal action by inhibition of the arginine-vasopressin (AVP) receptor V-2(V2R), the receptor involved in renal water reabsorption. Experiments were carried out in the 8-week-old Wistar rats receiving intravenous (iv) injections of vehicle, OT, OT-GKR or OT+OT-GKR combination. OT (10 mu mol/kg) increased urine outflow by 40% (P<0.01) and sodium excretion by 47% (P<0.01). Treatment with OT-GKR (10 mu mol/kg) decreased diuresis by 50% (P<0.001), decreased sodium excretion by 50% (P<0.05) and lowered potassium by 42% (P<0.05). OT antagonist (OTA) reduced diuresis and natriuresis exerted by OT, whereas the anti-diuretic effect of OT-GKR was unaffected by OTA. The treatment with V2R antagonist (V(2)A) in the presence and absence of OT induced diuresis, sodium and potassium outflow. V(2)A in the presence of OT-GKR only partially increased diuresis and natriuresis. Autoradiography and molecular docking analysis showed potent binding of OT-GKR to V2R. Finally, the release of cAMP from CHO cells overexpressing V-2 receptor was induced by low concentration of AVP (EC50:4.2e-011), at higher concentrations of OT (EC50:3.2e-010) and by the highest concentrations of OT-GKR (EC50:1.1e006). OT-GKR potentiated cAMP release when combined with AVP, but blocked cAMP release when combined with OT. These results suggest that OT-GKR by competing for the OT renal receptor (OTR) and binding to V2R in the kidney, induces anti-diuretic, anti-natriuretic, and anti-kaliuretic effects.	[Jankowski, Marek; Danalache, Bogdan A.; Plante, Eric; Menaouar, Ahmed; Florian, Maria; Tan, Ju Jing; Grygorczyk, Ryszard; Gutkowska, Jolanta] Univ Montreal, CRCHUM, Dept Med, Quebec City, PQ, Canada; [Broderick, Tom L.] Midwestern Univ, Coll Grad Studies, Dept Physiol, Glendale, AZ USA	Universite de Montreal; Midwestern University	Jankowski, M; Gutkowska, J (corresponding author), Univ Montreal, CRCHUM, Dept Med, Quebec City, PQ, Canada.	marek.jankowski@umontreal.ca; jolanta.gutkowska@umontreal.ca	Jankowski, Marek/AAF-7643-2019; Danalache, Bogdan Alexandru 1/B-3958-2010	Jankowski, Marek/0000-0002-1245-0733; 	Canadian Institutes of Health Research; Canadian Heart and Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This study was supported in part by the Canadian Institutes of Health Research and the Canadian Heart and Stroke Foundation to Jolanta Gutkowska and Marek Jankowski. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSTEIN M, 1988, PEPTIDES, V9, P87, DOI 10.1016/0196-9781(88)90014-9; AMICO JA, 1990, NEUROENDOCRINOLOGY, V51, P437, DOI 10.1159/000125371; BALMENT RJ, 1980, BRIT J PHARMACOL, V68, pP154; Bradley J, 2009, METHODS MOL BIOL, V552, P171, DOI 10.1007/978-1-60327-317-6_12; CHOU CL, 1995, AM J PHYSIOL-RENAL, V269, pF78, DOI 10.1152/ajprenal.1995.269.1.F78; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; Danalache BA, 2007, STEM CELLS, V25, P679, DOI 10.1634/stemcells.2005-0610; Danalache BA, 2014, J ENDOCRINOL, V220, P277, DOI 10.1530/JOE-13-0305; Danalache BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013643; Ecelbarger CA, 2001, EXP NEUROL, V171, P227, DOI 10.1006/exnr.2001.7775; Florian M, 2010, ENDOCRINOLOGY, V151, P482, DOI 10.1210/en.2009-0624; Gassanov N, 2008, STEM CELLS, V26, P45, DOI 10.1634/stemcells.2007-0289; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gutkowska J, 2012, J NEUROENDOCRINOL, V24, P599, DOI 10.1111/j.1365-2826.2011.02235.x; Gutkowska J, 1997, P NATL ACAD SCI USA, V94, P11704, DOI 10.1073/pnas.94.21.11704; Gutkowska J, 2007, AM J PHYSIOL-HEART C, V293, pH2262, DOI 10.1152/ajpheart.01320.2006; HAANWINCKEL MA, 1995, P NATL ACAD SCI USA, V92, P7902, DOI 10.1073/pnas.92.17.7902; Kocyigit UM, 2017, J BIOCHEM MOL TOXIC, V31, DOI 10.1002/jbt.21972; Light KC, 2005, HORM BEHAV, V47, P540, DOI 10.1016/j.yhbeh.2004.12.010; Manning M, 2012, J NEUROENDOCRINOL, V24, P609, DOI 10.1111/j.1365-2826.2012.02303.x; Menaouar A, 2014, INT J CARDIOL, V175, P38, DOI 10.1016/j.ijcard.2014.04.174; Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146; Mitchell BF, 1998, BIOL REPROD, V59, P1321, DOI 10.1095/biolreprod59.6.1321; Mitchell BF, 1998, REV REPROD, V3, P113, DOI 10.1530/revreprod/3.2.113; Moeller HB, 2012, PFLUG ARCH EUR J PHY, V464, P133, DOI 10.1007/s00424-012-1129-4; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; MORRIS M, 1992, AM J PHYSIOL, V263, pR738, DOI 10.1152/ajpregu.1992.263.3.R738; MUELLERHEUBACH E, 1995, AM J OBSTET GYNECOL, V173, P375, DOI 10.1016/0002-9378(95)90255-4; Ponomarchuk O, 2016, PFLUG ARCH EUR J PHY, V468, P2075, DOI 10.1007/s00424-016-1896-4; Rieg T, 2010, J AM SOC NEPHROL, V21, P2059, DOI 10.1681/ASN.2010040409; Sebti Y, 2015, RES PHARM SCI, V10, P259; Slusarz MJ, 2006, J PEPT SCI, V12, P171, DOI 10.1002/psc.713; Soares TJ, 1999, P NATL ACAD SCI USA, V96, P278, DOI 10.1073/pnas.96.1.278; Stockand JD, 2010, KIDNEY INT, V78, P849, DOI 10.1038/ki.2010.276; TRIBOLLET E, 1988, KIDNEY INT, V33, P959, DOI 10.1038/ki.1988.94; Varga EV, 1998, EUR J PHARMACOL, V348, pR1, DOI 10.1016/S0014-2999(98)00258-1; VERBALIS JG, 1991, ENDOCRINOLOGY, V128, P1317, DOI 10.1210/endo-128-3-1317; Viero C, 2010, CNS NEUROSCI THER, V16, pe138, DOI 10.1111/j.1755-5949.2010.00185.x; Walter MF, 2000, J ENDOCRINOL, V165, P19, DOI 10.1677/joe.0.1650019	39	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219205	10.1371/journal.pone.0219205	http://dx.doi.org/10.1371/journal.pone.0219205			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269062	Green Published, Green Submitted, gold			2022-12-26	WOS:000484927300052
J	Lindner, K; Ludwig, M; Bootz, F; Reber, U; Safavieh, Z; Eis-Hubinger, AM; Herberhold, S				Lindner, Kira; Ludwig, Michael; Bootz, Friedrich; Reber, Ulrike; Safavieh, Zahrasadat; Eis-Huebinger, Anna Maria; Herberhold, Stephan			Frequent detection of Saffold cardiovirus in adenoids	PLOS ONE			English	Article							VIRUS-INFECTION; AICHI VIRUS; GENOTYPE 3; CHILDREN; SEROEPIDEMIOLOGY; YAMAGATA	Saffold virus (SAFV) is classified into the Cardiovirus genus of the Picornaviridae family. Up to now, eleven genotypes have been identified however, their clinical significance remains unclear. Here, we investigated the presence of SAFV in asymptomatic patients admitted for adenoidectomy. A total of 70 adenoid tissue samples were collected from children with clinical symptoms caused by hypertrophy of adenoids but without symptoms of airway infection. Samples were investigated for SAFV by RT-nested PCR and sequence analysis. Eleven of 70 (15.7%) samples were positive for SAFV. Nasopharyngeal swabs were available from 45 children just before surgery. SAFV was rarely found and only in children with SAFV-positive adenoids 2/8. Our findings indicate that the presence of SAFV seems to be more frequent in adenoid tissue than expected. This could support the notion of a longer than previously anticipated persistence of SAFV nucleic acids in the respiratory tract and possibly a chronic infection. Further investigations are necessary to establish the role of SAFV infection in humans.	[Lindner, Kira; Bootz, Friedrich; Herberhold, Stephan] Univ Bonn, ENT Dept, Head & Neck Surg, Bonn, Germany; [Ludwig, Michael] Univ Bonn, Dept Clin Chem & Clin Pharmacol, Bonn, Germany; [Reber, Ulrike; Safavieh, Zahrasadat; Eis-Huebinger, Anna Maria] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany; [Lindner, Kira] Univ Bonn, Dept Gynecol & Obstet, Bonn, Germany; [Herberhold, Stephan] Waldkrankenhaus, ENT Dept, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn	Herberhold, S (corresponding author), Univ Bonn, ENT Dept, Head & Neck Surg, Bonn, Germany.; Eis-Hubinger, AM (corresponding author), Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany.; Herberhold, S (corresponding author), Waldkrankenhaus, ENT Dept, Bonn, Germany.	anna-maria.eis-huebinger@ukbonn.de; stephan.herberhold@johanniter-kliniken.de						Abed Y, 2008, EMERG INFECT DIS, V14, P834, DOI 10.3201/eid1405.071675; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Chiu CY, 2010, J VIROL, V84, P4407, DOI 10.1128/JVI.02536-09; Chiu CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/pnas.0805968105; Chua KB, 2011, EMERG INFECT DIS, V17, P1562, DOI 10.3201/eid1708.101380; Drexler JF, 2008, EMERG INFECT DIS, V14, P1398, DOI 10.3201/eid1409.080570; Drexler JF, 2010, J GEN VIROL, V91, P1418, DOI 10.1099/vir.0.018887-0; Galama J, 2011, EMERG INFECT DIS, V17, P1572, DOI 10.3201/eid1708.101953; Galama JMD, 2014, ANN CLIN TRANSL NEUR, V1, P618, DOI 10.1002/acn3.82; Herberhold S, 2009, J CLIN MICROBIOL, V47, P2682, DOI 10.1128/JCM.00899-09; Himeda T, 2012, J VIROL, V86, P1292, DOI 10.1128/JVI.06087-11; Himeda T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-110; Itagaki T, 2018, J MED VIROL, V90, P34, DOI 10.1002/jmv.24928; Itagaki T, 2011, PEDIATR INFECT DIS J, V30, P680, DOI 10.1097/INF.0b013e31821608a8; Itagaki T, 2010, SCAND J INFECT DIS, V42, P950, DOI 10.3109/00365548.2010.496791; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Kobayashi M, 2013, J INFECTION, V66, P191, DOI 10.1016/j.jinf.2012.10.022; Leguia M, 2015, PATHOGENS, V4, P816, DOI 10.3390/pathogens4040816; Li LL, 2017, J CLIN VIROL, V87, P37, DOI 10.1016/j.jcv.2016.12.003; Lin TL, 2015, J CLIN VIROL, V70, P7, DOI 10.1016/j.jcv.2015.06.100; Nielsen ACY, 2013, J CLIN VIROL, V57, P239, DOI 10.1016/j.jcv.2013.03.015; Nielsen ACY, 2012, EMERG INFECT DIS, V18, P7, DOI 10.3201/eid1801.110725; Nielsen TS, 2016, J CLIN VIROL, V74, P78, DOI 10.1016/j.jcv.2015.11.028; Oleszak EL, 2004, CLIN MICROBIOL REV, V17, P174, DOI 10.1128/CMR.17.1.174-207.2004; Ren LL, 2010, EMERG INFECT DIS, V16, P1158, DOI 10.3201/eid1607.091682; Sato M, 2009, J CLIN MICROBIOL, V47, P771, DOI 10.1128/JCM.02331-08; Tan SZK, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1908; Yodmeeklin A, 2015, J MED VIROL, V87, P702, DOI 10.1002/jmv.24114; Zhang XA, 2015, SCI REP-UK, V5, DOI 10.1038/srep07704; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							0218873	10.1371/journal.pone.0218873	http://dx.doi.org/10.1371/journal.pone.0218873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269055	Green Submitted, Green Published, gold			2022-12-26	WOS:000484927300028
J	Defnet, AE; Huang, WL; Polischak, S; Yadav, SK; Kane, MA; Shapiro, P; Deshpande, DA				Defnet, Amy E.; Huang, Weiliang; Polischak, Steven; Yadav, Santosh Kumar; Kane, Maureen A.; Shapiro, Paul; Deshpande, Deepak A.			Effects of ATP-competitive and function-selective ERK inhibitors on airway smooth muscle cell proliferation	FASEB JOURNAL			English	Article						asthma; airway inflammation; activator protein-1; proteomics; kinase inhibitor	SIGNAL-REGULATED KINASE; PROTEIN-COUPLED RECEPTORS; GROWTH-FACTOR RECEPTOR; TRANSCRIPTION FACTORS; GENE-EXPRESSION; DOCKING MOTIF; ACTIVATION; ASTHMA; COMPONENTS; PATHWAYS	Increased airway smooth muscle (ASM) cell mass and secretory functions are characteristics of airway inflammatory diseases, such as asthma. To date, there are no effective therapies to combat ASM cell proliferation, which contributes to bronchoconstriction and airway obstruction. Growth factors such as platelet-derived growth factor (PDGF) and the activation of the ERK1/2 are major regulators of ASM cell proliferation and airway remodeling in asthma. However, given the ubiquitous expression and multiple functions of ERK1/2, complete inhibition of ERK1/2 using ATP-competitive inhibitors may lead to unwanted off-target effects. Alternatively, we have identified compounds that are designed to target substrate docking sites and act as function-selective inhibitors of ERK1/2 signaling. Here, we show that both function-selective and ATP-competitive ERK1/2 inhibitors are effective at inhibiting PDGF-mediated proliferation, collagen production, and IL-6 secretion in ASM cells. Proteomic analysis revealed that both types of inhibitors had similar effects on reducing proteins related to TGF-beta and IL-6 signaling that are relevant to airway remodeling. However, function-selective ERK1/2 inhibitors caused fewer changes in protein expression compared with ATP-competitive inhibitors. These studies provide a molecular basis for the development of function-selective ERK1/2 inhibitors to mitigate airway remodeling in asthma with defined regulation of ERK1/2 signaling.-Defnet, A. E., Huang, W., Polischak, S., Yadav, S. K., Kane, M. A., Shapiro, P., Deshpande, D. A. Effects of ATP-competitive and function-selective ERK inhibitors on airway smooth muscle cell proliferation.	[Defnet, Amy E.; Huang, Weiliang; Kane, Maureen A.; Shapiro, Paul] Univ Maryland, Dept Pharmaceut Sci, 20 Penn St,Rm 561, Baltimore, MD 21201 USA; [Polischak, Steven; Yadav, Santosh Kumar; Deshpande, Deepak A.] Jefferson Univ, Dept Med, 1020 Locust St,Rm 543B, Philadelphia, PA 19107 USA	University System of Maryland; University of Maryland Baltimore; Jefferson University	Shapiro, P (corresponding author), Univ Maryland, Dept Pharmaceut Sci, 20 Penn St,Rm 561, Baltimore, MD 21201 USA.; Deshpande, DA (corresponding author), Jefferson Univ, Dept Med, 1020 Locust St,Rm 543B, Philadelphia, PA 19107 USA.	pshapiro@rx.umaryland.edu; deshpande@jefferson.edu	Yadav, Santosh/GQZ-7569-2022; YADAV, SANTOSH KUMAR/AAU-6594-2020	YADAV, SANTOSH KUMAR/0000-0001-7375-1698	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [AI26492]; University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]; NIH National Institute of General Medical Sciences [T32 GM066706]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI126492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases; University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant from the U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (AI26492; to P.S. and D.A.D.), and, in part, by the University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center (SOP1841-IQB2014). This work was also supported by NIH National Institute of General Medical Sciences Grant T32 GM066706 (to A.E.D.). A.E.D. and W.H. are co-first authors. The authors declare no conflicts of interest.	Ammit AJ, 2001, J APPL PHYSIOL, V91, P1431, DOI 10.1152/jappl.2001.91.3.1431; Amrani Y, 2003, INT J BIOCHEM CELL B, V35, P272, DOI 10.1016/S1357-2725(02)00259-5; Aronov AM, 2009, J MED CHEM, V52, P6362, DOI 10.1021/jm900630q; Ather JL, 2011, AM J RESP CELL MOL, V44, P631, DOI 10.1165/rcmb.2010-0106OC; Baud'huin M, 2013, CYTOKINE GROWTH F R, V24, P401, DOI 10.1016/j.cytogfr.2013.06.001; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; Billington CK, 2005, BIOCHEMISTRY-US, V44, P14595, DOI 10.1021/bi0510734; Black JL, 2001, AM J RESP CRIT CARE, V164, pS63, DOI 10.1164/ajrccm.164.supplement_2.2106059; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Bottoms SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009674; Bourke JE, 2011, EUR RESPIR J, V37, P173, DOI 10.1183/09031936.00008109; Burgess JK, 2008, J CELL PHYSIOL, V216, P673, DOI 10.1002/jcp.21450; Burkhard K, 2009, CURR TOP MED CHEM, V9, P678, DOI 10.2174/156802609789044416; Caramori G, 2013, CELL COMMUN ADHES, V20, P21, DOI 10.3109/15419061.2013.775257; Chen FM, 2006, BIOORG MED CHEM LETT, V16, P6281, DOI 10.1016/j.bmcl.2006.09.038; Chiappara G, 2007, ALLERGY, V62, P787, DOI 10.1111/j.1398-9995.2007.01417.x; Chiba Takahito, 2012, J Allergy (Cairo), V2012, P372384, DOI 10.1155/2012/372384; Dekkers Bart G J, 2009, Proc Am Thorac Soc, V6, P683, DOI 10.1513/pats.200907-056DP; DEMOLY P, 1992, AM J RESP CELL MOL, V7, P128, DOI 10.1165/ajrcmb/7.2.128; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; FROST JA, 1994, P NATL ACAD SCI USA, V91, P3844, DOI 10.1073/pnas.91.9.3844; Gauderman WJ, 2013, GENET EPIDEMIOL, V37, P603, DOI 10.1002/gepi.21748; Germann UA, 2017, MOL CANCER THER, V16, P2351, DOI 10.1158/1535-7163.MCT-17-0456; Girodet PO, 2011, PHARMACOL THERAPEUT, V130, P325, DOI 10.1016/j.pharmthera.2011.02.001; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Halwani R, 2010, CURR OPIN PHARMACOL, V10, P236, DOI 10.1016/j.coph.2010.06.004; Hancock CN, 2005, J MED CHEM, V48, P4586, DOI 10.1021/jm0501174; Hedges JC, 2000, AM J RESP CELL MOL, V23, P86, DOI 10.1165/ajrcmb.23.1.4014; Hershenson MB, 1999, AM J RESP CELL MOL, V21, P651, DOI 10.1165/ajrcmb.21.6.f168; Hirst Stuart J, 2004, J Allergy Clin Immunol, V114, pS2, DOI 10.1016/j.jaci.2004.04.039; Hou CC, 2011, MOL MED, V17, P807, DOI 10.2119/molmed.2010.00173; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kassel KM, 2009, AM J PHYSIOL-LUNG C, V296, pL693, DOI 10.1152/ajplung.90446.2008; Kong KC, 2006, FASEB J, V20, P1558, DOI 10.1096/fj.05-5622fje; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Krymskaya VP, 2000, AM J RESP CELL MOL, V23, P546, DOI 10.1165/ajrcmb.23.4.4115; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Loke TK, 2006, J ALLERGY CLIN IMMUN, V118, P368, DOI 10.1016/j.jaci.2006.04.055; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Oliver BGG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-71; Oram JF, 2001, J LIPID RES, V42, P1173; Orsini MJ, 1999, AM J PHYSIOL-LUNG C, V277, pL479, DOI 10.1152/ajplung.1999.277.3.L479; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Panettieri Reynold A. Jr., 2002, Journal of Allergy and Clinical Immunology, V110, pS269, DOI 10.1067/mai.2002.129429; Pera T., 2019, FASEB J; Pera T, 2018, FASEB J, V32, P862, DOI 10.1096/fj.201700555R; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Qi D, 2012, OMICS, V16, P489, DOI 10.1089/omi.2012.0042; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Samadani R, 2015, BIOCHEM J, V467, P425, DOI 10.1042/BJ20131571; Sharma P, 2017, SCI REP-UK, V7, DOI 10.1038/srep46166; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sullivan RJ, 2018, CANCER DISCOV, V8, P184, DOI 10.1158/2159-8290.CD-17-1119; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Williamson JC, 2016, PROTEOMICS, V16, P907, DOI 10.1002/pmic.201400545; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu T, 2015, J IMMUNOL, V195, P5539, DOI 10.4049/jimmunol.1501198; Zhou LM, 2003, RESP PHYSIOL NEUROBI, V137, P295, DOI 10.1016/S1569-9048(03)00154-X; Zuyderduyn S, 2008, EUR RESPIR J, V32, P265, DOI 10.1183/09031936.00051407	68	16	16	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10833	10843		10.1096/fj.201900680R	http://dx.doi.org/10.1096/fj.201900680R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31266368	Green Published, Bronze			2022-12-26	WOS:000489166300021
J	Forster, R; Sarginson, A; Velichkova, A; Hogg, C; Dorning, A; Horne, AW; Saunders, PTK; Greaves, E				Forster, Rachel; Sarginson, Alexandra; Velichkova, Atanaska; Hogg, Chloe; Dorning, Ashley; Horne, Andrew W.; Saunders, Philippa T. K.; Greaves, Erin			Macrophage-derived insulin-like growth factor-1 is a key neurotrophic and nerve-sensitizing factor in pain associated with endometriosis	FASEB JOURNAL			English	Article						hyperalgesia; leukocytes; neurotrophin; nerve	QUALITY-OF-LIFE; MOUSE MODEL; MOLECULAR-MECHANISMS; RAT MODEL; RECEPTOR; CELLS; WOMEN; EXPRESSION; INHIBITION; PATHWAYS	Endometriosis is a common incurable inflammatory disorder that is associated with debilitating pelvic pain in women. Macrophages are central to the pathophysiology of endometriosis: they dictate the growth and vascularization of endometriosis lesions and more recently have been shown to promote lesion innervation. The aim of this study was to determine the mechanistic role of macrophages in producing pain associated with endometriosis. Herein, we show that macrophage depletion in a mouse model of endometriosis can reverse abnormal changes in pain behavior. We identified that disease-modified macrophages exhibit increased expression of IGF-1 in an in vitro model of endometriosis-associated macrophages and confirmed expression by lesion-resident macrophages in mice and women. Concentrations of IGF-1 were elevated in peritoneal fluid from women with endometriosis and positively correlate with their pain scores. Mechanistically, we demonstrate that macrophage-derived IGF-1 promotes sprouting neurogenesis and nerve sensitization in vitro. Finally, we show that the Igf-1 receptor inhibitor linsitinib reverses the pain behavior observed in mice with endometriosis. Our data support a role for macrophage-derived IGF-1 as a key neurotrophic and sensitizing factor in endometriosis, and we propose that therapies that modify macrophage phenotype may be attractive therapeutic options for the treatment of women with endometriosis-associated pain.-Forster, R., Sarginson, A., Velichkova, A., Hogg, C., Dorning, A., Horne, A. W., Saunders, P. T. K., Greaves, E. Macrophage-derived insulin-like growth factor-1 is a key neurotrophic and nerve-sensitizing factor in pain associated with endometriosis.	[Forster, Rachel; Sarginson, Alexandra; Velichkova, Atanaska; Hogg, Chloe; Dorning, Ashley; Horne, Andrew W.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Saunders, Philippa T. K.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Greaves, Erin] Univ Warwick, Warwick Med Sch, Div Biomed Sci, Coventry CV2 2DX, W Midlands, England	University of Edinburgh; University of Edinburgh; University of Warwick	Greaves, E (corresponding author), Univ Warwick, Warwick Med Sch, Div Biomed Sci, Coventry CV2 2DX, W Midlands, England.	erin.greaves@warwick.ac.uk	Forster, Rachel/AAS-2634-2021; Saunders, Philippa/C-7489-2013	Velichkova, Atanaska/0000-0002-6941-1188; Saunders, Philippa/0000-0001-9051-9380; Hogg, Chloe/0000-0002-3277-5359	Medical Research Council Career Development Award [MR/M009238/1]; Rosetree's Trust research grant [A1759]; Medical Research Council Programme grant [MR/N024524/1]; Wellbeing of Women grant [R42533]; Medical Research Council (MRC) Centre grant [MR/N022556/1]; MRC [MR/M009238/2, MR/N024524/1, 1789503] Funding Source: UKRI	Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetree's Trust research grant; Medical Research Council Programme grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellbeing of Women grant(Wellbeing of Women (WoW)); Medical Research Council (MRC) Centre grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank all the women who gave informed consent for the use of material in this study, research nurses Helen Dewart and Jennifer Devlin [National Health Service (NHS) Lothian, Edinburgh, United Kingdom] who organized tissue collection, and Halima Hassan and Kathryn Newton (University of Edinburgh) for technical support. The authors also thank Ronnie Grant (University of Edinburgh) for the figure preparation. This work was supported by a Medical Research Council Career Development Award (MR/M009238/1; to E.G.), a Rosetree's Trust research grant (A1759; to E.G.), a Medical Research Council Programme grant (MR/N024524/1; to P.T.K.S.), a Wellbeing of Women grant (R42533 to A.W.H.), and a Medical Research Council (MRC) Centre grant (MR/N022556/1). The authors declare no conflicts of interest.	Andon FT, 2017, SEMIN IMMUNOL, V34, P103, DOI 10.1016/j.smim.2017.09.004; Bacci M, 2009, AM J PATHOL, V175, P547, DOI 10.2353/ajpath.2009.081011; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Becker CM, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.709; Berkley KJ, 2004, P NATL ACAD SCI USA, V101, P11094, DOI 10.1073/pnas.0403663101; Beste MT, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007988; Bulun SE, 2002, J REPROD IMMUNOL, V55, P21, DOI 10.1016/S0165-0378(01)00132-2; Capobianco A, 2011, AM J PATHOL, V179, P2651, DOI 10.1016/j.ajpath.2011.07.029; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Cousins FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086378; Coxon L, 2018, BEST PRACT RES CL OB, V51, P53, DOI 10.1016/j.bpobgyn.2018.01.014; Dodds KN, 2019, REPROD SCI, V26, P357, DOI 10.1177/1933719118773405; Fassbender A, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1209; Gao X, 2006, CURR MED RES OPIN, V22, P1787, DOI 10.1185/030079906X121084; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ghasemlou N, 2015, P NATL ACAD SCI USA, V112, pE6808, DOI 10.1073/pnas.1501372112; Gogacz M, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/3175394; Greaves E, 2017, SCI REP-UK, V7, DOI 10.1038/srep44169; Greaves E, 2015, AM J PATHOL, V185, P2286, DOI 10.1016/j.ajpath.2015.04.012; Greaves E, 2014, ENDOCRINOLOGY, V155, P4015, DOI 10.1210/en.2014-1086; Greaves E, 2014, J CLIN ENDOCR METAB, V99, pE1738, DOI 10.1210/jc.2014-2282; Greaves E, 2014, AM J PATHOL, V184, P1930, DOI 10.1016/j.ajpath.2014.03.011; Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007; HALME J, 1987, AM J OBSTET GYNECOL, V156, P783, DOI 10.1016/0002-9378(87)90333-4; HALME J, 1991, ANN NY ACAD SCI, V622, P266; Ho HN, 1997, HUM REPROD, V12, P2528, DOI 10.1093/humrep/12.11.2528; Jacobson TZ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001300.pub2; Ji RR, 2016, SCIENCE, V354, P572, DOI 10.1126/science.aaf8924; Ji RR, 2014, NAT REV DRUG DISCOV, V13, P533, DOI 10.1038/nrd4334; Johnson NP, 2013, HUM REPROD, V28, P1552, DOI 10.1093/humrep/det050; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kim JG, 2000, FERTIL STERIL, V73, P996, DOI 10.1016/S0015-0282(00)00493-3; Koutsilieris M, 2001, MOL MED, V7, P20, DOI 10.1007/BF03401835; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Li Y, 2014, EUR J PAIN, V18, P774, DOI 10.1002/j.1532-2149.2013.00420.x; Lin SF, 2016, NEUROREPORT, V27, P737, DOI 10.1097/WNR.0000000000000607; McKinnon BD, 2015, TRENDS ENDOCRIN MET, V26, P1, DOI 10.1016/j.tem.2014.10.003; Mert T, 2009, N-S ARCH PHARMACOL, V379, P445, DOI 10.1007/s00210-008-0387-3; Miller RE, 2012, P NATL ACAD SCI USA, V109, P20602, DOI 10.1073/pnas.1209294110; Miller Richard J, 2009, Handb Exp Pharmacol, P417, DOI 10.1007/978-3-540-79090-7_12; Mirkin D, 2007, J MANAGE CARE PHARM, V13, P262, DOI 10.18553/jmcp.2007.13.3.262; Miura M, 2011, PAIN, V152, P888, DOI 10.1016/j.pain.2011.01.004; Old EA, 2014, J CLIN INVEST, V124, P2023, DOI 10.1172/JCI71389; OOSTERLYNCK DJ, 1993, ARCH GYNECOL OBSTET, V253, P197, DOI 10.1007/BF02766646; Rahmioglu N, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1208; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Simoens S, 2012, HUM REPROD, V27, P1292, DOI 10.1093/humrep/des073; Tokushige N, 2006, HUM REPROD, V21, P3001, DOI 10.1093/humrep/del260; Tran LVP, 2009, HUM REPROD, V24, P835, DOI 10.1093/humrep/den483; Vardeh D, 2009, J CLIN INVEST, V119, P287, DOI 10.1172/JCI37098; Vitonis AF, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1244; Wang H, 2014, ENDOCRINOLOGY, V155, P168, DOI 10.1210/en.2013-1559; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yan X, 2017, J NEUROCHEM, V140, P963, DOI 10.1111/jnc.13952; Zhang Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005283; Zhou Y, 2016, J MOL MED, V94, P887, DOI 10.1007/s00109-016-1396-1	56	53	57	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11210	11222		10.1096/fj.201900797R	http://dx.doi.org/10.1096/fj.201900797R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31291762	Green Published, hybrid			2022-12-26	WOS:000489166300052
J	Agyenim-Boateng, KG; Lu, JN; Shi, YZ; Zhang, D; Yin, XG				Agyenim-Boateng, Kwadwo Gyapong; Lu, Jiannong; Shi, Yuzhen; Zhang, Dan; Yin, Xuegui			SRAP analysis of the genetic diversity of wild castor (Ricinus communis L.) in South China	PLOS ONE			English	Article							POPULATION-STRUCTURE; OIL; MARKERS; SSR; IMPROVEMENT; GERMPLASM	Castor bean is an important seed oil crop. Castor oil is a highly demanded oil for several industrial uses. Currently, castor bean varieties suffer from low productivity and high risk of insect pests and diseases. It is in urgent need to mine elite genes from wild materials for castor breeding. 29 pairs of polymorphic SRAP primers out of 361 pairs were used to analyse the genetic diversity of 473 wild castor materials from South China. 203 bands were amplified by the 29 pairs of primers, of which 169 bands were polymorphic, with a polymorphic percentage of 83.25%. With an average number of alleles per locus (A(p)) of 1.801, average number of effective alleles per locus (A(e)) of 1.713 and average percentage of polymorphic loci (P) of 90.04%, these primers were proven to be useful and effective. Nei' genetic distance between the materials ranged from 1.04 to 25.02, with an average of 13.03. At the genetic distance of 25.02, the materials clustered into two major groups, consistent with the result of population structure analysis. However, more subgroups existed between 5.21 and 13.32. Although not all the materials from the same region were clustered in the same group, an obvious trend existed where the groups were related to regions to a great extent. Based on multiple indices, the genetic diversity of materials from Hainan was the lowest. However, there was not much difference between West Guangdong and Guangxi, although the former was slightly higher. Moderate genetic differentiation was observed in wild materials in South China. The genetic differentiation mainly occurred within population, with maximum differentiation in Guangxi, followed by West Guangdong and the minimum in Hainan. Nonetheless, there was an extensive geneflow between populations. The above results provided a direction for the conservation and breeding application of these materials.	[Agyenim-Boateng, Kwadwo Gyapong; Lu, Jiannong; Shi, Yuzhen; Zhang, Dan; Yin, Xuegui] Guangdong Ocean Univ, Coll Agr Sci, Zhanjiang, Guangdong, Peoples R China	Guangdong Ocean University	Yin, XG (corresponding author), Guangdong Ocean Univ, Coll Agr Sci, Zhanjiang, Guangdong, Peoples R China.	yinxuegui@126.com	Agyenim-Boateng, Kwadwo Gyapong/AAW-5171-2020	Agyenim-Boateng, Kwadwo Gyapong/0000-0002-2878-5159	National Natural Science Foundation of China [31271759]; Guangdong Provincial Science and Technology Projects (China) [2013B060400024, 2014A020208116, 2016A020208015]; Project of Enhancing School with Innovation of Guangdong Ocean University (China) [GDOU2013050206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Projects (China); Project of Enhancing School with Innovation of Guangdong Ocean University (China)	This work was supported by the National Natural Science Foundation of China (31271759) to XY; Guangdong Provincial Science and Technology Projects (2013B060400024, 2014A020208116, 2016A020208015) (China) to XY; and the Project of Enhancing School with Innovation of Guangdong Ocean University (GDOU2013050206) (China) to XY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbagwa IO, 2014, INDIAN J BIOTECHNOL, V13, P486; Allan G, 2008, GENET RESOUR CROP EV, V55, P365, DOI 10.1007/s10722-007-9244-3; Amar MH, 2011, SCI HORTIC-AMSTERDAM, V128, P220, DOI 10.1016/j.scienta.2011.01.021; Bajay MM, 2009, CONSERV GENET RESOUR, V1, P237, DOI 10.1007/s12686-009-9058-z; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Budak H, 2004, THEOR APPL GENET, V109, P280, DOI 10.1007/s00122-004-1630-z; Budak H, 2004, HORTSCIENCE, V39, P955, DOI 10.21273/HORTSCI.39.5.955; Cesar AD, 2010, ENERG POLICY, V38, P4031, DOI 10.1016/j.enpol.2010.03.027; Clark PL., 2005, THESIS; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Foster JT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-13; Gepts P., 2004, Plant Breeding Reviews, V24, P1, DOI 10.1002/9780470650288.ch1; Goto E, 2002, OPHTHALMOLOGY, V109, P2030, DOI 10.1016/S0161-6420(02)01262-9; Jahnvi Bhatt, 2017, Annals of Agrarian Science, V15, P434, DOI 10.1016/j.aasci.2017.09.001; Jeong GT, 2009, APPL BIOCHEM BIOTECH, V156, P431, DOI 10.1007/s12010-008-8468-9; Kallamadi PR, 2015, IND CROP PROD, V66, P271, DOI 10.1016/j.indcrop.2014.12.061; Khanal S, 2007, CORNEA, V26, P175, DOI 10.1097/ICO.0b013e31802b492d; Krumm JT, 2005, THESIS; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Li G., 2013, SRAP MOL MARKER TECH; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Martin J H, 1967, PRINCIPLES FIELD CRO; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Morris B., 2004, Current Topics in Plant Biology, Volume 5, P63; Morris JB, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES - OILSEEDS, P251, DOI 10.1007/978-3-642-14871-2_15; Nei M., 1973, Genetic structure of populations. Proceedings of a conference sponsored by the University of Hawaii, 1973., P45; Ogunniyi DS, 2006, BIORESOURCE TECHNOL, V97, P1086, DOI 10.1016/j.biortech.2005.03.028; Perry BA, 1943, AM J BOT, V30, P527, DOI 10.2307/2437291; Pritchard JK, 2000, GENETICS, V155, P945; Purseglove JW, 1981, TROPICAL CROPS DICOT, P1; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Rukhsar, 2017, IND CROP PROD, V97, P316, DOI 10.1016/j.indcrop.2016.12.036; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; Senthilvel S, 2017, J PLANT BIOCHEM BIOT, V26, P27, DOI 10.1007/s13562-016-0356-8; Severino LS, 2012, AGRON J, V104, P853, DOI 10.2134/agronj2011.0210; Simoes KS, 2017, GENET MOL RES, V16; Singh AS, 2015, IND CROP PROD, V74, P55, DOI 10.1016/j.indcrop.2015.05.001; Sujatha M, 2008, BIOTECHNOL ADV, V26, P424, DOI 10.1016/j.biotechadv.2008.05.004; Thatikunta R, 2016, PHYSIOL MOL BIOL PLA, V22, P535, DOI 10.1007/s12298-016-0367-x; Tiroesele B, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.62; Vanaja M, 2008, PLANT SOIL ENVIRON, V54, P38, DOI 10.17221/386-PSE; Wang ML, 2017, GENOME, V60, P193, DOI 10.1139/gen-2016-0116; Wright S, 1931, GENETICS, V16, P0097; Yeh FC, 1997, POPGENE MICROSOFT WI; Zargar SM, 2016, SAUDI J BIOL SCI, V23, P139, DOI 10.1016/j.sjbs.2014.11.011	45	6	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219667	10.1371/journal.pone.0219667	http://dx.doi.org/10.1371/journal.pone.0219667			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295303	Green Submitted, Green Published, gold			2022-12-26	WOS:000484951800059
J	Talpin, A; Kattah, MG; Advincula, R; Fadrosh, D; Lynch, K; LaMere, B; Fujimura, KE; Nagalingam, NA; Malynn, BA; Lynch, SV; Ma, A				Talpin, Alice; Kattah, Michael G.; Advincula, Rommel; Fadrosh, Douglas; Lynch, Kole; LaMere, Brandon; Fujimura, Kei E.; Nagalingam, Nabeetha A.; Malynn, Barbara A.; Lynch, Susan V.; Ma, Averil			A20 in dendritic cells restrains intestinal anti-bacterial peptide expression and preserves commensal homeostasis	PLOS ONE			English	Article							MICROBIOTA; ACTIVATION	Microbial dysbiosis commonly occurs in patients with inflammatory bowel diseases (IBD). Exogenous causes of dysbiosis such as antibiotics and diet are well described, but host derived causes are understudied. A20 is a potent regulator of signals triggered by microbial pattern molecules, and A20 regulates susceptibility to intestinal inflammation in mice and in humans. We now report that mice lacking A20 expression in dendritic cells, A20(FL/FL) CD11c-Cre mice (or A20(dDC) mice), spontaneously develop colitogenic intestinal dysbiosis that is evident upon weaning and precedes the onset of colitis. Intestines from A20(dDC) mice express increased amounts of Reg3 beta and Reg3 gamma, but not Ang4. A20 deficient DCs promote gut microbiota perturbation in the absence of adaptive lymphocytes. Moreover, A20 deficient DCs directly induce expression of Reg3 beta and Reg3 gamma but not Ang 4 in normal intestinal epithelial cell enteroid cultures in the absence of other cell types. These findings reveal a pathophysiological pathway in which defective expression of an IBD susceptibility gene in DCs drives aberrant expression of anti-bacterial peptides and luminal dysbiosis that in turn confers host susceptibility to intestinal inflammation.	[Talpin, Alice; Kattah, Michael G.; Advincula, Rommel; Fadrosh, Douglas; Lynch, Kole; LaMere, Brandon; Fujimura, Kei E.; Nagalingam, Nabeetha A.; Malynn, Barbara A.; Lynch, Susan V.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu		Kattah, Michael/0000-0002-6067-6585	NIH [DK095693]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NIH, grant# DK095693 to AM. The funder played no role in the study design, data collection, decision to publish, or preparation of the manuscript.	Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Durack J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03157-4; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Kattah MG, 2018, J EXP MED, V215, P1839, DOI 10.1084/jem.20180198; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Koprivnjak T, 2002, J BIOL CHEM, V277, P47636, DOI 10.1074/jbc.M205104200; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lazar V, 2018, NAT MICROBIOL, V3, P718, DOI 10.1038/s41564-018-0164-0; Liang J, 2016, CELL REP, V25, P289; Morizane S, 2012, J DERMATOL, V39, P225, DOI 10.1111/j.1346-8138.2011.01483.x; Swafford D, 2018, J IMMUNOL, V200, P3259, DOI 10.4049/jimmunol.1701086; Tang C, 2018, NAT IMMUNOL, V19, P755, DOI 10.1038/s41590-018-0134-y; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Walker WA, 2015, PEDIATR RES, V77, P220, DOI 10.1038/pr.2014.160; Wang J, 2009, J IMMUNOL, V71, P3831; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Zheng CF, 2018, INFLAMM BOWEL DIS, V24, P2613, DOI 10.1093/ibd/izy165	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0218999	10.1371/journal.pone.0218999	http://dx.doi.org/10.1371/journal.pone.0218999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295268	Green Published, Green Submitted, gold			2022-12-26	WOS:000484951800010
J	Radisauskas, R; Tamosiunas, A; Kranciukaite-Butylkiniene, D; Milinaviciene, E; Malinauskiene, V; Bernotiene, G; Luksiene, D; Virviciute, D; Rastenyte, D				Radisauskas, Ricardas; Tamosiunas, Abdonas; Kranciukaite-Butylkiniene, Daina; Milinaviciene, Egle; Malinauskiene, Vilija; Bernotiene, Gailute; Luksiene, Dalia; Virviciute, Dalia; Rastenyte, Daiva			Long-term survival after stroke in Lithuania: Data from Kaunas population-based stroke registry	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ADJUSTED LIFE YEARS; GLOBAL BURDEN; CASE-FATALITY; ISCHEMIC-STROKE; SEX-DIFFERENCES; MORTALITY; TRENDS; DISEASE; PREVALENCE	Background There is a lack of reliable epidemiological data on long-term survival trends of first-ever stroke patients in Lithuanian population. Aims To evaluate trends in long-term survival after stroke and to determine the influence of some sociodemographic and lifestyle factors, time and subtype of stroke, and stroke care on survival. Methods All stroke events included in Kaunas stroke register database were ascertained and validated according to the standardized criteria outlined by the WHO MONICA Project. The study included all patients in Kaunas (Lithuania) city aged 25 to 64 years who experienced a stroke between 1986 and 2011. Death time was confirmed by the Office for National Death Statistics. Estimates of stroke long-term survival data and factors influencing survival changes were made by applying the Kaplan-Meier and Cox regression analysis. Results During the study period, 4,129 persons aged 25-64 years suffered from a first-ever stroke: 2,215 (53.6%) of them were men and 1,914 (46.4%)-women. Ischemic stroke was significantly more frequent in males than in females (80.6% and 78.6%, respectively, p<0.05) and subarachnoid hemorrhage was more common in women than in men (9.0% and 7.0% respectively, p<0.05). Of all first-ever stroke patients, 3,272 (79.2%) survived 1 year and 2,905 (70.4%) survived 5 years after stroke onset. The 1- and 5-years survival rate after a first-ever stroke in women was significantly higher as compared with that in men (Log-rank test p = 0.0001). The older (55-64 year) persons had poorer 1-year and 5-years survival rate as compared with persons in the younger (25-54 years) age group (Log-rank test p = 0.0001). Among persons with a first-ever stroke who had their stroke in 2007-2011, 1- and 5-year survival rate was higher compared with that in persons who had had a stroke in 1986-1990 and in 1997-2001 (Log-rank test p = 0.0001). The persons with a first-ever ischemic stroke had a better chance to survive first 1- and 5-years after stroke compared with persons who had intracerebral or subarachnoid haemorrhage. Only female gender was associated with higher 1- and 5-year survival rate after first-ever stroke. The older age, previous myocardial infarction and diabetes mellitus were associated with lower 1-and 5-year survival rate after first-ever stroke. Conclusions This population-based study of patients with first-ever stroke demonstrated that the long-term survival was better in women than men, and improved significantly in both men and women during the past decade. Long-term survival was better of those with first-ever ischemic stroke and of younger age-25 to 54 years.	[Radisauskas, Ricardas; Tamosiunas, Abdonas; Kranciukaite-Butylkiniene, Daina; Milinaviciene, Egle; Malinauskiene, Vilija; Bernotiene, Gailute; Luksiene, Dalia; Virviciute, Dalia] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania; [Radisauskas, Ricardas; Luksiene, Dalia] Lithuanian Univ Hlth Sci, Dept Environm & Occupat Med, Kaunas, Lithuania; [Tamosiunas, Abdonas] Lithuanian Univ Hlth Sci, Dept Prevent Med, Kaunas, Lithuania; [Kranciukaite-Butylkiniene, Daina] Lithuanian Univ Hlth Sci, Dept Family Med, Kaunas, Lithuania; [Milinaviciene, Egle] Lithuanian Univ Hlth Sci, Dept Rehabil, Kaunas, Lithuania; [Rastenyte, Daiva] Lithuanian Univ Hlth Sci, Dept Neurol, Kaunas, Lithuania	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences	Radisauskas, R (corresponding author), Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania.; Radisauskas, R (corresponding author), Lithuanian Univ Hlth Sci, Dept Environm & Occupat Med, Kaunas, Lithuania.	ricardas.radisauskas@lsmuni.lt	Tamosiunas, Abdonas/AAD-4274-2021; Radišauskas, Ričardas/AAT-8920-2021	Radišauskas, Ričardas/0000-0002-1227-2674				Arboix A, 2014, CLIN NEUROL NEUROSUR, V127, P19, DOI 10.1016/j.clineuro.2014.09.024; Ayis SA, 2013, J NEUROL NEUROSUR PS, V84, P604, DOI 10.1136/jnnp-2012-303525; Barker-Collo S, 2015, NEUROEPIDEMIOLOGY, V45, P203, DOI 10.1159/000441103; Bejot Y, 2008, REV NEUROL-FRANCE, V164, P138, DOI 10.1016/j.neurol.2007.06.003; Chen RL, 2010, NAT REV NEUROL, V6, P256, DOI 10.1038/nrneurol.2010.36; Dhamoon MS, 2018, J STROKE CEREBROVASC, V27, P210, DOI 10.1016/j.jstrokecerebrovasdis.2017.08.028; Di Carlo A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194786; Dolicanin Z, 2016, INT J PUBLIC HEALTH, V61, P131, DOI 10.1007/s00038-015-0760-1; Eliasson M, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-32; Eriksson M, 2011, J INTERN MED, V269, P219, DOI 10.1111/j.1365-2796.2010.02312.x; Fahey M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0185402; Feigin VL, 2010, NEUROLOGY, V75, P1597, DOI 10.1212/WNL.0b013e3181fb44b3; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P230, DOI 10.1159/000441106; Feigin VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134609; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Giang KW, 2013, STROKE, V44, P3338, DOI 10.1161/STROKEAHA.113.002936; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Greisenegger S, 2011, J NEUROL, V258, P1105, DOI 10.1007/s00415-010-5893-9; Henriksson KM, 2012, INT J STROKE, V7, P276, DOI 10.1111/j.1747-4949.2011.00706.x; Johansson S, 2010, J INTERN MED, V268, P594, DOI 10.1111/j.1365-2796.2010.02278.x; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Kleindorfer D, 2006, STROKE, V37, P2473, DOI 10.1161/01.STR.0000242766.65550.92; Krishnamurthi RV, 2015, NEUROEPIDEMIOLOGY, V45, P190, DOI 10.1159/000441098; Kulesh SD, 2011, STROKE, V42, P3274, DOI 10.1161/STROKEAHA.111.625400; Kunst AE, 2011, STROKE, V42, P2126, DOI 10.1161/STROKEAHA.110.599712; Modig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064928; Ng N, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.18195; Ovbiagele B, 2010, STROKE, V41, P1748, DOI 10.1161/STROKEAHA.110.585455; Peeters A, 2011, EUR J EPIDEMIOL, V26, P369, DOI 10.1007/s10654-011-9546-9; Putaala J, 2009, STROKE, V40, P2698, DOI 10.1161/STROKEAHA.109.554998; Radisauskas R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153942; Rastenyte D, 2006, SCAND J PUBLIC HEALT, V34, P488, DOI 10.1080/14034940600551640; Reklaitiene R, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-68; Rigby H, 2009, INT J STROKE, V4, P285, DOI 10.1111/j.1747-4949.2009.00289.x; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Saposnik G, 2008, STROKE, V39, P2310, DOI 10.1161/STROKEAHA.107.511402; Sutton CJ, 2010, J EPIDEMIOL COMMUN H, V64, P523, DOI 10.1136/jech.2008.086785; Tamosiunas A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3387-0; Terent A, 2009, J NEUROL NEUROSUR PS, V80, P881, DOI 10.1136/jnnp.2008.169102; Tu WJ, 2013, J NEUROENDOCRINOL, V25, P771, DOI 10.1111/jne.12052; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Vibo R, 2005, STROKE, V36, P2544, DOI 10.1161/01.STR.0000189633.33623.69; Wang YZ, 2013, STROKE, V44, P380, DOI 10.1161/STROKEAHA.112.680843; WHO MONICA Project, 1990, MONICA MAN 4; Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033; World Health Organization, 2016, GLOB BURD DIS 2014 U; Yang QH, 2006, CIRCULATION, V113, P1335, DOI 10.1161/CIRCULATIONAHA.105.570846	47	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219392	10.1371/journal.pone.0219392	http://dx.doi.org/10.1371/journal.pone.0219392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291344	gold, Green Published, Green Submitted			2022-12-26	WOS:000484947800077
J	Kijima, Y				Kijima, Yoko			Farmers' risk preferences and rice production: Experimental and panel data evidence from Uganda	PLOS ONE			English	Article							COTTON FARMERS; ATTITUDES; ADOPTION; CHOICE; TIME	Although rice has been a prominent cash crop in areas with access to lowland in Uganda, the adoption of rice and area expansion have stagnated despite the Government of Uganda's 2009 National Rice Development Policy and its commitment to doubling rice production over 10 years. Using panel data collected in 2010 and 2017 as well as risk preference data elicited via lab-in-the-field experiments conducted in rural Uganda, we find that farmers with higher loss aversion are less likely to grow rice and expand their rice cultivation areas. This study affirms that risk preferences play a critical role in agricultural production decisions.	[Kijima, Yoko] Natl Grad Inst Policy Studies GRIPS, Tokyo, Japan	National Graduate Institute for Policy Studies	Kijima, Y (corresponding author), Natl Grad Inst Policy Studies GRIPS, Tokyo, Japan.	kijima@grips.ac.ip		Kijima, Yoko/0000-0003-1568-1358				Andersen S, 2006, EXP ECON, V9, P383, DOI 10.1007/s10683-006-7055-6; Barham BL, 2014, J ECON BEHAV ORGAN, V97, P204, DOI 10.1016/j.jebo.2013.06.014; Benson T, 2008, AGR ECON-BLACKWELL, V39, P513, DOI 10.1111/j.1574-0862.2008.00356.x; BINSWANGER HP, 1981, ECON J, V91, P867, DOI 10.2307/2232497; BINSWANGER HP, 1980, AM J AGR ECON, V62, P395, DOI 10.2307/1240194; Cardenas JC, 2008, J DEV STUD, V44, P311, DOI 10.1080/00220380701848327; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Charness G, 2013, J ECON BEHAV ORGAN, V87, P43, DOI 10.1016/j.jebo.2012.12.023; Dercon S, 1996, ECON DEV CULT CHANGE, V44, P485, DOI 10.1086/452229; Fafchamps M, 1992, AM J AGR ECON, V74, P427; FEDER G, 1985, ECON DEV CULT CHANGE, V33, P255, DOI 10.1086/451461; Fitzgerald J, 1998, J HUM RESOUR, V33, P251, DOI 10.2307/146433; Harrison G., 2005, FIELD EXPT EC, V10; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Jack B. K., 2013, CONSTRAINTS ADOPTION; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kijima Y, 2012, WORLD DEV, V40, P1610, DOI 10.1016/j.worlddev.2012.04.008; Kikuchi M., 2014, Tropical Agriculture and Development, V58, P78; Knight J, 2003, J DEV STUD, V39, P1, DOI 10.1080/00220380312331293567; Liu EM, 2013, REV ECON STAT, V95, P1386, DOI 10.1162/REST_a_00295; Liu EM, 2013, J DEV ECON, V103, P202, DOI 10.1016/j.jdeveco.2012.12.005; MAAIF, 2009, UG NAT RIC DEV STRAT; Morrison W., 2014, IZA DISCUSSION PAPER, V8309; REARDON T, 1992, J DEV STUD, V28, P264, DOI 10.1080/00220389208422232; ROSENZWEIG MR, 1993, ECON J, V103, P56, DOI 10.2307/2234337; Schildberg-Horisch H, 2018, J ECON PERSPECT, V32, P135, DOI 10.1257/jep.32.2.135; Tanaka Y, 2015, GRIPS DISCUSSION PAP, V14; Tanaka Y, 2014, J AFR ECON, V23, P151, DOI 10.1093/jae/ejt020; Campenhout B, 2018, DEV POLICY REV, V36, pO605, DOI 10.1111/dpr.12356; Verschoor A, 2016, J ECON BEHAV ORGAN, V128, P134, DOI 10.1016/j.jebo.2016.05.009; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1	31	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219202	10.1371/journal.pone.0219202	http://dx.doi.org/10.1371/journal.pone.0219202			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4GX	31283797	Green Published, Green Submitted, gold			2022-12-26	WOS:000484939800022
J	Achtsnicht, S; Neuendorf, C; Fassbender, T; Nolke, G; Offenhausser, A; Krause, HJ; Schroper, F				Achtsnicht, Stefan; Neuendorf, Christian; Fassbender, Tobias; Noelke, Greta; Offenhaeusser, Andreas; Krause, Hans-Joachim; Schroeper, Florian			Sensitive and rapid detection of cholera toxin subunit B using magnetic frequency mixing detection	PLOS ONE			English	Article							VIBRIO-CHOLERAE; IMMUNOASSAY; LIPOSOMES; ASSAY	Cholera is a life-threatening disease caused by the cholera toxin (CT) as produced by some Vibrio cholerae serogroups. In this research we present a method which directly detects the toxin's B subunit (CTB) in drinking water. For this purpose we performed a magnetic sandwich immunoassay inside a 3D immunofiltration column. We used two different commercially available antibodies to capture CTB and for binding to superparamagnetic beads. ELISA experiments were performed to select the antibody combination. The beads act as labels for the magnetic frequency mixing detection technique. We show that the limit of detection depends on the type of magnetic beads. A nonlinear Hill curve was fitted to the calibration measurements by means of a custom-written python software. We achieved a sensitive and rapid detection of CTB within a broad concentration range from 0.2 ng/ml to more than 700 ng/ml.	[Achtsnicht, Stefan; Fassbender, Tobias; Offenhaeusser, Andreas; Krause, Hans-Joachim] Forschungszentrum Julich, Inst Complex Syst, Bioelect ICS 8, Julich, Germany; [Achtsnicht, Stefan] Rhein Westfal TH Aachen, Aachen, Germany; [Neuendorf, Christian; Noelke, Greta; Schroeper, Florian] Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; Fraunhofer Gesellschaft	Krause, HJ (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Bioelect ICS 8, Julich, Germany.; Schroper, F (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany.	h.-j.krause@fz-juelich.de; florian.schroeper@ime.fraunhofer.de	Schröper, Florian/ABB-9290-2020; Krause, Hans-Joachim/G-5247-2012; Offenhäusser, Andreas/E-7990-2012	Schröper, Florian/0000-0002-2490-3728; Krause, Hans-Joachim/0000-0002-7526-9894; Offenhäusser, Andreas/0000-0001-6143-2702; Achtsnicht, Stefan/0000-0003-0666-912X; Neuendorf, Christian/0000-0003-3432-1665	German Federal Ministry of Education and Research (BMBF) [13N13711, 13N13712]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Part of this research was supported by the German Federal Ministry of Education and Research (BMBF) [AquaNANO project, grant numbers 13N13711 and 13N13712]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Christof Steiner and Jennifer Laun (DITABIS AG, Pforzheim, Germany) for helpful discussions within the framework of the AquaNANO Project. Furthermore the authors want to thank Holger Spiegel (Fraunhofer IME, Aachen) for his help and information regarding the characteristics of the used antibodies.	Achtsnicht S, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19112599; Achtsnicht S, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19010148; Alam M, 2010, J CLIN MICROBIOL, V48, P3918, DOI 10.1128/JCM.00616-10; Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; [Anonymous], 2021, CHOL ROADM RES AG; Astalan AP, 2004, BIOSENS BIOELECTRON, V19, P945, DOI 10.1016/j.bios.2003.09.005; Azman AS, 2013, J INFECTION, V66, P432, DOI 10.1016/j.jinf.2012.11.013; Baldauf KJ, 2015, TOXINS, V7, P974, DOI 10.3390/toxins7030974; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Bunyakul N, 2009, ANAL BIOANAL CHEM, V393, P177, DOI 10.1007/s00216-008-2364-6; Centers Disease Control and Prevention, LAB ID VIBR CHOL; Centers Disease Control and Prevention Laboratory Methods for the Diagnosis of Vibrio cholerae-VII, DET CHOL TOX; Chen YT, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17102300; Chieh JJ, 2010, J APPL PHYS, V107, DOI 10.1063/1.3340861; Choi J, 2016, BIOSENS BIOELECTRON, V85, P1, DOI 10.1016/j.bios.2016.04.046; DRAGUNSKY EM, 1992, VACCINE, V10, P735, DOI 10.1016/0264-410X(92)90505-E; Edwards KA, 2007, ANAL BIOCHEM, V368, P39, DOI 10.1016/j.ab.2007.04.019; Fan EK, 2000, CURR OPIN STRUC BIOL, V10, P680, DOI 10.1016/S0959-440X(00)00152-4; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Hong CY, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2206557; Hong HB, 2011, J IMMUNOL METHODS, V365, P95, DOI 10.1016/j.jim.2010.12.005; Huq Anwar, 2012, Curr Protoc Microbiol, VChapter 6, DOI 10.1002/9780471729259.mc06a05s26; HyTest Ltd, DAT MON MOUS ANT TOX; Iqbal SS, 2000, BIOSENS BIOELECTRON, V15, P549, DOI 10.1016/S0956-5663(00)00108-1; Jobling MG, 2012, MBIO, V3, DOI 10.1128/mBio.00401-12; Khan SA, 2015, ANAL CHIM ACTA, V892, P167, DOI 10.1016/j.aca.2015.08.029; Kopic S, 2010, TOXINS, V2, P2132, DOI 10.3390/toxins2082132; Krause HJ, 2007, J MAGN MAGN MATER, V311, P436, DOI 10.1016/j.jmmm.2006.10.1164; Leclerc H, 2002, CRIT REV MICROBIOL, V28, P371, DOI 10.1080/1040-840291046768; Lee H, 2008, NAT MED, V14, P869, DOI 10.1038/nm.1711; LEVINE MM, 1983, MICROBIOL REV, V47, P510, DOI 10.1128/MMBR.47.4.510-550.1983; Matias WR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186710; Matz H, 1998, APPL SUPERCOND, V6, P577, DOI 10.1016/S0964-1807(99)00014-9; Merritt EA, 1998, J MOL BIOL, V282, P1043, DOI 10.1006/jmbi.1998.2076; Meyer MHF, 2007, BIOSENS BIOELECTRON, V22, P973, DOI 10.1016/j.bios.2006.04.001; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Peruski AH, 2003, CLIN DIAGN LAB IMMUN, V10, P506, DOI 10.1128/CDLI.10.4.506-513.2003; RAMAMURTHY T, 1992, J CLIN MICROBIOL, V30, P1783, DOI 10.1128/JCM.30.7.1783-1786.1992; Rettcher S, 2015, APPL ENVIRON MICROB, V81, P3039, DOI 10.1128/AEM.03667-14; Royal JM, 2017, TOXINS, V9, DOI 10.3390/toxins9120379; Shlyapnikov YM, 2012, ANAL CHEM, V84, P5596, DOI 10.1021/ac300567f; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; Stern D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0665-5; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Taylor M, 2015, TOXINS, V7, P2674, DOI 10.3390/toxins7072674; Thermo Fisher Scientific Inc, INSTR EZ LINK NHS PE; Vashist S.K., 2018, HDB IMMUNOASSAY TECH, P1, DOI DOI 10.1016/B978-0-12-811762-0.00001-3; Viswanathan S, 2006, ANAL CHEM, V78, P1115, DOI 10.1021/ac051435d; Walper SA, 2018, ACS SENSORS, V3, P1894, DOI 10.1021/acssensors.8b00420; World Health Organization, 2018, Weekly Epidemiological Record, V93, P489; Zhu K, 2014, TOXINS, V6, P1325, DOI 10.3390/toxins6041325	51	16	16	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219356	10.1371/journal.pone.0219356	http://dx.doi.org/10.1371/journal.pone.0219356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276546	Green Submitted, gold, Green Published			2022-12-26	WOS:000484936300069
J	Ichikawa, G; Kuribayashi, R; Ikenaka, Y; Ichise, T; Nakayama, SMM; Ishizuka, M; Taira, K; Fujioka, K; Sairenchi, T; Kobashi, G; Bonmatin, JM; Yoshihara, S				Ichikawa, Go; Kuribayashi, Ryota; Ikenaka, Yoshinori; Ichise, Takahiro; Nakayama, Shouta M. M.; Ishizuka, Mayumi; Taira, Kumiko; Fujioka, Kazutoshi; Sairenchi, Toshimi; Kobashi, Gen; Bonmatin, Jean-Marc; Yoshihara, Shigemi			LC-ESI/MS/MS analysis of neonicotinoids in urine of very low birth weight infants at birth	PLOS ONE			English	Article							INTESTINAL-ABSORPTION; SYSTEMIC INSECTICIDES; HUMAN EXPOSURE; CACO-2 CELLS; PESTICIDE; BEHAVIOR	Objectives Neonicotinoid insecticides are widely used systemic pesticides with nicotinic acetylcholine receptor agonist activity that are a concern as environmental pollutants. Neonicotinoids in humans and the environment have been widely reported, but few studies have examined their presence in fetuses and newborns. The objective of this study is to determine exposure to neonicotinoids and metabolites in very low birth weight (VLBW) infants. Methods An analytical method for seven neonicotinoids and one neonicotinoid metabolite, N-desmethylacetamiprid (DMAP), in human urine using LC-ESI/MS/MS was developed. This method was used for analysis of 57 urine samples collected within 48 hours after birth from VLBW infants of gestational age 23-34 weeks (male/female = 36/21, small for gestational age (SGA)/appropriate gestational age (AGA) = 6/51) who were admitted to the neonatal intensive care unit of Dokkyo Hospital from January 2009 to December 2010. Sixty-five samples collected on postnatal day 14 (M/F = 37/22, SGA/AGA = 7/52) were also analyzed. Results DMAP, a metabolite of acetamiprid, was detected in 14 urine samples collected at birth (24.6%, median level 0.048 ppb) and in 7 samples collected on postnatal day 14 (11.9%, median level 0.09 ppb). The urinary DMAP detection rate and level were higher in SGA than in AGA infants (both p<0.05). There were no correlations between the DMAP level and infant physique indexes (length, height, and head circumference SD scores). Conclusion These results provide the first evidence worldwide of neonicotinoid exposure in newborn babies in the early phase after birth. The findings suggest a need to examine potential neurodevelopmental toxicity of neonicotinoids and metabolites in human fetuses.	[Ichikawa, Go; Kuribayashi, Ryota; Yoshihara, Shigemi] Dokkyo Med Univ, Sch Med, Dept Pediat, Mibu, Tochigi, Japan; [Ikenaka, Yoshinori; Ichise, Takahiro; Nakayama, Shouta M. M.; Ishizuka, Mayumi] Hokkaido Univ, Dept Environm Vet Sci, Toxicol Lab, Fac Vet Med, Sapporo, Hokkaido, Japan; [Ikenaka, Yoshinori] North West Univ, Unit Environm Sci & Management, Water Res Grp, Potchefstroom, North West, South Africa; [Taira, Kumiko] Tokyo Womens Med Univ, Med Ctr East, Dept Anesthesiol, Arakawa Ku, Tokyo, Japan; [Fujioka, Kazutoshi] Albany Coll Pharm & Hlth Sci, Albany, NY USA; [Sairenchi, Toshimi; Kobashi, Gen] Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Mibu, Tochigi, Japan; [Bonmatin, Jean-Marc] CNRS, Ctr Biophys Mol, Orleans, France	Dokkyo Medical University; Hokkaido University; North West University - South Africa; Tokyo Women's Medical University; Albany College of Pharmacy & Health Sciences; Dokkyo Medical University; Centre National de la Recherche Scientifique (CNRS)	Ichikawa, G (corresponding author), Dokkyo Med Univ, Sch Med, Dept Pediat, Mibu, Tochigi, Japan.	go-i@zk9.so-net.ne.jp	IKENAKA, Yoshinori/F-8529-2012	Sairenchi, Toshimi/0000-0001-8896-6501; Ikenaka, Yoshinori/0000-0002-6633-6637	Ministry of Education, Culture, Sports, Science and Technology of Japan [17K2003807, 18H0413208, 15K00559]; Triodos Foundation; act beyond trust; JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Triodos Foundation; act beyond trust; JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development)	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan awarded to Y. Ikenaka (Nos. 17K2003807 and 18H0413208), and K. Taira (No.15K00559)(www.mext.go.jp).We also acknowledge financial support from Triodos Foundation and act beyond trust(http://www.tripdpsfoundation.nl).The study was supported by JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development) (https//www.jst.go.jp/global/). The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Berheim EH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40994-9; Brunet JL, 2008, J ENVIRON SCI HEAL B, V43, P261, DOI 10.1080/03601230701771446; Brunet JL, 2004, TOXICOL APPL PHARM, V194, P1, DOI 10.1016/j.taap.2003.08.018; Burke AP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35129-5; Caron-Beaudoin E, 2018, ENVIRON HEALTH PERSP, V126, DOI [10.1289/EHP2698, 10.1289/ehp2698]; Chagnon M, 2015, ENVIRON SCI POLLUT R, V22, P119, DOI 10.1007/s11356-014-3277-x; Cimino AM, 2017, ENVIRON HEALTH PERSP, V125, P155, DOI 10.1289/EHP515; Craddock HA, 2019, ENVIRON HEALTH-GLOB, V18, DOI 10.1186/s12940-018-0441-7; Di Prisco G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13171-z; Ek CJ, 2012, NEUROTOXICOLOGY, V33, P586, DOI 10.1016/j.neuro.2011.12.009; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; European Food Safety Authority, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3694, 10.2903/j.efsa.2015.4038]; Food Safety Commission of Japan, RISK ASS REP IM; Food Safety Commission of Japan, RISK ASS REP AC; Food Safety Commission of Japan, RISK ASS REP CLOTH; Fuke C, 2014, LEGAL MED-TOKYO, V16, P40, DOI 10.1016/j.legalmed.2013.10.007; Giorio C, 2021, ENVIRON SCI POLLUT R, V28, P11716, DOI 10.1007/s11356-017-0394-3; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Harada KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146335; Hirano T, 2018, TOXICOL LETT, V282, P57, DOI 10.1016/j.toxlet.2017.10.010; Hsiao CJ, 2016, NEUROREPORT, V27, P462, DOI 10.1097/WNR.0000000000000562; Ikenaka Y, 2019, ENVIRON TOXICOL CHEM, V38, P71, DOI 10.1002/etc.4316; Imamura T, 2010, CLIN TOXICOL, V48, P851, DOI 10.3109/15563650.2010.517207; IRAC International MoA Working Group, IRAC MOD ACT CLASS S; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Kavvalakis MP, 2013, CHEMOSPHERE, V93, P2612, DOI 10.1016/j.chemosphere.2013.09.087; Kawahata I, 2018, TOXICOLOGY, V394, P84, DOI 10.1016/j.tox.2017.12.004; Kimura-Kuroda J, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13100987; Kimura-Kuroda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032432; Lehmann E, 2018, ENVIRON INT, V111, P317, DOI 10.1016/j.envint.2017.10.025; Liang FW, 2018, PEDIATR NEONATOL, V59, P267, DOI 10.1016/j.pedneo.2017.08.013; Lin PC, 2013, BASIC CLIN PHARMACOL, V112, P282, DOI 10.1111/bcpt.12027; Mario JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142172; Ministry of Health Labour and Welfare, 2010, SPEC REP VIT STAT; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Osaka A, 2016, ENVIRON RES, V147, P89, DOI 10.1016/j.envres.2016.01.028; Pisa L, 2021, ENVIRON SCI POLLUT R, V28, P11749, DOI 10.1007/s11356-017-0341-3; Plant Products Safety Division & Plant Protection Division Food Safety and Consumer Affairs Bureau Ministry of Agriculture Forestry and Fisheries, 2010, NOYAK YOR 2009; Puga Beatriz, 2009, Pediatr Endocrinol Rev, V6 Suppl 3, P358; Sano K, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00228; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Sharma D, 2016, CLIN MED INSIGHTS-PE, V10, P67, DOI 10.4137/CMPed.S40070; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Taira K., 2014, JPN J CLIN ECOL, V23, P1; Taira K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080332; Tapparo A, 2012, ENVIRON SCI TECHNOL, V46, P2592, DOI 10.1021/es2035152; Tomizawa M, 2000, TOXICOL APPL PHARM, V169, P114, DOI 10.1006/taap.2000.9057; Ueyama J, 2015, ENVIRON SCI TECHNOL, V49, P14522, DOI 10.1021/acs.est.5b03062; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Vinod KV, 2015, AM J EMERG MED, V33, DOI 10.1016/j.ajem.2014.08.013; Wang X, 2018, ANNU REV PHARMACOL, V58, P471, DOI 10.1146/annurev-pharmtox-010617-052429; Wong KLK, 2019, ENVIRON SCI TECH LET, V6, P98, DOI 10.1021/acs.estlett.8b00706; Yeter O, 2014, J FORENSIC SCI, V59, P287, DOI 10.1111/1556-4029.12368; Zuercher P, 2017, CLIN CASE REP, V5, P1672, DOI 10.1002/ccr3.1146	55	36	36	9	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219208	10.1371/journal.pone.0219208	http://dx.doi.org/10.1371/journal.pone.0219208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260498	Green Published, gold, Green Submitted			2022-12-26	WOS:000484918700044
J	Baldwin, T; Baldwin, S; Klos, K; Bregitzer, P; Marshall, J				Baldwin, Thomas; Baldwin, Suzette; Klos, Kathy; Bregitzer, Phil; Marshall, Juliet			Deletion of the benzoxazinoid detoxification gene NAT1 in Fusarium graminearum reduces deoxynivalenol in spring wheat	PLOS ONE			English	Article							HEAD BLIGHT RESISTANCE; CORN-BORER LEPIDOPTERA; HYDROXAMIC ACIDS; BENZOXAZOLINONE CLASS; DIMBOA; MAIZE; BIOSYNTHESIS; METABOLITES; BIOTRANSFORMATION; VERTICILLIOIDES	Benzoxazinoid (Bx) metabolites produced by wheat and other members of the Poaceae have activity against Fusarium sp. that cause cereal diseases including Fusarium head blight (FHB) on wheat and barley. Certain Bx metabolites can be detoxified by Fusarium sp. with the arylamine N-acetyltransferase NAT1. Investigation of this pathway may reveal strategies for increasing FHB resistance, such as selection for higher levels of Bx metabolites within existing germplasm and/or engineering fungal susceptibility via host induced silencing of NAT1. We assessed the reactions of fifteen wheat cultivars or breeding lines adapted to the Northwestern United States to infection with F. graminearum Delta nat1 mutants that should be sensitive to Bx metabolites. Significant differences were noted in disease severity and deoxynivalenol (DON) among the cultivars 21 d after inoculation with either mutant or wildtype (PH1) strains. Mutant vs. wildtype strains did not result in significant variation for infection severity (as measured by % infected florets), but inoculation with Delta nat1 mutants vs. wildtype resulted in significantly lower DON concentrations in mature kernels (p < 0.0001). Of the cultivars tested, HRS3419 was the most resistant cultivar to PH1 (severity = 62%, DON = 45 ppm) and Delta nat1 mutants (severity = 61%, DON = 30 ppm). The cultivar most susceptible to infection was Kelse with PH1 (severity = 100%, DON = 292 ppm) and Delta nat1 mutants (severity = 100%, DON = 158 ppm). We hypothesized that sub-lethal Bx metabolite levels may suppress DON production in F. graminearum Delta nat1 mutants. In vitro assays of Bx metabolites BOA, MBOA, and DIMBOA at 30 mu M did not affect growth, but did reduce DON production by Delta nat1 and PH1. Although the levels of Bx metabolites are likely too low in the wheat cultivars we tested to suppress FHB, higher levels of Bx metabolites may contribute towards reductions in DON and	[Baldwin, Thomas; Klos, Kathy; Bregitzer, Phil] USDA ARS, Natl Small Grains Germplasm Res Facil, Aberdeen, ID 83210 USA; [Baldwin, Suzette; Marshall, Juliet] Univ Idaho Res & Extens, Dept Plant Soil & Entomol Sci, Idaho Falls, ID 83402 USA	United States Department of Agriculture (USDA); Idaho; University of Idaho	Baldwin, T (corresponding author), USDA ARS, Natl Small Grains Germplasm Res Facil, Aberdeen, ID 83210 USA.; Marshall, J (corresponding author), Univ Idaho Res & Extens, Dept Plant Soil & Entomol Sci, Idaho Falls, ID 83402 USA.	tom.baldwin@usda.gov; jmarshall@uidaho.edu			USDA-ARS Project [2050-21000-031-00, 59-0206-4-042]; USWBSI project Down with DON: Stable Expression of Proven Genes in a Marker-Free Background	USDA-ARS Project; USWBSI project Down with DON: Stable Expression of Proven Genes in a Marker-Free Background	This project was funded by USDA-ARS Project 2050-21000-031-00, No. 59-0206-4-042 and by the USWBSI project Down with DON: Stable Expression of Proven Genes in a Marker-Free Background. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, PLANT PHYSIOL, P111; Baldwin T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202798; Baldwin TT, 2018, FUNGAL GENET BIOL, V115, P90, DOI 10.1016/j.fgb.2018.01.002; BARRY D, 1994, ENVIRON ENTOMOL, V23, P177, DOI 10.1093/ee/23.1.177; Basse CW, 2005, PLANT PHYSIOL, V138, P1774, DOI 10.1104/pp.105.061200; BOHIDAR K, 1986, ANN APPL BIOL, V109, P193, DOI 10.1111/j.1744-7348.1986.tb03199.x; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; de Bruijn WJC, 2018, PHYTOCHEMISTRY, V155, P233, DOI 10.1016/j.phytochem.2018.07.005; Dutartre L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-64; Elek H, 2013, ANN APPL BIOL, V162, P100, DOI 10.1111/aab.12005; Etzerodt T, 2016, J AGR FOOD CHEM, V64, P4545, DOI 10.1021/acs.jafc.6b01162; Etzerodt T, 2015, INT J FOOD MICROBIOL, V214, P123, DOI 10.1016/j.ijfoodmicro.2015.07.014; FENG R, 1992, PESTIC BIOCHEM PHYS, V44, P147, DOI 10.1016/0048-3575(92)90112-D; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Garcia-Pedrajas MD, 2008, FUNGAL GENET BIOL, V45, P379, DOI 10.1016/j.fgb.2007.11.001; Ghag SB, 2014, PLANT BIOTECHNOL J, V12, P541, DOI 10.1111/pbi.12158; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glenn AE, 2009, J APPL MICROBIOL, V107, P657, DOI 10.1111/j.1365-2672.2009.04246.x; Glenn AE, 2003, APPL ENVIRON MICROB, V69, P3165, DOI 10.1128/AEM.69.6.3165-3169.2003; Glenn AE, 2002, MOL PLANT MICROBE IN, V15, P91, DOI 10.1094/MPMI.2002.15.2.91; Glenn AE, 2001, APPL ENVIRON MICROB, V67, P2973, DOI 10.1128/AEM.67.7.2973-2981.2001; Glenn AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147486; Glenn AE, 2010, FEBS LETT, V584, P3158, DOI 10.1016/j.febslet.2010.05.063; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; GROMBACHER AW, 1989, J KANSAS ENTOMOL SOC, V62, P103; Hallen-Adams HE, 2011, METHODS MOL BIOL, V722, P79, DOI 10.1007/978-1-61779-040-9_6; Handa H, 2008, MOL BREEDING, V22, P71, DOI 10.1007/s11032-008-9157-7; Huang YD, 2013, THEOR APPL GENET, V126, P619, DOI 10.1007/s00122-012-2006-4; Ilgen P, 2009, MOL PLANT MICROBE IN, V22, P899, DOI 10.1094/MPMI-22-8-0899; Kazan K, 2012, MOL PLANT PATHOL, V13, P399, DOI 10.1111/j.1364-3703.2011.00762.x; Kettle AJ, 2015, MOL PLANT PATHOL, V16, P946, DOI 10.1111/mpp.12250; Kettle AJ, 2015, FUNGAL GENET BIOL, V83, P1, DOI 10.1016/j.fgb.2015.08.005; King R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1756-1; KLUN JA, 1967, J ECON ENTOMOL, V60, P1529, DOI 10.1093/jee/60.6.1529; Koch A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005901; Koch A, 2013, P NATL ACAD SCI USA, V110, P19324, DOI 10.1073/pnas.1306373110; Kruidhof HM, 2014, EUR J AGRON, V52, P229, DOI 10.1016/j.eja.2013.09.003; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Meyer SLF, 2009, SOIL BIOL BIOCHEM, V41, P1555, DOI 10.1016/j.soilbio.2009.04.016; Mirmiran A, 2018, CAN J PLANT PATHOL, V40, P172, DOI 10.1080/07060661.2018.1442370; Niemeyer HM, 2009, J AGR FOOD CHEM, V57, P1677, DOI 10.1021/jf8034034; Nomura T, 2005, P NATL ACAD SCI USA, V102, P16490, DOI 10.1073/pnas.0505156102; Nomura T, 2003, PLANTA, V217, P776, DOI 10.1007/s00425-003-1040-5; Persans MW, 2001, PLANT PHYSIOL, V125, P1126, DOI 10.1104/pp.125.2.1126; Powell JJ, 2017, PLANT BIOTECHNOL J, V15, P533, DOI 10.1111/pbi.12651; Smist M, 2016, J ENVIRON SCI HEAL B, V51, P393, DOI 10.1080/03601234.2016.1142744; Soltoft M, 2008, BIOCHEM SYST ECOL, V36, P245, DOI 10.1016/j.bse.2007.10.008; Zasada IA, 2005, PHYTOPATHOLOGY, V95, P1116, DOI 10.1094/PHYTO-95-1116	48	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2019	14	7							e0214230	10.1371/journal.pone.0214230	http://dx.doi.org/10.1371/journal.pone.0214230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4NB	31299046	Green Published, gold, Green Submitted			2022-12-26	WOS:000484955800001
J	Pan, L; Yu, XL; Shao, JJ; Liu, ZC; Gao, T; Zheng, Y; Zeng, C; Liang, CZ; Chen, CY				Pan, Lei; Yu, Xiaolu; Shao, Jingjie; Liu, Zhichao; Gao, Tong; Zheng, Yu; Zeng, Chen; Liang, Chengzhi; Chen, Chanyou			Transcriptomic profiling and analysis of differentially expressed genes in asparagus bean (Vigna unguiculata ssp. sesquipedalis) under salt stress	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; HIGH-SALINITY STRESS; ABIOTIC STRESS; FUNCTIONAL GENOMICS; L. WALP.; ARABIDOPSIS; TOLERANCE; CROP; DROUGHT; COWPEA	Asparagus bean (Vigna unguiculata ssp. sesquipedalis) is a warm season legume which is widely distributed over subtropical regions and semiarid areas. It is mainly grown as a significant protein source in developing countries. Salinity, as one of the main abiotic stress factors, constrains the normal growth and yield of asparagus bean. This study used two cultivars (a salt-sensitive genotype and a salt-tolerant genotype) under salt stress vs. control to identify salt-stress-induced genes in asparagus bean using RNA sequencing. A total of 692,086,838 high-quality clean reads, assigned to 121,138 unigenes, were obtained from control and salt-treated libraries. Then, 216 root-derived DEGs (differentially expressed genes) and 127 leaf-derived DEGs were identified under salt stress between the two cultivars. Of these DEGs, thirteen were assigned to six transcription factors (TFs), including AP2/EREBP, CCHC(Zn), C2H2, WRKY, WD40-like and LIM. GO analysis indicated four DEGs might take effects on the "oxidation reduction", "transport" and "signal transduction" process. Moreover, expression of nine randomly-chosen DEGs was verified by quantitative real-time-PCR (qRT-PCR) analysis. Predicted function of the nine tested DEGs was mainly involved in the KEGG pathway of cation transport, response to osmotic stress, and phosphorelay signal transduction system. A salt-stress-related pathway of "SNARE interactions in vesicular transport" was concerned. As byproducts, 15, 321 microsatellite markers were found in all the unigenes, and 17 SNP linked to six salt-stress induced DEGs were revealed. These candidate genes provide novel insights for understanding the salt tolerance mechanism of asparagus bean in the future.	[Pan, Lei; Yu, Xiaolu; Shao, Jingjie; Gao, Tong; Chen, Chanyou] Jianghan Univ, Sch Life Sci, Hubei Prov Engn Res Ctr Legume Plants, Wuhan, Hubei, Peoples R China; [Pan, Lei; Liu, Zhichao; Zeng, Chen] George Washington Univ, Computat Biol Inst, Washington, DC 20052 USA; [Pan, Lei; Liu, Zhichao; Zeng, Chen] George Washington Univ, Dept Phys, Ctr Biomol Sci, Washington, DC 20052 USA; [Zheng, Yu] Jianghan Univ, Inst Interdisciplinary Res, Wuhan, Hubei, Peoples R China; [Liang, Chengzhi] Chinese Acad Sci, Inst Genet & Dev, Beijing, Peoples R China	Jianghan University; George Washington University; George Washington University; Jianghan University; Chinese Academy of Sciences	Pan, L; Chen, CY (corresponding author), Jianghan Univ, Sch Life Sci, Hubei Prov Engn Res Ctr Legume Plants, Wuhan, Hubei, Peoples R China.; Pan, L (corresponding author), George Washington Univ, Computat Biol Inst, Washington, DC 20052 USA.; Pan, L (corresponding author), George Washington Univ, Dept Phys, Ctr Biomol Sci, Washington, DC 20052 USA.	leipan@jhun.edu.cn; ccy@jhun.edu.cn		Pan, Lei/0000-0001-9563-0766	National Natural Science Foundation of China [31501369, 31701100]; China Scholarship Council Fund [201708420039]; Natural Science Foundation of Hubei province [2017CFB442]; Major Project of Technological Innovation of Hubei province [2017ABA14]; Science and Technology Support Program (Science and Technology Innovation Platform and Platform Construction) Project of Hubei province [2015BCE091]; Outstanding Young and Middle-aged Science and Technology Innovation Team Project of Hubei province [T201522]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council Fund(China Scholarship Council); Natural Science Foundation of Hubei province(Natural Science Foundation of Hubei Province); Major Project of Technological Innovation of Hubei province; Science and Technology Support Program (Science and Technology Innovation Platform and Platform Construction) Project of Hubei province; Outstanding Young and Middle-aged Science and Technology Innovation Team Project of Hubei province	This study was supported by the National Natural Science Foundation of China (31501369, 31701100), the China Scholarship Council Fund (201708420039), the Natural Science Foundation of Hubei province (2017CFB442), Major Project of Technological Innovation of Hubei province (2017ABA14), Science and Technology Support Program (Science and Technology Innovation Platform and Platform Construction) Project of Hubei province (2015BCE091), Outstanding Young and Middle-aged Science and Technology Innovation Team Project of Hubei province (T201522).	Assaha DVM, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00509; Bellegarde F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26349-w; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buchner P, 2014, J EXP BOT, V65, P5697, DOI 10.1093/jxb/eru231; Chen C, 2007, J HERED, V98, P655, DOI 10.1093/jhered/esm084; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; Dai XB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-321; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Demidchik V, 2015, ENVIRON EXP BOT, V109, P212, DOI 10.1016/j.envexpbot.2014.06.021; Deyholos MK, 2010, PLANT CELL ENVIRON, V33, P648, DOI 10.1111/j.1365-3040.2009.02092.x; Dong LD, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2379-4; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Glenn EP, 1999, CRIT REV PLANT SCI, V18, P227, DOI 10.1016/S0735-2689(99)00388-3; Gourcilleau D, 2011, DNA RES, V18, P77, DOI 10.1093/dnares/dsr001; Goyal E, 2016, SCI REP-UK, V6, DOI 10.1038/srep27752; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; Hamaji K, 2009, PLANT CELL PHYSIOL, V50, P2023, DOI 10.1093/pcp/pcp143; Hou Y, 2018, TREE GENET GENOMES, V14, DOI 10.1007/s11295-018-1242-4; Hu LX, 2015, BMC GENOMICS, V16, DOI [10.1186/s12859-015-0583-3, 10.1186/s12864-015-1799-3]; Jamil A, 2011, CRIT REV PLANT SCI, V30, P435, DOI 10.1080/07352689.2011.605739; Jayakannan M, 2015, PLANT GROWTH REGUL, V76, P25, DOI 10.1007/s10725-015-0028-z; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Jou Y, 2006, PLANT PHYSIOL, V141, P135, DOI 10.1104/pp.106.076786; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim YO, 2005, PLANT J, V42, P890, DOI 10.1111/j.1365-313X.2005.02420.x; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; Kongjaimun A, 2012, GENOME, V55, P81, DOI [10.1139/G11-078, 10.1139/g11-078]; Lai YS, 2018, P NATL ACAD SCI USA, V115, pE5203, DOI 10.1073/pnas.1802254115; Latz A, 2013, MOL PLANT, V6, P1274, DOI 10.1093/mp/sss158; Leshem Y, 2006, P NATL ACAD SCI USA, V103, P18008, DOI 10.1073/pnas.0604421103; Leshem Y, 2010, J EXP BOT, V61, P2615, DOI 10.1093/jxb/erq099; Li H, 2017, PLANT CELL, V29, P2016, DOI [10.1105/tpc.16.00972, 10.1105/tpc.17.00366]; Li S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2334-2; [李依 Li Yi], 2016, [植物遗传资源学报, Journal of Plant Genetic Resources], V17, P70; Li Y, 2018, PLANT BIOTECHNOL J, V16, P1201, DOI 10.1111/pbi.12863; Liu QH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123330; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonardi S, 2019, BIORXIV, DOI [10.1101/518969, DOI 10.1101/518969]; Lv SF, 2018, PLANT GROWTH REGUL, V84, P225, DOI 10.1007/s10725-017-0333-9; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; Munns R, 2016, FUNCT PLANT BIOL, V43, P1103, DOI 10.1071/FP16187; Munoz-Amatriain M, 2017, PLANT J, V89, P1042, DOI 10.1111/tpj.13404; Nacry P, 2013, PLANT SOIL, V370, P1, DOI 10.1007/s11104-013-1645-9; Ouyang B, 2007, J EXP BOT, V58, P507, DOI 10.1093/jxb/erl258; Pan L, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01544; Park SJ, 2009, PLANT CELL PHYSIOL, V50, P869, DOI 10.1093/pcp/pcp037; Poitout A, 2018, PLANT CELL, V30, P1243, DOI 10.1105/tpc.18.00011; Polle A, 2015, PLANT CELL ENVIRON, V38, P1794, DOI 10.1111/pce.12440; Quan RD, 2017, SCI REP-UK, V7, DOI 10.1038/srep44637; Ravelombola W, 2018, THEOR APPL GENET, V131, P79, DOI 10.1007/s00122-017-2987-0; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Sanchez DH, 2008, PLANT J, V53, P973, DOI 10.1111/j.1365-313X.2007.03381.x; Schomburg FM, 2003, PLANT CELL, V15, P151, DOI 10.1105/tpc.005975; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Shabala S, 2014, PHYSIOL PLANTARUM, V151, P257, DOI 10.1111/ppl.12165; Singh D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00737; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Smykal P, 2015, CRIT REV PLANT SCI, V34, P43, DOI 10.1080/07352689.2014.897904; Sun RH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00063; Sun XL, 2013, PLANT CELL TISS ORG, V113, P199, DOI 10.1007/s11240-012-0260-4; Tarte VN, 2015, PLANT CELL REP, V34, P1127, DOI 10.1007/s00299-015-1771-3; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tian ZD, 2010, PLANT BIOLOGY, V12, P689, DOI 10.1111/j.1438-8677.2009.00276.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Vij S, 2007, PLANT BIOTECHNOL J, V5, P361, DOI 10.1111/j.1467-7652.2007.00239.x; Wang XC, 2009, J PROTEOME RES, V8, P3331, DOI 10.1021/pr801083a; Win KT, 2015, BIOCATAL AGR BIOTECH, V4, P449, DOI 10.1016/j.bcab.2015.08.009; Xu P, 2017, PLANT BIOTECHNOL J, V15, P547, DOI 10.1111/pbi.12639; Xu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096877; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Yang O, 2009, GENE, V436, P45, DOI 10.1016/j.gene.2009.02.010; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yang YQ, 2018, NEW PHYTOL, V217, P523, DOI 10.1111/nph.14920; Yaxley JR, 2001, PLANT PHYSIOL, V125, P627, DOI 10.1104/pp.125.2.627; Yeo A, 1999, SCI HORTIC-AMSTERDAM, V78, P159; Zhang F, 2016, SCI REP-UK, V6, DOI 10.1038/srep20582; Zhao XF, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-016-2323-3; Zhu JH, 2002, PLANT CELL, V14, P3009, DOI 10.1105/tpc.006981	87	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2019	14	7							e0219799	10.1371/journal.pone.0219799	http://dx.doi.org/10.1371/journal.pone.0219799			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4NB	31299052	Green Published, Green Submitted, gold			2022-12-26	WOS:000484955800013
J	Abdullahi, OA; Ngari, MM; Sanga, D; Katana, G; Willetts, A				Abdullahi, Osman A.; Ngari, Moses M.; Sanga, Deche; Katana, Geoffrey; Willetts, Annie			Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya	PLOS ONE			English	Review							TRENDS; DEATHS; HIV	Background Globally in 2016, 1.7 million people died of Tuberculosis (TB). This study aimed to estimate all-cause mortality rate, identify features associated with mortality and describe trend in mortality rate from treatment initiation. Method A 5-year (2012-2016) retrospective analysis of electronic TB surveillance data from Kilifi County, Kenya. The outcome was all-cause mortality within 180 days after starting TB treatment. The risk factors examined were demographic and clinical features at the time of starting anti-TB treatment. We performed survival analysis with time at risk defined from day of starting TB treatment to time of death, lost-to-follow-up or completing treatment. To account for 'lost-to-follow-up' we used competing risk analysis method to examine risk factors for all-cause mortality. Results 10,717 patients receiving TB treatment, median (IQR) age 33 (24-45) years were analyzed; 3,163 (30%) were HIV infected. Overall, 585 (5.5%) patients died; mortality rate of 12.2 (95% CI 11.3-13.3) deaths per 100 person-years (PY). Mortality rate increased from 7.8 (95% CI 6.4-9.5) in 2012 to 17.7 (95% CI 14.9-21.1) in 2016 per 100PY (P-trend <0.0001). 449/585 (77%) of the deaths occurred within the first three months after starting TB treatment. The median time to death (IQR) declined from 87 (40-100) days in 2012 to 46 (18-83) days in 2016 (P-trend = 0. 04). Mortality rate per 100PY was 7.3 (95% CI 6.5-7.8) and 23.1 (95% CI 20.8-25.7) among HIV-uninfected and HIV-infected patients respectively. Age, being a female, extrapulmonary TB, being undernourished, HIV infected and year of diagnosis were significantly associated with mortality. Conclusions We found most deaths occurred within three months and an increasing mortality rate during the time under review among patients on TB treatment. Our results therefore warrant further investigation to explore host, disease or health system factors that may explain this trend.	[Abdullahi, Osman A.; Katana, Geoffrey; Willetts, Annie] Pwani Univ, Dept Publ Hlth, Kilifi, Kenya; [Ngari, Moses M.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Sanga, Deche] Kilifi Cty TB Control Program, Kilifi, Kenya; [Katana, Geoffrey] Kilifi Cty Dept Publ Hlth, Kilifi, Kenya	Pwani University	Abdullahi, OA (corresponding author), Pwani Univ, Dept Publ Hlth, Kilifi, Kenya.	o.abdullahi@pu.ac.ke		Abdullahi, Osman/0000-0001-5003-2973				Adamu AL, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2249-4; Agbor AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115211; [Anonymous], 2010, TREATM TUB GUID; Cazabon D, 2017, INT J INFECT DIS, V56, P111, DOI 10.1016/j.ijid.2016.10.016; Cherutich P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036797; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dangisso MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114225; Dememew ZG, 2016, INT J TUBERC LUNG D, V20, P1192, DOI 10.5588/ijtld.16.0005; Fine J P, 2001, Biostatistics, V2, P85, DOI 10.1093/biostatistics/2.1.85; Hanson CL, 2017, J INFECT DIS, V216, pS679, DOI 10.1093/infdis/jix387; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; Heunis JC, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3972-2; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Kenya National Bureau of Statistics, 2017, STAT ABSTRACT 2017; Mberu B, 2015, J URBAN HEALTH, V92, P422, DOI 10.1007/s11524-015-9943-6; Menon S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1718-5; Murray CJL, 2018, LANCET INFECT DIS, V18, P261, DOI 10.1016/S1473-3099(17)30703-X; Nagu TJ, 2017, INT J INFECT DIS, V56, P39, DOI 10.1016/j.ijid.2017.01.023; National TB and Lung Disease Program, 2014, NAT STRAT PLAN TUB L; National TB and Lung Disease Program, 2016, ANN REP 2016; National TB and Lung Disease Program, 2017, KEN TUB PREV SURV 20; Odone A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112017; Odone A, 2014, LANCET DIABETES ENDO, V2, P754, DOI 10.1016/S2213-8587(14)70164-0; Onyango DO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188235; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Takarinda Kudakwashe C, 2017, Tuberc Res Treat, V2017, P6232071, DOI 10.1155/2017/6232071; Verguet S, 2014, LANCET GLOB HEALTH, V2, pE698, DOI 10.1016/S2214-109X(14)70316-X; WHO, 2014, END TB STRAT; WHO, 2017, GLOB TUB REP 2017; WHO and UNICEF, 2017, KEN WHO UNICEF EST I; WHO (World Health Organization), 2011, WHO ANTHR VERS 3 2 2; Wobudeya E, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4988-y; World Health Organization, 2006, GLOB DAT BOD MASS IN; Zwang J, 2007, T ROY SOC TROP MED H, V101, P893, DOI 10.1016/j.trstmh.2007.04.023	35	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219191	10.1371/journal.pone.0219191	http://dx.doi.org/10.1371/journal.pone.0219191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295277	Green Published, Green Submitted, gold			2022-12-26	WOS:000484951800017
J	Baik, Y; Fane, O; Wang, Q; Modongo, C; Caiphus, C; Grover, S; Zetola, NM; Shin, SS				Baik, Yeonsoo; Fane, Othusitse; Wang, Qiao; Modongo, Chawangwa; Caiphus, Cynthia; Grover, Surbhi; Zetola, Nicola M.; Shin, Sanghyuk S.			Undetected tuberculosis at enrollment and after hospitalization in medical and oncology wards in Botswana	PLOS ONE			English	Article							LUNG-CANCER RISK; PULMONARY TUBERCULOSIS; DIAGNOSIS; YIELD	Cancer patients are at higher risk of tuberculosis (TB) infection, especially in hospital settings with high TB/HIV burden. The study was implemented among adult patients admitted to the largest tertiary-level referral hospital in Botswana. We estimated the TB prevalence at admission and the rate of newly diagnosed TB after hospitalization in the medical and oncology wards, separately. Presumptive TB cases were identified at admission through symptom screening and underwent the diagnostic evaluation through GeneXpert. Patients with no evidence of TB were followed-up until TB diagnosis or the end of the study. In the medical and oncology wards, four of 867 admitted patients and two of 240 had laboratory-confirmed TB at admission (prevalence = 461.4 and 833.3 per 100,000, respectively.) The post-admission TB rate from the medical wards was 28.3 cases per 1,000 person-year during 424.5 follow-up years (post-admission TB rate among HIV-positive versus.-negative = 54.1 and 9.8 per 1,000 person-year, respectively [Rate Ratio = 5.5]). No post-admission TB case was detected from the oncology ward. High rates of undetected TB at admission at both medical and oncology wards, and high rate of newly diagnosed TB after admission at medical wards suggest that TB screening and diagnostic evaluation should target all patients admitted to a hospital in high-burden settings.	[Baik, Yeonsoo] UCLA Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Fane, Othusitse; Modongo, Chawangwa; Zetola, Nicola M.] Botswana Upenn Partnership, Gaborone, Botswana; [Wang, Qiao; Shin, Sanghyuk S.] Univ Calif Irvine, Sue & Bill Gross Sch Nursing, Irvine, CA 92697 USA; [Modongo, Chawangwa] Univ Penn, Sch Med, Dept Infect Dis, Philadelphia, PA 19104 USA; [Caiphus, Cynthia] Botswana Minist Hlth, Princess Marina Hosp, Gaborone, Botswana; [Grover, Surbhi; Zetola, Nicola M.] Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Zetola, Nicola M.] Univ Maryland, Med Ctr, Dept Crit Care Med, Baltimore, MD 21201 USA	University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of Pennsylvania; University of Pennsylvania; University System of Maryland; University of Maryland Baltimore	Zetola, NM (corresponding author), Botswana Upenn Partnership, Gaborone, Botswana.; Shin, SS (corresponding author), Univ Calif Irvine, Sue & Bill Gross Sch Nursing, Irvine, CA 92697 USA.; Zetola, NM (corresponding author), Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA.	nzetola@gmail.com; ssshin2@uci.edu			National Institute of Allergy and Infectious Diseases [K01AI118559, R01AI097045, 5P30AI028697]; NATIONAL CANCER INSTITUTE [K08CA230170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI118559, P30AI028697] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases ((https://www.niaid.nih.gov/)) grants K01AI118559 to SSS; the National Institute of Allergy and Infectious Diseases grants R01AI097045 to NMZ and the National Institute of Allergy and Infectious Diseases grants 5P30AI028697 to UCLA CFAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Villaorduna C, DIAGNOSTIC CHARACTER; Behr MA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2738; Bhatt MLB, 2012, SOUTH ASIAN J CANCER, V1, P36, DOI 10.4103/2278-330X.96507; Cheng MP, 2017, CLIN INFECT DIS, V64, P635, DOI 10.1093/cid/ciw838; Christopoulos A, 2014, CLIN RESPIR J, V8, P375, DOI 10.1111/crj.12094; Cukic Vesna, 2017, Med Arch, V71, P212, DOI 10.5455/medarh.2017.71.212-214; Dobler CC, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00157-2017; Harikrishna J, 2012, J INDIAN ASS CLIN ME, V13, P3; Health BMo, 2016, HDB BOTSW 2016 INT H; Kamboj M, 2006, CLIN INFECT DIS, V42, P1592, DOI 10.1086/503917; Kompala T, 2013, CURR HIV-AIDS REP, V10, P264, DOI 10.1007/s11904-013-0164-x; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Liang HY, 2009, INT J CANCER, V125, P2936, DOI 10.1002/ijc.24636; Malone JL, 2004, CANCER-AM CANCER SOC, V101, P2713, DOI 10.1002/cncr.20698; Medrano BA, 2014, INFECT CONT HOSP EP, V35, P534, DOI 10.1086/675833; Menzies HJ, 2014, INT J TUBERC LUNG D, V18, P1026, DOI 10.5588/ijtld.13.0749; Ohene SA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2843-5; Organization WH, 2018, BOTSW TUB PROF; Puryear S, 2013, INT J TUBERC LUNG D, V17, P1049, DOI 10.5588/ijtld.12.0933; Reid MJA, 2012, INT J TUBERC LUNG D, V16, P1605, DOI 10.5588/ijtld.12.0033; Silva DR, 2013, J BRAS PNEUMOL, V39, P484, DOI 10.1590/S1806-37132013000400013; Simonsen DF, 2017, J INFECTION, V74, P590, DOI 10.1016/j.jinf.2017.03.012; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2013, WHO GUID APPR GUID R; Wu CY, 2011, CANCER-AM CANCER SOC, V117, P618, DOI 10.1002/cncr.25616; Yu YH, 2011, J THORAC ONCOL, V6, P32, DOI 10.1097/JTO.0b013e3181fb4fcc; Zetola NM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-409	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219678	10.1371/journal.pone.0219678	http://dx.doi.org/10.1371/journal.pone.0219678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295315	Green Published, gold			2022-12-26	WOS:000484951800062
J	Stur, E; Aristizabal-Pachon, AF; Peronni, KC; Agostini, LP; Waigel, S; Chariker, J; Miller, DM; Thomas, SD; Rezzoug, F; Detogni, RS; dos Reis, RS; Silva, WA; Louro, ID				Stur, Elaine; Aristizabal-Pachon, Andres Felipe; Peronni, Kamila Chagas; Agostini, Lidiane Pignaton; Waigel, Sabine; Chariker, Julia; Miller, Donald M.; Thomas, Shelia Dian; Rezzoug, Francine; Detogni, Raquel Spinasse; dos Reis, Raquel Silva; Silva Junior, Wilson Araujo; Louro, Iuri Drumond			Glyphosate-based herbicides at low doses affect canonical pathways in estrogen positive and negative breast cancer cell lines	PLOS ONE			English	Article							GENE-EXPRESSION; ROUNDUP; GLYCINE; GROWTH	Glyphosate is a broad-spectrum herbicide that is used worldwide. It represents a potential harm to surface water, and when commercially mixed with surfactants, its uptake is greatly magnified. The most well-known glyphosate-based product is Roundup. This herbicide is potentially an endocrine disruptor and many studies have shown the cytotoxicity potential of glyphosate-based herbicides. In breast cancer (BC) cell lines it has been demonstrated that glyphosate can induce cellular proliferation via estrogen receptors. Therefore, we aimed to identify gene expression changes in ER+ and ER- BC cell lines treated with Roundup and AMPA, to address changes in canonical pathways that would be related or not with the ER pathway, which we believe could interfere with cell proliferation. Using the Human Transcriptome Arrays 2.0, we identified gene expression changes in MCF-7 and MDA-MB-468 exposed to low concentrations and short exposure time to Roundup Original and AMPA. The results showed that at low concentration (0.05% Roundup) and short exposure (48h), both cell lines suffered deregulation of 11 canonical pathways, the most important being cell cycle and DNA damage repair pathways. Enrichment analysis showed similar results, except that MDA-MB-468 altered mainly metabolic processes. In contrast, 48h 10mM AMPA showed fewer differentially expressed genes, but also mainly related with metabolic processes. Our findings suggest that Roundup affects survival due to cell cycle deregulation and metabolism changes that may alter mitochondrial oxygen consumption, increase ROS levels, induce hypoxia, damage DNA repair, cause mutation accumulation and ultimately cell death. To our knowledge, this is the first study to analyze the effects of Roundup and AMPA on gene expression in triple negative BC cells. Therefore, we conclude that both compounds can cause cellular damage at low doses in a relatively short period of time in these two models, mainly affecting cell cycle and DNA repair.	[Stur, Elaine; Agostini, Lidiane Pignaton; Detogni, Raquel Spinasse; dos Reis, Raquel Silva; Louro, Iuri Drumond] Univ Fed Espirito Santo, Programa Posgrad Biotecnol, Vitoria, ES, Brazil; [Stur, Elaine; Agostini, Lidiane Pignaton; Detogni, Raquel Spinasse; dos Reis, Raquel Silva; Louro, Iuri Drumond] Univ Fed Espirito Santo, Dept Ciencias Biol Nucleo Genet Human & Mol, Vitoria, ES, Brazil; [Aristizabal-Pachon, Andres Felipe; Peronni, Kamila Chagas; Silva Junior, Wilson Araujo] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Ribeirao Preto, SP, Brazil; [Aristizabal-Pachon, Andres Felipe; Peronni, Kamila Chagas; Silva Junior, Wilson Araujo] Univ Sao Paulo, Ctr Med Genom HCRP, Ribeirao Preto, SP, Brazil; [Aristizabal-Pachon, Andres Felipe; Peronni, Kamila Chagas; Silva Junior, Wilson Araujo] Natl Inst Sci & Technol Stem Cell & Cell Therapy, Ribeirao Preto, SP, Brazil; [Aristizabal-Pachon, Andres Felipe; Peronni, Kamila Chagas; Silva Junior, Wilson Araujo] Ctr Cell Based Therapy, Ribeirao Preto, SP, Brazil; [Waigel, Sabine] Univ Louisville, JG Brown Canc Ctr, Mol Targets Program, Louisville, KY 40292 USA; [Chariker, Julia] Univ Louisville, Speed Sch Engn, Dept Comp Engn & Comp Sci, Louisville, KY 40292 USA; [Miller, Donald M.; Thomas, Shelia Dian; Rezzoug, Francine] Univ Louisville, James Graham Brown Canc Ctr, Dept Med, Louisville, KY 40292 USA	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Louisville; University of Louisville; University of Louisville	Louro, ID (corresponding author), Univ Fed Espirito Santo, Programa Posgrad Biotecnol, Vitoria, ES, Brazil.; Louro, ID (corresponding author), Univ Fed Espirito Santo, Dept Ciencias Biol Nucleo Genet Human & Mol, Vitoria, ES, Brazil.	iurilouro@yahoo.com	Silva Jr, Wilson Araújo/E-9487-2011; Aristizabal-Pachon, Andres Felipe felipe/J-3046-2015; Aristizabal-Pachon, Andres Felipe/AAM-3695-2021	Silva Jr, Wilson Araújo/0000-0001-9364-2886; Aristizabal-Pachon, Andres Felipe felipe/0000-0003-3004-4867; Aristizabal-Pachon, Andres Felipe/0000-0003-3004-4867	FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo); NIH [P20GM103436, P30GM106396]; J. G. Brown Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106396, P20GM103436] Funding Source: NIH RePORTER	FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. G. Brown Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ES and LPA were supported by FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo). Part of this work was performed with assistance of the UofL Genomics Facility, which is supported by NIH P20GM103436 (KY IDeA Networks of Biomedical Research Excellence), NIH P30GM106396 (UofL J. G. Brown Cancer Center Phase III CoBRE), the J. G. Brown Foundation, and user fees.	Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; Baluz K, 2002, REV BRAS CANCEROL, V48, P597; Benachour N, 2007, ARCH ENVIRON CON TOX, V53, P126, DOI 10.1007/s00244-006-0154-8; Nunez-Enriquez JC, 2016, ARCH MED RES, V47, P644, DOI 10.1016/j.arcmed.2016.12.005; Chaufan G, 2014, INT J TOXICOL, V33, P29, DOI 10.1177/1091581813517906; De Almeida LKS, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1464-z; Drug USF, 2018, QUEST ANSW GLYPH; Friess J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42087; Gasnier C, 2009, TOXICOLOGY, V262, P184, DOI 10.1016/j.tox.2009.06.006; Hassan HE, 2010, DRUG METAB DISPOS, V38, P157, DOI 10.1124/dmd.109.029199; Hokanson R, 2007, HUM EXP TOXICOL, V26, P747, DOI 10.1177/0960327107083453; IARC, 2017, IARC MONOGRAPHS EVAL, P464; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Komives T., 2016, ECOCYCLES, V2, P1, DOI [DOI 10.19040/ECOCYCLES.V2I2.60, 10.19040/ecocycles.v2i2.60]; Li QL, 2013, DRUG DES DEV THER, V7, P635, DOI 10.2147/DDDT.S49197; Marc J, 2004, TOXICOL SCI, V82, P436, DOI 10.1093/toxsci/kfh281; Marc J, 2002, CHEM RES TOXICOL, V15, P326, DOI 10.1021/tx015543g; Mesnage R, 2017, FOOD CHEM TOXICOL, V108, P30, DOI 10.1016/j.fct.2017.07.025; Miller A., 2010, GLYPHOSATE TECHNICAL; Mink PJ, 2012, REGUL TOXICOL PHARM, V63, P440, DOI 10.1016/j.yrtph.2012.05.012; Montiel-Leon JM, 2019, ENVIRON POLLUT, V250, P29, DOI 10.1016/j.envpol.2019.03.125; Myers JP, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0117-0; Richard S, 2005, ENVIRON HEALTH PERSP, V113, P716, DOI 10.1289/ehp.7728; Samsel Anthony, 2015, Surg Neurol Int, V6, P45, DOI 10.4103/2152-7806.153876; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Thongprakaisang S, 2013, FOOD CHEM TOXICOL, V59, P129, DOI 10.1016/j.fct.2013.05.057; Yao Y, 2016, DATA BRIEF, V7, P1438, DOI 10.1016/j.dib.2016.04.037	27	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219610	10.1371/journal.pone.0219610	http://dx.doi.org/10.1371/journal.pone.0219610			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295307	Green Published, Green Submitted, gold			2022-12-26	WOS:000484951800054
J	Shintaku, H; Yamaguchi, M; Toru, S; Kitagawa, M; Hirokawa, K; Yokota, T; Uchihara, T				Shintaku, Hiroshi; Yamaguchi, Mari; Toru, Shuta; Kitagawa, Masanobu; Hirokawa, Katsuiku; Yokota, Takanori; Uchihara, Toshiki			Three-dimensional surface models of autopsied human brains constructed from multiple photographs by photogrammetry	PLOS ONE			English	Article							SINGLE-CELL RESOLUTION; CRANIOSYNOSTOSIS	Virtual three-dimensional (3D) surface models of autopsied human brain hemispheres were constructed by integrating multiple two-dimensional (2D) photographs. To avoid gravity-dependent deformity, formalin-fixed hemispheres were placed on non-refractile, transparent acrylic plates, which allowed us to take 2D photographs from various different angles. Photogrammetric calculations using software (ReCap Pro cloud service, Autodesk, San Rafael, CA, USA) allowed us calculate the 3D surface of each brain hemisphere. Virtual brain models could be moved and rotated freely to allow smooth, seamless views from different angles and different magnifications. When viewing rotating 3D models on 2D screens, 3D aspects of the models were enhanced using motion parallax. Comparison of different brains using this method allowed us to identify disease-specific patterns of macroscopic atrophy, that were not apparent in conventional 2D photographs. For example, we observed frontal lobe atrophy in a progressive supranuclear palsy brain, and even more subtle atrophy in the superior temporal gyrus in amyotrophic lateral sclerosis-frontotemporal lobar degeneration. Thus, our method facilities recognition of gyral atrophy. In addition, it provides a much more powerful and suitable way of visualizing the overall appearance of the brain as a three-dimensional structure. Comparison of normal and diseased brains will allow us to associate different macroscopic changes in the brain to clinical manifestations of various diseases.	[Shintaku, Hiroshi; Uchihara, Toshiki] Tokyo Metropolitan Inst Med Sci, Lab Struct Neuropathol, Setagaya Ku, Tokyo, Japan; [Shintaku, Hiroshi; Yokota, Takanori; Uchihara, Toshiki] Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo, Japan; [Shintaku, Hiroshi; Hirokawa, Katsuiku] Nitobe Mem Nakano Gen Hosp, Dept Pathol, Nakano Ku, Tokyo, Japan; [Yamaguchi, Mari] Tokyo Metropolitan Inst Med Sci, MediaTechnol Lab, Setagaya Ku, Tokyo, Japan; [Toru, Shuta; Uchihara, Toshiki] Nitobe Mem Nakano Gen Hosp, Dept Neurol, Nakano Ku, Tokyo, Japan; [Kitagawa, Masanobu] Tokyo Med & Dent Univ, Dept Comprehens Pathol, Bunkyo Ku, Tokyo, Japan; [Uchihara, Toshiki] Nitobe Mem Nakano Gen Hosp, Neuromorph Lab, Nakano Ku, Tokyo, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Medical & Dental University (TMDU); Tokyo Metropolitan Institute of Medical Science; Tokyo Medical & Dental University (TMDU)	Uchihara, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Struct Neuropathol, Setagaya Ku, Tokyo, Japan.; Uchihara, T (corresponding author), Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo, Japan.; Uchihara, T (corresponding author), Nitobe Mem Nakano Gen Hosp, Dept Neurol, Nakano Ku, Tokyo, Japan.; Uchihara, T (corresponding author), Nitobe Mem Nakano Gen Hosp, Neuromorph Lab, Nakano Ku, Tokyo, Japan.	uchihara@nakanosogo.or.jp		Yokota, Takanori/0000-0002-6490-3263	Japan Society for the Promotion of Science KAKENHI [17H03555, 16K14572]; Japan Society for the Promotion of Science; Japan Foundation for Neuroscience and Mental health	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Foundation for Neuroscience and Mental health(Japan Foundation for Neuroscience and Mental Health)	TU: This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 17H03555 and 16K14572. Funder: Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/.ST: This work was supported by Japan Foundation for Neuroscience and Mental health, http://www.jfnm.or.jp/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P395, DOI 10.1007/s00401-011-0932-x; De Benedictis A, 2018, WORLD NEUROSURG, V115, pE279, DOI 10.1016/j.wneu.2018.04.036; Freudlsperger C, 2015, J CRANIO MAXILL SURG, V43, P593, DOI 10.1016/j.jcms.2015.02.017; Furukawa Y, 2010, IEEE T PATTERN ANAL, V32, P1362, DOI 10.1109/TPAMI.2009.161; Howard IP, 2002, SEEING DEPTH, V2, P239; Kim HR, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0256; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mannen H, 1966, Prog Brain Res, V21, P131; Meulstee JW, 2017, INT J ORAL MAX SURG, V46, P819, DOI 10.1016/j.ijom.2017.03.017; Moulon P, 2012, EUR C VIS MED PROD L, P5; Nocerino E, 2016, P ISPRS INT ARCH PHO, V5, P887, DOI [10.5194/isprs-archives-XLI-B5-887-2016, DOI 10.5194/ISPRS-ARCHIVES-XLI-B5-887-2016]; Qian S, 2011, ANN BIOMED ENG, V39, P2844, DOI 10.1007/s10439-011-0374-6; Remondino F, 2006, PHOTOGRAMM REC, V21, P269, DOI 10.1111/j.1477-9730.2006.00383.x; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Wilbrand JF, 2012, J CRANIO MAXILL SURG, V40, P726, DOI 10.1016/j.jcms.2012.01.007; Zakiewicz IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137571	18	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219619	10.1371/journal.pone.0219619	http://dx.doi.org/10.1371/journal.pone.0219619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291358	Green Submitted, Green Published, gold			2022-12-26	WOS:000484947800128
J	Asmamaw, M; Mereta, ST; Ambelu, A				Asmamaw, Mengistu; Mereta, Seid Tiku; Ambelu, Argaw			Exploring households' resilience to climate change-induced shocks using Climate Resilience Index in Dinki watershed, central highlands of Ethiopia	PLOS ONE			English	Article							COMMUNITY RESILIENCE; VARIABILITY; ADAPTATION	This study assessed households' resilience to climate change-induced shocks in Dinki watershed, northcentral highlands of Ethiopia. The data were collected through a cross-sectional survey conducted on 288 households, three focus group discussions, and 15 key informant interviews. The Climate Resilience Index (CRI) based on the three resilience capacities (absorptive, adaptive and transformative) frame was used to measure households' resilience to climate change-induced shocks on an agro-ecological unit of analysis. A principal component analysis (PCA) and multiple regression analysis were used to identify determinant factors and indicators to households' resilience, respectively. Findings indicate that the indexed scores of major components clearly differentiated the study communities in terms of their agro-ecological zones. Specifically, the absorptive capacity (0.495) was the leading contributing factor to resilience followed by adaptive (0.449) and transformative (0.387) capacities. Likewise, the Midland was relatively more resilient with a mean index value of 0.461. Both the PCA and multiple regression analysis indicated that access to and use of livelihood resources, such as farmlands and livestock holdings, diversity of income sources, infrastructure and social capital were determinants of households' resilience. In general, it might be due to their exposure to recurrent shocks coupled with limited adaptive capacities including underdeveloped public services, poor livelihood diversification practices, among others, the study communities showed minimal resilience capacity with a mean score of 0.44. Thus, in addition to short-term buffering strategies, intervention priority focusing on both adaptive and transformative capacities, particularly focusing on most vulnerable localities and constrained livelihood strategies, would contribute to ensuring long-term resilience in the study communities.	[Asmamaw, Mengistu; Mereta, Seid Tiku; Ambelu, Argaw] Jimma Univ, Dept Environm Hlth Sci & Technol, Jimma, Ethiopia; [Asmamaw, Mengistu] Debre Berhan Univ, Dept Biol, Debre Berhan, Ethiopia	Jimma University	Asmamaw, M (corresponding author), Jimma Univ, Dept Environm Hlth Sci & Technol, Jimma, Ethiopia.; Asmamaw, M (corresponding author), Debre Berhan Univ, Dept Biol, Debre Berhan, Ethiopia.	mengistuasmamaw21@gmail.com	Ambelu, Argaw/V-8317-2018; Mereta, Seid Tiku/HIA-0661-2022; Asmamaw, Mengistu/ABD-8054-2021; Ambelu, Argaw/GQA-6114-2022	Ambelu, Argaw/0000-0003-1898-4100; Asmamaw, Mengistu/0000-0001-9656-748X; Ambelu, Argaw/0000-0003-1898-4100				Alexander DE, 2013, RESILIENCE DISASTER, P2707; Alinovi L., 2010, MEASURING HOUSEHOLD; Andersen LE, 2013, BUILDING RESILIENCE, P1; [Anonymous], 2016, INT J ACED REASEARCH; Barrett CB, 2014, P NATL ACAD SCI USA, V111, P14625, DOI 10.1073/pnas.1320880111; Bene C., 2012, IDS WORKING PAPERS, V2012, P1; Bene C, 2016, FOOD SECUR, V8, P123, DOI 10.1007/s12571-015-0526-x; Berkes F., 2003, NAVIGATING SOCIAL EC, V1, P30; Bird K, 2010, ODI CPRC WORKING PAP; Boka GT, 2017, WORKING PAPER SERIES; Boukary AG, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8030181; Burke W, 2010, 327 ODI, P29; Choularton R., 2015, TECHNICAL SERIES, V5; Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013; d'Errico M, 2018, WORLD DEV, V104, P78, DOI 10.1016/j.worlddev.2017.11.020; d'Errico Marco, 2016, 1601 ESA FAO, P16; Darnhofer I, 2014, EUR REV AGRIC ECON, V41, P461, DOI 10.1093/erae/jbu012; Dirimie S., 2005, BACKGROUND RES PAPER; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Folke C, 2010, RESILIENCE THINKING, P15; Frankenberger T., 2013, COMMUNITY RESILIENCE; Gerlitz J.Y., 2014, POVERTY VULNERABILIT; Gibson, 2012, J FAMILY THEORY REV, V4, P148, DOI DOI 10.1111/J.1756-2589.2012.00119.X; Glover J, 2012, LOCAL ECON, V27, P355, DOI 10.1177/0269094212437833; Green D, 2009, RISKS CLIMATE CHANGE; Greenough G, 2001, ENVIRON HEALTH PERSP, V109, P191, DOI 10.2307/3435009; Gutu Tesso, 2012, Agricultural Sciences, V3, P871, DOI 10.4236/as.2012.36106; Kebede T., 2016, J FOOD SECUR, V4, P58, DOI [10.12691/jfs-4-3-2, DOI 10.12691/JFS-4-3-2]; Kothari C.R., 2014, REMETHODOLOGY METH; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Liu WT, 2014, CANADA ECOL SOC, V19, P1; Lulekal E, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-63; Maru YT, 2014, GLOBAL ENVIRON CHANG, V28, P337, DOI 10.1016/j.gloenvcha.2013.12.007; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Mekuyie M, 2018, CLIM RISK MANAG, V20, P64, DOI 10.1016/j.crm.2018.02.004; Mitchell T., 2012, AVIATION SPACE ENV M, DOI [10.3357/ASEM.3719.2013, DOI 10.3357/ASEM.3719.2013]; Nguyen KV, 2013, ECOL SOC, V18, DOI 10.5751/ES-05427-180313; Niehof A, 2004, FOOD POLICY, V29, P321, DOI 10.1016/j.foodpol.2004.07.009; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; Nyamwanza A. M., 2012, THESIS; Nyumba TO, 2018, METHODS ECOL EVOL, V9, P20, DOI 10.1111/2041-210X.12860; O'Brien K, 2012, PROG HUM GEOG, V36, P667, DOI 10.1177/0309132511425767; Pratikshya BM., 2014, P NATL ACAD SCI USA, V111, P9780, DOI [10.1073/pnas.1317166111, DOI 10.1073/PNAS.1317166111]; Sagara B., 2018, RESILIENCE MEASUREME; Shenggen F., 2014, INT FOOD POLICY RES, V230, DOI [10.2499/9780896296787, DOI 10.2499/9780896296787]; Steffen W, 2017, CRANKING INTENSITY C; Stocker T. F., 2013, CONTRIBUTION WORKING, DOI [10.1029/2001JD001516, DOI 10.1029/2001JD001516]; Sujithkumar PS., 2007, INDIAN J LABOUR ECON, V504, P715; Sullivan C., 2002, DERIVATION TESTING W; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Tambo JA, 2017, REG ENVIRON CHANGE, V17, P1505, DOI 10.1007/s10113-017-1113-9; Tambo JA, 2016, INT J DISAST RISK RE, V17, P85, DOI 10.1016/j.ijdrr.2016.04.005; Tobiko K, 2013, 18 IAP ANN C GEN M, P1; Vyas S, 2006, CONSTRUCTING SOCIOEC, P460, DOI [DOI 10.1093/HEAPOL/CZL029, 10.1093/heapol/czl029]; Walker B., 2004, Ecology and Society, V9, P5; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; Weldegebriel ZB, 2017, GEOENVIRON DISASTER, V4, P1, DOI [10.1186/s40677-017-0074-0, DOI 10.1186/S40677-017-0074-0]; Zseleczky Laura., 2014, ARE SHOCKS REALLY IN	58	7	7	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219393	10.1371/journal.pone.0219393	http://dx.doi.org/10.1371/journal.pone.0219393			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS7KI	31287852	Green Published, Green Submitted, gold			2022-12-26	WOS:000482328300019
J	Roper, JM; Smith, BL; Rae, JMC; Huang, E; Walker, CA; McNaughton, JL; Chen, A; Reidinger, KS				Roper, Jason M.; Smith, Brenda L.; Rae, Jessica M. Caverly; Huang, Emily; Walker, Carl A.; McNaughton, James L.; Chen, Alice; Reidinger, Kathy S.			Nutrient composition and safety evaluation of simulated isobutanol distillers dried grains with solubles and associated fermentation metabolites when fed to male Ross 708 broiler chickens (Gallus domesticus)	PLOS ONE			English	Article							GROWTH-PERFORMANCE; PREDICTION EQUATIONS; CORN; ACID; CALCIUM; DIGESTIBILITY; BUTANOL; PHYTASE; ENERGY; VALUES	Saccharomyces cerevisiae genetically engineered to enhance butanol production will be used in a manufacturing process similar to that of fuel ethanol production, including co-production of distillers products for animal feed. A poultry feeding trial was conducted with simulated isobutanol-derived dried distillers grains with solubles (bDDGS), comprising non fermentable corn solids and heat-inactivated Butamax modified yeast (BMY), to determine potential health effects. Simulated dried distillers grains were produced in 2 variants: bDDGS containing 10% (B10) or 50% (B50) BMY. The BMY concentrations were selected based on a conservative estimate from ethanol-derived distillers grains (eDDGS) approximating 2.5 and 12-fold margins of exposure. The B10 and B50 DDGS were evaluated in a 42-day feeding trial using male Ross 708 broiler chickens fed diets containing eDDGS, B50 DDGS, or B10 DDGS without or with isobutanol, 2,3-butanediol, and isobutyric acid metabolites each at target concentrations of 2 (B10-2), 5 (B10-5), or 10 (B10-10) times the anticipated specification limit in the commercial product. Diets were fed (n = 50 broilers/ treatment) in 3 phases: starter phase with 8% DDGS and grower and finisher phases each with 15% DDGS. No statistically significant differences or diet-related effects on mortality, clinical pathology, or organ weights, and no microscopic observations associated with consumption of diets containing B10, B50, or B10 supplemented with metabolites at any targeted exposure level were observed. A lower (P < 0.05) mean absolute bursa of Fabricius weight in the B10-10 group compared to the B10 group was considered to be within the range of biological variability. A non-significant trend toward lower weight, gains, and feed intake, and higher feed:gain ratio was observed in the B10-10 group, and was considered a non-adverse palatability effect of consuming high concentrations of metabolites. These results demonstrate that consumption of phase diets containing simulated DDGS from a novel isobutanol production process was well-tolerated.	[Roper, Jason M.; Rae, Jessica M. Caverly] DuPont Haskell Global Ctr Hlth Sci, Newark, DE 19711 USA; [Smith, Brenda L.; Huang, Emily; Walker, Carl A.] DuPont Pioneer, Johnston, IA USA; [McNaughton, James L.] AHPharma, Hebron, MD USA; [Chen, Alice] DuPont Ind Biosci, Palo Alto, CA USA; [Reidinger, Kathy S.] Butamax Adv Biofuels LLC, Wilmington, DE USA	DuPont; DuPont; Pioneer Hi-Bred International, Inc.	Roper, JM (corresponding author), DuPont Haskell Global Ctr Hlth Sci, Newark, DE 19711 USA.	jason.roper-1@dupont.com	Roper, Jason/AAF-8238-2019; Roper, Jason/Y-7059-2018	Roper, Jason/0000-0002-3594-666X	Butamax Advanced Biofuels, LLC	Butamax Advanced Biofuels, LLC	All funding for the work described herein was provided by Butamax Advanced Biofuels, LLC, the producer of Butamax Modified Yeast. K.S. Reidinger is an employee of Butamax Advanced Biofuels, LLC, the funders of this work. K.S. Reidinger had no role in the study design, or data collection and analysis.; The authors thank Mick Roberts (AHPharma, Hebron, MD) for technical conduct of the AMEn, AA and P Digestibility, and 42-day feeding trials, Anne B. Carlson (DuPont Pioneer, Johnston, IA) for coordination and conduct of treatment diet formulation, manufacture and characterization for the 42-day feeding trial, Fenn Li (Critical Path Services, Garnet Valley, PA) for analysis of metabolite concentrations in the treatment diets, and Christina Johnson (EPL BioAnalytical Services, Niantic, IL for nutrient composition analyses of the DDGS sources and phase diets. Additionally, the authors thank the National Corn to Ethanol Research Center (Edwardsville, IL) for their support in the preparation of the simulated isobutanol-derived distillers grains used in this work.	Al-Mansour S., 2011, International Journal of Poultry Science, V10, P603; AOAC, 1995, OFFICIAL METHODS ANA, V16th; AOAC, 2005, AOAC INT SUIT, V18; AOAC International, 2007, OFF METH AOAC INT; Association of American Feed Control Officials (AAFCO US), 2018, OFF PUBL FEED INGR 7; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BONNER JM, 1976, J DAIRY SCI, V59, P431, DOI 10.3168/jds.S0022-0302(76)84224-5; BOWES VA, 1989, CAN J VET RES, V53, P7; Cafe M.B., 2012, WORLDS POULT SCI J, V5, P143; Campbell TW, 2015, EXOTIC ANIMAL HEMATOLOGY AND CYTOLOGY, 4TH EDITION, P1, DOI 10.1002/9781118993705; Choi HS, 2008, ASIAN AUSTRAL J ANIM, V21, P414, DOI 10.5713/ajas.2008.70067; Corzo A, 2009, POULTRY SCI, V88, P432, DOI 10.3382/ps.2008-00406; Delezie E, 2015, J APPL POULTRY RES, V24, P115, DOI 10.3382/japr/pfv011; Delezie E, 2012, POULTRY SCI, V91, P2523, DOI 10.3382/ps.2011-01937; Doud DFR, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0864-3; DOWD MK, 1993, CEREAL CHEM, V70, P204; Dozier WA, 2015, J APPL POULTRY RES, V24, P436, DOI 10.3382/japr/pfv045; Driver JP, 2005, POULTRY SCI, V84, P1629, DOI 10.1093/ps/84.10.1629; Driver JP, 2005, POULTRY SCI, V84, P1406, DOI 10.1093/ps/84.9.1406; DSM Innovation Inc, 2016, SAF GEN REC SAF GRAS; EPA (US), 1986, EPA IRIS IS ALC CASR; European Chemicals Agency (ECHA), 2019, REG SUBST DAT; European Food Safety Authority (EFSA IT), 2011, EFSA J, V9, P5021; Fang CL, 2014, J ANIM PHYSIOL AN N, V98, P680, DOI 10.1111/jpn.12122; FASS, 2010, GUID CAR US AGR AN R, V3rd; FDA (US), 2009, TARG AN SAF VET PHAR; FDA (US), 2005, FDA COMPL PROGR GUID; Feldman D., 1996, SYNTHETIC POLYM TECH; Firestone D., 2009, OFFICIAL METHODS REC, V6th Edn; GALFI P, 1990, ACTA VET HUNG, V38, P3; Generoso WC, 2015, CURR OPIN BIOTECH, V33, P1, DOI 10.1016/j.copbio.2014.09.004; Guedes RLM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S4-S2; Gulland F. M. D., 1990, Veterinary Annual, V30, P126; Han JC, 2010, J AGR FOOD CHEM, V58, P3430, DOI 10.1021/jf9034833; Harr KE, 2002, VET CLIN PATH, V31, P140, DOI 10.1111/j.1939-165X.2002.tb00295.x; Harvey BG, 2011, J CHEM TECHNOL BIOT, V86, P2, DOI 10.1002/jctb.2540; Hochleithner Manfred, 1994, P223; Kim Y, 2008, BIORESOURCE TECHNOL, V99, P5165, DOI 10.1016/j.biortech.2007.09.028; Li P, 2015, J ANIM SCI, V93, P3458, DOI 10.2527/jas.2014-8782; LIU HJ, 1994, J CHROMATOGR A, V670, P59; Liu KS, 2012, DISTILLERS GRAINS: PRODUCTION, PROPERTIES, AND UTILIZATION, P143; Liu Q, 2009, ANIM FEED SCI TECH, V154, P58, DOI 10.1016/j.anifeedsci.2009.08.001; Loar RE, 2010, POULTRY SCI, V89, P2242, DOI 10.3382/ps.2010-00894; Lumpkins BS, 2004, POULTRY SCI, V83, P1891, DOI 10.1093/ps/83.11.1891; Martinez-Amezcua C, 2007, POULTRY SCI, V86, P2624, DOI 10.3382/ps.2007-00137; MATHISON GW, 1981, CAN J ANIM SCI, V61, P649, DOI 10.4141/cjas81-078; McNaughton J, 2014, POULTRY SCI, V93, P1713, DOI 10.3382/ps.2013-03645; Meloche KJ, 2014, POULTRY SCI, V93, P1428, DOI 10.3382/ps.2013-03712; Meloche KJ, 2013, POULTRY SCI, V92, P3176, DOI 10.3382/ps.2013-03290; MELUZZI A, 1992, POULTRY SCI, V71, P337, DOI 10.3382/ps.0710337; Metabolomics Innovation Center (MIC CA), 2018, BOV MET DAT VERS 1 0; MILLIKEN GA, 1996, ANAL MESSY DATA, V1; Misra AK, 2001, ASIAN AUSTRAL J ANIM, V14, P200, DOI 10.5713/ajas.2001.200; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; NRC, 1994, NUTR REQ POULTR; OECD (FR), 2004, SUBST INF DAT SHEET; OECD (FR), 2003, SUBST INF DAT SHEET; Organization for Economic Co-operation and Development (OECD FR), 2007, ENVJMMONO200728 OECD, V80, P28; Pahm AA, 2009, POULTRY SCI, V88, P571, DOI 10.3382/ps.2008-00184; Pariza MW, 2010, REGUL TOXICOL PHARM, V56, P332, DOI 10.1016/j.yrtph.2009.10.005; Pekel AY, 2013, J APPL POULTRY RES, V22, P814, DOI 10.3382/japr.2013-00728; Pietruszynska D, 2010, ZOOTECHNIKA, V38, P27; ROGERS SR, 1990, J MICRONUTR ANAL, V7, P27; Rudell E, 1983, Beitr Gerichtl Med, V41, P211; Rychen G, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5021; Schilling K, 1997, HUM EXP TOXICOL, V16, P722, DOI 10.1177/096032719701601205; Shim MY, 2011, POULTRY SCI, V90, P369, DOI 10.3382/ps.2010-00727; Shurson GC, 2018, ANIM FEED SCI TECH, V235, P60, DOI 10.1016/j.anifeedsci.2017.11.010; Silva PRL, 2007, BRAZ J POULTRY SCI, V9, P229, DOI 10.1590/S1516-635X2007000400004; SMYTH H F Jr, 1962, Am Ind Hyg Assoc J, V23, P95, DOI 10.1080/00028896209343211; Spiehs MJ, 2002, J ANIM SCI, V80, P2639; STAHLY TS, 1986, J ANIM SCI, V63, P1156, DOI 10.2527/jas1986.6341156x; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Stein HH, 2009, ASIAN AUSTRAL J ANIM, V22, P1016, DOI 10.5713/ajas.2009.80484; STRASSMAN M, 1960, J BIOL CHEM, V235, P700; Sulyok M, 2006, RAPID COMMUN MASS SP, V20, P2649, DOI 10.1002/rcm.2640; Tabler G.T., 2004, POULTRY SITE 1213; Tani Y, 2004, TOXICOL PATHOL, V32, P41, DOI 10.1080/01926230490260952; TITUS HW, 1959, POULTRY SCI, V38, P1114, DOI 10.3382/ps.0381114; Traesel C. K., 2011, Comparative Clinical Pathology, V20, P453, DOI 10.1007/s00580-010-1018-1; Tudor R, 2007, PLATIN MET REV, V51, P116, DOI 10.1595/147106707X216855; Turner TL, 2016, ADV BIOCHEM ENG BIOT; University of Minnesota (UMN), 2017, BIOF COPR AN FEEDS D; Waters Method, 1995, ANAL AMINO ACIDS FEE; Westfall PH, 1999, MULTIPLE COMP MULTIP; Wisker E, 2003, BRIT J NUTR, V90, P373, DOI 10.1079/BJN2003920; WIXOM RL, 1960, J BIOL CHEM, V235, P128; Wyant S, 2012, ISOBUTANOL COMES LIG; Yu MR, 2011, METAB ENG, V13, P373, DOI 10.1016/j.ymben.2011.04.002; ZIADI H, 1973, CR ACAD SCI D NAT, V276, P965	91	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219016	10.1371/journal.pone.0219016	http://dx.doi.org/10.1371/journal.pone.0219016			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283767	Green Published, gold, Green Submitted			2022-12-26	WOS:000484939800016
J	Tang, SL; Liu, XF; He, L; Liu, B; Qin, B; Feng, C				Tang, Shilong; Liu, Xianfan; He, Ling; Liu, Bo; Qin, Bin; Feng, Chuan			Application of a 3D pseudocontinuous arterial spin-labeled perfusion MRI scan combined with a postlabeling delay value in the diagnosis of neonatal hypoxic-ischemic encephalopathy	PLOS ONE			English	Article							BRAIN PERFUSION; VASCULAR DENSITY; PREDICT; HEAD; TECHNOLOGY; DIFFUSION; CHILDREN; NEWBORNS	Background Currently, there are many studies on the application of the 3D pseudocontinuous arterial spin-labeled (3D-pcASL) perfusion MRI technique for adult brain examinations, but few studies exist on the application of the technique for child brain examinations. Purpose To explore the application of a 3D-pcASL perfusion MRI scan combined with postlabeling delay (PLD) for assessing neonatal hypoxic-ischemic encephalopathy (HIE). Materials and methods Two-hundred neonates diagnosed with neonatal HIE were equally divided into five groups (40/group): 0-to <24-hour-old HIE group, 1-to <3-day-old HIE group, 3-to <7-day-old HIE group, 7-to <15-day-old HIE group and 15- to 28-day-old HIE group; 200 healthy neonates were equivalently divided. All 10 groups received a conventional and a 3D-pcASL perfusion MRI scan. For groups <3 days old, PLD values for the 3D-pcASL cerebral perfusion MRI scan were preset at 1025 ms; in all other groups, PLD values were preset at 1525 ms. CBF values for the 3D-pcASL cerebral perfusion MRI were compared between the HIE and corresponding control groups to determine the distinguishing characteristics of CBF values in HIE neonates. Results On the 3D-pcASL cerebral perfusion MRI scan, in the 1-to <3-day-old groups, HIE neonate CBF values were higher than those of controls in all brain regions (excluding the frontal lobe); in the 0- to <24-hour-old and 3- to <7-day-old groups, HIE neonate CBF values were lower than those of corresponding controls in all brain regions; in the 7- to <15-day-old and 15- to 28-day-old groups, there were no significant differences in the CBF values between groups in any brain regions. Conclusions The 3D-pcASL perfusion MRI scan combined with a PLD can assist in the early diagnosis of neonatal HIE, as this method more comprehensively reflects the HIE pathological process.	[Tang, Shilong; Liu, Xianfan] Chongqing Med Univ, Dept Radiol, Childrens Hosp, Chongqing, Peoples R China; [He, Ling] Chongqing Med Univ, Childrens Hosp, Key Lab Child Dev & Disorders, Minist Educ, Chongqing, Peoples R China; [Liu, Bo] Chongqing Med Univ, Childrens Hosp, Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Qin, Bin; Feng, Chuan] Chongqing Med Univ, Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Tang, SL (corresponding author), Chongqing Med Univ, Dept Radiol, Childrens Hosp, Chongqing, Peoples R China.	sltang66@163.com		Tang, Shilong/0000-0002-9207-7798				Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Badurdeen S, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9030049; Boudes E, 2014, NEUROIMAGE-CLIN, V6, P126, DOI 10.1016/j.nicl.2014.08.010; Boulouis G, 2017, AM J NEURORADIOL, V38, P633, DOI 10.3174/ajnr.A5065; Dangouloff-Ros V, 2016, RADIOLOGY, V281, P553, DOI 10.1148/radiol.2016152228; De Vis JB, 2015, EUR RADIOL, V25, P113, DOI 10.1007/s00330-014-3352-1; Guo J, 2018, J MAGN RESON IMAGING, V47, P1119, DOI 10.1002/jmri.25834; Guo LL, 2016, EXP THER MED, V12, P2835, DOI 10.3892/etm.2016.3740; Hu HH, 2017, MAGN RESON IMAGING, V35, P132, DOI 10.1016/j.mri.2016.08.019; Kaneta T, 2017, AM J NEURORADIOL, V38, P1562, DOI 10.3174/ajnr.A5238; Kikuchi K, 2017, J NEURO-ONCOL, V135, P561, DOI 10.1007/s11060-017-2604-8; Lee YK, 2017, NEURORADIOL J, V30, P28, DOI 10.1177/1971400916678229; Li ZW, 2016, EXP THER MED, V12, P297, DOI 10.3892/etm.2016.3318; Lim RP, 2017, J COMPUT ASSIST TOMO, V41, P854, DOI 10.1097/RCT.0000000000000633; Lindner T, 2017, MAGN RESON MED, V78, P1469, DOI 10.1002/mrm.26542; Mamlouk MD, 2016, CLIN IMAG, V40, P1040, DOI 10.1016/j.clinimag.2016.06.009; Morana G, 2017, EUR J NUCL MED MOL I, V44, P2084, DOI 10.1007/s00259-017-3777-2; Proisy M, 2016, AM J NEURORADIOL, V37, P1766, DOI 10.3174/ajnr.A4778; Proisy M, 2016, DIAGN INTERV IMAG, V97, P151, DOI 10.1016/j.diii.2015.09.001; Razek AAKA, 2018, EUR ARCH OTO-RHINO-L, V275, P1301, DOI 10.1007/s00405-018-4950-3; Seo Y, 2017, NEUROREPORT, V28, P845, DOI 10.1097/WNR.0000000000000844; Shrestha M, 2016, MAGN RESON MATER PHY, V29, P799, DOI 10.1007/s10334-016-0565-0; Silveira RC, 2015, J PEDIAT-BRAZIL, V91, pS78, DOI 10.1016/j.jped.2015.07.004; Sogabe S, 2017, NEURORADIOLOGY, V59, P587, DOI 10.1007/s00234-017-1828-9; Tortora D, 2017, NEUROIMAGE-CLIN, V15, P401, DOI 10.1016/j.nicl.2017.05.023; Won J, 2018, RADIOL MED, V123, P843, DOI 10.1007/s11547-018-0921-4; Wong AMC, 2017, J NEURORADIOLOGY, V44, P281, DOI 10.1016/j.neurad.2017.02.003; Yildiz EP, 2017, EXPERT REV NEUROTHER, V17, P449, DOI 10.1080/14737175.2017.1259567; Yokoyama H, 2017, BRAIN DEV-JPN, V39, P722, DOI 10.1016/j.braindev.2017.04.009; Zeng Q, 2017, AM J NEURORADIOL, V38, P1876, DOI 10.3174/ajnr.A5299; Zhang N, 2017, NEUROSCI BIOBEHAV R, V72, P168, DOI 10.1016/j.neubiorev.2016.11.023; Zou JX, 2014, EXP GERONTOL, V60, P31, DOI 10.1016/j.exger.2014.09.009	32	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219284	10.1371/journal.pone.0219284	http://dx.doi.org/10.1371/journal.pone.0219284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283776	Green Published, Green Submitted, gold			2022-12-26	WOS:000484939800026
J	Cole, BK; Ilikj, M; McCloskey, CB; Chavez-Bueno, S				Cole, Bryan K.; Ilikj, Marko; McCloskey, Cindy B.; Chavez-Bueno, Susana			Antibiotic resistance and molecular characterization of bacteremia Escherichia coli isolates from newborns in the United States	PLOS ONE			English	Article							ONSET NEONATAL SEPSIS; SPECTRUM-BETA-LACTAMASES; K1 STRAIN RS218; ANTIMICROBIAL SUSCEPTIBILITY; PHENOTYPIC CHARACTERIZATION; FEBRILE INFANTS; VIRULENCE; EPIDEMIOLOGY; BACTERIAL; PREVALENCE	Background Escherichia coli is a major cause of neonatal sepsis. Contemporary antibiotic resistance data and molecular characterization of neonatal E. coli bacteremia isolates in the US are limited. Methods E. coli blood isolates, antibiotic susceptibility data, and clinical characteristics were obtained from prospectively identified newborns from 2006 to 2016. The E. coli isolates were classified using an updated phylogrouping method and multi-locus sequence typing. The presence of several virulence traits was also determined. Results Forty-three newborns with E. coli bacteremia were identified. Mean gestational age was 32.3 (SD +/- 5.4) weeks. Median age was 7 days (interquartile range 0-10). Mortality (28%) occurred exclusively in preterm newborns. Resistance to ampicillin was 67%, to gentamicin was 14%, and to ceftriaxone was 2%; one isolate produced extended-spectrum beta lacta-mases. Phylogroup B2 predominated. Sequence type (ST) 95 and ST131 prevailed; ST1193 emerged recently. All isolates carried fimH, nlpI, and ompA, and 46% carried the K1 capsule. E. coli from newborns with bacteremia diagnosed at <72 hours old had more virulence genes compared to E. coli from newborns. 72 hours old. The hek/hra gene was more frequent in isolates from newborns who died than in isolates from survivors. Conclusion Antibiotic resistance in E. coli was prevalent in this large collection of bacteremia isolates from US newborns. Most strains belonged to distinctive extra-intestinal pathogenic E. coil phylogroups and STs. Further characterization of virulence genes in neonatal E. coli bacteremia strains is needed in larger numbers and in more geographically diverse areas.	[Cole, Bryan K.; Ilikj, Marko; Chavez-Bueno, Susana] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA; [McCloskey, Cindy B.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Cole, Bryan K.] Univ Arizona, Dept Child Hlth, Phoenix, AZ USA; [Chavez-Bueno, Susana] Univ Missouri, Childrens Mercy Hosp Kansas City, Dept Pediat, Kansas City, MO 64110 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Arizona; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City	Chavez-Bueno, S (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA.; Chavez-Bueno, S (corresponding author), Univ Missouri, Childrens Mercy Hosp Kansas City, Dept Pediat, Kansas City, MO 64110 USA.	Schavezbueno@cmh.edu			Oklahoma INBRE program [8P20GM103447]; NIH/NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103447] Funding Source: NIH RePORTER	Oklahoma INBRE program; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the Oklahoma INBRE program, award 8P20GM103447 from NIH/NIGMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghoribi MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101547; Banerjee R, 2013, ANTIMICROB AGENTS CH, V57, P6385, DOI 10.1128/AAC.01604-13; Bergin SP, 2015, PEDIATR INFECT DIS J, V34, P933, DOI 10.1097/INF.0000000000000769; Bingen-Bidois M, 2002, INFECT IMMUN, V70, P3216, DOI 10.1128/IAI.70.6.3216-3226.2002; Biondi E, 2013, PEDIATRICS, V132, P990, DOI 10.1542/peds.2013-1759; Bizzarro MJ, 2008, PEDIATRICS, V121, P689, DOI 10.1542/peds.2007-2171; Blanco J, 2013, J CLIN MICROBIOL, V51, P3358, DOI 10.1128/JCM.01555-13; Bonacorsi S, 2003, J INFECT DIS, V187, P1895, DOI 10.1086/375347; Bradley JS., 2019, NELSONS PEDIAT ANTIM, V25; Burdet C, 2014, PEDIATR INFECT DIS J, V33, P872, DOI 10.1097/INF.0000000000000309; Centers for Disease Control and Prevention, 2016, ACTIVE BACTERIAL COR; Charfi K, 2017, MICROB PATHOGENESIS, V110, P184, DOI 10.1016/j.micpath.2017.06.030; Chavez-Bueno S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00514-14; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2015, MICROBIOL-SGM, V161, P980, DOI 10.1099/mic.0.000063; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Cole BK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189032; Dando SJ, 2014, CLIN MICROBIOL REV, V27, P691, DOI 10.1128/CMR.00118-13; Day MW, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01598-14; Fagan RP, 2007, FEMS MICROBIOL LETT, V269, P248, DOI 10.1111/j.1574-6968.2006.00628.x; Fanaroff AA, 2007, AM J OBSTET GYNECOL, V196, DOI DOI 10.1016/J.AJ0G.2006.09.014; Geslain G, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-018-1376-4; Greenhow TL, 2012, PEDIATRICS, V129, pE590, DOI 10.1542/peds.2011-1546; Huynh BT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0843-x; Iqbal J, 2016, INFECT DIS-NOR, V48, P461, DOI 10.3109/23744235.2016.1144142; Jain A, 2003, J MED MICROBIOL, V52, P421, DOI 10.1099/jmm.0.04966-0; Johnson JR, 2012, INFECT IMMUN, V80, P1554, DOI 10.1128/IAI.06388-11; Johnson JR, 2003, J INFECT DIS, V188, P759, DOI 10.1086/377455; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Johnson TJ, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01913-18; Jolley Keith A, 2018, Wellcome Open Res, V3, P124, DOI 10.12688/wellcomeopenres.14826.1; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Maciel JF, 2017, MICROB PATHOGENESIS, V103, P119, DOI 10.1016/j.micpath.2016.12.020; Mahjoub-Messai F, 2011, J INFECT DIS, V203, P1844, DOI 10.1093/infdis/jir189; Mendoza-Palomar N, 2017, EUR J PEDIATR, V176, P1227, DOI 10.1007/s00431-017-2975-z; Mischler Matthew, 2015, Hosp Pediatr, V5, P293, DOI 10.1542/hpeds.2014-0121; Polin RA, 2012, PEDIATRICS, V129, P1006, DOI 10.1542/peds.2012-0541; Powell EC, 2018, ANN EMERG MED, V71, P211, DOI 10.1016/j.annemergmed.2017.07.488; Riveros M, 2017, AM J TROP MED HYG, V97, P1329, DOI 10.4269/ajtmh.17-0066; Roy S, 2015, EPIDEMIOL INFECT, V143, P3266, DOI 10.1017/S0950268815000539; Sader HS, 2014, DIAGN MICR INFEC DIS, V78, P443, DOI 10.1016/j.diagmicrobio.2013.11.025; Schrag SJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2013; Shakir SM, 2014, AM J PERINAT, V31, P975, DOI 10.1055/s-0034-1370341; Shane AL, 2017, LANCET, V390, P1770, DOI 10.1016/S0140-6736(17)31002-4; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; SOMAN M, 1985, AM J EPIDEMIOL, V121, P712, DOI 10.1093/aje/121.5.712; Soto SM, 2008, J CLIN MICROBIOL, V46, P1123, DOI 10.1128/JCM.01682-07; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Stoll BJ, 2005, PEDIATR INFECT DIS J, V24, P635, DOI 10.1097/01.inf.0000168749.82105.64; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; Tchesnokova VL, 2019, CLIN INFECT DIS, V68, P334, DOI 10.1093/cid/ciy525; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Teng CH, 2006, INFECT IMMUN, V74, P5609, DOI 10.1128/IAI.00321-06; Teng CH, 2010, INFECT IMMUN, V78, P3090, DOI 10.1128/IAI.00034-10; Vergnano S, 2005, ARCH DIS CHILD-FETAL, V90, P220, DOI 10.1136/adc.2002.022863; Watt S, 2003, J CLIN MICROBIOL, V41, P1929, DOI 10.1128/JCM.41.5.1929-1935.2003; Watterberg KL, 2015, PEDIATRICS, V136, P819, DOI 10.1542/peds.2015-2651; Weissman SJ, 2016, J PEDIAT INF DIS SOC, V5, P269, DOI 10.1093/jpids/piv013; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	60	25	27	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219352	10.1371/journal.pone.0219352	http://dx.doi.org/10.1371/journal.pone.0219352			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276562	Green Published, gold, Green Submitted			2022-12-26	WOS:000484936300067
J	Peng, W; Li, JW; Zhang, XY; Li, C; Wen, TF; Yan, LN; Yang, JY				Peng, Wei; Li, Jia-Wu; Zhang, Xiao-Yun; Li, Chuan; Wen, Tian-Fu; Yan, Lv-Nan; Yang, Jia-Yin			A novel model for predicting posthepatectomy liver failure in patients with hepatocellular carcinoma	PLOS ONE			English	Article							PLATELET COUNT; PORTAL-HYPERTENSION; PRINGLE MANEUVER; HEPATECTOMY; RESECTION; REGENERATION; ACTIVATION; STIFFNESS; CIRRHOSIS; SURVIVAL	Posthepatectomy liver failure (PHLF) is the most leading cause of mortality following hepatectomy in patients with hepatocellular carcinoma (HCC). Platelet count was reported to be a simple but useful indicator of liver cirrhosis and function of spleen. Spleen stiffness (SS) was used to evaluate the morphological change of spleen and was reported to be related to liver cirrhosis and portal hypertension. However, the predictive value of platelet to spleen stiffness ratio (PSR) on PHLF remains unknown. A retrospective study was performed to analyze 158 patients with HCC following hepatectomy from August 2015 to February 2016. Univariate and multivariate analyses were performed to evaluate the value of each risk factor for predicting PHLF. The predictive efficiency of the risk factors was evaluated by receiver operating characteristic (ROC) curve. PHLF occured in 23 (14.6%) patients. PSR (P<0.001, odds ratio (OR) = 0.622, 95% confidence interval (CI) 0.493 similar to 0.784), hepatic inflow occlusion (HIO) (P = 0.003, OR = 1.044, 95% CI 1.015 similar to 1.075) and major hepatectomy (P = 0.019, OR = 5.967, 95% CI 1.346 similar to 26.443) were demonstrated to be the independent predictive factors for development of PHLF in a multivariate analysis. Results of the present study suggested PSR is a novel and non-invasive model for predicting PHLF in patients with HCC.	[Peng, Wei; Zhang, Xiao-Yun; Li, Chuan; Wen, Tian-Fu; Yan, Lv-Nan; Yang, Jia-Yin] Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Sichuan, Peoples R China; [Peng, Wei; Zhang, Xiao-Yun; Li, Chuan; Wen, Tian-Fu; Yan, Lv-Nan; Yang, Jia-Yin] Sichuan Univ, West China Hosp, Liver Transplantat Ctr, Chengdu, Sichuan, Peoples R China; [Li, Jia-Wu] Sichuan Univ, Dept Ultrasound, West China Hosp, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Li, C (corresponding author), Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Sichuan, Peoples R China.; Li, C (corresponding author), Sichuan Univ, West China Hosp, Liver Transplantat Ctr, Chengdu, Sichuan, Peoples R China.	lichuan85@163.com		Peng, Wei/0000-0002-5780-2157	Applied Basic Research Program of Sichuan Province [2018JY0544]; Science and Technological Supports Project of Sichuan Province [2019YJ0149]	Applied Basic Research Program of Sichuan Province; Science and Technological Supports Project of Sichuan Province	This work was supported by grant from Applied Basic Research Program of Sichuan Province (grant number 2018JY0544, received by WP, http://xmgl.scst.gov.cn); and Science and Technological Supports Project of Sichuan Province (grant number 2019YJ0149, received by CL, http://xmgl.scst.gov.cn).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshagen K, 2007, AM J PHYSIOL-GASTR L, V292, pG1570, DOI 10.1152/ajpgi.00399.2006; Alkozai EM, 2010, ANN SURG, V251, P300, DOI 10.1097/SLA.0b013e3181b76557; Andreatos N, 2017, J GASTROINTEST SURG, V21, P238, DOI 10.1007/s11605-016-3246-4; Aryal B, 2018, CAN J GASTROENTEROL, V2018, DOI 10.1155/2018/9142672; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Buechter M, 2018, DIGEST LIVER DIS, V50, P54, DOI 10.1016/j.dld.2017.09.138; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Cescon M, 2009, ANN SURG, V249, P995, DOI 10.1097/SLA.0b013e3181a63c74; Chen Jing-song, 2015, Hepatogastroenterology, V62, P790; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Colecchia A, 2012, GASTROENTEROLOGY, V143, P646, DOI 10.1053/j.gastro.2012.05.035; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Golriz M, 2018, CAN J GASTROENTEROL, V2018, DOI 10.1155/2018/1275720; Hester CA, 2019, J SURG RES, V239, P253, DOI 10.1016/j.jss.2019.01.043; Kawasaki T, 2010, J HEPATOL, V53, P648, DOI 10.1016/j.jhep.2010.04.021; Kondo R, 2018, HEPATOL RES, V48, P1000, DOI 10.1111/hepr.13195; Kurokawa T, 2017, WORLD J GASTROENTERO, V23, P3228, DOI 10.3748/wjg.v23.i18.3228; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Maithel SK, 2011, J AM COLL SURGEONS, V212, P638, DOI 10.1016/j.jamcollsurg.2011.01.004; Man K, 1997, ANN SURG, V226, P704, DOI 10.1097/00000658-199712000-00007; Marasco G, 2019, J SURG ONCOL, V119, P400, DOI 10.1002/jso.25345; Mehrabi A, 2018, BRIT J SURG, V105, P1254, DOI 10.1002/bjs.10906; Murata S, 2007, WORLD J SURG, V31, P808, DOI 10.1007/s00268-006-0772-3; Nishio T, 2016, SURGERY, V159, P399, DOI 10.1016/j.surg.2015.06.024; Palmes D, 2004, TRANSPL INT, V17, P862, DOI 10.1111/j.1432-2277.2004.tb00522.x; Poon Ronnie T P, 2007, HPB (Oxford), V9, P166, DOI 10.1080/13651820701216182; Poon RTP, 2002, ANN SURG, V235, P373, DOI 10.1097/00000658-200203000-00009; Rahbari NN, 2011, ANN SURG ONCOL, V18, P3640, DOI 10.1245/s10434-011-1829-6; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Razavi-Shearer D, 2018, LANCET GASTROENTEROL, V3, P383, DOI 10.1016/S2468-1253(18)30056-6; Rossler F, 2016, ANN SURG, V264, P492, DOI 10.1097/SLA.0000000000001849; Shirata C, 2019, HEPATOL RES; Takuma Y, 2016, RADIOLOGY, V279, P609, DOI 10.1148/radiol.2015150690; Wang HQ, 2014, WORLD J GASTROENTERO, V20, P11871, DOI 10.3748/wjg.v20.i33.11871; Wu DB, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007864; Zhang ZH, 2017, J SURG RES, V210, P99, DOI 10.1016/j.jss.2016.11.002; Zhu YL, 2018, HEPATOL RES	37	11	11	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219219	10.1371/journal.pone.0219219	http://dx.doi.org/10.1371/journal.pone.0219219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269063	Green Submitted, Green Published, gold			2022-12-26	WOS:000484927300055
J	Sanchez, E; Liu, X; Huse, M				Sanchez, Elisa; Liu, Xin; Huse, Morgan			Actin clearance promotes polarized dynein accumulation at the immunological synapse	PLOS ONE			English	Article							CENTROSOME POLARIZATION; GRANULE SECRETION; T-CELLS; DRIVEN	Immunological synapse (IS) formation between a T cell and an antigen-presenting cell is accompanied by the reorientation of the T cell centrosome toward the interface. This polarization response is thought to enhance the specificity of T cell effector function by enabling the directional secretion of cytokines and cytotoxic factors toward the antigen-presenting cell. Centrosome reorientation is controlled by polarized signaling through diacylglycerol (DAG) and protein kinase C (PKC). This drives the recruitment of the motor protein dynein to the IS, where it pulls on microtubules to reorient the centrosome. Here, we used T cell receptor photoactivation and imaging methodology to investigate the mechanisms controlling dynein accumulation at the synapse. Our results revealed a remarkable spatiotemporal correlation between dynein recruitment to the synaptic membrane and the depletion of cortical filamentous actin (F-actin) from the same region, suggesting that the two events were causally related. Consistent with this hypothesis, we found that pharmacological disruption of F-actin dynamics in T cells impaired both dynein accumulation and centrosome reorientation. DAG and PKC signaling were necessary for synaptic F-actin clearance and dynein accumulation, while calcium signaling and microtubules were dispensable for both responses. Taken together, these data provide mechanistic insight into the polarization of cytoskeletal regulators and highlight the close coordination between microtubule and F-actin architecture at the IS.	[Sanchez, Elisa; Liu, Xin; Huse, Morgan] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Liu, Xin] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing, Peoples R China	Memorial Sloan Kettering Cancer Center; Tsinghua University	Huse, M (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA.	husem@mskcc.org	Liu, Xin/R-1101-2019	Huse, Morgan/0000-0001-9941-7719; Liu, Xin/0000-0002-6634-4012; Sanchez, Elisa/0000-0002-0544-1302	NIH [R01-AI087644, P30-CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087644] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the NIH (www.nih.gov)(R01-AI087644 to M. H., P30-CA008748 to MSKCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank C. Firl and A. Kepecs for technical support and members of the Huse lab for assistance and advice. This work was supported in part by the NIH (R01-AI087644 to M. H., P30-CA008748 to MSKCC).	Andres-Delgado L, 2012, J CELL BIOL, V198, P1025, DOI 10.1083/jcb.201202137; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Belin Brittany J, 2014, Bioarchitecture, V4, P189, DOI 10.1080/19490992.2014.1047714; Brown ACN, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001152; Chauveau A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005287; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; de la Roche M, 2013, SCIENCE, V342, P1247, DOI 10.1126/science.1244689; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Dustin ML, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002311; Freund-Brown J, 2017, J IMMUNOL, V199, P1973, DOI 10.4049/jimmunol.1700340; Gawden-Bone CM, 2018, IMMUNITY, V49, P427, DOI 10.1016/j.immuni.2018.08.017; Griffiths GM, 2010, J CELL BIOL, V189, P397, DOI 10.1083/jcb.201002027; Hartzell CA, 2016, ELIFE, V5, DOI 10.7554/eLife.14850; Hashimoto-Tane A, 2011, IMMUNITY, V34, P919, DOI 10.1016/j.immuni.2011.05.012; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Le Floc'h A, 2013, J EXP MED, V210, P2721, DOI 10.1084/jem.20131324; Liu X, 2015, CELL POLARITY 1: BIOLOGICAL ROLE AND BASIC MECHANISMS, P247, DOI 10.1007/978-3-319-14463-4_11; Liu X, 2013, P NATL ACAD SCI USA, V110, P11976, DOI 10.1073/pnas.1306180110; Markus Steven M, 2011, Bioarchitecture, V1, P209; Martin-Cofreces NB, 2008, J CELL BIOL, V182, P951, DOI 10.1083/jcb.200801014; Martin-Cofreces NB, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00024; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Murugesan S, 2016, J CELL BIOL, V215, P383, DOI 10.1083/jcb.201603080; Nath S, 2016, J IMMUNOL, V197, P2090, DOI 10.4049/jimmunol.1600180; Nyarko A, 2011, J BIOL CHEM, V286, P1556, DOI 10.1074/jbc.M110.171686; Quann EJ, 2011, NAT IMMUNOL, V12, P647, DOI 10.1038/ni.2033; Quann EJ, 2009, NAT IMMUNOL, V10, P627, DOI 10.1038/ni.1734; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Ritter AT, 2017, P NATL ACAD SCI USA, V114, pE6585, DOI 10.1073/pnas.1710751114; Ritter AT, 2015, IMMUNITY, V42, P864, DOI 10.1016/j.immuni.2015.04.013; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Sanchez E, 2018, JOVE-J VIS EXP, DOI 10.3791/56655; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2015, CURR BIOL, V25, P3239, DOI 10.1016/j.cub.2015.10.028; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Varma D, 2010, P NATL ACAD SCI USA, V107, P3493, DOI 10.1073/pnas.0908959107; Yi JS, 2013, J CELL BIOL, V202, P779, DOI 10.1083/jcb.201301004	39	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0210377	10.1371/journal.pone.0210377	http://dx.doi.org/10.1371/journal.pone.0210377			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269031	Green Published, Green Submitted, gold			2022-12-26	WOS:000484927300002
J	Barcellini, L; Borroni, E; Cimaglia, C; Girardi, E; Matteelli, A; Marchese, V; Stancanelli, G; Abubakar, I; Cirillo, DM				Barcellini, Lucia; Borroni, Emanuele; Cimaglia, Claudia; Girardi, Enrico; Matteelli, Alberto; Marchese, Valentina; Stancanelli, Giovanna; Abubakar, Ibrahim; Cirillo, Daniela Maria		E Detect TB Consortium	App-based symptoms screening with Xpert MTB/RIF Ultra assay used for active tuberculosis detection in migrants at point of arrivals in Italy: The E-DETECT TB intervention analysis	PLOS ONE			English	Article								Background From 2014 to 2017, the number of migrants who came to Italy via the Mediterranean route has reached an unprecedented level. The majority of refugees and migrants were rescued in the Central Mediterranean and disembarked at ports in the Sicily region. Rapid on-spot active TB screening intervention at the point of arrival will cover most migrants arriving in EU and by detecting TB prevalent cases will limit further transmission of the disease. Material and methods Between November 2016 and December 2017 newly arrived migrants at point of arrivals in Sicily, were screened for active Tuberculosis using a smartphone application, followed in symptomatic individuals by fast molecular test, Xpert MTB/RIF Ultra, on collected sputum samples. Results In the study period 3787 migrants received a medical evaluation. Eight hundred and ninety-one (23.5%) reported at least one protocol-defined Tuberculosis symptom. Fifteen (2.7%) were positive to at least one microbiological test revealing a post-entry screening prevalence rate of 396 per 100.000 individuals screened (95% CI: 2.22-6.53). In logistic regression analysis, those with cough and at least one other symptom had an increased probability of testing positive compared to persons with symptoms other than cough. Whole-genome-sequencing demonstrate two separate cases of transmission. Discussion To our knowledge this study reports first-time results of an active TB case finding strategy based on on-spot symptom screening using a smartphone application, followed by fast molecular test on collected sputum samples. Our preliminary findings reveal a post-entry screening prevalence rate of 396 per 100.000 individuals screened (95% CI: 2.22-6.53).	[Barcellini, Lucia; Borroni, Emanuele; Stancanelli, Giovanna; Cirillo, Daniela Maria] IRCCS San Raffaele Sci Inst, Emerging Bacterial Pathogens Unit, Div Immunol & Infect Dis, Milan, Italy; [Cimaglia, Claudia; Girardi, Enrico] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Clin Epidemiol Unit, Rome, Italy; [Matteelli, Alberto; Marchese, Valentina] Univ Brescia, Inst Infect & Trop Dis, Infect Dis, Brescia, Italy; [Abubakar, Ibrahim] Hlth Protect Agcy Colindale, TB Sect, London, England; [Abubakar, Ibrahim] UCL, London, England	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Lazzaro Spallanzani; University of Brescia; Health Protection Agency; University of London; University College London	Cirillo, DM (corresponding author), IRCCS San Raffaele Sci Inst, Emerging Bacterial Pathogens Unit, Div Immunol & Infect Dis, Milan, Italy.	cirillo.daniela@hsr.it	marchese, valentina/AAO-7828-2021; Cirillo, Daniela Maria/AAB-3646-2019; Borroni, Emanuele/K-5179-2016	marchese, valentina/0000-0002-5221-1614; Cirillo, Daniela Maria/0000-0001-6415-1535; stancanelli, giovanna/0000-0002-9729-8071; Borroni, Emanuele/0000-0001-6780-5119; Abubakar, Ibrahim/0000-0002-0370-1430	European Union [709624]	European Union(European Commission)	This study is part of the E-DETECT TB project (ref. 709624) which has received funding from the European Union's Health Programme (2014-2020). The content of this paper represents the views of the authors only and is their joint responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.	[Anonymous], 2017, WHO M REPORT TECHNIC; [Anonymous], TUB ASP EP DAT GEN; Council of Europe, 2017, REP IT GOV VIS IT CA; DNA Genotek, 2017, PROD DAT SHEET PD BR; Dorman SE, 2018, LANCET INFECT DIS, V18, P76, DOI [10.1016/S1473-3099(17)30691-6, 10.1016/s1473-3099(17)30691-6]; European Centre for Disease Prevention and Control, 2017, TUB SURV MON EUR TUB; Greenaway C, 2018, EURO SURVEILL, V23; Kohl TA, 2018, EBIOMEDICINE, V34, P131, DOI 10.1016/j.ebiom.2018.07.030; Kunst H, 2017, INT J TUBERC LUNG D, V21, P840, DOI 10.5588/ijtld.17.0036; Lederer DJ, 2019, ANN AM THORAC SOC, V16, P22, DOI 10.1513/AnnalsATS.201808-564PS; Lonnroth Knut, SYST SCREEN ACT TUB; Meehan CJ, 2018, EBIOMEDICINE, V37, P410, DOI 10.1016/j.ebiom.2018.10.013; [Ministero della Salute Istituto Superiore di Sanity Istituto Nazionale per la promozione della salute delle popolazioni Migranti ed it contrasto delle malattie della Poverty Society Italiana di Medicina delle Migrazioni], 2017, CONTR FRONT FRONT CO; Ngwatu BK, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01596-2017; Seedat F, 2018, LANCET INFECT DIS, V18, pE259, DOI 10.1016/S1473-3099(18)30117-8; Shete PB, 2018, INT J TUBERC LUNG D, V22, P835, DOI 10.5588/ijtld.17.0503; Tagliani E, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2756-3; UNHCR, EU EM REL MECH; UNHCR Central Mediterranean Risk Mitigation Strategy (CMRMS), 2017, CENTR MED ROUT WORK; United Nations High Commissioner for Refugees (UNHCR), REF MIGR ARR EUR 201; van't Hoog AH, SYSTEMATIC REV SENSI; Vanino E, 2017, CLIN INFECT DIS, V65, P1407, DOI 10.1093/cid/cix503; WHO, 2017, NEXT GEN XPERT MTB R	23	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0218039	10.1371/journal.pone.0218039	http://dx.doi.org/10.1371/journal.pone.0218039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260481	Green Submitted, Green Published, gold			2022-12-26	WOS:000484918700011
J	Couch, D; Yu, ZN; Nam, JH; Allen, C; Ramos, PS; da Silveira, WA; Hunt, KJ; Hazard, ES; Hardiman, G; Lawson, A; Chung, DJ				Couch, Daniel; Yu, Zhenning; Nam, Jin Hyun; Allen, Carter; Ramos, Paula S.; da Silveira, Willian A.; Hunt, Kelly J.; Hazard, Edward S.; Hardiman, Gary; Lawson, Andrew; Chung, Dongjun			GAIL: An interactive webserver for inference and dynamic visualization of gene-gene associations based on gene ontology guided mining of biomedical literature	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; IMMUNE-COMPLEX CLEARANCE; YEAST 2-HYBRID; INFORMATION; EXTRACTION; TOOL	In systems biology, inference of functional associations among genes is compelling because the construction of functional association networks facilitates biomarker discovery. Specifically, such gene associations in human can help identify putative biomarkers that can be used as diagnostic tools in treating patients. Although biomedical literature is considered a valuable data source for this task, currently only a limited number of webservers are available for mining gene-gene associations from the vast amount of biomedical literature using text mining techniques. Moreover, these webservers often have limited coverage of biomedical literature and also lack efficient and user-friendly tools to interpret and visualize mined relationships among genes. To address these limitations, we developed GAIL (Gene-gene Association Inference based on biomedical Literature), an interactive webserver that infers human gene-gene associations from Gene Ontology (GO) guided biomedical literature mining and provides dynamic visualization of the resulting association networks and various gene set enrichment analysis tools. We evaluate the utility and performance of GAIL with applications to gene signatures associated with systemic lupus erythematosus and breast cancer. Results show that GAIL allows effective interrogation and visualization of gene gene networks and their subnetworks, which facilitates biological understanding of gene gene associations. GAIL is available at http://chunglab.io/GAIL/.	[Couch, Daniel; Yu, Zhenning; Nam, Jin Hyun; Allen, Carter; Ramos, Paula S.; Hunt, Kelly J.; Lawson, Andrew; Chung, Dongjun] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Ramos, Paula S.; Hardiman, Gary] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA; [da Silveira, Willian A.] Med Univ South Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [da Silveira, Willian A.; Hazard, Edward S.; Hardiman, Gary] Med Univ South Carolina, Ctr Genom Med, Charleston, SC 29425 USA; [da Silveira, Willian A.; Hardiman, Gary] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [da Silveira, Willian A.; Hardiman, Gary] Queens Univ Belfast, Inst Global Food Secur, Belfast, Antrim, North Ireland	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Queens University Belfast; Queens University Belfast	Chung, DJ (corresponding author), Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA.	chungd@musc.edu	Lawson, Andrew/AAA-3140-2019; Chung, Dongjun/AAI-6032-2020	Chung, Dongjun/0000-0002-8072-5671; da Silveira, Willian Abraham/0000-0001-6370-2884; Hardiman, Gary/0000-0003-4558-0400; Nam, Jin Hyun/0000-0003-2165-5287; Ramos, Paula/0000-0002-9433-6634	NCI NIH HHS [R21 CA209848] Funding Source: Medline; NIAMS NIH HHS [K01 AR067280, P30 AR072582] Funding Source: Medline; NIDA NIH HHS [U01 DA045300] Funding Source: Medline; NIGMS NIH HHS [R01 GM122078] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA209848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR072582, K01AR067280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA045300] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barnes PJ, 1997, INT J BIOCHEM CELL B, V29, P867, DOI 10.1016/S1357-2725(96)00159-8; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Chung DJ, 2017, STAT MED, V36, P3461, DOI 10.1002/sim.7384; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Foundation DS, DJANG VERS 1 11; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Geva G, 2011, BIOINFORMATICS, V27, P111, DOI 10.1093/bioinformatics/btq652; Guney E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10331; Hagberg A. A., 2008, 7 PYTH SCI C SCIPY20; Harmston Nathan, 2010, Human Genomics, V5, P17; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Have CT, 2013, BIOINFORMATICS, V29, P3107, DOI 10.1093/bioinformatics/btt549; Howe LR, 2011, CANCER PREV RES, V4, P1149, DOI 10.1158/1940-6207.CAPR-11-0334; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kavai M, 2007, AUTOIMMUN REV, V6, P497, DOI 10.1016/j.autrev.2007.01.017; Kavai M, 2008, AUTOIMMUN REV, V8, P160, DOI 10.1016/j.autrev.2008.06.002; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Luo Y, 1997, BIOTECHNIQUES, V22, P350, DOI 10.2144/97222pf02; Mallory EK, 2016, BIOINFORMATICS, V32, P106, DOI 10.1093/bioinformatics/btv476; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Muthusamy B, 2013, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0121S41; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Ogris C, 2018, NUCLEIC ACIDS RES, V46, pD601, DOI 10.1093/nar/gkx1138; Papanikolaou NL, 2015, METHODS, V74, P47, DOI 10.1016/j.ymeth.2014.10.026; Pavlopoulos GA, 2014, METHODS MOL BIOL, V1159, P77, DOI 10.1007/978-1-4939-0709-0_5; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Poon H, 2014, BIOINFORMATICS, V30, P2840, DOI 10.1093/bioinformatics/btu383; Previde P, 2018, BIOCOMPUT-PAC SYM, P590; Qin TT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku678; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Sah P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-220; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Studham ME, 2014, BIOINFORMATICS, V30, P130, DOI 10.1093/bioinformatics/btu285; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tsoi LC, 2009, J BIOMED INFORM, V42, P824, DOI 10.1016/j.jbi.2009.03.009; Wang R, 2015, PROTEOMICS, V15, P1356, DOI 10.1002/pmic.201400377; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wei CH, 2013, NUCLEIC ACIDS RES, V41, pW518, DOI 10.1093/nar/gkt441; Wei CH, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas041; Yates B, 2017, NUCLEIC ACIDS RES, V45, pD619, DOI 10.1093/nar/gkw1033; Young KH, 1998, BIOL REPROD, V58, P302, DOI 10.1095/biolreprod58.2.302; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	52	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219195	10.1371/journal.pone.0219195	http://dx.doi.org/10.1371/journal.pone.0219195			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260503	Green Published, gold, Green Submitted			2022-12-26	WOS:000484918700043
J	Millogo, O; Doamba, JEO; Sie, A; Utzinger, J; Vounatsou, P				Millogo, Ourohire; Doamba, Jean Edouard Odilon; Sie, Ali; Utzinger, Jurg; Vounatsou, Penelope			Geographical variation in the association of child, maternal and household health interventions with under-five mortality in Burkina Faso	PLOS ONE			English	Article							SURVIVAL	Background Over the past 15 years, scaling up of cost effective interventions resulted in a remarkable decline of under-five mortality rates (U5MR) in sub-Saharan Africa. However, the reduction shows considerable heterogeneity. We estimated the association of child, maternal, and household interventions with U5MR in Burkina Faso at national and subnational levels and identified the regions with least effective interventions. Methods Data on health-related interventions and U5MR were extracted from the Burkina Faso Demographic and Health Survey (DHS) 2010. Bayesian geostatistical proportional hazards models with a Weibull baseline hazard were fitted on the mortality outcome. Spatially varying coefficients were considered to assess the geographical variation in the association of the health interventions with U5MR. The analyses were adjusted for child, maternal, and household characteristics, as well as climatic and environmental factors. Findings The average U5MR was as high as 128 per 1000 ranging from 81 (region of Centre-Est) to 223 (region of Sahel). At national level, DPT3 immunization and baby post-natal check within 24 hours after birth had the most important association with U5MR (hazard rates ratio (HRR) = 0.89, 95% Bayesian credible interval (BCI): 0.86-0.98 and HRR = 0.89, 95% BCI: 0.86-0.92, respectively). At sub-national level, the most effective interventions are the skilled birth attendance, and improved drinking water, followed by baby post-natal check within 24 hours after birth, vitamin A supplementation, antenatal care visit and all-antigens immunization (including BCG, Polio3, DPT3, and measles immunization). Centre-Est, Sahel, and Sud-Ouest were the regions with the highest number of effective interventions. There was no intervention that had a statistically important association with child survival in the region of Hauts Bassins. Interpretation The geographical variation in the magnitude and statistical importance of the association between health interventions and U5MR raises the need to deliver and reinforce health interventions at a more granular level. Priority interventions are DPT3 immunization, skilled birth attendance, baby post-natal visits in the regions of Sud-Ouest, Sahel, and Hauts Bassins, respectively. Our methodology could be applied to other national surveys, as it allows an incisive, data-driven and specific decision-making approach to optimize the allocation of health interventions at subnational level.	[Millogo, Ourohire; Utzinger, Jurg; Vounatsou, Penelope] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Millogo, Ourohire; Utzinger, Jurg; Vounatsou, Penelope] Univ Basel, Basel, Switzerland; [Millogo, Ourohire; Doamba, Jean Edouard Odilon; Sie, Ali] Ctr Rech Sante Nouna, Nouna, Burkina Faso	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Vounatsou, P (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Vounatsou, P (corresponding author), Univ Basel, Basel, Switzerland.	penelope.vounatsou@swisstph.ch	Millogo, Ourohiré/AGQ-3569-2022		European Research Council (ERC) [323180]; Swiss National Science Foundation (SNSF) Swiss Programme for Research on Global Issues for Development (R4D) project [IZ01Z0-147286]	European Research Council (ERC)(European Research Council (ERC)); Swiss National Science Foundation (SNSF) Swiss Programme for Research on Global Issues for Development (R4D) project(Swiss National Science Foundation (SNSF))	We are grateful to the Swiss National Science Foundation (SNSF) Swiss Programme for Research on Global Issues for Development (R4D) project no. IZ01Z0-147286. Penelope Vounatsou acknowledges financial support from the European Research Council (ERC) for advanced grant project no. 323180. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the MEASURE DHS Program for making the data available. We are grateful to the Swiss National Science Foundation (SNSF) Swiss Programme for Research on Global Issues for Development (R4D) project no. IZ01Z0-147286. Penelope Vounatsou acknowledges financial support from the European Research Council (ERC) for advanced grant project no. 323180.	Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Banerjee S., 2014, HIERARCHICAL MODELIN; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Becher H, 2016, TROP MED INT HEALTH, V21, P546, DOI 10.1111/tmi.12673; Burke M, 2016, LANCET GLOB HEALTH, V4, pE936, DOI [10.1016/s2214-109x(16)30212-1, 10.1016/S2214-109X(16)30212-1]; Countdown to 2030 Collaboration, 2018, LANCET, V391, P1538, DOI [10.1016/S0140-6736(18)30104-1, DOI 10.1016/S0140-6736(18)30104-1]; De Allegri M, 2011, HEALTH POLICY, V99, P210, DOI 10.1016/j.healthpol.2010.10.010; Dedefo M, 2016, SPAT SPATIO-TEMPORAL, V16, P43, DOI 10.1016/j.sste.2015.11.003; Diboulo E, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1282-x; Dos Santos S, 2008, POPUL SPACE PLACE, V14, P1, DOI 10.1002/psp.470; Ezeh OK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-521; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Henry SJF, 2013, POPUL ENVIRON, V34, P431, DOI 10.1007/s11111-012-0174-4; Jaeger SK, BMC PREGNANCY CHILDB; Kanmiki EW, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-24; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Munos M, 2016, AM J TROP MED HYG, V94, P584, DOI 10.4269/ajtmh.15-0585; Pullan RL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001626; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; Sartorius BKD, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0029-6; Sawyer CC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001287; Schoeps A, 2013, VACCINE, V32, P96, DOI 10.1016/j.vaccine.2013.10.063; Smith ER, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180722; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; WHO, 2016, WORLD HLTH STAT 2016; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0218163	10.1371/journal.pone.0218163	http://dx.doi.org/10.1371/journal.pone.0218163			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260473	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000484918700012
J	Tapp, A; Nancarrow, C; Morey, Y; Warren, S; Bowtell, N; Verne, J				Tapp, Alan; Nancarrow, Clive; Morey, Yvette; Warren, Stella; Bowtell, Nicola; Verne, Julia			Public responses to volunteer community care: Propositions for old age and end of life	PLOS ONE			English	Article							PALLIATIVE CARE; PEOPLE; PROJECTIONS; PROVISION	Background Funding shortages and an ageing population have increased pressures on state or insurance funded end of life care for older people. Across the world, policy debate has arisen about the potential role volunteers can play, working alongside health and social care professionals in the community to support and care for the ageing and dying. Aims The authors examined self-reported levels of care for the elderly by the public in England, and public opinions of community volunteering concepts to care for the elderly at the end of life. In particular, claimed willingness to help and to be helped by local people was surveyed. Methods A sample of 3,590 adults in England aged 45 or more from an online access panel responded to a questionnaire in late 2017. The survey data was weighted to be representative of the population within this age band. Key literature and formative qualitative research informed the design of the survey questionnaire, which was further refined after piloting. Results Preferences for different models of community volunteering were elicited. There was a preference for 'formal' models with increased wariness of 'informal' features. Whilst 32% of adults said they 'might join' depending on whom the group helped, unsurprisingly more personal and demanding types of help significantly reduced the claimed willingness to help. Finally, willingness to help (or be helped) by local community carers or volunteers was regarded as less attractive than care being provided by personal family, close friends or indeed health and care professionals. Conclusion Findings suggest that if community volunteering to care for elderly people at the end of life in England is to expand it may require considerable attention to the model including training for volunteers and protections for patients and volunteers as well as public education and promotion. Currently, in England, there is a clear preference for non-medical care to be delivered by close family or social care professionals, with volunteer community care regarded only as a back-up option.	[Tapp, Alan; Nancarrow, Clive; Morey, Yvette; Warren, Stella] Univ West England, Fac Business & Law, Bristol, Avon, England; [Bowtell, Nicola; Verne, Julia] Publ Hlth England, Natl End Life Care Intelligence Network, Bristol, Avon, England	University of West England; Public Health England	Tapp, A (corresponding author), Univ West England, Fac Business & Law, Bristol, Avon, England.	Alan.Tapp@uwe.ac.uk			Public Health England	Public Health England	This work was supported from Public Health England (https//www gov,uk/government/organisations/public-health-england) to AT. The funder JV (Public Health England) was involved in discussing initial project aims and research objectives. She was not involved in study design, data collection or analysis. She was party to the decision to publish. She was not involved in manuscript creation but has read the manuscript and is happy to be a co-author.	Abel J, 2018, BMJ SUPPORT PALLIAT, V1, P129; Abel Julian, 2011, BMJ Support Palliat Care, V1, P129, DOI 10.1136/bmjspcare-2011-000068; Alakeson V, 2016, BJPSYCH BULL, V40, P34, DOI 10.1192/pb.bp.114.048827; [Anonymous], 2016, MAK TIM GIVERS; [Anonymous], 2018, INDIVIDUALISM COLLEC; [Anonymous], 2015, AMBITIONS PALLIATIVE; Badrakalimuthu V, 2014, AGE AGEING, V43, P13, DOI 10.1093/ageing/aft151; Barry V., 2013, OVERVIEW COMPASSIONA; Blickem C, 2018, SAGE OPEN, V8, DOI 10.1177/2158244018787223; Bone AE, 2018, PALLIATIVE MED, V32, P329, DOI 10.1177/0269216317734435; Burbeck R, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-3; Candy B, 2015, INT J NURS STUD, V52, P756, DOI 10.1016/j.ijnurstu.2014.08.007; CLARY EG, 1994, J APPL SOC PSYCHOL, V24, P1129, DOI 10.1111/j.1559-1816.1994.tb01548.x; Commonwealth of Australia, 2010, SUPP AUSTR LIV WELL; Correa Santiago, 2018, Ann Palliat Med, V7, pAB009, DOI 10.21037/apm.2018.s009; Costa V, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0077-8; CQC, 2017, STAT AD SOC CAR SERV; Cross B. R, ACT LON; Davies H. I, 2004, PALLIATIVE CARE SOLI; Economist Intelligence Unit, 2010, QUAL DEATH RANK END; England P. H, 2018, ATL VAR PALL END LIF; Etkind SN, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0860-2; Etkind SN, 2018, J AM GERIATR SOC, V66, P1031, DOI 10.1111/jgs.15272; Foot J., 2010, GLASS HALF FULL ASSE; Gaughan J, 2017, INT J HLTH EC M 0228; Gawende A, 2014, BEING MORTAL MED WHA; Glasgow Centre for Population Health, 2012, BRIEF PAP CONC SER; Goossensen A., 2018, CHANGING FACE VOLUNT, P69; Gordon R, 2015, STRATEGIC SOCIAL MAR; Hanratty B, 2012, J PAIN SYMPTOM MANAG, V44, P74, DOI 10.1016/j.jpainsymman.2011.08.006; Hesse M, 2018, CHANGING FACE VOLUNT, P69; Higginson IJ, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0648-4; Holtgraves T, 1997, J APPL SOC PSYCHOL, V27, P1650, DOI 10.1111/j.1559-1816.1997.tb01618.x; Hospice Foundation, 2013, BRIEF HIST; KMIETOWICZ Z, 2013, BMJ-BRIT MED J, V346, P12871, DOI DOI 10.1136/BMJ.F1595; Krakowiak P., 2018, CHANGING FACE VOLUNT, P83; Kumar S, 2013, CURR OPIN SUPPORT PA, V7, P216, DOI 10.1097/SPC.0b013e3283610255; Flores SL, 2018, ANN PALLIAT MED, V7, pS15, DOI 10.21037/apm.2018.03.02; Linsi K, 2016, ROUT KEY THEME HEALT, P165; Mathie A., 2003, DEV PRACT, V13, P474, DOI DOI 10.1080/0961452032000125857; Molina Emilio Herrera, 2015, BMJ Support Palliat Care, V5 Suppl 1, pA9, DOI 10.1136/bmjspcare-2015-000906.29; Moorhouse P, 2010, CANADIAN REV ALZHEIM; Morris SM, 2017, HEALTH SOC CARE COMM, V25, P1704, DOI 10.1111/hsc.12232; Nancarrow C., 2014, ONLINE ACCESS PANELS; Nancarrow C., 2001, MARK REV, V2, P55, DOI [10.1362/1469347012569427, DOI 10.1362/1469347012569427]; Pelttari L., 2018, CHANGING FACE VOLUNT, P42; Phillips L.C., 2010, SAM ADV MANAGE J, V75, P12; Public Health England, 2015, WHAT WE KNOW NOW 201; Public Health England, 2014, NAT END LIF CAR INT; Qureshi H., 1989, CARING RELATIONSHIP; Rhodes R, 2018, CAMB Q HEALTHC ETHIC, V27, P137, DOI 10.1017/S0963180117000469; Sallnow L., 2018, CHANGING FACE VOLUNT, P185; Saunders C., 1990, HOSPICE PALLIATIVE C; Schneider W, 2017, BUNDESGESUNDHEITSBLA, V60, P69, DOI 10.1007/s00103-016-2472-y; Schuchter P., 2016, COMPASSIONATE COMMUN; Scott R., 2015, EUR J PALLIAT CARE, V22, P80; Scott R., 2018, CHANGING FACE VOLUNT; Smith Justin Davis, 1995, INTRO VOLUNTARY SECT; Sundstrom M, 2018, INT J QUAL STUD HEAL, V13, DOI 10.1080/17482631.2018.1474673; Tompkins B, 2018, ANN PALLIAT MED, V7, pS118, DOI 10.21037/apm.2018.03.16; Verne J, 2019, J PUBLIC HLTH; Wegleitner K, 2016, ROUT KEY THEME HEALT, P1; Whitehead P, 2014, CARING ELDERLY PERSO; Zaman S, 2018, MED HUMANIT, V44, DOI [10.1136/medhum-2016-010874, DOI 10.1136/MEDHUM-2016-010874]	65	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0218597	10.1371/journal.pone.0218597	http://dx.doi.org/10.1371/journal.pone.0218597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3YW	31260482	Green Published, gold, Green Submitted			2022-12-26	WOS:000484918700017
J	Dias, BT; Dias-Teixeira, KL; Godinho, JP; Faria, MS; Calegari-Silva, T; Mukhtar, MM; Lopes, U; Mottram, JC; Lima, APCA				Dias, Bruna T.; Dias-Teixeira, Karina Luisa; Godinho, Joseane P.; Faria, Marilia S.; Calegari-Silva, Teresa; Mukhtar, Maowia M.; Lopes, Ulisses; Mottram, Jeremy C.; Lima, Ana Paula C. A.			Neutrophil elastase promotes Leishmania donovani infection via interferon-beta	FASEB JOURNAL			English	Article						toll; serine protease; inhibitor; ISP	SERINE PEPTIDASES; IMMUNE-RESPONSE; HOST-DEFENSE; MACROPHAGES; INHIBITOR; TLR4; ACTIVATION; EXPRESSION; SURVIVAL	Visceral leishmaniasis is a deadly illness caused by Leishmania donovani that provokes liver and spleen inflammation and tissue destruction. In cutaneous leishmaniasis, the protein of L. major, named inhibitor of serine peptidases (ISP) 2, inactivates neutrophil elastase (NE) present at the macrophage surface, resulting in blockade of TLR4 activation, prevention of TNF-alpha and IFN-beta production, and parasite survival. We report poor intracellular growth of L. donovani in macrophages from knockout mice for NE (ela(-/-)), TLR4, or TLR2. NE and TLR4 colocalized with the parasite in the parasitophorous vacuole. Parasite load in the liver and spleen of ela(-/-) mice were reduced and accompanied by increased NO and decreased TGF-beta production. Expression of ISP2 was not detected in L. donovani, and a transgenic line constitutively expressing ISP2, displayed poor intracellular growth in macrophages and decreased burden in mice. Infected ela(-/-) macrophages displayed significantly lower IFN-beta mRNA than background mice macrophages, and the intracellular growth was fully restored by exogenous IFN-beta. We propose that L. donovani utilizes the host NE-TLR machinery to induce IFN-beta necessary for parasite survival and growth during early infection. Low or absent expression of parasite ISP2 in L. donovani is necessary to preserve the activation of the NE-TLR pathway.-Dias, B. T., Dias-Teixeira, K. L., Godinho, J. P., Faria, M. S., Calegari-Silva, T., Mukhtar, M. M., Lopes, U. G., Mottram, J. C., Lima, A. P. C. A. Neutrophil elastase promotes Leishmania donovani infection via interferon-beta.	[Dias, Bruna T.; Dias-Teixeira, Karina Luisa; Godinho, Joseane P.; Faria, Marilia S.; Calegari-Silva, Teresa; Lopes, Ulisses; Lima, Ana Paula C. A.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Mukhtar, Maowia M.] Ibn Sina Univ, Biosci Res Inst, Khartoum, Sudan; [Mottram, Jeremy C.] Univ York, York Biomed Res Inst, Dept Biol, York, N Yorkshire, England	Universidade Federal do Rio de Janeiro; University of York - UK	Lima, APCA (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ctr Ciencias Saude, Ave Carlos Chagas Filho 373,Bloco G,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.	anapaula@biof.ufrj.br	Dias Teixeira, Karina/J-4918-2017; Lima, Ana Paula CA/G-4122-2012	Dias Teixeira, Karina/0000-0002-6115-6768; 	Medical Reserve Corps (MRC)-Newton [MR/N017269/1]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); United Kingdom Research and Innovation via the Global Challenges Research Fund [MR/P027989/1]; MRC [MR/N017269/1, MR/P027989/1] Funding Source: UKRI	Medical Reserve Corps (MRC)-Newton; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); United Kingdom Research and Innovation via the Global Challenges Research Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Leticia Maneiras (Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro) for technical assistance, Dr. Bernhard Ryffel [Centre de Recherche Scientifique, (CNRS), Orleans, France] for the donation of ela2<SUP>-/-</SUP> mice, and Dr. Marcelo Bozza (Instituto de Microbiologia, Universidade Federal do Rio de Janeiro) for the donation of tlr4<SUP>-/-</SUP> and tlr2<SUP>-/-</SUP> mice. This work was supported by grants from Medical Reserve Corps (MRC)-Newton (MR/N017269/1), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; to A.P.C.A.L), and from United Kingdom Research and Innovation via the Global Challenges Research Fund under grant agreement "A Global Network for Neglected Tropical Diseases" (MR/P027989/1). A.P.C.A.L. and U.L. are National Council of Scientific and Technological Development (CNPq) fellows. The authors declare no conflicts of interest.	Alam MN, 2018, BIOCHIMIE, V147, P105, DOI 10.1016/j.biochi.2018.01.005; Alam MN, 2016, LIFE SCI, V144, P218, DOI 10.1016/j.lfs.2015.12.004; Albergante L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003334; Beattie L, 2011, INFECT IMMUN, V79, P1057, DOI 10.1128/IAI.00633-10; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; Devaney JM, 2003, FEBS LETT, V544, P129, DOI 10.1016/S0014-5793(03)00482-4; Eschenlauer SCP, 2009, CELL MICROBIOL, V11, P106, DOI 10.1111/j.1462-5822.2008.01243.x; Faria MS, 2014, FASEB J, V28, P3050, DOI 10.1096/fj.13-245126; Faria Marilia S., 2012, Journal of Parasitology Research, P930257, DOI 10.1155/2012/930257; Faria MS, 2011, J IMMUNOL, V186, P411, DOI 10.4049/jimmunol.1002175; Cezario GAG, 2011, MEM I OSWALDO CRUZ, V106, P573, DOI 10.1590/S0074-02762011000500010; Gomes NA, 2000, J IMMUNOL, V164, P2001, DOI 10.4049/jimmunol.164.4.2001; Goundry A, 2018, FASEB J, V32, P1315, DOI 10.1096/fj.201700797R; Gupta P, 2014, FASEB J, V28, P1756, DOI 10.1096/fj.13-238428; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Karmakar S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002646; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kaye PM, 2011, CLIN MICROBIOL INFEC, V17, P1462, DOI 10.1111/j.1469-0691.2011.03610.x; Khouri R, 2009, J IMMUNOL, V182, P2525, DOI 10.4049/jimmunol.0802860; McCall LI, 2015, J PROTEOME RES, V14, P1033, DOI 10.1021/pr5010604; Morrison LS, 2012, CELL MICROBIOL, V14, P1271, DOI 10.1111/j.1462-5822.2012.01798.x; Murray HW, 2013, INFECT IMMUN, V81, P2318, DOI 10.1128/IAI.01468-12; Nieto A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-39; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Paul J, 2014, INDIAN J BIOCHEM BIO, V51, P531; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Phillips R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000813; Podinovskaia M, 2015, FUTURE MICROBIOL, V10, P111, DOI 10.2217/fmb.14.103; Polando RE, 2018, PARASITE IMMUNOL, V40, DOI 10.1111/pim.12521; Rannikko EH, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0192-0; Ribeiro-Gomes FL, 2007, J IMMUNOL, V179, P3988, DOI 10.4049/jimmunol.179.6.3988; Rossi M, 2017, P NATL ACAD SCI USA, V114, P4987, DOI 10.1073/pnas.1621447114; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Smith DF, 2007, INT J PARASITOL, V37, P1173, DOI 10.1016/j.ijpara.2007.05.015; Srivastav S, 2015, EUR J IMMUNOL, V45, P2787, DOI 10.1002/eji.201445336; Teixeira DE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003594; Verma S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00063; Verma S, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2239-9; Vivarini AD, 2011, FASEB J, V25, P4162, DOI 10.1096/fj.11-185165	41	8	8	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10794	10807		10.1096/fj.201900524R	http://dx.doi.org/10.1096/fj.201900524R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284755	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000489166300018
J	Hwang, HJ; Yang, YR; Kim, HY; Choi, Y; Park, KS; Lee, H; Ma, JS; Yamamoto, M; Kim, J; Chae, YC; Choi, JH; Cocco, L; Berggren, PO; Jang, HJ; Suh, PG				Hwang, Hyeon-Jeong; Yang, Yong Ryoul; Kim, Hye Yun; Choi, Yoonii; Park, Kyoung-Su; Lee, Ho; Ma, Ji Su; Yamamoto, Masahiro; Kim, Jaeyoon; Chae, Young Chan; Choi, Jang Hyun; Cocco, Lucio; Berggren, Per-Olof; Jang, Hyun-Jun; Suh, Pann-Ghill			Phospholipase C-beta 1 potentiates glucose-stimulated insulin secretion	FASEB JOURNAL			English	Article						GPCR; GSIS; intracellular Ca2+; PLC-beta 1	PANCREATIC BETA-CELLS; PROTEIN-COUPLED RECEPTORS; 5-HYDROXYTRYPTAMINE RELEASE; DEPENDENT ACTIVATION; SIGNALING PATHWAYS; C ISOZYMES; CROSS-TALK; ISLETS; EXPRESSION; RESISTANCE	PLC-beta exerts biologic influences through GPCR. GPCRs are involved in regulating glucose-stimulated insulin secretion (GSIS). Previous studies have suggested that PLC-beta s might play an important role in pancreatic beta cells. However, because of a lack of the specific inhibitors of PLC-beta isozymes and appropriate genetic models, the in vivo function of specific PLC-beta isozymes in pancreatic beta cells and their physiologic relevance in the regulation of insulin secretion have not been studied so far. The present study showed that PLC-beta 1 was crucial for beta-cell function by generation of each PLC-beta conditional knockout mouse. Mice lacking PLC-beta 1 in beta cells exhibited a marked defect in GSIS, leading to glucose intolerance. In ex vivo studies, the secreted insulin level and Ca2+ response in Plcb1(f/f); pancreas/duodenum homeobox protein 1 (Pdx1)-Cre recombinase-estrogen receptor T2 (CreERt2) islets was lower than those in the Plcb1(f/f) islets under the high-glucose condition. PLC-beta 1 led to potentiate insulin secretion via stimulation of particular G(q)-protein-coupled receptors. Plcb1(f/f); Pdx1-CreERt2 mice fed a high-fat diet developed more severe glucose intolerance because of a defect in insulin secretion. The present study identified PLC-beta 1 as an important molecule that regulates beta cell insulin secretion and can be considered a candidate for therapeutic intervention in diabetes mellitus.-Hwang, H.-J., Yang, Y. R., Kim, H. Y., Choi, Y., Park, K.-S., Lee, H., Ma, J. S., Yamamoto, M., Kim, J., Chae, Y. C., Choi, J. H., Cocco, L., Berggren, P.-O., Jang, H.-J., Suh, P.-G. Phospholipase C beta 1 potentiates glucose-stimulated insulin secretion.	[Hwang, Hyeon-Jeong; Kim, Hye Yun; Choi, Yoonii; Park, Kyoung-Su; Chae, Young Chan; Choi, Jang Hyun; Jang, Hyun-Jun; Suh, Pann-Ghill] Ulsan Natl Inst Sci & Technol, Sch Life Sci, 50 UNIST Gil, Ulsan, South Korea; [Choi, Jang Hyun] Ulsan Natl Inst Sci & Technol, Korea Mouse Phenotyping Ctr, Ulsan, South Korea; [Yang, Yong Ryoul] Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Daejeon, South Korea; [Lee, Ho] Natl Canc Ctr, Canc Expt Resources Branch, Goyang Si, South Korea; [Ma, Ji Su; Yamamoto, Masahiro] Osaka Univ, Res Inst Microbial Dis, Dept Immunoparasitol, Suita, Osaka, Japan; [Kim, Jaeyoon; Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Dept Mol Med & Surg, Stockholm, Sweden; [Kim, Jaeyoon; Berggren, Per-Olof] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Cocco, Lucio] Univ Bologna, Dept Biomed Sci, Signalling Lab, Bologna, Italy	Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Cancer Center - Korea (NCC); Osaka University; Karolinska Institutet; Pohang University of Science & Technology (POSTECH); University of Bologna	Jang, HJ; Suh, PG (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Life Sci, 50 UNIST Gil, Ulsan, South Korea.	hyunjun86@unist.ac.kr; pgsuh@unist.ac.kr	Cocco, Lucio/AAI-2206-2020	Cocco, Lucio/0000-0002-9206-8277; Berggren, Per-Olof/0000-0001-8991-413X	Bio and Medical Technology Development Program of the National Research Foundation (NRF) [NRF-2014M3A9D8034456, NRF-2017R1E1A1A01074510]; Korea Mouse Phenotyping Project of the Ministry of Science and Information and Communications Technology (ICT) through the NRF [2016M3A9D5A01952411]	Bio and Medical Technology Development Program of the National Research Foundation (NRF); Korea Mouse Phenotyping Project of the Ministry of Science and Information and Communications Technology (ICT) through the NRF	The authors thank Prof. Jun-Ichi Miyazaki (Osaka University, Suita, Japan) for the gift of mouse pancreatic beta-cell line MIN6; Il Shin Kim, Jeong Woo Shin, and Dohee Kim [all from Ulsan national Institute of Science (UNIST)-Optical Biomed Imaging Center] for help with mice; and Jin-Hoe Hur and Hong-Chan Jung (both from UNIST-Optical Biomed Imaging Center) for technical help. This work was supported by a grant from the Bio and Medical Technology Development Program of the National Research Foundation (NRF) (NRF-2014M3A9D8034456 and NRF-2017R1E1A1A01074510) and by Korea Mouse Phenotyping Project (2016M3A9D5A01952411) of the Ministry of Science and Information and Communications Technology (ICT) through the NRF. The authors declare no conflicts of interest.	Adamski FM, 1999, BBA-GENE STRUCT EXPR, V1444, P55, DOI 10.1016/S0167-4781(98)00260-7; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; BIDEN TJ, 1987, J BIOL CHEM, V262, P3567; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Doyle ME, 2003, PHARMACOL REV, V55, P105, DOI 10.1124/pr.55.1.7; FEHMANN HC, 1990, FEBS LETT, V262, P279, DOI 10.1016/0014-5793(90)80210-A; Fiume R, 2012, FASEB J, V26, P203, DOI 10.1096/fj.11-186510; Fridlyand LE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152869; Gorogawa S, 2004, BIOCHEM BIOPH RES CO, V319, P1159, DOI 10.1016/j.bbrc.2004.05.095; Guillausseau PJ, 2008, DIABETES METAB, V34, pS43, DOI 10.1016/S1262-3636(08)73394-9; GYLFE E, 1978, J ENDOCRINOL, V78, P239, DOI 10.1677/joe.0.0780239; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; HOMMA Y, 1989, BIOCHEM BIOPH RES CO, V164, P406, DOI 10.1016/0006-291X(89)91734-8; HUTTON JC, 1983, BIOCHEM J, V210, P297, DOI 10.1042/bj2100297; JHON DY, 1993, J BIOL CHEM, V268, P6654; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kim JK, 2012, J BIOL CHEM, V287, P21012, DOI 10.1074/jbc.M111.337865; Kim MJ, 2001, PANCREAS, V22, P47, DOI 10.1097/00006676-200101000-00008; Kim SS, 2001, EXP MOL MED, V33, P164, DOI 10.1038/emm.2001.28; Kong KC, 2010, P NATL ACAD SCI USA, V107, P21181, DOI 10.1073/pnas.1011651107; Kyriazis GA, 2012, P NATL ACAD SCI USA, V109, pE524, DOI 10.1073/pnas.1115183109; Lee YS, 2013, CELL, V153, P413, DOI 10.1016/j.cell.2013.03.001; Liu DY, 2008, HYPERTENS RES, V31, P1989, DOI 10.1291/hypres.31.1989; Malbon CC, 2004, BIOCHEM J, V379, P1, DOI 10.1042/BJ20031648; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Meszaros JG, 2000, AM J PHYSIOL-CELL PH, V278, pC154, DOI 10.1152/ajpcell.2000.278.1.C154; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; MONTAGUE W, 1985, BIOCHEM J, V227, P483, DOI 10.1042/bj2270483; Navarro G, 2016, CELL METAB, V23, P837, DOI 10.1016/j.cmet.2016.03.015; Ning SL, 2015, BRIT J PHARMACOL, V172, P5050, DOI 10.1111/bph.13271; Ohara-Imaizumi M, 2013, P NATL ACAD SCI USA, V110, P19420, DOI 10.1073/pnas.1310953110; Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68; PARK D, 1992, J BIOL CHEM, V267, P16048; Ryzhov S, 2006, MOL PHARMACOL, V70, P727, DOI 10.1124/mol.106.022780; Sassmann A, 2010, J CLIN INVEST, V120, P2184, DOI 10.1172/JCI41541; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Shang WB, 2002, PANCREAS, V25, P393, DOI 10.1097/00006676-200211000-00012; Shirakawa O, 2001, PROG NEURO-PSYCHOPH, V25, P867, DOI 10.1016/S0278-5846(01)00149-X; Smith PA, 1999, J PHYSIOL-LONDON, V521, P651, DOI 10.1111/j.1469-7793.1999.00651.x; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; Tian YR, 2001, DIABETES, V50, P2505, DOI 10.2337/diabetes.50.11.2505; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Winzell MS, 2007, PHARMACOL THERAPEUT, V116, P437, DOI 10.1016/j.pharmthera.2007.08.002; WOLF BA, 1988, J BIOL CHEM, V263, P3565; Xie LH, 1999, P NATL ACAD SCI USA, V96, P15292, DOI 10.1073/pnas.96.26.15292; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276; Yamada H, 2016, SCI REP-UK, V6, DOI 10.1038/srep25912; Yang Yong Ryoul, 2013, Advances in Biological Regulation, V53, P232, DOI 10.1016/j.jbior.2013.08.003; ZAWALICH WS, 1995, ENDOCRINOLOGY, V136, P4903, DOI 10.1210/en.136.11.4903	55	12	13	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10668	10679		10.1096/fj.201802732RR	http://dx.doi.org/10.1096/fj.201802732RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31268747				2022-12-26	WOS:000489166300008
J	Tembo, M; Wozniak, KL; Bainbridge, RE; Carlson, AE				Tembo, Maiwase; Wozniak, Katherine L.; Bainbridge, Rachel E.; Carlson, Anne E.			Phosphatidylinositol 4,5-bisphosphate (PIP2) and Ca2+ are both required to open the Cl- channel TMEM16A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride channel; phospholipid; calcium; patch clamp; oocyte; Xenopus; signal transduction; anion channel; transmembrane member 16A (TMEM16A)	POTASSIUM CHANNELS; INDEPENDENT ACTIVATION; K+ CHANNEL; CALCIUM; PROTEINS; PHOSPHOINOSITIDES; MECHANISM; EXCHANGE; RUNDOWN; BINDING	Transmembrane member 16A (TMEM16A) is a widely expressed Ca2+-activated Cl- channel with various physiological functions ranging from mucosal secretion to regulating smooth muscle contraction. Understanding how TMEM16A controls these physiological processes and how its dysregulation may cause disease requires a detailed understanding of how cellular processes and second messengers alter TMEM16A channel gating. Here we assessed the regulation of TMEM16A gating by recording Ca2+-evoked Cl- currents conducted by endogenous TMEM16A channels expressed in Xenopus laevis oocytes, using the inside-out configuration of the patch clamp technique. During continuous application of Ca2+, we found that TMEM16A-conducted currents decay shortly after patch excision. Such current rundown is common among channels regulated by phosphatidylinositol 4,5-bisphosphate (PIP2). Thus, we sought to investigate a possible role of PIP2 in TMEM16A gating. Consistently, synthetic PIP2 rescued the current after rundown, and the application of PIP2 modulating agents altered the speed kinetics of TMEM16A current rundown. First, two PIP2 sequestering agents, neomycin and anti-PIP2, applied to the intracellular surface of excised patches sped up TMEM16A current rundown to nearly twice as fast. Conversely, rephosphorylation of phosphatidylinositol (PI) derivatives into PIP2 using Mg-ATP or inhibiting dephosphorylation of PIP2 using beta-glycerophosphate slowed rundown by nearly 3-fold. Our results reveal that TMEM16A regulation is more complicated than it initially appeared; not only is Ca2+ necessary to signal TMEM16a opening, but PIP2 is also required. These findings improve our understanding of how the dysregulation of these pathways may lead to disease and suggest that targeting these pathways could have utility for potential therapies.	[Tembo, Maiwase; Wozniak, Katherine L.; Bainbridge, Rachel E.; Carlson, Anne E.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carlson, AE (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	acarlson@pitt.edu	Carlson, Anne/I-9495-2019	Carlson, Anne/0000-0003-2724-1325; Wozniak, Katherine/0000-0002-3797-2116; Bainbridge, Rachel/0000-0002-6014-2030	American Heart Association Predoctoral Fellowship [18PRE33960391]; National Institutes of Health [R01GM125638]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM125638] Funding Source: NIH RePORTER	American Heart Association Predoctoral Fellowship(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Predoctoral Fellowship 18PRE33960391 (to M.T.) and National Institutes of Health Grant R01GM125638 (to A. E. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Boskey AL, 1996, J BONE MINER RES, V11, P1694; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Bulley S, 2012, CIRC RES, V111, P1027, DOI 10.1161/CIRCRESAHA.112.277145; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; COLLINS A, 1992, J PHYSIOL-LONDON, V454, P27, DOI 10.1113/jphysiol.1992.sp019253; Dang SY, 2017, NATURE, V552, P426, DOI 10.1038/nature25024; De Jesus-Perez JJ, 2018, BBA-MOL CELL BIOL L, V1863, P299, DOI 10.1016/j.bbalip.2017.12.009; Doignon F, 2016, MOL CELL BIOL, V36, P765, DOI 10.1128/MCB.00843-15; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; EGAN TM, 1992, J NEUROSCI, V12, P1964; Ferrera L, 2010, PHYSIOLOGY, V25, P357, DOI 10.1152/physiol.00030.2010; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hasani HJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191905; Heinze C, 2014, J CLIN INVEST, V124, P675, DOI 10.1172/JCI70025; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Hughes TET, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06753-6; Jeng G, 2016, J GEN PHYSIOL, V148, P393, DOI 10.1085/jgp.201611651; Lim NK, 2016, J GEN PHYSIOL, V148, P375, DOI 10.1085/jgp.201611650; Mall MA, 2015, J CYST FIBROS, V14, P561, DOI 10.1016/j.jcf.2015.06.002; ONO K, 1992, J PHYSIOL-LONDON, V454, P673, DOI 10.1113/jphysiol.1992.sp019286; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Paulino C, 2017, NATURE, V552, P421, DOI 10.1038/nature24652; Peters CJ, 2018, NEURON, V97, P1063, DOI 10.1016/j.neuron.2018.01.048; Pritchard HAT, 2014, BRIT J PHARMACOL, V171, P4311, DOI 10.1111/bph.12778; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; Saleh SN, 2009, J PHYSIOL-LONDON, V587, P5361, DOI 10.1113/jphysiol.2009.180331; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Ta CM, 2017, BRIT J PHARMACOL, V174, P2984, DOI 10.1111/bph.13913; Tang QY, 2015, J BIOL CHEM, V290, P16517, DOI 10.1074/jbc.M115.640409; Tembo M, 2019, J GEN PHYSIOL, V151, P404, DOI 10.1085/jgp.201912320; Tian YM, 2011, FASEB J, V25, P1058, DOI 10.1096/fj.10-166884; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wozniak KL, 2018, J GEN PHYSIOL, V150, P1239, DOI 10.1085/jgp.201812069; Wozniak KL, 2018, J GEN PHYSIOL, V150, P1249, DOI 10.1085/jgp.201812071; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Xie LH, 2008, J PHYSIOL-LONDON, V586, P1833, DOI 10.1113/jphysiol.2007.147868; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Ye WL, 2018, P NATL ACAD SCI USA, V115, pE1667, DOI 10.1073/pnas.1718728115; Zawieja SD, 2019, J GEN PHYSIOL, V151, P532, DOI 10.1085/jgp.201812294; Zhang Guohui, 2018, Cold Spring Harb Protoc, V2018, DOI 10.1101/pdb.prot099051; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	51	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12556	12564		10.1074/jbc.RA118.007128	http://dx.doi.org/10.1074/jbc.RA118.007128			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31266809	hybrid, Green Published			2022-12-26	WOS:000484402700026
J	Delespaul, L; Merle, C; Lesluyes, T; Lagarde, P; Le Guellec, S; Perot, G; Baud, J; Carlotti, M; Danet, C; Fevre, M; Rousseau, B; Durrieu, S; Teichmann, M; Coindre, JM; Lartigue, L; Chibon, F				Delespaul, Lucile; Merle, Candice; Lesluyes, Tom; Lagarde, Pauline; Le Guellec, Sophie; Perot, Gaelle; Baud, Jessica; Carlotti, Martina; Danet, Coralie; Fevre, Murielle; Rousseau, Benoit; Durrieu, Stephanie; Teichmann, Martin; Coindre, Jean-Michel; Lartigue, Lydia; Chibon, Frederic			Fusion-mediated chromosomal instability promotes aneuploidy patterns that resemble human tumors	ONCOGENE			English	Article							MARROW-DERIVED CELLS; SOFT-TISSUE SARCOMAS; PURKINJE NEURONS; LARGE SERIES; CANCER; BONE; DNA; METASTASIS; MUSCLE; CONDENSATION	Oncogenesis is considered to result from chromosomal instability, in addition to oncogene and tumor-suppressor alterations. Intermediate to aneuploidy and chromosomal instability, genome doubling is a frequent event in tumor development but the mechanisms driving tetraploidization and its impact remain unexplored. Cell fusion, one of the pathways to tetraploidy, is a physiological process involved in mesenchymal cell differentiation. Besides simple genome doubling, cell fusion results in the merging of two different genomes that can be destabilized upon proliferation. By testing whether cell fusion is involved in mesenchymal oncogenesis, we provide evidence that it induces genomic instability and mediates tumor initiation. After a latency period, the tumor emerges with the cells most suited for its development. Furthermore, hybrid tumor genomes were stabilized after this selection process and were very close to those of human pleomorphic mesenchymal tumors. Thus genome restructuring triggered by cell fusion may account for the chromosomal instability involved in oncogenesis.	[Delespaul, Lucile; Merle, Candice; Lesluyes, Tom; Le Guellec, Sophie; Perot, Gaelle; Chibon, Frederic] CRCT, INSERM U1037, F-31037 Toulouse, France; [Delespaul, Lucile; Lesluyes, Tom; Lagarde, Pauline; Baud, Jessica; Lartigue, Lydia] INSERM U1218, 229 Cours Argonne, F-33076 Bordeaux, France; [Delespaul, Lucile; Lesluyes, Tom; Coindre, Jean-Michel; Lartigue, Lydia] Univ Bordeaux, 146 Rue Leo Saignat, F-33000 Bordeaux, France; [Merle, Candice] Univ Toulouse, 3 Paul Sabatier,118 Route Narbonne, F-31062 Toulouse 9, France; [Merle, Candice; Lesluyes, Tom] IUCT Oncopole, Inst Claudius Regaud, Toulouse, France; [Lagarde, Pauline; Baud, Jessica; Coindre, Jean-Michel] Bergonie Inst, Dept Biopathol, 229 Cours Argonne, F-33076 Bordeaux, France; [Le Guellec, Sophie; Perot, Gaelle; Chibon, Frederic] IUCT Oncopole, Inst Claudius Regaud, Dept Pathol, Toulouse, France; [Carlotti, Martina] INSERM U1053, 146 Rue Leo Saignat, F-33000 Bordeaux, France; [Danet, Coralie; Fevre, Murielle; Rousseau, Benoit] Bordeaux Univ, Anim Facil A2, 146 Rue Leo Saignat, F-33000 Bordeaux, France; [Durrieu, Stephanie; Teichmann, Martin] ARNA Lab, CNRS UMR 5320, INSERM U1212, F-33000 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Claudius Regaud; UNICANCER; Institut Bergonie; UNICANCER; Institut Claudius Regaud; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Chibon, F (corresponding author), CRCT, INSERM U1037, F-31037 Toulouse, France.; Chibon, F (corresponding author), IUCT Oncopole, Inst Claudius Regaud, Dept Pathol, Toulouse, France.	frederic.chibon@inserm.fr	Delespaul, Lucile/AAZ-1073-2021; Pérot, Gaëlle/W-8038-2019; Lesluyes, Tom/GSD-4621-2022; Lesluyes, Tom/AAB-6229-2019; Teichmann, Martin/M-7407-2014	Lesluyes, Tom/0000-0003-2251-5884; Lesluyes, Tom/0000-0003-2251-5884; chibon, Frederic/0000-0002-6548-2181; Delespaul, Lucile/0000-0002-9509-6425; Teichmann, Martin/0000-0002-5257-0510	Fondation ARC pour la Recherche Contre le Cancer; Fondation Recherche Medicale	Fondation ARC pour la Recherche Contre le Cancer; Fondation Recherche Medicale	This work was supported by the Fondation ARC pour la Recherche Contre le Cancer (to T.L.) and the Fondation Recherche Medicale (to L.L. and L.D.). We acknowledge personnel of CREFRE US006 for technical assistance.	Aichel O., 1911, VORTRAGE AUFSATZE EN, P92; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Bielski CM, 2018, NAT GENET, V50, P1189, DOI 10.1038/s41588-018-0165-1; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Chakraborty A, 2004, BONE MARROW TRANSPL, V34, P183, DOI 10.1038/sj.bmt.1704547; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chibon F, 2000, CANCER RES, V60, P6339; Clawson GA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184451; Clawson GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134320; Clawson GA, 2013, SCIENCE, V342, P699, DOI 10.1126/science.1244270; Clawson GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041052; Commo F, 2016, BIOINFORMATICS, V32, P1402, DOI 10.1093/bioinformatics/btv718; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; Ding JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041942; Dittmar T, 2015, INT J MOL SCI, V16, P30362, DOI 10.3390/ijms161226240; Dodd RD, 2010, DIS MODEL MECH, V3, P557, DOI 10.1242/dmm.005223; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; Duelli D, 2007, NAT REV CANCER, V7, P968, DOI 10.1038/nrc2272; Duelli DM, 2007, CURR BIOL, V17, P431, DOI 10.1016/j.cub.2007.01.049; Durrieu-Gaillard S, 2018, CELL CYCLE, V17, P605, DOI 10.1080/15384101.2017.1405881; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fletcher CD, 2012, WHO CLASSIFICATION T; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gast CE, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat7828; Gibault L, 2011, J PATHOL, V223, P64, DOI 10.1002/path.2787; Giroux V, 2017, NAT REV CANCER, V17, P594, DOI 10.1038/nrc.2017.68; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; Kemeny LV, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060826; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; KOVACS G, 1985, LANCET, V1, P350; KOVACS G, 1985, INT J CANCER, V36, P637, DOI 10.1002/ijc.2910360602; Kurgyis Z, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060980; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; LaBerge GS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168581; Lazar AJ, 2017, CELL, V171, P950, DOI 10.1016/j.cell.2017.10.014; Lazebnik Y, 2014, CELL CYCLE, V13, P2323, DOI 10.4161/cc.29704; Lazova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066731; Li GH, 2013, STEM CELLS, V31, P2304, DOI 10.1002/stem.1491; Lu X, 2009, P NATL ACAD SCI USA, V106, P9385, DOI 10.1073/pnas.0900108106; Luo F, 2016, ONCOTARGET, V7, P30924, DOI 10.18632/oncotarget.9045; Margolis RL, 2005, CANCER CELL, V8, P353, DOI 10.1016/j.ccr.2005.10.017; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; MUKHOPADHYAY KD, 2011, PLOS ONE, V0006; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Pawelek JM, 2005, LANCET ONCOL, V6, P988, DOI 10.1016/S1470-2045(05)70466-6; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Perot G, 2010, AM J PATHOL, V177, P2080, DOI 10.2353/ajpath.2010.100104; Perot G, 2009, CANCER RES, V69, P2269, DOI 10.1158/0008-5472.CAN-08-1443; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Santaguida S, 2015, NAT REV MOL CELL BIO, V16, P473, DOI 10.1038/nrm4025; Targa A, 2018, CURR OPIN CELL BIOL, V52, P136, DOI 10.1016/j.ceb.2018.03.007; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Turajlic S, 2018, CELL, V173, P581, DOI 10.1016/j.cell.2018.03.057; Van Mater D, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123687; Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123; Vitale I, 2011, CELL DEATH DIFFER, V18, P1403, DOI 10.1038/cdd.2010.145; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Walsh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027500; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Yano T, 2010, INT J MOL MED, V25, P153, DOI 10.3892/ijmm_00000325; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhou XF, 2015, AM J PATHOL, V185, P2049, DOI 10.1016/j.ajpath.2015.03.014	75	16	16	0	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2019	38	33					6083	6094		10.1038/s41388-019-0859-6	http://dx.doi.org/10.1038/s41388-019-0859-6			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IR6TP	31270395				2022-12-26	WOS:000481572400001
J	Qian, JY; Gao, J; Sun, X; Cao, MD; Shi, L; Xia, TS; Zhou, WB; Wang, S; Ding, Q; Wei, JF				Qian, Jia-Yi; Gao, Jian; Sun, Xi; Cao, Meng-Da; Shi, Liang; Xia, Tian-Song; Zhou, Wen-Bin; Wang, Shui; Ding, Qiang; Wei, Ji-Fu			KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner	ONCOGENE			English	Article							METHYLTRANSFERASE METTL3 PROMOTES; STEM-LIKE CELLS; RNA-METHYLATION; M(6)A; EXPRESSION; N-6-METHYLADENOSINE; TRANSLATION; IDENTIFICATION; PROGRESSION; KEGG	Most N6-methyladenosine (m(6)A) associated regulatory proteins (i.e., m(6)A writer, eraser, and reader proteins) are involved in the pathogenesis of various cancers, mostly in m(6)A-dependent manners. As a component in the m(6)A 'writers', KIAA1429 is reported to be an RNA-binding protein and involved in the m(6)A modification, mRNA splicing and processing. Till now, the functions of KIAA1429 in tumorigenesis and related mechanism have not been reported. In the present study, we found KIAA1429 was highly expressed in breast cancer tissues, but frequently down-regulated in non-cancerous breast tissues. The overall survival of breast cancer patients with high-expression KIAA1429 was significantly shorter than those with low-expression KIAA1429. Then, we demonstrated that KIAA1429 was associated with breast cancer proliferation and metastasis in vivo and in vitro. The potential targeting genes of KIAA1429 in breast cancer were identified by RNA immunoprecipitation sequencing. One of these genes is cyclin-dependent kinase 1 (CDK1), which plays an oncogenic role in cancers. Furthermore, we confirmed that KIAA1429 played its oncogenic role in breast cancer by regulating CDK1 by an m(6)A-independent manner. 5'-fluorouracil was found to be very effective in reducing the expression of KIAA1429 and CDK1 in breast cancer. These findings indicated that KIAA1429 could promote breast cancer progression and was correlated with pathogenesis. It may represent a promising therapeutic strategy on breast cancer, especially in combination with CDK1 treatment.	[Qian, Jia-Yi; Sun, Xi; Shi, Liang; Xia, Tian-Song; Zhou, Wen-Bin; Wang, Shui; Ding, Qiang] Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Breast Dis Ctr, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Gao, Jian] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Cao, Meng-Da; Wei, Ji-Fu] Nanjing Med Univ, Affiliated Hosp 1, Res Div Clin Pharmacol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University; Nanjing Medical University	Wang, S; Ding, Q (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Breast Dis Ctr, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.; Wei, JF (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Res Div Clin Pharmacol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	ws0801@hotmail.com; dingqiang@njmu.edu.cn; weijifu@hotmail.com	Gao, Jian/AAU-8293-2021	Gao, Jian/0000-0002-2722-7067	National Natural Science Foundation of China [81572595, 81572607, 81602336]; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China [grant numbers 81572595, 81572607, 81602336], and the Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Barbieri I, 2017, NATURE, V552, P126, DOI 10.1038/nature24678; Cai XL, 2018, CANCER LETT, V415, P11, DOI 10.1016/j.canlet.2017.11.018; Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683; Chen X, 2015, MED ORAL PATOL ORAL, V20, pE7, DOI 10.4317/medoral.19841; Cui Q, 2017, CELL REP, V18, P2622, DOI 10.1016/j.celrep.2017.02.059; Dai DJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0129-x; Dassi E, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00067; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Fry Nate J, 2018, Oncotarget, V9, P31231, DOI 10.18632/oncotarget.25782; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Gao SY, 2014, ASIAN PAC J CANCER P, V15, P6437, DOI 10.7314/APJCP.2014.15.15.6437; Garcia-Maurino SM, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00071; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haussmann IU, 2016, NATURE, V540, P301, DOI 10.1038/nature20577; Hong S, 2017, J CANCER PREV, V22, P203, DOI 10.15430/JCP.2017.22.4.203; Jiang GL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2911-z; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim SJ, 2008, ANN ONCOL, V19, P68, DOI 10.1093/annonc/mdm358; Knuckles P, 2018, GENE DEV, V32, P415, DOI 10.1101/gad.309146.117; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Ma JZ, 2017, HEPATOLOGY, V65, P529, DOI 10.1002/hep.28885; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Niessen M, 2001, GENETICS, V157, P679; Pan YT, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0590-8; Panneerdoss S, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar8263; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Payton M, 2006, CANCER RES, V66, P4299, DOI 10.1158/0008-5472.CAN-05-2507; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Su R, 2018, CELL, V172, P90, DOI 10.1016/j.cell.2017.11.031; Tang C, 2018, P NATL ACAD SCI USA, V115, pE325, DOI 10.1073/pnas.1717794115; Tang JY, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0706-6; Tsai WC, 2008, DIS MARKERS, V24, P89, DOI 10.1155/2008/945197; Visvanathan A, 2018, ONCOGENE, V37, P522, DOI 10.1038/onc.2017.351; Wang SW, 2017, CANCER LETT, V408, P112, DOI 10.1016/j.canlet.2017.08.030; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wen J, 2018, MOL CELL, V69, P1028, DOI 10.1016/j.molcel.2018.02.015; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Yue YA, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0019-0; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zhang CZ, 2016, ONCOTARGET, V7, P64527, DOI 10.18632/oncotarget.11743; Zhang CZ, 2016, P NATL ACAD SCI USA, V113, pE2047, DOI 10.1073/pnas.1602883113; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132	56	105	106	4	43	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2019	38	33					6123	6141		10.1038/s41388-019-0861-z	http://dx.doi.org/10.1038/s41388-019-0861-z			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IR6TP	31285549				2022-12-26	WOS:000481572400004
J	Curtis, L; Burford, JH; England, GCW; Freeman, SL				Curtis, Laila; Burford, John H.; England, Gary C. W.; Freeman, Sarah L.			Risk factors for acute abdominal pain (colic) in the adult horse: A scoping review of risk factors, and a systematic review of the effect of management-related changes	PLOS ONE			English	Review							EPIPLOIC FORAMEN; ANOPLOCEPHALA-PERFOLIATA; VETERINARY JOURNALS; ILEAL IMPACTION; SMALL-INTESTINE; ASSOCIATION; ENTRAPMENT; POPULATION; PREVALENCE; DIETARY	Acute abdominal pain (colic) is the most common reason for emergency veterinary treatment in the horse. Consolidation of data through a systematic review is important to inform evidence-based medicine and clinical guidelines, but there are currently no published systematic reviews on colic in the horse. The aim of this study was to identify, categorize and appraise the evidence on factors associated with increased risk of developing abdominal pain (colic) due to gastrointestinal disease in the adult horse. A scoping review was performed to identify and categorize evidence on all risk factors for colic. A systematic review of management-related risk factors was then performed following PRISMA guidelines. Both searches were conducted in Medline, CAB Abstracts and Web of Science databases, and publications were assessed against inclusion and exclusion criteria. For the scoping review, study and participant characteristics of included publications and key results were extracted and tabulated. For the systematic review, cohort, case-control or cross-sectional studies investigating acute abdominal pain in horses within two weeks of management changes were assessed. Study characteristics, participant characteristics and study results of included publications for the systematic review were extracted and tabulated. Included publications were appraised using the Joanna Briggs Institute Critical Appraisal Tools for cohort, case-control and cross-sectional studies. The scoping review search identified 3,756 publications. Fifty eight studies met final inclusion criteria, and 22 categories of risk factors were identified. These were grouped into three broad areas: horse-related factors, management-related factors and environment-related factors. The largest body of evidence related to management change. The systematic review of management change identified 410 publications: 14 met inclusion criteria for analysis. These consisted of one cohort, eight case-control and five cross-sectional studies. The studies were conducted between 1990-2008, and the majority of studies were located in the USA (8/14) or UK (3/14). The risk factors related to management change that were assessed were feed, carer, exercise, pasture, water and housing. The largest bodies of evidence for increased risk of colic associated with management change were changes in feed (5/14 publications) and recent change in housing (3/14). Most studies (8/14) did not meet the JBI criterion on confounding factors. There was marked heterogeneity of study methodologies and measures. This is the first study to use a combined scoping and systematic review to analyse evidence for modifiable risk factors for a common condition in the horse. It provides a comprehensive review that will be a key resource for researchers, veterinary practitioners and horse owners. It identified modifiable risk factors associated with an increased risk of colic which should be a key target for preventative health programmes. The findings from the critical appraisal were used to develop recommendations for future research to improve the quality of evidence-based veterinary medicine.	[Curtis, Laila; Burford, John H.; England, Gary C. W.; Freeman, Sarah L.] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England; [Curtis, Laila] 10 Cranage Pl, Middlewich, Cheshire, England	University of Nottingham	Freeman, SL (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England.	sarah.freeman@nottingham.ac.uk	Freeman, Sarah/H-1228-2011; England, Gary C.W./G-5432-2011	Freeman, Sarah/0000-0002-3119-2207; England, Gary/0000-0001-5800-3106; Burford, John/0000-0003-0505-1520	University of Nottingham	University of Nottingham	Dr Laila Curtis PhD studentship was funded by the University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer DC, 2008, EQUINE VET J, V40, P405, DOI 10.2746/042516408X312149; Archer DC, 2008, EQUINE VET J, V40, P224, DOI 10.2746/042516408X266079; Archer DC, 2004, VET REC, V155, P793; Archer DC, 2004, JAVMA-J AM VET MED A, V224, P562, DOI 10.2460/javma.2004.224.562; Archer Debra C, 2006, BMC Vet Res, V2, P27, DOI 10.1186/1746-6148-2-27; Archer DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112072; Arksey Hilary., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Back H, 2013, VET PARASITOL, V197, P580, DOI 10.1016/j.vetpar.2013.07.020; Bailey SR, 2003, APPL ENVIRON MICROB, V69, P2087, DOI 10.1128/AEM.69.4.2087-2093.2003; Bizhga S., 2017, Albanian Journal of Agricultural Sciences, V16, P33; Boswinkel M, 2007, TIJDSCHR DIERGENEESK, V132, P508; Bowden A, 2017, EQUINE VET J, V49, P11, DOI [10.1111/evj.14_12732, DOI 10.1111/EVJ.14_12732]; Buczinski S, 2018, PREV VET MED, V161, P50, DOI 10.1016/j.prevetmed.2018.10.011; Cohen ND, 2006, EQUINE VET J, V38, P526, DOI 10.2746/042516406X155975; Cohen ND, 2000, J AM VET MED ASSOC, V216, P1787, DOI 10.2460/javma.2000.216.1787; COHEN ND, 1995, J AM VET MED ASSOC, V206, P667; Cohen ND, 1996, J AM VET MED ASSOC, V208, P697; Cohen ND, 1999, J AM VET MED ASSOC, V215, P53; Curtis L, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0160-9; Diakakis N, 2017, J HELL VET MED SOC, V68, P455; Egan S, 2019, EQUINE VET J, V51, P813, DOI 10.1111/evj.13076; Egenvall A, 2008, J VET INTERN MED, V22, P1029, DOI 10.1111/j.1939-1676.2008.0136.x; Escalona EE, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-S1-S3; Grindlay DJC, 2012, J VET MED EDUC, V39, P404, DOI 10.3138/jvme.1111.109R; Hassanpour A, 2007, P 13 INT C AN HYG TA; Hassel DM, 2008, RES VET SCI, V85, P476, DOI 10.1016/j.rvsc.2008.03.001; Hassel DM, 2004, J VET INTERN MED, V18, P346, DOI 10.1892/0891-6640(2004)18&lt;346:DRFACP&gt;2.0.CO;2; Hillyer MH, 2002, EQUINE VET J, V34, P455, DOI 10.2746/042516402776117746; Hillyer MH, 2001, EQUINE VET J, V33, P380, DOI 10.2746/042516401776249499; Hudson JM, 2001, J AM VET MED ASSOC, V219, P1419, DOI 10.2460/javma.2001.219.1419; Husted L, 2005, EQUINE VET J, V37, P351, DOI 10.2746/0425164054529373; Joanna Briggs Institute (JBI), 2015, J BRIGGS I REV MAN S; John JR, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0887-2; Kaneene JB, 1997, PREV VET MED, V30, P23, DOI 10.1016/S0167-5877(96)01102-6; Kaya G, 2009, J ANIM PHYSIOL AN N, V93, P339, DOI 10.1111/j.1439-0396.2008.00874.x; Leblond A, 2002, P SOC VET EP PREV ME; Little D, 2002, EQUINE VET J, V34, P464, DOI 10.2746/042516402776117773; Majdoubi J, 2009, LECT NOTES ARTIF INT, V5711, P277, DOI 10.1007/978-3-642-04595-0_34; Malamed R, 2010, EQUINE VET J, V42, P686, DOI 10.1111/j.2042-3306.2010.00096.x; Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54; Marr CM, 2012, EQUINE VET J, V44, P384, DOI 10.1111/j.2042-3306.2012.00593.x; Mehdi S, 2006, J EQUINE VET SCI, V26, P171, DOI 10.1016/j.jevs.2006.02.008; MERLIN JS, 2014, BMC MED RES METHODOL, V9, DOI DOI 10.1371/JOURNAL.PONE.0111765; Morris D. D., 1993, Proceedings of the Annual Convention of the American Association of Equine Practitioners, V38, P441; MORRIS DD, 1989, EQUINE VET J, V21, P119, DOI 10.1111/j.2042-3306.1989.tb05672.x; Network E., 2019, PREF REP IT SYST REV; Newton JR, 2004, EQUINE VET J, V36, P105, DOI [10.2746/0425164044868639, 10.2746/0425164044868710]; Olusa T. A. O., 2014, Journal of Veterinary Medicine and Animal Health, V6, P192; Patipa LA, 2012, JAVMA-J AM VET MED A, V240, P1488, DOI 10.2460/javma.240.12.1488; Pearce N, 2012, INT J EPIDEMIOL, V41, P393, DOI 10.1093/ije/dys049; Proudman C J, 2000, Equine Vet J Suppl, P37; Proudman CJ, 1998, EQUINE VET J, V30, P194, DOI 10.1111/j.2042-3306.1998.tb04487.x; PROUDMAN CJ, 1992, EQUINE VET J, V24, P90, DOI 10.1111/j.2042-3306.1992.tb02789.x; PROUDMAN CJ, 1993, EQUINE VET J, V25, P224, DOI 10.1111/j.2042-3306.1993.tb02948.x; Ravat S, 2020, PHYSIOTHER THEOR PR, V36, P1279, DOI 10.1080/09593985.2019.1570575; Reeves MJ, 1996, PREV VET MED, V26, P285, DOI 10.1016/0167-5877(95)00551-X; REEVES MJ, 1989, PREV VET MED, V7, P149, DOI 10.1016/0167-5877(89)90006-8; Rose WJ, 2017, ANIM HEALTH RES REV, V18, P177, DOI 10.1017/S1466252317000068; Salem SE, 2017, EQUINE VET J, V49, P201, DOI 10.1111/evj.12573; Sargeant JM, 2017, J VET INTERN MED, V31, P1035, DOI 10.1111/jvim.14741; Scantlebury CE, 2015, EQUINE VET J, V47, P202, DOI 10.1111/evj.12276; Scantlebury CE, 2011, EQUINE VET J, V43, P81, DOI 10.1111/j.2042-3306.2011.00383.x; Scherrer NM, 2016, JAVMA-J AM VET MED A, V249, P90, DOI 10.2460/javma.249.1.90; Senior JM, 2004, VET REC, V155, P321, DOI 10.1136/vr.155.11.321; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Stancampiano L, 2017, VET PARASITOL, V247, P33, DOI 10.1016/j.vetpar.2017.09.020; Suthers JM, 2013, EQUINE VET J, V45, P558, DOI 10.1111/evj.12039; Tinker MK, 1997, EQUINE VET J, V29, P448, DOI 10.1111/j.2042-3306.1997.tb03157.x; Tinker MK, 1997, EQUINE VET J, V29, P454, DOI 10.1111/j.2042-3306.1997.tb03158.x; Toews LC, 2017, J MED LIBR ASSOC, V105, P233, DOI 10.5195/jmla.2017.246; Traub-Dargatz JL, 2001, J AM VET MED ASSOC, V219, P67, DOI 10.2460/javma.2001.219.67; Tricco AC, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0116-4; Trotz-Williams L, 2008, VET PARASITOL, V153, P73, DOI 10.1016/j.vetpar.2008.01.016; UHLINGER C, 1990, EQUINE VET J, V22, P251, DOI 10.1111/j.2042-3306.1990.tb04263.x; White N. A., 2009, Australian Equine Veterinarian, V28, P42	75	27	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219307	10.1371/journal.pone.0219307	http://dx.doi.org/10.1371/journal.pone.0219307			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295284	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800024
J	Larrea-Sarmiento, A; Alvarez, AM; Stack, JP; Arif, M				Larrea-Sarmiento, Adriana; Alvarez, Anne M.; Stack, James P.; Arif, Mohammad			Synergetic effect of non-complementary 5 ' AT-rich sequences on the development of a multiplex TaqMan real-time PCR for specific and robust detection of Clavibacter michiganensis and C. michiganensis subsp. nebraskensis	PLOS ONE			English	Article							ALIGNMENT; VIRUS; GENE	Clavibacter is an agriculturally important genus comprising a single species, Clavibacter michiganensis, and multiple subspecies, including, C. michiganensis subsp. nebraskensis which causes Goss's wilt/blight of corn, accounts for high yield losses and is listed among the five most significant diseases of corn in the United States of America. Our research objective was to develop a robust and rapid multiplex TaqMan real-time PCR (qPCR) to detect C. michiganensis in general and C. michiganensis subsp. nebraskensis with enhanced reliability and accuracy by adding non-complementary AT sequences to the 5' end of the forward and reverse primers. Comparative genomic analyses were performed to identify unique and conserved gene regions for primer and probe design. The unique genomic regions, ABC transporter ATP-binding protein CDS/ABC-transporter permease and MFS transporter were determined for specific detection of C. michiganensis and C. m. subsp. nebraskensis, respectively. The AT-rich sequences at the 5' position of the primers enhanced the reaction efficiency and sensitivity of rapid qPCR cycling; the reliability, accuracy and high efficiency of the developed assay was confirmed after testing with 59 strains from inclusivity and exclusivity panels-no false positives or false negatives were detected. The assays were also validated through naturally and artificially infected corn plant samples; all samples were detected for C. michiganensis and C. m. subsp. nebraskensis with 100% accuracy. The assay with 5' AT-rich sequences detected up to 10- and 100-fg of C. michiganensis and C. michiganensis subsp. nebraskensis genome targets, respectively. No adverse effect was observed when sensitivity assays were spiked with host genomic DNA. Addition of 5' AT-rich sequences enhanced the qPCR reaction efficiency from 0.82 (M = -3.83) and 0.91 (M = -3.54) to 1.04 (with optimum slope value; M = -3.23) for both C. michiganensis and C. michiganensis subsp. nebraskensis, respectively; an increase of 10-fold sensitivity was also obtained with C. michiganensis primer set. The methodology proposed here can be used to optimize reaction efficiency and to harmonize diagnostic protocols which have prodigious applications in routine diagnostics, biosecurity and microbial forensics.	[Larrea-Sarmiento, Adriana; Alvarez, Anne M.; Arif, Mohammad] Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA; [Stack, James P.] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA	University of Hawaii System; University of Hawaii Manoa; Kansas State University	Arif, M (corresponding author), Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA.	arif@hawaii.edu		Arif, Mohammad/0000-0002-5887-2050	USDA National Institute of Food and Agriculture, Hatch project [9038H]; National Science Foundation [NSF] [1561663]	USDA National Institute of Food and Agriculture, Hatch project; National Science Foundation [NSF](National Science Foundation (NSF))	This work was supported by the USDA National Institute of Food and Agriculture, Hatch project 9038H, managed by the College of Tropical Agriculture and Human Resources, and National Science Foundation [NSF; Award Number - 1561663].	Afonina I, 2007, BIOTECHNIQUES, V43, P770, DOI 10.2144/000112631; Agarkova IV, 2011, CAN J MICROBIOL, V57, P366, DOI [10.1139/W11-016, 10.1139/w11-016]; Ahmed FA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34275-0; Al-Zahrani JM, 2015, ANN THORAC MED, V10; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arif M, 2014, APPL ENVIRON MICROB, V80, P320, DOI 10.1128/AEM.02340-13; Arif M, 2013, MOL BIOTECHNOL, V55, P17, DOI 10.1007/s12033-012-9617-5; Arif M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156182; Arif M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129810; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dobhal S, 2019, J APPL MICROBIOL, V126, P388, DOI 10.1111/jam.14128; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichenlaub R, PLANT ASS BACTERIA, P385; Eichenlaub R, 2011, ANNU REV PHYTOPATHOL, V49, P445, DOI 10.1146/annurev-phyto-072910-095258; Jackson T. A., 2007, Plant Health Progress, P0919; Zamora-Macorra EJ, 2015, EUR J PLANT PATHOL, V143, P779, DOI 10.1007/s10658-015-0729-1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larrea-Sarmiento A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32295-4; Lebuhn M, 2000, INT J SYST EVOL MICR, V50, P2207, DOI 10.1099/00207713-50-6-2207; Li X, 2018, INT J SYST EVOL MICR, V68, P234, DOI 10.1099/ijsem.0.002492; McNally RR, 2016, PHYTOPATHOLOGY, V106, P1465, DOI 10.1094/PHYTO-05-16-0190-R; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; NORMAN D, 1989, PLANT DIS, V73, P654, DOI 10.1094/PD-73-0654; Ping OY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081647; Przewodowski W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169785; Tambong JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172295; Tambong JT, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00768-15; Vandenbussche F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164463; Vreeburg R. A. M., 2016, Bulletin OEPP, V46, P112, DOI 10.1111/epp.12278; Yasuhara-Bell J, 2015, INT J SYST EVOL MICR, V65, P811, DOI 10.1099/ijs.0.000022; Yasuhara-Bell J, 2013, PHYTOPATHOLOGY, V103, P1220, DOI 10.1094/PHYTO-03-13-0078-R	31	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0218530	10.1371/journal.pone.0218530	http://dx.doi.org/10.1371/journal.pone.0218530			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295263	Green Submitted, Green Published, gold			2022-12-26	WOS:000484951800007
J	Li, YK; Liu, JM; Ren, JD				Li, Yakun; Liu, Jiaomin; Ren, Jiadong			Social recommendation model based on user interaction in complex social networks	PLOS ONE			English	Article							TRUST; INFORMATION; ALGORITHMS	The user interaction in online social networks can not only reveal the social relationships among users in e-commerce systems, but also imply the social preferences of a target user for recommendation services. However, the current research has rarely explored the impact of social interaction on recommendation performance, especially now that recommender systems face increasing challenges and suffer from poor efficiency due to social data overload. Therefore, applied research on user interaction has become increasingly necessary in the field of social recommendation. In this paper, we develop a novel social recommendation method based on the user interaction in complex social networks, called the SRUI model, to present a basis for improving the efficiency of the recommender systems. Specifically, a weighted social interaction network is first mapped to represent the interactions among social users according to the gathered information about historical user behavior. Thereafter, the complete path set is mined by the complete path mining (CPM) algorithm to find social similar neighbors with tastes similar to those of the target user. Finally, the social similar tendencies of the users on the complete paths are obtained to predict the final ratings of items through the SRUI model. A series of experimental results based on two real public datasets show that our approach performs better than other state-of-the-art methods in terms of recommendation performance.	[Li, Yakun; Liu, Jiaomin; Ren, Jiadong] Yanshan Univ, Coll Informat Sci & Engn, Qinhuangdao, Hebei, Peoples R China; [Li, Yakun; Ren, Jiadong] Key Lab Comp Virtual Technol & Syst Integrat Hebe, Qinhuangdao, Hebei, Peoples R China	Yanshan University	Li, YK (corresponding author), Yanshan Univ, Coll Informat Sci & Engn, Qinhuangdao, Hebei, Peoples R China.; Li, YK (corresponding author), Key Lab Comp Virtual Technol & Syst Integrat Hebe, Qinhuangdao, Hebei, Peoples R China.	15033564136@163.com		Li, Yakun/0000-0002-8694-3063				Alahmadi DH, 2015, EXPERT SYSTEMS APPL, V42; Andreasen T, 2004, DATA KNOWL ENG, V48, P199, DOI 10.1016/S0169-023X(03)00105-8; [Anonymous], [No title captured]; Bello-Orgaz G, 2016, INFORM FUSION, V28, P45, DOI 10.1016/j.inffus.2015.08.005; Chamoso P, 2018, INFORM SCIENCES, V433, P204, DOI 10.1016/j.ins.2017.12.050; Cheng WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155739; Chow WS, 2008, INFORM MANAGE-AMSTER, V45, P458, DOI 10.1016/j.im.2008.06.007; Corbellini A, 2015, J INF SCI, V41, P686, DOI 10.1177/0165551515588669; Deng SG, 2014, EXPERT SYST APPL, V41, P8075, DOI 10.1016/j.eswa.2014.07.012; Espejo R, 2011, KYBERNETES, V40, P559; Fields B, 2011, IEEE T MULTIMEDIA, V13, P674, DOI 10.1109/TMM.2011.2111365; Golbeck J., 2005, COMPUTING APPL TRUST; Guo GB, 2017, KNOWL-BASED SYST, V122, P17, DOI 10.1016/j.knosys.2017.01.027; Guo Guibing, 2015, P 23 C US MOD AD PER; Haruna K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184516; Herlocker J, 2002, INFORM RETRIEVAL, V5, P287, DOI 10.1023/A:1020443909834; Jansen BJ, 2011, J INF SCI, V37, P120, DOI 10.1177/0165551510396975; Koohborfardhaghighi S, 2013, APPL INTELL, V38, P255, DOI 10.1007/s10489-012-0371-y; Lee S, 2010, COMPUT IND, V61, P329, DOI 10.1016/j.compind.2009.12.004; Lerman K, 2007, IEEE INTERNET COMPUT, V11, P16, DOI 10.1109/MIC.2007.136; Li Q, 2010, INFORM SCIENCES, V180, P4929, DOI 10.1016/j.ins.2010.08.044; Li Y, 2017, MATER RES EXPRESS, V4, DOI 10.1088/2053-1591/aa9200; Lisovich MA, 2010, IEEE SECUR PRIV, V8, P11, DOI 10.1109/MSP.2010.40; Liu G, 2011, AAAI C ART INT; Liu GF, 2013, IEEE T SERV COMPUT, V6, P152, DOI 10.1109/TSC.2011.58; Lu HQ, 2016, NEUROCOMPUTING, V216, P61, DOI 10.1016/j.neucom.2016.07.011; Maier C, 2015, EUR J INFORM SYST, V24, P447, DOI 10.1057/ejis.2014.3; Massa P, 2007, RECSYS 07: PROCEEDINGS OF THE 2007 ACM CONFERENCE ON RECOMMENDER SYSTEMS, P17; Papagelis M, 2005, ENG APPL ARTIF INTEL, V18, P781, DOI 10.1016/j.engappai.2005.06.010; Park C, 2016, INFORM SCI; Rojas G, 2017, IEEE LAT AM T, V15, P753, DOI 10.1109/TLA.2017.7896404; Shi Y., 2009, P 3 ACM C REC SYST, P125, DOI DOI 10.1145/1639714.1639736; Song Y, 2011, ACM T WEB, V5, DOI 10.1145/1921591.1921595; Sun JS, 2015, INFORM PROCESS MANAG, V51, P444, DOI 10.1016/j.ipm.2014.09.002; Suo Qi, 2015, EXPERT SYSTEMS APPL, V42; Szabo G, 2010, COMMUN ACM, V53, P80, DOI 10.1145/1787234.1787254; Wang R., 2014, J COMPUT INFORM SYST, V10, P10003; Wang Z, 2013, IEEE T MULTIMEDIA, V15, P698, DOI 10.1109/TMM.2012.2237022; Yuan W, 2011, APPL INTELL, V35, P399, DOI 10.1007/s10489-010-0230-7; Zeng D, 2010, IEEE INTELL SYST, V25, P13, DOI 10.1109/MIS.2010.151; Zhang XH, 2013, KNOWL-BASED SYST, V42, P74, DOI 10.1016/j.knosys.2013.01.017; Zhang ZJ, 2015, APPL INTELL, V43, P695, DOI 10.1007/s10489-015-0681-y; Zhao Z, 2015, IEEE T KNOWL DATA EN, V27, P993, DOI 10.1109/TKDE.2014.2356461	44	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218957	10.1371/journal.pone.0218957	http://dx.doi.org/10.1371/journal.pone.0218957			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291288	Green Submitted, gold, Green Published			2022-12-26	WOS:000484947800043
J	Centi, L; Groman-Yaroslavski, I; Friedman, N; Oron, M; Prevost, M; Zaidner, Y				Centi, Laura; Groman-Yaroslavski, Iris; Friedman, Neta; Oron, Maya; Prevost, Marion; Zaidner, Yossi			The bulb retouchers in the Levant: New insights into Middle Palaeolithic retouching techniques and mobile tool-kit composition	PLOS ONE			English	Article							NESHER RAMLA; BONE RETOUCHERS; RAW-MATERIAL; SITE; CAVE; NEANDERTHALS; ORGANIZATION; VARIABILITY; PLEISTOCENE; OCCUPATION	In this paper we describe two assemblages of flint retouchers or "bulb retouchers" retrieved from Nesher Ramla and Quneitra, two Middle Palaeolithic, open-air sites in the Levant. The site of Nesher Ramla yielded the largest assemblage of bulb retouchers (n = 159) currently known, allowing a detailed investigation of this poorly known phenomenon. An extensive experimental program and use-wear analysis enabled us to characterize the different sets of traces related to the retouching activity and to identify different motions applied by the knappers in the course of this action. In both sites, blanks used as bulb retouchers were almost exclusively retouched items, with a special emphasis on convergent morphotypes in Nesher Ramla. The use of retouched items as bulb retouchers is a common trait over different time spans and geographical areas. Our data suggests that bulb retouchers were versatile, multi-purpose tools with a long use-life, transported over long distances as components of the hunter-gatherer mobile tool kit. The high frequencies of bulb retouchers within some archaeological units of Nesher Ramla appear to be connected to the highly curated nature of the lithic assemblages, in turn reflecting a high mobility of the human groups that produced them.	[Centi, Laura; Friedman, Neta; Prevost, Marion; Zaidner, Yossi] Hebrew Univ Jerusalem, Inst Archaeol, Dept Prehistor Archaeol, Jerusalem, Israel; [Groman-Yaroslavski, Iris; Oron, Maya] Univ Haifa, Zinman Inst Archaeol, Use Wear Anal Lab, Haifa, Israel; [Oron, Maya] Israel Antiqu Author, Dept Prehist, Jerusalem, Israel	Hebrew University of Jerusalem; University of Haifa	Centi, L (corresponding author), Hebrew Univ Jerusalem, Inst Archaeol, Dept Prehistor Archaeol, Jerusalem, Israel.	laura.centi@mail.huji.ac.il		Zaidner, Yossi/0000-0002-4247-4824; Centi, Laura/0000-0001-9865-718X	Israel Science Foundation [1773/15]	Israel Science Foundation(Israel Science Foundation)	Funded by Y.Z. Israel Science Foundation grant (number 1773/15). https://www.isf.org.il. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams G, 2014, QUATERN INT, V326, P274, DOI 10.1016/j.quaint.2013.10.022; Adler D. S., 2004, SETTLEMENT DYNAMICS, P91; Adler D. S., 2002, THESIS HARVARD U; [Anonymous], [No title captured]; [Anonymous], 2004, SOL OCCUPATION ACHEU; [Anonymous], 2004, THESIS; Bamforth D.B., 1997, ARCHAEOLOGICAL PAPER, V7, P109, DOI DOI 10.1525/AP3A.1997.7.1.109; BINFORD LR, 1979, J ANTHROPOL RES, V35, P255, DOI 10.1086/jar.35.3.3629902; Binford LR., 1977, STONE TOOLS CULTURAL, P24; Blake EsC, 2007, EXPERIENCING ARCHAEO; Blasco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076780; Bourguignon L, 2001, PREHISTOIRE APPROCHE, P35; BOUSMAN C. B., 1993, LITHIC TECHNOL, V18, P59, DOI DOI 10.1080/01977261.1993.11720897; CHASE PG, 1990, CURR ANTHROPOL, V31, P443, DOI 10.1086/203869; Cohen VY, 1999, J WORLD PREHIST, V13, P265, DOI 10.1023/A:1022389613280; Cowan Frank, 2002, EXPERIMENTAL ARCHAEO, V1035, P25; Crater-Gershtein KM, 2018, THESIS; Daujeard C., 2018, ORIGINS BONE TOOL TE, P93; Daujeard C, 2014, QUATERN INT, V326, P492, DOI 10.1016/j.quaint.2013.12.022; De Beaune S, 1989, GALLIA PREHISTOIRE, V31, P27, DOI DOI 10.3406/GALIP.1989.2264; DIBBLE HL, 1987, AM ANTIQUITY, V52, P109, DOI 10.2307/281062; Doyon L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194318; Ekshtain R, 2017, GEOARCHAEOLOGY, V32, P189, DOI 10.1002/gea.21585; Ekshtain R, 2014, QUATERN INT, V331, P248, DOI 10.1016/j.quaint.2013.07.025; Friesem DE, 2014, QUATERN INT, V331, P128, DOI 10.1016/j.quaint.2013.03.023; Goren-Inbar N., 1990, QUNEITRA MOUSTERIAN, V31; Griggo C, 2011, HUNTING CAMPS PREHIS, P105; Jequier CA, 2012, CR PALEVOL, V11, P283, DOI 10.1016/j.crpv.2011.12.001; Kolosov Y. U. G., 1997, ARCEOLOGICKE ROZHL, VXLIX, P124; Kuhn S. L, 1995, ECOLOGICAL PERSPECTI; KUHN SL, 1992, J ANTHROPOL RES, V48, P185, DOI 10.1086/jar.48.3.3630634; KUHN SL, 1994, AM ANTIQUITY, V59, P426, DOI 10.2307/282456; Mallye JB, 2012, J ARCHAEOL SCI, P39; Marks A.E, 2004, MIDDLE PALEOLITHIC E, V3, P377; Mathias C., 2018, BUTTLETI ARQUEOLOGIC, V40, P323; Moigne AM, 2016, QUATERN INT, V409, P195, DOI 10.1016/j.quaint.2015.06.059; Mozota M., 2018, ORIGINS BONE TOOL TE, P15; Muslim C., 2018, ORIGIN BONE TOOL TEC; Nelson M.C., 1991, ARCHAEOLOGICAL METHO, P57, DOI DOI 10.2307/20170213; Nicoud E., 2010, REV ARCHEOLOGIE PREH, P107; Oron M, 2014, QUATERN INT, V331, P186, DOI 10.1016/j.quaint.2013.04.013; Parry WJ., 1987, ORG CORE TECHNOLOGY, P285; Plisson H, 1988, HOMME NEANDERTAL, V4, P121; Praslov ND, 1968, RANNII PALEOLIT SEVE, P155; quier C., 2018, ORIGINS BONE TOOL TE, P269, DOI [10.11588/propylaeum.408.590, DOI 10.11588/PROPYLAEUM.408.590]; Raynal J-P, 2003, C INT, P45; Riel-Salvatore J, 2004, AM ANTIQUITY, V69, P257, DOI 10.2307/4128419; ROLLAND N, 1990, AM ANTIQUITY, V55, P480, DOI 10.2307/281279; Rosell J., 2018, ORIGINS BONE TOOL TE; Rosell J, 2015, QUATERN INT, V361, P297, DOI 10.1016/j.quaint.2014.08.009; Rots V., 2010, PREHENSION HAFTING T, DOI 10.2307/j.ctt9qf05s; Rougier H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29005; Seveque N, 2018, ORIGINS BONE TOOL TE, V35, P133; SHOTT M, 1986, J ANTHROPOL RES, V42, P15, DOI 10.1086/jar.42.1.3630378; Smith GM, 2013, J ARCHAEOL SCI, V40, P3754, DOI 10.1016/j.jas.2013.05.002; Sorensen A, 2014, J ARCHAEOL SCI, V42, P476, DOI 10.1016/j.jas.2013.11.032; Stepanchuk V. N., 1999, PREHISTOIRE EUROPEEN, V13, P33; Stepanchuk V. N., 1992, ARCHEOL ROZHL, VXLIV, P505; Stepanchuk VN, 2017, QUATERN INT, V428, P132, DOI 10.1016/j.quaint.2015.11.042; Stepanchuk VN, 1993, ANTHROPOLOGIE, VXXXI, P45; Thiebaut C., 2010, PALETHINOLOGIE VARIA, P3; Thun Hohenstein U, 2018, ORIGINS BONE TOOL TE, P235; Tixier J., 2000, RECHERCHE HOMME PREH, V95, P125; Tsatskin A, 2014, GEOMORPHOLOGY, V229, P45; Tsatskin A, 2014, QUATERN INT, V331, P103, DOI 10.1016/j.quaint.2013.10.050; van Gijn A., 1989, PRINCIPALS FUNCTIONA, V22; Verna C, 2011, J HUM EVOL, V60, P145, DOI 10.1016/j.jhevol.2010.07.027; Veselsky A. P., 2008, PALAEOLITHIC SITES C, V3, P427; Yeshurun R., 2018, ORIGINS BONE TOOL TE, P287; Zaidner Y, 2012, MIDDLE UPPER PALEOLI; Zaidner Y, 2016, QUATERNARY SCI REV, V138, P76, DOI 10.1016/j.quascirev.2016.02.016; Zaidner Y, 2015, QUATERN INT, V361, P178, DOI 10.1016/j.quaint.2014.11.037; Zaidner Y, 2014, J HUM EVOL, V66, P1, DOI 10.1016/j.jhevol.2013.06.005; Ziaei M., 1990, QUNEITRA MOUSTERIAN, V31, P232	74	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0218859	10.1371/journal.pone.0218859	http://dx.doi.org/10.1371/journal.pone.0218859			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4FP	31276507	Green Published, gold, Green Submitted			2022-12-26	WOS:000484936300024
J	Wess, G; Wallukat, G; Fritscher, A; Becker, NP; Wenzel, K; Muller, J; Schimke, I				Wess, Gerhard; Wallukat, Gerd; Fritscher, Anna; Becker, Niels-Peter; Wenzel, Katrin; Mueller, Johannes; Schimke, Ingolf			Doberman pinschers present autoimmunity associated with functional autoantibodies: A model to study the autoimmune background of human dilated cardiomyopathy	PLOS ONE			English	Article							MUSCARINIC RECEPTOR AUTOANTIBODIES; PROTEIN-COUPLED RECEPTORS; ANIMAL-MODELS; PATHOGENIC AUTOANTIBODIES; NEUTRALIZATION; EPITOPE; DEATH; SERUM; 1ST	Background Autoimmunity associated with autoantibodies against the beta 1-adrenergic receptor (beta 1-AAB) is increasingly accepted as the driver of human dilated cardiomyopathy (DCM). Unfortunately, there is a lack of animal models to extend the knowledge about beta 1-AAB autoimmunity in DCM and to develop appropriate treatment strategies. Objectives To introduce an animal model, we investigated the beta 1-AAB associated autoimmunity in Doberman Pinscher (DP) with dilated cardiomyopathy, which has similarities to human DCM. Materials and methods Eighty-seven DP with cardiomyopathy in terms of pathological ECG and echocardiography (DoCM) and 31 dogs (at enrollment) without DoCM (controls) were analyzed for serum activity of beta 1-AAB with a bioassay that records the chronotropic response of spontaneously beating cultured neonatal rat cardiomyocytes to the DP's IgG. To locate the receptor binding site of beta 1-AAB and the autoantibody's sensitivity to inhibition, competing experiments with related blockers were performed with the bioassay. In controls that developed DoCM during follow-up, beta 1-AAB were analyzed during progress. Results Fifty-nine (67.8%) DoCM dogs and 19 (61.3%) controls were beta 1-AAB positive. Of the controls that developed DoCM, 8 were beta 1-AAB positive (p = 0.044 vs. dogs remaining in the control group); their beta 1-AAB activity increased with the cardiomyopathy progress (p< 0.02). To supplement DoCM group with the 9 animals which developed cardiomyopathy in the follow up, a more pronounced beta 1-AAB positivity became visible in the DoCM group (p = 0.066). Total and cardiac mortality were higher in beta 1-AAB positive DP (p = 0.002; p = 0037). The dogs' beta 1-AAB recognized a specific epitope on the second extracellular receptor and were sensitive to inhibition by drugs already successfully tested to inhibit the corresponding human autoantibody. Conclusions Doberman Pinschers presented beta 1-AAB associated autoimmunity, similar as in the pathogenesis of human DCM. Consequently, DP could compensate the lack of animal models for the investigation of beta 1-AAB autoimmunity in human DCM.	[Wess, Gerhard; Fritscher, Anna] Ludwig Maximilians Univ Munchen, Clin Small Anim Med, Munich, Germany; [Wallukat, Gerd; Becker, Niels-Peter; Wenzel, Katrin; Mueller, Johannes; Schimke, Ingolf] Berlin Cures GmbH, Berlin, Germany	University of Munich	Schimke, I (corresponding author), Berlin Cures GmbH, Berlin, Germany.	schimke@berlincures.de						Bartsch H, 2017, WILEY SER MATER ELEC, P653; Becker NP, 2017, AUTOIMMUN REV, V16, P269, DOI 10.1016/j.autrev.2017.01.012; Becker NP, 2019, FRONTIERS BIOSCIENCE, V24, P14; Bornholz B, 2017, HEART RHEUMATOLOGIC, P49; Caforio ALP, 2008, AUTOIMMUNITY, V41, P35, DOI 10.1080/08916930701619235; Caforio ALP, 2013, HEART FAIL REV, V18, P715, DOI 10.1007/s10741-012-9364-5; CALVERT CA, 1986, COMP CONT EDUC PRACT, V8, P417; Calvert CA, 2009, CURRENT VET THERAPY, P800; Camacho P, 2016, AM J CARDIOVASC DIS, V6, P70; Charron P, 2018, EUR HEART J, V39, P1784, DOI 10.1093/eurheartj/ehx819; Dandel M, 2012, EUR J HEART FAIL, V14, P1374, DOI 10.1093/eurjhf/hfs123; FU LX, 1993, J CLIN INVEST, V91, P1964, DOI 10.1172/JCI116416; Fu MLX, 1996, INT J CARDIOL, V54, P127, DOI 10.1016/0167-5273(96)02589-2; Geraghty NK, 2011, THESIS; Haberland A, 2016, EUR J PHARMACOL, V789, P37, DOI 10.1016/j.ejphar.2016.06.061; Haberland A, 2014, MOL CELL BIOCHEM, V393, P177, DOI 10.1007/s11010-014-2057-8; Haberland A, 2011, CIRC RES, V109, P986, DOI 10.1161/CIRCRESAHA.111.253849; Hamlin RL, 2007, PHARMACOL THERAPEUT, V113, P276, DOI 10.1016/j.pharmthera.2006.08.006; Hensley MT, 2017, J CELL MOL MED, V21, P1503, DOI 10.1111/jcmm.13077; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Iwata M, 2001, J AM COLL CARDIOL, V37, P418, DOI 10.1016/S0735-1097(00)01109-8; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; Lopes R, 2006, AM J VET RES, V67, P963, DOI 10.2460/ajvr.67.6.963; MAGNUSSON Y, 1990, J CLIN INVEST, V86, P1658, DOI 10.1172/JCI114888; Matsui S, 1999, J Card Fail, V5, P246, DOI 10.1016/S1071-9164(99)90009-X; Mausberg TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020042; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Meurs KM, 2007, J VET INTERN MED, V21, P1016, DOI 10.1892/0891-6640(2007)21[1016:APGEOF]2.0.CO;2; Milani-Nejad N, 2014, J MUSCLE RES CELL M, V35, P225, DOI 10.1007/s10974-014-9386-9; Mueller J, 2018, J AM COLL CARDIOL, V71, P645, DOI 10.1016/S0735-1097(18)31186-0; Nikolaev VO, 2007, J AM COLL CARDIOL, V50, P423, DOI 10.1016/j.jacc.2007.03.051; Nussinovitch U, 2010, HEART, V96, P1518, DOI 10.1136/hrt.2010.195255; Nussinovitch U, 2012, CLIN REV ALLERG IMMU, V42, P298, DOI 10.1007/s12016-010-8235-x; O'Grady MR, 2008, J VET INTERN MED, V22, P897, DOI 10.1111/j.1939-1676.2008.0116.x; O'Grady MR, 2004, VET CLIN N AM-SMALL, V34, P1187, DOI 10.1016/j.cvsm.2004.05.009; Owczarek-Lipska M, 2013, ANIM GENET, V44, P239, DOI 10.1111/j.1365-2052.2012.02396.x; Palm D, 2007, patent, Patent No. [EP1866335 (A2), WO2006103101 (A2), 2006103101]; Pei JH, 2012, EUR J HEART FAIL, V14, P887, DOI 10.1093/eurjhf/hfs082; Petric A Domanjko, 2002, J Vet Cardiol, V4, P17, DOI 10.1016/S1760-2734(06)70019-4; Recchia FA, 2007, VET RES COMMUN, V31, P35, DOI 10.1007/s11259-007-0005-8; Satta N, 2015, CURR DRUG TARGETS, V16, P342, DOI 10.2174/1389450115666141125122416; Schimke I, 2012, Aptamers that inhibit interaction between antibody and 2nd extracellular loop of human beta-1-adrenergic receptor, Patent No. [WO 2012000889, 2012000889]; Schimke I, 2012, Patent No. [WO 2012119938 A2, 2012119938]; SMUCKER ML, 1990, J AM COLL CARDIOL, V16, P200, DOI 10.1016/0735-1097(90)90480-D; Stork S, 2006, AM HEART J, V152, P697, DOI 10.1016/j.ahj.2006.05.004; Tidholm A, 1997, J AM ANIM HOSP ASSOC, V33, P544, DOI 10.5326/15473317-33-6-544; Wallukat G, 2000, HERZ, V25, P261, DOI 10.1007/s000590050017; WALLUKAT G, 1995, J MOL CELL CARDIOL, V27, P397, DOI 10.1016/S0022-2828(08)80036-3; Wallukat G, 2002, NEW ENGL J MED, V347, P1806, DOI 10.1056/NEJM200211283472220; WALLUKAT G, 1987, BIOMED BIOCHIM ACTA, V46, pS634; Wallukat G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192778; Wallukat G, 2016, ATHEROSCLEROSIS, V244, P44, DOI 10.1016/j.atherosclerosis.2015.11.001; Wallukat G, 2010, J AM COLL CARDIOL, V55, P463, DOI 10.1016/j.jacc.2009.06.064; Wang LF, 2015, J INTERN MED, V278, P369, DOI 10.1111/joim.12395; Wenzel K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192615; Wess G, 2017, J VET CARDIOL, V19, P405, DOI 10.1016/j.jvc.2017.08.006; Wess G, 2010, J VET INTERN MED, V24, P533, DOI 10.1111/j.1939-1676.2010.0479.x	57	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0214263	10.1371/journal.pone.0214263	http://dx.doi.org/10.1371/journal.pone.0214263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276517	Green Published, gold, Green Submitted			2022-12-26	WOS:000484936300005
J	Abbas, UL; Glaubius, RL; Ding, YJ; Hood, G				Abbas, Ume L.; Glaubius, Robert L.; Ding, Yajun; Hood, Gregory			Drug resistance from preferred antiretroviral regimens for HIV infection in South Africa: A modeling study	PLOS ONE			English	Article							DISCRETE-EVENT SIMULATION; SUB-SAHARAN AFRICA; FOLLOW-UP; PREEXPOSURE PROPHYLAXIS; STOCHASTIC SIMULATION; VIROLOGICAL OUTCOMES; THERAPY PROGRAM; NATIONAL-SURVEY; PERSISTENCE; PREVENTION	Background Tenofovir-containing regimens comprise the preferred first-line antiretroviral therapy (ART) in many countries including South Africa, where utilization of second-line regimens is limited. Considerable HIV drug resistance has occurred among persons failing tenofovir-containing first-line ART. We evaluated drug resistance at the population level using mathematical modeling. Setting Heterosexual HIV epidemic in KwaZulu-Natal, South Africa. Methods We constructed a stochastic individual-based model and simulated scenarios of ART implementation, either CD4-based (threshold < 500 cells/mL) or Fast-track (81% coverage by 2020), with consideration of major drug-associated mutations (M184V, K65R and non-nucleoside reverse transcriptase inhibitor (NNRTI)). Using base case and uncertainty analyses, we assessed (majority) drug resistance levels. Results By 2030, the median total resistance (proportion of HIV-infected persons with drug resistance) is predicted to reach 31.4% (interquartile range (IQR): 16.5%-50.2%) with CD4-based ART, decreasing to 14.5% (IQR: 7.7%-25.8%) with Fast-track implementation. In both scenarios, we find comparably high prevalence (similar to 80%) of acquired NNRTI-associated, M184V and K65R mutations. Over 48% of individuals with acquired resistance harbor dual, 44% triple and 7% just single drug mutations. Drug-resistant HIV is predicted to comprise 40% (IQR: 27%-50%) of incident infections, while 70% of prevalent transmitted resistance is NNRTI-associated. At 2018, the projected total resistance is 15% (IQR: 7.5%-25%), with 18% (IQR: 13%-24%) of incident infections from transmitted drug-resistant HIV. Conclusions WHO-recommended preferred first-line ART could lead to substantial drug resistance. Effective surveillance of HIV drug resistance and utilization of second-line as well as alternative first-line regimens is crucial.	[Abbas, Ume L.; Ding, Yajun] Baylor Coll Med, Sect Infect Dis, Dept Med, Houston, TX 77030 USA; [Abbas, Ume L.; Ding, Yajun] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Abbas, Ume L.; Glaubius, Robert L.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Abbas, Ume L.; Glaubius, Robert L.] Cleveland Clin, Dept Infect Dis, Cleveland, OH 44106 USA; [Hood, Gregory] Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA; [Glaubius, Robert L.] Avenir Hlth, Glastonbury, CT USA; [Ding, Yajun] PROS Holdings Inc, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Abbas, UL (corresponding author), Baylor Coll Med, Sect Infect Dis, Dept Med, Houston, TX 77030 USA.; Abbas, UL (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Abbas, UL (corresponding author), Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA.; Abbas, UL (corresponding author), Cleveland Clin, Dept Infect Dis, Cleveland, OH 44106 USA.	ume.abbase@bcm.edu	Abbas, Ume/AAW-4590-2021	Abbas, Ume/0000-0002-2075-3179	Bill and Melinda Gates Foundation [OPP1005974]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by a grant (OPP1005974) from the Bill and Melinda Gates Foundation awarded to U.L.A.	Abbas UL, 2013, J INFECT DIS, V208, P224, DOI 10.1093/infdis/jit150; Aghokeng AF, 2014, CLIN INFECT DIS, V58, P99, DOI 10.1093/cid/cit627; [Anonymous], 2017, UNAIDS DAT 2017; [Anonymous], 2016, LANCET INFECT DIS, V16, P565, DOI [10.1016/S1473-3099(15)00536-8, DOI 10.1016/S1473-3099(15)00536-8]; Arlinghaus S. L., 1994, PRACTICAL HDB CURVE; Banks J, 2009, DISCRETE EVENT SYSTE, V5th; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Boender TS, 2016, J ANTIMICROB CHEMOTH, V71, P2918, DOI 10.1093/jac/dkw218; Boyd MA, 2015, LANCET HIV, V2, pE42, DOI 10.1016/S2352-3018(14)00061-7; Carlson JM, 2014, SCIENCE, V345, DOI 10.1126/science.1254031; Castro H, 2013, J INFECT DIS, V208, P1459, DOI 10.1093/infdis/jit345; Chick SE, 2000, MATH BIOSCI, V166, P45, DOI 10.1016/S0025-5564(00)00028-6; Chimukangara B, 2019, AIDS RES HUM RETROV, V35, P129, DOI [10.1089/AID.2018.0202, 10.1089/aid.2018.0202]; Clouse K, 2013, AIDS, V27, P645, DOI 10.1097/QAD.0b013e32835c12f9; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Deeks SG, 2005, J INFECT DIS, V192, P1537, DOI 10.1086/496892; Dorward P, 2018, LANCET HIV, V5, pE400, DOI 10.1016/S2352-3018(18)30093-6; Fox MP, 2010, JAIDS-J ACQ IMM DEF, V53, P500, DOI 10.1097/QAI.0b013e3181bcdac1; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Glaubius R, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25282; Glaubius RL, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw125; Glaubius RL, 2016, CLIN INFECT DIS, V63, P539, DOI 10.1093/cid/ciw321; Glynn P. W., 1983, 1983 Winter Simulation Conference Proceedings, P39; Grimsrud AT, 2013, J CLIN EPIDEMIOL, V66, P1006, DOI 10.1016/j.jclinepi.2013.03.013; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Hamers RL, 2012, LANCET INFECT DIS, V12, P307, DOI 10.1016/S1473-3099(11)70255-9; Han YS, 2016, INFECT GENET EVOL, V46, P286, DOI 10.1016/j.meegid.2016.06.047; Hosseinipour MC, 2013, J INFECT DIS, V207, pS49, DOI 10.1093/infdis/jit107; Hunt GM, 2012, CLIN INFECT DIS, V54, pS334, DOI 10.1093/cid/cir1017; Hunt GM, 2017, J ANTIMICROB CHEMOTH, V72, P3141, DOI 10.1093/jac/dkx252; Ingalls RG, 2013, WINT SIMUL C PROC, P291, DOI 10.1109/WSC.2013.6721428; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Johnston V, 2014, J INFECT DIS, V209, P711, DOI 10.1093/infdis/jit411; Kadanoff LP, 2009, J STAT PHYS, V137, P777, DOI 10.1007/s10955-009-9814-1; Karnon J, 2012, MED DECIS MAKING, V32, P701, DOI 10.1177/0272989X12455462; Koopman JS, 2001, ANN NY ACAD SCI, V954, P268; La Rosa AM, 2016, LANCET HIV, V3, pE247, DOI 10.1016/S2352-3018(16)30011-X; Law A. M., 2000, SIMULATION MODELING; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; Mahy M, 2010, SEX TRANSM INFECT, V86, pI28, DOI 10.1136/sti.2010.044255; Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Mehta SD, 2013, AIDS, V27, P2899, DOI 10.1097/01.aids.0000432444.30308.2d; MILLER DK, 1994, MED DECIS MAKING, V14, P52, DOI 10.1177/0272989X9401400107; Moorhouse M, 2019, JAIDS-J ACQ IMM DEF, V80, P73, DOI 10.1097/QAI.0000000000001883; Moorhouse Michelle A., 2018, South. Afr. j. HIV med. (Online), V19, P1, DOI 10.4102/sajhivmed.v19i1.917; Moyo S, 2019, C RETR OPP INF CROI; Nichols BE, 2014, AIDS, V28, P73, DOI 10.1097/01.aids.0000433239.01611.52; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Paquet AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014638; Parboosing R, 2011, J MED VIROL, V83, P1508, DOI 10.1002/jmv.22143; Parikh UM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059787; Paton NI, 2017, LANCET HIV, V4, pE341, DOI 10.1016/S2352-3018(17)30065-6; Phillips AN, 2019, LANCET HIV, V6, pE116, DOI 10.1016/S2352-3018(18)30317-5; Phillips AN, 2018, LANCET HIV, V5, pE146, DOI 10.1016/S2352-3018(17)30190-X; Phillips AN, 2017, J INFECT DIS, V215, P1362, DOI 10.1093/infdis/jix089; Raftery AE, 2010, BIOMETRICS, V66, P1162, DOI 10.1111/j.1541-0420.2010.01399.x; Rhee SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145772; Samuel R, 2016, JAIDS-J ACQ IMM DEF, V73, P384, DOI 10.1097/QAI.0000000000001116; Shisana O, 2014, S AFRICAN NATL HIV P; Simon PL, 2013, IMA J APPL MATH, V78, P945, DOI 10.1093/imamat/hxs001; Smith S., 2017, DOLUTEGRAVIR TLD ROL; South Africa National AIDS Council, 2012, NAT STRAT PLAN HIV S; South Africa National AIDS Council (SANAC), 2017, LET OUR ACT COUNT S; South African National Department of Health, 2014, NAT CONS GUID PREV M; Steegen K, 2017, J ANTIMICROB CHEMOTH, V72, P210, DOI 10.1093/jac/dkw358; Steegen K, 2016, J INFECT DIS, V214, P1826, DOI 10.1093/infdis/jiw491; Steegen K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166305; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Stroustrup B., 2013, C PROGRAMMING LANGUA; The Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK END AIDS; Trignetti M, 2009, AIDS RES HUM RETROV, V25, P57, DOI 10.1089/aid.2008.0159; UNAIDS, 2017, END AIDS PROGR 90 90; UNAIDS, 2015, UND FAST TRACK; Wagner BG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041212; WHO, 2012, WHO HIV DRUG RES REP; Wijting I, 2017, LANCET HIV, V4, pE547, DOI 10.1016/S2352-3018(17)30152-2; Wirden M, 2004, ANTIMICROB AGENTS CH, V48, P644, DOI 10.1128/AAC.48.2.644-647.2004; World Health Organisation (WHO), 2017, GUID PUBL HLTH RESP; World Health Organisation (WHO), 2017, HIV DRUG RES REP 201; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2017, SUPPL 2016 CONS GUID; World Health Organization (WHO), 2017, GLOB ACT PLAN HIV DR; Xu HT, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-14; Yucesan E., 1992, ACM Transactions on Modeling and Computer Simulation, V2, P82, DOI 10.1145/132277.132281; Zeigler B., 1984, MULTIFACETTED MODELL; Zeigler B.P., 1976, THEORY MODELING SIMU; Zeigler BP, 2017, IFAC PAPERSONLINE, V50, P3039, DOI 10.1016/j.ifacol.2017.08.672	91	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0218649	10.1371/journal.pone.0218649	http://dx.doi.org/10.1371/journal.pone.0218649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269034	gold, Green Published, Green Submitted			2022-12-26	WOS:000484927300020
J	Mukai, N; Nakayama, Y; Ishi, S; Murakami, T; Ogawa, S; Kageyama, K; Murakami, S; Sasada, Y; Yoshioka, J; Nakajima, Y				Mukai, Nobuhiro; Nakayama, Yoshinobu; Ishi, Sachiyo; Murakami, Takayuki; Ogawa, Satoru; Kageyama, Kyoko; Murakami, Satoshi; Sasada, Yuji; Yoshioka, Jun; Nakajima, Yasufumi			Cold storage conditions modify microRNA expressions for platelet transfusion	PLOS ONE			English	Article							MESSENGER-RNA; APHERESIS PLATELETS; APOPTOSIS; BLOOD; TEMPERATURE; INFLAMMATION; BIOGENESIS; REACTIVITY	MicroRNAs (miRNAs) are small RNA molecules that modulate gene and protein expression in hematopoiesis. Platelets are known to contain a fully functional miRNA machinery. While platelets used for transfusion are normally stored at room temperature, recent evidence suggests more favorable effects under a cold-storage condition, including higher adhesion and aggregation properties. Thus, we sought to determine whether functional differences in platelets are associated with the differential profiling of platelet miRNA expressions. To obtain the miRNA expression profile, next-generation sequencing was performed on human platelets obtained from 10 healthy subjects. The miRNAs were quantified after being stored in three different conditions: 1) baseline (before storage), 2) stored at 22 degrees C with agitation for 72 h, and 3) stored at 4 degrees C for 72 h. Following the identification of miRNAs by sequencing, the results were validated at the level of mature miRNAs from 18 healthy subjects, by using quantitative polymerase chain reaction (qPCR). Differential expression was observed for 125 miRNAs that were stored at 4 degrees C and 9 miRNAs stored at 22 degrees C as compared to the baseline. The validation study by qPCR confirmed that storage at 4 degrees C increased the expression levels (fold change 95% CI) of mir-20a-5p (1.87, p<0.0001), mir-10a-3p (1.88, p<0.0001), mir-16-2-3p (1.54, p<0.01), and mir-223-5p (1.38, p<0.05), compared with those of the samples stored at 22 degrees C. These results show that miRNAs correlate with platelet quality under specific storage conditions. The data indicate that miRNAs could be potentially used as biomarkers of platelet quality.	[Mukai, Nobuhiro; Nakayama, Yoshinobu; Ishi, Sachiyo; Murakami, Takayuki; Ogawa, Satoru] Kyoto Prefectural Univ Med, Dept Anesthesiol & Crit Care, Kyoto, Japan; [Nakayama, Yoshinobu; Yoshioka, Jun] CUNY City Coll, Sch Med, Dept Mol Cellular & Biomed Sci, New York, NY 10031 USA; [Kageyama, Kyoko] Otokoyama Hosp, Dept Anesthesiol, Kyoto, Japan; [Murakami, Satoshi] Life Technol Japan Ltd, Life Solut Grp, Thermo Fisher Sci, Tokyo, Japan; [Sasada, Yuji] Kyoto Prefectural Univ Med, Dept Transfus Med & Cell Therapy, Kyoto, Japan; [Nakajima, Yasufumi] Kansai Med Univ, Dept Anesthesiol & Crit Care, Osaka, Japan; [Nakajima, Yasufumi] Outcomes Res Consortium, Cleveland, OH USA	Kyoto Prefectural University of Medicine; City University of New York (CUNY) System; City College of New York (CUNY); Thermo Fisher Scientific; Kyoto Prefectural University of Medicine; Kansai Medical University	Nakayama, Y (corresponding author), Kyoto Prefectural Univ Med, Dept Anesthesiol & Crit Care, Kyoto, Japan.; Nakayama, Y (corresponding author), CUNY City Coll, Sch Med, Dept Mol Cellular & Biomed Sci, New York, NY 10031 USA.	na-yoshi@koto.kpu-m.ac.jp	Nakayama, Yoshinobu/GNO-9970-2022		Japanese Ministry of Education, Culture, Sports, Science and Technology [17K11093, 18K16457]; Philip V. & Anna S Brown Foundation; LaRue S. Fisher and Walter F. Fisher Memorial Trust; Bank of America, N. A., Trustee; NIH [1R01HL130861]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130861] Funding Source: NIH RePORTER	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Philip V. & Anna S Brown Foundation; LaRue S. Fisher and Walter F. Fisher Memorial Trust; Bank of America, N. A., Trustee; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (Nos. 17K11093, 18K16457) to Y. Nakayama and S. Ishii. This work was also supported by awards from the Philip V. & Anna S Brown Foundation, the LaRue S. Fisher and Walter F. Fisher Memorial Trust, and Bank of America, N. A., Trustee, and a NIH grant 1R01HL130861 to J. Yoshioka.	Abdelmohsen K, 2012, AGEING RES REV, V11, P491, DOI 10.1016/j.arr.2012.01.003; Bauersachs J, 2011, CIRC RES, V109, P334, DOI 10.1161/CIRCRESAHA.110.228676; Beppu S, 2009, ANESTHESIOLOGY, V111, P1227, DOI 10.1097/ALN.0b013e3181c155ce; Bray PF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-1; Brecher ME, 2013, TRANSFUSION, V53, P221, DOI 10.1111/j.1537-2995.2012.03708.x; Capocelli KE, 2014, CURR OPIN HEMATOL, V21, P491, DOI 10.1097/MOH.0000000000000081; Chen XJ, 2018, TRANSFUS MED HEMOTH, V45, P397, DOI 10.1159/000489321; Dahiya N, 2017, PLATELETS, V28, P74, DOI 10.1080/09537104.2016.1203405; Edelstein LC, 2013, NAT MED, V19, P1609, DOI 10.1038/nm.3385; Elgheznawy A, 2015, CIRC RES, V117, P157, DOI 10.1161/CIRCRESAHA.117.305784; Elling V, 2015, BULL INST MATH ACAD, V10; Frank D, 2012, J MOL CELL CARDIOL, V52, P711, DOI 10.1016/j.yjmcc.2011.12.001; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; Kannan M, 2009, TRANSFUSION, V49, P1443, DOI 10.1111/j.1537-2995.2009.02140.x; Kato M, 2013, AGEING RES REV, V12, P429, DOI 10.1016/j.arr.2012.03.012; Knight JE, 2000, MOL CELL BIOL, V20, P6374, DOI 10.1128/MCB.20.17.6374-6379.2000; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Landry P, 2009, NAT STRUCT MOL BIOL, V16, P961, DOI 10.1038/nsmb.1651; Leytin V, 2012, BLOOD REV, V26, P51, DOI 10.1016/j.blre.2011.10.002; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Metcalfe C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163006; Montgomery RK, 2013, TRANSFUSION, V53, P1520, DOI 10.1111/j.1537-2995.2012.03917.x; Mukai N, 2018, CRIT CARE MED, V46, pE761, DOI 10.1097/CCM.0000000000003197; Mukai N, 2018, PEDIATR RES, V83, P866, DOI 10.1038/pr.2017.327; MURPHY S, 1969, NEW ENGL J MED, V280, P1094, DOI 10.1056/NEJM196905152802004; MURPHY S, 1976, TRANSFUSION, V16, P2; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720; Pidcoke HF, 2014, SHOCK, V41, P51, DOI 10.1097/SHK.0000000000000078; Pilotte J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028446; Pontes TB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129399; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Reddoch KM, 2014, SHOCK, V41, P54, DOI 10.1097/SHK.0000000000000082; Sharma S, 2011, AM FAM PHYSICIAN, V83, P719; Stec DE, 2007, RENAL FAILURE, V29, P543, DOI 10.1080/08860220701391878; Stroncek DF, 2007, LANCET, V370, P427, DOI 10.1016/S0140-6736(07)61198-2; Sunderland N, 2017, CIRC RES, V120, P418, DOI 10.1161/CIRCRESAHA.116.309303; Teruel-Montoya R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102259; VALERI CR, 1974, NEW ENGL J MED, V290, P353, DOI 10.1056/NEJM197402142900702; van der Wal DE, 2010, J THROMB HAEMOST, V8, P2554, DOI 10.1111/j.1538-7836.2010.04043.x; van der Wal DE, 2012, HAEMATOL-HEMATOL J, V97, P1514, DOI 10.3324/haematol.2011.059956; Vojtechova Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179645; Yu SF, 2014, BLOOD TRANSFUS-ITALY, V12, P541, DOI 10.2450/2014.0291-13; Zhang ZP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111873	44	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0218797	10.1371/journal.pone.0218797	http://dx.doi.org/10.1371/journal.pone.0218797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269049	Green Submitted, Green Published, gold			2022-12-26	WOS:000484927300026
J	Zhang, L; Chen, XM; Sindreu, C; Lu, S; Storm, DR; Zweifel, LS; Xia, ZG				Zhang, Liang; Chen, Xuanmao; Sindreu, Carlos; Lu, Song; Storm, Daniel R.; Zweifel, Larry S.; Xia, Zhengui			Dynamics of a hippocampal neuronal ensemble encoding trace fear memory revealed by in vivo Ca2+ imaging	PLOS ONE			English	Article							DORSAL HIPPOCAMPUS; SINGLE NEURONS; CA1; INVOLVEMENT; EXTINCTION; MECHANISMS; EXPRESSION; RETRIEVAL; BRAIN; LONG	Although the biochemical signaling events in area CA1 of the hippocampus underlying memory acquisition, consolidation, retrieval, and extinction have been extensively studied, little is known about the activity dynamics of hippocampal neurons in CA1 during Pavlovian fear conditioning. Here, we use fiber-optic confocal microscopy coupled with the calcium indicator GCaMP6m to monitor neuron activity in freely moving mice during trace fear conditioning. We show that the activity of a group of CA1 neurons increases not only after the stimulus presentations, but also during the stimulus-free trace period when the conditioned mice exhibit a high level of freezing behavior. Therefore, we designate these cells "trace cells". Interestingly, the activity of the trace cells increases in response to the conditioned stimuli during memory retrieval but diminishes during memory extinction. Importantly, the dynamics of neuron activity exhibit a high degree of correlation with the freezing behavior of the mice, suggesting that a neuronal ensemble responsible for encoding the trace fear memory is repeatedly reactivated during memory retrieval and later extinguished during memory extinction.	[Zhang, Liang; Lu, Song; Xia, Zhengui] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Chen, Xuanmao; Sindreu, Carlos; Storm, Daniel R.; Zweifel, Larry S.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Zweifel, Larry S.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Xia, ZG (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	zxia@uw.edu	; sindreu, carlos/D-3901-2014	Chen, Xuanmao/0000-0002-0057-8510; Zhang, Liang/0000-0003-0319-195X; sindreu, carlos/0000-0001-6730-8278	National Institutes of Health [T32 ES007032-37]; University of Washington Superfund Research Program - National Institute of Environmental Health Sciences [P42ES004696]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004696, T32ES007032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Superfund Research Program - National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (https://www.nih.gov/) Environmental Pathology/Toxicology training grant T32 ES007032-37 to L.Z., and the University of Washington Superfund Research Program funded by the National Institute of Environmental Health Sciences P42ES004696 to Z.X.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brzozka MM, 2013, BEHAV BRAIN RES, V237, P348, DOI 10.1016/j.bbr.2012.10.001; Burman MA, 2004, LEARN MEMORY, V11, P205, DOI 10.1101/lm.66004; CAI DJ, 2008, PMC, DOI DOI 10.1038/NATURE17955; Chen GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008256; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; Chowdhury N, 2005, BEHAV NEUROSCI, V119, P1396, DOI 10.1037/0735-7044.119.5.1396; Dunsmoor JE, 2015, NEURON, V88, P47, DOI 10.1016/j.neuron.2015.09.028; Gershman SJ, 2012, LEARN BEHAV, V40, P255, DOI 10.3758/s13420-012-0080-8; Gershman SJ, 2010, PSYCHOL REV, V117, P197, DOI 10.1037/a0017808; Gilmartin MR, 2012, NEUROBIOL LEARN MEM, V97, P452, DOI 10.1016/j.nlm.2012.03.009; Gilmartin MR, 2005, BEHAV NEUROSCI, V119, P164, DOI 10.1037/0735-7044.119.1.164; GUIMARAIS M, 2011, FRONT BEHAV NEUROSCI, V5, DOI DOI 10.1371/JOURNAL.PONE.0015982; Guo WX, 2011, NAT MED, V17, P559, DOI 10.1038/nm.2336; Harnett NG, 2016, NEUROBIOL LEARN MEM, V136, P97, DOI 10.1016/j.nlm.2016.09.019; Hebb DO, 1949, WILEY; Hollon NG, 2014, P NATL ACAD SCI USA, V111, P18357, DOI 10.1073/pnas.1419770111; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; Kaczorowski CC, 2011, NEUROBIOL AGING, V32, P1452, DOI 10.1016/j.neurobiolaging.2009.09.003; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Kwapis JL, 2017, NEUROPSYCHOPHARMACOL, V42, P1688, DOI 10.1038/npp.2017.23; Kwapis JL, 2011, LEARN MEMORY, V18, P728, DOI 10.1101/lm.023945.111; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; McEchron MD, 2003, J NEUROSCI, V23, P1535, DOI 10.1523/JNEUROSCI.23-04-01535.2003; Misane I, 2005, HIPPOCAMPUS, V15, P418, DOI 10.1002/hipo.20067; Modi MN, 2014, ELIFE, V3, DOI 10.7554/eLife.01982; PAVLOV IP, 1927, PRESS, V430, DOI DOI 10.1101/LM.614807; PMID, PMC, DOI DOI 10.7554/ELIFE.14321; PMID, PMC, DOI DOI 10.1016/J.NLM.2012.03.009; PMID, PMC, DOI DOI 10.1101/LM.023945.111; PMID, PMC, DOI DOI 10.1038/NATURE17955; Quinn JJ, 2008, LEARN MEMORY, V15, P368, DOI 10.1101/lm.813608; Raybuck JD, 2014, BEHAV PROCESS, V101, P103, DOI 10.1016/j.beproc.2013.08.016; Raybuck JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015982; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; SHAN KQ, 2016, ELIFE, V5, DOI DOI 10.7554/ELIFE; Smith DR, 2007, LEARN MEMORY, V14, P597, DOI 10.1101/lm.614807; Zamorano C, 2018, NEUROSCIENCE, V370, P101, DOI 10.1016/j.neuroscience.2017.03.034	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219152	10.1371/journal.pone.0219152	http://dx.doi.org/10.1371/journal.pone.0219152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4CE	31269057	Green Submitted, Green Published, gold			2022-12-26	WOS:000484927300046
J	Masonjones, HD; Rose, E				Masonjones, Heather D.; Rose, Emily			When more is not merrier: Using wild population dynamics to understand the effect of density on ex situ seahorse mating behaviors	PLOS ONE			English	Article							HIPPOCAMPUS-GUTTULATUS; AUSTRALIAN SEAHORSE; STOCKING DENSITY; ENVIRONMENTAL ENRICHMENT; SOCIAL PROMISCUITY; DWARF SEAHORSE; LIFE-HISTORY; PAIR BONDS; SPACE USE; GROWTH	Seahorses are considered one of the most iconic examples of a monogamous species in the animal kingdom. This study investigates the relationship between stocking density and mating and competitive behavior from the context of the field biology of the dwarf seahorse, Hippocampus zosterae (Jordan & Gilbert). Animals were housed in 38 liter tanks at a range of densities and sex ratios (from 2-8 animals per tank), and their reproductive and other social behaviors were monitored from tank introduction through copulation. At low tank densities and even sex ratios but comparatively high field densities, frequency of both mating and competitive behaviors was low in trials. A higher level of males in tanks across all densities increased competition, activity levels, and aggression leading to egg transfer errors and brood expulsion, resulting in lower reproductive success. Across seahorse species, mean and maximum wild densities were consistently lower than those used in ex situ breeding, with adult sex ratios that were significantly female biased. However, significant variation exists in wild seahorse densities across species, with higher densities detected in focal/mark recapture studies and on artificial habitat structures than reported with belt transect sampling techniques. Interchange of knowledge gained in both aquarium and wild contexts will allow us to better understand the biology of this genus, and improve reproduction in captivity. Interpreting ex situ reproductive behaviors of seahorses within various densities reported from natural populations will help us predict the impact of conservation efforts and increase the likelihood of long-term persistence of populations for this threatened genus.	[Masonjones, Heather D.; Rose, Emily] Univ Tampa, Biol Dept, Tampa, FL 33606 USA; [Masonjones, Heather D.] Tufts Univ, Dept Biol, Boston, MA 02111 USA	University of Tampa; Tufts University	Masonjones, HD (corresponding author), Univ Tampa, Biol Dept, Tampa, FL 33606 USA.; Masonjones, HD (corresponding author), Tufts Univ, Dept Biol, Boston, MA 02111 USA.	hmasonjones@ut.edu		Mason, Heather/0000-0001-7171-2919; Rose, Emily/0000-0002-8794-1887				Aylesworth L, 2017, ANIM CONSERV, V20, P444, DOI 10.1111/acv.12332; Bell EM, 2003, ENVIRON BIOL FISH, V67, P35, DOI 10.1023/A:1024440717162; Claassens L, 2018, J FISH BIOL, V92, P2000, DOI 10.1111/jfb.13639; Claassens L, 2018, ENVIRON BIOL FISH, V101, P723, DOI 10.1007/s10641-018-0732-4; Colson DJ, 1998, ENVIRON BIOL FISH, V51, P221, DOI 10.1023/A:1007434714122; Correia M, 2018, ENVIRON BIOL FISH, V101, P1357, DOI 10.1007/s10641-018-0782-7; Correia M, 2015, J EXP MAR BIOL ECOL, V471, P1, DOI 10.1016/j.jembe.2015.05.012; Cunha M, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1335; Curtis JMR, 2006, J FISH BIOL, V68, P707, DOI 10.1111/j.0022-1112.2006.00952.x; Dzyuba B, 2006, J EXP BIOL, V209, P3055, DOI 10.1242/jeb.02336; El Balaa R, 2011, J APPL ICHTHYOL, V27, P1052, DOI 10.1111/j.1439-0426.2011.01740.x; Faleiro F, 2008, AQUACULTURE, V282, P33, DOI 10.1016/j.aquaculture.2008.05.038; Faleiro F, 2013, J SEA RES, V78, P85, DOI 10.1016/j.seares.2012.10.014; Fedrizzi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132308; Fiedler K., 1954, Zeitschrift fuer Tierpsychologie, V11, P358; Foster SJ, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00429.x; Garner JP, 2005, ILAR J, V46, P106, DOI 10.1093/ilar.46.2.106; Harasti D, 2016, MAR ECOL PROG SER, V546, P173, DOI 10.3354/meps11619; Horinouchi M, 2005, ESTUAR COAST SHELF S, V65, P53, DOI 10.1016/j.ecss.2005.05.003; Jones AG, 1998, MOL ECOL, V7, P1497, DOI 10.1046/j.1365-294x.1998.00481.x; Koerber AS, 2009, J AM ASSOC LAB ANIM, V48, P65; KUMAR A, 1993, PHYSIOL BEHAV, V54, P1169, DOI 10.1016/0031-9384(93)90343-E; Kvarnemo C, 2000, J EVOLUTION BIOL, V13, P882, DOI 10.1046/j.1420-9101.2000.00228.x; Kvarnemo C, 2007, P ROY SOC B-BIOL SCI, V274, P521, DOI 10.1098/rspb.2006.3753; Lee JSF, 2008, J FISH BIOL, V72, P1736, DOI 10.1111/j.1095-8649.2008.01848.x; Lockyear Jacqueline, 1997, Aquarium Sciences and Conservation, V1, P129, DOI 10.1023/A:1018395803722; Lockyear Jacqueline F., 2006, African Journal of Aquatic Science, V31, P275, DOI 10.2989/16085910609503897; Lopez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117538; Martin-Smith KM, 2005, BIOL CONSERV, V123, P533, DOI 10.1016/j.biocon.2005.01.003; Martinez-Cardenas L, 2012, AQUAC RES, V43, P1536, DOI 10.1111/j.1365-2109.2011.02958.x; Masonjones H, 2017, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2017-3.RLTS.T10089A46910143.en, DOI 10.2305/IUCN.UK.2017-3.RLTS.T10089A46910143.EN]; Masonjones HD, 1996, COPEIA, P634, DOI 10.2307/1447527; Masonjones HD, 2000, ANIM BEHAV, V59, P11, DOI 10.1006/anbe.1999.1269; Masonjones HD, 2001, COMP BIOCHEM PHYS A, V129, P541, DOI 10.1016/S1095-6433(01)00291-4; Masonjones HD, 1997, SEXUAL SELECTION DWA; Masonjones HD, 2010, CURR ZOOL, V56, P118, DOI 10.1093/czoolo/56.1.118; MCARDLE BH, 1990, J ANIM ECOL, V59, P439, DOI 10.2307/4873; McCullough EL, 2018, EVOLUTION, V72, P893, DOI 10.1111/evo.13455; Moreau MA, 2004, MAR FRESHWATER RES, V55, P231, DOI 10.1071/MF03159; Murugan A, 2009, AQUACULTURE, V290, P87, DOI 10.1016/j.aquaculture.2009.01.033; Naud MJ, 2009, BEHAV ECOL, V20, P160, DOI 10.1093/beheco/arn128; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; Paczolt KA, 2010, NATURE, V464, P401, DOI 10.1038/nature08861; Palma J, 2008, AQUACULTURE, V278, P55, DOI 10.1016/j.aquaculture.2008.03.019; Perante NC, 2002, J FISH BIOL, V60, P821, DOI 10.1006/jfbi.2002.1878; Ratterman NL, 2009, ETHOLOGY, V115, P339, DOI 10.1111/j.1439-0310.2009.01619.x; Roberts EK, 2012, SCIENCE, V335, P1222, DOI 10.1126/science.1213600; Roberts LJ, 2011, BIOL CONSERV, V144, P1972, DOI 10.1016/j.biocon.2011.04.017; Rosa IL, 2007, NEOTROP ICHTHYOL, V5, P405, DOI 10.1590/S1679-62252007000300020; Rose E, 2014, J HERED, V105, P828, DOI 10.1093/jhered/esu050; Sagebakken G, 2010, P ROY SOC B-BIOL SCI, V277, P971, DOI 10.1098/rspb.2009.1767; SCHWAGMEYER PL, 1979, AM NAT, V114, P932, DOI 10.1086/283541; Simpson M, 2019, J FISH BIOL, V95, P555, DOI 10.1111/jfb.14002; Sogabe A, 2014, AQUACULTURE SCI, V62, P199; Sogabe A, 2008, BIOL LETTERS, V4, P362, DOI 10.1098/rsbl.2008.0157; STRAWN KIRK, 1958, COPEIA, V1958, P16, DOI 10.2307/1439534; Sutherland WJ, 2006, ECOLOGICAL CENSUS TECHNIQUES: A HANDBOOK, 2ND EDITION, P1, DOI 10.2277/ 0521606365; Vincent ACJ, 2011, J FISH BIOL, V78, P1681, DOI 10.1111/j.1095-8649.2011.03003.x; VINCENT ACJ, 1994, BEHAVIOUR, V128, P135, DOI 10.1163/156853994X00082; Vincent ACJ, 2005, ENVIRON BIOL FISH, V72, P1, DOI 10.1007/s10641-004-4192-7; Vincent ACJ, 2004, BEHAVIOUR, V141, P141, DOI 10.1163/156853904322890780; Vincent ACJ, 1995, ANIM BEHAV, V50, P1557, DOI 10.1016/0003-3472(95)80011-5; Wickins-Drazilova D, 2006, J AGR ENVIRON ETHIC, V19, P27, DOI 10.1007/s10806-005-4380-2; Wilson AB, 2007, MOL ECOL, V16, P2345, DOI 10.1111/j.1365-294X.2007.03243.x; Wong JM, 2003, AQUACULTURE, V228, P107, DOI 10.1016/S0044-8486(03)00320-X; Woodall LC, 2018, MAR BIOL, V165, DOI 10.1007/s00227-017-3274-y; Woodall LC, 2011, CONSERV GENET, V12, P1645, DOI 10.1007/s10592-011-0253-6; Woods CMC, 2003, AQUACULTURE, V218, P167, DOI 10.1016/S0044-8486(02)00202-8; Zar J.H., 2010, BIOSTAT ANAL; Zhang D, 2010, AQUAC RES, V42, P9, DOI 10.1111/j.1365-2109.2010.02482.x	70	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2019	14	7							e0218069	10.1371/journal.pone.0218069	http://dx.doi.org/10.1371/journal.pone.0218069			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3ZV	31265478	Green Published, gold, Green Submitted			2022-12-26	WOS:000484921200007
J	Guo, M; Ma, XY; Feng, YW; Han, SD; Dong, Q; Cui, M; Zhao, YX				Guo, Min; Ma, Xiaoye; Feng, Yiwei; Han, Sida; Dong, Qiang; Cui, Mei; Zhao, Yanxin			In chronic hypoxia, glucose availability and hypoxic severity dictate the balance between HIF-1 and HIF-2 in astrocytes	FASEB JOURNAL			English	Article						neuron apoptosis; hypoxic preconditioning; EPO; VEGF; iNOS	INDUCIBLE FACTOR-1-ALPHA; NEUROTROPHIC FACTOR; BRAIN-INJURY; ERYTHROPOIETIN; STROKE; EXPRESSION; PROTEINS; MOUSE; NEUROPROTECTION; NEUROGENESIS	Astrocyte function is an important contributor to cellular viability during brain hypoxia and ischemia. Levels of the hypoxia-inducible transcription factors (HIFs) HIF-1 and HIF-2 are increased in hypoxic conditions and impact the neuroprotective properties of astrocytes. For example, HIF-2 induces levels of erythropoietin (EPO), a neuroprotectant, by astrocytes. In contrast, HIF-1 activity in astrocytes diminishes the viability of neurons in cocultures during hypoxia. Thus, HIF-1 and HIF-2 may have opposing effects on astrocytes. In this study, we explore the balance of HIF-1 and HIF-2 signaling in astrocytes during chronic (1-7 d) hypoxia while altering the degree of hypoxia and glucose availability. In addition, we investigate the effects of these conditions on neuron apoptosis. During exposure to chronic moderate hypoxia (2% O-2) and plentiful glucose (10 mM), HIF-2 and EPO abundance increases from d 1 to 7. Similarly, pretreatment with moderate hypoxia markedly increases the abundance of HIF-2 and EPO when astrocytes are subsequently exposed to severe hypoxia (0.5% O-2; 24 h) in 10 mM glucose, which inhibits neuron apoptosis in coculture. Although HIF-1 targets the expression increase during the 7 d in chronic moderate hypoxia (2% O-2) and limited glucose (2 mM), further exposure to severe hypoxia (0.5% O-2; 24 h) induces a decrease of most HIF-1 targets in astrocytes. Notably, in astrocyte exposure to 2% O-2 prior to 0.5% O-2, the expression of iNOS, an HIF-1-regulated protein, keeps increasing when glucose is limited, whereas EPO and VEGF abundance is suppressed, inducing increased apoptosis of neurons in coculture under limited glucose (2 mM). Thus, both hypoxic severity and glucose abundance regulate the balance of HIF-1 and HIF-2 activity in astrocytes, leading to diverse effects on neurons. These results could have important implications on the adaptive or pathologic role of astrocytes during chronic hypoxia and ischemia.-Guo, M., Ma, X., Feng, Y., Han, S., Dong, Q., Cui, M., Zhao, Y. In chronic hypoxia, glucose availability and hypoxic severity dictate the balance between HIF-1 and HIF-2 in astrocytes.	[Guo, Min; Feng, Yiwei; Han, Sida; Cui, Mei] Fudan Univ, Huashan Hosp, Minist Educ, Frontiers Ctr Brain Sci,Dept Neurol, Shanghai, Peoples R China; [Ma, Xiaoye; Zhao, Yanxin] Fudan Univ, Huashan Hosp, State Key Lab Med Neurobiol, Frontiers Ctr Brain Sci,Dept Neurol,Minist Educ, Shanghai, Peoples R China; [Dong, Qiang] Tongji Univ, Peoples Hosp 10, Dept Neurol, Shanghai, Peoples R China	Fudan University; Fudan University; Tongji University	Cui, M (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, 12 Middle Urumqi Rd, Shanghai 200040, Peoples R China.; Zhao, YX (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Neurol, Sch Med, Shanghai 200072, Peoples R China.	cuimei@fudan.edu.cn; zhao_yanxin@126.com			National Natural Science Foundation of China [81870915, 81571109, 81571033]; Science and Technology Commission of Shanghai Municipality [16411970200, 18140901900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The authors thank Dr. Randall Johnson (University of California, San Diego, La Jolla, CA, USA) and Dr. M. Celeste Simon (University of Pennsylvania School of Medicine, Philadelphia, PA, USA) for permission to use the floxed HIF-1 alpha and -2 alpha mice, respectively. This study was supported by the National Natural Science Foundation of China (81870915, 81571109, and 81571033) and grants from the Science and Technology Commission of Shanghai Municipality (16411970200 and 18140901900). The authors declare no conflicts of interest.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Arai Ken, 2009, Exp Transl Stroke Med, V1, P6, DOI 10.1186/2040-7378-1-6; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brunelle JK, 2004, J BIOL CHEM, V279, P4305, DOI 10.1074/jbc.M312241200; Byts Nadiya, 2009, Exp Transl Stroke Med, V1, P4, DOI 10.1186/2040-7378-1-4; Chang YS, 2005, PEDIATR RES, V58, P106, DOI 10.1203/01.PDR.0000163616.89767.69; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Diaz Z, 2005, J NEUROCHEM, V93, P392, DOI 10.1111/j.1471-4159.2005.03038.x; Fernando MS, 2006, STROKE, V37, P1391, DOI 10.1161/01.STR.0000221308.94473.14; Fogal B, 2007, J NEUROSCI, V27, P10094, DOI 10.1523/JNEUROSCI.2459-07.2007; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Gonzalez FF, 2007, DEV NEUROSCI-BASEL, V29, P321, DOI 10.1159/000105473; GROTE J, 1981, PFLUG ARCH EUR J PHY, V391, P195, DOI 10.1007/BF00596170; Grote J, 1996, J AUTONOM NERV SYST, V57, P168, DOI 10.1016/0165-1838(95)00096-8; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; Harvey BK, 2003, EXP NEUROL, V183, P47, DOI 10.1016/S0014-4886(03)00080-3; Harvey BK, 2005, PHARMACOL THERAPEUT, V105, P113, DOI 10.1016/j.pharmthera.2004.09.003; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; Hirayama Y, 2017, GLIA, V65, P523, DOI 10.1002/glia.23109; Hirayama Y, 2015, J NEUROSCI, V35, P3794, DOI 10.1523/JNEUROSCI.4218-14.2015; Holmquist L, 2005, INT J CANCER, V116, P218, DOI 10.1002/ijc.21024; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Iwai M, 2007, STROKE, V38, P2795, DOI 10.1161/STROKEAHA.107.483008; Jelkmann W, 2004, INTERNAL MED, V43, P649, DOI 10.2169/internalmedicine.43.649; Li DD, 2005, EUR J NEUROSCI, V22, P1319, DOI 10.1111/j.1460-9568.2005.04335.x; Lin JHC, 2008, J NEUROSCI, V28, P681, DOI 10.1523/JNEUROSCI.3827-07.2008; Liu J, 2006, GLIA, V53, P360, DOI 10.1002/glia.20289; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Malhotra S, 2006, J NEUROSCI RES, V83, P19, DOI 10.1002/jnr.20705; Marti HH, 2004, J EXP BIOL, V207, P3233, DOI 10.1242/jeb.01049; MASUDA S, 1994, J BIOL CHEM, V269, P19488; METZGER H, 1977, PFLUG ARCH EUR J PHY, V370, P201, DOI 10.1007/BF00581695; Prass K, 2003, STROKE, V34, P1981, DOI 10.1161/01.STR.0000080381.76409.B2; Reitmeir R, 2011, BRAIN, V134, P84, DOI 10.1093/brain/awq344; Rempe DA, 2007, J BIOL CHEM, V282, P16187, DOI 10.1074/jbc.M702203200; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Ryan HE, 2000, CANCER RES, V60, P4010; Sheldon RA, 2009, DEV NEUROSCI-BASEL, V31, P452, DOI 10.1159/000232563; Smith EE, 2010, STROKE, V41, pS139, DOI 10.1161/STROKEAHA.110.596056; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Studer L, 2000, J NEUROSCI, V20, P7377; Trollmann R, 2009, BRAIN DEV-JPN, V31, P503, DOI 10.1016/j.braindev.2009.03.007; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; Vangeison G, 2008, J NEUROSCI, V28, P1988, DOI 10.1523/JNEUROSCI.5323-07.2008; Vangeison G, 2009, NEUROSCIENTIST, V15, P579, DOI 10.1177/1073858409332405; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; Zhao YX, 2011, J CEREBR BLOOD F MET, V31, P1412, DOI 10.1038/jcbfm.2010.230; Zhao YX, 2010, NEUROTHERAPEUTICS, V7, P439, DOI 10.1016/j.nurt.2010.07.004	55	15	16	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11123	11136		10.1096/fj.201900402RR	http://dx.doi.org/10.1096/fj.201900402RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31298941	Bronze			2022-12-26	WOS:000489166300046
J	Wan, S; van Der Veen, JN; N'Goma, JCB; Nelson, RC; Vance, DE; Jacobs, RL				Wan, Sereana; van Der Veen, Jelske N.; N'Goma, Jean-Claude Bakala; Nelson, Randal C.; Vance, Dennis E.; Jacobs, Rene L.			Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance	FASEB JOURNAL			English	Article						phosphatidylcholine; PC; PE ratio; IR; obesity; NAFLD	METABOLIC SYNDROME; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLCHOLINE; DISEASE; OBESITY; INFLAMMATION; METHYLATION; RATIO; MICE	Phosphatidylethanolamine (PE) N-methyltransferase (PEMT) accounts for similar to 30% of hepatic phosphatidylcholine (PC) biosynthesis. Pemt(-/-) mice fed a high-fat diet are protected against diet-induced obesity (DIO) and insulin resistance (IR) but develop nonalcoholic fatty liver disease (NAFLD) associated with a decreased PC:PE ratio. We investigated whether the lack of hepatic PEMT or the lack of PEMT in other tissues (where it is expressed at low levels) is responsible for or contributes to the protection against DIO and IR in Pemt(-/-) mice. Furthermore, we investigated whether decreasing PEMT expression with antisense oligonucleotides (ASOs) would result in metabolic benefits in both lean and obese mice without negatively impacting liver health. We both restored hepatic PEMT in Pemt(-/-) mice via adeno-associated virus delivery and decreased hepatic PEMT with ASOs in wild-type and ob/ob mice. Weight gain, insulin sensitivity, and indices of liver function were determined. We report that the protection against DIO and IR and the development of NAFLD is dependent on hepatic PEMT activity. NAFLD, associated with a significant decrease in the hepatic PC:PE ratio, was exacerbated by PEMT deficiency in obese mice, suggesting that phospholipid insufficiency promotes NAFLD progression during obesity or overnutrition. Hepatic PEMT is critical for maintaining phospholipid balance, which is crucial for a healthy liver.-Wan, S., van der Veen, J. N., Bakala N'Goma, J.-C., Nelson, R. C., Vance, D. E., Jacobs, R. L. Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance.	[Wan, Sereana; van Der Veen, Jelske N.; N'Goma, Jean-Claude Bakala; Nelson, Randal C.; Vance, Dennis E.; Jacobs, Rene L.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Jacobs, Rene L.] Univ Alberta, Dept Agr Food & Nutr Sci, 4002 E Li Ka Shing Ctr Hlth Res Innovat, Edmonton, AB T6G 2E1, Canada	University of Alberta; University of Alberta	Jacobs, RL (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, 4002 E Li Ka Shing Ctr Hlth Res Innovat, Edmonton, AB T6G 2E1, Canada.	rjacobs@ualberta.ca			Canadian Institutes of Health [MOP5182]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	The authors thank Susanne Lingrell (University of Alberta) for excellent technical assistance, and Ionis Pharmaceuticals (Carlsbad, CA, USA) for providing ASOs. The authors also thank Mark Graham (Ionis Pharmaceuticals) for important assistance and suggestions in these studies. This research was supported by a grant from the Canadian Institutes of Health (MOP5182). The authors declare no conflicts of interest.	Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; BLEISCH VR, 1952, AM J PATHOL, V28, P369; Castro AVB, 2014, ARQ BRAS ENDOCRINOL, V58, P600, DOI 10.1590/0004-2730000003223; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gaggini M, 2013, NUTRIENTS, V5, P1544, DOI 10.3390/nu5051544; Gao X, 2015, BBA-MOL BASIS DIS, V1852, P2689, DOI 10.1016/j.bbadis.2015.09.006; Gao X, 2015, BBA-MOL CELL BIOL L, V1851, P152, DOI 10.1016/j.bbalip.2014.11.006; Hartz CS, 2006, J NUTR, V136, P3005, DOI 10.1093/jn/136.12.3005; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lian JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25747; Ling J, 2012, HEPATOLOGY, V55, P1094, DOI 10.1002/hep.24782; Lu FB, 2018, EXPERT REV GASTROENT, V12, P491, DOI 10.1080/17474124.2018.1460202; Martinez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI 10.1002/hep.22159; Martinez-Una M, 2013, HEPATOLOGY, V58, P1296, DOI 10.1002/hep.26399; Oh MS, 2016, PEDIATR GASTROENTERO, V19, P199, DOI 10.5223/pghn.2016.19.3.199; Perfield JW, 2013, J OBES, V2013, DOI 10.1155/2013/296537; RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366; Schmitt J, 2015, LIVER INT, V35, P1133, DOI 10.1111/liv.12456; Sung KC, 2018, ATHEROSCLEROSIS, V275, P50, DOI 10.1016/j.atherosclerosis.2018.05.042; van der Veen JN, 2019, FASEB J, V33, P5045, DOI 10.1096/fj.201802117R; van der Veen JN, 2017, BBA-BIOMEMBRANES, V1859, P1558, DOI 10.1016/j.bbamem.2017.04.006; van der Veen JN, 2017, J LIPID RES, V58, P656, DOI 10.1194/jlr.M070631; van der Veen JN, 2016, AM J PHYSIOL-GASTR L, V310, pG526, DOI 10.1152/ajpgi.00243.2015; Vance DE, 2014, BBA-BIOMEMBRANES, V1838, P1477, DOI 10.1016/j.bbamem.2013.10.018; Watanabe M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092647; Yu RZ, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.26	29	18	18	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10986	10995		10.1096/fj.201900679R	http://dx.doi.org/10.1096/fj.201900679R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284753				2022-12-26	WOS:000489166300034
J	Wei, S; Zhou, HM; Wang, Q; Zhou, S; Li, CY; Liu, R; Qiu, JN; Shi, CY; Lu, L				Wei, Song; Zhou, Haoming; Wang, Qi; Zhou, Shun; Li, Changyong; Liu, Rui; Qiu, Jiannan; Shi, Chengyu; Lu, Ling			RIP3 deficiency alleviates liver fibrosis by inhibiting ROCK1-TLR4-NF-kappa B pathway in macrophages	FASEB JOURNAL			English	Article						CCl4; BDL; HFD; inflammation	HEPATIC STELLATE CELLS; PROTEIN-KINASE 3; KAPPA-B; INJURY; REGENERATION; INFLAMMATION; MOLECULES	Liver fibrosis is an important pathologic process in injured liver tissues. A protein kinase, receptor-interacting protein (RIP)3, plays a crucial role in mediating different diseases. However, the role of RIP3 in macrophages in liver fibrosis has not yet been studied. In our study, we found that RIP3 expression was up-regulated in liver tissues and macrophages of humans and mice with liver fibrosis. Absence of RIP3 in macrophages could alleviate inflammation and macrophage or neutrophil accumulation in mice after carbon tetrachloride (CCl4) or bile duct ligation (BDL) treatment. Importantly, RIP3 deficiency in macrophages could decrease CCl4-induced and BDL-induced liver fibrosis in mice. Moreover, RIP3 deficiency could inhibit the TLR4-NF-kappa B pathway through suppressing Rho-associated coiled-coil containing protein kinase (ROCK)1 in macrophages. To explore the connection of ROCK1 and RIP3 in macrophages of mice with liver fibrosis in vivo, ROCK1-overexpressed macrophages were infused to RIP3-deficient mice, which resulted in increased inflammation and liver fibrosis. In conclusion, our findings suggest that RIP3 plays a crucial proinflammatory role in liver fibrosis by regulating the ROCK1-TLR4-NF-kappa B signaling pathway in macrophages and therefore may be a potential therapeutic target for immune-mediated liver fibrosis.-Wei, S., Zhou, H., Wang, Q., Zhou, S., Li, C., Liu, R., Qiu, J., Shi, C., Lu, L. RIP3 deficiency alleviates liver fibrosis by inhibiting ROCK1-TLR4-NF-kappa B pathway in macrophages.	[Wei, Song; Lu, Ling] Southeast Univ, Sch Med, 87 Ding Jia Qiao Rd, Nanjing 210009, Jiangsu, Peoples R China; [Zhou, Haoming; Wang, Qi; Zhou, Shun; Liu, Rui; Qiu, Jiannan; Shi, Chengyu; Lu, Ling] Nanjing Med Univ, Hepatobiliary Ctr, Collaborat Innovat Ctr Canc Med, Jiangsu Key Lab Xenotransplantat,Affiliated Hosp, Nanjing, Jiangsu, Peoples R China; [Zhou, Haoming; Wang, Qi; Zhou, Shun; Liu, Rui; Qiu, Jiannan; Shi, Chengyu; Lu, Ling] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Li, Changyong] Wuhan Univ, Sch Basic Med Sci, Dept Physiol, Wuhan, Hubei, Peoples R China	Southeast University - China; Nanjing Medical University; Nanjing Medical University; Wuhan University	Lu, L (corresponding author), Southeast Univ, Sch Med, 87 Ding Jia Qiao Rd, Nanjing 210009, Jiangsu, Peoples R China.	lvling@njmu.edu.cn	lu, lu/HII-7530-2022; lu, lu/HGA-0894-2022	Li, Changyong/0000-0003-4001-037X	National Natural Science Foundation of China [81521004, 1310108001, 81100270, 81210108017, 81600450, 31700791]; National Science Foundation of Jiangsu Province [BK20131024, BE2016766]; 863 Young Scientists Special Fund [SS2015AA0209322]; Foundation of Jiangsu Collaborative Innovation Center of Biomedical Functional Materials; Dumont Research Foundation - Priority Academic Program Development (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Jiangsu Province; 863 Young Scientists Special Fund; Foundation of Jiangsu Collaborative Innovation Center of Biomedical Functional Materials; Dumont Research Foundation - Priority Academic Program Development (PAPD)	This study was supported by the National Natural Science Foundation of China (Grants 81521004, 1310108001, 81100270, 81210108017, 81600450, and 31700791), the National Science Foundation of Jiangsu Province (Grants BK20131024 and BE2016766), the 863 Young Scientists Special Fund (Grant SS2015AA0209322), the Foundation of Jiangsu Collaborative Innovation Center of Biomedical Functional Materials (to L.L.), the Dumont Research Foundation, and a project funded by the Priority Academic Program Development (PAPD). The authors declare no conflicts of interest.	Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Cai ZY, 2014, NAT CELL BIOL, V16, P200, DOI 10.1038/ncb2908; Chen LY, 2002, J IMMUNOL, V169, P3934, DOI 10.4049/jimmunol.169.7.3934; Chen WW, 2019, FASEB J, V33, P3451, DOI 10.1096/fj.201801086RR; Chen Z, 2019, ADV SCI, V6, DOI 10.1002/advs.201801361; Freise N., 2019, BLOOD; Gagliardi PA, 2019, MOL BIOL EVOL, V36, P376, DOI 10.1093/molbev/msy229; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Lu L, 2018, HEPATOLOGY, V67, P1041, DOI 10.1002/hep.29593; Ma LP, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0752-1; Matsuda M, 2018, HEPATOLOGY, V67, P296, DOI 10.1002/hep.29421; Mokdad AA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0145-y; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Nitschke M, 2012, BLOOD, V120, P2249, DOI 10.1182/blood-2012-03-417923; Pan Q, 2018, GASTROENTEROLOGY, V155, P1578, DOI 10.1053/j.gastro.2018.07.031; Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429; Ramachandran A, 2013, HEPATOLOGY, V58, P2099, DOI 10.1002/hep.26547; Ren JM, 2017, CELL MOL IMMUNOL, V14, P639, DOI 10.1038/cmi.2017.31; Roychowdhury S, 2013, HEPATOLOGY, V57, P1773, DOI 10.1002/hep.26200; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Segain JP, 2003, GASTROENTEROLOGY, V124, P1180, DOI 10.1016/S0016-5085(03)00283-X; Son G, 2007, AM J PHYSIOL-GASTR L, V293, pG631, DOI 10.1152/ajpgi.00185.2007; Tanimizu N, 2013, J CELL SCI, V126, P5239, DOI 10.1242/jcs.133082; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114071; Zhou S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00948	33	15	18	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11180	11193		10.1096/fj.201900752R	http://dx.doi.org/10.1096/fj.201900752R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31295018				2022-12-26	WOS:000489166300050
J	Adebiyi, MG; Zhao, ZY; Ye, YQ; Manalo, J; Hong, Y; Lee, CC; Xian, W; McKeon, F; Culp-Hill, R; D' Alessandro, A; Kellems, RE; Yoo, SH; Han, L; Xia, Y				Adebiyi, Morayo G.; Zhao, Zhaoyang; Ye, Youqiong; Manalo, Jeanne; Hong, Yue; Lee, Cheng Chi; Xian, Wa; McKeon, Frank; Culp-Hill, Rachel; D' Alessandro, Angelo; Kellems, Rodney E.; Yoo, Seung-Hee; Han, Leng; Xia, Yang			Circadian period 2: a missing beneficial factor in sickle cell disease by lowering pulmonary inflammation, iron overload, and mortality	FASEB JOURNAL			English	Article						circadian clock; lung; heme-iron metabolism	MOLECULAR OSCILLATOR; ELEVATED ADENOSINE; CARBON-MONOXIDE; VASOOCCLUSION; PROMOTES; GENETICS; RHYTHMS; PROTECT; CLOCK	The circadian clock is important for cellular and organ function. However, its function in sickle cell disease (SCD), a life-threatening hemolytic disorder, remains unknown. Here, we performed an unbiased microarray screen, which revealed significantly altered expression of circadian rhythmic genes, inflammatory response genes, and iron metabolic genes in SCD Berkeley transgenic mouse lungs compared with controls. Given the vital role of period 2 (Per2) in the core clock and the unrecognized role of Per2 in SCD, we transplanted the bone marrow (BM) of SCD mice to Per2(Luciferase) mice, which revealed that Per2 expression was up-regulated in SCD mouse lung. Next, we transplanted the BM of SCD mice to period 1 (Per1)/Per2 double deficient [Per1/Per2 double knockout (dKO)] and wild-type mice, respectively. We discovered that Per1/Per2 dKO mice transplanted with SCD BM (SCD -> Per1/Per2 dKO) displayed severe irradiation sensitivity and were more susceptible to an early death. Although we observed an increase of peripheral inflammatory cells, we did not detect differences in erythrocyte sickling. However, there was further lung damage due to elevated pulmonary congestion, inflammatory cell infiltration, iron overload, and secretion of IL-6 in lavage fluid. Overall, we demonstrate that Per1/Per2 is beneficial to counteract elevated systemic inflammation, lung tissue inflammation, and iron overload in SCD.-Adebiyi, M. G., Zhao, Z., Ye, Y., Manalo, J., Hong, Y., Lee, C. C., Xian, W., McKeon, F., Culp-Hill, R., D' Alessandro, A., Kellems, R. E., Yoo, S.-H., Han, L., Xia, Y. Circadian period 2: a missing beneficial factor in sickle cell disease by lowering pulmonary inflammation, iron overload, and mortality.	[Adebiyi, Morayo G.; Zhao, Zhaoyang; Ye, Youqiong; Manalo, Jeanne; Lee, Cheng Chi; Kellems, Rodney E.; Yoo, Seung-Hee; Han, Leng; Xia, Yang] Univ Texas Houston, McGovern Med Sch, Dept Biochem & Mol Biol, 6431 Fannin St,MSB 6-200, Houston, TX 77030 USA; [Xian, Wa; Han, Leng; Xia, Yang] Univ Texas Houston, McGovern Med Sch, Inst Mol Med, Houston, TX USA; [Hong, Yue; McKeon, Frank] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Culp-Hill, Rachel; D' Alessandro, Angelo] Univ Colorado, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston; University of Colorado System; University of Colorado Anschutz Medical Campus	Xia, Y (corresponding author), Univ Texas Houston, McGovern Med Sch, Dept Biochem & Mol Biol, 6431 Fannin St,MSB 6-200, Houston, TX 77030 USA.	yang.xia@uth.tmc.edu	D'Alessandro, Angelo/AAA-4695-2019; Han, Leng/HCH-3491-2022; Culp-Hill, Rachel/AAH-3234-2021	D'Alessandro, Angelo/0000-0002-2258-6490; Han, Leng/0000-0002-7380-2640; Manalo, Jeanne/0000-0001-7289-8102	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL114457, HL113574, HL137990, HL136969]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113574, R01HL137990, P01HL114457, R01HL136969] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank all the supporting authors, members of Y.X.'s laboratory for expertise, and the core facility at the University of Houston for providing the expertise needed to perform the microarray studies. Studies were performed with support of U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL114457 (to Y.X.), HL113574 (to Y.X.), HL137990 (to Y.X.), and HL136969 (to Y.X.). The authors declare no conflicts of interest.	Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Belcher JD, 2013, BLOOD, V122, P2757, DOI 10.1182/blood-2013-02-486282; Bennewitz MF, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89761; Blanco RA, 2007, AM J CLIN NUTR, V86, P1016, DOI 10.1093/ajcn/86.4.1016; Boehning D, 2002, SCIENCE, V298, P2339, DOI 10.1126/science.1080339; Chen XM, 2017, FOOD CHEM, V218, P15, DOI 10.1016/j.foodchem.2016.09.016; da Silva JB, 2012, MICROB PATHOGENESIS, V52, P206, DOI 10.1016/j.micpath.2012.01.002; DESANCHEZ VC, 1995, CAN J PHYSIOL PHARM, V73, P339, DOI 10.1139/y95-044; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gage Gregory J, 2012, J Vis Exp, DOI 10.3791/3564; Ghosh S, 2013, J CLIN INVEST, V123, P4809, DOI 10.1172/JCI64578; Gile J, 2018, CRIT CARE MED, V46, pE600, DOI 10.1097/CCM.0000000000003077; Hadden H, 2012, J APPL PHYSIOL, V113, P385, DOI 10.1152/japplphysiol.00244.2012; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; He BK, 2016, CELL METAB, V23, P610, DOI 10.1016/j.cmet.2016.03.007; Hu X, 2016, CELL REP, V16, P106, DOI 10.1016/j.celrep.2016.05.080; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Keikhaei B, 2013, EUR CYTOKINE NETW, V24, P45, DOI 10.1684/ecn.2013.0328; Korencic A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05782; Liu H, 2018, BLOOD ADV, V2, P1957, DOI 10.1182/bloodadvances.2018015784; Liu YF, 2018, BLOOD, V131, P1600, DOI 10.1182/blood-2017-12-819870; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Rees DC, 2012, BRIT J HAEMATOL, V156, P433, DOI 10.1111/j.1365-2141.2011.08961.x; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sun KQ, 2015, BLOOD, V125, P1643, DOI 10.1182/blood-2014-08-595751; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Wen JM, 2010, FASEB J, V24, P740, DOI 10.1096/fj.09-144147; Wu HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29637; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang DC, 2016, BLOOD, V127, P801, DOI 10.1182/blood-2015-09-618538; Zhang YJ, 2014, J CLIN INVEST, V124, P2750, DOI 10.1172/JCI74604; Zhang YJ, 2012, MICROBES INFECT, V14, P863, DOI 10.1016/j.micinf.2012.05.005; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280; Zhao SS, 2018, FASEB J, V32, P2855, DOI 10.1096/fj.201600788RR; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	40	2	2	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10528	10537		10.1096/fj.201900246RR	http://dx.doi.org/10.1096/fj.201900246RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31260634	Green Published			2022-12-26	WOS:000482214200064
J	Mosquera, PS; Lourenco, BH; Gimeno, SGA; Malta, MB; Castro, MC; Cardoso, MA; Manitto, AM; Damasceno, AA; da Silva, BP; de Souza, RM; Cal-das de Castro, M				Mosquera, Paola Soledad; Lourenco, Barbara H.; Gimeno, Suely G. A.; Malta, Maira B.; Castro, Marcia C.; Cardoso, Marly Augusto; Manitto, Alicia Matijasevich; Damasceno, Ana Alice; da Silva, Bruno Pereira; de Souza, Rodrigo Medeiros; Cal-das de Castro, Marcia		MINA-BRAZIL Working Grp	Factors affecting exclusive breastfeeding in the first month of life among Amazonian children	PLOS ONE			English	Article							SOCIAL SUPPORT; PACIFIER USE; DURATION; DETERMINANTS; POPULATION; RISK; INTERVENTIONS; PREVALENCE; INITIATION; PATTERNS	Early life feeding practices can directly affect the growth, development, and survival of a child. This study aimed to estimate the frequency of and factors associated with exclusive breastfeeding (EBF) in the first month of life among Amazonian infants. We used data of 1,523 mother -child pairs of the MINA -Brazil birth cohort study. Mothers were interviewed soon after delivery at baseline and by telephone at 30-45 days postpartum (n = 962, 63.2% of those eligible). Kaplan -Meier survival analysis and accelerated failure -time (AFT) models were used to estimate the probability of EBF and the factors associated with EBF duration in the first month. At 30 days of age, 36.7% of the studied population (95% confidence interval [CI] 33.6-39.8) were exclusively breastfed, with a median duration of 16 days. Considering all eligible children for follow-up, the probability of EBF in the first month was 43.7% (95% CI 40.4-46.8), and the median duration was 30 days. The duration of EBF (time -ratio, TR) was 28% longer among multiparous mothers (TR 1.28; 95% CI 1.11-1.48). The use of a pacifier and the occurrence of wheezing were associated with a reduced EBF duration by 33% (TR 0.67; 95% CI 0.58-0.77) and 19% (TR 0.80; 95% CI 0.70-0.93), respectively. These results highlight that EBF among children in the Brazilian Amazon is considerably below international recommendations, and indicate the immediate need to plan and implement actions to promote and support breastfeeding early in life.	[Mosquera, Paola Soledad; Lourenco, Barbara H.; Gimeno, Suely G. A.; Malta, Maira B.; Cardoso, Marly Augusto] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil; [Castro, Marcia C.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Lourenco, Barbara H.; Gimeno, Suely G. A.; Malta, Maira B.; Cardoso, Marly Augusto; Manitto, Alicia Matijasevich] Univ Sao Paulo, Sao Paulo, Brazil; [Damasceno, Ana Alice; da Silva, Bruno Pereira; de Souza, Rodrigo Medeiros] Univ Fed Acre, Cruzeiro Do Sul, Brazil; [Cal-das de Castro, Marcia] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Universidade de Sao Paulo; Harvard University; Harvard T.H. Chan School of Public Health; Universidade de Sao Paulo; Harvard University; Harvard T.H. Chan School of Public Health	Cardoso, MA (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil.	marlyac@usp.br	Mosquera, Paola/GPG-4114-2022; Mosquera, Paola/GPX-8138-2022; Mosquera, Paola/AAC-5136-2019; Cardoso, Marly Augusto/B-8010-2013; Lourenco, Barbara/H-8291-2012	Mosquera, Paola/0000-0001-8423-7344; Cardoso, Marly Augusto/0000-0003-0973-3908; Lourenco, Barbara/0000-0002-2006-674X	Brazilian National Council of Technological and Scientific Development, CNPq [407255/2013-3]; Sao Paulo Research Foundation, FAPESP [2016/00270-6]; CNPq [133448/2016-9]	Brazilian National Council of Technological and Scientific Development, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The present study was funded by the Brazilian National Council of Technological and Scientific Development, CNPq (Grant no. 407255/2013-3); the Sao Paulo Research Foundation, FAPESP (Grant no. 2016/00270-6). P.S.M. received Master of Public Health scholarships from CNPq (Grant no. 133448/2016-9). The views expressed in the present article are those of the authors and not necessarily those of any funding agencies. The funders had no role in the design and analysis of the study or in the writing of this article.	Al Mamun A, 2015, ACTA DIABETOL, V52, P837, DOI 10.1007/s00592-014-0690-z; Al-Sahab B, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-20; Albernaz E, 2008, J PEDIAT-BRAZIL, V84, P560, DOI 10.1590/S0021-75572008000700015; [Anonymous], 2008, LANCET, DOI DOI 10.1016/S0140-6736(07)61693-6; de Franca GVA, 2007, REV SAUDE PUBL, V41, P711, DOI 10.1590/S0034-89102007000500004; Aune D, 2014, NUTR METAB CARDIOVAS, V24, P107, DOI 10.1016/j.numecd.2013.10.028; Baby Friendly Hospital Initiative Hong Kong Association, 2018, WORLD BREASTF WEEK W; Boccolini CS, 2017, REV SAUDE PUBL, V51, DOI 10.11606/S1518-8787.2017051000029; Boccolini CS, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005971; Brasil. Ministerio da Saude, 2009, PESQ AL MAT NAS CAP; Buccini GD, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12384; Cesar JA, 1997, REV SAUDE PUBL, V31, P53, DOI 10.1590/S0034-89101997000100008; Chowdhury R, 2015, ACTA PAEDIATR, V104, P96, DOI 10.1111/apa.13102; Morgado CMD, 2013, CIENC SAUDE COLETIVA, V18, P367, DOI 10.1590/S1413-81232013000200008; Diallo FB, 2009, PAN AFR MED J, V2; Santo LCD, 2007, BIRTH-ISS PERINAT C, V34, P212, DOI 10.1111/j.1523-536X.2007.00173.x; Edmond K, 2016, LANCET GLOB HEALTH, V4, pE266, DOI 10.1016/S2214-109X(16)00040-1; Ferreira MU, 2007, J TROP PEDIATRICS, V53, P119, DOI 10.1093/tropej/fml083; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; frederick Leboyer, 1995, SHANTALA ARTE TRADIC; Friedmen LM, 2010, FUNDAMENTALS OF CLINICAL TRIALS, FOURTH EDITION, P1; Furuta M, 2016, MATERN CHILD NUTR, V12, P808, DOI 10.1111/mcn.12176; Gimeno SGA, 1997, DIABETES CARE, V20, P1256, DOI 10.2337/diacare.20.8.1256; Horta BL, 2015, ACTA PAEDIATR, V104, P14, DOI 10.1111/apa.13139; Jessri M, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-77; Jones MP, 1996, J AM STAT ASSOC, V91, P222, DOI 10.2307/2291399; Kaunonen M, 2012, J CLIN NURS, V21, P1943, DOI 10.1111/j.1365-2702.2012.04071.x; Khanal V, 2016, BMC PREGNANCY CHILDB, P1, DOI [10.1186/s12884-015-0735-5, DOI 10.1186/S12884-015-0735-5]; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Kramer MS, 2001, JAMA-J AM MED ASSOC, V286, P322, DOI 10.1001/jama.286.3.322; Laubereau B, 2004, J PEDIATR-US, V144, P602, DOI 10.1016/j.jpeds.2003.12.029; Lauria L, 2016, ANN I SUPER SANITA, V52, P457, DOI 10.4415/ANN_16_03_18; Lawlor DA, 2005, ARCH DIS CHILD, V90, P582, DOI 10.1136/adc.2004.055335; Lindau JF, 2015, EUR J PEDIATR, V174, P533, DOI 10.1007/s00431-014-2428-x; Lowe AJ, 2006, J ALLERGY CLIN IMMUN, V117, P682, DOI 10.1016/j.jaci.2005.10.027; Mallol J, 2010, THORAX, V65, P1004, DOI 10.1136/thx.2009.115188; Mascarenhas Maria Laura W., 2006, J. Pediatr. (Rio J.), V82, P289, DOI [10.2223/JPED.1506, 10.1590/S0021-75572006000500011]; Miliku K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080995; Moraes Lillian Sanchez Lacerda, 2014, Rev. paul. pediatr., V32, P313, DOI [10.1590/S0103-05822014000400006, 10.1016/j.rpped.2014.06.004]; NEIFERT M, 1995, J PEDIATR-US, V126, pS125, DOI 10.1016/S0022-3476(95)90252-X; Oribe M, 2014, GAC SANIT, V29, P4, DOI DOI 10.1016/J.GACETA.2014.08.002; Pacheco-Gonzalez RM, 2016, NPJ PRIM CARE RESP M, V26, DOI 10.1038/npjpcrm.2015.77; Patel A., 2015, REPROD HLTH S2, V12, pS10; Patil CL, 2015, J HEALTH POPUL NUTR, V34, DOI 10.1186/s41043-015-0004-2; Pincelli A, 2018, AM J TROP MED HYG, V99, P73, DOI 10.4269/ajtmh.18-0135; Quigley MA, 2007, PEDIATRICS, V119, pE837, DOI 10.1542/peds.2006-2256; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Saldiva Silvia Regina Dias Medici, 2011, Cad. Saúde Pública, V27, P2253, DOI 10.1590/S0102-311X2011001100018; Scott JA, 2006, PEDIATRICS, V117, pE646, DOI 10.1542/peds.2005-1991; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Tait P, 2000, J MIDWIFERY WOM HEAL, V45, P212, DOI 10.1016/S1526-9523(00)00011-8; Tavoulari EF, 2015, MIDWIFERY, V31, P323, DOI 10.1016/j.midw.2014.10.006; Toschke AM, 2002, J PEDIATR-US, V141, P764, DOI 10.1067/mpd.2002.128890; United Nations Children's Fund (UNICEF), 2016, STAT WORLDS CHILDR 2, P180; Venancio SI, 2013, REV SAUDE PUBL, V47, P1205, DOI 10.1590/S0034-8910.2013047004676; Verduci E, 2016, ALLERGOL IMMUNOPATHO; Verduci E, 2017, ALLERGOL IMMUNOPATH, V45, P316, DOI 10.1016/j.aller.2016.08.013; VICTORA CG, 1987, LANCET, V2, P319; Victora CG, 1997, PEDIATRICS, V99, P445, DOI 10.1542/peds.99.3.445; Vieira Graciete Oliveira, 2004, Rev. Bras. Saude Mater. Infant., V4, P143, DOI 10.1590/S1519-38292004000200004; Vieira TO, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-175; WHO, 2018, 10 STEPS SUCC BREAST; WHO-WORLD HEALTH ORGANIZATION, 2002, OPT DUR EXCL BREASTF; World Health Organization, 2017, GLOB ACT PLAN PUBL H, P1; World Health Organization, 2009, ACC MED REAS US BREA; Xu FL, 2007, ASIA PAC J CLIN NUTR, V16, P316	67	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219801	10.1371/journal.pone.0219801	http://dx.doi.org/10.1371/journal.pone.0219801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4LN	31295320	gold, Green Submitted, Green Published			2022-12-26	WOS:000484951800073
J	Wang, YG; Tseng, LC; Lin, M; Hwang, JS				Wang, Yan-Guo; Tseng, Li-Chun; Lin, Mao; Hwang, Jiang-Shiou			Vertical and geographic distribution of copepod communities at late summer in the Amerasian Basin, Arctic Ocean	PLOS ONE			English	Article							ZOOPLANKTON DISTRIBUTION; CALANUS-GLACIALIS; KUROSHIO CURRENT; CANADIAN BASIN; LIFE-CYCLE; SEA; MESOZOOPLANKTON; ASSEMBLAGES; TEMPERATURE; ATLANTIC	Zooplankton plays a pivotal role in linking primary production to higher level consumers in the food webs of marine ecosystems. The distribution of zooplankton is affected by general water conditions, monsoons, currents, and spatial and temporal factors. In the Arctic Ocean, the sea surface is naturally covered with ice. Under ice, water masses interplay to create complex environments that facilitate the transport and distribution of zooplankton, thus altering community structures at geospatial and vertical scales. The present study investigated the species composition and copepod community structures by using geospatial and multiple depth scales, and using multivariate analyses to evaluate the relation of sampling stations and layers. During July-August 2010, zooplankton samples were collected and the temperature and salinity of seawater measured from three stations in the Canada Basin and two stations in the Makarov Basin of the Arctic Ocean (maximum distance of approximately 1400 km). A total of 55 copepod species (including 25 species that were solely identified to the generic level) and 7 taxa of copepodites, altogether belonging to 28 genera, 11 families, and 2 orders were identified, and significant differences were detected in copepod community structures among sampling strata and at geospatial scales. Numerically, Calanus hyperboreus, Calanus copepodite, Calanoida copepodite, Calanus glacialis, and Metridia longa were the most dominant species and taxa. At the local scale, copepod compositions responded differently at each of the sampling stations. At the geospatial scale, the distance between stations MS03 and ICE explained variations in the pattern of dominant species and of copepod community richness. Our study demonstrated varied spatial distribution which indicates that (1) the abundance of copepods at 0-200 m was significantly higher than at other strata, (2) vertical strata affected the distribution of copepod communities, and (3) the interplay of North Pacific and Atlantic waters shaping the copepod assemblage structure at geospatial scales in the Arctic Ocean. The results of our research provide base data for Arctic zooplankton biodiversity and biogeographic distribution.	[Wang, Yan-Guo; Lin, Mao] Minist Nat Resources, Inst Oceanog 3, Xiamen, Fujian, Peoples R China; [Tseng, Li-Chun; Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Tseng, Li-Chun; Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Lin, Mao] Collaborat Innovat Ctr Deep Sea Biol, Hangzhou, Zhejiang, Peoples R China; [Hwang, Jiang-Shiou] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan	Ministry of Natural Resources of the People's Republic of China; National Taiwan Ocean University; National Taiwan Ocean University; Kaohsiung Medical University	Lin, M (corresponding author), Minist Nat Resources, Inst Oceanog 3, Xiamen, Fujian, Peoples R China.; Hwang, JS (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan.; Hwang, JS (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan.; Lin, M (corresponding author), Collaborat Innovat Ctr Deep Sea Biol, Hangzhou, Zhejiang, Peoples R China.; Hwang, JS (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan.	linmao@tio.org.cn; jshwang@mail.ntou.edu.tw		Tseng, Li-Chun/0000-0003-0251-565X	National Natural Science Foundation of China [41306204]; Ministry of Science and Technology of Taiwan [MOST 105-2811-M-019-008, MOST 106-2811-M-019-004, MOST 107-2811-M-019-004, MOST 104-2611-M-019-004, MOST 105-2621-M-019-001, MOST 105-2918-I-019- 001, MOST 106-2621-M-019-001, MOST 107-2621-M-019-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	The financial support from the National Natural Science Foundation of China (Grant no. 41306204) to Y.-G. Wang; the support from Ministry of Science and Technology of Taiwan (Grant no. MOST 105-2811-M-019-008, MOST 106-2811-M-019-004 and MOST 107-2811-M-019-004) to L.-C. Tseng, as well as (MOST 104-2611-M-019-004, MOST 105-2621-M-019-001, MOST 105-2918-I-019- 001, MOST 106-2621-M-019-001 and MOST 107-2621-M-019-001) to J.-S. Hwang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIA: Arctic Climate Impact Assessment, 2004, IMP WARM ARCT ARCT C; [Anonymous], 1991, COPEPOD EVOLUTION; Ashjian CJ, 2003, DEEP-SEA RES PT I, V50, P1235, DOI 10.1016/S0967-0637(03)00129-8; Auel Holger, 1999, Berichte zur Polarforschung, V319, P1; Batnes AS, 2015, POLAR BIOL, V38, P51, DOI 10.1007/s00300-013-1415-4; Bourgain P, 2013, OCEAN SCI, V9, P447, DOI 10.5194/os-9-447-2013; Bourgain P, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051045; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Boxshall GA, 2004, INTRO COPEPOD DIVERS, P966; Brodskij K.A., 1983, Opredeliteli po Faune SSSR, V135, P1; Brodskiy KA, 1977, POLIT GEOGR, V1, P143, DOI DOI 10.1080/10889377709388621; Brodsky KA, 1950, OPRED FAUNE SSSR, V35, P1967; BUCHANAN RA, 1982, ARCTIC, V35, P41; Calbet A, 2005, AQUAT MICROB ECOL, V38, P157, DOI 10.3354/ame038157; Coachman L.K., 1961, ARCTIC, V14, P147, DOI [10.14430/arctic3670, DOI 10.14430/ARCTIC3670]; Cohen JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126247; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Conover R.J., 1991, Journal of Marine Systems, V2, P1, DOI 10.1016/0924-7963(91)90011-I; Darnis G, 2014, J PLANKTON RES, V36, P1092, DOI 10.1093/plankt/fbu035; Darnis G, 2012, CLIMATIC CHANGE, V115, P179, DOI 10.1007/s10584-012-0483-8; Dickerson KD, 2010, RIVER RES APPL, V26, P605, DOI 10.1002/rra.1268; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dunbar MJ, 1968, ARCTIC DRIFTING STAT, P315; Dvoretsky VG, 2014, RUSS J MAR BIOL+, V40, P95, DOI 10.1134/S1063074014020035; Ershova EA, 2015, POLAR BIOL, V38, P1461, DOI 10.1007/s00300-015-1709-9; Falk-Petersen S, 2009, MAR BIOL RES, V5, P18, DOI 10.1080/17451000802512267; Forest A, 2011, PROG OCEANOGR, V91, P410, DOI 10.1016/j.pocean.2011.05.002; Gislason A, 2003, HYDROBIOLOGIA, V503, P195, DOI 10.1023/B:HYDR.0000008498.87941.7d; Gluchowska M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171715; GRAINGER EH, 1965, J FISH RES BOARD CAN, V22, P543, DOI 10.1139/f65-049; Grice GD, 1967, P US NATL MUS, V122, P249; Grote U, 2015, POLAR BIOL, V38, P1025, DOI 10.1007/s00300-015-1664-5; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harris R., 2000, ICES ZOOPLANKTON MET; Hirche HJ, 2007, DEEP-SEA RES PT II, V54, P2729, DOI 10.1016/j.dsr2.2007.08.006; Hirche HJ, 1997, MAR BIOL, V128, P607, DOI 10.1007/s002270050127; Hopcroft RR, 2005, POLAR BIOL, V28, P198, DOI 10.1007/s00300-004-0680-7; Hsiao SH, 2011, ZOOL STUD, V50, P475; Hunt BPV, 2014, J GEOPHYS RES-OCEANS, V119, P2518, DOI 10.1002/2013JC009156; Hunt GL, 2008, DEEP-SEA RES PT II, V55, P1919, DOI 10.1016/j.dsr2.2008.04.032; Hwang JS, 2007, J EXP MAR BIOL ECOL, V352, P12, DOI 10.1016/j.jembe.2007.06.034; Hwang JS, 2005, J PLANKTON RES, V27, P205, DOI 10.1093/plankt/fbh162; Kosobokova K, 2000, DEEP-SEA RES PT I, V47, P2029, DOI 10.1016/S0967-0637(00)00015-7; Kosobokova K.N., 1989, Issledovaniya Fauny Morei, V41, P24; Kosobokova KN, 1999, POLAR BIOL, V22, P254, DOI 10.1007/s003000050418; Kosobokova KN, 1998, POLAR BIOL, V19, P63; Kosobokova K, 2009, PROG OCEANOGR, V82, P265, DOI 10.1016/j.pocean.2009.07.006; Kosobokova Ksenia N., 2011, Marine Biodiversity, V41, P29, DOI 10.1007/s12526-010-0057-9; Kosobokova KN, 2010, DEEP-SEA RES PT II, V57, P96, DOI 10.1016/j.dsr2.2009.08.009; Kwasniewski S, 2003, J PLANKTON RES, V25, P1, DOI 10.1093/plankt/25.1.1; Laakmann S, 2009, DEEP-SEA RES PT I, V56, P741, DOI 10.1016/j.dsr.2008.12.017; Lappo S, 2003, INT OCEAN ATLAS INFO, V8; Markhaseva Elena L., 1996, Trudy Zoologicheskogo Instituta, V268, P1; MATTHEWS J B L, 1972, Bulletin of the British Museum (Natural History) Zoology, V24, P1; MUMM N, 1993, POLAR BIOL, V13, P451; Nahrgang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098452; Nelson RJ, 2012, 2012123 DFO CAN SCI, V123; Newton R, 2013, J GEOPHYS RES-OCEANS, V118, P2133, DOI 10.1002/jgrc.20101; Parkinson CL, 2013, GEOPHYS RES LETT, V40, DOI 10.1002/grl.50349; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Rudels B, 2000, J MARINE SYST, V25, P77, DOI 10.1016/S0924-7963(00)00009-9; Rudels B, 1994, POLAR OCEANS THEIR R, P33, DOI [10.1029/GM085, DOI 10.1029/GM085P0033]; Saiz E, 2013, DEEP-SEA RES PT I, V72, P17, DOI 10.1016/j.dsr.2012.10.003; SARS GO, 1903, CRUSTAEA NORWAY, V4, P1; Schlosser P, 1995, DEEP-SEA RES PT II, V42, P1341, DOI 10.1016/0967-0645(95)00045-3; Sirenko BI, 2001, RUSSIAN ACAD SCI ZOO, V51; Smith S.L., 1990, P527; Spielhagen RF, 2011, SCIENCE, V331, P450, DOI 10.1126/science.1197397; Steele M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031651; Stroeve JC, 2014, GEOPHYS RES LETT, V41, P1216, DOI 10.1002/2013GL058951; Stroeve JC, 2012, CLIMATIC CHANGE, V110, P1005, DOI 10.1007/s10584-011-0101-1; Tseng LC, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-2; Tseng LC, 2011, J EXP MAR BIOL ECOL, V398, P47, DOI 10.1016/j.jembe.2010.12.007; Wassmann P, 2011, PROG OCEANOGR, V90, P1, DOI 10.1016/j.pocean.2011.02.002; Woodgate RA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021747; Xie H, 2013, CRYOSPHERE, V7, P1057, DOI 10.5194/tc-7-1057-2013	76	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219319	10.1371/journal.pone.0219319	http://dx.doi.org/10.1371/journal.pone.0219319			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295285	gold, Green Submitted, Green Published			2022-12-26	WOS:000484951800025
J	Helleland, L; Bergesen, LF; Rinnan, KJ; Engelsen, IB; Hordnes, K; Trovik, J				Helleland, Liva; Bergesen, Lena Flekke; Rinnan, Karen Jakobsen; Engelsen, Ingeborg Boe; Hordnes, Knut; Trovik, Jone			Endometrial ablation; less is more? Historical cohort study comparing long-term outcomes from two time periods and two treatment modalities for 854 women	PLOS ONE			English	Article							COMPLICATIONS; HYSTEROSCOPY; RESECTION	Background Abnormal uterine bleeding needs surgical treatment if medical therapy fails. After introduction of non-hysteroscopic endometrial ablation as alternative to hysteroscopic endometrial resection, we aimed to compare short and long-term outcomes for women treated with these two minimally-invasive procedures. A secondary goal was comparing the present cohort to a previous cohort of women treated with hysteroscopic resection only. Materials and methods Historical cohort study of women treated for abnormal uterine bleeding with hysteroscopic resection or endometrial ablation at Haukeland University Hospital during 2006-2014. Similar patient file and patient-reported outcome data were collected from 386 hysteroscopic resections in a previous cohort (1992-1998). Categorical variables were compared by Chi-square or Fisher's Exact-test, linear variables by Mann-Whitney U-test and time to hysterectomy by the Kaplan-Meier method. Results During 2006-2014, 772 women were treated with endometrial resection or ablation, 468 women (61%) consented to study-inclusion; 333 women (71%) were treated with hysteroscopic resection and 135 (29%) with endometrial ablation. Preoperative characteristics were significantly different for women treated with hysteroscopic resection compared to endometrial ablation in the 2006-2014-cohort and between the two time-cohorts regarding menopausal, sterilization and myoma status (p <= 0.036). The endometrial ablation group had significantly shorter operation time, median 13 minutes (95% Confidence Interval (CI) 12-14) and a lower complication rate (2%) versus operation time, median 25 minutes (95% CI 23-26) and complication rate (13%) in the hysteroscopy group, all p <= 0.001. The patient-reported rate of satisfaction with treatment was equivalent in both groups (85%, p=0.955). The endometrial ablation group had lower hysterectomy rate (8% vs 16%, p=0.024). Patient-reported satisfaction rate was higher (85%) in the 2006-2014-cohort compared with the 1992-1998-cohort (73%), p<0.001. Conclusions Endometrial ablation has similar patient satisfaction rate, but shorter operation time and lower complication rate and may be a good alternative to hysteroscopic resection for treatment of abnormal uterine bleeding.	[Helleland, Liva; Engelsen, Ingeborg Boe; Trovik, Jone] Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway; [Bergesen, Lena Flekke; Rinnan, Karen Jakobsen; Trovik, Jone] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Hordnes, Knut] Betanien Hosp, Dept Gynecol Outpatient Care, Bergen, Norway; [Engelsen, Ingeborg Boe] Bergen Specialist Ctr, Gynecol, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen	Trovik, J (corresponding author), Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway.; Trovik, J (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	jone.trovik@helse-bergen.no		Trovik, Jone/0000-0002-3808-6407				Busund B, 2003, ACTA OBSTET GYN SCAN, V82, P65, DOI 10.1034/j.1600-0412.2003.820112.x; Chang YN, 2011, FERTIL STERIL, V96, P957, DOI 10.1016/j.fertnstert.2011.07.1146; Clarke MA, 2018, JAMA INTERN MED, V178, P1210, DOI 10.1001/jamainternmed.2018.2820; Engelsen IB, 2006, ACTA OBSTET GYN SCAN, V85, P82, DOI 10.1080/00016340500424314; Famuyide AO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188176; Fergusson RJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000329.pub2; HALLBERG L, 1966, ACTA OBSTET GYN SCAN, V45, P320, DOI 10.3109/00016346609158455; Istre O, 1991, ACTA OBSTET GYN SCAN, V70, P363, DOI 10.3109/00016349109007889; Jansen FW, 2000, OBSTET GYNECOL, V96, P266, DOI 10.1016/S0029-7844(00)00865-6; Marjoribanks J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003855.pub3; NCMP NCSP and NCRP, 2018, CLASS MED SURG PROC; Pennant M, 2017, BJOG-INT J OBSTET GY, V124, P404, DOI 10.1111/1471-0528.14385; Peuranpaa P, 2014, ACTA OBSTET GYN SCAN, V93, P654, DOI 10.1111/aogs.12394; Philip CA, 2018, EUR J OBSTET GYN R B, V227, P46, DOI 10.1016/j.ejogrb.2018.04.001; Rodriguez MB, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001501.pub5; Shveiky D, 2007, J MINIM INVAS GYN, V14, P218, DOI 10.1016/j.jmig.2006.07.019; Soini T, 2017, OBSTET GYNECOL, V130, P554, DOI 10.1097/AOG.0000000000002166; Stahlman Shauna, 2017, MSMR, V24, P30; van den Brink MJ, 2017, FAM PRACT, V34, P673, DOI 10.1093/fampra/cmx050; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120	20	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219294	10.1371/journal.pone.0219294	http://dx.doi.org/10.1371/journal.pone.0219294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291298	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800066
J	Liang, SF; Shih, YH; Chen, PY; Kuo, CE				Liang, Sheng-Fu; Shih, Yu-Hsuan; Chen, Peng-Yu; Kuo, Chih-En			Development of a human-computer collaborative sleep scoring system for polysomnography recordings	PLOS ONE			English	Article								The overnight polysomnographic (PSG) recordings of patients were scored by an expert to diagnose sleep disorders. Visual sleep scoring is a time-consuming and subjective process. Automatic sleep staging methods can help; however, the mechanism and reliability of these methods are not fully understood. Therefore, experts often need to rescore the recordings to obtain reliable results. Here, we propose a human-computer collaborative sleep scoring system. It is a rule-based automatic sleep scoring method that follows the American Academy of Sleep Medicine (AASM) guidelines to perform an initial scoring. Then, the reliability level of each epoch is analyzed based on physiological patterns during sleep and the characteristics of various stage changes. Finally, experts would only need to rescore epochs with a low-reliability level. The experimental results show that the average agreement rate between our system and fully manual scorings can reach 90.42% with a kappa coefficient of 0.85. Over 50% of the manual scoring time can be reduced. Due to the demonstrated robustness and applicability, the proposed approach can be integrated with various PSG systems or automatic sleep scoring methods for sleep monitoring in clinical or homecare applications in the future.	[Liang, Sheng-Fu; Shih, Yu-Hsuan; Chen, Peng-Yu] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan, Taiwan; [Liang, Sheng-Fu] Minist Sci & Technol, Al Biomed Res Ctr NCKU, Tainan, Taiwan; [Kuo, Chih-En] Feng Chia Univ, Dept Automat Control Engn, Taichung, Taiwan	National Cheng Kung University; Feng Chia University	Kuo, CE (corresponding author), Feng Chia Univ, Dept Automat Control Engn, Taichung, Taiwan.	cekuo@fcu.edu.tw	Kuo, Chih-En/AAG-1751-2020	Kuo, Chih-En/0000-0001-6305-205X	Ministry of Science and Technology, Taiwan [MOST 105-2221-E-006-221, 106-2218-E-006-019, 107-2221-E-006-217-MY2, 106-2218-E-035-013-MY2, 108-2634-F-006-012]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology, Taiwan. (MOST 105-2221-E-006-221, 106-2218-E-006-019, 107-2221-E-006-217-MY2, 106-2218-E-035-013-MY2, and 108-2634-F-006-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Science and Technology, Taiwan. (MOST 105-2221-E-006-221, 106-2218-E-006-019, 107-2221-E-006-217-MY2, 106-2218-E-035-013-MY2, and 108-2634-F-006-012).	Aboalayon KAI, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18090272; Alvarez-Estevez D, 2018, ARXIV180906216; Berry R.B., 2012, AASM MANUAL SCORING, V176, P2012; Biswal S., 2017, SLEEPNET AUTOMATED S; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dimitriadis SI, 2018, CLIN NEUROPHYSIOL, V129, P815, DOI 10.1016/j.clinph.2017.12.039; Dong H, 2018, IEEE T NEUR SYS REH, V26, P324, DOI 10.1109/TNSRE.2017.2733220; Fraiwan L, 2012, COMPUT METH PROG BIO, V108, P10, DOI 10.1016/j.cmpb.2011.11.005; Kang DY, 2018, IEEE T BIO-MED ENG, V65, P1201, DOI 10.1109/TBME.2017.2702123; Koley B, 2012, COMPUT BIOL MED, V42, P1186, DOI 10.1016/j.compbiomed.2012.09.012; Lajnef T, 2015, J NEUROSCI METH, V250, P94, DOI 10.1016/j.jneumeth.2015.01.022; Lan KC, 2015, J NEUROSCI METH, V246, P142, DOI 10.1016/j.jneumeth.2015.03.013; Langkvist M., 2012, ADV ARTIFICIAL NEURA, V2012; Liang SF, 2016, IEEE T BIO-MED ENG, V63, P2108, DOI 10.1109/TBME.2015.2510365; Liang SF, 2015, IEEE T INSTRUM MEAS, V64, P2977, DOI 10.1109/TIM.2015.2433652; Liang SF, 2012, IEEE T INSTRUM MEAS, V61, P1649, DOI 10.1109/TIM.2012.2187242; Liang SF, 2012, J NEUROSCI METH, V205, P169, DOI 10.1016/j.jneumeth.2011.12.022; Memar P, 2018, IEEE T NEUR SYS REH, V26, P84, DOI 10.1109/TNSRE.2017.2776149; Motamedi-Fakhr S, 2014, BIOMED SIGNAL PROCES, V10, P21, DOI 10.1016/j.bspc.2013.12.003; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Patanaik A, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy041; Peker M, 2016, NEUROCOMPUTING, V207, P165, DOI 10.1016/j.neucom.2016.04.049; Ronzhina M, 2012, SLEEP MED REV, V16, P251, DOI 10.1016/j.smrv.2011.06.003; Rosenberg RS, 2013, J CLIN SLEEP MED, V9, P81, DOI 10.5664/jcsm.2350; Sun H, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx139; Supratak A, 2017, IEEE T NEUR SYS REH, V25, P1998, DOI 10.1109/TNSRE.2017.2721116; Tsinalis Orestis, 2016, arXiv; Tsinalis O, 2016, ANN BIOMED ENG, V44, P1587, DOI 10.1007/s10439-015-1444-y; Younes M, 2016, J CLIN SLEEP MED, V12, P885, DOI 10.5664/jcsm.5894; Zhang JM, 2017, IEEE T BIOMED CIRC S, V11, P1097, DOI 10.1109/TBCAS.2017.2719631; Zhang L, 2018, SLEEP, V41, pA118, DOI 10.1093/sleep/zsy061.306; Zhu GH, 2014, IEEE J BIOMED HEALTH, V18, P1813, DOI 10.1109/JBHI.2014.2303991	32	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218948	10.1371/journal.pone.0218948	http://dx.doi.org/10.1371/journal.pone.0218948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291270	gold, Green Submitted, Green Published			2022-12-26	WOS:000484947800042
J	Felice, A; Franchi, M; De Martin, S; Vitacolonna, N; Iacumin, L; Civilini, M				Felice, Antonella; Franchi, Marinella; De Martin, Stefano; Vitacolonna, Nicola; Iacumin, Lucilla; Civilini, Marcello			Environmental surveillance and spatio-temporal analysis of Legionella spp. in a region of northeastern Italy (2002-2017)	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE; WATER NETWORK; HOT-WATER; PNEUMOPHILA; PATHOGENS; EPIDEMIOLOGY; OUTBREAKS; SAMPLES	Legionella spp. are considered an important cause of potentially preventable morbidity and mortality, making environmental surveillance a crucial component of risk assessment plans. In this work, 20,319 water samples were collected in 3,983 environmental surveys during a 16-year period by ARPA, the Regional Agency for Environmental Protection, Friuli Venezia Giulia, and the results were studied to better understand the diffusion mechanisms of Legionella. The data showed a strong seasonal signal, a prevalence of L. pneumophila serogroup 2-15 in most environments (63% of positive samples), a prevalence of L. pneumophila serogroup 1 in swimming pool-associated environments (82% of positive samples), a persistent presence of Legionella in hospitals and a recurrent presence of Legionella in other facilities such as hotels, possibly years after interventions, highlighting the difficulty of eradicating the bacteria. Retrospective spatio-temporal analyses on geocoded historical data were carried out with SaTScan using an ordinal model with risk as a covariate to identify potential clusters with an excess of cases in the higher-risk categories. Although no outbreaks occurred during the period of study, such analyses identified spatially restricted zones with unusual contamination, which sometimes were also areas in which several surveys triggered by notifications of clinical cases were performed. Simulations of periodic prospective analyses permitted the assessment of the efficacy of the method in early detection of such clusters. The proposed method may be a useful tool in environmental surveillance, prevention and control of Legionella.	[Felice, Antonella; Franchi, Marinella; De Martin, Stefano] ARPA Reg Agcy Environm Protect Friuli Venezia Giu, Microbiol Lab, Udine, Italy; [Vitacolonna, Nicola] Univ Udine, Dept Math Comp Sci & Phys, Udine, Italy; [Iacumin, Lucilla; Civilini, Marcello] Univ Udine, Dept Agr Food Environm & Anim Sci, Udine, Italy	Regional Environmental Protection Agency - Italy; University of Udine; University of Udine	Civilini, M (corresponding author), Univ Udine, Dept Agr Food Environm & Anim Sci, Udine, Italy.	marcello.civilini@uniud.it	Iacumin, Lucilla/ABD-7559-2021; Comi, Giuseppe/GYE-0141-2022	Iacumin, Lucilla/0000-0003-2967-8109; 				[Anonymous], 2012, 126892012 ISOTS; [Anonymous], 2005, GAZZETTA UFFICIALE R; [Anonymous], 2019, ANN EP REP 2017; Bauer M, 2008, J EPIDEMIOL COMMUN H, V62, P913, DOI 10.1136/jech.2007.063784; Berjeaud JM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00486; BLACKMON JA, 1981, AM J PATHOL, V103, P429; Borella P, 2005, APPL ENVIRON MICROB, V71, P5805, DOI 10.1128/AEM.71.10.5805-5813.2005; Buultjens AH, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.01482-17, 10.1128/aem.01482-17]; Carraro Elisabetta, 2004, Ann Ist Super Sanita, V40, P117; Casini B, 2018, J HOSP INFECT, V98, P46, DOI 10.1016/j.jhin.2017.09.006; Cilloniz C, 2017, RESPIROLOGY, V22, P778, DOI 10.1111/resp.12978; Cohen, 2013, INT J SCI TECHNOL, V2, P187; De Filippis P, 2018, SCI TOTAL ENVIRON, V643, P715, DOI 10.1016/j.scitotenv.2018.06.216; Durkalski VL, 2003, STAT MED, V22, P2417, DOI 10.1002/sim.1438; Dusserre E, 2008, APPL ENVIRON MICROB, V74, P4817, DOI 10.1128/AEM.02899-07; Falkinham JO, 2015, ENVIRON HEALTH PERSP, V123, P749, DOI 10.1289/ehp.1408692; Garrison Laurel E, 2016, MMWR Morb Mortal Wkly Rep, V65, P576, DOI 10.15585/mmwr.mm6522e1; Hamilton KA, 2018, CURR ENV HLTH REP, V5, P263, DOI 10.1007/s40572-018-0201-4; Jung I, 2007, STAT MED, V26, P1594, DOI 10.1002/sim.2607; Kirschner AKT, 2016, WATER RES, V93, P276, DOI 10.1016/j.watres.2016.02.016; Kulldorff M, 2018, SATSCAN USER GUIDE; Leoni E, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081612; McClung RP, 2017, MMWR-MORBID MORTAL W, V66, P1222, DOI 10.15585/mmwr.mm6644a4; Morio F, 2008, INT J HYG ENVIR HEAL, V211, P403, DOI 10.1016/j.ijheh.2007.06.002; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Ohno A, 2008, APPL ENVIRON MICROB, V74, P4585, DOI 10.1128/AEM.00083-08; Oliva G, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00003; Phin N, 2014, LANCET INFECT DIS, V14, P1011, DOI 10.1016/S1473-3099(14)70713-3; Prussin AJ, 2017, BUILD ENVIRON, V123, P684, DOI 10.1016/j.buildenv.2017.06.024; Ricketts K D, 2004, Euro Surveill, V9, P5, DOI 10.2807/esm.09.10.00480-en; Rota M, 2018, ASD, V31, P7; Scaturro M, 2007, INFECT CONT HOSP EP, V28, P1089, DOI 10.1086/519869; Shah PP, 2018, LEGIONNAIRES DIS SUR; Soderberg MA, 2008, APPL ENVIRON MICROB, V74, P5583, DOI 10.1128/AEM.00067-08; Szewzyk U, 2000, ANNU REV MICROBIOL, V54, P81, DOI 10.1146/annurev.micro.54.1.81; Totaro M, 2018, J HOSP INFECT, V98, P60, DOI 10.1016/j.jhin.2017.08.021; Vouga M, 2016, CLIN MICROBIOL INFEC, V22, P12, DOI 10.1016/j.cmi.2015.10.010; Whiley H, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01330; Yu VL, 2002, J INFECT DIS, V186, P127, DOI 10.1086/341087; Zahran S, 2018, P NATL ACAD SCI USA, V115, pE1730, DOI 10.1073/pnas.1718679115	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0218687	10.1371/journal.pone.0218687	http://dx.doi.org/10.1371/journal.pone.0218687			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287819	Green Published, gold			2022-12-26	WOS:000482328300006
J	Liu, XY; Zhang, XJ; Sun, BC; Hao, LY; Liu, C; Zhang, DF; Tang, HJ; Li, CH; Li, YX; Shi, YS; Xie, XQ; Song, YC; Wang, TY; Li, Y				Liu, Xuyang; Zhang, Xiaojing; Sun, Baocheng; Hao, Luyang; Liu, Cheng; Zhang, Dengfeng; Tang, Huaijun; Li, Chunhui; Li, Yongxiang; Shi, Yunsu; Xie, Xiaoqing; Song, Yanchun; Wang, Tianyu; Li, Yu			Genome-wide identification and comparative analysis of drought-related microRNAs in two maize inbred lines with contrasting drought tolerance by deep sequencing	PLOS ONE			English	Article							STRESS-REGULATED MICRORNAS; NAC TRANSCRIPTION FACTOR; DIFFERENTIAL EXPRESSION; SMALL RNAS; ABIOTIC STRESS; SALT STRESS; GENE; DATABASE; RESISTANCE; MIRNAS	Drought has become one of the most serious abiotic stresses influencing crop production worldwide. Understanding the molecular regulatory networks underlying drought adaption and tolerance in crops is of great importance for future breeding. microRNAs (miRNAs), as important components of post-transcriptional regulation, play crucial roles in drought response and adaptation in plants. Here, we report a miRNome analysis of two maize inbred lines with contrasting levels of drought tolerance under soil drought in the field. Differential expression analysis showed 11 and 34 miRNAs were uniquely responded to drought in H082183 (drought tolerant) and Lv28 (drought sensitive), respectively, in leaves. In roots, 19 and 23 miRNAs uniquely responded to drought in H082183 and Lv28, respectively. Expression analysis of these drought-responsive miRNA-mRNA modules revealed miR164-MYB, miR164-NAC, miR159-MYB, miR156-SPL and miR160-ARF showed a negative regulatory relationship. Further analysis showed that the miR164-MYB and miR164NAC modules in the tolerant line modulated the stress response in an ABA (abscisic acid)dependent manner, while the miR156-SPL and miR160-ARF modules in the sensitive line participated in the inhibition of metabolism in drought-exposed leaves. Together, our results provide new insight into not only drought-tolerance-related miRNA regulation networks in maize but also key miRNAs for further characterization and improvement of maize drought tolerance.	[Liu, Xuyang; Zhang, Xiaojing; Hao, Luyang; Zhang, Dengfeng; Li, Chunhui; Li, Yongxiang; Shi, Yunsu; Song, Yanchun; Wang, Tianyu; Li, Yu] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Sun, Baocheng; Liu, Cheng; Tang, Huaijun; Xie, Xiaoqing] Xinjiang Acad Agr Sci, Inst Grain Crops, Urumqi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Wang, TY; Li, Y (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.	wangtianyu@caas.cn; liyu03@caas.cn	li, yongxiang/GPW-6930-2022; li, yong/HDN-3885-2022		National Key Research and Development Program of China [2016YFD0100303]; Sci-tech Innovation Program of Chinese Academy of Agricultural Sciences [Y2016PT10]	National Key Research and Development Program of China; Sci-tech Innovation Program of Chinese Academy of Agricultural Sciences	This work was supported by the National Key Research and Development Program of China (2016YFD0100303) and the Sci-tech Innovation Program of Chinese Academy of Agricultural Sciences (Y2016PT10).	Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Akdogan G, 2016, FUNCT INTEGR GENOMIC, V16, P221, DOI 10.1007/s10142-015-0452-1; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Aravind J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00941; Axtell MJ, 2018, PLANT CELL, V30, P272, DOI 10.1105/tpc.17.00851; Aydinoglu F, 2019, GENE, V690, P57, DOI 10.1016/j.gene.2018.12.042; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Barrera-Figueroa BE, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-132; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Blum A, 2014, FUNCT PLANT BIOL, V41, P1191, DOI 10.1071/FP14018; Bo XC, 2005, BIOINFORMATICS, V21, P1401, DOI 10.1093/bioinformatics/bti211; Bonnet E, 2006, NEW PHYTOL, V171, P451, DOI 10.1111/j.1469-8137.2006.01806.x; Brown ME, 2008, SCIENCE, V319, P580, DOI 10.1126/science.1154102; Cai HS, 2015, GENE, V558, P227, DOI 10.1016/j.gene.2014.12.066; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Cheah BH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1851-3; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Chuck G, 2010, DEVELOPMENT, V137, P1243, DOI 10.1242/dev.048348; Cui LG, 2014, PLANT J, V80, P1108, DOI 10.1111/tpj.12712; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Ding YF, 2013, J EXP BOT, V64, P3077, DOI 10.1093/jxb/ert164; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fang YJ, 2014, J EXP BOT, V65, P2119, DOI 10.1093/jxb/eru072; Feng H, 2014, MOL PLANT PATHOL, V15, P284, DOI 10.1111/mpp.12089; Ferdous J, 2015, PLANT BIOTECHNOL J, V13, P293, DOI 10.1111/pbi.12318; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gao S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19736; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Hackenberg M, 2015, PLANT BIOTECHNOL J, V13, P2, DOI 10.1111/pbi.12220; Huang QJ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0644-9; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jia XY, 2009, PLANT MOL BIOL, V71, P51, DOI 10.1007/s11103-009-9508-8; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jovanovic Z, 2014, PLANT PHYSIOL BIOCH, V83, P26, DOI 10.1016/j.plaphy.2014.07.008; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Leng XP, 2017, FUNCT INTEGR GENOMIC, V17, P697, DOI 10.1007/s10142-017-0565-9; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Li J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-220; Li JS, 2013, J INTEGR AGR, V12, P1414, DOI 10.1016/S2095-3119(13)60311-1; Li MJ, 2016, J PLANT RES, V129, P1097, DOI 10.1007/s10265-016-0857-5; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Lobell DB, 2014, SCIENCE, V344, P516, DOI 10.1126/science.1251423; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu M, 2013, PLANT CELL TISS ORG, V115, P443, DOI 10.1007/s11240-013-0375-2; Lu M, 2012, PLANT CELL REP, V31, P1701, DOI 10.1007/s00299-012-1284-2; Lu XY, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24952; Luan MD, 2015, GENE, V555, P178, DOI 10.1016/j.gene.2014.11.001; Luan MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091369; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Mao HD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9326; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Si LZ, 2016, NAT GENET, V48, P447, DOI 10.1038/ng.3518; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang JY, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.77; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Turner M, 2013, PLANT PHYSIOL, V162, P2042, DOI 10.1104/pp.113.220699; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang HY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00067; Wang YG, 2014, BIOCHEM GENET, V52, P474, DOI 10.1007/s10528-014-9661-x; Wei LY, 2009, INT J PLANT SCI, V170, P979, DOI 10.1086/605122; Xia KF, 2012, PLOS ONE, V7, P364, DOI 10.1371/journal.pone.0030039; Xu SG, 2013, ROCK CHARACTERISATION, MODELLING AND ENGINEERING DESIGN METHODS, P303; Xue T, 2017, PLANT SCI, V262, P182, DOI 10.1016/j.plantsci.2017.06.008; Yang TX, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39397-7; Yin FQ, 2014, FUNCT INTEGR GENOMIC, V14, P319, DOI 10.1007/s10142-014-0365-4; Zhang FT, 2016, BIOTECHNOL LETT, V38, P711, DOI 10.1007/s10529-015-2012-0; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang XJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179477; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhao Y, 2017, PLANT CELL PHYSIOL, V58, P1319, DOI 10.1093/pcp/pcx086; Zhao YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep23890; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhu C, 2011, PHYSIOL PLANTARUM, V143, P1, DOI 10.1111/j.1399-3054.2011.01477.x	87	22	26	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219176	10.1371/journal.pone.0219176	http://dx.doi.org/10.1371/journal.pone.0219176			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276526	Green Published, gold, Green Submitted			2022-12-26	WOS:000484936300045
J	Pedroza, M; To, S; Smith, J; Agarwal, SK				Pedroza, Mesias; To, Sarah; Smith, Jennifer; Agarwal, Sandeep K.			Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride	PLOS ONE			English	Article							PULMONARY-FIBROSIS; CELL-ADHESION	Background and aims Liver fibrosis is characterized by the excessive deposition of extracellular matrix (ECM) leading to impaired function and cirrhosis. Previous reports support a role for cadherin-11 (CDH11) in regulating the development of dermal and pulmonary fibrosis. In the current report, the extent to which CDH11 modulates the development of liver fibrosis induced by carbon tetrachloride (CCL4) was assessed. Methods Wild type (WT) and CDH11 deficient (CDH11(-/-)) mice were treated with CCl4 or vehicle control for 8 weeks to induce liver fibrosis. Liver fibrosis was assessed by histology, collagen content, and RTPCR of fibrotic mediators. Results Livers from WT mice treated with CCl4 had increased levels of CDH11 which localized to injured hepatocytes, hepatic stellate cells, and macrophages. Interestingly, CDH11(-/-) mice had decreased histological evidence of liver fibrosis, collagen deposition, alpha-smooth muscle actin (alpha-SMA) accumulation, and mRNA levels of fibrotic mediators such as Col1-alpha 1, Snail, TGF-beta and IL-6. Conclusions These data demonstrate that CDH11 is increased during liver fibrosis, is an important regulator of liver fibrosis induced by CCL4 and suggest that CDH11 may be a potential therapeutic target for liver fibrosis.	[Pedroza, Mesias; To, Sarah; Smith, Jennifer; Agarwal, Sandeep K.] Baylor Coll Med, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA	Baylor College of Medicine	Agarwal, SK (corresponding author), Baylor Coll Med, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA.	skagarwa@bcm.edu		Smith, Jennifer/0000-0001-6518-6983	NIH [R01AR062056, T32 AI053831]; Scleroderma Foundation Established Investigator Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI053831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Foundation Established Investigator Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The funding for this study came from multiple sources including: NIH R01AR062056 (SKA), the Scleroderma Foundation Established Investigator Award (SKA), and NIH T32 AI053831 (MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER ML, 1986, HEPATOLOGY, V6, P36, DOI 10.1002/hep.1840060108; Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Goodwin M, 2004, J MOL HISTOL, V35, P839, DOI 10.1007/s10735-004-1833-2; Guyot C, 2006, INT J BIOCHEM CELL B, V38, P135, DOI 10.1016/j.biocel.2005.08.021; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lee YC, 2013, MOL CANCER RES, V11, P1401, DOI 10.1158/1541-7786.MCR-13-0108; Liu TH, 2012, BIOMARK INSIGHTS, V7, P105, DOI 10.4137/BMI.S10009; Lodyga M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aao3469; Murphy Sherry L, 2017, Natl Vital Stat Rep, V66, P1; Pedroza M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187109; Pedroza M, 2018, RHEUMATOLOGY, V57, P1838, DOI 10.1093/rheumatology/kex347; Pedroza M, 2016, FASEB J, V30, P129, DOI 10.1096/fj.15-273953; Pedroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022667; Row S, 2016, J CELL SCI, V129, P2950, DOI 10.1242/jcs.183772; Schneider DJ, 2012, FASEB J, V26, P503, DOI 10.1096/fj.11-186098; Wu MH, 2014, ARTHRITIS RHEUMATOL, V66, P1010, DOI 10.1002/art.38275; Zhao YL, 2016, BIOMED REP, V4, P269, DOI 10.3892/br.2016.578	21	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0218971	10.1371/journal.pone.0218971	http://dx.doi.org/10.1371/journal.pone.0218971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269038	Green Published, Green Submitted, gold			2022-12-26	WOS:000484927300033
J	Gilson, P; Franczak, C; Dubouis, L; Husson, M; Rouyer, M; Demange, J; Perceau, M; Leroux, A; Merlin, JL; Harle, A				Gilson, Pauline; Franczak, Claire; Dubouis, Ludovic; Husson, Marie; Rouyer, Marie; Demange, Jessica; Perceau, Marie; Leroux, Agnes; Merlin, Jean-Louis; Harle, Alexandre			Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pipetting in a fully-automated platform and Next-Generation Sequencing for laboratory workflow optimisation	PLOS ONE			English	Article							PCR	Background Assessment of KRAS, NRAS (RAS) and BRAF mutations is a standard in the management of patients with metastatic colorectal cancer (mCRC). Mutations could be assessed using next-generation sequencing (NGS) or real-time PCR-based assays. Times to results are 1 to 2 weeks for NGS and 1 to 3 days for real-time PCR-based assays. Using NGS can delay first-line treatment commencement and using PCR-based assays is limited by the number of possible analysed targets. The Idylla system is a real-time PCR cartridge-based assay, able to analyse hotspots mutations using one section of FFPE tumour tissue sample. To combine short delays and analysis of a large gene-panel, we propose here a laboratory workflow combining the Idylla system and NGS and compatible with FFPE samples with low tissue quantity. In this study we evaluated and validated the Idylla system for the analysis of RAS and BRAF mutations by pipetting directly DNA in the cartridge instead of FFPE section as recommended by the manufacturer. Materials and methods DNA extracted from 29 FFPE samples from mCRC patients with NGS-characterized RAS and BRAF mutations were tested with the Idylla KRAS and the Idylla NRAS-BRAF mutation tests to assess sensitivity, specificity, reproducibility and limit of detection of each test. Results A 100% concordance was found between NGS and Idylla results for the determination of KRAS (12/12), NRAS (12/12) and BRAF (11/11) mutations with a sensitivity and a specificity of 100%. The system showed a good reproducibility with CV inferior to 3%. LOD was reached with 2.5 ng of DNA for KRAS and NRAS mutations and 5 ng of DNA for BRAF mutations. Conclusions The analysis of RAS and BRAF mutations using DNA pipetted directly in the cartridge of the Idylla system showed a good sensitivity, specificity, reproducibility and LOD, and can be integrated in a laboratory workflow for samples with few tissue without compromising a further complete tumour characterization using NGS.	[Gilson, Pauline; Merlin, Jean-Louis; Harle, Alexandre] Univ Lorraine, Inst Cancerol Lorraine, Serv Biopathol, CNRS UMR 7039 CRAN, Vandoeuvre Les Nancy, France; [Gilson, Pauline; Franczak, Claire; Dubouis, Ludovic; Husson, Marie; Rouyer, Marie; Demange, Jessica; Perceau, Marie; Leroux, Agnes; Merlin, Jean-Louis; Harle, Alexandre] Inst Cancerol Lorraine, Serv Biopathol, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Institut de cancerologie de Lorraine (ICL); Universite de Lorraine; UNICANCER; Institut de cancerologie de Lorraine (ICL)	Harle, A (corresponding author), Univ Lorraine, Inst Cancerol Lorraine, Serv Biopathol, CNRS UMR 7039 CRAN, Vandoeuvre Les Nancy, France.; Harle, A (corresponding author), Inst Cancerol Lorraine, Serv Biopathol, Vandoeuvre Les Nancy, France.	a.harle@nancy.unicancer.fr		Harle, Alexandre/0000-0001-9548-6522	Biocartis	Biocartis	All reagents for this study have been provided free of charge by Biocartis, manufacturer of the Idylla (TM) system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional source of support has been received for this study.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Clarke CN, 2015, J GASTROINTEST ONCOL, V6, P660, DOI 10.3978/j.issn.2078-6891.2015.077; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Luca C, 2017, J CLIN PATHOL, V70, P295, DOI 10.1136/jclinpath-2016-203989; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; Franczak C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43646-0; Franczak C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212801; Harle A, 2016, TARGET ONCOL, V11, P363, DOI 10.1007/s11523-015-0404-7; Harle A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153576; Laurent-Puig P, 2015, CLIN CANCER RES, V21, P1087, DOI 10.1158/1078-0432.CCR-14-0983; Leufkens AM, 2011, SCAND J GASTROENTERO, V46, P887, DOI 10.3109/00365521.2011.574732; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Sanz-Garcia E, 2017, ANN ONCOL, V28, P2648, DOI 10.1093/annonc/mdx401; Solassol J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163444; Uguen A, 2018, J CLIN PATHOL, V71, P757, DOI 10.1136/jclinpath-2018-205189; Van Cutsem E, 2016, ANN ONCOL, V27, P1386, DOI 10.1093/annonc/mdw235; van der Velden DL, 2017, ANN ONCOL, V28, P3070, DOI 10.1093/annonc/mdx528	19	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2019	14	7							e0219204	10.1371/journal.pone.0219204	http://dx.doi.org/10.1371/journal.pone.0219204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3ZV	31265477	Green Submitted, Green Published			2022-12-26	WOS:000484921200023
J	Bhatt, N; Budhathoki, SS; Lucero-Prisno, DEI; Shrestha, G; Bhattachan, M; Thapa, J; Sunny, AK; Upadhyaya, P; Ghimire, A; Pokharel, PK				Bhatt, Navin; Budhathoki, Shyam Sundar; Lucero-Prisno, Don Eliseo Ill; Shrestha, Gambhir; Bhattachan, Meika; Thapa, Jeevan; Sunny, Avinash K.; Upadhyaya, Pawan; Ghimire, Anup; Pokharel, Paras K.			What motivates open defecation? A qualitative study from a rural setting in Nepal	PLOS ONE			English	Article							SANITATION; HYGIENE; DEMAND	Introduction Open defecation is ongoing in Nepal despite the rise in efforts for increasing latrine coverage and its use. Understanding the reasons for open defecation would complement the ongoing efforts to achieve the 'open defecation free' status in Nepal. This study aimed at exploring different motivations of people who practice open defecation in a village in Nepal. Methods This study was conducted among the people from the Hattimudha village in Morang district of eastern Nepal, who practiced open defecation. Maximum variation sampling method was used to recruit participants for 20 in-depth interviews and 2 focus group discussions. We adopted a content analysis approach to analyze the data. Results We categorized different reasons for open defecation as motivation by choice and motivation by compulsion. Open defecation by choice as is expressed as a medium for socializing, a habit and an enjoyable outdoor activity that complies with spiritual and religious norms. Open defecation by compulsion include reasons such as not having a latrine at home or having an alternative use for the latrine structures. Despite having a private latrine at home or access to a public latrine, people were compelled to practice open defecation due to constraints of norms restricting latrine use and hygiene issues in general. For women the issues with privacy and issues refraining women to use the same latrine as men compelled women to look for open defecation places. Conclusion Open defecation is either a voluntary choice or a compulsion. This choice is closely linked with personal preferences, cultural and traditional norms with special concerns for privacy for women and girls in different communities. The ongoing campaigns to promote latrine construction and its use needs to carefully consider these factors in order to reduce the open defecation practices and increase the use of sanitary latrines.	[Bhatt, Navin; Budhathoki, Shyam Sundar; Shrestha, Gambhir; Bhattachan, Meika; Thapa, Jeevan; Sunny, Avinash K.; Upadhyaya, Pawan; Ghimire, Anup; Pokharel, Paras K.] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Lucero-Prisno, Don Eliseo Ill] London Sch Hyg & Trop Med, London, England; [Lucero-Prisno, Don Eliseo Ill] Univ Philippines Open Univ, Laguna, Philippines; [Bhatt, Navin] Bayalpata Hosp Nyaya Hlth Nepal Possible, Achham, Nepal; [Budhathoki, Shyam Sundar; Sunny, Avinash K.] Golden Community, Lalitpur, Nepal; [Shrestha, Gambhir] BP Koirala Mem Canc Hosp, Bharatpur, Nepal; [Thapa, Jeevan] Patan Acad Hlth Sci, Lalitpur, Nepal	B.P. Koirala Institute of Health Sciences; University of London; London School of Hygiene & Tropical Medicine; University of the Philippines System; University of the Philippines Open University	Budhathoki, SS (corresponding author), Golden Community, Lalitpur, Nepal.	ss.budhathoki@gmail.com	Budhathoki, Shyam Sundar/X-5167-2018	Budhathoki, Shyam Sundar/0000-0002-8614-1087; Thapa, Jeevan/0000-0002-5101-9460; Lucero-Prisno, Don Eliseo III/0000-0002-2179-6365; Bhatt, Navin/0000-0002-2260-373X; Shrestha, Gambhir/0000-0002-9975-9804; Kayastha, Avinash/0000-0002-9965-181X	BPKIHS	BPKIHS	We acknowledge the support received from Ms. Urusha Silwal, Colorado State University, Colorado, USA in the editing process. The authors acknowledge the support received from the BPKIHS and from the residents of Hattimudha for their participation and coordination during data collection.	Aiemjoy K, 2017, AM J TROP MED HYG, V96, P65, DOI 10.4269/ajtmh.16-0541; [Anonymous], 2004, MAX VAR SAMPL SURV C, P1; Banda K, 2007, T ROY SOC TROP MED H, V101, P1124, DOI 10.1016/j.trstmh.2007.05.004; Barnard S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071438; Bikas Shrot Kendra, 2017, SUST OP DEF FREE CAM; Budhathoki Shyam Sundar, 2017, BMC Res Notes, V10, P209, DOI 10.1186/s13104-017-2539-3; Budhathoki Shyam Sundar, 2016, Trop Med Health, V44, P7, DOI 10.1186/s41182-016-0006-9; Caruso BA, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000414; Central Bureau of Statistics, 2012, NAT POP HOUS CENS 20, V1; Clair R.P., 2018, QUALITATIVE RES REPO, V19, P51; Clair R. P., 2003, EXPRESSIONS ETHNOGRA; Clair RP, 2019, HEALTH COMMUN, V34, P1231, DOI 10.1080/10410236.2018.1473705; Coffey D., 2014, ECON POLIT WEEKLY, P43; Crabtree BF., 1999, DOING QUALITATIVE RE, V2nd ed; Crocker J, 2017, INT J HYG ENVIR HEAL, V220, P551, DOI 10.1016/j.ijheh.2017.02.011; Deen T, 2014, UN VOWS ELIMINATE OP, P1; Department of Water Supply and Sewerage, 2011, NAT SAN HYG MAST PLA; Environment Sanitation Section National Sanitation and Hygiene Coordination Committee (NSHCC), 2018, ENV SAN SECT; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Harter M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5287-y; Jenkins MW, 2007, SOC SCI MED, V64, P2427, DOI 10.1016/j.socscimed.2007.03.010; Mara D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000363; McMichael C, 2016, SOC SCI MED, V163, P28, DOI 10.1016/j.socscimed.2016.06.051; Ministry of Education PRC, 2018, ORD HIGH SCH MATH CU, V2017, P1; Ministry of Health and Population (MOHP), 2017, NEP DEM HLTH SURV 20; Ministry of Health & Population, 2016, 207374 MIN HLTH POP; Pokharel P.K., 2016, KATHMANDU U MED J, Vvol. 55, P293; Practical Action Consulting, 2006, BANGL RUR SAN SUPPL; Robinson A., 2006, Waterlines, V25, P8, DOI 10.3362/0262-8104.2006.046; Routray P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2206-3; Sahoo KC, 2015, SOC SCI MED, V139, P80, DOI 10.1016/j.socscimed.2015.06.031; Shiras T, 2018, BMC INT HEALTH HUM R, V18, DOI 10.1186/s12914-018-0169-z; Steering Committee for National Sanitation Action, 2006, GUID SCH LED TOT SAN; Thys S, 2015, PLOS NEGLECT TROP D, V9, P1; UNICEF, 2013, BIG STEPS OP DEF FRE, P1; UNICEF Regional Office for South Asia, 2018, UNICEF S AS 2018 202, P1; United Nations, 2016, SUSTAINABLE DEV GOAL; USAID Water Team, 2017, GLOB WATERS, V8, P1; Vyas S, 2018, J DEV STUD, V54, P2119, DOI 10.1080/00220388.2018.1469742; Waterkeyn J, 2005, SOC SCI MED, V61, P1958, DOI 10.1016/j.socscimed.2005.04.012; World Health Organization, 2017, INTEGRATED CARE OLDE, P1; World Health Organization, 2018, SNAK ENV NEGL TROP D, P1	42	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219246	10.1371/journal.pone.0219246	http://dx.doi.org/10.1371/journal.pone.0219246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3YW	31260506	Green Submitted, Green Published, gold			2022-12-26	WOS:000484918700047
J	Best, RL; LaPointe, NE; Liang, JH; Ruan, K; Shade, MF; Wilson, L; Feinstein, SC				Best, Rebecca L.; LaPointe, Nichole E.; Liang, Jiahao; Ruan, Kevin; Shade, Madeleine F.; Wilson, Leslie; Feinstein, Stuart C.			Tau isoform-specific stabilization of intermediate states during microtubule assembly and disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tau protein (tau); microtubule; microtubule-associated protein (MAP); tauopathy; neurodegeneration; neurodegenerative disease; Alzheimer disease; cytoskeleton; neurofibrillary tangle; neuronal protein	ALPHA-BETA-TUBULIN; SLOWLY HYDROLYZABLE ANALOG; DYNAMIC INSTABILITY; NEURITE OUTGROWTH; GTP HYDROLYSIS; DEPOLYMERIZATION PRODUCTS; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; STRUCTURAL TRANSITIONS; FTDP-17 MUTATIONS	The microtubule (MT)-associated protein tau regulates the critical growing and shortening behaviors of MTs, and its normal activity is essential for neuronal development and maintenance. Accordingly, aberrant tau action is tightly associated with Alzheimer's disease and is genetically linked to several additional neurodegenerative diseases known as tauopathies. Although tau is known to promote net MT growth and stability, the precise mechanistic details governing its regulation of MT dynamics remain unclear. Here, we have used the slowly-hydrolyzable GTP analog, guanylyl-(alpha,beta)-methylene-diphosphonate (GMPCPP), to examine the structural effects of tau at MT ends that may otherwise be too transient to observe. The addition of both four-repeat (4R) and three-repeat (3R) tau isoforms to pre-formed GMPCPP MTs resulted in the formation of extended, multiprotofilament-wide projections at MT ends. Furthermore, at temperatures too low for assembly of bona fide MTs, both tau isoforms promoted the formation of long spiral ribbons from GMPCPP tubulin heterodimers. In addition, GMPCPP MTs undergoing cold-induced disassembly in the presence of 4R tau (and to a much lesser extent 3R tau) also formed spirals. Finally, three pathological tau mutations known to cause neurodegeneration and dementia were differentially compromised in their abilities to stabilize MT disassembly intermediates. Taken together, we propose that tau promotes the formation/stabilization of intermediate states in MT assembly and disassembly by promoting both longitudinal and lateral tubulin-tubulin contacts. We hypothesize that these activities represent fundamental aspects of tau action that normally occur at the GTP-rich ends of GTP/GDP MTs and that may be compromised in neurodegeneration-causing tau variants.	[Best, Rebecca L.; LaPointe, Nichole E.; Liang, Jiahao; Ruan, Kevin; Shade, Madeleine F.; Wilson, Leslie; Feinstein, Stuart C.] Univ Calif Santa Barbara, Neurosci Res Inst, Bldg 571,Rm 6129, Santa Barbara, CA 93106 USA; [Best, Rebecca L.; LaPointe, Nichole E.; Liang, Jiahao; Ruan, Kevin; Shade, Madeleine F.; Wilson, Leslie] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Liang, Jiahao] Univ Calif San Francisco, Dept Pharmaceut Chem, 1700 4th St, San Francisco, CA 94158 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California San Francisco	Feinstein, SC (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Bldg 571,Rm 6129, Santa Barbara, CA 93106 USA.	feinstei@lifesci.ucsb.edu		Ruan, Kevin/0000-0002-8319-3092; Best, Rebecca/0000-0001-7183-879X; Feinstein, Stuart/0000-0002-1662-6759; Liang, Jiahao/0000-0002-6701-4808	UCSB Academic Senate Research Grant; National Science Foundation [1650114]	UCSB Academic Senate Research Grant; National Science Foundation(National Science Foundation (NSF))	This work was supported, in whole or in part, by UCSB Academic Senate Research Grant 2017-2018 (to S.C.F.) and National Science Foundation Grant 1650114 (to R.L.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Arnal I, 2000, J CELL BIOL, V149, P767, DOI 10.1083/jcb.149.4.767; Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Best RL, 2017, METHOD CELL BIOL, V141, P3, DOI 10.1016/bs.mcb.2017.06.001; Breuzard G, 2013, J CELL SCI, V126, P2810, DOI 10.1242/jcs.120832; Brouhard GJ, 2014, J CELL BIOL, V207, P323, DOI 10.1083/jcb.201407095; Brunden KR, 2017, NEUROBIOL DIS, V105, P328, DOI 10.1016/j.nbd.2016.12.021; Bunker JM, 2006, J BIOL CHEM, V281, P11856, DOI 10.1074/jbc.M509420200; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Caudron N, 2002, J BIOL CHEM, V277, P50973, DOI 10.1074/jbc.M209753200; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Combs B, 2012, BIOCHEMISTRY-US, V51, P8597, DOI 10.1021/bi3010818; DeTure M, 2000, BRAIN RES, V853, P5, DOI 10.1016/S0006-8993(99)02124-1; Devred F, 2004, BIOCHEMISTRY-US, V43, P10520, DOI 10.1021/bi0493160; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Duan AR, 2017, J MOL BIOL, V429, P1424, DOI 10.1016/j.jmb.2017.03.018; Elie-Caille C, 2007, CURR BIOL, V17, P1765, DOI 10.1016/j.cub.2007.08.063; ERICKSON H P, 1974, Journal of Supramolecular Structure, V2, P393, DOI 10.1002/jss.400020228; ERICKSON HP, 1986, ANN NY ACAD SCI, V466, P552, DOI 10.1111/j.1749-6632.1986.tb38432.x; ESMAELIAZAD B, 1994, J CELL SCI, V107, P869; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; FRIGON RP, 1975, BIOCHEMISTRY-US, V14, P4559, DOI 10.1021/bi00692a001; FYGENSON DK, 1994, PHYS REV E, V50, P1579, DOI 10.1103/PhysRevE.50.1579; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Goedert M, 2000, BBA-MOL BASIS DIS, V1502, P110, DOI 10.1016/S0925-4439(00)00037-5; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Guesdon A, 2016, NAT CELL BIOL, V18, P1102, DOI 10.1038/ncb3412; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hinrichs MH, 2012, J BIOL CHEM, V287, P38559, DOI 10.1074/jbc.M112.369785; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; Hoog JL, 2011, J CELL SCI, V124, P693, DOI 10.1242/jcs.072967; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Janning D, 2014, MOL BIOL CELL, V25, P3541, DOI 10.1091/mbc.E14-06-1099; Janosi IM, 2002, BIOPHYS J, V83, P1317, DOI 10.1016/S0006-3495(02)73902-7; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1986, J MOL BIOL, V187, P61, DOI 10.1016/0022-2836(86)90406-7; Kadavath H, 2015, P NATL ACAD SCI USA, V112, P7501, DOI 10.1073/pnas.1504081112; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; KARR TL, 1980, J BIOL CHEM, V255, P8560; Kellogg EH, 2018, SCIENCE, V360, P1242, DOI 10.1126/science.aat1780; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; KIM H, 1986, ANN NY ACAD SCI, V466, P218, DOI 10.1111/j.1749-6632.1986.tb38396.x; KIRSCHNER M W, 1974, Journal of Supramolecular Structure, V2, P412, DOI 10.1002/jss.400020229; KIRSCHNER MW, 1975, ANN NY ACAD SCI, V253, P90, DOI 10.1111/j.1749-6632.1975.tb19195.x; KIRSCHNER MW, 1974, P NATL ACAD SCI USA, V71, P1159, DOI 10.1073/pnas.71.4.1159; KIRSCHNER MW, 1975, J MOL BIOL, V99, P263, DOI 10.1016/S0022-2836(75)80144-6; KIRSCHNER MW, 1986, NATURE, V324, P621, DOI 10.1038/324621a0; Konzack S, 2007, J NEUROSCI, V27, P9916, DOI 10.1523/JNEUROSCI.0927-07.2007; Kutter S, 2016, J MOL BIOL, V428, P1742, DOI 10.1016/j.jmb.2016.03.010; Leboeuf AC, 2008, J BIOL CHEM, V283, P36406, DOI 10.1074/jbc.M803519200; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Levy SF, 2005, J BIOL CHEM, V280, P13520, DOI 10.1074/jbc.M413490200; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Li XH, 2017, BIOPHYS J, V112, P2567, DOI 10.1016/j.bpj.2017.05.006; Li XH, 2015, J AM CHEM SOC, V137, P9218, DOI 10.1021/jacs.5b04561; Liu CWA, 1999, CELL MOTIL CYTOSKEL, V43, P232, DOI 10.1002/(SICI)1097-0169(1999)43:3<232::AID-CM6>3.0.CO;2-7; Makrides V, 2004, P NATL ACAD SCI USA, V101, P6746, DOI 10.1073/pnas.0400992101; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Margolin G, 2012, MOL BIOL CELL, V23, P642, DOI 10.1091/mbc.E11-08-0688; Martinho M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32096-9; Maurer SP, 2014, CURR BIOL, V24, P372, DOI 10.1016/j.cub.2013.12.042; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; Miller HP, 2010, METHOD CELL BIOL, V95, P3, DOI 10.1016/S0091-679X(10)95001-2; Mozziconacci J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003821; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Nagiec EE, 2001, J NEUROSCI RES, V63, P268, DOI 10.1002/1097-4547(20010201)63:3<268::AID-JNR1020>3.0.CO;2-E; Odde DJ, 1999, J CELL SCI, V112, P3283; PANDA D, 1995, BIOCHEMISTRY-US, V34, P11117, DOI 10.1021/bi00035a017; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Roostalu J, 2017, NAT REV MOL CELL BIO, V18, P702, DOI 10.1038/nrm.2017.75; Samsonov A, 2004, J CELL SCI, V117, P6129, DOI 10.1242/jcs.01531; SANDOVAL IV, 1980, J BIOL CHEM, V255, P8952; SANDOVAL IV, 1981, J BIOL CHEM, V256, P8795; SANDOVAL IV, 1978, P NATL ACAD SCI USA, V75, P3178, DOI 10.1073/pnas.75.7.3178; SANDOVAL IV, 1977, P NATL ACAD SCI USA, V74, P4881, DOI 10.1073/pnas.74.11.4881; SANDOVAL IV, 1980, J BIOL CHEM, V255, P6966; Santarella RA, 2004, J MOL BIOL, V339, P539, DOI 10.1016/j.jmb.2004.04.008; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Sept D, 2003, PROTEIN SCI, V12, P2257, DOI 10.1110/ps.03187503; SINGER WD, 1989, MOL PHARMACOL, V36, P366; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Spillantini MG, 2000, NEUROGENETICS, V2, P193, DOI 10.1007/s100480050065; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Stumpff Jason, 2007, Methods Mol Biol, V392, P37; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Tran PT, 1997, J CELL BIOL, V138, P105, DOI 10.1083/jcb.138.1.105; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; VanBuren V, 2002, P NATL ACAD SCI USA, V99, P6035, DOI 10.1073/pnas.092504999; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Vorobjev IA, 1997, J CELL SCI, V110, P2635; VOTER WA, 1984, J BIOL CHEM, V259, P430; Wang HW, 2005, CELL CYCLE, V4, P1157, DOI 10.4161/cc.4.9.2042; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; WatermanStorer CM, 1997, CURR BIOL, V7, pR369, DOI 10.1016/S0960-9822(06)00177-1; WEINGARTEN MD, 1974, BIOCHEMISTRY-US, V13, P5529, DOI 10.1021/bi00724a012; WILSON L, 1982, J MOL BIOL, V159, P125, DOI 10.1016/0022-2836(82)90035-3; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012	118	5	5	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12265	12280		10.1074/jbc.RA119.009124	http://dx.doi.org/10.1074/jbc.RA119.009124			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31266806	Green Published, hybrid			2022-12-26	WOS:000484402700001
J	Noeparast, A; Giron, P; Noor, A; Shahi, RB; De Brakeleer, S; Eggermont, C; Vandenplas, H; Boeckx, B; Lambrechts, D; De Greve, J; Teugels, E				Noeparast, Amir; Giron, Philippe; Noor, Alfiah; Shahi, Rajendra Bahadur; De Brakeleer, Sylvia; Eggermont, Carolien; Vandenplas, Hugo; Boeckx, Bram; Lambrechts, Diether; De Greve, Jacques; Teugels, Erik			CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition	ONCOGENE			English	Article							DABRAFENIB PLUS TRAMETINIB; C-RAF; COMBINED BRAF; MAPK PATHWAY; B-RAF; KINASE; ACTIVATION; SORAFENIB; KRAS; PHOSPHORYLATION	Two out of 41 non-small cell lung cancer patients enrolled in a clinical study were found with a somatic CRAF mutation in their tumor, namely CRAF(P261A) and CRAF(P207S). To our knowledge, both mutations are novel in lung cancer and CRAF(P261A) has not been previously reported in cancer. Expression of CRAF(P261A) in HEK293T cells and BEAS-2B lung epithelial cells led to increased ERK pathway activation in a dimer-dependent manner, accompanied with loss of CRAF phosphorylation at the negative regulatory S259 residue. Moreover, stable expression of CRAF(P261A) in mouse embryonic fibroblasts and BEAS-2B cells led to anchorage-independent growth. Consistent with a previous report, we could not observe a gain-of-function with CRAF(P207S). Type II but not type I RAF inhibitors suppressed the CRAF(P261A)-induced ERK pathway activity in BEAS-2B cells, and combinatorial treatment with type II RAF inhibitors and a MEK inhibitor led to a stronger ERK pathway inhibition and growth arrest. Our findings suggest that the acquisition of a CRAF(P261A) mutation can provide oncogenic properties to cells, and that such cells are sensitive to combined MEK and type II RAF inhibitors. CRAF mutations should be diagnostically and therapeutically explored in lung and perhaps other cancers.	[Noeparast, Amir; Giron, Philippe; Noor, Alfiah; Shahi, Rajendra Bahadur; De Brakeleer, Sylvia; Eggermont, Carolien; Vandenplas, Hugo; De Greve, Jacques; Teugels, Erik] Vrije Univ Brussel, UZ Brussel, Oncol Ctr, Lab Mol Oncol, Brussels, Belgium; [Noeparast, Amir; Giron, Philippe; Noor, Alfiah; Shahi, Rajendra Bahadur; De Brakeleer, Sylvia; Eggermont, Carolien; Vandenplas, Hugo; De Greve, Jacques; Teugels, Erik] Vrije Univ Brussel, UZ Brussel, Oncol Ctr, Dept Med Oncol, Brussels, Belgium; [Boeckx, Bram; Lambrechts, Diether] VIB, Vesalius Res Ctr, B-3000 Leuven, Belgium; [Boeckx, Bram; Lambrechts, Diether] Katholieke Univ Leuven, Dept Oncol, Lab Translat Genet, B-3000 Louvain, Belgium	University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); KU Leuven	Noeparast, A; De Greve, J; Teugels, E (corresponding author), Vrije Univ Brussel, UZ Brussel, Oncol Ctr, Lab Mol Oncol, Brussels, Belgium.; Noeparast, A; De Greve, J; Teugels, E (corresponding author), Vrije Univ Brussel, UZ Brussel, Oncol Ctr, Dept Med Oncol, Brussels, Belgium.	amir.noeparast@vub.be; jacques.degreve@uzbrussel.be; eteugels@uzbrussel.be	, Noeparast/AAV-7252-2020; Lambrechts, Diether/AAJ-3167-2020; De Greve, Jacques/J-4939-2012	, Noeparast/0000-0002-3216-5630; Lambrechts, Diether/0000-0002-3429-302X; Giron, Philippe/0000-0002-1331-1890; Shahi, Rajendra Bahadur/0000-0002-7751-6852; De Greve, Jacques/0000-0002-2389-0742; Teugels, Erik/0000-0002-7828-4555; Eggermont, Carolien/0000-0001-6411-6422	Cancer Plan 29-39 Belgium; Wetenschappelijk Fonds Willy Gepts of the UZ Brussel; Interdisciplinary Research Program (IRP) Vrije Universiteit Brussel; Vrije Universiteit Brussel; Armand Everaert; Research Foundation-Flanders (FWO); Emmanuel van der Schueren research scholarship by Kom op Tegen Kanker	Cancer Plan 29-39 Belgium; Wetenschappelijk Fonds Willy Gepts of the UZ Brussel; Interdisciplinary Research Program (IRP) Vrije Universiteit Brussel; Vrije Universiteit Brussel; Armand Everaert; Research Foundation-Flanders (FWO)(FWO); Emmanuel van der Schueren research scholarship by Kom op Tegen Kanker	Grant Support The work was funded by the Cancer Plan 29-39 Belgium and by the Wetenschappelijk Fonds Willy Gepts of the UZ Brussel; Noeparast A. was funded by an Interdisciplinary Research Program (IRP) Vrije Universiteit Brussel. Noor A. is the beneficiary of Ph.D. Fellowship from Vrije Universiteit Brussel and was funded by Armand Everaert. Giron P. and Eggermont C. are the beneficiaries of a Ph.D. Fellowship from the Research Foundation-Flanders (FWO) and Emmanuel van der Schueren research scholarship by Kom op Tegen Kanker.	Antony R, 2013, CANCER RES, V73, P4840, DOI 10.1158/0008-5472.CAN-12-4089; Arnault JP, 2012, CLIN CANCER RES, V18, P263, DOI 10.1158/1078-0432.CCR-11-1344; Atefi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27454; Baik CS, 2017, ONCOLOGIST, V22, P786, DOI 10.1634/theoncologist.2016-0458; Chen YC, 2017, SCI REP-UK, V7, DOI 10.1038/srep44123; Corcoran RB, 2015, J CLIN ONCOL, V33, P4023, DOI 10.1200/JCO.2015.63.2471; Dankner M, 2018, ONCOGENE, V37, P3183, DOI 10.1038/s41388-018-0171-x; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Dierks C, 2013, BLOOD, V122, P4121; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Fouladi F, 2015, LEUKEMIA LYMPHOMA, V56, P2690, DOI 10.3109/10428194.2014.1003055; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Greger JG, 2012, MOL CANCER THER, V11, P909, DOI 10.1158/1535-7163.MCT-11-0989; Hatzivassiliou G, 2013, NATURE, V501, P232, DOI 10.1038/nature12441; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Holderfield M, 2014, BRIT J CANCER, V111, P640, DOI 10.1038/bjc.2014.139; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Imielinski M, 2014, J CLIN INVEST, V124, P1582, DOI 10.1172/JCI72763; Johnson DB, 2014, J CLIN ONCOL, V32, P3697, DOI 10.1200/JCO.2014.57.3535; Karoulia Z, 2017, NAT REV CANCER, V17, P676, DOI 10.1038/nrc.2017.79; King AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062613; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Lamba S, 2014, CELL REP, V8, P1475, DOI 10.1016/j.celrep.2014.07.033; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Li L, 2010, J CHROMATOGR B, V878, P3033, DOI 10.1016/j.jchromb.2010.08.049; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Long GV, 2017, ANN ONCOL, V28, P1631, DOI 10.1093/annonc/mdx176; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; MOLNAR E, 2018, ONCOGENE, V18, DOI DOI 10.1186/S12885-018-4455-X; Molzan M, 2012, J MOL BIOL, V423, P486, DOI 10.1016/j.jmb.2012.08.009; Molzan M, 2010, MOL CELL BIOL, V30, P4698, DOI 10.1128/MCB.01636-09; Noeparast Amir, 2018, Oncotarget, V9, P16110, DOI 10.18632/oncotarget.24576; Noeparast A, 2017, ONCOTARGET, V8, P60094, DOI 10.18632/oncotarget.11635; Nussinov Ruth, 2018, Biophys Rev, V10, P1263, DOI 10.1007/s12551-018-0461-0; Peng SB, 2015, CANCER CELL, V28, P384, DOI 10.1016/j.ccell.2015.08.002; Planchard D, 2016, LANCET ONCOL, V17, P984, DOI 10.1016/S1470-2045(16)30146-2; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Roring M, 2012, EMBO J, V31, P2629, DOI 10.1038/emboj.2012.100; Rosell R, 2017, LANCET ONCOL, V18, P1286, DOI 10.1016/S1470-2045(17)30678-2; Shapira S, 2007, CELL DEATH DIFFER, V14, P895, DOI 10.1038/sj.cdd.4402057; Takezawa K, 2009, CANCER RES, V69, P6515, DOI 10.1158/0008-5472.CAN-09-1076; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Vakana E, 2017, ONCOTARGET, V8, P9251, DOI 10.18632/oncotarget.14002; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Whittaker SR, 2015, MOL CANCER THER, V14, P2700, DOI 10.1158/1535-7163.MCT-15-0136-T; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Zang MW, 2008, J BIOL CHEM, V283, P31429, DOI 10.1074/jbc.M802855200; Zhang C, 2015, NATURE, V526, P583, DOI 10.1038/nature14982	55	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 1	2019	38	31					5933	5941		10.1038/s41388-019-0866-7	http://dx.doi.org/10.1038/s41388-019-0866-7			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IT3GE	31285551	Green Published, hybrid			2022-12-26	WOS:000482740000002
J	Lukic, J; Vukotic, G; Stanisavljevic, N; Kosanovic, D; Molnar, Z; Begovic, J; Terzic-Vidojevic, A; Jeney, G; Ljubobratovic, U				Lukic, Jovanka; Vukotic, Goran; Stanisavljevic, Nemanja; Kosanovic, Dejana; Molnar, Zsuzsanna; Begovic, Jelena; Terzic-Vidojevic, Amarela; Jeney, Galina; Ljubobratovic, Uros			Solid state treatment with Lactobacillus paracasei subsp. paracasei BGHN14 and Lactobacillus rhamnosus BGT10 improves nutrient bioavailability in granular fish feed	PLOS ONE			English	Article							DIGESTIVE ENZYMES; NEUTRAL LIPIDS; PROTEIN; FERMENTATION; LARVAE; DEGRADATION; AQUACULTURE; PLANTARUM; QUALITY; PHOSPHOLIPIDS	The aim of this research was to improve nutritive value of fishmeal-based feed by lactobacilli in order to achieve satisfactory nutrient availability needed to support fish development. Feed was solid-state treated at a laboratory scale with the combination of Lactobacillus paracaseisubsp. paracasei BGHN14 and Lactobacillus rhamnosus BGT10 in different experimental settings, which included the variation of strain ratio, total lactobacilli concentration, percentage of moisture and duration of incubation. Short peptides, soluble proteins, phospho-, neutral and unsaturated lipids were quantified. Differences among treated and control feeds were evaluated by Student t-test, while Gaussian process regression (GPR) modeling was employed to simulate the incubation process and define the optimal treatment combination in the context of overall feed nutritional profile. Treatment duration was shown to be the critical determinant of final outcome, either as single factor or via interaction with strain ratio. Optimal nutrient balance was achieved with 12 h incubation period, 260% moisture, 75:25 and 50:50 BGHN14:BGT10 ratios and 200 mg of lactobacilli per g of dry feed. This study should serve as the basis for large-scale tests which would simulate on-farm production of both fishmeal-based and unconventional, lower cost aquafeed with added value.	[Lukic, Jovanka; Vukotic, Goran; Stanisavljevic, Nemanja; Begovic, Jelena; Terzic-Vidojevic, Amarela] Univ Belgrade, IMGGE, Belgrade, Serbia; [Vukotic, Goran] Univ Belgrade, Fac Biol, Belgrade, Serbia; [Kosanovic, Dejana] Inst Virol Vaccines & Sera Torlak, Belgrade, Serbia; [Molnar, Zsuzsanna; Jeney, Galina; Ljubobratovic, Uros] Res Inst Fisheries & Aquaculture NAIK HAKI, Szarvas, Hungary	University of Belgrade; University of Belgrade	Lukic, J (corresponding author), Univ Belgrade, IMGGE, Belgrade, Serbia.	lukicjovanka@imgge.bg.ac.rs	Ljubobratović, Uroš/AAI-3583-2020; Lukic, Jovanka/AAU-9006-2020; Lukic, Jovanka/HHS-0787-2022	Lukic, Jovanka/0000-0002-4959-2057; Vukotic, Goran/0000-0001-9343-6214; Ljubobratovic, Uros/0000-0002-1972-467X; Stanisavljevic, Nemanja/0000-0001-5576-1833; Begovic, Jelena/0000-0001-9599-3815; Terzic-Vidojevic, Amarela/0000-0003-2919-7057	European Union's Horizon 2020 research and innovation programme [652831]; European Regional and Development Fund; Government of Hungary [GINOP-2.3.2-15-2016-00025]; Ministry of Education, Science and Technological Development of the Republic of Serbia [173019]	European Union's Horizon 2020 research and innovation programme; European Regional and Development Fund; Government of Hungary; Ministry of Education, Science and Technological Development of the Republic of Serbia	This research has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 652831 (AQUAEXCEL2020), https://ec.europa.eu/programmes/horizon2020/, European Regional and Development Fund and the Government of Hungary within the project GINOP-2.3.2-15-2016-00025, http://www.kormany.hu/en, https://ec.europa.eu/regional_policy/en/funding/erdf/, and by the National project No. 173019 of the Ministry of Education, Science and Technological Development of the Republic of Serbia, http://www.mpn.gov.rs/.This output reflects only the author's view and the funders cannot be held responsible for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis M., 2015, FOOD SCI QUAL MANAG, V41, P101; Amadou I, 2011, J FOOD BIOCHEM, V35, P1686, DOI 10.1111/j.1745-4514.2010.00493.x; Andersen Synne M, 2016, Front Biosci (Elite Ed), V8, P143; [Anonymous], [No title captured]; [Anonymous], 2018, EFSA J; [Anonymous], 2011, LARVAL FISH NUTR; BROCKERH.H, 1974, ADV CHEM SER, P131; Budzko E., 2018, THESIS; Cahu C, 2003, AQUACULTURE, V227, P245, DOI 10.1016/S0044-8486(03)00507-6; Cheng YS, 2011, LIPIDS, V46, P95, DOI 10.1007/s11745-010-3494-0; Craig S, 2002, UNDERSTANDING FISH N, P1; DESNUELLE P, 1963, J LIPID RES, V4, P369; Di Cagno R, 2002, APPL ENVIRON MICROB, V68, P623, DOI 10.1128/AEM.68.2.623-633.2002; Engrola S, 2018, EMERGING ISSUES FISH, P219; Gao YL, 2013, J INTEGR AGR, V12, P869, DOI 10.1016/S2095-3119(13)60305-6; Garba Lawal, 2017, Journal of Applied Sciences, V17, P282, DOI 10.3923/jas.2017.282.295; Goeritz I, 2014, J SCI FOOD AGR, V94, P438, DOI 10.1002/jsfa.6262; Gutierrez T, 2009, BIOTECHNOL BIOENG, V103, P207, DOI 10.1002/bit.22218; Hammoumi A, 1998, PROCESS BIOCHEM, V33, P423, DOI 10.1016/S0032-9592(97)00092-7; Hamre K, 2013, REV AQUACULT, V5, pS26, DOI 10.1111/j.1753-5131.2012.01086.x; Higgins BT, 2014, ANAL BIOCHEM, V465, P81, DOI 10.1016/j.ab.2014.07.020; Holt G.J., 2011, LARVAL FISH NUTR, P353, DOI DOI 10.1002/9780470959862.CH13; Izquierdo M, 2011, LARVAL FISH NUTR, P54; Kolkovski S, 2013, WOODHEAD PUBL FOOD S, P203, DOI 10.1533/9780857097460.1.203; Kolkovski S, 2009, BASICS, P315, DOI 10.1533/9781845696474.3.315; Kolkovski S, 2001, AQUACULTURE, V200, P181, DOI 10.1016/S0044-8486(01)00700-1; Kolkovski S, 2010, 2004258 DEP FISH, V198; Kristinsson HG, 2000, CRIT REV FOOD SCI, V40, P43, DOI 10.1080/10408690091189266; Kvale A, 2007, AQUACULT NUTR, V13, P170, DOI 10.1111/j.1365-2095.2007.00464.x; Laporte J., 2015, J ANIM RES NUTR, V01, P1, DOI [10.21767/2572-5459.100007, DOI 10.21767/2572-5459.100007]; Liang KH, 2012, J AGR FOOD CHEM, V60, P11771, DOI 10.1021/jf302836v; Ljubobratovic U, 2017, RES VET SCI, V115, P451, DOI 10.1016/j.rvsc.2017.07.018; Lopez-Alvarado J., 1997, Journal of Applied Aquaculture, V7, P53, DOI 10.1300/J028v07n03_06; MacWilliams MP, 2006, LURIA BROTH LB LURIA; McSweeney PLH, 1997, LAIT, V77, P41, DOI 10.1051/lait:199713; Mei CL, 2016, CHEM IND CHEM ENG Q, V22, P127, DOI 10.2298/CICEQ150125026M; Dallagnol AM, 2013, APPL MICROBIOL BIOT, V97, P3129, DOI 10.1007/s00253-012-4520-3; Mika A, 2016, LWT-FOOD SCI TECHNOL, V70, P199, DOI 10.1016/j.lwt.2016.02.051; Morais S, 2007, AQUACULTURE, V268, P106, DOI 10.1016/j.aquaculture.2007.04.033; Mpurino JLP, 2012, AQUAC NUTR, V18, P73; Nayak SK, 2010, FISH SHELLFISH IMMUN, V29, P2, DOI 10.1016/j.fsi.2010.02.017; New MB, 1993, FAO FISHERIES TECHNI, V343, P1; Pandey B., 2018, LIFE SCI; Pandey G., 2013, INT RES J PHARM, V4, P23, DOI [10.7897/2230-8407.04306, DOI 10.7897/2230-8407.04306]; Refstie S., 2001, Recent Advances in Animal Nutrition in Australia, V13, P195; Ren XJ, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0633-9; Rokey Galen J., 2010, R. Bras. Zootec., V39, P510, DOI 10.1590/S1516-35982010001300055; Ronnestad I, 1999, AQUACULTURE, V177, P201, DOI 10.1016/S0044-8486(99)00082-4; Ronnestad I, 2013, REV AQUACULT, V5, pS59, DOI 10.1111/raq.12010; Ruas-Madiedo P, 2012, HDB ANIMAL BASED FER, P131; Samuelsen TA, 2016, AQUACULT NUTR, V22, P120, DOI 10.1111/anu.12235; Sargent John R., 2002, P181; Sheen SS, 2014, J AQUAC MAR BIO, V1, P1; SHEWFELT RL, 1981, J FOOD BIOCHEM, V5, P79, DOI 10.1111/j.1745-4514.1981.tb00663.x; Tocher DR, 2008, AQUACULTURE, V280, P21, DOI 10.1016/j.aquaculture.2008.04.034; Twining CW, 2016, OIKOS, V125, P749, DOI 10.1111/oik.02910; Uppada Sita Ramyasree, 2017, Journal of Genetic Engineering and Biotechnology, V15, P331, DOI 10.1016/j.jgeb.2017.07.008; Vikas P. A., 2014, Journal of Applied Aquaculture, V26, P271, DOI 10.1080/10454438.2014.942124; Waltermann M, 2005, J BACTERIOL, V187, P3607, DOI 10.1128/JB.187.11.3607-3619.2005; Wojciak KM, 2012, J FOOD QUALITY, V35, P353, DOI 10.1111/j.1745-4557.2012.00458.x; Wold PA, 2007, AQUACULTURE, V272, P502, DOI 10.1016/j.aquaculture.2007.06.034; Yin YL, 2015, INTERDISCIP SCI, V7, P205, DOI 10.1007/s12539-015-0262-0; Zambonino-Infante Jose Luis, 2008, P281; Zhu Xiangxin, 2012, Stat Anal Data Min, V5, P509, DOI 10.1002/sam.11163; Zotta T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099189; Zymon M., 2007, POLISH J FOOD NUTR S, V57, P647	66	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219558	10.1371/journal.pone.0219558	http://dx.doi.org/10.1371/journal.pone.0219558			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295295	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800046
J	Tu, IT; Cheng, YS; Mo, PC; Hsu, HY; Kuo, LC; Jou, IM; Su, FC				Tu, I-Te; Cheng, Yu-Shiuan; Mo, Pu-Chun; Hsu, Hsiu-Yun; Kuo, Li-Chieh; Jou, I-Ming; Su, Fong-Chin			Classifying hand sensorimotor functions of the chronic kidney disease patients using novel manual tactile test and pinch-holding-up activity	PLOS ONE			English	Article							CARPAL-TUNNEL SYNDROME; PRECISION GRIP; NERVE REPAIR; HEMODIALYSIS; COMPLICATIONS; MANIPULATION; PERCEPTION; DURATION; IMPACTS; MUSCLE	Hand function deterioration brings about inconvenience to the daily lives of the chronic kidney disease patients. However, a full spectrum of hand function examination is absent. Therefore, this study aimed to classify the hand sensorimotor functions of the chronic kidney disease patients using the novel sensorimotor assessment tools, manual tactile test (MTT) and pinch -holding -up activity (PHUA) test, and explore the feasibility in comparison with traditional evaluations in the clinical practice. 68 stage -5 chronic kidney disease patients and 50 healthy subjects were recruited in this study. A series of conventional evaluations and two novel hand function tools, manual tactile test and pinch -holding -up activity test were conducted from the perspective of hand dexterity, sensory input threshold, force generation and sensorimotor control. Independent t -test was used to find out group differences and the receiver operating characteristic curve was used to determine accuracy of the tests. In our results, significant reduction of hand dexterity, sensory input, force generation and sensorimotor control was found in patients from an overall perspective. This trend was discovered to be the same when dividing the subjects into the old and young age group. From the receiver operator characteristic curves, nearly all the areas under the curve of all tests were over 0.8. The novel evaluation tools, the manual tactile test and pinch -holding -up activity, were found to have comparable or even better accuracy than the traditional ones. The shape and weight subtests of the manual tactile test displayed the highest accuracy. To sum up, by incorporating the novel and conventional assessment tests, this study built up the fundamental understanding of the hand functions in multiple dimensions and consolidate the clinical merits of applying the two novel tools, manual tactile test and pinch -holding -up activity, on chronic kidney disease patients.	[Tu, I-Te; Cheng, Yu-Shiuan; Mo, Pu-Chun; Hsu, Hsiu-Yun; Kuo, Li-Chieh; Su, Fong-Chin] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Tu, I-Te] Chi Mei Med Ctr, Dept Internal Med, Div Nephrol, Tainan, Taiwan; [Hsu, Hsiu-Yun; Kuo, Li-Chieh] Natl Cheng Kung Univ, Dept Occupat Therapy, Tainan, Taiwan; [Jou, I-Ming] E Da Hosp, Dept Orthoped, Kaohsiung, Taiwan; [Su, Fong-Chin] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan	National Cheng Kung University; Chi Mei Hospital; National Cheng Kung University; E-Da Hospital; National Cheng Kung University	Su, FC (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan.; Su, FC (corresponding author), Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan.	fcsu@mail.ncku.edu.tw	Hsu, Hsiu-Yun/AGZ-2698-2022; SU, FONG-CHIN/C-8094-2011; Kuo, Li-Chieh/ABC-3826-2021	SU, FONG-CHIN/0000-0002-3870-4842; Kuo, Li-Chieh/0000-0001-7728-0096	Chi Mei Medical Center, Liouying [CLFHR10707]	Chi Mei Medical Center, Liouying	This study was supported and funded by Chi Mei Medical Center, Liouying, grant number: CLFHR10707 (http://www.chimei.org.tw/main/cmh_department/54220/english/) awarded to ITT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hayk K, 2007, NEUROLOGIST, V13, P188, DOI 10.1097/01.nrl.0000263699.53969.e9; Amirjani N, 2007, MUSCLE NERVE, V35, P788, DOI 10.1002/mus.20750; Amirjani N, 2011, MUSCLE NERVE, V43, P171, DOI 10.1002/mus.21856; Augurelle AS, 2003, J NEUROPHYSIOL, V89, P665, DOI 10.1152/jn.00249.2002; Bell-Krotoski J A, 1997, J Hand Ther, V10, P297; CHAPMAN CE, 1994, CAN J PHYSIOL PHARM, V72, P558, DOI 10.1139/y94-080; CHARRA B, 1988, BLOOD PURIFICAT, V6, P117, DOI 10.1159/000169493; Chiu HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093305; Duruoz MT, 2003, SWISS MED WKLY, V133, P433; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; GILBERT MS, 1988, J BONE JOINT SURG AM, V70A, P1145, DOI 10.2106/00004623-198870080-00005; Hansson P, 2007, PAIN, V129, P256, DOI 10.1016/j.pain.2007.03.030; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hsu HY, 2018, PM&R, V10, P146, DOI 10.1016/j.pmrj.2017.07.001; Hsu HY, 2017, J HAND THER, V30, P65, DOI 10.1016/j.jht.2016.03.004; Hsu HY, 2016, ARCH PHYS MED REHAB, V97, P983, DOI 10.1016/j.apmr.2016.01.008; Hsu HY, 2015, DIABETES-METAB RES, V31, P385, DOI 10.1002/dmrr.2623; Hsu HY, 2014, ARCH PHYS MED REHAB, V95, P717, DOI 10.1016/j.apmr.2013.11.017; Hsu HY, 2013, ARCH PHYS MED REHAB, V94, P451, DOI 10.1016/j.apmr.2012.07.024; Hsu HY, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-26; Johansen KL, 2003, KIDNEY INT, V63, P291, DOI 10.1046/j.1523-1755.2003.00704.x; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1992, EXP BRAIN RES, V89, P192, DOI 10.1007/BF00229016; Limaye V, 2001, ANN RHEUM DIS, V60, P278, DOI 10.1136/ard.60.3.278; Mafra D, 2008, NEPHROL DIAL TRANSPL, V23, P2461, DOI 10.1093/ndt/gfn053; Nardin R, 2005, ARCH NEUROL-CHICAGO, V62, P271, DOI 10.1001/archneur.62.2.271; Norman JF, 2016, PERCEPTION, V45, P1387, DOI 10.1177/0301006616659073; Norman JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068577; Norman JF, 2009, PERCEPTION, V38, P1347, DOI 10.1068/p6367; Rizzo MA, 2012, J NEPHROL, V25, P170, DOI 10.5301/jn.5000087; Rosen B, 2001, J HAND SURG-BRIT EUR, V26, P196, DOI 10.1054/jhsb.2001.0567; SCHWARZ A, 1984, CLIN NEPHROL, V22, P133; Tander B, 2007, RENAL FAILURE, V29, P477, DOI 10.1080/08860220701268167; THORNBURY JM, 1981, J GERONTOL, V36, P34, DOI 10.1093/geronj/36.1.34; Tremblay F., 2016, SCHOLARPEDIA TOUCH, P351, DOI [10.2991/978-94-6239-133-8_29, DOI 10.2991/978-94-6239-133-8_29]; WESTLING G, 1984, EXP BRAIN RES, V53, P277	37	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219762	10.1371/journal.pone.0219762	http://dx.doi.org/10.1371/journal.pone.0219762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4LN	31295337	gold, Green Submitted, Green Published			2022-12-26	WOS:000484951800068
J	Donner, DB; Nakakura, EK; Venook, AP; Lenz, HJ; Zhang, W; Hwang, J; Bergsland, EK; Lin, MH; Toriguchi, K; Antonia, RJ; Warren, RS				Donner, David B.; Nakakura, Eric K.; Venook, Alan P.; Lenz, Heinz-Josef; Zhang, Wu; Hwang, Jimee; Bergsland, Emily K.; Lin, Meng Hsun; Toriguchi, Kan; Antonia, Ricardo J.; Warren, Robert S.			High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinoma	PLOS ONE			English	Article							COLORECTAL-CANCER PATIENTS; INDEPENDENT PROGNOSTIC-FACTOR; MESSENGER-RNA EXPRESSIONS; DIHYDROPYRIMIDINE DEHYDROGENASE; CLINICAL-SIGNIFICANCE; POLYMORPHISMS; FLUOROURACIL; CHEMOTHERAPY; SURVIVAL; 5-FLUOROURACIL	Introduction Prognosis after resection of hepatocellular carcinoma (HCC) is highly variable. Compared to clinicopathologic factors, the use of molecular markers to predict outcome has not been well studied. We investigated the prognostic importance of thymidylate synthase (TS) gene expression and polymorphisms in patients after resection of HCC. Methods Patients who underwent complete resection of HCC for whom tissue was available were identified. TS gene expression level and polymorphisms were determined in HCC specimens. Prognostic factors were evaluated using Kaplan-Meier curves and Cox proportional hazard models. Results The study included 67 patients. In univariate analysis, variables that negatively influenced survival included TNM stage, microvascular invasion, and high TS expression. For the high TS expression group, median survival was 54 months and 5-year actuarial survival was 47%. For the low TS expression group, median survival was not reached and the 5-year actuarial survival was 91%. In multivariate analysis, only high TS expression remained an independent predictor of poor survival (HR = 10.77, 95% CI 1.36-84.91; P = 0.02). TS gene polymorphisms were not associated with TS expression or overall survival. Conclusions High TS expression predicts poor outcome after resection of HCC. Molecular markers might be robust predictors of patient outcome after resection of HCC.	[Donner, David B.; Nakakura, Eric K.; Lin, Meng Hsun; Toriguchi, Kan; Antonia, Ricardo J.; Warren, Robert S.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Donner, David B.; Nakakura, Eric K.; Venook, Alan P.; Hwang, Jimee; Bergsland, Emily K.; Lin, Meng Hsun; Toriguchi, Kan; Antonia, Ricardo J.; Warren, Robert S.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Venook, Alan P.; Bergsland, Emily K.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Lenz, Heinz-Josef; Zhang, Wu] Univ Southern Calif, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA USA; [Hwang, Jimee] Univ Calif San Francisco, Biostat Core Facil, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of Southern California; University of California System; University of California San Francisco	Donner, DB; Nakakura, EK (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.; Donner, DB; Nakakura, EK (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	david.donner@ucsf.edu; eric.nakakura@ucsf.edu	Toriguchi, Kan/AAA-9525-2020	Toriguchi, Kan/0000-0001-7567-9263; Antonia, Ricardo/0000-0003-2864-8098	National Comprehensive Cancer Network (NCCN); Roche Laboratories, Inc.; Littlefield Family Foundation	National Comprehensive Cancer Network (NCCN); Roche Laboratories, Inc.; Littlefield Family Foundation	This study was approved and funded by the National Comprehensive Cancer Network (NCCN) from general research support provided by Roche Laboratories, Inc. and by the Littlefield Family Foundation. The funding agencies were not involved in the design of the study and collection, analysis and interpretation of data, and in writing the manuscript.	Blum HE, 2005, WORLD J GASTROENTERO, V11, P7391; Chen M, 2007, ONCOGENE, V26, P4817, DOI 10.1038/sj.onc.1210273; Choti MA, 2002, J VASC INTERV RADIOL, V13, pS197, DOI 10.1016/S1051-0443(07)61787-4; Danenberg PV, 2004, FRONT BIOSCI-LANDMRK, V9, P2484, DOI 10.2741/1410; Dotor E, 2006, J CLIN ONCOL, V24, P1603, DOI 10.1200/JCO.2005.03.5253; Edler D, 2000, CLIN CANCER RES, V6, P1378; Edler D, 2000, CLIN CANCER RES, V6, P488; Etienne MC, 2002, J CLIN ONCOL, V20, P2832, DOI 10.1200/JCO.2002.09.091; Fujiwaki R, 2000, ONCOLOGY-BASEL, V59, P152, DOI 10.1159/000012153; Gosens MI, 2008, INT J CANCER, V123, P1941, DOI 10.1002/ijc.23740; Graziano F, 2008, BRIT J CANCER, V99, P716, DOI 10.1038/sj.bjc.6604555; Hothorn T, 2008, BIOMETRICS, V64, P1263, DOI 10.1111/j.1541-0420.2008.00995.x; Huang ZH, 2009, CANCER CHEMOTH PHARM, V63, P911, DOI 10.1007/s00280-008-0815-6; Ichikawa W, 2003, CLIN CANCER RES, V9, P786; JOHNSTON PG, 1995, CANCER RES, V55, P1407; Kawakami K, 2005, CLIN CANCER RES, V11, P3778, DOI 10.1158/1078-0432.CCR-04-2428; Kawakami K, 2001, CLIN CANCER RES, V7, P4096; Kelley Robin K, 2013, Am Soc Clin Oncol Educ Book, DOI 10.1200/EdBook_AM.2013.33.e137; Kuramochi H, 2008, INT J ONCOL, V32, P201; Leichman CG, 2001, CURR OPIN ONCOL, V13, P291, DOI 10.1097/00001622-200107000-00013; Lencioni R, 2010, ONCOLOGIST, V15, P42, DOI 10.1634/theoncologist.2010-S4-42; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lurje G, 2009, MOL CANCER THER, V8, P1000, DOI 10.1158/1535-7163.MCT-08-0219; Mandola MV, 2004, PHARMACOGENETICS, V14, P319, DOI 10.1097/00008571-200405000-00007; Mandola MV, 2003, CANCER RES, V63, P2898; Marsh S, 2001, INT J ONCOL, V19, P383; Masuzaki Ryota, 2008, Indian J Gastroenterol, V27, P113; Mizutani Y, 2003, CLIN CANCER RES, V9, P1453; Morganti M, 2005, EUR J CANCER, V41, P2176, DOI 10.1016/j.ejca.2005.06.016; Nakagawa T, 2002, LUNG CANCER, V35, P165, DOI 10.1016/S0169-5002(01)00407-X; Nathan H, 2009, ANN SURG, V250, P970, DOI 10.1097/SLA.0b013e3181b25183; Nii A, 2009, HEPATOL RES, V39, P274, DOI 10.1111/j.1872-034X.2008.00457.x; Nomura T, 2002, INT J UROL, V9, P368, DOI 10.1046/j.1442-2042.2002.00479.x; Okano Y, 2017, ONCOL LETT, V14, P930, DOI 10.3892/ol.2017.6241; Pestalozzi BC, 1997, J CLIN ONCOL, V15, P1923, DOI 10.1200/JCO.1997.15.5.1923; PINEDO HM, 1988, J CLIN ONCOL, V6, P1653, DOI 10.1200/JCO.1988.6.10.1653; Poon RTP, 2000, ANN SURG, V231, P544, DOI 10.1097/00000658-200004000-00014; Pullarkat S. T., 2001, Pharmacogenomics Journal, V1, P65; Rahman L, 2004, CANCER CELL, V5, P341, DOI 10.1016/S1535-6108(04)00080-7; Schwartz M, 2007, NAT CLIN PRACT ONCOL, V4, P424, DOI 10.1038/ncponc0844; Shintani Y, 2003, INT J CANCER, V104, P790, DOI 10.1002/ijc.11014; Stoehlmacher J, 2008, CANCER LETT, V272, P221, DOI 10.1016/j.canlet.2008.07.008; Sunaga M, 2007, J CHEMOTHERAPY, V19, P709, DOI 10.1179/joc.2007.19.6.709; Suzuki M, 1999, ONCOLOGY-BASEL, V57, P50, DOI 10.1159/000012000; Takahashi T, 2007, HEPATO-GASTROENTEROL, V54, P1612; Tandon P, 2009, LIVER INT, V29, P502, DOI 10.1111/j.1478-3231.2008.01957.x; Tsourouflis G, 2008, DIGEST DIS SCI, V53, P1289, DOI 10.1007/s10620-007-0008-x; Wang X, 2017, CLIN RES HEPATOL GAS, V41, P319, DOI 10.1016/j.clinre.2016.10.012; Zhao HY, 2013, ONCOTARGETS THER, V6, P811, DOI 10.2147/OTT.S46498	50	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219469	10.1371/journal.pone.0219469	http://dx.doi.org/10.1371/journal.pone.0219469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291332	Green Submitted, Green Published, gold			2022-12-26	WOS:000484947800092
J	Marques-Galvez, JE; Morte, A; Navarro-Rodenas, A; Garcia-Carmona, F; Perez-Gilabert, M				Eduardo Marques-Galvez, Jose; Morte, Asuncion; Navarro-Rodenas, Alfonso; Garcia-Carmona, Francisco; Perez-Gilabert, Manuela			Purification and characterization of Terfezia claveryi TcCAT-1, a desert truffle catalase upregulated in mycorrhizal symbiosis	PLOS ONE			English	Article							TERFEZIA-CLAVERYI CHATIN; HISTOCHEMICAL-LOCALIZATION; HYDROGEN-PEROXIDE; DIVERSITY; GENE	Terfezia claveryi Chatin is a mycorrhizal fungus that forms ectendomycorrhizal associations with plants of Helianthemum genus. Its appreciated edibility and drought resistance make this fungus a potential alternative crop in arid and semiarid areas of the Mediterranean region. In order to increase the knowledge about the biology of this fungus in terms of mycorrhiza formation and response to drought stress, a catalase from T. claveryi (TcCAT-1) has been purified to apparent homogeneity and biochemically characterized; in addition, the expression pattern of this enzyme during different stages of T. claveryi biological cycle and under drought stress conditions are reported. The results obtained, together with the phylogenetic analysis and homology modeling, indicate that TcCAT-1 is a homotetramer large subunit size monofunctional-heme catalase belonging to Clade 2. The highest expression of this enzyme occurs in mature mycorrhiza, revealing a possible role in mycorrhiza colonization, but it is not upregulated under drought stress. However, the H2O2 content of mycorrhizal plants submitted to drought stress is lower than in well watered treatments, suggesting that mycorrhization improves the plant's oxidative stress response, although not via TcCAT-1 upregulation.	[Eduardo Marques-Galvez, Jose; Morte, Asuncion; Navarro-Rodenas, Alfonso] Thader Biotechnol SL, Campus Espinardo, Murcia, Spain; [Eduardo Marques-Galvez, Jose; Morte, Asuncion; Navarro-Rodenas, Alfonso] Univ Murcia, Fac Biol, Dept Biol Vegetal Bot, Campus Espinardo, Murcia, Spain; [Garcia-Carmona, Francisco; Perez-Gilabert, Manuela] Univ Murcia, Fac Biol, Dept Bioquim & Biol Mol A, Campus Espinardo, Murcia, Spain	University of Murcia; University of Murcia	Perez-Gilabert, M (corresponding author), Univ Murcia, Fac Biol, Dept Bioquim & Biol Mol A, Campus Espinardo, Murcia, Spain.	mpg@um.es	Marqués-Gálvez, Jose Eduardo/AAR-5587-2020; Morte, Asunción/AAS-6917-2021; Pérez-Gilabert, Manuela/E-5676-2016; Morte, Asunción/L-4536-2014; Ródenas, Alfonso Navarro/AAB-1938-2020	Morte, Asunción/0000-0002-6426-0202; Pérez-Gilabert, Manuela/0000-0002-3706-5786; Morte, Asunción/0000-0002-6426-0202; Garcia-Carmona, Francisco/0000-0002-1318-7690; Navarro Rodenas, Alfonso/0000-0001-9123-4547	Spanish grants from AEI-FEDER, UE [CGL2016-78946-R, AGL2017-86526P]; Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia [20866/PI/18, 19893/GERM/15]; MINECO (Ministerio de Economia y Empresa, Gobierno de Espana) [IJCI-2016-28252, DI-14-06904]	Spanish grants from AEI-FEDER, UE; Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia(Fundacion Seneca); MINECO (Ministerio de Economia y Empresa, Gobierno de Espana)	This work was supported by Spanish grants from AEI-FEDER, UE (CGL2016-78946-R; AGL2017-86526P) and from Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia (20866/PI/18 and 19893/GERM/15). ANR holds a postdoctoral contract (IJCI-2016-28252) and JEMG a PhD grant (DI-14-06904) both from MINECO (Ministerio de Economia y Empresa, Gobierno de Espana). Additionally, Thader Biotechnology SL (https://thaderbiotechnology.com/) provided support in the form of salary to JEMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section.	Arenas F, 2018, MYCORRHIZA, V28, P691, DOI 10.1007/s00572-018-0867-3; Bacelar EA, 2009, ACTA PHYSIOL PLANT, V31, P611, DOI 10.1007/s11738-009-0272-9; Baptista P, 2007, MYCORRHIZA, V17, P185, DOI 10.1007/s00572-006-0091-4; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Brakensiek D. L., 1979, Agriculture Handbook, Science and Education Administration, US Department of Agriculture; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chantasingh D, 2013, BIOL CONTROL, V67, P85, DOI 10.1016/j.biocontrol.2013.08.004; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Diaz A, 2005, BIOCHIMIE, V87, P205, DOI 10.1016/j.biochi.2004.10.014; Diaz A, 2001, FREE RADICAL BIO MED, V31, P1323, DOI 10.1016/S0891-5849(01)00637-2; Diaz A, 2009, J MOL BIOL, V386, P218, DOI 10.1016/j.jmb.2008.12.019; Fu X, 2014, INT J ANTENN PROPAG, V2014, DOI 10.1155/2014/631820; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gutierrez A, 2003, MYCORRHIZA, V13, P299, DOI 10.1007/s00572-003-0236-7; Hansberg W, 2012, ARCH BIOCHEM BIOPHYS, V525, P170, DOI 10.1016/j.abb.2012.05.014; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kimoto H, 2012, INT J MOL SCI, V13, P1733, DOI 10.3390/ijms13021733; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambais MR, 2003, NEW PHYTOL, V160, P421, DOI 10.1046/j.1469-8137.2003.00881.x; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morte A, 2000, MYCORRHIZA, V10, P115, DOI 10.1007/s005720000066; Morte A., 2012, EDIBLE ECTOMYCORRHIZ, V34, DOI [10.1007/978-3-642-33823-6_14, DOI 10.1007/978-3-642-33823-6_14]; Morte A., 2008, MYCORRHIZA, DOI [10.1007/978-3-540-78826-3_23, DOI 10.1007/978-3-540-78826-3_23]; Morte A., 2017, MYCORRHIZA ECO PHYSL, P23, DOI [DOI 10.1007/978-3-319-57849-1_2, 10.1007/978-3-319-57849-1_2]; Morte A, 2010, SYMBIOSIS, V52, P133, DOI 10.1007/s13199-010-0080-4; Navarro-Rodenas A, 2015, PLANT CELL ENVIRON, V38, P2475, DOI 10.1111/pce.12552; Navarro-Rodenas A, 2013, MOL PLANT MICROBE IN, V26, P1068, DOI 10.1094/MPMI-07-12-0178-R; Nelsen CE, 1987, ECOPHYSIOLOGY VA MYC, P71; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Pedranzani H, 2016, MYCORRHIZA, V26, P141, DOI 10.1007/s00572-015-0653-4; Perez-Gilabert M, 2005, J AGR FOOD CHEM, V53, P5754, DOI 10.1021/jf050334d; Perez-Gilabert M, 2005, J AGR FOOD CHEM, V53, P3666, DOI 10.1021/jf048087l; Perez-Gilabert M, 2001, J AGR FOOD CHEM, V49, P1922, DOI 10.1021/jf001009n; Perez-Gilabert M, 2001, PHYSIOL PLANTARUM, V113, P203, DOI 10.1034/j.1399-3054.2001.1130207.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Porcel R, 2004, J EXP BOT, V55, P1743, DOI 10.1093/jxb/erh188; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roth-Bejerano N, 2014, DESERT TRUFFLES, P69, DOI DOI 10.1007/978-3-642-40096-4_5; Ruiz-Lozano J. M., 2008, MYCORRHIZA STATE ART, P185, DOI [10.1007/978-3-540- 78826-3_10, DOI 10.1007/978-3-540-78826-3_10]; Salzer P, 1999, PLANTA, V208, P319, DOI 10.1007/s004250050565; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; SEAH TCM, 1973, J BIOL CHEM, V248, P2889; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Switala J, 1999, BIOCHEMISTRY-US, V38, P3895, DOI 10.1021/bi982863z; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vizzini A, 2008, MYCORRHIZA GENETICS, P707, DOI DOI 10.1007/978-3-540-78826-3_33; Wang L, 2017, GENES, V8, P1; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Wu QS, 2006, J PLANT PHYSIOL, V163, P1101, DOI 10.1016/j.jplph.2005.09.001	53	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219300	10.1371/journal.pone.0219300	http://dx.doi.org/10.1371/journal.pone.0219300			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291312	Green Submitted, gold, Green Published			2022-12-26	WOS:000484947800069
J	Neuenkamp, L; Zobel, M; Lind, E; Gerz, M; Moora, M				Neuenkamp, Lena; Zobel, Martin; Lind, Eva; Gerz, Maret; Moora, Mari			Arbuscular mycorrhizal fungal community composition determines the competitive response of two grassland forbs	PLOS ONE			English	Article							ROOT COLONIZATION; PLANT-ROOTS; BIODIVERSITY; COEXISTENCE; PHOSPHORUS; DIVERSITY; IDENTITY; GRASSES; GROWTH	We performed a greenhouse experiment to assess how differences in AM fungal community composition affect competitive response of grassland plant species. We used a full factorial design to determine how inoculation with natural AM fungal communities from different habitats in Western Estonia affects the growth response of two grassland forbs (Leontodon hispidus L., Plantago lanceolata L.) to competition with a dominant grass (Festuca rubra L.). We used AM fungal inocula that were known to differ in AM fungal diversity and composition: more diverse AM fungal communities from open grasslands and less diverse AM fungal communities from former grassland densely overgrown by pines (young pine forest). The presence of AM fungi balanced competition between forb and grass species, by enhancing competitive response of the forbs. The magnitude of this effect was dependent on forb species identity and on the origin of the AM fungal inoculum in the soil. The grassland inoculum enhanced the competitive response of the forb species more effectively than the forest inoculum, but inoculum-specific competitive responses varied according to the habitat preference of the forb species. Our findings provide evidence that composition and diversity of natural AM fungal communities, as well as co-adaptation of plant hosts and AM-fungal communities to local habitat conditions, can determine plant-plant interactions and thus ultimately influence plant community structure in nature.	[Neuenkamp, Lena; Zobel, Martin; Lind, Eva; Gerz, Maret; Moora, Mari] Univ Tartu, Inst Ecol & Earth Sci, Tartu, Estonia; [Neuenkamp, Lena] Univ Bern, Inst Plant Sci, Bern, Switzerland	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Bern	Neuenkamp, L (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Tartu, Estonia.; Neuenkamp, L (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	lena.neuenkamp@ips.unibe.ch	Neuenkamp, Lena/W-8814-2019; Zobel, Martin/H-1336-2015; Moora, Mari/D-1961-2009	Neuenkamp, Lena/0000-0001-6108-5720; Zobel, Martin/0000-0001-7957-6704; Moora, Mari/0000-0002-4819-7506	Estonian Research Council [IUT 20-28]; European Regional Development Fund (Centre of Excellence EcolChange)	Estonian Research Council(Estonian Research Council); European Regional Development Fund (Centre of Excellence EcolChange)	This study was funded by grants from the Estonian Research Council (IUT 20-28) to EL, LN, MG, MM and MZ and by the European Regional Development Fund (Centre of Excellence EcolChange) to LN, MG, MM and MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by grants from the Estonian Research Council (IUT 20-28) and by the European Regional Development Fund (Centre of Excellence EcolChange). We are grateful to Ulle Saks for the help in the greenhouse and for two anonymous reviewers and the editor C Gao for their constructive comments on an earlier version of the manuscript.	Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Auge RM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01084; Bardgett RD, 2014, NATURE, V515, P505, DOI 10.1038/nature13855; Bazzaz F.A., 1990, PERSPECTIVES PLANT C, P240; Bennett AE, 2009, OECOLOGIA, V160, P807, DOI 10.1007/s00442-009-1345-6; Bever JD, 2012, ANNU REV MICROBIOL, V66, P265, DOI 10.1146/annurev-micro-092611-150107; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Garcia de Leon D, 2016, ACTA OECOL, V77, P128, DOI 10.1016/j.actao.2016.10.006; Goldberg D. E., 1990, Perspectives on plant competition., P27; Goldberg DE, DESIGN ANAL ECOLOGIC, P77; Hart MM, 2003, TRENDS ECOL EVOL, V18, P418, DOI 10.1016/S0169-5347(03)00127-7; HETRICK BAD, 1990, CAN J BOT, V68, P461, DOI 10.1139/b90-061; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; Johnson NC, 2010, P NATL ACAD SCI USA, V107, P2093, DOI 10.1073/pnas.0906710107; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jung SC, 2012, J CHEM ECOL, V38, P651, DOI 10.1007/s10886-012-0134-6; Kardol P, 2010, TRENDS ECOL EVOL, V25, P670, DOI 10.1016/j.tree.2010.09.001; Keddy P, 1998, J VEG SCI, V9, P777, DOI 10.2307/3237043; Kiers ET, 2000, ECOL LETT, V3, P106, DOI 10.1046/j.1461-0248.2000.00126.x; Klironomos J, 2011, NEW PHYTOL, V189, P366, DOI 10.1111/j.1469-8137.2010.03550.x; KOIDE RT, 1989, NEW PHYTOL, V111, P35, DOI 10.1111/j.1469-8137.1989.tb04215.x; Koorem K, 2017, PLANT SOIL, V410, P259, DOI 10.1007/s11104-016-3004-0; KOSKE RE, 1989, MYCOL RES, V92, P486, DOI 10.1016/S0953-7562(89)80195-9; Landis FC, 2004, NEW PHYTOL, V164, P493, DOI 10.1111/j.1469-8137.2004.01202.x; Lin GG, 2015, J ECOL, V103, P1224, DOI 10.1111/1365-2745.12429; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Mariotte P, 2013, MYCORRHIZA, V23, P267, DOI 10.1007/s00572-012-0465-8; Martensson LM, 2012, APPL SOIL ECOL, V54, P55, DOI 10.1016/j.apsoil.2011.12.006; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Moora M, 2004, FUNCT ECOL, V18, P554, DOI 10.1111/j.0269-8463.2004.00876.x; Moora M, 2016, MYCORRHIZA, V26, P735, DOI 10.1007/s00572-016-0709-0; Moora M, 2010, POSITIVE PLANT INTERACTIONS AND COMMUNITY DYNAMICS, P79; Neuenkamp L, 2019, FUNGAL ECOL, V40, P140, DOI 10.1016/j.funeco.2018.05.004; Neuenkamp L, 2018, NEW PHYTOL, V220, P1236, DOI 10.1111/nph.14995; Opik M, 2014, BOTANY, V92, P135, DOI 10.1139/cjb-2013-0110; Osborne OG, 2018, NEW PHYTOL, V217, P1254, DOI 10.1111/nph.14850; Partel M, 1999, LANDSCAPE ECOL, V14, P187, DOI 10.1023/A:1008040114832; Pozo MJ, 2015, NEW PHYTOL, V205, P1431, DOI 10.1111/nph.13252; Rua MA, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0698-9; Sabais ACW, 2012, OECOLOGIA, V170, P1021, DOI 10.1007/s00442-012-2375-z; Scheublin TR, 2007, J ECOL, V95, P631, DOI 10.1111/j.1365-2745.2007.01244.x; Shi NN, 2016, FUNGAL ECOL, V20, P115, DOI 10.1016/j.funeco.2015.12.007; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Spatafora JW, 2016, MYCOLOGIA, V108, P1028, DOI 10.3852/16-042; Stanescu S, 2017, OECOLOGIA, V183, P479, DOI 10.1007/s00442-016-3771-6; Torrez V, 2016, APPL VEG SCI, V19, P7, DOI 10.1111/avsc.12193; Uibopuu A, 2012, PLANT SOIL, V356, P331, DOI 10.1007/s11104-011-1116-0; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vogelsang KM, 2006, NEW PHYTOL, V172, P554, DOI 10.1111/j.1469-8137.2006.01854.x; Wagg C, 2011, ECOLOGY, V92, P1303, DOI 10.1890/10-1915.1; Wang SG, 2017, ENVIRON POLLUT, V226, P104, DOI 10.1016/j.envpol.2017.03.074; Wilson GWT, 1998, AM J BOT, V85, P1732, DOI 10.2307/2446507; Wubs ERJ, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.107, 10.1038/nplants.2016.107]	55	6	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219527	10.1371/journal.pone.0219527	http://dx.doi.org/10.1371/journal.pone.0219527			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291331	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800106
J	De-Lima, AKS; Paschoaletto, IP; Pinho, LD; Benmamman, P; Klaczko, J				Soares De-Lima, Anderson Kennedy; Paschoaletto, Ingrid Pinheiro; Pinho, Lorena de Oliveira; Benmamman, Piktor; Klaczko, Julia			Are hemipenial traits under sexual selection in Tropidurus lizards? Hemipenial development, male and female genital morphology, allometry and coevolution in Tropidurus torquatus (Squamata: Tropiduridae)	PLOS ONE			English	Article							SERPENTES DIPSADIDAE; MOLECULAR-DATA; XENODONTINAE; REAPPRAISAL; EVOLUTION; REPTILIA; SNAKES; CHOICE; GENUS; SIZE	Male genitalia show considerable morphological variation among animals with internal fertilization and exhibit a high level of evolvability in lizards. Studies have suggested that sexual selection may be driving hemipenial evolution against natural selection and pleiotropy. Given the direct interaction of male and female genitals, coevolution of the aforementioned is posited by several hypotheses of genital evolution. However, there are only a few studies on female genitalia morphology, resulting in a lack of coevolution description and understanding. Studies of allometric patterns have filled some gaps by answering questions about male genital evolution and could prove a powerful tool in clarifying coevolution between male and female genitals. Here, we studied the genital morphology of Tropidurus torquatus. This Tropidurus lizard species is an emerging Neotropical lizard model organism notable for having enlarged hemipenial lobes in contrast with other tropidurid species. In this study, we analyzed hemipenial development in early and late stages, describing both morphological variation and ontogenetic allometric pattern. We used quantitative traits to describe male and female genital morphology, examining their static allometric patterns and correspondence. Our study provides a quantitative discussion on the evolution of lizard genitals, suggesting that sexual selection plays an important role in genital evolution in Tropidurus lizards.	[Soares De-Lima, Anderson Kennedy; Paschoaletto, Ingrid Pinheiro; Pinho, Lorena de Oliveira; Benmamman, Piktor; Klaczko, Julia] Univ Brasilia, Lab Comparat Vertebrate Anat, Brasilia, DF, Brazil; [Soares De-Lima, Anderson Kennedy; Paschoaletto, Ingrid Pinheiro; Pinho, Lorena de Oliveira; Benmamman, Piktor; Klaczko, Julia] Univ Brasilia, Dept Physiol Sci, Brasilia, DF, Brazil; [Soares De-Lima, Anderson Kennedy; Benmamman, Piktor] Univ Brasilia, Grad Program Zool, Brasilia, DF, Brazil; [Soares De-Lima, Anderson Kennedy; Benmamman, Piktor] Univ Brasilia, Inst Biol Sci, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia	Klaczko, J (corresponding author), Univ Brasilia, Lab Comparat Vertebrate Anat, Brasilia, DF, Brazil.; Klaczko, J (corresponding author), Univ Brasilia, Dept Physiol Sci, Brasilia, DF, Brazil.	jklaczko@gmail.com	Klaczko, Julia/N-1406-2013; De-Lima, Anderson K S/V-5778-2018; De-Lima, Anderson Kennedy Soares/W-9453-2019	Klaczko, Julia/0000-0002-9215-380X; De-Lima, Anderson K S/0000-0002-5790-8584; De-Lima, Anderson Kennedy Soares/0000-0002-5790-8584	Research Support Foundation of the Federal District [FAPDF 0193.001637/2017]	Research Support Foundation of the Federal District	This study was funded by the Research Support Foundation of the Federal District (FAPDF 0193.001637/2017).	Ah-King M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001851; Andonov K, 2017, ANAT REC, V300, P1680, DOI 10.1002/ar.23622; ARNOLD EN, 1986, J NAT HIST, V20, P1221, DOI 10.1080/00222938600770811; ARNOLD EN, 1986, BIOL J LINN SOC, V29, P263, DOI 10.1111/j.1095-8312.1986.tb00279.x; Arnqvist G, 1997, BIOL J LINN SOC, V60, P365; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Bernardo Pedro Henrique, 2012, South American Journal of Herpetology, V7, P134; Bohme W, 2009, J ZOOL SYST EVOL RES, V47, P189, DOI 10.1111/j.1439-0469.2008.00495.x; Bonduriansky R, 2007, EVOLUTION, V61, P838, DOI 10.1111/j.1558-5646.2007.00081.x; Brennan PLR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a017749; Brennan PLR, 2016, INTEGR COMP BIOL, V56, P669, DOI 10.1093/icb/icw018; COOPER WE, 1993, ANIM BEHAV, V45, P683, DOI 10.1006/anbe.1993.1083; D'Angiolella AB, 2016, CAN J ZOOL, V94, P251, DOI 10.1139/cjz-2015-0194; de Carvalho AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054852, 10.1371/journal.pone.0059736]; Dowling HG, 1960, ZOOLOGICA, P17, DOI [10.1016/j.cell.2016.03.039, DOI 10.1016/J.CELL.2016.03.039]; Eberhard W, 2009, J EVOLUTION BIOL, V22, P435, DOI 10.1111/j.1420-9101.2008.01654.x; Eberhard WG, 1998, EVOLUTION, V52, P415, DOI 10.1111/j.1558-5646.1998.tb01642.x; EBERHARD WG, 1995, TRENDS ECOL EVOL, V10, P493, DOI 10.1016/S0169-5347(00)89205-8; Eberhard WG, 2009, EVOLUTION, V63, P48, DOI 10.1111/j.1558-5646.2008.00528.x; Firman RC, 2017, TRENDS ECOL EVOL, V32, P368, DOI 10.1016/j.tree.2017.02.010; Frost DR, 2001, MOL PHYLOGENET EVOL, V21, P352, DOI 10.1006/mpev.2001.1015; Frost DR, 1992, AM MUSEUM NOVIT, V3033; Gilman CA, 2019, J MORPHOL, V280, P184, DOI 10.1002/jmor.20930; GOULD SJ, 1973, NATURE, V244, P375, DOI 10.1038/244375a0; Gredler ML, 2015, SEX DEV, V9, P53, DOI 10.1159/000364817; Gredler ML, 2015, SEX DEV, V9, P21, DOI 10.1159/000363757; Harvey MB, 1998, HERPETOLOGICA, V54, P493; House CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063807; INGER RF, 1962, SYST ZOOL, V11, P32, DOI 10.2307/2411447; Jadin RC, 2012, J HERPETOL, V46, P393, DOI 10.1670/11-237; Klaczko J, 2015, J ZOOL, V295, P44, DOI 10.1111/jzo.12178; Klaczko J, 2017, BIOL J LINN SOC, V122, P627; Klaczko J, 2015, J HERPETOL, V49, P462, DOI 10.1670/13-152; Klaver CJJ, 1986, BONN ZOOL MONOGR, V22, P1; Kohlsdorf Tiana, 2006, PHYLLOMEDUSA, V5, P109; Langerhans RB, 2016, INTEGR COMP BIOL, V56, P741, DOI 10.1093/icb/icw101; Leal F, 2015, SEX DEV, V9, P6, DOI 10.1159/000363758; Myers CW, 2014, B AM MUS NAT HIST, P1; OLSSON M, 1994, ANIM BEHAV, V48, P193, DOI 10.1006/anbe.1994.1226; Orbach DN, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1265; PESANTES OS, 1994, J HERPETOL, V28, P93, DOI 10.2307/1564686; Nogueira KDPC, 2011, MICRON, V42, P377, DOI 10.1016/j.micron.2010.10.008; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; Prudente ALC, 2010, COPEIA, P397, DOI 10.1643/CH-08-193; Py-Daniel TR, 2017, ANAT REC, V300, P277, DOI 10.1002/ar.23500; R Core Team, 2018, R LANG ENV STAT COMP; Ramirez-Ponce A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172388; RODRIGUES M T, 1987, Arquivos de Zoologia (Sao Paulo), V31, P105; Roscito JG, 2012, ZOOLOGY, V115, P302, DOI 10.1016/j.zool.2012.03.003; Nunes PMS, 2014, ANAT REC, V297, P482, DOI 10.1002/ar.22876; Nunes PMS, 2012, ZOOL J LINN SOC-LOND, V166, P361, DOI 10.1111/j.1096-3642.2012.00846.x; Sanchez-Martinez PM, 2007, ACTA ZOOL-STOCKHOLM, V88, P289, DOI 10.1111/j.1463-6395.2007.00282.x; Showalter I, 2014, BIOL J LINN SOC, V111, P183, DOI 10.1111/bij.12184; Simmons LW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1379; Tschopp P, 2014, NATURE, V516, P391, DOI 10.1038/nature13819; VITT LJ, 1985, CAN J ZOOL, V63, P995, DOI 10.1139/z85-148; VONBERTALANFFY L, 1952, EVOLUTION, V6, P387, DOI 10.1111/j.1558-5646.1952.tb01438.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Werneburg I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005887; Zaher H, 1999, B AM MUS NAT HIST, P1; Ziegler Thomas, 2002, Bulletin of the Natural History Museum Zoology Series, V68, P51	61	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219053	10.1371/journal.pone.0219053	http://dx.doi.org/10.1371/journal.pone.0219053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291313	gold, Green Submitted, Green Published			2022-12-26	WOS:000484947800046
J	Wang, LC; Tan, YJ; Wei, C; Zhang, HJ; Luo, P; Zhang, SM; Ma, X				Wang, Lichan; Tan, Yajun; Wei, Chen; Zhang, Huajie; Luo, Peng; Zhang, Shumin; Ma, Xiao			A preliminary study on the application of PspA as a carrier for group A meningococcal polysaccharide	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; SURFACE PROTEIN; HUMAN IMMUNITY; PROTECTION; DISEASE; IMMUNOGENICITY; EPIDEMIOLOGY; IMMUNIZATION; MENAFRIVAC	This study aimed to explore the feasibility of pneumococcal surface protein A (PspA) as a carrier protein. Three recombinant pneumococcal surface proteins from three different clades were expressed by the prokaryotic expression system and conjugated to group A meningococcal polysaccharide (GAMP) to generate three polysaccharide-protein conjugates. The conjugates, unconjugated proteins, GAMP, and GAMP-TT vaccine bulk (used as positive control) were immunized into mice, and their immune effects were assessed by the methods of enzyme-linked immunosorbent assay (ELISA), flow cytometry (FCM), and serum bactericidal assay (SBA). The results showed that the polysaccharide-protein conjugates could produce higher levels of anti-GAMP IgG titers (P < 0.05), higher ratios of Th1/Th2 (P < 0.05), and higher levels of serum bactericidal activity (P < 0.05), compared with the unconjugated GAMP. The conjugation of PspAs to GAMP also enhanced the anti-PspA responses compared with unconjugated PspAs except for PspA3. In conclusion, the results indicated that the three PspAs were appropriate carrier proteins, as demonstrated by the characteristics of T-cell dependent responses to the GAMP, and might protect against group A of epidemic cerebrospinal meningitis.	[Wang, Lichan; Tan, Yajun; Wei, Chen; Zhang, Huajie; Luo, Peng; Zhang, Shumin; Ma, Xiao] Minist Hlth Res Qual & Standardizat Biotech Prod, Key Lab, Natl Inst Food & Drug Control, DTaP & Toxins Div, Beijing, Peoples R China	National Institute of Food & Drug Control - China	Zhang, SM; Ma, X (corresponding author), Minist Hlth Res Qual & Standardizat Biotech Prod, Key Lab, Natl Inst Food & Drug Control, DTaP & Toxins Div, Beijing, Peoples R China.	zhangsm@nicpbp.org.cn; maxiao421@sina.cn		Wang, Lichan/0000-0002-5078-6393	National high-tech research and development plan (project 863) [2012AA02A402]	National high-tech research and development plan (project 863)	This research was provided financial support by National high-tech research and development plan (project 863), project number: 2012AA02A402. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, CHINESE PHARMACOPEI, P80; Barnes GK, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1975-3; Batista RS, 2017, ASIAN PAC J TROP MED, V10, P1019, DOI 10.1016/j.apjtm.2017.10.004; Briles DE, 1998, CLIN MICROBIOL REV, V11, P645, DOI 10.1128/CMR.11.4.645; COSTANTINO P, 1992, VACCINE, V10, P691, DOI 10.1016/0264-410X(92)90091-W; Dick W E Jr, 1989, Contrib Microbiol Immunol, V10, P48; Girard MP, 2006, VACCINE, V24, P4692, DOI 10.1016/j.vaccine.2006.03.034; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; GOTSCHLICH EC, 1969, J EXP MED, V129, P1385, DOI 10.1084/jem.129.6.1385; GOTSCHLICH EC, 1969, J EXP MED, V129, P1367, DOI 10.1084/jem.129.6.1367; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kothari N, 2015, VACCINE, V33, P783, DOI 10.1016/j.vaccine.2014.12.032; Kothari N, 2014, VACCINE, V32, P5755, DOI 10.1016/j.vaccine.2014.08.041; Lin HY, 2015, MICROB PATHOGENESIS, V83-84, P35, DOI 10.1016/j.micpath.2015.04.006; Mawas F, 2006, VACCINE, V24, P3505, DOI 10.1016/j.vaccine.2006.02.021; MCDANIEL LS, 1994, MICROB PATHOGENESIS, V17, P323, DOI 10.1006/mpat.1994.1078; MCDANIEL LS, 1991, INFECT IMMUN, V59, P222, DOI 10.1128/IAI.59.1.222-228.1991; Melin MM, 2008, CLIN VACCINE IMMUNOL, V15, P1529, DOI 10.1128/CVI.00181-08; Miyaji EN, 2002, INFECT IMMUN, V70, P5086, DOI 10.1128/IAI.70.9.5086-5090.2002; Moon H, 2011, PROTOCOL MULTIPLEXED; Pizza M, 2015, CURR OPIN MICROBIOL, V23, P68, DOI 10.1016/j.mib.2014.11.006; Pollabauer EM, 2009, VACCINE, V27, P1674, DOI 10.1016/j.vaccine.2009.01.005; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; Snape MD, 2005, LANCET INFECT DIS, V5, P21, DOI 10.1016/S1473-3099(04)01251-4; Stein K E, 1994, Int J Technol Assess Health Care, V10, P167; STEIN KE, 1992, J INFECT DIS, V165, pS49, DOI 10.1093/infdis/165-Supplement_1-S49; Tan LKK, 2010, NEW ENGL J MED, V362, P1511, DOI 10.1056/NEJMra0906357; Trotter CL, 2017, LANCET INFECT DIS, V17, P867, DOI [10.1016/S1473-3099(17)30301-8, 10.1016/s1473-3099(17)30301-8]; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; Wakabi W, 2009, LANCET, V373, P1836, DOI 10.1016/S0140-6736(09)61008-4; Wang LC, 2015, CHIN MED BIOTECHNOL, V10, P335	34	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218427	10.1371/journal.pone.0218427	http://dx.doi.org/10.1371/journal.pone.0218427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291272	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800021
J	Su, WC; Hao, HD; Ding, MZ; Wu, RH; Xu, HL; Xue, F; Shen, CC; Sun, LL; Lu, CT				Su, Wangcang; Hao, Hongdan; Ding, Mingzhen; Wu, Renhai; Xu, Hongle; Xue, Fei; Shen, Changchao; Sun, Lanlan; Lu, Chuantao			Adsorption and degradation of imazapic in soils under different environmental conditions	PLOS ONE			English	Article							HERBICIDE; SORPTION; BIODEGRADATION; IMAZETHAPYR; PERSISTENCE; CARRYOVER; PH; TEMPERATURE; PEANUT; MAIZE	Imazapic is widely used in peanut production, and its residues can cause damage to succeeding crops planted in the following year. The planting area of peanut is large in Henan province. Inceptisol is the main soil type in Henan Province and was used in laboratory experiments that were conducted to investigate imazapic degradation in soil under various environmental conditions. The results indicated that the imazapic degradation rate increased with an increase in temperature, soil pH, and soil moisture, and decreased with organic matter content. The use of biogas slurry as a soil amendment accelerated imazapic degradation. The half-life of imazapic in sterilized soil (364.7 d) was longer than in unsterilized soil (138.6 d), which suggested that there was a significant microbial contribution to imazapic degradation. Imazapic adsorption was also examined and was found to be well described by the Freundlich isotherm. The results indicate that soil has a certain adsorption capacity for imazapic.	[Su, Wangcang; Hao, Hongdan; Wu, Renhai; Xu, Hongle; Xue, Fei; Shen, Changchao; Sun, Lanlan; Lu, Chuantao] Henan Acad Agr Sci, Inst Plant Protect, Key Lab Integrated Pest Management Crops Southern, Henan Key Lab Crop Pest Control, Zhengzhou, Henan, Peoples R China; [Ding, Mingzhen] Nanjing Univ, Jinling Coll, Nanjing, Jiangsu, Peoples R China	Henan Academy of Agricultural Sciences; Nanjing University	Wu, RH; Xu, HL (corresponding author), Henan Acad Agr Sci, Inst Plant Protect, Key Lab Integrated Pest Management Crops Southern, Henan Key Lab Crop Pest Control, Zhengzhou, Henan, Peoples R China.	renhai.wu@163.com; xuhongle@126.com			Special Fund for Agro-scientific Research in the Public Interest [201203098]; Jiangsu Province University Natural Science Foundation of China [16KJB150016]	Special Fund for Agro-scientific Research in the Public Interest; Jiangsu Province University Natural Science Foundation of China	This research was supported by the Special Fund for Agro-scientific Research in the Public Interest (201203098) and the Jiangsu Province University Natural Science Foundation of China (No. 16KJB150016).; The study was supported by the Special Fund for Agro-scientific Research in the Public Interest (201203098) and the Jiangsu Province University Natural Science Foundation of China (No. 16KJB150016).	Aichele TM, 2005, WEED TECHNOL, V19, P154, DOI 10.1614/WT-04-057R; Alister C, 2005, CROP PROT, V24, P375, DOI 10.1016/j.cropro.2004.09.011; [Anonymous], 218512008 GBT; Bresnahan GA, 2000, J AGR FOOD CHEM, V48, P1929, DOI 10.1021/jf990543w; Bundt AC, 2015, PLANTA DANINHA, V33, P341, DOI 10.1590/0100-83582015000200020; Chen T., 2007, STUDY ANAL METHOD EN; Chen X.Y., 2010, FINE CHEM INTERMED, V40, P1; Cupples AM, 2000, J ENVIRON QUAL, V29, P786, DOI 10.2134/jeq2000.00472425002900030014x; Dong W, 2007, HENAN AGR SCI, P8; El Madani M, 2003, FRESEN ENVIRON BULL, V12, P1114; Gao C, 2013, TOXICITY MIDAZOLINON; GOETZ AJ, 1990, WEED SCI, V38, P421, DOI 10.1017/S0043174500056782; Gomez E, 2006, BIORESOURCE TECHNOL, V97, P1484, DOI 10.1016/j.biortech.2005.06.021; Grey TL, 2005, WEED TECHNOL, V19, P1045, DOI 10.1614/WT-04-256R1.1; Grichar WJ, 2012, INT J AGRON, V2012, DOI 10.1155/2012/809587; Hultgren RP, 2002, J AGR FOOD CHEM, V50, P3236, DOI 10.1021/jf011477c; Jordan DL, 2009, WEED TECHNOL, V23, P6, DOI 10.1614/WT-08-041.1; Ju P., 2008, EFFECTS RADISH VEGET; Kadian N, 2008, BIORESOURCE TECHNOL, V99, P4642, DOI 10.1016/j.biortech.2007.06.064; Krauss M, 2002, SOIL SCI SOC AM J, V66, P430, DOI 10.2136/sssaj2002.0430; Kurola J, 2007, SOIL BIOL BIOCHEM, V39, P1206, DOI 10.1016/j.soilbio.2006.11.005; Marchesan E, 2010, WEED TECHNOL, V24, P6, DOI 10.1614/WT-08-153.1; Matocha MA, 2003, WEED TECHNOL, V17, P325, DOI 10.1614/0890-037X(2003)017[0325:TPOIIP]2.0.CO;2; Prostko EP, 2005, WEED TECHNOL, V19, P875, DOI 10.1614/WT-04-292R2.1; Quan GX, 2015, J ENVIRON QUAL, V44, P1631, DOI 10.2134/jeq2014.12.0528; SHELTON DR, 1991, J AGR FOOD CHEM, V39, P2063, DOI 10.1021/jf00011a036; Su WC, 2017, PHOTOSYNTHETICA, V55, P294, DOI 10.1007/s11099-016-0641-3; Su WC, 2017, J ENVIRON QUAL, V46, P553, DOI 10.2134/jeq2016.11.0449; [苏旺苍 Su Wangcang], 2014, [农药, Agrochemicals], V53, P260; [苏旺苍 Su Wangcang], 2013, [麦类作物学报, Journal of Triticeae Crops], V33, P1226; Szmigielski AM, 2011, HERBICIDES AND ENVIRONMENT, P217; [谭蓉 Tan Rong], 2017, [中国粉体技术, China Powder Science and Technology], V23, P82; Tang Mei-zhen, 2010, Journal of Ecology and Rural Environment, V26, P185; tenHulscher TEM, 1996, CHEMOSPHERE, V32, P609, DOI 10.1016/0045-6535(95)00345-2; Ulbrich AV, 2005, WEED TECHNOL, V19, P986, DOI 10.1614/WT-04-208R2.1; Wang HL, 2007, J ENVIRON SCI, V19, P1108, DOI 10.1016/S1001-0742(07)60180-6; Wei K, 2004, SOIL HENAN PROVINCE; [王学东 Wu Xuedong], 2004, [环境科学研究, Research of Environmental Sciences], V17, P42; York A. C., 2000, Journal of Cotton Science, V4, P210; [尤民生 You Minsheng], 2004, [生态学杂志, Chinese Journal of Ecology], V23, P73; [张胜田 Zhang Shengtian], 2017, [环境工程学报, Chinese Journal of Environmental Engineering], V11, P3839; [赵爽 Zhao Shuang], 2009, [植物保护, Plant Protection], V35, P15	42	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219462	10.1371/journal.pone.0219462	http://dx.doi.org/10.1371/journal.pone.0219462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283795	Green Submitted, Green Published, gold			2022-12-26	WOS:000484939800036
J	Passari, AK; Upadhyaya, K; Singh, G; Abdel-Azeem, AM; Thankappan, S; Uthandi, S; Hashem, A; Abd Allah, EF; Malik, JA; Alqarawi, AS; Gupta, VK; Ranjan, S; Singh, BP				Passari, Ajit Kumar; Upadhyaya, Kalidas; Singh, Garima; Abdel-Azeem, Ahmed M.; Thankappan, Sugitha; Uthandi, Sivakumar; Hashem, Abeer; Abd Allah, Elsayed Fathi; Malik, Jahangir Ahmed; Alqarawi, A. S.; Gupta, Vijai Kumar; Ranjan, Sanjay; Singh, Bhim Pratap			Enhancement of disease resistance, growth potential, and photosynthesis in tomato (Solanum lycopersicum) by inoculation with an endophytic actinobacterium, Streptomyces thermocarboxydus strain BPSAC147	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; WHEAT TRITICUM-AESTIVUM; SUBTILIS BERA 71; PLANT-GROWTH; CHLOROPHYLL FLUORESCENCE; ANTIFUNGAL ACTIVITY; BIOSYNTHETIC GENE; NATIVE PLANTS; STRESS; ACID	Biotic stresses in plants have a significant impact on agricultural productivity. In the present study, in vivo experiments were conducted to determine the physiological responses of tomato (Solanum lycopersicum L.) seedlings by inoculation with an endophytic actinobacterium, Streptomyces thermocarboxydus isolate BPSAC147 under greenhouse conditions. Further, photochemical quantum yield of photosystem II (PSII) (F-v/F-m), photochemical quenching (qP) and non-photochemical (NPQ) were calculated in seedlings inoculated with S. thermocarboxydus (T1) and were compared with control (T0) plants. Furthermore, the electron transport rate (ETR) of PSII exhibited a significant increase in T1 plants, relative to T0 plants. These results indicate that inoculation of tomato seedlings with S. thermocarboxydus had a positive effect on the process of photosynthesis, resulting in enhanced chlorophyll fluorescence parameters due to increased ETR in the thylakoid membrane. GC-MS analysis showed significant differences in the volatile compounds in the different treatments performed under greenhouse conditions. The present study suggests that S. thermocarboxydus can be used as new biocontrol agent to control Fusarium wilt in tomato crops and enhance productivity by enhancing photosynthesis.	[Passari, Ajit Kumar; Singh, Garima; Singh, Bhim Pratap] Mizoram Univ, Dept Biotechnol, Aizawl, Mizoram, India; [Passari, Ajit Kumar] Univ Nacl Autonoma Mexico, Dept Biol Mol & Biotecnol, Inst Invest Biomed, Mexico City, DF, Mexico; [Upadhyaya, Kalidas] Mizoram Univ, Dept Forestry, Aizawl, Mizoram, India; [Abdel-Azeem, Ahmed M.] Suez Canal Univ, Dept Bot, Ismailia, Egypt; [Thankappan, Sugitha; Uthandi, Sivakumar] Tamil Nadu Agr Univ, Biocatalysts Lab, Dept Agr Microbiol, Coimbatore, Tamil Nadu, India; [Hashem, Abeer] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh, Saudi Arabia; [Hashem, Abeer] ARC, Mycol & Plant Dis Survey Dept, Plant Pathol Res Inst, Giza, Egypt; [Abd Allah, Elsayed Fathi; Malik, Jahangir Ahmed; Alqarawi, A. S.] Tallinn Univ Technol, Dept Chem & Biotechnol, ERA Chair Green Chem, Tallinn, Estonia; [Gupta, Vijai Kumar] King Saud Univ, Plant Prod Dept, Coll Food & Agr Sci, Riyadh, Saudi Arabia; [Ranjan, Sanjay] Spectraritec, Ranjit Nagar Commercial Complex, Delhi, India	Mizoram University; Universidad Nacional Autonoma de Mexico; Mizoram University; Egyptian Knowledge Bank (EKB); Suez Canal University; Tamil Nadu Agricultural University; King Saud University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Tallinn University of Technology; King Saud University	Singh, BP (corresponding author), Mizoram Univ, Dept Biotechnol, Aizawl, Mizoram, India.	bhimpratap@gmail.com	Uthandi, Sivakumar/C-3277-2018; Gupta, Vijai Kumar/O-2445-2014; Hashem, Abeer/AAX-5952-2021; Abdel-Azeem, Ahmed Mohamed Ahmed/I-3637-2015; Singh, Garima/H-7719-2017; Singh, Bhim Pratap/G-7268-2016; Abd_Allah, Elsayed Fathi/N-6846-2017; Passari, Ajit Kumar/X-9807-2019	Uthandi, Sivakumar/0000-0002-7116-1317; Gupta, Vijai Kumar/0000-0003-1565-5918; Abdel-Azeem, Ahmed Mohamed Ahmed/0000-0003-2897-3966; Singh, Garima/0000-0002-8052-5725; Singh, Bhim Pratap/0000-0002-9911-4125; Abd_Allah, Elsayed Fathi/0000-0002-8509-8953; Passari, Ajit Kumar/0000-0002-1150-8075	Department of Biotechnology, Government of India, New Delhi under DBT's Unit of Excellence programme [102/IFD/SAN/4290-4291/2016-2017]; Deanship of Scientific Research at King Saud University [RG-1435-014]	Department of Biotechnology, Government of India, New Delhi under DBT's Unit of Excellence programme; Deanship of Scientific Research at King Saud University(King Saud University)	BPS is thankful to the Department of Biotechnology, Government of India, New Delhi for financial support under DBT's Unit of Excellence programme for NE (102/IFD/SAN/4290-4291/2016-2017). The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding to the Research Group number (RG-1435-014). Author SR is employed by Spectraritec. Spectraritec provided support in the form of salary for author SR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abbamondi GR, 2016, CHEM BIOL TECHNOL AG, V3, DOI 10.1186/s40538-015-0051-3; Abd Allah EF, 2018, J PLANT INTERACT, V13, P37, DOI 10.1080/17429145.2017.1414321; AGARWAL DK, 1985, J TOXICOL ENV HEALTH, V16, P61, DOI 10.1080/15287398509530719; Babu AN, 2015, PLANT SCI, V231, P62, DOI 10.1016/j.plantsci.2014.11.006; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Barnawal D, 2017, PHYSIOL PLANTARUM, V161, P502, DOI 10.1111/ppl.12614; Begum IF, 2016, INDIAN J MICROBIOL, V56, P426, DOI 10.1007/s12088-016-0609-1; Bi JB, 2017, BIOMED PHARMACOTHER, V95, P974, DOI 10.1016/j.biopha.2017.09.012; Calatayud A, 2002, PHYSIOL PLANTARUM, V116, P308, DOI 10.1034/j.1399-3054.2002.1160305.x; Dias MP, 2017, PLANT PHYSIOL BIOCH, V118, P479, DOI 10.1016/j.plaphy.2017.07.017; Dinesh R, 2017, CRIT REV MICROBIOL, V43, P546, DOI 10.1080/1040841X.2016.1270895; Egamberdieva D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01887; Golinska P, 2015, ANTON LEEUW INT J G, V108, P267, DOI 10.1007/s10482-015-0502-7; Gouda S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01538; Goudjal Y, 2016, BIOCONTROL SCI TECHN, V26, P1691, DOI 10.1080/09583157.2016.1234584; Goudjal Y, 2014, MICROBIOL RES, V169, P59, DOI 10.1016/j.micres.2013.06.014; Guo L, 2008, MOLECULES, V13, P2114, DOI 10.3390/molecules13092114; Hardoim PR, 2015, MICROBIOL MOL BIOL R, V79, P293, DOI 10.1128/MMBR.00050-14; Hashem A, FRONT MICROBIOL, V7, P1167, DOI [10.3389/fmicb.2016.01167, DOI 10.3389/FMICB.2016.01167]; Hashem A, 2017, J PLANT INTERACT, V12, P390, DOI 10.1080/17429145.2017.1373871; Horia E, 2007, CARCINOGENESIS, V28, P809, DOI 10.1093/carcin/bgl183; Jog R, 2014, MICROBIOL-SGM, V160, P778, DOI 10.1099/mic.0.074146-0; Jones SE, 2019, MBIO, V10, DOI 10.1128/mBio.00171-19; Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3; Kapilan R., 2015, Archives of Applied Science Research, V7, P17; Koh RH, 2007, J MICROBIOL BIOTECHN, V17, P1805; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kumar A, 2014, BIOCATAL AGR BIOTECH, V3, P121, DOI 10.1016/j.bcab.2014.08.003; Kumar S, 2015, SUSTAIN DEV BIODIVER, V12, P297, DOI 10.1007/978-3-319-24654-3_11; Lasudee K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01247; Lee S, 2015, ARCH MICROBIOL, V197, P723, DOI 10.1007/s00203-015-1104-5; Li W., 2007, FRONTIERS AGR CHINA, V1, P265; Liu XM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00774; Lv XR, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00221; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Meena KK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00172; Melis A, 1999, TRENDS PLANT SCI, V4, P130, DOI 10.1016/S1360-1385(99)01387-4; Mercier J, 2005, BIOL CONTROL, V32, P401, DOI 10.1016/j.biocontrol.2004.12.002; Morath Shannon U., 2012, Fungal Biology Reviews, V26, P73, DOI 10.1016/j.fbr.2012.07.001; Ni Z, 2009, PROTOC EXCH, DOI [10.1038/nprot.2009.12, DOI 10.1038/NPROT.2009.12]; Okoye FBC, 2011, NAT PROD RES, V25, P1941, DOI 10.1080/14786419.2010.512272; Othman AR, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0528-4; Passari AK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12235-4; Passari AK, 2016, RES MICROBIOL, V167, P692, DOI 10.1016/j.resmic.2016.07.001; Passari AK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00273; Rania AB, 2016, BIOCONTROL SCI TECHN, V26, P1139, DOI 10.1080/09583157.2016.1188264; Ranjan S, 2014, PLANT PHYSIOL BIOCH, V79, P48, DOI 10.1016/j.plaphy.2014.03.007; Ranjan S, 2012, PLANT PHYSIOL BIOCH, V52, P66, DOI 10.1016/j.plaphy.2011.11.008; Rey T, 2017, TRENDS PLANT SCI, V22, P30, DOI 10.1016/j.tplants.2016.10.008; Ribeiro RV, 2003, PHYSIOL MOL PLANT P, V62, P167, DOI 10.1016/S0885-5765(03)00038-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sathya A, 2017, 3 BIOTECH, V7, DOI [10.1007/s13205-017-0736-3, 10.]; Schutz L, 2018, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02204; Shanmugam V, 2011, BIOL CONTROL, V57, P85, DOI 10.1016/j.biocontrol.2011.02.001; Sharma P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00347; SOHRABI M, 2014, CLIN MICROBIAL, V3, DOI DOI 10.4172/2327-5073.1000151; Sturz AV, 2000, APPL SOIL ECOL, V15, P183, DOI 10.1016/S0929-1393(00)00094-9; Takahashi S, 2004, PLANT MOL BIOL, V56, P29, DOI 10.1007/s11103-004-2200-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tetard-Jones C, 2016, PEST MANAG SCI, V72, P203, DOI 10.1002/ps.4147; Varsha KK, 2015, INT J FOOD MICROBIOL, V211, P44, DOI 10.1016/j.ijfoodmicro.2015.06.025; Wan MG, 2008, BIOL CONTROL, V46, P552, DOI 10.1016/j.biocontrol.2008.05.015; Wang CL, 2013, FEMS MICROBIOL LETT, V341, P45, DOI 10.1111/1574-6968.12088; Yandigeri MS, 2012, PLANT GROWTH REGUL, V68, P411, DOI 10.1007/s10725-012-9730-2; Wayhs CAY, 2014, CELL BIOCHEM FUNCT, V32, P711, DOI 10.1002/cbf.3076; Samaniego-Gamez BY, 2016, CHIL J AGR RES, V76, DOI 10.4067/S0718-58392016000400003; Yoon MA, 2006, BIOL PHARM BULL, V29, P735, DOI 10.1248/bpb.29.735; Zamoum M, 2015, J PLANT DIS PROTECT, V122, P215, DOI 10.1007/BF03356555; Zhang HM, 2008, PLANT J, V56, P264, DOI 10.1111/j.1365-313X.2008.03593.x; Zhang H, 2007, PLANTA, V226, P839, DOI 10.1007/s00425-007-0530-2; Zhao Jiangyan, 2011, Weishengwu Xuebao, V51, P1318; Zhao X, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01968; Zothanpuia, 2018, MICROB CELL FACT, V17, DOI 10.1186/s12934-018-0912-0	73	22	22	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219014	10.1371/journal.pone.0219014	http://dx.doi.org/10.1371/journal.pone.0219014			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269087	gold, Green Published, Green Submitted			2022-12-26	WOS:000484927300038
J	Emelyanova, L; Boukatina, A; Myers, C; Oyarzo, J; Lustgarten, J; Shi, Y; Jahangir, A				Emelyanova, Larisa; Boukatina, Anna; Myers, Cheryl; Oyarzo, Janice; Lustgarten, Joseph; Shi, Yang; Jahangir, Arshad			High calories but not fat content of lard-based diet contribute to impaired mitochondrial oxidative phosphorylation in C57BL/6J mice heart	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; CHILDHOOD OBESITY; ACID-COMPOSITION; BLOOD-PRESSURE; WESTERN DIET; DYSFUNCTION; ENERGETICS; STRESS; LIPOTOXICITY; METABOLISM	Purpose High calorie intake leads to obesity, a global socio-economic and health problem, reaching epidemic proportion in children and adolescents. Saturated and monounsaturated fatty acids from animal (lard) fat are major components of the western-pattern diet and its regular consumption leads to obesity, a risk factor for cardiovascular disease. However, no clear evidence exists whether consumption of diet rich in saturated (SFAs) and monounsaturated (MUFAs) fatty acids has detrimental effects on cardiac structure and energetics primarily due to excessive calories. We, therefore, sought to determine the impact of high calories versus fat content in diet on cardiac structure and mitochondrial energetics. Methods Six-week-old C57BL/6J mice were fed with high calorie, high lard fat-based diet (60% fat, HFD), high-calorie and low lard fat-based diet (10% fat, LFD), and lower-calorie and fat diet (standard chow, 12% fat, SCD) for 10 weeks. Results The HFD- and LFD-fed mice had higher body weight, ventricular mass and thickness of posterior and septal wall with increased cardiomyocytes diameter compared to the SCD-fed mice. These changes were associated with a reduction in the mitochondrial oxidative phosphorylation (OXPHOS) complexes I and III activity compared to the SCD-fed mice without significant differences between the HFD- and LFD-fed animals. The HFD-fed animals had higher level of malondialdehyde (MDA) than LFD and SCD-fed mice. Conclusions We assume that changes in cardiac morphology and selective reduction of the OXPHOS complexes activity observed in the HFD- and LFD-fed mice might be related to excessive calories with additional effect of fat content on oxidative stress.	[Emelyanova, Larisa; Shi, Yang] Aurora Hlth Care, Aurora St Lukes Med Ctr, Ctr Integrat Res Cardiovasc Aging, Milwaukee, WI 53204 USA; [Boukatina, Anna; Myers, Cheryl; Oyarzo, Janice; Lustgarten, Joseph] Mayo Clin, Scottsdale, AZ USA; [Jahangir, Arshad] Aurora Hlth Care, Aurora Cardiovasc Serv, Milwaukee, WI USA	Mayo Clinic; Mayo Clinic Phoenix	Emelyanova, L (corresponding author), Aurora Hlth Care, Aurora St Lukes Med Ctr, Ctr Integrat Res Cardiovasc Aging, Milwaukee, WI 53204 USA.	publishing75@aurora.org			National Institutes of Health [NIH R01 HL101240, R01 HL089542]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grants (NIH R01 HL101240 and R01 HL089542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurrachim D, 2014, BBA-MOL CELL BIOL L, V1841, P1525, DOI 10.1016/j.bbalip.2014.07.016; Aguila MB, 2003, NUTRITION, V19, P347, DOI 10.1016/S0899-9007(02)00934-6; Akki A, 2009, CARDIOVASC RES, V81, P610, DOI 10.1093/cvr/cvn316; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; [Anonymous], 2016, J AM HEART ASS; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Barton M, 2012, ACTA PHARMACOL SIN, V33, P189, DOI 10.1038/aps.2011.204; Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Brainard RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083174; Bridger T, 2009, PAED CHILD HEALT-CAN, V14, P177, DOI 10.1093/pch/14.3.177; Buege J A, 1978, Methods Enzymol, V52, P302; Calligaris SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060931; Cavalera M, 2014, TRANSL RES, V164, P323, DOI 10.1016/j.trsl.2014.05.001; Chicco AJ, 2008, HYPERTENSION, V52, P549, DOI 10.1161/HYPERTENSIONAHA.108.114264; Duda MK, 2007, CARDIOVASC RES, V76, P303, DOI 10.1016/j.cardiores.2007.07.002; Emelyanova L, 2018, J GERONTOL A-BIOL, V73, P608, DOI 10.1093/gerona/glx160; Emelyanova L, 2016, AM J PHYSIOL-HEART C, V311, pH54, DOI 10.1152/ajpheart.00699.2015; Friedemann C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4759; FRY M, 1981, J BIOL CHEM, V256, P1874; Funtikova AN, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0107-z; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; German JB, 2004, AM J CLIN NUTR, V80, P550; Halade GV, 2012, CARDIOVASC RES, V93, P4, DOI 10.1093/cvr/cvr298; Jahangiri A, 2006, FREE RADICAL BIO MED, V40, P1592, DOI 10.1016/j.freeradbiomed.2005.12.026; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Kolwicz SC, 2016, BBA-MOL CELL BIOL L, V1861, P1472, DOI 10.1016/j.bbalip.2016.03.028; Korvald C, 2000, AM J PHYSIOL-HEART C, V278, pH1345, DOI 10.1152/ajpheart.2000.278.4.H1345; Krauss Ronald M., 1998, Circulation, V98, P1472; Kubant R, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.40; Leifert WR, 2001, J NUTR BIOCHEM, V12, P365, DOI 10.1016/S0955-2863(01)00151-6; Li X, 2010, CELL PHYSIOL BIOCHEM, V26, P41, DOI 10.1159/000315104; Li YY, 1997, PROSTAGLANDINS, V54, P511, DOI 10.1016/S0090-6980(97)00122-6; Licholai JA, 2018, OBESITY, V26, P1026, DOI 10.1002/oby.22195; Littlejohns B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100579; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; O'Connell KA, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.9; Okere IC, 2006, AM J PHYSIOL-HEART C, V291, pH38, DOI 10.1152/ajpheart.01295.2005; Pepe S, 2002, CIRCULATION, V105, P2303, DOI 10.1161/01.CIR.0000015604.88808.74; Qin FZ, 2014, AM J PHYSIOL-HEART C, V306, DOI 10.1152/ajpheart.00084.2014; Qin FZ, 2012, CIRCULATION, V125, P1757, DOI 10.1161/CIRCULATIONAHA.111.067801; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Ramsden CE, 2010, BRIT J NUTR, V104, P1586, DOI 10.1017/S0007114510004010; Russo SB, 2012, J CLIN INVEST, V122, P3919, DOI 10.1172/JCI63888; Schipke J, 2014, J ANAT, V225, P539, DOI 10.1111/joa.12236; Schmocker C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010180; Sharma N, 2007, CARDIOVASC RES, V73, P257, DOI 10.1016/j.cardiores.2006.11.007; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Nguyen S, 2017, J NUTR BIOCHEM, V46, P137, DOI 10.1016/j.jnutbio.2017.05.009; Stanley WC, 2012, CIRC RES, V110, P764, DOI [10.1161/CIRCRESAHA.111.253104, 10.1161/circresaha.111.253104]; Stypmann J, 2009, LAB ANIM-UK, V43, P127, DOI 10.1258/la.2007.06001e; Sullivan EM, 2017, J NUTR BIOCHEM, V45, P94, DOI 10.1016/j.jnutbio.2017.04.004; Takahashi R, 2005, CARDIOVASC RES, V68, P213, DOI 10.1016/j.cardiores.2005.05.018; Tiemann K, 2003, AM J PHYSIOL-HEART C, V284, pH464, DOI 10.1152/ajpheart.00540.2002; Vincent HK, 2010, J HUM NUTR DIET, V23, P20, DOI 10.1111/j.1365-277X.2009.00987.x; Vincent HK, 2001, INT J OBESITY, V25, P378, DOI 10.1038/sj.ijo.0801536; Wang Q, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002076; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Yanty NAM, 2011, J OLEO SCI, V60, P333, DOI 10.5650/jos.60.333; Zeng H, 2015, J CELL MOL MED, V19, P1847, DOI 10.1111/jcmm.12556; Zhao WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133132	64	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2019	14	7							e0217045	10.1371/journal.pone.0217045	http://dx.doi.org/10.1371/journal.pone.0217045			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3ZV	31265457	Green Published, gold, Green Submitted			2022-12-26	WOS:000484921200003
J	Catanzaro, MP; Weiner, A; Kaminaris, A; Li, CR; Cai, F; Zhao, FY; Kobayashi, S; Kobayashi, T; Huang, Y; Sesaki, H; Liang, QR				Catanzaro, Michael P.; Weiner, Ashley; Kaminaris, Amanda; Li, Cairong; Cai, Fei; Zhao, Fengyi; Kobayashi, Satoru; Kobayashi, Tamayo; Huang, Yuan; Sesaki, Hiromi; Liang, Qiangrong			Doxorubicin-induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy	FASEB JOURNAL			English	Article						cardiotoxicity; anti-tumor agents; mitochondrial quality control; heart failure	CARDIAC MITOCHONDRIA; HEART; ANTHRACYCLINES; DEXRAZOXANE; ADRIAMYCIN; PROTECTION; CARDIOTOXICITY; RECRUITMENT; RESISTANCE; AUTOPHAGY	Doxorubicin (Dox) is a widely used antineoplastic agent that can cause heart failure. Dox cardiotoxicity is closely associated with mitochondrial damage. Mitochondrial fission and mitophagy are quality control mechanisms that normally help maintain a pool of healthy mitochondria. However, unchecked mitochondrial fission and mitophagy may compromise the viability of cardiomyocytes, predisposing them to cell death. Here, we tested this possibility by using Dox-treated H9c2 cardiac myoblast cells expressing either the mitochondria-targeted fluorescent protein MitoDsRed or the novel dual-fluorescent mitophagy reporter mt-Rosella. Dox induced mitochondrial fragmentation as shown by reduced form factor, aspect ratio, and mean mitochondrial size. This effect was abolished by short interference RNA-mediated knockdown of dynamin-related protein 1 (DRP1), a major regulator of fission. Importantly, DRP1 knockdown decreased cell death as indicated by the reduced number of propidium iodide-positive cells and the cleavage of caspase-3 and poly (ADP-ribose) polymerase. Moreover, DRP1-deficient mice were protected from Dox-induced cardiac damage, strongly supporting a role for DRP1-dependent mitochondrial fragmentation in Dox cardiotoxicity. In addition, Dox accelerated mitophagy flux, which was attenuated by DRP1 knockdown, as assessed by the mitophagy reporter mt-Rosella, suggesting the necessity of mitochondrial fragmentation in Dox-induced mitophagy. Knockdown of parkin, a positive regulator of mitophagy, dramatically diminished Dox-induced cell death, whereas overexpression of parkin had the opposite effect. Together, these results suggested that Dox cardiotoxicity was mediated, at least in part, by the increased mitochondrial fragmentation and accelerated mitochondrial degradation by the lysosome. Strategies that limit mitochondrial fission and mitophagy in the physiologic range may help reduce Dox cardiotoxicity.-Catanzaro, M. P., Weiner, A., Kaminaris, A., Li, C., Cai, F., Zhao, F., Kobayashi, S., Kobayashi, T., Huang, Y., Sesaki, H., Liang, Q. Doxorubicin-induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy.	[Catanzaro, Michael P.; Weiner, Ashley; Kaminaris, Amanda; Kobayashi, Satoru; Kobayashi, Tamayo; Huang, Yuan; Liang, Qiangrong] New York Inst Technol, Coll Osteopath Med, Dept Biomed Sci, New York, NY USA; [Li, Cairong] Hubei Univ Sci & Technol, Clin Med Coll, Xianning, Peoples R China; [Cai, Fei] Hubei Univ Sci & Technol, Hubei Key Lab Diabet & Angiopathy, Xianning, Peoples R China; [Zhao, Fengyi] Xi An Jiao Tong Univ, Hlth Sci Ctr, Affiliated Hosp 1, Dept Endocrinol, Xian, Shaanxi, Peoples R China; [Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA	New York Institute Technology; Hubei University of Science & Technology; Hubei University of Science & Technology; Xi'an Jiaotong University; Johns Hopkins University	Liang, QR (corresponding author), New York Inst Technol, Coll Osteopath Med, Northern Blvd,POB 8000, Old Westbury, NY 11568 USA.	qliang03@nyit.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [1R15HL137130-01A1]; American Heart Association [15SDG25080077]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL137130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123266] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Q.L. was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant 1R15HL137130-01A1, and S.K. was supported by American Heart Association Grant 15SDG25080077. The authors declare no conflicts of interest.	Ackers-Johnson M, 2016, CIRC RES, V119, P909, DOI 10.1161/CIRCRESAHA.116.309202; Basit F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.133; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; BIANCHI C, 1987, EXP MOL PATHOL, V46, P123, DOI 10.1016/0014-4800(87)90036-0; Branco AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129303; Chang YW, 2013, MOL CELL PROTEOMICS, V12, P3094, DOI 10.1074/mcp.M113.027649; DAVIES KJA, 1986, J BIOL CHEM, V261, P3060; DOROSHOW JH, 1986, J BIOL CHEM, V261, P3068; Elliott AM, 2009, MOL CANCER RES, V7, P79, DOI 10.1158/1541-7786.MCR-08-0235; Gharanei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077713; Hasinoff BB, 2007, CARDIOVASC TOXICOL, V7, P140, DOI 10.1007/s12012-007-0023-3; Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Injac R, 2008, TECHNOL CANCER RES T, V7, P497, DOI 10.1177/153303460800700611; Kageyama Y, 2012, J CELL BIOL, V197, P535, DOI 10.1083/jcb.201110034; Kitay BM, 2013, HUM MOL GENET, V22, P1601, DOI 10.1093/hmg/ddt009; Koleini N, 2017, ONCOTARGET, V8, P46663, DOI 10.18632/oncotarget.16944; Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011; Li DL, 2016, CIRCULATION, V133, P1668, DOI 10.1161/CIRCULATIONAHA.115.017443; Liang QR, 2016, J MOL CELL CARDIOL, V95, P57, DOI 10.1016/j.yjmcc.2015.12.025; Link G, 1996, J LAB CLIN MED, V127, P272, DOI 10.1016/S0022-2143(96)90095-5; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Maeda Miho, 2008, Journal of Nippon Medical School, V75, P320; Mijaljica D, 2011, JOVE-J VIS EXP, DOI 10.3791/2779; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Mohammad IS, 2018, BIOMED PHARMACOTHER, V100, P335, DOI 10.1016/j.biopha.2018.02.038; Nah J, 2017, COMPR PHYSIOL, V7, P1407, DOI 10.1002/cphy.c170005; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Pereira GC, 2011, CURR PHARM DESIGN, V17, P2113; Sardao VA, 2009, CELL BIOL TOXICOL, V25, P227, DOI 10.1007/s10565-008-9070-1; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Song MS, 2017, CELL METAB, V26, P872, DOI 10.1016/j.cmet.2017.09.023; Song MS, 2015, CIRC RES, V117, P346, DOI 10.1161/CIRCRESAHA.117.306859; Swain SM, 1997, J CLIN ONCOL, V15, P1318, DOI 10.1200/JCO.1997.15.4.1318; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Tebbi CK, 2007, J CLIN ONCOL, V25, P493, DOI 10.1200/JCO.2005.02.3879; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; van der Pal HJ, 2010, ARCH INTERN MED, V170, P1247, DOI 10.1001/archinternmed.2010.233; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Wallace KB, 2007, CARDIOVASC TOXICOL, V7, P101, DOI 10.1007/s12012-007-0008-2; Wang JX, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.41; Wei SN, 2015, CARDIOVASC TOXICOL, V15, P377, DOI 10.1007/s12012-014-9306-7; Xu XM, 2013, J BIOL CHEM, V288, P18077, DOI 10.1074/jbc.M113.474650; Xu XM, 2012, J PHARMACOL EXP THER, V341, P183, DOI 10.1124/jpet.111.189589; Yin J, 2018, TOXICOL IN VITRO, V51, P1, DOI 10.1016/j.tiv.2018.05.001; Zhou SY, 2001, CANCER RES, V61, P771	47	73	76	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11096	11108		10.1096/fj.201802663R	http://dx.doi.org/10.1096/fj.201802663R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31291545	Green Published			2022-12-26	WOS:000489166300044
J	Driller, R; Ballaschk, M; Schmieder, P; Uchanska-Ziegler, B; Ziegler, A; Loll, B				Driller, Ronja; Ballaschk, Martin; Schmieder, Peter; Uchanska-Ziegler, Barbara; Ziegler, Andreas; Loll, Bernhard			Metal-triggered conformational reorientation of a self-peptide bound to a disease-associated HLA-B*27 subtype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmunity; nuclear magnetic resonance (NMR); X-ray crystallography; crystal structure; major histocompatibility complex (MHC); autoimmune disease; ankylosing spondylitis; conformational change; HLA-B*27; peptide dynamics; ensemble refinement; hypersensitivity; NMR spectroscopy	MAJOR HISTOCOMPATIBILITY COMPLEX; HLA-B27 SUBTYPES; ANKYLOSING-SPONDYLITIS; LIGAND INTERACTIONS; STRUCTURAL BASIS; SOFT ACIDS; T-CELLS; ANTIGEN; HYPERSENSITIVITY; SPONDYLOARTHRITIS	Conformational changes of major histocompatibility complex (MHC) antigens have the potential to be recognized by T cells and may arise from polymorphic variation of the MHC molecule, the binding of modifying ligands, or both. Here, we investigated whether metal ions could affect allele-dependent structural variation of the two minimally distinct human leukocyte antigen (HLA)-B*27:05 and HLA-B*27:09 subtypes, which exhibit differential association with the rheumatic disease ankylosing spondylitis (AS). We employed NMR spectroscopy and X-ray crystallography coupled with ensemble refinement to study the AS-associated HLA-B*27:05 subtype and the AS-nonassociated HLA-B*27:09 in complex with the self-peptide pVIPR (RRKWRRWHL). Both techniques revealed that pVIPR exhibits a higher degree of flexibility when complexed with HLA-B*27:05 than with HLA-B*27:09. Furthermore, we found that the binding of the metal ion Cu2+ or Ni2+, but not Mn2+, Zn2+, or Hg2+, affects the structure of a pVIPR-bound HLA-B*27 molecule in a subtype-dependent manner. In HLA-B*27:05, the metals triggered conformational reorientations of pVIPR, but no such structural changes were observed in the HLA-B*27:09 subtype, with or without bound metal ion. These observations provide the first demonstration that not only major histocompatibility complex class II, but also class I, molecules can undergo metal ion-induced conformational alterations. Our findings suggest that metals may have a role in triggering rheumatic diseases such as AS and also have implications for the molecular basis of metal-induced hypersensitivities and allergies.	[Driller, Ronja; Loll, Bernhard] Free Univ Berlin, AG Strukturbiochem, Inst Chemie Biochem, Takustr 6, D-14195 Berlin, Germany; [Ballaschk, Martin; Schmieder, Peter] Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany; [Uchanska-Ziegler, Barbara] Free Univ Berlin, Charite Univ Med Berlin, Inst Immungenet, Thielallee 73, D-14195 Berlin, Germany; [Uchanska-Ziegler, Barbara; Ziegler, Andreas] Ziegler Biosolut, Fahrgasse 5, D-79761 Waldshut Tiengen, Germany; [Loll, Bernhard] MoloX GmbH, Takustr 6, D-14195 Berlin, Germany	Free University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Loll, B (corresponding author), Free Univ Berlin, AG Strukturbiochem, Inst Chemie Biochem, Takustr 6, D-14195 Berlin, Germany.; Ziegler, A (corresponding author), Ziegler Biosolut, Fahrgasse 5, D-79761 Waldshut Tiengen, Germany.	ziegler-biosolutions@gmx.de; loll@chemie.fu-berlin.de	Loll, Bernhard/J-4815-2019; Ballaschk, Martin/AAV-2426-2021	Loll, Bernhard/0000-0001-7928-4488; Schmieder, Peter/0000-0001-9968-9327; Driller, Ronja/0000-0001-8834-9087	Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie	Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie	We are grateful to Christina Schnick and Claudia Alings for excellent technical assistance. We acknowledge access to beamline BL14.2 of the BESSY II storage ring (Berlin, Germany) via the Joint Berlin MX-Laboratory sponsored by the Helmholtz Zentrum Berlin fur Materialien und Energie, the Freie Universitat Berlin, the Humboldt-Universitat zu Berlin, the Max-Delbruck Centrum, and the Leibniz-Institut fur Molekulare Pharmakologie. We also acknowledge beamtime and support at beamline P14 of PETRA III (Deutsches Elektronen Synchrotron, Hamburg, Germany).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ayres CM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00966; Beerbaum M, 2013, J BIOMOL NMR, V57, P167, DOI 10.1007/s10858-013-9777-z; Beltrami A, 2008, J BIOL CHEM, V283, P27189, DOI 10.1074/jbc.M802818200; BENJAMIN R, 1990, IMMUNOL TODAY, V11, P137, DOI 10.1016/0167-5699(90)90051-A; Bowness P, 2015, ANNU REV IMMUNOL, V33, P29, DOI 10.1146/annurev-immunol-032414-112110; BREWERTON DA, 1973, LANCET, V1, P904; Budinger L, 2000, ALLERGY, V55, P108, DOI 10.1034/j.1398-9995.2000.00107.x; Burnley BT, 2012, ELIFE, V1, DOI 10.7554/eLife.00311; Clayton GM, 2014, CELL, V158, P132, DOI 10.1016/j.cell.2014.04.048; Colbert RA, 2017, BEST PRACT RES CL RH, V31, P797, DOI 10.1016/j.berh.2018.07.012; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dulger S, 2019, JCR-J CLIN RHEUMATOL, V25, P288, DOI 10.1097/RHU.0000000000000851; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian H, 2011, FEBS J, V278, P1713, DOI 10.1111/j.1742-4658.2011.08097.x; Fabian H, 2010, ARTHRITIS RHEUM-US, V62, P978, DOI 10.1002/art.27316; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; Fiorillo MT, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01475; Fiorillo MT, 2000, J CLIN INVEST, V106, P47, DOI 10.1172/JCI9295; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; Fodor J, 2018, J IMMUNOL, V200, P4134, DOI 10.4049/jimmunol.1800315; Fontenot AP, 2016, J IMMUNOL, V196, P22, DOI 10.4049/jimmunol.1502011; Gamerdinger K, 2003, J EXP MED, V197, P1345, DOI 10.1084/jem.20030121; GROS P, 1990, SCIENCE, V249, P1149, DOI 10.1126/science.2396108; Hafstrand I, 2019, P NATL ACAD SCI USA, V116, P5055, DOI 10.1073/pnas.1807656116; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Haustein K.-O., 2008, TABAKABHANGIGKEIT, P44; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Illing PT, 2013, CURR OPIN IMMUNOL, V25, P81, DOI 10.1016/j.coi.2012.10.002; Inman RD, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2610; Jiang JS, 2017, SCIENCE, V358, P1064, DOI 10.1126/science.aao5154; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klareskog L, 2011, SEMIN IMMUNOL, V23, P92, DOI 10.1016/j.smim.2011.01.014; Loll B, 2016, ARTHRITIS RHEUMATOL, V68, P1172, DOI 10.1002/art.39567; Loll B, 2011, PROTEIN SCI, V20, P278, DOI 10.1002/pro.559; de Castro JAL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02463; Lu L, 2003, J EXP MED, V197, P567, DOI 10.1084/jem.20021762; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGonagle D, 2015, NAT REV RHEUMATOL, V11, P731, DOI 10.1038/nrrheum.2015.147; McShan AC, 2018, NAT CHEM BIOL, V14, P811, DOI 10.1038/s41589-018-0096-2; Narzi D, 2008, J BIOL CHEM, V283, P23093, DOI 10.1074/jbc.M710234200; Narzi D, 2012, J MOL BIOL, V415, P429, DOI 10.1016/j.jmb.2011.11.021; Natarajan K, 2019, CRIT REV BIOCHEM MOL, V54, P164, DOI 10.1080/10409238.2019.1610352; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; PEARSON RG, 1990, COORDIN CHEM REV, V100, P403, DOI 10.1016/0010-8545(90)85016-L; Ramos M, 2002, J BIOL CHEM, V277, P28749, DOI 10.1074/jbc.M204155200; ROMAGNOLI P, 1991, EMBO J, V10, P1303, DOI 10.1002/j.1460-2075.1991.tb07648.x; Rotzschke O, 2002, P NATL ACAD SCI USA, V99, P16946, DOI 10.1073/pnas.212643999; Rowley B, 2005, MOL IMMUNOL, V42, P833, DOI 10.1016/j.molimm.2004.07.050; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schiraldi M, 2009, TRENDS IMMUNOL, V30, P502, DOI 10.1016/j.it.2009.07.005; Schittenhelm RB, 2016, MOL CELL PROTEOMICS, V15, P1867, DOI 10.1074/mcp.M115.056358; Schittenhelm RB, 2015, ARTHRITIS RHEUMATOL, V67, P702, DOI 10.1002/art.38963; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Taurog JD, 2009, ADV EXP MED BIOL, V649, P245; Thomas C, 2017, SCIENCE, V358, P1060, DOI 10.1126/science.aao6001; Uchanska-Ziegler B, 2012, EUR J CELL BIOL, V91, P274, DOI 10.1016/j.ejcb.2011.03.003; Wang Y, 2013, IMMUNOL RES, V55, P83, DOI 10.1007/s12026-012-8351-1; Wax PM, 2013, J MED TOXICOL, V9, P303, DOI 10.1007/s13181-013-0347-2; Wendling D, 2013, EXPERT REV CLIN IMMU, V9, P511, DOI [10.1586/ECI.13.35, 10.1586/eci.13.35]; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Yin L, 2013, PROTEIN CELL, V4, P8, DOI 10.1007/s13238-012-2077-7; Zernich D, 2004, J EXP MED, V200, P13, DOI 10.1084/jem.20031680; Zheng H, 2017, ACTA CRYSTALLOGR D, V73, P223, DOI 10.1107/S2059798317001061	66	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2019	294	36					13269	13279		10.1074/jbc.RA119.008937	http://dx.doi.org/10.1074/jbc.RA119.008937			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FN	31296658	hybrid, Green Published			2022-12-26	WOS:000486417200006
J	Arriagada, C; Silva, P; Millet, M; Solano, L; Moraga, C; Torres, VA				Arriagada, Cecilia; Silva, Patricio; Millet, Martial; Solano, Luis; Moraga, Carolina; Torres, Vicente A.			Focal adhesion kinase-dependent activation of the early endocytic protein Rab5 is associated with cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						focal adhesion; cell migration; PTK2 protein tyrosine kinase 2 (PTK2); focal adhesion kinase (FAK); metastasis; tumor; small GTPase; early endosome; endocytic trafficking; integrin complex; Rab5	PHOSPHATIDYLINOSITOL 3-KINASE; P85 SUBUNIT; INTEGRIN; CASPASE-8; FAK	Focal adhesion kinase (FAK) is a central regulator of integrin-dependent cell adhesion and migration and has recently been shown to co-localize with endosomal proteins. The early endocytic protein Rab5 controls integrin trafficking, focal adhesion disassembly, and cell migration and has been shown to be activated upon integrin engagement by mechanisms that remain unclear. Because FAK is a critical regulator of integrin-dependent signaling and Rab5 recapitulates FAK-mediated effects, we evaluated the possibility that FAK activates Rab5 and contributes to cell migration. Pulldown assays revealed that Rab5-GTP levels are decreased upon treatment with a pharmacological inhibitor of FAK, PF562,271, in resting A549 cells. These events were associated with decreased peripheral Rab5 puncta and a reduced number of early endosome antigen 1 (EEA1)-positive early endosomes. Accordingly, as indicated by FAK inhibition experiments and in FAK-null fibroblasts, adhesion-induced FAK activity increased Rab5-GTP levels. In fact, expression of WT FAK and FAK/Y180A/M183A (open conformation), but not FAK/Arg(454) (kinase-dead), augmented Rab5-GTP levels in FAK-null fibroblasts and A549 cells. Moreover, expression of a GDP-bound Rab5 mutant (Rab5/S34N) or shRNA-mediated knockdown of endogenous Rab5 prevented FAK-induced A549 cell migration, whereas expression of WT or GTP-bound Rab5 (Rab5/Q79L), but not Rab5/S34N, promoted cell migration in FAK-null fibroblasts. Mechanistically, FAK co-immunoprecipitated with the GTPase-activating protein p85 alpha in a phosphorylation (Tyr(397))-dependent manner, preventing Rab5-GTP loading, as shown by knockdown and transfection recovery experiments. Taken together, these results reveal that FAK activates Rab5, leading to cell migration.	[Arriagada, Cecilia; Silva, Patricio; Millet, Martial; Solano, Luis; Moraga, Carolina; Torres, Vicente A.] Univ Chile, Fac Dent, Inst Res Dent Sci, Olivos 943, Santiago 8380000, Chile; [Silva, Patricio] Univ Cent Chile, Fac Hlth Sci, Santiago 8380000, Chile; [Torres, Vicente A.] Univ Chile, Adv Ctr Chron Dis, Santiago 8380000, Chile	Universidad de Chile; Universidad Central de Chile; Universidad de Chile	Torres, VA (corresponding author), Univ Chile, Fac Dent, Inst Res Dent Sci, Olivos 943, Santiago 8380000, Chile.	vatorres@med.uchile.cl		Arriagada, Cecilia/0000-0002-5351-2240; Torres, Vicente A/0000-0002-5973-7248	Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant [1180495]; Comision Nacional de Investigacion Cientifica y Tecnologica FONDAP [15130011]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [3170660]	Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant; Comision Nacional de Investigacion Cientifica y Tecnologica FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant 1180495 (to V. A. T.), Comision Nacional de Investigacion Cientifica y Tecnologica FONDAP Grant 15130011 (to V. A. T.), and Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant 3170660 (to P. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alanko J, 2015, NAT CELL BIOL, V17, P1412, DOI 10.1038/ncb3250; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Chamberlain MD, 2008, J BIOL CHEM, V283, P15861, DOI 10.1074/jbc.M800941200; Chamberlain MD, 2010, CELL SIGNAL, V22, P1562, DOI 10.1016/j.cellsig.2010.05.025; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Diaz J, 2014, J CELL SCI, V127, P2401, DOI 10.1242/jcs.141689; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Frittoli E, 2014, J CELL BIOL, V206, P307, DOI 10.1083/jcb.201403127; Guo LL, 2009, PATHOL RES PRACT, V205, P847, DOI 10.1016/j.prp.2009.07.005; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Kleinschmidt EG, 2017, CURR OPIN CELL BIOL, V45, P24, DOI 10.1016/j.ceb.2017.01.003; Lanzetti L, 2017, CANCER RES, V77, P1813, DOI 10.1158/0008-5472.CAN-16-3403; Lazo OM, 2013, J NEUROSCI, V33, P6112, DOI 10.1523/JNEUROSCI.4630-12.2013; Liu SS, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-58; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Mendoza P, 2014, CURR MOL MED, V14, P235, DOI 10.2174/1566524014666140128111347; Mendoza Pablo, 2014, Small GTPases, V5, pe28195, DOI 10.4161/sgtp.28195; Mendoza P, 2013, J CELL SCI, V126, P3835, DOI 10.1242/jcs.119727; Mendoza PA, 2018, CELL ADHES MIGR, V12, P185, DOI 10.1080/19336918.2017.1377388; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nader GPF, 2016, NAT CELL BIOL, V18, P491, DOI 10.1038/ncb3333; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Palamidessi A, 2013, CURR BIOL, V23, P2355, DOI 10.1016/j.cub.2013.09.060; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Senft J, 2007, CANCER RES, V67, P11505, DOI 10.1158/0008-5472.CAN-07-5755; Silva P, 2016, ONCOTARGET, V7, P29548, DOI 10.18632/oncotarget.8794; Torres VA, 2014, CELL ADHES MIGR, V8, P84, DOI 10.4161/cam.28510; Torres VA, 2010, MOL BIOL CELL, V21, P369, DOI 10.1091/mbc.E09-09-0769; Torres VA, 2008, J BIOL CHEM, V283, P36280, DOI 10.1074/jbc.M805878200; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133	33	8	9	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12836	12845		10.1074/jbc.RA119.008667	http://dx.doi.org/10.1074/jbc.RA119.008667			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31292193	Green Published, hybrid			2022-12-26	WOS:000484414600024
J	Sanchez, CP; Cubel, SM; Nyboer, B; Jankowska-Dollken, M; Schaeffer-Reiss, C; Ayoub, D; Planelles, G; Lanzer, M				Sanchez, Cecilia P.; Cubel, Sonia Moliner; Nyboer, Britta; Jankowska-Doellken, Monika; Schaeffer-Reiss, Christine; Ayoub, Daniel; Planelles, Gabrielle; Lanzer, Michael			Phosphomimetic substitution at Ser-33 of the chloroquine resistance transporter PfCRT reconstitutes drug responses in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Plasmodium; drug transport; drug resistance; phosphorylation; kinetics; genome editing; kinase inhibitors; PfCRT; transport velocity; virulence factor	MALARIA PARASITES; PROTEIN-KINASE; OKADAIC ACID; PHOSPHORYLATION; SUBSTRATE; SUSCEPTIBILITY; MUTATIONS; MECHANISM; AFFINITY; REVEALS	The chloroquine resistance transporter PfCRT of the human malaria parasite Plasmodium falciparum confers resistance to the former first-line antimalarial drug chloroquine, and it modulates the responsiveness to a wide range of quinoline and quinoline-like compounds. PfCRT is post-translationally modified by phosphorylation, palmitoylation, and, possibly, ubiquitination. However, the impact of these post-translational modifications on P. falciparum biology and, in particular, the drug resistance-conferring activity of PfCRT has remained elusive. Here, we confirm phosphorylation at Ser-33 and Ser-411 of PfCRT of the chloroquine-resistant P. falciparum strain Dd2 and show that kinase inhibitors can sensitize drug responsiveness. Using CRISPR/Cas9 genome editing to generate genetically engineered PfCRT variants in the parasite, we further show that substituting Ser-33 with alanine reduced chloroquine and quinine resistance by similar to 50% compared with the parental P. falciparum strain Dd2, whereas the phosphomimetic amino acid aspartic acid could fully and glutamic acid could partially reconstitute the level of chloroquine/quinine resistance. Transport studies conducted in the parasite and in PfCRT-expressing Xenopus laevis oocytes linked phosphomimetic substitution at Ser-33 to increased transport velocity. Our data are consistent with phosphorylation of Ser-33 relieving an autoinhibitory intramolecular interaction within PfCRT, leading to a stimulated drug transport activity. Our findings shed additional light on the function of PfCRT and suggest that chloroquine could be reevaluated as an antimalarial drug by targeting the kinase in P. falciparum that phosphorylates Ser-33 of PfCRT.	[Sanchez, Cecilia P.; Cubel, Sonia Moliner; Nyboer, Britta; Jankowska-Doellken, Monika; Lanzer, Michael] Heidelberg Univ Hosp, Ctr Infect Dis Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany; [Schaeffer-Reiss, Christine; Ayoub, Daniel] Univ Strasbourg, Lab Spectrometrie Masse Bioorgan, CNRS, IPHC,UMR 7178, F-67037 Strasbourg, France; [Planelles, Gabrielle] Univ Paris 06, INSERM, Ctr Rech Cordeliers, Unite 1138,CNRS,ERL8228, F-75006 Paris, France; [Cubel, Sonia Moliner] Heidelberg Univ, Heidelberg Biosci Int Grad Sch, Heidelberg, Germany; [Ayoub, Daniel] Glenmark Pharmaceut SA, Chemin Combeta 5, CH-2300 La Chaux De Fonds, Switzerland; [Lanzer, Michael] Res Cluster Excellence CellNetworks, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Ruprecht Karls University Heidelberg	Lanzer, M (corresponding author), Heidelberg Univ Hosp, Ctr Infect Dis Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.; Lanzer, M (corresponding author), Res Cluster Excellence CellNetworks, Heidelberg, Germany.	michael.lanzer@med.uni-heidelberg.de	Lanzer, Michael/E-9752-2013; Planelles, Gabrielle/F-9603-2013	Lanzer, Michael/0000-0002-0220-6526; Planelles, Gabrielle/0000-0002-7314-8837; Ayoub, Daniel/0000-0001-6433-9917	joint French-German Research Initiative - Agence Nationale de la Recherche (ANR); Deutsche Forschungsgemeinschaft (DFG) (EVOTRANSPORT) [ANR-14-CE35-0012-01, LA 941/11-1]; Partenariat Hubert Curien (PHC) PROCOPE [30995WE, 57051467]	joint French-German Research Initiative - Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft (DFG) (EVOTRANSPORT)(German Research Foundation (DFG)); Partenariat Hubert Curien (PHC) PROCOPE	This work was supported by the joint French-German Research Initiative sponsored by the Agence Nationale de la Recherche (ANR) and the Deutsche Forschungsgemeinschaft (DFG) (EVOTRANSPORT/Grant ANR-14-CE35-0012-01 and Grant LA 941/11-1) and the Partenariat Hubert Curien (PHC) PROCOPE (Grants 30995WE and ID 57051467). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal S, 2017, J INFECT DIS, V216, P468, DOI 10.1093/infdis/jix334; Antony HA, 2019, ACTA TROP, V189, P84, DOI 10.1016/j.actatropica.2018.10.001; Aryal B, 2015, BIOCHEM SOC T, V43, P966, DOI 10.1042/BST20150128; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bakouh N, 2017, J BIOL CHEM, V292, P16109, DOI 10.1074/jbc.M117.805200; Bellanca S, 2014, J BIOL CHEM, V289, P36336, DOI 10.1074/jbc.M114.614206; Ciarimboli G, 2005, J AM SOC NEPHROL, V16, P1562, DOI 10.1681/ASN.2004040256; Coronado LM, 2014, BBA-GEN SUBJECTS, V1840, P2032, DOI 10.1016/j.bbagen.2014.02.009; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dhingra SK, 2017, MBIO, V8, DOI [10.1128/mBio.00303-17, 10.1128/mbio.00303-17]; Dounay AB, 2002, CURR MED CHEM, V9, P1939, DOI 10.2174/0929867023368791; Egan TJ, 2006, J INORG BIOCHEM, V100, P916, DOI 10.1016/j.jinorgbio.2005.11.005; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Gabryszewski SJ, 2016, MOL BIOL EVOL, V33, P1554, DOI 10.1093/molbev/msw037; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Heinberg A, 2015, ANN NY ACAD SCI, V1342, P10, DOI 10.1111/nyas.12662; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holland Z, 2009, EUKARYOT CELL, V8, P388, DOI 10.1128/EC.00334-08; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Juge N, 2015, P NATL ACAD SCI USA, V112, P3356, DOI 10.1073/pnas.1417102112; Kuhn Y, 2010, TRAFFIC, V11, P236, DOI 10.1111/j.1600-0854.2009.01018.x; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2012, J PROTEOME RES, V11, P5323, DOI 10.1021/pr300557m; Lin-Moshier Yaping, 2013, Cold Spring Harb Protoc, V2013, DOI 10.1101/pdb.prot072793; Lucet IS, 2012, FUTURE MED CHEM, V4, P2295, DOI [10.4155/FMC.12.183, 10.4155/fmc.12.183]; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Mehrens T, 2000, J AM SOC NEPHROL, V11, P1216, DOI 10.1681/ASN.V1171216; Moritz AE, 2015, J BIOL CHEM, V290, P29095, DOI 10.1074/jbc.M115.667055; Patzewitz EM, 2013, ANTIOXID REDOX SIGN, V19, P683, DOI 10.1089/ars.2012.4625; Petersen I, 2015, MOL MICROBIOL, V97, P381, DOI 10.1111/mmi.13035; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; SAITOH M, 1987, J BIOL CHEM, V262, P7796; Sanchez CP, 2007, MOL MICROBIOL, V64, P407, DOI 10.1111/j.1365-2958.2007.05664.x; Sanchez CP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004382; Sanchez CP, 2011, MOL MICROBIOL, V82, P865, DOI 10.1111/j.1365-2958.2011.07855.x; Sanchez CP, 2004, BIOCHEMISTRY-US, V43, P16365, DOI 10.1021/bi048241x; Sanchez CP, 2003, BIOCHEMISTRY-US, V42, P9383, DOI 10.1021/bi034269h; SARDET C, 1991, J BIOL CHEM, V266, P19166; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Summers RL, 2014, P NATL ACAD SCI USA, V111, pE1759, DOI 10.1073/pnas.1322965111; Summers RL, 2012, CELL MOL LIFE SCI, V69, P1967, DOI 10.1007/s00018-011-0906-0; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tran CV, 2004, MICROBIOL-SGM, V150, P1, DOI 10.1099/mic.0.26818-0; Umeda D, 2008, EUR J PHARMACOL, V590, P61, DOI 10.1016/j.ejphar.2008.05.029; van Schalkwyk DA, 2016, J INFECT DIS, V213, P800, DOI 10.1093/infdis/jiv509; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; Yamaki T, 1979, Rinsho Byori, VSuppl 40, P67; Yuan J, 2011, SCIENCE, V333, P724, DOI 10.1126/science.1205216; ZIMMER M, 1984, EUR J BIOCHEM, V139, P295, DOI 10.1111/j.1432-1033.1984.tb08007.x	54	7	7	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12766	12778		10.1074/jbc.RA119.009464	http://dx.doi.org/10.1074/jbc.RA119.009464			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31285265	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000484414600018
J	Suh, CH; Yoon, HM; Jungid, SC; Choi, YJ				Suh, Chong Hyun; Yoon, Hee Mang; Jungid, Seung Chai; Choi, Young Jun			Accuracy and precision of ultrasound shear wave elasticity measurements according to target elasticity and acquisition depth: A phantom study	PLOS ONE			English	Article							RADIATION FORCE; SPEED MEASUREMENTS; ELASTOGRAPHY; STRAIN; REPEATABILITY; LIVER	Objective To investigate the accuracy and precision of ultrasound shear wave elasticity measurements as a function of target elasticity and acquisition depth. Materials and methods Using five ultrasound systems (VTQ, VTIQ, EPIQ 5, Aixplorer, and Aplio 500), two operators independently measured shear wave elasticities in two phantoms containing five different target elasticities (8 +/- 3, 14 +/- 4, 25 +/- 6, 45 +/- 8, and 80 +/- 12 kPa) at depths of 15, 30, 35, and 60 mm. Accuracy was assessed by evaluating measurement errors and the proportions of outliers, while factors affecting accuracy were assessed using logistic regression analysis. Measurement errors were defined as differences between the measured values and 1) the margins of the target elasticity, and 2) the median values of the target elasticity. Outliers were defined as measured values outside the margins of the target elasticity. Precision was assessed by calculating the reproducibility of measurements using the within-subject coefficient of variation (wCV). Results Mean measurement errors and the proportions of outliers were higher for high than for low target elasticities (p<0.001), but did not differ in relation to acquisition depth, either within an elastography system or across the different systems. Logistic regression analysis showed that target elasticity (p<0.001) significantly affected accuracy, whereas acquisition depth (p>0.05) did not. The wCV for the 80 +/- 12 kPa target (31.33%) was significantly higher than that for lower elasticity targets (6.96-10.43 kPa; p<0.001). The wCV did not differ across acquisition depths. The individual elastography systems showed consistent results. Conclusions Targets with high elasticity showed lower accuracy and lower precision than targets with low elasticity, while acquisition depth did not show consistent patterns in either accuracy or precision.	[Suh, Chong Hyun; Yoon, Hee Mang; Jungid, Seung Chai; Choi, Young Jun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Suh, Chong Hyun; Yoon, Hee Mang; Jungid, Seung Chai; Choi, Young Jun] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Jungid, SC (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.	dynamics79@gmail.com			Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea [2016-719]	Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea	This work was supported by the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea, grant no. 2016-719 to SCJ (http://en.ails.amc.seoul.kr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr RG, 2015, RADIOLOGY, V275, P45, DOI 10.1148/radiol.14132404; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Carlsen JF, 2015, AM J ROENTGENOL, V204, pW236, DOI 10.2214/AJR.14.13076; Choi YJ, 2015, ULTRASONOGRAPHY, V34, P157, DOI 10.14366/usg.15007; Cournane S, 2012, ULTRASOUND, V20, P16, DOI 10.1258/ult.2011.011033; Dillman JR, 2015, PEDIATR RADIOL, V45, P376, DOI 10.1007/s00247-014-3150-6; Feltz CJ, 1996, STAT MED, V15, P647, DOI 10.1002/(SICI)1097-0258(19960330)15:6<647::AID-SIM184>3.0.CO;2-P; Gourtsoyianni S, 2017, RADIOLOGY, V284, P552, DOI 10.1148/radiol.2017161375; Klauser AS, 2014, RADIOLOGY, V272, P622, DOI 10.1148/radiol.14121765; Lee SH, 2014, RADIOLOGY, V270, P344, DOI 10.1148/radiol.13130561; Mulabecirovic A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189671; Mulabecirovic A, 2016, ULTRASOUND MED BIOL, V42, P2572, DOI 10.1016/j.ultrasmedbio.2016.07.002; Park SH, 2016, CLIN MOL HEPATOL, V22, P406, DOI 10.3350/cmh.2016.0106; Samir AE, 2015, RADIOLOGY, V277, P565, DOI 10.1148/radiol.2015141627; Shin HJ, 2016, EUR RADIOL, V26, P3361, DOI 10.1007/s00330-016-4212-y; Sigrist RMS, 2017, THERANOSTICS, V7, P1303, DOI 10.7150/thno.18650; Suh CH, 2017, EUR RADIOL, V27, P222, DOI 10.1007/s00330-016-4378-3; Suh CH, 2014, RADIOLOGY, V271, P895, DOI 10.1148/radiol.14131251; Sullivan DC, 2015, RADIOLOGY, V277, P813, DOI 10.1148/radiol.2015142202; Wang CZ, 2014, ULTRASOUND MED BIOL, V40, P461, DOI 10.1016/j.ultrasmedbio.2013.10.021; Wang Kai, 2014, International Journal of Computational Biology and Drug Design, V7, P183, DOI 10.1504/IJCBDD.2014.061656; Woo H, 2015, RADIOLOGY, V277, P881, DOI 10.1148/radiol.2015141975; Yamanaka N, 2012, J ULTRAS MED, V31, P1239; Zhao H, 2011, ULTRASOUND MED BIOL, V37, P1884, DOI 10.1016/j.ultrasmedbio.2011.07.012	24	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219621	10.1371/journal.pone.0219621	http://dx.doi.org/10.1371/journal.pone.0219621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295308	Green Published, Green Submitted, gold			2022-12-26	WOS:000484951800057
J	Itami, T; Hanazono, K; Oyama, N; Sano, T; Makita, K; Yamashita, K				Itami, Takaharu; Hanazono, Kiwamu; Oyama, Norihiko; Sano, Tadashi; Makita, Kohei; Yamashita, Kazuto			Cardiovascular effects of intravenous colforsin in normal and acute respiratory acidosis canine models: A dose-response study	PLOS ONE			English	Article							DOBUTAMINE; DOPAMINE; DOGS; FORSKOLIN; ISOFLURANE; HYPERTENSION; HYPERCAPNIA; ANESTHESIA; DOPPLER; VOLUME	In acidosis, catecholamines are attenuated, and higher doses are often required to improve cardiovascular function. Colforsin activates adenylate cyclase in cardiomyocytes without beta-adrenoceptor. Here, six beagles were administered colforsin or dobutamine four times during eucapnia (partial pressure of arterial carbon dioxide 35-40 mm Hg; normal) and hypercapnia (ibid 90-110 mm Hg; acidosis) conditions. The latter was induced by CO2 inhalation. Anesthesia was induced with propofol and maintained with isoflurane. Cardiovascular function was measured by thermodilution and a Swan-Ganz catheter at baseline and 60 min after 0.3 mu g/kg/min (low), 0.6 mu g/kg/min (middle), and 1.2 mu g/kg/min (high) colforsin administration. The median pH was 7.38 [range 7.33-7.42] and 7.01 [range 6.96-7.08] at baseline in the Normal and Acidosis conditions, respectively. Endogenous adrenaline and noradrenaline levels at baseline were significantly (P < 0.05) higher in the Acidosis than in the Normal condition. Colforsin induced cardiovascular effects similar to those caused by dobutamine. Colforsin increased cardiac output in the Normal condition (baseline: 3.9 +/- 0.2 L/kg/m(2) [mean +/- standard error], low: 5.2 +/- 0.4 L/kg/min(2), middle: 7.0 +/- 0.4 L/kg/m(2), high: 9.4 +/- 0.2 L/kg/m(2); P < 0.001) and Acidosis condition (baseline: 6.1 +/- 0.3 L/kg/m(2), low: 6.2 +/- 0.2 L/kg/m(2), middle: 7.2 +/- 0.2 L/kg/m(2), high: 8.3 +/- 0.2 L/kg/m(2); P < 0.001). Colforsin significantly increased heart rate and decreased systemic vascular resistance compared to values at baseline. Both drugs increased pulmonary artery pressure, but colforsin (high: 13.3 +/- 0.6 mmHg in Normal and 20.1 +/- 0.2 mmHg in Acidosis) may have lower clinical impact on the pulmonary artery than dobutamine (high: 19.7 +/- 0.6 in Normal and 26.7 +/- 0.5 in Acidosis). Interaction between both drugs and experimental conditions was observed in terms of cardiovascular function, which were similarly attenuated with colforsin and dobutamine under acute respiratory acidosis.	[Itami, Takaharu; Hanazono, Kiwamu; Oyama, Norihiko; Makita, Kohei; Yamashita, Kazuto] Rakuno Gakuen Univ, Dept Vet Med, Ebetsu, Hokkaido, Japan; [Sano, Tadashi] Rakuno Gakuen Univ, Dept Vet Sci, Ebetsu, Hokkaido, Japan	Rakuno Gakuen University; Rakuno Gakuen University	Itami, T (corresponding author), Rakuno Gakuen Univ, Dept Vet Med, Ebetsu, Hokkaido, Japan.	t-itami@rakuno.ac.jp		Itami, Takaharu/0000-0002-4692-2495; Hanazono, Kiwamu/0000-0002-6626-4709	JSPS KAKENHI [JP 26861516]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP 26861516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth E, 2007, CRIT CARE MED, V35, pS508, DOI 10.1097/01.CCM.0000278047.06965.20; Borgarelli Michele, 2004, J Vet Cardiol, V6, P27, DOI 10.1016/S1760-2734(06)70055-8; CLOWES GHA, 1955, ANN SURG, V142, P446, DOI 10.1097/00000658-195509000-00011; Davel AP, 2015, LIFE SCI, V125, P49, DOI 10.1016/j.lfs.2015.01.018; DiBartola S. P., 2012, FLUID ELECTROLYTE AC, P331; Dyson DH, 2006, AM J VET RES, V67, P1121, DOI 10.2460/ajvr.67.7.1121; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Hagiya K, 2013, J CARDIOTHOR VASC AN, V27, P925, DOI 10.1053/j.jvca.2012.09.019; Haskins S, 2005, COMPARATIVE MED, V55, P156; HIRASAWA A, 1993, J CARDIOVASC PHARM, V22, P847, DOI 10.1097/00005344-199312000-00011; Hosono M, 1999, Nihon Yakurigaku Zasshi, V114, P83; Kellihan HB, 2010, VET CLIN N AM-SMALL, V40, P623, DOI 10.1016/j.cvsm.2010.03.011; LEIGHTON KM, 1976, CAN ANAESTH SOC J, V23, P176, DOI 10.1007/BF03005689; LINDNER E, 1983, ARZNEIMITTEL-FORSCH, V33-2, P1436; MARSH JD, 1988, AM J PHYSIOL, V254, pH20, DOI 10.1152/ajpheart.1988.254.1.H20; McIntosh VJ, 2011, AM J PHYSIOL-HEART C, V301, pH1127, DOI 10.1152/ajpheart.00711.2010; METZGER H, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1248; Philipson L. H., 2002, Journal of Allergy and Clinical Immunology, V110, pS313, DOI 10.1067/mai.2002.129702; Ramirez J, 2000, CRIT CARE MED, V28, P1918, DOI 10.1097/00003246-200006000-00039; Riordan LL, 2012, FLUID ELECTROLYTE AC, P269; Robertson, 2015, VET ANAESTH ANALG, P496; ROBIE NW, 1975, AM HEART J, V90, P340, DOI 10.1016/0002-8703(75)90323-3; Rosati M, 2007, AM J VET RES, V68, P483, DOI 10.2460/ajvr.68.5.483; RUFFOLO RR, 1987, AM J MED SCI, V294, P244, DOI 10.1097/00000441-198710000-00005; Schotola H, 2012, CRIT CARE, V16, DOI 10.1186/cc11468; Serres F, 2007, J VET INTERN MED, V21, P1280, DOI 10.1892/07-064.1; Serres FJ, 2006, JAVMA-J AM VET MED A, V229, P1772, DOI 10.2460/javma.229.11.1772; SHEBUSKI RJ, 1988, PHARMACOLOGY, V36, P35, DOI 10.1159/000138344; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Tavares-Silva M, 2017, J CARDIOVASC PHARM T, V22, P485, DOI 10.1177/1074248417696818; WALLEY KR, 1990, CIRC RES, V67, P628, DOI 10.1161/01.RES.67.3.628; WATTWIL LMT, 1987, ANESTH ANALG, V66, P1234; WOODSON LC, 1980, HORM METAB RES, V12, P434, DOI 10.1055/s-2007-999168; Yoneyama M, 2002, CIRC J, V66, P1150, DOI 10.1253/circj.66.1150	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0213414	10.1371/journal.pone.0213414	http://dx.doi.org/10.1371/journal.pone.0213414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291253	Green Submitted, gold, Green Published			2022-12-26	WOS:000484947800005
J	Maessen, JHJ; Raab, J; Haverkate, M; Smollich, M; ter Waarbeek, HLG; Eilers, R; Timen, A				Maessen, Jacklien H. J.; Raab, Jorg; Haverkate, Manon; Smollich, Martin; ter Waarbeek, Henriette L. G.; Eilers, Renske; Timen, Aura			How prepared are we for cross-border outbreaks? An exploratory analysis of cross-border response networks for outbreaks of multidrug resistant microorganisms in the Netherlands and Germany	PLOS ONE			English	Article							SOCIAL NETWORKS; PUBLIC-HEALTH; GOVERNANCE; CENTRALITY	Background The emergence and spread of multidrug resistant microorganisms is a serious threat to transnational public health. Therefore, it is vital that cross-border outbreak response systems are constantly prepared for fast, rigorous, and efficient response. This research aims to improve transnational collaboration by identifying, visualizing, and exploring two cross-border response networks that are likely to unfold during outbreaks involving the Netherlands and Germany. Methods Quantitative methods were used to explore response networks during a cross-border outbreak of carbapenem resistant Enterobacteriaceae in healthcare settings. Eighty-six Dutch and German health professionals reflected on a fictive but realistic outbreak scenario (response rate approximate to 70%). Data were collected regarding collaborative relationships between stakeholders during outbreak response, prior working relationships, and trust in the networks. Network analysis techniques were used to analyze the networks on the network level (density, centralization, clique structures, and similarity of tie constellations between two networks) and node level (brokerage measures and degree centrality). Results Although stakeholders mainly collaborate with stakeholders belonging to the same country, transnational collaboration is present in a centralized manner. Integration of the network is reached, since several actors are beneficially positioned to coordinate transnational collaboration. However, levels of trust are moderately low and prior-existing cross-border working relationships are sparse. Conclusion Given the explored network characteristics, we conclude that the system has a promising basis to achieve effective coordination. However, future research has to determine what kind of network governance form might be most effective and efficient in coordinating the necessary cross-border response activity. Furthermore, networks identified in this study are not only crucial in times of outbreak containment, but should also be fostered in times of non-crisis.	[Maessen, Jacklien H. J.; Raab, Jorg] Tilburg Univ, Dept Org Studies, Tilburg, Netherlands; [Haverkate, Manon; Eilers, Renske; Timen, Aura] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Smollich, Martin] Univ Hosp Schleswig Holstein, Lubeck, Germany; [ter Waarbeek, Henriette L. G.] Publ Hlth Serv Zuid Limburg, Heerlen, Netherlands; [Timen, Aura] Vrije Univ Amsterdam, Athena Inst Res Innovat & Commun Hlth & Life Sci, Amsterdam, Netherlands	Tilburg University; Netherlands National Institute for Public Health & the Environment; University of Kiel; Schleswig Holstein University Hospital; Vrije Universiteit Amsterdam	Maessen, JHJ (corresponding author), Tilburg Univ, Dept Org Studies, Tilburg, Netherlands.	jacklienmaessen@gmail.com	Timen, Aura/GLV-4130-2022	Maessen, Jacklien/0000-0003-1805-9388; Raab, Jorg/0000-0002-4013-7541	INTERREG V A funded project EurHealth-1Health [202085]; European Union; Dutch Ministry of Health, Welfare and Sport (VWS); Ministry of Economy, Innovation, Digitalisation and Energy of the German Federal State of North Rhine-Westphalia; German Federal State of Lower Saxony; RIVM (National Institute for Public Health and the Environment) of the Netherlands	INTERREG V A funded project EurHealth-1Health; European Union(European Commission); Dutch Ministry of Health, Welfare and Sport (VWS); Ministry of Economy, Innovation, Digitalisation and Energy of the German Federal State of North Rhine-Westphalia; German Federal State of Lower Saxony; RIVM (National Institute for Public Health and the Environment) of the Netherlands	The study was partly supported by the INTERREG V A funded project EurHealth-1Health (202085), which is part of a Dutch-German crossborder network supported by the European Union, the Dutch Ministry of Health, Welfare and Sport (VWS), the Ministry of Economy, Innovation, Digitalisation and Energy of the German Federal State of North Rhine-Westphalia and the German Federal State of Lower Saxony. Furthermore, the study was undertaken with support from the RIVM (National Institute for Public Health and the Environment) of the Netherlands. There was no additional external funding received for this study.	Abbasi A, 2012, STRUCTURAL DYNAMICS; Bdeir F, 2013, KNOWL MAN RES PRACT, V11, P241, DOI 10.1057/kmrp.2012.1; Berthod O, 2017, J PUBL ADM RES THEOR, V27, P352, DOI 10.1093/jopart/muw050; Bond Katherine C, 2013, Emerg Health Threats J, V6, DOI 10.3402/ehtj.v6i0.19913; Borgatti S, 2013, ANAL SOCIAL NETWORKS, P128; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Borgatti SP, 2006, SOC NETWORKS, V28, P124, DOI 10.1016/j.socnet.2005.05.001; Bowater L, 2016, MICROBES FIGHT BACK; Brandes U, 2004, MATH VIS, P321; Bryson JM, 2006, PUBLIC ADMIN REV, V66, P44, DOI 10.1111/j.1540-6210.2006.00665.x; Ciccolini M, 2013, INT J MED MICROBIOL, V303, P380, DOI 10.1016/j.ijmm.2013.02.003; Cunningham FC, 2012, BMJ QUAL SAF, V21, P239, DOI 10.1136/bmjqs-2011-000187; de Vries M, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6376-7; Dente MG, 2009, EUROSURVEILLANCE, V14; Deurenberg RH, 2009, EMERG INFECT DIS, V15, P727, DOI 10.3201/eid1505.071618; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gould R. V., 1989, SOCIOL METHODOL, V19, P89, DOI DOI 10.2307/270949; Hoppe B, 2010, LEADERSHIP QUART, V21, P600, DOI 10.1016/j.leaqua.2010.06.004; Jombart Thibaut, 2009, PLoS Curr, V1, pRRN1026; Kalish Y, 2008, ASIAN J SOC PSYCHOL, V11, P53, DOI 10.1111/j.1467-839X.2007.00243.x; Kilduff M, 2010, ACAD MANAG ANN, V4, P317, DOI 10.1080/19416520.2010.494827; Kluytmans-VandenBergh MFQ, 2005, INFECTION, V33, P309, DOI 10.1007/s15010-005-5079-z; Kossinets G, 2006, SOC NETWORKS, V28, P247, DOI 10.1016/j.socnet.2005.07.002; Kuijper E, 2011, NEDERLANDS TIJDSCHRI, V155; Mate SE, 2018, CLIN INFECT DIS, V67, P1147, DOI 10.1093/cid/ciy281; Mays GP, 2010, PREV CHRONIC DIS, V7; McEvily B., 2004, TRUST DISTRUST ORG, P189; Moynihan DP, 2009, J PUBL ADM RES THEOR, V19, P895, DOI 10.1093/jopart/mun033; Muller J, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0047-6; Popp J. K., 2014, INTERORGANIZATIONAL; Provan KG, 2008, J PUBL ADM RES THEOR, V18, P229, DOI 10.1093/jopart/mum015; Provan KG, 2007, J MANAGE, V33, P479, DOI 10.1177/0149206307302554; Provan KG, 2011, HEALTH CARE MANAGE R, V36, P315, DOI 10.1097/HMR.0b013e31820e1124; PROVAN KG, 1995, ADMIN SCI QUART, V40, P1, DOI 10.2307/2393698; Provan KG, 1998, ACAD MANAGE J, V41, P453, DOI 10.2307/257084; Raab J, 2015, J PUBL ADM RES THEOR, V25, P479, DOI 10.1093/jopart/mut039; Savoia E, 2009, PUBLIC HEALTH REP, V124, P138, DOI 10.1177/003335490912400117; SCOTT J., 1991, SOCIAL NETWORK ANAL; Smith JA, 2013, SOC NETWORKS, V35, P652, DOI 10.1016/j.socnet.2013.09.003; Tambo E, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-29; Vasavada T, 2013, PUBLIC MANAG REV, V15, P363, DOI 10.1080/14719037.2013.769854; Wasserman S, 1994, SOCIAL NETWORK ANALY, V8; Willemsen I, 2008, INFECT CONT HOSP EP, V29, P1110, DOI 10.1086/592408; Wolbers Jeroen., 2013, J HOMEL SECUR EMERG, V10, P555, DOI DOI 10.1515/JHSEM-2013-0019	44	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219548	10.1371/journal.pone.0219548	http://dx.doi.org/10.1371/journal.pone.0219548			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4JZ	31291355	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800112
J	Lin, YW; Zhou, YQ; Faghri, F; Shawl, MJ; Campbell, RH				Lin, Yu-Wei; Zhou, Yuqian; Faghri, Faraz; Shawl, Michael J.; Campbell, Roy H.			Analysis and prediction of unplanned intensive care unit readmission using recurrent neural networks with long shortterm memory	PLOS ONE			English	Article							ELECTRONIC HEALTH RECORD; HOSPITAL READMISSIONS; RISK-FACTORS; DISCHARGE; MODELS; SPECIFICITY; SENSITIVITY; PNEUMONIA; OUTCOMES	Background Unplanned readmission of a hospitalized patient is an indicator of patients' exposure to risk and an avoidable waste of medical resources. In addition to hospital readmission, intensive care unit (ICU) readmission brings further financial risk, along with morbidity and mortality risks. Identification of high-risk patients who are likely to be readmitted can provide significant benefits for both patients and medical providers. The emergence of machine learning solutions to detect hidden patterns in complex, multi-dimensional datasets provides unparalleled opportunities for developing an efficient discharge decision-making support system for physicians and ICU specialists. Methods and findings We used supervised machine learning approaches for ICU readmission prediction. We used machine learning methods on comprehensive, longitudinal clinical data from the MIMIC-III to predict the ICU readmission of patients within 30 days of their discharge. We incorporate multiple types of features including chart events, demographic, and ICD-9 embeddings. We have utilized recent machine learning techniques such as Recurrent Neural Networks (RNN) with Long Short-Term Memory (LSTM), by this we have been able to incorporate the multivariate features of EHRs and capture sudden fluctuations in chart event features (e.g. glucose and heart rate). We show that our LSTM-based solution can better capture high volatility and unstable status in ICU patients, an important factor in ICU readmission. Our machine learning models identify ICU readmissions at a higher sensitivity rate of 0.742 (95% CI, 0.718-0.766) and an improved Area Under the Curve of 0.791 (95% CI, 0.782-0.800) compared with traditional methods. We perform in-depth deep learning performance analysis, as well as the analysis of each feature contribution to the predictive model. Conclusion Our manuscript highlights the ability of machine learning models to improve our ICU decision-making accuracy and is a real-world example of precision medicine in hospitals. These data-driven solutions hold the potential for substantial clinical impact by augmenting clinical decision-making for physicians and ICU specialists. We anticipate that machine learning models will improve patient counseling, hospital administration, allocation of healthcare resources and ultimately individualized clinical care.	[Lin, Yu-Wei; Shawl, Michael J.] Univ Illinois, Dept Business Adm, Champaign, IL USA; [Zhou, Yuqian] Univ Illinois, Dept Elect & Comp Engn, Champaign, IL USA; [Faghri, Faraz; Campbell, Roy H.] Univ Illinois, Dept Comp Sci, Champaign, IL 61820 USA; [Faghri, Faraz] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Faghri, F (corresponding author), Univ Illinois, Dept Comp Sci, Champaign, IL 61820 USA.; Faghri, F (corresponding author), NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA.	faghri2@illnois.edu	Zhou, Yuqian/AGY-3776-2022; Campbell, Roy/O-1141-2019	Zhou, Yuqian/0000-0001-7100-113X; Campbell, Roy/0000-0002-3754-7777				Alba AC, 2017, JAMA-J AM MED ASSOC, V318, P1377, DOI 10.1001/jama.2017.12126; [Anonymous], MULTITASK PREDICTION; [Anonymous], LEARNING DIAGNOSE LS; [Anonymous], 2017, FY2018 IPPS FINAL RU; Baillie CA, 2013, J HOSP MED, V8, P689, DOI 10.1002/jhm.2106; Berry C, 2008, HEART, V94, P296, DOI 10.1136/hrt.2006.110999; Brown SES, 2013, MED CARE, V51, P706, DOI 10.1097/MLR.0b013e318293c2fa; Calvert J, 2017, J MED ECON, V20, P646, DOI 10.1080/13696998.2017.1307203; Casalini F, 2017, INT J QUAL HEALTH C, V29, P256, DOI 10.1093/intqhc/mzx011; Chen LM, 1998, CRIT CARE MED, V26, P1834, DOI 10.1097/00003246-199811000-00025; Choi E, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1495, DOI 10.1145/2939672.2939823; Choi Youngduck, 2016, AMIA Jt Summits Transl Sci Proc, V2016, P41; Curto S, 2016, IEEE INT FUZZY SYST; De Alba I, 2014, OCHSNER J, V14, P649; Desautels T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017199; Dungan Kathleen M, 2012, J Diabetes Sci Technol, V6, P1045; elHassouni A, DATA DRIVEN MODELS M; Emons MF, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2015-000160; Evans NR, 2012, CLIN MED, V12, P137, DOI 10.7861/clinmedicine.12-2-137; Guo T, 2016, PROCEEDINGS OF 3RD IEEE/ACM INTERNATIONAL CONFERENCE ON DATA SCIENCE AND ADVANCED ANALYTICS, (DSAA 2016), P816, DOI 10.1109/DSAA.2016.92; Halm EA, 2002, ARCH INTERN MED, V162, P1278, DOI 10.1001/archinte.162.11.1278; Hammill BG, 2011, CIRC-CARDIOVASC QUAL, V4, P60, DOI 10.1161/CIRCOUTCOMES.110.954693; Harutyunyan H., 2017, MULTITASK LEARNING B; He DN, 2014, J AM MED INFORM ASSN, V21, P272, DOI 10.1136/amiajnl-2013-002151; Hoogendoorn M, 2016, IEEE ENG MED BIO, P2464, DOI 10.1109/EMBC.2016.7591229; Hosein FS, 2013, CRIT CARE, V17, DOI 10.1186/cc12747; Hug C., 2009, DETECTING HAZARDOUS; Jamei M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181173; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kennedy CE, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-40; Kim H, 2010, AM J MANAG CARE, V16, P760; Kramer AA, 2013, CRIT CARE MED, V41, P24, DOI 10.1097/CCM.0b013e3182657b8a; Lee J, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-62; Mao QQ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017833; Mathew AT, 2015, KIDNEY INT, V88, P1250, DOI 10.1038/ki.2015.307; McAdams-DeMarco MA, 2013, AM J TRANSPLANT, V13, P2091, DOI 10.1111/ajt.12300; McIlvennan CK, 2015, CIRCULATION, V131, P1796, DOI 10.1161/CIRCULATIONAHA.114.010270; Nijhawan AE, 2015, AIDS PATIENT CARE ST, V29, P465, DOI 10.1089/apc.2015.0096; Parikh R, 2008, INDIAN J OPHTHALMOL, V56, P45, DOI 10.4103/0301-4738.37595; Pepe MS, 2016, CLIN CHEM, V62, P737, DOI 10.1373/clinchem.2015.252163; Ponzoni CR, 2017, ANN AM THORAC SOC, V14, P1312, DOI 10.1513/AnnalsATS.201611-851OC; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; RUBINS HB, 1988, AM J MED, V84, P863, DOI 10.1016/0002-9343(88)90064-2; Shadmi E, 2015, MED CARE, V53, P283, DOI 10.1097/MLR.0000000000000315; Shams I, 2015, HEALTH CARE MANAG SC, V18, P19, DOI 10.1007/s10729-014-9278-y; SINGER DE, 1981, NEW ENGL J MED, V304, P625, DOI 10.1056/NEJM198103123041101; Singh A, 2015, J BIOMED INFORM, V53, P220, DOI 10.1016/j.jbi.2014.11.005; Sood MM, 2011, CLIN J AM SOC NEPHRO, V6, P613, DOI 10.2215/CJN.01160210; VINSON JM, 1990, J AM GERIATR SOC, V38, P1290, DOI 10.1111/j.1532-5415.1990.tb03450.x; Wellner B, 2017, JMIR MED INF, V5, DOI 10.2196/medinform.8680; ZAGER RA, 1986, AM J PHYSIOL, V251, pF87, DOI 10.1152/ajprenal.1986.251.1.F87; Zhang M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a2752; Zhang Y., 2015, ARXIV	55	42	43	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0218942	10.1371/journal.pone.0218942	http://dx.doi.org/10.1371/journal.pone.0218942			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4GX	31283759	Green Submitted, gold, Green Published			2022-12-26	WOS:000484939800014
J	Montes-Casado, M; Ojeda, G; Aragoneses-Fenoll, L; Lopez, D; de Andres, B; Gaspar, ML; Dianzani, U; Rojo, JM; Portoles, P				Montes-Casado, Maria; Ojeda, Gloria; Aragoneses-Fenoll, Laura; Lopez, Daniel; de Andres, Belen; Luisa Gaspar, Maria; Dianzani, Umberto; Rojo, Jose M.; Portoles, Pilar			ICOS deficiency hampers the homeostasis, development and function of NK cells	PLOS ONE			English	Article							T-LYMPHOCYTE ACTIVATION; IFN-GAMMA PRODUCTION; INDUCIBLE COSTIMULATOR; DENDRITIC CELLS; INNATE; MATURATION; LIGAND; RESPONSIVENESS; EXPRESSION; RECEPTOR	Signaling through the inducible costimulator ICOS is required for the homeostasis and function of various immune cell populations, with an outstanding role in the generation and maintenance of germinal centers. Very recently, it has been suggested that the clinical phenotype of ICOS-deficient patients is much broader than initially anticipated and the innate immune response might be also affected. However, the role of the ICOS/ICOS-Ligand axis in the homeostasis and development of innate NK cells is not known, and reports on its participation in NK cell activation are scarce. NK cells may express low levels of ICOS that are markedly enhanced upon activation. We show here that ICOS-deficient (ICOS-KO) mice present low NK cell numbers and defects in the homeostasis of these cells, with delayed maturation and altered expression of the developmental NK cell markers CD122, NK1.1, CD11b or CD27. Our experiments in mixed bone marrow chimera mice indicate that, both, cell-intrinsic defects of ICOS-KO NK and deficiencies in the milieu of these mice contribute to the altered phenotype. ICOS-deficient NK cells show impaired production of IFN-gamma and cytotoxicity, and a final outcome of defects in NK cell-mediated effector function during the response to poly(I:C) or vaccinia virus infection in vivo. Interestingly, we show that murine innate cells like IL-2-cultured NK and bone marrow-derived dendritic cells can simultaneously express ICOS and ICOS-Ligand; both molecules are functional in NK intracellular signaling, enhancing early phosphorylation of Akt and Erk, or IFN-gamma secretion in IL-2-activated NK cells. Our study shows the functional importance of the ICOS/ICOS-L pair in NK cell homeostasis, differentiation and activity and suggests novel therapeutic targets for NK manipulation.	[Montes-Casado, Maria; Ojeda, Gloria; Aragoneses-Fenoll, Laura; Lopez, Daniel; de Andres, Belen; Luisa Gaspar, Maria; Portoles, Pilar] Ctr Nacl Microbiol Virol & Inmunol Sanitarias Maja, Inst Salud Carlos III ISCIII, Madrid, Spain; [Dianzani, Umberto] UPO, IRCAD, Novara, Italy; [Dianzani, Umberto] UPO, Dept Hlth Sci, Novara, Italy; [Rojo, Jose M.] CSIC, Ctr Invest Biol, Madrid, Spain	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Portoles, P (corresponding author), Ctr Nacl Microbiol Virol & Inmunol Sanitarias Maja, Inst Salud Carlos III ISCIII, Madrid, Spain.; Rojo, JM (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	jmrojo@cib.csic.es; pportols@isciii.es	Portoles, Pilar/R-9492-2019; de Andres, Belen/D-4712-2016; Rojo, Jose/ABH-1189-2020; López, Daniel/I-2632-2014; Montes-Casado, María/U-5859-2019; Gaspar, Maria Luisa/P-5436-2014	Portoles, Pilar/0000-0001-6973-0835; López, Daniel/0000-0003-0268-5878; Montes-Casado, María/0000-0002-0350-7734; Gaspar, Maria Luisa/0000-0001-9858-3862; DIANZANI, Umberto/0000-0001-6723-3931; Rojo, Jose M./0000-0001-9032-0072	Accion Estrategica en Salud (Institute de Salud Carlos III, ISCIII, MINECO, Spain) [P113/02153, PI16C111/00012, P113/01809, P114/00049]; Ministerio de Economia y Competitividad MINECO/FEDER, Spain [SAF2015-70880-R, SAF2014-58052]; Associazione Italiana per la Ricerca sul Cancro, AIRC, Milan [IG20714]; Fondazione Amid di Jean, Torino, Italy	Accion Estrategica en Salud (Institute de Salud Carlos III, ISCIII, MINECO, Spain); Ministerio de Economia y Competitividad MINECO/FEDER, Spain; Associazione Italiana per la Ricerca sul Cancro, AIRC, Milan(Fondazione AIRC per la ricerca sul cancro); Fondazione Amid di Jean, Torino, Italy	This work was supported by grants from the Accion Estrategica en Salud (Institute de Salud Carlos III, ISCIII, MINECO, Spain) (P113/02153 and PI16C111/00012 to P.P.; P113/01809 to J.M.R.; and P114/00049 to BdA); grants from Ministerio de Economia y Competitividad MINECO/FEDER, Spain (SAF2015-70880-R to M.L.G. and SAF2014-58052 to D.L.); and grants from Associazione Italiana per la Ricerca sul Cancro, AIRC, Milan (IG20714) and the Fondazione Amid di Jean, Torino, Italy (to U. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta YY, 2011, CELL MOL LIFE SCI, V68, P3065, DOI 10.1007/s00018-010-0606-1; Akbari O, 2008, J IMMUNOL, V180, P5448, DOI 10.4049/jimmunol.180.8.5448; Aragoneses-Fenoll L, 2016, BIOCHEM PHARMACOL, V106, P56, DOI 10.1016/j.bcp.2016.02.005; Bousfiha A, 2015, J CLIN IMMUNOL, V35, P727, DOI 10.1007/s10875-015-0198-5; Brady J, 2010, J IMMUNOL, V185, P6679, DOI 10.4049/jimmunol.0903354; Buonfiglio D, 2000, EUR J IMMUNOL, V30, P3463, DOI 10.1002/1521-4141(2000012)30:12<3463::AID-IMMU3463>3.0.CO;2-5; Burmeister Y, 2008, J IMMUNOL, V180, P774, DOI 10.4049/jimmunol.180.2.774; Cairo C, 2015, IMMUNOLOGY, V144, P422, DOI 10.1111/imm.12386; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Chung Y, 2008, J IMMUNOL, V180, P2276, DOI 10.4049/jimmunol.180.4.2276; Cortez VS, 2016, IMMUNOL LETT, V179, P19, DOI 10.1016/j.imlet.2016.07.005; Dianzani C, 2010, J IMMUNOL, V185, P3970, DOI 10.4049/jimmunol.0903269; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Feito MJ, 2003, EUR J IMMUNOL, V33, P204, DOI 10.1002/immu.200390023; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Geiger TL, 2016, CURR OPIN IMMUNOL, V39, P82, DOI 10.1016/j.coi.2016.01.007; Goh W, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00130; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hansen ML, 2011, MOL IMMUNOL, V48, P2087, DOI 10.1016/j.molimm.2011.07.008; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hedl M, 2014, IMMUNITY, V40, P734, DOI 10.1016/j.immuni.2014.04.011; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kaneda H, 2005, BIOCHEM BIOPH RES CO, V327, P201, DOI 10.1016/j.bbrc.2004.12.004; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; Maazi H, 2015, ONCOTARGET, V6, P24584, DOI 10.18632/oncotarget.5245; Maazi H, 2015, IMMUNITY, V42, P538, DOI 10.1016/j.immuni.2015.02.007; Marcais A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00450; Martinez J, 2008, J IMMUNOL, V180, P1592, DOI 10.4049/jimmunol.180.3.1592; NANDI D, 1994, J IMMUNOL, V152, P3361; O'Sullivan TE, 2015, IMMUNITY, V43, P634, DOI 10.1016/j.immuni.2015.09.013; Occhipinti S, 2013, J IMMUNOL, V190, P1125, DOI 10.4049/jimmunol.1201816; Ogasawara K, 2002, J IMMUNOL, V169, P3676, DOI 10.4049/jimmunol.169.7.3676; Paclik D, 2015, EUR J IMMUNOL, V45, P2766, DOI 10.1002/eji.201545635; PECK AB, 1973, J IMMUNOL METHODS, V3, P147, DOI 10.1016/0022-1759(73)90030-6; Redoglia V, 1996, EUR J IMMUNOL, V26, P2781, DOI 10.1002/eji.1830261134; Rojo JM, 2008, INT IMMUNOL, V20, P577, DOI 10.1093/intimm/dxn016; Roussel L, 2018, J EXP MED, V215, P3151, DOI 10.1084/jem.20180668; Schepp J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00964; Seillet C, 2016, CURR TOP MICROBIOL, V395, P37, DOI 10.1007/82_2015_474; Simpson TR, 2010, CURR OPIN IMMUNOL, V22, P326, DOI 10.1016/j.coi.2010.01.001; Sitnicka E, 2011, J INNATE IMMUN, V3, P329, DOI 10.1159/000323925; Stojanovic A, 2014, J IMMUNOL, V192, P4184, DOI 10.4049/jimmunol.1302091; Takahashi N, 2009, J IMMUNOL, V182, P5515, DOI 10.4049/jimmunol.0803256; Tang GS, 2009, CELL MOL LIFE SCI, V66, P3067, DOI 10.1007/s00018-009-0090-7; Toomey JA, 2003, J LEUKOCYTE BIOL, V74, P233, DOI 10.1189/jlb.0303097; Watanabe M, 2008, J IMMUNOL, V180, P5222, DOI 10.4049/jimmunol.180.8.5222; Wikenheiser DJ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00304; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yagi J, 1999, J IMMUNOL, V163, P3083; Yong PFK, 2009, IMMUNOL REV, V229, P101, DOI 10.1111/j.1600-065X.2009.00764.x; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zhang QF, 2017, CELL MOL IMMUNOL, V14, P819, DOI 10.1038/cmi.2016.28; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	60	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219449	10.1371/journal.pone.0219449	http://dx.doi.org/10.1371/journal.pone.0219449			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283790	Green Published, Green Submitted, gold			2022-12-26	WOS:000484939800035
J	Huang, CY; Chen, DR				Huang, Chiao-Yu; Chen, Duan-Rung			Association of weight change patterns in late adolescence with young adult wage differentials: A multilevel longitudinal study	PLOS ONE			English	Article							BODY-MASS INDEX; OBESITY; GENDER; CONSEQUENCES; OVERWEIGHT; HEALTH; EARNINGS; IMPACT; SIZE	Background Numerous studies have demonstrated that different weight change patterns from adolescence to adulthood may exert different effects on opportunities from which individuals subsequently benefit. Objectives This study aimed to investigate the association of weight change patterns from late adolescence to young adulthood with monthly wage in young adulthood for both genders in Taiwan. Methods A nationally representative retrospective panel of 3730 young people (1707 men and 2023 women) from the Taiwan Educational Panel Survey (2001-2014) was included. Individuals were divided into four weight-change-pattern categories based on changes in their body mass index at two time points that were 7 years apart, between late adolescence (aged 18-19 years) and young adulthood (aged 25-26 years). These categories were (1) no obesity, (2) obesity reversal, (3) developing obesity, and (4) persistent obesity. Cross-classified, hierarchical linear regression modeling analysis was performed to explore the association of weight change patterns with monthly wage in young adulthood, after adjustment for both individual-and contextual-level variables. Results Of the weight-change-pattern categories for both genders, individuals with persistent obesity had the lowest monthly wage. For women, the mean monthly wage decreased progressively for the categories of no obesity, obesity reversal, developing obesity, and persistent obesity (test for difference, P = 0.016; test for trend, P = 0.026). Women with persistent obesity earned 20% less per month than did those who were never obese (P = 0.024), after controlling for individual and contextual factors. For men, no association was found between weight change patterns and monthly wage. Conclusion Persistent obesity from late adolescence to young adulthood is associated with low monthly wage in young adulthood in women but not in men. These findings highlight the urgency of addressing persistent obesity early in life, especially for women.	[Huang, Chiao-Yu] Taipei City Hosp, Dept Family Med, Renai Branch, Taipei, Taiwan; [Huang, Chiao-Yu] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei, Taiwan; [Chen, Duan-Rung] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Behav & Community Sci, Taipei, Taiwan	Taipei City Hospital; National Taiwan University; National Taiwan University	Chen, DR (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Behav & Community Sci, Taipei, Taiwan.	duan@ntu.edu.tw		Chen, Duan-Rung/0000-0002-6391-987X; Huang, Chiao-Yu/0000-0002-7248-3545	Ministry of Science and Technology, Taiwan [102-2410-H-002 -073 -MY3, 106-2314-B-002 -109 -MY3]; Innovation and Policy Center for Population Health and Sustainable Environment (Population Health Research Center, PHRC), College of Public Health, National Taiwan University from The Featured Areas Research Center Program within Ministry of Education in T [NTU-107L9003]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Innovation and Policy Center for Population Health and Sustainable Environment (Population Health Research Center, PHRC), College of Public Health, National Taiwan University from The Featured Areas Research Center Program within Ministry of Education in T	This project was partially funded by the Ministry of Science and Technology (102-2410-H-002 -073 -MY3 and 106-2314-B-002 -109 -MY3), Taiwan. This work was also supported by the Innovation and Policy Center for Population Health and Sustainable Environment (Population Health Research Center, PHRC), College of Public Health, National Taiwan University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education in Taiwan (grant number NTU-107L9003). No additional external funding was received for this study.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BROWN C, 1989, J POLIT ECON, V97, P1027, DOI 10.1086/261642; Cawley J, 2004, J HUM RESOUR, V39, P451, DOI 10.2307/3559022; Center for Survey Research Academia Sinica in Taiwan SRDA, TAIW ED PAN SURV 201; Chen DuanRung, 2014, Health, V6, P2399, DOI 10.4236/health.2014.618276; Chiang PH, 2013, RES DEV DISABIL, V34, P3504, DOI 10.1016/j.ridd.2013.06.023; Clarke PJ, 2010, AM J EPIDEMIOL, V172, P540, DOI 10.1093/aje/kwq156; Cohen AK, 2013, OBES REV, V14, P989, DOI 10.1111/obr.12062; Conley D, 2006, ADV HEALTH ECON HEAL, V17, P253, DOI 10.1016/S0731-2199(06)17010-7; Crosnoe R, 2007, SOCIOL EDUC, V80, P241, DOI 10.1177/003804070708000303; Cseh A, 2008, SOUTH ECON J, V75, P383; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; Dannefer D, 1987, AGING INTRACOHORT DI; de Hollander EL, 2013, AM J EPIDEMIOL, V178, P804, DOI 10.1093/aje/kwt053; Ferraro KF, 2003, AM SOCIOL REV, V68, P707, DOI 10.2307/1519759; Field AE, 2007, OBESITY, V15, P2357, DOI 10.1038/oby.2007.279; Flint SW, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00647; Frisco ML, 2013, AM J EPIDEMIOL, V178, P22, DOI 10.1093/aje/kws462; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; Goodman E, 2003, J ADOLESCENT HEALTH, V33, P140, DOI 10.1016/S1054-139X(03)00247-7; HALVORSEN R, 1980, AM ECON REV, V70, P474; Hamilton D, 2017, OBESITY REV; Han E, 2011, ECON HUM BIOL, V9, P381, DOI 10.1016/j.ehb.2011.07.002; Huang CC, 2016, J POPUL RES, V33, P221, DOI 10.1007/s12546-016-9170-3; Kuan P. - Y, 2017, J CHINESE STAT ASS, V55, P25; LAM D, 1993, J POLIT ECON, V101, P710, DOI 10.1086/261894; Lee H, 2016, J ADOLESCENT HEALTH, V59, P472, DOI 10.1016/j.jadohealth.2016.05.015; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Merten MJ, 2008, J YOUTH ADOLESCENCE, V37, P1111, DOI 10.1007/s10964-008-9281-z; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Patton GC, 2011, J ADOLESCENT HEALTH, V48, P275, DOI 10.1016/j.jadohealth.2010.06.019; Rooth DO, 2009, J HUM RESOUR, V44, P710, DOI 10.1353/jhr.2009.0027; Rosenbaum JE, 1999, SOCIOL EDUC, V72, P179, DOI 10.2307/2673228; Sabia JJ, 2007, SOUTH ECON J, V73, P871, DOI 10.2307/20111933; SARGENT JD, 1994, ARCH PEDIAT ADOL MED, V148, P681, DOI 10.1001/archpedi.1994.02170070019003; Segal LM, 1998, WAGE DIFFERENTIALS T; Shinall JB, 2015, OCCUPATIONAL CHARACT, P16; Slade P, 2017, ECON HUM BIOL, V27, P223, DOI 10.1016/j.ehb.2017.07.001; Spence M., 1978, UNCERTAINTY EC, P281; Su MC, 2014, J NURS RES, V22, P28, DOI 10.1097/jnr.0000000000000017; World Health Organization, 2011, NCD GLOB MON FRAM	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219123	10.1371/journal.pone.0219123	http://dx.doi.org/10.1371/journal.pone.0219123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4FP	31276537	Green Submitted, Green Published, gold			2022-12-26	WOS:000484936300037
J	Nori, VS; Hane, CA; Martin, DC; Kravetz, AD; Sanghavi, DM				Nori, Vijay S.; Hane, Christopher A.; Martin, David C.; Kravetz, Alexander D.; Sanghavi, Darshak M.			Identifying incident dementia by applying machine learning to a very large administrative claims dataset	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; VARIABLE SELECTION; MEDICARE CLAIMS; RISK; CLASSIFICATION; REGULARIZATION; PREDICTION; MEMANTINE	Alzheimer's disease and related dementias (ADRD) are highly prevalent conditions, and prior efforts to develop predictive models have relied on demographic and clinical risk factors using traditional logistical regression methods. We hypothesized that machine-learning algorithms using administrative claims data may represent a novel approach to predicting ADRD. Using a national de-identified dataset of more than 125 million patients including over 10,000 clinical, pharmaceutical, and demographic variables, we developed a cohort to train a machine learning model to predict ADRD 4-5 years in advance. The Lasso algorithm selected a 50-variable model with an area under the curve (AUC) of 0.693. Top diagnosis codes in the model were memory loss (780.93), Parkinson's disease (332.0), mild cognitive impairment (331.83) and bipolar disorder (296.80), and top pharmacy codes were psychoactive drugs. Machine learning algorithms can rapidly develop predictive models for ADRD with massive datasets, without requiring hypothesis-driven feature engineering.	[Nori, Vijay S.; Hane, Christopher A.; Martin, David C.; Sanghavi, Darshak M.] OptumLabs, Cambridge, MA 02142 USA; [Kravetz, Alexander D.] Devoted Hlth, Waltham, MA USA	Optum	Nori, VS (corresponding author), OptumLabs, Cambridge, MA 02142 USA.	vijay.nori@optum.com						Abner EL, 2016, ALZHEIMERS DEMENT, V12, P882, DOI 10.1016/j.jalz.2015.12.006; Adaszewski S, 2013, NEUROBIOL AGING, V34, P2815, DOI 10.1016/j.neurobiolaging.2013.06.015; Adelborg K, 2017, EUR J HEART FAIL, V19, P253, DOI 10.1002/ejhf.631; Alzheimer's Assoc, 2018, ALZHEIMERS DEMENT, V14, P367, DOI 10.1016/j.jalz.2018.02.001; Barnes DE, 2009, NEUROLOGY, V73, P173, DOI 10.1212/WNL.0b013e3181a81636; Boustani M, 2005, GERONTOLOGIST, V45, P56, DOI 10.1093/geront/45.suppl_1.56; Brown I, 2012, EXPERT SYST APPL, V39, P3446, DOI 10.1016/j.eswa.2011.09.033; CALLAHAN CM, 1995, ANN INTERN MED, V122, P422, DOI 10.7326/0003-4819-122-6-199503150-00004; Chodosh J, 2004, J AM GERIATR SOC, V52, P1051, DOI 10.1111/j.1532-5415.2004.52301.x; CPT, 2014, CPT 2014 CURR PROC T; Drummond C., 2003, P WORKSH LEARN IMB D; Dyrba M, 2015, J NEUROIMAGING, V25, P738, DOI 10.1111/jon.12214; Exalto LG, 2013, LANCET DIABETES ENDO, V1, P183, DOI 10.1016/S2213-8587(13)70048-2; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gamberger D., 2017, SCI REP, V7, P1, DOI DOI 10.1038/S41598-016-0028-X; Grande LA, 2008, ANESTH ANALG, V107, P1380, DOI 10.1213/ane.0b013e3181733ddd; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; Harris-Kojetin L, 2016, VITAL HLTH STAT, V3, P1; Hastie T., 2009, THE ELEMENTS OF STAT, DOI DOI 10.1007/B94608; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; KING G, 2001, POLITICAL ANAL, V0009; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Kubat M., 1997, ICML; Lao ZQ, 2004, NEUROIMAGE, V21, P46, DOI 10.1016/j.neuroimage.2003.09.027; Li S, 2007, AM J NEURORADIOL, V28, P1339, DOI 10.3174/ajnr.A0620; Lu FH, 2014, STAT MED, V33, P401, DOI 10.1002/sim.5937; McCoy RG, 2016, HEALTH SERV RES, V51, P1896, DOI 10.1111/1475-6773.12461; Newcomer R, 1999, J AM GERIATR SOC, V47, P215, DOI 10.1111/j.1532-5415.1999.tb04580.x; OptumLabs, 2015, OPTUMLABS DAT WAR TE; Romero JP, 2014, J ALZHEIMERS DIS, V39, P741, DOI 10.3233/JAD-131622; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Pugazhenthi S, 2017, BBA-MOL BASIS DIS, V1863, P1037, DOI 10.1016/j.bbadis.2016.04.017; RAJKOMAR A, 2018, NPJ DIGIT MED, V1; Rusanen M, 2014, J ALZHEIMERS DIS, V42, P183, DOI 10.3233/JAD-132363; Shankle WR, 1997, P 6 C ART INT MED EU; Smith Marianne, 2008, Issues Ment Health Nurs, V29, P817, DOI 10.1080/01612840802182839; So A, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7070651; Tang EYH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136181; Taylor DH, 2009, J ALZHEIMERS DIS, V17, P807, DOI 10.3233/JAD-2009-1099; Wallace PJ, 2014, HEALTH AFFAIR, V33, P1187, DOI 10.1377/hlthaff.2014.0038; Witten IH, 2011, MOR KAUF D, P1; Zdanys K, 2008, PROG NEURO-PSYCHOPH, V32, P1362, DOI 10.1016/j.pnpbp.2008.01.008; Zhang YD, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00066; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	46	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0203246	10.1371/journal.pone.0203246	http://dx.doi.org/10.1371/journal.pone.0203246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4FP	31276468	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300001
J	Pena-Gonzalez, I; Fernandez-Fernandez, J; Cervello, E; Moya-Ramon, M				Pena-Gonzalez, Ivan; Fernandez-Fernandez, Jaime; Cervello, Eduardo; Moya-Ramon, Manuel			Effect of biological maturation on strength-related adaptations in young soccer players	PLOS ONE			English	Article							MATURITY OFFSET; SPRINT; PERFORMANCE; PREDICTION; VALIDATION; VELOCITY	Strength training is crucial for soccer players' long-term development at early ages and the biological maturation may influence specific strength-training adaptations. The aim of this study was to propose a strength-training programme for the strength development of prepubertal players and to analyse the adaptations to this training programme in players with different maturity status. One hundred and thirty young male soccer players participated in an 8-week strength-training programme consisting of two sessions per week (20-minutes of a combination of plyometric and resistance exercises) which was conducted prior to their normal soccer training. Three maturity groups were defined according to the years from/to their peak height velocity (PHV) as Pre-, Mid- and Post-PHV. Initial differences between the maturity groups were found in anthropometrical (weight and height) and physical performance variables (One Repetition Maximum (RM), Peak Power output (PP), 30-m sprint and T-test). The strength-training programme was beneficial for the three maturity groups (p<0.05) with general greater improvements for the Pre- and Mid-PHV groups, with large effects in RM, PP and T-test, than for the Post-PHV group (moderate effects). The strength-training programme proposed in the present study seems to be positive for the strength-related development in young soccer players especially for Pre- and Mid-PHV players. The differences in the training adaptations for players with different maturity status suggest the individualization of the training stimulus for the correct long-term development of the players.	[Pena-Gonzalez, Ivan; Cervello, Eduardo; Moya-Ramon, Manuel] Miguel Hernandez Univ Elche, Dept Sports Sci, Alicante, Spain; [Fernandez-Fernandez, Jaime] Univ Leon, Fac Phys Act & Sport Sci, Leon, Spain	Universidad Miguel Hernandez de Elche; Universidad de Leon	Moya-Ramon, M (corresponding author), Miguel Hernandez Univ Elche, Dept Sports Sci, Alicante, Spain.	mmoya@umh.es	Peña-González, Iván/ABX-4183-2022; Fernandez-Fernandez, Jaime/AAO-9270-2020; MOYA, MANUEL/F-7172-2016; cervello, eduardo/ABC-5973-2020	MOYA, MANUEL/0000-0002-2291-5899; Pena-Gonzalez, Ivan/0000-0001-6810-0911				Asadi A, 2018, J SPORT SCI, V36, P2405, DOI 10.1080/02640414.2018.1459151; Chaouachi A, 2014, J STRENGTH COND RES, V28, P401, DOI 10.1519/JSC.0b013e3182987059; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Comfort P, 2014, J STRENGTH COND RES, V28, P173, DOI 10.1519/JSC.0b013e318291b8c7; Gonzalez-Badillo JJ, 2010, INT J SPORTS MED, V31, P347, DOI 10.1055/s-0030-1248333; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Koziel SM, 2018, SPORTS MED, V48, P221, DOI 10.1007/s40279-017-0750-y; Lloyd RS, 2016, J STRENGTH COND RES, V30, P1239, DOI 10.1519/JSC.0000000000001216; Lloyd RS, 2014, J STRENGTH COND RES, V28, P1454, DOI 10.1519/JSC.0000000000000391; Lloyd RS, 2012, STRENGTH COND J, V34, P61, DOI 10.1519/SSC.0b013e31825760ea; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; Malina RM, 2014, J SPORT SCI, V32, P424, DOI 10.1080/02640414.2013.828850; Meylan CMP, 2014, SCAND J MED SCI SPOR, V24, pE156, DOI 10.1111/sms.12128; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Moran J, 2017, PEDIATR EXERC SCI, V29, P194, DOI 10.1123/pes.2016-0151; Moran J, 2017, J SPORT SCI, V35, P1041, DOI 10.1080/02640414.2016.1209306; Radnor JM, 2017, J STRENGTH COND RES, V31, P787, DOI 10.1519/JSC.0000000000001527; de Villarreal ES, 2015, J STRENGTH COND RES, V29, P1894, DOI 10.1519/JSC.0000000000000838; Semenick, 1990, STRENGTH COND J, V12; Sherar LB, 2005, J PEDIATR-US, V147, P508, DOI 10.1016/j.jpeds.2005.04.041	20	13	14	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219355	10.1371/journal.pone.0219355	http://dx.doi.org/10.1371/journal.pone.0219355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276566	gold, Green Submitted, Green Published			2022-12-26	WOS:000484936300068
J	Young, RE; Graf, J; Miserocchi, I; Van Horn, RM; Gordon, MB; Anderson, CR; Sefcik, LS				Young, Rachel E.; Graf, Jodi; Miserocchi, Isabella; Van Horn, Ryan M.; Gordon, Melissa B.; Anderson, Christopher R.; Sefcik, Lauren S.			Optimizing the alignment of thermoresponsive poly(N-isopropyl acrylamide) electrospun nanofibers for tissue engineering applications: A factorial design of experiments approach	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; HYBRID HYDROGELS; CELL; SURFACE; DETACHMENT; SCAFFOLDS; POLYMER; ORIENTATION; FIBERS; GROWTH	Thermoresponsive polymers, such as poly(N-isopropyl acrylamide) (PNIPAM), have been identified and used as cell culture substrates, taking advantage of the polymer's lower critical solution temperature (LCST) to mechanically harvest cells. This technology bypasses the use of biochemical enzymes that cleave important cell-cell and cell-matrix interactions. In this study, the process of electrospinning is used to fabricate and characterize aligned PNIPAM nanofiber scaffolds that are biocompatible and thermoresponsive. Nanofiber scaffolds produced by electrospinning possess a 3D architecture that mimics native extracellular matrix, providing physical and chemical cues to drive cell function and phenotype. We present a factorial design of experiments (DOE) approach to systematically determine the effects of different electrospinning process parameters on PNIPAM nanofiber diameter and alignment. Results show that high molecular weight PNIPAM can be successfully electrospun into both random and uniaxially aligned nanofiber mats with similar fiber diameters by simply altering the speed of the rotating mandrel collector from 10,000 to 33,000 RPM. PNIPAM nanofibers were crosslinked with OpePOSS, which was verified using FTIR. The mechanical properties of the scaffolds were characterized using dynamic mechanical analysis, revealing an order of magnitude difference in storage modulus (MPa) between cured and uncured samples. In summary, cross-linked PNIPAM nanofiber scaffolds were determined to be stable in aqueous culture, biocompatible, and thermoresponsive, enabling their use in diverse cell culture applications.	[Young, Rachel E.; Graf, Jodi; Miserocchi, Isabella; Van Horn, Ryan M.; Gordon, Melissa B.; Anderson, Christopher R.; Sefcik, Lauren S.] Lafayette Coll, Dept Chem & Biomol Engn, Easton, PA 18042 USA	Lafayette College	Sefcik, LS (corresponding author), Lafayette Coll, Dept Chem & Biomol Engn, Easton, PA 18042 USA.	andersol@lafayette.edu		Young, Rachel/0000-0003-3321-3603; Gordon, Melissa B./0000-0001-5881-3432				Allen ACB, 2017, BIOMATER SCI-UK, V5, P1661, DOI 10.1039/c7bm00324b; Canavan HE, 2005, J BIOMED MATER RES A, V75A, P1, DOI 10.1002/jbm.a.30297; Canavan HE, 2005, LANGMUIR, V21, P1949, DOI 10.1021/la048546c; Cicotte KN, 2017, BIOINTERPHASES, V12, DOI 10.1116/1.4984933; Coles SR, 2010, J APPL POLYM SCI, V117, P2251, DOI 10.1002/app.32022; Costolo MA, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/03/035707; Cui ZW, 2007, BIOMACROMOLECULES, V8, P1280, DOI 10.1021/bm061045g; Edwards MD, 2010, EUR POLYM J, V46, P1175, DOI 10.1016/j.eurpolymj.2010.03.017; Fonck E, 2009, STROKE, V40, P2552, DOI 10.1161/STROKEAHA.108.528091; Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007; Jose MV, 2009, ACTA BIOMATER, V5, P305, DOI 10.1016/j.actbio.2008.07.019; Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037; Li D, 2003, NANO LETT, V3, P1167, DOI 10.1021/nl0344256; Li H, 2013, ZOOKEYS, P15, DOI 10.3897/zookeys.321.5454; Liao S, 2006, BIOMED MATER, V1, pR45, DOI 10.1088/1748-6041/1/3/R01; Maeda T, 2017, FIBERS, V5, DOI 10.3390/fib5010013; MARTINSGREEN M, 1997, PRINCIPLES TISSUE EN, P23; Meng ZX, 2010, MAT SCI ENG C-MATER, V30, P1204, DOI 10.1016/j.msec.2010.06.018; Mitchell GR, 2013, PROCEDIA ENGINEER, V59, P117, DOI 10.1016/j.proeng.2013.05.100; Moran MT, 2007, J BIOMED MATER RES A, V81A, P870, DOI 10.1002/jbm.a.31089; Nakayama M, 2010, MAT MATTERS, V5; Okuzaki H, 2009, SYNTHETIC MET, V159, P2273, DOI 10.1016/j.synthmet.2009.07.046; Park SH, 2011, J APPL POLYM SCI, V120, P1800, DOI 10.1002/app.33395; Pelton R, 2010, J COLLOID INTERF SCI, V348, P673, DOI 10.1016/j.jcis.2010.05.034; Rhodes JM, 2007, J CELL MOL MED, V11, P176, DOI 10.1111/j.1582-4934.2007.00031.x; Rockwood DN, 2008, POLYMER, V49, P4025, DOI 10.1016/j.polymer.2008.06.018; Ruiter FAA, 2017, BIOMED MATER, V12, DOI 10.1088/1748-605X/aa7b54; SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R; Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009; Sefcik LS, 2013, CELL MOL BIOENG, V6, P287, DOI 10.1007/s12195-013-0286-7; Sensini A, 2018, MATERIALS, V11, DOI 10.3390/ma11101963; Seyedmahmoud R, 2015, J BIOMED MATER RES A, V103, P91, DOI 10.1002/jbm.a.35153; Shen CH, 2015, RSC ADV, V5, P53782, DOI 10.1039/c5ra08668j; Slemming-Adamsen P, 2015, MACROMOL MATER ENG, V300, P1226, DOI 10.1002/mame.201500160; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Takahashi H, 2015, ADV HEALTHC MATER, V4, P2388, DOI 10.1002/adhm.201500194; Tan AR, 2008, J BIOMED MATER RES A, V87A, P1034, DOI 10.1002/jbm.a.31853; Tang ZL, 2012, POLYMERS-BASEL, V4, P1478, DOI 10.3390/polym4031478; Teo WE, 2005, NANOTECHNOLOGY, V16, P918, DOI 10.1088/0957-4484/16/6/049; Thermofisher, USDA TECHNICAL B, P12; Tong YD, 2018, RSC ADV, V8, P13813, DOI 10.1039/c8ra01584h; Wang J, 2013, PROC SPIE INT SOC OP; Wang J, 2011, SOFT MATTER, V7, P4364, DOI 10.1039/c1sm00010a; Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3; Yang GH, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/9/1/015005; Zeng K, 2009, J POLYM SCI POL PHYS, V47, P504, DOI 10.1002/polb.21655	47	13	13	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219254	10.1371/journal.pone.0219254	http://dx.doi.org/10.1371/journal.pone.0219254			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276542	Green Submitted, Green Published, gold			2022-12-26	WOS:000484936300054
J	Das, Q; Lepp, D; Yin, XH; Ross, K; McCallum, JL; Warriner, K; Marcone, MF; Diarra, MS				Das, Quail; Lepp, Dion; Yin, Xianhua; Ross, Kelly; McCallum, Jason L.; Warriner, Keith; Marcone, Massimo F.; Diarra, Moussa S.			Transcriptional profiling of Salmonella enterica serovar Enteritidis exposed to ethanolic extract of organic cranberry pomace	PLOS ONE			English	Article							ESCHERICHIA-COLI; TYPHIMURIUM INVASION; VIRULENCE GENES; EXPRESSION; RESISTANCE; PATHOGENESIS; INHIBITION; METABOLISM; MOTILITY; SEQUENCE	Non-typhoidal Salmonella enterica serovars continue to be an important food safety issue worldwide. Cranberry (Vaccinium macrocarpon Ait) fruits possess antimicrobial properties due to their various acids and phenolic compounds; however, the underlying mechanism of actions is poorly understood. We evaluated the effects of cranberry extracts on the growth rate of Salmonella enterica serovars Typhimurium, Enteritidis and Heidelberg and on the transcriptomic profile of Salmonella Enteritidis to gain insight into phenotypic and transcriptional changes induced by cranberry extracts on this pathogen. An ethanolic extract from cranberry pomaces (KCOH) and two of its sub-fractions, anthocyanins (CRFa20) and non-anthocyanin polyphenols (CRFp85), were used. The minimum inhibitory (MICs) and bactericidal (MBCs) concentrations of these fractions against tested pathogens were obtained using the broth micro-dilution method according to the Clinical Laboratory Standard Institute's guidelines. Transcriptional profiles of S. Enteritidis grown in cation-adjusted Mueller-Hinton broth supplemented with or without 2 or 4 mg/ml of KCOH were compared by RNA-Seq to reveal gene modulations serving as markers for biological activity. The MIC and MBC values of KCOH were 8 and 16 mg/mL, respectively, against all tested S. enterica isolates. The MIC value was 4 mg/mL for both CRFa20 and CRFp85 sub-fractions, and a reduced MBC value was obtained for CRFp85 (4 mg/ml). Treatment of S. Enteritidis with KCOH revealed a concentration-dependent transcriptional signature. Compared to the control, 2 mg/ml of KCOH exposure resulted in 89 differentially expressed genes (DEGs), of which 53 and 36 were downregulated and upregulated, respectively. The upregulated genes included those involved in citrate metabolism, enterobactin synthesis and transport, and virulence. Exposure to 4 mg/ml KCOH led to the modulated expression of 376 genes, of which 233 were downregulated and 143 upregulated, which is 4.2 times more DEGs than from exposure to 2 mg/ml KCOH. The downregulated genes were related to flagellar motility, Salmonella Pathogenicity Island-1 (SPI-1), cell wall/membrane biogenesis, and transcription. Moreover, genes involved in energy production and conversion, carbohydrate transport and metabolism, and coenzyme transport and metabolism were upregulated during exposure to 4 mg/ml KCOH. Overall, 57 genes were differentially expressed (48 downregulated and 9 upregulated) in response to both concentrations. Both concentrations of KCOH downregulated expression of hilA, which is a major SPI-1 transcriptional regulator. This study provides information on the response of Salmonella exposed to cranberry extracts, which could be used in the control of this important foodborne pathogen.	[Das, Quail; Warriner, Keith; Marcone, Massimo F.] Univ Guelph, Dept Food Sci, Guelph, ON, Canada; [Das, Quail; Lepp, Dion; Yin, Xianhua; Diarra, Moussa S.] Agr & Agri Food Canada, Guelph Res & Dev Ctr, Guelph, ON, Canada; [Ross, Kelly] Agr & Agri Food Canada, Summerland Res & Dev Ctr, Summerland, BC, Canada; [McCallum, Jason L.] Agr & Agri Food Canada, Charlottetown Res & Dev Ctr, Charlottetown, PE, Canada	University of Guelph; Agriculture & Agri Food Canada; Agriculture & Agri Food Canada; Agriculture & Agri Food Canada	Diarra, MS (corresponding author), Agr & Agri Food Canada, Guelph Res & Dev Ctr, Guelph, ON, Canada.	moussa.diarra@canada.ca			OMFRA HQP, Agriculture and Agri-Food Canada through the Organic Science Cluster II program [AIP CL-02 AGR-10383]; Canadian Federal Genomic Research and Development Initiative on Antimicrobial resistance (GRDI-AMR); OMFRA HQP program; Agriculture and Agri-Food Canada through the Organic Science Cluster II program [AIP CL-02 AGR-10383]	OMFRA HQP, Agriculture and Agri-Food Canada through the Organic Science Cluster II program; Canadian Federal Genomic Research and Development Initiative on Antimicrobial resistance (GRDI-AMR); OMFRA HQP program; Agriculture and Agri-Food Canada through the Organic Science Cluster II program	QD was supported by OMFRA HQP, Agriculture and Agri-Food Canada through the Organic Science Cluster II program (#AIP CL-02 AGR-10383); the Canadian Federal Genomic Research and Development Initiative on Antimicrobial resistance (GRDI-AMR) and OMFRA HQP program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by Agriculture and Agri-Food Canada through the Organic Science Cluster II program (#AIP CL-02 AGR-10383), the Canadian Federal Genomic Research and Development Initiative on Antimicrobial resistance (GRDI-AMR) and OMFRA HQP program. The authors thank S. Chekabab and J. Tang for assistance and help.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bajaj V, 1995, MOL MICROBIOL, V18, P715, DOI 10.1111/j.1365-2958.1995.mmi_18040715.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betancor L, 2010, J CLIN MICROBIOL, V48, P2413, DOI 10.1128/JCM.02137-09; Boddicker JD, 2003, J BACTERIOL, V185, P525, DOI 10.1128/JB.185.2.525-533.2003; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bott M, 1997, ARCH MICROBIOL, V167, P78, DOI 10.1007/s002030050419; Boyd EF, 1997, J BACTERIOL, V179, P1985, DOI 10.1128/jb.179.6.1985-1991.1997; Chan M, 2013, COLLOID SURFACE B, V110, P275, DOI 10.1016/j.colsurfb.2013.03.047; Chekabab SM, 2019, J FOOD PROTECT, V82, P548, DOI 10.4315/0362-028X.JFP-18-371; Chiu CH, 1996, J CLIN MICROBIOL, V34, P2619, DOI 10.1128/JCM.34.10.2619-2622.1996; Dandekar T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00164; Das Q, 2017, FOOD CONTROL, V73, P650, DOI 10.1016/j.foodcont.2016.09.019; Dhanani AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128773; Diarra MS, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-90; Diarrassouba F, 2007, J FOOD PROTECT, V70, P1316, DOI 10.4315/0362-028X-70.6.1316; Ebrahimnejad H., 2014, RECENT ADV REDOX ACT, P211, DOI [10.1007/978-94-017-8953-0_8, DOI 10.1007/978-94-017-8953-0_8]; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Encheva V, 2009, MICROBIOL-SGM, V155, P2429, DOI 10.1099/mic.0.026138-0; Eng SK, 2015, FRONT LIFE SCI, V8, P284, DOI 10.1080/21553769.2015.1051243; Frawley ER, 2013, P NATL ACAD SCI USA, V110, P12054, DOI 10.1073/pnas.1218274110; Gal-Mor O, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00088-18; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Gonzalez-Lamothe R, 2009, INT J MOL SCI, V10, P3400, DOI 10.3390/ijms10083400; Harmidy K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027267; Harrison JE, 2013, J FOOD PROCESS PRES, V37, P356, DOI 10.1111/j.1745-4549.2011.00655.x; Hidalgo G, 2011, APPL ENVIRON MICROB, V77, P6852, DOI 10.1128/AEM.05561-11; Howell K, 2015, INTEGR FOOD NUTR MET, V2, P9, DOI [10.1016/j.mib.2006.12.002, DOI 10.1016/J.MIB.2006.12.002]; Huang JY, 2016, MMWR MORBIDITY MORTA, V65; ISHIGURO N, 1992, J BIOL CHEM, V267, P9559; Johnson TJ, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.00362-18, 10.1128/aem.00362-18]; Johny AK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01828; Jones MA, 2007, AVIAN PATHOL, V36, P199, DOI 10.1080/03079450701264118; Kim W, 2004, MOL MICROBIOL, V54, P702, DOI 10.1111/j.1365-2958.2004.04295.x; Kirby CW, 2013, PHYTOCHEMISTRY, V94, P284, DOI 10.1016/j.phytochem.2013.06.017; Liu M, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00746-18; Maisuria VB, 2016, SCI REP-UK, V6, DOI 10.1038/srep30169; Mani-Lopez E, 2012, FOOD RES INT, V45, P713, DOI 10.1016/j.foodres.2011.04.043; Manon R, 2012, SALMONELLA DISTRIBUT; Martinez-Flores I, 2016, SCI REP-UK, V6, DOI 10.1038/srep37858; Mouttotou N, 2017, CURRENT TOPICS SALMO, P21, DOI 10.5772/67438; Negi PS, 2012, INT J FOOD MICROBIOL, V156, P7, DOI 10.1016/j.ijfoodmicro.2012.03.006; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Porcheron G, 2013, FRONT CELL INFECT MI, V3, P90, DOI [DOI 10.3389/FCIMB.2013.00090, 10.3389/fcimb.2013.00090]; Public Health Agency of Canada, 2018, FOODNET CAN ANN REP; Raffatellu M, 2005, INFECT IMMUN, V73, P146, DOI 10.1128/IAI.73.1.146-154.2005; Ranfaing J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29082-6; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Vaquero MJR, 2010, J AGR FOOD CHEM, V58, P6048, DOI 10.1021/jf903966p; Rodriguez-Saona L.E., 2001, CURRENT PROTOCOLS FO, DOI DOI 10.1002/0471142913.FAF0101S00; Ross KA, 2017, INT J FRUIT SCI, V17, P202, DOI 10.1080/15538362.2017.1285264; Ryan D, 2015, APPL ENVIRON MICROB, V81, P8054, DOI 10.1128/AEM.02172-15; Salaheen S, 2016, INT J FOOD MICROBIOL, V237, P128, DOI 10.1016/j.ijfoodmicro.2016.08.027; Spector MP, 2012, FOOD RES INT, V45, P455, DOI 10.1016/j.foodres.2011.06.056; Vandeplas S, 2017, BURL DODDS AGR SCI, V13, P17, DOI 10.19103/AS.2016.0010.26; Wang D, 2013, METALLOMICS, V5, P372, DOI 10.1039/c3mt20217h; Wiedemann A, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00791; Wojnicz D, 2016, INT J FOOD SCI NUTR, V67, P1005, DOI 10.1080/09637486.2016.1211996	58	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219163	10.1371/journal.pone.0219163	http://dx.doi.org/10.1371/journal.pone.0219163			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269043	Green Published, gold, Green Submitted			2022-12-26	WOS:000484927300047
J	Chen, YN; Wall, KM; Fofana, K; Navarro-Colorado, C				Chen, Yi No; Wall, Kristin M.; Fofana, Kadija; Navarro-Colorado, Carlos			Nutrition indicators as potential predictors of AIDS-defining illnesses among ARV-naive HIV-positive adults in Kapiri Mposhi, Zambia 2008-2009	PLOS ONE			English	Article							BODY-MASS INDEX; HAND GRIP STRENGTH; ANTIRETROVIRAL THERAPY; INFECTED ADULTS; WEIGHT-LOSS; TUBERCULOSIS; MORTALITY; MALNUTRITION; ADHERENCE; COMMUNITY	Early changes in nutritional status may be predictive of subsequent HIV disease progression in people living with HIV (PLHIV). In addition to conventional anthropometric assessment using body mass index (BMI) and mid-upper arm circumferences (MUAC), measures of strength and fatigability may detect earlier changes in nutrition status which predict HIV disease progression. This study aims to examine the association between various nutritional metrics relevant in resource-scarce setting and HIV disease progression. The HIV disease progression outcome was defined as any occurrence of an incident AIDS-defining illnesses (ADI) among antiretroviral treatment (ART)-naive PLHIV. From 2008-2009, HIV+ Zambian adult men and non-pregnant women were followed for 9 months at a Doctors without Borders (Medecins Sans Frontiers, MSF) HIV clinic in Kapiri Mposhi, Zambia. Since the study was conducted in the time period when former WHO recommendations on ART (i.e., <= 200 CD4 cell count as opposed to treating all individuals regardless of CD4 cell count or disease stage) were followed, caution should be applied when considering the implications from this study's results to improve HIV case management under current clinical guidelines, or when comparing findings from this study with studies conducted in recent years. Bivariable and multivariable logistic regression was used to assess the associations between baseline nutritional measurements and the outcome of incident ADI. Self-reported loss of appetite study (AOR 1.90, 95% CI 1.04, 3.45, P = 0.036) and moderate wasting based on MUAC classification (AOR 2.40, 95% CI 1.13, 5.10, P = 0.022) were independently associated with increased odds of developing incident ADI within 9 months, while continuous increments (in psi) of median handgrip strength (AOR 0.74, 95% CI 0.60, 0.91, P = 0.004) was independently associated with decreased odds of incident ADI only among women. The association between low BMI and the short-term outcome of ADI was attenuated after controlling for these nutritional indicators. These findings warrant further research to validate the consistency of these observed associations among larger ART-naive HIV-infected populations, as well as to develop nutritional assessment tools for identifying disease progression risk among ART-naive PLHIV.	[Chen, Yi No; Wall, Kristin M.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Fofana, Kadija] Georgia State Univ, Div Epidemiol & Biostat, Sch Publ Hlth, Atlanta, GA 30303 USA; [Navarro-Colorado, Carlos] Ctr Dis Control & Prevent, Div Global Dis Protect, Ctr Global Hlth, Atlanta, GA USA	Emory University; Rollins School Public Health; University System of Georgia; Georgia State University; Centers for Disease Control & Prevention - USA	Wall, KM (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	kmwall@emory.edu		Wall, Kristin/0000-0001-8547-2004	Doctors Without Borders/Medecins Sans Frontieres-OCBA	Doctors Without Borders/Medecins Sans Frontieres-OCBA	This work was supported by Doctors Without Borders/Medecins Sans Frontieres-OCBA.	Anand Deepika, 2014, Indian J Community Med, V39, P161, DOI 10.4103/0970-0218.137153; [Anonymous], 2015, HIV AIDS COUNTR SHOU; [Anonymous], 2018, HIV AIDS ZAMB BRIGHT; Audain KA, 2015, P NUTR SOC, V74, P517, DOI 10.1017/S0029665115000063; Brito NB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160480; Donaldson SI, 2002, J BUS PSYCHOL, V17, P245, DOI 10.1023/A:1019637632584; Duggal Shalini, 2012, Clin Dev Immunol, V2012, P784740, DOI 10.1155/2012/784740; FerroLuzzi A, 1996, BRIT J NUTR, V75, P3, DOI 10.1079/BJN19960105; Filteau S, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0253-8; Giri PA, 2013, N AM J MED SCI, V5, P37, DOI [10.4103/1947-2714.114169, 10.4103/1947-2714.106193, 10.4103/1947-2714.107537]; GORBACH SL, 1993, NUTR REV, V51, P226, DOI 10.1111/j.1753-4887.1993.tb03110.x; Gupta RK, 2015, AIDS, V29, P1363, DOI 10.1097/QAD.0000000000000685; Gustafson P, 2007, INFECTION, V35, P69, DOI 10.1007/s15010-007-6090-3; Hayes R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002292; Humphreys J, 2002, NUTRITION, V18, P616, DOI 10.1016/S0899-9007(02)00756-6; HUNT DR, 1985, JPEN-PARENTER ENTER, V9, P701, DOI 10.1177/0148607185009006701; Jeejeebhoy KN, 1998, GASTROENTEROL CLIN N, V27, P347, DOI 10.1016/S0889-8553(05)70007-8; Kelly P, 2002, ACTA TROP, V83, P151, DOI 10.1016/S0001-706X(02)00095-5; Kikuchi H, 2015, BIOPSYCHOSOC MED, V9, DOI 10.1186/s13030-014-0029-6; Koethe JR, 2013, PUBLIC HEALTH NUTR, V16, P549, DOI 10.1017/S1368980012002960; Koethe JR, 2011, CLIN INFECT DIS, V53, P952, DOI 10.1093/cid/cir606; Koethe JR, 2010, AM J CLIN NUTR, V91, p1138S, DOI 10.3945/ajcn.2010.28608D; Koethe JR, 2010, JAIDS-J ACQ IMM DEF, V53, P507, DOI 10.1097/QAI.0b013e3181b32baf; Koopman JJE, 2015, AGE AGEING, V44, P465, DOI 10.1093/ageing/afu165; Liu EJ, 2011, J INFECT DIS, V204, P282, DOI 10.1093/infdis/jir246; Malvy D, 2001, J AM COLL NUTR, V20, P609, DOI 10.1080/07315724.2001.10719065; Maro I, 2010, INT J TUBERC LUNG D, V14, P1447; Mehra D, 2015, FOOD INSECURITY PUBL; Mfinanga S, 2015, LANCET, V385, P2173, DOI 10.1016/S0140-6736(15)60164-7; Ndubani P, 2006, PLACE ZAMBIA IDENTIF; Nekatebeb H, 2010, BODY MASS INDEX MIDU; Norman K, 2011, CLIN NUTR, V30, P135, DOI 10.1016/j.clnu.2010.09.010; Oliveira I, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001587; Paul R, THE HEALTH, P14; Pinstrup-Andersen P, 2009, FOOD SECUR, V1, P5, DOI 10.1007/s12571-008-0002-y; Powell-Tuck J, 2003, CLIN NUTR, V22, P307, DOI 10.1016/S0261-5614(03)00009-8; Rehman AM, 2015, PUBLIC HEALTH NUTR, V18, P742, DOI 10.1017/S1368980014000718; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; Sharma A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143740; Skurnick JH, 1996, J ACQ IMMUN DEF SYND, V12, P75, DOI 10.1097/00042560-199605010-00011; Sultana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121456; van der Sande MAB, 2004, JAIDS-J ACQ IMM DEF, V37, P1288, DOI 10.1097/01.qai.0000122708.59121.03; Watson R, 2015, HLTH HIV INFECTED PE; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; Wheeler D A, 1999, AIDS Read, V9, P347; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; Woodd SL, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1894-3; World Health Organisation, 2007, WHO CAS DEF HIV SURV; Xu L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01073-z; Young S, 2014, AIDS BEHAV, V18, pS505, DOI 10.1007/s10461-013-0547-4; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	51	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2019	14	7							e0219111	10.1371/journal.pone.0219111	http://dx.doi.org/10.1371/journal.pone.0219111			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3ZV	31265479	Green Submitted, Green Published, gold			2022-12-26	WOS:000484921200020
J	Rejlova, L; Chrtek, J; Travnicek, P; Lucanova, M; Vit, P; Urfus, T				Rejlova, Ludmila; Chrtek, Jindrich; Travnicek, Pavel; Lucanova, Magdalena; Vit, Petr; Urfus, Tomas			Polyploid evolution: The ultimate way to grasp the nettle	PLOS ONE			English	Article							NUCLEAR-DNA CONTENT; GENOME SIZE VARIATION; CENTAUREA-STOEBE; ECOLOGICAL DIFFERENTIATION; CHAMERION-ANGUSTIFOLIUM; HABITAT DIFFERENTIATION; COLONIZATION ABILITIES; TETRAPLOID CYTOTYPES; CHROMOSOME COUNTS; GENETIC-STRUCTURE	Polyploidy is one of the major forces of plant evolution and widespread mixed-ploidy species offer an opportunity to evaluate its significance. We therefore selected the cosmopolitan species Urtica dioica (stinging nettle), examined its cytogeography and pattern of absolute genome size, and assessed correlations with bioclimatic and ecogeographic data (latitude, longitude, elevation). We evaluated variation in ploidy level using an extensive dataset of 7012 samples from 1317 populations covering most of the species' distribution area. The widespread tetraploid cytotype (87%) was strongly prevalent over diploids (13%). A subsequent analysis of absolute genome size proved a uniform Cx-value of core U. dioica (except for U. d. subsp. cypria) whereas other closely related species, namely U. bianorii, U. kioviensis and U. simensis, differed significantly. We detected a positive correlation between relative genome size and longitude and latitude in the complete dataset of European populations and a positive correlation between relative genome size and longitude in a reduced dataset of diploid accessions (the complete dataset of diploids excluding U. d. subsp. kurdistanica). In addition, our data indicate an affinity of most diploids to natural and near-natural habitats and that the tetraploid cytotype and a small part of diploids (population from the Po river basin in northern Italy) tend to inhabit synanthropic sites. To sum up, the pattern of ploidy variation revealed by our study is in many aspects unique to the stinging nettle, being most likely first of all driven by the greater ecological plasticity and invasiveness of the tetraploid cytotype.	[Rejlova, Ludmila; Chrtek, Jindrich; Travnicek, Pavel; Lucanova, Magdalena; Vit, Petr; Urfus, Tomas] Czech Acad Sci, Inst Bot, Pruhonice, Czech Republic; [Rejlova, Ludmila; Chrtek, Jindrich; Urfus, Tomas] Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic; [Lucanova, Magdalena] Univ South Bohemia, Dept Bot, Fac Sci, Ceske Budejovice, Czech Republic; [Vit, Petr] Czech Univ Life Sci Prague, Fac Environm Sci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague; University of South Bohemia Ceske Budejovice; Czech University of Life Sciences Prague	Rejlova, L; Urfus, T (corresponding author), Czech Acad Sci, Inst Bot, Pruhonice, Czech Republic.; Rejlova, L; Urfus, T (corresponding author), Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic.	rejlovalud@gmail.com; tomas.urfus@natur.cuni.cz	Urfus, Tomas/ABC-1854-2020; Travnicek, Pavel/G-9028-2012; Lucanova, Magdalena/B-2721-2013	Urfus, Tomas/0000-0001-6878-6503; Travnicek, Pavel/0000-0002-5806-1645; Rejlova, Ludmila/0000-0003-4347-2860; Lucanova, Magdalena/0000-0002-4612-3693	Czech Science Foundation [GA 17-20201S]; Charles University [1206617, 204069]; Czech Academy of Sciences [RVO 67985939]	Czech Science Foundation(Grant Agency of the Czech Republic); Charles University; Czech Academy of Sciences(Czech Academy of Sciences)	The research was supported by the Czech Science Foundation (project no. GA 17-20201S), Charles University (GAUK project no. 1206617 and the Research Centre programme no. 204069) and the Czech Academy of Sciences (long-term research development project no. RVO 67985939). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was supported by the Czech Science Foundation (project no. GA 17-20201S), Charles University (GAUK project no. 1206617 and the Research Centre programme no. 204069) and the Czech Academy of Sciences (long-term research development project no. RVO 67985939). The funders had no role in the design of the study, collection and analysis of data, the decision to publish this paper or the preparation of the manuscript.	AGRESTI A, 2007, WILEY SERIES PROBABI; Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; [Anonymous], 2018, LANG ENV STAT COMP; Atalay I, 1996, J ARID ENVIRON, V32, P23, DOI 10.1006/jare.1996.0003; Baack EJ, 2005, NEW PHYTOL, V167, P623, DOI 10.1111/j.1469-8137.2005.01433.x; Bacci L, 2009, IND CROP PROD, V29, P480, DOI 10.1016/j.indcrop.2008.09.005; Baduel P, 2016, PLANT PHYSIOL, V171, P437, DOI 10.1104/pp.15.01875; Bolchovskich ZV, 1969, CHROMOSOMNYJE CISLA; Bredemann G., 1959, GRO E BRENNESSEL URT; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Buggs RJA, 2007, EVOLUTION, V61, P125, DOI 10.1111/j.1558-5646.2007.00010.x; Burnier J, 2009, MOL ECOL, V18, P3730, DOI 10.1111/j.1365-294X.2009.04281.x; Burton TL, 2000, EVOLUTION, V54, P1182, DOI 10.1111/j.0014-3820.2000.tb00553.x; Cabezudo B., 2011, FLORA VASCULAR ANDAL, P913; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Certner M, 2017, ANN BOT-LONDON, V120, P303, DOI 10.1093/aob/mcx032; Chrtek J., 1974, FLORA IRANICA FLORA, P1; Chumova Z, 2017, ANN BOT-LONDON, V120, P285, DOI 10.1093/aob/mcx021; Chumova Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133748; DANIHELKA J., 2004, ZPRAVY CES BOT SPOLE, V39, P25; Darlington C. D., 1955, CHROMOSOME ATLAS FLO; Di Virgilio N, 2015, IND CROP PROD, V68, P42, DOI 10.1016/j.indcrop.2014.08.012; DOLEZEL J, 1989, BIOL PLANTARUM, V31, P113, DOI 10.1007/BF02907241; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Domin K., 1944, CASOPIS CES LEKARNIC, V3, P92; Domin K., 1944, CASOPIS CESKEHO LEKA, V57, P59; Douda J, 2016, APPL VEG SCI, V19, P147, DOI 10.1111/avsc.12201; Ebner Karl, 1912, FLOSZEREI SCHIFFAHRT; Erinc S, 1978, ENV HIST NEAR MIDDLE, P67; Farag MA, 2013, PHYTOCHEMISTRY, V96, P170, DOI 10.1016/j.phytochem.2013.09.016; Farzami B, 2003, J ETHNOPHARMACOL, V89, P47, DOI 10.1016/S0378-8741(03)00220-4; Frajman B, 2009, SYST BIOL, V58, P328, DOI 10.1093/sysbio/syp030; Francis D, 2008, ANN BOT-LONDON, V101, P747, DOI 10.1093/aob/mcn038; GEL'TMAN D V, 1984, Botanicheskii Zhurnal (St. Petersburg), V69, P1524; GEL'TMAN D V, 1990, Botanicheskii Zhurnal (St. Petersburg), V75, P840; GEL'TMAN D V, 1982, Botanicheskii Zhurnal (St. Petersburg), V67, P1413; Geltman D., 1981, BOT ZH, V67, P788; Geltman D., 1988, NOVOSTI SYSTEMATIKY, V25, P68; Grant V., 1981, PLANT SPECIATION; Grosse-Veldmann B, 2018, CLADISTICS, V34, P131, DOI 10.1111/cla.12193; Grosse-Veldmann B, 2016, MOL PHYLOGENET EVOL, V102, P9, DOI 10.1016/j.ympev.2016.05.019; Grosse-Veldmann B, 2015, PHYTOTAXA, V208, P239, DOI 10.11646/phytotaxa.208.4.1; GrosseVeldmann B., 2016, THESIS U BONN BONN; Henning T, 2014, PHYTOTAXA, V162, P61, DOI 10.11646/phytotaxa.162.2.1; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Husband BC, 2004, NEW PHYTOL, V161, P703, DOI 10.1046/j.1469-8137.2004.00998.x; IVINS JD, 1952, J ECOL, V40, P380, DOI 10.2307/2256806; James JK, 2005, EVOLUTION, V59, P2533, DOI 10.1111/j.0014-3820.2005.tb00967.x; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jonsell B., 2010, FLORA NORDICA; Kao RH, 2007, NEW PHYTOL, V175, P764, DOI 10.1111/j.1469-8137.2007.02145.x; Kolar F, 2017, TRENDS PLANT SCI, V22, P1041, DOI 10.1016/j.tplants.2017.09.011; Koutecky P, 2015, PLANT SYST EVOL, V301, P1115, DOI 10.1007/s00606-014-1153-2; Kreiner JM, 2017, NEW PHYTOL, V214, P879, DOI 10.1111/nph.14423; Kuhne G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43533; Lafuma L, 2003, PLANT SYST EVOL, V243, P59, DOI 10.1007/s00606-003-0075-0; Leitch IJ, 2005, ANN BOT-LONDON, V95, P207, DOI 10.1093/aob/mci014; Leitch IJ, 2004, BIOL J LINN SOC, V82, P651, DOI 10.1111/j.1095-8312.2004.00349.x; Levin D. A, 2002, OX ECOL EV; Linder HP, 2014, ANN BOT-LONDON, V113, P1175, DOI 10.1093/aob/mcu047; Lippert Wolfgang, 2006, Berichte der Bayerischen Botanischen Gesellschaft zur Erforschung der Heimischen Flora, V76, P85; Loureiro J, 2010, PRESLIA, V82, P3; Love A., 1961, CHROMOSOME NUMBERS C; Love A, 1948, REPORTS U I APPL S B, V3; LUMARET R, 1987, OECOLOGIA, V73, P436, DOI 10.1007/BF00385262; Madlung A, 2013, HEREDITY, V110, P99, DOI 10.1038/hdy.2012.79; Magri D, 2008, J BIOGEOGR, V35, P450, DOI 10.1111/j.1365-2699.2007.01803.x; Maherali H, 2009, NEW PHYTOL, V184, P721, DOI 10.1111/j.1469-8137.2009.02997.x; Majovsky J, 1987, KARYOTAXONOMICKY PRE; Mandakova Terezie, 2016, Curr Protoc Plant Biol, V1, P43, DOI 10.1002/cppb.20009; Mandakova T, 2010, PLANT CELL, V22, P2277, DOI 10.1105/tpc.110.074526; Marhold K, 2007, CHROMOSOME NUMBER SU; Meikle R. D., 1985, FLORA CYPRUS; Mohammadi A, 2016, CELL MOL BIOL, V62, P78, DOI 10.14715/cmb/2016.62.3.13; Moreno M., 1987, FLORA VASCULAR ANDAL, V1, P154; Mraz P, 2006, BIOLOGIA, V61, P115, DOI 10.2478/s11756-006-0017-9; Mraz P, 2011, INT J PLANT SCI, V172, P386, DOI 10.1086/658151; Nassar NMA, 2006, GENET MOL RES, V5, P536; NASSAR NMA, 1992, FIELD CROP RES, V30, P173, DOI 10.1016/0378-4290(92)90066-I; Nemeckova H, 2019, ANN BOT FENN, V56, P57, DOI 10.5735/085.056.0111; Obbard DJ, 2006, EVOLUTION, V60, P1801, DOI 10.1111/j.0014-3820.2006.tb00524.x; Ohri D, 1998, ANN BOT-LONDON, V82, P75, DOI 10.1006/anbo.1998.0765; Olsen C, 1921, J ECOL, V9, P1, DOI 10.2307/2255757; Otiskova V, 2014, PRESLIA, V86, P67; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pagad S, 2018, SCI DATA, V5, DOI 10.1038/sdata.2017.202; Paiva J, 1993, FLORA IBERICA PLANTA, P262; Pandit MK, 2011, J ECOL, V99, P1108, DOI 10.1111/j.1365-2745.2011.01838.x; Pignatti S., 1982, FLORA DITALIA, V1-3; POLLARD AJ, 1982, NEW PHYTOL, V92, P453, DOI 10.1111/j.1469-8137.1982.tb03403.x; Pustovoitova TN, 1996, RUSS J PLANT PHYSL+, V43, P232; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Ramsey J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0352; Ramsey J, 2011, P NATL ACAD SCI USA, V108, P7096, DOI 10.1073/pnas.1016631108; Renny-Byfield S, 2014, AM J BOT, V101, P1711, DOI 10.3732/ajb.1400119; Renny-Byfield S, 2013, PLANT J, V74, P829, DOI 10.1111/tpj.12168; Rice A, 2015, NEW PHYTOL, V206, P19, DOI 10.1111/nph.13191; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Roberts N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18646-7; Rosche C, 2018, PLANT BIOLOGY, V20, P75, DOI 10.1111/plb.12628; Rosche C, 2017, J ECOL, V105, P425, DOI 10.1111/1365-2745.12670; ROTHERA SL, 1986, NEW PHYTOL, V102, P449, DOI 10.1111/j.1469-8137.1986.tb00822.x; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Schlaepfer DR, 2008, J BIOGEOGR, V35, P2119, DOI 10.1111/j.1365-2699.2008.01937.x; Schmitt T, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-9; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Schonswetter P, 2007, MOL PHYLOGENET EVOL, V42, P92, DOI 10.1016/j.ympev.2006.06.016; Simmons HG., 1910, VETENSKAPLIGA PRAKTI; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Sonnleitner M, 2010, ANN BOT-LONDON, V106, P967, DOI 10.1093/aob/mcq192; Spaniel S, 2008, FOLIA GEOBOT, V43, P131, DOI 10.1007/s12224-008-9008-7; Stebbins GL, 1950, ARTIFICIAL NATURAL H, P7; Suda J, 2006, CYTOM PART A, V69A, P273, DOI 10.1002/cyto.a.20253; Suda J, 2015, NEW PHYTOL, V205, P994, DOI 10.1111/nph.13107; Symonds VV, 2010, EVOLUTION, V64, P1984, DOI [10.1111/j.1558-5646.2010.00978-x, 10.1111/j.1558-5646.2010.00978.x]; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Tesitelova T, 2013, NEW PHYTOL, V199, P1022, DOI 10.1111/nph.12348; THOMPSON JD, 1992, TRENDS ECOL EVOL, V7, P302, DOI 10.1016/0169-5347(92)90228-4; Tischler G, 1950, CHROMOSOMENZAHLEN GE; Townsend CC, 1974, FLORA IRAQ, VIII; Treier UA, 2009, ECOLOGY, V90, P1366, DOI 10.1890/08-0420.1; Tutin T. G., 1964, FLORA EUROPAEA, V1; Tuxen R., 1956, HEUTIGE POTENTIELLE; Vit P, 2016, BOT J LINN SOC, V182, P637, DOI 10.1111/boj.12474; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; Weigend M., 2005, HOPPEA, V66, P101; Weigend Maximilian, 2006, Willdenowia, V36, P811, DOI 10.3372/wi.36.36212; Weiss-Schneeweiss H, 2013, CYTOGENET GENOME RES, V140, P137, DOI 10.1159/000351727; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Wu ZY, 2013, MOL PHYLOGENET EVOL, V69, P814, DOI 10.1016/j.ympev.2013.06.022; Yan HH, 2016, GENOME, V59, P209, DOI 10.1139/gen-2015-0132; Zozomova-Lihova J, 2015, AM J BOT, V102, P1380, DOI 10.3732/ajb.1500052; [No title captured]	136	10	10	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0218389	10.1371/journal.pone.0218389	http://dx.doi.org/10.1371/journal.pone.0218389			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260474	Green Submitted, Green Published, gold			2022-12-26	WOS:000484918700015
J	Sun, B; Zhao, XD; Ming, JG; Liu, X; Liu, DM; Jiang, CL				Sun, Bo; Zhao, Xudong; Ming, Jianguang; Liu, Xing; Liu, Daming; Jiang, Chuanlu			Stepwise detection and evaluation reveal miR-10b and miR-222 as a remarkable prognostic pair for glioblastoma	ONCOGENE			English	Article							GLIOMA-CELLS; PTEN; APOPTOSIS; P53; EXPRESSION; PATHWAY; MDM2; TEMOZOLOMIDE; SUPPRESSION; P27(KIP1)	Despite the existence of many clinical and molecular factors reported that contribute to survival in glioblastoma, prevailing studies fell into partial or local feature selection for survival analysis. We proposed a feature selection strategy including not only joint covariate detection but also its evaluations, and performed it on miRNA expression profiles with glioblastoma. MiR-10b and miR-222 were selected as the most significant two-dimensional feature. Crucially, we integrated in vitro experiments on GBM cells and in vivo studies on a mouse model of human glioma to elucidate the synergistic effects between miR-10b and miR-222. Inhibition of miR-10b and miR-222 strongly suppress GBM cells growth, invasion, and induce apoptosis by co-targeting PTEN and leading to activation of p53 ultimately. We also demonstrated that miR-10b and miR-222 co-target BIM to induce apoptosis independent of p53 status. The results define mir-10b and mir-222 important roles in gliomagenesis and provided a reliable survival analysis strategy.	[Sun, Bo; Ming, Jianguang; Liu, Daming; Jiang, Chuanlu] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin 150086, Heilongjiang, Peoples R China; [Zhao, Xudong] Northeast Forestry Univ, Coll Informat & Comp Engn, Harbin 150040, Heilongjiang, Peoples R China; [Liu, Xing] Beijing Neurosurg Inst, Beijing 100050, Peoples R China	Harbin Medical University; Northeast Forestry University - China; Beijing Neurosurgical Institute	Jiang, CL (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin 150086, Heilongjiang, Peoples R China.; Zhao, XD (corresponding author), Northeast Forestry Univ, Coll Informat & Comp Engn, Harbin 150040, Heilongjiang, Peoples R China.	zhaoxudong@nefu.edu.cn; jcl6688@163.com			National Key Research and Development Plan [2016YFC0902500]; National Natural Science Foundation of China [81702972, 81572701, 81772666]; Special Fund Project of Translational Medicine in the Chinese-Russian Medical Research Center [CR201417]; Fundamental Research Funds for the Central Universities [2572018BH01]; Specialized Personnel Start-up Grant [41113237]	National Key Research and Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund Project of Translational Medicine in the Chinese-Russian Medical Research Center; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Personnel Start-up Grant	This work is supported by the National Key Research and Development Plan (No. 2016YFC0902500); the National Natural Science Foundation of China (No. 81702972, No. 81572701, and No. 81772666); the Special Fund Project of Translational Medicine in the Chinese-Russian Medical Research Center (No. CR201417). Besides, Xudong Zhao would like to thank the financial support of Fundamental Research Funds for the Central Universities (No. 2572018BH01) and Specialized Personnel Start-up Grant (No. 41113237).	Bahena-Ocampo I, 2016, EMBO REP, V17, P648, DOI 10.15252/embr.201540678; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang CJ, 2004, J BIOL CHEM, V279, P29841, DOI 10.1074/jbc.M401488200; Chen HY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0435-y; Chen LC, 2012, ONCOL REP, V27, P854, DOI 10.3892/or.2011.1535; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cheng W, 2015, ONCOTARGET, V6, P29285, DOI 10.18632/oncotarget.4978; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; COX DR, 1972, J R STAT SOC B, V34, P187; Duda R.O., 2006, PATTERN CLASSIFICATI; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Fan QW, 2007, CANCER RES, V67, P7960, DOI 10.1158/0008-5472.CAN-07-2154; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Han B, 2017, AGING-US, V9, P1885, DOI 10.18632/aging.101271; Hombach-Klonisch S, 2018, PHARMACOL THERAPEUT, V184, P13, DOI 10.1016/j.pharmthera.2017.10.017; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Ji YC, 2015, TUMOR BIOL, V36, P4461, DOI 10.1007/s13277-015-3086-y; Kim J, 2014, CANCER RES, V74, P1541, DOI 10.1158/0008-5472.CAN-13-1449; Klein JP, 2014, CH CRC HANDB MOD STA, P1; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Liu X, 2014, ONCOTARGET, V5, P11681, DOI 10.18632/oncotarget.2585; Martin A, 2005, CANCER CELL, V7, P591, DOI 10.1016/j.ccr.2005.05.006; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Ming JG, 2017, AGING-US, V9, P1233, DOI 10.18632/aging.101224; Mure H, 2010, NEURO-ONCOLOGY, V12, P221, DOI 10.1093/neuonc/nop026; Niyazi M, 2016, ONCOTARGET, V7, P45764, DOI 10.18632/oncotarget.9945; Niyazi M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-153; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Suh SS, 2012, P NATL ACAD SCI USA, V109, P5316, DOI 10.1073/pnas.1202465109; Sun CQ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3017948; Terasawa K, 2009, FEBS J, V276, P3269, DOI 10.1111/j.1742-4658.2009.07041.x; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wu YW, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4327-9; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang CZ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-119; Zhang W, 2012, NEURO-ONCOLOGY, V14, P712, DOI 10.1093/neuonc/nos089; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	45	18	19	1	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2019	38	33					6142	6157		10.1038/s41388-019-0867-6	http://dx.doi.org/10.1038/s41388-019-0867-6			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IR6TP	31289362	Green Published, hybrid			2022-12-26	WOS:000481572400005
J	Sharma, K; LeBlanc, R; Haque, M; Nishimori, K; Reid, MM; Teruyama, R				Sharma, Kaustubh; LeBlanc, Ryan; Haque, Masudul; Nishimori, Katsuhiko; Reid, Madigan M.; Teruyama, Ryoichi			Sexually dimorphic oxytocin receptor expressing neurons in the preoptic area of the mouse brain	PLOS ONE			English	Article							MESSENGER-RIBONUCLEIC-ACID; STIMULATES C-FOS; MATERNAL-BEHAVIOR; SEX-DIFFERENCES; STRIA TERMINALIS; BED NUCLEUS; PARAVENTRICULAR NUCLEUS; PARENTAL BEHAVIOR; NEURAL MECHANISMS; BINDING-SITES	Oxytocin is involved in the regulation of social behaviors including parental behaviors in a variety of species. Oxytocin triggers social behaviors by binding to oxytocin receptors (OXTRs) in various parts of the brain. OXTRs are present in the preoptic area (POA) where hormone-sensitive sexually dimorphic nuclei exist. The present study was conducted to examine whether sex differences exist in the distribution of neurons expressing OXTRs in the POA. Using OXTR-Venus (an enhanced variant of yellow fluorescent protein) mice, the distribution of OXTR-Venus cells in the POA was compared between sexes. The total number of OXTR-Venus cells in the medial POA (MPOA) was significantly greater in females than in males. No detectable OXTR-Venus cells were observed in the anteroventral periventricular nucleus (AVPV) within the MPOA in most of the brain sections from males. We further examined the total number of OXTR-Venus cells in the AVPV and the rest of the MPOA between the sexes. The total number of OXTR-Venus cells in the AVPV in females (615 43) was significantly greater than that in males (14 2), whereas the total number of OXTRVenus cells in the rest of the MPOA did not differ significantly between the sexes. Thus, the sexually dimorphic expression of OXTR-Venus specifically occurred in the AVPV, but not in the rest of the MPOA. We also examined whether the expression of OXTR in the AVPV is driven by the female gonadal hormone, estrogen. Immunocytochemistry and single-cell RTPCR revealed the presence of the estrogen receptor a in OXTR-Venus cells in the female AVPV. Moreover, ovariectomy resulted in the absence of OXTR-Venus expression in the AVPV, whereas estrogen replacement therapy restored OXTR-Venus expression. These results demonstrate that the expression of OXTR in the AVPV is primarily female specific and estrogen dependent. The presence of the sexually dimorphic expression of OXTR in the AVPV suggests the involvement of OXTR neurons in the AVPV in the regulation of female-specific behavior and/or physiology.	[Sharma, Kaustubh; LeBlanc, Ryan; Haque, Masudul; Reid, Madigan M.; Teruyama, Ryoichi] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Nishimori, Katsuhiko] Tohoku Univ, Dept Mol & Cell Biol, Grad Sch Agr Sci, Sendai, Miyagi, Japan; [Nishimori, Katsuhiko] Fukushima Med Univ, Lab Obes & Internal Inflammat, Fukushima, Japan	Louisiana State University System; Louisiana State University; Tohoku University; Fukushima Medical University	Teruyama, R (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	rteruyama@lsu.edu						Arakawa H, 2015, PHYSIOL BEHAV, V146, P36, DOI 10.1016/j.physbeh.2015.04.016; Argiolas A, 2013, PROG NEUROBIOL, V108, P80, DOI 10.1016/j.pneurobio.2013.06.006; Bales KL, 2007, NEUROSCIENCE, V144, P38, DOI 10.1016/j.neuroscience.2006.09.009; Beery AK, 2008, J COMP NEUROL, V507, P1847, DOI 10.1002/cne.21638; Borrow AP, 2012, HORM BEHAV, V61, P266, DOI 10.1016/j.yhbeh.2011.11.001; Bosch OJ, 2008, P NATL ACAD SCI USA, V105, P17139, DOI 10.1073/pnas.0807412105; BRIDGES RS, 1984, ENDOCRINOLOGY, V114, P930, DOI 10.1210/endo-114-3-930; BROOKS RJ, 1983, BEHAV NEURAL BIOL, V37, P149, DOI 10.1016/S0163-1047(83)91159-7; Calcagnoli F, 2013, PSYCHOPHARMACOLOGY, V229, P639, DOI 10.1007/s00213-013-3124-7; Campbell P, 2009, J COMP NEUROL, V516, P321, DOI 10.1002/cne.22116; Cao JY, 2011, J COMP NEUROL, V519, P2954, DOI 10.1002/cne.22648; Cao Y, 2014, HORM BEHAV, V65, P57, DOI 10.1016/j.yhbeh.2013.11.005; CARTER CS, 1992, ANN NY ACAD SCI, V652, P204, DOI 10.1111/j.1749-6632.1992.tb34356.x; Chalfin L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5569; Champagne F, 2001, P NATL ACAD SCI USA, V98, P12736, DOI 10.1073/pnas.221224598; DaCosta APC, 1996, J NEUROENDOCRINOL, V8, P163, DOI 10.1046/j.1365-2826.1996.04411.x; de Jong TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091701; DUBOISDAUPHIN M, 1992, NEUROREPORT, V3, P797, DOI 10.1097/00001756-199209000-00019; Dumais KM, 2016, FRONT NEUROENDOCRIN, V40, P1, DOI 10.1016/j.yfrne.2015.04.003; Dumais KM, 2013, HORM BEHAV, V64, P693, DOI 10.1016/j.yhbeh.2013.08.012; Elands J, 1988, J Chem Neuroanat, V1, P293; Fleming JGW, 2006, ENDOCRINOLOGY, V147, P899, DOI 10.1210/en.2005-1120; Franczak A, 2002, REPROD NUTR DEV, V42, P327, DOI 10.1051/rnd:2002029; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Hammock EAD, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00195; Harony-Nicolas H, 2014, PSYCHONEUROENDOCRINO, V39, P121, DOI 10.1016/j.psyneuen.2013.10.004; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; INSEL TR, 1993, J NEUROENDOCRINOL, V5, P619, DOI 10.1111/j.1365-2826.1993.tb00531.x; INSEL TR, 1992, PSYCHONEUROENDOCRINO, V17, P3, DOI 10.1016/0306-4530(92)90073-G; INSEL TR, 1989, PHYSIOL BEHAV, V45, P1033, DOI 10.1016/0031-9384(89)90234-5; INSEL TR, 1991, NEUROSCIENCE, V43, P623, DOI 10.1016/0306-4522(91)90321-E; Ivell R, 1999, MOL CELL ENDOCRINOL, V151, P95, DOI 10.1016/S0303-7207(99)00025-8; Jard S, 1987, PROG BRAIN RES <D>, V72, P173; KELLY J, 1980, BRAIN RES, V197, P1, DOI 10.1016/0006-8993(80)90430-8; Kuroda KO, 2011, PROG NEURO-PSYCHOPH, V35, P1205, DOI 10.1016/j.pnpbp.2011.02.008; Lonstein JS, 2000, NEUROSCIENCE, V100, P557, DOI 10.1016/S0306-4522(00)00287-6; Lonstein JS, 2000, NEUROSCI BIOBEHAV R, V24, P669, DOI 10.1016/S0149-7634(00)00036-1; Lonstein JS, 2000, NEUROENDOCRINOLOGY, V72, P91, DOI 10.1159/000054576; Mamrut S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056869; MCCARTHY MM, 1994, NEUROENDOCRINOLOGY, V59, P432, DOI 10.1159/000126689; Menon R, 2018, CURR BIOL, V28, P1066, DOI 10.1016/j.cub.2018.02.044; Numan M, 1996, DEV PSYCHOBIOL, V29, P23, DOI 10.1002/(SICI)1098-2302(199601)29:1<23::AID-DEV2>3.0.CO;2-O; NUMAN M, 1977, J COMP PHYSIOL PSYCH, V91, P146, DOI 10.1037/h0077304; NUMAN M, 1988, BEHAV NEUROSCI, V102, P381, DOI 10.1037/0735-7044.102.3.381; Numan M, 2007, DEV PSYCHOBIOL, V49, P12, DOI 10.1002/dev.20198; Numan Michael, 2006, Behav Cogn Neurosci Rev, V5, P163, DOI 10.1177/1534582306288790; Numan M, 2016, HORM BEHAV, V77, P98, DOI 10.1016/j.yhbeh.2015.05.015; Numan M, 2009, FRONT NEUROENDOCRIN, V30, P46, DOI 10.1016/j.yfrne.2008.10.002; Olazabal DE, 2016, HORM BEHAV, V77, P132, DOI 10.1016/j.yhbeh.2015.04.006; PEDERSEN CA, 1979, P NATL ACAD SCI USA, V76, P6661, DOI 10.1073/pnas.76.12.6661; Pedersen CA, 2006, NEUROSCIENCE, V139, P843, DOI 10.1016/j.neuroscience.2006.01.002; PEDERSEN CA, 1994, BEHAV NEUROSCI, V108, P1163, DOI 10.1037/0735-7044.108.6.1163; QuinonesJenab V, 1997, NEUROENDOCRINOLOGY, V65, P9, DOI 10.1159/000127160; Rosen GJ, 2008, NEUROSCIENCE, V155, P809, DOI 10.1016/j.neuroscience.2008.05.039; Scott N, 2015, NATURE, V525, P519, DOI 10.1038/nature15378; Sheehan T, 2001, NEUROSCIENCE, V106, P341, DOI 10.1016/S0306-4522(01)00286-X; Simerly RB, 1998, BEHAV BRAIN RES, V92, P195, DOI 10.1016/S0166-4328(97)00191-5; Simerly RB, 1997, P NATL ACAD SCI USA, V94, P14077, DOI 10.1073/pnas.94.25.14077; Smeltzer MD, 2006, NEUROSCI LETT, V394, P146, DOI 10.1016/j.neulet.2005.10.019; Smith CJW, 2017, BRAIN STRUCT FUNCT, V222, P981, DOI 10.1007/s00429-016-1260-7; STERN JM, 1989, BEHAV NEURAL BIOL, V52, P20, DOI 10.1016/S0163-1047(89)90134-9; STERN JM, 1991, BEHAV NEUROSCI, V105, P984, DOI 10.1037/0735-7044.105.6.984; STERN JM, 1989, J COMP PSYCHOL, V103, P269, DOI 10.1037/0735-7036.103.3.269; SVARE B, 1981, PHYSIOL BEHAV, V27, P921, DOI 10.1016/0031-9384(81)90062-7; Tora A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-647; Toth I, 2012, PSYCHOPHARMACOLOGY, V223, P149, DOI 10.1007/s00213-012-2702-4; Tribollet E, 2002, NEUROENDOCRINOLOGY, V75, P113, DOI 10.1159/000048227; Uhl-Bronner S, 2005, NEUROSCIENCE, V135, P147, DOI 10.1016/j.neuroscience.2005.05.025; Vaccari C, 1998, ENDOCRINOLOGY, V139, P5015, DOI 10.1210/en.139.12.5015; VANLEENGOED E, 1987, J ENDOCRINOL, V112, P275, DOI 10.1677/joe.0.1120275; Veening JG, 2014, PHARMACOL BIOCHEM BE, V121, P16, DOI 10.1016/j.pbb.2013.11.025; Wersinger SR, 1997, HORM BEHAV, V32, P176, DOI 10.1006/hbeh.1997.1419; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009; YOSHIMURA R, 1993, ENDOCRINOLOGY, V133, P1239, DOI 10.1210/en.133.3.1239; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Zuloaga DG, 2014, J COMP NEUROL, V522, P358, DOI 10.1002/cne.23400	77	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219784	10.1371/journal.pone.0219784	http://dx.doi.org/10.1371/journal.pone.0219784			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295328	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800072
J	Abe, Y; Konno, H; Yoshida, S; Yamauchi, T; Yamasaki, K; Denda, M; Nishizawa, M				Abe, Yuina; Konno, Hajime; Yoshida, Shotaro; Yamauchi, Takeshi; Yamasaki, Kenshi; Denda, Mitsuhiro; Nishizawa, Matsuhiko			Red light-promoted skin barrier recovery: Spatiotemporal evaluation by transepidermal potential	PLOS ONE			English	Article							WATER-LOSS; INDICATOR; LASER; TIME	The light-promoted recovery of epidermal barrier of skin was evaluated by the associated recovery of transepidermal potential (TEP), the potential difference between the surface and dermis of skin, by using porcine skin samples. An accelerated recovery of TEP was observed by irradiation of red light with the irradiance of 40 mW/cm(2) and a duration of >10 min. The influence of the light stimulation to the surroundings (similar to 20 mm) was also observed. The irradiations of blue and purple lights were ineffective in accelerating the barrier recovery. These characteristics of the light stimulation would be useful for the design of effective and safe phototherapy devices for skin. The present study proves that the TEP can serve as a spatiotemporal indicator of the epidermal barrier function.	[Abe, Yuina; Konno, Hajime; Yoshida, Shotaro; Nishizawa, Matsuhiko] Tohoku Univ, Dept Finemech, Grad Sch Engn, Sendai, Miyagi, Japan; [Yamauchi, Takeshi; Yamasaki, Kenshi] Tohoku Univ, Grad Sch Med, Dept Dermatol, Seiryo Machi, Sendai, Miyagi, Japan; [Denda, Mitsuhiro] Shiseido Res Ctr, Kanazawa Ku, Yokohama, Kanagawa, Japan	Tohoku University; Tohoku University; Shiseido Company, Limited	Nishizawa, M (corresponding author), Tohoku Univ, Dept Finemech, Grad Sch Engn, Sendai, Miyagi, Japan.	nishizawa@biomems.mech.tohoku.ac.jp	Yoshida, Shotaro/T-2672-2019; Yamasaki, Kenshi/C-8905-2018	Yoshida, Shotaro/0000-0002-7417-5722; Abe, Yuina/0000-0001-9249-1449; Yamasaki, Kenshi/0000-0002-5495-4956	Tohoku University Institute for Promoting Graduate Degree Programs Division for Interdisciplinary Advanced Research and Education (DIARE), Center of Innovation Program (COI-Stream); MIRAI Project of Japan Science and Technology Agency (JST) [17944087]; Ministry of Education, Culture, Sports, Science and Technology, Japan [17J03919, 18H04158, 18K19896]	Tohoku University Institute for Promoting Graduate Degree Programs Division for Interdisciplinary Advanced Research and Education (DIARE), Center of Innovation Program (COI-Stream); MIRAI Project of Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Tohoku University Institute for Promoting Graduate Degree Programs Division for Interdisciplinary Advanced Research and Education (DIARE), Center of Innovation Program (COI-Stream), MIRAI Project (17944087) of Japan Science and Technology Agency (JST), and financially by Grand-in-Aid for JSPS Research Fellow (17J03919), Scientific Research A (18H04158) and Challenging Exploratory Research (18K19896) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Shiseido Research Center provided support in the form of salaries for an author MD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the "author contributions" section.	Abe Y, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0080-0; BARKER AT, 1982, AM J PHYSIOL, V242, pR358, DOI 10.1152/ajpregu.1982.242.3.R358; Barolet D, 2008, SEMIN CUTAN MED SURG, V27, P227, DOI 10.1016/j.sder.2008.08.003; Brancaleon L, 2002, LASER MED SCI, V17, P173, DOI 10.1007/s101030200027; Chabert R, 2015, SKIN RES TECHNOL, V21, P426, DOI 10.1111/srt.12210; Denda M, 2001, BIOCHEM BIOPH RES CO, V284, P112, DOI 10.1006/bbrc.2001.4925; Denda M, 2008, J INVEST DERMATOL, V128, P1335, DOI 10.1038/sj.jid.5701168; Dube J, 2010, TISSUE ENG PT A, V16, P3055, DOI [10.1089/ten.tea.2010.0030, 10.1089/ten.TEA.2010.0030]; GRUBAUER G, 1989, J LIPID RES, V30, P323; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Kawai E, 2008, EXP DERMATOL, V17, P688, DOI 10.1111/j.1600-0625.2007.00692.x; Kawai E, 2011, EXP DERMATOL, V20, P757, DOI 10.1111/j.1600-0625.2011.01298.x; Lanzafame RJ, 2007, LASER SURG MED, V39, P534, DOI 10.1002/lsm.20519; Nouri Keyvan, 2006, J Cosmet Dermatol, V5, P14, DOI 10.1111/j.1473-2165.2006.00217.x; Papadavid E, 2003, INT J DERMATOL, V42, P480, DOI 10.1046/j.1365-4362.2003.01784.x; Peplow PV, 2010, PHOTOMED LASER SURG, V28, P291, DOI 10.1089/pho.2008.2446; PINNAGODA J, 1990, CONTACT DERMATITIS, V22, P164, DOI 10.1111/j.1600-0536.1990.tb01553.x; Silvestre MA, 2003, THERIOGENOLOGY, V59, P1469, DOI 10.1016/S0093-691X(02)01185-8; Tsutsumi M, 2009, CELL TISSUE RES, V338, P99, DOI 10.1007/s00441-009-0848-0; Tsutsumi M, 2009, EXP DERMATOL, V18, P567, DOI 10.1111/j.1600-0625.2009.00851.x	20	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219198	10.1371/journal.pone.0219198	http://dx.doi.org/10.1371/journal.pone.0219198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291308	gold, Green Published, Green Submitted			2022-12-26	WOS:000484947800056
J	Fernandez-Nino, JA; Bonilla-Tinoco, LJ; Manrique-Espinoza, BS; Salinas-Rodriguez, A; Santos-Luna, R; Roman-Perez, S; Morales-Carmona, E; Duncan, DT				Alfredo Fernandez-Nino, Julian; Juliana Bonilla-Tinoco, Laura; Soledad Manrique-Espinoza, Betty; Salinas-Rodriguez, Aaron; Santos-Luna, Rene; Roman-Perez, Susana; Morales-Carmona, Evangelina; Duncan, Dustin T.			Neighborhood features and depression in Mexican older adults: A longitudinal analysis based on the study on global AGEing and adult health (SAGE), waves 1 and 2 (2009-2014)	PLOS ONE			English	Article							SYMPTOMS; ASSOCIATION; MULTIMORBIDITY; ENVIRONMENTS; ORGANIZATION; GENDER; AGE	A growing body of literature shows that neighborhood characteristics influence older adults' mental health. Therefore, the aim of this study was to examine the association between structural and social characteristics of the neighborhood, and depression in Mexican older adults. A longitudinal study was conducted based on waves 1 (2009-2010) and 2 (2014) of the Mexican sample from the Study on global AGEing and adult health (SAGE). A street-network buffer around each participant's household was used to define neighborhood, so that built environment and social characteristics were assessed within it. Depression was ascertained by using an algorithm based on the Composite International Diagnostic Interview. In the analysis, multilevel logistic regression models were constructed separately for each built and social environments measurement, adjusted for socioeconomic, demographic and health-related covariates, and stratified by area of residence (urban versus rural). The results showed that a length of space between 15-45 meters restricted to vehicles was significantly associated with a lower risk of depression in older adults from the urban area (OR: 0.44; IC 95% 0.23-0.83) and the protective association appeared to be larger with increasing space with this restriction, although it lacked significance. Contrarily, the built environment measures were not predictive of depression in the rural setting. On the other hand, none of the variables from the social environment had a significant association, although safety appeared to behave as a risk factor in the overall (OR: 1.48; CI 95% 0.96-2.30; p = 0.08) and rural (OR: 3.44; CI 95% 0.95-12.45; p = 0.06) samples, as it reached marginal significance. Research about neighborhood effects on older adults' mental health is an emergent field that has shown that depression might be treated not only from the individual-level,but also from the neighborhood-level. Additionally, further research is needed, especially in low- and middle-income countries, to help guide neighborhood policies.	[Alfredo Fernandez-Nino, Julian] Univ Norte, Dept Publ Hlth, Barranquilla, Atlantico, Colombia; [Juliana Bonilla-Tinoco, Laura] Univ Ind Santander, Dept Publ Hlth, Santander, Colombia; [Soledad Manrique-Espinoza, Betty; Salinas-Rodriguez, Aaron; Santos-Luna, Rene; Roman-Perez, Susana; Morales-Carmona, Evangelina] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Duncan, Dustin T.] NYU, Sch Hlth, Spatial Epidemiol Lab, New York, NY 10003 USA	Universidad del Norte; Universidad Industrial de Santander; Instituto Nacional de Salud Publica; New York University	Duncan, DT (corresponding author), NYU, Sch Hlth, Spatial Epidemiol Lab, New York, NY 10003 USA.	dustin.duncan@nyumc.org	Salinas-Rodriguez, Aaron/L-4395-2019; Manrique Espinoza, Betty Soledad/HHS-7564-2022; Fernández-Niño, Julián Alfredo/AHE-6038-2022	Salinas-Rodriguez, Aaron/0000-0001-5645-814X; Manrique Espinoza, Betty Soledad/0000-0002-3535-2124; Fernández-Niño, Julián Alfredo/0000-0002-8948-8481; Morales-Carmona, Evangelina/0000-0002-5186-4605	US National Institute on Aging [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-0, R01-AG034479, R21-AG034263]	US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	SAGE is supported by the US National Institute on Aging through Interagency Agreements OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-0) and through research grants R01AG034479 and R21-AG034263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper uses data from the WHO World Health Surveys/Multi-Country Survey Study (as appropriate) and from WHO's Study on Global Ageing and Adult Health (SAGE). SAGE is supported by the US National Institute on Aging through Interagency Agreements OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-0) and through research grants R01-AG034479 and R21-AG034263.	Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Fernandez-Nino JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108127; Almejo R, 2013, INDICE ABSOLUTO MARG; [Anonymous], 2003, NEIGHBORHOODS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195138382.003.0014; Arokiasamy P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0402-8; Barber S, 2018, SOC SCI MED, V199, P67, DOI 10.1016/j.socscimed.2017.05.047; Bassett E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076554; Beard JR, 2016, GERONTOLOGIST, V56, pS163, DOI 10.1093/geront/gnw037; Beard JR, 2009, AM J PUBLIC HEALTH, V99, P1308, DOI 10.2105/AJPH.2007.125104; Bowling A, 2007, SOC SCI MED, V64, P2533, DOI 10.1016/j.socscimed.2007.03.009; Carpiano RM, 2006, SOC SCI MED, V62, P165, DOI 10.1016/j.socscimed.2005.05.020; Consejo Nacional de Poblacion (CONAPO), 2015, IND MARG ENT FED MUN; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Day R, 2008, HEALTH PLACE, V14, P299, DOI 10.1016/j.healthplace.2007.07.001; de Mello MT, 2013, J AFFECT DISORDERS, V149, P241, DOI 10.1016/j.jad.2013.01.035; Duncan DT, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/10316; Duncan DT, 2014, AM J EPIDEMIOL, V179, P373, DOI 10.1093/aje/kwt251; Fernandez-Nino JA, 2016, BIOMEDICA, V36, P188, DOI 10.7705/biomedica.v36i2.2710; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Garcia R, 2009, ANN IEEE SYM FIELD P, P243, DOI 10.1109/FCCM.2009.45; Gunn JM, 2012, SOC PSYCH PSYCH EPID, V47, P175, DOI 10.1007/s00127-010-0330-z; Hansen AY, 2015, CURR OBES REP, V4, P484, DOI 10.1007/s13679-015-0180-9; Hernandez R, 2015, J AGING HEALTH, V27, P551, DOI 10.1177/0898264314553211; Hirsch JA, 2016, ENVIRON BEHAV, V48, P55, DOI 10.1177/0013916515607312; Hirsch JA, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-51; Hybels CF, 2006, AM J GERIAT PSYCHIAT, V14, P498, DOI 10.1097/01.JGP.0000194649.49784.29; Instituto Nacional de Salud Publica, 2014, WAV 1 MEX NAT REP, DOI [10.3886/ICPSR28502.v2, DOI 10.3886/ICPSR28502.V2]; Ivey SL, 2015, AGING MENT HEALTH, V19, P713, DOI 10.1080/13607863.2014.962006; Kim D, 2008, EPIDEMIOL REV, V30, P101, DOI 10.1093/epirev/mxn009; Koike Quintanar SA, 2014, NEIGHBORHOOD EFFECTS; Kowal P, 2010, SOCIAL NETWORKS HLTH; Kowal P, 2012, WHO STUDY GLOBAL AGE; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Kruger DJ, 2007, AM J COMMUN PSYCHOL, V40, P261, DOI 10.1007/s10464-007-9139-7; Kubzansky LD, 2005, AM J EPIDEMIOL, V162, P253, DOI 10.1093/aje/kwi185; Loukopoulos P., 2005, FUTURE URBAN SUSTAIN; MacMillan F, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020217; Martin DG, 2003, URBAN GEOGR, V24, P361, DOI 10.2747/0272-3638.24.5.361; Matheson FI, 2006, SOC SCI MED, V63, P2604, DOI 10.1016/j.socscimed.2006.07.001; Miles R, 2012, J URBAN HEALTH, V89, P1, DOI 10.1007/s11524-011-9621-2; Moore KA, 2016, J URBAN HEALTH, V93, P572, DOI 10.1007/s11524-016-0042-0; Nieuwenhuijsen MJ, 2016, ENVIRON INT, V94, P251, DOI 10.1016/j.envint.2016.05.032; Oliver LN, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-41; Organizacion Mundial de la Salud (OMS), 2015, SAL VEJ INF MUND ENV, P45; Ouari O, 2011, ELECTRON PARAMAG RES, V22, P1, DOI 10.1039/9781849730877-00001; Oxley JA, 1999, P ANN C ASS, P279; Park RE, 1915, AM J SOCIOL, V20, P577, DOI 10.1086/212433; Putnam R., 1993, AM PROSPECT, V13, P35, DOI DOI 10.1287/mnsc.1120.1644; Ramlagan S, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-100; Reinikka R, 2012, AFR HUM DEV SER, P19; Rodda J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5219; Rojas Valdes RI, 2017, NEIGHBORHOOD EFFECTS; Ross CE, 2001, J HEALTH SOC BEHAV, V42, P258, DOI 10.2307/3090214; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Sabatini F., 2006, SOCIAL SPATIAL SEGRE; Sampson RJ, 2002, ANNU REV SOCIOL, V28, P443, DOI 10.1146/annurev.soc.28.110601.141114; Sampson RJ, 2003, NEIGHBORHOODS HLTH, P132, DOI DOI 10.1093/ACPROF:OSO/9780195138382.003.0006; Sastry N, 2002, LABOR POPULATION WOR, DOI [10.1016/S0021-8693(02)00518-5, DOI 10.1016/S0021-8693(02)00518-5]; Scanlin K, 2014, J PHYS ACT HEALTH, V11, P1085, DOI 10.1123/jpah.2012-0224; Schmidt N.M., 2018, NEIGHBORHOODS HLTH, P155; Soni N, 2016, LAND USE POLICY, V57, P139, DOI 10.1016/j.landusepol.2016.05.009; Stafford M, 2005, SOC SCI MED, V60, P1681, DOI 10.1016/j.socscimed.2004.08.028; Szarata A, 2017, TRANSP RES PROC, V27, P752, DOI 10.1016/j.trpro.2017.12.018; Talen E., 2013, INT J SUSTAINABLE LA, V1, P42; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Weisenbach SL, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0463-y; Wilson-Genderson M, 2013, SOC SCI MED, V85, P43, DOI 10.1016/j.socscimed.2013.02.028; World Health Organization, 2016, WAVE, V2; World Health Organization, 2012, WAVE, V1; Yen IH, 2009, AM J PREV MED, V37, P455, DOI 10.1016/j.amepre.2009.06.022; Yousefian A, 2010, PREV MED, V50, pS86, DOI 10.1016/j.ypmed.2009.08.018; Yu R, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101199; Zegeer C.V., 1996, PEDESTRIAN BICYCLE O, V27, DOI [DOI 10.1016/0022-4375(96)86965-9, 10.1016/0022-4375(96)86965-9]	73	8	8	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219540	10.1371/journal.pone.0219540	http://dx.doi.org/10.1371/journal.pone.0219540			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4JZ	31291353	gold, Green Submitted, Green Published			2022-12-26	WOS:000484947800108
J	Krishnan, SG; Fun, WH; Ramadras, MD; Yunus, R; Lye, YF; Sararaks, S				Krishnan, Sheila Gopal; Fun, Weng Hong; Ramadras, Malini Devi; Yunus, Rahmah; Lye, Yik Fan; Sararaks, Sondi			Pertussis clinical case definition: Time for change in developing countries?	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; HOSPITALIZED INFANTS; CHILDREN; PARAPERTUSSIS; SENSITIVITY; INFECTIONS; RESURGENCE; DIAGNOSIS; FEATURES; VACCINE	Background Developing countries still struggle with late detection and mortality from pertussis. A review of clinical case definitions is necessary for early disease detection. This paper aimed to study possible clinical characteristics for earlier pertussis detection in a sporadic setting. Methods We conducted a retrospective review of medical and laboratory records in a general paediatric ward of a district hospital in a developing country. Inclusion criteria were all children hospitalised with nasopharyngeal swab taken for Bordetella pertussis. We compared sensitivity and specificity of World Health Organization diagnostic criteria with other clinical characteristics. Polymerase chain reaction Bordetella pertussis was the gold standard used. Results Out of 207 eligible admissions, the study retrieved 128 complete records. Approximately half of the children were less than 3 months old. The World Health Organization diagnostic criteria had a low sensitivity (15%), but high specificity (92%). In comparison, combinations that included paroxysmal cough, ill contact and facial congestion had higher sensitivity. Increasing cough duration improved specificity while compromising sensitivity. Conclusion Several clinical characteristics such as paroxysmal cough, facial congestion and a history of ill contact have potential for early clinical detection. Conventional emphasis on cough duration may hamper early detection.	[Krishnan, Sheila Gopal; Ramadras, Malini Devi; Yunus, Rahmah; Lye, Yik Fan] Hosp Kulim, Dept Paediat, Kedah, Malaysia; [Fun, Weng Hong; Sararaks, Sondi] Inst Hlth Syst Res, Ctr Hlth Outcomes Res, Selangor, Malaysia; [Krishnan, Sheila Gopal] Hosp Manjung, Dept Paediat, Perak, Malaysia		Fun, WH (corresponding author), Inst Hlth Syst Res, Ctr Hlth Outcomes Res, Selangor, Malaysia.	funwenghong@yahoo.co.uk	Sararaks, Sondi/AAI-9784-2021	Sararaks, Sondi/0000-0002-2180-3166	Ministry of Health Malaysia	Ministry of Health Malaysia	This project was funded by the Ministry of Health Malaysia. The funder had no role in study design, data collection, analysis, decision to publish, preparation or review of the manuscript.; We thank the Director-General of Health Malaysia for permission to publish this paper. We express our deepest gratitude to Dato' Dr HSS Amar Singh, Head, Clinical Research Centre, Hospital Ipoh, Perak and Ms Chiew Shoen Chuen, clinical pharmacist, Clinical Research Centre Hospital Manjung for their guidance and invaluable support. We thank Dr Fauziah Abdul Wahab, Hospital Kulim Director and Dr Zainab Ishak, Head of Paediatric Department for their leadership, support and commitment as well as Dr. Wan Noraini Wan Yussof, Head of Bacteriology Section, National Public Health Laboratory for providing us with the summary of laboratory method for PCRBp. The authors thank all personnel instrumental in data collection.	[Anonymous], 2014, Wkly Epidemiol Rec, V89, P337; Baptista Paulo N, 2007, BMC Pediatr, V7, P21, DOI 10.1186/1471-2431-7-21; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Centers for Disease Control and Prevention, 2017, PERT WHOOP COUGH SIG; Centers for Disease Control and Prevention, 2017, PERT WHOOP COUGH DIS; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Cherry JD, 2012, CLIN INFECT DIS, V54, P1756, DOI 10.1093/cid/cis302; Crespo I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139993; Crowcroft NS, 2003, ARCH DIS CHILD, V88, P802, DOI 10.1136/adc.88.9.802; Desjardins M, 2018, Can Commun Dis Rep, V44, P190, DOI [10.14745/ccdr.v44i09a01, 10.14745/ccdr.44i09a01]; Ebell MH, 2017, J AM BOARD FAM MED, V30, P308, DOI 10.3122/jabfm.2017.03.160330; Glanz JM, 2013, JAMA PEDIATR, V167, P1060, DOI 10.1001/jamapediatrics.2013.2353; Halperin SA, 1999, CLIN INFECT DIS, V28, P1238, DOI 10.1086/514792; Jogi P, 2018, INFECTION, V46, P83, DOI 10.1007/s15010-017-1095-z; Kent A, 2014, MEDICINE, V42, P8, DOI [10.1016/j.mpmed.2013.10, DOI 10.1016/J.MPMED.2013.10]; Kimberlin DWBM, 2018, REPORT COMMITTEE INF; King AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066150; Lissauer T, 2012, ILLUSTRATED TXB PAED, V4th; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Ministry of Health Malaysia, 2014, MAL STAT MED 2009 20; Ministry of Health Malaysia, 2013, HLTH IND 2013 IND MO, P209; Ministry of Health Malaysia, 2010, CAS INV OUTBR MAN HE; Ministry of Health Malaysia, 2012, HLTH IND 2012 IND MO, P197; Ministry of Railways of the People's Republic of China, 2013, HIGH SPEED RAILWAY B, P20; Muloiwa R, 2014, INT J INFECT DIS, V21, P150, DOI 10.1016/j.ijid.2014.03.736; National Public Health Laboratory, 2016, MKAK SERV HDB 2016; PATRIARCA PA, 1988, AM J PUBLIC HEALTH, V78, P833, DOI 10.2105/AJPH.78.7.833; Rezal RS, 2015, EXPERT REV ANTI-INFE, V13, P1547, DOI 10.1586/14787210.2015.1085303; Riise OR, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0487-4; Shapiro ED, 2012, JAMA-J AM MED ASSOC, V308, P2149, DOI 10.1001/jama.2012.65031; Shojaei J, 2014, ANN MED HEALTH SCI R, V4, P910, DOI 10.4103/2141-9248.144911; Sivasampu S, 2017, NATL MED CARE STAT P; Tan Tina, 2005, Pediatr Infect Dis J, V24, pS10, DOI 10.1097/01.inf.0000160708.43944.99; VESSELINOVAJENKINS CK, 1978, J EPIDEMIOL COMMUN H, V32, P194, DOI 10.1136/jech.32.3.194; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; World Health Organisation, 2008, WHO REC STAND SURV S; Zouari A, 2012, DIAGN MICR INFEC DIS, V72, P303, DOI 10.1016/j.diagmicrobio.2012.01.002	37	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219534	10.1371/journal.pone.0219534	http://dx.doi.org/10.1371/journal.pone.0219534			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291359	gold, Green Published, Green Submitted			2022-12-26	WOS:000484947800107
J	Morishita, M; Sada, KE; Matsumoto, Y; Hayashi, K; Asano, Y; Asano, SH; Ohashi, K; Miyawaki, Y; Katsuyama, E; Watanabe, H; Kawabata, T; Wada, J				Morishita, Michiko; Sada, Ken-Ei; Matsumoto, Yoshinori; Hayashi, Keigo; Asano, Yosuke; Asano, Sumie Hiramatsu; Ohashi, Keiji; Miyawaki, Yoshia; Katsuyama, Eri; Watanabe, Haruki; Kawabata, Tomoko; Wada, Jun			Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; CLINICAL CHARACTERISTICS; PREEMPTIVE THERAPY; RHEUMATIC-DISEASES; JAPANESE PATIENTS; SINGLE-CENTER; PREVENTION; GANCICLOVIR; PROPHYLAXIS; MANAGEMENT	Aims Cytomegalovirus (CMV) infection under immunosuppression sometimes causes death. This study aimed to elucidate risk factors for CMV infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV). Methods Patients with AAV who underwent remission induction treatment at Okayama University Hospital between 2006 and 2016 were retrospectively analyzed. The primary outcome was the development of CMV infection within 3 months. Results Of the 111 patients, 13 (11.7%) patients developed CMV infection. Patients with CMV infection were older (p = 0.030) and had a higher body mass index (p = 0.029) in comparison to those without CMV infection. A higher proportion had a severe form (p = 0.001) and granulomatosis with polyangiitis (GPA) (p = 0.001), as well as a higher Birmingham Vasculitis Activity Score (p = 0.018) and C-reactive protein (p = 0.018) levels at baseline. Using logistic regression analysis, severe form and GPA were independent risk factors (odds ratio [OR] = 9.68, 95% confidence interval [CI] = 1.92-60.23, and OR = 7.46, 95% CI = 1.46-47.60, respectively). In addition, patients with CMV infection were more likely than those without infection to be glucocorticoid-related diabetes mellitus (p = 0.025). Conclusion Our study highlights disease severity and subgroups of AAV as risk factors for CMV infection.	[Morishita, Michiko; Sada, Ken-Ei; Matsumoto, Yoshinori; Hayashi, Keigo; Asano, Yosuke; Asano, Sumie Hiramatsu; Ohashi, Keiji; Miyawaki, Yoshia; Katsuyama, Eri; Watanabe, Haruki; Kawabata, Tomoko; Wada, Jun] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan	Okayama University	Sada, KE (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan.	sadakenn@okayama-u.ac.jp	WADA, Jun/B-2023-2011; Watanabe, Haruki/HHN-1425-2022; Watanabe, Haruki/AAU-1673-2020	WADA, Jun/0000-0003-1468-5170; Watanabe, Haruki/0000-0001-7837-086X; Watanabe, Haruki/0000-0001-7837-086X; Sada, Ken-ei/0000-0003-1020-0818; Miyawaki, Yoshia/0000-0002-6981-3443				Ariza-Heredia EJ, 2014, CANCER LETT, V342, P1, DOI 10.1016/j.canlet.2013.09.004; Bruminhent J, 2015, LIVER TRANSPLANT, V21, P539, DOI 10.1002/lt.24078; Bruminhent J, 2014, WORLD J HEPATOL, V6, P370, DOI 10.4254/wjh.v6.i6.370; Charlier C, 2009, ANN RHEUM DIS, V68, P658, DOI 10.1136/ard.2008.088302; Chen Y, 2016, J CLIN VIROL, V75, P10, DOI 10.1016/j.jcv.2015.12.003; de Groot K, 2009, ANN INTERN MED, V150, P670, DOI 10.7326/0003-4819-150-10-200905190-00004; Diaz-Pedroche C, 2006, TRANSPLANTATION, V82, P30, DOI 10.1097/01.tp.0000225830.76907.d0; Feng S, 2016, TRANSPL P, V48, P2695, DOI 10.1016/j.transproceed.2016.08.015; Fernandez-Ruiz M, 2015, TRANSPL INT, V28, P1042, DOI 10.1111/tri.12586; Gujadhur A, 2014, TRANSPLANTATION, V97, pE55, DOI 10.1097/TP.0000000000000114; Hellmich B, 2007, ANN RHEUM DIS, V66, P605, DOI 10.1136/ard.2006.062711; Hjelmesaeth J, 2004, DIABETOLOGIA, V47, P1550, DOI 10.1007/s00125-004-1499-z; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jutte A, 2000, HIV Med, V1, P123, DOI 10.1046/j.1468-1293.2000.00015.x; Kitagawa K, 2016, CLIN EXP NEPHROL, V20, P703, DOI 10.1007/s10157-015-1199-7; Kronbichler A, 2015, EUR J CLIN INVEST, V45, P346, DOI 10.1111/eci.12410; Monforte V, 2005, TRANSPLANT P, V37, P4039, DOI 10.1016/j.transproceed.2005.09.141; Morton M, 2012, RHEUMATOL INT, V32, P3373, DOI 10.1007/s00296-011-2151-0; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P1827, DOI 10.1136/ard.2008.101279; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P310, DOI 10.1136/ard.2008.088096; Nomura JH, 2016, TRANSPL INFECT DIS, V18, P957, DOI 10.1111/tid.12616; Paya CV, 2002, J INFECT DIS, V185, P854, DOI 10.1086/339449; Rayes A, 2011, PEDIATR BLOOD CANCER, V56, P1140, DOI 10.1002/pbc.22938; Sada KE, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4550; Singh N, 2000, TRANSPLANTATION, V70, P717, DOI 10.1097/00007890-200009150-00002; Sridhar S, 2015, J CLIN VIROL, V65, P87, DOI 10.1016/j.jcv.2015.02.009; Takizawa Y, 2008, RHEUMATOLOGY, V47, P1373, DOI 10.1093/rheumatology/ken231; Thomasini RL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180841; Watanabe-Imai K, 2017, MOD RHEUMATOL, V27, P646, DOI 10.1080/14397595.2016.1226468; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Xue Y, 2016, CHINESE MED J-PEKING, V129, P267, DOI 10.4103/0366-6999.174490	31	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218705	10.1371/journal.pone.0218705	http://dx.doi.org/10.1371/journal.pone.0218705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291263	Green Submitted, Green Published, gold			2022-12-26	WOS:000484947800031
J	Sah, RK; Yang, A; Bah, FB; Adlat, S; Bohio, AA; Oo, ZM; Wang, CH; Myint, MZZ; Bahadar, N; Zhang, LQ; Feng, XC; Zheng, YW				Sah, Rajiv Kumar; Yang, Analn; Bah, Fatoumata Binta; Adlat, Salah; Bohio, Ameer Ali; Oo, Zin Mar; Wang, Chenhao; Myint, May Zun Zaw; Bahadar, Noor; Zhang, Luqing; Feng, Xuechao; Zheng, Yaowu			Transcriptome profiling of mouse brain and lung under Dip2a regulation using RNA-sequencing	PLOS ONE			English	Article							GENE; DROSOPHILA; EXPRESSION	Disconnected interacting protein 2 homolog A (DIP2A) is highly expressed in nervous system and respiratory system of developing embryos. However, genes regulated by Dip2a in developing brain and lung have not been systematically studied. Transcriptome of brain and lung in embryonic 19.5 day (E19.5) were compared between wild type and Dip2a(-/-) mice. An average of 50 million reads per sample was mapped to the reference sequence. A total of 214 DEGs were detected in brain (82 up and 132 down) and 1900 DEGs in lung (1259 up and 641 down). GO enrichment analysis indicated that DEGs in both Brain and Lung were mainly enriched in biological processes 'DNA-templated transcription and Transcription from RNA polymerase II promoter', 'multicellular organism development', 'cell differentiation' and 'apoptotic process'. In addition, COG classification showed that both were mostly involved in 'Replication, Recombination, and Repair', 'Signal transduction and mechanism', 'Translation, Ribosomal structure and Biogenesis' and 'Transcription'. KEGG enrichment analysis showed that brain was mainly enriched in 'Thyroid cancer' pathway whereas lung in 'Complement and Coagulation Cascades' pathway. Transcription factor (TF) annotation analysis identified Zinc finger domain containing (ZF) proteins were mostly regulated in lung and brain. Interestingly, study identified genes Skor2, Gpr3711, Runx1, Erbb3, Frmd7, Fut10, Sox11, Hapln1, Tfap2c and Plxnb3 from brain that play important roles in neuronal cell maturation, differentiation, and survival; genes Hoxa5, Eya1, Errfi1, Sox11, Shh, Igf1, Ccbe1, Crh, Fgf9, Lama5, Pdgfra, Ptn, Rbp4 and Wnt7a from lung are important in lung development. Expression levels of the candidate genes were validated by qRT-PCR. Genome wide transcriptional analysis using wild type and Dip2a knockout mice in brain and lung at embryonic day 19.5 (E19.5) provided a genetic basis of molecular function of these genes.	[Sah, Rajiv Kumar; Yang, Analn; Bah, Fatoumata Binta; Adlat, Salah; Oo, Zin Mar; Wang, Chenhao; Myint, May Zun Zaw; Bahadar, Noor; Zhang, Luqing; Feng, Xuechao; Zheng, Yaowu] Northeast Normal Univ, Sch Life Sci, Transgen Res Ctr, Changchun, Jilin, Peoples R China; [Bohio, Ameer Ali; Zhang, Luqing; Feng, Xuechao; Zheng, Yaowu] Northeast Normal Univ, Key Lab Mol Epigenet, Minist Educ, Changchun, Jilin, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Zhang, LQ; Feng, XC; Zheng, YW (corresponding author), Northeast Normal Univ, Sch Life Sci, Transgen Res Ctr, Changchun, Jilin, Peoples R China.; Zhang, LQ; Feng, XC; Zheng, YW (corresponding author), Northeast Normal Univ, Key Lab Mol Epigenet, Minist Educ, Changchun, Jilin, Peoples R China.	Zhanglq479@nenu.edu.cn; fengxc997@nenu.edu.cn; zhengyw442@nenu.edu.cn	ADLAT, SALAH/AAE-3401-2021; Bahadar, Noor/A-3832-2016	ADLAT, SALAH/0000-0001-5318-8762; feng, xuechao/0000-0003-2444-3757	National Natural Science Foundation of China [31301189, 81270953]; Natural Science Foundation of Jilin Province [20160101344JC]; Science and Technology Project of Jilin Provincial Education [JJKH20180023KJ]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province; Science and Technology Project of Jilin Provincial Education	This study was supported by 31301189 Natural National Science Foundation of China: http://www.nsfc.gov.cn/, LQZ; 81270953 National Natural Science Foundation of China: http://www.nsfc.gov.cn/, YWZ; 20160101344JC The Natural Science Foundation of Jilin Province: http://kjt.jl.gov.cn/, XCF; JJKH20180023KJ Science and Technology Project of Jilin Provincial Education: http://jyt.jl.gov.cn/, XCF. The funders had no role in study design, data collection and analysis or decision to publish.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Betts-Henderson J, 2010, HUM MOL GENET, V19, P342, DOI 10.1093/hmg/ddp500; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; CAMPOS AR, 1995, J NEUROBIOL, V28, P313, DOI 10.1002/neu.480280305; Coelho DJ, 2005, NEUROSCIENCE, V134, P907, DOI 10.1016/j.neuroscience.2005.04.060; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Egger G, 2014, NEUROGENETICS, V15, P117, DOI 10.1007/s10048-014-0394-0; El-Hashash AHK, 2011, DEV BIOL, V350, P112, DOI 10.1016/j.ydbio.2010.11.022; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; HEILIG JS, 1991, EMBO J, V10, P809, DOI 10.1002/j.1460-2075.1991.tb08013.x; Jakus Z, 2014, J EXP MED, V211, P815, DOI 10.1084/jem.20132308; Jin N, 2009, DEVELOPMENT, V136, P3347, DOI 10.1242/dev.032979; Kikkawa Y, 2006, DEV BIOL, V296, P265, DOI 10.1016/j.ydbio.2006.04.463; Kong R, 2016, AM J MED GENET B, V171, P203, DOI 10.1002/ajmg.b.32392; Kumar A, 2013, J BIOL CHEM, V288, P28859, DOI 10.1074/jbc.M113.469403; Laht P, 2015, EXP CELL RES, V335, P269, DOI 10.1016/j.yexcr.2015.05.007; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Landry-Truchon K, 2017, J EXP BIOL, V220, P4571, DOI 10.1242/jeb.165084; Li H., 2018, J TRANSL NEUROSCI, V3, P4, DOI [10.21767/2573-5349.100017, DOI 10.21767/2573-5349.100017]; Lin L, 2011, DEV DYNAM, V240, P52, DOI 10.1002/dvdy.22489; Long KR, 2018, NEURON, V99, P702, DOI 10.1016/j.neuron.2018.07.013; Maden M, 2004, CURR TOP DEV BIOL, V61, P153, DOI 10.1016/S0070-2153(04)61007-6; Marazziti D, 2013, P NATL ACAD SCI USA, V110, P16486, DOI 10.1073/pnas.1314819110; Muglia LJ, 1999, AM J RESP CELL MOL, V20, P181, DOI 10.1165/ajrcmb.20.2.3381; Mukhopadhyay M, 2002, GENE, V293, P59, DOI 10.1016/S0378-1119(02)00694-7; Newman Donna R., 2010, P AM THORACIC SOC, P7; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; STELLER H, 1987, CELL, V50, P1139, DOI 10.1016/0092-8674(87)90180-2; Tanaka M, 2010, FEBS J, V277, P4278, DOI 10.1111/j.1742-4658.2010.07816.x; Wang BP, 2011, DEVELOPMENT, V138, P4487, DOI 10.1242/dev.067264; Wang Zhan-shan, 2018, Huanjing Kexue, V39, P1, DOI 10.13227/j.hjkx.201705276; Weng TT, 2009, J BIOL CHEM, V284, P28021, DOI 10.1074/jbc.M109.052530; Yin YJ, 2011, DEVELOPMENT, V138, P3169, DOI 10.1242/dev.065110; Yoshikawa M, 2007, DEV BIOL, V303, P663, DOI 10.1016/j.ydbio.2006.12.007; Yu Hongwei, 2004, BMC Developmental Biology, V4; Zhang D, 2015, NANOSCALE RES LETT, V10, P1, DOI 10.1186/s11671-014-0718-x; Zhang L., 2015, PLOS ONE, V10; Zhu YZ, 2012, INT J MOL SCI, V13, P15767, DOI 10.3390/ijms131215767	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0213702	10.1371/journal.pone.0213702	http://dx.doi.org/10.1371/journal.pone.0213702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291246	gold, Green Submitted, Green Published			2022-12-26	WOS:000484947800006
J	Stennett-Brown, RK; Stephenson, TS; Taylor, MA				Stennett-Brown, Roxann K.; Stephenson, Tannecia S.; Taylor, Michael A.			Caribbean climate change vulnerability: Lessons from an aggregate index approach	PLOS ONE			English	Article							ISLAND DEVELOPING STATES; MODEL	The study examines the potential influence of sub-regional variations in climate, and specifically heavy rain events, in determining relative vulnerabilities of locations in twelve Caribbean countries. An aggregate vulnerability index, referred to as the Caribbean Vulnerability Score (CVS), is created using historical demographic and socioeconomic data and climate data representing extreme rain events. Four scenarios are explored. Firstly, comparative vulnerabilities are determined when heavy rainfall is incorporated in CVS versus when it is excluded. The impact of climate change is also investigated using future climate data derived from statistical downscaling but holding demographic and socioeconomic sub-indices constant. The analysis is repeated with projections of future demographic structure from the Shared Socioeconomic Pathway data (SSP3), future climate projections and constant socioeconomic. Finally, the sensitivity of the results is examined with respect to applying different weights i.e. versus using equal weights for the climate and non-climatic components of CVS as is done for the first three scenarios. Results suggest that the inclusion of historical susceptibility to rainfall extremes influences relative vulnerabilities within the Caribbean when compared to the rankings of vulnerability derived using only socioeconomic and demographic inputs. In some cases significant increases in relative rankings are noted. Projected changes in the intensity of rain events across the Caribbean region in the 2030s and 2050s, do not significantly alter the top and lowest ranked vulnerable locations when demographic and socioeconomic indices are held constant. Changes may however occur in the order of the top ranked locations dependent on scenario and time slice. In general, future shifts in relative vulnerabilities were found to be dependent on (i) changes in both future climate and demographic scenarios, (ii) the time horizons being considered, and (iii) the weighting assigned to climate in the future.	[Stennett-Brown, Roxann K.; Stephenson, Tannecia S.; Taylor, Michael A.] Univ West Indies, Dept Phys, Mona, Jamaica; [Stennett-Brown, Roxann K.] Univ West Indies, Fac Engn, Mona, Jamaica	University West Indies Mona Jamaica; University West Indies Mona Jamaica	Stennett-Brown, RK (corresponding author), Univ West Indies, Dept Phys, Mona, Jamaica.; Stennett-Brown, RK (corresponding author), Univ West Indies, Fac Engn, Mona, Jamaica.	roxann.stennett02@uwimona.edu.jm			Investment Plan for the Caribbean Regional Track of the Pilot Programme for Climate Resilience (PPCR) through the Inter-American Development Bank [RG-T2255]; University of the West Indies (UWI) Mona Campus; Climate Investment Fund through the Inter-American Development Bank; Caribbean Catastrophe Risk Insurance Facility (CCRIF); The Investment Plan for the Caribbean Regional Track of the Pilot Programme for Climate Resilience (PPCR); University of the West Indies Mona Campus	Investment Plan for the Caribbean Regional Track of the Pilot Programme for Climate Resilience (PPCR) through the Inter-American Development Bank; University of the West Indies (UWI) Mona Campus; Climate Investment Fund through the Inter-American Development Bank; Caribbean Catastrophe Risk Insurance Facility (CCRIF); The Investment Plan for the Caribbean Regional Track of the Pilot Programme for Climate Resilience (PPCR); University of the West Indies Mona Campus	This research was facilitated through funding received from the Investment Plan for the Caribbean Regional Track of the Pilot Programme for Climate Resilience (PPCR) provided through the Inter-American Development Bank. MT was the recipient of this grant. The grant number is RG-T2255. URL of PPCR https://ppcrja.org.jm/project/investment-plan-for-the-caribbean-regional-track/. RSB received an internship scholarship and a University Postgraduate Scholarship from The Caribbean Catastrophe Risk Insurance Facility (CCRIF) and the The University of the West Indies (UWI) Mona Campus respectively, which provided support in the initial stages of this study. URL of CCRIF: https://www.ccrif.org/content/regional-internship-programme.URL of UWI: https://www.mona.uwi.edu/postgrad/scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was facilitated through funding received from The Investment Plan for the Caribbean Regional Track of the Pilot Programme for Climate Resilience (PPCR). The PPCR is executed by the Mona Office for Research and Innovation at the University of the West Indies with grant funding from the Climate Investment Fund through the Inter-American Development Bank.; Our gratitude is extended to The University of the West Indies Mona Campus for funding received through a University Postgraduate Scholarship. We also express thanks to The Caribbean Catastrophe Risk Insurance Facility (CCRIF) for funding received to aid this study.	Acevedo S., 2016, 16199 IMF; [Anonymous], 2014, VULN IND CLIM CHANG; [Anonymous], 2001, GLOB ENV CHANG PART, DOI [10.1016/S1464-2867(01)00018-3, DOI 10.1016/S1464-2867(01)00018-3]; [Anonymous], 2014, CLIM CHANG 2014 IMP; Atkins JP., 2000, COMMONWEALTH VULNERA, DOI [10.14217/9781848597167-en, DOI 10.14217/9781848597167-EN]; BRIGUGLIO L, 1995, WORLD DEV, V23, P1615, DOI 10.1016/0305-750X(95)00065-K; Campbell JD, 2011, INT J CLIMATOL, V31, P1866, DOI 10.1002/joc.2200; Ganase SA, 2011, 42 43 ANN C MON STUD; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Guillaumont P, 2010, J DEV STUD, V46, P828, DOI 10.1080/00220381003623814; Hall TC, 2013, THEOR APPL CLIMATOL, V113, P271, DOI 10.1007/s00704-012-0779-7; Inter-American Development Bank, 2011, IDBTN790; Inter-American Development Bank, 2010, IDBTN790; Jones PD, 2016, INT J CLIMATOL, V36, P4141, DOI 10.1002/joc.4624; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Karmalkar AV, 2013, ATMOSFERA, V26, P283, DOI 10.1016/S0187-6236(13)71076-2; McLean NM, 2015, ADV METEOROL, V2015, P18; McSweeney C, 2010, B AM METEOROL SOC, V91, P157, DOI 10.1175/2009BAMS2826.1; McSweeney C., 2010, UNDP CLIMATE CHANGE; Nakaegawa T, 2014, THEOR APPL CLIMATOL, V116, P155, DOI 10.1007/s00704-013-0934-9; Peterson TC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002251; Rao CAR, 2016, CURR SCI INDIA, V110, P1939, DOI 10.18520/cs/v110/i10/1939-1946; Rhiney K, 2015, GEOGR COMPASS, V9, P97, DOI 10.1111/gec3.12199; Riahi K, 2017, GLOBAL ENVIRON CHANG, V42, P153, DOI 10.1016/j.gloenvcha.2016.05.009; Simpson M.C., 2010, QUANTIFICATION MAGNI; SOPAC, 2005, BUILD RES SIDS ENV V; Stennett-Brown RK, 2017, INT J CLIMATOL, V37, P4828, DOI 10.1002/joc.5126; Stephenson TS, 2014, INT J CLIMATOL, V34, P2957, DOI 10.1002/joc.3889; Tank AMGK, 2009, GUIDELINES ANAL EXTR; Taylor MA, 2012, CARIBBEAN STUD, V40, P169, DOI DOI 10.1353/crb.2012.0020; Taylor MA, 2018, J CLIMATE, V31, P2907, DOI [10.1175/JCLI-D-17-0074.1, 10.1175/jcli-d-17-0074.1]; Taylor MA, 2013, B AM METEOROL SOC, V94, P1065, DOI 10.1175/BAMS-D-11-00235.1; Wilby RL, 2002, ENVIRON MODELL SOFTW, V17, P147; World Bank, 2010, 70108 WORLD BANK; Yusuf A, 2009, EEPSEA SPECIAL TECHN	35	16	16	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219250	10.1371/journal.pone.0219250	http://dx.doi.org/10.1371/journal.pone.0219250			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291297	gold, Green Submitted, Green Published			2022-12-26	WOS:000484947800061
J	Ryser, S; Tenorio, E; Estelles, A; Kauvar, LM				Ryser, Stefan; Tenorio, Edgar; Estelles, Angeles; Kauvar, Lawrence M.			Human antibody repertoire frequently includes antibodies to a bacterial biofilm associated protein	PLOS ONE			English	Article							ORGANIZATION; MECHANISM	We have previously described a native human monoclonal antibody, TRL1068, that disrupts bacterial biofilms by extracting from the biofilm matrix key scaffolding proteins in the DNABII family, which are present in both gram positive and gram negative bacterial species. The antibiotic resistant sessile bacteria released from the biofilm then revert to the antibiotic sensitive planktonic state. Qualitative resensitization to antibiotics has been demonstrated in three rodent models of acute infections. We report here the surprising discovery that antibodies against the target family were found in all twenty healthy humans surveyed, albeit at a low level requiring a sensitive single B-cell assay for detection. We have cloned 21 such antibodies. Aside from TRL1068, only one (TRL1330) has all the biochemical properties believed necessary for pharmacological efficacy (broad spectrum epitope specificity and high affinity). We suggest that the other anti-DNABII antibodies, while not necessarily curative, reflect an immune response at some point in the donor's history to these components of biofilms. Such an immune response could reflect exposure to bacterial reservoirs that have been previously described in chronic non-healing wounds, periodontal disease, chronic obstructive pulmonary disease, colorectal cancer, rheumatoid arthritis, and atherosclerotic artery explants. The detection of anti-DNABII antibodies in all twenty surveyed donors with no active infection suggests that bacterial biofilm reservoirs may be present periodically in most healthy individuals. Biofilms routinely shed bacteria, creating a continuous low level inflammatory stimulus. Since chronic subclinical inflammation is thought to contribute to most aging-related diseases, suppression of bacterial biofilm has potential value in delaying age-related pathology.	[Ryser, Stefan; Tenorio, Edgar; Estelles, Angeles; Kauvar, Lawrence M.] Trellis Biosci LLC, Redwood City, CA 94062 USA		Kauvar, LM (corresponding author), Trellis Biosci LLC, Redwood City, CA 94062 USA.	lkauvar@trellisbio.com		Kauvar, Lawrence/0000-0002-7742-267X	Trellis Bioscience LLC; SBIR grant from US National Institute of Allergy and Infectious Diseases [5SB1AI120425-04]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SB1AI120425] Funding Source: NIH RePORTER	Trellis Bioscience LLC; SBIR grant from US National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All authors are employees or consultants with an equity interest in Trellis Bioscience LLC, which funded the study. The funder thereby had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. Further, the funder has an issued US Patent (#10,233,234) on TRL1068 that is discussed in the manuscript, for which an IND is projected in the first half of 2020. Partial support was provided from an SBIR grant from US National Institute of Allergy and Infectious Diseases to LK: 5SB1AI120425-04, https://sbir.nih.gov/niaid/index.; All authors are employees or consultants with an equity interest in Trellis Bioscience LLC, which funded the study. Partial support was provided from an SBIR grant from US National Institute of Allergy and Infectious Diseases: 5SB1AI120425-04.	Ahearn CP, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx042; Bjarnsholt T, 2013, APMIS, V121, P1, DOI 10.1111/apm.12099; Brockson ME, 2014, MOL MICROBIOL, V93, P1246, DOI 10.1111/mmi.12735; Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111; Devaraj A, 2015, MOL MICROBIOL, V96, P1119, DOI 10.1111/mmi.12994; Emerenini BO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132385; Estelles A, 2016, ANTIMICROB AGENTS CH, V60, P2292, DOI 10.1128/AAC.02588-15; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Goodman SD, 2011, MUCOSAL IMMUNOL, V4, P625, DOI 10.1038/mi.2011.27; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Harriman WD, 2009, J IMMUNOL METHODS, V341, P135, DOI 10.1016/j.jim.2008.11.009; Jiao YQ, 2011, APPL ENVIRON MICROB, V77, P5230, DOI 10.1128/AEM.03005-10; Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08; Lanter BB, 2015, INFECT IMMUN, V83, P3960, DOI 10.1128/IAI.00510-15; Lanter BB, 2014, MBIO, V5, DOI 10.1128/mBio.01206-14; Lebeaux D, 2013, PATHOGENS, V2, P288, DOI 10.3390/pathogens2020288; Li B, 2017, MOLECULES, V22, DOI DOI 10.1002/J0R.23656; Liu D, 2008, CELL MICROBIOL, V10, P262, DOI 10.1111/j.1462-5822.2007.01040.x; Loyola-Rodriguez JP, 2010, J ORAL MICROBIOL, V2, P1; O'Donovan A, 2011, AGING BODY COMPOSITI, V6, P19687, DOI DOI 10.1371/J0URNAL.P0NE.0019687; Ortiz P, 2009, J PERIODONTOL, V80, P535, DOI 10.1902/jop.2009.080447; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; SEGALL AM, 1994, EMBO J, V13, P4536, DOI 10.1002/j.1460-2075.1994.tb06775.x; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Turnbull L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11220; van Leeuwen M, 2008, ARTERIOSCL THROM VAS, V28, P84, DOI 10.1161/ATVBAHA.107.154807; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Xiong YQ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00904-17; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004	30	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219256	10.1371/journal.pone.0219256	http://dx.doi.org/10.1371/journal.pone.0219256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287831	gold, Green Published, Green Submitted			2022-12-26	WOS:000482328300012
J	Akata, K; Muratani, T; Yatera, K; Naito, K; Noguchi, S; Yamasaki, K; Kawanami, T; Kido, T; Mukae, H				Akata, Kentaro; Muratani, Tetsuro; Yatera, Kazuhiro; Naito, Keisuke; Noguchi, Shingo; Yamasaki, Kei; Kawanami, Toshinori; Kido, Takashi; Mukae, Hiroshi			Induction of plasmid-mediated AmpC beta-lactamase DHA-1 by piperacillin/tazobactam and other beta-lactams in Enterobacteriaceae	PLOS ONE			English	Article							RESISTANCE; PENICILLINS; EXPRESSION; MORGANII	Chromosomal AmpC beta-lactamase induction by several types of beta-lactams has been reported, but not enough data are available on DHA-1 beta-lactamase, a plasmid-mediated AmpC beta-lactamase. Therefore, we evaluated the DHA-1 beta-lactamase induction by various antibiotics including piperacillin/tazobactam (PIP/TZB) in this study. Six strains (Enterobacter cloacae 2 strains, Citrobacter freundii 1 strain, Serratia marcescens 2 strain, and Morganella morganii 1 strain) possessing chromosomal inducible AmpC beta-lactamase were used as controls. Four strains (Escherichia coli 2 strains, Klebsiella pneumoniae 1 strain, and C. koseri 1 strain) possessing DHA-1 beta-lactamase were used. The beta-lactamase activities were determined by a spectrophotometer using nitrocefin. beta-lactamase induction by PIP, PIP/TZB was not observed in any strains and beta-lactamase induction by third- and fourth-generation cephems was not observed in most strains. The induction ratios of the chromosomal AmpC beta-lactamase in the reference group by PIP/TZB were <1.51, and those of the DHA-1 beta-lactamase were <1.36, except for K. pneumoniae Rkp2004 (2.22). The beta-lactamase induction by first- and second-generation cephems, flomoxef, and carbapenem differed in each strain. Cefmetazole (CMZ) strongly induced beta-lactamase. This study demonstrated that the induction of DHA-1 beta-lactamase was similar to that of chromosomal AmpC using various Enterobacteriaceae, although the induction of beta-lactamase in both groups by PIP/TZB was low. We also reported that the induction of PIP/TZB, a beta-lactamase inhibitor combination antibiotic, against various AmpC-producing Enterobacteriaceae, including DHA-1 producers, was low.	[Akata, Kentaro; Yatera, Kazuhiro; Naito, Keisuke; Noguchi, Shingo; Yamasaki, Kei; Kawanami, Toshinori; Kido, Takashi] Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka, Japan; [Muratani, Tetsuro] Kyurin Med Lab, Dept Clin Microbiol, Kitakyushu, Fukuoka, Japan; [Mukae, Hiroshi] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki, Nagasaki, Japan	University of Occupational & Environmental Health - Japan; Nagasaki University	Yatera, K (corresponding author), Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka, Japan.	yatera@med.uoeh-u.ac.jp		Yatera, Kazuhiro/0000-0002-2955-4432				AKOVA M, 1990, J ANTIMICROB CHEMOTH, V25, P199, DOI 10.1093/jac/25.2.199; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Barnaud G, 1998, ANTIMICROB AGENTS CH, V42, P2352, DOI 10.1128/AAC.42.9.2352; Bauernfeind A, 1997, ANTIMICROB AGENTS CH, V41, P2041, DOI 10.1128/AAC.41.9.2041; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Clinical Laboratory Standard Institute, 2015, M07A10 CLIN LAB STAN, VTwelfth; Dietz H, 1997, ANTIMICROB AGENTS CH, V41, P2113, DOI 10.1128/AAC.41.10.2113; GOOTZ TD, 1983, ANTIMICROB AGENTS CH, V23, P91, DOI 10.1128/AAC.23.1.91; Hanson ND, 1999, CURR PHARM DESIGN, V5, P881; Hennequin C, 2018, J ANTIMICROB CHEMOTH, V73, P2981, DOI 10.1093/jac/dky285; Jacobs C, 1997, CELL, V88, P823, DOI 10.1016/S0092-8674(00)81928-5; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Kadima TA, 1997, ANTIMICROB AGENTS CH, V41, P2177, DOI 10.1128/AAC.41.10.2177; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; MINAMI S, 1983, J ANTIBIOT, V36, P1387, DOI 10.7164/antibiotics.36.1387; MINAMI S, 1980, ANTIMICROB AGENTS CH, V18, P382, DOI 10.1128/AAC.18.3.382; Muratani T, 2006, INT J ANTIMICROB AG, V27, P491, DOI 10.1016/j.ijantimicag.2006.03.007; Philippon A, 2002, ANTIMICROB AGENTS CH, V46, P1, DOI 10.1128/AAC.46.1.1-11.2002; Poirel L, 1999, ANTIMICROB AGENTS CH, V43, P769, DOI 10.1128/AAC.43.4.769; SANDERS CC, 1987, ANNU REV MICROBIOL, V41, P573, DOI 10.1146/annurev.mi.41.100187.003041; SYKES R B, 1976, Journal of Antimicrobial Chemotherapy, V2, P115, DOI 10.1093/jac/2.2.115; Trepanier S, 1997, ANTIMICROB AGENTS CH, V41, P2399, DOI 10.1128/AAC.41.11.2399; WEBER DA, 1990, ANTIMICROB AGENTS CH, V34, P156, DOI 10.1128/AAC.34.1.156; YAGINUMA S, 1974, JPN J MICROBIOL, V18, P113, DOI 10.1111/j.1348-0421.1974.tb00798.x; Yamasaki K, 2010, J CLIN MICROBIOL, V48, P3267, DOI 10.1128/JCM.02111-09	25	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0218589	10.1371/journal.pone.0218589	http://dx.doi.org/10.1371/journal.pone.0218589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283769	Green Published, gold, Green Submitted			2022-12-26	WOS:000484939800009
J	Kawanishi, Y; Yoshioka, E; Sago, Y; Itoh, T; Miyamoto, T; Sengoku, K; Ito, Y; Ito, S; Miyashita, C; Araki, A; Endo, T; Cho, K; Minakami, H; Kishi, R; Kawamoto, T; Saito, H; Kishi, R; Yaegashi, N; Hashimoto, K; Mori, C; Ito, S; Yamagata, Z; Inadera, H; Kamijima, M; Nakayama, T; Iso, H; Shima, M; Hirooka, Y; Suganuma, N; Kusuhara, K; Katoh, T				Kawanishi, Yasuyuki; Yoshioka, Eiji; Sago, Yasuaki; Itoh, Toshihiro; Miyamoto, Toshinobu; Sengoku, Kazuo; Ito, Yoshiya; Ito, Sachiko; Miyashita, Chihiro; Araki, Atsuko; Endo, Toshiaki; Cho, Kazutoshi; Minakami, Hisanori; Kishi, Reiko; Kawamoto, Toshihiro; Saito, Hirohisa; Kishi, Reiko; Yaegashi, Nobuo; Hashimoto, Koichi; Mori, Chisato; Ito, Shuichi; Yamagata, Zentaro; Inadera, Hidekuni; Kamijima, Michihiro; Nakayama, Takeo; Iso, Hiroyasu; Shima, Masayuki; Hirooka, Yasuaki; Suganuma, Narufumi; Kusuhara, Koichi; Katoh, Takahiko		Japan Environm Childrens Study Grp	The relationship between prenatal psychological stress and placental abruption in Japan, The Japan Environment and Children's Study (JECS)	PLOS ONE			English	Article							MENTAL-HEALTH; PANIC-ATTACK; PREGNANCY; PERFORMANCE; DISORDERS; RISK; ANXIETY; WOMEN; K10; K6	Background Prenatal psychological stress may increase the risk of placental abruption (PA). This study aimed to clarify the effects of psychological distress during pregnancy and exposure to stressful life events in the year before or during pregnancy on the occurrence of PA in Japanese women. Methods Using a nationwide prospective birth cohort study, we obtained data from 103,099 women between January 2011 and March 2014. Information on exposure to 14 stressful life events and psychological distress (Kessler 6 scale) was collected using a self-administered questionnaire during pregnancy. Clinical diagnoses of PA were obtained from medical records. A total of 80,799 women with singleton births were analyzed using logistic regression models that adjusted for possible confounders. Results PA was diagnosed in 335 (0.4%) women. There was no significant difference in the Kessler 6 score during pregnancy between the PA group and non-PA group. Exposure to the death of a child in the year before or during pregnancy was significantly associated with PA in multigravid women (adjusted odds ratio [aOR] 3.57; 95% confidence interval [CI] 1.50-8.34). A spouse's loss of employment was significantly associated with PA in parous women (aOR 3.25; 95% CI 1.40-7.56). Conclusions This study identified the possible effects of exposure to the death of a child on PA occurrence that adjusted for important confounding factors.	[Kawanishi, Yasuyuki; Yoshioka, Eiji; Sago, Yasuaki] Asahikawa Med Univ, Dept Social Med, Asahikawa, Hokkaido, Japan; [Kawanishi, Yasuyuki] Doshisha Univ, Ctr Baby Sci, Kyoto, Japan; [Kawanishi, Yasuyuki] Nagaoka Healthcare Ctr, Kyoto, Japan; [Itoh, Toshihiro] Asahikawa Med Univ, Dept Nursing, Lab Publ Hlth, Asahikawa, Hokkaido, Japan; [Miyamoto, Toshinobu; Sengoku, Kazuo] Asahikawa Med Univ, Dept Obstet & Gynecol, Asahikawa, Hokkaido, Japan; [Ito, Yoshiya] Japanese Red Cross Hokkaido Coll Nursing, Fac Nursing, Kitami, Hokkaido, Japan; [Ito, Sachiko; Miyashita, Chihiro; Araki, Atsuko; Kishi, Reiko] Hokkaido Univ, Ctr Environm & Hlth Sci, Sapporo, Hokkaido, Japan; [Endo, Toshiaki] Sapporo Med Univ, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan; [Cho, Kazutoshi; Minakami, Hisanori] Hokkaido Univ Hosp, Ctr Perinatal Med, Sapporo, Hokkaido, Japan; [Kawamoto, Toshihiro; Saito, Hirohisa] Natl Ctr Child Hlth & Dev, Med Support Ctr JECS, Tokyo, Japan; [Kishi, Reiko] Hokkaido Univ, Hokkaido Reg Ctr JECS, Sapporo, Hokkaido, Japan; [Yaegashi, Nobuo] Tohoku Univ, Miyagi Reg Ctr JECS, Sendai, Miyagi, Japan; [Hashimoto, Koichi] Fukushima Med Univ, Fukushima Reg Ctr JECS, Fukushima, Japan; [Mori, Chisato] Chiba Univ, Chiba Reg Ctr JECS, Chiba, Japan; [Ito, Shuichi] Yokohama City Univ, Kanagawa Reg Ctr JECS, Yokohama, Kanagawa, Japan; [Yamagata, Zentaro] Univ Yamanashi, Koshin Reg Ctr JECS, Chuo, Japan; [Inadera, Hidekuni] Univ Toyama, Toyama Reg Ctr JECS, Toyama, Japan; [Kamijima, Michihiro] Nagoya City Univ, Aichi Reg Ctr JECS, Nagoya, Aichi, Japan; [Nakayama, Takeo] Kyoto Univ, Kyoto Reg Ctr JECS, Kyoto, Japan; [Iso, Hiroyasu] Osaka Univ, Osaka Reg Ctr JECS, Suita, Osaka, Japan; [Shima, Masayuki] Hyogo Coll Med, Hyogo Reg Ctr JECS, Nishinomiya, Hyogo, Japan; [Hirooka, Yasuaki] Tottori Univ, Tottori Reg Ctr JECS, Yonago, Tottori, Japan; [Suganuma, Narufumi] Kochi Univ, Kochi Reg Ctr JECS, Nankoku, Kochi, Japan; [Kusuhara, Koichi] Univ Occupat & Environm Hlth, Fukuoka Reg Ctr JECS, Kitakyushu, Fukuoka, Japan; [Katoh, Takahiko] Kumamoto Univ, South Kyushu Okinawa Reg Ctr JECS, Kumamoto, Japan	Asahikawa Medical College; Doshisha University; Asahikawa Medical College; Asahikawa Medical College; Hokkaido University; Sapporo Medical University; Hokkaido University; National Center for Child Health & Development - Japan; Hokkaido University; Tohoku University; Fukushima Medical University; Chiba University; Yokohama City University; University of Yamanashi; University of Toyama; Nagoya City University; Kyoto University; Osaka University; Hyogo College of Medicine; Tottori University; Kochi University; University of Occupational & Environmental Health - Japan; Kumamoto University	Kawanishi, Y (corresponding author), Asahikawa Med Univ, Dept Social Med, Asahikawa, Hokkaido, Japan.; Kawanishi, Y (corresponding author), Doshisha Univ, Ctr Baby Sci, Kyoto, Japan.; Kawanishi, Y (corresponding author), Nagaoka Healthcare Ctr, Kyoto, Japan.	y-kawani@asahikavva-med.a.c.jp	Yoshioka, Eiji/AAY-5495-2020; Ikeda-Araki, Atsuko/A-4105-2012; NAKAYAMA, Takeo/HCH-0537-2022; Ito, Shuichi/AAD-1962-2022	Ikeda-Araki, Atsuko/0000-0002-3065-262X; Yoshioka, Eiji/0000-0003-3316-1057	Ministry of the Environment, the Government of Japan	Ministry of the Environment, the Government of Japan	The Japan Environment and Children's Study was funded by the Ministry of the Environment, the Government of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association (APA), 1987, DIAGNOSTIC AND STATI; Ananth CV, 1999, JAMA-J AM MED ASSOC, V282, P1646, DOI 10.1001/jama.282.17.1646; Baumann P, 2000, AM J OBSTET GYNECOL, V183, P815, DOI 10.1067/mob.2000.108847; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; Class QA, 2011, PSYCHOSOM MED, V73, P234, DOI 10.1097/PSY.0b013e31820a62ce; COHEN LS, 1989, J CLIN PSYCHIAT, V50, P266; Coussons-Read ME, 2007, BRAIN BEHAV IMMUN, V21, P343, DOI 10.1016/j.bbi.2006.08.006; CRNIC KA, 1990, CHILD DEV, V61, P1628, DOI 10.2307/1130770; de Paz NC, 2011, J AFFECT DISORDERS, V130, P280, DOI 10.1016/j.jad.2010.07.024; Elsasser DA, 2010, EUR J OBSTET GYN R B, V148, P125, DOI 10.1016/j.ejogrb.2009.10.005; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Glynn LM, 2004, J PSYCHOSOM RES, V56, P47, DOI 10.1016/S0022-3999(03)00133-8; Jablensky AV, 2005, AM J PSYCHIAT, V162, P79, DOI 10.1176/appi.ajp.162.1.79; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 1998, ARCH GEN PSYCHIAT, V55, P801, DOI 10.1001/archpsyc.55.9.801; Khashan AS, 2008, PSYCHOSOM MED, V70, P688, DOI 10.1097/PSY.0b013e318177940d; Khatun S, 2001, SEMIN THROMB HEMOST, V27, P79, DOI 10.1055/s-2001-14078; Laszlo KD, 2014, PSYCHOL MED, V44, P1855, DOI 10.1017/S0033291713002353; Laszlo KD, 2013, HYPERTENSION, V62, P183, DOI 10.1161/HYPERTENSIONAHA.111.00550; Markovitz J H, 2001, Curr Hypertens Rep, V3, P25; Matsuda Y, 2011, J OBSTET GYNAECOL RE, V37, P538, DOI 10.1111/j.1447-0756.2010.01408.x; Michikawa T, 2018, J EPIDEMIOL, V28, P99, DOI 10.2188/jea.JE20170018; Michikawa T, 2015, J EPIDEMIOL, V25, P452, DOI 10.2188/jea.JE20140186; Oyelese Y, 2006, OBSTET GYNECOL, V108, P1005, DOI 10.1097/01.AOG.0000239439.04364.9a; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Roy-Byrne PP, 2006, LANCET, V368, P1023, DOI 10.1016/S0140-6736(06)69418-X; RYDHSTROM H, 1989, J REPROD MED, V34, P901; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Tikkanen M, 2011, ACTA OBSTET GYN SCAN, V90, P140, DOI 10.1111/j.1600-0412.2010.01030.x; von Kanel R, 2001, PSYCHOSOM MED, V63, P531, DOI 10.1097/00006842-200107000-00003; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Watanabe A, 2005, PSYCHIAT CLIN NEUROS, V59, P119, DOI 10.1111/j.1440-1819.2005.01345.x	36	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219379	10.1371/journal.pone.0219379	http://dx.doi.org/10.1371/journal.pone.0219379			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4GX	31283785	gold, Green Published, Green Submitted			2022-12-26	WOS:000484939800032
J	Ranade, SS; Delhomme, N; Garcia-Gil, MR				Ranade, Sonali Sachin; Delhomme, Nicolas; Garcia-Gil, M. Rosario			Global gene expression analysis in etiolated and de-etiolated seedlings in conifers	PLOS ONE			English	Article							FAR-RED LIGHT; PHYTOCHROME-A; CHLOROPHYLL BIOSYNTHESIS; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; EXTENSION GROWTH; DE-ETIOLATION; PLANT-GROWTH; COP1; DARK	Plant life cycle begins with germination of seed below the ground. This is followed by seedling's development in the dark: skotomorphogenesis; and then a light-mediated growth: photomorphogenesis. After germination, hypocotyl grows rapidly to reach the sun, which involves elongation of shoot at the expense of root and cotyledons. Upon reaching ground level, seedling gets exposed to sunlight following a switch from the etiolated (skotomorphogenesis) to the de-etiolated (photomorphogenesis) stage, involving a series of molecular and physiological changes. Gymnosperms have evolved very differently and adopted diverse strategies as compared to angiosperms; with regards to response to light quality, conifers display a very mild high-irradiance response as compared to angiosperms. Absence of apical hook and synthesis of chlorophyll during skotomorphogenesis are two typical features in gymnosperms which differentiate them from angiosperms (dicots). Information regarding etiolation and de-etiolation processes are well understood in angiosperms, but these mechanisms are less explored in conifer species. It is, therefore, interesting to know how similar these processes are in conifers as compared to angiosperms. We performed a global expression analysis (RNA sequencing) on etiolated and de-etiolated seedlings of two economically important conifer species in Sweden to review the differentially expressed genes associated with the two processes. Based on the results, we propose that high levels of HY5 in conifers under DARK condition coupled with expression of few other genes associated with de-etiolation in angiosperms e.g. SPA, DET1 (lower expression under DARK) and CRY1 (higher expression under DARK), leads to partial expression of photomorphogenic genes in the DARK phenotype in conifers as displayed by absence of apical hook, opening of cotyledons and synthesis of chlorophyll.	[Ranade, Sonali Sachin; Delhomme, Nicolas; Garcia-Gil, M. Rosario] Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, Umea, Sweden; [Ranade, Sonali Sachin] Umea Univ, Umea Plant Sci Ctr, Dept Plant Physiol, Umea, Sweden	Swedish University of Agricultural Sciences; Umea University; Umea University	Garcia-Gil, MR (corresponding author), Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, Umea, Sweden.	m.rosario.garcia@slu.se	Delhomme, Nicolas/B-9187-2015	Delhomme, Nicolas/0000-0002-3053-0796; Garcia Gil, Rosario/0000-0002-6834-6708	Kempe Foundations [JCK-1311]; Kungl. Skogs-och Lantbruksakademien [H14-0150-ADA, KSLA-H14-0150-ADA]; Swedish Research Council; Swedish Research Council (VR); Swedish Governmental Agency for Innovation Systems (VINNOVA)	Kempe Foundations; Kungl. Skogs-och Lantbruksakademien; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council (VR)(Swedish Research Council); Swedish Governmental Agency for Innovation Systems (VINNOVA)(Vinnova)	The study was funded by a grant from The Kempe Foundations (http://www.kempe.com/index_english. html) (Grant number: JCK-1311) to RGG. The study was also funded by a grant from the Kungl. Skogs-och Lantbruksakademien (http://www.ksla.se/) (Grant number: H14-0150-ADA) to SSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Skogforsk for providing seeds and the UPSC bioinformatics facility (https://bioinfomatics.upsc.se) for technical support with regards to the RNA-Seq data pre-processing and analyses. We acknowledge the support from Science for Life Laboratory (SciLifeLab), the Knut and Alice Wallenberg Foundation, the National Genomics Infrastructure funded by the Swedish Research Council, and Uppsala Multidisciplinary Centre for Advanced Computational Science for assistance with massively parallel sequencing and access to the UPPMAX computational infrastructure. We acknowledge the Umea Core facility Electron Microscopy at Umea University and the National Microscopy Infrastructure, NMI (VR-RFI 2016-00968) for providing assistance in microscopy. We thank the personal from Wallenberg greenhouse at SLU, Umea for help with the handling of plants. This work was supported by the Kempe Foundation (JCK-1311) and Kungl. Skogs-och Lantbruksakademien (KSLA-H14-0150-ADA). We also acknowledge Swedish Research Council (VR) and Swedish Governmental Agency for Innovation Systems (VINNOVA) for their funding to the Umea Plant Science Centre under the Berzelii programme.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson SL, 1997, ADV GENET, V35, P1, DOI 10.1016/S0065-2660(08)60446-0; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Armstrong GA, 1998, J PHOTOCH PHOTOBIO B, V43, P87, DOI 10.1016/S1011-1344(98)00063-3; Batschauer A, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P211, DOI 10.1002/352760510X.ch10; BOGDANOV.M, 1973, PHYSIOL PLANTARUM, V29, P17, DOI 10.1111/j.1399-3054.1973.tb04802.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borgstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019119; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; CHORY J, 1991, PLANT CELL, V3, P445, DOI 10.1105/tpc.3.5.445; Christie JM, 2001, J BIOL CHEM, V276, P11457, DOI 10.1074/jbc.R100004200; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; Clapham DH, 2002, PHYSIOL PLANTARUM, V114, P207, DOI 10.1034/j.1399-3054.2002.1140206.x; Clapham DH, 1998, PHYSIOL PLANTARUM, V102, P71, DOI 10.1034/j.1399-3054.1998.1020110.x; DENG XW, 1991, GENE DEV, V5, P1172, DOI 10.1101/gad.5.7.1172; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fittinghoff K, 2006, PLANT J, V47, P577, DOI 10.1111/j.1365-313X.2006.02812.x; Franklin KA, 2007, PLANT SIGNAL BEHAV, V2, P383, DOI 10.4161/psb.2.5.4261; Gangappa SN, 2016, MOL PLANT, V9, P1353, DOI 10.1016/j.molp.2016.07.002; Garcia-Gutierrez A, 1998, PLANT J, V13, P187, DOI 10.1046/j.1365-313X.1998.00018.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gu NN, 2012, MOL PLANT, V5, P85, DOI 10.1093/mp/ssr052; Hardtke CS, 2000, PLANT PHYSIOL, V124, P1548, DOI 10.1104/pp.124.4.1548; HRIB J, 1986, BIOL PLANTARUM, V28, P180, DOI 10.1007/BF02894594; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Klepikova AV, 2016, PLANT J, V88, P1058, DOI 10.1111/tpj.13312; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kubo H, 1999, PLANT CELL, V11, P1217, DOI 10.1105/tpc.11.7.1217; Lau OS, 2012, TRENDS PLANT SCI, V17, P584, DOI 10.1016/j.tplants.2012.05.004; Leivar P, 2008, CURR BIOL, V18, P1815, DOI 10.1016/j.cub.2008.10.058; Leivar P, 2014, PLANT CELL, V26, P56, DOI 10.1105/tpc.113.120857; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Li Jigang, 2011, Arabidopsis Book, V9, pe0148, DOI 10.1199/tab.0148; Liu B, 2011, GENE DEV, V25, P1029, DOI 10.1101/gad.2025011; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; MANCINELLI AL, 1985, BOT REV, V51, P107, DOI 10.1007/BF02861059; McClung CR, 2011, MOL CELL, V43, P693, DOI 10.1016/j.molcel.2011.08.013; MCNELLIS TW, 1994, PLANT CELL, V6, P487, DOI 10.1105/tpc.6.4.487; Morelli G, 2000, PLANT PHYSIOL, V122, P621, DOI 10.1104/pp.122.3.621; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Osnato M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1810; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; QUAIL PH, 1991, ANNU REV GENET, V25, P389, DOI 10.1146/annurev.ge.25.120191.002133; R Development Core Team R, 2015, R A LANGUAGE AND ENV; Ranade SS, 2013, TREE PHYSIOL, V33, P195, DOI 10.1093/treephys/tps131; Razzak A, 2017, PLANT CELL ENVIRON, V40, P1332, DOI 10.1111/pce.12921; Saijo Y, 2003, GENE DEV, V17, P2642, DOI 10.1101/gad.1122903; Schoefs B, 1998, PLANT PHYSIOL, V118, P1159, DOI 10.1104/pp.118.4.1159; Schoefs B, 1997, BOOKS SOIL PLANT ENV, P49; Schroeder DF, 2002, CURR BIOL, V12, P1462, DOI 10.1016/S0960-9822(02)01106-5; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; SHARROCK RA, 1989, GENE DEV, V3, P1745, DOI 10.1101/gad.3.11.1745; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; SPURNY M, 1975, BIOL PLANTARUM, V17, P43, DOI 10.1007/BF02921073; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stolarik T, 2017, PHOTOSYNTH RES, V132, P165, DOI 10.1007/s11120-017-0354-2; Su L, 2015, INT J MOL SCI, V16, P12199, DOI 10.3390/ijms160612199; Sundell D, 2015, NEW PHYTOL, V208, P1149, DOI 10.1111/nph.13557; Takano M, 2005, PLANT CELL, V17, P3311, DOI 10.1105/tpc.105.035899; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Torii KU, 1999, J BIOL CHEM, V274, P27674, DOI 10.1074/jbc.274.39.27674; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Weller JL, 2001, PLANT J, V26, P283, DOI 10.1046/j.1365-313X.2001.01027.x; Xu Dongqing, 2016, F1000Res, V5, DOI 10.12688/f1000research.7346.1; Xu DQ, 2014, PLANT CELL, V26, P1981, DOI 10.1105/tpc.114.124024; Yanagawa Y, 2004, GENE DEV, V18, P2172, DOI 10.1101/gad.1229504; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Zhu DM, 2008, PLANT CELL, V20, P2307, DOI 10.1105/tpc.107.056580; Zimin A, 2014, GENETICS, V196, P875, DOI 10.1534/genetics.113.159715	72	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219272	10.1371/journal.pone.0219272	http://dx.doi.org/10.1371/journal.pone.0219272			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276530	Green Submitted, Green Published, gold			2022-12-26	WOS:000484936300056
J	Lessaid, T; dos Santos, JW; Correia, RA; Ladle, RJ; Malhado, ACM				Lessaid, Thaina; dos Santos, Janisson W.; Correia, Ricardo A.; Ladle, Richard J.; Malhado, Ana C. M.			Known unknowns: Filling the gaps in scientific knowledge production in the Caatinga	PLOS ONE			English	Article							MULTIMODEL INFERENCE; SAMPLING EFFORT; BIODIVERSITY; BIAS; SHORTFALLS; AMAZON; PLANTS; NEEDS	The Caatinga is an ecologically unique semi-arid region of northeast Brazil characterized by high levels of endemism and severe anthropogenic threats from agricultural development and climate change. It is also one of the least known biomes in Brazil due to a combination of inadequate investment, low regional research capacity and difficult working conditions. However, while the lack of scientific knowledge of the Caatinga is well known, the spatial and temporal distribution of knowledge production has not been investigated. This is important because such biases undermine the development of effective conservation policy and practice and increase the uncertainty associated with conservation actions. Here, we map the geography of conservation knowledge production in the Caatinga and use an innovative hurdle model to identify the presumptive factors driving these patterns. Our analysis revealed strong geographic patterns, with research sites concentrated in the east of the region and in areas close to roads and research centres. There was also a positive association between conservation knowledge production and risk of desertification, indicating that conservation scientists are responding to conservation challenges faced by Caatinga's fauna and flora arising from climate change. Our results also highlight the pivotal role of pioneer scientists (those who develop research sites in previously unstudied/understudied areas) in determining the future geographic patterns of knowledge production. We conclude our article with a brief discussion of potential policies for increasing the spatial representativeness of conservation research in this remarkable ecosystem.	[Lessaid, Thaina; dos Santos, Janisson W.; Correia, Ricardo A.; Ladle, Richard J.; Malhado, Ana C. M.] Univ Fed Alagoas, Inst Biol Sci & Hlth, Campus AC Simoes,Ave Lourival Melo Mota S-N, Maceio, AL, Brazil; [Correia, Ricardo A.] Univ Aveiro, DBIO, Aveiro, Portugal; [Correia, Ricardo A.] Univ Aveiro, CESAM Ctr Environm & Marine Studies, Aveiro, Portugal	Universidade Federal de Alagoas; Universidade de Aveiro; Universidade de Aveiro	Lessaid, T (corresponding author), Univ Fed Alagoas, Inst Biol Sci & Hlth, Campus AC Simoes,Ave Lourival Melo Mota S-N, Maceio, AL, Brazil.	thainalessaps@gmail.com	Malhado, Ana C M/I-3089-2012; Correia, Ricardo A./G-9427-2016; Ladle, Richard/E-4228-2014	Malhado, Ana C M/0000-0003-3621-779X; Correia, Ricardo A./0000-0001-7359-9091; Ladle, Richard/0000-0003-3200-3946; Lessa, Thaina/0000-0002-3337-6317	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Brazilian National Council for Scientific and Technological Development CNPq [448688/2014-0]; FCT - Fundacao para a Ciencia e Tecnologia [SFRH/BPD/118635/2016]; CESAM [UID/AMB/50017 -POCI-01-0145-FEDER-007638]; FCT/MCTES through national funds (PIDDAC); FEDER, within the PT2020 Partnership Agreement; FEDER, within the Compete 2020; CNPq [310953/2014-6, 310349/2015-0]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Council for Scientific and Technological Development CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FCT - Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); CESAM; FCT/MCTES through national funds (PIDDAC); FEDER, within the PT2020 Partnership Agreement; FEDER, within the Compete 2020; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) Finance Code 001 (fellowships to TLPS e JWS) and was also funded by the Brazilian National Council for Scientific and Technological Development CNPq (#448688/2014-0). RAC is currently funded by a post-doctoral grant from FCT - Fundacao para a Ciencia e Tecnologia (SFRH/BPD/118635/2016). This work also benefited from financial support from CESAM (UID/AMB/50017 -POCI-01-0145-FEDER-007638), FCT/MCTES through national funds (PIDDAC), and co-funding by the FEDER, within the PT2020 Partnership Agreement and Compete 2020. RJL and ACMM are supported by CNPq (#310953/2014-6 and #310349/2015-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar H, 2019, ENVIRON CONSERV, V46, P219, DOI 10.1017/S0376892919000018; Andrade-Lima D., 1981, REV BRAS BOTA NICA, V4, P149; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2017, RELAT CIENTIF TECN I; Barton K, 2020, MUMIN MULTIMODEL INF; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Bragagnolo C., 2017, CAATINGA, P335, DOI [10.1007/978-3-319-68339, DOI 10.1007/978-3-319-68339, 10.1007/978-3-319-68339-3_12, DOI 10.1007/978-3-319-68339-3_12]; BUCHER EH, 1987, REV CHIL HIST NAT, V60, P265; Burnham K P, 2003, MODEL SELECT MULTIMO; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Carmignotto A. P., 2017, CAATINGA LARGEST TRO, P211, DOI DOI 10.1007/978-3-319-68339-3_8; Choubin B, 2017, METEOROL APPL, V24, P376, DOI 10.1002/met.1635; Correia RA, 2016, BIODIVERS CONSERV, V25, P1503, DOI 10.1007/s10531-016-1122-x; dos Santos JG, 2015, BIODIVERS CONSERV, V24, P2853, DOI 10.1007/s10531-015-0981-x; Engemann K, 2015, ECOL EVOL, V5, P807, DOI 10.1002/ece3.1405; Fisher R, 2011, CONSERV LETT, V4, P64, DOI 10.1111/j.1755-263X.2010.00146.x; Garda A.A., 2017, CAATINGA LARGEST TRO, P133, DOI [10.1007/978-3-319-68339-3_5, DOI 10.1007/978-3-319-68339-3_5, 10.1007/978-3- 319-68339-3_5]; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Hortal J, 2015, ANNU REV ECOL EVOL S, V46, P523, DOI 10.1146/annurev-ecolsys-112414-054400; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Kareiva P, 2012, BIOSCIENCE, V62, P962, DOI 10.1525/bio.2012.62.11.5; Karl JW, 2013, BIOSCIENCE, V63, P674, DOI 10.1525/bio.2013.63.8.10; Karl JW, 2013, TRENDS ECOL EVOL, V28, P383, DOI 10.1016/j.tree.2013.05.001; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Kuper W, 2006, BOT J LINN SOC, V150, P355, DOI 10.1111/j.1095-8339.2006.00494.x; Laurance WF, 2013, TRENDS ECOL EVOL, V28, P261, DOI 10.1016/j.tree.2013.01.017; Lewis G., 1985, S E PIAUL ZINE, V2, P214, DOI [10.1111/j.1467-8748.1985.tb00225.x, DOI 10.1111/J.1467-8748.1985.TB00225.X]; Lima SMQ, 2017, CAATINGA LARGEST TRO, P97, DOI [10.1007/978-3-319-68339-3_4, DOI 10.1007/978-3-319-68339-3_4]; Lobo JM, 2018, ECOL INDIC, V91, P241, DOI 10.1016/j.ecolind.2018.03.077; Malhado ACM, 2011, SCIENCE, V331, P857, DOI 10.1126/science.331.6019.857-a; Meine C, 2006, CONSERV BIOL, V20, P631, DOI 10.1111/j.1523-1739.2006.00449.x; Moro MF, 2014, PHYTOTAXA, V160, P1; Neves CEB, 2017, SOCIOL DIALOGUE, V3, P4, DOI [10.20336/sid.v3.i1.71, DOI 10.20336/SID.V3.I1.71]; NOGUEIRANETO P, 1979, ENVIRON CONSERV, V6, P95, DOI 10.1017/S0376892900002514; Oliveira U, 2016, DIVERS DISTRIB, V22, P1232, DOI 10.1111/ddi.12489; Pedrosa RHL, 2014, INT HIGHER ED, DOI [10.6017/ihe.2014.77.5679, DOI 10.6017/IHE.2014.77.5679]; Piel AK, 2015, GLOB ECOL CONSERV, V3, P188, DOI 10.1016/j.gecco.2014.11.014; Pitman NCA, 2011, TROP CONSERV SCI, V4, P64, DOI 10.1177/194008291100400107; Popper K., 2014, CONJECTURES REFUTATI; Rapini A, 2006, TOWARDS GREATER KNOW; Regalado A, 2010, SCIENCE, V330, P1306, DOI 10.1126/science.330.6009.1306; Rocchini D, 2017, SCI TOTAL ENVIRON, V584, P282, DOI 10.1016/j.scitotenv.2016.12.038; Salazar LF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029695; Santos JC, 2011, TROP CONSERV SCI, V4, P276, DOI 10.1177/194008291100400306; Schulman L, 2007, J BIOGEOGR, V34, P1388, DOI 10.1111/j.1365-2699.2007.01716.x; Silva JMC, 2017, CAATINGA LARGEST TRO; Simpson R, 2002, DEFINITIONS BIODIVER; SOUZA B. I. D., 2015, MERCATOR-FORTALEZA, V14, P131; Stropp J, 2016, GLOBAL ECOL BIOGEOGR, V25, P1085, DOI 10.1111/geb.12468; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	52	10	10	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219359	10.1371/journal.pone.0219359	http://dx.doi.org/10.1371/journal.pone.0219359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269071	gold, Green Submitted, Green Published			2022-12-26	WOS:000484927300061
J	Daniels, SR; Liyasova, M; Kales, SC; Nau, MM; Ryan, PE; Green, JE; Lipkowitz, S				Daniels, Silvano Rakeem; Liyasova, Mariya; Kales, Stephen C.; Nau, Marion M.; Ryan, Philip E.; Green, Jeffrey E.; Lipkowitz, Stanley			Loss of function Cbl-c mutations in solid tumors	PLOS ONE			English	Article							UBIQUITIN LIGASE ACTIVITY; V-CBL; PROTEIN; TYROSINE; TRANSFORMATION; DEGRADATION; ACTIVATION; ONCOGENE; BINDING; CANCER	Receptor Tyrosine Kinase (RTK) signaling is essential for normal biological processes and disruption of this regulation can lead to tumor initiation and progression. Cbl proteins (Cbl, Cbl-b and Cbl-c) are a family of RING finger (RF) ubiquitin ligases that negatively regulate a variety of RTKs, including EGFR, MET, and RET. Recent studies have identified Cbl mutations associated with human myeloid neoplasias in approximately 5% of the cases. Cbl-c is the most recently identified human Cbl protein and is expressed exclusively in epithelial cells. We identified a novel cDNA that was isolated from a mouse mammary cancer from the C3(1) Large T Antigen transgenic model. This mutant cDNA encodes a protein that has a deletion in the RF domain of Cbl-c, thereby resembling known Cbl family mutations associated with myeoloid neoplasias. Genomic analysis of both parental and transgenic lines shows no evidence of germline mutation indicating that this mutation is likely a somatic mutation. The mutant protein enhances transformation of NIH 3T3 cells when expressed in combination with SV40 Large T antigen. Together these data are consistent with a second hit mutation. In overexpression studies, this mutant Cbl-c protein fails to mediate ubiquitination of activated EGFR and acts in a dominant negative fashion to prevent ubiquitination and downregulation of the activated EGFR by wild type Cbl proteins. Mechanistically, the mutant Cbl-c binds to the EGFR and prevents recruitment of the wild type Cbl protein. Furthermore, data mining reveals Cbl-c mutations associated with solid tumors in humans. Subsequent cell-based analysis demonstrates a similar loss of E3 function and dominant negative effects for one of these human mutations. These data suggest that like Cbl mutations in myeloid neoplasms, loss of Cbl-c function may contribute to the pathogenesis of solid tumors in murine models and in humans.	[Daniels, Silvano Rakeem; Liyasova, Mariya; Kales, Stephen C.; Nau, Marion M.; Ryan, Philip E.; Lipkowitz, Stanley] NCI, Womens Malignancies Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Green, Jeffrey E.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Kales, Stephen C.] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Ryan, Philip E.] NIH, Off Intramural Training & Educ, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA	Lipkowitz, S (corresponding author), NCI, Womens Malignancies Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	lipkowis@navmed.nci.nih.gov		Lipkowitz, Stanley/0000-0002-6103-2255; Kales, Stephen C./0000-0002-8702-5766	National Cancer Institute; Cbl Proteins as Regulators of Tyrosine Kinase Signaling; Transgenic Models for Breast Cancer;  [ZIA BC 010977]; NATIONAL CANCER INSTITUTE [ZIABC010977, ZIABC005740] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cbl Proteins as Regulators of Tyrosine Kinase Signaling; Transgenic Models for Breast Cancer; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by ZIA BC 010977, Cbl Proteins as Regulators of Tyrosine Kinase Signaling, Intramural Funding from National Cancer Institute, https//ccr.cancer.gov/, to SRD; ZIA BC 010977, Cbl Proteins as Regulators of Tyrosine Kinase Signaling, Intramural Funding from National Cancer Institute, https//ccr.cancer gov/, to ML; ZIA BC 010977, Cbl Proteins as Regulators of Tyrosine Kinase Signaling, Intramural Funding from National Cancer Institute, https://ccr.cancer.gov/, to SCK; ZIA BC 010977, Cbl Proteins as Regulators of Tyrosine Kinase Signaling, Intramural Funding from National Cancer Institute, https://ccr.cancer.gov/, to MMN; ZIA BC 010977, Cbl Proteins as Regulators of Tyrosine Kinase Signaling, Intramural Funding from National Cancer Institute, https://ccr.cancer.gov, to PER; ZIA BC 005740, Transgenic Models for Breast Cancer, Intramural Funding from National Cancer Institute, https://ccr.cancer.gov/, to JEG; and ZIA BC 010977, Cbl Proteins as Regulators of Tyrosine Kinase Signaling, Intramural Funding from National Cancer Institute, https://ccr.cancer.gov/, to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research. We thank Zi Yao Liu for providing mouse tumors from the C3(1) SV40 Large T antigen (Tag) transgenic mouse for genomic analysis. We thank members of the Lipkowitz laboratory (Yoshimi Greer, David Wisniewski, and Donna Voeller) for their review of this manuscript.	Bisson SA, 2002, ONCOGENE, V21, P3677, DOI 10.1038/sj.onc.1205510; BLAKE TJ, 1991, ONCOGENE, V6, P653; BLAKE TJ, 1993, EMBO J, V12, P2017, DOI 10.1002/j.1460-2075.1993.tb05851.x; Bonita DP, 1997, MOL CELL BIOL, V17, P4597, DOI 10.1128/MCB.17.8.4597; Calco GN, 2014, J BIOL CHEM, V289, P7307, DOI 10.1074/jbc.M113.537878; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Davies GC, 2006, ONCOGENE, V25, P6497, DOI 10.1038/sj.onc.1209662; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Ettenberg SA, 1999, ONCOGENE, V18, P1855, DOI 10.1038/sj.onc.1202499; Ettenberg SA, 2001, J BIOL CHEM, V276, P27677, DOI 10.1074/jbc.M102641200; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; Griffiths EK, 2003, MOL CELL BIOL, V23, P7708, DOI 10.1128/MCB.23.21.7708-7718.2003; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kales SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087116; Kales SC, 2010, CANCER RES, V70, P4789, DOI 10.1158/0008-5472.CAN-10-0610; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; KEANE MM, 1995, ONCOGENE, V10, P2367; Kim M, 1999, GENE, V239, P145, DOI 10.1016/S0378-1119(99)00356-X; Kim M, 2004, ONCOGENE, V23, P1645, DOI 10.1038/sj.onc.1207298; LANGDON WY, 1990, CURR TOP MICROBIOL, V166, P159; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Ma K, 2013, VESICLE TRAFFICKING, P219, DOI [10.1007/978-1-4614-6528-7_11, DOI 10.1007/978-1-4614-6528-7_11]; MAROULAKOU IG, 1994, P NATL ACAD SCI USA, V91, P11236, DOI 10.1073/pnas.91.23.11236; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Nau MM, 2003, GENE, V308, P103, DOI 10.1016/S0378-1119(03)00471-2; Nau MM, 2008, CBL PROTEINS, P3; Ryan PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049428; Ryan PE, 2010, J BIOL CHEM, V285, P23687, DOI 10.1074/jbc.M109.091157; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Slape C, 2008, BLOOD, V112, P2017, DOI 10.1182/blood-2008-01-135186; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tan YHC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008972; Tsui CC, 2008, J NEUROSCI, V28, P8789, DOI 10.1523/JNEUROSCI.2738-08.2008	42	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219143	10.1371/journal.pone.0219143	http://dx.doi.org/10.1371/journal.pone.0219143			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260484	gold, Green Published, Green Submitted			2022-12-26	WOS:000484918700035
J	McCrary, MR; Jiang, MQ; Giddens, MM; Zhang, JY; Owino, S; Wei, ZZ; Zhong, WW; Gu, XH; Xin, H; Hall, RA; Wei, L; Yu, SP				McCrary, Myles R.; Jiang, Michael Q.; Giddens, Michelle M.; Zhang, James Y.; Owino, Sharon; Wei, Zheng Z.; Zhong, Weiwei; Gu, Xiaohuan; Xin, Huang; Hall, Randy A.; Wei, Ling; Yu, Shan P.			Protective effects of GPR37 via regulation of inflammation and multiple cell death pathways after ischemic stroke in mice	FASEB JOURNAL			English	Article						apoptosis; autophagy; mTOR; microglial; astrogliosis	PROTEIN-COUPLED RECEPTORS; FOCAL CEREBRAL-ISCHEMIA; PHARMACOLOGICALLY INDUCED HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; REACTIVE ASTROCYTES; BRAIN-INJURY; PROSAPOSIN; EXPRESSION; AUTOPHAGY; RECOVERY	GPCR 37 (GPR37) is a GPCR expressed in the CNS; its physiological and pathophysiological functions are largely unknown. We tested the role of GPR37 in the ischemic brain of GPR37 knockout (KO) mice, exploring the idea that GPR37 might be protective against ischemic damage. In an ischemic stroke model, GPR37 KO mice exhibited increased infarction and cell death compared with wild-type (WT) mice, measured by 2,3,5-triphenyl-2H-tetrazolium chloride and TUNEL staining 24 h after stroke. Moreover, more severe functional deficits were detected in GPR37 KO mice in the adhesive-removal and corner tests. In the peri-infarct region of GPR37 KO mice, there was significantly more apoptotic and autophagic cell death accompanied by caspase-3 activation and attenuated mechanistic target of rapamycin signaling. GPR37 deletion attenuated astrocyte activation and astrogliosis compared with WT stroke controls 24-72 h after stroke. Immunohistochemical staining showed more ionized calcium-binding adapter molecule 1-positive cells in the ischemic cortex of GPR37 KO mice, and RT-PCR identified an enrichment of M1-type microglia or macrophage markers in the GPR37 KO ischemic cortex. Western blotting demonstrated higher levels of inflammatory factors IL-1 beta, IL-6, monocyte chemoattractant protein, and macrophage inflammatory protein-1 alpha in GPR37-KO mice after ischemia. Thus, GPR37 plays a multifaceted role after stroke, suggesting a novel target for stroke therapy.-McCrary, M. R., Jiang, M. Q., Giddens, M. M., Zhang, J. Y., Owino, S., Wei, Z. Z., Zhong, W., Gu, X., Xin, H., Hall, R. A., Wei, L., Yu, S. P. Protective effects of GPR37 via regulation of inflammation and multiple cell death pathways after ischemic stroke in mice.	[McCrary, Myles R.; Jiang, Michael Q.; Zhang, James Y.; Wei, Zheng Z.; Zhong, Weiwei; Gu, Xiaohuan; Xin, Huang; Wei, Ling; Yu, Shan P.] Emory Univ, Dept Anesthesiol, Sch Med, 101 Woodruff Circle,Suite 620B, Atlanta, GA 30322 USA; [Giddens, Michelle M.; Owino, Sharon; Hall, Randy A.] Emory Univ, Dept Pharmacol, Sch Med, Atlanta, GA 30322 USA; [Yu, Shan P.] Atlanta Vet Affairs Med Ctr, Ctr Visual & Neurocognit Rehabil, Decatur, GA USA	Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Yu, SP (corresponding author), Emory Univ, Dept Anesthesiol, Sch Med, 101 Woodruff Circle,Suite 620B, Atlanta, GA 30322 USA.	spyu@emory.edu	Wei, Zheng Zachory/I-2109-2019; Zhang, James/HHS-8616-2022	Wei, Zheng Zachory/0000-0001-7682-9286; McCrary, Myles/0000-0002-4572-7372	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [NS085568, NS091585, NS088413, NS073378]; Veterans Affairs National Merit Grant [RX000666]; American Heart Association [POST25710112, PRE25710020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088413, R42NS073378, R01NS091585, R44NS073378, R01NS085568] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000666] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs National Merit Grant; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grants NS085568 (to L.W. and S.P.Y.), NS091585 (to L.W.), NS088413 (to R.A.H.), and NS073378 (to S.P.Y.), a Veterans Affairs National Merit Grant RX000666 (to S.P.Y.), an American Heart Association Postdoctoral Fellowship POST25710112 (to Z.Z.W.), and a Predoctoral Fellowship PRE25710020 (to J.Z.). The authors declare no conflicts of interest.	Alavi MS, 2018, BIOMED PHARMACOTHER, V98, P222, DOI 10.1016/j.biopha.2017.12.056; Bang SS, 2018, J CLIN INVEST, V128, P3568, DOI 10.1172/JCI99888; Barreto GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027881; Bazan NG, 2012, EXP NEUROL, V236, P122, DOI 10.1016/j.expneurol.2012.04.007; Belayev L, 2017, CELL DEATH DIFFER, V24, P1091, DOI 10.1038/cdd.2017.55; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Choudhury GR, 2016, NEUROBIOL DIS, V85, P234, DOI 10.1016/j.nbd.2015.05.003; Donohue PJ, 1998, MOL BRAIN RES, V54, P152, DOI 10.1016/S0169-328X(97)00336-7; Eglen RM, 2007, ASSAY DRUG DEV TECHN, V5, P425, DOI 10.1089/adt.2007.062; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fujita-Jimbo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051155; Gandia J, 2013, J NEUROCHEM, V125, P362, DOI 10.1111/jnc.12196; Giddens MM, 2017, NEUROBIOL DIS, V106, P181, DOI 10.1016/j.nbd.2017.07.006; Girard S, 2013, GLIA, V61, P813, DOI 10.1002/glia.22478; Hayakawa K, 2010, J CEREBR BLOOD F MET, V30, P871, DOI 10.1038/jcbfm.2009.257; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Huang YH, 2015, FEBS LETT, V589, P1607, DOI 10.1016/j.febslet.2015.05.007; Igase K, 1999, J CEREBR BLOOD F MET, V19, P298, DOI 10.1097/00004647-199903000-00008; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2007, NEUROSCI RES, V59, P413, DOI 10.1016/j.neures.2007.08.005; Jiang MQ, 2017, BRAIN PATHOL, V27, P480, DOI 10.1111/bpa.12425; Jolly S, 2018, GLIA, V66, P47, DOI 10.1002/glia.23198; Kadowaki M, 2009, METHOD ENZYMOL, V452, P199, DOI 10.1016/S0076-6879(08)03613-6; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kotani Y, 1996, J NEUROCHEM, V66, P2019; Lee EJ, 2011, AUTOPHAGY, V7, P689, DOI 10.4161/auto.7.7.15450; Lee JH, 2018, EXP NEUROL, V305, P1, DOI 10.1016/j.expneurol.2018.02.015; Lee JH, 2017, NEURAL REGEN RES, V12, P341, DOI 10.4103/1673-5374.202915; Lee JH, 2016, NEUROBIOL DIS, V96, P248, DOI 10.1016/j.nbd.2016.09.013; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Lin CW, 2016, NEUROSCI BULL, V32, P137, DOI 10.1007/s12264-016-0017-x; Liu BH, 2018, GLIA, V66, P2414, DOI 10.1002/glia.23480; Lopes JP, 2015, J NEUROCHEM, V134, P135, DOI 10.1111/jnc.13109; de Maturana RL, 2010, CNS NEUROL DISORD-DR, V9, P601, DOI 10.2174/187152710793361531; Lu AG, 2000, NEUROREPORT, V11, P1791, DOI 10.1097/00001756-200006050-00039; Lundius EG, 2014, J BIOL CHEM, V289, P4660, DOI 10.1074/jbc.M113.510883; Mandillo S, 2013, GENES BRAIN BEHAV, V12, P465, DOI 10.1111/gbb.12041; Marazziti D, 2004, P NATL ACAD SCI USA, V101, P10189, DOI 10.1073/pnas.0403661101; Marazziti D, 2007, P NATL ACAD SCI USA, V104, P9846, DOI 10.1073/pnas.0703368104; Marazziti D, 2009, FASEB J, V23, P1978, DOI 10.1096/fj.08-121210; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Meyer RC, 2013, P NATL ACAD SCI USA, V110, P9529, DOI 10.1073/pnas.1219004110; Mohamad O, 2013, J PHYSIOL-LONDON, V591, P149, DOI 10.1113/jphysiol.2012.239251; Morato X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10147-x; Niu B, 2017, NEUROSCI BULL, V33, P627, DOI 10.1007/s12264-017-0156-8; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058; Rezgaoui M, 2006, J CELL SCI, V119, P542, DOI 10.1242/jcs.02766; Rial D, 2017, NEUROSCI LETT, V638, P162, DOI 10.1016/j.neulet.2016.12.040; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; Selenica MLB, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-86; Sims NR, 2017, NEUROCHEM INT, V107, P88, DOI 10.1016/j.neuint.2016.12.016; Sladek CD, 2012, J NEUROENDOCRINOL, V24, P554, DOI 10.1111/j.1365-2826.2011.02268.x; Smith BM, 2017, NEUROSCIENCE, V358, P49, DOI 10.1016/j.neuroscience.2017.06.006; Smith NJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00275; Tomita Hiroaki, 2013, Frontiers in Genetics, V4, P297, DOI 10.3389/fgene.2013.00297; Valdenaire O, 1998, FEBS LETT, V424, P193, DOI 10.1016/S0014-5793(98)00170-7; Wang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096765; Wang P, 2018, PROG NEUROBIOL, V163, P98, DOI 10.1016/j.pneurobio.2018.01.001; Wei HP, 2016, TRANSL STROKE RES, V7, P497, DOI 10.1007/s12975-016-0484-4; Yang HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10884; Yao CY, 2013, MOL MED REP, V8, P543, DOI 10.3892/mmr.2013.1543; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	64	26	27	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10680	10691		10.1096/fj.201900070R	http://dx.doi.org/10.1096/fj.201900070R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31268736	Bronze, Green Published			2022-12-26	WOS:000489166300009
J	Hoffman, KS; Vargas-Rodriguez, O; Bak, DW; Mukai, T; Woodward, LK; Weerapana, E; Soll, D; Reynolds, NM				Hoffman, Kyle S.; Vargas-Rodriguez, Oscar; Bak, Daniel W.; Mukai, Takahito; Woodward, Laura K.; Weerapana, Eranthie; Soll, Dieter; Reynolds, Noah M.			A cysteinyl-tRNA synthetase variant confers resistance against selenite toxicity and decreases selenocysteine misincorporation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						selenocysteine; aminoacyl tRNA synthetase; transfer RNA (tRNA); translation; selenium; Escherichia coli (E; coli); protein engineering; Astragalus bisulcatus; cysteinyl-tRNA synthetase; selenite toxicity	ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PLANTS; VOLATILIZATION; SULFUR; AMINOACYLATION; PURIFICATION; ASSIMILATION; MECHANISM; SEQUENCE	Selenocysteine (Sec) is the 21st genetically encoded amino acid in organisms across all domains of life. Although structurally similar to cysteine (Cys), the Sec selenol group has unique properties that are attractive for protein engineering and biotechnology applications. Production of designer proteins with Sec (selenoproteins) at desired positions is now possible with engineered translation systems in Escherichia coli. However, obtaining pure selenoproteins at high yields is limited by the accumulation of free Sec in cells, causing undesired incorporation of Sec at Cys codons due to the inability of cysteinyl-tRNA synthetase (CysRS) to discriminate against Sec. Sec misincorporation is toxic to cells and causes protein aggregation in yeast. To overcome this limitation, here we investigated a CysRS from the selenium accumulator plant Astragalus bisulcatus that is reported to reject Sec in vitro. Sequence analysis revealed a rare His -> Asn variation adjacent to the CysRS catalytic pocket. Introducing this variation into E. coli and Saccharomyces cerevisiae CysRS increased resistance to the toxic effects of selenite and selenomethionine (SeMet), respectively. Although the CysRS variant could still use Sec as a substrate in vitro, we observed a reduction in the frequency of Sec misincorporation at Cys codons in vivo. We surmise that the His -> Asn variation can be introduced into any CysRS to provide a fitness advantage for strains burdened by Sec misincorporation and selenium toxicity. Our results also support the notion that the CysRS variant provides higher specificity for Cys as a mechanism for plants to grow in selenium-rich soils.	[Hoffman, Kyle S.; Vargas-Rodriguez, Oscar; Mukai, Takahito; Woodward, Laura K.; Soll, Dieter; Reynolds, Noah M.] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06511 USA; [Soll, Dieter] Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06511 USA; [Bak, Daniel W.; Weerapana, Eranthie] Boston Coll, Dept Chem, Chestnut Hill, MA 02167 USA	Yale University; Yale University; Boston College	Reynolds, NM (corresponding author), Univ Illinois, Dept Biol, One Univ Dr, Springfield, IL 62703 USA.	nmreynol@uis.edu		Bak, Daniel/0000-0002-2252-1718; Soll, Dieter/0000-0002-3077-8986; Vargas-Rodriguez, Oscar/0000-0002-2301-2800	National Institutes of Health [R35GM122560, R01GM117004, R01GM118431-01A1]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the Department of Energy [DE-FG02-98ER20311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117004, R35GM122560, R01GM118431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R35GM122560 (to D. S.) and R01GM117004 and R01GM118431-01A1 (to E. W.); the genetic experiments were supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the Department of Energy Grant DE-FG02-98ER20311 (to D. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abo M, 2018, MOL PHARMACEUT, V15, P743, DOI 10.1021/acs.molpharmaceut.7b00832; Bak DW, 2018, CELL CHEM BIOL, V25, P1157, DOI 10.1016/j.chembiol.2018.05.017; Bockhorn J, 2008, P NATL ACAD SCI USA, V105, P17682, DOI 10.1073/pnas.0805642105; BOHMAN K, 1979, MOL GEN GENET, V176, P53, DOI 10.1007/BF00334295; BROWN TA, 1981, PLANT PHYSIOL, V67, P1051, DOI 10.1104/pp.67.5.1051; BURNELL JN, 1981, PLANT PHYSIOL, V68, P788; BURNELL JN, 1980, J INORG BIOCHEM, V12, P343, DOI 10.1016/S0162-0134(00)80275-5; BURNELL JN, 1979, PLANT PHYSIOL, V63, P1095, DOI 10.1104/pp.63.6.1095; BURNELL JN, 1977, PLANT PHYSIOL, V60, P670, DOI 10.1104/pp.60.5.670; Cakir O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135677; de Souza MP, 1998, PLANT PHYSIOL, V117, P1487, DOI 10.1104/pp.117.4.1487; Ellis Danielle R., 2004, BMC Plant Biology, V4, P1, DOI 10.1186/1471-2229-4-1; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fernandes AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050727; FIMMEL AL, 1977, J GEN MICROBIOL, V103, P37, DOI 10.1099/00221287-103-1-37; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6318; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Freeman JL, 2006, PLANT PHYSIOL, V142, P124, DOI 10.1104/pp.106.081158; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GIRLING CA, 1984, AGR ECOSYST ENVIRON, V11, P37, DOI 10.1016/0167-8809(84)90047-1; Gupta M, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02074; Hondal RJ, 2001, J AM CHEM SOC, V123, P5140, DOI 10.1021/ja005885t; HUBER RE, 1967, ARCH BIOCHEM BIOPHYS, V122, P164, DOI 10.1016/0003-9861(67)90136-1; Lazard Myriam, 2017, BioMolecular Concepts, V8, P93, DOI 10.1515/bmc-2017-0007; Lazard M, 2015, J BIOL CHEM, V290, P10741, DOI 10.1074/jbc.M115.640375; Lazard M, 2010, J BIOL CHEM, V285, P32029, DOI 10.1074/jbc.M110.139865; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; LeDuc DL, 2004, PLANT PHYSIOL, V135, P377, DOI 10.1104/pp.103.026989; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; LITOV RE, 1991, PEDIATRICS, V87, P339; Lyons GH, 2005, PLANT SOIL, V270, P179, DOI 10.1007/s11104-004-1390-1; Malkowski MG, 2007, P NATL ACAD SCI USA, V104, P6678, DOI 10.1073/pnas.0610337104; McDermott JR, 2010, MOL BIOL CELL, V21, P3934, DOI 10.1091/mbc.E10-06-0513; Mousa R, 2017, ANGEW CHEM INT EDIT, V56, P15818, DOI 10.1002/anie.201706876; Mukai T, 2018, ANGEW CHEM INT EDIT, V57, P7215, DOI 10.1002/anie.201713215; Muller S, 1997, ARCH MICROBIOL, V168, P421, DOI 10.1007/s002030050517; Nauser T, 2006, BIOCHEMISTRY-US, V45, P6038, DOI 10.1021/bi0602260; Newberry KJ, 2002, EMBO J, V21, P2778, DOI 10.1093/emboj/21.11.2778; Pilon-Smits EAH, 2009, CURR OPIN BIOTECH, V20, P207, DOI 10.1016/j.copbio.2009.02.001; Plateau P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44761; Qian Y, 2013, CHEMBIOCHEM, V14, P1410, DOI 10.1002/cbic.201300396; Reich HJ, 2016, ACS CHEM BIOL, V11, P821, DOI 10.1021/acschembio.6b00031; SHRIFT A, 1976, PLANT PHYSIOL, V58, P248, DOI 10.1104/pp.58.3.248; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SINGH R, 1991, J ORG CHEM, V56, P6931, DOI 10.1021/jo00024a041; So BR, 2011, J BIOL CHEM, V286, P31810, DOI 10.1074/jbc.M111.232611; Sors TG, 2005, PLANT J, V42, P785, DOI 10.1111/j.1365-313X.2005.02413.x; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Turner RJ, 1998, BIOMETALS, V11, P223, DOI 10.1023/A:1009290213301; Vargas-Rodriguez O, 2018, RNA BIOL, V15, P471, DOI 10.1080/15476286.2018.1474074; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weerapana E, 2007, NAT PROTOC, V2, P1414, DOI 10.1038/nprot.2007.194; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; WEISS KF, 1965, J BACTERIOL, V90, P857, DOI 10.1128/JB.90.4.857-862.1965; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010; YOUNG PA, 1975, ARCH BIOCHEM BIOPHYS, V171, P483, DOI 10.1016/0003-9861(75)90057-0; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; Zayed A, 1998, PLANTA, V206, P284, DOI 10.1007/s004250050402; Zhang CM, 2003, J MOL BIOL, V327, P911, DOI 10.1016/S0022-2836(03)00241-9; ZIEVE R, 1984, SCI TOTAL ENVIRON, V32, P197, DOI 10.1016/0048-9697(84)90131-1	62	10	10	4	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12855	12865		10.1074/jbc.RA119.008219	http://dx.doi.org/10.1074/jbc.RA119.008219			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31296657	Green Published, hybrid			2022-12-26	WOS:000484414600026
J	Fell, GL; Anez-Bustillos, L; Dao, DT; Baker, MA; Nandivada, P; Cho, BS; Pan, A; O'Loughlin, AA; Nose, V; Gura, KM; Puder, M				Fell, Gillian L.; Anez-Bustillos, Lorenzo; Dao, Duy T.; Baker, Meredith A.; Nandivada, Prathima; Cho, Bennet S.; Pan, Amy; O'Loughlin, Alison A.; Nose, Vania; Gura, Kathleen M.; Puder, Mark			Alpha-tocopherol in intravenous lipid emulsions imparts hepatic protection in a murine model of hepatosteatosis induced by the enteral administration of a parenteral nutrition solution	PLOS ONE			English	Article							FATTY-ACID DEFICIENCY; FISH-OIL; LIVER-DISEASE; GENE-EXPRESSION; PPAR-GAMMA; STEATOSIS; FAILURE; MICE; SUPPLEMENTATION; INFLAMMATION	Intestinal failure-associated liver disease (IFALD) is a risk of parenteral nutrition (PN)-dependence. Intravenous soybean oil-based parenteral fat can exacerbate the risk of IFALD while intravenous fish oil can minimize its progression, yet the mechanisms by which soybean oil harms and fish oil protects the liver are uncertain. Properties that differentiate soybean and fish oils include a-tocopherol and phytosterol content. Soybean oil is rich in phytosterols and contains little a-tocopherol. Fish oil contains abundant a-tocopherol and little phytosterols. This study tested whether a-tocopherol confers hepatoprotective properties while phytosterols confer hepatotoxicity to intravenous fat emulsions. Utilizing emulsions formulated in the laboratory, a soybean oil emulsion (SO) failed to protect from hepatosteatosis in mice administered a PN solution enterally. An emulsion of soybean oil containing alpha-tocopherol (SO+AT) preserved normal hepatic architecture. A fish oil emulsion (FO) and an emulsion of fish oil containing phytosterols (FO+P) protected from steatosis in this model. Expression of hepatic acetyl CoA carboxylase (ACC) and peroxisome proliferator-activated receptor gamma (PPAR gamma), was increased in animals administered SO. ACC and PPAR. levels were comparable to chow-fed controls in animals receiving SO+AT, FO, and FO+P. This study suggests a hepatoprotective role for alpha-tocopherol in liver injury induced by the enteral administration of a parenteral nutrition solution. Phytosterols do not appear to compromise the hepatoprotective effects of fish oil.	[Fell, Gillian L.; Anez-Bustillos, Lorenzo; Dao, Duy T.; Baker, Meredith A.; Cho, Bennet S.; Pan, Amy; O'Loughlin, Alison A.; Puder, Mark] Boston Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA; [Nandivada, Prathima] Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA; [Nose, Vania] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Gura, Kathleen M.] Boston Childrens Hosp, Dept Pharm, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital	Puder, M (corresponding author), Boston Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA.	mark.puder@childrens.harvard.edu		Cho, Bennet/0000-0002-1440-0019; Dao, Duy/0000-0001-9915-7080	National Institutes of Health [1F32DK104525-01, 5T32HL007734, T35HL110843]; Howard Hughes Medical Institute Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL110843, T32HL007734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK104525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by: GLF: National Institutes of Health, Grant 1F32DK104525-01; MAB and DTD: National Institutes of Health, Grant 5T32HL007734; BSC: National Institutes of Health, Grant T35HL110843, and Howard Hughes Medical Institute Training Grant (no number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwayn IPJ, 2005, PEDIATR RES, V57, P445, DOI 10.1203/01.PDR.0000153672.43030.75; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Bedoucha M, 2001, J HEPATOL, V35, P17, DOI 10.1016/S0168-8278(01)00066-6; Calkins KL, 2014, JPEN-PARENTER ENTER, V38, P682, DOI 10.1177/0148607113495416; Carter BA, 2007, PEDIATR RES, V62, P301, DOI 10.1203/PDR.0b013e3181256492; de Meijer VE, 2009, JPEN-PARENTER ENTER, V33, P541, DOI 10.1177/0148607109332773; Diamond IR, 2009, J PEDIATR GASTR NUTR, V48, P209, DOI 10.1097/MPG.0b013e318182c8f6; Driscoll DF, 2007, AM J HEALTH-SYST PH, V64, P2032, DOI 10.2146/ajhp070097; Driscoll DF, 2006, PHARM RES-DORDR, V23, P1959, DOI 10.1007/s11095-006-9092-4; El Kasmi KC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006898; El-Basioni BMM, 2017, WIREL COMMUN MOB COM, P1, DOI 10.1155/2017/7493269; Fell GL, 2017, JPEN-PARENTER ENTER, V41, P181, DOI 10.1177/0148607116640275; Gupte AA, 2010, HEPATOLOGY, V52, P2001, DOI 10.1002/hep.23941; Gura KM, 2006, PEDIATRICS, V118, pE197, DOI 10.1542/peds.2005-2662; HOLMAN RT, 1960, J NUTR, V70, P405, DOI 10.1093/jn/70.3.405; Hosui A, 2017, HEPATOL RES, V47, P813, DOI 10.1111/hepr.12816; Hukkinen M, 2017, JPEN-PARENTER ENTER, V41, P1014, DOI 10.1177/0148607116637855; Jeppesen PB, 1998, AM J CLIN NUTR, V68, P126, DOI 10.1093/ajcn/68.1.126; Jia Y, 2016, J NUTR BIOCHEM, V28, P9, DOI [10.1016/j.jnutbio.2015.09.015, 10.20463/jenb.2016.0055]; Kalish BT, 2013, AM J PHYSIOL-GASTR L, V305, pG818, DOI 10.1152/ajpgi.00106.2013; Kurvinen A, 2012, J PEDIATR GASTR NUTR, V54, P803, DOI 10.1097/MPG.0b013e3182474118; Lam HS, 2014, NEONATOLOGY, V105, P290, DOI 10.1159/000358267; Le HD, 2012, JPEN-PARENTER ENTER, V36, P431, DOI 10.1177/0148607111414580; Maruyama H, 2016, INT J MED SCI, V13, P169, DOI 10.7150/ijms.13581; Mascioli EA, 1996, NUTRITION, V12, P245, DOI 10.1016/S0899-9007(96)90850-3; Meisel JA, 2011, J PEDIATR SURG, V46, P666, DOI 10.1016/j.jpedsurg.2010.08.018; Muto M, 2017, JPEN-PARENTER ENTER, V41, P575, DOI 10.1177/0148607115612030; Ng K, 2016, JPEN-PARENTER ENTER, V40, P656, DOI 10.1177/0148607114567900; Pharmacopoeia TUS, 2012, GLOB SIZ DISTR LIP I, P321; Puder M, 2009, ANN SURG, V250, P395, DOI 10.1097/SLA.0b013e3181b36657; Saboori S, 2015, EUR J CLIN NUTR, V69, P867, DOI 10.1038/ejcn.2014.296; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shing CM, 2014, CARDIOVASC THER, V32, P270, DOI 10.1111/1755-5922.12096; Sorrell M, 2016, J PEDIAT GASTROENTER, V1; Tahan V, 2007, DIGEST DIS SCI, V52, P3465, DOI 10.1007/s10620-007-9756-x; Teng J, 2015, J PEDIATR GASTR NUTR, V60, P702, DOI 10.1097/MPG.0000000000000739; Xu ZD, 2015, EUR J LIPID SCI TECH, V117, P15, DOI 10.1002/ejlt.201400182; Xu ZD, 2012, NUTRIENTS, V4, P904, DOI 10.3390/nu4080904; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zheng JY, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010055	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0217155	10.1371/journal.pone.0217155	http://dx.doi.org/10.1371/journal.pone.0217155			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295333	Green Published, Green Submitted, gold			2022-12-26	WOS:000484951800004
J	Lundeen, T; Musange, S; Azman, H; Nzeyimana, D; Murindahabi, N; Butrick, E; Walker, D				Lundeen, Tiffany; Musange, Sabine; Azman, Hana; Nzeyimana, David; Murindahabi, Nathalie; Butrick, Elizabeth; Walker, Dilys			Nurses' and midwives' experiences of providing group antenatal and postnatal care at 18 health centers in Rwanda: A mixed methods study	PLOS ONE			English	Article								Background The East Africa Preterm Birth Initiative-Rwanda began a cluster randomized controlled trial of group antenatal care (ANC) and postnatal care (PNC) in Rwanda in 2017. That trial will report its primary outcome, gestational length at birth, after data collection concludes in 2019. This nested study includes providers of ANC and/or PNC at the 18 health centers randomized to provide the group model of ANC/PNC and the 18 health centers randomized to continue providing ANC/PNC in the traditional, individual visit model. The objective of this study is to understand the experiences of providers of group ANC/PNC and compare their job satisfaction and perceived stress with individual ANC/PNC providers. Methods We collected both quantitative and qualitative data from providers (nurses and midwives) who were recruited by health center directors to participate as group ANC and PNC facilitators at intervention sites and from a similar number of providers of standard ANC and PNC at control sites. Quantitative data was collected with questionnaires administered at baseline and approximately 9 months later (follow up). Qualitative data was collected in 3 focus groups of group ANC/PNC providers conducted one year after group care began. Results Eighty-six percent of nurses and midwives surveyed who implemented group ANC and PNC reported that they prefer group care to the traditional individual model of ANC and PNC. Perceived stress levels and job satisfaction results were similar between groups. Mixed focus group discussions among both nurses and midwives experienced in group ANC and PNC suggest that the group model of care has advantages for both service beneficiaries and providers. When providers described implementation challenges, their peers in the focus groups offered them suggestions to cope and improve service delivery. Discussion These results are consistent with studies of providers of group ANC and PNC in other LMIC contexts with respect to the perceived benefits of group care. This study adds new insights into the ways peer providers can help one another solve implementation problems. When given the opportunity to meet as a group, these study participants offered one another peer support and shared knowledge about best practices for successful implementation of group ANC/PNC.	[Lundeen, Tiffany; Azman, Hana; Butrick, Elizabeth; Walker, Dilys] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Musange, Sabine; Nzeyimana, David; Murindahabi, Nathalie] Univ Rwanda, Sch Publ Hlth, Kigali, Rwanda; [Walker, Dilys] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	University of California System; University of California San Francisco; University of Rwanda; University of California System; University of California San Francisco	Lundeen, T (corresponding author), Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA.	tiffany.lundeen@gmail.com	Musange, Sabine F./AAC-3652-2019	Nzeyimana, David/0000-0002-1389-7107	East Africa Preterm Birth Initiative - Bill and Melinda Gates Foundation [OPP1107312]; East Africa Preterm Birth Initiative	East Africa Preterm Birth Initiative - Bill and Melinda Gates Foundation; East Africa Preterm Birth Initiative	This trial is supported by the East Africa Preterm Birth Initiative, a multi-year, multi-country effort generously funded by the Bill and Melinda Gates Foundation (OPP1107312). All the authors had some portion of their salary supported by the East Africa Preterm Birth Initiative.	Baldwin K, 2011, J PERINAT ED; Benediktsson I, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S5; Bloomfield J, 2013, J MIDWIFERY WOMENS H; Cohen S, 1983, J HLTH SOC BEHAV; Gaudion A., 2011, BRIT J MIDWIFERY, V19, P796, DOI DOI 10.12968/BJ0M.2011.19.12.796; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kamugundu D, RWANDA MASTER FACILI; Kania-Richmond A, 2017, MATERN CHILD HLTH J, V21, P1327, DOI 10.1007/s10995-016-2236-1; Klima C, 2009, J MIDWIFERY WOMENS H; Lori JR, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1414-5; Mazzoni SE, 2017, AM J OBSTET GYNECOLO; McNeil DA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S6; National Institute of Statistics of Rwanda Ministry of Finance and Economic Planning Ministry of Health The DHS Program ICF International, 2016, RWAND DEM HLTH SURV; Novick G, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.03.026; Patil CL, 2017, INT J GYNECOL OBSTET, V139, P290, DOI 10.1002/ijgo.12324; Patil CL, 2013, MIDWIFERY, V29, P1190, DOI 10.1016/j.midw.2013.05.008; Pope C, 2000, BMJ; Rising SS, 2004, J MIDWIFERY WOM HEAL, V49, P398, DOI 10.1111/j.1542-2011.2004.tb04433.x; Sayinzoga F, 2018, J MIDWIFERY WOMENS H; Sayinzoga F, 2018, J MIDWIFER      0925; Teate A, 2013, WOMEN BIRTH; WHO, 2016, 2030A6938 WHO	22	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219471	10.1371/journal.pone.0219471	http://dx.doi.org/10.1371/journal.pone.0219471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295335	Green Submitted, Green Published, gold			2022-12-26	WOS:000484951800036
J	Sakamoto, T; Ishio, Y; Ishida, Y; Mogi, K; Kikusui, T				Sakamoto, Takashi; Ishio, Yukino; Ishida, Yuiko; Mogi, Kazutaka; Kikusui, Takefumi			Low maternal care enhances the skin barrier resistance of offspring in mice	PLOS ONE			English	Article							GENE-EXPRESSION; DRY SKIN; BEHAVIOR; DEPRIVATION; MECHANISMS; SEPARATION; RESPONSES; FEMALE; FIBERS; STIMULATION	Deprivation of maternal care via lack of somatosensory input causes offspring to experience adverse consequences, especially in the central nervous system. However, little is known about the developmental effect of maternal care on peripheral tissues such as the skin, which includes cutaneous sensory neurons. In the present study, we examined the involvement of maternal care in the development of the skin. We investigated offspring reared by early-weaned mother mice who spontaneously showed lower frequency of licking/grooming on nursing. Offspring of early-weaned mothers showed higher resistance against skin barrier disruption than did offspring of normally-weaned mothers, and had normal skin barrier function in the intact trunk skin. In the dorsal root ganglion of early-weaned mother offspring, we also found up-regulation of mRNA levels of the Mas-related G-protein coupled receptor B4 (MrgprB4), which is a marker of sensory neurons that detect gentle stroking. We further found that levels of MrgprB4 mRNA were correlated with the enhancement of skin resistance. The present findings suggest that maternal somatosensory inputs have a developmental impact on the cutaneous sensory neurons of the skin in offspring. Interestingly, the present results suggest that lower maternal care has a benefit on the skin resistance. This provides important information for understanding the development of peripheral tissues in offspring reared under severe conditions such as lower maternal care in the wild.	[Sakamoto, Takashi; Ishio, Yukino; Ishida, Yuiko; Mogi, Kazutaka; Kikusui, Takefumi] Azabu Univ, Dept Anim Sci & Biotechnol, Sagamihara, Kanagawa, Japan	Azabu University	Mogi, K (corresponding author), Azabu Univ, Dept Anim Sci & Biotechnol, Sagamihara, Kanagawa, Japan.	mogik@azabu-u.ac.jp		Mogi, Kazutaka/0000-0002-0689-9761	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan [18H02356, 15H02479]; Kao Corporation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kao Corporation	This work was supported by the Japan Society for the Promotion of Science and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (18H02356 to KM and 15H02479 to TK). Kao Corporation provided support in the form of salaries for authors [TS] and research materials, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brauer J, 2016, CEREB CORTEX, V26, P3544, DOI 10.1093/cercor/bhw137; Buhe V, 2016, ACTA DERM-VENEREOL, V96, P314, DOI 10.2340/00015555-2235; Chatterjee D, 2007, BRAIN RES, V1158, P11, DOI 10.1016/j.brainres.2007.04.069; Cheng C, 2015, J NEUROPATH EXP NEUR, V74, P804, DOI 10.1097/NEN.0000000000000219; Christie KJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4670; Eckert RL, 2005, J INVEST DERMATOL, V124, P481, DOI 10.1111/j.0022-202X.2005.23627.x; Figueiredo IL, 2016, NUTRITION, V32, P1019, DOI 10.1016/j.nut.2016.02.016; Franklin TB, 2012, NEURON, V75, P747, DOI 10.1016/j.neuron.2012.08.016; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Gargiulo S, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-255; Giachino C, 2007, NEUROSCIENCE, V145, P568, DOI 10.1016/j.neuroscience.2006.12.042; Gonzalez A, 2001, DEV PSYCHOBIOL, V38, P11, DOI 10.1002/1098-2302(2001)38:1<11::AID-DEV2>3.0.CO;2-B; Gracia-Rubio I, 2016, PROG NEURO-PSYCHOPH, V65, P104, DOI 10.1016/j.pnpbp.2015.09.003; Gruber R, 2015, AM J PATHOL, V185, P2777, DOI 10.1016/j.ajpath.2015.06.021; Gueniche A, 2010, EUR J DERMATOL, V20, P731, DOI 10.1684/ejd.2010.1108; Irmak MK, 2010, MED HYPOTHESES, V75, P162, DOI 10.1016/j.mehy.2010.02.011; Johnson JG, 1999, ARCH GEN PSYCHIAT, V56, P600, DOI 10.1001/archpsyc.56.7.600; Kanari K, 2005, BEHAV BRAIN RES, V156, P45, DOI 10.1016/j.bbr.2004.05.008; Kikusui T, 2005, BEHAV BRAIN RES, V162, P200, DOI 10.1016/j.bbr.2005.03.013; Kikusui T, 2007, BRAIN RES, V1133, P115, DOI 10.1016/j.brainres.2006.11.031; Kikusui T, 2006, BEHAV BRAIN RES, V175, P96, DOI 10.1016/j.bbr.2006.08.007; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Li M, 2013, BRAIN RES, V1518, P82, DOI 10.1016/j.brainres.2013.04.026; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lovic V, 2004, BEHAV BRAIN RES, V148, P209, DOI 10.1016/S0166-4328(03)00206-7; Luo JL, 2011, J PAIN, V12, P600, DOI 10.1016/j.jpain.2010.11.005; Maitre NL, 2017, CURR BIOL, V27, P1048, DOI 10.1016/j.cub.2017.02.036; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Miyamoto T, 2002, JPN J PHARMACOL, V88, P285, DOI 10.1254/jjp.88.285; Mogi K, 2016, DEV PSYCHOBIOL, V58, P1034, DOI 10.1002/dev.21437; Ohlsson A, 2013, PEDIATRICS, V131, pE881, DOI 10.1542/peds.2012-2121; Ohta K, 2014, INT J DEV NEUROSCI, V33, P15, DOI 10.1016/j.ijdevneu.2013.10.007; Okano J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166215; PANDEY SC, 1989, INDIAN J EXP BIOL, V27, P87; Pedersen L, 2006, ACTA DERM-VENEREOL, V86, P308, DOI 10.2340/00015555-0080; Plotsky PM, 2005, NEUROPSYCHOPHARMACOL, V30, P2192, DOI 10.1038/sj.npp.1300769; Recamier-Carballo S, 2017, BEHAV PHARMACOL, V28, P545, DOI 10.1097/FBP.0000000000000324; Roggenkamp D, 2013, J INVEST DERMATOL, V133, P1620, DOI 10.1038/jid.2012.464; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Shin SY, 2016, NEUROSCIENCE, V316, P221, DOI 10.1016/j.neuroscience.2015.12.041; Stander S, 2009, EXP DERMATOL, V18, P417, DOI 10.1111/j.1600-0625.2009.00861.x; Takatsuru Y, 2009, BRAIN RES, V1294, P45, DOI 10.1016/j.brainres.2009.07.092; Tominaga M, 2007, J DERMATOL SCI, V48, P103, DOI 10.1016/j.jdermsci.2007.06.003; TRICKETT PK, 1995, DEV REV, V15, P311, DOI 10.1006/drev.1995.1012; Tsuruta D, 2002, TRENDS CELL BIOL, V12, P355, DOI 10.1016/S0962-8924(02)02316-4; Vrontou S, 2013, NATURE, V493, P669, DOI 10.1038/nature11810; Xie K, 2018, P NATL ACAD SCI USA, V115, pE2348, DOI 10.1073/pnas.1707337115; Yuki T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161759	49	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219674	10.1371/journal.pone.0219674	http://dx.doi.org/10.1371/journal.pone.0219674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295326	Green Submitted, Green Published, gold			2022-12-26	WOS:000484951800060
J	Salatkaite, S; Siupsinskas, L; Gudas, R				Salatkaite, Saule; Siupsinskas, Laimonas; Gudas, Rimtautas			Translation and cultural adaptation of Lithuanian version of the anterior cruciate ligament return to sport after injury (ACL-RSI) scale	PLOS ONE			English	Article							RECONSTRUCTION; VALIDATION; LEVEL	Purpose To translate, cross-culturally adapt and validate the scale to Lithuanian. Methods The process of translation and cultural adaptation followed the recommendations of international guidelines. All included patients were after unilateral ACL reconstruction. Study participants completed Tegner Activity Scale, IKDC and ACL-RSI-Lt questionnaires. Reliability, construct validity and internal consistency were measured. Results Study included sixty-five patients after ACL reconstruction: mean age 25.55 +/- 6.77, mean height 180.91 +/- 11.78 cm, mean weight 79.12 +/- 14.88 kg and mean BMI 24.01 +/- 2.90. The ACL-RSI-Lt showed excellent internal consistency (Cronbanch's alpha 0.94). Scale scores were correlated with IKDC score (r = 0.637, p < 0.001) and IKDC subscales (r = 0.530-0.581, p < 0.001) and Tegner activity score (r = 0.303-0.493, p < 0.001). Tegner activity score before injury was significantly higher than after ACLR (6.95 +/- 1.49 vs. 6.1 +/- 1.37, p < 0.001). Conclusions The ACL-RSI is successfully translated into Lithuanian (ACL-RSI-Lt). It is valid and reliable scale to evaluate the psychological impact of returning to sports in Lithuanian patients after ACLR surgery.	[Salatkaite, Saule; Siupsinskas, Laimonas; Gudas, Rimtautas] Lithuanian Univ Hlth Sci, Med Acad, Dept Sports Med, Kaunas, Lithuania; [Gudas, Rimtautas] Hosp Lithuanian Univ Hlth Sci, Sports Trauma & Arthroscop Unit, Kaunas, Lithuania	Lithuanian University of Health Sciences; Hospital of Lithuanian University of Health Sciences Kauno Klinikos	Salatkaite, S (corresponding author), Lithuanian Univ Hlth Sci, Med Acad, Dept Sports Med, Kaunas, Lithuania.	saule.salatkaite@lsmuni.lt						Andriacchi TP, 2009, J BONE JOINT SURG AM, V91A, P95, DOI 10.2106/JBJS.H.01408; Ardern CL, 2013, AM J SPORT MED, V41, P1549, DOI 10.1177/0363546513489284; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bohu Y, 2015, KNEE SURG SPORT TR A, V23, P1192, DOI 10.1007/s00167-014-2942-4; Brand E, 2009, ORTHOPEDICS, V32, P335, DOI 10.3928/01477447-20090502-01; Briggs KK, 2009, AM J SPORT MED, V37, P898, DOI 10.1177/0363546508330149; Chen TW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183095; Chmielewski T, 2019, KNEE SURG SPORT TR A, V27, P397, DOI 10.1007/s00167-018-5048-6; FERMANIAN J, 1984, REV EPIDEMIOL SANTE, V32, P408; Harput G, 2017, KNEE SURG SPORT TR A, V25, P159, DOI 10.1007/s00167-016-4288-6; Irrgang JJ, 2001, AM J SPORT MED, V29, P600, DOI 10.1177/03635465010290051301; Kvist J, 2013, SCAND J MED SCI SPOR, V23, P568, DOI 10.1111/j.1600-0838.2011.01438.x; Lai CCH, 2018, BRIT J SPORT MED, V52, P128, DOI 10.1136/bjsports-2016-096836; Langford JL, 2009, BRIT J SPORT MED, V43, P377, DOI 10.1136/bjsm.2007.044818; Lentz TA, 2015, AM J SPORT MED, V43, P345, DOI 10.1177/0363546514559707; Lyman S, 2009, J BONE JOINT SURG AM, V91A, P2321, DOI 10.2106/JBJS.H.00539; McGrath TM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116688443; Paterno MV, 2018, SPORTS HEALTH, V10, P228, DOI 10.1177/1941738117745806; Rosso Federica, 2018, Joints, V6, P23, DOI 10.1055/s-0038-1636931; Shea KG, 2015, J BONE JOINT SURG AM, V97A, P672, DOI 10.2106/JBJS.N.01257; Silva LO, 2018, BRAZ J PHYS THER, V22, P127, DOI 10.1016/j.bjpt.2017.09.006; Slagers AJ, 2017, J SPORT SCI, V35, P393, DOI 10.1080/02640414.2016.1167230; Swanenburg J, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13976; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Trigsted SM, 2018, KNEE SURG SPORT TR A, V26, P3682, DOI 10.1007/s00167-018-4950-2; Webster KE, 2008, PHYS THER SPORT, V9, P9, DOI 10.1016/j.ptsp.2007.09.003; Welling W, 2018, KNEE SURG SPORT TR A, V26, P3636, DOI 10.1007/s00167-018-4916-4	27	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219593	10.1371/journal.pone.0219593	http://dx.doi.org/10.1371/journal.pone.0219593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295302	gold, Green Published, Green Submitted			2022-12-26	WOS:000484951800049
J	Laneri, K; Cabella, B; Prado, PI; Coutinho, RM; Kraenkel, RAP				Laneri, Karina; Cabella, Brenno; Prado, Paulo Inacio; Coutinho, Renato Mendes; Kraenkel, Roberto Andre Prime			Climate drivers of malaria at its southern fringe in the Americas	PLOS ONE			English	Article							ANOPHELES-PSEUDOPUNCTIPENNIS; MODELS; ABUNDANCE; TRANSMISSION; TEMPERATURE; CAUSALITY; INFERENCE	In this work we analyze potential environmental drivers of malaria cases in Northwestern Argentina. We inspect causal links between malaria and climatic variables by means of the convergent cross mapping technique, which provides a causality criterion from the theory of dynamic systems. Analysis is based on 12 years of weekly malaria P. vivax cases in Tartagal, Salta, Argentina-at the southern fringe of malaria incidence in the Americas-together with humidity and temperature time-series spanning the same period. Our results show that there are causal links between malaria cases and both maximum temperature, with a delay of five weeks, and minimum temperature, with delays of zero and twenty two weeks. Humidity is also a driver of malaria cases, with thirteen weeks delay between cause and effect. Furthermore we also determined the sign and strength of the effects. Temperature has always a positive non-linear effect on cases, with maximum temperature effects more pronounced above 25 degrees C and minimum above 17 degrees C, while effects of humidity are more intricate: maximum humidity above 85% has a negative effect, whereas minimum humidity has a positive effect on cases. These results might be signaling processes operating at short (below 5 weeks) and long (over 12 weeks) time delays, corresponding to effects related to parasite cycle and mosquito population dynamics respectively. The non-linearities found for the strength of the effect of temperature on malaria cases make warmer areas more prone to higher increases in the disease incidence. Moreover, our results indicate that an increase of extreme weather events could enhance the risks of malaria spreading and re-emergence beyond the current distribution. Both situations, warmer climate and increase of extreme events, will be remarkably increased by the end of the century in this hot spot of climate change.	[Laneri, Karina] Ctr Atom Bariloche, CONICET, Grp Fis Estadist & Interdisciplinaria, San Carlos De Bariloche, Rio Negro, Argentina; [Cabella, Brenno; Kraenkel, Roberto Andre Prime] Univ Estadual Paulista UNESP, Inst Fis Teor, Sao Paulo, SP, Brazil; [Prado, Paulo Inacio] Univ Sao Paulo, Inst Biociencias, LAGE, Dept Ecol, Sao Paulo, SP, Brazil; [Coutinho, Renato Mendes] Univ Fed ABC, CMCC, Santo Andre, SP, Brazil	Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Federal do ABC (UFABC)	Laneri, K (corresponding author), Ctr Atom Bariloche, CONICET, Grp Fis Estadist & Interdisciplinaria, San Carlos De Bariloche, Rio Negro, Argentina.	karinalaneri@gmail.com	Cabella, Brenno C.T./G-6169-2012; Prado, Paulo Inácio/AAN-6512-2021; Prado, Paulo I/G-3353-2012; Coutinho, Renato M/H-9133-2017; Kraenkel, Roberto A/B-5479-2010	Cabella, Brenno C.T./0000-0003-2214-645X; Prado, Paulo Inácio/0000-0002-7174-5005; Coutinho, Renato M/0000-0002-2828-8558; Kraenkel, Roberto A/0000-0001-5602-5184; Laneri, Karina/0000-0001-8536-4695	ICTP-South American Institute for Fundamental Research (ICTP-SAIFR), via the FAPESP [2016/01343-7]; CAPES through a PNPD fellowship [88882.317469/2019-01]; CNPq (Brazil); FAPESP [2014/23497-0]	ICTP-South American Institute for Fundamental Research (ICTP-SAIFR), via the FAPESP; CAPES through a PNPD fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	K.L. is member of CONICET, Argentina. We thank the ICTP-South American Institute for Fundamental Research (ICTP-SAIFR) for support, via the FAPESP grant #2016/01343-7. B.C. thanks CAPES for support through a PNPD fellowship #88882.317469/2019-01. R.A.K. and P.I.P. thank CNPq (Brazil) for partial support. R.M.C. thanks FAPESP for partial support through a fellowship (grant #2014/23497-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank two anonymous reviewers for their careful reading and helpful comments on the manuscript. We thank the Ministry of Health of Argentina and the National Meteorological Service of Argentina for providing the datasets. K.L. is member of CONICET, Argentina. We thank the ICTP-South American Institute for Fundamental Research (ICTP-SAIFR) for support, via the FAPESP grant #2016/01343-7. B.C. thanks Capes for support through a PNPD fellowship. R.A.K. and P.I.P. thank CNPq (Brazil) for partial support. R.M.C. thanks FAPESP for partial support through a fellowship (grant #2014/23497-0).	Alonso D, 2010, PROCEEDINGS OF THE R; [Anonymous], 1962, WHO MONOGRAPHIES SER; [Anonymous], 2001, THESIS; Baeza A, 2013, P NATL ACAD SCI USA, V110, P15157, DOI 10.1073/pnas.1305728110; Baskerville EB, 2017, P NATL ACAD SCI USA, V114, pE2270, DOI 10.1073/pnas.1700369114; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; Becking LE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075996, 10.1371/journal.pone.0079276]; Bhadra A, 2011, J AM STAT ASSOC, V106, P440, DOI 10.1198/jasa.2011.ap10323; Blanford JI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01300; Boyce R, 2016, J INFECT DIS, V214, P1403, DOI 10.1093/infdis/jiw363; Brookshire ENJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8148; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cadena Dacosta A., 1932, CONV MARC CAMB CLIM; Caminade C, 2016, J INFECT DIS, V214, P1300, DOI 10.1093/infdis/jiw368; Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111; Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552; Carter ED., 2012, ENEMY BLOOD MALARIA; Chang CW, 2017, ECOL RES, V32, P785, DOI 10.1007/s11284-017-1469-9; Chen YH, 2004, PHYS LETT A, V324, P26, DOI 10.1016/j.physleta.2004.02.032; Clark AT, 2015, ECOLOGY, V96, P1174, DOI 10.1890/14-1479.1; Cobey S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169050; Juri MJD, 2015, J VECTOR ECOL, V40, P36, DOI 10.1111/jvec.12130; Juri MJD, 2010, ACTA TROP, V115, P234, DOI 10.1016/j.actatropica.2010.04.003; Deyle ER, 2016, P NATL ACAD SCI USA, V113, P13081, DOI 10.1073/pnas.1607747113; Deyle ER, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2258; Deyle ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018295; Espinosa M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004621; Fan BH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06749; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Greenpeace, 2009, DEF PRINC CAUS IN TA; Hostetler JA, 2015, ECOLOGY, V96, P1713, DOI 10.1890/14-1487.1; Ionides EL, 2015, P NATL ACAD SCI USA, V112, P719, DOI 10.1073/pnas.1410597112; Juri MJD, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-18; Juri MJD, 2005, REV SAUDE PUBL, V39, P565, DOI 10.1590/S0034-89102005000400008; Laneri K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000898; Laneria K, 2015, P NATL ACAD SCI USA, V112, P8786, DOI 10.1073/pnas.1419047112; Manguin S, 1996, J AM MOSQUITO CONTR, V12, P619; Marinazzo D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.144103; McBride JC, 2015, NEUROIMAGE-CLIN, V7, P258, DOI 10.1016/j.nicl.2014.12.005; Ohm JR, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2761-4; Roy M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001979; Sattabongkot J, 2004, TRENDS PARASITOL, V20, P192, DOI 10.1016/j.pt.2004.02.001; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Shapiro LLM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003489; Sugihara G, 2017, P NATL ACAD SCI USA, V114, pE2272, DOI 10.1073/pnas.1700998114; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Tajima S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004537; Ushio M, 2018, NATURE, V554, P360, DOI 10.1038/nature25504; van Nes EH, 2015, NAT CLIM CHANGE, V5, P445, DOI [10.1038/nclimate2568, 10.1038/NCLIMATE2568]; Vera C, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025759; Wang XH, 2014, NATURE, V506, P212, DOI 10.1038/nature12915; WHO, 2017, WORLD MALARIA REPORT; WHO WMO UNEP, 2003, CLIMATE CHANGE HLTH; Ye H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14750; Zaidenberg M., 2014, RAZYEIE, VIX, P6	57	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219249	10.1371/journal.pone.0219249	http://dx.doi.org/10.1371/journal.pone.0219249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291316	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800060
J	Menezes, NA; Marinho, MMF				Menezes, Naercio A.; Marinho, Manoela M. F.			A new species of Knodus Eigenmann (Characiformes: Characidae: Stevardiinae) with comments on nuptial tubercles and gill gland in characiform fishes	PLOS ONE			English	Article							TELEOSTEI; BASIN; PHYLOGENY; SERRA; OSTARIOPHYSI; LEBIASINIDAE; BRAZIL	Knodus nuptialis n. sp. is described from the Rio Curua drainage, Rio Xingu basin, Brazil. It can be diagnosed from its congeners by having dentary teeth decreasing gradually in size posteriorly, outer premaxillary teeth row with five cusps, 12-15 branched anal-fin rays and a single humeral spot. The species presents notable sexual dimorphism consisting of densely concentrated nuptial tubercles on head, body, and fins, gill-gland, and bony hooks in the anal fin of mature males. It was found that these sexually dimorphic features are useful and functional in males of the new species only during the reproductive season and after this period, they become atrophied, and eventually disappear. The list of characiform species presenting breeding tubercles is updated and nine species and two genera of the Characidae, Deuterodon and Bryconacidnus, are for the first time reported to have breeding tubercles.	[Menezes, Naercio A.; Marinho, Manoela M. F.] Univ Sao Paulo, Museu Zool, Secao Peixes, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Marinho, MMF (corresponding author), Univ Sao Paulo, Museu Zool, Secao Peixes, Sao Paulo, SP, Brazil.	manoela.marinho@gmail.com	Fapesp, Biota/F-8655-2017; Menezes, Naercio A./K-8763-2013	Fapesp, Biota/0000-0002-9887-8449; Menezes, Naercio A./0000-0002-9634-6051	Fundacao de Amparo a Pesquisa (FAPESP) [2011/50282-7, 2016/19075-9, 2017/09321-5, 2018/114115]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa (FAPESP) (http://www.fapesp.br/) through: 1. The South American Characiform Inventory (2011/50282-7) (NAM, MMFM) 2. Evolution and Diversity of Gymnotiformes (2016/19075-9) (NAM, MMFM) 3. Miniature Characiformes (2017/09321-5; 2018/114115) (NAM, MMFM). Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (http://www.cnpq.br/) (NAM).	Burns JR, 1996, COPEIA, P627; CHERNOFF B, 1990, P ACAD NAT SCI PHILA, V142, P261; de Oliveira CLC, 2012, NEOTROP ICHTHYOL, V10, P349, DOI 10.1590/S1679-62252012005000005; Eigenmann CH, 1917, MEMOIRS MUSEUM COMP, V23, P1; Eigenmann CH, 1914, NEW FISHES W COLOMBI, V19, P1; Ferreira K., 2007, THESIS; FINK W L, 1976, Proceedings of the Biological Society of Washington, V88, P331; Fink W.L., 1974, Smithsonian Contributions to Zoology, VNo. 172, P1; Fricke R, 2019, CATALOG FISHES ELECT; Gery J., 1977, CHARACOIDS WORLD; Gonçalves Taís K., 2005, Neotrop. ichthyol., V3, P433, DOI 10.1590/S1679-62252005000300012; Ingenito LFS, 2014, NEOTROP ICHTHYOL, V12, P281, DOI 10.1590/1982-0224-20130117; Ingenito LFS, 2005, COPEIA, P765; Lima F.C.T., 2013, PEIXES RIO MADEIRA, VI, P213; Londono-Burbano A, 2011, NEOTROP ICHTHYOL, V9, P709, DOI 10.1590/S1679-62252011000400003; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; Marinho MMF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183069; Meek S., 1916, FIELD MUS NAT HIST Z, V10, P217; MENEZES NA, 1990, P BIOL SOC WASH, V103, P380; Mirakhorlo M, 2018, COMPUT METHOD BIOMEC, V21, P548, DOI 10.1080/10255842.2018.1490952; MYERS GEORGE S., 1930, PROC BIOL SOC WASHINGTON, V43, P65; Netto-Ferreira AL, 2012, NEOTROP ICHTHYOL, V10, P487, DOI 10.1590/S1679-62252012000300002; Netto-Ferreira AL, 2011, NEOTROP ICHTHYOL, V9, P767, DOI 10.1590/S1679-62252011000400008; Pavanelli CS, 2006, COPEIA, P89; Pavanelli CS, 2003, COPEIA, P337; Protogino LC, 2006, ZOOTAXA, P1, DOI 10.11646/zootaxa.1297.1.1; Roman-Valencia C, 2000, REV BIOL TROP, V48, P449; Social Science Statistics, 2018, T TEST CALC 2 IND ME; Taphorn DC, 1992, GUANARA MONOGRAFIAS; Tavares DO, 1854, THESIS; Taylor WR, 1985, CYBIUM, V9, P10; Teran GE, 2017, NEOTROP ICHTHYOL, V15, DOI 10.1590/1982-0224-20160165; Teran GE, 2015, ACTA ZOOL-STOCKHOLM, V96, P335, DOI 10.1111/azo.12081; Thomaz AT, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0403-4; Torres-Mejia M, 2005, COPEIA, P812; van der Sleen Peter, 2018, P128; Vari RP, 2004, P BIOL SOC WASH, V117, P551; Wiley ML., 1970, B AM MUS NAT HIST, V143, P145; Zanata AM, 2008, ZOOTAXA, P28, DOI 10.11646/zootaxa.1908.1.2; Zanata Angela M., 2004, Neotrop. ichthyol., V2, P45, DOI 10.1590/S1679-62252004000200001; Zanata AM, 2018, ZOOTAXA, V4438, P471, DOI 10.11646/zootaxa.4438.3.3	41	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0217915	10.1371/journal.pone.0217915	http://dx.doi.org/10.1371/journal.pone.0217915			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291277	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800016
J	Osumi, M; Nobusako, S; Zama, T; Yokotani, N; Shimada, S; Maeda, T; Morioka, S				Osumi, Michihiro; Nobusako, Satoshi; Zama, Takuro; Yokotani, Naho; Shimada, Sotaro; Maeda, Takaki; Morioka, Shu			The relationship and difference between delay detection ability and judgment of sense of agency	PLOS ONE			English	Article							SELF; NEUROREHABILITATION; SCHIZOPHRENIA; ATTRIBUTION; INTEGRATION; PAIN	Judgment of agency involves the comparison of motor intention and proprioceptive/visual feedback, in addition to a range of cognitive factors. However, few studies have experimentally examined the differences or correlations between delay detection ability and judgment of agency. Thus, the present study investigated the relationship between delay detection ability and agency judgment using the delay detection task and the agency attribution task. Fifty-eight participants performed the delay detection and agency attribution tasks, and the time windows of each measure were analyzed using logistic curve fitting. The results revealed that the time window of judgment of agency was significantly longer than that of delay detection, and there was a slight correlation between the time windows in each task. The results supported a two-step model of agency, suggesting that judgment of agency involved not only comparison of multisensory information but also several cognitive factors. The study firstly revealed the model in psychophysical experiments.	[Osumi, Michihiro; Nobusako, Satoshi; Yokotani, Naho; Morioka, Shu] Kio Univ, Neurorehabil Res Ctr, Nara, Japan; [Zama, Takuro; Shimada, Sotaro] Meiji Univ, Sch Sci & Technol, Dept Elect & Bioinformat, Kawasaki, Kanagawa, Japan; [Maeda, Takaki] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan	Meiji University; Keio University	Morioka, S (corresponding author), Kio Univ, Neurorehabil Res Ctr, Nara, Japan.	s.morioka@kio.ac.jp	Morioka, Shu/AAH-9229-2019; Shimada, Sotaro/AAC-2484-2019	Morioka, Shu/0000-0003-2853-1789; nobusako, satoshi/0000-0001-7183-5054; ZAMA, Takuro/0000-0002-7125-2112	JSPS KAKENHI [17H05915]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI, Grant-in-Aid for Scientific Research on Innovative Areas "Understanding brain plasticity on body representations to promote their adaptive functions" (Grant Number 17H05915) to SM.; We thank Benjamin Knight, MSc., from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript. Research supported by JSPS KAKENHI, Grant-in-Aid for Scientific Research on Innovative Areas "Understanding brain plasticity on body representations to promote their adaptive functions" (Grant Number 17H05915).	Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Cohen J.E., 1988, STAT POWER ANAL BEHA; Farrer C, 2008, BEHAV NEUROL, V19, P53, DOI 10.1155/2008/425267; Frith CD, 2014, NEUROPSYCHOLOGIA, V55, P137, DOI 10.1016/j.neuropsychologia.2013.09.007; Galderisi S, 2014, CURR TOP BEHAV NEURO, V21, P103, DOI 10.1007/7854_2014_322; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Haggard P, 2017, NAT REV NEUROSCI, V18, P197, DOI 10.1038/nrn.2017.14; Ismail MAF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159619; Kalckert A, 2019, PERCEPTION, V48, P447, DOI 10.1177/0301006619839286; Kong GQ, 2017, CONSCIOUS COGN, V52, P115, DOI 10.1016/j.concog.2017.04.018; Maeda T, 2013, PSYCHIAT RES, V209, P386, DOI 10.1016/j.psychres.2013.04.017; Maeda T, 2012, PSYCHIAT RES, V198, P1, DOI 10.1016/j.psychres.2011.10.021; Marotta A, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00291; Minohara R, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01165; Moore JW, 2012, CONSCIOUS COGN, V21, P59, DOI 10.1016/j.concog.2011.08.010; Nobusako S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00114; Noel JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep17467; Osumi M, 2017, EUR J PAIN, V21, P140, DOI 10.1002/ejp.910; Osumi M, 2018, HUM MOVEMENT SCI, V57, P251, DOI 10.1016/j.humov.2017.09.003; Saposnik G, 2016, LANCET NEUROL, V15, P1019, DOI 10.1016/S1474-4422(16)30121-1; Shimada S, 2005, NEUROIMAGE, V24, P1225, DOI 10.1016/j.neuroimage.2004.10.039; Shimada S, 2010, EXP BRAIN RES, V201, P359, DOI 10.1007/s00221-009-2028-6; Straube B, 2017, EXP BRAIN RES, V235, P3207, DOI 10.1007/s00221-017-5053-x; Sugimori E, 2013, ACTA PSYCHOL, V143, P35, DOI 10.1016/j.actpsy.2013.01.007; Synofzik M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00127; Tsakiris M, 2005, COGNITION, V96, P215, DOI 10.1016/j.cognition.2004.08.002; Villiger M, 2013, NEUROREHAB NEURAL RE, V27, P675, DOI 10.1177/1545968313490999; Wen W, 2017, CONSCIOUS COGN, V53, P89, DOI 10.1016/j.concog.2017.06.008; Wen W, 2015, CONSCIOUS COGN, V37, P83, DOI 10.1016/j.concog.2015.08.012; Wenke D, 2009, PSYCHOL RES-PSYCH FO, V73, P587, DOI 10.1007/s00426-009-0239-x	31	8	9	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219222	10.1371/journal.pone.0219222	http://dx.doi.org/10.1371/journal.pone.0219222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS7KI	31287829	Green Published, Green Submitted, gold			2022-12-26	WOS:000482328300011
J	Hoang, GT; Gantet, P; Nguyen, KH; Phung, NTP; Ha, LT; Nguyen, TT; Lebrun, M; Courtois, B; Pham, XH				Giang Thi Hoang; Gantet, Pascal; Kien Huu Nguyen; Nhung Thi Phuong Phung; Loan Thi Ha; Tuan Thanh Nguyen; Lebrun, Michel; Courtois, Brigitte; Xuan Hoi Pham			Genome-wide association mapping of leaf mass traits in a Vietnamese rice landrace panel	PLOS ONE			English	Article							ORYZA-SATIVA-L.; FLAG LEAF; REPRODUCTIVE STAGE; DROUGHT-RESISTANCE; BIOMASS ACCUMULATION; PHYSIOLOGICAL TRAITS; PHOTOSYNTHETIC RATE; CELLULOSE SYNTHESIS; INBRED POPULATION; GENETIC-BASIS	Leaf traits are often strongly correlated with yield, which poses a major challenge in rice breeding. In the present study, using a panel of Vietnamese rice landraces genotyped with 21,623 single-nucleotide polymorphism markers, a genome-wide association study (GWAS) was conducted for several leaf traits during the vegetative stage. Vietnamese land races are often poorly represented in panels used for GWAS, even though they are adapted to contrasting agrosystems and can contain original, valuable genetic determinants. A panel of 180 rice varieties was grown in pots for four weeks with three replicates under nethouse conditions. Different leaf traits were measured on the second fully expanded leaf of the main tiller, which often plays a major role in determining the photosynthetic capacity of the plant. The leaf fresh weight, turgid weight and dry weight were measured; then, from these measurements, the relative tissue weight and leaf dry matter percentage were computed. The leaf dry matter percentage can be considered a proxy for the photosynthetic efficiency per unit leaf area, which contributes to yield. By a GWAS, thirteen QTLs associated with these leaf traits were identified. Eleven QTLs were identified for fresh weight, eleven for turgid weight, one for dry weight, one for relative tissue weight and one for leaf dry matter percentage. Eleven QTLs presented associations with several traits, suggesting that these traits share common genetic determinants, while one QTL was specific to leaf dry matter percentage and one QTL was specific to relative tissue weight. Interestingly, some of these QTLs colocalize with leaf- or yield-related QTLs previously identified using other material. Several genes within these QTLs with a known function in leaf development or physiology are reviewed.	[Giang Thi Hoang; Kien Huu Nguyen; Nhung Thi Phuong Phung; Loan Thi Ha; Xuan Hoi Pham] Agr Genet Inst, Natl Key Lab Plant Cell Biotechnol, Hanoi, Vietnam; [Gantet, Pascal; Lebrun, Michel] Univ Sci & Technol Hanoi, Hanoi, Vietnam; [Gantet, Pascal; Lebrun, Michel] Univ Montpellier, IRD, Montpellier, France; [Gantet, Pascal] Univ Montpellier, IRD, UMR DIADE, Montpellier, France; [Gantet, Pascal] Palacky Univ Olomouc, Ctr Reg Hand Biotechnol & Agr Res, Dept Mol Biol, Slechtitelu 27, Olomouc, Czech Republic; [Tuan Thanh Nguyen] Vietnam Natl Univ Agr, Fac Agron, Dept Genet & Plant Breeding, Hanoi, Vietnam; [Lebrun, Michel] Univ Montpellier, IRD, UMR LSTM, Montpellier, France; [Courtois, Brigitte] Cirad, UMR AGAP, Montpellier, France; [Courtois, Brigitte] Univ Montpellier, CIRAD, INRA, Montpellier SupAgro, Montpellier, France	Vietnam Academy of Science & Technology (VAST); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Palacky University Olomouc; Vietnam National University of Agriculture (VNUA); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Universite de Montpellier; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier	Pham, XH (corresponding author), Agr Genet Inst, Natl Key Lab Plant Cell Biotechnol, Hanoi, Vietnam.	xuanhapham@gmail.com	Nguyen, Kien/ABE-3796-2020; COURTOIS, Brigitte/A-4004-2009	Pham, Xuan Hoi/0000-0002-9629-2970; COURTOIS, Brigitte/0000-0003-2118-7102; Gantet, Pascal/0000-0003-1314-0187; Huu Nguyen, Kien/0000-0003-3172-3503	French Ministry of Foreign Affairs and International Development; Ministry of Science and Technology of Vietnam, project "Application of functional genomics and association genetics to characterize genes involved in abiotic stresses tolerance in rice"; CGIAR Research Program (CRP) on Rice Agri -food Systems (RICE, 2017-2022)	French Ministry of Foreign Affairs and International Development; Ministry of Science and Technology of Vietnam, project "Application of functional genomics and association genetics to characterize genes involved in abiotic stresses tolerance in rice"; CGIAR Research Program (CRP) on Rice Agri -food Systems (RICE, 2017-2022)(CGIAR)	In addition to institutional funding, this work was supported by the French Ministry of Foreign Affairs and International Development, the Ministry of Science and Technology of Vietnam as part of the project "Application of functional genomics and association genetics to characterize genes involved in abiotic stresses tolerance in rice", and the CGIAR Research Program (CRP) on Rice Agri -food Systems (RICE, 2017-2022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkhalik AF, 2005, THEOR APPL GENET, V110, P1226, DOI 10.1007/s00122-005-1955-2; Al-Tahir F. M. M., 2014, J MED PLANTS STUDIES, V2, P01; Asch F, 1999, FIELD CROP RES, V62, P191, DOI 10.1016/S0378-4290(99)00020-9; Baldoni E, 2013, BIOL PLANTARUM, V57, P691, DOI 10.1007/s10535-013-0331-3; BERDAHL JD, 1972, CROP SCI, V12, P177, DOI 10.2135/cropsci1972.0011183X001200020006x; Berwal MK, 2017, VEGETOS, V31, P1; Birsin M. A., 2005, Tarim Bilimleri Dergisi, V11, P364; CHAPIN FS, 1983, ECOLOGY, V64, P376, DOI 10.2307/1937083; Chaudhary N, 2010, MOL GENET GENOMICS, V283, P13, DOI 10.1007/s00438-009-0495-x; Cho SH, 2013, NEW PHYTOL, V198, P1071, DOI 10.1111/nph.12231; Condon A. G., 2006, Drought adaptation in cereals, P171; Courtois B, 2000, MOL BREEDING, V6, P55, DOI 10.1023/A:1009652326121; Courtois B, 2003, EUPHYTICA, V134, P335, DOI 10.1023/B:EUPH.0000004987.88718.d6; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Farooq M, 2010, J INTEGR PLANT BIOL, V52, P578, DOI 10.1111/j.1744-7909.2010.00955.x; Fujino K, 2008, MOL GENET GENOMICS, V279, P499, DOI 10.1007/s00438-008-0328-3; Hoang GT, 2019, RICE, V12, DOI 10.1186/s12284-018-0258-6; GLADUN IV, 1993, RUSS PLANT PHYSIOL+, V40, P215; Gomez MS., 2006, AM, V2, P161, DOI [10.3844/ajbbsp.2006.161.169, DOI 10.3844/AJBBSP.2006.161.169]; Guru T, 2017, IND J PLANT PHYSL; Hemamalini GS, 2000, EUPHYTICA, V112, P69, DOI 10.1023/A:1003854224905; Hu J, 2010, PLANT MOL BIOL, V73, P283, DOI 10.1007/s11103-010-9614-7; Ishiwata A, 2013, PLANT CELL PHYSIOL, V54, P779, DOI 10.1093/pcp/pct032; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; JENNINGS PETER R., 1964, CROP SCI, V4, P13, DOI 10.2135/cropsci1964.0011183X000400010005x; Jiang GH, 2004, THEOR APPL GENET, V108, P688, DOI 10.1007/s00122-003-1465-z; Jiao BB, 2012, MOL PLANT, V5, P205, DOI 10.1093/mp/ssr081; Kashiwagi J., 2006, J SAT AGR RES, V2, P1; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Khowaja FS, 2008, FIELD CROP RES, V106, P248, DOI 10.1016/j.fcr.2007.12.008; Ta KN, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1504-1; Lafitte R, 1999, MOL APPROACHES GENET, P97; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; Li JW, 2011, PLANT PROD SCI, V14, P177, DOI 10.1626/pps.14.177; Lim PO, 2005, CURR TOP DEV BIOL, V67, P49, DOI 10.1016/S0070-2153(05)67002-0; Lin P, 2001, ECOL ENG, V16, P415, DOI 10.1016/S0925-8574(00)00126-9; Liu CG, 2014, J INTEGR AGR, V13, P316, DOI 10.1016/S2095-3119(13)60498-0; [罗伟 Luo Wei], 2008, [分子植物育种, Molecular Plant Breeding], V6, P853; MacMillan K, 2006, THEOR APPL GENET, V113, P953, DOI 10.1007/s00122-006-0357-4; MAHMOOD A, 1991, CEREAL RES COMMUN, V19, P305; Perez-Perez JM, 2010, J PLANT RES, V123, P15, DOI 10.1007/s10265-009-0267-z; Murchie EH, 2002, PLANT PHYSIOL, V130, P1999, DOI 10.1104/pp.011098; Phung NTP, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0747-y; Phung NTP, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0371-7; ODA M, 1992, JARQ-JPN AGR RES Q, V26, P19; Ordog Vince, 2011, PLANT PHYSIOL; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Poorter H, 1998, INHERENT VARIATION IN PLANT GROWTH, P309; Poorter H, 1999, NEW PHYTOL, V143, P163, DOI 10.1046/j.1469-8137.1999.00428.x; Price AH, 2002, J EXP BOT, V53, P989, DOI 10.1093/jexbot/53.371.989; Price AH, 2002, FIELD CROP RES, V76, P25, DOI 10.1016/S0378-4290(02)00010-2; Price AH, 2002, PLANT MOL BIOL, V48, P683, DOI 10.1023/A:1014805625790; Qi J, 2008, PLANT PHYSIOL, V147, P1947, DOI 10.1104/pp.108.118778; Qu MN, 2017, PLANT PHYSIOL, V175, P248, DOI 10.1104/pp.17.00332; Quarrie SA, 1997, PLANT MOL BIOL, V35, P155, DOI 10.1023/A:1005864202924; Rahman MA, 2013, J LIFE EARTH SCI, V8, P49; Ren DY, 2016, RICE, V9, DOI [10.1186/s12284-016-0076-7, 10.1186/s12284-014-0039-9]; Robin S, 2003, THEOR APPL GENET, V107, P1288, DOI 10.1007/s00122-003-1360-7; Shen Bo, 2003, Acta Genetica Sinica, V30, P1133; SMART RE, 1974, PLANT PHYSIOL, V53, P258, DOI 10.1104/pp.53.2.258; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Song XQ, 2013, MOL PLANT, V6, P768, DOI 10.1093/mp/sst025; Sparnaaij LD, 1996, EUPHYTICA, V90, P183, DOI 10.1007/BF00023857; Stettler M, 2009, MOL PLANT, V2, P1233, DOI 10.1093/mp/ssp093; Takai T, 2010, RICE, V3, P172, DOI 10.1007/s12284-010-9047-6; Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442; Tang XX, 2018, THEOR APPL GENET, V131, P801, DOI 10.1007/s00122-017-3036-8; Teng S, 2004, EUPHYTICA, V135, P1, DOI 10.1023/B:EUPH.0000009487.89270.e9; Thomas H, 2014, J EXP BOT, V65, P3889, DOI 10.1093/jxb/eru037; TOMOSHIRO T, 1983, JPN J CROP SCI, V52, P299; Tripathy JN, 2000, THEOR APPL GENET, V100, P1197, DOI 10.1007/s001220051424; Tsukaya H, 2005, INT J DEV BIOL, V49, P547, DOI 10.1387/ijdb.041921ht; Vangahun JM, 2012, THESIS; Vile D, 2005, ANN BOT-LONDON, V96, P1129, DOI 10.1093/aob/mci264; Wang DK, 2016, J GENET GENOMICS, V43, P601, DOI 10.1016/j.jgg.2016.09.002; Wang P, 2011, THEOR APPL GENET, V123, P1319, DOI 10.1007/s00122-011-1669-6; Wang YP, 2004, CHINESE J RICE SCI, V19, P13; Weraduwagel SM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00167; Xiong DL, 2016, ANN BOT-LONDON, V117, P963, DOI 10.1093/aob/mcw022; Xu CG, 2004, THEOR APPL GENET, V109, P640, DOI 10.1007/s00122-004-1671-3; Xu XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114313; Yang RF, 2011, ANN BOT-LONDON, V107, P1087, DOI 10.1093/aob/mcr057; Yang WN, 2015, J EXP BOT, V66, P5605, DOI 10.1093/jxb/erv100; Yang YL, 2018, BOTANY, V96, P249, DOI 10.1139/cjb-2017-0161; Yoo SC, 2009, PLANT PHYSIOL, V150, P388, DOI 10.1104/pp.109.136648; Yoshida A, 2013, P NATL ACAD SCI USA, V110, P767, DOI 10.1073/pnas.1216151110; YOSHIDA S, 1972, ANN REV PLANT PHYSIO, V23, P437, DOI 10.1146/annurev.pp.23.060172.002253; Yue B, 2006, GENETICS, V172, P1213, DOI 10.1534/genetics.105.045062; Yue B, 2005, THEOR APPL GENET, V111, P1127, DOI 10.1007/s00122-005-0040-1; Zhang BC, 2009, PLANT MOL BIOL, V71, P509, DOI 10.1007/s11103-009-9536-4	91	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219274	10.1371/journal.pone.0219274	http://dx.doi.org/10.1371/journal.pone.0219274			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283792	Green Published, gold			2022-12-26	WOS:000484939800025
J	Rose, JP; Wademan, C; Weir, S; Wood, JS; Todd, BD				Rose, Jonathan P.; Wademan, Cara; Weir, Suzanne; Wood, John S.; Todd, Brian D.			Traditional trapping methods outperform eDNA sampling for introduced semi-aquatic snakes	PLOS ONE			English	Article							SITE OCCUPANCY MODELS; ENVIRONMENTAL DNA; OPTIMAL SURVEILLANCE; DESIGNING OCCUPANCY; PERSISTENCE; DROUGHT	Given limited resources for managing invasive species, traditional survey methods may not be feasible to implement at a regional scale. Environmental DNA (eDNA) sampling has proven to be an effective method for detecting some invasive species, but comparisons between the detection probability of eDNA and traditional survey methods using modern occupancy modeling methods are rare. We developed a qPCR assay to detect two species of watersnake (Nerodia fasciata and Nerodia sipedon) introduced to California, USA, and we compared the efficacy of eDNA and aquatic trapping. We tested 3-9 water samples each from 30 sites near the known range of N. fasciata, and 61 sites near the known range of N. sipedon. We also deployed aquatic funnel traps at a subset of sites for each species. We detected N. fasciata eDNA in three of nine water samples from just one site, but captured N. fasciata in traps at three of ten sites. We detected N. sipedon eDNA in five of six water samples from one site, which was also the only site of nine at which this species was captured in traps. Traditional trapping surveys had a higher probability of detecting watersnakes than eDNA surveys, and both survey methods had higher detection probability for N. sipedon than N. fasciata. Occupancy models that integrated both trapping and eDNA surveys estimated that 5 sites (95% Credible Interval: 4-10) of 91 were occupied by watersnakes (both species combined), although snakes were only detected at four sites (three for N. fasciata, one for N. sipedon). Our study shows that despite the many successes of eDNA surveys, traditional sampling methods can have higher detection probability for some species. We recommend those tasked with managing species invasions explicitly compare eDNA and traditional survey methods in an occupancy framework to inform their choice of the best method for detecting nascent populations.	[Rose, Jonathan P.; Todd, Brian D.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Wademan, Cara] Univ Calif Davis, Dept Med & Epidemiol, Davis, CA 95616 USA; [Weir, Suzanne; Wood, John S.] Pisces Mol LLC, Boulder, CO USA	University of California System; University of California Davis; University of California System; University of California Davis	Rose, JP (corresponding author), Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA.	jonathanpatrickrose@gmail.com		Todd, Brian/0000-0003-3133-791X	United States Fish and Wildlife Service [F14AC01074]; Center for Natural Lands Management [MB704]	United States Fish and Wildlife Service(US Fish & Wildlife Service); Center for Natural Lands Management	BDT received Cooperative Agreement award #F14AC01074 from the United States Fish and Wildlife Service (https://www.fws.gov) and award #MB704 from the Center for Natural Lands Management (https://cnlm.org) to support this study. The U.S. Fish and Wildlife Service and Center for Natural Lands Management provided feedback on high priority areas for surveying for the presence of non-native watersnakes in California. Other than that contribution during the study design stage, the funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. Pisces Molecular, LLC provided support in the form of salaries for authors JSW and SW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Burger J, 2005, ARCH ENVIRON CON TOX, V49, P232, DOI 10.1007/s00244-004-0098-9; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Denwood MJ, 2016, J STAT SOFTW, V71, P1, DOI 10.18637/jss.v071.i09; Dobosy JR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-80; Durso AM, 2011, BIOL CONSERV, V144, P1508, DOI 10.1016/j.biocon.2011.01.020; Epanchin-Niell RS, 2012, ECOL LETT, V15, P803, DOI 10.1111/j.1461-0248.2012.01800.x; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fukumoto S, 2015, J APPL ECOL, V52, P358, DOI 10.1111/1365-2664.12392; Garrard GE, 2008, AUSTRAL ECOL, V33, P986, DOI 10.1111/j.1442-9993.2008.01869.x; Garrard GE, 2015, CONSERV BIOL, V29, P216, DOI 10.1111/cobi.12351; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Guillera-Arroita G, 2014, ECOL EVOL, V4, P1751, DOI 10.1002/ece3.1056; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Halstead BJ, 2017, EVALUATION EFFICACY, DOI [10.3133/ofr20171123, DOI 10.3133/OFR20171123]; Hodzic E, 2013, VECTOR-BORNE ZOONOT, V13, P694, DOI 10.1089/vbz.2012.1189; Hunter ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121655; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Lahoz-Monfort JJ, 2016, MOL ECOL RESOUR, V16, P673, DOI 10.1111/1755-0998.12486; Laramie M.B., 2015, US GEOL SURV TECH ME, V2, pA13, DOI DOI 10.3133/TM2A13; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Miller DA, 2011, ECOLOGY, V92, P1422, DOI 10.1890/10-1396.1; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; R Core Team, 2018, R A LANGUAGE AND ENV; Robeson SM, 2015, GEOPHYS RES LETT, V42, P6771, DOI 10.1002/2015GL064593; Rose JP, 2017, BIOL INVASIONS, V19, P2885, DOI 10.1007/s10530-017-1491-4; Rose JP, 2013, J HERPETOL, V47, P421, DOI 10.1670/12-119; Royle JA, 2006, ECOLOGY, V87, P835, DOI 10.1890/0012-9658(2006)87[835:GSOMAF]2.0.CO;2; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguier A, 2014, J APPL ECOL, V51, P871, DOI 10.1111/1365-2664.12262; Wintle BA, 2012, DIVERS DISTRIB, V18, P417, DOI 10.1111/j.1472-4642.2011.00874.x	44	11	11	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2019	14	7							e0219244	10.1371/journal.pone.0219244	http://dx.doi.org/10.1371/journal.pone.0219244			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3ZV	31265475	Green Published, gold, Green Submitted			2022-12-26	WOS:000484921200025
J	Bickes, MS; Pirr, S; Heinemann, AS; Fehlhaber, B; Halle, S; Vollger, L; Willers, M; Richter, M; Bohne, C; Albrecht, M; Langer, M; Pfeifer, S; Jonigk, D; Vieten, G; Ure, B; von Kaisenberg, C; Forster, R; Von Koeckritz-Blickwede, M; Hansen, G; Viemann, D				Bickes, Marie Sophie; Pirr, Sabine; Heinemann, Anna Sophie; Fehlhaber, Beate; Halle, Stephan; Voellger, Lena; Willers, Maike; Richter, Manuela; Boehne, Carolin; Albrecht, Melanie; Langer, Melissa; Pfeifer, Sandra; Jonigk, Danny; Vieten, Gertrud; Ure, Benno; von Kaisenberg, Constantin; Foerster, Reinhold; Von Koeckritz-Blickwede, Maren; Hansen, Gesine; Viemann, Dorothee			Constitutive TNF-alpha signaling in neonates is essential for the development of tissue-resident leukocyte profiles at barrier sites	FASEB JOURNAL			English	Article						newborn infant; endothelium; leukocyte trafficking; neonatal immunity; sepsis	ENDOTHELIAL-CELL ACTIVATION; NECROSIS-FACTOR-ALPHA; ADHESION MOLECULES; DENDRITIC CELL; MACROPHAGE ONTOGENY; GENE-EXPRESSION; CRITICALLY-ILL; SEPTIC SHOCK; SEPSIS; MONOCYTES	Newborn infants have a high disposition to develop systemic inflammatory response syndromes (SIRSs) upon inflammatory or infectious challenges. Moreover, there is a considerable trafficking of hematopoietic cells to tissues already under noninflammatory conditions. These age-specific characteristics suggest a hitherto unappreciated crucial role of the vascular endothelium during the neonatal period. Here, we demonstrate that healthy neonates showed already strong endothelial baseline activation, which was mediated by a constitutively increased production of TNF-alpha. In mice, pharmacological inhibition of TNF-alpha directly after birth prevented subsequent fatal SIRS but completely abrogated the recruitment of leukocytes to sites of infection. Importantly, in healthy neonates, blocking TNF-alpha at birth disrupted the physiologic leukocyte trafficking, which resulted in persistently altered leukocyte profiles at barrier sites. Collectively, these data suggest that constitutive TNF-alpha-mediated sterile endothelial activation in newborn infants contributes to the increased risk of developing SIRS but is needed to ensure the postnatal recruitment of leukocytes to organs and interfaces.-Bickes, M. S., Pirr, S., Heinemann, A. S., Fehlhaber, B., Halle, S., Vollger, L., Willers, M., Richter, M., Bohne, C., Albrecht, M., Langer, M., Pfeifer, S., Jonigk, D., Vieten, G., Ure, B., von Kaisenberg, C., Forster, R., von Kockritz-Blickwede, M., Hansen, G., Viemann, D. Constitutive TNF-alpha signaling in neonates is essential for the development of tissue-resident leukocyte profiles at barrier sites.	[Bickes, Marie Sophie; Pirr, Sabine; Heinemann, Anna Sophie; Fehlhaber, Beate; Voellger, Lena; Willers, Maike; Richter, Manuela; Boehne, Carolin; Albrecht, Melanie; Hansen, Gesine; Viemann, Dorothee] Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Pirr, Sabine; Foerster, Reinhold; Hansen, Gesine; Viemann, Dorothee] Hannover Med Sch, Cluster Excellence Resolving Infect Susceptibil R, Hannover, Germany; [Halle, Stephan; Foerster, Reinhold] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Jonigk, Danny] Hannover Med Sch, Dept Pathol, Hannover, Germany; [Vieten, Gertrud; Ure, Benno] Hannover Med Sch, Dept Pediat Surg, Hannover, Germany; [von Kaisenberg, Constantin] Hannover Med Sch, Dept Obstet & Gynecol, Hannover, Germany; [Richter, Manuela] Childrens Hosp Auf der Bult, Hannover, Germany; [Langer, Melissa; Pfeifer, Sandra; Von Koeckritz-Blickwede, Maren] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses RIZ, Dept Physiol Chem, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Veterinary Medicine Hannover, Foundation	Viemann, D (corresponding author), Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	viemann.dorothee@mh-hannover.de	von Kaisenberg, Constantin/AAR-2756-2021	Viemann, Dorothee/0000-0002-9009-3559	Appenrodt Foundation; German Research Foundation [VI 538/6-1]; Volkswagen Foundation [Az 90005]; German Research Foundation under Germany's Cluster of Excellence Resolving Infection Susceptibility (RESIST) [EXC 2155-390874280]; MSD Sharp and Dohme (Haar, Germany); Hannover Medical School	Appenrodt Foundation; German Research Foundation(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); German Research Foundation under Germany's Cluster of Excellence Resolving Infection Susceptibility (RESIST); MSD Sharp and Dohme (Haar, Germany); Hannover Medical School	The authors thank Sabine Schreek, Jennifer Schoning (both from the Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany), and Christiane Ritter (Institute of Immunology, Hannover Medical School, Hannover, Germany) for excellent technical support. The authors thank all parents contributing to this study. The authors also thank the doctors and nurses of the Neonatal Intensive Care Unit of the Hannover Medical School for support and cooperation. This work was supported by grants from the Appenrodt Foundation, the German Research Foundation (VI 538/6-1), and the Volkswagen Foundation (Az 90005) to D.V., the German Research Foundation under Germany's Cluster of Excellence Resolving Infection Susceptibility (RESIST; EXC 2155-390874280; Project ID B1 and B3 to G.H. and D.V.), and from MSD Sharp and Dohme (Haar, Germany) (2014) and a clinical leave stipend of the Hannover Medical School to S.P. The authors declare no conflicts of interest.	Aird WC, 2005, J THROMB HAEMOST, V3, P1392, DOI 10.1111/j.1538-7836.2005.01328.x; Ait-Oufella H, 2010, INTENS CARE MED, V36, P1286, DOI 10.1007/s00134-010-1893-6; Austermann J, 2014, CELL REP, V9, P2112, DOI 10.1016/j.celrep.2014.11.020; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; BAUSS F, 1987, INFECT IMMUN, V55, P1622, DOI 10.1128/IAI.55.7.1622-1625.1987; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Boldt J, 1996, INTENS CARE MED, V22, P122, DOI 10.1007/BF01720718; Brook B, 2017, SEMIN IMMUNOPATHOL, V39, P615, DOI 10.1007/s00281-017-0651-z; Cook Donald N, 2007, Proc Am Thorac Soc, V4, P234, DOI 10.1513/pats.200701-026AW; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Doster RS, 2018, J INNATE IMMUN, V10, P3, DOI 10.1159/000480373; Fehlhaber B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42414-4; Fei Y, 2011, J INFECT DIS, V204, P348, DOI 10.1093/infdis/jir266; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; FREUDENBERG MA, 1991, INFECT IMMUN, V59, P2110, DOI 10.1128/IAI.59.6.2110-2115.1991; Galloway JB, 2011, RHEUMATOLOGY, V50, P124, DOI 10.1093/rheumatology/keq242; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Habtezion A, 2016, GASTROENTEROLOGY, V150, P340, DOI 10.1053/j.gastro.2015.10.046; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heinemann AS, 2017, FASEB J, V31, P1153, DOI 10.1096/fj.201601083R; Hofer S, 2009, CRIT CARE, V13, DOI 10.1186/cc7923; Ikumi N, 2013, HEMODIAL INT, V17, P133, DOI 10.1111/j.1542-4758.2012.00723.x; Jang JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004579; Kayal S, 1998, AM J RESP CRIT CARE, V157, P776, DOI 10.1164/ajrccm.157.3.9705034; Khakpour S, 2015, INNATE IMMUN-LONDON, V21, P827, DOI 10.1177/1753425915606525; Kjaergaard AG, 2016, APMIS, V124, P846, DOI 10.1111/apm.12585; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052; Lee CZW, 2018, NAT REV IMMUNOL, V18, P716, DOI 10.1038/s41577-018-0054-y; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lories RJU, 2007, ARTHRITIS RHEUM, V56, P489, DOI 10.1002/art.22372; Marques M, 2010, J CROHNS COLITIS, V4, P110, DOI 10.1016/j.crohns.2009.08.005; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; McGovern N, 2017, NATURE, V546, P662, DOI 10.1038/nature22795; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Nussbaum C, 2013, J LEUKOCYTE BIOL, V93, P175, DOI 10.1189/jlb.0912468; Nussbaum C, 2011, J REPROD IMMUNOL, V90, P74, DOI 10.1016/j.jri.2011.01.022; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Schlichting DE, 2011, MICROVASC RES, V81, P216, DOI 10.1016/j.mvr.2010.11.011; Schuetz P, 2011, SHOCK, V36, P104, DOI 10.1097/SHK.0b013e31821e4e04; Seleme MC, 2017, J VIROL, V91, DOI 10.1128/JVI.01983-16; Shapiro NI, 2010, CRIT CARE, V14, DOI 10.1186/cc9290; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; SILVA AT, 1990, J INFECT DIS, V162, P421, DOI 10.1093/infdis/162.2.421; Skibsted S, 2013, SHOCK, V39, P427, DOI 10.1097/SHK.0b013e3182903f0d; Takahashi M, 1996, CARDIOVASC RES, V32, P422, DOI 10.1016/0008-6363(96)00085-5; Tanoue T, 2016, NAT REV IMMUNOL, V16, P295, DOI 10.1038/nri.2016.36; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Ulas T, 2017, NAT IMMUNOL, V18, P622, DOI 10.1038/ni.3745; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Vassiliou AG, 2014, CYTOKINE, V69, P240, DOI 10.1016/j.cyto.2014.06.010; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Yoo JW, 2015, INFECT DIS-NOR, V47, P393, DOI 10.3109/00365548.2014.1001999; Zhang XM, 2017, NAT REV IMMUNOL, V17, P495, DOI 10.1038/nri.2017.54; Zhao J, 2008, P NATL ACAD SCI USA, V105, P7528, DOI 10.1073/pnas.0800152105; Zonneveld R, 2014, CRIT CARE, V18, DOI 10.1186/cc13733	71	4	4	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10633	10647		10.1096/fj.201900796R	http://dx.doi.org/10.1096/fj.201900796R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31262195				2022-12-26	WOS:000489166300006
J	Gommers, LMM; Ederveen, THA; van der Wijst, J; Overmars-Bos, C; Kortman, GAM; Boekhorst, J; Bindels, RJM; de Baaij, JHF; Hoenderop, JGJ				Gommers, Lisanne M. M.; Ederveen, Thomas H. A.; van der Wijst, Jenny; Overmars-Bos, Caro; Kortman, Guus A. M.; Boekhorst, Jos; Bindels, Ren J. M.; de Baaij, Jeroen H. F.; Hoenderop, Joost G. J.			Low gut microbiota diversity and dietary magnesium intake are associated with the development of PPI-induced hypomagnesemia	FASEB JOURNAL			English	Article						omeprazole; organic acids; gut microbiome; magnesium deficiency	PROTON-PUMP INHIBITORS; CHAIN FATTY-ACIDS; MG2+; DISEASE; RATS	Proton pump inhibitors (PPIs) are used by millions of patients for the treatment of stomach acid-reflux diseases. Although PPIs are generally considered safe, about 13% of the users develop hypomagnesemia. Despite rising attention for this issue, the underlying mechanism is still unknown. Here, we examine whether the gut microbiome is involved in the development of PPI-induced hypomagnesemia in wild-type C57BL/6J mice. After 4 wk of treatment under normal or low dietary Mg2+ availability, omeprazole significantly reduced serum Mg2+ levels only in mice on a low-Mg2+ diet without affecting the mRNA expression of colonic or renal Mg2+ transporters. Overall, 16S rRNA gene sequencing revealed a lower gut microbial diversity in omeprazole-treated mice. Omeprazole induced a shift in microbial composition, which was associated with a 3- and 2-fold increase in the abundance of Lactobacillus and Bifidobacterium, respectively. To examine the metabolic consequences of these microbial alterations, the colonic composition of organic acids was evaluated. Low dietary Mg2+ intake, independent of omeprazole treatment, resulted in a 10-fold increase in formate levels. Together, these results imply that both omeprazole treatment and low dietary Mg2+ intake disturb the gut internal milieu and may pose a risk for the malabsorption of Mg2+ in the colon.-Gommers, L. M. M., Ederveen, T. H. A., van der Wijst, J., Overmars-Bos, C., Kortman, G. A. M., Boekhorst, J., Bindels, R. J. M., de Baaij, J. H. F., Hoenderop, J. G. J. Low gut microbiota diversity and dietary magnesium intake are associated with the development of PPI-induced hypomagnesemia.	[Gommers, Lisanne M. M.; van der Wijst, Jenny; Overmars-Bos, Caro; Bindels, Ren J. M.; de Baaij, Jeroen H. F.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr Radboudumc, Dept Physiol, RIMLS, Nijmegen, Netherlands; [Ederveen, Thomas H. A.; Boekhorst, Jos] Radboud Univ Nijmegen, Med Ctr Radboudumc, CMBI, RIMLS, Nijmegen, Netherlands; [Ederveen, Thomas H. A.; Kortman, Guus A. M.; Boekhorst, Jos] NIZO Food Res, Ede, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; NIZO Food Research	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol 286, Geert Grootepl 26-28,POB 9101, NL-6500 HB Nijmegen, Netherlands.	joost.hoenderop@radboudumc.nl	Ederveen, Thomas HA/G-6294-2016; van der Wijst, Jenny/T-1620-2019; Kortman, Guus AM/F-9690-2010; de Baaij, Jeroen/P-5704-2015; Bos, Caro/V-2390-2017; Gommers, Lisanne/O-8313-2016	Ederveen, Thomas HA/0000-0003-0068-1275; van der Wijst, Jenny/0000-0002-1547-516X; de Baaij, Jeroen/0000-0003-2372-8486; Bos, Caro/0000-0001-5016-9435; Kortman, Guus/0000-0002-8076-0661; Boekhorst, Jos/0000-0002-4807-7838	Netherlands Organization for Scientific Research [NWO VICI 016.130.668, NWO VENI 016.186.012]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The authors thank D. Reijnen (Radboud University Medical Center, Nijmegen, The Netherlands), H. Janssen-Wagener (Radboud University Medical Center, Nijmegen, The Netherlands), M. Berkt-van Ginkel (Radboud University Medical Center, Nijmegen, The Netherlands), S. van Boxtel (Radboud University Medical Center, Nijmegen, The Netherlands), and A. Hanssen (Radboud University Medical Center, Nijmegen, The Netherlands) for their excellent technical support with the animal study, and H. Dijkman (Radboud University Medical Center, Nijmegen, The Netherlands) for the technical support and expertise in the histological evaluation. This study was approved by the animal ethics board of Radboud University Nijmegen (RU DEC 2015-0112), and by the Dutch Central Commission for Animal Experiments (CCD; AVD103002016382). This work was supported by grants from the Netherlands Organization for Scientific Research (NWO VICI 016.130.668 to J.G.J.H. and NWO VENI 016.186.012 to J.H.F.D.B.). The authors declare no conflicts of interest.	Alou M.T., 2016, HUM MICROBIOME J, V1, P3, DOI [10.1016/j.humic.2016.09.001, DOI 10.1016/J.HUMIC.2016.09.001]; BIRCH JR, 1971, J CELL SCI, V8, P693; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clooney AG, 2016, ALIMENT PHARM THER, V43, P974, DOI 10.1111/apt.13568; de Baaij JHF, 2016, SCI REP-UK, V6, DOI 10.1038/srep28565; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Florentin Matilda, 2012, World J Nephrol, V1, P151, DOI 10.5527/wjn.v1.i6.151; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Heidelbaugh JJ, 2012, THER ADV GASTROENTER, V5, P219, DOI 10.1177/1756283X12437358; Hess MW, 2016, ALIMENT PHARM THER, V43, P1178, DOI 10.1111/apt.13619; Hess MW, 2012, ALIMENT PHARM THER, V36, P405, DOI 10.1111/j.1365-2036.2012.05201.x; Hoorn EJ, 2010, AM J KIDNEY DIS, V56, P112, DOI 10.1053/j.ajkd.2009.11.019; Hughes ER, 2017, CELL HOST MICROBE, V21, P208, DOI 10.1016/j.chom.2017.01.005; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Jackson MA, 2016, GUT, V65, P749, DOI 10.1136/gutjnl-2015-310861; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kurstjens S, 2019, FASEB J, V33, P7192, DOI 10.1096/fj.201801778RR; Kurstjens S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38351-3; Lameris ALL, 2013, PFLUG ARCH EUR J PHY, V465, P1613, DOI 10.1007/s00424-013-1306-0; Lameris AL, 2015, AM J PHYSIOL-GASTR L, V308, pG206, DOI 10.1152/ajpgi.00093.2014; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Malfertheiner P, 2017, NAT REV GASTRO HEPAT, V14, P697, DOI 10.1038/nrgastro.2017.117; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Mosca A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00455; Nakashima A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143656; Naser SA, 2014, WORLD J DIABETES, V5, P527, DOI 10.4239/wjd.v5.i4.527; Naughton V, 2011, APPL PHYSIOL NUTR ME, V36, P161, DOI 10.1139/H10-088; Nehra AK, 2018, MAYO CLIN PROC, V93, P240, DOI 10.1016/j.mayocp.2017.10.022; NRC (National Research Council), 1995, NUTR REQ LAB AN, VFourth Revised, DOI [10.17226/4758, DOI 10.17226/4758]; Pachikian BD, 2010, J NUTR, V140, P509, DOI 10.3945/jn.109.117374; Pham TAN, 2014, CURR OPIN MICROBIOL, V17, P67, DOI 10.1016/j.mib.2013.12.002; Ramakrishna BS, 2013, J GASTROEN HEPATOL, V28, P9, DOI 10.1111/jgh.12294; Scanlan BJ, 2007, MOL CELL BIOCHEM, V306, P59, DOI 10.1007/s11010-007-9554-y; Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044; Schnoll-Sussman Felice, 2017, Curr Treat Options Gastroenterol, V15, P1, DOI 10.1007/s11938-017-0115-5; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Thursby E, 2017, BIOCHEM J, V474, P1823, DOI 10.1042/BCJ20160510; Vindigni SM, 2016, THER ADV GASTROENTER, V9, P606, DOI 10.1177/1756283X16644242; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weaver CM, 2011, J AGR FOOD CHEM, V59, P6501, DOI 10.1021/jf2009777; William JH, 2014, NEPHROLOGY, V19, P798, DOI 10.1111/nep.12330	45	24	25	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11235	11246		10.1096/fj.201900839R	http://dx.doi.org/10.1096/fj.201900839R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31299175				2022-12-26	WOS:000489166300054
J	Li, HD; Zhou, X; Li, YJ; Ma, XK; Gonzales, RJ; Qiu, SF; Shi, FD; Liu, Q				Li, Handong; Zhou, Xing; Li, Yujing; Ma, Xiaokuang; Gonzales, Rayna J.; Qiu, Shenfeng; Shi, Fu-Dong; Liu, Qiang			The selective sphingosine 1-phosphate receptor 1 modulator RP101075 improves microvascular circulation after cerebrovascular thrombosis	FASEB JOURNAL			English	Article						immune modulation; inflammation; S1PR; microcirculation; 2-photon imaging	ACUTE ISCHEMIC-STROKE; FINGOLIMOD; FTY720; COMBINATION; ACTIVATION; MODELS; MICE	Sphingosine-1-phosphate receptor (S1PR) modulators provide protection in preclinical and clinical studies for ischemic stroke, but the influences of S1PR modulation on microvascular thrombosis remain poorly understood. This study investigates the impact of a selective S1PR1 modulator RP101075 on microvascular circulation in a mouse model of laser-induced thrombosis. The flow velocity of cortical arterioles in mice was measured in vivo under 2-photon laser scanning microscopy. Thrombosis was induced in cortical arterioles by laser irritation. At 30 min after laser-induced thrombosis, mice were treated with either RP101075 or vehicle. RP101075 did not alter the flow velocity of cortical arterioles under physiologic conditions. Laser-induced thrombosis led to a pronounced reduction of flow velocity in cortical arterioles that persisted for >= 90 min. The reduction of flow velocity in cortical arterioles following thrombosis was significantly attenuated following RP101075 treatment. RP101075 did not significantly affect coagulation time, bleeding time, heart rate, and blood pressure. In addition, RP101075 treatment reduced thrombus volume, which was accompanied by a reduction of leukocyte content in the thrombus. Our findings demonstrate that the selective S1PR1 modulator RP101075 improves microvascular circulation after thrombosis, implying a component of improved microvascular circulation to the benefit of S1PR modulation in cerebral ischemia.-Li, H., Zhou, X., Li, Y., Ma, X., Gonzales, R. J., Qiu, S., Shi, F.-D., Liu, Q. The selective sphingosine 1-phosphate receptor 1 modulator RP101075 improves microvascular circulation after cerebrovascular thrombosis.	[Li, Handong; Li, Yujing; Ma, Xiaokuang; Gonzales, Rayna J.; Qiu, Shenfeng; Liu, Qiang] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA; [Zhou, Xing] Tsinghua Univ, Sch Med, Inst Immunol, Dept Basic Med Sci, Beijing, Peoples R China; [Li, Yujing; Shi, Fu-Dong; Liu, Qiang] St Josephs Hosp, Barrow Neurol Inst, 350 West Thomas Rd, Phoenix, AZ 85013 USA	University of Arizona; Tsinghua University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Liu, Q (corresponding author), St Josephs Hosp, Barrow Neurol Inst, 350 West Thomas Rd, Phoenix, AZ 85013 USA.	qiang.liu@dignityhealth.org	li, yu/HGL-9518-2022; Liu, Qiang/HHZ-3181-2022; Li, yujing/GQA-4109-2022; Ma, Xiaokuang/GWC-2936-2022	Ma, Xiaokuang/0000-0001-7900-6779; Gonzales, Rayna/0000-0003-1716-8988	American Heart Association; Arizona Biomedical Research Center; Valley Partner research grant	American Heart Association(American Heart Association); Arizona Biomedical Research Center; Valley Partner research grant	The authors thank Dr. Hai Qi (Tsinghua University) for helpful discussion and Kristofer Wood (Barrow Neurological Institute) for editorial assistance. This study was supported, in part, by an American Heart Association research grant, an Arizona Biomedical Research Center grant, and a Valley Partner research grant. The authors declare no conflicts of interest.	Aktas O, 2010, NAT REV NEUROL, V6, P373, DOI 10.1038/nrneurol.2010.76; Brait VH, 2016, STROKE, V47, P3053, DOI 10.1161/STROKEAHA.116.015371; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; De Meyer SF, 2016, STROKE, V47, P1165, DOI 10.1161/STROKEAHA.115.011238; Fu Y, 2014, P NATL ACAD SCI USA, V111, P18315, DOI 10.1073/pnas.1416166111; Hasegawa Y, 2010, STROKE, V41, P368, DOI 10.1161/STROKEAHA.109.568899; Jin WN, 2016, J CEREBR BLOOD F MET, V36, P1464, DOI 10.1177/0271678X15611137; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kono M, 2014, J CLIN INVEST, V124, P2076, DOI 10.1172/JCI71194; Kraft P, 2013, STROKE, V44, P3202, DOI 10.1161/STROKEAHA.113.002880; Lou NH, 2016, P NATL ACAD SCI USA, V113, P1074, DOI 10.1073/pnas.1520398113; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Sandborn WJ, 2016, NEW ENGL J MED, V374, P1754, DOI 10.1056/NEJMoa1513248; Scott F. L., 2013, METABOLITES RPC1063, P05; Sun N, 2016, STROKE, V47, P1899, DOI 10.1161/STROKEAHA.115.012236; Timony G. A., 2014, PHARMACOKINETICS PHA, P1; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Zhang JH, 2012, NAT REV NEUROL, V8, P711, DOI 10.1038/nrneurol.2012.210; Zhang L, 2012, TRENDS PHARMACOL SCI, V33, P415, DOI 10.1016/j.tips.2012.04.006; Zhu ZL, 2015, CIRCULATION, V132, P1104, DOI 10.1161/CIRCULATIONAHA.115.016371	20	6	6	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10935	10941		10.1096/fj.201900282R	http://dx.doi.org/10.1096/fj.201900282R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284754				2022-12-26	WOS:000489166300029
J	Vo, TM; Jain, S; Burchett, R; Monckton, EA; Godbout, R				The Minh Vo; Jain, Saket; Burchett, Rebecca; Monckton, Elizabeth A.; Godbout, Roseline			A positive feedback loop involving nuclear factor IB and calpain 1 suppresses glioblastoma cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glioblastoma; transcription factor; calpain; cancer biology; protein phosphorylation; gene regulation; cysteine protease; cell migration; immunofluorescence; nuclear factor I	MALIGNANT-GLIOMA-CELL; ACID-BINDING PROTEIN; CALPASTATIN LOCALIZATION; BREAST-CANCER; B-FABP; INVASION; BRAIN; CALCINEURIN; EXPRESSION; SYSTEM	Glioblastoma (GBM) is a brain tumor that remains largely incurable because of its highly-infiltrative properties. Nuclear factor I (NFI)-type transcription factors regulate genes associated with GBM cell migration and infiltration. We have previously shown that NFI activity depends on the NFI phosphorylation state and that calcineurin phosphatase dephosphorylates and activates NFI. Calcineurin is cleaved and activated by calpain proteases whose activity is, in turn, regulated by an endogenous inhibitor, calpastatin (CAST). The CAST gene is a target of NFI in GBM cells, with differentially phosphorylated NFIs regulating the levels of CAST transcript variants. Here, we uncovered an NFIB-calpain 1-positive feedback loop mediated through CAST and calcineurin. In NFI-hyperphosphorylated GBM cells, NFIB expression decreased the CAST-to-calpain 1 ratio in the cytoplasm. This reduced ratio increased autolysis and activity of cytoplasmic calpain 1. Conversely, in NFI-hypophosphorylated cells, NFIB expression induced differential subcellular compartmentalization of CAST and calpain 1, with CAST localizing primarily to the cytoplasm and calpain 1 to the nucleus. Overall, this altered compartmentalization increased nuclear calpain 1 activity. We also show that nuclear calpain 1, by cleaving and activating calcineurin, induces NFIB dephosphorylation. Of note, knockdown of calpain 1, NFIB, or both increased GBM cell migration and up-regulated the pro-migratory factors fatty acid-binding protein 7 (FABP7) and Ras homolog family member A (RHOA). In summary, our findings reveal bidirectional cross-talk between NFIB and calpain 1 in GBM cells. A physiological consequence of this positive feedback loop appears to be decreased GBM cell migration.	[The Minh Vo; Jain, Saket; Burchett, Rebecca; Monckton, Elizabeth A.; Godbout, Roseline] Univ Alberta, Cross Canc Inst, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada	University of Alberta	Godbout, R (corresponding author), Univ Alberta, Cross Canc Inst, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	rgodbout@ualberta.ca	Jain, Saket/ABD-4746-2020; Godbout, Roseline/I-4639-2016	Jain, Saket/0000-0002-8655-2951; Burchett, Rebecca/0000-0002-0328-2336; Godbout, Roseline/0000-0002-4779-9265	Canadian Institutes of Health Research [130314]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant 130314. The authors declare that they have no conflicts of interest with the contents of this article.	Averna M, 2003, CELL MOL LIFE SCI, V60, P2669, DOI 10.1007/s00018-003-3288-0; Averna M, 2001, BIOCHEM J, V354, P25, DOI 10.1042/0264-6021:3540025; Baudry M, 2016, TRENDS NEUROSCI, V39, P235, DOI 10.1016/j.tins.2016.01.007; Bisgrove DA, 2000, J BIOL CHEM, V275, P30668, DOI 10.1074/jbc.M003828200; Breznik B, 2017, ONCOTARGET, V8, P25482, DOI 10.18632/oncotarget.16041; Brun M, 2018, NEOPLASIA, V20, P1023, DOI 10.1016/j.neo.2018.08.007; Brun M, 2013, J BIOL CHEM, V288, P24104, DOI 10.1074/jbc.M113.455832; Brun M, 2009, J MOL BIOL, V391, P282, DOI 10.1016/j.jmb.2009.06.041; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Croce K, 1999, J BIOL CHEM, V274, P36321, DOI 10.1074/jbc.274.51.36321; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; De Rosa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052113; Denny SK, 2016, CELL, V166, P328, DOI 10.1016/j.cell.2016.05.052; Ding FR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155504; Donkor IO, 2011, EXPERT OPIN THER PAT, V21, P601, DOI 10.1517/13543776.2011.568480; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; Fane ME, 2017, EBIOMEDICINE, V16, P63, DOI 10.1016/j.ebiom.2017.01.013; FigueiredoPereira ME, 1996, J BIOL CHEM, V271, P16455, DOI 10.1074/jbc.271.28.16455; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Ge LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042661; Godbout R, 1998, ONCOGENE, V16, P1955, DOI 10.1038/sj.onc.1201740; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Heng YHE, 2012, NEUROSIGNALS, V20, P159, DOI 10.1159/000330651; Kallenberg K, 2013, J NEURO-ONCOL, V112, P217, DOI 10.1007/s11060-013-1049-y; Kaloshi G, 2007, J NEURO-ONCOL, V84, P245, DOI 10.1007/s11060-007-9377-4; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P9870, DOI 10.1073/pnas.152336999; Kulkarni S, 2002, J BIOL CHEM, V277, P24435, DOI 10.1074/jbc.M203457200; Lal S, 2012, J NEUROSCI RES, V90, P769, DOI 10.1002/jnr.22794; Leloup L, 2011, EXPERT OPIN THER TAR, V15, P309, DOI 10.1517/14728222.2011.553611; Li HQ, 2004, BBA-MOL CELL RES, V1691, P91, DOI 10.1016/j.bbamcr.2003.12.006; Liang Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-97; Liu R, 2009, NEURO-ONCOLOGY, V11, P330, DOI 10.1215/15228517-2008-093; Liu RZ, 2019, J PATHOL, V247, P186, DOI 10.1002/path.5182; Lokuta MA, 2003, P NATL ACAD SCI USA, V100, P4006, DOI 10.1073/pnas.0636533100; Mason S, 2009, MOL NEUROBIOL, V39, P10, DOI 10.1007/s12035-008-8048-6; Mason W P, 2007, Curr Oncol, V14, P110, DOI 10.3747/co.2007.119; Melloni E, 1996, BIOCHEM BIOPH RES CO, V229, P193, DOI 10.1006/bbrc.1996.1779; Mirabello L, 2015, CANCER DISCOV, V5, P920, DOI 10.1158/2159-8290.CD-15-0125; Mita R, 2007, NEOPLASIA, V9, P734, DOI 10.1593/neo.07439; Mita R, 2010, J BIOL CHEM, V285, P37005, DOI 10.1074/jbc.M110.170076; NISHIMURA T, 1991, J BIOL CHEM, V266, P11842; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Ogura K, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-97; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Pu X, 2016, HISTOPATHOLOGY, V68, P1021, DOI 10.1111/his.12896; Riss T.L., 2004, ASSAY GUIDANCE MANUA, P289; ROTHIG HJ, 1985, DRUG EXP CLIN RES, V11, P123; Santos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033468; Shankar A, 2014, CHIN J CANCER, V33, P148, DOI 10.5732/cjc.013.10095; Sheetz Michael P., 1999, P233; Staib P, 1998, ANN ONCOL, V9, P221, DOI 10.1023/A:1008235801218; Stifanese R, 2010, J BIOL CHEM, V285, P631, DOI 10.1074/jbc.M109.031674; Storr SJ, 2016, ONCOTARGET, V7, P47927, DOI 10.18632/oncotarget.10066; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Stringer BW, 2016, ONCOTARGET, V7, P29306, DOI 10.18632/oncotarget.8720; Talamillo A, 2017, ONCOGENE, V36, P1733, DOI 10.1038/onc.2016.341; Vo TM, 2019, J BIOL CHEM, V294, P1173, DOI 10.1074/jbc.RA118.004787; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Wu HY, 2007, ACTA MED OKAYAMA, V61, P123; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; YANG BS, 1993, MOL CELL BIOL, V13, P3093, DOI 10.1128/MCB.13.5.3093; Yoshioka K, 1999, CANCER RES, V59, P2004; Zhou MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100620	67	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12638	12654		10.1074/jbc.RA119.008291	http://dx.doi.org/10.1074/jbc.RA119.008291			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31262726	hybrid, Green Published			2022-12-26	WOS:000484414600008
J	Chen, XH; Mangala, LS; Mooberry, L; Bayraktar, E; Dasari, SK; Ma, SL; Ivan, C; Court, KA; Rodriguez-Aguayo, C; Bayraktar, R; Raut, S; Sabnis, N; Kong, XC; Yang, XB; Lopez-Berestein, G; Lacko, AG; Sood, AK				Chen, Xiuhui; Mangala, Lingegowda S.; Mooberry, Linda; Bayraktar, Emine; Dasari, Santosh K.; Ma, Shaolin; Ivan, Cristina; Court, Karem A.; Rodriguez-Aguayo, Cristian; Bayraktar, Recep; Raut, Sangram; Sabnis, Nirupama; Kong, Xianchao; Yang, Xianbin; Lopez-Berestein, Gabriel; Lacko, Andras G.; Sood, Anil K.			Identifying and targeting angiogenesis-related microRNAs in ovarian cancer	ONCOGENE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ENDOTHELIAL GROWTH-FACTOR; TUMOR-GROWTH; MIR-204; DELIVERY; EXPRESSION; PACLITAXEL; THERAPY; THROMBOSPONDIN-1; IDENTIFICATION	Current anti-angiogenic therapy for cancer is based mainly on inhibition of the vascular endothelial growth factor pathway. However, due to the transient and only modest benefit from such therapy, additional approaches are needed. Deregulation of microRNAs (miRNAs) has been demonstrated to be involved in tumor angiogenesis and offers opportunities for a new therapeutic approach. However, effective miRNA-delivery systems are needed for such approaches to be successful. In this study, miRNA profiling of patient data sets, along with in vitro and in vivo experiments, revealed that miR-204-5p could promote angiogenesis in ovarian tumors through THBS1. By binding with scavenger receptor class B type 1 (SCARB1), reconstituted high-density lipoprotein-nanoparticles (rHDL-NPs) were effective in delivering miR-204-5p inhibitor (miR-204-5p-inh) to tumor sites to suppress tumor growth. These results offer a new understanding of miR-204-5p in regulating tumor angiogenesis.	[Chen, Xiuhui; Mangala, Lingegowda S.; Bayraktar, Emine; Dasari, Santosh K.; Ma, Shaolin; Court, Karem A.; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Chen, Xiuhui; Kong, Xianchao] Harbin Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Harbin, Heilongjiang, Peoples R China; [Mangala, Lingegowda S.; Bayraktar, Emine; Ivan, Cristina; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Mooberry, Linda; Raut, Sangram; Sabnis, Nirupama; Lacko, Andras G.] Univ North Texas, Hlth Sci Ctr, Dept Physiol & Anat, Ft Worth, TX USA; [Ivan, Cristina; Rodriguez-Aguayo, Cristian; Bayraktar, Recep; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Yang, Xianbin] AM Biotechnol, Houston, TX USA; [Lacko, Andras G.] Univ North Texas, Hlth Sci Ctr, Dept Pediat, Ft Worth, TX USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Harbin Medical University; University of Texas System; UTMD Anderson Cancer Center; University of North Texas System; University of North Texas Denton; University of Texas System; UTMD Anderson Cancer Center; University of North Texas System; University of North Texas Denton; University of Texas System; UTMD Anderson Cancer Center	Mangala, LS; Sood, AK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA.; Mangala, LS; Sood, AK (corresponding author), Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA.; Sood, AK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	lsmangala@mdanderson.org; asood@mdanderson.org	Sood, Anoop Kumar/A-7344-2013; dasari, santosh kumar/V-3867-2019; Chen, Xiuhui/CAE-9641-2022; Court, Karem A./C-2328-2014	Sood, Anoop Kumar/0000-0001-5702-4108; dasari, santosh kumar/0000-0003-3078-3424; Court, Karem A./0000-0002-6334-6960; Bayraktar, Recep/0000-0002-8227-2055; RODRIGUEZ-AGUAYO, CRISTIAN/0000-0002-7880-7723; Chen, Xiuhui/0000-0002-7184-9568; Bayraktar, Emine/0000-0002-5189-1507; Ivan, Cristina/0000-0002-4848-0168	National Institutes of Health [CA016672, UH3TR000943, P50 CA217685, P50 CA098258, R35 CA209904]; Ovarian Cancer Research Fund, Inc.; Blanton-Davis Ovarian Cancer Research Program; American Cancer Society Research Professor Award; Frank McGraw Memorial Chair in Cancer Research; CPRIT [DP150091]; Foundation for Women's Cancer Grant; SPORE in Ovarian Cancer at MD Anderson [P50 CA217685]; NATIONAL CANCER INSTITUTE [R35CA209904, P50CA217685, P50CA098258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund, Inc.; Blanton-Davis Ovarian Cancer Research Program; American Cancer Society Research Professor Award(American Cancer Society); Frank McGraw Memorial Chair in Cancer Research; CPRIT; Foundation for Women's Cancer Grant; SPORE in Ovarian Cancer at MD Anderson; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported, in part, by the National Institutes of Health (CA016672, UH3TR000943, P50 CA217685, P50 CA098258, R35 CA209904), Ovarian Cancer Research Fund, Inc. (Program Project Development Grant), Mr. and Mrs. Daniel P. Gordon, The Blanton-Davis Ovarian Cancer Research Program, the American Cancer Society Research Professor Award, and the Frank McGraw Memorial Chair in Cancer Research (AKS) and CPRIT (DP150091; LSM). SKD was supported by Foundation for Women's Cancer Grant, CRA was supported by the P50 CA217685 from the SPORE in Ovarian Cancer at MD Anderson.	Al-Abd AM, 2017, J ADV RES, V8, P591, DOI 10.1016/j.jare.2017.06.006; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Cao YH, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0084-4; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Dey N, 2015, AM J TRANSL RES, V7, P1675; Dunn LL, 2014, DIABETES, V63, P675, DOI 10.2337/db13-0417; Flores-Perez A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34504; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Imam JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052397; Inforzato A, 2010, J BIOL CHEM, V285, P17681, DOI 10.1074/jbc.M109.085639; Jayson GC, 2016, LANCET, V388, P518, DOI 10.1016/S0140-6736(15)01088-0; Johnson R, 2017, BREAST CANCER-TARGET, V9, P383, DOI 10.2147/BCTT.S131038; Kaalund SS, 2014, EPILEPSIA, V55, P2017, DOI 10.1111/epi.12839; Kang Y, 2013, JNCI-J NATL CANCER I, V105, P1485, DOI 10.1093/jnci/djt210; Kuai R, 2017, INT J NANOMED, V12, P6581, DOI 10.2147/IJN.S140591; Kuai R, 2016, ACS NANO, V10, P3015, DOI 10.1021/acsnano.5b07522; Lacko AG, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00247; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Lee H, 2016, SCI REP-UK, V6, DOI 10.1038/srep25287; Li Y, 2017, CANCER LETT, V397, P111, DOI 10.1016/j.canlet.2017.03.032; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Mooberry LK, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00466; Mutharasan RK, 2016, J MATER CHEM B, V4, P188, DOI 10.1039/c5tb01332a; Niu G, 2010, CURR DRUG TARGETS, V11, P1000, DOI 10.2174/138945010791591395; Ohana R, 2015, DEVELOPMENT, V142, P2487, DOI 10.1242/dev.121533; Pecot CV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3427; Qiu YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1331, DOI 10.1159/000354531; Rajora MA, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00326; Resovi A, 2014, MATRIX BIOL, V37, P83, DOI 10.1016/j.matbio.2014.01.012; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shahzad MMK, 2011, NEOPLASIA, V13, P309, DOI 10.1593/neo.101372; Simonsen JB, 2016, NANOMED-NANOTECHNOL, V12, P2161, DOI 10.1016/j.nano.2016.05.009; Son JC, 2017, CANCER INFORM, V16, DOI 10.1177/1176935117702878; Tatiparti K, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7040077; Todorova K, 2017, HORM CANCER-US, V8, P28, DOI 10.1007/s12672-016-0279-9; Vickers KC, 2014, J LIPID RES, V55, P4, DOI 10.1194/jlr.R035964; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang W, 2014, ONCOL REP, V32, P2127, DOI 10.3892/or.2014.3439; Wang XJ, 2016, BIOMED PHARMACOTHER, V82, P202, DOI 10.1016/j.biopha.2016.04.060; Wu SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11169; Xu GL, 2016, MOL ENDOCRINOL, V30, P917, DOI 10.1210/me.2016-1056; Yan HL, 2015, INT J GYNECOL CANCER, V25, P944, DOI 10.1097/IGC.0000000000000456; Yu B, 2013, BLOOD, V121, P136, DOI 10.1182/blood-2012-01-407742; Zhang FR, 2016, EUR J PHARM SCI, V92, P11, DOI 10.1016/j.ejps.2016.06.017; Zhang J, 2012, MODERN PATHOL, V25, P456, DOI 10.1038/modpathol.2011.170; Zhang WC, 2014, TUMOR BIOL, V35, P6235, DOI 10.1007/s13277-014-2202-8; Zhao Y, 2014, BIOCHEM BIOPH RES CO, V454, P183, DOI 10.1016/j.bbrc.2014.10.068	53	30	33	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2019	38	33					6095	6108		10.1038/s41388-019-0862-y	http://dx.doi.org/10.1038/s41388-019-0862-y			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IR6TP	31289363	Green Accepted			2022-12-26	WOS:000481572400002
J	d'Auriac, MBA; Strand, DA; Mjelde, M; Demars, BOL; Thaulow, J				d'Auriac, Marc B. Angles; Strand, David A.; Mjelde, Marit; Demars, Benoit O. L.; Thaulow, Jens			Detection of an invasive aquatic plant in natural water bodies using environmental DNA	PLOS ONE			English	Article							SUBMERSED MACROPHYTES; DECAY-RATES; EDNA; QUANTIFICATION; VIABILITY; LAKE	The ability to detect founding populations of invasive species or rare species with low number of individuals is important for aquatic ecosystem management. Traditional approaches use historical data, knowledge of the species' ecology and time-consuming surveys. Within the past decade, environmental DNA (eDNA) has emerged as a powerful additional tracking tool. While much work has been done with animals, comparatively very little has been done with aquatic plants. Here we investigated the transportation and seasonal changes in eDNA concentrations for an invasive aquatic species, Elodea canadensis, in Norway. A specific probe assay was developed using chloroplast DNA to study the fate of the targeted eDNA through space and time. The spatial study used a known source of Elodea canadensis within Lake Nordbytjern 400 m away from the lake outlet flowing into the stream Tveia. The rate of disappearance of E. canadensis eDNA was an order of magnitude loss over about 230 m in the lake and 1550 m in the stream. The time series study was performed monthly from May to October in lake Steinsfjorden harbouring E. canadensis, showing that eDNA concentrations varied by up to three orders of magnitude, peaking during fall. In both studies, the presence of suspended clay or turbidity for some samples did not hamper eDNA analysis. This study shows how efficient eDNA tools may be for tracking aquatic plants in the environment and provides key spatial and temporal information on the fate of eDNA.	[d'Auriac, Marc B. Angles; Strand, David A.; Mjelde, Marit; Demars, Benoit O. L.; Thaulow, Jens] Norwegian Inst Water Res NIVA, Oslo, Norway; [Strand, David A.] Norwegian Vet Inst, Oslo, Norway	Norwegian Institute for Water Research (NIVA); Norwegian Veterinary Institute	d'Auriac, MBA (corresponding author), Norwegian Inst Water Res NIVA, Oslo, Norway.	mad@niva.no	Demars, Benoit/ABF-4296-2021; Angles d'Auriac, Marc/ABE-6889-2021	Angles d'Auriac, Marc/0000-0001-6385-663X; Thaulow, Jens/0000-0002-4063-6738	Vannomrade Leira-Nitelva [180256]; Norwegian Institute for Water Research (NIVA)	Vannomrade Leira-Nitelva; Norwegian Institute for Water Research (NIVA)	This work was funded by Vannomrade Leira-Nitelva/180256 and by a Norwegian Institute for Water Research (NIVA) internal strategic financing.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez AJ, 1998, MOL ECOL, V7, P775, DOI 10.1046/j.1365-294x.1998.00339.x; Andruszkiewicz EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176343; Barnes MA, 2013, INVAS PLANT SCI MANA, V6, P320, DOI 10.1614/IPSM-D-12-00060.1; Berge D, 1989 NIVA RAPPORT O; Bogen J, 1991, DELRAPPORT I PROSJEK; Buxton AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191737; CARPENTER SR, 1986, AQUAT BOT, V26, P341, DOI 10.1016/0304-3770(86)90031-8; Coughlan NE, 2018, AQUAT BOT, V150, P9, DOI 10.1016/j.aquabot.2018.06.001; Coughlan NE, 2017, BIOL INVASIONS, V19, P625, DOI 10.1007/s10530-016-1293-0; Davy CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130965; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Demars B, 2018, 2018 CONTRACT NO 73; Demars BOL, 2014, WATER-SUI, V6, P868, DOI 10.3390/w6040868; Deutschmann B, 2019, SCI TOTAL ENVIRON, V655, P321, DOI 10.1016/j.scitotenv.2018.11.247; Doi H, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170568; Doi H, 2017, FRESHWATER BIOL, V62, P30, DOI 10.1111/fwb.12846; Egeter B, 2018, GENOME, V61, P807, DOI 10.1139/gen-2018-0071; Fahner NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157505; Fossoy F, 2018, 2018 1586 CONTRACT N; Fujiwara A, 2016, FRESHW SCI, V35, P748, DOI 10.1086/685882; Gantz CA, 2018, BIOL INVASIONS, V20, P2535, DOI 10.1007/s10530-018-1718-z; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hagman CHC, 2015, HYDROBIOLOGIA, V744, P1, DOI 10.1007/s10750-014-2050-y; Hellsten S., 2014, 26513 EUR EN; Hulley EN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210165; Hussner A, 2012, WEED RES, V52, P297, DOI 10.1111/j.1365-3180.2012.00926.x; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Klymus KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177643; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Kuzmina ML, 2018, APPL PLANT SCI, V6, DOI 10.1002/aps3.1155; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Matsuhashi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156217; Mauvisseau Q, 2018, HYDROBIOLOGIA, V805, P163, DOI 10.1007/s10750-017-3288-y; Minamoto T, 2017, MOL ECOL RESOUR, V17, P324, DOI 10.1111/1755-0998.12586; Mjelde M, 2012 CONTRACT NO 641; Mjelde M, 2012, VASSPEST ELODEA CANA; Mjelde M, 2012, ANN LIMNOL-INT J LIM, V48, P225, DOI 10.1051/limn/2012016; MOLLER TR, 1985, OIKOS, V45, P8, DOI 10.2307/3565216; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pluess T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048157; Pluess T, 2012, BIOL INVASIONS, V14, P1365, DOI 10.1007/s10530-011-0160-2; Reinhardt T, 2019, AQUAT CONSERV, V29, P353, DOI 10.1002/aqc.3038; Rice CJ, 2018, FRESHWATER BIOL, V63, P443, DOI 10.1111/fwb.13081; RORSLETT B, 1986, AQUAT BOT, V26, P325, DOI 10.1016/0304-3770(86)90030-6; Rorslett B., 1985, VERH INT VEREIN LIMN, V22, P2920, DOI DOI 10.1080/03680770.1983.11897803; Sansom BJ, 2017, ENVIRON SCI TECHNOL, V51, P14244, DOI 10.1021/acs.est.7b05199; Sassoubre LM, 2016, ENVIRON SCI TECHNOL, V50, P10456, DOI 10.1021/acs.est.6b03114; Saxena A, 2014, INT J STROKE, V9, P4; Schneider SC, 2016, EUR J PHYCOL, V51, P282, DOI 10.1080/09670262.2016.1147085; Scriver M, 2015, AQUAT BOT, V122, P27, DOI 10.1016/j.aquabot.2015.01.003; Simpson DA., 1984, WATSONIA J BOT SOC I, V15, P1; Smart AS, 2015, ECOL APPL, V25, P1944, DOI 10.1890/14-1751.1; Spens J, 2017, METHODS ECOL EVOL, V8, P635, DOI 10.1111/2041-210X.12683; SPICER KW, 1988, CAN J PLANT SCI, V68, P1035, DOI 10.4141/cjps88-125; Stoeckle BC, 2016, AQUAT CONSERV, V26, P1120, DOI 10.1002/aqc.2611; Strand DA, 2019, J APPL ECOL, V56, P1661, DOI 10.1111/1365-2664.13404; Sutcliffe C, 2018, BIOL INVASIONS, V20, P399, DOI 10.1007/s10530-017-1541-y; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Takahashi MK, 2018, J WILDLIFE MANAGE, V82, P217, DOI 10.1002/jwmg.21349; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Ushio M, 2017, MOL ECOL RESOUR, V17, pe63, DOI 10.1111/1755-0998.12690; Valentin RE, 2018, FRONT ECOL ENVIRON, V16, P265, DOI 10.1002/fee.1811; Wacker S., 2019, ENV DNA, V1, P64, DOI [10.1002/edn3.10, DOI 10.1002/EDN3.10]; DG	69	11	11	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2019	14	7							e0219700	10.1371/journal.pone.0219700	http://dx.doi.org/10.1371/journal.pone.0219700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4NB	31299064	Green Published, Green Submitted, gold			2022-12-26	WOS:000484955800010
J	Scott, E; Kallis, G; Zografos, C				Scott, Evon; Kallis, Giorgos; Zografos, Christos			Why environmentalists eat meat	PLOS ONE			English	Article							BEHAVIOR; CONSUMPTION; ATTITUDE; TALK; DONT; GAP	Why do people who care about the environment adopt behaviours that are not consistent with their beliefs? Previous studies approach this as a case of cognitive dissonance, researchers looking into the strategies through which people reduce gaps between their attitudes and their behaviours. Here we start from the premise that there is no dissonance, and that people have consistent reasons of why they are doing what they are doing. The research task is then to shed light on these reasons. Using Q-methodology, a mixed quantitative-qualitative approach, we interviewed 42 environmentally-minded researchers asking them why they eat meat. Our interviewees were aware of and cared about the environmental and ethical impacts of meat eating, but reasoned that they eat meat because either technological, or political changes are more important than what they personally do, because of doubts about the impact of personal action in a complex world, or simply because they lack the determination to stop eating meat. Our analysis suggests that policies and messages that try to educate or guilt meat-eaters are unlikely to work with those well aware of the impacts of their actions.	[Scott, Evon; Kallis, Giorgos] Univ Autonoma Barcelona, ICTA UAB, Barcelona, Spain; [Kallis, Giorgos] ICREA, Barcelona, Spain; [Zografos, Christos] Univ Pompeu Fabra, John Hopkins Univ, Publ Policy Ctr, Barcelona, Spain; [Zografos, Christos] Univ Pompeu Fabra, Dept Polit & Social Sci, Res Grp Hlth Inequal, Environm,Employment Condit Network GREDS EMCONET, Barcelona, Spain	Autonomous University of Barcelona; ICREA; Pompeu Fabra University; Pompeu Fabra University	Scott, E (corresponding author), Univ Autonoma Barcelona, ICTA UAB, Barcelona, Spain.	evon.scott@gmail.com	Scott, Evon/ABE-2619-2020; Scott, Evon/AAR-6864-2021; Zografos, Christos/AAH-7300-2021; KALLIS, GIORGOS/B-9448-2015	KALLIS, GIORGOS/0000-0003-0688-9552	Spanish Ministry of Economy and Competitiveness - Spanish Ministry of Science, Innovation and Universities [MDM-2015-0552, RYC-2015-17372]; Spanish Ministry of Economy and Competitiveness - European Social Fund [MDM-2015-0552, RYC-2015-17372]	Spanish Ministry of Economy and Competitiveness - Spanish Ministry of Science, Innovation and Universities; Spanish Ministry of Economy and Competitiveness - European Social Fund	Our research benefited from financial support from the Spanish Ministry of Economy and Competitiveness, through the "Maria de Maeztu" program for Units of Excellence (MDM-2015-0552) and through the Ramon y Cajal programme (RYC-2015-17372) co-funded by the Spanish Ministry of Science, Innovation and Universities, and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry J, 1999, ECOL ECON, V28, P337, DOI 10.1016/S0921-8009(98)00053-6; Bastian B, 2017, PERS SOC PSYCHOL REV, V21, P278, DOI 10.1177/1088868316647562; Blake J., 1999, LOCAL ENVIRON, V4, P257, DOI [10.1080/13549839908725599, DOI 10.1080/13549839908725599]; Brown S.R., 1980, POLITICAL SUBJECTIVI; Brown S.R., 1993, OPERANT SUBJECTIVITY, V16, P91, DOI DOI 10.15133/J.OS.1993.002; Carrington MJ, 2010, J BUS ETHICS, V97, P139, DOI 10.1007/s10551-010-0501-6; Caruana R, 2016, J BUS ETHICS, V136, P215, DOI 10.1007/s10551-014-2444-9; Chatzidakis A, 2007, J BUS ETHICS, V74, P89, DOI 10.1007/s10551-006-9222-2; ELLIOT AJ, 1994, J PERS SOC PSYCHOL, V67, P382, DOI 10.1037/0022-3514.67.3.382; Ellis G, 2007, J ENVIRON PLANN MAN, V50, P517, DOI 10.1080/09640560701402075; Festinger L., 1962, THEORY COGNITIVE DIS; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Kunst JR, 2016, APPETITE, V105, P758, DOI 10.1016/j.appet.2016.07.009; Loughnan S, 2010, APPETITE, V55, P156, DOI 10.1016/j.appet.2010.05.043; Moraes C, 2012, J MARKET MANAG-UK, V28, P103, DOI 10.1080/0267257X.2011.615482; Piazza J, 2015, APPETITE, V91, P114, DOI 10.1016/j.appet.2015.04.011; PLOUS S, 1993, J SOC ISSUES, V49, P11, DOI 10.1111/j.1540-4560.1993.tb00907.x; Ruby MB, 2011, APPETITE, V56, P447, DOI 10.1016/j.appet.2011.01.018; Sammer K., 2006, BUSINESS STRATEGY EN, V15, P185, DOI [10.1002/bse.522, DOI 10.1002/BSE.522]; Schmolck P., 2014, PQMETHOD MANUAL VERS; Sedova I, 2016, APPETITE, V107, P415, DOI 10.1016/j.appet.2016.08.102; Stainton Rogers R., 1995, RETHINKING METHODS P, P192; Vermeir I, 2006, J AGR ENVIRON ETHIC, V19, P169, DOI 10.1007/s10806-005-5485-3; Watts S., 2012, DOING Q METHODOLOGIC; Young W, 2010, SUSTAIN DEV, V18, P20, DOI 10.1002/sd.394	25	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219607	10.1371/journal.pone.0219607	http://dx.doi.org/10.1371/journal.pone.0219607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4LN	31295301	gold, Green Published, Green Submitted			2022-12-26	WOS:000484951800052
J	Mocumbi, AO; Cebola, B; Muloliwa, A; Sebastiao, F; Sitefane, SJ; Manafe, N; Dobe, I; Lumbandali, N; Keates, A; Stickland, N; Chan, YK; Stewart, S				Mocumbi, Ana O.; Cebola, Bonifacio; Muloliwa, Artur; Sebastiao, Frederico; Sitefane, Samuel J.; Manafe, Naisa; Dobe, Igor; Lumbandali, Norberto; Keates, Ashley; Stickland, Nerolie; Chan, Yih-Kai; Stewart, Simon			Differential patterns of disease and injury in Mozambique: New perspectives from a pragmatic, multicenter, surveillance study of 7809 emergency presentations	PLOS ONE			English	Article							GLOBAL BURDEN; HEALTH; CARE; MANAGEMENT; COUNTRIES; STROKE; MAPUTO; TRENDS	Background There is a paucity of primary data to understand the overall pattern of disease and injuries as well as related health-service utilization in resource-poor countries in Africa. Objective To generate reliable and robust data describing the pattern of emergency presentations attributable to communicable disease (CD), non-communicable disease (NCD) and injuries in three different regions of Mozambique. Methods We undertook a pragmatic, prospective, multicentre surveillance study of individuals (all ages) presenting to the emergency departments of three hospitals in Southern (Maputo), Central (Beira) and Northern (Nampula) Mozambique. During 24-hour surveillance in the seasonally distinct months of April and October 2016/2017, we recorded data on 7,809 participants randomly selected from 39,124 emergency presentations to the three participating hospitals. Applying a pragmatic surveillance protocol, data were prospectively collected on the demography, clinical history, medical profile and treatment of study participants. Findings A total of 4,021 males and 3,788 (48.5%) females comprising 630 infants (8.1%), 2,070 children (26.5%), 1,009 adolescents (12.9%) and, 4,100 adults (52.5%) were studied. CD was the most common presentation (3,914 cases/50.1%) followed by NCD (1,963/25.1%) and injuries (1,932/24.7%). On an adjusted basis, CD was more prevalent in younger individuals (17.9 +/- 17.7 versus 26.6 +/- 19.2 years; p<0.001), females (51.7% versus 48.7%-OR 1.137, 95% CI 1.036-1.247; p=0.007), the capital city of Maputo (59.6%) versus the more remote cities of Beira (42.8%-OR 0.532, 95% CI 0.476-0.594) and Nampula (45.8%-OR 0.538, 95% CI 0.480-0.603) and, during April (51.1% versus 49.3% for October-OR 1.142, 95% CI 1.041-1.253; p=0.005). Conversely, NCD was progressively more prevalent in older individuals, females and in the regional city of Beira, whilst injuries were more prevalent in males (particularly adolescent/young men) and the northern city of Nampula. On a 24-hour basis, presentation patterns were unique to each hospital. Interpretation Applying highly pragmatic surveillance methods suited to the low-resource setting of Mozambique, these unique data provide critical insights into the differential pattern of CD, NCD and injury. Consequently, they highlight specific health priorities across different regions and seasons in Southern Africa.	[Mocumbi, Ana O.; Manafe, Naisa; Dobe, Igor; Lumbandali, Norberto] Inst Nacl Saude, Maputo, Mozambique; [Mocumbi, Ana O.; Stewart, Simon] Univ Eduardo Mondlane, Maputo, Mozambique; [Cebola, Bonifacio] Hosp Cent Beira, Beira, Mozambique; [Muloliwa, Artur] Direccao Prov Sofala, Beira, Mozambique; [Sebastiao, Frederico] Hosp Cent Nampula, Nampula, Mozambique; [Sitefane, Samuel J.] Hosp Geral Mavalane, Maputo, Mozambique; [Keates, Ashley; Stickland, Nerolie; Chan, Yih-Kai] Australian Catholic Univ, Melbourne, Vic, Australia	Eduardo Mondlane University; Australian Catholic University	Mocumbi, AO (corresponding author), Inst Nacl Saude, Maputo, Mozambique.; Mocumbi, AO (corresponding author), Univ Eduardo Mondlane, Maputo, Mozambique.	amocumbi@gmail.com	; Stewart, Simon/M-3316-2016	Mocumbi, Ana/0000-0002-9564-2860; Stewart, Simon/0000-0001-9032-8998; Keates, Ashley K/0000-0001-8799-9627	National Health and Medical Research Council of Australia [1044897]; Pfizer Investigator Initiated Grant [WT221693]; Pfizer Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Pfizer Investigator Initiated Grant; Pfizer Foundation	The MOZART Study was co-funded by the National Health and Medical Research Council of Australia (1044897) and a Pfizer Investigator Initiated Grant (WT221693) by the Pfizer Foundation. AM and SS received the awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Taibo CLA, 2016, INT J EMERG MED, V9, DOI 10.1186/s12245-016-0105-8; [Anonymous], 2010, INT STAT CLASSIFICAT; Bachani AM, 2018, B WORLD HEALTH ORGAN, V96, P423, DOI 10.2471/BLT.17.200949; Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987; Bruce N, 2000, B WORLD HEALTH ORGAN, V78, P1078; Damasceno A, 2010, STROKE, V41, P2463, DOI 10.1161/STROKEAHA.110.594275; Gomes J, 2015, CLIN NEUROL NEUROSUR, V129, P72, DOI 10.1016/j.clineuro.2014.12.002; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Jessen N, 2018, J HYPERTENS, V36, P779, DOI 10.1097/HJH.0000000000001618; Kassebaum N, 2017, JAMA PEDIATR, V171, P573, DOI 10.1001/jamapediatrics.2017.0250; Kieny MP, 2017, B WORLD HEALTH ORGAN, V95, P537, DOI 10.2471/BLT.16.187476; Kigozi E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198091; Koon AD, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-54; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kwan GF, 2016, CIRCULATION, V133, P2561, DOI 10.1161/CIRCULATIONAHA.116.008731; Lim SS, 2016, LANCET, V388, P1813, DOI 10.1016/S0140-6736(16)31467-2; Llibre JM, 2018, LANCET, V391, P839, DOI 10.1016/S0140-6736(17)33095-7; Lunze K, 2017, B WORLD HEALTH ORGAN, V95, P333, DOI [10.2471/BLT.16.170092, 10.2471/blt.16.170092]; Mayor A, 2015, NEW ENGL J MED, V373, P1607, DOI 10.1056/NEJMoa1406459; Msyamboza KP, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-41; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Orsini J, 2016, J COMMUNITY HOSP INT, V6, DOI 10.3402/jchimp.v6.33478; Otwombe K, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.25670; Relatorio MISAU, 2016, PLAN NAC DES REC HUM; Sagara I, 2018, LANCET, V391, P1378, DOI 10.1016/S0140-6736(18)30291-5; Sana A, 2018, BMJ OPEN RESPIR RES, V5, DOI 10.1136/bmjresp-2017-000246; Sankar J, 2015, INDIAN J CRIT CARE M, V19, P474, DOI 10.4103/0972-5229.162469; Silva-Matos C, 2011, DIABETES METAB, V37, P237, DOI 10.1016/j.diabet.2010.10.006; Victor B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108654; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Vroh JBB, 2016, SANTE PUBLIQUE, V28, P647; World Health Organization, 2013, GLOB ACT PLAN PREV C	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219273	10.1371/journal.pone.0219273	http://dx.doi.org/10.1371/journal.pone.0219273			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291292	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800064
J	Schafer, D; Prati, D; Schall, P; Ammer, C; Fischer, M				Schaefer, Deborah; Prati, Daniel; Schall, Peter; Ammer, Christian; Fischer, Markus			Exclusion of large herbivores affects understorey shrub vegetation more than herb vegetation across 147 forest sites in three German regions	PLOS ONE			English	Article							SEED DISPERSAL; MANAGEMENT INTENSITY; SPECIES COMPOSITION; NORTHERN GERMANY; VASCULAR PLANTS; GROUND FLORA; ROE DEER; IMPACT; RED; POPULATION	Background Many studies have analysed the effect of browsing by large herbivores on tree species but far fewer studies have studied their effect on understorey shrubs and herbs. Moreover, while many studies have shown that forest features and management intensity strongly influence understorey vegetation, the influence of such variation on the effect of large-herbivore exclusion is not known. This study In this study, we analysed changes of species richness, Shannon diversity, evenness and cover of understorey herbs and shrubs after excluding large herbivores for seven years on 147 forest sites, differing in management intensity and forest features, in three regions of Germany (Schwabische Alb, Hainich-Dun, Schorfheide-Chorin). Further, we studied how the effect of large-herbivore exclusion on understorey vegetation was influenced by forest management intensity and several forest features. Results As expected, exclusion of large herbivores resulted in highly variable results. Nevertheless, we found that large-herbivore exclusion significantly increased cover and Shannon diversity of shrub communities, while it did not affect herb communities. Forest management intensity did not influence the effect of large-herbivore exclusion while some forest features, most often relative conifer cover, did. In forests with high relative conifer cover, large-herbivore exclusion decreased species richness and cover of herbs and increased Shannon diversity of herbs and shrubs, while in forests with low relative conifer cover large-herbivore exclusion increased species richness and cover of herbs, and decreased Shannon diversity of herbs and shrubs. Conclusion We suggest that browsing by large herbivores should be included when studying understorey shrub communities, however when studying understorey herb communities the effects of browsing are less general and depend on forest features.	[Schaefer, Deborah; Prati, Daniel; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Schall, Peter; Ammer, Christian] Univ Gottingen, Silviculture & Forest Ecol Temperate Zones, Gottingen, Germany	University of Bern; University of Gottingen	Schafer, D (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	deborah.schaefer@boga.unibe.ch	Schall, Peter/Q-5962-2019; Fischer, Markus/C-6411-2008; Ammer, Christian/ABG-7360-2020; Ammer, Christian/ABG-4629-2020	Schall, Peter/0000-0003-4808-818X; Fischer, Markus/0000-0002-5589-5900; Ammer, Christian/0000-0002-4235-0135; Schafer, Deborah/0000-0001-9591-841X	DFG Priority Program 1374 "Infrastructure-BiodiversityExploratories" [FI 1246/15-2, PR 728/2-3]	DFG Priority Program 1374 "Infrastructure-BiodiversityExploratories"	The work has been funded by the DFG Priority Program 1374 "Infrastructure-BiodiversityExploratories" (FI 1246/15-2; PR 728/2-3), which was received by DP and MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Judith Hinderling and Torsten Meene for their excellent help during fieldwork, Caterina Penone for discussions about and advice on the choice of forest features and Marion Schrumpf and Ingo Schoning for providing information on the soil parameters. We further thank the managers of the three Exploratories, Kirsten Reichel-Jung, Swen Renner, Katrin Hartwich, Sonja Gockel, Kerstin Wiesner, and Martin Gorke for their work in maintaining the plot and project infrastructure; Christiane Fischer and Simone Pfeiffer for giving support through the central office, Michael Owonibi for managing the central data base, and Eduard Linsenmair, Dominik Hessenmoller, Jens Nieschulze, Ingo Schoning, Franois Buscot, Ernst-Detlef Schulze, Wolfgang W. Weisser and the late Elisabeth Kalko for their role in setting up the Biodiversity Exploratories program. Fieldwork permits were issued by the responsible state environmental offices of Baden-Wurttemberg, Thuringen, and Brandenburg (according to 72 BbgNatSchG).	AGNEW ADQ, 1970, ECOLOGY, V51, P735, DOI 10.2307/1934057; Ammer C, 1996, FOREST ECOL MANAG, V88, P43, DOI 10.1016/S0378-1127(96)03808-X; Ammer C, 2011, WALD WILD KONFLIKT A; ANDERSON RC, 1979, J APPL ECOL, V16, P855, DOI 10.2307/2402859; ANDREN H, 1993, J APPL ECOL, V30, P133, DOI 10.2307/2404277; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Bergstrom Roger, 2003, Journal for Nature Conservation (Jena), V10, P203, DOI 10.1078/1617-1381-00020; BIERZYCHUDEK P, 1982, NEW PHYTOL, V90, P757, DOI 10.1111/j.1469-8137.1982.tb03285.x; Boch S, 2013, BASIC APPL ECOL, V14, P496, DOI 10.1016/j.baae.2013.06.001; Burbaite Lina, 2010, Acta Zoologica Lituanica, V20, P179, DOI 10.2478/v10043-010-0038-z; Chaudhary A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23954; Collard A, 2010, FOREST ECOL MANAG, V260, P649, DOI 10.1016/j.foreco.2010.05.021; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; George LO, 1999, ECOLOGY, V80, P833, DOI 10.1890/0012-9658(1999)080[0833:TFUAAE]2.0.CO;2; GILL RMA, 1992, FORESTRY, V65, P145, DOI 10.1093/forestry/65.2.145; Gill RMA, 2001, FORESTRY, V74, P209, DOI 10.1093/forestry/74.3.209; Gossner MM, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00177.1; Heinken T, 2006, BASIC APPL ECOL, V7, P31, DOI 10.1016/j.baae.2005.04.006; Heinken Thilo, 2000, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V122, P449; Heinze E, 2011, FOREST ECOL MANAG, V261, P288, DOI 10.1016/j.foreco.2010.10.022; Heurich M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120960; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Horsley SB, 2003, ECOL APPL, V13, P98, DOI 10.1890/1051-0761(2003)013[0098:WTDIOT]2.0.CO;2; HORSLEY SB, 1983, CAN J FOREST RES, V13, P61, DOI 10.1139/x83-009; Hyatt LA, 2000, J ECOL, V88, P516, DOI 10.1046/j.1365-2745.2000.00465.x; Jedrzejewska B, 1997, ACTA THERIOL, V42, P399; Kahl T, 2014, NAT CONSERV-BULGARIA, P15, DOI 10.3897/natureconservation.7.7281; Kirby KJ, 2001, FORESTRY, V74, P219, DOI 10.1093/forestry/74.3.219; Knight TM, 2003, AM J BOT, V90, P1207, DOI 10.3732/ajb.90.8.1207; Koerner SE, 2018, NAT ECOL EVOL, V2, P1925, DOI 10.1038/s41559-018-0696-y; Kuijper DPJ, 2011, EUR J FOREST RES, V130, P895, DOI 10.1007/s10342-011-0523-3; Kullberg Y, 2001, SCAND J FOREST RES, V16, P371, DOI 10.1080/02827580152496768; Kumar P, 2018, J ECOL, V106, P1266, DOI 10.1111/1365-2745.12861; McEuen AB, 2004, ECOLOGY, V85, P507, DOI 10.1890/03-4006; Milner JM, 2006, J APPL ECOL, V43, P721, DOI 10.1111/j.1365-2664.2006.01183.x; Mitchell FJG, 2005, J ECOL, V93, P168, DOI 10.1111/j.1365-2745.2004.00964.x; Muller A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177431; Newman M, 2014, FOREST ECOL MANAG, V321, P136, DOI 10.1016/j.foreco.2013.09.010; Ohse B, 2017, ECOL EVOL, V7, P6779, DOI 10.1002/ece3.3217; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Pinheiro J, 2020, R PACKAGE VERSION 31; Potvin F, 2003, ECOSCIENCE, V10, P487, DOI 10.1080/11956860.2003.11682796; Rooney TP, 2001, FORESTRY, V74, P201, DOI 10.1093/forestry/74.3.201; Schall P, 2018, BASIC APPL ECOL, V32, P39, DOI 10.1016/j.baae.2018.02.007; Schall P, 2013, EUR J FOREST RES, V132, P379, DOI 10.1007/s10342-013-0681-6; Schmidt M, 2004, EUR J FOREST RES, V123, P167, DOI 10.1007/s10342-004-0029-3; Small CJ, 2003, PLANT ECOL, V164, P37, DOI 10.1023/A:1021209528643; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; SORENSEN AE, 1986, ANNU REV ECOL SYST, V17, P443, DOI 10.1146/annurev.es.17.110186.002303; Stockton SA, 2005, BIOL CONSERV, V126, P118, DOI 10.1016/j.biocon.2005.06.006; Stromayer KAK, 1997, WILDLIFE SOC B, V25, P227; Tremblay JP, 2007, J APPL ECOL, V44, P552, DOI 10.1111/j.1365-2664.2007.01290.x; Vera F. W. M., 2000, Grazing ecology and forest history, DOI 10.1079/9780851994420.0000; von Oheimb G, 2005, EUR J FOREST RES, V124, P55, DOI 10.1007/s10342-005-0053-y; vonOheimb G, 1999, MITT BUNDESFORSCH AN, V195, P279; Watkinson AR, 2001, FORESTRY, V74, P231, DOI 10.1093/forestry/74.3.231; Webster CR, 2005, BIOL CONSERV, V125, P297, DOI 10.1016/j.biocon.2005.03.027; WELCH D, 1991, FORESTRY, V64, P61, DOI 10.1093/forestry/64.1.61; Whigham DE, 2004, ANNU REV ECOL EVOL S, V35, P583, DOI 10.1146/annurev.ecolsys.35.021103.105708; WILSON SD, 1993, ECOLOGY, V74, P599, DOI 10.2307/1939319	62	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218741	10.1371/journal.pone.0218741	http://dx.doi.org/10.1371/journal.pone.0218741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291260	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800033
J	Hawryl, A; Hawryl, M; Waksmundzka-Hajnos, M				Hawryl, Anna; Hawryl, Miroslaw; Waksmundzka-Hajnos, Monika			Liquid chromatography fingerprint analysis and antioxidant activity of selected lavender species with chemometric calculations	PLOS ONE			English	Article							ESSENTIAL OILS; QUALITY; COMPONENTS; EXTRACTS; PREDICTION; ALIGNMENT	The extracts of seven Lavandulae species (Lavandula stoechas, Lavandula lanata, Lavandula viridis, Lavandula angustifolia "Rosea", Lavandula angustifolia "Afropurpurea", Lavandula angustifolia and one unknown) were analyzed using the reversed-phase-high performance liquid chromatography-diode array detection (RP-HPLC-DAD) with gradient elution technique to obtain the chromatographic fingerprint profiles. The HPLC analysis was performed using the Kinetex RP18 chromatographic column and eluent consisting of methanol-water-0.1% formic acid (5-100% (v/v)) at 30 degrees C with the run time of 60 min. and the detection wavelength 280 nm. The chromatograms were preliminary processed with the smoothing, noise reduction, background subtraction and alignment using the SpecAlign program (version 2.4.1). The presence of selected standards (apigenin, myricetin, luteolin, luteolin 7-glucoside, chlorogenic acid, caffeic acid, ferulic acid) in the extracts was confirmed. The chemical similarity between studied plants was evaluated using the Cluster Analysis (Pearson correlation coefficient, r, and Euclidean) and PCA. The preliminary antioxidant activity of studied extracts was evaluated based on the total phenolic content (Folin-Ciocalteu method), ferric ion reducing antioxidant parameter (FRAP) and alpha,alpha-diphenyl-beta-picrylhydrazyl (DPPH) free radical scavenging method using the spectrophotometric technique.	[Hawryl, Anna; Hawryl, Miroslaw; Waksmundzka-Hajnos, Monika] Med Univ Lublin, Fac Pharm, Dept Inorgan Chem, Lublin, Poland	Medical University of Lublin	Hawryl, A (corresponding author), Med Univ Lublin, Fac Pharm, Dept Inorgan Chem, Lublin, Poland.	anna.hawryl@umlub.pl	Hawrył, Mirosław/GLN-5484-2022	Hawryl, Miroslaw/0000-0003-3286-763X; Hawryl, Anna/0000-0002-8924-169X				Alexa E, 2018, ANAL CELL PATHOL, V2018, DOI 10.1155/2018/2678924; Aloglu AK, 2016, TALANTA, V161, P503, DOI 10.1016/j.talanta.2016.09.014; [Anonymous], 1991, GUID ASS HERB MED; Areias FM, 2000, J LIQ CHROMATOGR R T, V23, P2563, DOI 10.1081/JLC-100100510; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Cavanagh HMA, 2002, PHYTOTHER RES, V16, P301, DOI 10.1002/ptr.1103; Celik SE, 2017, J CHROMATOGR SCI, V55, P291, DOI 10.1093/chromsci/bmw184; Chang YX, 2008, J CHROMATOGR A, V1208, P76, DOI 10.1016/j.chroma.2008.08.054; Ciesla L., 2012, CHROMATOGR RES INT, V9; Daszykowski M, 2007, J CHROMATOGR A, V1176, P1, DOI 10.1016/j.chroma.2007.10.099; Contreras MD, 2018, ELECTROPHORESIS, V39, P1284, DOI 10.1002/elps.201700393; Gabrieli C, 2003, PHARMAZIE, V58, P426; Gilani AH, 2000, J ETHNOPHARMACOL, V71, P161, DOI 10.1016/S0378-8741(99)00198-1; Gulcin I, 2004, FOOD CHEM, V87, P393, DOI 10.1016/j.foodchem.2003.12.008; Hawryl A, 2017, J LIQ CHROMATOGR R T, V40, P36, DOI 10.1080/10826076.2017.1282373; Hawryl AM, 2017, ANAL LETT, V50, P2078, DOI 10.1080/00032719.2016.1263645; Hawryl AM, 2016, J BRAZIL CHEM SOC, V27, P1736, DOI 10.5935/0103-5053.20160054; Jiang W, 2013, CHROMATOGRAPHIA, V76, P1067, DOI 10.1007/s10337-013-2513-8; Kirmizibekmez H, 2009, NAT PROD COMMUN, V4, P1001; Kovatcheva EG, 2001, FOOD CHEM, V72, P295, DOI 10.1016/S0308-8146(00)00229-6; Liu X, 2016, CHEMOMETR INTELL LAB, V152, P54, DOI 10.1016/j.chemolab.2016.01.006; Peng L, 2011, FOOD CHEM, V125, P1064, DOI 10.1016/j.foodchem.2010.09.079; Rodrigues MJ, 2019, S AFR J BOT, V120, P87, DOI 10.1016/j.sajb.2017.12.003; Sabara D., 2009, SCI B TU LODZ, V73, P33; Sosa S, 2005, PHYTOMEDICINE, V12, P271, DOI 10.1016/j.phymed.2004.02.007; Spiridon I, 2011, NAT PROD RES, V25, P1657, DOI 10.1080/14786419.2010.521502; Tang DQ, 2010, ANAL BIOANAL CHEM, V396, P3087, DOI 10.1007/s00216-010-3536-8; Turek C, 2012, FOOD RES INT, V46, P341, DOI 10.1016/j.foodres.2011.12.028; Turek C, 2011, J FOOD SCI, V76, pC1365, DOI 10.1111/j.1750-3841.2011.02416.x; Turek C, 2011, ANAL BIOANAL CHEM, V400, P3109, DOI 10.1007/s00216-011-4976-5; Wong CC, 2006, FOOD CHEM, V97, P705, DOI 10.1016/j.foodchem.2005.05.049; Wong JWH, 2005, BIOINFORMATICS, V21, P2088, DOI 10.1093/bioinformatics/bti300; Wu QY, 2011, INT J MOL SCI, V12, P8740, DOI 10.3390/ijms12128740; Yan SK, 2005, J CHROMATOGR A, V1090, P90, DOI 10.1016/j.chroma.2005.07.066; Yu YP, 2018, J CHROMATOGR B, V1095, P149, DOI 10.1016/j.jchromb.2018.07.031	35	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0218974	10.1371/journal.pone.0218974	http://dx.doi.org/10.1371/journal.pone.0218974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287826	gold, Green Submitted, Green Published			2022-12-26	WOS:000482328300008
J	Lamb, MC; Kimmel, DG; Field, EK				Lamb, Madison C.; Kimmel, David G.; Field, Erin K.			The effects of temperature on Bosmina longirostris susceptibility to microcystin-LR acute toxicity	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; CLIMATE-CHANGE; GLOBAL EXPANSION; CYANOBACTERIA; ZOOPLANKTON; AERUGINOSA; TOLERANCE; DAPHNIA; TOXINS; EUTROPHICATION	Harmful algal blooms are an ongoing threat to many aquatic systems throughout the world. In the Chowan River, North Carolina, the frequency of toxin producing Microcystis aeruginosa blooms has increased since 1975 along with an average 0.71 degrees C rise in water temperature. The combined effect of microcystin-LR toxin and rising temperatures on a dominant zooplankter in the system, Bosmina longirostris, was the focus of this study. Laboratory studies were conducted to determine how microcystin-LR, produced from M. aeruginosa blooms, affected B. longirostris mortality under different temperature regimes. At 25 degrees C, the LC50 for B. longirostris was 26.3 mu g L-1 suggesting that B. longirostris can survive typical current bloom microcystin-LR concentrations ranging 0.1 mu g L-1 to 2.0 mu g L-1, but would be susceptible to higher concentrations they may be periodically exposed to. Mortality was assessed at a constant microcystin-LR concentration of 26.3 mu g L-1 over 15-35 degrees C, and it was found that B. longirostris mortality increased at higher temperatures. B. longirostris mortality increased approximately 18% due to microcystin-LR alone over 2 degrees C between 25 degrees C and 27 degrees C when exposed to the LC50 concentration. The increased prevalence of toxic M. aeruginosa blooms and increasing temperatures due to climate change may reduce B. longirostris populations, potentially affecting larval fish and fisheries in the Chowan River, North Carolina.	[Lamb, Madison C.; Field, Erin K.] East Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Kimmel, David G.] US NOAA, Alaska Fisheries Sci Ctr, Seattle, WA USA	University of North Carolina; East Carolina University; National Oceanic Atmospheric Admin (NOAA) - USA	Field, EK (corresponding author), East Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	fielde14@ecu.edu	Kimmel, David/AFM-9673-2022	Kimmel, David/0000-0001-7232-7801; Field, Erin/0000-0002-2121-1355	Lerner Gray Memorial Fund of the American Museum of Natural History	Lerner Gray Memorial Fund of the American Museum of Natural History	Author ML was awarded the Lerner Gray Memorial Fund of the American Museum of Natural History (https://www.amnh.org/our-research/richard-gilder-graduate-school/academics-and-research/fellowship-and-grant-opportunities/research-grants-and-studentexchange-fellowships/the-lerner-gray-fund-for-marine-research). The funder had no role in studydesign, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; [Anonymous], 2017, ASMFC STOCK STAT OV; Arora VK, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046270; Binion SM, 2011, THESIS; Butler N, 2009, MICROCYSTINS BRIEF O, P5; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; DEMOTT WR, 1991, LIMNOL OCEANOGR, V36, P1346, DOI 10.4319/lo.1991.36.7.1346; Edwards M, 2006, LIMNOL OCEANOGR, V51, P820, DOI 10.4319/lo.2006.51.2.0820; Englund G, 2011, ECOL LETT, V14, P914, DOI 10.1111/j.1461-0248.2011.01661.x; Ferrao AS, 2000, FRESHWATER BIOL, V45, P1, DOI 10.1046/j.1365-2427.2000.00613.x; Finney D.J., 1952, JSTOR; FULTON RS, 1987, LIMNOL OCEANOGR, V32, P634, DOI 10.4319/lo.1987.32.3.0634; FULTON RS, 1987, J PLANKTON RES, V9, P837, DOI 10.1093/plankt/9.5.837; FULTON RS, 1988, FRESHWATER BIOL, V20, P263, DOI 10.1111/j.1365-2427.1988.tb00450.x; FULTON RS, 1988, J PLANKTON RES, V10, P771, DOI 10.1093/plankt/10.4.771; Ger KA, 2009, SCI TOTAL ENVIRON, V407, P4852, DOI 10.1016/j.scitotenv.2009.05.043; Ger KA, 2016, HARMFUL ALGAE, V52, P34, DOI 10.1016/j.hal.2015.12.008; Gobler CJ, 2017, P NATL ACAD SCI USA, V114, P4975, DOI 10.1073/pnas.1619575114; Gordon H., 2010, CSIRO MK3 5 CLIMATE; Gustafsson S, 2005, ECOLOGY, V86, P2561, DOI 10.1890/04-1710; Gustafsson S, 2004, AQUAT ECOL, V38, P37, DOI 10.1023/B:AECO.0000020985.47348.5e; Hansson LA, 2007, FRESHWATER BIOL, V52, P1290, DOI 10.1111/j.1365-2427.2007.01765.x; Harke MJ, 2016, HARMFUL ALGAE, V54, P4, DOI 10.1016/j.hal.2015.12.007; Heinle D. R., 1969, Chesapeake Science, V10, P186, DOI 10.2307/1350456; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Hietala J, 1997, FRESHWATER BIOL, V37, P299, DOI 10.1046/j.1365-2427.1997.d01-555.x; Huang B, 2017, INFORM NNCFE; Jiang XD, 2017, FRESHWATER BIOL, V62, P429, DOI 10.1111/fwb.12877; Jiang XD, 2016, SCI REP-UK, V6, DOI 10.1038/srep25319; Jiang XD, 2014, FUND APPL LIMNOL, V184, P11, DOI 10.1127/1863-9135/2014/0580; Khan AH, 2013, ICES J MAR SCI, V70, P915, DOI 10.1093/icesjms/fst002; Lichti DA, 2017, PEERJ, V5, DOI 10.7717/peerj.3667; Manning SR, 2017, CURRENT OPINION FOOD, DOI [10.1016/j.cofs.2017.05.004, DOI 10.1016/J.COFS.2017.05.004]; Moorman MC, 2017, 23311258 US GEOL SUR; Mullen DM, 1986, 821156 US DEP INT FI; North Carolina Department of Public Health, 2012, ALG BLOOM EV 2005 20; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Paerl H W, 2001, ScientificWorldJournal, V1, P76; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2013, MICROB ECOL, V65, P995, DOI 10.1007/s00248-012-0159-y; Paerl HW, 2012, WATER RES, V46, P1349, DOI 10.1016/j.watres.2011.08.002; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Reinikainen M, 2002, MAR BIOL, V140, P577, DOI 10.1007/s00227-001-0720-6; Sarnelle O, 2005, LIMNOL OCEANOGR, V50, P1565, DOI 10.4319/lo.2005.50.5.1565; Sarnelle O, 2010, J PLANKTON RES, V32, P471, DOI 10.1093/plankt/fbp151; Schmidt GA, 2006, J CLIMATE, V19, P153, DOI 10.1175/JCLI3612.1; Sharma NK, 2010, POLLUT SCI TECHNOL A, P73; Tonk L, 2009, HARMFUL ALGAE, V8, P219, DOI 10.1016/j.hal.2008.05.005; Verbitsky VB, 2009, INLAND WATER BIOL, V2, P67, DOI 10.1134/S1995082909010106; Winslow S. E., 1985, N CAROLINA ANADROMOU; Witherspoon AM, 1979, UNCWRRI79129 N CAR S; Zhang X, 2012, B ENVIRON CONTAM TOX, V88, P20, DOI 10.1007/s00128-011-0450-5	53	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219342	10.1371/journal.pone.0219342	http://dx.doi.org/10.1371/journal.pone.0219342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287833	Green Published, gold, Green Submitted			2022-12-26	WOS:000482328300018
J	Lin, YM; Chiou, YY; Wu, MH; Huang, SS; Shen, SH				Lin, Yuan-Mao; Chiou, Yi-You; Wu, Mei-Han; Huang, Shan Su; Shen, Shu-Huei			Postablation assessment of hepatocellular carcinoma using dual-energy CT: Comparison of half versus standard iodine contrast medium	PLOS ONE			English	Article							LOW-TUBE-VOLTAGE; ITERATIVE RECONSTRUCTION ALGORITHM; COMPUTED-TOMOGRAPHY; RADIOFREQUENCY ABLATION; LIVER-LESIONS; IMAGE QUALITY; ABDOMINAL CT; HEPATIC CT; NOISE; MDCT	This retrospective study was aimed to evaluate the reduced iodine load on image quality and diagnostic performance in multiphasic hepatic CT using a novel monoenergetic reconstruction algorithm (nMERA) in assessment of local tumor progression after radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC). Ninety patients who underwent CT 1 month after RFA of HCC. Forty-five patients had multiphasic hepatic dual-energy CT with a half-reduced contrast medium (HRCM) of 277.5 mg I/kg. The nMERA (40-70-keV) images were reconstructed in each phase. Another 45 patients received a standard contrast medium (SCM) of 555 mg I/kg, and the images were reconstructed as a simulated 120-kVp images. Primary outcome was accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) in assessment of local tumor progression. Additional advanced assessments included the image noise, attenuation value, contrast-to-noise ratio (CNR), and subjective image quality between the groups. The accuracy, sensitivity and specificity of nMERA HRCM images were 95.7%, 100% and 93.9% for 40 keV, 95.7%, 85.7% and 100% for 50 keV, 83.0%, 42.8% and 100% for 60 keV, and 83.0%, 42.9% and 100% for 70 keV. The AUROC was 0.99, 0.99, 0.94, and 0.93 for 40-70 keV nMERA HRCM images, respectively. Compared with simulated 120-kVp SCM images, nMERA HRCM images demonstrated comparable noise at 70-keV (P < 0.05), and comparable CNR at 40- and 50-keV (P < 0.05). nMERA DECT enables the contrast medium to be reduced to up to 50% in multiphasic hepatic CT while preserving diagnostic accuracy.	[Lin, Yuan-Mao; Chiou, Yi-You; Huang, Shan Su; Shen, Shu-Huei] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Lin, Yuan-Mao; Chiou, Yi-You; Wu, Mei-Han; Shen, Shu-Huei] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Wu, Mei-Han] Cheng Hsin Gen Hosp, Dept Med Imaging, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Cheng Hsin General Hospital	Shen, SH (corresponding author), Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan.; Shen, SH (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	shshen@vghtpe.gov.tw		Lin, Yuan-Mao/0000-0002-0275-9593	Yen Tjing Ling Medical Foundation [CI-10723]; Taipei Veterans General Hospital [V107D31-001-MY3-2]; Wong-Vung-Hau Radiology Foundation	Yen Tjing Ling Medical Foundation; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Wong-Vung-Hau Radiology Foundation	Dr. Shu-Huei Shen received grants from Yen Tjing Ling Medical Foundation (CI-10723) and Taipei Veterans General Hospital (V107D31-001-MY3-2). Dr. Yuan-Mao Lin received a grant from Wong-Vung-Hau Radiology Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2014, RADIOLOGY, V273, P241, DOI 10.1148/radiol.14132958; Albrecht MH, 2016, INVEST RADIOL, V51, P582, DOI 10.1097/RLI.0000000000000272; Albrecht MH, 2016, EUR RADIOL, V26, P1863, DOI 10.1007/s00330-015-3970-2; Albrecht MH, 2015, EUR RADIOL, V25, P2493, DOI 10.1007/s00330-015-3627-1; Bae KT, 2010, RADIOLOGY, V256, P32, DOI 10.1148/radiol.10090908; Chopra S, 2001, AM J ROENTGENOL, V177, P381, DOI 10.2214/ajr.177.2.1770381; Clark ZE, 2015, ABDOM IMAGING, V40, P852, DOI 10.1007/s00261-014-0253-3; Davenport MS, 2014, AM J ROENTGENOL, V202, P784, DOI 10.2214/AJR.13.11369; De Cecco CN, 2016, EUR J RADIOL, V85, P695, DOI 10.1016/j.ejrad.2016.01.007; Goshima S, 2016, AM J ROENTGENOL, V206, P518, DOI 10.2214/AJR.15.15138; Grant KL, 2014, INVEST RADIOL, V49, P586, DOI 10.1097/RLI.0000000000000060; Hanson GJ, 2018, ABDOM RADIOL, V43, P1404, DOI 10.1007/s00261-017-1327-9; Husarik DB, 2015, INVEST RADIOL, V50, P695, DOI 10.1097/RLI.0000000000000171; Leng S, 2015, RADIOLOGY, V276, P562, DOI 10.1148/radiol.2015140857; Lv PJ, 2017, EUR RADIOL, V27, P374, DOI 10.1007/s00330-016-4349-8; Marin D, 2016, AM J ROENTGENOL, V206, P1222, DOI 10.2214/AJR.15.15512; Martin SS, 2017, EUR J RADIOL, V97, P1, DOI 10.1016/j.ejrad.2017.10.008; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; McGahan JP, 2001, AM J ROENTGENOL, V176, P3, DOI 10.2214/ajr.176.1.1760003; Mileto A, 2014, AM J ROENTGENOL, V203, P838, DOI 10.2214/AJR.13.12179; Nagayama Y, 2018, EUR RADIOL, V28, P1719, DOI 10.1007/s00330-017-5114-3; Nakaura T, 2012, RADIOLOGY, V264, P445, DOI 10.1148/radiol.12111082; Noda Y, 2015, EUR J RADIOL, V84, P11, DOI 10.1016/j.ejrad.2014.10.008; Obuchowski NA, 2005, AM J ROENTGENOL, V184, P364, DOI 10.2214/ajr.184.2.01840364; Park MH, 2008, RADIOGRAPHICS, V28, P379, DOI 10.1148/rg.282075038; Shuman WP, 2017, ABDOM RADIOL, V42, P759, DOI 10.1007/s00261-016-1041-z; Smith JJ, 2002, RADIOLOGY, V225, P13, DOI 10.1148/radiol.2251011304; Taguchi N, 2017, EUR RADIOL, V27, P812, DOI 10.1007/s00330-016-4435-y; Yu LF, 2011, MED PHYS, V38, P6371, DOI 10.1118/1.3658568; Yu MH, 2013, AM J ROENTGENOL, V201, P23, DOI 10.2214/AJR.12.10000; Zhang D, 2011, MED PHYS, V38, DOI 10.1118/1.3613349	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219577	10.1371/journal.pone.0219577	http://dx.doi.org/10.1371/journal.pone.0219577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287838	gold, Green Submitted, Green Published			2022-12-26	WOS:000482328300033
J	Flojgaard, C; Froslev, TG; Brunbjerg, AK; Bruun, HH; Moeslund, J; Hansen, AJ; Ejrnaes, R				Flojgaard, Camilla; Froslev, Tobias Guldberg; Brunbjerg, Ane Kirstine; Bruun, Hans Henrik; Moeslund, Jesper; Hansen, Anders Johannes; Ejrnaes, Rasmus			Predicting provenance of forensic soil samples: Linking soil to ecological habitats by metabarcoding and supervised classification	PLOS ONE			English	Article							ELLENBERG INDICATOR VALUES; DNA; BIODIVERSITY; TOOL	Environmental DNA (eDNA) is increasingly applied in ecological studies, including studies with the primary purpose of criminal investigation, in which eDNA from soil can be used to pair samples or reveal sample provenance. We collected soil eDNA samples as part of a large national biodiversity research project across 130 sites in Denmark. We investigated the potential for soil eDNA metabarcoding in predicting provenance in terms of environmental conditions, habitat type and geographic regions. We used linear regression for predicting environmental gradients of light, soil moisture, pH and nutrient status (represented by Ellenberg Indicator Values, EIVs) and Quadratic Discriminant Analysis (QDA) to predict habitat type and geographic region. eDNA data performed relatively well as a predictor of environmental gradients (R-2 > 0.81). Its ability to discriminate between habitat types was variable, with high accuracy for certain forest types and low accuracy for heathland, which was poorly predicted. Geographic region was also less accurately predicted by eDNA. We demonstrated the application of provenance prediction in forensic science by evaluating and discussing two mock crime scenes. Here, we listed the plant species from annotated sequences, which can further aid in identifying the likely habitat or, in case of rare species, a geographic region. Predictions of environmental gradients and habitat types together give an overall accurate description of a crime scene, but care should be taken when interpreting annotated sequences, e.g. due to erroneous assignments in GenBank. Our approach demonstrates that important habitat properties can be derived from soil eDNA, and exemplifies a range of potential applications of eDNA in forensic ecology.	[Flojgaard, Camilla; Brunbjerg, Ane Kirstine; Moeslund, Jesper; Ejrnaes, Rasmus] Aarhus Univ, Dept Biosci, Sect Biodivers, Ronde, Denmark; [Froslev, Tobias Guldberg; Hansen, Anders Johannes] Nat Hist Museum Denmark, Copenhagen, Denmark; [Bruun, Hans Henrik] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Aarhus University; University of Copenhagen	Flojgaard, C (corresponding author), Aarhus Univ, Dept Biosci, Sect Biodivers, Ronde, Denmark.	camf@bios.au.dk	Bruun, Hans Henrik/C-4476-2008; Hansen, Anders Johannes/A-5608-2013; Froslev, Tobias Guldberg/D-4940-2017	Bruun, Hans Henrik/0000-0003-0674-2577; Hansen, Anders Johannes/0000-0002-1890-2702; Moeslund, Jesper Erenskjold/0000-0001-8591-7149; Brunbjerg, Ane Kirstine/0000-0003-0666-6535; Froslev, Tobias Guldberg/0000-0002-3530-013X; Flojgaard, Camilla/0000-0002-5829-8503; Ejrnaes, Rasmus/0000-0003-2538-8606	Innovation Fund Denmark Grand Solutions [6151-00002B]; VILLUM foundation [VKR-023343]	Innovation Fund Denmark Grand Solutions; VILLUM foundation(Villum Fonden)	We consider this a contribution to a national research project to develop soil forensic methods for Denmark supported by Innovation Fund Denmark Grand Solutions (grant no. 6151-00002B, https://innovationsfonden.dk/, awarded to AJH) based on data collected in Biowide, a nationwide survey of biodiversity in Denmark supported by the VILLUM foundation (grant no. VKR-023343, https://veluxfoundations.dk/, awarded to RE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angold PG, 2006, SCI TOTAL ENVIRON, V360, P196, DOI 10.1016/j.scitotenv.2005.08.035; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bartelheimer M, 2016, FUNCT ECOL, V30, P506, DOI 10.1111/1365-2435.12531; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Brunbjerg A. K., 2017, BIORXIV, DOI [10.1101/158030, DOI 10.1101/158030]; Brunbjerg AK, 2017, BASIC APPL ECOL, V18, P86, DOI 10.1016/j.baae.2016.09.002; Bunce RGH, 1999, ECOFACT, V2; Buxton AS, 2017, SCI REP-UK, V7, DOI 10.1038/srep46294; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Clemmensen KE, 2015, NEW PHYTOL, V205, P1525, DOI 10.1111/nph.13208; Coyle HM, 2005, CROAT MED J, V46, P606; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Diekmann M, 2003, BASIC APPL ECOL, V4, P493, DOI 10.1078/1439-1791-00185; Diekmann M, 1998, J ECOL, V86, P269, DOI 10.1046/j.1365-2745.1998.00250.x; Ejrnaes R, 2000, J VEG SCI, V11, P573, DOI 10.2307/3246587; Ejrnaes R, 2002, ECOL APPL, V12, P1180, DOI 10.2307/3061044; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1, DOI DOI 10.1002/FEDR.19931040323; Froslev TG, 2019, BIOL CONSERV, V233, P201, DOI 10.1016/j.biocon.2019.02.038; Froslev TG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01312-x; Giampaoli S, 2014, FORENSIC SCI INT, V240, P41, DOI 10.1016/j.forsciint.2014.02.028; Grantham NS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122605; Habtom H, 2017, FORENSIC SCI INT-GEN, V26, P21, DOI 10.1016/j.fsigen.2016.10.005; Hartvig P., 2015, ATLAS FLORA DANICA; Joseph Isaac, 2011, J Forensic Dent Sci, V3, P89, DOI 10.4103/0975-1475.92154; Kress WJ, 2015, TRENDS ECOL EVOL, V30, P25, DOI 10.1016/j.tree.2014.10.008; Mildenhall DC, 2006, FORENSIC SCI INT, V163, P231, DOI 10.1016/j.forsciint.2005.11.028; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Ripley B., 2022, PACKAGE MASS; RITZ K., 2008, CRIMINAL ENV SOIL FO; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Schaffers AP, 2000, J VEG SCI, V11, P225, DOI 10.2307/3236802; Sensabaugh GF, 2009, CRIMINAL AND ENVIRONMENTAL SOIL FORENSICS, P49, DOI 10.1007/978-1-4020-9204-6_4; Szibor R, 1998, NATURE, V395, P449, DOI 10.1038/26646; TABERLET P, 2018, ENV DNA BIOD RES MON, pNIL6; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Tighe M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21530-7; Torsvik V, 1996, J IND MICROBIOL, V17, P170, DOI 10.1007/BF01574690; Venables WN., 2002, MODERN APPL STAT S 4; Wiltshire PEJ, 2009, CRIMINAL AND ENVIRONMENTAL SOIL FORENSICS, P129, DOI 10.1007/978-1-4020-9204-6_9; Wood S, 2018, MIXED GAM COMPUTATIO, V1, P8; Young JM, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fiw207; 1992, OFFICIAL J L, V206, P7	47	17	18	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0202844	10.1371/journal.pone.0202844	http://dx.doi.org/10.1371/journal.pone.0202844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IL9RQ	31283764	Green Submitted, Green Published, gold			2022-12-26	WOS:000477622200001
J	Qu, ZJ; Sun, XB; Chen, XQ; Yuan, SG				Qu, Zhijian; Sun, Xubing; Chen, Xinqiang; Yuan, Shengao			A novel RFID multi-tag anti-collision protocol for dynamic vehicle identification	PLOS ONE			English	Article							ALGORITHM; ALOHA; TRACKING; ACCURATE; SYSTEM; ENERGY; MODEL	In order to obtain the information of the vehicle tags in adverse traffic conditions, we proposed a novel reservation framework named reservation to cancel idle-dynamic frame slotted ALOHA (RTCI-DFSA) algorithm. Firstly, the framework employed reservation mechanism to remove idle slot, and thus improve the system identification efficiency. Secondly, the vehicle information was identified by the tag serialization polling identification method. The experimental results showed that the proposed RTCI-DFSA algorithm performed better than the traditional frame slotted ALOHA (FSA) and dynamic frame slotted ALOHA (DFSA) algorithms. More specifically, the tag loss rate of the proposed framework is significantly lower than the frame length fixed and conventional dynamic vehicle identification algorithms. In addition, the experimental results demonstrated that the throughput rate of the proposed algorithm increased from 0.368 to 0.6. Besides, the identification efficiency and applicability of the proposed framework were both higher than other tag identification algorithms.	[Qu, Zhijian; Sun, Xubing; Yuan, Shengao] East China Jiaotong Univ, Elect & Automat Engn Coll, Nanchang, Jiangxi, Peoples R China; [Chen, Xinqiang] Shanghai Maritime Univ, Inst Logist Sci & Engn, Shanghai, Peoples R China	East China Jiaotong University; Shanghai Maritime University	Chen, XQ (corresponding author), Shanghai Maritime Univ, Inst Logist Sci & Engn, Shanghai, Peoples R China.	chenxinqiang@stu.shmtu.edu.cn			National Natural Science Foundation of China [51867009]; Foundation Plan for Distinguished Young Scholars in Jiangxi Province [20162BCB23045]; Applied and Cultivation Program of Science and Technology Department of Jiangxi Province [20181BBE58010]; Cultivation Program of Science and Technology Department of Jiangxi Province [20181BBE58010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation Plan for Distinguished Young Scholars in Jiangxi Province; Applied and Cultivation Program of Science and Technology Department of Jiangxi Province; Cultivation Program of Science and Technology Department of Jiangxi Province	This work was supported by the National Natural Science Foundation of China(51867009 to ZQ); Foundation Plan for Distinguished Young Scholars in Jiangxi Province(20162BCB23045 to ZQ); Applied and Cultivation Program of Science and Technology Department of Jiangxi Province (20181BBE58010 to ZQ).; This work was supported by the National Natural Science Foundation of China(51867009); This research is also supported by Foundation Plan for Distinguished Young Scholars in Jiangxi Province(20162BCB23045) and Applied and Cultivation Program of Science and Technology Department of Jiangxi Province(20181BBE58010).	Azpilicueta L, 2016, IEEE VEH TECHNOL MAG, V11, P29, DOI 10.1109/MVT.2016.2549995; Boyer C, 2014, IEEE T COMMUN, V62, P770, DOI 10.1109/TCOMM.2013.120713.130417; Bu GW, 2018, COMPUT NETW, V146, P200, DOI 10.1016/j.comnet.2018.09.017; Chao KH, 2014, INT J DISTRIB SENS N, DOI 10.1155/2014/694545; Chen WT, 2016, IEEE T VEH TECHNOL, V65, P3342, DOI 10.1109/TVT.2015.2441052; Chen WT, 2009, IEEE T AUTOM SCI ENG, V6, P9, DOI 10.1109/TASE.2008.917093; Chen XW, 2019, J RURAL HEALTH, V35, P405, DOI 10.1111/jrh.12335; Dongwook L, 2008, 2008 14TH EUROPEAN W; Du Y, 2013, 2013 6 INT C IM SIGN; Fei X, 2013, J TRANSP ENG, V139, P1058, DOI 10.1061/(ASCE)TE.1943-5436.0000538; He YJ, 2013, IEEE WIREL COMMUN, V20, P152, DOI 10.1109/MWC.2013.6664486; Huang YP, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18092787; Jia XL, 2012, IEEE T COMMUN, V60, P2285, DOI 10.1109/TCOMM.2012.051512.110448; Kang L, 2012, IEEE T PARALL DISTR, V23, P735, DOI 10.1109/TPDS.2011.240; Konstantinou N, 2012, IEEE T COMMUN, V60, P352, DOI 10.1109/TCOMM.2011.112811.100142; Larionov AA, 2017, IEEE J RADIO FREQ ID, V1, P3, DOI 10.1109/JRFID.2017.2751592; Liang WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139558; Lu SP, 2017, J MANUF SYST, V44, P179, DOI 10.1016/j.jmsy.2017.03.009; Nafar F, 2018, IEEE SENS J, V18, P7281, DOI 10.1109/JSEN.2018.2855410; Park J, 2007, IEEE COMMUN LETT, V11, P452, DOI 10.1109/LCOMM.2007.061581; Pedraza C, 2018, IEEE INTEL TRANSP SY, V10, P28, DOI 10.1109/MITS.2018.2806641; Raghunandan KS, 2018, IEEE T CIRC SYST VID, V28, P2276, DOI 10.1109/TCSVT.2017.2713806; Solic P, 2014, IEEE SENS J, V14, P3637, DOI 10.1109/JSEN.2014.2330418; Su J, 2019, IEEE T COMMUN, V67, P2527, DOI 10.1109/TCOMM.2018.2884001; Su J, 2016, IEEE COMMUN LETT, V20, P2394, DOI 10.1109/LCOMM.2016.2592964; Su J, 2015, CHINESE J ELECTRON, V24, P679, DOI 10.1049/cje.2015.10.003; Sze WK, 2015, IEEE T PARALL DISTR, V26, P3303, DOI 10.1109/TPDS.2014.2383403; Tan RT, 2008, PROC CVPR IEEE, P2347, DOI 10.1109/cvpr.2008.4587643; Tang JJ, 2019, ACCIDENT ANAL PREV, V122, P226, DOI 10.1016/j.aap.2018.10.016; Tang JJ, 2018, PHYSICA A, V506, P566, DOI 10.1016/j.physa.2018.04.073; Wang JQ, 2014, SENSORS-BASEL, V14, P4225, DOI 10.3390/s140304225; Wang Y, 2015, IEEE SIGNAL PROC LET, V22, P1274, DOI 10.1109/LSP.2015.2396911; Wang YF, 2018, IEEE T INTELL TRANSP, V19, P123, DOI 10.1109/TITS.2017.2690679; Wang ZL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206741; Yan Y, 2017, PHYSICA A, V477, P149, DOI 10.1016/j.physa.2017.02.040; Yang L, 2015, IEEE T MOBILE COMPUT, V14, P2188, DOI 10.1109/TMC.2014.2381232; Zhang DG, 2014, INT J COMMUN SYST, V27, P3312, DOI 10.1002/dac.2543; Zhang S, 2018, PHYSICA A, V512, P537, DOI 10.1016/j.physa.2018.08.034; Zhen B, 2005, IEICE T COMMUN, VE88B, P991, DOI 10.1093/ietcom/e88-b.3.991; Zong F, 2019, PHYSICA A, V515, P258, DOI 10.1016/j.physa.2018.09.090; Zou YJ, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11020418; Zou YJ, 2018, J APPL STAT, V45, P1652, DOI 10.1080/02664763.2017.1389863	42	2	2	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219344	10.1371/journal.pone.0219344	http://dx.doi.org/10.1371/journal.pone.0219344			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276545	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300066
J	Waerp, HKL; Waters, SM; McCabe, MS; Cormican, P; Salte, R				Waerp, Hilde K. L.; Waters, Sinead M.; McCabe, Matthew S.; Cormican, Paul; Salte, Ragnar			Long-term effects of prior diets, dietary transition and pregnancy on adipose gene expression in dairy heifers	PLOS ONE			English	Article							AMINO-ACID-METABOLISM; BOVINE MAMMARY-GLAND; DIFFERENTIAL EXPRESSION; NUTRITIONAL REGULATION; TISSUE INFLAMMATION; GROWTH; INSULIN; ENERGY; COWS; ACTIVATION	Adipose tissue is highly involved in whole-body metabolism and is the main site for lipid synthesis, storage and mobilization in ruminants. Therefore, knowledge about adipose tissue responses to different diets is important, especially in growing heifers as the feeding regimes of replacement heifers affect their future success as dairy cows. However, at gene expression level such knowledge is limited. As part of a larger feed trial, adipose tissue biopsies from 24 Norwegian Red heifers were collected at 12 months of age (12MO) and at month seven of gestation (PREG) and analyzed by next-generation mRNA sequencing. Between these two sampling points, all heifers had gone through a successful conception and a feed change from four dietary treatments of high or low energy (HE/LE) and protein (HP/LP) content (treatments LPHE, HPHE, LPLE and HPLE) to a low-energy, low-protein pregnancy feed given to all animals. Gene expression differences between different feed treatments at 12MO are described in an earlier publication from our group. The main objectives of this study were to investigate the long-term effects of diets differing in protein and energy density level on gene expression in adipose tissue of growing replacement dairy heifers. To achieve this, we examined the post-treatment effects between the treatment groups at month seven of gestation; 6 months after the termination of experimental feeding, and the long-term gene expression changes occurring in the adipose tissue between 12MO and PREG. Post-treatment group comparisons showed evidence of long-term effects of dietary treatment on adipose gene expression. Differences between protein treatments were smaller than between energy treatments. Adipose gene expression changes from 12MO to PREG were much larger for the HE than the LE treatments and seemed to mostly be explained by the characteristics of the diet change. 97 genes displayed a unidirectional expression change for all groups from 12MO to PREG, and are considered to be treatment-independent, possibly caused by pregnancy or increased age. This study provides candidate genes and key regulators for further studies on pregnancy preservation (TGFB1, CFD) and metabolic regulation and efficiency (PI3K, RICTOR, MAP4K4,) in dairy cattle.	[Waerp, Hilde K. L.; Salte, Ragnar] Norwegian Univ Life Sci, Fac Biosci, Dept Anim & Aquacultural Sci, As, Norway; [Waters, Sinead M.; McCabe, Matthew S.; Cormican, Paul] TEAGASC, Anim & Biosci Res Dept, Anim & Grassland Res & Innovat Ctr, Dunsany, Meath, Ireland	Norwegian University of Life Sciences; Teagasc	Waerp, HKL (corresponding author), Norwegian Univ Life Sci, Fac Biosci, Dept Anim & Aquacultural Sci, As, Norway.	hilde.lyby@nmbu.no		Waerp, Hilde Kristine Lyby/0000-0002-5531-5849	Research Council of Norway (Oslo) [199448]	Research Council of Norway (Oslo)(Research Council of Norway)	This study was partly was funded by The Research Council of Norway (Oslo) project number 199448: The salary of HKLW was partly from this grant; TINE SA Norwegian dairies, Felleskjopet agricultural cooperative and Animalia AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section. No additional external funding was received for this study.	Abeni F, 2012, LIVEST SCI, V149, P7, DOI 10.1016/j.livsci.2012.06.003; Akter SH, 2012, J DAIRY SCI, V95, P3032, DOI 10.3168/jds.2011-4856; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arimon M, 2015, NEUROBIOL DIS, V84, P109, DOI 10.1016/j.nbd.2015.06.013; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown NL, 1999, MOL HUM REPROD, V5, P668, DOI 10.1093/molehr/5.7.668; Busiello RA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00036; Canovas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102551; Chelikani PK, 2009, J DAIRY SCI, V92, P1430, DOI 10.3168/jds.2008-1385; Chilliard Y, 2000, P NUTR SOC, V59, P127, DOI 10.1017/S002966510000015X; Chu WM, 2013, CANCER LETT, V328, P222, DOI 10.1016/j.canlet.2012.10.014; Connor EE, 2007, J DAIRY SCI, V90, pE55, DOI 10.3168/jds.2006-466; Contreras GA, 2018, J DAIRY SCI, V101, P2737, DOI 10.3168/jds.2017-13340; Contreras GA, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0174-4; Contreras GA, 2016, J DAIRY SCI, V99, P10009, DOI 10.3168/jds.2016-11552; Contreras GA, 2015, J DAIRY SCI, V98, P6176, DOI 10.3168/jds.2015-9370; De Koster J, 2018, J DAIRY SCI, V101, P7608, DOI 10.3168/jds.2017-14318; Denny KJ, 2013, AM J REPROD IMMUNOL, V69, P3, DOI 10.1111/aji.12000; Donahue AC, 2004, SEMIN CELL DEV BIOL, V15, P183, DOI 10.1016/j.semcdb.2003.12.024; Erlanson-Albertsson C, 2003, ACTA PHYSIOL SCAND, V178, P405, DOI 10.1046/j.1365-201X.2003.01159.x; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fain JN, 2005, METABOLISM, V54, P1546, DOI 10.1016/j.metabol.2005.05.024; FRAYN KN, 1991, CLIN SCI, V80, P471, DOI 10.1042/cs0800471; Gabler MT, 2003, J DAIRY SCI, V86, P268, DOI 10.3168/jds.S0022-0302(03)73605-4; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; GOODMAN HM, 1964, AM J PHYSIOL, V206, P129, DOI 10.1152/ajplegacy.1964.206.1.129; Guzik TJ, 2017, CARDIOVASC RES, V113, P1009, DOI 10.1093/cvr/cvx108; Haussler S, 2017, VET IMMUNOL IMMUNOP, V183, P45, DOI 10.1016/j.vetimm.2016.12.005; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; Ji P, 2014, J DAIRY SCI, V97, P3431, DOI 10.3168/jds.2013-7295; Ji P, 2014, J DAIRY SCI, V97, P3441, DOI 10.3168/jds.2013-7296; Jin W, 2012, J ANIM SCI, V90, P171, DOI 10.2527/jas.2011-4229; Joseph SJ, 2010, BIOINFORM BIOL INSIG, V4, P19; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Khan MJ, 2014, GENE REGUL SYST BIO, V8, P97, DOI 10.4137/GRSB.S14116; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; KOWALCHUK JM, 1988, BIOCHEM J, V249, P705, DOI 10.1042/bj2490705; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kung LM, 1996, ANIM FEED SCI TECH, V59, P167, DOI 10.1016/0377-8401(95)00897-7; Le Lay S, 2004, BIOCHEM SOC T, V32, P103, DOI 10.1042/BST0320103; Leal LN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201929; Lewis TL, 2013, J CELL BIOL, V202, P837, DOI 10.1083/jcb.201305098; Li X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097230; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Loor JJ, 2006, PHYSIOL GENOMICS, V27, P29, DOI 10.1152/physiolgenomics.00036.2006; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; McCabe M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-193; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McCormack SE, 2013, PEDIATR OBES, V8, P52, DOI 10.1111/j.2047-6310.2012.00087.x; Meyer MJ, 2006, J DAIRY SCI, V89, P4289, DOI 10.3168/jds.S0022-0302(06)72475-4; Meyer MJ, 2006, J DAIRY SCI, V89, P4298, DOI 10.3168/jds.S0022-0302(06)72476-6; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ortega-Molina A, 2015, CELL METAB, V21, P558, DOI 10.1016/j.cmet.2015.02.017; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Peng B, 2017, J OBSTET GYNAECOL RE, V43, P30, DOI 10.1111/jog.13156; Poveda NE, 2016, SCI REP-UK, V6, DOI 10.1038/srep20073; Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289; Richani K, 2005, J MATERN-FETAL NEO M, V17, P239, DOI 10.1080/14767050500072722; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rocco SM, 2013, J DAIRY SCI, V96, P3108, DOI 10.3168/jds.2012-6097; Rohn TT, 2002, NEUROBIOL DIS, V11, P341, DOI 10.1006/nbdi.2002.0549; ROMERO R, 1988, AM J OBSTET GYNECOL, V159, P655, DOI 10.1016/S0002-9378(88)80028-0; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Salleh MS, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3622-9; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schaible AM, 2013, PROSTAG LEUKOTR ESS, V89, P245, DOI 10.1016/j.plefa.2013.06.004; Schoenberg KM, 2011, J DAIRY SCI, V94, P6021, DOI 10.3168/jds.2011-4533; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; SEJRSEN K, 1994, P NUTR SOC, V53, P103, DOI 10.1079/PNS19940014; Sejrsen K, 2000, DOMEST ANIM ENDOCRIN, V19, P93, DOI 10.1016/S0739-7240(00)00070-9; Shigematsu M, 2016, CAN J ANIM SCI, V96, P457, DOI 10.1139/cjas-2016-0020; Shigeoka T, 2013, J CELL BIOL, V202, P991, DOI 10.1083/jcb.201305139; SNELL K, 1977, BIOCHEM BIOPH RES CO, V77, P925, DOI 10.1016/S0006-291X(77)80066-1; Sumner JM, 2007, J DAIRY SCI, V90, P5237, DOI 10.3168/jds.2007-0307; Sumner-Thomson JM, 2011, J DAIRY SCI, V94, P361, DOI 10.3168/jds.2010-3447; Takeshita A, 2010, J REPROD DEVELOP, V56, P508, DOI 10.1262/jrd.10-036K; Tucker HA, 2000, J DAIRY SCI, V83, P874, DOI 10.3168/jds.S0022-0302(00)74951-4; Vailati-Riboni M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3191-3; Van Amburgh ME, 1998, J DAIRY SCI, V81, P527, DOI 10.3168/jds.S0022-0302(98)75604-8; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Volden H., 2011, NORFOR NORDIC FEED E; Waerp HKL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201284; Weber KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152274; Wozniak SE, 2009, DIGEST DIS SCI, V54, P1847, DOI 10.1007/s10620-008-0585-3; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Yahagi N, 2003, J BIOL CHEM, V278, P25395, DOI 10.1074/jbc.M302364200; Yu JJ, 2009, ANN NY ACAD SCI, V1173, pE10, DOI 10.1111/j.1749-6632.2009.04952.x; Zhang HB, 2015, ANIM SCI J, V86, P392, DOI 10.1111/asj.12316; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	96	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0218723	10.1371/journal.pone.0218723	http://dx.doi.org/10.1371/journal.pone.0218723			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269511	Green Published, Green Submitted, gold			2022-12-26	WOS:000484927300024
J	Chen, CY; Yu, IS; Pai, CH; Lin, CY; Lin, SR; Chen, YT; Lin, SW				Chen, Chun-Yu; Yu, I-Shing; Pai, Chen-Hsueh; Lin, Chien-Yu; Lin, Shu-Rung; Chen, You-Tzung; Lin, Shu-Wha			Embryonic Cul4b is important for epiblast growth and location of primitive streak layer cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; TRANSCRIPTION FACTOR; BETA-CATENIN; TROPHOBLAST DIFFERENTIATION; HEPATOCELLULAR-CARCINOMA; LINEAGE ALLOCATION; UBIQUITIN LIGASE; AXIS FORMATION; MOUSE EMBRYO; GENE	Cul4b-null (Cul4b(Delta/)Y) mice undergo growth arrest and degeneration during the early embryonic stages and die at E9.5. The pathogenic causes of this lethality remain incompletely characterized. However, it has been hypothesized that the loss of Cul4b function in extraembryonic tissues plays a key role. In this study, we investigated possible causes of death for Cul4b-null embryos, particularly in regard to the role of embryonic Cul4b. First, we show that the loss of embryonic Cul4b affects the growth of the inner cell mass in vitro and delays epiblast development during the gastrulation period at E6.5 similar to E7.5 in vivo, as highlighted by the absence of the epiblastic transcription factor Brachyury from E6.5 similar to E7.5. Additionally, at E7.5, strong and laterally expanded expression of Eomes and Fgf8 signaling was detected. Sectioning of these embryos showed disorganized primitive streak layer cells. Second, we observed that Mash2-expressing cells were present in the extraembryonic tissues of Cul4b-deficient embryos at E6.5 but were absent at E7.5. In addition, the loss of Cul4b resulted in decreased expression of cyclin proteins, which are required for the cell cycle transition from G1 to S. Taken together, these observations suggest that the embryonic expression of Cul4b is important for epiblast growth during E6.5 similar to E7.5, and the loss of Cul4b results in either delayed growth of the epiblast or defective localization of primitive streak layer cells. As a result, the signaling activity mediated by the epiblast for subsequent ectoplacental cone development is affected, with the potential to induce growth retardation and lethality in Cul4(Delta/)Y embryos.	[Chen, Chun-Yu; Pai, Chen-Hsueh; Lin, Chien-Yu; Lin, Shu-Wha] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan; [Yu, I-Shing] Natl Taiwan Univ, Coll Med, Lab Anim Ctr, Taipei, Taiwan; [Lin, Shu-Rung] Chung Yuan Christian Univ, Dept Biosci Technol, Coll Sci, Taoyuan, Taiwan; [Lin, Shu-Rung] Chung Yuan Christian Univ, Ctr Nanotechnol, Taoyuan, Taiwan; [Lin, Shu-Rung] Chung Yuan Christian Univ, Ctr Biomed Technol, Taoyuan, Taiwan; [Chen, You-Tzung] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei, Taiwan; [Lin, Shu-Wha] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Lab Med, Coll Med, Taipei, Taiwan; [Lin, Shu-Wha] Natl Taiwan Univ, Ctr Genom Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; Chung Yuan Christian University; Chung Yuan Christian University; Chung Yuan Christian University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lin, SW (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan.; Lin, SW (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Lab Med, Coll Med, Taipei, Taiwan.; Lin, SW (corresponding author), Natl Taiwan Univ, Ctr Genom Med, Taipei, Taiwan.	mtshuwha@ntu.edu.tw	Chen, Chun-Yu/L-7084-2013	Chen, Chun-Yu/0000-0001-7199-3271; Pai, Chen-Hsueh/0000-0001-5425-897X; CHEN, YOU-TZUNG/0000-0001-6510-3420	Ministry of Science and Technology (Taiwan); MOST [103-2314-B-002-006-MY2, 104-2320-B-002-059-MY3, 102-2320-B-033-003, 102-2632-M-033001-MY3, 105-2320-B-033-003, 105-2319-B-002-001, 105-2320-13-002-052-MY3, 105-2320-6-002-053-MY3, 106-2319-6-002-001, 107-2319-6-002-001, 108-2319-6-002-002];  [102-2632-M-033-001-MY3];  [105-2320-B-002-052-MY3];  [105-2320-B-002-053-MY3];  [106-2319-B-002-001];  [107-2319-B-002-001];  [108-2319-B-002-002]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan); MOST(Ministry of Science & Technology (MOST), Republic of Korea); ; ; ; ; ; 	This study is supported by Ministry of Science and Technology (Taiwan). Taiwan MOST Web site: https//www.most.gov.tw/. ISY is supported by MOST (103-2314-B-002-006-MY2, 104-2320-B-002-059-MY3). SRL is supported by MOST (102-2320-B-033-003, 102-2632-M-033001-MY3, 105-2320-B-033-003). SWL is supported by MOST (105-2319-B-002-001, 105-2320-13-002-052-MY3, 105-2320-6-002-053-MY3, 106-2319-6-002-001, 107-2319-6-002-001, 108-2319-6-002-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the technical services provided by the Transgenic Mouse Model Core Facility of the National Core Facility for Biopharmaceuticals, the Ministry of Science and Technology, Taiwan and the Gene Knockout Mouse Core Laboratory of National Taiwan University, Center of Genomic Medicine. We thank the National RNAi Core Facility at the Academia Sinica for the preparation of shRNA lentiviruses. We also thank Professor Shinichi Nishikawa (RIKEN) and Associate Research Fellow Dr. Yu-Ting Yan (IBMS, Academia Sinica, Taiwan) for dissection of early embryos and technique of whole-mount in-situ hybridization. ISY is supported by MOST (103-2314-B-002-006-MY2, 104-2320-B-002-059-MY3). SRL is supported by MOST (102-2320-B-033-003, 102-2632-M-033-001-MY3, 105-2320-B-033-003). SWL is supported by MOST (105-2319-B-002-001, 105-2320-B-002-052-MY3, 105-2320-B-002-053-MY3, 106-2319-B-002-001, 107-2319-B-002-001, 108-2319-B-002-002).	Alisch RS, 2007, PLOS GENET, V3, P2565, DOI 10.1371/journal.pgen.0030227; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Beck S, 2002, NAT CELL BIOL, V4, P981, DOI 10.1038/ncb890; BEDDINGTON RSP, 1992, DEVELOPMENT, P157; Chen CY, 2012, HUM MOL GENET, V21, P4270, DOI 10.1093/hmg/dds261; Chen P, 2016, TUMOR BIOL, V37, P29, DOI 10.1007/s13277-015-4154-z; Chen T, 2017, J CELL PHYSIOL, V232, P3261, DOI 10.1002/jcp.25797; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Ciruna BG, 1999, MECH DEVELOP, V81, P199, DOI 10.1016/S0925-4773(98)00243-3; Cox BJ, 2010, GENOME RES, V20, P1154, DOI 10.1101/gr.105106.110; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; Erlebacher A, 2004, DEV BIOL, V275, P158, DOI 10.1016/j.ydbio.2004.07.032; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Fujiwara T, 2002, DEVELOPMENT, V129, P4685; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Hancock SN, 1999, MECH DEVELOP, V81, P205, DOI 10.1016/S0925-4773(98)00244-5; Hayashi Shigemi, 2002, Gene Expression Patterns, V2, P93, DOI 10.1016/S0925-4773(02)00292-7; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; He F, 2018, BIOMED REP, V9, P305, DOI 10.3892/br.2018.1134; Ho JY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/161628; Hoffman JA, 2013, DEVELOPMENT, V140, P1665, DOI 10.1242/dev.087387; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; HUNT CV, 1976, J REPROD FERTIL, V46, P305; Jia L, 2017, J BIOL CHEM, V292, P2966, DOI 10.1074/jbc.M116.765230; Jiang BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037070; Kobayashi S, 2016, DEVELOPMENT, V143, P2958, DOI 10.1242/dev.136739; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Le Bin GC, 2014, DEVELOPMENT, V141, P1001, DOI 10.1242/dev.096875; Li PY, 2017, ONCOL LETT, V14, P1265, DOI 10.3892/ol.2017.6297; Lin CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20227; Liu LR, 2012, CELL RES, V22, P1258, DOI 10.1038/cr.2012.48; Mao XW, 2017, ONCOTARGET, V8, P77241, DOI 10.18632/oncotarget.20455; Merzouk S, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-11; Mi J, 2017, MOL ONCOL, V11, P305, DOI 10.1002/1878-0261.12038; Miao CG, 2018, J MOL MED, V96, P495, DOI 10.1007/s00109-018-1635-8; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishiyama M, 2004, MOL CELL BIOL, V24, P8386, DOI 10.1128/MCB.24.19.8386-8394.2004; Pauklin S, 2016, GENE DEV, V30, P421, DOI 10.1101/gad.271452.115; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Qian YY, 2015, CANCER RES, V75, P5070, DOI 10.1158/0008-5472.CAN-15-0898; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Rossant J, 2003, PHILOS T ROY SOC B, V358, P1341, DOI 10.1098/rstb.2003.1329; ROSSANT J, 1977, J EMBRYOL EXP MORPH, V39, P183; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Soncin F, 2015, CELL MOL LIFE SCI, V72, P1291, DOI 10.1007/s00018-014-1794-x; Song BJ, 2015, INT J CLIN EXP PATHO, V8, P10394; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanaka M, 1997, DEV BIOL, V190, P55, DOI 10.1006/dbio.1997.8685; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tripathi R, 2007, J BIOSCIENCES, V32, P1133, DOI 10.1007/s12038-007-0114-0; Turner DA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0063-7; Uy GD, 2002, DEVELOPMENT, V129, P3913; Wang XG, 2016, ONCOL RES, V24, P271, DOI 10.3727/096504016X14666990347473; Wianny F, 1998, DEV DYNAM, V212, P49, DOI 10.1002/(SICI)1097-0177(199805)212:1<49::AID-AJA5>3.0.CO;2-2; WILSON V, 1995, DEVELOPMENT, V121, P877; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; YELIAN FD, 1993, J CELL BIOL, V121, P923, DOI 10.1083/jcb.121.4.923; Yin Y, 2016, J BIOL CHEM, V291, P6923, DOI 10.1074/jbc.M115.699660; Yuan JP, 2015, ONCOTARGET, V6, P15209, DOI 10.18632/oncotarget.3829; Yuan JP, 2015, J PATHOL, V235, P784, DOI 10.1002/path.4492; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	71	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219221	10.1371/journal.pone.0219221	http://dx.doi.org/10.1371/journal.pone.0219221			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260508	Green Published, Green Submitted, gold			2022-12-26	WOS:000484918700046
J	Lim, SW; Shin, YJ; Luo, K; Quan, Y; Ko, EJ; Ha Chung, B; Yang, CW				Lim, Sun Woo; Shin, Yoo Jin; Luo, Kang; Quan, Yi; Ko, Eun Jeong; Ha Chung, Byung; Yang, Chul Woo			Host cell in vivo production of the synthetic drug anti-CD25/IL-10 using minicircle vector	FASEB JOURNAL			English	Article						biological drug; transplantation; graft rejection; immune tolerance	GENE-THERAPY; GRAFT-SURVIVAL; DNA VECTOR; RAT-LIVER; EXPRESSION; ALLOGRAFT; CYCLOSPORINE; REJECTION; DETERMINANTS; BASILIXIMAB	Synthetic biologic drugs are highly successful for induction therapy in transplantation, but the development of novel biologics is limited because of the high cost of synthesis and purification. In this study, we developed a novel strategy for the production of synthetic protein drugs in vivo by the host itself. We utilized minicircle (MC) technology, which can robustly express a target molecule and secrete it from cells, as an indirect method to produce a protein of interest in vivo. We designed an MC vector containing the sequences of basiliximab (anti-CD25 mAb) and IL-10. We verified the substantial production of the anti-CD25/IL-10 protein from the MC in vitro and in vivo. The therapeutic effect of MC-derived anti-CD25/IL-10 was evaluated in a skin allograft mouse model by single intravenous infusion. Mice treated with the MC encoding anti-CD25/IL-10 exhibited prolonged skin allograft survival times accompanied by improved histologic changes and immunologic regulation. These findings indicate that the anti-CD25/IL-10 protein drug obtained by MC technology is functionally active and relevant for reducing allograft rejection. This self-reproducible strategy for synthetic protein drugs using MCs is a promising tool for transplantation.-Lim, S. W., Shin, Y. J., Luo, K., Quan, Y., Ko, E. J., Chung, B. H., Yang, C. W. Host cell in vivo production of the synthetic drug anti-CD25/IL-10 using minicircle vector.	[Lim, Sun Woo; Shin, Yoo Jin; Luo, Kang; Quan, Yi; Ko, Eun Jeong; Ha Chung, Byung; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Lim, Sun Woo; Shin, Yoo Jin; Luo, Kang; Quan, Yi; Ko, Eun Jeong; Ha Chung, Byung; Yang, Chul Woo] Catholic Univ Korea, Transplant Res Ctr, Seoul, South Korea; [Ko, Eun Jeong; Ha Chung, Byung; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Nephrol,Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Yang, CW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Sch Med, Div Nephrol,Dept Internal Med, 222 Banpo Daero, Seoul 06591, South Korea.	yangch@catholic.ac.kr		Ko, Eun Jeong/0000-0002-5604-1296	Korean Health Technology Research and Development Project, Ministry for Health and Welfare [HI16C1641, HI14C3417]	Korean Health Technology Research and Development Project, Ministry for Health and Welfare	This work was supported by the Korean Health Technology Research and Development Project, Ministry for Health and Welfare (HI16C1641 and HI14C3417). The authors declare no conflicts of interest.	Andrianaivo F, 2004, J GENE MED, V6, P877, DOI 10.1002/jgm.574; Bunnapradist S, 2003, J AM SOC NEPHROL, V14, P208, DOI 10.1097/01.ASN.0000037678.54984.41; Buscail L, 2015, MOL THER, V23, P779, DOI 10.1038/mt.2015.1; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Flechner SM, 1996, TRANSPLANTATION, V62, P1235, DOI 10.1097/00007890-199611150-00009; Gill DR, 2009, GENE THER, V16, P165, DOI 10.1038/gt.2008.183; Grenda R, 2015, PEDIATR NEPHROL, V30, P1087, DOI 10.1007/s00467-014-2886-4; Hamawy MM, 2003, DRUG NEWS PERSPECT, V16, P277, DOI 10.1358/dnp.2003.16.5.829315; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Heidt S, 2010, CLIN EXP IMMUNOL, V159, P199, DOI 10.1111/j.1365-2249.2009.04051.x; Herweijer H, 2007, GENE THER, V14, P99, DOI 10.1038/sj.gt.3302891; Huang M, 2009, CIRCULATION, V120, pS230, DOI 10.1161/CIRCULATIONAHA.108.841155; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; Kobayashi N, 2004, J GENE MED, V6, P584, DOI 10.1002/jgm.541; Lebranchu Y, 2002, AM J TRANSPLANT, V2, P48, DOI 10.1034/j.1600-6143.2002.020109.x; Malek TR, 2002, TRENDS IMMUNOL, V23, P465, DOI 10.1016/S1471-4906(02)02308-6; Maniar LEG, 2013, MOL THER, V21, P131, DOI 10.1038/mt.2012.244; Maruyama H, 2002, J GENE MED, V4, P333, DOI 10.1002/jgm.281; McFarland HI, 2009, CURRENT PROTOCOLS IM, V84, P441; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Munye MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23125; Nashan B, 1997, LANCET, V350, P1193, DOI 10.1016/S0140-6736(97)09278-7; Osborn MJ, 2011, MOL THER, V19, P450, DOI 10.1038/mt.2010.249; Pirsch JD, 1996, TRANSPLANTATION, V61, P1581, DOI 10.1097/00007890-199606150-00006; REEM GH, 1984, J BIOL RESP MODIF, V3, P195; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314; UEDA H, 1991, TRANSPLANTATION, V52, P437, DOI 10.1097/00007890-199109000-00008; UEDA H, 1990, TRANSPLANTATION, V50, P545, DOI 10.1097/00007890-199010000-00002; WELTE K, 1984, J EXP MED, V160, P1390, DOI 10.1084/jem.160.5.1390; Wolff JA, 2005, ADV GENET, V54, P3, DOI 10.1016/S0065-2660(05)54001-X; Yi H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05961; Zhang XH, 2001, HUM GENE THER, V12, P2179, DOI 10.1089/10430340152710522; Zuo YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019407	35	1	1	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10889	10901		10.1096/fj.201900833R	http://dx.doi.org/10.1096/fj.201900833R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31266358				2022-12-26	WOS:000489166300025
J	Hill, SE; Kwon, MS; Martin, MD; Suntharalingam, A; Hazel, A; Dickey, CA; Gumbart, JC; Lieberman, RL				Hill, Shannon E.; Kwon, Michelle S.; Martin, Mackenzie D.; Suntharalingam, Amirthaa; Hazel, Anthony; Dickey, Chad A.; Gumbart, James C.; Lieberman, Raquel L.			Stable calcium-free myocilin olfactomedin domain variants reveal challenges in differentiating between benign and glaucoma-causing mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein structure; protein misfolding; protein secretion; extracellular matrix protein; X-ray crystallography; molecular dynamics; protein aggregation; glaucoma	TRABECULAR MESHWORK; EXTRACELLULAR-MATRIX; MOLECULAR-DYNAMICS; PROTEIN STABILITY; MUTANT MYOCILIN; ER STRESS; GENE; TIGR/MYOCILIN; PREVALENCE; REFINEMENT	Nonsynonymous gene mutations can be beneficial, neutral, or detrimental to the stability, structure, and biological function of the encoded protein, but the effects of these mutations are often not readily predictable. For example, the beta-propeller olfactomedin domain of myocilin (mOLF) exhibits a complex interrelationship among structure(s), stability, and aggregation. Numerous mutations within mOLF are linked to glaucoma; the resulting variants are less stable, aggregation-prone, and sequestered intracellularly, causing cytotoxicity. Here, we report the first stable mOLF variants carrying substitutions in the calcium-binding site that exhibit solution characteristics indistinguishable from those of glaucoma variants. Crystal structures of these stable variants at 1.8-2.0-angstrom resolution revealed features that we could not predict by molecular dynamics simulations, including loss of loop structure, helix unwinding, and a blade shift. Double mutants that combined a stabilizing substitution and a selected glaucoma-causing single-point mutant rescued in vitro folding and stability defects. In the context of full-length myocilin, secretion of stable single variants was indistinguishable from that of the WT protein, and the double mutants were secreted to varying extents. In summary, our finding that mOLF can tolerate particular substitutions that render the protein stable despite a conformational switch emphasizes the complexities in differentiating between benign and glaucoma-causing variants and provides new insight into the possible biological function of myocilin.	[Hill, Shannon E.; Kwon, Michelle S.; Martin, Mackenzie D.; Dickey, Chad A.; Gumbart, James C.; Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, 901 Atlantic Dr NW, Atlanta, GA 30332 USA; [Hazel, Anthony; Gumbart, James C.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Suntharalingam, Amirthaa; Dickey, Chad A.] Univ S Florida, Dept Mol Med, Tampa, FL 33613 USA; [Suntharalingam, Amirthaa; Dickey, Chad A.] Univ S Florida, Byrd Alzheimers Res Inst, Tampa, FL 33613 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Lieberman, RL (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, 901 Atlantic Dr NW, Atlanta, GA 30332 USA.	Raquel.lieberman@chemistry.gatech.edu		Hazel, Anthony/0000-0002-8195-7909; Kwon, Michelle/0000-0003-4772-1553	National Institutes of Health Equipment [S10_RR25528, S10_RR028976]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL EYE INSTITUTE [R01EY021205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123169] Funding Source: NIH RePORTER	National Institutes of Health Equipment(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Petit Institute Core Facility for access to instrumentation. Southeast Regional Collaborative Access Team (SER-CAT) is supported by its member institutions and National Institutes of Health Equipment Grants S10_RR25528 and S10_RR028976. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Acott TS, 2014, J OCUL PHARMACOL TH, V30, P94, DOI 10.1089/jop.2013.0185; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anholt RRH, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00006; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Burns JN, 2011, BIOCHEMISTRY-US, V50, P5824, DOI 10.1021/bi200231x; Burns JN, 2010, ACS CHEM BIOL, V5, P477, DOI 10.1021/cb900282e; Case D. A., 2019, AMBER 19; Challa P, 2002, J GLAUCOMA, V11, P416, DOI 10.1097/00061198-200210000-00008; Cheng H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003926; Clark AF, 2012, INVEST OPHTH VIS SCI, V53, P2473, DOI 10.1167/iovs.12-9483g; Colon W, 2017, BIOCHEMISTRY-US, V56, P6179, DOI 10.1021/acs.biochem.7b00942; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Donegan RK, 2015, HUM MOL GENET, V24, P2111, DOI 10.1093/hmg/ddu730; Donegan RK, 2012, J BIOL CHEM, V287, P43370, DOI 10.1074/jbc.M112.408906; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eshed Y, 2007, J CELL BIOL, V177, P551, DOI 10.1083/jcb.200612139; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gershenson A, 2014, NAT CHEM BIOL, V10, P884, DOI 10.1038/nchembio.1670; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Goldenzweig A, 2016, MOL CELL, V63, P337, DOI 10.1016/j.molcel.2016.06.012; Han HJ, 2015, J BIOL CHEM, V290, P3612, DOI 10.1074/jbc.M114.627547; Hartmann MD, 2017, SUBCELL BIOCHEM, V82, P63, DOI 10.1007/978-3-319-49674-0_3; Hill SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130888; Hill SE, 2014, J MOL BIOL, V426, P921, DOI 10.1016/j.jmb.2013.12.002; Huard DJE, 2018, ACS CHEM BIOL, V13, P933, DOI 10.1021/acschembio.7b01083; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jain A, 2017, P NATL ACAD SCI USA, V114, P11199, DOI 10.1073/pnas.1706193114; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keller KE, 2007, INVEST OPHTH VIS SCI, V48, P1164, DOI 10.1167/iovs.06-0875; Levin EJ, 2007, STRUCTURE, V15, P1040, DOI 10.1016/j.str.2007.06.019; Li Q, 2019, MOL GENET GENOMICS, V294, P875, DOI 10.1007/s00438-019-01549-9; Liton PB, 2008, J GLAUCOMA, V17, P378, DOI 10.1097/IJG.0b013e31815f52a8; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Mancl JM, 2019, STRUCTURE, V27, P785, DOI 10.1016/j.str.2019.02.006; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDowell CM, 2012, EXP EYE RES, V100, P65, DOI 10.1016/j.exer.2012.04.016; Orwig SD, 2012, J MOL BIOL, V421, P242, DOI 10.1016/j.jmb.2011.12.016; Orwig SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016347; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rasband MN, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020495; Reich L, 2009, BIOPHYS CHEM, V141, P186, DOI 10.1016/j.bpc.2009.01.015; Sacca SC, 2009, MUTAT RES-FUND MOL M, V667, P98, DOI 10.1016/j.mrfmmm.2008.11.002; SCHREIBER C, 1994, STRUCTURE, V2, P945, DOI 10.1016/S0969-2126(94)00096-4; Schultz JE, 2013, TRENDS BIOCHEM SCI, V38, P538, DOI 10.1016/j.tibs.2013.08.005; SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Stothert AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18344-4; Stothert AR, 2016, EXP EYE RES, V144, P38, DOI 10.1016/j.exer.2015.08.017; Stothert AR, 2014, HUM MOL GENET, V23, P6470, DOI 10.1093/hmg/ddu367; Stumpff F, 2000, OPHTHALMOLOGICA, V214, P33, DOI 10.1159/000027471; Suntharalingam A, 2012, J BIOL CHEM, V287, P40661, DOI 10.1074/jbc.M112.384800; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Valastyan JS, 2014, DIS MODEL MECH, V7, P9, DOI 10.1242/dmm.013474; Vollrath D, 2006, EXP EYE RES, V82, P1030, DOI 10.1016/j.exer.2005.10.007; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Whitford PC, 2007, J MOL BIOL, V366, P1661, DOI 10.1016/j.jmb.2006.11.085; Wiggs JL, 2017, HUM MOL GENET, V26, pR21, DOI 10.1093/hmg/ddx184; Wiggs JL, 1998, AM J HUM GENET, V63, P1549, DOI 10.1086/302098; Zenga LC, 2005, FEBS LETT, V579, P5443, DOI 10.1016/j.febslet.2005.08.064; Zhou ZH, 1999, HUM MOL GENET, V8, P2221, DOI 10.1093/hmg/8.12.2221; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	72	8	8	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12717	12728		10.1074/jbc.RA119.009419	http://dx.doi.org/10.1074/jbc.RA119.009419			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31270212	Green Published, hybrid			2022-12-26	WOS:000484414600014
J	Olotu, C; Lehmensiek, F; Koch, B; Kiefmann, M; Riegel, AK; Hammerschmidt, S; Kiefmann, R				Olotu, Cynthia; Lehmensiek, Felix; Koch, Bastian; Kiefmann, Martina; Riegel, Ann-Kathrin; Hammerschmidt, Sven; Kiefmann, Rainer			Streptococcus pneumoniae inhibits purinergic signaling and promotes purinergic receptor P2Y(2) internalization in alveolar epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pneumonia; purinergic receptor; lung; calcium; receptor internalization; Streptococcus; ATP; alveolar epithelial cells; receptor phosphorylation; Streptococcus pneumoniae; virulence	NUCLEOTIDE RECEPTOR; EXPRESSION; ADHERENCE; CA2+; DESENSITIZATION; TRANSDUCTION; RELEASE; UTP; PHOSPHORYLATION; TRANSLOCATION	Bacterial pneumonia is a global health challenge that causes up to 2 million deaths each year. Purinergic signaling plays a pivotal role in healthy alveolar epithelium. Here, we used fluorophore-based analysis and live-cell calcium imaging to address the question of whether the bacterial pathogen Streptococcus pneumoniae directly interferes with purinergic signaling in alveolar epithelial cells. Disturbed purinergic signaling might result in pathophysiologic changes like edema formation and atelectasis, which are commonly seen in bacterial pneumonia. Purine receptors are mainly activated by ATP, mediating a cytosolic calcium response. We found that this purinergic receptor P2Y(2)-mediated response is suppressed in the presence of S. pneumoniae in A549 and isolated primary alveolar cells in a temperature-dependent manner. Downstream inositol 3-phosphate (IP3) signaling appeared to be unaffected, as calcium signaling via protease-activated receptor 2 remained unaltered. S. pneumoniae-induced suppression of the P2Y(2)-mediated calcium response depended on the P2Y(2) phosphorylation sites Ser-243, Thr-344, and Ser-356, which are involved in receptor desensitization and internalization. Spinning-disk live-cell imaging revealed that S. pneumoniae induces P2Y(2) translocation into the cytosol. In conclusion, our results show that S. pneumoniae directly inhibits purinergic signaling by inducing P2Y(2) phosphorylation and internalization, resulting in the suppression of the calcium response of alveolar epithelial cells to ATP, thereby affecting cellular integrity and function.	[Olotu, Cynthia; Lehmensiek, Felix; Koch, Bastian; Kiefmann, Martina; Riegel, Ann-Kathrin; Kiefmann, Rainer] Univ Med Ctr Hamburg Eppendorf, Ctr Anesthesiol & Intens Care Med, Martinistr 52, D-22051 Hamburg, Germany; [Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Inst Genet & Funct Genom, Dept Mol Genet & Infect Biol, Felix Hausdorff Str 8, D-17489 Greifswald, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Ernst Moritz Arndt Universitat Greifswald	Olotu, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Anesthesiol & Intens Care Med, Martinistr 52, D-22051 Hamburg, Germany.	c.olotu@uke.de	Hammerschmidt, Sven/G-2598-2010	Hammerschmidt, Sven/0000-0002-6382-6681				Adamou JE, 1998, INFECT IMMUN, V66, P820, DOI 10.1128/IAI.66.2.820-822.1998; Andersson K, 1999, INFECT IMMUN, V67, P2567, DOI 10.1128/IAI.67.5.2567-2574.1999; Asmat TM, 2011, J BIOL CHEM, V286, P17861, DOI 10.1074/jbc.M110.212225; Baxt LA, 2013, SCIENCE, V340, P697, DOI 10.1126/science.1235771; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bonnet M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00016; Burnstock G, 2012, PHARMACOL REV, V64, P834, DOI 10.1124/pr.111.005389; Cohen A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40779-0; Communi D, 1999, BRIT J PHARMACOL, V127, P562, DOI 10.1038/sj.bjp.0702560; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Nguyen CT, 2014, INFECT IMMUN, V82, P3802, DOI 10.1128/IAI.02012-14; Davis IC, 2004, AM J PHYSIOL-LUNG C, V286, pL112, DOI 10.1152/ajplung.00218.2003; Delclaux C, 2003, EUR RESPIR J, V22, p10S, DOI 10.1183/09031936.03.00420203; Devor DC, 1999, AM J PHYSIOL-CELL PH, V276, pC827, DOI 10.1152/ajpcell.1999.276.4.C827; DOBBS LG, 2002, CULTURE EPITHELIAL C, P277; DOUGLAS WHJ, 1974, IN VITRO CELL DEV B, V10, P230; Facco M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093612; Falzoni S, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0101; Flores RV, 2005, MOL CELL BIOCHEM, V280, P35, DOI 10.1007/s11010-005-8050-5; Garrad RC, 1998, J BIOL CHEM, V273, P29437, DOI 10.1074/jbc.273.45.29437; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Goldman N, 2013, CELL CALCIUM, V53, P297, DOI 10.1016/j.ceca.2013.01.004; Haglund CM, 2011, J CELL BIOL, V195, P7, DOI 10.1083/jcb.201103148; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hoffmann G, 1995, BIOCHEM BIOPH RES CO, V217, P575, DOI 10.1006/bbrc.1995.2814; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Hu L, 2005, MICROBIOL-SGM, V151, P3097, DOI 10.1099/mic.0.27866-0; Isakson BE, 2001, AM J PHYSIOL-CELL PH, V281, pC1291, DOI 10.1152/ajpcell.2001.281.4.C1291; Jacob T, 2002, INFECT IMMUN, V70, P6399, DOI 10.1128/IAI.70.11.6399-6408.2002; Jala VR, 2005, J BIOL CHEM, V280, P4880, DOI 10.1074/jbc.M409821200; Johansson E. W., 2006, PNEUMONIA FORGOTTEN; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kern B, 2015, CELL MICROBIOL, V17, P1811, DOI 10.1111/cmi.12474; Kolli BK, 2008, MOL BIOCHEM PARASIT, V158, P163, DOI 10.1016/j.molbiopara.2007.12.010; Koslowski R, 2004, HISTOCHEM CELL BIOL, V121, P509, DOI 10.1007/s00418-004-0662-4; Krachler AM, 2011, J CELL BIOL, V195, P1083, DOI 10.1083/jcb.201107132; Lazarowski ER, 2001, NEWS PHYSIOL SCI, V16, P1; Le Duc D, 2017, ADV IMMUNOL, V136, P85, DOI 10.1016/bs.ai.2017.05.006; Lee IT, 2013, INT J BIOCHEM CELL B, V45, P1657, DOI 10.1016/j.biocel.2013.05.006; LETOURNEAU J, 2011, JOVE-J VIS EXP   MAY, DOI DOI 10.3791/2783; Ligeti E, 2012, ACTA PHYSIOL, V204, P469, DOI 10.1111/j.1748-1716.2012.02414.x; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; MAJEED M, 1994, INFECT IMMUN, V62, P126, DOI 10.1128/IAI.62.1.126-134.1994; Malloy JL, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-8; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Mccoy KL, 2010, MOL PHARMACOL, V77, P1005, DOI 10.1124/mol.109.062018; Merriam LA, 2013, J NEUROSCI, V33, P4614, DOI 10.1523/JNEUROSCI.4999-12.2013; Nhieu GT, 2004, BIOL CELL, V96, P93, DOI 10.1016/j.biocel.2003.10.006; Ostrowska E, 2007, AM J PHYSIOL-LUNG C, V293, pL1208, DOI 10.1152/ajplung.00137.2007; PACE J, 1993, CELL, V72, P505, DOI 10.1016/0092-8674(93)90070-7; Park JY, 2016, ARCH PHARM RES, V39, P293, DOI 10.1007/s12272-016-0712-1; Parker D, 2011, MBIO, V2, DOI 10.1128/mBio.00016-11; PARR CE, 1994, P NATL ACAD SCI USA, V91, P3275, DOI 10.1073/pnas.91.8.3275; Qiao R, 2008, AM J RESP CELL MOL, V38, P239, DOI 10.1165/rcmb.2007-0172OC; Repp H, 2002, CELL MICROBIOL, V4, P483, DOI 10.1046/j.1462-5822.2002.00207.x; Ribet D, 2015, MICROBES INFECT, V17, P173, DOI 10.1016/j.micinf.2015.01.004; RICE WR, 1987, BRIT J PHARMACOL, V91, P833, DOI 10.1111/j.1476-5381.1987.tb11282.x; Rolan HG, 2013, CELL HOST MICROBE, V14, P306, DOI 10.1016/j.chom.2013.08.013; Saleh M, 2013, EMBO MOL MED, V5, P1852, DOI 10.1002/emmm.201202435; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Schafer R, 2003, AM J PHYSIOL-LUNG C, V285, pL376, DOI 10.1152/ajplung.00447.2002; Schmeck B, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-98; Sharif O, 2013, J IMMUNOL, V190, P5640, DOI 10.4049/jimmunol.1202270; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Sromek SM, 1998, MOL PHARMACOL, V54, P485, DOI 10.1124/mol.54.3.485; Talbot UM, 1996, INFECT IMMUN, V64, P3772, DOI 10.1128/IAI.64.9.3772-3777.1996; Teng HB, 2003, J PHYSIOL-LONDON, V551, P103, DOI 10.1113/jphysiol.2003.041152; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Tulapurkar ME, 2006, J NEUROCHEM, V96, P624, DOI 10.1111/j.1471-4159.2005.03594.x; Ubl JJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1339, DOI 10.1152/ajplung.00392.2001; WALDRON RT, 1994, J BIOL CHEM, V269, P11927; Yilmaz O, 2008, CELL MICROBIOL, V10, P863, DOI 10.1111/j.1462-5822.2007.01089.x; Zemskov Evgeny, 2011, J Cardiovasc Dis Res, V2, P14, DOI 10.4103/0975-3583.78582	75	8	8	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12795	12806		10.1074/jbc.RA118.007236	http://dx.doi.org/10.1074/jbc.RA118.007236			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31289122	hybrid, Green Published			2022-12-26	WOS:000484414600020
J	Talbot, BE; Vandorpe, DH; Stotter, BR; Alper, SL; Schlondorff, JS				Talbot, Brianna E.; Vandorpe, David H.; Stotter, Brian R.; Alper, Seth L.; Schlondorff, Johannes S.			Transmembrane insertases and N-glycosylation critically determine synthesis, trafficking, and activity of the nonselective cation channel TRPC6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						channel activation; CRISPR; Cas; endoplasmic reticulum (ER); N-linked glycosylation; protein translocation; transient receptor potential channels (TRP channels); post-translational modification (PTM); nonselective cation channel	RECEPTOR POTENTIAL CHANNELS; OF-FUNCTION MUTATION; SMOOTH-MUSCLE; SURFACE EXPRESSION; CALCIUM-ENTRY; CANONICAL 6; CA2+ ENTRY; ACTIVATION; MEMBRANE; PODOCYTES	Transient receptor potential cation channel subfamily C member 6 (TRPC6) is a widely expressed ion channel. Gain-of-function mutations in the human TRPC6 channel cause autosomal-dominant focal segmental glomerulosclerosis, but the molecular components involved in disease development remain unclear. Here, we found that overexpression of gain-of-function TRPC6 channel variants is cytotoxic in cultured cells. Exploiting this phenotype in a genome-wide CRISPR/Cas screen for genes whose inactivation rescues cells from TRPC6-associated cytotoxicity, we identified several proteins essential for TRPC6 protein expression, including the endoplasmic reticulum (ER) membrane protein complex transmembrane insertase. We also identified transmembrane protein 208 (TMEM208), a putative component of a signal recognition particle-independent (SND) ER protein-targeting pathway, as being necessary for expression of TRPC6 and several other ion channels and transporters. TRPC6 expression was also diminished by loss of the previously uncharacterized WD repeat domain 83 opposite strand (WDR83OS), which interacted with both TRPC6 and TMEM208. Additionally enriched among the screen hits were genes involved in N-linked protein glycosylation. Deletion of the mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (MGAT1), necessary for the generation of complex N-linked glycans, abrogated TRPC6 gain-of-function variant-mediated Ca2+ influx and extracellular signal-regulated kinase activation in HEK cells, but failed to diminish cytotoxicity in cultured podocytes. However, mutating the two TRPC6 N-glycosylation sites abrogated the cytotoxicity of mutant TRPC6 and reduced its surface expression. These results expand the targets of TMEM208-mediated ER translocation to include multipass transmembrane proteins and suggest that TRPC6 N-glycosylation plays multiple roles in modulating channel trafficking and activity.	[Talbot, Brianna E.; Vandorpe, David H.; Stotter, Brian R.; Alper, Seth L.; Schlondorff, Johannes S.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA; [Stotter, Brian R.] Harvard Med Sch, Boston Childrens Hosp, Div Nephrol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Schlondorff, JS (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA.	jschlond@bidmc.harvard.edu	Stotter, Brian/AAX-9688-2020	Stotter, Brian/0000-0003-1505-7424; Schlondorff, Johannes/0000-0002-9973-9731; Talbot, Brianna/0000-0002-7959-9479	National Institutes of Health [R01DK115438, T32 DK007726]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007726, R01DK115438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK115438 (to J. S.) and T32 DK007726 (B. R. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alessandri-Haber N, 2009, J NEUROSCI, V29, P6217, DOI 10.1523/JNEUROSCI.0893-09.2009; Ambudkar I. S., 2007, V179, P541; Anderson M, 2013, AM J PHYSIOL-CELL PH, V305, pC276, DOI 10.1152/ajpcell.00095.2013; Aviram N, 2016, NATURE, V540, P134, DOI 10.1038/nature20169; Azumaya CM, 2018, J BIOL CHEM, V293, P10381, DOI 10.1074/jbc.RA118.003183; Barger CJ, 2019, CANCERS, V11, DOI 10.3390/cancers11020251; Basora N, 2003, J BIOL CHEM, V278, P31709, DOI 10.1074/jbc.M304437200; Beech DJ, 2004, J PHYSIOL-LONDON, V559, P685, DOI 10.1113/jphysiol.2004.068734; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Bouron A, 2016, ADV EXP MED BIOL, V898, P201, DOI 10.1007/978-3-319-26974-0_10; Casson J, 2017, J CELL SCI, V130, P3851, DOI 10.1242/jcs.207829; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Chaudhuri P, 2016, P NATL ACAD SCI USA, V113, P2110, DOI 10.1073/pnas.1600371113; Chiluiza D, 2013, J BIOL CHEM, V288, P18407, DOI 10.1074/jbc.M113.463059; Chitwood PJ, 2018, CELL, V175, P1507, DOI 10.1016/j.cell.2018.10.009; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Damann N, 2009, ACTA PHYSIOL, V195, P3, DOI 10.1111/j.1748-1716.2008.01918.x; Davis J, 2012, DEV CELL, V23, P705, DOI 10.1016/j.devcel.2012.08.017; de Souza LB, 2014, CELL CALCIUM, V56, P43, DOI 10.1016/j.ceca.2014.05.001; Dettmer U, 2010, J BIOL CHEM, V285, P26174, DOI 10.1074/jbc.M110.132548; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dietrich A, 2014, HANDB EXP PHARMACOL, V222, P157, DOI 10.1007/978-3-642-54215-2_7; Ding YF, 2011, J BIOL CHEM, V286, P31799, DOI 10.1074/jbc.M111.248344; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doleschal B, 2015, CARDIOVASC RES, V106, P163, DOI 10.1093/cvr/cvv022; Du WL, 2010, J CLIN INVEST, V120, P3480, DOI 10.1172/JCI43165; Dyachenko V, 2009, CELL CALCIUM, V45, P38, DOI 10.1016/j.ceca.2008.06.003; Estacion M, 2006, J PHYSIOL-LONDON, V572, P359, DOI 10.1113/jphysiol.2005.103143; Gigante M, 2011, CLIN J AM SOC NEPHRO, V6, P1626, DOI 10.2215/CJN.07830910; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Gonzales AL, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004732; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Graham S, 2010, J BIOL CHEM, V285, P23464, DOI 10.1074/jbc.M109.093500; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Gudermann Thomas, 2004, Sci STKE, V2004, ppe35; Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099; Hassdenteufel S, 2017, FEBS LETT, V591, P3211, DOI 10.1002/1873-3468.12831; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hofmann K, 2017, BBA-MOL BASIS DIS, V1863, P560, DOI 10.1016/j.bbadis.2016.12.002; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hofstra JM, 2013, NEPHROL DIAL TRANSPL, V28, P1830, DOI 10.1093/ndt/gfs572; Ilatovskaya DV, 2018, J AM SOC NEPHROL, V29, P1917, DOI 10.1681/ASN.2018030280; Inoue R, 2019, SEMIN CELL DEV BIOL, V94, P40, DOI 10.1016/j.semcdb.2018.11.002; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Jiang LN, 2011, EXP BIOL MED, V236, P184, DOI 10.1258/ebm.2010.010237; Kanda S, 2011, MOL BIOL CELL, V22, P1824, DOI 10.1091/mbc.E10-12-0929; Kim EY, 2019, BIOCHEM BIOPHYS REP, V17, P139, DOI 10.1016/j.bbrep.2018.12.006; Kim EY, 2012, MOL PHARMACOL, V82, P728, DOI 10.1124/mol.112.079376; Kim EY, 2012, AM J PHYSIOL-RENAL, V302, pF298, DOI 10.1152/ajprenal.00423.2011; Kistler AD, 2013, J BIOL CHEM, V288, P36598, DOI 10.1074/jbc.M113.488122; Krall P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012859; KUMAR R, 1990, P NATL ACAD SCI USA, V87, P9948, DOI 10.1073/pnas.87.24.9948; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Lemos VS, 2007, BIOCHEM BIOPH RES CO, V352, P130, DOI 10.1016/j.bbrc.2006.10.160; Liu BC, 2013, BBA-MOL CELL RES, V1833, P1434, DOI 10.1016/j.bbamcr.2013.02.031; Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404; Maddirevula S, 2019, GENET MED, V21, P1164, DOI 10.1038/s41436-018-0288-x; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Nikolova-Krstevski Vesna, 2017, JACC Basic Transl Sci, V2, P575, DOI 10.1016/j.jacbts.2017.05.006; Nilius B, 2005, PFLUG ARCH EUR J PHY, V451, P1, DOI 10.1007/s00424-005-1462-y; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Przybylla S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159778; Quick K, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120068; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110; Riehle M, 2016, J AM SOC NEPHROL, V27, P2771, DOI 10.1681/ASN.2015030318; Roshanravan H, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00351; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Satoh T, 2015, ELIFE, V4, DOI 10.7554/eLife.06306; Schilling William P, 2004, Novartis Found Symp, V258, P18; Schlondorff J, 2009, AM J PHYSIOL-CELL PH, V296, pC558, DOI 10.1152/ajpcell.00077.2008; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Spires D, 2018, AM J PHYSIOL-RENAL, V315, pF1091, DOI 10.1152/ajprenal.00155.2018; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tai YL, 2008, J CELL SCI, V121, P2301, DOI 10.1242/jcs.026906; Tang QL, 2018, CELL RES, V28, P746, DOI 10.1038/s41422-018-0038-2; Thakur DP, 2016, P NATL ACAD SCI USA, V113, P1092, DOI 10.1073/pnas.1522294113; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Tian DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001200; Usenovic M, 2012, HUM MOL GENET, V21, P3785, DOI 10.1093/hmg/dds206; Verheijden KAT, 2018, J AM SOC NEPHROL, V29, P2099, DOI 10.1681/ASN.2016111248; Wang LM, 2019, KIDNEY INT, V95, P321, DOI 10.1016/j.kint.2018.09.026; Weber EW, 2015, J EXP MED, V212, P1883, DOI 10.1084/jem.20150353; Weissmann N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1660; Welsh DG, 2002, CIRC RES, V90, P248, DOI 10.1161/hh0302.105662; Wideman Jeremy G, 2015, F1000Res, V4, P624, DOI 10.12688/f1000research.6944.1; Wilson C, 2014, AM J PHYSIOL-RENAL, V306, pF1018, DOI 10.1152/ajprenal.00662.2013; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Wu YL, 2017, KIDNEY INT, V91, P830, DOI 10.1016/j.kint.2016.09.039; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240; Xu XP, 2013, BIOPHYS J, V104, p454A, DOI 10.1016/j.bpj.2012.11.2513; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yao H, 2009, CELL DEATH DIFFER, V16, P1681, DOI 10.1038/cdd.2009.108; Yu H, 2016, J AM SOC NEPHROL, V27, P3308, DOI 10.1681/ASN.2015080896; Zhao YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064228; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003; Zhou J, 2008, NAT NEUROSCI, V11, P741, DOI 10.1038/nn.2127	111	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12655	12669		10.1074/jbc.RA119.008299	http://dx.doi.org/10.1074/jbc.RA119.008299			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31266804	hybrid, Green Published			2022-12-26	WOS:000484414600009
J	Jiang, C; Li, Y; He, JL				Jiang, Chong; Li, Yu; He, Jia-li			Analysis of vertically loaded piles considering crushing characteristics of crushed stones	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; TRANSFER BEHAVIOR; VARIATIONAL APPROACH; SETTLEMENT ANALYSIS; SKIN FRICTION; SINGLE PILE; DEFORMATION; MODEL	In this paper, a method was developed to assess the vertical response of piles considering crushing characteristics. A load transfer model of a pile is built and the relationship between the crushing characteristics and load transfer function of a pile was analyzed. Based on the analysis results, the transfer equation of load function considering the crushing characteristics was derived using the finite difference method. The ideal side resistance and the load transfer mechanism of a pile can be obtained by the transfer equation of load function. The predicted response of piles with the proposed method is in good agreement with the response observed in some pile tests reported in the literature. Further study was conducted to discuss the effect of the parameters related to the load transfer model considering crushing characteristics on the load-settlement response of a single pile.	[Jiang, Chong; Li, Yu; He, Jia-li] Cent S Univ, Sch Resources & Safety Engn, Changsha, Hunan, Peoples R China	Central South University	Jiang, C; Li, Y (corresponding author), Cent S Univ, Sch Resources & Safety Engn, Changsha, Hunan, Peoples R China.	jiangchong@csu.edu.cn; yuli0523@csu.edu.cn	li, yu/GRJ-6434-2022	He, Jia-Li/0000-0003-1827-9719; Jiang, Chong/0000-0002-7199-4693	National Natural Science Foundation of China [51678570, 51478479]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (Grant No. 51678570;51478479).	Abchir Z, 2016, GEOTECHNIQUE, V66, P137, DOI 10.1680/jgeot.15.P.097; Ai ZY, 2009, COMPUT GEOTECH, V36, P427, DOI 10.1016/j.compgeo.2008.06.001; BAI Shu-tian, 1997, J HYDROELECTRICITY, P22; Carrubba P, 1997, CAN GEOTECH J, V34, P230, DOI 10.1139/t96-104; Comodromos EM, 2009, COMPUT GEOTECH, V36, P819, DOI 10.1016/j.compgeo.2009.01.011; Dong Y, 2007, ROCK SOIL MECH, V28, P1269; Guo WD, 1999, GEOTECHNIQUE, V49, P161, DOI 10.1680/geot.1999.49.2.161; HARDIN BO, 1985, J GEOTECH ENG-ASCE, V111, P1177, DOI 10.1061/(ASCE)0733-9410(1985)111:10(1177); Indraratna B, 1998, J GEOTECH GEOENVIRON, V124, P439, DOI 10.1061/(ASCE)1090-0241(1998)124:5(439); Jiang C., 2018, ADV CIVIL ENG, P1; JIANG Wu-jun, 2017, J GEOTECH ENG, V39, P67; KRAFT LM, 1981, J GEOTECH ENG-ASCE, V107, P1543; Lee C.Y., 1991, COMPUT GEOTECH, V11, P295, DOI [10.1016/0266-352X(91)90014-7, DOI 10.1016/0266-352X(91)90014-7]; Lee KM, 2001, CAN GEOTECH J, V38, P1063, DOI 10.1139/cgj-38-5-1063; Li JP, 2012, KSCE J CIV ENG, V16, P325, DOI 10.1007/s12205-012-1341-y; Liu J, 2004, COMPUT GEOTECH, V31, P127, DOI 10.1016/j.compgeo.2004.01.001; Ma D, 2019, SCI TOTAL ENVIRON, V664, P436, DOI 10.1016/j.scitotenv.2019.02.059; Ma D, 2018, WATER-SUI, V10, DOI 10.3390/w10091187; Ma D, 2017, ENG GEOL, V217, P61, DOI 10.1016/j.enggeo.2016.12.006; Mandolini A, 1997, GEOTECHNIQUE, V47, P791, DOI 10.1680/geot.1997.47.4.791; Marsal RJ, 1967, INT J ROCK MECH MIN, V12, P67; Meng SJ, 2005, ROCK SOIL MECH, V26, P33; O'Neill MW, 2001, J GEOTECH GEOENVIRON, V127, P3, DOI 10.1061/(ASCE)1090-0241(2001)127:1(3); Qi F, 2018, J ELECTRON INF TECHN, V40, P87, DOI 10.11999/JEIT170388; [秦红玉 Qin Hongyu], 2004, [岩土力学, Rock and Soil Mechanics], V25, P1575; RADHAKRISHNAN R, 1989, J GEOTECH ENG-ASCE, V115, P755, DOI 10.1061/(ASCE)0733-9410(1989)115:6(755); RANDOLPH MF, 1979, GEOTECHNIQUE, V29, P423, DOI 10.1680/geot.1979.29.4.423; ROSENBERG P, 1976, CAN GEOTECH J, V13, P324, DOI 10.1139/t76-033; Said I, 2009, COMPUT GEOTECH, V36, P6, DOI 10.1016/j.compgeo.2008.02.011; Shen WY, 1997, INT J NUMER ANAL MET, V21, P741; Shen WY, 1999, GEOTECHNIQUE, V49, P199, DOI 10.1680/geot.1999.49.2.199; Shen WY, 2000, GEOTECHNIQUE, V50, P349, DOI 10.1680/geot.2000.50.4.349; Sheng DC, 2005, COMPUT GEOTECH, V32, P17, DOI 10.1016/j.compgeo.2004.10.004; Tong CX, 2018, CAN GEOTECH J, V55, P246, DOI 10.1139/cgj-2017-0098; Xiao HB, 2002, STRUCT DES TALL BUIL, V11, P285, DOI 10.1002/tal.201; [Xiao Zhaoran 肖昭然], 2002, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V24, P640; Xie HS, 2019, GEOFLUIDS, DOI 10.1155/2019/1756856; Xu KJ, 2000, INT J NUMER ANAL MET, V24, P1109, DOI 10.1002/1096-9853(20001225)24:15<1109::AID-NAG72>3.0.CO;2-N; Zhang QQ, 2014, J ENG MECH, V140, P102, DOI 10.1061/(ASCE)EM.1943-7889.0000640; Zhang QQ, 2012, J CENT SOUTH UNIV, V19, P2037, DOI 10.1007/s11771-012-1242-8; Zhang QQ, 2010, COMPUT GEOTECH, V37, P969, DOI 10.1016/j.compgeo.2010.08.003; Zhang S, 2015, GEOTECHNIQUE, V65, P911, DOI 10.1680/jgeot.14.P.240	42	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219003	10.1371/journal.pone.0219003	http://dx.doi.org/10.1371/journal.pone.0219003			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295272	Green Submitted, Green Published, gold			2022-12-26	WOS:000484951800011
J	Kyvsgaard, N; Mikkelsen, TS; Thastum, M; Christensen, AE; Wehner, PS; Nysom, K; Herlin, T				Kyvsgaard, Nini; Mikkelsen, Torben Stamm; Thastum, Mikael; Christensen, Anne Estmann; Wehner, Peder Skov; Nysom, Karsten; Herlin, Troels			Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children	PLOS ONE			English	Article							ANTICIPATORY NAUSEA; RHEUMATOID-ARTHRITIS; RECOMMENDATIONS; PREVALENCE; VALIDATION; SYMPTOMS; PARENTS	Objectives To analyse the internal consistency of an adaption of the methotrexate intolerance severity score (MISS); and to describe and compare the level of methotrexate intolerance evaluated by the MISS in Danish children with juvenile idiopathic arthritis (JIA) or acute lymphoblastic leukaemia (ALL), treated with low-dose methotrexate (MTX). Methods Cross-sectional study of children diagnosed with JIA or ALL, treated with low-dose MTX, aged 9 years or above, and cognitively intact. The patient's parents completed the MISS. MTX intolerance was defined as a total MISS score above 6. Results We enrolled 120 children with JIA and 23 children with ALL. The MISS had a good internal consistency in the JIA group. The median MISS score was higher in the JIA group than in the ALL group (JIA: 8; ALL: 1; p<0.0001); and the JIA group had a larger proportion of MTX intolerant children than the ALL group (JIA: 73/120; ALL: 4/23; p<0.001). Within both the JIA group and the ALL group, the MISS total score was not significantly correlated with age, MTX dose or the duration of low-dose MTX treatment. Conclusion In the JIA group the level of MTX intolerance was higher and more attributed to anticipatory, associative and behavioural symptoms than in the ALL group. The MISS may help to uncover whether MTX intolerance is present and which aspects are affected in the individual patient, thus guiding intervention. The MISS may also be applicable within leukaemia care.	[Kyvsgaard, Nini; Mikkelsen, Torben Stamm; Herlin, Troels] Aarhus Univ Hosp, Dept Clin Med, Paediat & Adolescent Med, Aarhus, Denmark; [Thastum, Mikael] Aarhus Univ, Aarhus BSS, Dept Psychol & Behav Sci, Aarhus, Denmark; [Christensen, Anne Estmann] Odense Univ Hosp, HC Andersen Childrens Hosp, Dept Paediat Rheumatol, Odense, Denmark; [Wehner, Peder Skov] Odense Univ Hosp, HC Andersen Childrens Hosp, Dept Pediat Hematol & Oncol, Odense, Denmark; [Nysom, Karsten] Rigshosp, Pediat & Adolescent Med, Copenhagen, Denmark	Aarhus University; Aarhus University; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen	Kyvsgaard, N (corresponding author), Aarhus Univ Hosp, Dept Clin Med, Paediat & Adolescent Med, Aarhus, Denmark.	nini.kyvsgaard@rm.dk	Nysom, Karsten/AAW-9563-2020; Thastum, Mikael/A-3443-2008	Thastum, Mikael/0000-0001-8582-5682	Danish Childhood Cancer Foundation; Danish Rheumatism Association [R128-A2294, R141-A4002]; Arvid Nilsson' Foundation	Danish Childhood Cancer Foundation; Danish Rheumatism Association; Arvid Nilsson' Foundation	This work was funded by the Danish Childhood Cancer Foundation (https://boernecancerfonden.dk) to NK; the Danish Rheumatism Association (R128-A2294; R141-A4002) (https://www.gigtforeningen.dk) to NK and the Arvid Nilsson' Foundation (http://arvidnilssonsfond.dk) to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsufyani K, 2004, J RHEUMATOL, V31, P179; Beukelman T, 2011, ARTHRIT CARE RES, V63, P465, DOI 10.1002/acr.20460; Brunner HI, 2005, JCR-J CLIN RHEUMATOL, V11, P194, DOI 10.1097/01.rhu.0000173616.81928.44; Bulatovic M, 2011, ARTHRITIS RHEUM-US, V63, P2007, DOI 10.1002/art.30367; Chausset A, 2017, CLIN RHEUMATOL, V36, P1281, DOI 10.1007/s10067-017-3638-1; Dupont-Lucas C, 2017, INFLAMM BOWEL DIS, V23, P298, DOI 10.1097/MIB.0000000000001014; Dupuis LL, 2017, SUPPORT CARE CANCER, V25, P317, DOI 10.1007/s00520-016-3330-z; Dupuis LL, 2014, PEDIATR BLOOD CANCER, V61, P1506, DOI 10.1002/pbc.25063; Franova J, 2016, PEDIATR RHEUMATOL, V14, DOI 10.1186/s12969-016-0099-z; GIANNINI EH, 1992, NEW ENGL J MED, V326, P1043, DOI 10.1056/NEJM199204163261602; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hashkes PJ, 2005, JAMA-J AM MED ASSOC, V294, P1671, DOI 10.1001/jama.294.13.1671; Hofel L, 2018, PEDIATR RHEUMATOL, V16, DOI 10.1186/s12969-018-0228-y; Levinsen M, 2015, CANCER CHEMOTH PHARM, V75, P59, DOI 10.1007/s00280-014-2613-7; Lopez-Lopez E, 2014, PHARMACOGENOMICS, V15, P1383, DOI [10.2217/PGS.14.106, 10.2217/pgs.14.106]; Patil P, 2014, CLIN RHEUMATOL, V33, P403, DOI 10.1007/s10067-013-2389-x; Petty RE, 2004, J RHEUMATOL, V31, P390; Pui Ching-Hon, 2004, Hematology Am Soc Hematol Educ Program, P118; Roscoe JA, 2011, SUPPORT CARE CANCER, V19, P1533, DOI 10.1007/s00520-010-0980-0; Scheuern A, 2017, RHEUMATOLOGY, V56, P901, DOI 10.1093/rheumatology/kew507; Scheuern A, 2016, PEDIATR RHEUMATOL, V14, DOI 10.1186/s12969-016-0071-y; Toft N, 2018, LEUKEMIA, V32, P606, DOI 10.1038/leu.2017.265; Toft N, 2013, EUR J HAEMATOL, V90, P404, DOI 10.1111/ejh.12097; van der Meer A, 2007, CLIN EXP RHEUMATOL, V25, P480; van Dijkhuizen EHP, 2015, PEDIATR RHEUMATOL, V13, DOI 10.1186/s12969-015-0002-3; Zuber Zbigniew, 2016, Reumatologia (Warsaw), V54, P19, DOI 10.5114/reum.2016.58757	26	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219539	10.1371/journal.pone.0219539	http://dx.doi.org/10.1371/journal.pone.0219539			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295288	gold, Green Published, Green Submitted			2022-12-26	WOS:000484951800042
J	Rahmannia, S; Diana, A; Luftimas, DE; Gurnida, DA; Herawati, DMD; Houghton, LA; Gibson, RS				Rahmannia, Sofa; Diana, Aly; Luftimas, Dimas Erlangga; Gurnida, Dida Akhmad; Herawati, Dewi Marhaeni Diah; Houghton, Lisa Anne; Gibson, Rosalind Susan			Poor dietary diversity and low adequacy of micronutrient intakes among rural Indonesian lactating women from Sumedang district, West Java	PLOS ONE			English	Article							BREAST-MILK; VITAMIN-A; NUTRITIONAL-STATUS; IRON-DEFICIENCY; ZINC; INFANTS; MOTHERS; SUPPLEMENTATION; INCREASES; RISK	Information on micronutrient adequacy of diets of rural Indonesian lactating women is lacking, despite their high nutrient requirements. This is of concern because deficits in micronutrient intakes may compromise the health of both mothers and infants. This study aimed to assess micronutrient adequacy and dietary diversity (DD) among rural lactating women and explore relationships between micronutrient adequacy, DD, and intakes of energy and food groups consumed. We measured in-home 12-h weighed food records and 12-h recalls over three non-consecutive days from 121 exclusively breastfeeding women at 2-5 months postpartum. Next, we calculated intakes of energy and 11 micronutrients and estimated probability of adequacy (PA) for usual intakes of 11 micronutrients for each women taking into account national fortification of wheat flour with thiamin, riboflavin, folate, zinc, and iron. We assessed DD from nine food groups consumed. Energy and macronutrient balance were within recommended ranges, yet population prevalence of adequacy was less than 50% for niacin, vitamins B6 and C, and less than 60% for calcium, vitamin B12 and vitamin A, all micronutrients not targeted by the national wheat flour fortification program. In contrast, population prevalence of adequacy for the fortified micronutrients was at least 60%, with iron and zinc attaining 79% and 97%, respectively. Overall mean population prevalence of micro nutrient adequacy was 57% and mean ( SD) DD score was 4.3 1.2. Mean PAs, a composite measure based on individual PAs over 11 micronutrients, were strongly correlated with energy intakes and with DD scores. In the multivariate models with maternal education and wealth index as covariates, organ meats were the most important determinant of mean PA after controlling for energy intake. In conclusion, despite wheat flour fortification, lactating mothers remained at risk of multiple micronutrient inadequacies. Increasing intakes of animal source foods including organ meats, and fruits and vegetables should be considered.	[Rahmannia, Sofa] Univ Padjadjaran, Fac Med, Grad Sch Biomed Sci Master Program, Bandung, West Java, Indonesia; [Rahmannia, Sofa] Univ Pasundan, Fac Med, Bandung, Indonesia; [Diana, Aly; Luftimas, Dimas Erlangga; Gurnida, Dida Akhmad; Herawati, Dewi Marhaeni Diah] Univ Padjadjaran, Fac Med, Bandung, Indonesia; [Houghton, Lisa Anne; Gibson, Rosalind Susan] Univ Otago, Dept Human Nutr, Dunedin, New Zealand	Universitas Padjadjaran; Pasundan University; Universitas Padjadjaran; University of Otago	Rahmannia, S (corresponding author), Univ Padjadjaran, Fac Med, Grad Sch Biomed Sci Master Program, Bandung, West Java, Indonesia.; Rahmannia, S (corresponding author), Univ Pasundan, Fac Med, Bandung, Indonesia.	sofa.rahmannia@gmail.com	HERAWATI, DEWI MARHAENI DIAH/GSM-9063-2022; Rahmannia, Sofa/AAE-2084-2021; Houghton, Lisa/F-5305-2011	Rahmannia, Sofa/0000-0003-2988-1334; Houghton, Lisa/0000-0002-2276-6205; Luftimas, Dimas Erlangga/0000-0002-6955-2968; Diana, Aly/0000-0002-9394-5235	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study is made possible by the support of the Bill and Melinda Gates Foundation to LAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe SK, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010647.pub2; Allen LH, 2018, ADV NUTR, V9, p275S, DOI 10.1093/advances/nmy018; Allen LH, 2012, ADV NUTR, V3, P362, DOI 10.3945/an.111.001172; Arimond M, 2011, FOOD NUTR TECH ASSIS, P11; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Arsenault JE, 2013, J NUTR, V143, P197, DOI 10.3945/jn.112.169524; Atkinson SA, 2007, FOOD NUTR BULL, V28, pS61, DOI 10.1177/15648265070281S107; Becquey E, 2010, J NUTR, V140, p2079S, DOI 10.3945/jn.110.123356; Bognar A., 2002, TABLES WEIGHT YIELD; Cepeda-Lopez AC, 2010, INT J VITAM NUTR RES, V80, P263, DOI 10.1024/0300-9831/a000033; Chan SSL, 2007, J FOOD COMPOS ANAL, V20, P609, DOI 10.1016/j.jfca.2007.03.003; Chen HJ, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-18; Daniels L, AM J CLIN NUTR; Deegan KL, 2012, J NUTR, V142, P112, DOI 10.3945/jn.111.143917; Dewey KG, 2004, ADV EXP MED BIOL, V554, P91; Diana A, 2017, BRIT J NUTR, V118, P830, DOI 10.1017/S0007114517002860; Diana A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175952; Dijkhuizen MA, 2001, AM J CLIN NUTR, V73, P786; Dror DK, 2018, ADV NUTR, V9, p358S, DOI 10.1093/advances/nmx019; Dror DK, 2018, ADV NUTR, V9, p278S, DOI 10.1093/advances/nmy022; Duggan C, 2014, J NUTR, V144, P758, DOI 10.3945/jn.113.187278; Dumrongwongsiri O, 2015, ASIA PAC J CLIN NUTR, V24, P273, DOI 10.6133/apjcn.2015.24.2.06; FAO/INFOODS, 2012, FAO INFOODS DENS DAT; Foote JA, 2004, J NUTR, V134, P1779; Gibson R, 2005, PRINCIPLES NUTR ASSE; Harttig U, 2011, EUR J CLIN NUTR, V65, pS87, DOI 10.1038/ejcn.2011.92; Henjum S, 2015, PUBLIC HEALTH NUTR, V18, P3201, DOI 10.1017/S1368980015000671; Henjum S, 2014, BRIT J NUTR, V112, P132, DOI 10.1017/S0007114514000592; Herawati N, 2000, B ENVIRON CONTAM TOX, V64, P33, DOI 10.1007/s001289910006; Institute of Medicine, 2001, DIETARY REFERENCE IN; International Zinc Nutrition Consultative Group (IZiNCG), 2004, Food Nutr Bull, V25, pS99; Liu Z, J PHARMACOKINET PHAR; Lohmann TG, 1988, ANTHROPOMETRIC STAND; Madanijah S, 2016, BRIT J NUTR, V116, pS67, DOI 10.1017/S0007114516001306; Moran VH, 2010, MATERN CHILD NUTR, V6, P39, DOI [10.1111/j.1740-8709.2010.00276.x, 10.1111/j.1/40-8/09.2010.00276.x]; MOSER PB, 1983, AM J CLIN NUTR, V38, P101, DOI 10.1093/ajcn/38.1.101; Muslimatun S, 2001, J NUTR, V131, P2664, DOI 10.1093/jn/131.10.2664; Nakamori M, 2009, J NUTR SCI VITAMINOL, V55, P338, DOI 10.3177/jnsv.55.338; Otten J.J., 2006, DIETARY REFERENCE IN, DOI DOI 10.17226/11537; PRENTICE A, 1995, AM J CLIN NUTR, V62, P58, DOI 10.1093/ajcn/62.1.58; STOLTZFUS RJ, 1993, J NUTR, V123, P666, DOI 10.1093/jn/123.4.666; Torheim LE, 2010, J NUTR, V140, p2051S, DOI 10.3945/jn.110.123463; Vasquez-Caicedo AL, 2008, EUROPEAN FOOD INFORA; WHO, 2006, GUIDELINES FOOD FORT; WHO, 2003, WHO TECHN REP SER; WHO, 2011, VIT A SUPPL POSTP WO; World Health Organization Food and Agriculture Organization of the United Nations United Nations University, 2004, REP JOINT FAO WHO UN	47	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219675	10.1371/journal.pone.0219675	http://dx.doi.org/10.1371/journal.pone.0219675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295313	Green Published, Green Submitted, gold			2022-12-26	WOS:000484951800061
J	Ayele, TA; Worku, A; Kebede, Y; Zuma, K; Kasim, A; Shkedy, Z				Ayele, Tadesse Awoke; Worku, Alemayehu; Kebede, Yigzaw; Zuma, Khangelani; Kasim, Adetayo; Shkedy, Ziv			Model-based prediction of CD4 cells counts in HIV-infected adults on antiretroviral therapy in Northwest Ethiopia: A flexible mixed effects approach	PLOS ONE			English	Article							REGRESSION; MORTALITY; TIME	Background CD4 cell counts is widely used as a biomarker for treatment progression when studying the efficacy of drugs to treat HIV-infected patients. In the past, it had been also used in determining eligibility to initiate antiretroviral therapy. The main aim of this was to model the evolution of CD4 counts over time and use this model for an early prediction of subject-specific time to cross a pre-specified CD4 threshold. Methods Hospital based retrospective cohort study of HIV-infected patients was conducted from January 2009 to December 2014 at University of Gondar hospital, Northwest Ethiopia. Fractional polynomial random effect model is used to model the evolution of CD4 counts over time in response to treatment and to estimate the individual probability to be above a pre-selected CD4 threshold. Human subject research approval for this study was received from University of Gondar Research Ethics Committee and the medical director of the hospital. Results A total of 1347 patients were included in the analysis presented in this paper. The cohort contributed a total of 236.58 per 100 person-years of follow-up. Later the data were divided into two periods: the first is the estimation period in which the parameters of the model are estimated and the second is the prediction period. Based on the parameters from the estimation period, model based prediction for the time to cross a threshold was estimated. The correlations between observed and predicted values of CD4 levels in the estimation period were 0.977 and 0.982 for Neverapine and Efavirenz containing regimens, respectively; while the correlation between the observed and predicted CD4 counts in the prediction period are 0.742 and 0.805 for NVP and EFV, respectively. Conclusions The model enables us to estimate a subject-specific expected time to cross a CD4 threshold and to estimate a subject-specific probability to have CD4 count above a pre-specified threshold at each time point. By predicting long-term outcomes of CD4 count of the patients one can advise patient about the potential ART benefits that accrue in the long-term.	[Ayele, Tadesse Awoke; Kebede, Yigzaw] Univ Gondar, Epidemiol & Biostat, Gondar, Ethiopia; [Worku, Alemayehu] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Zuma, Khangelani] Hlth Sci Res Council, Pretoria, South Africa; [Kasim, Adetayo] Univ Durham, Wolfson Res Inst, Durham, England; [Shkedy, Ziv] Hasselt Univ, I BioStat, Diepenbeek, Belgium	University of Gondar; Addis Ababa University; Durham University; Hasselt University	Ayele, TA (corresponding author), Univ Gondar, Epidemiol & Biostat, Gondar, Ethiopia.	tawoke7@gmail.com	Shkedy, Ziv/AAQ-3096-2020	Shkedy, Ziv/0000-0002-6306-0823	University of Gondar; University of Gondar, Ethiopia	University of Gondar; University of Gondar, Ethiopia	The authors would like to thank University of Gondar for funding this research and TA received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the University of Gondar and Hasselt University for the collaboration established to work on the project. The authors gratefully acknowledge the financial support from University of Gondar, Ethiopia. Our gratitude also goes to the staff of ART clinic of the hospital who collected the data and organized the database information according to the format.	[Anonymous], 2010, CONS GUID US ANT DRU; Aregay M, 2013, J BIOPHARM STAT, V23, P1228, DOI 10.1080/10543406.2013.834917; Awoke T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168323; Baneshi MR, 2013, INT J PREVENTIVE MED, V4, P414; Blas-Garcia A., 2011, RECENT TRANSLATIONAL, P275; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Dangerous Drugs England Dangerous Drugs Scotland., 2013, CONTROLLED DRUGS SUP; Ford N, 2017, CURR OPIN HIV AIDS, V12, P123, DOI 10.1097/COH.0000000000000348; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Huldrych F, 2014, JAMA, V312; Jacobson Lisa P., 2002, Curr Infect Dis Rep, V4, P88, DOI 10.1007/s11908-002-0072-5; Kestens L., 2013, IMMUNE SYSTEM HIV VI; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Kitagawa G., 1998, SELECTED PAPERS HIRO; Lawton M, 2015, J CLIN EPIDEMIOL, V68, P1355, DOI 10.1016/j.jclinepi.2015.05.003; Lubyayi L., 2015, BIOMETR BIOSTAT INT, V2, P53; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; De La Hoz JM, 2014, COLOMB MEDICA, V45, P162; Minga AK, 2011, AIDS, V25, P819, DOI 10.1097/QAD.0b013e32834625d3; Notermans DW, 1999, J INFECT DIS, V180, P1050, DOI 10.1086/315013; Ntokamunda J, 2014, J TROP MED, P9; Quinn TC, 2008, AIDS, V22, pS7, DOI 10.1097/01.aids.0000327510.68503.e8; Reda AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058595; Reddy T, 2016, PHARM STAT, V15, P541, DOI 10.1002/pst.1774; Richard J, 2014, IMMUNE SYSTEM HIV AG; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Royston P, ANAL BASED FRACTIONA; Sabin CA, 2009, CURR OPIN INFECT DIS, V22, P191, DOI 10.1097/QCO.0b013e328326cd34; Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075; Taylor JMG, 1998, STAT MED, V17, P2381, DOI 10.1002/(SICI)1097-0258(19981030)17:20&lt;2381::AID-SIM926&gt;3.0.CO;2-S; Teeranaipong P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154221; van Leth F, 2005, AIDS, V19, P463, DOI 10.1097/01.aids.0000162334.12815.5b; Verbeke G, 2009, SPRINGER SER STAT, P1; Walker S, 2003, JAIDS-J ACQ IMM DEF, V32, P303, DOI 10.1097/00126334-200303010-00010; WHO, 2006, ANT DRUGS TREAT PREG; Wood E, 2005, LANCET INFECT DIS, V5, P407, DOI 10.1016/S1473-3099(05)70162-6; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2016, US ANT DRUGS TREAT P	41	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218514	10.1371/journal.pone.0218514	http://dx.doi.org/10.1371/journal.pone.0218514			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291281	Green Published, Green Accepted, gold			2022-12-26	WOS:000484947800025
J	Calner, P; Sperring, H; Ruiz-Mercado, G; Miller, NS; Andry, C; Battisti, L; Scrudder, K; Shea, F; Chan, A; Schechter-Perkins, EM				Calner, Paul; Sperring, Heather; Ruiz-Mercado, Glorimar; Miller, Nancy S.; Andry, Chris; Battisti, Leandra; Scrudder, Katy; Shea, Fiona; Chan, Angelica; Schechter-Perkins, Elissa M.			HCV screening, linkage to care, and treatment patterns at different sites across one academic medical center	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SUSTAINED VIROLOGICAL RESPONSE; BIRTH COHORT; INFECTION; CASCADE	Background It is unclear whether sites that screen large numbers of patients for Hepatitis C Virus but achieve limited follow-up are more or less effective at having patients succeed through linkage and treatment than lower volume sites that have higher linkage percentages. The objective was to compare the rates of HCV identification, linkage to care, and treatment success between different study sites including the Emergency Department, 3 outpatient clinics with unique patients, and the inpatient setting at one medical center Methods This is a descriptive analysis of 2 years of data from a protocol that integrated HCV screening and treatment into clinical services throughout multiple departments in one medical center. The program used a best practice advisory to prompt testing at all sites, with different triggers for it to fire at each site, and one central navigation program that attempted to link all patients diagnosed with hepatitis C virus to outpatient care. Outcomes included volume of tests performed in each site, Antibody and RNA rates at each site, demographic data, navigation and linkage outcomes, and post-linkage treatment completion. Results 28,435 patients were screened across 5 clinical locations. RNA+ rates and absolute numbers linked to MD (linkage rates among all RNA+) were: ED 7.2% RNA+, 224 (22.6%) linked; Inpatient 14.8% RNA+, 27 (17.6%) linked, General Internal Medicine 3.9% RNA+, 269 (65.8%) linked, Infectious Diseases 4.0% RNA+, 34(70.8%) linked, Family Medicine 2.0% RNA+, 28 (75.7%) linked. Demographics, linkage barriers, and treatment initiation rates were different at all sites. Conclusion Among sites there were differences in the sociodemographic characteristics of patients diagnosed with HCV, as well as differences in the success linking patients to outpatient care. At this medical center, the ED screened the most patients, the inpatient area had the highest RNA positivity rate, the FM clinic had the highest linkage rate, GIM linked the most patients by absolute number, and GIM also had the highest number of patients start treatment.	[Calner, Paul; Schechter-Perkins, Elissa M.] Boston Univ, Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Sperring, Heather] Boston Univ, Med Ctr, Dept Gen Internal Med, Masters Program Publ Hlth,Sect Infect Dis, Boston, MA USA; [Ruiz-Mercado, Glorimar; Scrudder, Katy; Shea, Fiona; Chan, Angelica] Boston Univ, Med Ctr, Dept Gen Internal Med, Ctr Infect Dis & Publ Hlth Programs,Sect Infect D, Boston, MA USA; [Miller, Nancy S.; Andry, Chris] Boston Univ, Med Ctr, Dept Pathol & Lab Med, Clin Microbiol & Mol Diagnost Lab Med, Boston, MA USA; [Battisti, Leandra] Boston Med Ctr, Dept Pharm Operat & Project Management, Boston, MA USA	Boston University; Boston University; Boston University; Boston University; Boston Medical Center	Schechter-Perkins, EM (corresponding author), Boston Univ, Med Ctr, Dept Emergency Med, Boston, MA 02215 USA.	Elissa.Perkins@bmc.org		Sperring, Heather/0000-0002-1347-5748; Calner, Paul/0000-0002-4912-6902; Miller, Nancy/0000-0001-5878-0896; Schechter-Perkins, Elissa/0000-0003-1798-9663	Gilead Sciences, Inc.'s FOCUS Program	Gilead Sciences, Inc.'s FOCUS Program	Support for the BMC HCV testing program was provided by a grant from Gilead Sciences, Inc.'s FOCUS Program. FOCUS funding does not support activities beyond screening and linkage to care. No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ES, 2017, CLIN INFECT DIS, V64, P1540, DOI 10.1093/cid/cix163; [Anonymous], 2017, HEP C VIR INF SURV R; [Anonymous], 2 NEW FED SURV SHOW, DOI [10.1377/hblog20180913.896261/full/, DOI 10.1377/HBLOG20180913.896261/FULL/]; [Anonymous], 2017, HEP C INF; Bourgi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161241; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Coyle C, 2016, PUBLIC HEALTH REP, V131, P65, DOI 10.1177/00333549161310S211; Fox MP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002268; Goel A, 2017, J VIRAL HEPATITIS, V24, P477, DOI 10.1111/jvh.12669; Jonas MC, 2016, CLIN INFECT DIS, V62, P1290, DOI 10.1093/cid/ciw086; Linas BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097317; Machado SM, 2017, REV SAUDE PUBL, V51, DOI [10.1590/s1518-8787.2017051006468, 10.1590/S1518-8787.2017051006468]; MacLean CD, 2018, J VIRAL HEPATITIS, V25, P939, DOI 10.1111/jvh.12885; Maier MM, 2016, AM J PUBLIC HEALTH, V106, P353, DOI 10.2105/AJPH.2015.302927; Norton BL, 2016, CLIN GASTROENTEROL H, V14, P1356, DOI 10.1016/j.cgh.2016.04.017; Pearlman BL, 2011, CLIN INFECT DIS, V52, P889, DOI 10.1093/cid/cir076; Schechter-Perkins EM, 2018, ACAD EMERG MED, V25, P1216, DOI 10.1111/acem.13484; Simmons B, 2015, CLIN INFECT DIS, V61, P730, DOI 10.1093/cid/civ396; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Spradling PR, 2012, CLIN INFECT DIS, V55, P1047, DOI 10.1093/cid/cis616; Swain MG, 2010, GASTROENTEROLOGY, V139, P1593, DOI 10.1053/j.gastro.2010.07.009; Zuckerman A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199174	22	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218388	10.1371/journal.pone.0218388	http://dx.doi.org/10.1371/journal.pone.0218388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291275	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800019
J	Gomes, RA; Almeida, C; Correia, C; Guerreiro, A; Simplicio, AL; Abreu, IA; Alves, PG				Gomes, Ricardo A.; Almeida, Conceicao; Correia, Catarina; Guerreiro, Ana; Simplicio, Ana Luisa; Abreu, Isabel A.; Alves, Patricia Gomes			Exploring the analytical power of the QTOF MS platform to assess monoclonal antibodies quality attributes	PLOS ONE			English	Article							THERAPEUTIC ANTIBODIES; MASS-SPECTROMETRY; GLYCOSYLATION; DISULFIDE; DIGESTION; GLYCANS	The biopharmaceutical industry is growing at a fast pace, making nowadays 20% of the pharma market. Within this market, therapeutic monoclonal antibodies (mAbs) are the dominant product class. With the patent expirations, biosimilars and, perhaps more relevant, biobetters, are in fast development. Thus, a comprehensive characterization at the molecular level of antibodies heterogeneity such as glycoforms, post-translational modifications (PTMs) and sequence variations is of utmost importance. Mass spectrometry (MS)-based approaches are undoubtedly the most powerful analytical strategies to monitor and define an array of critical quality attributes on mAbs. In this work, we demonstrate the analytical power of the Q-TOF MS platform for comprehensive and detailed analysis at molecular levels of an in-house produced mAb. This methodology involves minimal sample preparation procedures and provides an extensive collection of valuable data in a short period of time.	[Gomes, Ricardo A.; Almeida, Conceicao; Correia, Catarina; Guerreiro, Ana; Simplicio, Ana Luisa; Abreu, Isabel A.; Alves, Patricia Gomes] ITQB IBET, UniMS Mass Spectrometry Unit, Oeiras, Portugal		Alves, PG (corresponding author), ITQB IBET, UniMS Mass Spectrometry Unit, Oeiras, Portugal.	palves@ibet.pt	Abreu, Isabel A/I-5081-2013; Gomes-Alves, Patrícia/AAH-5643-2021; Gomes-Alves, Patrícia I/F-7875-2011; Gomes, Ricardo/E-8379-2012	Abreu, Isabel A/0000-0002-5566-2146; Gomes-Alves, Patrícia/0000-0001-7245-6785; Gomes-Alves, Patrícia I/0000-0001-7245-6785; Leite Guerreiro, Ana Catarina/0000-0001-7733-6336; Gomes, Ricardo/0000-0001-7155-0059				Alter G, 2018, SEMIN IMMUNOL, V39, P102, DOI 10.1016/j.smim.2018.05.003; Bapiro TE, 2016, ANAL CHEM, V88, P6190, DOI 10.1021/acs.analchem.6b01167; Beck A, 2013, ANAL CHEM, V85, P715, DOI 10.1021/ac3032355; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chang TW, 2007, ADV IMMUNOL, V93, P63, DOI 10.1016/S0065-2776(06)93002-8; Chelius D, 2008, J PHARMACEUT BIOMED, V47, P285, DOI 10.1016/j.jpba.2008.01.018; Diepold K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030295; Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042; Hua S, 2011, ANALYST, V136, P3663, DOI 10.1039/c1an15093f; Huhn C, 2009, PROTEOMICS, V9, P882, DOI 10.1002/pmic.200800715; Liu HC, 2012, MABS-AUSTIN, V4, P17, DOI 10.4161/mabs.4.1.18347; Lyubarskaya Y, 2015, PHARM BIOPROCESS, V3, P313, DOI 10.4155/PBP.15.10; Melmer M, 2010, ANAL BIOANAL CHEM, V398, P905, DOI 10.1007/s00216-010-3988-x; Moritz B, 2017, ELECTROPHORESIS, V38, P769, DOI 10.1002/elps.201600425; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Reid CQ, 2010, BIOTECHNOL BIOENG, V107, P85, DOI 10.1002/bit.22790; Reusch D, 2015, GLYCOBIOLOGY, V25, P1325, DOI 10.1093/glycob/cwv065; Rogers RS, 2015, MABS-AUSTIN, V7, P881, DOI 10.1080/19420862.2015.1069454; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Sjogren J, 2016, ANALYST, V141, P3114, DOI 10.1039/c6an00071a; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang X, 2018, PROTEIN CELL, V9, P74, DOI 10.1007/s13238-017-0447-x; Wei BC, 2017, MABS-AUSTIN, V9, P586, DOI 10.1080/19420862.2017.1300214; Weiner GJ, 2015, NAT REV CANCER, V15, P361, DOI 10.1038/nrc3930; Zhang L, 2016, MABS-AUSTIN, V8, P205, DOI 10.1080/19420862.2015.1117719; Zheng SY, 2017, AAPS PHARMSCITECH, V18, P42, DOI 10.1208/s12249-015-0403-0	27	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219156	10.1371/journal.pone.0219156	http://dx.doi.org/10.1371/journal.pone.0219156			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291294	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800052
J	Narayan, R; Olsson, N; Wagar, LE; Medeiros, BC; Meyer, E; Czerwinski, D; Khodadoust, MS; Zhang, L; Schultz, L; Davis, MM; Elias, JE; Levy, R				Narayan, Rupa; Olsson, Niclas; Wagar, Lisa E.; Medeiros, Bruno C.; Meyer, Everett; Czerwinski, Debra; Khodadoust, Michael S.; Zhang, Lichao; Schultz, Liora; Davis, Mark M.; Elias, Joshua E.; Levy, Ron			Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin	PLOS ONE			English	Article							NPM1 MUTATIONS; PEPTIDES; CANCER; GENE; IDENTIFICATION; EXPRESSION; LANDSCAPE; RELEVANCE; ANTIGENS; AFFINITIES	Somatic mutations in cancer are a potential source of cancer specific neoantigens. Acute myeloid leukemia (AML) has common recurrent mutations shared between patients in addition to private mutations specific to individuals. We hypothesized that neoantigens derived from recurrent shared mutations would be attractive targets for future immunotherapeutic approaches. Here we sought to study the HLA Class I and II immunopeptidome of thirteen primary AML tumor samples and two AML cell lines (OCI-AML3 and MV4-11) using mass spectrometry to evaluate for endogenous mutation-bearing HLA ligands from common shared AML mutations. We identified two endogenous, mutation-bearing HLA Class I ligands from nucleophosmin (NPM1). The ligands, AVEEVSLRK from two patient samples and C(cys) LAVEEVSL from OCI-AML3, are predicted to bind the common HLA haplotypes, HLA-A*03:01 and HLA-A*02:01 respectively. Since NPM1 is mutated in approximately one-third of patients with AML, the finding of endogenous HLA ligands from mutated NPM1 supports future studies evaluating immunotherapeutic approaches against this shared target, for this subset of patients with AML.	[Narayan, Rupa; Medeiros, Bruno C.] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Olsson, Niclas; Zhang, Lichao; Elias, Joshua E.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Wagar, Lisa E.; Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Meyer, Everett] Stanford Univ, Dept Med, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Czerwinski, Debra; Khodadoust, Michael S.; Levy, Ron] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Schultz, Liora] Stanford Univ, Dept Pediat, Div Hematol Oncol, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Narayan, Rupa] Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02114 USA; [Medeiros, Bruno C.] Genentech Inc, San Francisco, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Harvard University; Massachusetts General Hospital; Roche Holding; Genentech	Narayan, R (corresponding author), Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA.; Narayan, R (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02114 USA.	Rnarayan3@mgh.harvard.edu		Khodadoust, Michael/0000-0001-9061-7351; Davis, Mark/0000-0001-6868-657X; Medeiros, Bruno/0000-0001-6972-8137; Wagar, Lisa/0000-0001-5980-3586; Schultz, Liora/0000-0001-9512-7597; Olsson, Niclas/0000-0002-9746-0542	Stanford Cancer Center Fellowship; Knut and Alice Wallenberg Foundation Postdoctoral Fellowship; National Institutes of Health, National Center for Advancing Translational Science, Clinical and Translational Science Award [TL1TR001084, UL1TR001085]; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER	Stanford Cancer Center Fellowship; Knut and Alice Wallenberg Foundation Postdoctoral Fellowship; National Institutes of Health, National Center for Advancing Translational Science, Clinical and Translational Science Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Stanford Cancer Center Fellowship (R.N.); the Knut and Alice Wallenberg Foundation Postdoctoral Fellowship (N.O.); and also supported by a National Institutes of Health, National Center for Advancing Translational Science, Clinical and Translational Science Award (TL1TR001084 and UL1TR001085). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulou E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3039; Anguille S, 2012, LEUKEMIA, V26, P2186, DOI 10.1038/leu.2012.145; Bassani-Sternberg M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13404; Becker H, 2010, J CLIN ONCOL, V28, P596, DOI 10.1200/JCO.2009.25.1496; Berlin C, 2015, LEUKEMIA, V29, P647, DOI 10.1038/leu.2014.233; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Estey EH, 2013, AM J HEMATOL, V88, P317, DOI 10.1002/ajh.23404; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Gale RE, 2008, BLOOD, V111, P2776, DOI 10.1182/blood-2007-08-109090; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Greiner J, 2017, HAEMATOLOGICA, V102, P499, DOI 10.3324/haematol.2017.176461; Greiner J, 2012, BLOOD, V120, P1282, DOI 10.1182/blood-2011-11-394395; Haferlach C, 2013, BLOOD, V122, p51LP; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; INOUE K, 1994, BLOOD, V84, P3071, DOI 10.1182/blood.V84.9.3071.3071; Kalaora S, 2016, ONCOTARGET, V7, P5110, DOI 10.18632/oncotarget.6960; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Khalili JS, 2012, ONCOIMMUNOLOGY, V1, P1281, DOI 10.4161/onci.21511; Khodadoust MS, 2017, NATURE, V543, P723, DOI 10.1038/nature21433; Kowalewski DJ, 2015, P NATL ACAD SCI USA, V112, pE166, DOI 10.1073/pnas.1416389112; Kuzelova K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127637; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Liso A, 2008, LEUKEMIA, V22, P424, DOI 10.1038/sj.leu.2404887; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; MIWA H, 1992, LEUKEMIA, V6, P405; Muller M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01367; Ochsenreither S, 2012, BLOOD, V119, P5492, DOI 10.1182/blood-2011-07-365890; Olsson N, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700410; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pratcorona M, 2013, BLOOD, V121, P2734, DOI 10.1182/blood-2012-06-431122; Quentmeier H, 2005, LEUKEMIA, V19, P1760, DOI 10.1038/sj.leu.2403899; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; Rajasagi M, 2014, BLOOD, V124, P453, DOI 10.1182/blood-2014-04-567933; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Snauwaert S, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22943; Suzuki T, 2005, BLOOD, V106, P2854, DOI 10.1182/blood-2005-04-1733; Swoboda RK, 2010, INT J CANCER, V127, P1124, DOI 10.1002/ijc.25133; van der Lee DI, 2019, J CLIN INVEST, V129, P774, DOI 10.1172/JCI97482; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; WESIERSKAGADEK J, 1992, BLOOD, V79, P1081; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]	47	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219547	10.1371/journal.pone.0219547	http://dx.doi.org/10.1371/journal.pone.0219547			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291378	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800111
J	Baker, E; Sims, R; Leonenko, G; Frizzati, A; Harwood, JC; Grozeva, D; Morgan, K; Passmore, P; Holmes, C; Powell, J; Brayne, C; Gill, M; Mead, S; Bossu, P; Spalletta, G; Goate, AM; Maier, W; Heun, R; Jessen, F; Peters, O; Dichgans, M; FroLich, L; Ramirez, A; Jones, L; Hardy, J; Ivanov, D; Hill, M; Holmans, P; Allen, ND; Morgan, BP; Seshadri, S; Schellenberg, GD; Amouyel, P; Williams, J; Escott-Price, V				Baker, Emily; Sims, Rebecca; Leonenko, Ganna; Frizzati, Aura; Harwood, Janet C.; Grozeva, Detelina; Morgan, Kevin; Passmore, Peter; Holmes, Clive; Powell, John; Brayne, Carol; Gill, Michael; Mead, Simon; Bossu, Paola; Spalletta, Gianfranco; Cruchaga, Carlos; Maier, Wolfgang; Heun, Reinhard; Jessen, Frank; Peters, Oliver; Dichgans, Martin; FroeLich, Lutz; Ramirez, Alfredo; Jones, Lesley; Hardy, John; Ivanov, Dobril; Hill, Matthew; Holmans, Peter; Allen, Nicholas D.; Morgan, B. Paul; Seshadri, Sudha; Schellenberg, Gerard D.; Amouyel, Philippe; Williams, Julie; Escott-Price, Valentina		GERAD PERADES Consortia; CHARGE Consortia; ADGC Consortia; EADI Consortia; IGAP Consortia	Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease	PLOS ONE			English	Article							COMMON VARIANTS; PGC-1-ALPHA; DIFFERENTIATION; ZNF423; ALPHA; ANNOTATION; GENERATION; IMMUNITY; BRAIN; CD2AP	Late onset Alzheimer's disease is the most common form of dementia for which about 30 susceptibility loci have been reported. The aim of the current study is to identify novel genes associated with Alzheimer's disease using the largest up-to-date reference single nucleotide polymorphism (SNP) panel, the most accurate imputation software and a novel gene-based analysis approach which tests for patterns of association within genes, in the powerful genome-wide association dataset of the International Genomics of Alzheimer's Project Consortium, comprising over 7 million genotypes from 17,008 Alzheimer's cases and 37,154 controls. In addition to earlier reported genes, we detected three novel gene-wide significant loci PPARGC1A (p = 2.2 x 10(-6)), RORA (p = 7.4 x 10(-7)) and ZNF423 (p = 2.1 x 10(-6)). PPARGC1A and RORA are involved in circadian rhythm; circadian disturbances are one of the earliest symptoms of Alzheimer's disease. PPARGC1A is additionally linked to energy metabolism and the generation of amyloid beta plaques. RORA is involved in a variety of functions apart from circadian rhythm, such as cholesterol metabolism and inflammation. The ZNF423 gene resides in an Alzheimer's disease-specific protein network and is likely involved with centrosomes and DNA damage repair.	[Baker, Emily; Sims, Rebecca; Leonenko, Ganna; Frizzati, Aura; Harwood, Janet C.; Grozeva, Detelina; Jones, Lesley; Holmans, Peter; Williams, Julie; Escott-Price, Valentina] Cardiff Univ, Div Psychol Med & Clin Neurosci, Ctr Neuropsychiat Genet & Genom, Med Res Council, Cardiff, S Glam, Wales; [Baker, Emily; Ivanov, Dobril; Hill, Matthew; Allen, Nicholas D.; Morgan, B. Paul; Williams, Julie; Escott-Price, Valentina] Cardiff Univ, UK Dementia Res Inst, Cardiff, S Glam, Wales; [Morgan, Kevin] Univ Nottingham, Sch Life Sci, Human Genet, Life Sci Bldg A27,Univ Pk, Nottingham NG7 2RD, England; [Passmore, Peter] Queens Univ, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Holmes, Clive] Univ Southampton, Sch Med, Div Clin Neurosci, Southampton, Hants, England; [Powell, John] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London, England; [Powell, John] QIMR Berghofer Med Res Inst, Genet Epidemiol, Herston, Qld, Australia; [Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Gill, Michael] St James Hosp, Mercers Inst Res Ageing, Dublin, Ireland; [Gill, Michael] James Hosp, Dublin, Ireland; [Gill, Michael] Trinity Coll Dublin, Dublin, Ireland; [Mead, Simon] UCL, Inst Prion Dis, MRC Prion Unit, London, England; [Bossu, Paola] IRCCS Santa Lucia Fdn, Dept Clin & Behav Neurol, Expt Neuropsychobiol Lab, Rome, Italy; [Spalletta, Gianfranco] IRCCS Santa Lucia Fdn, Lab Neuropsychiat, Rome, Italy; [Cruchaga, Carlos] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Cruchaga, Carlos; Maier, Wolfgang] Washington Univ, Sch Med, Hope Ctr Program Prot Aggregat & Neurodegenerat, St Louis, MO USA; [Maier, Wolfgang] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Heun, Reinhard; Jessen, Frank] German Ctr Neurodegenerat Dis DZNE, D-53127 Bonn, Germany; [Jessen, Frank] Univ Bonn, Dept Psychiat & Psychotherapy, D-53127 Bonn, Germany; [Ramirez, Alfredo] Univ Cologne, Dept Psychiat & Psychotherapy, D-50937 Cologne, Germany; [Peters, Oliver] Charite, Dept Psychiat & Psychotherapy, Berlin, Germany; [Peters, Oliver] German Ctr Neurodegenerat Dis DZNE, Berlin, Germany; [Dichgans, Martin] Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Dichgans, Martin] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Dichgans, Martin] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [FroeLich, Lutz] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Heidelberg, Germany; [Ramirez, Alfredo] Univ Hosp Bonn, Dept Neurodegenerat Dis & Geriatr Psychiat, Bonn, Germany; [Hardy, John] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Schellenberg, Gerard D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Amouyel, Philippe] Univ Lille, CHU Lille, Univ Hosp,INSERM,Inst Pasteur Lille, LabEx DISTALZ,UMR1167,RID,AGE Risk Factors & Mol, F-59000 Lille, France	Cardiff University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Cardiff University; University of Nottingham; Queens University Belfast; University of Southampton; University of London; King's College London; QIMR Berghofer Medical Research Institute; University of Cambridge; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; University of London; University College London; IRCCS Santa Lucia; IRCCS Santa Lucia; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); Washington University (WUSTL); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Bonn; University of London; University College London; Boston University; University of Pennsylvania; Pennsylvania Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille	Williams, J; Escott-Price, V (corresponding author), Cardiff Univ, Div Psychol Med & Clin Neurosci, Ctr Neuropsychiat Genet & Genom, Med Res Council, Cardiff, S Glam, Wales.; Williams, J; Escott-Price, V (corresponding author), Cardiff Univ, UK Dementia Res Inst, Cardiff, S Glam, Wales.	WilliamsJ@cardiff.ac.uk; EscottPriceV@cardiff.ac.uk	Brayne, Carol/AAA-4285-2020; Dichgans, Martin/HCH-3247-2022; Frölich, Lutz/AAA-6940-2019; Jessen, Frank/AAK-6170-2020; Cruchaga, Carlos/ABF-4065-2020; Hardy, John/C-2451-2009; Bossù, Paola/E-4832-2014; , beccie/AAM-3770-2021; Hill, Matthew/E-7730-2010	Brayne, Carol/0000-0001-5307-663X; Dichgans, Martin/0000-0002-0654-387X; Frölich, Lutz/0000-0003-1494-0813; Cruchaga, Carlos/0000-0002-0276-2899; Hardy, John/0000-0002-3122-0423; Bossù, Paola/0000-0002-1432-0078; , beccie/0000-0002-3885-1199; Mead, Simon/0000-0002-4326-1468; Grozeva, Detelina/0000-0003-3239-8415; Seshadri, Sudha/0000-0001-6135-2622; Williams, Julie/0000-0002-4069-0259; Ivanov, Dobril/0000-0001-6271-6301; Ramirez, Alfredo/0000-0003-4991-763X; Peters, Oliver/0000-0003-0568-2998; Allen, Nicholas/0000-0003-4009-186X; Hill, Matthew/0000-0001-6776-8709	MRC Centre for Neuropsychiatric Genetics and Genomics; MRC; UK Dementia Research Institute; UKDRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, U01AG052409] Funding Source: NIH RePORTER; MRC [MR/M009076/1, G0701075, MC_PC_17112, MR/L023784/1, G0901254, G0300429, G0600237, UKDRI-3003, UKDRI-3002, G0900652, G0400074, MC_UU_00024/1, MC_UP_1604/1, G0902227, MC_U123160651, UKDRI-1009, MR/K01417X/1, MR/K013041/1, G0502157, MR/J004758/1, MR/L023784/2, MC_UU_00024/8, G1001253, G1100540] Funding Source: UKRI	MRC Centre for Neuropsychiatric Genetics and Genomics(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Dementia Research Institute; UKDRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the MRC Centre for Neuropsychiatric Genetics and Genomics for supporting this project and the MRC for supporting author EB. This project was also supported by the UK Dementia Research Institute. We would like to acknowledge the grants supporting the following authors: UKDRI (UKDRIdata023) EB, DI, MH, NDA, BPM, JW, VEP; MRC Centre for Neuropsychiatric Genetics and Genomics (MR/L010305/1) EB, RS, GL, JH, DG, LJ, PH, VEP; Dementia Platforms UK-DPUK (MR/L023784/2) JH, GL, VEP, JW, DG.; We thank the MRC Centre for Neuropsychiatric Genetics and Genomics for supporting this project and the MRC for supporting author Emily Baker. This project was also supported by the UK Dementia Research Institute.	Acquaah-Mensah GK, 2015, J ALZHEIMERS DIS, V44, P827, DOI 10.3233/JAD-141731; Alcaraz WA, 2006, P NATL ACAD SCI USA, V103, P19424, DOI 10.1073/pnas.0609184103; Ashabi G, 2012, BEHAV BRAIN RES, V232, P165, DOI 10.1016/j.bbr.2012.04.006; Baker E, 2018, GENET EPIDEMIOL, V42, P366, DOI 10.1002/gepi.22117; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bond HM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00255; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Chauvet C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022545; Cook Donald N, 2015, Nucl Receptor Res, V2; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Escott-Price V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094661; Feng XB, 2014, ARTHRITIS RHEUMATOL, V66, P3413, DOI 10.1002/art.38879; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Gulec C, 2017, EXP CELL RES, V353, P6, DOI 10.1016/j.yexcr.2017.02.028; Harder L, 2013, J EXP MED, V210, P2289, DOI 10.1084/jem.20130497; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hood S, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00170; Hu YS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0252-z; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Jesse S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09148-7; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Jones L, 2015, ALZHEIMERS DEMENT, V11, P658, DOI 10.1016/j.jalz.2014.05.1757; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Journiac N, 2009, P NATL ACAD SCI USA, V106, P21365, DOI 10.1073/pnas.0911782106; Katsouri L, 2016, P NATL ACAD SCI USA, V113, P12292, DOI 10.1073/pnas.1606171113; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kim K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00215-1; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Luo C, 2016, TRENDS CANCER, V2, P619, DOI 10.1016/j.trecan.2016.09.006; Martinez-Redondo V, 2015, DIABETOLOGIA, V58, P1969, DOI 10.1007/s00125-015-3671-z; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Miller MW, 2013, J AFFECT DISORDERS, V151, P702, DOI 10.1016/j.jad.2013.07.022; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nijland PG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0170-2; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; Qin WP, 2009, ARCH NEUROL-CHICAGO, V66, P352, DOI 10.1001/archneurol.2008.588; Sato T, 2011, NEUROBIOL AGING, V32, P1626, DOI 10.1016/j.neurobiolaging.2009.10.009; Sayad A, 2017, METAB BRAIN DIS, V32, P1595, DOI 10.1007/s11011-017-0049-6; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Signaroldi E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10753; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Soyal SM, 2012, HUM MOL GENET, V21, P3461, DOI 10.1093/hmg/dds177; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Tsunemi T, 2012, PROG NEUROBIOL, V97, P142, DOI 10.1016/j.pneurobio.2011.10.004; Vogel MW, 2000, J NEUROBIOL, V42, P323, DOI 10.1002/(SICI)1097-4695(20000215)42:3<323::AID-NEU4>3.0.CO;2-2	57	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0218111	10.1371/journal.pone.0218111	http://dx.doi.org/10.1371/journal.pone.0218111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283791	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000484939800007
J	Vignaux, PA; Bregio, C; Hathaway, NA				Vignaux, Patricia A.; Bregio, Celyn; Hathaway, Nathaniel A.			Contribution of promoter DNA sequence to heterochromatin formation velocity and memory of gene repression in mouse embryo fibroblasts	PLOS ONE			English	Article							HISTONE H3; LYSINE 9; METHYLATION PATTERNS; CPG ISLAND; CANCER; METHYLTRANSFERASE; ORGANIZATION; BINDING; MAINTENANCE; EXPRESSION	Durable gene silencing through the formation of compact heterochromatin domains plays a critical role during mammalian development in establishing defined tissues capable of retaining cellular identity. Hallmarks of heterochromatin gene repression are the binding of heterochromatin protein 1 (HP1), trimethylation of lysine 9 on histone H3 (H3K9me3) and the methylation of cytosine residues of DNA. HP1 binds directly to the H3K9me3 histone modification, and while DNA methyltransferases have been found in complex with histone methyltransferases and HP1, there remains much to be known about the relationship between DNA sequence and HP1 in differentiated mammalian cells. To further explore this interplay in a controlled system, we designed a system to test the effect of promoter CpG content on the formation kinetics and memory of an HP1-mediated heterochromatin domain in mouse embryo fibroblasts (MEF)s. To do this, we have constructed a side-by-side comparison of wild-type (CpGFull) and CpG-depleted (CpGDep) promoter-driven reporter constructs in the context of the Chromatin in vivo Assay (CiA), which uses chemically-induced proximity (CIP) to tether the chromoshadow domain of HP1 alpha (csHP1 alpha) to a fluorescent reporter gene in a reversible, chemically-dependent manner. By comparing the response of CpGFull and CpGDep reporter constructs, we discovered that the heterochromatin formation by recruitment of csHP1 alpha is unaffected by the underlying CpG dinucleotide content of the promoter, as measured by the velocity of gene silencing or enrichment of H3K9me3 at the silenced gene. However, recovery from long-term silencing is measurably faster in the CpG-depleted reporter lines. These data provide evidence that the stability of the HP1 heterochromatin domain is reliant on the underlying DNA sequence. Moreover, these cell lines represent a new modular system with which to study the effect of the underlying DNA sequences on the efficacy of epigenetic modifiers.	[Vignaux, Patricia A.; Bregio, Celyn; Hathaway, Nathaniel A.] UNC Eshelman Sch Pharm, Ctr Integrat Chem Biol & Drug Discovery, Div Chem Biol & Med Chem, Chapel Hill, NC 27515 USA; [Vignaux, Patricia A.; Hathaway, Nathaniel A.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Hathaway, NA (corresponding author), UNC Eshelman Sch Pharm, Ctr Integrat Chem Biol & Drug Discovery, Div Chem Biol & Med Chem, Chapel Hill, NC 27515 USA.; Hathaway, NA (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA.	hathaway@unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022		U.S. National Institutes of Health [R01GM118653]; Institute for Innovation, University of North Carolina at Chapel Hill [RX03712111]; University Cancer Research Fund; Eshelman Institute for Innovation; Cancer Center Core Support Grant; UNC Lineberger Comprehensive Cancer Center; North Carolina Biotech Center Institutional Support Grant [2017-IDG-1025, Grant 2012-IDG-1006]; National Institutes of Health [1UM2AI30836-01]; University of North Carolina at Chapel Hill; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118653] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Innovation, University of North Carolina at Chapel Hill; University Cancer Research Fund; Eshelman Institute for Innovation; Cancer Center Core Support Grant; UNC Lineberger Comprehensive Cancer Center; North Carolina Biotech Center Institutional Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina at Chapel Hill; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NAH R01GM118653 from the U.S. National Institutes of Health, https://www.nigms.nih.gov/Eshelman Institute for Innovation, University of North Carolina at Chapel Hill RX03712111 to Dr. Hathaway The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Hathaway laboratory members for many helpful discussions. We also would like to thank S. Pattenden, J. Norris-Drouin, and all members of the Center for Integrative Chemical Biology and Drug Discovery for advice and technical support. We thank S. Clinkscales for critical reading of this manuscript. We acknowledge M. Rheli for sharing plasmids used or adapted in this study. We also acknowledge E. Trudeau of the UNC Flow Cytometry Core Facility for performing cell sorting on the cell lines used in this study. We thank S. Ahmed and E H. Lister-Shimauchi for sharing their Southern Blot protocol, equipment, and hands-on advice used to produce knock-in analysis. This work was supported in part by Grant R01GM118653 from the U.S. National Institutes of Health, the University Cancer Research Fund, University of North Carolina at Chapel Hill, and the Eshelman Institute for Innovation. Flow cytometry data was obtained at the UNC Flow Cytometry Core Facility funded by P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center. Research reported in this publication was supported in part by the North Carolina Biotech Center Institutional Support Grant 2012-IDG-1006, by the North Carolina Biotech Center Institutional Support Grant 2017-IDG-1025, and by the National Institutes of Health 1UM2AI30836-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Ayrapetov MK, 2014, P NATL ACAD SCI USA, V111, P9169, DOI 10.1073/pnas.1403565111; Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Butler KV, 2018, ACS SYNTH BIOL, V7, P38, DOI 10.1021/acssynbio.7b00295; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; Chen JY, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.71; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chiarella AM, 2018, JOVE-J VIS EXP, DOI 10.3791/58222; Chiarella AM, 2018, BIOCHEMISTRY-US, V57, P2756, DOI 10.1021/acs.biochem.8b00075; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Edwards JR, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0130-8; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Fujita N, 2003, J BIOL CHEM, V278, P24132, DOI 10.1074/jbc.M302283200; Gessaman JD, 2017, P NATL ACAD SCI USA, V114, pE9598, DOI 10.1073/pnas.1715049114; Gilbert N, 2007, J CELL BIOL, V177, P401, DOI 10.1083/jcb.200607133; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hedrich CM, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0685-1; Hervouet E, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0450-y; Ho SCL, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0300-y; Hyde SC, 2008, NAT BIOTECHNOL, V26, P549, DOI 10.1038/nbt1399; Hyun K, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.11; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Kirschmann DA, 2000, CANCER RES, V60, P3359; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kungulovski G, 2016, TRENDS GENET, V32, P101, DOI 10.1016/j.tig.2015.12.001; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Laufer BI, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0023-7; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee YH, 2015, J NAT SCI, V1, P1; Lee YH, 2013, NUCLEIC ACIDS RES, V41, P5784, DOI 10.1093/nar/gkt231; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lei Y, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1566-2; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Nishibuchi G, 2017, CHROMOSOME RES, V25, P77, DOI 10.1007/s10577-016-9547-3; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Rose NR, 2014, BBA-GENE REGUL MECH, V1839, P1362, DOI 10.1016/j.bbagrm.2014.02.007; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Slee RB, 2012, ONCOGENE, V31, P3244, DOI 10.1038/onc.2011.502; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stanton BZ, 2017, NAT GENET, V49, P282, DOI 10.1038/ng.3735; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Xia LM, 2017, CANCER CELL, V31, P653, DOI 10.1016/j.ccell.2017.04.005; Yamamoto K, 2003, BIOCHEM BIOPH RES CO, V301, P287, DOI 10.1016/S0006-291X(02)03021-8; Yokoyama Y, 2013, CANCER SCI, V104, P889, DOI 10.1111/cas.12166; Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356	57	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0217699	10.1371/journal.pone.0217699	http://dx.doi.org/10.1371/journal.pone.0217699			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269077	Green Submitted, Green Published, gold			2022-12-26	WOS:000484927300006
J	Abdulmalik, MA; Ayoub, JJ; Mahmoud, A; Hwalla, N; Ghazeeri, G; Nassar, A; Yunis, K; Itani, S; Al Thani, A; Bashwar, Z; Bawadi, H; Chatila, A; Assi, C; Batakji, S; Mogharbel, Z; Elfasakhany, S; Mahdi, Z; Nasreddine, L; Naja, F				Abdulmalik, Mariam Ali; Ayoub, Jennifer J.; Mahmoud, Amira; Hwalla, Nahla; Ghazeeri, Ghina; Nassar, Anwar; Yunis, Khalid; Itani, Saadeddine; Al Thani, Al Anoud; Bashwar, Zelaikha; Bawadi, Hiba; Chatila, Aya; Assi, Chirine; Batakji, Sarah; Mogharbel, Zeina; Elfasakhany, Sara; Mahdi, Zeinab; Nasreddine, Lara; Naja, Farah		MINA Collaborators	Pre-pregnancy BMI, gestational weight gain and birth outcomes in Lebanon and Qatar: Results of the MINA cohort	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; NUTRITION TRANSITION; MATERNAL OBESITY; PRETERM BIRTH; PREGNANCY; ASSOCIATION; OVERWEIGHT; PATTERNS; AGE	Accumulating evidence has highlighted the role of maternal nutritional status on fetal development, birth outcomes and child health. The Mother and Infant Nutritional Assessment (MINA) cohort is a 3-year follow-up study of pregnant women and their children in Qatar and Lebanon. This study reports on the characteristics and determinants of pre-pregnancy BMI and Gestational Weight Gain (GWG) of MINA particiants, as well as birth outcomes. A total of 272 pregnant women were recruited during their first trimester from primary healthcare centers as well as private clinics in Beirut (n = 194) and Doha (n = 147). During the first visit, data collection included pre-pregnancy weight, sociodemographic and lifestyle characteristics. The weight before delivery and neonatal outcomes were extracted from the medical records. GWG was calculated as the difference between weight before delivery and pre-pregnancy weight and was classified into insufficient, adequate, and excessive, as per the IOM criteria. Overall, 42.1% of women had a pre-pregnancy BMI >= 25 Kg/m(2) (58% in Qatar vs 30.8% in Lebanon, p< 0.001). Only 30.2% of women had adequate GWG, while 25.7% and 44.1% of women had insufficient and excessive GWG, respectively. In the cohort 68.7% of infants had a weight adequate-for-gestational age (AGA), 6.7% were SGA and 24.6% were LGA. The proportions of LGA were higher with greater GWG (p< 0.05). After adjustment, Qatari women were 3 times more likely to be overweight or obese before pregnancy while a higher education level was associated with significantly lower odds of pre-pregnancy BMI >= 25 Kg/m(2). Pre-pregnancy BMI >= 25 Kg/m(2) and regular breakfast consumption were predictors of excessive GWG (OR: 3.20, CI: 1.48-6.91; OR: 2.84, CI: 1.15-7.02, respectively). The high prevalence of pre-pregnancy overweight and excessive GWG among MINA participants underscores the need for culture-specific intervention programs to promote healthy body weight in women of childbearing age, and prevent excessive weight gain during pregnancy.	[Abdulmalik, Mariam Ali] Primary Hlth Care Corp, Doha, Qatar; [Ayoub, Jennifer J.; Nasreddine, Lara; Naja, Farah] Amer Univ Beirut, Fac Agr & Food Sci, Nutr & Food Sci Dept, Beirut, Lebanon; [Mahmoud, Amira] Minist Publ Hlth, Publ Hlth Dept, Doha, Qatar	Hamad Medical Corporation; Primary Health Care Corporation (PHCC); American University of Beirut	Nasreddine, L; Naja, F (corresponding author), Amer Univ Beirut, Fac Agr & Food Sci, Nutr & Food Sci Dept, Beirut, Lebanon.	ln10@aub.edu.lb; fn14@aub.edu.lb		Nasreddine, Lara/0000-0003-3707-8218; Naja, Farah/0000-0002-8861-3498	Qatar National Research Fund (QNRF) under the National Priorities Research Program [NPRP 6-247-3-061]	Qatar National Research Fund (QNRF) under the National Priorities Research Program	F.N. obtained the funding for the study. This research was supported by the Qatar National Research Fund (QNRF) under the National Priorities Research Program (NPRP 6-247-3-061). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Thani M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060698; Al Thani M, 2015, NUTRIENTS, V7, P7593, DOI 10.3390/nu7095355; Al-Thani MH, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009514; Alberico S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-23; ALNohair S, 2014, INT J HEALTH SCI-IJH, V8, P79, DOI 10.12816/0006074; AlSeaidan M, 2016, PAEDIATR PERINAT EP, V30, P408, DOI 10.1111/ppe.12296; Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Athukorala C, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-56; Ayoub JJ, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0616-5; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Bianchi C, 2018, DIABETES RES CLIN PR, V144, P286, DOI 10.1016/j.diabres.2018.08.019; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bocca-Tjeertes IF, 2014, PEDIATRICS, V133, pE643, DOI 10.1542/peds.2013-0985; Bodnar LM, 2016, OBESITY, V24, P490, DOI 10.1002/oby.21335; Bogaerts A, 2012, CLIN OBES, V2, P150, DOI 10.1111/cob.12004; Boudet-Berquier J, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1456-8; Calik KY, 2018, SAUDI J BIOL SCI, V25, P1085, DOI 10.1016/j.sjbs.2018.02.014; Campbell EE, 2016, J MATERN-FETAL NEO M, V29, P3527, DOI 10.3109/14767058.2015.1137894; Chamieh MC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1605-9; Chasan-Taber L, 2004, MED SCI SPORT EXER, V36, P1750, DOI 10.1249/01.MSS.0000142303.49306.0D; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Chiavaroli V, 2016, J PEDIATR-US, V170, P307, DOI 10.1016/j.jpeds.2015.11.043; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Department of Statistics, 2013, JORD POP FAM HLTH SU; El Rafei R, 2016, PAEDIATR PERINAT EP, V30, P38, DOI 10.1111/ppe.12249; Costa BMF, 2012, SAO PAULO MED J, V130, P242, DOI 10.1590/S1516-31802012000400007; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Gaillard R, 2015, INT J OBESITY, V39, P677, DOI 10.1038/ijo.2014.175; Gauster M, 2007, J CLIN ENDOCR METAB, V92, P2256, DOI 10.1210/jc.2006-2403; Gil-Sanchez Alfonso, 2011, Frontiers in Genetics, V2, P57, DOI 10.3389/fgene.2011.00057; Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635; Haj Bakri A, 2013, QATAR STEPWISE REPOR; Henriksen T, 2008, ACTA OBSTET GYN SCAN, V87, P134, DOI 10.1080/00016340801899289; Hill B, 2017, OBES REV, V18, P755, DOI 10.1111/obr.12538; Hill B, 2016, WOMEN HEALTH ISS, V26, P123, DOI 10.1016/j.whi.2015.09.012; Hillemeier MM, 2011, J WOMENS HEALTH, V20, P703, DOI 10.1089/jwh.2010.2397; Hong SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194454; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Jiang H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-12; Koyanagi A, 2013, LANCET, V381, P476, DOI 10.1016/S0140-6736(12)61605-5; Lau EY, 2014, J OBES, V2014, DOI 10.1155/2014/524939; Leddy Meaghan A, 2008, Rev Obstet Gynecol, V1, P170; Lee Joung Min, 2014, Obstet Gynecol Sci, V57, P442, DOI 10.5468/ogs.2014.57.6.442; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Liu XM, 2011, ARCH GYNECOL OBSTET, V283, P65, DOI 10.1007/s00404-009-1288-5; Luu TM, 2016, CAN MED ASSOC J, V188, P736, DOI 10.1503/cmaj.150450; Lynch CM, 2008, AM J PERINAT, V25, P163, DOI 10.1055/s-2008-1061496; Maziak W, 2014, HEALTH POLICY PLANN, V29, P784, DOI 10.1093/heapol/czt055; Miao M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00441-z; Ministry of Health, 2003, NONC DIS THEIR RISK; Ministry of Public Health State of Qatar, 2017, CLIN GUID STAT QAT D; Naja F, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0864-5; Naja F, 2011, PUBLIC HEALTH NUTR, V14, P1570, DOI 10.1017/S136898001100070X; Nasreddine L, 2018, E MEDITERR HEALTH J, V24, P77, DOI 10.26719/2018.24.1.77; Nasreddine L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-798; Ng SW, 2011, EUR J CLIN NUTR, V65, P1328, DOI 10.1038/ejcn.2011.135; Ng SW, 2011, OBES REV, V12, P1, DOI 10.1111/j.1467-789X.2010.00750.x; Non-communicable Diseases Risk Factors Survey, 2022, NONCOMMUNICABLE DIS; Norman JE, 2011, P NUTR SOC, V70, P450, DOI 10.1017/S0029665111003077; Okamoto K, 2002, J CLIN EPIDEMIOL, V55, P505, DOI 10.1016/S0895-4356(01)00515-7; Phelan S, 2011, WOMENS HEALTH, V7, P641, DOI [10.2217/WHE.11.70, 10.2217/whe.11.70]; Poston L, 2012, CURR OPIN CLIN NUTR, V15, P252, DOI 10.1097/MCO.0b013e3283527cf2; Radwan H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198278; Rosato V, 2016, ADV NUTR, V7, P455, DOI 10.3945/an.115.009548; Samura Tirah, 2016, Glob Adv Health Med, V5, P87, DOI 10.7453/gahmj.2015.094; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Shaw GM, 2014, PAEDIATR PERINAT EP, V28, P302, DOI 10.1111/ppe.12125; Sibai AM, 2011, ANN NUTR METAB, V57, P193, DOI 10.1159/000321527; Siega-Riz AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.002; UNICEF, 2014, LOW BIRTHW; Vinturache A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0422-y; Walker R, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070944; WHO, 2016, ASS NAT CAP PREV CON; Wise LA, 2010, EPIDEMIOLOGY, V21, P243, DOI 10.1097/EDE.0b013e3181cb61a9; Woodall A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-103; World Health Organization. WHO, 2019, NUTRITION; Xiao LL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41073; Yekta Zahra, 2006, BMC Pregnancy Childbirth, V6, P15; Young TK, 2002, AM J OBSTET GYNECOL, V187, P312, DOI 10.1067/mob.2002.126200; Zhao R, 2018, WOMEN BIRTH, V31, pE20, DOI 10.1016/j.wombi.2017.06.003	81	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2019	14	7							e0219248	10.1371/journal.pone.0219248	http://dx.doi.org/10.1371/journal.pone.0219248			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3ZV	31265481	Green Published, Green Submitted			2022-12-26	WOS:000484921200026
J	Ke, DS; Ji, LM; Wang, Y; Fu, XM; Chen, JY; Wang, F; Zhao, DB; Xue, Y; Lan, XH; Hou, JM				Ke, Dianshan; Ji, Lianmei; Wang, Yu; Fu, Xiaomin; Chen, Jinyan; Wang, Fan; Zhao, Dongbao; Xue, Ying; Lan, Xuhua; Hou, Jianming			JNK1 regulates RANKL-induced osteoclastogenesis via activation of a novel Bcl-2-Beclin1-autophagy pathway	FASEB JOURNAL			English	Article						metabolic bone diseases; osteoclast precursors; p-JNK1; p-Bcl-2; LC3	INDUCED AUTOPHAGY; BECLIN 1; C-JUN; POSTMENOPAUSAL WOMEN; UP-REGULATION; BONE LOSS; APOPTOSIS; PROTEIN; LIGAND; CELLS	JNK1 plays an important role in osteoclastogenesis in response to the osteoclastogenic cytokine receptor activator for nuclear factor-kappa B ligand (RANKL). JNK1 is widely accepted as an autophagy regulator under stress conditions. However, the role of JNK1-mediated autophagy in osteoclastogenesis remains largely unknown. In the current study, our data showed that JNK1 inhibition by a pharmacological inhibitor or RNA interference significantly reduced the autophagic response induced by RANKL in osteoclast precursors (OCPs) derived from bone marrow-derived macrophages. Overexpression of the key autophagy protein Beclin1 rescued autophagy deficiency and osteoclastogenesis in the presence of a JNK inhibitor (SP600125). In contrast, JNK activator (anisomycin)-induced autophagy was blocked by Beclin1 knockdown in OCPs. In addition, JNK1 inhibition increased apoptosis and blocked autophagy, whereas overexpression of Beclin1 reversed the enhanced apoptosis induced by JNK1 inhibition in OCPs. Furthermore, RANKL could induce the phosphorylation of Bcl-2, subsequently dissociating Beclin1 from the Bcl-2-Beclin1 complex, which could be blocked by JNK1 inhibition. Collectively, this study revealed that JNK1 regulated osteoclastogenesis by activating Bcl-2-Beclin1-autophagy signaling in addition to the classic c-Jun/activator protein 1 pathway, which provided the first evidence for the contribution of JNK1 signaling to OCP autophagy and the autophagic mechanism underlying JNK1-regulated osteoclastogenesis. An important osteoclastogenesis-regulating signaling pathway (JNK1-Bcl-2-Beclin1-autophagy activation) was identified, which provides novel potential targets for the clinical therapy of metabolic bone diseases.-Ke, D., Ji, L., Wang, Y., Fu, X., Chen, J., Wang, F., Zhao, D., Xue, Y., Lan, X., Hou, J. JNK1 regulates RANKL-induced osteoclastogenesis via activation of a novel Bcl-2-Beclin1-autophagy pathway.	[Ke, Dianshan; Xue, Ying; Lan, Xuhua; Hou, Jianming] Fujian Med Univ, Shengli Clin Med Coll, Fuzhou, Fujian, Peoples R China; [Ke, Dianshan] Southern Med Univ, Affiliated Hosp 3, Acad Orthoped Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Ji, Lianmei; Zhao, Dongbao] Naval Med Univ, Changhai Hosp, Dept Rheumatol & Immunol, Shanghai, Peoples R China; [Wang, Yu] Chifeng Hosp, Dept Orthopaed, Chifeng, Peoples R China; [Fu, Xiaomin] Johns Hopkins Univ, Dept Pediat, Div Metab & Endocrinol, Baltimore, MD USA; [Chen, Jinyan; Wang, Fan] Fujian Acad Med Sci, Inst Immunol, Fuzhou, Fujian, Peoples R China; [Xue, Ying; Lan, Xuhua; Hou, Jianming] Fujian Prov Hosp, Dept Endocrinol, Key Lab Endocrinol, 134 Dong Jie Rd, Fuzhou 350001, Fujian, Peoples R China	Fujian Medical University; Southern Medical University - China; Naval Medical University; Johns Hopkins University; Fujian Provincial Hospital	Hou, JM (corresponding author), Fujian Prov Hosp, Dept Endocrinol, Key Lab Endocrinol, 134 Dong Jie Rd, Fuzhou 350001, Fujian, Peoples R China.	hjm996@126.com			Fujian Provincial Hospital, Fujian Province [2017LHJJ05]; Fourth Round of the Fujian Provincial Joint Tackling Project between the Health and Education Joint Research Fund of National Health and the Family Planning Commission of China [wkj2016-2-02]; National Natural Science Foundation of China [81471607]; Sailing Fund from Fujian Medical University [2017XQ1131]	Fujian Provincial Hospital, Fujian Province; Fourth Round of the Fujian Provincial Joint Tackling Project between the Health and Education Joint Research Fund of National Health and the Family Planning Commission of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sailing Fund from Fujian Medical University	The authors thank Professor Lin Chen (Third Military Medical University; Chongqing, China) and Dr. Wenquan Liang (Southern Medical University) for providing support of experimental technique and Dr. Wang Zheng (Center for Cancer and Immunology Research, Children's National Medical Center; Washington, D. C., USA) for reviewing the article. This work was supported by high-level hospital grants from Fujian Provincial Hospital, Fujian Province (2017LHJJ05), the Fourth Round of the Fujian Provincial Joint Tackling Project between the Health and Education Joint Research Fund of National Health and the Family Planning Commission of China (wkj2016-2-02), The National Natural Science Foundation of China (81471607), and The Sailing Fund from Fujian Medical University (2017XQ1131). The authors declare no conflicts of interest.	Alayev A, 2014, CELL CYCLE, V13, P371, DOI 10.4161/cc.27355; Boyce BF, 2013, J BONE MINER RES, V28, P711, DOI 10.1002/jbmr.1885; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Chen YQ, 2017, J CELL COMMUN SIGNAL, V11, P219, DOI 10.1007/s12079-016-0364-4; Chung YH, 2014, J CELL PHYSIOL, V229, P1963, DOI 10.1002/jcp.24646; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Dai QG, 2017, J BIOL CHEM, V292, P196, DOI 10.1074/jbc.M116.764761; Datta HK, 2008, J CLIN PATHOL, V61, P577, DOI 10.1136/jcp.2007.048868; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Hariharan N, 2011, ANTIOXID REDOX SIGN, V14, P2179, DOI 10.1089/ars.2010.3488; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hazzalin CA, 1998, MOL CELL BIOL, V18, P1844, DOI 10.1128/MCB.18.4.1844; He WY, 2012, AUTOPHAGY, V8, P1811, DOI 10.4161/auto.22145; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Ikeda F, 2008, J BONE MINER RES, V23, P907, DOI 10.1359/JBMR.080211; Jin HO, 2016, SCI REP-UK, V6, DOI 10.1038/srep28945; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Karakashev S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03031-3; Ke DS, 2018, BIOCHEM BIOPH RES CO, V497, P890, DOI 10.1016/j.bbrc.2018.02.164; Kikuchi Y, 2005, NEPHROL DIAL TRANSPL, V20, P1573, DOI 10.1093/ndt/gfh888; Kim J, 2012, J CELL BIOCHEM, V113, P220, DOI 10.1002/jcb.23347; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Li RF, 2014, J HISTOCHEM CYTOCHEM, V62, P879, DOI 10.1369/0022155414551367; Lin NY, 2016, ANN RHEUM DIS, V75, P1203, DOI 10.1136/annrheumdis-2015-207240; Lin NY, 2013, ANN RHEUM DIS, V72, P761, DOI 10.1136/annrheumdis-2012-201671; Liu WJ, 2014, AUTOPHAGY, V10, P243, DOI 10.4161/auto.27004; Liu XQ, 2014, BIOMATERIALS, V35, P5721, DOI 10.1016/j.biomaterials.2014.04.006; Liu YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33614; Lu XM, 2009, BIOCHEM BIOPH RES CO, V390, P494, DOI 10.1016/j.bbrc.2009.09.123; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Ni ZH, 2014, FREE RADICAL BIO MED, V70, P194, DOI 10.1016/j.freeradbiomed.2014.02.012; Ochotny N, 2013, J CELL BIOCHEM, V114, P2823, DOI 10.1002/jcb.24630; Park H, 2015, ANTIOXID REDOX SIGN, V22, P63, DOI 10.1089/ars.2013.5748; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Sambandam Y, 2016, J CELL BIOCHEM, V117, P118, DOI 10.1002/jcb.25255; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Smink JJ, 2012, J MOL MED, V90, P25, DOI 10.1007/s00109-011-0823-6; Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200; Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581; Teitelbaum SL, 2004, J CLIN INVEST, V114, P463, DOI 10.1172/JCI200422644; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Udagawa N, 2000, ENDOCRINOLOGY, V141, P3478, DOI 10.1210/en.141.9.3478; Wang GY, 2017, INT J MED SCI, V14, P698, DOI 10.7150/ijms.19800; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wu HB, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0540-y; Wu XJ, 2005, J BONE MINER RES, V20, P107, DOI 10.1359/JBMR.041022; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Xiu Y, 2014, J CLIN INVEST, V124, P297, DOI 10.1172/JCI66947; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	56	24	25	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11082	11095		10.1096/fj.201802597RR	http://dx.doi.org/10.1096/fj.201802597RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31295022				2022-12-26	WOS:000489166300043
J	Lee, JJ; Park, IH; Rhee, WJ; Kim, HS; Shin, JS				Lee, Je-Jung; Park, In Ho; Rhee, Woo Joong; Kim, Hee Sue; Shin, Jeon-Soo			HMGB1 modulates the balance between senescence and apoptosis in response to genotoxic stress	FASEB JOURNAL			English	Article						cancer; metastasis; cell fate; doxorubicin; camptothecin	CELLULAR SENESCENCE; SECRETORY PHENOTYPE; CANCER CELLS; PROTEIN; TUMORIGENESIS; SUPPRESSION; AUTOPHAGY; RELEASE; COMPLEX; P53	High mobility group box-1 (HMGB1) is involved in various diseases and is associated with the resistance of many types of human cancers to chemotherapy; however, its role in cancer metastasis remains unexplored. This study examined the HMGB1 status of both highly and poorly metastatic cancer cells in response to genotoxic stress. The weakly and highly metastatic mouse melanoma cell lines (B16 vs. B16-F10), human melanoma cell lines (SK-MEL-28 vs. SK-MEL-24), colon cancer cell lines (DLD-1 vs. LS174T), and wild-type (WT) vs. HMGB1 knockout (KO) mouse embryonic fibroblasts (MEFs) were treated with doxorubicin (Dox) and camptothecin (CPT), and then cellular morphology, senescence-associated beta-galactosidase staining, lactate dehydrogenase release, and caspase-3 activation were used to assess cell fate. To investigate the role of HMGB1 in p21 expression, HMGB1 and p21 expressions were examined by Western blotting, and the HMGB1-mediated p21 promoter luciferase assay was performed after small interfering RNA or overexpression of HMGB1 prior to Dox treatment. Although highly metastatic mouse melanoma B16-F10 cells preferred senescence, with persistent HMGB1 expression, poorly metastatic B16 cells entered apoptosis, with decreasing HMGB1 levels via cleavage under Dox treatment. Similarly, more metastatic human melanoma SK-MEL-24 and human colon cancer LS174T cells underwent senescence, whereas fewer metastatic melanoma SK-MEL-28 and DLD-1 cells exhibited apoptosis under Dox stimulation. In senescent B16-F10, SK-MEL-24, and LS174T cells treated with Dox, p21 levels were increased by persistent HMGB1 expression. Furthermore, HMGB1 depletion caused a senescence-apoptosis shift with p21 down-regulation in B16-F10 cells, and HMGB1 overexpression switched from apoptosis to senescence concomitantly with increased p21 expression in B16 cells after Dox treatment. The same effects were observed in both cell pairs of mouse melanoma and human colon cancer cells treated with CPT, another genotoxic stressor. Indeed, although WT MEF entered senescence accompanied by p21 increase, HMGB1 KO underwent apoptosis with p21 decrease by Dox treatment. In our cell model system, we demonstrated that highly metastatic cancer cells preferentially enter senescence, whereas apoptosis predominates in weakly metastatic cancer cells under genotoxic stress, which depends on the presence or absence of HMGB1, suggesting that the HMGB1-p21 axis is required for genotoxic stress-induced senescence. These findings suggest that HMGB1 modulation of cancers with different metastatic status could be a strategy for selectively enforcing tumor suppression.-Lee, J.-J., Park, I. H., Rhee, W. J., Kim, H. S., Shin, J.-S. HMGB1 modulates the balance between senescence and apoptosis in response to genotoxic stress.	[Lee, Je-Jung; Rhee, Woo Joong; Kim, Hee Sue; Shin, Jeon-Soo] Yonsei Univ, Coll Med, Dept Microbiol, 50-1 Yonsei Ro, Seoul 03722, South Korea; [Lee, Je-Jung; Park, In Ho; Shin, Jeon-Soo] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea; [Park, In Ho; Shin, Jeon-Soo] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Rhee, Woo Joong; Shin, Jeon-Soo] Inst for Basic Sci Korea, Ctr Nanomed, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Institute for Basic Science - Korea (IBS)	Shin, JS (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.	jsshin6203@yuhs.ac		Park, In Ho/0000-0003-2190-5469; Rhee, Woo Joong/0000-0001-9690-0553; Shin, Jeon-Soo/0000-0002-8294-3234	National Research Foundation of Korea (NRF) - Korean government [2014R1A4A1008625, 2017R1A2B3006704, 2017R1D1A1B03028551, 2019R1I1A1A01041284, 2019R1A6A1A03032869]; Research Center Program of the Institute for Basic Science (IBS) in Korea [IBS-R026-D1]; Brain Korea 21 PLUS Project for Medical Science	National Research Foundation of Korea (NRF) - Korean government; Research Center Program of the Institute for Basic Science (IBS) in Korea; Brain Korea 21 PLUS Project for Medical Science	This work was supported by grants from the National Research Foundation of Korea (NRF) funded by the Korean government (2014R1A4A1008625, 2017R1A2B3006704, 2017R1D1A1B03028551, 2019R1I1A1A01041284, and 2019R1A6A1A03032869), the Research Center Program of the Institute for Basic Science (IBS) in Korea (IBS-R026-D1), and the Brain Korea 21 PLUS Project for Medical Science. The authors declare no conflicts of interest.	Biran A, 2017, AGING CELL, V16, P661, DOI 10.1111/acel.12592; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Byun HO, 2009, CANCER RES, V69, P4638, DOI 10.1158/0008-5472.CAN-08-4042; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Cianfrocca R, 2017, CELL DEATH DIFFER, V24, P1811, DOI 10.1038/cdd.2017.121; CILLO C, 1987, CANCER RES, V47, P2604; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Efstathiou JA, 1999, P NATL ACAD SCI USA, V96, P2316, DOI 10.1073/pnas.96.5.2316; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Galanos P, 2016, NAT CELL BIOL, V18, P777, DOI 10.1038/ncb3378; Georgakopoulou E, 2016, MECH AGEING DEV, V156, P17, DOI 10.1016/j.mad.2016.03.010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jiao Y, 2007, ACTA PHARMACOL SIN, V28, P1957, DOI 10.1111/j.1745-7254.2007.00669.x; Jin YH, 2000, J BIOL CHEM, V275, P30256, DOI 10.1074/jbc.M001902200; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Laine A, 2013, CANCER DISCOV, V3, P182, DOI 10.1158/2159-8290.CD-12-0292; LeBlanc PM, 2014, J BIOL CHEM, V289, P7777, DOI 10.1074/jbc.M113.541474; Lee JJ, 2011, CELL DEATH DIFFER, V18, P666, DOI 10.1038/cdd.2010.139; Li QL, 2014, ONCOTARGET, V5, P6387, DOI 10.18632/oncotarget.2201; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Livesey KM, 2012, CANCER RES, V72, P1996, DOI 10.1158/0008-5472.CAN-11-2291; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mao Zhiyong, 2012, Aging (Albany NY), V4, P431; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Nehil M, 2014, ONCOGENE, V33, P5151, DOI 10.1038/onc.2013.459; Papazoglu C, 2007, J PATHOL, V211, P124, DOI 10.1002/path.2086; Prieur A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1473; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Ru H, 2015, CELL, V163, P1807, DOI 10.1016/j.cell.2015.12.003; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Swift LH, 2014, INT J MOL SCI, V15, P3403, DOI 10.3390/ijms15033403; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Tsou SH, 2016, INT J MOL MED, V37, P233, DOI 10.3892/ijmm.2015.2406; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Zagelbaum J, 2016, P NATL ACAD SCI USA, V113, P11853, DOI 10.1073/pnas.1606721113	39	24	25	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10942	10953		10.1096/fj.201900288R	http://dx.doi.org/10.1096/fj.201900288R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284735				2022-12-26	WOS:000489166300030
J	Rathod, S; Ramsey, M; DiGiorgio, D; Berrios, R; Finkelman, FD; Fernandez, CA				Rathod, Sanjay; Ramsey, Manda; DiGiorgio, Danielle; Berrios, Roberto; Finkelman, Fred D.; Fernandez, Christian A.			Asparaginase immune complexes induce Fc-gamma RIII-dependent hypersensitivity in naive mice	FASEB JOURNAL			English	Article						antidrug antibodies; leukemia; basophil activation test; anaphylaxis; immunogenicity	ACUTE LYMPHOBLASTIC-LEUKEMIA; ESCHERICHIA-COLI ASPARAGINASE; HIGHER-RISK; CHILDREN; ANTIBODIES; ANAPHYLAXIS; EXPRESSION; BASOPHILS; IMPACT	Asparaginase (ASNase) is an important drug for the treatment of leukemias. However, hypersensitivity to ASNase can increase the risk of leukemia relapse. Two mechanisms of ASNase hypersensitivity have been identified in mice. The existence of a pathway involving anti-ASNase IgG and Fc-gamma receptor III (Fc-gamma RIII) implies that IgG and ASNase immune complexes (ICs) could directly induce hypersensitivity. The aim of this study was to detect ASNase ICs in mice after hypersensitivity reactions and determine their role in hypersensitivity. Protein G beads were used to detect plasma ASNase ICs by flow cytometry. Anti-ASNase IgG was purified from the plasma of sensitized mice, and ASNase ICs were prepared ex vivo at various ratios of ASNase to anti-ASNase IgG. The levels of ASNase ICs detected after hypersensitivity reactions correlated with reaction severity (R-2 = 0.796; P = 0.0005). ASNase ICs prepared ex vivo required high levels of anti-ASNase IgG for formation, and binding to naive and sensitized immune cells depended on soluble anti-ASNase IgG, antigen:antibody ratio, and Fc-gamma RIII. Similarly, basophil activation by ASNase ICs depended on the antigen:antibody ratio and Fc-gamma RIII. Consistent with the ex vivo results, naive mice receiving ASNase ICs developed hypersensitivity reactions. Our data demonstrate that ASNase ICs can directly contribute to the onset and severity of ASNase hypersensitivity.-Rathod, S., Ramsey, M., DiGiorgio, D., Berrios, R., Finkelman, F. D., Fernandez, C. A. Asparaginase immune complexes induce Fc-gamma RIII-dependent hypersensitivity in naive mice.	[Rathod, Sanjay; Ramsey, Manda; DiGiorgio, Danielle; Berrios, Roberto; Fernandez, Christian A.] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Rathod, Sanjay; Ramsey, Manda; DiGiorgio, Danielle; Berrios, Roberto; Fernandez, Christian A.] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Finkelman, Fred D.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH USA; [Finkelman, Fred D.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Fernandez, CA (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, Sch Pharm, Dept Pharmaceut Sci, 335 Sutherland Dr, Pittsburgh, PA 15261 USA.	chf63@pitt.edu	Rathod, Sanjay/AAT-2556-2021; Rathod, Sanjay/AAQ-6512-2020; Rathod, Sanjay/AAX-9224-2021	Rathod, Sanjay/0000-0003-1755-8222; 	University of Pittsburgh School of Pharmacy (Pittsburgh, PA, USA); U.S. National Institutes of Health, National Cancer Institute [RO1 CA216815]; NATIONAL CANCER INSTITUTE [R01CA216815] Funding Source: NIH RePORTER	University of Pittsburgh School of Pharmacy (Pittsburgh, PA, USA); U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the University of Pittsburgh School of Pharmacy (Pittsburgh, PA, USA) and U.S. National Institutes of Health, National Cancer Institute Grant RO1 CA216815. The authors declare no conflicts of interest.	Asselin B, 2015, LEUKEMIA LYMPHOMA, V56, P2273, DOI 10.3109/10428194.2014.1003056; Avramis VI, 2002, BLOOD, V99, P1986, DOI 10.1182/blood.V99.6.1986; Bandyopadhyay S, 2005, J IMMUNOL METHODS, V297, P13, DOI 10.1016/j.jim.2004.11.014; Bhatt VR, 2014, FUTURE ONCOL, V10, P2593, DOI 10.2217/fon.14.239; Burke MJ, 2014, FUTURE ONCOL, V10, P2615, DOI 10.2217/fon.14.138; Chauhan AK, 2015, J BIOL CHEM, V290, P5127, DOI 10.1074/jbc.M114.599266; DAVIES KA, 1990, J IMMUNOL, V144, P4613; Fernandez CA, 2015, BLOOD, V126, P69, DOI 10.1182/blood-2015-02-628800; Fernandez CA, 2015, J PHARMACOL EXP THER, V352, P541, DOI 10.1124/jpet.114.220780; Fernandez CA, 2014, BLOOD, V124, P1266, DOI 10.1182/blood-2014-03-563742; Fernandez CA, 2013, INT J CLIN EXP MED, V6, P478; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Iwamoto H, 2016, TOXICOL LETT, V242, P53, DOI 10.1016/j.toxlet.2015.11.024; Iwamoto H, 2015, IMMUN INFLAMM DIS, V3, P280, DOI 10.1002/iid3.67; Kawedia JD, 2011, BLOOD, V117, P2340, DOI 10.1182/blood-2010-10-311969; Liu C, 2012, LEUKEMIA, V26, P2303, DOI 10.1038/leu.2012.102; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; Muller HJ, 1998, CRIT REV ONCOL HEMAT, V28, P97, DOI 10.1016/S1040-8428(98)00015-8; OETTGEN H F, 1970, Cancer, V25, P253, DOI 10.1002/1097-0142(197002)25:2<253::AID-CNCR2820250204>3.0.CO;2-U; Panosyan EH, 2004, J PEDIAT HEMATOL ONC, V26, P217, DOI 10.1097/00043426-200404000-00002; Rathod S, 2019, HAEMATOLOGICA, V104, P319, DOI 10.3324/haematol.2018.199448; Reber LL, 2017, J ALLERGY CLIN IMMUN, V140, P335, DOI 10.1016/j.jaci.2017.06.003; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Vrooman LM, 2013, J CLIN ONCOL, V31, P1202, DOI 10.1200/JCO.2012.43.2070; Woo MH, 1998, LEUKEMIA, V12, P1527, DOI 10.1038/sj.leu.2401162; Woo MH, 2000, J CLIN ONCOL, V18, P1525, DOI 10.1200/JCO.2000.18.7.1525	28	3	3	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10996	11005		10.1096/fj.201900857	http://dx.doi.org/10.1096/fj.201900857			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284767	Green Published			2022-12-26	WOS:000489166300035
J	Adamopoulos, A; Heidebrecht, T; Roosendaal, J; Touw, WG; Phan, IQ; Beijnen, J; Perrakis, A				Adamopoulos, Athanassios; Heidebrecht, Tatjana; Roosendaal, Jeroen; Touw, Wouter G.; Phan, Isabelle Q.; Beijnen, Jos; Perrakis, Anastassis			The domain architecture of the protozoan protein J-DNA-binding protein 1 suggests synergy between base J DNA binding and thymidine hydroxylase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA binding protein; small-angle X-ray scattering (SAXS); mass spectrometry (MS); hydroxylase; 5-hydroxymethylcytosine (5-hmC); beta-D-glucosyl-hydroxymethyluracil (base J); epigenetics; kinetoplastid parasites; thymidine hydroxylase	SMALL-ANGLE SCATTERING; BIOLOGICAL MACROMOLECULES; X-RAY; STRUCTURAL BASIS; GENOMIC DNA; SAXS DATA; HYDROXYMETHYLURACIL; RECOGNITION; RESOLUTION; GLUCOSYLTRANSFERASE	J-DNA-binding protein 1 (JBP1) contributes to the biosynthesis and maintenance of base J (beta-d-glucosyl-hydroxymethyluracil), an epigenetic modification of thymidine (T) confined to pathogenic protozoa such as Trypanosoma and Leishmania. JBP1 has two known functional domains: an N-terminal T hydroxylase (TH) homologous to the 5-methylcytosine hydroxylase domain in TET proteins and a J-DNA-binding domain (JDBD) that resides in the middle of JBP1. Here, we show that removing JDBD from JBP1 results in a soluble protein (Delta-JDBD) with the N- and C-terminal regions tightly associated together in a well-ordered structure. We found that this Delta-JDBD domain retains TH activity in vitro but displays a 15-fold lower apparent rate of hydroxylation compared with JBP1. Small-angle X-ray scattering (SAXS) experiments on JBP1 and JDBD in the presence or absence of J-DNA and on Delta-JDBD enabled us to generate low-resolution three-dimensional models. We conclude that Delta-JDBD, and not the N-terminal region of JBP1 alone, is a distinct folding unit. Our SAXS-based model supports the notion that binding of JDBD specifically to J-DNA can facilitate T hydroxylation 12-14 bp downstream on the complementary strand of the J-recognition site. We postulate that insertion of the JDBD module into the Delta-JDBD scaffold during evolution provided a mechanism that synergized J recognition and T hydroxylation, ensuring inheritance of base J in specific sequence patterns following DNA replication in kinetoplastid parasites.	[Adamopoulos, Athanassios; Heidebrecht, Tatjana; Touw, Wouter G.; Perrakis, Anastassis] Netherlands Canc Inst, Dept Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Roosendaal, Jeroen; Beijnen, Jos] Netherlands Canc Inst, Dept Clin Pharmacol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Phan, Isabelle Q.] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle Struct Genom Ctr Infect Dis, Seattle, WA 98109 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Seattle Children's Hospital	Perrakis, A (corresponding author), Netherlands Canc Inst, Dept Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.perrakis@nki.nl	Perrakis, Anastassis/E-8704-2013	Perrakis, Anastassis/0000-0002-1151-6227	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [714.014.002]; NIAID, National Institutes of Health, Department of Health and Human Services [HHSN272201700059C]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); NIAID, National Institutes of Health, Department of Health and Human Services	This work was supported by Nederlandse Organisatie voor Wetenschappelijk Onderzoek Grant 714.014.002. Work from the Seattle Structural Genomics Center for Infectious Disease was supported by NIAID, National Institutes of Health, Department of Health and Human Services, under Contract HHSN272201700059C. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bizien T, 2016, PROTEIN PEPTIDE LETT, V23, P217, DOI 10.2174/0929866523666160106153655; Bullard W, 2014, J BIOL CHEM, V289, P20273, DOI 10.1074/jbc.M114.579821; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Cliffe LJ, 2012, J BIOL CHEM, V287, P19886, DOI 10.1074/jbc.M112.341974; Cliffe LJ, 2010, NUCLEIC ACIDS RES, V38, P3923, DOI 10.1093/nar/gkq146; Cliffe LJ, 2009, NUCLEIC ACIDS RES, V37, P1452, DOI 10.1093/nar/gkn1067; Cross M, 1999, EMBO J, V18, P6573, DOI 10.1093/emboj/18.22.6573; Dong D, 2017, NATURE, V546, P436, DOI 10.1038/nature22377; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Genest PA, 2007, NUCLEIC ACIDS RES, V35, P2116, DOI 10.1093/nar/gkm050; Genest PA, 2015, NUCLEIC ACIDS RES, V43, P2102, DOI 10.1093/nar/gkv095; GOMMERSAMPT JH, 1993, CELL, V75, P1129, DOI 10.1016/0092-8674(93)90322-H; Grover RK, 2007, ANGEW CHEM INT EDIT, V46, P2839, DOI 10.1002/anie.200604635; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; Heidebrecht T, 2012, J AM CHEM SOC, V134, P13357, DOI 10.1021/ja303423t; Heidebrecht T, 2011, NUCLEIC ACIDS RES, V39, P5715, DOI 10.1093/nar/gkr125; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu LL, 2015, NATURE, V527, P118, DOI 10.1038/nature15713; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Iyer LM, 2013, NUCLEIC ACIDS RES, V41, P7635, DOI 10.1093/nar/gkt573; Konarev PV, 2015, IUCRJ, V2, P352, DOI 10.1107/S2052252515005163; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Luna-Vargas MPA, 2011, J STRUCT BIOL, V175, P113, DOI 10.1016/j.jsb.2011.03.017; Mohanty B, 2016, J MOL BIOL, V428, P4298, DOI 10.1016/j.jmb.2016.08.028; Mooij WTM, 2009, NUCLEIC ACIDS RES, V37, pW402, DOI 10.1093/nar/gkp256; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Petoukhov MV, 2015, ACTA CRYSTALLOGR D, V71, P1051, DOI 10.1107/S1399004715002576; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Piiadov V, 2019, PROTEIN SCI, V28, P454, DOI 10.1002/pro.3528; Rambo RP, 2015, METHOD ENZYMOL, V558, P363, DOI 10.1016/bs.mie.2015.02.004; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rambo RP, 2010, CURR OPIN STRUC BIOL, V20, P128, DOI 10.1016/j.sbi.2009.12.015; Roosendaal J, 2019, J PHARMACEUT BIOMED, V164, P16, DOI 10.1016/j.jpba.2018.10.001; Schindler CEM, 2016, STRUCTURE, V24, P1387, DOI 10.1016/j.str.2016.06.007; Sekar A, 2014, MOL BIOCHEM PARASIT, V196, P9, DOI 10.1016/j.molbiopara.2014.07.005; Shen A, 2009, STRUCTURE, V17, P769, DOI 10.1016/j.str.2009.02.018; Shkumatov AV, 2015, ACTA CRYSTALLOGR D, V71, P1347, DOI 10.1107/S1399004715007154; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; van Luenen HGAM, 2012, CELL, V150, P909, DOI 10.1016/j.cell.2012.07.030; vanLeeuwen F, 1996, NUCLEIC ACIDS RES, V24, P2476, DOI 10.1093/nar/24.13.2476; vanLeeuwen F, 1997, GENE DEV, V11, P3232, DOI 10.1101/gad.11.23.3232; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Yu Z, 2007, NUCLEIC ACIDS RES, V35, P2107, DOI 10.1093/nar/gkm049	48	0	0	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12815	12825		10.1074/jbc.RA119.007393	http://dx.doi.org/10.1074/jbc.RA119.007393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31292194	hybrid, Green Published			2022-12-26	WOS:000484414600022
J	Michalak, KP; Przekoracka-Krawczyk, A; Naskrecki, R				Michalak, Krzysztof Piotr; Przekoracka-Krawczyk, Anna; Naskrecki, Ryszard			Parameters of the crossing points between center of pressure and center of mass signals are potential markers of postural control efficiency	PLOS ONE			English	Article							INVERTED PENDULUM; ANKLE STIFFNESS; VISUAL INPUT; SHORT-RANGE; BALANCE; BODY; STANCE; SWAY; GRAVITY; TRUNK	Posturographic signals were recorded for 384 subjects of different ages and with old persons with gait disturbances. Four conditions were used: Eyes Open/Closed vs. Head Normal/Bent Back. 'Center of Pressure' (CoP) signals were decomposed into 'Center of Mass' (CoM) and the remaining difference between Center of Pressure and Center of Mass (CoPM). The Zero-Crossing points in which the Center of Mass and Center of Pressure paths cross each other have been extracted. Velocity of CoM, velocity of CoPM and acceleration of CoPM in Zero-Crossing points were analyzed to be potential markers of balance efficiency. Three factors causing the deterioration of balance quality were analyzed: closing eyes, bending the head back and patient age. The influence of the given factors was measured using the significance p of the t-Student test and Cohen's d effect size and applied to differences for the logarithms of three of the mentioned above variables measured without and with the given deteriorating factor. In the majority of comparisons, the proposed new parameters of balance quality possessed higher statistical power to detect deteriorated balance quality than the standard parameters: standard deviation of the signal and ellipse area covering 90% of the signal envelope. Most valuable are the velocity and acceleration of CoPM for the medio-lateral direction. Logarithms of the analyzed parameters are proposed to be used in analyses because they possess normal or close to normal distribution and they are less sensitive to single high values occurring often in measurements.	[Michalak, Krzysztof Piotr; Przekoracka-Krawczyk, Anna; Naskrecki, Ryszard] Adam Mickiewicz Univ, Lab Vis Sci & Optometry, Fac Phys, Poznan, Poland; [Michalak, Krzysztof Piotr; Przekoracka-Krawczyk, Anna] Adam Mickiewicz Univ, NanoBioMed Ctr, Vis & Neurosci Lab, Poznan, Poland	Adam Mickiewicz University; Adam Mickiewicz University	Michalak, KP (corresponding author), Adam Mickiewicz Univ, Lab Vis Sci & Optometry, Fac Phys, Poznan, Poland.; Michalak, KP (corresponding author), Adam Mickiewicz Univ, NanoBioMed Ctr, Vis & Neurosci Lab, Poznan, Poland.	kmichalak@amu.edu.pl	Naskrecki, Ryszard/AAB-1865-2020; Michalak, Krzysztof Piotr/O-7865-2018	Naskrecki, Ryszard/0000-0002-7925-047X; Michalak, Krzysztof Piotr/0000-0002-0267-5605; Przekoracka-Krawczyk, Anna/0000-0003-2401-4135				Bottaro A, 2005, HUM MOVEMENT SCI, V24, P588, DOI 10.1016/j.humov.2005.07.006; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Caron O, 1997, J BIOMECH, V30, P1169, DOI 10.1016/S0021-9290(97)00094-8; Casadio M, 2005, GAIT POSTURE, V21, P410, DOI 10.1016/j.gaitpost.2004.05.005; COLLINS JJ, 1995, EXP BRAIN RES, V103, P151, DOI 10.1007/BF00241972; Duarte BP, 2011, CONTROL EQUILIBRIUM, V23, DOI [10.1152/japplphysiol.01229.2005, DOI 10.1152/JAPPLPHYSIOL.01229.2005]; Duarte M, 2002, EXP BRAIN RES, V146, P60, DOI 10.1007/s00221-002-1154-1; GAGEY P-M, 1991, Acta Oto-Rhino-Laryngologica Belgica, V45, P335; HASAN SS, 1996, GAIT POSTURE, V4, P11; Horlings CGC, 2008, CLIN NEUROPHYSIOL, V119, P2338, DOI 10.1016/j.clinph.2008.07.221; Horlings CGC, 2009, NEUROSCIENCE, V161, P904, DOI 10.1016/j.neuroscience.2009.04.005; Horlings CGC, 2009, ANN NY ACAD SCI, V1164, P1, DOI 10.1111/j.1749-6632.2009.03872.x; Jacono M, 2004, MOTOR CONTROL, V8, P292, DOI 10.1123/mcj.8.3.292; Kato T, 2014, GAIT POSTURE, V40, P107, DOI 10.1016/j.gaitpost.2014.03.006; Lafond D, 2004, J BIOMECH, V37, P1421, DOI 10.1016/S0021-9290(03)00251-3; Lakie M, 2003, J PHYSIOL-LONDON, V551, P357, DOI 10.1113/jphysiol.2002.036939; Lakie M, 2006, J PHYSIOL-LONDON, V577, P403, DOI 10.1113/jphysiol.2006.116772; Loram ID, 2007, J PHYSIOL-LONDON, V584, P661, DOI 10.1113/jphysiol.2007.140046; Loram ID, 2011, J PHYSIOL-LONDON, V589, P307, DOI 10.1113/jphysiol.2010.194712; Loram ID, 2009, J NEUROPHYSIOL, V102, P460, DOI 10.1152/jn.00007.2009; Loram ID, 2002, J PHYSIOL-LONDON, V545, P1041, DOI 10.1113/jphysiol.2002.025049; Loram ID, 2006, J APPL PHYSIOL, V100, P1311, DOI 10.1152/japplphysiol.01229.2005; Loram ID, 2005, J PHYSIOL-LONDON, V564, P295, DOI 10.1113/jphysiol.2004.076307; Loram ID, 2002, J PHYSIOL-LONDON, V540, P1111, DOI 10.1113/jphysiol.2001.013077; Michalak K. P., 2007, BIOCYBERN BIOMED ENG, V27, P71; Michalak KP, 2014, APPL INFORM SYSTEMS, V05, P183; Michalak KP, 2018, OPTYKA, V6, P38; Michalak Krzysztof Piotr, 2014, ScientificWorldJournal, V2014, P403893, DOI 10.1155/2014/403893; Przekoracka-Krawczyk A, 2014, VISION RES, V98, P35, DOI 10.1016/j.visres.2014.03.008; Sasaki O, 2002, EXP BRAIN RES, V147, P1, DOI 10.1007/s00221-002-1170-1; Schmid M, 2008, NEUROSCIENCE, V153, P1079, DOI 10.1016/j.neuroscience.2008.03.024; Sparto PJ, 2018, AGING CLIN EXP RES, V30, P633, DOI 10.1007/s40520-017-0819-3; Stolze H, 2000, EXP AGING RES, V26, P159, DOI 10.1080/036107300243623; Vonk J, 2010, AUDIOL NEURO-OTOL, V15, P261, DOI 10.1159/000258682; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Zatsiorsky VM, 1999, MOTOR CONTROL, V3, P28, DOI 10.1123/mcj.3.1.28; Zatsiorsky VM, 2000, MOTOR CONTROL, V4, P185, DOI 10.1123/mcj.4.2.185	38	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2019	14	7							e0219460	10.1371/journal.pone.0219460	http://dx.doi.org/10.1371/journal.pone.0219460			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4NB	31299055	Green Submitted, gold, Green Published			2022-12-26	WOS:000484955800005
J	Dias, PHS; Araujo-Vieira, K; de Carvalho-e-Silva, AMPT; Orrico, VGD				Dias, Pedro H. S.; Araujo-Vieira, Katyuscia; de Carvalho-e-Silva, Ana Maria P. T.; Orrico, Victor G. D.			Larval anatomy of Dendropsophus decipiens (A. Lutz 1925) (Anura: Hylidae: Dendropsophini) with considerations to larvae of this genus	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; AMAZON BASIN; TADPOLES; FROGS; MORPHOLOGY; AMPHIBIA; CHONDROCRANIUM; CLASSIFICATION; EVOLUTIONARY; MUSCULATURE	The Dendropsophus decipiens Glade comprises four species: D. berthalutzae, D. decipiens, D. haddadi, and D. oliveirai. Tadpoles of these species were described, but data on their internal morphology are lacking. We provide the first description of the buccopharyngeal anatomy, chondrocranial morphology, and cranial, hyoid and hyobranchial musculature of the tadpole of D. decipiens. Larvae of D. decipiens are characterized by the absence of lingual papillae, presence of fan -like papilla on the buccal floor, presence of a single -element suprarostral cartilage, presence of a small triangular process at the basis of the processus muscularis, m. levator mandibulae lateralis inserted on the nasal sac, and m. subarcualis rectus II -IV with a single, continuous slip. Tadpoles are likely macrophagous, although not as specialized as those of other species of the genus, suggesting some degree of diversification on the feeding habits within Dendropsophus.	[Dias, Pedro H. S.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, SP, Brazil; [Araujo-Vieira, Katyuscia] Consejo Nacl Invest Cient & Tecn, Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Herpetol, Buenos Aires, DF, Argentina; [de Carvalho-e-Silva, Ana Maria P. T.] Univ Fed Estado Rio De Janeiro, Dept Zool, Lab Biossistemat Anfibios, Rio De Janeiro, RJ, Brazil; [Orrico, Victor G. D.] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil	Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Universidade Federal do Estado do Rio de Janeiro; Universidade Estadual de Santa Cruz	Dias, PHS (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, SP, Brazil.	pedrodiasherpeto@gmail.com	Araujo-Vieira, Katyuscia/AAD-3973-2019; dos Santos Dias, Pedro Henrique/V-1282-2018; Orrico, Victor/G-9796-2012	Araujo-Vieira, Katyuscia/0000-0002-8193-2736; dos Santos Dias, Pedro Henrique/0000-0002-6428-6496; Orrico, Victor/0000-0002-4560-4006	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/57067-9, 2012/10000-5, 2012/12500-5, 2013/20420-4, 2013/20423-3, 2013/50741-7, 2014/50342-8, 2015/11239-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [310467/2017-9]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 404/2013, 820/2015]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), procs 2007/57067-9, 2012/10000-5, 2012/12500-5, 2013/20420-4, 2013/20423-3, 2013/50741-7, 2014/50342-8, 2015/11239-0 (http://www.fapesp.br/) to PHSD, KAV, VGDO; the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Grant 310467/2017-9 (http://cnpq.br/) to VGDO; and the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), PICT 404/2013 and 820/2015 (https://www.argentina.gob.ar/ciencia/agencia) to KAV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu R.O., 2013, SITIENTIBUS CB, V13, P1, DOI [10.13102/scb202, DOI 10.13102/SCB202]; Alcalde L, 2006, ACTA ZOOL-STOCKHOLM, V87, P91, DOI 10.1111/j.1463-6395.2006.00205.x; Alcalde L, 2006, AMPHIBIA-REPTILIA, V27, P241, DOI 10.1163/156853806777239959; Alcalde L, 2011, ZOOTAXA, P19; ALTIG R, 1989, HERPETOL MONOGR, V3, P81, DOI [DOI 10.2307/1466987, 10.2307/1466987]; Altig R, 2007, FRESHWATER BIOL, V52, P386, DOI 10.1111/j.1365-2427.2006.01694.x; Bokermann W. C. A., 1962, Neotropica, V8, P81; Candioti MFV, 2007, ZOOTAXA, P1; Candioti Maria Florencia Vera, 2004, Cuadernos de Herpetologia, V18, P3; Candioti MFV, 2004, J MORPHOL, V261, P206, DOI 10.1002/jmor.10239; Carvalho-e-Silva Sergio Potsch, 2003, Rev. Bras. Zool., V20, P553, DOI 10.1590/S0101-81752003000300029; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229, DOI 10.3109/10520297709116780; Dias PHD, 2018, S AM J HERPETOL, V13, P44, DOI 10.2994/SAJH-D-16-00055.1; Duellman W.E., 1983, P33; Duellman WE, 2016, ZOOTAXA, V4104, P1, DOI 10.11646/zootaxa.4104.1.1; Echeverria Dinorah D., 1997, Alytes (Paris), V15, P26; Fabrezi M., 1992, Acta Zoologica Lilloana, V41, P155; Fabrezi Marissa, 1997, Cuadernos de Herpetologia, V11, P37; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Faivovich J, 2018, S AM J HERPETOL, V13, P1, DOI 10.2994/SAJH-D-17-00115.1; Faivovich J, 2014, S AM J HERPETOL, V9, P207, DOI 10.2994/SAJH-D-14-00032.1; Fouquet A, 2011, ZOOTAXA, P59, DOI 10.11646/zootaxa.3035.1.3; Frost DR., 2019, AMPHIBIAN SPECIES WO; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gosner K. L., 1960, Herpetologica, V16, P183; Grosjean S, 2004, BIOL J LINN SOC, V81, P171, DOI 10.1111/j.1095-8312.2003.00272.x; Haas A, 2003, CLADISTICS, V19, P23, DOI 10.1111/j.1096-0031.2003.tb00405.x; HAAS A, 1995, J MORPHOL, V224, P241, DOI 10.1002/jmor.1052240302; Haas A, 2001, J MORPHOL, V247, P1, DOI 10.1002/1097-4687(200101)247:1<1::AID-JMOR1000>3.0.CO;2-3; Haas A, 2014, ZOOMORPHOLOGY, V133, P321, DOI 10.1007/s00435-014-0226-7; Haas Alexander, 1996, Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg, V36, P33; Jetz W, 2018, NAT ECOL EVOL, V2, P850, DOI 10.1038/s41559-018-0515-5; Kaplan M, 1997, J HERPETOL, V31, P230, DOI 10.2307/1565391; Lavilla E. O., 1992, Acta Zoologica Lilloana, V42, P5; Lourenco-De-Moraes R, 2012, ZOOTAXA, P86, DOI 10.11646/zootaxa.3476.1.5; Orrico VGD, 2014, ZOOTAXA, V3881, P341, DOI 10.11646/zootaxa.3881.4.3; Peixoto Oswaldo L., 1997, Herpetological Review, V28, P146; Peloso PLV, 2016, S AM J HERPETOL, V11, P66, DOI 10.2994/SAJH-D-16-00003.1; Pugliese Adriana, 2000, Alytes (Paris), V18, P73; Pyron RA, 2014, SYST BIOL, V63, P779, DOI 10.1093/sysbio/syu042; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rivera-Correa M, 2013, ZOOTAXA, V3686, P447, DOI 10.11646/zootaxa.3686.4.3; Ruas DS, 2018, ZOOTAXA, V4375, P296, DOI 10.11646/zootaxa.4375.2.10; RUIBAL R, 1988, COPEIA, P591; SATEL SL, 1981, COPEIA, P129, DOI 10.2307/1444047; Suarez P, 2013, CYTOGENET GENOME RES, V141, P295, DOI 10.1159/000354997; Vera Candioti MF, 2005, ACTA ZOOL-STOCKHOLM, V86, P1, DOI 10.1111/j.0001-7272.2005.00178.x; Wassersug R.J., 1976, Occasional Papers Mus Nat Hist Univ Kans, VNo. 48, P1; Wassersug R.J., 1980, INTERNAL ORAL FEATUR, V68, P1, DOI [10.5962/bhl.title.16230, DOI 10.5962/BHL.TITLE.16230]; WASSERSUG RJ, 1979, J MORPHOL, V159, P393, DOI 10.1002/jmor.1051590307; WASSERSUG RJ, 1979, BIOL J LINN SOC, V12, P225, DOI 10.1111/j.1095-8312.1979.tb00056.x; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882; Wiens JJ, 2010, MOL PHYLOGENET EVOL, V55, P871, DOI 10.1016/j.ympev.2010.03.013; Wild ER, 1999, J MORPHOL, V242, P229, DOI 10.1002/(SICI)1097-4687(199912)242:3<229::AID-JMOR3>3.0.CO;2-N; Wild ER, 1997, J MORPHOL, V232, P169, DOI 10.1002/(SICI)1097-4687(199705)232:2<169::AID-JMOR4>3.0.CO;2-5	55	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219716	10.1371/journal.pone.0219716	http://dx.doi.org/10.1371/journal.pone.0219716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295323	gold, Green Published, Green Submitted			2022-12-26	WOS:000484951800066
J	Grozner, D; Sulyok, KM; Kreizinger, Z; Ronai, Z; Janosi, S; Turcsanyi, I; Karolyi, HF; Kovacs, AB; Kiss, MJ; Volokhov, D; Gyuranecz, M				Grozner, Denes; Sulyok, Kinga Maria; Kreizinger, Zsuzsa; Ronai, Zsuzsanna; Janosi, Szilard; Turcsanyi, Ibolya; Karolyi, Henrik Fulop; Kovacs, Aron Botond; Kiss, Marton Jozsef; Volokhov, Dmitriy; Gyuranecz, Miklos			Detection of Mycoplasma anatis, M. anseris, M. cloacale and Mycoplasma sp. 1220 in waterfowl using species-specific PCR assays	PLOS ONE			English	Article							GEESE; IDENTIFICATION; INFECTION; PATHOGENICITY; INFLAMMATION; SEQUENCES; STRAIN; DUCKS	Mycoplasma anatis, M. anseris, M. cloacale and M. sp. 1220 colonise geese and ducks, and could be associated with infections of avian respiratory and nervous systems, cause mild to severe inflammation of cloaca and genital tracts, and embryo lethality. Co-occurrence of these Mycoplasma species in waterfowl is frequently detected and the identification of these mycoplasmas to the species level at a regular microbiology laboratory is difficult due to their similar morphological, cultural and biochemical properties. Moreover, species differentiation is only possible based on the sequence analysis of the product of a genus-specific PCR assay. Therefore, the aim of the current study was to develop an effective and robust method for the identification of these species in avian clinical specimens. Polymerase chain reaction (PCR) assays using species-specific primers, which target housekeeping genes in order to identify these species, were designed in the present study. The developed PCR assays can precisely identify these four mycoplasmas to the species level directly from DNA samples extracted from clinical specimens, and no cross-amplification was observed among these species and with other well-known avian mycoplasmas. The average sensitivity of the assays was 10(1)-10(2) genomic equivalents per reaction. These conventional PCR assays can be run simultaneously at the same PCR cycling program, and the species can be differentiated directly (without sequence analysis) by gel electrophoresis due to the specific sizes of the amplicons. In conclusion, the presented species-specific assays were found to be suitable for routine use at regular veterinary diagnostic laboratories and promote the rapid, simple and cost-effective differentiation of these waterfowl Mycoplasma species.	[Grozner, Denes; Sulyok, Kinga Maria; Kreizinger, Zsuzsa; Karolyi, Henrik Fulop; Kovacs, Aron Botond; Gyuranecz, Miklos] Hungarian Acad Sci, Ctr Agr Res, Inst Vet Med Res, Budapest, Hungary; [Ronai, Zsuzsanna; Janosi, Szilard; Turcsanyi, Ibolya] Natl Food Chain Safety Off, Vet Diagnost Directorate, Budapest, Hungary; [Karolyi, Henrik Fulop; Gyuranecz, Miklos] Univ Vet Med, Dept Microbiol & Infect Dis, Budapest, Hungary; [Kiss, Marton Jozsef] TOLL 96 Kft, Hajdusamson, Hungary; [Volokhov, Dmitriy] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; University of Veterinary Medicine Budapest; US Food & Drug Administration (FDA)	Gyuranecz, M (corresponding author), Hungarian Acad Sci, Ctr Agr Res, Inst Vet Med Res, Budapest, Hungary.; Gyuranecz, M (corresponding author), Univ Vet Med, Dept Microbiol & Infect Dis, Budapest, Hungary.	m.gyuranecz@gmail.com	Kovács, Áron/AAX-8682-2020	Grozner, Denes/0000-0002-2154-7537; Kovacs, Aron Botond/0000-0001-6013-819X; Gyuranecz, Miklos/0000-0002-5698-5713	Lendulet (Momentum) program of the Hungarian Academy of Sciences [LP2012-22]; National Research, Development and Innovation Office [Elvonal KKP_19 129751]; Bolyai Janos Research Fellowship of the Hungarian Academy of Sciences; Bolyai+ Fellowship of the New National Excellence Program of the Ministry of Human Capacities [UNKP-18-4]	Lendulet (Momentum) program of the Hungarian Academy of Sciences; National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Bolyai Janos Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Bolyai+ Fellowship of the New National Excellence Program of the Ministry of Human Capacities	This work was funded by the Lendulet (Momentum) program (LP2012-22) of the Hungarian Academy of Sciences (http://mta.hu/lendulet/) and the Elvonal KKP_19 129751 grant of the National Research, Development and Innovation Office (https://nkfih.gov.hu/palyazoknak/nkfi-alap/tamogatott-projektek-kkp-19).MG and ZK were supported by the Bolyai Janos Research Fellowship of the Hungarian Academy of Sciences (http://mta.hu/bolyai-osztondij/bolyaijanos-kutatasi-osztondij-105319).MG was supported by the Bolyai+ Fellowship (UNKP-18-4) of the New National Excellence Program of the Ministry of Human Capacities (http://www.kormany.hu/hu/emberi-eroforrasok-miniszteriuma/oktatasert-felelos-allamtitkarsag).The funders provided support in the form of salaries for authors DG, KMS, ZK, ABK and MG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The TOLL 96 Kft. provided support in the form of salaries for MJK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'authors contributions' section.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BENCINA D, 1987, AVIAN PATHOL, V16, P653, DOI 10.1080/03079458708436413; BRADBURY JM, 1987, AVIAN PATHOL, V16, P183, DOI 10.1080/03079458708436363; BRADBURY JM, 1988, INT J SYST BACTERIOL, V38, P74, DOI 10.1099/00207713-38-1-74; BRADBURY JM, 1984, INT J SYST BACTERIOL, V34, P389, DOI 10.1099/00207713-34-4-389; CZIFRA G, 1986, ACTA VET HUNG, V34, P211; Dobos-Kovacs M, 2009, AVIAN PATHOL, V38, P239, DOI 10.1080/03079450902912127; Grozner D, 2018, MICROBIOL RESOUR ANN, V7, DOI 10.1128/MRA.00939-18; Grozner D, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0799-0; Guo WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046018; HINZ KH, 1994, J VET MED B, V41, P145, DOI 10.1111/j.1439-0450.1994.tb00217.x; Huang JF, 2012, WORLD POULTRY SCI J, V68, P551, DOI 10.1017/S0043933912000645; IVANICS E, 1988, J VET MED B, V35, P368, DOI 10.1111/j.1439-0450.1988.tb00509.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kobelt DJ, 1998, ANAL LETT, V31, P41, DOI 10.1080/00032719808001832; Lauerman LH, 1995, AVIAN DIS, V39, P804, DOI 10.2307/1592417; Pisal RV, 2016, FOLIA BIOL-PRAGUE, V62, P203; Ramirez AS, 2008, VET MICROBIOL, V128, P279, DOI 10.1016/j.vetmic.2007.10.023; Raviv Z, 2009, AVIAN DIS, V53, P103, DOI 10.1637/8469-091508-Reg.1; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; ROBERTS DH, 1964, J COMP PATHOL THERAP, V74, P447, DOI 10.1016/S0368-1742(64)80051-5; ROBERTS DH, 1964, VET REC, V76, P1512; SAMUEL MD, 1995, J WILDLIFE DIS, V31, P172, DOI 10.7589/0090-3558-31.2.172; Sprygin A. V., 2012, Sel'skokhozyaistvennaya Biologiya, P87; STIPKOVITS L, 1993, AVIAN PATHOL, V22, P171, DOI 10.1080/03079459308418908; STIPKOVITS L, 1987, AVIAN PATHOL, V16, P453, DOI 10.1080/03079458708436395; STIPKOVITS L, 1985, AVIAN PATHOL, V14, P57, DOI 10.1080/03079458508436207; STIPKOVITS L, 1984, ACTA VET HUNG, V32, P117; Stipkovits L, 2012, POULTRY SCI, V91, P2812, DOI 10.3382/ps.2012-02310; Stipkovits L, 1996, REV SCI TECH OIE, V15, P1495, DOI 10.20506/rst.15.4.986; STIPKOVITS L, 1979, ZBL BAKT-INT J MED M, V245, P171; STIPKOVITS L, 1986, AVIAN PATHOL, V15, P289, DOI 10.1080/03079458608436289; Szathmary S, 2016, United States Pat Appl Publ, Patent No. [0082094 A1, 0082094A1]; TIONG SK, 1990, VET REC, V127, P64; VARGA Z, 1986, ARCH EXP VET MED, V40, P105; Volokhov D V., 2010, 18 IOM C CHIANC TERM, P78; Volokhov DV, 2012, MOL PHYLOGENET EVOL, V62, P515, DOI 10.1016/j.ympev.2011.11.002	37	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219071	10.1371/journal.pone.0219071	http://dx.doi.org/10.1371/journal.pone.0219071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295269	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000484951800013
J	Wu, HX; Zhang, BJ; Cai, GM; Li, J; Gu, XB				Wu, Hongxun; Zhang, Bingjie; Cai, Gangming; Li, Jie; Gu, Xiaobo			American College of Radiology thyroid imaging report and data system combined with K-RAS mutation improves the management of cytologically indeterminate thyroid nodules	PLOS ONE			English	Article							UNDETERMINED SIGNIFICANCE/FOLLICULAR LESION; BETHESDA SYSTEM; BRAF MUTATION; US FEATURES; CANCER; DIAGNOSIS; IMPACT; ATYPIA; V600E; ASSAY	We investigated whether use of American College of Radiology thyroid imaging report and data system (ACR TIRADS) in combination with K-RAS mutation status may facilitate risk stratification of patients with cytological Bethesda Category III and IV thyroid nodules. Ultrasonographic, cytological, and histopathological diagnoses were retrospectively correlated with K-RAS mutation status in a series of 43 cytologically indeterminate thyroid nodules (CITNs) that were referred for surgical excision. K-RAS mutations were detected in 8/43 (18.6%) fine-needle aspiration (FNA) samples as against 11/43 (25.6%) surgical specimens. ACR TIRADS level (TR) TR3 lesions had a malignancy risk of 40%; the K-RAS mutation rate in FNA samples and surgical specimens of category TR3 lesions was 40% and 60%, respectively. K-RAS mutation-positive malignancy was significantly more frequently detected in follicular neoplasm/suspicious for follicular neoplasm (FN/SFN) lesions than that in atypia or follicular lesion of undetermined significance (AUS/FLUS) (P<0.01). Combined use of ACR TIRADS (TR5 as the diagnostic threshold) and K-RAS mutation status helped identify 83.3% (10/12) malignant nodules (58.6% specificity, 45.5% positive predictive value, 89.5% negative predictive value, and 65.9% accuracy). CITNs with ACR TIRADS category TR3 showed an unexpectedly high risk of malignancy. K-RAS mutation-positive FN/SFN nodules have a 50% risk of malignancy and surgery should be recommended. Combined use of ACR TIRADS and K-RAS mutation may facilitate risk-stratification of patients with CITNs. The high negative predictive value (NPV) for malignancy seems sufficient to allow conservative management of patients with active surveillance.	[Wu, Hongxun; Zhang, Bingjie; Li, Jie] Minist Hlth, Jiangyuan Hosp, Jiangsu Key Lab Mol Nucl Med,Dept Ultrasound, Key Lab Nucl Med,Jiangsu Inst Nucl Med, Wuxi, Jiangsu, Peoples R China; [Cai, Gangming; Gu, Xiaobo] Minist Hlth, Jiangyuan Hosp, Jiangsu Key Lab Mol Nucl Med,Clin Mol Biol Lab, Key Lab Nucl Med,Jiangsu Inst Nucl Med, Wuxi, Jiangsu, Peoples R China		Wu, HX (corresponding author), Minist Hlth, Jiangyuan Hosp, Jiangsu Key Lab Mol Nucl Med,Dept Ultrasound, Key Lab Nucl Med,Jiangsu Inst Nucl Med, Wuxi, Jiangsu, Peoples R China.	whxmd@outlook.com	Wu, Hong xun/AAD-8875-2022	Wu, Hong xun/0000-0003-2837-2458	Wuxi Municipal Science and Technology Development Planning Funds [CSE31N1622]; Wuxi Health and Family Planning Commission Planning Funds [MS 201633]; Jiangsu Provincial Key Medical Discipline (Laboratory) [ZDXKA2016017]; Innovation Capacity Development Plan of Jiangsu Province [BM2018023]	Wuxi Municipal Science and Technology Development Planning Funds; Wuxi Health and Family Planning Commission Planning Funds; Jiangsu Provincial Key Medical Discipline (Laboratory); Innovation Capacity Development Plan of Jiangsu Province	The work was supported by Wuxi Municipal Science and Technology Development Planning Funds [grant number CSE31N1622] to HW; and Wuxi Health and Family Planning Commission Planning Funds [grant number MS 201633] to HW; and Jiangsu Provincial Key Medical Discipline (Laboratory) [grant number ZDXKA2016017] to HW; and Innovation Capacity Development Plan of Jiangsu Province [grant number BM2018023] to HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; Bongiovanni M, 2012, ACTA CYTOL, V56, P333, DOI 10.1159/000339959; Cantara S, 2010, J CLIN ENDOCR METAB, V95, P1365, DOI 10.1210/jc.2009-2103; Cibas ES, 2009, AM J CLIN PATHOL, V132, P658, DOI 10.1309/AJCPPHLWMI3JV4LA; de Biase D, 2014, J CLIN ENDOCR METAB, V99, pE1530, DOI 10.1210/jc.2013-4389; Dyhdalo K, 2014, CANCER CYTOPATHOL, V122, P114, DOI 10.1002/cncy.21356; Eszlinger M, 2015, THYROID, V25, P401, DOI 10.1089/thy.2014.0362; Gandolfi G, 2013, J CLIN ENDOCR METAB, V98, pE934, DOI 10.1210/jc.2012-3930; Ha EJ, 2016, KOREAN J RADIOL, V17, P811, DOI 10.3348/kjr.2016.17.5.811; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Horvath E, 2009, J CLIN ENDOCR METAB, V94, P1748, DOI 10.1210/jc.2008-1724; Hsiao SJ, 2014, ENDOCR-RELAT CANCER, V21, pT301, DOI 10.1530/ERC-14-0166; Kwak JY, 2011, RADIOLOGY, V260, P892, DOI 10.1148/radiol.11110206; Medici M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0419-z; Middleton WD, 2017, AM J ROENTGENOL, V208, P1324, DOI 10.2214/AJR.16.17613; Nikiforov YE, 2015, THYROID, V25, P1217, DOI 10.1089/thy.2015.0305; Nikiforov YE, 2011, J CLIN ENDOCR METAB, V96, P3390, DOI 10.1210/jc.2011-1469; Ohori NP, 2010, CANCER CYTOPATHOL, V118, P17, DOI 10.1002/cncy.20063; Rho M, 2017, ULTRASOUND Q, V33, P284, DOI 10.1097/RUQ.0000000000000313; Stence Aaron A., 2015, Yale Journal of Biology and Medicine, V88, P351; Tessler FN, 2017, J AM COLL RADIOL, V14, P587, DOI 10.1016/j.jacr.2017.01.046; Torregrossa L, 2016, J CLIN ENDOCR METAB, V101, P4413, DOI 10.1210/jc.2016-1775; Wang CCC, 2011, THYROID, V21, P243, DOI 10.1089/thy.2010.0243; Xing MZ, 2013, LANCET, V381, P1058, DOI 10.1016/S0140-6736(13)60109-9; Yip L, 2014, ANN SURG, V260, P163, DOI 10.1097/SLA.0000000000000215; Zhang YZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16927	26	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219383	10.1371/journal.pone.0219383	http://dx.doi.org/10.1371/journal.pone.0219383			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295281	Green Published, Green Submitted, gold			2022-12-26	WOS:000484951800029
J	Qureshi, S; Ahmad, K; Fatima, P; Hassan, RM; Sherali, F; Lalani, N; Jehan, F; Ali, SA; Qamar, FN				Qureshi, Sonia; Ahmad, Khalil; Fatima, Paras; Hassan, Rabia M.; Sherali, Farheen; Lalani, Naureen; Jehan, Fyezah; Ali, Syed Asad; Qamar, Farah Naz			Outcome of inadvertent high dose BCG administration in newborns at a tertiary care hospital, Karachi- Case series	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN	Bacillus Calmette-Guerin (BCG) vaccine is given to newborns soon after birth. BCG vaccine overdose has been rarely reported. Here we report the outcome of newborns who accidently received high dose BCG at a tertiary care hospital, Karachi. We reviewed records of 26 newborns, who accidentally received intradermal high dose BCG, used for the treatment of urinary bladder cancers and 80 times higher dose than the BCG used for routine vaccination. The incident happened from 14-16 th April, 2016 at Aga Khan University Hospital, Karachi. Analysis was carried out using SPSS. A total of 23/26(88.5%) newborns were followed for atleast 3 months and 11/26 (42.3%) were followed for atleast one year. 13/26 (50%) were male. All 26 patients were prescribed isoniazid and rifampicin for 3 months. 3/26 (11.5%) were lost to follow-up before completion of anti-tuberculous drugs (ATT). Lesions at the BCG site were observed in 16/26 (61.5%) infants, of which 15 (93.8%) had a papule, 3 (18.8%) developed a pustule, 3 (18.8%) had skin induration and 2 (12.5%) had skin erythema. Axillary lymphadenopathy was observed in 1/26 (3.8%) patient. Coagulation was deranged in 3/26 (11.5%) of babies. Intracranial bleeding was observed in 1/26 (3.8%) case. Localized skin lesions were the most common adverse events. None of them developed clinical tuberculosis. Chemoprophylaxis for inadvertent high dose BCG administration should be given for atleast 3 months. Furthermore, vigilant follow-up, transparency and disclosure are the vital steps in the management of any medical error.	[Qureshi, Sonia; Ahmad, Khalil; Hassan, Rabia M.; Sherali, Farheen; Lalani, Naureen; Jehan, Fyezah; Ali, Syed Asad; Qamar, Farah Naz] Aga Khan Univ, Dept Pediat & Child Hlth, Karachi, Pakistan; [Fatima, Paras] Aga Khan Univ, Karachi, Pakistan	Aga Khan University; Aga Khan University	Qamar, FN (corresponding author), Aga Khan Univ, Dept Pediat & Child Hlth, Karachi, Pakistan.	farah.qamar@aku.edu		Qureshi, Sonia/0000-0002-1099-2483; Ali, Syed Asad/0000-0001-5274-7665				Al-Maqbali Ali Abdullah, 2016, Oman Med J, V31, P315, DOI 10.5001/omj.2016.61; [Anonymous], 2016, INTRAVESICAL THERAPY; Ashraf T., 2015, PAK PEDIAT J, V39, P115; Chen G, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006135; Kang SY, 2010, NEUROL SCI, V31, P199, DOI 10.1007/s10072-009-0187-7; Lotte A, 1984, Adv Tuberc Res, V21, P107; Miles MM, 1996, BRIT MED J, V312, P1205; OBRIEN KL, 1995, PEDIATRICS, V95, P414; Puliyel JM, 1996, BRIT MED J, V313, P528, DOI 10.1136/bmj.313.7056.528; Rafati M, 2015, J PHARM CARE, V2, P132; Ritz N, 2009, VACCINE, V27, P5562, DOI 10.1016/j.vaccine.2009.07.043; Sampaziotis F, 2012, BRIT J CLIN PHARMACO, V73, P826, DOI 10.1111/j.1365-2125.2011.04158.x; Taylor JA, 2004, PEDIATRICS, V114, P729, DOI 10.1542/peds.2003-1124-L; Wei SH, 2018, PEDIATR NEONATOL, V59, P208, DOI 10.1016/j.pedneo.2017.07.004; World Health Organization, 2012, INF SHEET OBS RAT BC; World Health Organization, 2012, IMMUNIZATION VACCINE; Yakar F, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-13; Yarmohammadi Aliasghar, 2007, Urol J, V4, P121; Zheng YQ, 2015, EXPERT REV VACCINES, V14, P1255, DOI 10.1586/14760584.2015.1068124	19	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219324	10.1371/journal.pone.0219324	http://dx.doi.org/10.1371/journal.pone.0219324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291329	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800074
J	Geng, YH; Cao, GJ; Wang, LC; Wang, SH				Geng, Yuhui; Cao, Guojun; Wang, Lichun; Wang, Shuhua			Effects of equal chemical fertilizer substitutions with organic manure on yield, dry matter, and nitrogen uptake of spring maize and soil nitrogen distribution	PLOS ONE			English	Article							LONG-TERM APPLICATION; INORGANIC FERTILIZERS; MICROBIAL BIOMASS; CROPPING SYSTEMS; USE EFFICIENCY; CATTLE MANURE; WHEAT; PRODUCTIVITY; LEGUME; PADDY	In order to maintain high yields and protect the environment, the replacement of chemical fertilizers with organic ones has received increasing attention in recent years. A 2-year field experiment (2015-2016) was carried out to assess the effects of substituting equal amounts of mineral fertilizer with organic manure on the yield, dry matter (DM), and nitrogen (N) uptake of spring maize (Zea mays L.) and on the mineral N (Nmin) distribution in the soil profile. The treatments included chemical fertilizer; different amounts of maize straw, cow manure, and chicken manure; and an unfertilized control (CK). Compared with the chemical fertilizer treatments, equal amounts of substitutions with cow manure or chicken manure increased production, and a 25% nutrient substitution resulted in the best yield increase. Straw return had no effect on maize production, and 100% straw return resulted in reduced production. The N accumulation and DM content both exhibited a slow-fast-slow growth trend throughout the various growth stages, and the average N uptake and DM accumulation in response to the treatments followed the order of chicken manure > cow manure > chemical fertilizer > straw return > CK. The Nmin content in the profile not only increased as the Nmin application rate increased but also showed greater increases at certain depths than at the surface, indicating that excessive N led to leaching. These results suggest that an appropriate proportion of organic substitution not only provides enough nutrients but also improves the soil environment and leads to increased yields. This technique represents a practical method of continuously increasing production and reducing the risk of N leaching.	[Geng, Yuhui; Cao, Guojun; Wang, Shuhua] Jilin Agr Univ, Coll Resources & Environm, Changchun, Jilin, Peoples R China; [Wang, Lichun] Jilin Acad Agr Sci, Inst Agr Environm & Resources Res, Changchun, Jilin, Peoples R China	Jilin Agricultural University; Jilin Academy of Agricultural Sciences	Cao, GJ (corresponding author), Jilin Agr Univ, Coll Resources & Environm, Changchun, Jilin, Peoples R China.; Wang, LC (corresponding author), Jilin Acad Agr Sci, Inst Agr Environm & Resources Res, Changchun, Jilin, Peoples R China.	cgj72@126.com; wlc1960@163.com		cao, guojun/0000-0002-8709-514X	National Key Research and Development Program of China [2017YFD0201505]	National Key Research and Development Program of China	This study was supported by the National Key Research and Development Program of China (2017YFD0300604) and the National Key Research and Development Program of China (2017YFD0201505).	Adediran JA, 2004, J PLANT NUTR, V27, P1163, DOI 10.1081/PLN-120038542; Ahmad R, 2008, RENEW AGR FOOD SYST, V23, P243, DOI 10.1017/S1742170508002299; AZAM F, 1985, PLANT SOIL, V86, P3, DOI 10.1007/BF02185020; Bedada W, 2014, AGR ECOSYST ENVIRON, V195, P193, DOI 10.1016/j.agee.2014.06.017; Bharali A, 2017, SOIL TILL RES, V168, P81, DOI 10.1016/j.still.2016.12.001; Bhogal A, 1997, SOIL USE MANAGE, V13, P111, DOI 10.1111/j.1475-2743.1997.tb00568.x; Bi LD, 2009, AGR ECOSYST ENVIRON, V129, P534, DOI 10.1016/j.agee.2008.11.007; BREMER E, 1992, SOIL SCI SOC AM J, V56, P1155, DOI 10.2136/sssaj1992.03615995005600040025x; Celik I, 2010, GEODERMA, V160, P236, DOI 10.1016/j.geoderma.2010.09.028; Chen QW, 2016, EUR J AGRON, V80, P137, DOI 10.1016/j.eja.2016.08.002; Chen YL, 2014, FIELD CROP RES, V159, P1, DOI 10.1016/j.fcr.2014.01.002; Conacher J, 1998, BIOL AGRIC HORTIC, V16, P145, DOI 10.1080/01448765.1998.9755229; Diacono M, 2010, AGRON SUSTAIN DEV, V30, P401, DOI 10.1051/agro/2009040; Dordas CA, 2008, NUTR CYCL AGROECOSYS, V80, P283, DOI 10.1007/s10705-007-9143-1; Duan YH, 2011, SOIL SCI SOC AM J, V75, P1562, DOI 10.2136/sssaj2010.0315; Dunjana N, 2012, SOIL USE MANAGE, V28, P221, DOI 10.1111/j.1475-2743.2012.00394.x; Edmeades DC, 2003, NUTR CYCL AGROECOSYS, V66, P165, DOI 10.1023/A:1023999816690; El Sheikha, 2016, NUTR FOOD TECHNOL, V2, P1, DOI DOI 10.16966/2470-6086.112; Gastal F, 2002, J EXP BOT, V53, P789, DOI 10.1093/jexbot/53.370.789; GROFFMAN PM, 1987, PLANT SOIL, V97, P315, DOI 10.1007/BF02383222; Hao MD, 2005, PEDOSPHERE, V15, P189; Hao XH, 2008, NUTR CYCL AGROECOSYS, V81, P17, DOI 10.1007/s10705-007-9145-z; HARRIS GH, 1994, AGRON J, V86, P910, DOI 10.2134/agronj1994.00021962008600050028x; Hou XQ, 2012, SOIL RES, V50, P507, DOI 10.1071/SR11339; Huang S, 2010, AGR ECOSYST ENVIRON, V138, P44, DOI 10.1016/j.agee.2010.03.015; Kramer AW, 2002, AGR ECOSYST ENVIRON, V91, P233, DOI 10.1016/S0167-8809(01)00226-2; LADD JN, 1986, SOIL BIOL BIOCHEM, V18, P417, DOI 10.1016/0038-0717(86)90048-9; Li H, 2017, J INTEGR AGR, V16, P937, DOI 10.1016/S2095-3119(16)61559-9; Li JT, 2007, PEDOSPHERE, V17, P568, DOI 10.1016/S1002-0160(07)60067-8; Liang Q, 2012, NUTR CYCL AGROECOSYS, V92, P21, DOI 10.1007/s10705-011-9469-6; Liu MQ, 2009, APPL SOIL ECOL, V42, P166, DOI 10.1016/j.apsoil.2009.03.006; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Lu R.K, 2000, ANAL METHOD SOIL AGR; Manna MC, 2007, SOIL TILL RES, V94, P397, DOI 10.1016/j.still.2006.08.013; Martinez E, 2017, EUR J AGRON, V83, P78, DOI 10.1016/j.eja.2016.10.002; Pan GX, 2009, AGR ECOSYST ENVIRON, V131, P274, DOI 10.1016/j.agee.2009.01.020; Pan GX, 2009, AGR ECOSYST ENVIRON, V129, P344, DOI 10.1016/j.agee.2008.10.008; Pinitpaitoon S, 2011, FIELD CROP RES, V124, P302, DOI 10.1016/j.fcr.2011.06.018; Prasad JVNS, 2016, SOIL TILL RES, V156, P131, DOI 10.1016/j.still.2015.10.013; Reganold J. P., 1995, American Journal of Alternative Agriculture, V10, P36, DOI 10.1017/S088918930000610X; Sanz-Cobena A, 2017, AGR ECOSYST ENVIRON, V238, P5, DOI 10.1016/j.agee.2016.09.038; Schroder J, 2005, BIORESOURCE TECHNOL, V96, P253, DOI 10.1016/j.biortech.2004.05.015; Singh U., 2001, TheScientificWorldJOURNAL, V1, P880, DOI 10.1100/tsw.2001.361; Tong YN, 1997, NUTR CYCL AGROECOSYS, V48, P225; Wang XL, 2017, AGR WATER MANAGE, V187, P88, DOI 10.1016/j.agwat.2017.03.017; Wen ZH, 2016, PEDOSPHERE, V26, P62, DOI 10.1016/S1002-0160(15)60023-6; Xin XL, 2017, FIELD CROP RES, V208, P27, DOI 10.1016/j.fcr.2017.03.011; Zavattaro L, 2016, EUR J AGRON, V77, P199, DOI 10.1016/j.eja.2016.02.004; Zhang YL, 2016, SOIL TILL RES, V155, P85, DOI 10.1016/j.still.2015.08.006; Zhao BQ, 2010, AGRON J, V102, P216, DOI 10.2134/agronj2009.0182; Zhao J, 2016, APPL SOIL ECOL, V99, P1, DOI 10.1016/j.apsoil.2015.11.006; Zhong WH, 2007, APPL SOIL ECOL, V36, P84, DOI 10.1016/j.apsoil.2006.12.001	52	69	73	25	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219512	10.1371/journal.pone.0219512	http://dx.doi.org/10.1371/journal.pone.0219512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287845	Green Published, gold, Green Submitted			2022-12-26	WOS:000482328300027
J	McGinley, G; Bendiksen, BA; Zhang, LL; Aronsen, JM; Norden, ES; Sjaastad, I; Espe, EKS				McGinley, Gary; Bendiksen, Bard A.; Zhang, Lili; Aronsen, Jan Magnus; Norden, Einar Sjaastad; Sjaastad, Ivar; Espe, Emil K. S.			Accelerated magnetic resonance imaging tissue phase mapping of the rat myocardium using compressed sensing with iterative soft-thresholding	PLOS ONE			English	Article							BREATH-HOLD; MRI; MOTION; TRACKING; STRAIN	Introduction Tissue Phase Mapping (TPM) MRI can accurately measure regional myocardial velocities and strain. The lengthy data acquisition, however, renders TPM prone to errors due to variations in physiological parameters, and reduces data yield and experimental throughput. The purpose of the present study is to examine the quality of functional measures (velocity and strain) obtained by highly undersampled TPM data using compressed sensing reconstruction in infarcted and non-infarcted rat hearts. Methods Three fully sampled left-ventricular short-axis TPM slices were acquired from 5 non-infarcted rat hearts and 12 infarcted rat hearts in vivo. The datasets were used to generate retrospectively (simulated) undersampled TPM datasets, with undersampling factors of 2, 4, 8 and 16. Myocardial velocities and circumferential strain were calculated from all datasets. The error introduced from undersampling was then measured and compared to the fully sampled data in order to validate the method. Finally, prospectively undersampled data were acquired and compared to the fully sampled datasets. Results Bland Altman analysis of the retrospectively undersampled and fully sampled data revealed narrow limits of agreement and little bias (global radial velocity: median bias = -0.01 cm/s, 95% limits of agreement = [-0.16, 0.20] cm/s, global circumferential strain: median bias = -0.01% strain, 95% limits of agreement = [-0.43, 0.51] % strain, all for 4x undersampled data at the mid-ventricular level). The prospectively undersampled TPM datasets successfully demonstrated the feasibility of method implementation. Conclusion Through compressed sensing reconstruction, highly undersampled TPM data can be used to accurately measure the velocity and strain of the infarcted and non-infarcted rat myocardium in vivo, thereby increasing experimental throughput and simultaneously reducing error introduced by physiological variations over time.	[McGinley, Gary; Bendiksen, Bard A.; Zhang, Lili; Aronsen, Jan Magnus; Norden, Einar Sjaastad; Sjaastad, Ivar; Espe, Emil K. S.] Oslo Univ Hosp, Inst Expt Med Res, Oslo, Norway; [McGinley, Gary; Bendiksen, Bard A.; Zhang, Lili; Aronsen, Jan Magnus; Norden, Einar Sjaastad; Sjaastad, Ivar; Espe, Emil K. S.] Univ Oslo, Oslo, Norway; [McGinley, Gary; Bendiksen, Bard A.; Zhang, Lili; Aronsen, Jan Magnus; Norden, Einar Sjaastad; Sjaastad, Ivar; Espe, Emil K. S.] Univ Oslo, KG Jebsen Ctr Cardiac Res, Oslo, Norway; [McGinley, Gary; Bendiksen, Bard A.; Zhang, Lili; Aronsen, Jan Magnus; Norden, Einar Sjaastad; Sjaastad, Ivar; Espe, Emil K. S.] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Bendiksen, Bard A.; Aronsen, Jan Magnus; Norden, Einar Sjaastad] Bjorknes Univ Coll, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Espe, EKS (corresponding author), Oslo Univ Hosp, Inst Expt Med Res, Oslo, Norway.; Espe, EKS (corresponding author), Univ Oslo, Oslo, Norway.; Espe, EKS (corresponding author), Univ Oslo, KG Jebsen Ctr Cardiac Res, Oslo, Norway.; Espe, EKS (corresponding author), Univ Oslo, Ctr Heart Failure Res, Oslo, Norway.	ekespe@medisin.uio.no	Espe, Emil/AAF-6293-2020	Espe, Emil/0000-0001-8500-4921	South-Eastern Norway Regional Health Authority (Oslo, Norway); KG Jebsen Center for Cardiac Research and Center for Heart Failure Research (Oslo, Norway)	South-Eastern Norway Regional Health Authority (Oslo, Norway); KG Jebsen Center for Cardiac Research and Center for Heart Failure Research (Oslo, Norway)	This work was supported by South-Eastern Norway Regional Health Authority (Oslo, Norway), KG Jebsen Center for Cardiac Research and Center for Heart Failure Research (Oslo, Norway). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletras AH, 1999, J MAGN RESON, V137, P247, DOI 10.1006/jmre.1998.1676; Aronsen JM, 2017, AM J PHYSIOL-HEART C, V312, pH932, DOI 10.1152/ajpheart.00668.2016; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Chen X, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0253-2; Dall'Armellina E, 2012, MAGN RESON MED, V67, P541, DOI 10.1002/mrm.23022; Delfino JG, 2008, J MAGN RESON IMAGING, V27, P522, DOI 10.1002/jmri.21211; Espe EKS, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005997; Espe EKS, 2014, MAGN RESON MED, V72, P1096, DOI 10.1002/mrm.25023; Espe EKS, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-82; Espe EKS, 2013, MAGN RESON MED, V69, P48, DOI 10.1002/mrm.24226; Ibrahim ESH, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-36; Jung B, 2006, EUR J CARDIO-THORAC, V29, pS150, DOI 10.1016/j.ejcts.2006.02.066; Jung B, 2008, MAGN RESON MED, V60, P1169, DOI 10.1002/mrm.21764; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Paul J, 2016, MAGN RESON MED, V75, P789, DOI 10.1002/mrm.25669; PELC NJ, 1995, JMRI-J MAGN RESON IM, V5, P339, DOI 10.1002/jmri.1880050319; Rahman ZU, 2017, WORLD J CARDIOL, V9, P312, DOI 10.4330/wjc.v9.i4.312; Simpson R, 2014, MAGN RESON MED, V72, P659, DOI 10.1002/mrm.24971; Sjaastad I, 2000, J APPL PHYSIOL, V89, P1445, DOI 10.1152/jappl.2000.89.4.1445; Wang HF, 2009, IEEE ENG MED BIO, P2672, DOI 10.1109/IEMBS.2009.5334086; Wech T, 2014, ROFO-FORTSCHR RONTG, V186, P37, DOI 10.1055/s-0033-1350521; Wech T, 2011, J MAGN RESON IMAGING, V34, P1072, DOI 10.1002/jmri.22718; Zhu YD, 1997, IEEE T MED IMAGING, V16, P840	23	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0218874	10.1371/journal.pone.0218874	http://dx.doi.org/10.1371/journal.pone.0218874			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276508	gold, Green Published, Green Submitted			2022-12-26	WOS:000484936300026
J	Wieben, ED; Aleff, RA; Basu, S; Sarangi, V; Bowman, B; McLaughlin, IJ; Mills, JR; Butz, ML; Highsmith, EW; Ida, CM; Ekholm, JM; Baratz, KH; Fautsch, MP				Wieben, Eric D.; Aleff, Ross A.; Basu, Shubham; Sarangi, Vivekananda; Bowman, Brett; McLaughlin, Ian J.; Mills, John R.; Butz, Malinda L.; Highsmith, Edward W.; Ida, Cristiane M.; Ekholm, Jenny M.; Baratz, Keith H.; Fautsch, Michael P.			Amplification-free long-read sequencing of TCF4 expanded trinucleotide repeats in Fuchs Endothelial Corneal Dystrophy	PLOS ONE			English	Article							INTERRUPTIONS	Amplification of a CAG trinucleotide motif (CTG18.1) within the TCF4 gene has been strongly associated with Fuchs Endothelial Corneal Dystrophy (FECD). Nevertheless, a small minority of clinically unaffected elderly patients who have expanded CTG18.1 sequences have been identified. To test the hypothesis that the CAG expansions in these patients are protected from FECD because they have interruptions within the CAG repeats, we utilized a combination of an amplification-free, long-read sequencing method and a new target-enrichment sequence analysis tool developed by Pacific Biosciences to interrogate the sequence structure of expanded repeats. The sequencing was successful in identifying a previously described interruption within an unexpanded allele and provided sequence data on expanded alleles greater than 2000 bases in length. The data revealed considerable heterogeneity in the size distribution of expanded repeats within each patient. Detailed analysis of the long sequence reads did not reveal any instances of interruptions to the expanded CAG repeats, but did reveal novel variants within the AGG repeats that flank the CAG repeats in two of the five samples from clinically unaffected patients with expansions. This first examination of the sequence structure of CAG repeats in CTG18.1 suggests that factors other than interruptions to the repeat structure account for the absence of disease in some elderly patients with repeat expansions in the TCF4 gene.	[Wieben, Eric D.; Aleff, Ross A.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Basu, Shubham; Sarangi, Vivekananda] Mayo Clin, Div Biostat & Bioinformat, Rochester, MN USA; [Basu, Shubham; Sarangi, Vivekananda] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Bowman, Brett; McLaughlin, Ian J.; Ekholm, Jenny M.] Pacific Biosci Calif Inc, Menlo Pk, CA USA; [Mills, John R.; Butz, Malinda L.; Highsmith, Edward W.; Ida, Cristiane M.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Baratz, Keith H.; Fautsch, Michael P.] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Fautsch, MP (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA.	fautsch@mayo.edu			National Eye Institute [EY21727, EY26490]; Robert Waller Career Development Award; Mayo Foundation for Medical Education and Research	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Robert Waller Career Development Award; Mayo Foundation for Medical Education and Research	Funding for this project was provided by National Eye Institute grants EY21727 (MPF) and EY26490 (MPF), Robert Waller Career Development Award (KHB), and the Mayo Foundation for Medical Education and Research (MPF, KHB, EDW). Pacific Biosciences provided support for employees associated with the company (BB, IJM, JME).	Baker BS, 2002, J ALGORITHM, V42, P231, DOI 10.1006/jagm.2002.1214; Breschel TS, 1997, HUM MOL GENET, V6, P1855, DOI 10.1093/hmg/6.11.1855; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; Ebbert MTW, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0274-4; Hafford-Tear NJ, 2019, GENET MED, V21, P2092, DOI 10.1038/s41436-019-0453-x; Hoijer I, 2018, HUM MUTAT, V39, P1262, DOI 10.1002/humu.23580; Kraus-Perrotta Cara, 2016, Cerebellum Ataxias, V3, P20; Matsuura T, 2006, AM J HUM GENET, V78, P125, DOI 10.1086/498654; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; Stolle CA, 2008, MOVEMENT DISORD, V23, P1303, DOI 10.1002/mds.22012; Tsai YC., 2017, BIORXIV, DOI [10.1101/203919, DOI 10.1101/203919]; WATERMAN MS, 1976, ADV MATH, V20, P367, DOI 10.1016/0001-8708(76)90202-4; Wieben ED, 2014, INVEST OPHTH VIS SCI, V55, P6101, DOI 10.1167/iovs.14-14958; Wieben ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049083	15	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219446	10.1371/journal.pone.0219446	http://dx.doi.org/10.1371/journal.pone.0219446			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276570	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300082
J	do Amaral, CC; Fernandes, GF; Rodrigues, AM; Burger, E; de Camargo, ZP				do Amaral, Cristiane Candida; Fernandes, Geisa Ferreira; Rodrigues, Anderson Messias; Burger, Eva; de Camargo, Zoilo Pires			Proteomic analysis of Paracoccidioides brasiliensis complex isolates: Correlation of the levels of differentially expressed proteins with in vivo virulence	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEINS; CANDIDA-ALBICANS; BINDING; ARMADILLOS; STRESS; RNA; HOMEOSTASIS; RESISTANCE; ANTIBODIES; RESPONSES	Background Paracoccidioidomycosis (PCM) is a systemic mycosis commonly found in Latin America that is caused by distinct species of Paracoccidioides genus: Paracoccidioides brasiliensis complex (S1, PS2, PS3 and PS4) and Paracoccidioides lutzii. Its pathobiology has been recently explored by different approaches to clarify the mechanisms of host-pathogen interactions underpinning PCM. The diversity of clinical forms of this disease has been attributed to both host-and fungus-related factors. Methodology/Principal findings For better understanding of the molecular underpinnings of host-fungus interactions, we evaluated in vivo virulence of nine Paracoccidioides brasiliensis complex isolates and correlated it to protein expression profiles obtained by two-dimensional gel electrophoresis. Based on the recovery of viable fungi from mouse organs, the isolates were classified as those having low, moderate, or high virulence. Highly virulent isolates overexpressed proteins related to adhesion process and stress response, probably indicating important roles of those fungal proteins in regulating the colonization capacity, survival, and ability to escape host immune system reaction. Moreover, highly virulent isolates exhibited enhanced expression of glycolytic pathway enzymes concomitantly with repressed expression of succinylCoA ligase beta chain, a protein related to the tricarboxylic acid cycle. Conclusions/Significance Our findings may point to the mechanisms used by highly virulent P. brasiliensis isolates to withstand host immune reactions and to adapt to transient iron availability as strategies to survive and overcome stress conditions inside the host.	[do Amaral, Cristiane Candida] Fed Univ Sao Paulo UNIFESP, Discipline Infect Dis, Dept Med, Sao Paulo, Brazil; [Fernandes, Geisa Ferreira; Rodrigues, Anderson Messias; de Camargo, Zoilo Pires] Fed Univ Sao Paulo UNIFESP, Discipline Cellular Biol, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Burger, Eva] Fed Univ Alfenas UNIFAL, Dept Microbiol & Immunol, Alfenas, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Alfenas	de Camargo, ZP (corresponding author), Fed Univ Sao Paulo UNIFESP, Discipline Cellular Biol, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil.	zpcamargo1@gmail.com	Rodrigues, Anderson M./V-4069-2019	Rodrigues, Anderson M./0000-0003-0891-4563	Sao Paulo Research Foundation (FAPESP); National Council for Scientific and Technological Development (CNPq); Coordination for the Improvement of Higher Education Personnel (CAPES); FAPESP [2009/54024-2, 2017/27265-5]; CNPq [429594/2018-6, 150605/2015-3]; CAPES [88887.177846/2018-00]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported, in part, by grants from Sao Paulo Research Foundation (FAPESP), the National Council for Scientific and Technological Development (CNPq) and Coordination for the Improvement of Higher Education Personnel (CAPES). ZPdC acknowledges the financial support of FAPESP (2009/54024-2) and CNPq (429594/2018-6). AMR acknowledges the financial support of FAPESP (2017/27265-5) and CAPES (88887.177846/2018-00). GFF is a fellow and acknowledges the financial support of CNPq (150605/2015-3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBORNOZ MB, 1971, SABOURAUD, V9, P248; Alves Lysangela Ronalte, 2016, World J Biol Chem, V7, P78, DOI 10.4331/wjbc.v7.i1.78; Andre DC, 2004, MICROBES INFECT, V6, P549, DOI 10.1016/j.micinf.2004.02.010; Arantes TD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004606; Chaves EGA, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0393-9; Ariyachet C, 2013, INFECT IMMUN, V81, P1267, DOI 10.1128/IAI.00864-12; Arrigo AP, 2005, ANTIOXID REDOX SIGN, V7, P414, DOI 10.1089/ars.2005.7.414; Askew C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000612; Barbosa MS, 2006, INFECT IMMUN, V74, P382, DOI 10.1128/IAI.74.1.382-389.2006; Barbosa S. F. C., 1981, Revista do Instituto Adolfo Lutz, V41, P121; BIAGIONI L, 1984, T ROY SOC TROP MED H, V78, P617, DOI 10.1016/0035-9203(84)90220-7; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bocca AL, 2013, FUTURE MICROBIOL, V8, P1177, DOI 10.2217/fmb.13.68; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUMMER E, 1990, MYCOPATHOLOGIA, V109, P13, DOI 10.1007/BF00437001; Bueno JP, 1997, J MED VET MYCOL, V35, P213; Buissa-Filho R, 2008, INFECT IMMUN, V76, P3321, DOI 10.1128/IAI.00349-08; CALICH VLG, 1985, BRIT J EXP PATHOL, V66, P585; Camargo ZP, 2003, MED MYCOL, V41, P539, DOI 10.1080/13693780310001615358; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; CASTANEDA E, 1988, INFECT IMMUN, V56, P1771, DOI 10.1128/IAI.56.7.1771-1777.1988; Castilho DG, 2014, J PROTEOME RES, V13, P4259, DOI 10.1021/pr5002274; Chagas RF, 2008, FUNGAL GENET BIOL, V45, P1470, DOI 10.1016/j.fgb.2008.08.007; Chaves E. G., 2015, SABIOS REVISTA DE SA, V15, P53, DOI 10.1186/s12866-015-0393-9; da Fonseca CA, 2001, MICROBES INFECT, V3, P535, DOI 10.1016/S1286-4579(01)01409-5; Dagley MJ, 2011, MOL MICROBIOL, V79, P968, DOI 10.1111/j.1365-2958.2010.07503.x; Dantas AS, 2008, MYCOL RES, V112, P747, DOI 10.1016/j.mycres.2007.11.018; de Camargo ZP, 2008, MYCOPATHOLOGIA, V165, P289, DOI 10.1007/s11046-007-9060-5; DECAMARGO ZP, 1988, J CLIN MICROBIOL, V26, P2147, DOI 10.1128/JCM.26.10.2147-2151.1988; Desjardins CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002345; Dias-Melicio LA, 2006, MICROBIOL IMMUNOL, V50, P307, DOI 10.1111/j.1348-0421.2006.tb03798.x; FA VA NETTO Celeste., 1961, Revista do Instituto Adolfo Lutz, V21, P99; Fernandes FF, 2017, MBIO, V8, DOI [10.1128/mBio.00537-17, 10.1128/mbio.00537-17]; FERREIRA MS, 1990, J MED VET MYCOL, V28, P253; Gank KD, 2008, EUKARYOT CELL, V7, P1318, DOI 10.1128/EC.00402-07; Garcia Nilam Maciel, 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P227, DOI 10.1590/S0036-46651993000300003; Gegembauer G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002986; Gezuele E, 1989, PROCEEDINGS IV INTER; Glazier VE, 2014, VIRULENCE, V5, P351, DOI 10.4161/viru.27187; Grossklaus DD, 2013, MICROBES INFECT, V15, P347, DOI 10.1016/j.micinf.2012.12.002; Grosso DD, 2003, INFECT IMMUN, V71, P6534, DOI 10.1128/IAI.71.11.6534-6542.2003; Hahn RC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007437; Hahn RC, 2014, AM J TROP MED HYG, V91, P394, DOI 10.4269/ajtmh.13-0482; Harvey R, 2017, BIOCHEM SOC T, V45, P1007, DOI 10.1042/BST20160364; Hebeler-Barbosa F, 2003, MED MYCOL, V41, P89, DOI 10.1080/714043903; Hrycyk MF, 2018, MED MYCOL, V56, P950, DOI 10.1093/mmy/myx142; Jackson Brian, 2011, Human Genomics, V5, P283; KRISHNAN K, 2014, BMC GENOMICS, V15, DOI DOI 10.4161/RNA.8.2.15391; Kurokawa Cilmery S., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P257, DOI 10.1590/S0036-46652005000500004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee K, 2016, MOL CELLS, V39, P179, DOI 10.14348/molcells.2016.2359; Li ZH, 2011, RNA BIOL, V8, P305, DOI 10.4161/rna.8.2.15391; Longo L.V.G., 2014, EUPA OPEN PROTEOMICS, V3, P216, DOI [10.1016/j.euprot.2014.03.003, DOI 10.1016/J.EUPROT.2014.03.003]; Bailao EFLC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002856; Lutz A., 1908, BRAS MED, V22, P121; Macoris SAG, 2006, MEM I OSWALDO CRUZ, V101, P331, DOI 10.1590/S0074-02762006000300019; Marcos CM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00719; Missall TA, 2006, EUKARYOT CELL, V5, P518, DOI 10.1128/EC.5.3.518-529.2006; Missall TA, 2004, EUKARYOT CELL, V3, P835, DOI 10.1128/EC.3.4.835-846.2004; Montagnoli C, 2003, EUR J IMMUNOL, V33, P1193, DOI 10.1002/eji.200323790; Moreira SFI, 2004, YEAST, V21, P173, DOI 10.1002/yea.1077; Munoz JF, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00213-16; NIMRICHTER L, 2016, FRONT MICROBIOL, V7, DOI DOI 10.3389/FMICB.2014.00719; Nishikaku AS, 2008, BRAZ J INFECT DIS, V12, P57, DOI 10.1590/S1413-86702008000100013; Parente AFA, 2015, MICROBES INFECT, V17, P575, DOI 10.1016/j.micinf.2015.03.012; Parente AFA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022810; Parente-Rocha JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137619; Fortes MRP, 2011, AN BRAS DERMATOL, V86, P516, DOI 10.1590/S0365-05962011000300014; Pigosso LL, 2013, FUNGAL GENET BIOL, V60, P87, DOI 10.1016/j.fgb.2013.07.008; Preville X, 1999, EXP CELL RES, V247, P61, DOI 10.1006/excr.1998.4347; PUCCIA R, 1986, INFECT IMMUN, V53, P199, DOI 10.1128/IAI.53.1.199-206.1986; Ribeiro LRR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/852574; Roberto TN, 2016, MED MYCOL, V54, P240, DOI 10.1093/mmy/myv083; Rodrigues AM, 2015, J PROTEOMICS, V115, P8, DOI 10.1016/j.jprot.2014.11.013; Romani L, 1999, CURR OPIN MICROBIOL, V2, P363, DOI 10.1016/S1369-5274(99)80064-2; Salvemini F, 1999, J BIOL CHEM, V274, P2750, DOI 10.1074/jbc.274.5.2750; SANTOS RD, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0052470; Schrettl M, 2011, CURR OPIN MICROBIOL, V14, P400, DOI 10.1016/j.mib.2011.06.002; Silva PFF, 2015, GENET MOL RES, V14, P17416, DOI 10.4238/2015.December.21.11; Silva-Vergara ML, 1998, MED MYCOL, V36, P37, DOI 10.1080/02681219880000061; Silva-Vergara ML, 2000, MED MYCOL, V38, P193, DOI 10.1080/714030937; SINGERVERMES LM, 1994, CLIN EXP IMMUNOL, V97, P113, DOI 10.1111/j.1365-2249.1994.tb06588.x; Singh S, 2013, FREE RADICAL BIO MED, V56, P89, DOI 10.1016/j.freeradbiomed.2012.11.010; Mendes-Giannini MJS, 2006, MICROBES INFECT, V8, P1550, DOI 10.1016/j.micinf.2006.01.012; TABORDA CP, 1993, MED MYCOL, V31, P347, DOI DOI 10.1080/02681219380000441; Tamayo D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004481; TEIXEIRA HC, 1987, BRAZ J MED BIOL RES, V20, P587; Teixeira MM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004397; Theodoro RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037694; Tillmann AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126940; Toledo RG, 2010, MOL IMMUNOL, V48, P26, DOI 10.1016/j.molimm.2010.09.015; Turissini DA, 2017, FUNGAL GENET BIOL, V106, P9, DOI 10.1016/j.fgb.2017.05.007; Vaejo MC, 2012, J PROTEOME RES, V11, P1676, DOI 10.1021/pr200872s; Vallejo MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039463; Van Assche E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00141; Weber SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052470	97	11	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2019	14	7							e0218013	10.1371/journal.pone.0218013	http://dx.doi.org/10.1371/journal.pone.0218013			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3ZV	31265468	Green Published, Green Submitted			2022-12-26	WOS:000484921200005
J	Liu, ZC; Yang, K; Yan, XM; Wang, TQ; Jiang, T; Zhou, Q; Qi, J; Qian, ND; Zhou, HB; Chen, B; Huang, P; Guo, L; Zhang, XK; Xu, X; Jiang, M; Deng, L				Liu, Zhuochao; Yang, Kai; Yan, Xueming; Wang, Tianqi; Jiang, Tao; Zhou, Qi; Qi, Jin; Qian, Niandong; Zhou, Hanbing; Chen, Bo; Huang, Ping; Guo, Lei; Zhang, Xingkai; Xu, Xing; Jiang, Min; Deng, Lianfu			The effects of tranylcypromine on osteoclastogenesis in vitro and in vivo	FASEB JOURNAL			English	Article						osteoclasts; monoamine oxidase inhibitor; bone loss	DIFFERENTIATION; INHIBITORS; CANCER; DERIVATIVES; ACTIVATION; LSD1; EXPRESSION; DENOSUMAB; DRUGS; NFAT2	Identification of anti-osteoclastogenic agents is important for the treatment of bone loss diseases that feature excessive osteoclast (OC) activity and bone resorption. Tranylcypromine (TCP), an irreversible inhibitor of monoamine oxidase (MAO), has been used as an antidepressant and anxiolytic agent in the clinical treatment of mood and anxiety disorders. TCP has been discovered to exert anabolic effect on osteoblasts, and MAO-A has also been verified as an important mediator in prostate cancer cells to accelerate osteoclastogenesis. In current study, we were focused on TCP and MAO-A effects on osteoclastogenesis. As illustrated by tartrate-resistant acid phosphatase staining, TCP was capable of inhibiting osteoclastogenesis induced by receptor activators of the NF-kappa B ligand (RANKL) in bone marrow-derived macrophage cells without any cytotoxicity. It was also shown to effectively suppress bone resorption of OCs. The subsequent study revealed that TCP inhibited osteoclastogenesis-related genes in a time-dependent manner through protein kinase B (AKT)-mediated mechanism followed by the nuclear factor of activated T cells, cytoplasmic 1 (NFATc1)-c-fos pathway. And TCP could overcome the osteoclastogenic effects of AKT activator SC79. In addition, our results indicated that the expression and catalytic activity of MAO-A were up-regulated by RANKL stimulation and down-regulated by TCP in vitro and in vivo. Furthermore, the effects of MAO-A knockdown on OC differentiation indicated that MAO-A played an important role in osteoclastogenesis in vitro and might contribute to the inhibitory effects of TCP. And AKT, NFATc1, and c-fos were involved in the MAO-A pathway. Notably, our in vivo study reflected that TCPs were capable of restoring the bone loss in LPS-induced calvaria osteolysis and estrogen deficiency-induced osteoporosis models. Thus, our current work provided a potential option for the treatment of bone loss diseases and highlighted the important role of MAO-A in osteoclastogenesis as well.-Liu, Z., Yang, K., Yan, X., Wang, T., Jiang, T., Zhou, Q., Qi, J., Qian, N., Zhou, H., Chen, B., Huang, P., Guo, L., Zhang, X., Xu, X., Jiang, M., Deng, L. The effects of tranylcypromine on osteoclastogenesis in vitro and in vivo.	[Liu, Zhuochao; Yang, Kai; Yan, Xueming; Wang, Tianqi; Jiang, Tao; Zhou, Qi; Qi, Jin; Qian, Niandong; Zhou, Hanbing; Chen, Bo; Huang, Ping; Guo, Lei; Xu, Xing; Jiang, Min; Deng, Lianfu] Shanghai Jiao Tong Univ, Shanghai Key Lab Bone & Joint Dis, Shanghai Ruijin Hosp, Shanghai Inst Traumatol & Orthopaed,Sch Med, Shanghai, Peoples R China; [Liu, Zhuochao; Zhang, Xingkai] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Dept Orthoped, Shanghai, Peoples R China; [Jiang, Tao] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Dept Traumatol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, X; Jiang, M (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Shanghai Inst Traumatol & Orthopaed, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.	xuxing0510315@126.com; jiangm263@163.com			Natural Science Foundation of China [81703576, 81502902]; Shanghai Municipal Health Bureau Young Scientific Research Project [20154Y0005, 201840185]; Committee of Science and Technology Young Scientific Research Foundation of Shanghai [16ZR1431900]; Natural Science Foundation of Shanghai [17140901800]; Ruijing Young Talent Program [GCQN-2017-A16, GCQN-2017-B22]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau Young Scientific Research Project; Committee of Science and Technology Young Scientific Research Foundation of Shanghai; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Ruijing Young Talent Program	This work was supported by the Natural Science Foundation of China (81703576, 81502902), Shanghai Municipal Health Bureau Young Scientific Research Project (20154Y0005, 201840185), Committee of Science and Technology Young Scientific Research Foundation of Shanghai (16ZR1431900), Natural Science Foundation of Shanghai (17140901800), and Ruijing Young Talent Program (GCQN-2017-A16, GCQN-2017-B22). The authors declare no conflicts of interest.	Altar CA, 2003, BIOL PSYCHIAT, V54, P703, DOI 10.1016/S0006-3223(03)00073-8; Anagnostis P, 2015, CLIMACTERIC, V18, P32, DOI 10.3109/13697137.2015.1099092; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bartell SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4773; Battaglino R, 2004, J BONE MINER RES, V19, P1420, DOI 10.1359/JBMR.040606; Binda C, 2010, J AM CHEM SOC, V132, P6827, DOI 10.1021/ja101557k; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brown JP, 2014, CAN FAM PHYSICIAN, V60, P324; BURGER A, 1948, J AM CHEM SOC, V70, P2198, DOI 10.1021/ja01186a062; Campas Clara, 2009, Drug News Perspect, V22, P126, DOI 10.1358/dnp.2009.22.2.1334453; Cao X, 2011, NAT MED, V17, P1344, DOI 10.1038/nm.2499; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Duan YC, 2017, EUR J MED CHEM, V140, P392, DOI 10.1016/j.ejmech.2017.09.038; Furuya M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02541-w; Gokosmanoglu F, 2016, J RES MED SCI, V21, DOI 10.4103/1735-1995.193503; Halleen JM, 2006, CLIN LAB, V52, P499; Huang J, 2017, CHEM ECOL, V8, P1, DOI DOI 10.3389/FNEUR.2017.00626]; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ivy AS, 2003, PHARMACOL BIOCHEM BE, V75, P81, DOI 10.1016/S0091-3057(03)00044-3; Jones LH, 2017, NAT REV DRUG DISCOV, V16, P285, DOI 10.1038/nrd.2016.244; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Koide M, 2017, J BONE MINER RES, V32, P2074, DOI 10.1002/jbmr.3175; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Metozzi A, 2015, EXPERT REV ENDOCRINO, V10, P153, DOI 10.1586/17446651.2015.979787; Mollard E, 2018, INT J WOMENS HEALTH, V10, P1, DOI 10.2147/IJWH.S147006; Mukherjee A, 2012, MOL CELL BIOL, V32, P490, DOI 10.1128/MCB.06361-11; Poole L, 2018, J PSYCHOSOM RES, V113, P30, DOI 10.1016/j.jpsychores.2018.07.009; Sawant A, 2013, CANCER RES, V73, P672, DOI 10.1158/0008-5472.CAN-12-2202; Schulz-Fincke J, 2018, EUR J MED CHEM, V144, P52, DOI 10.1016/j.ejmech.2017.12.001; Shi CG, 2016, J BONE MINER RES, V31, P1003, DOI 10.1002/jbmr.2770; Soysa NS, 2016, BIOCHEM BIOPH RES CO, V476, P115, DOI 10.1016/j.bbrc.2016.05.019; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Strittmatter SM, 2014, NAT MED, V20, P590, DOI 10.1038/nm.3595; Sun J, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0015-x; Sun K, 2017, BIOORG MED CHEM LETT, V27, P5036, DOI 10.1016/j.bmcl.2017.10.003; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Ulrich S, 2017, EUR NEUROPSYCHOPHARM, V27, P697, DOI 10.1016/j.euroneuro.2017.05.007; Wilson SR, 2009, J BIOL CHEM, V284, P2584, DOI 10.1074/jbc.M805280200; Wu JB, 2017, CANCER CELL, V31, P368, DOI 10.1016/j.ccell.2017.02.003; Xiong JH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05244-y; Xiong JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138189; Xu X, 2016, EUR J MED CHEM, V123, P769, DOI 10.1016/j.ejmech.2016.08.004; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zheng YC, 2016, CURR TOP MED CHEM, V16, P2179, DOI 10.2174/1568026616666160216154042	49	9	9	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9828	9841		10.1096/fj.201802242RR	http://dx.doi.org/10.1096/fj.201802242RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31291555				2022-12-26	WOS:000482214200012
J	Mandati, V; Del Maestro, L; Dingli, F; Lombard, B; Loew, D; Molinie, N; Romero, S; Bouvard, D; Louvard, D; Gautreau, AM; Pasmant, E; Lallemand, D				Mandati, Vinay; Del Maestro, Laurence; Dingli, Florent; Lombard, Berangere; Loew, Damarys; Molinie, Nicolas; Romero, Stephane; Bouvard, Daniel; Louvard, Daniel; Gautreau, Alexis M.; Pasmant, Eric; Lallemand, Dominique			Phosphorylation of Merlin by Aurora A kinase appears necessary for mitotic progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; mitosis; phosphorylation; tumor suppressor gene; tubulin; cell proliferation; Aurora A; isoforms; Merlin; neurofibromatosis type 2; NF2; Merlin; NF2; ezrin	TUMOR-SUPPRESSOR GENE; NEUROFIBROMATOSIS TYPE-2; MISSENSE MUTATION; ERM PROTEINS; CELL CORTEX; NF2; ACTIVATION; TUMORIGENESIS; PRODUCT; PATHWAY	Although Merlin's function as a tumor suppressor and regulator of mitogenic signaling networks such as the Ras/rac, Akt, and Hippo pathways is well-documented, in mammals as well as in insects, its role during cell cycle progression remains unclear. In this study, using a combination of approaches, including FACS analysis, time-lapse imaging, immunofluorescence microscopy, and co-immunoprecipitation, we show that Ser-518 of Merlin is a substrate of the Aurora protein kinase A during mitosis and that its phosphorylation facilitates the phosphorylation of a newly discovered site, Thr-581. We found that the expression in HeLa cells of a Merlin variant that is phosphorylation-defective on both sites leads to a defect in centrosomes and mitotic spindles positioning during metaphase and delays the transition from metaphase to anaphase. We also show that the dual mitotic phosphorylation not only reduces Merlin binding to microtubules but also timely modulates ezrin interaction with the cytoskeleton. Finally, we identify several point mutants of Merlin associated with neurofibromatosis type 2 that display an aberrant phosphorylation profile along with defective alpha-tubulin-binding properties. Altogether, our findings of an Aurora A-mediated interaction of Merlin with alpha-tubulin and ezrin suggest a potential role for Merlin in cell cycle progression.	[Mandati, Vinay; Del Maestro, Laurence; Louvard, Daniel; Lallemand, Dominique] PSL Res Univ, CNRS, UMR144, Inst Curie, F-75005 Paris, France; [Dingli, Florent; Lombard, Berangere; Loew, Damarys] PSL Res Univ, Inst Curie, Lab Spectrometrie Masse Prote, F-75005 Paris, France; [Molinie, Nicolas; Romero, Stephane; Gautreau, Alexis M.] Inst Polytech Paris, CNRS, UMR7654, BIOC, F-91128 Palaiseau, France; [Bouvard, Daniel] INSERM, U823, Inst Albert Bonniot, F-38042 Grenoble, France; [Pasmant, Eric] Univ Paris 05, Sorbonne Paris Cite, INSERM, Inst Cochin,U1016, F-75014 Paris, France; [Mandati, Vinay] Cold Spring Harbor Lab, New York, NY 11724 USA; [Del Maestro, Laurence] Univ Paris, CNRS, UMR 7216, Epigenet & Cell Fate, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cold Spring Harbor Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Lallemand, D (corresponding author), Univ Paris 05, Sorbonne Paris Cite, INSERM, Inst Cochin,U1016, F-75014 Paris, France.	dominique.lallemand@inserm.fr	Gautreau, Alexis/AAT-2751-2020; Pasmant, Eric/O-7249-2017; Romero, Stephane/K-5998-2017; lallemand, dominique/O-7445-2017; Romero, Stephane/GLR-3472-2022; Mandati, Vinay/AAZ-1898-2020	Gautreau, Alexis/0000-0002-2369-4362; Pasmant, Eric/0000-0002-1881-8762; Romero, Stephane/0000-0002-7358-3871; lallemand, dominique/0000-0002-0212-7342; Romero, Stephane/0000-0002-7358-3871; 	Pierre Gilles de Gennes Foundation; Association pour la Recherche sur le Cancer (ARC); Association Neurofibromatose et Recklinghausen (ANR); Institut National du Cancer (INCA); Centre Nationale de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Institut Curie	Pierre Gilles de Gennes Foundation; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association Neurofibromatose et Recklinghausen (ANR)(French National Research Agency (ANR)); Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Centre Nationale de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Curie	This work was supported by the Pierre Gilles de Gennes Foundation (to V. M.). The project was also supported by Association pour la Recherche sur le Cancer (ARC), Association Neurofibromatose et Recklinghausen (ANR), and Institut National du Cancer (INCA), Centre Nationale de la Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), and Institut Curie. The authors declare that they have no conflicts of interest with the contents of this article.	Baser ME, 2002, AM J HUM GENET, V71, P715, DOI 10.1086/342716; Boin A, 2014, NEURO-ONCOLOGY, V16, P1196, DOI 10.1093/neuonc/nou020; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Chinthalapudi K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03648-4; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Ganem NJ, 2012, J CELL BIOL, V199, P871, DOI 10.1083/jcb.201210040; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Giovannini M, 2000, GENE DEV, V14, P1617; Giovannini M, 1999, GENE DEV, V13, P978, DOI 10.1101/gad.13.8.978; Gronholm M, 2006, ONCOGENE, V25, P4389, DOI 10.1038/sj.onc.1209475; Guerrant W, 2016, CANCER RES, V76, P3507, DOI 10.1158/0008-5472.CAN-15-1144; Hebert AM, 2012, GENE DEV, V26, P2709, DOI 10.1101/gad.194027.112; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Kluwe L, 1996, HUM GENET, V97, P224, DOI 10.1007/BF02265270; Kschonsak YT, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214544; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Lallemand D, 2009, ONCOGENE, V28, P854, DOI 10.1038/onc.2008.427; Lallemand D, 2009, J CELL SCI, V122, P4141, DOI 10.1242/jcs.045914; Laulajainen M, 2012, J CELL MOL MED, V16, P2161, DOI 10.1111/j.1582-4934.2012.01525.x; Laulajainen M, 2011, NEOPLASIA, V13, P643, DOI 10.1593/neo.11356; Li W, 2014, CANCER CELL, V26, P48, DOI 10.1016/j.ccr.2014.05.001; Li W, 2012, EMBO REP, V13, P204, DOI 10.1038/embor.2012.11; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; Machicoane M, 2014, J CELL BIOL, V205, P791, DOI 10.1083/jcb.201401049; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; McClatchey AI, 1997, GENE DEV, V11, P1253, DOI 10.1101/gad.11.10.1253; Meng JJ, 2000, J NEUROSCI RES, V62, P491, DOI 10.1002/1097-4547(20001115)62:4<491::AID-JNR3>3.0.CO;2-D; Moleirinho S, 2017, ELIFE, V6, DOI 10.7554/eLife.23966; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Muranen T, 2005, ONCOGENE, V24, P1150, DOI 10.1038/sj.onc.1208283; Muranen T, 2007, HUM MOL GENET, V16, P1742, DOI 10.1093/hmg/ddm122; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pellock BJ, 2007, DEV BIOL, V304, P102, DOI 10.1016/j.ydbio.2006.12.021; Reboutier D, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00290; Ruttledge MH, 1996, AM J HUM GENET, V59, P331; Schulz A, 2013, NAT NEUROSCI, V16, P426, DOI 10.1038/nn.3348; Scoles DR, 1996, NEUROLOGY, V47, P544, DOI 10.1212/WNL.47.2.544; Sher I, 2012, DEV CELL, V22, P703, DOI 10.1016/j.devcel.2012.03.008; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; Smole Z, 2014, CANCER RES, V74, P353, DOI 10.1158/0008-5472.CAN-13-1334; Solinet S, 2013, J CELL BIOL, V202, P251, DOI 10.1083/jcb.201304052; Su T, 2017, DEV CELL, V40, P478, DOI 10.1016/j.devcel.2017.02.004; TIKOO A, 1994, J BIOL CHEM, V269, P23387; Xing WC, 2017, BIOCHEM BIOPH RES CO, V493, P46, DOI 10.1016/j.bbrc.2017.09.077; Yabuta N, 2011, CELL CYCLE, V10, P2724, DOI 10.4161/cc.10.16.16873; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015	52	6	7	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12992	13005		10.1074/jbc.RA118.006937	http://dx.doi.org/10.1074/jbc.RA118.006937			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296571	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000486416000011
J	Majem, B; Parrilla, A; Jimenez, C; Suarez-Cabrera, L; Barber, M; Marin, A; Castellvi, J; Tamayo, G; Moreno-Bueno, G; Ponce, J; Matias-Guiu, X; Alameda, F; Romero, I; Sanchez, JL; Perez-Benavente, A; Moran, S; Esteller, M; Reventos, J; Rigau, M; Gil-Moreno, A; Segura, MF; Santamaria, A				Majem, Blanca; Parrilla, Alfonso; Jimenez, Carlos; Suarez-Cabrera, Leticia; Barber, Marta; Marin, Andrea; Castellvi, Josep; Tamayo, Gabriel; Moreno-Bueno, Gema; Ponce, Jordi; Matias-Guiu, Xavier; Alameda, Francesc; Romero, Ignacio; Luis Sanchez, Jose; Perez-Benavente, Asuncion; Moran, Sebastian; Esteller, Manel; Reventos, Jaume; Rigau, Marina; Gil-Moreno, Antonio; Segura, Miguel F.; Santamaria, Anna			MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways	ONCOGENE			English	Article							SPHEROID FORMATION; DNA METHYLATION; ELEVATED CDCP1; EXPRESSION; PLAGL2; CELLS; PROGRESSION; CARCINOMA; SURVIVAL; LEUKEMIA	Ovarian cancer is the most lethal gynecological malignancy due to the silent nature on its early onset and the rapid acquisition of drug resistance. Histologically heterogeneous, it includes several subtypes with different mutational landscapes, hampering the development of effective targeted therapies. Non-coding RNAs are emerging as potential new therapeutic targets in cancer. To search for a microRNA signature related to ovarian carcinomas and study its potential as effective targeted therapy, we examined the expression of 768 miRNA in a large collection of tumor samples and found miR-654-5p to be infraexpressed in ovarian serous carcinomas, the most common and aggressive type. Restoration of miR654-5p levels reduced tumor cell viability in vitro and in vivo and impaired sphere formation capacity and viability of ovarian cancer patient-derived ascitic cells ex vivo. CDCP1 and PLAGL2 oncogenes were found to be the most relevant direct miR-654-5p targets and both genes convey in a molecular signature associated with key cancer pathways relevant to ovarian tumorigenesis, such as MYC, WNT and AKT pathways. Together, we unveiled the tumor suppressor function of miR-654-5p, suggesting that its restoration or co-targeting of CDCP1 and PLAGL2 may be an effective therapeutic approach for ovarian cancer.	[Majem, Blanca; Parrilla, Alfonso; Suarez-Cabrera, Leticia; Barber, Marta; Marin, Andrea; Tamayo, Gabriel; Santamaria, Anna] UAB, Cell Cycle & Canc Lab, Grp Biomed Res Urol, Vall Hebron Res Inst VHIR, Barcelona 08035, Spain; [Jimenez, Carlos; Segura, Miguel F.] UAB, Grp Translat Res Child & Adolescent Canc, Vall Hebron Res Inst VHIR, Barcelona 08035, Spain; [Castellvi, Josep] Vall Hebron Univ Hosp, Dept Pathol, Barcelona 08035, Spain; [Moreno-Bueno, Gema] UAM, Dept Biochem, Inst Invest Biomed Alberto Sols, CIBERONC,IdiPaz,CSIC, Madrid 28029, Spain; [Moreno-Bueno, Gema] Fdn MD Anderson Int, Madrid 28033, Spain; [Ponce, Jordi] Univ Barcelona, Univ Hosp Bellvitge IDIBELL, Dept Gynaecol, Barcelona 08908, Spain; [Matias-Guiu, Xavier] Univ Lleida, Dept Pathol, Hosp Univ Arnau de Vilanova, IRB Lleida, Lleida 25198, Spain; [Matias-Guiu, Xavier; Reventos, Jaume] Hosp Univ Bellvitge, CIBERONC, IDIBELL, Dept Pathol, Barcelona 08908, Spain; [Alameda, Francesc] Hosp del Mar, Pathol Dept, Barcelona 08003, Spain; [Romero, Ignacio] IVO, Dept Med Oncol, Valencia 46009, Spain; [Luis Sanchez, Jose; Perez-Benavente, Asuncion; Gil-Moreno, Antonio] UAB, Dept Gynecol Oncol, Vall Hebron Univ Hosp, Barcelona 08035, Spain; [Luis Sanchez, Jose; Perez-Benavente, Asuncion; Gil-Moreno, Antonio] UAB, CIBERONC, Grp Biomed Res Gynecol, Vall Hebron Res Inst VHIR, Barcelona 08035, Spain; [Moran, Sebastian; Esteller, Manel] Bellvitge Biomed Res Inst IDIBELL, CIBERONC, Canc Epigenet & Biol Program PEBC, Barcelona 08908, Spain; [Esteller, Manel] UB, Physiol Sci Dept, Sch Med & Hlth Sci, Barcelona 08036, Spain; [Esteller, Manel] ICREA, Barcelona 08010, Spain; [Reventos, Jaume] Univ Int Catalunya, Dept Basic Sci, Barcelona 08017, Spain; [Rigau, Marina] Bellvitge Biomed Res Inst IDIBELL, Barcelona 08908, Spain; [Majem, Blanca] Bellvitge Biomed Res Inst IDIBELL, Cell Death Regulat Grp, Oncobell Program, Barcelona 08908, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari Vall d'Hebron; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Texas System; UTMD Anderson Cancer Center; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Universitat de Lleida; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Instituto Valenciano De Oncologia; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; ICREA; Universitat Internacional de Catalunya (UIC); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Santamaria, A (corresponding author), UAB, Cell Cycle & Canc Lab, Grp Biomed Res Urol, Vall Hebron Res Inst VHIR, Barcelona 08035, Spain.	anna.santamaria@vhir.org	matias-guiu, xavier/C-3039-2009; /AAD-2326-2020; Castellvi, Josep/C-5092-2014; Segura, Miguel F/J-4749-2013; Majem, Blanca/AAN-6687-2021; Esteller, Manel/L-5956-2014; Moreno-Bueno, Gema/K-9354-2016; PEREZ BENAVENTE, ASUNCION/J-8272-2016	matias-guiu, xavier/0000-0002-7201-6605; /0000-0001-9219-3492; Castellvi, Josep/0000-0001-5745-9996; Segura, Miguel F/0000-0003-0916-3618; Esteller, Manel/0000-0003-4490-6093; Moreno-Bueno, Gema/0000-0002-5030-6687; PEREZ BENAVENTE, ASUNCION/0000-0003-1872-9003	Instituto de la Mujer Dexeus [DEXEUSB29/012]; CIBER [CB16/12/00328]; SGR [2017 SGR 1661]; Fondos FEDER [RTC-2015-3821-1]; Instituto Carlos III [PI15/00238, PI17/00564]; Miguel Servet Program [CP13/00158, CPII18/00027, CPII16/00006]; predoctoral VHIR fellowships [VHIR: PRED-VHIR-2014-11, PRED-VHIR-2017]; AGAUR predoctoral fellowship [AGAUR: 2017FI_ B_ 00095]; Ministerio de Economia y Competitividad	Instituto de la Mujer Dexeus; CIBER; SGR; Fondos FEDER(European Commission); Instituto Carlos III(Instituto de Salud Carlos III); Miguel Servet Program; predoctoral VHIR fellowships; AGAUR predoctoral fellowship; Ministerio de Economia y Competitividad(Spanish Government)	We are thankful to Drs. Diego Arango and Agueda Martinez, Dr. Sung Goo Park and Dr. Rosanna Paciucci for 9E10 c-Myc, anti-HAX1 and anti-RB and anti-p-RB antibodies, respectively. We thank Dr. Francesc Vinals, Dr. Barbara Vanderhyden, Dr. Antonio Rosato, Dr. Erich A. Nigg and the Ovarian Cancer Research Team for cell lines. We are grateful to Drs. Aroa Soriano and Luz Jubierre for experimental help. We acknowledge technical support from the Flow Cytometry Facility at Center of Genomic Regulation (CRG) and the Unitat d'Estadistica i Bioinformatica (UEB) and the Unitat d'Alta Tecnologia (UAT) at VHIR. We thank all our lab members for support and helpful discussions. This work was supported in part by grants from Instituto de la Mujer Dexeus (DEXEUSB29/012), CIBER (CB16/12/00328), SGR (2017 SGR 1661), the Ministerio de Economia y Competitividad and Fondos FEDER (RTC-2015-3821-1), Instituto Carlos III (PI15/00238 to A. S. and PI17/00564 to M. F. S) and the Miguel Servet Program (CP13/00158 and CPII18/00027 to AS. and CPII16/00006 to MFS). AP and LS were supported by predoctoral VHIR fellowships and CJ by an AGAUR predoctoral fellowship (VHIR: PRED-VHIR-2014-11 and PRED-VHIR-2017; AGAUR: 2017FI_ B_ 00095, respectively).	Adair SJ, 2009, CANCER IMMUNOL IMMUN, V58, P589, DOI 10.1007/s00262-008-0582-6; Banerjee S, 2013, CLIN CANCER RES, V19, P961, DOI 10.1158/1078-0432.CCR-12-2243; Beg MS, 2017, INVEST NEW DRUG, V35, P180, DOI 10.1007/s10637-016-0407-y; Bi LL, 2016, ONCOL REP, V36, P2563, DOI 10.3892/or.2016.5055; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chen MW, 2017, CANCER RES, V77, P1955, DOI 10.1158/0008-5472.CAN-16-1115; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; George A, 2017, NAT REV CLIN ONCOL, V14, P284, DOI 10.1038/nrclinonc.2016.191; Harrington BS, 2016, BRIT J CANCER, V114, P417, DOI 10.1038/bjc.2015.471; He Y, 2016, ONCOGENE, V35, P468, DOI 10.1038/onc.2015.101; Hensen K, 2002, CANCER RES, V62, P1510; Honkoop AH, 1997, AM J CLIN PATHOL, V107, P211, DOI 10.1093/ajcp/107.2.211; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Jaco F, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-24; Ji WD, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010021; Jubierre L, 2016, ONCOGENE, V35, P5179, DOI 10.1038/onc.2016.50; Karnezis AN, 2017, NAT REV CANCER, V17, P65, DOI 10.1038/nrc.2016.113; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Klinkebiel D, 2016, MOL CANCER RES, V14, P787, DOI 10.1158/1541-7786.MCR-16-0097; Landrette SF, 2011, LEUKEMIA, V25, P655, DOI 10.1038/leu.2010.301; Landrette SF, 2005, BLOOD, V105, P2900, DOI 10.1182/blood-2004-09-3630; Li Jianqi, 2015, Zhonghua Zhong Liu Za Zhi, V37, P324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maire G, 2011, CANCER GENET-NY, V204, P138, DOI 10.1016/j.cancergen.2010.12.012; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Matulonis UA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.61; Moran S, 2014, EPIGENETICS-US, V9, P829, DOI 10.4161/epi.28790; Ostling P, 2011, CANCER RES, V71, P1956, DOI 10.1158/0008-5472.CAN-10-2421; Paydas S, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0749-5; Poole CJ, 2017, GENES-BASEL, V8, DOI 10.3390/genes8050142; Prahm KP, 2016, APMIS, V124, P337, DOI 10.1111/apm.12514; Reyes-Gonzalez JM, 2015, MOL CANCER THER, V14, P2260, DOI 10.1158/1535-7163.MCT-14-0801; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Sehouli J, 2016, GEBURTSH FRAUENHEILK, V76, P164, DOI 10.1055/s-0035-1558185; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Soriano A, 2016, ONCOTARGET, V7, P9271, DOI 10.18632/oncotarget.7005; Takahashi M, 2016, CANCER SCI, V107, P417, DOI 10.1111/cas.12892; Tan YY, 2016, AM J CANCER RES, V6, P522; Ueland FR, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7010014; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wang YP, 2017, ONCOL REP, V37, P1961, DOI 10.3892/or.2017.5485; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Zehavi L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-44; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zheng HW, 2010, CANCER CELL, V17, P497, DOI 10.1016/j.ccr.2010.03.020	49	44	47	1	19	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 8	2019	38	32					6035	6050		10.1038/s41388-019-0860-0	http://dx.doi.org/10.1038/s41388-019-0860-0			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IP8XH	31278368	Green Published			2022-12-26	WOS:000480329900003
J	Zhu, YX; He, D; Bo, H; Liu, ZX; Xiao, MQ; Xiang, L; Zhou, JD; Liu, Y; Liu, XM; Gong, L; Ma, YN; Zhou, YH; Zhou, M; Xiong, W; Yang, F; Xing, XW; Li, RH; Li, W; Cao, K				Zhu, Yuxing; He, Dong; Bo, Hao; Liu, Zexian; Xiao, Mengqing; Xiang, Liang; Zhou, Jianda; Liu, Yan; Liu, Xiaoming; Gong, Lian; Ma, Yanni; Zhou, Yanhong; Zhou, Ming; Xiong, Wei; Yang, Fei; Xing, Xiaowei; Li, Ruhong; Li, Wei; Cao, Ke			The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway	ONCOGENE			English	Article							NONCODING RNAS; BREAST-CANCER; CARCINOMA; RADIOTHERAPY; CHEMORADIOTHERAPY; TUMORIGENICITY; PROGRESSION; MIR-27B; GROWTH; NPC	Long non-coding RNA (lncRNA) plays an important role in malignant tumor occurrence, development, and chemoresistance, but the mechanism of how they affect nasopharyngeal cancer (NPC) paclitaxel chemosensitivity is unclear. In this study, lncRNA array of CNE-1 and HNE-2 paclitaxel-resistant cells and their parental strains revealed that the paclitaxel-resistant strains had significantly lower MRVI1-AS1 (murine retrovirus integration site 1 homolog antisense RNA 1) expression than the parental strains, and that MRVI1-AS1 overexpression in vitro and in vivo increased paclitaxel chemosensitivity. Further, MRVI1-AS1 upregulated ATF3 (activating transcription factor 3) by simultaneously inhibiting miR-513a-5p (microRNA-513a-5p) and miR-27b-3p expression levels to increase NPC paclitaxel chemosensitivity. Chromatin immunoprecipitation and quantitative real-time PCR showed that ATF3 could feed-back MRVI1-AS1 regulation positively. Furthermore, MRVI1-AS1 and ATF3 could form a positive feedback loop, which promoted the expression of RASSF1 (Ras association domain family member 1), a Hippo-TAZ (tafazzin) signaling pathway regulatory factor, thereby inhibiting TAZ expression. The MTT (3-[4,5- dimethylthiazol- 2- yl]- 2,5 diphenyltetrazolium bromide) assay and flow cytometry showed that the decreased TAZ increased NPC cell paclitaxel chemosensitivity. Overall, the results indicate that the MRVI1-AS1/ATF3 signaling pathway can increase NPC paclitaxel chemosensitivity by modulating the Hippo-TAZ signaling pathway. Therefore, targeting the loop may be a new NPC treatment strategy.	[Zhu, Yuxing; Xiao, Mengqing; Xiang, Liang; Gong, Lian; Ma, Yanni; Cao, Ke] Cent S Univ, Dept Oncol, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China; [He, Dong] Hunan Univ Chinese Med, Dept Respirat, Peoples Hosp Hunan Prov 2, Changsha 410000, Hunan, Peoples R China; [Bo, Hao] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha 410083, Hunan, Peoples R China; [Liu, Zexian] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Zhou, Jianda; Liu, Yan] Cent S Univ, Xiangya Hosp 3, Dept Plast Surg, Changsha 410013, Hunan, Peoples R China; [Liu, Xiaoming] Cent S Univ, Dept Gastroenterol, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China; [Zhou, Yanhong; Zhou, Ming; Xiong, Wei] Cent S Univ, Canc Res Inst, Minist Hlth, Changsha 410078, Hunan, Peoples R China; [Zhou, Yanhong; Zhou, Ming; Xiong, Wei] Cent S Univ, Key Lab Carcinogenesis, Minist Hlth, Changsha 410078, Hunan, Peoples R China; [Yang, Fei] Cent S Univ, Sch Publ Hlth, Changsha 410078, Hunan, Peoples R China; [Xing, Xiaowei] Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha 410013, Hunan, Peoples R China; [Li, Ruhong] Kunming Med Univ, Yanan Affiliated Hosp, Kunming 650051, Yunnan, Peoples R China; [Li, Wei] Cent S Univ, Xiangya Hosp 3, Dept Otolaryngol Head Neck Surg, Changsha 410013, Hunan, Peoples R China	Central South University; Hunan University of Chinese Medicine; Central South University; State Key Lab Oncology South China; Sun Yat Sen University; Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; Kunming Medical University; Central South University	Cao, K (corresponding author), Cent S Univ, Dept Oncol, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China.	csucaoke@163.com	wu, Xianrui/AAM-6540-2021; Liu, Zexian/D-1153-2011	wu, Xianrui/0000-0003-4803-5934; Liu, Zexian/0000-0001-9698-0610; Cao, Ke/0000-0001-5392-2306	National Natural Science Foundation of China [81874137]; Outstanding Youth Foundation of Hunan Province [2018JJ1047]; Huxiang Young Talent Project [2016RS3022]; Innovation-Driven Project of Central South University [2017CX012]; Fundamental Research Funds for the Central Universities of Central South University [2018zzts955]; New Xiangya Talent Projects of the Third Xiangya Hospital of Central South University [20150201, JY201710]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth Foundation of Hunan Province; Huxiang Young Talent Project; Innovation-Driven Project of Central South University; Fundamental Research Funds for the Central Universities of Central South University; New Xiangya Talent Projects of the Third Xiangya Hospital of Central South University	This work was supported by the National Natural Science Foundation of China (81874137), the Outstanding Youth Foundation of Hunan Province (2018JJ1047), the Huxiang Young Talent Project (2016RS3022), the Innovation-Driven Project of Central South University (2017CX012), the Fundamental Research Funds for the Central Universities of Central South University, Grant/Award Number: 2018zzts955, and the New Xiangya Talent Projects of the Third Xiangya Hospital of Central South University (20150201, JY201710).	Blanchard P, 2015, LANCET ONCOL, V16, P645, DOI 10.1016/S1470-2045(15)70126-9; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Chang YS, 2017, P NATL ACAD SCI USA, V114, pE7159, DOI 10.1073/pnas.1700455114; Chueh AC, 2017, CLIN CANCER RES, V23, P5573, DOI 10.1158/1078-0432.CCR-17-0466; Giovinazzi S, 2012, ONCOGENE, V31, P13, DOI 10.1038/onc.2011.211; Guo Z, 2017, ONCOTARGET, V8, P62286, DOI 10.18632/oncotarget.19725; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Kassler Susannah, 2012, Mol Biol Int, V2012, P263267, DOI 10.1155/2012/263267; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lee JJ, 2012, ONCOGENE, V31, P3818, DOI 10.1038/onc.2011.543; Lin CR, 2018, TRENDS CELL BIOL, V28, P287, DOI 10.1016/j.tcb.2017.11.008; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Liu J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0246-6; Lo KW, 2012, SEMIN CANCER BIOL, V22, P79, DOI 10.1016/j.semcancer.2011.12.011; Matsui M, 2017, NAT REV DRUG DISCOV, V16, P167, DOI 10.1038/nrd.2016.117; Maugeri-Sacca M, 2018, PHARMACOL THERAPEUT, V186, P60, DOI 10.1016/j.pharmthera.2017.12.011; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Muti P, 2018, CARCINOGENESIS, V39, P98, DOI 10.1093/carcin/bgx126; Oh YK, 2008, MOL CANCER RES, V6, P1232, DOI 10.1158/1541-7786.MCR-07-0297; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Ren SL, 2016, ONCOL REP, V36, P1861, DOI 10.3892/or.2016.4981; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shen SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100664; Sun YQ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0113-5; Suzuki M, 2016, J CLIN INVEST, V126, P254, DOI 10.1172/JCI79775; Taniue K, 2016, P NATL ACAD SCI USA, V113, P12739, DOI 10.1073/pnas.1605938113; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Totaro A, 2018, NAT CELL BIOL, V20, P888, DOI 10.1038/s41556-018-0142-z; van Heesch S, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r6; Wang QS, 2017, CELL CYCLE, V16, P795, DOI 10.1080/15384101.2017.1301334; Wang SY, 2017, J CLIN INVEST, V127, P4498, DOI 10.1172/JCI91553; Wang YF, 2009, J BIOL CHEM, V284, P23094, DOI 10.1074/jbc.M109.012617; Xiong H, 2017, ONCOGENE, V36, P3528, DOI 10.1038/onc.2016.521; Yang YQ, 2018, J INVEST DERMATOL, V138, P2205, DOI 10.1016/j.jid.2018.03.1510; You R, 2017, THERANOSTICS, V7, P4825, DOI 10.7150/thno.21815; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zeng QH, 2018, CLIN CANCER RES, V24, P445, DOI 10.1158/1078-0432.CCR-17-0419; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhu J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.361	40	30	30	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 8	2019	38	32					6065	6081		10.1038/s41388-019-0858-7	http://dx.doi.org/10.1038/s41388-019-0858-7			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IP8XH	31273338				2022-12-26	WOS:000480329900005
J	Chrismas, BCR; Taylor, L; Cherif, A; Sayegh, S; Bailey, DP				Chrismas, Bryna C. R.; Taylor, Lee; Cherif, Anissa; Sayegh, Suzan; Bailey, Daniel P.			Breaking up prolonged sitting with moderate-intensity walking improves attention and executive function in Qatari females	PLOS ONE			English	Article							COGNITIVE PERFORMANCE; POSTPRANDIAL GLYCEMIA; GLUCOSE; CONSUMPTION; STATEMENT; APPETITE; OFFICE; MOOD; TIME	Background Cultural, environmental and logistical factors promote a sedentary lifestyle within Qatar, particularly for females. Sedentary behaviour is acutely associated with poor cognitive function and fatigue, and chronically may be implicated with cognitive decline (i.e. Alzheimer's disease). Purpose To examine the effects of breaking up sitting with short-duration frequent walking bouts on cognitive function and fatigue in Qatari females. Method Eleven sedentary (sitting. >= 7 h/day) females completed three visits; the first being familiarisation. In a cross-over randomised manner, experimental visits two and three were identical, except participants either remained seated for 5-h (SIT) or interrupted their sitting every 30-min with a 3-min moderate-intensity walk (WALK) on a motorised treadmill. The Computerised Mental Performance Assessment System (COMPASS) assessed cognition at baseline (-15-min), and then at 2.5-h and 5-h into the experimental conditions. Specific COMPASS tasks employed were; serial-3 subtractions (2-min), serial-7 subtractions (2-min), simple reaction time (RT; 50 stimuli), rapid visual information processing [RVIP (5-min)], choice reaction time (CRT; 50 stimuli), and Stroop (60 stimuli); and a visual analogue scale for fatigue (VAS-F) was completed at the same time intervals. Results There was a significant condition effect for CRT (f = 26.7, p = 0.007). On average CRT was 101 s (95% CI = -47 to -156 s) quicker in WALK compared to SIT. There was a significant time effect for CRT (f = 15.5, p = 0.01). On average CRT was 134 s slower at 5-h compared to baseline (p = 0.006; 95% CI = -64 to -203 s), and 114 s slower at 5-h compared to 2.5-h (p = 0.01; 95% CI = -44 to -183 s). There was a significant interaction effect for RT in the Stroop incongruent task (f = 10.0, p = 0.03). On average RT was 210 s quicker at 2.5-h in WALK compared to SIT (p = 0.01; 95% CI = -76 to -346 s). Conclusion Breaking up prolonged sitting with moderate-intensity walking offers an ecologically valid intervention to enhance some aspects of cognitive function, whilst not affecting fatigue in sedentary Qatari females. Whilst these findings are promising, the long-term effects of breaking up sitting on cognitive function requires testing before population level recommendations can be made.	[Chrismas, Bryna C. R.] Qatar Univ, Coll Arts & Sci, Sport Sci Program, Doha, Qatar; [Taylor, Lee; Cherif, Anissa] Qatar Orthopaed & Sports Med Hosp, Athlete Hlth & Performance Res Ctr, ASPETAR, Doha, Qatar; [Taylor, Lee] Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Sayegh, Suzan] Qatar Orthopaed & Sports Med Hosp, ASPETAR, Exercise Med, Doha, Qatar; [Bailey, Daniel P.] Univ Bedfordshire, Inst Sport & Phys Act Res, Sch Sport Sci & Phys Act, Bedford, England	Qatar University; Aspetar Orthopaedic & Sports Medicine Hospital; Loughborough University; Aspetar Orthopaedic & Sports Medicine Hospital; University of Bedfordshire	Chrismas, BCR (corresponding author), Qatar Univ, Coll Arts & Sci, Sport Sci Program, Doha, Qatar.	bchrismas@qu.edu.qa	Bailey, Daniel/HDL-7697-2022	Bailey, Daniel/0000-0003-3772-630X; Chrismas, Bryna/0000-0003-3498-3829	Qatar University Centre for Health Sciences SEED interdisciplinary grant [CHSS-SF-16-2]; Qatar National Library	Qatar University Centre for Health Sciences SEED interdisciplinary grant; Qatar National Library(Qatar National Research Fund (QNRF))	Funding for this study was received from Qatar University Centre for Health Sciences SEED interdisciplinary grant (CHSS-SF-16-2). The publication of this article was funded by the Qatar National Library.	Bailey DP, 2017, EUR J APPL PHYSIOL, V117, P1299, DOI 10.1007/s00421-017-3610-4; Bailey DP, 2016, APPL PHYSIOL NUTR ME, V41, P324, DOI 10.1139/apnm-2015-0462; Bailey DP, 2015, J SCI MED SPORT, V18, P294, DOI 10.1016/j.jsams.2014.03.008; Baker R, 2018, ERGONOMICS, V61, P877, DOI 10.1080/00140139.2017.1420825; Bergouignan A, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0437-z; Bergouignan A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32044; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Buckley JP, 2015, BRIT J SPORT MED, V49, P1357, DOI 10.1136/bjsports-2015-094618; Carter SE, 2018, J APPL PHYSIOL, V125, P790, DOI 10.1152/japplphysiol.00310.2018; Chan AW, 2015, REV PANAM SALUD PUBL, V38, P506; Gibson AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185143; Grafen G, 2002, MODERN STAT LIFE SCI; Haskell-Ramsay CF, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010085; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; Hoyland A, 2008, NEUROSCI BIOBEHAV R, V32, P72, DOI 10.1016/j.neubiorev.2007.05.006; HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006; Karakolis T, 2014, APPL ERGON, V45, P799, DOI 10.1016/j.apergo.2013.10.001; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kennedy DO, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121332; Kennedy DO, 2000, PSYCHOPHARMACOLOGY, V149, P63, DOI 10.1007/s002139900335; Klautzer L, 2014, INT J HEALTH POLICY, V2, P109, DOI 10.15171/ijhpm.2014.33; Labonte-LeMoyne E, 2015, COMPUT HUM BEHAV, V46, P1, DOI 10.1016/j.chb.2014.12.054; Larson MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121309; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Lovden M, 2013, CURR OPIN PSYCHIATR, V26, P239, DOI 10.1097/YCO.0b013e32835f4135; Magnon V, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00239; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Ojo SO, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030417; Poromaa IS, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00380; Qatar Biobank, QAT BIOB REP QATAR20; Qatar National Physical Activity Guidelines, 2014, QAT NAT PHYS ACT GUI; Reay JL, 2005, J PSYCHOPHARMACOL, V19, P357, DOI 10.1177/0269881105053286; Sayegh S, 2016, INT J WOMENS HEALTH, V8, P287, DOI 10.2147/IJWH.S99943; Scholey AB, 2010, J PSYCHOPHARMACOL, V24, P1505, DOI 10.1177/0269881109106923; Sperlich B, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01279; Veasey RC, 2015, NUTRIENTS, V7, P5712, DOI 10.3390/nu7075250; Vincent Grace E., 2018, Neurobiology of Sleep and Circadian Rhythms, V4, P17, DOI 10.1016/j.nbscr.2017.09.001; Wennberg P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009630; West B. T., 2014, LINEAR MIXED MODELS; Wheeler Michael J, 2017, Alzheimers Dement (N Y), V3, P291, DOI 10.1016/j.trci.2017.04.001	40	20	20	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2019	14	7							e0219565	10.1371/journal.pone.0219565	http://dx.doi.org/10.1371/journal.pone.0219565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4NB	31299061	Green Published, Green Submitted, gold			2022-12-26	WOS:000484955800008
J	Rody, WJ; Chamberlain, CA; Emory-Carter, AK; McHugh, KP; Wallet, SM; Spicer, V; Krokhin, O; Holliday, LS				Rody, Wellington J., Jr.; Chamberlain, Casey A.; Emory-Carter, Alyssa K.; McHugh, Kevin P.; Wallet, Shannon M.; Spicer, Victor; Krokhin, Oleg; Holliday, L. Shannon			The proteome of extracellular vesicles released by clastic cells differs based on their substrate	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; OSTEOCLASTIC BONE-RESORPTION; PEPTIDE RETENTION PREDICTION; ANGIOTENSIN-II; V-ATPASE; EXOSOMES; RECEPTOR; BINDING; IDENTIFICATION; ODONTOCLASTS	Extracellular vesicles (EVs) from osteoclasts are important regulators in intercellular communication. Here, we investigated the proteome of EVs from clastic cells plated on plastic (clasts), bone (osteoclasts) and dentin (odontoclasts) by two-dimensional high performance liquid chromatography mass spectrometry seeking differences attributable to distinct mineralized matrices. A total of 1,952 proteins were identified. Of the 500 most abundant proteins in EVs, osteoclast and odontoclast EVs were 83.3% identical, while clasts shared 70.7% of the proteins with osteoclasts and 74.2% of proteins with odontoclasts. For each protein, the differences between the total ion count values were mapped to an expression ratio histogram (Z-score) in order to detect proteins differentially expressed. Stabilin-1 and macrophage mannose receptor-1 were significantly-enriched in EVs from odontoclasts compared with osteoclasts (Z = 2.45, Z = 3.34) and clasts (Z = 13.86, Z = 1.81) and were abundant in odontoclast EVs. Numerous less abundant proteins were differentially-enriched. Subunits of known protein complexes were abundant in clastic EVs, and were present at levels consistent with them being in assembled protein complexes. These included the proteasome, COP1, COP9, the T complex and a novel sub-complex of vacuolar H+-ATPase (V-ATPase), which included the (pro) renin receptor. The (pro) renin receptor was immunoprecipitated using an anti-E-subunit antibody from detergent-solubilized EVs, supporting the idea that the V-ATPase subunits present were in the same protein complex. We conclude that the protein composition of EVs released by clastic cells changes based on the substrate. Clastic EVs are enriched in various protein complexes including a previously undescribed V-ATPase sub-complex.	[Rody, Wellington J., Jr.; Holliday, L. Shannon] SUNY Stony Brook, Sch Dent Med, Dept Orthodont & Pediat Dent, Stony Brook, NY 11794 USA; [Chamberlain, Casey A.; Emory-Carter, Alyssa K.] Univ Florida, Coll Dent, Dept Orthodont, Gainesville, FL USA; [McHugh, Kevin P.] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL USA; [Wallet, Shannon M.] East Carolina Univ, Sch Dent Med, Greenville, NC 27858 USA; [Spicer, Victor; Krokhin, Oleg] Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada; [Holliday, L. Shannon] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32611 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of North Carolina; East Carolina University; State University System of Florida; University of Florida	Rody, WJ; Holliday, LS (corresponding author), SUNY Stony Brook, Sch Dent Med, Dept Orthodont & Pediat Dent, Stony Brook, NY 11794 USA.; Holliday, LS (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32611 USA.	wellington.rody@stonybrookmedicine.edu; sholliday@dental.ufl.edu	Chamberlain, Casey/ABD-2813-2020; Holliday, Lexie/GYQ-4972-2022	Chamberlain, Casey/0000-0002-3633-8594; Holliday, Lexie/0000-0002-0844-1965	American Association of Orthodontists Foundation (AAOF); Fred T. Schudy Memorial Research Award; Southern Association of Orthodontists (SAO) resident award; NIH-NIDCR [R21 DE023900]	American Association of Orthodontists Foundation (AAOF); Fred T. Schudy Memorial Research Award; Southern Association of Orthodontists (SAO) resident award; NIH-NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the American Association of Orthodontists Foundation (AAOF), Fred T. Schudy Memorial Research Award (to WJR), a Southern Association of Orthodontists (SAO) resident award (to AKEC) and NIH-NIDCR R21 DE023900 (to LSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arana-Chavez VE, 2009, INT J BIOCHEM CELL B, V41, P446, DOI 10.1016/j.biocel.2008.09.007; Bar-Nun S, 2012, BBA-MOL CELL RES, V1823, P67, DOI 10.1016/j.bbamcr.2011.07.009; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Campanella ME, 2008, BLOOD, V112, P3900, DOI 10.1182/blood-2008-03-146159; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Cotter K, 2015, TRENDS BIOCHEM SCI, V40, P611, DOI 10.1016/j.tibs.2015.08.005; Cypryk W, 2014, J PROTEOME RES, V13, P2468, DOI 10.1021/pr4012552; Donmez BO, 2012, PHARMACOL REP, V64, P878, DOI 10.1016/S1734-1140(12)70882-4; Dwivedi RC, 2008, ANAL CHEM, V80, P7036, DOI 10.1021/ac800984n; Fenyo D, 2003, ANAL CHEM, V75, P768, DOI 10.1021/ac0258709; Gilmore AP, 1996, STRUCTURE, V4, P647, DOI 10.1016/S0969-2126(96)00069-X; Haraszti RA, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.32570; Harokopakis-Hajishengallis Evlambia, 2007, J Oral Sci, V49, P1, DOI 10.2334/josnusd.49.1; Hatton R, 1997, J ENDOCRINOL, V152, P5, DOI 10.1677/joe.0.1520005; Holliday LS, 2017, ORTHOD CRANIOFAC RES, V20, P95, DOI 10.1111/ocr.12165; Holliday LS, 2009, ORTHOD CRANIOFAC RES, V12, P105, DOI 10.1111/j.1601-6343.2009.01443.x; Holliday LS, 1997, J BIOL CHEM, V272, P22053, DOI 10.1074/jbc.272.35.22053; Holliday LS, 2003, CALCIFIED TISSUE INT, V72, P206, DOI 10.1007/s00223-002-1008-7; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Huynh N, 2016, J DENT RES, V95, P673, DOI 10.1177/0022034516633189; Ikebuchi Y, 2018, NATURE, V561, P195, DOI 10.1038/s41586-018-0482-7; Izu Y, 2009, J BIOL CHEM, V284, P4857, DOI 10.1074/jbc.M807610200; Karimi N, 2018, CELL MOL LIFE SCI, V75, P2873, DOI 10.1007/s00018-018-2773-4; Kato JY, 2009, GENES CELLS, V14, P1209, DOI 10.1111/j.1365-2443.2009.01349.x; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Knowles HJ, 2012, VIRCHOWS ARCH, V461, P205, DOI 10.1007/s00428-012-1274-3; Kourembanas S, 2015, ANNU REV PHYSIOL, V77, P13, DOI 10.1146/annurev-physiol-021014-071641; Krokhin OV, 2006, ANAL CHEM, V78, P7785, DOI 10.1021/ac060777w; Kunjappu MJ, 2014, BBA-MOL CELL RES, V1843, P2, DOI 10.1016/j.bbamcr.2013.03.008; Kzhyshkowska J, 2010, THESCIENTIFICWORLDJO, V10, P2039, DOI 10.1100/tsw.2010.189; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lee BS, 1996, AM J PHYSIOL-CELL PH, V270, pC382, DOI 10.1152/ajpcell.1996.270.1.C382; Li DF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10872; Liu CW, 2013, TRENDS BIOCHEM SCI, V38, P103, DOI 10.1016/j.tibs.2012.11.009; Marine JC, 2012, NAT REV CANCER, V12, P455, DOI 10.1038/nrc3271; Marsh JA, 2015, ANNU REV BIOCHEM, V84, P551, DOI 10.1146/annurev-biochem-060614-034142; Marton N, 2017, CELL MOL LIFE SCI, V74, P3599, DOI 10.1007/s00018-017-2535-8; Matsumoto Y, 1994, Kokubyo Gakkai Zasshi, V61, P123; Nguyen G, 2010, J AM SOC NEPHROL, V21, P18, DOI 10.1681/ASN.2009030300; Nolan John P, 2015, Curr Protoc Cytom, V73, DOI 10.1002/0471142956.cy1314s73; Paterson EK, 2018, FEBS J, V285, P8, DOI 10.1111/febs.14123; Perica T, 2012, BIOCHEM SOC T, V40, P475, DOI 10.1042/BST20120056; Peters J, 2017, PFLUG ARCH EUR J PHY, V469, P1245, DOI 10.1007/s00424-017-2005-z; POLLARD TD, 1984, NATURE, V312, P403, DOI 10.1038/312403a0; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rody WJ, 2017, ORTHOD CRANIOFAC RES, V20, P89, DOI 10.1111/ocr.12162; Rody WJ, 2014, AM J ORTHOD DENTOFAC, V145, P787, DOI 10.1016/j.ajodo.2014.03.013; Sasaki T, 2003, MICROSC RES TECHNIQ, V61, P483, DOI 10.1002/jemt.10370; Shimizu H, 2009, HYPERTENS RES, V32, P786, DOI 10.1038/hr.2009.99; Sun WJ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.15; Takeuchi T, 2015, P NATL ACAD SCI USA, V112, pE2497, DOI 10.1073/pnas.1412651112; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Toro EJ, 2012, CURR PROTEIN PEPT SC, V13, P180; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wang Z, 2011, ORAL DIS, V17, P129, DOI 10.1111/j.1601-0825.2010.01718.x; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yesim F, 2001, MOL VIS, V7, P234; Zaidi M, 2018, NATURE, V561, P180, DOI 10.1038/d41586-018-05960-x; Zhang YT, 2014, ENDOCRINE, V47, P598, DOI 10.1007/s12020-014-0196-z	61	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219602	10.1371/journal.pone.0219602	http://dx.doi.org/10.1371/journal.pone.0219602			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291376	Green Submitted, Green Published, gold			2022-12-26	WOS:000484947800123
J	Suzuki, L; ten Kate, FJC; Gotink, AW; Stoop, H; Doukas, M; Nieboer, D; Spaander, MCW; van Lanschot, JJB; van Wijnhoven, BPL; Koch, AD; Bruno, MJ; Looijenga, LHJ; Biermann, K				Suzuki, Lucia; ten Kate, Fiebo J. C.; Gotink, Annieke W.; Stoop, Hans; Doukas, Michail; Nieboer, Daan; Spaander, Manon C. W.; van Lanschot, Jan J. B.; van Wijnhoven, Bas P. L.; Koch, Arjun D.; Bruno, Marco J.; Looijenga, Leendert H. J.; Biermann, Katharina			Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma	PLOS ONE			English	Article							CANCER; HGC-1; PROMOTES; PROGRESSION; PROTEIN; MARKER; GW112; CLASSIFICATION; EPIDEMIOLOGY; DELETION	To date no informative biomarkers exist to accurately predict presence of lymph node metastases (LNM) in esophageal adenocarcinoma (EAC). We studied the discriminative value of Olfactomedin 4 (OLFM4), an intestinal stem cell marker, in EAC. Patients who had undergone esophagectomy as single treatment modality for both advanced (pT2-4) and early (pT1b) adenocarcinoma of the esophagus or gastro-esophageal junction were selected for this study from an institutional database (Erasmus MC University Medical Center, Rotterdam, The Netherlands). Surgical resection specimens of 196 advanced and 44 early EAC were examined. OLFM4 expression was studied by immunohistochemistry and categorized as low (<30%) or high (> = 30%) expression. Low OLFM4 was associated with poor differentiation grade in both advanced (60% vs. 34.8%, p = 0.001) and early EAC (39.1% vs. 9.5%, p = 0.023). LNM were present in 161 (82.1%) of advanced and 9 (20.5%) of early EAC respectively. Low OLFM4 was independently associated with the presence of LNM in advanced EAC in multivariable analysis (OR 2.7; 95% CI, 1.16-6.41; p = 0.022), but not in early EAC (OR 2.1; 95% CI, 0.46-9.84; p = 0.338). However, the difference in association with LNM between advanced (OR 2.7; 95% CI, 1.18-6.34; p = 0.019) and early (OR 2.3; 95% CI, 0.47-11.13; p = 0.302) EAC was non-significant (p = 0.844), suggesting that the lack of significance in early EAC is due to the small number of patients in this group. OLFM4 was not of significance for the disease free and overall survival. Overall, low expression of intestinal stem cell marker OLFM4 was associated with the presence of LNM. Our study suggests that OLFM4 could be an informative marker with the potential to improve preoperative assessment in patients with EAC. Further studies are needed to confirm the value of OLFM4 as a biomarker for LNM.	[Suzuki, Lucia; ten Kate, Fiebo J. C.; Stoop, Hans; Doukas, Michail; Looijenga, Leendert H. J.; Biermann, Katharina] Erasmus MC, Univ Med Ctr Rotterdam, Canc Inst, Dept Pathol, Rotterdam, Netherlands; [Gotink, Annieke W.; Spaander, Manon C. W.; Koch, Arjun D.; Bruno, Marco J.] Erasmus MC, Univ Med Ctr Rotterdam, Canc Inst, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Nieboer, Daan] Erasmus MC, Univ Med Ctr Rotterdam, Canc Inst, Dept Publ Hlth, Rotterdam, Netherlands; [van Lanschot, Jan J. B.; van Wijnhoven, Bas P. L.] Erasmus MC, Univ Med Ctr Rotterdam, Canc Inst, Dept Surg, Rotterdam, Netherlands; [Looijenga, Leendert H. J.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Biermann, K (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Canc Inst, Dept Pathol, Rotterdam, Netherlands.	k.biermann@erasmusmc.nl		Suzuki, Lucia/0000-0003-1876-0801	Erasmus MC fellowship	Erasmus MC fellowship	This study was funded by the Erasmus MC fellowship appointed to Dr. K. Biermann (KB) entitled "Barrett esophagus: improved prediction of progression by targeted risk stratification". Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2018, GASTROENTEROLOGY, V154, P360, DOI 10.1053/j.gastro.2017.08.023; Akutsu Y, 2011, SURG TODAY, V41, P1190, DOI 10.1007/s00595-011-4542-y; Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]; Bergeron EJ, 2014, J THORAC CARDIOV SUR, V147, P765, DOI 10.1016/j.jtcvs.2013.10.003; Bertero L, 2018, VIRCHOWS ARCH, V472, P519, DOI 10.1007/s00428-017-2276-y; Chen L, 2011, CARCINOGENESIS, V32, P986, DOI 10.1093/carcin/bgr065; Chin KL, 2008, BRIT J HAEMATOL, V143, P421, DOI 10.1111/j.1365-2141.2008.07368.x; Coleman HG, 2018, GASTROENTEROLOGY, V154, P390, DOI 10.1053/j.gastro.2017.07.046; Cuellar SLB, 2017, EUR J RADIOL, V88, P56, DOI 10.1016/j.ejrad.2017.01.001; Cuellar SLB, 2014, J THORAC ONCOL, V9, P1202, DOI 10.1097/JTO.0000000000000222; Duan C, 2014, J CELL MOL MED, V18, P863, DOI 10.1111/jcmm.12232; Dubecz A, 2015, ANN THORAC SURG, V99, P1879, DOI 10.1016/j.athoracsur.2015.02.112; Dutkowski P, 2002, HEPATO-GASTROENTEROL, V49, P176; Edge SB, 2010, AJCC CANC STAGING MA; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Grotenhuis BA, 2013, WORLD J SURG, V37, P147, DOI 10.1007/s00268-012-1804-9; Grover PK, 2010, CANCER METAST REV, V29, P761, DOI 10.1007/s10555-010-9262-z; Guo LL, 2015, BMB REP, V48, P630, DOI 10.5483/BMBRep.2015.48.11.130; Jang BG, 2015, VIRCHOWS ARCH, V467, P285, DOI 10.1007/s00428-015-1793-9; Jang BG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127300; Khanna LG, 2015, BEST PRACT RES CL GA, V29, P179, DOI 10.1016/j.bpg.2014.12.005; Kim KK, 2010, MOL CARCINOGEN, V49, P259, DOI 10.1002/mc.20596; Kobayashi D, 2007, CANCER SCI, V98, P334, DOI 10.1111/j.1349-7006.2007.00397.x; Li HZ, 2013, AM J PATHOL, V183, P1329, DOI 10.1016/j.ajpath.2013.06.028; Liu W, 2007, HISTOPATHOLOGY, V51, P157, DOI 10.1111/j.1365-2559.2007.02763.x; Liu W, 2016, ONCOGENE, V35, P5237, DOI 10.1038/onc.2016.58; Liu WL, 2008, CLIN CANCER RES, V14, P1041, DOI 10.1158/1078-0432.CCR-07-4125; Liu WL, 2006, EXP CELL RES, V312, P1785, DOI 10.1016/j.yexcr.2006.02.011; Luo ZY, 2011, J CANCER RES CLIN, V137, P1713, DOI 10.1007/s00432-011-1042-9; Pech O, 2010, ENDOSCOPY, V42, P456, DOI 10.1055/s-0029-1244022; Seko N, 2010, EXP THER MED, V1, P73, DOI 10.3892/etm_00000013; Shaheen NJ, 2016, AM J GASTROENTEROL, V111, P30, DOI 10.1038/ajg.2015.322; SNYDER DA, 1991, BIOCHEMISTRY-US, V30, P9143, DOI 10.1021/bi00102a004; Sobin L, 2009, TNM CLASSIFICATION M; Tekola Bezawit D, 2014, J Gastrointest Cancer, V45, P342, DOI 10.1007/s12029-014-9616-9; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; Wang WP, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2017.12.17; Winiker M, 2018, DIS ESOPHAGUS, V31, DOI 10.1093/dote/dox113; Xiong B, 2017, BIOMED PHARMACOTHER, V86, P67, DOI 10.1016/j.biopha.2016.11.081; Zhang JC, 2002, GENE, V283, P83, DOI 10.1016/S0378-1119(01)00763-6; Zhang XW, 2004, CANCER RES, V64, P2474, DOI 10.1158/0008-5472.CAN-03-3443; Zhao J, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.42	42	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219494	10.1371/journal.pone.0219494	http://dx.doi.org/10.1371/journal.pone.0219494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283789	gold, Green Submitted, Green Published			2022-12-26	WOS:000484939800037
J	Teder, H; Paluoja, P; Rekker, K; Salumets, A; Krjutskov, K; Palta, P				Teder, Hindrek; Paluoja, Priit; Rekker, Kadri; Salumets, Andres; Krjutskov, Kaarel; Palta, Priit			Computational framework for targeted high coverage sequencing based NIPT Computational framework for targeted high coverage sequencing based NIPT	PLOS ONE			English	Article							CELL-FREE DNA; DOWN-SYNDROME; MEIOTIC STAGE; MATERNAL AGE; ANEUPLOIDY; PLASMA; NONDISJUNCTION; TRISOMY-21; FRACTION; GENESIS	Non-invasive prenatal testing (NIPT) enables accurate detection of fetal chromosomal trisomies. The majority of publicly available computational methods for sequencing-based NIPT analyses rely on low-coverage whole-genome sequencing (WGS) data and are not applicable for targeted high-coverage sequencing data from cell-free DNA samples. Here, we present a novel computational framework for a targeted high-coverage sequencing-based NIPT analysis. The developed framework uses a hidden Markov model (HMM) in conjunction with a supplemental machine learning model, such as decision tree (DT) or support vector machine (SVM), to detect fetal trisomy and parental origin of additional fetal chromosomes. These models were developed using simulated datasets covering a wide range of biologically relevant scenarios with various chromosomal quantities, parental origins of extra chromosomes, fetal DNA fractions, and sequencing read depths. Developed models were tested on simulated and experimental targeted sequencing datasets. Consequently, we determined the functional feasibility and limitations of each proposed approach and demonstrated that read count-based HMM achieved the best overall classification accuracy of 0.89 for detecting fetal euploidies and trisomies on simulated dataset. Furthermore, we show that by using the DT and SVM on the HMM classification results, it was possible to increase the final trisomy classification accuracy to 0.98 and 0.99, respectively. We demonstrate that read count and allelic ratio-based models can achieve a high accuracy (up to 0.98) for detecting fetal trisomy even if the fetal fraction is as low as 2%. Currently, existing commercial NIPT analysis requires at least 4% of fetal fraction, which can be possibly a challenge in case of early gestational age (<10 weeks) or high maternal body mass index (>35 kg/m(2)). More accurate detection can be achieved at higher sequencing depth using HMM in conjunction with supplemental models, which significantly improve the trisomy detection especially in borderline scenarios (e.g., very low fetal fraction) and enables to perform NIPT even earlier than 10 weeks of pregnancy.	[Teder, Hindrek; Paluoja, Priit; Rekker, Kadri; Salumets, Andres; Krjutskov, Kaarel] Competence Ctr Hlth Technol, Tartu, Estonia; [Teder, Hindrek; Salumets, Andres] Univ Tartu, Inst Biomed & Translat Med, Dept Biomed, Tartu, Estonia; [Paluoja, Priit] Univ Tartu, Inst Comp Sci, Tartu, Estonia; [Rekker, Kadri; Salumets, Andres] Univ Tartu, Dept Obstet & Gynecol, Inst Clin Med, Tartu, Estonia; [Salumets, Andres] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Salumets, Andres] Helsinki Univ Hosp, Helsinki, Finland; [Krjutskov, Kaarel] Univ Helsinki, Res Program Mol Neurol, Res Programs Unit, Helsinki, Finland; [Krjutskov, Kaarel] Folkhalsan Inst Genet, Helsinki, Finland; [Palta, Priit] Univ Tartu, Inst Genom, Estonian Genome Ctr, Tartu, Estonia; [Palta, Priit] Univ Helsinki, FIMM, Helsinki, Finland	University of Tartu; University of Tartu; University of Tartu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Tartu; University of Helsinki	Teder, H (corresponding author), Competence Ctr Hlth Technol, Tartu, Estonia.; Teder, H (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Dept Biomed, Tartu, Estonia.	hindrek.teder@gmail.com	Palta, Priit/W-2477-2019; Teder, Hindrek/E-7807-2017	Palta, Priit/0000-0001-9320-7008; Teder, Hindrek/0000-0001-6608-7979; Paluoja, Priit/0000-0002-2016-661X	Estonian Ministry of Education and Research [IUT34-16]; Enterprise Estonia [EU48695]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Enterprise Estonia	Funded by (AS) IUT34-16. Estonian Ministry of Education and Research. https://WWW.hm.ee/en. (AS) EU48695. Enterprise Estonia. https://WWW.eas.ee/?lang=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; ANTONARAKIS SE, 1992, AM J HUM GENET, V50, P544; Ashoor G, 2013, ULTRASOUND OBST GYN, V41, P26, DOI 10.1002/uog.12331; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Freeman SB, 2007, PUBLIC HEALTH REP, V122, P62, DOI 10.1177/003335490712200109; Ghosh S, 2010, GENET RES, V92, P189, DOI 10.1017/S0016672310000224; Gil MM, 2015, ULTRASOUND OBST GYN, V45, P249, DOI 10.1002/uog.14791; Gole J, 2016, FERTIL STERIL, V105, pE25, DOI 10.1016/j.fertnstert.2015.12.076; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2000, CLIN GENET, V57, P95, DOI 10.1034/j.1399-0004.2000.570201.x; Jia CW, 2015, CHINESE MED J-PEKING, V128, P2772, DOI 10.4103/0366-6999.167352; Jiang PY, 2012, BIOINFORMATICS, V28, P2883, DOI 10.1093/bioinformatics/bts549; Johansson LF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02031-5; Kang XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161928; Karczewski KJ, 2019, PREPRINT, DOI [10.1101/531210v2, DOI 10.1101/531210V2]; Kermany AR, 2014, BIOINFORMATICS, V30, P2035, DOI 10.1093/bioinformatics/btu159; Kim SK, 2015, PRENATAL DIAG, V35, P810, DOI 10.1002/pd.4615; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liao GJW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038154; Liao GJW, 2011, CLIN CHEM, V57, P92, DOI 10.1373/clinchem.2010.154336; Loane M, 2013, EUR J HUM GENET, V21, P27, DOI 10.1038/ejhg.2012.94; Malcher C, 2018, GENET MOL BIOL, V41, P545, DOI [10.1590/1678-4685-GMB-2017-0177, 10.1590/1678-4685-gmb-2017-0177]; Miller CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016327; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Sauk M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23589-8; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Teder H, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0072-5; Umbarger MA, 2016, FERTIL STERIL, V106, pE152, DOI 10.1016/j.fertnstert.2016.07.449; Yoon PW, 1996, AM J HUM GENET, V58, P628; Zimmermann B, 2012, PRENATAL DIAG, V32, P1233, DOI 10.1002/pd.3993	32	5	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0209139	10.1371/journal.pone.0209139	http://dx.doi.org/10.1371/journal.pone.0209139			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283802	gold, Green Published, Green Submitted			2022-12-26	WOS:000484939800002
J	Fu, R; Noguchi, H; Kaneko, S; Kawamura, A; Kang, C; Takahashi, H; Tamiya, N				Fu, Rong; Noguchi, Haruko; Kaneko, Shuhei; Kawamura, Akira; Kang, Cheolmin; Takahashi, Hideto; Tamiya, Nanako			How do cardiovascular diseases harm labor force participation? Evidence of nationally representative survey data from Japan, a super-aged society	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY HEART-DISEASE; INSTRUMENTAL VARIABLES; SOCIOECONOMIC-STATUS; DIETARY PATTERNS; RISK-FACTORS; ECONOMIC BURDEN; HEALTH; OBESITY; IMPACT	Objective To evaluate how cardiovascular diseases harm labor force participation (LFP) among the Japanese population and verify the validity of plasma biomarkers as instrumental variables of cardiovascular diseases after adjusting for a broad set of confounders including dietary intake. Design Using nationally representative repeated cross-sectional surveys in Japan, the Comprehensive Survey of Living Conditions and National Health and Nutrition Survey, with plasma biomarkers as instrumental variables for quasi-randomization. Setting Onset of cardiovascular diseases in those receiving regular treatment for hypertension, intracerebral hemorrhage, intracerebral infarction, angina pectoris, myocardial infarction, or other types of cardiovascular diseases. Participants A total of 65,615 persons aged >= 20 years (35,037 women and 30,578 men) who completed a survey conducted every three years from 1995 through 2013. Main outcome measures Respondent employment and weekly working hours during each survey year. Results Cardiovascular diseases significantly and remarkably reduced the probability of working by 15.4% (95% CI: -30.6% to -0.2%). The reduction in working probability was detected for women only. Respondents aged. 40 years were less likely to work once diagnosed and the reduction was enlarged for those aged. 65 years, while those aged < 40 years appeared to be unaffected. Probability of engaging in manual labor significantly decreased once diagnosed; however, no impact was found for cognitive occupations. Among employed respondents, the adverse effects of cardiovascular diseases decreased working hours by five hours per week. Validity of the biomarker instrumental variables was generally verified. Conclusions A vicious circle is suggested between LFP and unfavorable health. However, the effects vary across age, sex, and occupation type, even after adjusting for causal effects, which could cause a downward bias in LFP impact. Attributes cardiovascular disease, labor force participation, instrumental variable method as quasi-randomization, plasma biomarker, Comprehensive Survey of Living Conditions, National Health and Nutrition Survey.	[Fu, Rong; Noguchi, Haruko; Kaneko, Shuhei; Kawamura, Akira; Kang, Cheolmin] Waseda Univ, Fac Polit Sci & Econ, Tokyo, Japan; [Takahashi, Hideto] Natl Inst Publ Hlth, Saitama, Japan; [Tamiya, Nanako] Univ Tsukuba, Hlth Serv Res & Dev Ctr, Tsukuba, Ibaraki, Japan; [Tamiya, Nanako] Univ Tsukuba, Fac Med, Dept Hlth Serv Res, Tsukuba, Ibaraki, Japan	Waseda University; National Institute of Public Health - Japan; University of Tsukuba; University of Tsukuba	Fu, R (corresponding author), Waseda Univ, Fac Polit Sci & Econ, Tokyo, Japan.	nataliefu1988@aoni.waseda.jp	Noguchi, Haruko/ABF-3059-2020; Kawamura, Akira/AAX-3214-2021; FU, Rong/O-7293-2018	Noguchi, Haruko/0000-0002-4437-8238; Kaneko, Shuhei/0000-0001-7093-2418; FU, Rong/0000-0002-2850-1697	Japan Society for the Promotion of Science (JSPS KAKENHI) [17H07182]; Japanese Ministry of Health, Labour and Welfare [H29-Junkankitou-Ippan-002]; Organization for University Research Initiatives of Waseda University	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Organization for University Research Initiatives of Waseda University	RF is funded by Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number 17H07182). HN is funded by funded by the Japanese Ministry of Health, Labour and Welfare (H29-Junkankitou-Ippan-002), Organization for University Research Initiatives of Waseda University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Alavinia SM, 2009, AM J IND MED, V52, P49, DOI 10.1002/ajim.20648; Alissa EM, 2017, CRIT REV FOOD SCI, V57, P1950, DOI 10.1080/10408398.2015.1040487; Blundell R, 2013, FISC STUD, V34, P1, DOI 10.1111/j.1475-5890.2013.00175.x; Brown HS, 2005, HEALTH ECON, V14, P537, DOI 10.1002/hec.942; Burgess S, 2017, STAT METHODS MED RES, V26, P2333, DOI 10.1177/0962280215597579; Burgess S, 2013, INT J EPIDEMIOL, V42, P1134, DOI 10.1093/ije/dyt093; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; FARQUHAR JW, 1990, JAMA-J AM MED ASSOC, V264, P359, DOI 10.1001/jama.264.3.359; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Gaziano TA, 2007, HEALTH AFFAIR, V26, P13, DOI 10.1377/hlthaff.26.1.13; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gupta ND, 2015, SOC SCI MED, V136, P44, DOI 10.1016/j.socscimed.2015.05.008; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Kagamimori S, 2009, SOC SCI MED, V68, P2152, DOI 10.1016/j.socscimed.2009.03.030; Kahn ME, 1998, J LABOR ECON, V16, P878, DOI 10.1086/209909; Kang H, 2016, J AM STAT ASSOC, V111, P132, DOI 10.1080/01621459.2014.994705; KIVIMA S, 2002, BMJ-BRIT MED J, V325, P7369; Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42; Lairon D, 2007, EUR J CLIN NUTR, V61, P1145, DOI 10.1038/sj.ejcn.1602749; Laslett LJ, 2012, J AM COLL CARDIOL, P60, DOI DOI 10.1016/J.JACC.2012.11.002; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Lemieux I, 2001, ARCH INTERN MED, V161, P2685, DOI 10.1001/archinte.161.22.2685; Liu JLY, 2002, HEART, V88, P597, DOI 10.1136/heart.88.6.597; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Martikainen P, 2003, SOC SCI MED, V56, P1397, DOI 10.1016/S0277-9536(02)00137-5; Matoba T, 2003, INT ARCH OCC ENV HEA, V76, P302, DOI 10.1007/s00420-002-0412-7; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Mishra G, 2002, EUR J CLIN NUTR, V56, P687, DOI 10.1038/sj.ejcn.1601391; Nanri A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174848; National Institute of Public Health, 2002, ETHICAL GUIDELINES F; Nichols GA, 2010, AM J MANAG CARE, V16, pE86; Norton EC, 2008, HEALTH ECON, V17, P1089, DOI 10.1002/hec.1383; Ohira T, 2013, CIRC J, V77, P1646, DOI 10.1253/circj.CJ-13-0702; PATSCH JR, 1992, ARTERIOSCLER THROMB, V12, P1336, DOI 10.1161/01.ATV.12.11.1336; Phan HM, 2008, AM J GERIATR CARDIOL, V17, P101; Reddy KS, 2004, PUBLIC HEALTH NUTR, V7, P167, DOI 10.1079/PHN2003587; Rodbard HW, 2009, AM J HEALTH PROMOT, V23, P353, DOI 10.4278/ajhp.081010-QUAN-243; Seuring T., 2016, IZA DISCUSSION PAPER; Spencer JPE, 2008, BRIT J NUTR, V99, P12, DOI 10.1017/S0007114507798938; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Trevisan E, 2016, LABOUR ECON, V43, P171, DOI 10.1016/j.labeco.2016.04.002; Tunceli K, 2005, DIABETES CARE, V28, P2662, DOI 10.2337/diacare.28.11.2662; von Hinke S, 2016, J HEALTH ECON, V45, P131, DOI 10.1016/j.jhealeco.2015.10.007; Weggemans RM, 2001, AM J CLIN NUTR, V73, P885; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; World Health Organization, WORLD HEART DAY; Yoshiike N, 1996, J EPIDEMIOL, V6, P189, DOI 10.2188/jea.6.3sup_189; Yu WH, 2005, DEMOGRAPHY, V42, P693, DOI 10.1353/dem.2005.0039; Zhang XH, 2009, J HEALTH ECON, V28, P91, DOI 10.1016/j.jhealeco.2008.08.001	53	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219149	10.1371/journal.pone.0219149	http://dx.doi.org/10.1371/journal.pone.0219149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4FP	31276516	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300040
J	Han, J; Kubala, M; Aranda-Michel, E; Trumble, DR				Han, Jooli; Kubala, Matthew; Aranda-Michel, Edgar; Trumble, Dennis R.			Ventricle-specific epicardial pressures as a means to optimize direct cardiac compression for circulatory support: A pilot study	PLOS ONE			English	Article							DIASTOLIC WALL THICKNESS; ANGIOGRAPHY; TOMOGRAPHY; PREDICTOR; VALUES	Direct cardiac compression (DCC) holds enormous potential as a safe and effective means to treat heart failure patients who require long-term, or even permanent, biventricular support. However, devices developed to date are not tuned to meet the individual compression requirements of the left and right ventricles, which can differ substantially. In this paper, a systematic study examining the relationship, range, and effect of independent pressures on the left and right epicardial surfaces of a passive human heart model was performed as a means to optimize cardiac output via DCC support. Hemodynamic and tissue deformation effects produced by varying epicardial compressions were examined using finite element analysis. Results indicate that 1) designing a direct cardiac compression pump that applies separate pressures to the left and right ventricles is critical to maintain equivalent stroke volume for both ventricles, and 2) left and right ventricular epicardial pressures of 340 mmHg and 44 mmHg, respectively, are required to induce normal ejection fractions in a passive heart. This pilot study provides fundamental insights and guidance towards the design of improved direct cardiac compression devices for long-term circulatory support.	[Han, Jooli; Kubala, Matthew; Aranda-Michel, Edgar; Trumble, Dennis R.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Han, J (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.	joolih@andrew.cmu.edu		Aranda-Michel, Edgar/0000-0001-6812-3056; Kubala, Matthew/0000-0001-9511-2002; Han, Jooli/0000-0002-5115-7791	National Institutes of Health [5 R01 EB019468-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB019468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was funded by a grant from the National Institutes of Health (5 R01 EB019468-02) to DRT. The funders had no role in study design, data collection and analysis,	ANSTADT GL, 1966, T AM SOC ART INT ORG, V12, P72; Armstrong DWJ, 2010, CAN J CARDIOL, V26, pE35, DOI 10.1016/S0828-282X(10)70004-0; Ascione L, 2008, J AM SOC ECHOCARDIOG, V21, P1055, DOI 10.1016/j.echo.2008.06.002; Cwajg JM, 2000, J AM COLL CARDIOL, V35, P1152, DOI 10.1016/S0735-1097(00)00525-8; Eidem BW, 2012, ECHOCARDIOGRAPHY PED; El Missiri AM, 2016, EGYPT HEART J, V68, P209, DOI 10.1016/j.ehj.2016.01.002; Fuchs A, 2016, EUR HEART J-CARD IMG, V17, P1009, DOI 10.1093/ehjci/jev337; GUCCIONE JM, 1991, J BIOMECH ENG-T ASME, V113, P42, DOI 10.1115/1.2894084; Guccione JM, PASSIVE MAT PROPERTI; HAGAN AD, 1974, CIRCULATION, V50, P248, DOI 10.1161/01.CIR.50.2.248; Han J, 2018, DESIGN MUSCLE POWERE; Han J, 2019, BIOENGINEERING-BASEL, V6, DOI 10.3390/bioengineering6010018; Kovalova S, 2006, EUR J ECHOCARDIOGR, V7, P293, DOI 10.1016/j.euje.2005.06.010; LOWE JE, 1991, ANN THORAC SURG, V52, P1237, DOI 10.1016/0003-4975(91)90007-D; REDINGTON AN, 1988, BRIT HEART J, V59, P23; Soohoo E, 2017, ANN BIOMED ENG, V45, P1434, DOI 10.1007/s10439-017-1812-x; Wagholikar KB, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-1066-7	17	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219162	10.1371/journal.pone.0219162	http://dx.doi.org/10.1371/journal.pone.0219162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276569	Green Submitted, Green Published, gold			2022-12-26	WOS:000484936300043
J	Khalil, MNA; Choucry, MA; El Senousy, AS; Hassan, A; El-Marasy, SA; El Awdan, SA; Omar, FA				Khalil, Mohammed N. A.; Choucry, Mouchira A.; El Senousy, Amira S.; Hassan, Azza; El-Marasy, Salma A.; El Awdan, Sally A.; Omar, Farghaly A.			Ambrosin, a potent NF-kappa beta inhibitor, ameliorates lipopolysaccharide induced memory impairment, comparison to curcumin	PLOS ONE			English	Article							SESQUITERPENE LACTONES; ALZHEIMERS-DISEASE; MOUSE MODEL; NEUROINFLAMMATION; ACTIVATION; EXPRESSION; INFLAMMATION; ALPHA; MICE	Despite its poor bioavailability, curcumin is a promising natural polyphenol targeting NF-kappa beta. NF-kappa beta is a target for new therapeutics because it plays a pivotal role in the pathophysiology of Alzheimer disease (AD). In contrast, ambrsoin, a sesquiterpene lactone which is a potent NF-kappa beta inhibitor, is scarcely studied in AD models. The current work aims to assess the efficacy of ambrosin as a possible remedy for AD. In silico studies showed that bioavailability and BBB permeability could be favorable for ambrosin over curcumin. Memory impairment was induced in mice by single intraperitoneal injection of LPS (0.4 mg/kg). Treated groups received curcumin (100 mg/kg) or ambrosin at doses (5 or 10 mg/kg) for 7 days. Mice in treated groups showed a significant improvement in memory functions during Morris water maze and object recognition tests. Curcumin and ambrosin (10 mg/kg) inhibited the upsurge of NF-kappa beta p65 transcript and protein levels. Consequently, downstream pro-inflammatory and nitrosative mediators were inhibited, namely, TNF-alpha, IL-1 beta, COX-2 and iNOS. BACE1 was inhibited, thereby reducing amyloid plaques (A beta) deposition and eventually reducing inflammation and apoptosis of neurons as revealed by immunohistopathological examination. In conclusion, ambrosin can be repurposed as AD remedy after further pharmacokinetic/pharamacodynamic assessments. It could serve as an additional lead drug for AD therapeutics.	[Khalil, Mohammed N. A.; Choucry, Mouchira A.; El Senousy, Amira S.] Cairo Univ, Dept Pharmacognosy, Fac Pharm, Cairo, Egypt; [Hassan, Azza] Cairo Univ, Fac Vet Med, Dept Pathol, Giza Sq, Giza, Egypt; [El-Marasy, Salma A.; El Awdan, Sally A.] Natl Res Ctr, Dept Pharmacol, Giza, Egypt; [Omar, Farghaly A.] Assiut Univ, Fac Pharm, Dept Pharmaceut Chem, Assiut, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Assiut University	Khalil, MNA (corresponding author), Cairo Univ, Dept Pharmacognosy, Fac Pharm, Cairo, Egypt.	mohamed.nabil@pharma.cu.edu.eg	Khalil, Mohammed/GPS-4976-2022	Khalil, Mohammed/0000-0002-1134-1164				Abdelgaleil SAM, 2011, AFR J MICROBIOL RES, V5, P3385; Amoah SKS, 2015, EUR J PHARMACOL, V769, P195, DOI 10.1016/j.ejphar.2015.11.018; Bromley-Brits Kelley, 2011, J Vis Exp, DOI 10.3791/2920; Cavin C, 2005, BIOCHEM BIOPH RES CO, V327, P742, DOI 10.1016/j.bbrc.2004.12.061; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a; Choodej S, 2018, PLANTA MED, V84, P329, DOI 10.1055/s-0043-120115; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; El-Marasy SA, 2019, CHEM-BIOL INTERACT, V299, P111, DOI 10.1016/j.cbi.2018.11.021; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Ghantous A, 2013, DRUG DISCOV TODAY, V18, P894, DOI 10.1016/j.drudis.2013.05.005; Goozee KG, 2016, BRIT J NUTR, V115, P449, DOI 10.1017/S0007114515004687; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Hegazy MEF, 2016, PLANTA MED, V82, P138, DOI 10.1055/s-0035-1558088; Hehner SP, 1998, J BIOL CHEM, V273, P1288, DOI 10.1074/jbc.273.3.1288; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; HERZ W, 1981, PHYTOCHEMISTRY, V20, P1601, DOI 10.1016/S0031-9422(00)98540-6; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Jae Youl C., 2006, CURR ENZYM INHIB, V2, P329, DOI DOI 10.2174/157340806778699299; Jobin C, 1999, J IMMUNOL, V163, P3474; Karunaweera N, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00024; Kaur U, 2015, CURR TOP MED CHEM, V15, P446, DOI 10.2174/1568026615666150114160543; Kenawy S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183565; Kitazawa M, 2011, J IMMUNOL, V187, P6539, DOI 10.4049/jimmunol.1100620; Koch E, 2001, BIOCHEM PHARMACOL, V62, P795, DOI 10.1016/S0006-2952(01)00714-6; Li XZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12393; Mazumder AG, 2017, BASIC CLIN PHARMACOL, V120, P426, DOI 10.1111/bcpt.12694; Minett T, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0601-z; Catorce MN, 2016, CURR NEUROPHARMACOL, V14, P155, DOI 10.2174/1570159X14666151204122017; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Rungeler P, 1999, BIOORGAN MED CHEM, V7, P2343, DOI 10.1016/S0968-0896(99)00195-9; Saeed M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00267; Sanmukhani J, 2011, ACTA POL PHARM, V68, P769; Seo EJ, 2018, PHARMACOL RES, V129, P262, DOI 10.1016/j.phrs.2017.11.030; Serafini MM, 2017, PHARMACOL RES, V124, P146, DOI 10.1016/j.phrs.2017.08.004; Shi ZM, 2016, J NEUROL SCI, V366, P127, DOI 10.1016/j.jns.2016.05.022; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Siedle B, 2004, J MED CHEM, V47, P6042, DOI 10.1021/jm049937r; Sotillo WS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184304; Srinivasan M, 2015, EXPERT OPIN THER TAR, V19, P471, DOI 10.1517/14728222.2014.989834; Svensson D, 2018, PHYTOMEDICINE, V50, P118, DOI 10.1016/j.phymed.2018.04.011; van Breemen Richard B, 2005, Expert Opin Drug Metab Toxicol, V1, P175, DOI 10.1517/17425255.1.2.175; Van Eldik Linda J, 2016, Alzheimers Dement (N Y), V2, P99, DOI 10.1016/j.trci.2016.05.001; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Venigalla M, 2016, NEUROCHEM INT, V95, P63, DOI 10.1016/j.neuint.2015.10.011; Villagomez R., 2014, J BIOMEDICAL SCI ENG, DOI DOI 10.4236/JBISE.2014.710083; Wahlang B, 2011, EUR J PHARM BIOPHARM, V77, P275, DOI 10.1016/j.ejpb.2010.12.006	49	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219378	10.1371/journal.pone.0219378	http://dx.doi.org/10.1371/journal.pone.0219378			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276550	Green Submitted, Green Published, gold			2022-12-26	WOS:000484936300071
J	Taylor, A; Murillo, R; Businelle, MS; Chen, TA; Kendzor, DE; McNeill, LH; Reitzel, LR				Taylor, Ashley; Murillo, Rosenda; Businelle, Michael S.; Chen, Tzu-An; Kendzor, Darla E.; McNeill, Lorna H.; Reitzel, Lorraine R.			Physical activity and sleep problems in homeless adults	PLOS ONE			English	Article							SELF-RATED HEALTH; MORTALITY; DURATION; EXERCISE; ATTITUDES; SMOKING; QUALITY; PEOPLE; POLICY; LINKS	Background For the estimated 554,000 homeless individuals on any given night in the United States, obtaining quality sleep is often challenging. This group is known to have multiple health disparities, potentially affected by sleep problems; therefore, identifying lifestyle factors-such as physical activity-that are associated with improving both quality and quantity of sleep has important implications for public health. Here, we examine associations of physical activity with subjective sleep problems within a large sample of homeless adults. Methods Participants were homeless adults recruited from Dallas and Oklahoma (N = 747; 66.1% men, M-age = 43.7 +/- 12.1). Participants self-reported insufficient sleep (number of days without sufficient rest/sleep in the last month; categorized as 0, 1-13, 14-29, or >= 30 days), sleep duration (over average 24 hours; categorized as <= 6 [short sleeper], 7-9 [optimal sleeper], or >= 10 hours [long sleeper]), and unintentional daytime sleep (number of days with unintentional sleep in the last month; categorized as 0 vs >= 30 days). Physical activity was assessed subjectively using the BRFSS Physical Activity Questionnaire. Regression analyses were performed to examine the associations between physical activity and sleep problems, controlling for age, sex, race, education, body mass, months homeless, at-risk drinking, self-rated health, serious mental illness, smoking status, and recruitment city. Results Failure to meet/exceed physical activity guidelines was associated with higher likelihood of being a long sleeper (OR = 2.64, 95% CI: 1.46, 4.78) but a lower likelihood of having >= 30 days of insufficient rest/sleep (OR = 0.52, 95% CI: 0.29, 0.93). Conclusions Findings suggest that physical activity promotion may hold promise for addressing the problem of too much sleep, but not other manifestations of sleep problems among this vulnerable group.	[Taylor, Ashley; Murillo, Rosenda; Chen, Tzu-An; Reitzel, Lorraine R.] Univ Houston, Coll Educ, Dept Psychol Hlth & Learning Sci, Houston, TX 77004 USA; [Taylor, Ashley; Murillo, Rosenda; Chen, Tzu-An; Reitzel, Lorraine R.] Univ Houston, Hlth Res Inst, Houston, TX 77004 USA; [Businelle, Michael S.; Kendzor, Darla E.] Univ Texas Dallas, Hlth Sci Ctr, Sch Publ Hlth, Dallas, TX USA; [McNeill, Lorna H.; Reitzel, Lorraine R.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Houston, TX 77030 USA; [Businelle, Michael S.; Kendzor, Darla E.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Tobacco Res Ctr, Oklahoma City, OK USA	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Texas System; University of Texas Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Reitzel, LR (corresponding author), Univ Houston, Coll Educ, Dept Psychol Hlth & Learning Sci, Houston, TX 77004 USA.; Reitzel, LR (corresponding author), Univ Houston, Hlth Res Inst, Houston, TX 77004 USA.; Reitzel, LR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Houston, TX 77030 USA.	Lrreitzel@uh.edu		Taylor, Ashley/0000-0003-4465-6194; Businelle, Michael/0000-0002-9038-2238	University of Texas School of Public Health; University of Texas MD Anderson Cancer Center; American Cancer Society [MRSGT-12-114-01-CPPB, MRSGT-10-104-001-CPHPS]; Oklahoma Tobacco Research Center at the University of Oklahoma Health Sciences Center; University of Houston; National Cancer Institute [P20CA221697, P20CA221696, P20CA221697-S1]; Stephenson Cancer Center Support grant [P30CA225520];  [P20CA221696/P20CA221697]; NATIONAL CANCER INSTITUTE [P20CA221696, P20CA221697, P30CA225520] Funding Source: NIH RePORTER	University of Texas School of Public Health; University of Texas MD Anderson Cancer Center; American Cancer Society(American Cancer Society); Oklahoma Tobacco Research Center at the University of Oklahoma Health Sciences Center; University of Houston; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stephenson Cancer Center Support grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Study 1: This work was supported by institutional funding provided by the University of Texas School of Public Health (to MSB) and the University of Texas MD Anderson Cancer Center (to LRR). Additional support for this work came from American Cancer Society grant MRSGT-12-114-01-CPPB (to MSB) and MRSGT-10-104-001-CPHPS (to DEK). Study 2: This work was supported by institutional funding provided by the Oklahoma Tobacco Research Center at the University of Oklahoma Health Sciences Center (to MSB), with additional support from the University of Houston (to LRR). This study was also supported by funding from the American Cancer Society grant MRSGT-12-114-01-CPPB (to MSB). Current manuscript: Work to complete the current manuscript was supported by the National Cancer Institute (P20CA221697 to LRR, P20CA221696 to LHM, and P20CA221697-S1 to RM). The first author (AT) is a trainee supported on P20CA221696/P20CA221697. Authorship of this study was supported by funding from the Stephenson Cancer Center Support grant (P30CA225520), as relevant to MSB and DEK. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring organizations.	2018 Physical Activity Guidelines Advisory Committee, 2018, 2018 PHYS ACT GUID A; [Anonymous], 2018, PHYS ACTIVITY; [Anonymous], 1998, PSYCEXTRA DATASET; [Anonymous], 2014, STATE INDICATOR REPO; Arozullah AM, 2007, MED CARE, V45, P1026, DOI 10.1097/MLR.0b013e3180616c1b; Baggett TP, 2018, J AM COLL CARDIOL, V71, P2585, DOI 10.1016/j.jacc.2018.02.077; Baggett TP, 2013, JAMA-J AM MED ASSOC, V309, P2109, DOI 10.1001/jama.2013.3044; Benyamini Y, 1999, RES AGING, V21, P392, DOI 10.1177/0164027599213002; Bradley AJ, 2017, PSYCHOL MED, V47, P1678, DOI 10.1017/S0033291717000186; Businelle MS, 2015, ADDICT BEHAV, V40, P51, DOI 10.1016/j.addbeh.2014.08.013; Businelle MS, 2013, AM J PUBLIC HLTH, V103; CDC, 2011, BEH RISK FACT SURV S, P42; Centers for Disease Control and Prevention (CDC), 2006, BEH RISK FACT SURV S; Chang HL, 2015, AM J HEALTH BEHAV, V39, P14, DOI 10.5993/AJHB.39.1.2; Cusack L, 2013, AUST J PRIM HEALTH, V19, P250, DOI 10.1071/PY12048; Faubel R, 2009, J SLEEP RES, V18, P427, DOI 10.1111/j.1365-2869.2009.00759.x; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Garey L, 2019, BEHAV MED, V45, P40, DOI 10.1080/08964289.2018.1447905; Hale L, 2013, SOC SCI MED, V79, P16, DOI 10.1016/j.socscimed.2012.07.021; Hill TD, 2009, HEALTH PLACE, V15, P1006, DOI 10.1016/j.healthplace.2009.04.001; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Humphreys Janice, 2005, Issues Ment Health Nurs, V26, P771, DOI 10.1080/01612840591008401; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Kalak N, 2012, J ADOLESCENT HEALTH, V51, P615, DOI 10.1016/j.jadohealth.2012.02.020; Kaskie RE, 2017, NAT SCI SLEEP, V9, P227, DOI 10.2147/NSS.S121076; Kline CE, 2014, AM J LIFESTYLE MED, V8, P375, DOI 10.1177/1559827614544437; Knutson KL, 2012, AM J HUM BIOL, V24, P361, DOI 10.1002/ajhb.22219; Kredlow MA, 2015, J BEHAV MED, V38, P427, DOI 10.1007/s10865-015-9617-6; Kruk J, 2013, ASIAN PAC J CANCER P, V14, P3993, DOI 10.7314/APJCP.2013.14.7.3993; Lee BA, 2005, AM BEHAV SCI, V48, P1055, DOI 10.1177/0002764204274200; Leger D, 2017, JAMA INTERN MED, V177, P278, DOI 10.1001/jamainternmed.2016.7827; Liu Y, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130334; Loprinzi PD, 2011, MENT HEALTH PHYS ACT, V4, P65, DOI DOI 10.1016/J.MHPA.2011.08.001; Magee CA, 2011, SLEEP MED, V12, P346, DOI 10.1016/j.sleep.2010.09.013; McKnight-Eily L. R., 2011, Morbidity and Mortality Weekly Report, V60, P233; McNamara RH, 2013, POLICING, V36, P357, DOI 10.1108/13639511311329741; Nettleton S, 2012, CRIT PUBLIC HEALTH, V22, P319, DOI 10.1080/09581596.2012.657611; Nutt David, 2008, Dialogues Clin Neurosci, V10, P329; Patel SR, 2006, SLEEP, V29, P881, DOI 10.1093/sleep/29.7.881; Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]; Reitzel LR, 2017, AM J HEALTH BEHAV, V41, P760, DOI 10.5993/AJHB.41.6.10; ROOM R, 1990, RES ADV ALCOHOL DRUG, V10, P39; Schnittker J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084933; Shankar A, 2011, SLEEP, V34, P1173, DOI 10.5665/SLEEP.1232; Stein Michael D, 2005, Subst Abus, V26, P1, DOI 10.1300/J465v26n01_01; Stults-Kolehmainen MA, 2014, SPORTS MED, V44, P81, DOI 10.1007/s40279-013-0090-5; Taylor EM, 2016, AM J HEALTH BEHAV, V40, P455, DOI 10.5993/AJHB.40.4.7; Taylor LC, 2001, AM J COMMUN PSYCHOL, V29, P443, DOI 10.1023/A:1010323914202; Theofilou P, 2013, HLTH PSYCHOL RES; U. S. Department of Housing and Urban Development, 2010, SSRN ELECT J; Uher I, 2018, PHYS ACT REV, V6, P203, DOI 10.16926/par.2018.06.25; WETTER DW, 1994, PREV MED, V23, P328, DOI 10.1006/pmed.1994.1046; Yang QZ, 2009, J PAEDIATR CHILD H, V45, P414, DOI 10.1111/j.1440-1754.2009.01530.x; Youngstedt SD, 1997, SLEEP, V20, P203, DOI 10.1093/sleep/20.3.203; Zhang Na, 2008, Neurosci Bull, V24, P45, DOI 10.1007/s12264-008-0910-z	55	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0218870	10.1371/journal.pone.0218870	http://dx.doi.org/10.1371/journal.pone.0218870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4FP	31276513	Green Submitted, Green Published, gold			2022-12-26	WOS:000484936300025
J	Kamal, N; Ochssner, I; Schwandner, A; Viehover, P; Hausmann, L; Topfer, R; Weisshaar, B; Holtgrawe, D				Kamal, Nadia; Ochssner, Iris; Schwandner, Anna; Viehoever, Prisca; Hausmann, Ludger; Toepfer, Reinhard; Weisshaar, Bernd; Holtgraewe, Daniela			Characterization of genes and alleles involved in the control of flowering time in grapevine	PLOS ONE			English	Article							MADS-BOX GENES; ARABIDOPSIS-THALIANA; INFLORESCENCE ARCHITECTURE; EXPRESSION ANALYSIS; EUCALYPTUS-GRANDIS; PSEUDO-TESTCROSS; BINDING PROTEIN; VITIS-VINIFERA; FAMILY; TRANSCRIPTION	Grapevine (Vitis vinifera) is one of the most important perennial crop plants in worldwide. Understanding of developmental processes like flowering, which impact quality and quantity of yield in this species is therefore of high interest. This gets even more important when considering some of the expected consequences of climate change. Earlier bud burst and flowering, for example, may result in yield loss due to spring frost. Berry ripening under higher temperatures will impact wine quality. Knowledge of interactions between a genotype or allele combination and the environment can be used for the breeding of genotypes that are better adapted to new climatic conditions. To this end, we have generated a list of more than 500 candidate genes that may play a role in the timing of flowering. The grapevine genome was exploited for flowering time control gene homologs on the basis of functional data from model organisms like A. thaliana. In a previous study, a mapping population derived from early flowering GF. GA-47-42 and late flowering 'Villard Blanc' was analyzed for flowering time QTLs. In a second step we have now established a workflow combining amplicon sequencing and bioinformatics to follow alleles of selected candidate genes in the F-1 individuals and the parental genotypes. Allele combinations of these genes in individuals of the mapping population were correlated with early or late flowering phenotypes. Specific allele combinations of flowering time candidate genes within and outside of the QTL regions for flowering time on chromosome 1, 4, 14, 17, and 18 were found to be associated with an early flowering phenotype. In addition, expression of many of the flowering candidate genes was analyzed over consecutive stages of bud and inflorescence development indicating functional roles of these genes in the flowering control network.	[Kamal, Nadia; Viehoever, Prisca; Weisshaar, Bernd; Holtgraewe, Daniela] Bielefeld Univ, Fac Biol, Bielefeld, Germany; [Kamal, Nadia; Viehoever, Prisca; Weisshaar, Bernd; Holtgraewe, Daniela] Ctr Biotechnol, Bielefeld, Germany; [Ochssner, Iris; Schwandner, Anna; Hausmann, Ludger; Toepfer, Reinhard] JKI, Inst Grapevine Breeding Geilweilerhof, Siebeldingen, Germany; [Kamal, Nadia] Helmholtz Ctr Munich, Plant Genome & Syst Biol, Neuherberg, Germany	University of Bielefeld; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Weisshaar, B (corresponding author), Bielefeld Univ, Fac Biol, Bielefeld, Germany.; Weisshaar, B (corresponding author), Ctr Biotechnol, Bielefeld, Germany.	dholtgra@cebitec.uni-bielefeld.de	Hausmann, Ludger/GRR-4424-2022; Hausmann, Ludger/H-7869-2017; Weisshaar, Bernd/B-3859-2014	Hausmann, Ludger/0000-0002-4046-9626; Hausmann, Ludger/0000-0002-4046-9626; Weisshaar, Bernd/0000-0002-7635-3473; Kamal, Nadia/0000-0002-3258-4130; Schwandner, Anna/0000-0001-8755-1435; Holtgrawe, Daniela/0000-0002-1062-4576	German Research Foundation (DFG) [WE 1576/16-1, TO 152/5-1]; DFG; Open Access Publication Fund of Bielefeld University	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Open Access Publication Fund of Bielefeld University	We acknowledge the financial support of the German Research Foundation (DFG) to BW (WE 1576/16-1) and RT (TO 152/5-1) in the frame of SPP1530. We also acknowledge support for the Article Processing Charge by the DFG and the Open Access Publication Fund of Bielefeld University. The funding body did not influence the design of the study, the data collection, the analysis, the interpretation of data, or the writing of the manuscript.	Adam-Blondon A-F, 2011, GENETICS GENOMICS BR; Aguiar D, 2012, J COMPUT BIOL, V19, P577, DOI 10.1089/cmb.2012.0084; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Bansal V, 2008, BIOINFORMATICS, V24, pI153, DOI 10.1093/bioinformatics/btn298; Bellaoui M, 2001, PLANT CELL, V13, P2455, DOI 10.1105/tpc.13.11.2455; Boden SA, 2014, PLANT CELL, V26, P1557, DOI 10.1105/tpc.114.123794; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boss PK, 2003, FUNCT PLANT BIOL, V30, P593, DOI 10.1071/FP02112; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; Bouche F, 2016, NUCLEIC ACIDS RES, V44, pD1167, DOI 10.1093/nar/gkv1054; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Calonje M, 2004, PLANT PHYSIOL, V135, P1491, DOI 10.1104/pp.104.040832; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Canaguier A, 2017, GENOM DATA, V14, P56, DOI 10.1016/j.gdata.2017.09.002; Carmona MJ, 2007, CAN J BOT, V85, P701, DOI 10.1139/B07-059; Causier B, 2010, MOL BIOL EVOL, V27, P2651, DOI 10.1093/molbev/msq156; Chen XB, 2010, J INTEGR PLANT BIOL, V52, P946, DOI 10.1111/j.1744-7909.2010.00987.x; Chen XM, 1999, MOL CELL, V3, P349, DOI 10.1016/S1097-2765(00)80462-1; Cheng CX, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1324-8; Cipriani G, 2011, GENETICS GENOMICS BR; Costantini L, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-38; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diaz-Riquelme J, 2009, PLANT PHYSIOL, V149, P354, DOI 10.1104/pp.108.131052; Ding Z, 2007, PLANT CELL, V19, P1522, DOI 10.1105/tpc.106.047241; Douglas SJ, 2005, DEV BIOL, V284, P451, DOI 10.1016/j.ydbio.2005.06.011; Douglas SJ, 2002, PLANT CELL, V14, P547, DOI 10.1105/tpc.010391; Doyle MR, 2005, PLANT J, V41, P376, DOI 10.1111/j.1365-313X.2004.02300.x; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Duchene E, 2012, THEOR APPL GENET, V124, P623, DOI 10.1007/s00122-011-1734-1; Ehrenreich IM, 2009, GENETICS, V183, P325, DOI 10.1534/genetics.109.105189; Fechter I, 2014, THEOR APPL GENET, V127, P1857, DOI 10.1007/s00122-014-2310-2; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Foyer CH, 2012, PLANT SIGNAL BEHAV, V7, P276, DOI 10.4161/psb.18770; GEHRING WJ, 1992, TRENDS BIOCHEM SCI, V17, P277, DOI 10.1016/0968-0004(92)90434-B; Gokbayrak Zeliha, 2006, Turkish Journal of Agriculture and Forestry, V30, P273; GRATTAPAGLIA D, 1995, THEOR APPL GENET, V90, P933, DOI 10.1007/BF00222906; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Hall A, 2003, PLANT CELL, V15, P2719, DOI 10.1105/tpc.013730; Heintzen C, 1997, P NATL ACAD SCI USA, V94, P8515, DOI 10.1073/pnas.94.16.8515; Hong-Hermesdorf A, 2006, FEBS LETT, V580, P932, DOI 10.1016/j.febslet.2006.01.018; Huang X, 2013, P NATL ACAD SCI USA, V110, P16669, DOI 10.1073/pnas.1316622110; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Joly D, 2004, PLANT SCI, V166, P1427, DOI 10.1016/j.plantsci.2003.12.041; Carmona MJ, 2008, J EXP BOT, V59, P2579, DOI 10.1093/jxb/ern160; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Khalil-Ur-Rehman M, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-016-0960-8; Kikis EA, 2005, PLANT J, V44, P300, DOI 10.1111/j.1365-313X.2005.02531.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kramer EM, 1998, GENETICS, V149, P765; Lancia G, 2001, SNPS PROBLEMS COMPLE, P182, DOI [10. 1007/3-540-44676-1_15 ., DOI 10.1007/3-540-44676-1_15]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Lorenz D. H., 1995, Australian Journal of Grape and Wine Research, V1, P100, DOI 10.1111/j.1755-0238.1995.tb00085.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M, 2016, WHATSHAP FAST ACCURA, DOI [10.1109/MS.2016.136, DOI 10.1109/MS.2016.136]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mullins MG., 1992, BIOL GRAPEVINE BIOL; Nakamichi N, 2002, BIOSCI BIOTECH BIOCH, V66, P2429, DOI 10.1271/bbb.66.2429; Peng MS, 2006, PLANT J, V46, P282, DOI 10.1111/j.1365-313X.2006.02691.x; Poupin MJ, 2007, GENE, V404, P10, DOI 10.1016/j.gene.2007.08.005; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Rawat R, 2009, P NATL ACAD SCI USA, V106, P16883, DOI 10.1073/pnas.0813035106; Riechmann JL, 1998, BIOL CHEM, V379, P633; Rienth M, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0850-0; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Shu K, 2016, J EXP BOT, V67, P195, DOI 10.1093/jxb/erv459; Sreekantan L, 2006, FUNCT PLANT BIOL, V33, P1129, DOI 10.1071/FP06144; Sreekantan L, 2010, PLANT MOL BIOL, V73, P191, DOI 10.1007/s11103-010-9611-x; Srivastava AK, 2015, PLANT PHYSIOL, V169, P2922, DOI 10.1104/pp.15.01184; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Tomasi D, 2011, AM J ENOL VITICULT, V62, P329, DOI 10.5344/ajev.2011.10108; Tseng TS, 2004, PLANT CELL, V16, P1550, DOI 10.1105/tpc.019224; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Upadhyay A, 2015, BIOL PLANTARUM, V59, P436, DOI 10.1007/s10535-015-0521-2; Van der Auwera GA, 2013, CURR PROTOCOLS BIOIN, V43, P1110; Vasconcelos MC, 2009, AM J ENOL VITICULT, V60, P411; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Venglat SP, 2002, P NATL ACAD SCI USA, V99, P4730, DOI 10.1073/pnas.072626099; Vitulo N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-99; Wang Y, 2008, PLANT BIOLOGY, V10, P548, DOI 10.1111/j.1438-8677.2008.00072.x; Ward N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101850; Yamasaki K, 2006, FEBS LETT, V580, P2109, DOI 10.1016/j.febslet.2006.03.014; Zyprian E, 2018, VITIS, V57, P119, DOI 10.5073/vitis.2018.57.119-123; Zyprian E, 2016, MOL GENET GENOMICS, V291, P1573, DOI 10.1007/s00438-016-1200-5	88	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0214703	10.1371/journal.pone.0214703	http://dx.doi.org/10.1371/journal.pone.0214703			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269026	Green Published, gold, Green Submitted			2022-12-26	WOS:000484927300003
J	Kim, GD; Ng, HP; Patel, N; Mahabeleshwar, GH				Kim, Gun-Dong; Ng, Hang Pong; Patel, Nibedita; Mahabeleshwar, Ganapati H.			Kruppel-like factor 6 and miR-223 signaling axis regulates macrophage-mediated inflammation	FASEB JOURNAL			English	Article						myeloid cells; gene regulation; transcription factor; tissue inflammation	TRANSCRIPTION FACTORS; ADIPOSE-TISSUE; MICRORNA-223; EXPRESSION; PROGENITOR; ALPHA	Macrophage-mediated inflammation is an explicitly robust biologic response that plays a critical role in maintaining tissue homeostasis by eliminating deleterious agents. These tissue macrophages tailor appropriate responses to external cues by altering inflammatory gene expression. Therefore, transcription factors and regulators that modulate inflammatory gene expression play an essential role in shaping the macrophage inflammatory response. Here, we identify that Kruppel-like factor (KLF)6 promotes inflammation by restraining microRNA-223 (miR-223) expression in macrophages. We uncovered that pro- and anti-inflammatory agents oppositely regulate KLF6 and miR-223 expression in macrophages. Using complementary gain- and loss-of-function studies, we observed that overexpression of KLF6 attenuates and deficiency of KLF6 elevates miR-223 expression in macrophages. Furthermore, heightened miR-223 expression in KLF6-deficient macrophages significantly attenuates inducible proinflammatory gene expression. Concordantly, myeloid-Klf6 deficiency significantly curbs diet-induced adipose tissue inflammation, obesity, glucose intolerance, and insulin resistance. At the molecular level, KLF6 directly represses miR-223 expression by occupying its promoter region. More importantly, genetic inhibition of miR-223-3P in KLF6-deficient macrophages completely reversed attenuated proinflammatory gene expression in macrophages. Collectively, our studies reveal that KLF6 promotes proinflammatory gene expression and functions by repressing miR-223 expression in macrophages.-Kim, G.-D., Ng, H. P., Patel, N., Mahabeleshwar, G. H. Kruppel-like factor 6 and miR-223 signaling axis regulates macrophage-mediated inflammation.	[Kim, Gun-Dong; Ng, Hang Pong; Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Patel, Nibedita; Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Cardiovasc Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Mahabeleshwar, GH (corresponding author), Case Western Reserve Univ, 2103 Cornell Rd,Room WRB-5527, Cleveland, OH 44106 USA.	ghm4@case.edu	NG, Hang Pong/AAB-2427-2020		U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL126626, HL141423]; Crohn's and Colitis Foundation of America Senior Research Award [421904]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL141423, R01HL126626] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Crohn's and Colitis Foundation of America Senior Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL126626 and HL141423, as well as the Crohn's and Colitis Foundation of America Senior Research Award 421904 (to G.H.M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chu AY, 2017, NAT GENET, V49, P125, DOI 10.1038/ng.3738; Date D, 2014, J BIOL CHEM, V289, P10318, DOI 10.1074/jbc.M113.526749; De Graeve F, 2003, GENE, V314, P55, DOI 10.1016/S0378-1119(03)00720-0; Deiuliis JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165962; Deschamps M, 2016, AM J HUM GENET, V98, P5, DOI 10.1016/j.ajhg.2015.11.014; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Goodman WA, 2016, MUCOSAL IMMUNOL, V9, P1250, DOI 10.1038/mi.2016.1; Hotamisligil GS, 2017, IMMUNITY, V47, P406, DOI 10.1016/j.immuni.2017.08.009; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kim CK, 2017, GASTROENTEROLOGY, V152, P1845, DOI 10.1053/j.gastro.2017.03.035; Kim GD, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00452-17; Kim GD, 2016, J BIOL CHEM, V291, P21271, DOI 10.1074/jbc.M116.738617; Koritschoner NP, 1997, J BIOL CHEM, V272, P9573; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Lopez YON, 2017, MOL BIOSYST, V13, P106, DOI 10.1039/c6mb00596a; Milagro FI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054319; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Neudecker V, 2017, J EXP MED, V214, P1737, DOI 10.1084/jem.20160462; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Qi WE, 2011, INT J BIOCHEM CELL B, V43, P383, DOI 10.1016/j.biocel.2010.11.008; Russo L, 2018, IMMUNOLOGY, V155, P407, DOI 10.1111/imm.13002; Salinas YD, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0387-0; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Vian L, 2014, CELL DEATH DIFFER, V21, P290, DOI 10.1038/cdd.2013.145; Vickers KC, 2014, P NATL ACAD SCI USA, V111, P14518, DOI 10.1073/pnas.1215767111; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wen DZ, 2015, OBES RES CLIN PRACT, V9, P398, DOI 10.1016/j.orcp.2015.01.006; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Ying W, 2015, J CLIN INVEST, V125, P4149, DOI 10.1172/JCI81656; Zhou WQ, 2018, CELL REP, V22, P1810, DOI 10.1016/j.celrep.2018.01.058; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	43	23	23	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10902	10915		10.1096/fj.201900867RR	http://dx.doi.org/10.1096/fj.201900867RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31262200	Green Published			2022-12-26	WOS:000489166300026
J	Zeng, X; Qu, XJ; Zhao, CY; Xu, L; Hou, KZ; Liu, YP; Zhang, N; Feng, J; Shi, S; Zhang, LY; Xiao, JW; Guo, ZG; Teng, YE; Che, XF				Zeng, Xue; Qu, Xiujuan; Zhao, Chenyang; Xu, Lu; Hou, Kezuo; Liu, Yunpeng; Zhang, Na; Feng, Jing; Shi, Sha; Zhang, Lingyun; Xiao, Jiawen; Guo, Zhigang; Teng, Yuee; Che, Xiaofang			FEN1 mediates miR-200a methylation and promotes breast cancer cell growth via MET and EGFR signaling	FASEB JOURNAL			English	Article						flap endonuclease 1; PCNA; DNA methyltransferases; tumor progression	FLAP ENDONUCLEASE-1; DNA METHYLTRANSFERASES; MICRORNA-200 FAMILY; ADJUVANT THERAPY; GENE-EXPRESSION; PROSTATE-CANCER; DNMT1; HYPOMETHYLATION; PROGRESSION; TRANSITION	Flap endonuclease 1 (FEN1) is recognized as a pivotal factor in DNA replication, long-patch excision repair, and telomere maintenance. Excessive FEN1 expression has been reported to be closely associated with cancer progression, but the specific mechanism has not yet been explored. In the present study, we demonstrated that FEN1 promoted breast cancer cell proliferation via an epigenetic mechanism of FEN1-mediated up-regulation of DNA methyltransferase (DNMT)1 and DNMT3a. FEN1 was proved to interact with DNMT3a through proliferating cell nuclear antigen (PCNA) to suppress microRNA (miR)-200a-5p expression mediated by methylation. Furthermore, miR-200a-5p was identified to repress breast cancer cell proliferation by inhibiting the expression of its target genes, hepatocyte growth factor (MET), and epidermal growth factor receptor (EGFR). Overall, our data surprisingly demonstrate that FEN1 promotes breast cancer cell growth via the formation of FEN1/PCNA/DNMT3a complex to inhibit miR-200a expression by DNMT-mediated methylation and to recover the target genes expression of miR-200a, MET, and EGFR. The novel epigenetic mechanism of FEN1 on proliferation promotion provides a significant clue that FEN1 might serve as a predictive biomarker and therapeutic target for breast cancer.-Zeng, X., Qu, X., Zhao, C., Xu, L., Hou, K., Liu, Y., Zhang, N., Feng, J., Shi, S., Zhang, L., Xiao, J., Guo, Z., Teng, Y., Che, X. FEN1 mediates miR-200a methylation and promotes breast cancer cell growth via MET and EGFR signaling.	[Zeng, Xue; Qu, Xiujuan; Xu, Lu; Hou, Kezuo; Liu, Yunpeng; Feng, Jing; Shi, Sha; Zhang, Lingyun; Teng, Yuee; Che, Xiaofang] China Med Univ, Hosp 1, Dept Med Oncol, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China; [Zeng, Xue; Qu, Xiujuan; Xu, Lu; Hou, Kezuo; Liu, Yunpeng; Feng, Jing; Shi, Sha; Zhang, Lingyun; Teng, Yuee; Che, Xiaofang] China Med Univ, Hosp 1, Key Lab Anticanc Drugs & Biotherapy Liaoning Prov, Shenyang, Liaoning, Peoples R China; [Zeng, Xue; Zhang, Na] China Med Univ, Canc Hosp, Liaoning Canc Hosp & Inst, Dept Radiotherapy, Shenyang, Liaoning, Peoples R China; [Zhao, Chenyang] China Med Univ, Res Ctr Med Genom, Shenyang, Liaoning, Peoples R China; [Xiao, Jiawen] Shenyang Fifth People Hosp, Dept Med Oncol, Shenyang, Liaoning, Peoples R China; [Guo, Zhigang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University; Nanjing Normal University	Teng, YE; Che, XF (corresponding author), China Med Univ, Hosp 1, Dept Med Oncol, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China.	yeteng@cmu.edu.cn; xfche@cmu.edu.cn			National Natural Science Foundation of China [81672605]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2017ZX09304025]; Science and Technology Plan Project of Liaoning Province [2015020457, 2015020458, 201602452]; General Project of Liaoning Province, Department of Education [L2015588]; Foundation for Selected Overseas Chinese Scholar; Centre Leading Local Special Fund for Science and Technology of Liaoning Province [2016007010]; Key Research and Development Program of Shenyang [17-230-9-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of the Ministry of Science and Technology of China; Science and Technology Plan Project of Liaoning Province; General Project of Liaoning Province, Department of Education; Foundation for Selected Overseas Chinese Scholar; Centre Leading Local Special Fund for Science and Technology of Liaoning Province; Key Research and Development Program of Shenyang	This work was supported by the National Natural Science Foundation of China (81672605), the National Science and Technology Major Project of the Ministry of Science and Technology of China (2017ZX09304025), the Science and Technology Plan Project of Liaoning Province (2015020457, 2015020458, 201602452), the General Project of Liaoning Province, Department of Education (L2015588), the Foundation for Selected Overseas Chinese Scholar 2015, the Centre Leading Local Special Fund for Science and Technology of Liaoning Province (2016007010), and the Key Research and Development Program of Shenyang (17-230-9-01). The authors declare no conflicts of interest.	Abdel-Fatah TMA, 2014, MOL ONCOL, V8, P1326, DOI 10.1016/j.molonc.2014.04.009; Castilla MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047709; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Baretti M, 2018, CURR PROB CANCER, V42, P530, DOI 10.1016/j.currproblcancer.2018.03.001; Beattie TR, 2011, BIOCHEM SOC T, V39, P70, DOI 10.1042/BST0390070; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; da Cruz AT, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/528345; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Finger L David, 2012, Subcell Biochem, V62, P301, DOI 10.1007/978-94-007-4572-8_16; Gao Y, 2018, EBIOMEDICINE, V31, P243, DOI 10.1016/j.ebiom.2018.04.025; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Hamidi T, 2015, EPIGENOMICS-UK, V7, P247, DOI [10.2217/EPI.14.80, 10.2217/epi.14.80]; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hata K, 2002, DEVELOPMENT, V129, P1983; He LF, 2017, MOL ONCOL, V11, P1302, DOI 10.1002/1878-0261.12118; He LF, 2016, EBIOMEDICINE, V14, P32, DOI 10.1016/j.ebiom.2016.11.012; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Hervouet E, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0450-y; Hilmarsdottir B, 2014, GENES-BASEL, V5, P804, DOI 10.3390/genes5030804; Humphries B, 2015, ONCOTARGET, V6, P6472, DOI 10.18632/oncotarget.3052; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kinney SRM, 2008, MOL CANCER RES, V6, P1365, DOI 10.1158/1541-7786.MCR-08-0040; Krause A, 2005, CANCER LETT, V225, P111, DOI 10.1016/j.canlet.2004.10.035; Lam JS, 2006, BJU INT, V98, P445, DOI 10.1111/j.1464-410X.2006.06224.x; Lim YY, 2013, J CELL SCI, V126, P2256, DOI 10.1242/jcs.122275; Linklater ES, 2016, ONCOTARGET, V7, P69903, DOI 10.18632/oncotarget.12065; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lyko F, 2018, NAT REV GENET, V19, P81, DOI 10.1038/nrg.2017.80; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; Nikolova T, 2009, ANTICANCER RES, V29, P2453; Nimura K, 2006, GENES CELLS, V11, P1225, DOI 10.1111/j.1365-2443.2006.01012.x; Ning XH, 2015, CANCER LETT, V359, P198, DOI 10.1016/j.canlet.2015.01.005; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Parashar S, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4482-7; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Robaina MC, 2015, EXP MOL PATHOL, V98, P200, DOI 10.1016/j.yexmp.2015.03.006; Romagnolo DF, 2016, MOL NUTR FOOD RES, V60, P1310, DOI 10.1002/mnfr.201501063; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Sato M, 2003, ONCOGENE, V22, P7243, DOI 10.1038/sj.onc.1206977; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Shimamura S, 2008, CANCER SCI, V99, P1960, DOI 10.1111/j.1349-7006.2008.00913.x; Singh P, 2008, MOL CANCER RES, V6, P1710, DOI 10.1158/1541-7786.MCR-08-0269; Thomas ML, 2018, CANCERS, V10, DOI 10.3390/cancers10040101; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Wang J., 2015, BMC CANCER, V15; Wang KJ, 2014, INT J MOL MED, V33, P1268, DOI 10.3892/ijmm.2014.1682; Yi YW, 2015, INT J ONCOL, V47, P122, DOI 10.3892/ijo.2015.2982; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884	55	26	27	6	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10717	10730		10.1096/fj.201900273R	http://dx.doi.org/10.1096/fj.201900273R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31266372				2022-12-26	WOS:000489166300012
J	Ishizuka, S; Tsuchiya, S; Ohashi, Y; Terabe, K; Askew, EB; Ishizuka, N; Knudson, CB; Knudson, W				Ishizuka, Shinya; Tsuchiya, Saho; Ohashi, Yoshifumi; Terabe, Kenya; Askew, Emily B.; Ishizuka, Naoko; Knudson, Cheryl B.; Knudson, Warren			Hyaluronan synthase 2 (HAS2) overexpression diminishes the procatabolic activity of chondrocytes by a mechanism independent of extracellular hyaluronan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hyaluronan; chondrocyte; matrix metalloproteinase (MMP); metabolomics; osteoarthritis; inflammation; cartilage catabolism; hyaluronan synthase 2 (HAS2); aggrecan	MOLECULAR-WEIGHT HYALURONAN; ARTICULAR-CARTILAGE; PROTEOGLYCAN AGGREGATE; OSTEOARTHRITIS; EXPRESSION; METABOLISM; AGGRECAN; RECEPTOR; GROWTH; CD44	Osteoarthritis (OA) is a progressive degenerative disease of the joints caused in part by a change in the phenotype of resident chondrocytes within affected joints. This altered phenotype, often termed proinflammatory or procatabolic, features enhanced production of endoproteinases and matrix metallo-proteinases (MMPs) as well as secretion of endogenous inflammatory mediators. Degradation and reduced retention of the proteoglycan aggrecan is an early event in OA. Enhanced turnover of hyaluronan (HA) is closely associated with changes in aggrecan. Here, to determine whether experimentally increased HA production promotes aggrecan retention and generates a positive feedback response, we overexpressed HA synthase-2 (HAS2) in chondrocytes via an inducible adenovirus construct (HA synthase-2 viral overexpression; HAS2-OE). HAS2-OE incrementally increased high-molecular-mass HA >100-fold within the cell-associated and growth medium pools. More importantly, our results indicated that the HAS2-OE expression system inhibits MMP3, MMP13, and other markers of the procatabolic phenotype (such as TNF-stimulated gene 6 protein (TSG6)) and also enhances aggrecan retention. These markers were inhibited in OA-associated chondrocytes and in chondrocytes activated by interleukin-1 beta (IL1 beta), but also chondrocytes activated by lipopolysaccharide (LPS), tumor necrosis factor alpha (TNF alpha), or HA oligosaccharides. However, the enhanced extracellular HA resulting from HAS2-OE did not reduce the procatabolic phenotype of neighboring nontransduced chondrocytes as we had expected. Rather, HA-mediated inhibition of the phenotype occurred only in transduced cells. In addition, high HA biosynthesis rates, especially in transduced procatabolic chondrocytes, resulted in marked changes in chondrocyte dependence on glycolysis versus oxidative phosphorylation for their metabolic energy needs.	[Ishizuka, Shinya; Tsuchiya, Saho; Ohashi, Yoshifumi; Terabe, Kenya; Askew, Emily B.; Ishizuka, Naoko; Knudson, Cheryl B.; Knudson, Warren] East Carolina Univ, Dept Anat & Cell Biol, Brody Sch Med, 600 Moye Blvd,Mailstop 620, Greenville, NC 27834 USA; [Ishizuka, Shinya; Terabe, Kenya; Ishizuka, Naoko] Nagoya Univ, Grad Sch Med, Dept Orthoped Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan	University of North Carolina; East Carolina University; Nagoya University	Knudson, W (corresponding author), East Carolina Univ, Dept Anat & Cell Biol, Brody Sch Med, 600 Moye Blvd,Mailstop 620, Greenville, NC 27834 USA.	knudsonw@ecu.edu		Ishizuka, Shinya/0000-0003-1877-9502	National Institutes of Health [R01-AR039507, R21-AR066581, R21-AR072682]; Mizutani Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR072682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizutani Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported in part by National Institutes of Health Grants R01-AR039507 (to C. B. K.), R21-AR066581 (to W. K.), and R21-AR072682 (to W. K.) as well as a grant from the Mizutani Foundation (to W. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ariyoshi W, 2012, ARTHRITIS RHEUM-US, V64, P187, DOI 10.1002/art.33329; Ariyoshi W, 2010, J BIOL CHEM, V285, P36216, DOI 10.1074/jbc.M110.129270; Campo GM, 2011, BBA-MOL BASIS DIS, V1812, P1170, DOI 10.1016/j.bbadis.2011.06.006; Campo GM, 2010, BIOCHEM PHARMACOL, V80, P480, DOI 10.1016/j.bcp.2010.04.024; Campo GM, 2010, BIOCHIMIE, V92, P204, DOI 10.1016/j.biochi.2009.10.006; Chanmee T, 2016, J BIOL CHEM, V291, P24105, DOI 10.1074/jbc.M116.751263; Chanmee T, 2014, J BIOL CHEM, V289, P26038, DOI 10.1074/jbc.M114.564120; Chou CH, 2018, OSTEOARTHR CARTILAGE, V26, P245, DOI 10.1016/j.joca.2017.10.019; Danielson BT, 2015, J BIOL CHEM, V290, P9555, DOI 10.1074/jbc.M115.643171; Durigova M, 2008, OSTEOARTHR CARTILAGE, V16, P98, DOI 10.1016/j.joca.2007.05.002; Durigova M, 2011, EUR CELLS MATER, V21, P31, DOI 10.22203/eCM.v021a03; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Flory JJE, 2006, ARTHRITIS RHEUM-US, V54, P443, DOI 10.1002/art.21623; FOSANG AJ, 1991, MATRIX, V11, P17, DOI 10.1016/S0934-8832(11)80223-4; Furuta J, 2017, J ORTHOP RES, V35, P331, DOI 10.1002/jor.23266; Goldberg VM, 2005, OSTEOARTHR CARTILAGE, V13, P216, DOI 10.1016/j.joca.2004.11.010; Goldring MB, 2015, CURR OPIN PHARMACOL, V22, P51, DOI 10.1016/j.coph.2015.03.004; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; Hascall VC, 2014, MATRIX BIOL, V35, P14, DOI 10.1016/j.matbio.2014.01.014; Hirabara S, 2013, BIOCHEM BIOPH RES CO, V430, P519, DOI 10.1016/j.bbrc.2012.12.003; HOLMES MWA, 1988, BIOCHEM J, V250, P435, DOI 10.1042/bj2500435; Huang Y, 2016, MATRIX BIOL, V56, P74, DOI 10.1016/j.matbio.2016.04.002; Iacob S, 2006, INT J BIOCHEM CELL B, V38, P123, DOI 10.1016/j.biocel.2005.08.011; Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbrc.2004.06.029; Ishizuka S, 2016, J BIOL CHEM, V291, P12087, DOI 10.1074/jbc.M115.709683; Jiang H, 2002, J BIOL CHEM, V277, P10531, DOI 10.1074/jbc.M108654200; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Knudson W, 2000, ARTHRITIS RHEUM-US, V43, P1165, DOI 10.1002/1529-0131(200005)43:5<1165::AID-ANR27>3.0.CO;2-H; Knudson W, 2019, MATRIX BIOL, V78-79, P32, DOI 10.1016/j.matbio.2018.02.005; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Liu-Bryan R, 2015, NAT REV RHEUMATOL, V11, P35, DOI 10.1038/nrrheum.2014.162; Liu-Bryan R, 2010, ARTHRITIS RHEUM-US, V62, P2004, DOI 10.1002/art.27475; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; Mehlhorn AT, 2006, TISSUE ENG, V12, P2853, DOI 10.1089/ten.2006.12.2853; Mellor L, 2013, J BIOL CHEM, V288, P25838, DOI 10.1074/jbc.M113.494872; Mobasheri A, 2017, NAT REV RHEUMATOL, V13, P302, DOI 10.1038/nrrheum.2017.50; MORALES TI, 1988, J BIOL CHEM, V263, P3632; Muto J, 2009, MOL IMMUNOL, V47, P449, DOI 10.1016/j.molimm.2009.08.026; NG CK, 1992, ARCH BIOCHEM BIOPHYS, V298, P70, DOI 10.1016/0003-9861(92)90095-E; Nishida Y, 1999, J BIOL CHEM, V274, P21893, DOI 10.1074/jbc.274.31.21893; Nishida Y, 2000, ARTHRITIS RHEUM, V43, P1315, DOI 10.1002/1529-0131(200006)43:6<1315::AID-ANR14>3.0.CO;2-#; Ohno S, 2006, J BIOL CHEM, V281, P17952, DOI 10.1074/jbc.M602750200; Orlowsky EW, 2015, J RHEUMATOL, V42, P363, DOI 10.3899/jrheum.140382; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rasmussen TB, 2003, ARCH VIROL, V148, P2005, DOI 10.1007/s00705-003-0145-2; RIZKALLA G, 1992, J CLIN INVEST, V90, P2268, DOI 10.1172/JCI116113; Roughley Peter J, 2014, J Exp Orthop, V1, P8, DOI 10.1186/s40634-014-0008-7; Ruppert SM, 2014, IMMUNOL RES, V58, P186, DOI 10.1007/s12026-014-8495-2; Sandy JD, 2015, OSTEOARTHR CARTILAGE, V23, P1939, DOI 10.1016/j.joca.2015.03.027; Schmitz I, 2010, OSTEOARTHR CARTILAGE, V18, P447, DOI 10.1016/j.joca.2009.10.007; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Strand V, 2015, J PAIN RES, V8, P217, DOI 10.2147/JPR.S83076; Sztrolovics R, 2002, BIOCHEM J, V362, P473, DOI 10.1042/0264-6021:3620473; Terabe K, 2019, ARCH BIOCHEM BIOPHYS, V665, P1, DOI 10.1016/j.abb.2019.01.038; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	62	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13562	13579		10.1074/jbc.RA119.008567	http://dx.doi.org/10.1074/jbc.RA119.008567			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31270213	Green Published, hybrid			2022-12-26	WOS:000486418600005
J	Jo, S; Lockridge, A; Alejandro, EU				Jo, Seokwon; Lockridge, Amber; Alejandro, Emilyn U.			eIF4G1 and carboxypeptidase E axis dysregulation in O-GlcNAc transferase- deficient pancreatic beta-cells contributes to hyperproinsulinemia in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); insulin synthesis; post-translational modification (PTM); diabetes; Chop; eIF4G1; ER-stress; hyperproinsulinemia; islet	LINKED N-ACETYLGLUCOSAMINE; ACUTE INSULIN-RESPONSE; ENDOPLASMIC-RETICULUM; INTACT PROINSULIN; GLUCOSE; GLCNACYLATION; GLYCOSYLATION; RESISTANCE; SECRETION; PROTEINS	An early hallmark of type 2 diabetes is a failure of proinsulin-to-insulin processing in pancreatic beta-cells, resulting in hyperproinsulinemia. Proinsulin processing is quite sensitive to nutrient flux, and beta-cell-specific deletion of the nutrient-sensing protein modifier OGlcNAc transferase (beta OGTKO) causes beta-cell failure and diabetes, including early development of hyperproinsulinemia. The mechanisms underlying this latter defect are unknown. Here, using several approaches, including site-directed mutagenesis, Click O-GlcNAc labeling, immunoblotting, and immunofluorescence and EM imaging, we provide the first evidence for a relationship between the O-GlcNAcylation of eukaryotic translation initiation factor 4 gamma 1 (eIF4G1) and carboxypeptidase E (CPE)-dependent proinsulin processing in beta OGTKO mice. We first established that beta OGTKO hyperproinsulinemia is independent of age, sex, glucose levels, and endoplasmic reticulum-CCAAT enhancer-binding protein homologous protein (CHOP)-mediated stress status. Of note, OGT loss was associated with a reduction in beta-cell-resident CPE, and genetic reconstitution of CPE in beta OGTKO islets rescued the dysfunctional proinsulin-to-insulin ratio. We show that although CPE is not directly OGlcNAc modified in islets, overexpression of the suspected OGT target eIF4G1, previously shown to regulate CPE translation in beta-cells, increases islet CPE levels, and fully reverses beta OGTKO islet-induced hyperproinsulinemia. Furthermore, our results reveal that OGT O-GlcNAc-modifies eIF4G1 at Ser-61 and that this modification is critical for eIF4G1 protein stability. Together, these results indicate a direct link between nutrient-sensitive OGT and insulin processing, underscoring the importance of post-translational O-GlcNAc modification in general cell physiology.	[Jo, Seokwon; Lockridge, Amber; Alejandro, Emilyn U.] Univ Minnesota, Med Sch, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Alejandro, EU (corresponding author), Univ Minnesota, Med Sch, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.	ealejand@umn.edu		Lockridge, Amber/0000-0003-1122-6286; Jo, Seokwon/0000-0002-8989-4893	National Institutes of Health, NIDDK [K01 DK103823, R21 DK112144, R03 DK114465, R01 DK115720, F31 DK113694, 5T32DK083250]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK112144, K01DK103823, T32DK083250, R03DK114465, R01DK115720, F31DK113694] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health, NIDDK Grants K01 DK103823, R21 DK112144, R03 DK114465, and R01 DK115720 (to E.U. A.), and F31 DK113694, 5T32DK083250 (to A. L). E.U. A. is the guarantor of this work. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alejandro EU, 2015, CELL REP, V13, P2527, DOI 10.1016/j.celrep.2015.11.020; Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Blandino-Rosano M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16014; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Bravo R, 2013, INT REV CEL MOL BIO, V301, P215, DOI 10.1016/B978-0-12-407704-1.00005-1; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Chu KY, 2011, ISLETS, V3, P155, DOI 10.4161/isl.3.4.15767; de Queiroz RM, 2016, J BIOL CHEM, V291, P18897, DOI 10.1074/jbc.M116.734533; Dhanvantari S, 2002, BIOCHEMISTRY-US, V41, P52, DOI 10.1021/bi015698n; FRICKER LD, 1990, J BIOL CHEM, V265, P2476; Furuta M, 1998, J BIOL CHEM, V273, P3431, DOI 10.1074/jbc.273.6.3431; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; GELDING SV, 1995, CLIN ENDOCRINOL, V42, P255, DOI 10.1111/j.1365-2265.1995.tb01873.x; Gomez E, 2004, J BIOL CHEM, V279, P53937, DOI 10.1074/jbc.M408682200; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00183; Horing E, 2012, ACTA NEUROPATHOL, V124, P83, DOI 10.1007/s00401-011-0940-x; Issad T, 2010, DIABETES METAB, V36, P423, DOI 10.1016/j.diabet.2010.09.001; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Liew CW, 2014, P NATL ACAD SCI USA, V111, pE2319, DOI 10.1073/pnas.1323066111; Liu M, 2014, VITAM HORM, V95, P35, DOI 10.1016/B978-0-12-800174-5.00002-8; Lockridge AD, 2016, ISLETS, V8, P195, DOI 10.1080/19382014.2016.1260797; Ma JF, 2013, EXPERT REV PROTEOMIC, V10, P365, DOI 10.1586/14789450.2013.820536; Mykkanen L, 1999, DIABETOLOGIA, V42, P1060, DOI 10.1007/s001250051271; NAGAMATSU S, 1987, ENDOCRINOLOGY, V120, P1225, DOI 10.1210/endo-120-4-1225; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Pfutzner A, 2004, DIABETES CARE, V27, P682, DOI 10.2337/diacare.27.3.682; Roder ME, 1999, DIABETES CARE, V22, P609, DOI 10.2337/diacare.22.4.609; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Varlamov O, 1997, ENDOCRINOLOGY, V138, P4883, DOI 10.1210/en.138.11.4883; Xu SL, 2017, P NATL ACAD SCI USA, V114, pE1536, DOI 10.1073/pnas.1610452114; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Zethelius B, 2003, DIABETOLOGIA, V46, P20, DOI 10.1007/s00125-002-0995-2; Zhang XQ, 2018, NAT CHEM BIOL, V14, P909, DOI 10.1038/s41589-018-0120-6	39	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13040	13050		10.1074/jbc.RA119.008670	http://dx.doi.org/10.1074/jbc.RA119.008670			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31300553	hybrid, Green Published			2022-12-26	WOS:000486416000015
J	LaRock, DL; Sands, JS; Ettouati, E; Richard, M; Bushway, PJ; Adler, ED; Nizet, V; LaRock, CN				LaRock, Doris L.; Sands, Jenna S.; Ettouati, Ethan; Richard, Marine; Bushway, Paul J.; Adler, Eric D.; Nizet, Victor; LaRock, Christopher N.			Inflammasome inhibition blocks cardiac glycoside cell toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammasome; cardiomyocyte; macrophage; IL-1; cell death; caspase 1 (CASP1); cardiac glycoside	NLRP3 INFLAMMASOME; NERIUM-OLEANDER; HEART-FAILURE; DIGOXIN; ACTIVATION; MORTALITY; ASSOCIATION; RECRUITMENT; PYROPTOSIS; IL-1-BETA	Chronic heart failure and cardiac arrhythmias have high morbidity and mortality, and drugs for the prevention and management of these diseases are a large part of the pharmaceutical market. Among these drugs are plant-derived cardiac glycosides, which have been used by various cultures over millennia as both medicines and poisons. We report that digoxin and related compounds activate the NLRP3 inflammasome in macrophages and cardiomyocytes at concentrations achievable during clinical use. Inflammasome activation initiates the maturation and release of the inflammatory cytokine IL-1 beta and the programmed cell death pathway pyroptosis in a caspase-1-dependent manner. Notably, the same fluxes of potassium and calcium cations that affect heart contraction also induce inflammasome activation in human but not murine cells. Pharmaceuticals that antagonize these fluxes, including glyburide and verapamil, also inhibit inflammasome activation by cardiac glycosides. Cardiac glycoside-induced cellular cytotoxicity and IL-1 beta signaling are likewise antagonized by inhibitors of the NLRP3 inflammasome or the IL-1 receptor-targeting biological agent anakinra. Our results inform on the molecular mechanism by which the inflammasome integrates the diverse signals that activate it through secondary signals like cation flux. Furthermore, this mechanism suggests a contribution of the inflammasome to the toxicity and adverse events associated with cardiac glycosides use in humans and that targeted anti-inflammatories could provide an additional adjunct therapeutic countermeasure.	[LaRock, Doris L.; Ettouati, Ethan; Richard, Marine; Nizet, Victor; LaRock, Christopher N.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [LaRock, Doris L.; Ettouati, Ethan; Richard, Marine; Nizet, Victor; LaRock, Christopher N.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Richard, Marine] Inst Superieur Sante & Bioproduits, F-49000 Angers, France; [Bushway, Paul J.; Adler, Eric D.] Univ Calif San Diego, Dept Cardiovasc Med, La Jolla, CA 92093 USA; [LaRock, Doris L.; Sands, Jenna S.; LaRock, Christopher N.] Emory Sch Med, Dept Microbiol & Immunol, Atlanta, GA USA; [LaRock, Doris L.; Sands, Jenna S.; LaRock, Christopher N.] Emory Sch Med, Dept Med, Atlanta, GA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Emory University; Emory University	Nizet, V (corresponding author), Univ Calif San Diego, Sch Med, 9500 Gilman Dr,Mail Code 0760, La Jolla, CA 92093 USA.; LaRock, CN (corresponding author), Emory Univ, Sch Med, 1510 Clifton Rd NE,Ste 3019, Atlanta, GA 30322 USA.	vnizet@ucsd.edu; christopher.larock@emory.edu	LaRock, Christopher/E-1554-2013; Nizet, Victor/AAF-3190-2019	LaRock, Christopher/0000-0003-3035-5331; Nizet, Victor/0000-0003-3847-0422; LaRock, Doris/0000-0002-2661-6853; Sands, Jenna/0000-0001-9107-7780	NICHD, National Institutes of Health [HD090259]; NIAID, National Institutes of Health [AI130223]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI130223] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by NICHD, National Institutes of Health Grant HD090259 (to V.N.) and NIAID, National Institutes of Health Grant AI130223 (to C. N. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed A, 2006, EUR HEART J, V27, P178, DOI 10.1093/eurheartj/ehi687; Ainscough JS, 2015, J BIOL CHEM, V290, P31151, DOI 10.1074/jbc.M115.680694; Aslani MR, 2007, IRAN J VETERINARY RE, V8, P58; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Chao MW, 2017, SCI REP-UK, V7, DOI 10.1038/srep46134; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; COLTART J, 1972, BMJ-BRIT MED J, V2, P318, DOI 10.1136/bmj.2.5809.318; Dawson A. H., 2016, MEDICINE, V44, P158, DOI [10.1016/j.mpmed.2015.12.006, DOI 10.1016/J.MPMED.2015.12.006]; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; ESPOSITO AL, 1988, J INFECT DIS, V157, P1084, DOI 10.1093/infdis/157.5.1084; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; GUPTA RS, 1986, J CELL PHYSIOL, V127, P197, DOI 10.1002/jcp.1041270202; Hensler ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002446; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Ip WKE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7931; KARJALAINEN J, 1974, ACTA PHARMACOL TOX, V34, P385; Karthikeyan G, 2019, HEART, V105, P363, DOI 10.1136/heartjnl-2018-313614; KELLY RA, 1992, AM J CARDIOL, V69, pG108, DOI 10.1016/0002-9149(92)91259-7; KINLAY S, 1995, J TOXICOL-CLIN TOXIC, V33, P55, DOI 10.3109/15563659509020216; Kobayashi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176676; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; LaRock CN, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3539; LaRock CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003793; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; LEOR J, 1995, CARDIOVASC DRUG THER, V9, P723, DOI 10.1007/BF00878556; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Perry G, 1997, NEW ENGL J MED, V336, P525; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P871, DOI 10.1001/jama.289.7.871; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Roberts DM, 2016, BRIT J CLIN PHARMACO, V81, P488, DOI 10.1111/bcp.12814; SCHWARTZ WL, 1974, VET PATHOL, V11, P259, DOI 10.1177/030098587401100307; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Van Tassell BW, 2013, CIRCULATION, V128, P1910, DOI 10.1161/CIRCULATIONAHA.113.003199; Withering W, 1785, ACCOUNT FOXGLOVE SOM; WOOLF AD, 1992, NEW ENGL J MED, V326, P1739, DOI 10.1056/NEJM199206253262604; Xiao AY, 2002, J NEUROSCI, V22, P1350, DOI 10.1523/JNEUROSCI.22-04-01350.2002; YAMATO K, 1989, J CELL PHYSIOL, V139, P610, DOI 10.1002/jcp.1041390322; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1161/CIR.0000000000000509, 10.1016/j.jacc.2017.04.025]; Yang QF, 2005, P NATL ACAD SCI USA, V102, P9631, DOI 10.1073/pnas.0504097102; Yaron JR, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.277	53	7	7	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12846	12854		10.1074/jbc.RA119.008330	http://dx.doi.org/10.1074/jbc.RA119.008330			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31300552	hybrid, Green Published			2022-12-26	WOS:000484414600025
J	Botta, F; Martin-Arevalo, E; Lupianez, J; Bartolomeo, P				Botta, Fabiano; Martin-Arevalo, Elisa; Lupianez, Juan; Bartolomeo, Paolo			Does spatial attention modulate sensory memory?	PLOS ONE			English	Article							VISUAL-ATTENTION; NEURAL CORRELATE; ICONIC MEMORY; CONSCIOUSNESS; MECHANISMS; AWARENESS	According to some theoretical models, information contained in visual short-term memory (VSTM) consists of two main memory stages/storages: sensory memory, a system wherein information is stored for a brief time with high detail and low resistance to visual interference, and visual working memory, a low-capacity system wherein information is protected from visual interference and maintained for longer delays. Previous studies have consistently shown a strong relationship between attention and visual working memory. However, evidence is contradictory on whether or not attention modulates the construction and maintenance of visual representations in sensory memory. Here, we examined whether and how spatial attention differentially affects sensory and working memory contents, by separately analysing attentional costs and attentional benefits. Results showed that both sensory memory and visual working memory were reliably affected by the distribution of spatial attention, suggesting that spatial attention modulates the VSTM content starting from very early stages of memory storage. Moreover, endogenously attending a specific location led to similar performance in sensory and working memory, and therefore to larger attentional benefits in working memory (where there was more room for improvement than in sensory memory, because of worse performance in unattended locations). On the other hand, exogenous attentional capture by peripheral unpredictive cues produced invariant attentional costs and invariant attentional benefits regardless of the memory type, with performance being higher in sensory memory than in working memory even at the attended location.	[Botta, Fabiano; Martin-Arevalo, Elisa; Lupianez, Juan] Univ Granada, Dept Expt Psychol, Granada, Spain; [Botta, Fabiano; Martin-Arevalo, Elisa; Lupianez, Juan] Univ Granada, Brain Mind & Behav Res Ctr CIMCYC, Granada, Spain; [Bartolomeo, Paolo] Sorbonne Univ, Inst Cerveau & Moelle Epiniere ICM, CNRS UMR 7225, INSERM U 1127, Paris, France	University of Granada; University of Granada; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Botta, F (corresponding author), Univ Granada, Dept Expt Psychol, Granada, Spain.; Botta, F (corresponding author), Univ Granada, Brain Mind & Behav Res Ctr CIMCYC, Granada, Spain.	fabianobotta@ugr.es	Martín-Arévalo, Elisa/N-2364-2019; Lupiáñez, Juan/G-1453-2010; Bartolomeo, Paolo/B-3046-2009	Martín-Arévalo, Elisa/0000-0002-4546-6440; Lupiáñez, Juan/0000-0001-6157-9894; Botta, Fabiano/0000-0002-3325-9217; Bartolomeo, Paolo/0000-0002-2640-6426	Marie Curie IF fellowship; Juan de la Cierva postdoctoral fellowship from the Spanish Ministry of Economy, Industry, and Competitiveness [IJCI-2015-23204]; ANR [ANR-16-CE37-0005, ANR-10-IAIHU-06];  [PSI2015-73503-JIN]	Marie Curie IF fellowship; Juan de la Cierva postdoctoral fellowship from the Spanish Ministry of Economy, Industry, and Competitiveness; ANR(French National Research Agency (ANR)); 	FB was supported by a Marie Curie IF fellowship and by national research project PSI2015-73503-JIN. EMA was supported by a Juan de la Cierva postdoctoral fellowship from the Spanish Ministry of Economy, Industry, and Competitiveness (IJCI-2015-23204). PB was supported by ANR through ANR-16-CE37-0005 and ANR-10-IAIHU-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshamian A, 2018, J NEUROSCI, V38, P10286, DOI 10.1523/JNEUROSCI.3360-17.2018; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Bartolomeo P, 2014, ATTENTION DISORDERS; Block N, 1996, TRENDS NEUROSCI, V19, P456, DOI 10.1016/S0166-2236(96)20049-9; Botta F, 2014, ACTA PSYCHOL, V150, P1, DOI 10.1016/j.actpsy.2014.03.013; Botta F, 2010, Q J EXP PSYCHOL, V63, P1590, DOI 10.1080/17470210903443836; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Carrasco M, 2009, PROG BRAIN RES, V176, P65, DOI 10.1016/S0079-6123(09)17605-7; Chica AB, 2008, VISION RES, V48, P2251, DOI 10.1016/j.visres.2008.06.022; Chica AB, 2014, NEUROSCI BIOBEHAV R, V40, P35, DOI 10.1016/j.neubiorev.2014.01.002; Chica AB, 2013, CEREB CORTEX, V23, P1269, DOI 10.1093/cercor/bhs087; Chica AB, 2013, BEHAV BRAIN RES, V237, P107, DOI 10.1016/j.bbr.2012.09.027; Chica AB, 2012, NEUROPSYCHOLOGIA, V50, P621, DOI 10.1016/j.neuropsychologia.2011.12.020; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; FRIEDMANHILL SR, 1995, SCIENCE, V269, P853, DOI 10.1126/science.7638604; Funes MJ, 2007, J EXP PSYCHOL HUMAN, V33, P348, DOI 10.1037/0096-1523.33.2.348; Kouider S, 2010, TRENDS COGN SCI, V14, P301, DOI 10.1016/j.tics.2010.04.006; Lamme VAF, 2003, TRENDS COGN SCI, V7, P12, DOI 10.1016/S1364-6613(02)00013-X; Lamme VAF, 2004, NEURAL NETWORKS, V17, P861, DOI 10.1016/j.neunet.2004.02.005; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; Mack A, 2016, CONSCIOUS COGN, V40, P1, DOI 10.1016/j.concog.2015.12.006; Mack A, 2015, CONSCIOUS COGN, V33, P291, DOI 10.1016/j.concog.2014.12.016; Makovski T, 2012, PSYCHON B REV, V19, P470, DOI 10.3758/s13423-012-0235-9; Naccache L, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0357; Persuh M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00126; Pinto Y, 2017, J EXP PSYCHOL GEN, V146, P214, DOI 10.1037/xge0000255; Ricker TJ, 2018, ANN N Y ACAD SCI; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Schmidt BK, 2002, PERCEPT PSYCHOPHYS, V64, P754, DOI 10.3758/BF03194742; Sergent C, 2013, CURR BIOL, V23, P150, DOI 10.1016/j.cub.2012.11.047; Sligte IG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001699; Souza AS, 2016, ATTEN PERCEPT PSYCHO, V78, P1839, DOI 10.3758/s13414-016-1108-5; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Vandenbroucke ARE, 2014, PSYCHOL SCI, V25, P861, DOI 10.1177/0956797613516146; Vandenbroucke ARE, 2011, NEUROPSYCHOLOGIA, V49, P1559, DOI 10.1016/j.neuropsychologia.2010.12.044; Wagenmakers EJ, 2018, PSYCHON B REV, V25, P58, DOI [10.3758/s13423-017-1323-7, 10.3758/s13423-017-1343-3]	39	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219504	10.1371/journal.pone.0219504	http://dx.doi.org/10.1371/journal.pone.0219504			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4LN	31295296	gold, Green Published, Green Submitted			2022-12-26	WOS:000484951800039
J	Hjelm, TE; Matovu, A; Mugisha, N; Lofgren, J				Hjelm, Tove Ekdahl; Matovu, Alphonsus; Mugisha, Noleb; Lofgren, Jenny			Breast cancer care in Uganda: A multicenter study on the frequency of breast cancer surgery in relation to the incidence of breast cancer	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; DIAGNOSIS; SERIES; HEALTH; BRCA1	Background Breast cancer is the most common cancer in women worldwide. Considerable funding and efforts are invested in breast cancer research and healthcare, but only a fraction of this reaches women and healthcare systems in low income countries. Surgical treatment is an essential part of breast cancer care, but access to surgery is in general very limited in low income countries such as Uganda. In this study, the previously unknown nationwide rate of breast cancer surgery was investigated. Methods and findings This was a multicenter, retrospective study, investigating breast cancer surgery in the public healthcare system in Uganda. Data were collected from operating theater registries at primary, secondary and tertiary level healthcare centres throught the country, including 14 general hospitals, the 14 regional referral hospitals and the national referral hospital. Patients who underwent major surgery for breast cancer at these hospitals during 2013 and 2014 were included. The number of breast cancer procedures performed, geographical variation, level of healthcare staff performing surgery and patient characteristics were investigated. After correction for missing data, a total of 137 breast cancer procedures were performed each year within the public healthcare system, corresponding to 5.7% of the breast cancer incidence in the country at that time. Most procedures (n = 161, 59.0%) were performed at the national referral hospital by qualified surgeons. Many of the patients were young; 30.1% being less than 40 years old. The proportion of male breast cancers in the study was large (6.2%). Conclusions The rate of breast cancer surgery in Uganda is minimal and in several parts of the country breast cancer surgery is not performed at all. More resources must be directed towards breast cancer in low income countries such as Uganda. The fact that the patients were young calls for further research, prevention and treatment specifically targeting young women in the study setting.	[Hjelm, Tove Ekdahl] Stockholm South Gen Hosp, Dept Oncol, Stockholm, Sweden; [Matovu, Alphonsus] Mubende Reg Referral Hosp, Mubende, Uganda; [Mugisha, Noleb] Uganda Canc Inst, Dept Oncol, Kampala, Uganda; [Lofgren, Jenny] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet	Hjelm, TE (corresponding author), Stockholm South Gen Hosp, Dept Oncol, Stockholm, Sweden.	tove.ekdahl@gmail.com	Löfgren, Jenny/J-6694-2019	Löfgren, Jenny/0000-0001-5884-0369; Ekdahl, Tove/0000-0002-2863-7025	Department of Public Health and Clinical Medicine, Unit of Research, Education, and Development, Ostersund, Umea University; Swedish Society of Medicine	Department of Public Health and Clinical Medicine, Unit of Research, Education, and Development, Ostersund, Umea University; Swedish Society of Medicine	The study was funded by The Department of Public Health and Clinical Medicine, Unit of Research, Education, and Development, Ostersund, Umea University and The Swedish Society of Medicine.	Adeloye D, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.010419; Anders CK, 2009, SEMIN ONCOL, V36, P237, DOI 10.1053/j.seminoncol.2009.03.001; Anderson BO, 2015, BREAST J, V21, P111, DOI 10.1111/tbj.12357; Awadelkarim KD, 2007, BREAST CANCER RES TR, V102, P189, DOI 10.1007/s10549-006-9303-z; Basro S, 2010, WORLD J SURG, V34, P1427, DOI 10.1007/s00268-009-0299-5; Cazap E, 2016, J CLIN ONCOL, V34, P14, DOI 10.1200/JCO.2015.61.9189; Dickens C, 2014, INT J CANCER, V135, P2173, DOI 10.1002/ijc.28861; Edge J, 2014, SAMJ S AFR MED J, V104, P377, DOI 10.7196/SAMJ.8249; Fackenthal JD, 2005, J MED GENET, V42, P276, DOI 10.1136/jmg.2004.020446; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Ferlay J, 2018, INT J CANC; Ferley J., 2013, GLOBOCAN 2012 V1 0 C; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Gakwaya A, 2008, BRIT J CANCER, V99, P63, DOI 10.1038/sj.bjc.6604435; Galukande M, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0632-4; Igene H, 2008, BREAST J, V14, P428, DOI 10.1111/j.1524-4741.2008.00618.x; Meara JG, 2015, SURGERY, V157, P834, DOI 10.1016/j.surg.2015.02.009; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nelson AM, 2016, J CLIN ONCOL, V34, P20, DOI 10.1200/JCO.2015.61.9767; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Sullivan R, 2015, LANCET ONCOL, V16, P1193, DOI 10.1016/S1470-2045(15)00223-5; Sutter SA, 2017, J GLOB ONCOL, V3, P162, DOI 10.1200/JGO.2016.003095; The World Bank, CANC DIS CONTR PRIOR; Tumusiime G, 2017, WORLD J SURG, V41, P370, DOI 10.1007/s00268-016-3714-8; Unicef, 2012, STATISTICS, DOI [10.1080/02331888.2010.545408, DOI 10.1080/02331888.2010.545408]; Vanderpuye V, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0124-y; Yousef AJA, 2017, SEMIN ONCOL, V44, P267, DOI 10.1053/j.seminoncol.2017.11.002	27	3	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219601	10.1371/journal.pone.0219601	http://dx.doi.org/10.1371/journal.pone.0219601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295322	Green Submitted, Green Published, gold			2022-12-26	WOS:000484951800051
J	Wedel, C; Moller, CM; Budtz-Lilly, J; Eldrup, N				Wedel, Charlotte; Moller, Cecilie M.; Budtz-Lilly, Jacob; Eldrup, Nikolaj			Red blood cell transfusion associated with increased morbidity and mortality in patients undergoing elective open abdominal aortic aneurysm repair	PLOS ONE			English	Article							CRITICALLY-ILL; PREOPERATIVE ANEMIA; SURGERY; IMMUNOMODULATION; INFECTION; TRIM	Background Red blood cell (RBC) transfusions are associated with increased mortality and morbidity. The aim of this analysis was to examine the association between RBC transfusions and long-term survival for patients undergoing elective open infrarenal abdominal aortic aneurysm (AAA) repair with up to 15 years of follow-up. Methods Prospective cohort study using data from The Danish Vascular Registry from 2000-2015. Primary endpoint was all-cause mortality. Secondary endpoints were in-hospital complications. Transfused patients were divided into subgroups based on received RBC transfusions (1, 2-3, 4-5 or >5). Using Cox regression multi-adjusted analysis, non-transfused patients were compared to transfused patients (1, 2-3, 4-5, >5 transfusions) for both primary and secondary endpoints. Results There were 3 876 patients included with a mean survival of 9.1 years. There were 801 patients who did not receive transfusions. Overall 30-day mortality was 3.1% (121 patients) and 3.6% (112) for all transfused patients. For the five subgroups 30-day mortality was: No transfusions 1.1% (9 patients), 1 RBC 1.2% (4 patients), 2-3 RBC 2.2% (26 patients), 4-5 RBC 1.9% (14 patients) and >5 RBC 7.9% (68 patients). After receiving RBCs, the hazard ratio for death was 1.54 (95% CI 1.27-1.85) compared to non-transfused patients. There was a significant increase in mortality when receiving 2-3 RBC: HR 1.32 (95% CI 1.07-1.62), 4-5 RBC: 1.64 (1.32-2.03) and >5 RBC: 1.96 (1.27-1.85) in a multi-adjusted model. Conclusion There is a dose-dependent association between RBC transfusions received during elective AAA repair and an increase in short-and long-term mortality. Approximately 25% of included patients had preoperative anemia. These findings should raise awareness regarding potentially unnecessary and harmful RBC transfusions.	[Wedel, Charlotte; Moller, Cecilie M.; Budtz-Lilly, Jacob; Eldrup, Nikolaj] Aarhus Univ Hosp, Dept Cardiothorac & Vasc Surg, Aarhus, Denmark; [Eldrup, Nikolaj] Aarhus Univ Hosp, Danish Vasc Registry, Aarhus, Denmark	Aarhus University; Aarhus University	Wedel, C (corresponding author), Aarhus Univ Hosp, Dept Cardiothorac & Vasc Surg, Aarhus, Denmark.	charlotte_wedel@hotmail.com		Budtz-Lilly, Jacob/0000-0002-6181-6391; Eldrup, Nikolaj/0000-0002-7980-5295				Aquina CT, 2016, DIS COLON RECTUM, V59, P411, DOI 10.1097/DCR.0000000000000588; Beattie WS, 2009, ANESTHESIOLOGY, V110, P574, DOI 10.1097/ALN.0b013e31819878d3; Blajchman MA, 2005, HEMATOLOGY, V10, P208, DOI 10.1080/10245330512331390447; Buddeberg F, 2008, BEST PRACT RES-CLIN, V22, P503, DOI 10.1016/j.bpa.2008.05.003; Bursi F, 2009, EUR J VASC ENDOVASC, V37, P311, DOI 10.1016/j.ejvs.2008.12.002; Carless Paul A, 2010, Cochrane Database Syst Rev, pCD001888, DOI 10.1002/14651858.CD001888.pub4; Carson JL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub3; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; French CJ, 2002, MED J AUSTRALIA, V177, P548, DOI 10.5694/j.1326-5377.2002.tb04950.x; Gombotz H, 2007, TRANSFUSION, V47, P1468, DOI 10.1111/j.1537-2995.2007.01286.x; Gunst MA, 2007, CURR OPIN CRIT CARE, V13, P428, DOI 10.1097/MCC.0b013e32826385ef; Hebert PC, 1999, CRIT CARE, V3, P57, DOI 10.1186/cc310; Henry DA, 2011, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD001886.PUB3; Holst LB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1354; Konigstein M, 2016, CAN J CARDIOL, V32, DOI 10.1016/j.cjca.2015.10.032; Laustsen J, 2004, EUR J VASC ENDOVASC, V27, P216, DOI 10.1016/j.ejvs.2003.11.011; Leal-Noval SM, 2001, CHEST, V119, P1461, DOI 10.1378/chest.119.5.1461; Leal-Noval SR, 2000, CRIT CARE MED, V28, P935, DOI 10.1097/00003246-200004000-00004; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Obi AT, 2015, J VASC SURG, V61, P1000, DOI 10.1016/j.jvs.2014.10.106; Rao MP, 2002, ANAESTHESIA, V57, P530, DOI 10.1046/j.1365-2044.2002.02514.x; Seicean A, 2013, SPINE, V38, P1331, DOI 10.1097/BRS.0b013e3182912c6b; Smilowitz NR, 2016, AM J MED, V129, P315, DOI 10.1016/j.amjmed.2015.10.012; Tan TW, 2013, J AM COLL SURGEONS, V216, P1005, DOI 10.1016/j.jamcollsurg.2013.01.006; Vamvakas EC, 2007, BLOOD REV, V21, P327, DOI 10.1016/j.blre.2007.07.003; van de Watering LMG, 1998, CIRCULATION, V97, P562; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Walsh TS, 2004, TRANSFUSION, V44, P1405, DOI 10.1111/j.1537-2995.2004.04085.x; Westbrook A, 2010, INTENS CARE MED, V36, P1138, DOI 10.1007/s00134-010-1867-8	30	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219263	10.1371/journal.pone.0219263	http://dx.doi.org/10.1371/journal.pone.0219263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295273	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800022
J	Barthels, F; Barrada, JR; Roncero, M				Barthels, Friederike; Barrada, Juan R.; Roncero, Maria			Orthorexia nervosa and healthy orthorexia as new eating styles	PLOS ONE			English	Article							BEHAVIOR QUESTIONNAIRE DEBQ; FACTOR-ANALYTIC VALIDATION; NEGATIVE AFFECT; MEASUREMENT INVARIANCE; CONSTRUCT-VALIDITY; PANAS; STUDENTS	It was recently proposed that healthy orthorexia (HeOr) and orthorexia nervosa (OrNe) should be differentiated. The aim of the present study was to analyze whether the two dimensions of orthorexia can be considered new eating styles or basically equivalent to restrained eating behavior. Two samples of university students (sample 1, n = 460; sample 2, n = 509) completed the Teruel Orthorexia Scale (TOS), the Dutch Eating Behavior Questionnaire (DEBQ), and the Positive and Negative Affect Schedule (PANAS). Factor analysis with the TOS and DEBQ items together revealed an adequate fit for the preexisting five-factor solution (TOS: OrNe and HeOr; DEBQ: Restrained Eating, Emotional Eating, and External Eating). This result points out that these factors are conceptually distinguishable. Moreover, we tested whether the different eating styles presented different patterns of correlations with gender, body mass index (BMI), and age, and whether OrNe and HeOr predicted Positive and Negative Affect after controlling for Restrained, Emotional, and External Eating. Whereas Restrained and Emotional Eating were higher for women and increased with BMI in both samples, HeOr and OrNe presented much lower associations with these variables. OrNe was positively related to Negative Affect and negatively to Positive Affect, whereas HeOr was positively related to Positive Affect. Again, this result supports the assumption that OrNe is a new variant of disordered eating, whereas HeOr could possibly be seen as a protective behavior.	[Barthels, Friederike] Heinrich Heine Univ Dusseldorf, Inst Expt Psychol, Dept Clin Psychol, Dusseldorf, Germany; [Barrada, Juan R.] Univ Zaragoza, Teruel, Spain; [Roncero, Maria] Univ Valencia, Valencia, Spain	Heinrich Heine University Dusseldorf; University of Zaragoza; University of Valencia	Barrada, JR (corresponding author), Univ Zaragoza, Teruel, Spain.	barrada@unizar.es	Roncero, Maria/D-9720-2011; Barrada, Juan Ramón/B-8930-2008	Roncero, Maria/0000-0002-4213-3106; Barrada, Juan Ramón/0000-0001-6887-6277	Government of Aragon (Group S31_17D), Department of Innovation, Research and University; FEDER, "Building Europe from Aragon"	Government of Aragon (Group S31_17D), Department of Innovation, Research and University; FEDER, "Building Europe from Aragon"	This research was funded by the Government of Aragon (Group S31_17D), Department of Innovation, Research and University and FEDER, "Building Europe from Aragon". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan NP, 2015, J PERS ASSESS, V97, P616, DOI 10.1080/00223891.2015.1038388; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Barnes MA, 2017, EAT WEIGHT DISORD-ST, V22, P177, DOI 10.1007/s40519-016-0280-x; Barrada JR, 2018, J SEX MARITAL THER, V44, P149, DOI 10.1080/0092623X.2017.1335665; Barrada JR, 2018, AN PSICOL-SPAIN, V34, P283, DOI 10.6018/analesps.34.2.299671; Barrada JR, 2016, EUR EAT DISORD REV, V24, P503, DOI 10.1002/erv.2448; Barthels F, 2018, EAT WEIGHT DISORD-ST, V23, P159, DOI 10.1007/s40519-018-0479-0; Barthels F, 2015, ERNAHRUNGS UMSCHAU, V62, pM568; Barthels F, 2015, Z KL PSYCH PSYCHOTH, V44, P97, DOI 10.1026/1616-3443/a000310; Correa AB, 2017, SEX RES SOC POLICY, V14, P445, DOI 10.1007/s13178-017-0274-0; Bruch H, 1973, HUNGER AWARENESS IND, P44; Brytek-Matera A, 2015, J EAT DISORD, V3, DOI [10.1186/s40337-016-0105-3, 10.1186/s40337-015-0038-2]; Cebolla A, 2014, APPETITE, V73, P58, DOI 10.1016/j.appet.2013.10.014; Cena H, 2019, EAT WEIGHT DISORD-ST, V24, P209, DOI 10.1007/s40519-018-0606-y; Chard CA, 2019, EAT WEIGHT DISORD-ST, V24, P275, DOI 10.1007/s40519-018-0570-6; Cole DA, 2014, PSYCHOL METHODS, V19, P300, DOI 10.1037/a0033805; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Dakanalis A, 2013, APPETITE, V71, P187, DOI 10.1016/j.appet.2013.08.010; Depa J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030697; Donini L M, 2005, Eat Weight Disord, V10, pe28; Dunn TM, 2016, EAT BEHAV, V21, P11, DOI 10.1016/j.eatbeh.2015.12.006; Finney SJ, 2013, QUANT METH EDUC BEHA, P439; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; Garrido LE, 2020, ASSESSMENT, V27, P1349, DOI 10.1177/1073191118780461; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Hallquist MN, 2018, STRUCT EQU MODELING, V25, P621, DOI 10.1080/10705511.2017.1402334; He JB, 2019, EAT WEIGHT DISORD-ST, V24, P453, DOI 10.1007/s40519-019-00656-1; Herman CP, 2008, PHYSIOL BEHAV, V94, P722, DOI 10.1016/j.physbeh.2008.04.014; Herman C. P., 1980, OBESITY, P208; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joiner TE, 1997, J PERS ASSESS, V68, P600, DOI 10.1207/s15327752jpa6803_8; Kerin JL, 2019, APPETITE, V132, P139, DOI 10.1016/j.appet.2018.10.011; Kotov R, 2017, J ABNORM PSYCHOL, V126, P454, DOI 10.1037/abn0000258; Parra-Fernandez ML, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216583; Luciano JV, 2014, PSYCHOL ASSESSMENT, V26, P395, DOI 10.1037/a0035284; Luo XC, 2016, J ABNORM PSYCHOL, V125, P715, DOI 10.1037/abn0000174; Marsh HW, 2013, PSYCHOL METHODS, V18, P257, DOI 10.1037/a0032773; McComb SE, 2019, APPETITE, V140, P50, DOI 10.1016/j.appet.2019.05.005; McGrath RE, 2006, PSYCHOL METHODS, V11, P386, DOI 10.1037/1082-989X.11.4.386; Missbach B, 2017, APPETITE, V108, P521, DOI 10.1016/j.appet.2016.07.010; Missbach B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135772; Moroze RM, 2015, PSYCHOSOMATICS, V56, P397, DOI 10.1016/j.psym.2014.03.003; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Ortuno-Sierra J, 2015, PSYCHOL ASSESSMENT, V27, pE1, DOI 10.1037/pas0000107; POLIVY J, 1985, AM PSYCHOL, V40, P193, DOI 10.1037/0003-066X.40.2.193; Price M, 2015, APPETITE, V95, P203, DOI 10.1016/j.appet.2015.07.006; R Core Team, 2018, R LANG ENV STAT COMP; Barrada JR, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00339; Barrada JR, 2020, EUR J PSYCHOL ASSESS, V36, P19, DOI 10.1027/1015-5759/a000482; Roncero M, 2017, SPAN J PSYCHOL, V20, DOI 10.1017/sjp.2017.36; Sandin B, 1999, PSICOTHEMA, V11, P37; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Varga M, 2013, EAT WEIGHT DISORD-ST, V18, P103, DOI 10.1007/s40519-013-0026-y; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Winkens LHH, 2018, J ACAD NUTR DIET, V118, P1277, DOI 10.1016/j.jand.2018.01.015; ZEVON MA, 1982, J PERS SOC PSYCHOL, V43, P111, DOI 10.1037/0022-3514.43.1.111	56	50	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219609	10.1371/journal.pone.0219609	http://dx.doi.org/10.1371/journal.pone.0219609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4JZ	31291364	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800125
J	Nava-Castro, KE; Solleiro-Villavicencio, H; del Rio-Araiza, VH; Segovia-Mendoza, M; Perez-Torres, A; Morales-Montor, J				Elizabeth Nava-Castro, Karen; Solleiro-Villavicencio, Helena; Hugo del Rio-Araiza, Victor; Segovia-Mendoza, Mariana; Perez-Torres, Armando; Morales-Montor, Jorge			Sex-associated protective effect of early bisphenol-A exposure during enteric infection with Trichinella spiralis in mice	PLOS ONE			English	Article							MECHANISMS	Bisphenol A (BPA) is an endocrine disruptor compound with estrogenic activity, possessing affinity for both nuclear (ERa and ER beta) and membrane estrogen receptors. The main source of BPA exposure comes from the contamination of food and water by plastic storage containers or disposable bottles, among others, in which case BPA is easily ingested. Exposure to BPA during early pregnancy leads to lifelong effects; however, its effect on the immune system has not been fully studied. Since endocrine and immune systems interact in a bidirectional manner, the disruption of the former may cause permanent alterations of the latter, thus affecting a future anti-parasitic response. In this study, neonate BALB/c mice were exposed to a single dose of BPA (250 mu g/kg); once sexual maturity was reached, they were orally infected with Trichinella spiralis (T. spiralis). The analyses performed after 5 days of infection revealed a decreased parasitic load in the duodenum of mice in the BPA-treated group. Flow cytometry analyses also revealed changes in the immune cell subpopulations of the infected animals when compared to the BPA-treated group. RT-PCR analyses of duodenum samples showed an increased expression of TNF-alpha, IFN-gamma, IL-4, IL-5, and IL-9 in the BPA-treated group. These findings show a new aspect whereby early-life exposure to BPA contributes to the protection against T. spiralis by modulating the anti-parasitic immune response.	[Elizabeth Nava-Castro, Karen] Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Dept Ciencias Ambientales, Lab Genotoxicol & Med Ambientales, Mexico City, DF, Mexico; [Solleiro-Villavicencio, Helena] Univ Nacl Autonoma Mexico, Dept Fisiol, Fac Med Vet & Zootecnia, Mexico City, DF, Mexico; [Hugo del Rio-Araiza, Victor] Univ Nacl Autonoma Mexico, Dept Parasitol, Fac Med, Mexico City, DF, Mexico; [Segovia-Mendoza, Mariana; Morales-Montor, Jorge] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City, DF, Mexico; [Perez-Torres, Armando] Univ Nacl Autonoma Mexico, Fac Med, Dept Biol Celular & Tisular, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Morales-Montor, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City, DF, Mexico.	jmontor66@biomedicas.unam.mx	Montor, Jorge/B-1224-2012	Montor, Jorge/0000-0002-9461-610X; del Rio Araiza, Victor Hugo/0000-0002-7868-6407	Programa de Apoyo a Proyectos de Innovacion Tecnologica (PAPIIT) [IN-209719, IA202919]; Direccion General de Asuntos del Personal Academico (DGAPA); Universidad Nacional Autonoma de Mexico (UNAM); Fronteras en la Ciencia, Consejo Nacional de Ciencia y Tecnologia (CONACYT) [FC-2016-2125]; Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico	Programa de Apoyo a Proyectos de Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Direccion General de Asuntos del Personal Academico (DGAPA); Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Fronteras en la Ciencia, Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This work was supported by grant IN-209719 and grant IA202919 from Programa de Apoyo a Proyectos de Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico (UNAM) (http://dgapa.unam.mx/) to JMM and KENC. In addition, this work was supported by grant FC-2016-2125 from Fronteras en la Ciencia, Consejo Nacional de Ciencia y Tecnologia (CONACYT) to JMM (www.conacyt.mx). MSM has a Post-Doctoral fellowship from the Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashour DS, 2013, EXPERT REV CLIN IMMU, V9, P669, DOI 10.1586/1744666X.2013.811187; Della Bella C, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12412; Devleesschauwer B, 2015, INT J PARASITOL, V45, P95, DOI 10.1016/j.ijpara.2014.05.006; Ibarra-Coronado EG, 2015, INT J BIOL SCI, V11, P901, DOI 10.7150/ijbs.11907; Palacios-Arreola MI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10135-1; Kiyama R, 2015, ENVIRON INT, V83, P11, DOI 10.1016/j.envint.2015.05.012; Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110; Legeay S, 2017, FUND CLIN PHARMACOL, V31, P594, DOI 10.1111/fcp.12300; Menard S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112752; Mendes JJA, 2002, FOOD CHEM TOXICOL, V40, P781, DOI 10.1016/S0278-6915(02)00018-2; Mersha MD, 2015, BEHAV BRAIN FUNCT, V11, DOI 10.1186/s12993-015-0071-y; Mondal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034623; Morales MAG, 2002, INFECT IMMUN, V70, P233, DOI 10.1128/IAI.70.1.233-239.2002; Murata M, 2018, BIOTECHNOL ADV, V36, P311, DOI 10.1016/j.biotechadv.2017.12.002; Santangeli S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21982; Stiefel F, 2016, APPL MICROBIOL BIOT, V100, P113, DOI 10.1007/s00253-015-6956-8; Sugita-Konishi Y, 2003, TOXICOL LETT, V136, P217, DOI 10.1016/S0378-4274(02)00388-0; Tan L, 2015, TOXICOL LETT, V235, P75, DOI 10.1016/j.toxlet.2015.03.010; Tian XL, 2003, INT ARCH ALLERGY IMM, V132, P240, DOI 10.1159/000074305; Vaiserman A, 2014, AGING DIS, V5, P419, DOI 10.14336/AD.2014.0500419; vom Saal FS, 2016, J ANIM SCI, V94, P2722, DOI 10.2527/jas.2015-0211; Watkins DJ, 2017, ENVIRON RES, V159, P143, DOI 10.1016/j.envres.2017.07.051; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Yan HM, 2008, ENVIRON HEALTH PERSP, V116, P514, DOI 10.1289/ehp.10829; Zhou D, 2016, ENVIRON POLLUT, V208, P767, DOI 10.1016/j.envpol.2015.10.057	25	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218198	10.1371/journal.pone.0218198	http://dx.doi.org/10.1371/journal.pone.0218198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291264	gold, Green Published, Green Submitted			2022-12-26	WOS:000484947800018
J	Eto, M; Hashimoto, T; Shimizu, T; Iwatsubo, T				Eto, Miki; Hashimoto, Tadafumi; Shimizu, Takao; Iwatsubo, Takeshi			Characterization of the unique In Vitro effects of unsaturated fatty acids on the formation of amyloid beta fibrils	PLOS ONE			English	Article							A-BETA; DOCOSAHEXAENOIC ACID; ALZHEIMERS-DISEASE; DHA DIET; PATHOLOGY; PROTEIN; GENE; CHOLESTEROL; OLIGOMERS; PEPTIDE	Accumulation of amyloid beta (A beta) peptides, the major component of amyloid fibrils in senile plaques, is one of the main causes of Alzheimer's disease. Docosahexaenoic acid (DHA) is a fatty acid abundant in the brain, and is reported to have protective effects against Alzheimer's disease, although the mechanistic effects of DHA against Alzheimer's pathophysiology remain unclear. Because dietary supplementation of DHA in A beta precursor protein transgenic mice ameliorates A beta pathology and behavioral deficits, we hypothesize that DHA may affect the fibrillization and deposition of A beta. Here we studied the effect of different types of fatty acids on A beta fibril formation by in vitro A beta fibrillization assay. Formation of amyloid fibrils consists of two steps, i.e., the initial nucleation phase and the following elongation phase. We found that unsaturated fatty acids, especially DHA, accelerated the formation of A beta fibrils with a unique short and curved morphology in its nucleation phase, which did not elongate further into the long and straight, mature A beta fibrils. Addition of DHA afterwards did not modify the morphology of the mature A beta(1-40) fibrils. The short and curved A beta fibrils formed in the presence of DHA did not facilitate the elongation phase of A beta fibril formation, suggesting that DHA promotes the formation of "off-pathway" conformers of A beta. Our study unravels a possible mechanism of how DHA acts protectively against the pathophysiology of Alzheimer's disease.	[Eto, Miki; Hashimoto, Tadafumi; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Tokyo, Japan; [Eto, Miki; Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Tokyo, Japan; [Hashimoto, Tadafumi] Univ Tokyo, Grad Sch Med, Dept Innovat Dementia Prevent, Tokyo, Japan	University of Tokyo; National Center for Global Health & Medicine - Japan; University of Tokyo	Iwatsubo, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neuropathol, Tokyo, Japan.	iwatsubo@m.u-tokyo.ac.jp	Shimizu, Takao/AAV-7052-2021	Hashimoto, Tadafumi/0000-0001-5442-4800	Japan Society for the Promotion of Science [17H04193]; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research	This study was funded by Japan Society for the Promotion of Science (17H04193), Takeda Science Foundation, and Mochida Memorial Foundation for Medical and Pharmaceutical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amtul Z, 2011, J BIOL CHEM, V286, P6100, DOI 10.1074/jbc.M110.183608; Arai T, 2014, CHEMBIOCHEM, V15, P2577, DOI 10.1002/cbic.201402430; Arimon M, 2008, J MOL BIOL, V384, P1157, DOI 10.1016/j.jmb.2008.09.063; Arsenault D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017397; Astarita G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012538; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Brown AM, 2016, BIOPHYS J, V111, P937, DOI 10.1016/j.bpj.2016.08.001; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Cunnane SC, 2012, J ALZHEIMERS DIS, V29, P691, DOI 10.3233/JAD-2012-110629; Frigerio CS, 2016, ANNU REV NEUROSCI, V39, P57, DOI 10.1146/annurev-neuro-070815-014015; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Grimm MOW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/814390; Grimm MOW, 2011, J BIOL CHEM, V286, P14028, DOI 10.1074/jbc.M110.182329; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hashimoto M, 2008, J NEUROCHEM, V107, P1634, DOI 10.1111/j.1471-4159.2008.05731.x; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hooijmans CR, 2007, NEUROBIOL DIS, V28, P16, DOI 10.1016/j.nbd.2007.06.007; Hooijmans CR, 2009, NEUROBIOL DIS, V33, P482, DOI 10.1016/j.nbd.2008.12.002; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Hori Y, 2015, J BIOL CHEM, V290, P15163, DOI 10.1074/jbc.M114.622209; Hossain S, 2009, J NEUROCHEM, V111, P568, DOI 10.1111/j.1471-4159.2009.06336.x; Hur J, 2018, FASEB J, V32, P4972, DOI 10.1096/fj.201800200R; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; MARCHESELLI VL, 1990, J NUTR BIOCHEM, V1, P382, DOI 10.1016/0955-2863(90)90009-A; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Perez SE, 2010, J NEUROSCI RES, V88, P1026, DOI 10.1002/jnr.22266; Prasad MR, 1998, NEUROCHEM RES, V23, P81, DOI 10.1023/A:1022457605436; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; Sahlin C, 2007, EUR J NEUROSCI, V26, P882, DOI 10.1111/j.1460-9568.2007.05719.x; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; Streltsov VA, 2011, J NEUROSCI, V31, P1419, DOI 10.1523/JNEUROSCI.4259-10.2011; Teng E, 2015, NEUROBIOL DIS, V82, P552, DOI 10.1016/j.nbd.2015.09.002; Umhau JC, 2009, J LIPID RES, V50, P1259, DOI 10.1194/jlr.M800530-JLR200; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wang PY, 2010, J NUTR BIOCHEM, V21, P345, DOI 10.1016/j.jnutbio.2009.01.012	49	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219465	10.1371/journal.pone.0219465	http://dx.doi.org/10.1371/journal.pone.0219465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291354	gold, Green Submitted, Green Published			2022-12-26	WOS:000484947800090
J	Francisco-Gonzalez, L; Rubio-San-Simon, A; Gonzalez-Tome, MI; Manzanares, A; Epalza, C; Santos, MD; Gastanaga, T; Merino, P; Ramos-Amador, JT				Francisco-Gonzalez, Laura; Rubio-San-Simon, Alba; Isabel Gonzalez-Tome, Maria; Manzanares, Angela; Epalza, Cristina; del Mar Santos, Maria; Gastanaga, Teresa; Merino, Paloma; Tomas Ramos-Amador, Jose			Congenital transmission of Chagas disease in a non-endemic area, is an early diagnosis possible?	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI	Background Chagas disease (CD) is an emergent disease in Europe, due to immigration. The aims of this study are to describe the epidemiological characteristics of a cohort of Chagas infected pregnant women in Spain, to assess the vertical transmission (VT) rate and evaluate the usefulness of the PCR in the diagnosis of congenital infection in the first months of life. Methods A descriptive, retrospective study including Chagas seropositive pregnant women who were attended at three tertiary hospitals in Madrid, from January 2012 to September 2016. Infants were examined by PCR at birth and 1 month later and serologically studied at 9 months or later. Children were considered infected when the parasite was detected by PCR at any age or when serology remained positive without decline over the age of 9 months. Results We included 122 seropositive-infected pregnant women, 81% were from Bolivia and only 8.2% had been treated before. 125 newborns were studied and finally 109 were included (12.8% lost the follow-up before performing the last serology). The VT rate was 2.75% (95% CI: 0,57-8,8%). Infected infants had positive PCR at birth and 1 month later. All of them were treated successfully with benznidazole (PCR and serology became negative later on). All non-infected children presented negative PCR. The mean age at which uninfected patients had negative serology was 10.5 months. Conclusions The VT rate is in keeping with literature and confirms the need to carry out a screening in pregnant women coming from endemic areas. PCR seems to be a useful tool to provide early diagnosis of congenital	[Francisco-Gonzalez, Laura] Univ Complutense Madrid, Hosp Clin San Carlos, Dept Pediat, Madrid, Spain; [Rubio-San-Simon, Alba; Isabel Gonzalez-Tome, Maria; Manzanares, Angela; Epalza, Cristina] Hosp Doce Octubre, Dept Pediat, Madrid, Spain; [del Mar Santos, Maria] Hosp Gregorio Maranon, Dept Pediat, Madrid, Spain; [Gastanaga, Teresa] Hosp Clin San Carlos, Dept Obstet & Gynaecol, Madrid, Spain; [Merino, Paloma] Hosp Clin San Carlos, Dept Microbiol, Madrid, Spain; [Tomas Ramos-Amador, Jose] Univ Complutense Madrid, Hosp Clin San Carlos, Inst Invest Sanitaria, Dept Pediat,IdISSC, Madrid, Spain	Complutense University of Madrid; Hospital Clinico San Carlos; Hospital Universitario 12 de Octubre; General University Gregorio Maranon Hospital; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Complutense University of Madrid; Hospital Clinico San Carlos	Gonzalez-Tome, MI (corresponding author), Hosp Doce Octubre, Dept Pediat, Madrid, Spain.	maribelgt@hotmail.com	Rubio, Alba/GZK-6328-2022	RUBIO-SAN-SIMON, Alba/0000-0001-6426-7423				Altcheh J, 2011, PEDIATRICS, V127, pE212, DOI 10.1542/peds.2010-1172; Bern C, 2009, CLIN INFECT DIS, V49, P1667, DOI 10.1086/648070; Blasco-Hernandez T, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30201; Brasil PEAA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-337; Ferrer E, 2013, ENFERM INFEC MICR CL, V31, P277, DOI 10.1016/j.eimc.2012.09.007; Flores-Chavez Maria, 2008, Cases J, V1, P302, DOI 10.1186/1757-1626-1-302; Holguera TG, 2016, J OBSTET GYNAECOL, V36, P672, DOI 10.3109/01443615.2016.1148680; Holguera T, 2018, AN PEDIAT BARC, V88, P122; Howard EJ, 2014, BJOG-INT J OBSTET GY, V121, P22, DOI 10.1111/1471-0528.12396; Gonzalez-Tome MI, 2018, AN PEDIATR, V88, P119, DOI 10.1016/j.anpedi.2018.01.005; Gonzalez-Tome MI, 2013, ENFERM INFEC MICR CL, V31, P535, DOI 10.1016/j.eimc.2012.09.010; Messenger LA, 2018, CURR OPIN INFECT DIS, V31, P415, DOI [10.1097/QCO.0000000000000478, 10.1097/qco.0000000000000478]; Murcia L, 2017, J INFECT DIS, V215, P1452, DOI 10.1093/infdis/jix087; Norman FF, 2011, ANN TROP MED PARASIT, V105, P425, DOI 10.1179/1364859411Y.0000000033; Seiringer P, 2017, DIAGN MICR INFEC DIS, V88, P225, DOI 10.1016/j.diagmicrobio.2017.04.003; World Health Organization (WHO), 2019, CHAG DIS AM TRYP	16	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218491	10.1371/journal.pone.0218491	http://dx.doi.org/10.1371/journal.pone.0218491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291269	gold, Green Published, Green Submitted			2022-12-26	WOS:000484947800024
J	Heidenreich, E; Wodenweber, R; Kirschhofer, F; Nusser, M; Friedrich, F; Fahl, K; Kruse, O; Rost, B; Franzreb, M; Brenner-Weiss, G; Rokitta, S				Heidenreich, Elena; Woerdenweber, Robin; Kirschhoefer, Frank; Nusser, Michael; Friedrich, Frank; Fahl, Kirsten; Kruse, Olaf; Rost, Bjoern; Franzreb, Matthias; Brenner-Weiss, Gerald; Rokitta, Sebastian			Ocean acidification has little effect on the biochemical composition of the coccolithophore Emiliania huxleyi	PLOS ONE			English	Article							LIFE-CYCLE STAGES; CARBONIC-ACID; LIGHT; ACCLIMATION; EXPRESSION; RESPONSES; SEAWATER; DISSOCIATION; CARBONATION; METABOLISM	Owing to the hierarchical organization of biology, from genomes over transcriptomes and proteomes down to metabolomes, there is continuous debate about the extent to which data and interpretations derived from one level, e.g. the transcriptome, are in agreement with other levels, e.g. the metabolome. Here, we tested the effect of ocean acidification (OA; 400 vs. 1000 mu atm CO2) and its modulation by light intensity (50 vs. 300 mu mol photons m(-2) s(-1)) on the biomass composition (represented by 75 key metabolites) of diploid and haploid life-cycle stages of the coccolithophore Emiliania huxleyi (RCC1216 and RCC1217) and compared these data with interpretations from previous physiological and gene expression screenings. The metabolite patterns showed minor responses to OA in both life-cycle stages. Whereas previous gene expression analyses suggested that the observed increased biomass buildup derived from lipid and carbohydrate storage, this dataset suggests that OA slightly increases overall biomass of cells, but does not significantly alter their metabolite composition. Generally, light was shown to be a more dominant driver of metabolite composition than OA, increasing the relative abundances of amino acids, mannitol and storage lipids, and shifting pigment contents to accommodate increased irradiance levels. The diploid stage was shown to contain vastly more osmolytes and mannitol than the haploid stage, which in turn had a higher relative content of amino acids, especially aromatic ones. Besides the differences between the investigated cell types and the general effects on biomass buildup, our analyses indicate that OA imposes only negligible effects on E. huxleyi's biomass composition.	[Heidenreich, Elena; Kirschhoefer, Frank; Nusser, Michael; Franzreb, Matthias; Brenner-Weiss, Gerald] Karlsruhe Inst Technol, Inst Funct Interfaces, Dept Bioengn & Biosyst, Analyt Biochem, Eggenstein Leopoldshafen, Germany; [Woerdenweber, Robin; Kruse, Olaf] Bielefeld Univ, Ctr Biotechnol CeBiTec, Dept Biol, Algae Biotechnol & Bioenergy, Bielefeld, Germany; [Friedrich, Frank] Karlsruhe Inst Technol, Competence Ctr Mat Moisture CMM, Hermann Helmholtz Pl 1, Eggenstein Leopoldshafen, Germany; [Fahl, Kirsten] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Marine Geol & Paleontol, Bremerhaven, Germany; [Rost, Bjoern; Rokitta, Sebastian] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Marine Biogeosci, Bremerhaven, Germany; [Rost, Bjoern] Univ Bremen, Bremen, Germany	Helmholtz Association; Karlsruhe Institute of Technology; University of Bielefeld; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen	Heidenreich, E (corresponding author), Karlsruhe Inst Technol, Inst Funct Interfaces, Dept Bioengn & Biosyst, Analyt Biochem, Eggenstein Leopoldshafen, Germany.; Rokitta, S (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Marine Biogeosci, Bremerhaven, Germany.	elena.heidenreich@kit.edu; sebastian.rokitta@awi.de	Rost, Bjoern/B-4447-2015; Kruse, Olaf/O-1127-2015; Rokitta, Sebastian/ABC-6832-2020	Rost, Bjoern/0000-0001-5452-5505; Rokitta, Sebastian/0000-0002-7540-9033; Kruse, Olaf/0000-0001-9874-382X; Fahl, Dr., Kirsten/0000-0001-9317-4656	federal ministry for education and research, Germany [ZeBiCa2 (031A158E)]	federal ministry for education and research, Germany(Federal Ministry of Education & Research (BMBF))	This work was supported by the federal ministry for education and research, Germany, via the project ZeBiCa2 (031A158E) to EH, SR and RW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolombri U, 2015, SCIENCE, P348; [Anonymous], 2009, LIMNOL OCEANOGR, V54, P1855, DOI [10.4319/lo.2009.54.6.1855, DOI 10.4319/LO.2009.54.6.1855]; Bach LT, 2011, LIMNOL OCEANOGR, V56, P2040, DOI 10.4319/lo.2011.56.6.2040; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; DICKSON AG, 1990, J PHYS CHEM-US, V94, P7978, DOI 10.1021/j100383a042; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dyhrman ST, 2003, J PLANKTON RES, V25, P1215, DOI 10.1093/plankt/fbg086; Fernie AR, 2012, PLANT PHYSL, V158; Gage DA, 1997, NATURE, V387, P891, DOI 10.1038/43160; Gao KS, 2009, LIMNOL OCEANOGR, V54, P1855, DOI 10.4319/lo.2009.54.6.1855; Garrido JL, 2016, ENVIRON MICROBIOL, V18, P4412, DOI 10.1111/1462-2920.13373; Gebser B, 2013, MAR DRUGS, V11, P2168, DOI 10.3390/md11062168; GRONE T, 1992, MAR BIOL, V112, P497, DOI 10.1007/BF00356296; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Hoppe CJM, 2011, J EXP MAR BIOL ECOL, V406, P54, DOI 10.1016/j.jembe.2011.06.008; Houdan A, 2005, MAR ECOL PROG SER, V292, P139, DOI 10.3354/meps292139; Jones BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061868; Jones BM, 2011, MAR BIOTECHNOL, V13, P496, DOI 10.1007/s10126-010-9320-0; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; Kottmeier DM, 2016, NEW PHYTOL, V211, P126, DOI 10.1111/nph.13885; Kottmeier DM, 2014, PHOTOSYNTH RES, V121, P265, DOI 10.1007/s11120-014-9984-9; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kubica P, 2012, J CHROMATOGR B, V907, P34, DOI 10.1016/j.jchromb.2012.08.031; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; Langer Gerald, 2011, Journal of Nannoplankton Research, V32, P29; Lefebvre SC, 2010, J PHYCOL, V46, P123, DOI 10.1111/j.1529-8817.2009.00793.x; Llewellyn CA, 2010, MAR DRUGS, V8, P1273, DOI 10.3390/md8041273; Mausz MA, 2015, J PLANT PHYSIOL, V172, P137, DOI 10.1016/j.jplph.2014.05.014; Mckew BA, 2015, ENVIRON MICROBIOL, V17, P4050, DOI 10.1111/1462-2920.12957; McKew BA, 2013, NEW PHYTOL, V200, P74, DOI 10.1111/nph.12373; McKew BA, 2013, NEW PHYTOL, V200, P61, DOI 10.1111/nph.12352; Mckim SM, 2006, PLANT PHYSIOL BIOCH, V44, P857, DOI 10.1016/j.plaphy.2006.10.018; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Monteiro FM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501822; Mussgnug JH, 2005, PLANT CELL, V17, P3409, DOI 10.1105/tpc.105.035774; Obata T, 2013, METABOLITES, V3, P168, DOI 10.3390/metabo3010168; Olson MB, 2017, J EXP MAR BIOL ECOL, V488, P72, DOI 10.1016/j.jembe.2016.12.008; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Richier S, 2011, MAR BIOL, V158, P551, DOI 10.1007/s00227-010-1580-8; Richier S, 2009, APPL ENVIRON MICROB, V75, P3366, DOI 10.1128/AEM.02737-08; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Rokitta SD, 2012, CHARACTERIZATION LIF; Rokitta SD, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00109; Rokitta SD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1051; Rokitta SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052212; Rokitta SD, 2012, LIMNOL OCEANOGR, V57, P607, DOI 10.4319/lo.2012.57.2.0607; Rokitta SD, 2011, J PHYCOL, V47, P829, DOI 10.1111/j.1529-8817.2011.01014.x; Rost B, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P99; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Spielmeyer A, 2011, CHEMBIOCHEM, V12, P2276, DOI 10.1002/cbic.201100416; Stolte W, 2000, J PHYCOL, V36, P529, DOI 10.1046/j.1529-8817.2000.99158.x; von Dassow P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r114; Wallace D, 2006, MS EXCEL PROGRAM DEV; Wordenweber R, 2018, LIMNOL OCEANOGR, V63, P203, DOI 10.1002/lno.10624; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB	58	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218564	10.1371/journal.pone.0218564	http://dx.doi.org/10.1371/journal.pone.0218564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291290	gold, Green Published, Green Submitted			2022-12-26	WOS:000484947800027
J	Pozzobon, D; Nogueira, LAC; Ferreira, PH; Steffens, D; Beckenkamp, PR; Blyth, FM; Ferreira, ML				Pozzobon, Daniel; Calazans Nogueira, Leandro A.; Ferreira, Paulo H.; Steffens, Daniel; Beckenkamp, Paula R.; Blyth, Fiona M.; Ferreira, Manuela L.			Return to self-reported physical activity level after an event of acute low back pain	PLOS ONE			English	Article							SF-36 HEALTH SURVEY; RISK; VALIDITY	Background Regular physical activity participation is known to promote better mobility and coordination. Although previous research has established that lack of physical activity participation may increase the risk of developing low back pain, the role of physical activity as a predictor of recovery among symptomatic individuals remains unclear. Objective To evaluate whether: (i) the level of physical activity participation before an acute episode of low back pain predicts recovery within 12 months following the acute pain episode (i.e. index episode); and (ii) participants return to their pre-pain level of physical activity participation 12 months from the index episode. Design This study used longitudinal data from the TRIGGERS case-crossover study. Setting This study was conducted through over-the-phone interviews to participants that presented to 300 primary care clinics with a new episode of acute low back pain. Participants This study included 999 consecutive patients, aged 18 years or older. Follow-up assessment was completed at 12 months following the index episode. Methods This is a cohort study where consecutive patients, aged 18 years or older, that presented with a new episode of acute low back pain were recruited between October 2011 and November 2012. Main outcome measurements Self-reported level of physical activity participation. Results A total of 830 participants completed the study. When comparing participants who reported pain at 12 months follow-up with those without pain, all participants reported similar levels of physical activity participation one week before (p = 0.449), one week after (p = 0.812) and 12 months after the index episode (p = 0.233). The level of physical activity participation before the index episode was not a reliable predictor of presence of pain at either 3 or 12 months follow-up (OR 0.99; 95% CI 0.993 to 1.003; p = 0.523 and OR 1; 95% CI 0.992 to 1.008; p = 0.923, respectively). Conclusion Physical activity participation did not predict recovery from the pain episode. Also all participants returned to their pre-pain level of physical activity participation after 12 months.	[Pozzobon, Daniel; Ferreira, Manuela L.] Univ Sydney, Inst Bone & Joint Res, Kolling Inst, Sydney Med Sch, Sydney, NSW, Australia; [Calazans Nogueira, Leandro A.] Augusto Motta Univ Ctr UNISUAM, Rehabil Sci Postgrad Program, Rio De Janeiro, RJ, Brazil; [Calazans Nogueira, Leandro A.] Fed Inst Rio de Janeiro IFRJ, Physiotherapy Dept, Rio De Janeiro, RJ, Brazil; [Ferreira, Paulo H.; Beckenkamp, Paula R.] Univ Sydney, Musculoskeletal Hlth, Fac Hlth Sci, Discipline Physiotherapy, Sydney, NSW, Australia; [Steffens, Daniel] RPAH, Surg Outcomes Res Ctr SOuRCe, Sydney, NSW, Australia; [Blyth, Fiona M.] Univ Sydney, Concord Clin Sch, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Centro Universitario Augusto Motta (UNISUAM); Instituto Federal do Rio de Janeiro (IFRJ); University of Sydney; University of Sydney	Pozzobon, D (corresponding author), Univ Sydney, Inst Bone & Joint Res, Kolling Inst, Sydney Med Sch, Sydney, NSW, Australia.	dpoz5597@uni.sydney.edu.au	Beckenkamp, Paula/ABC-6591-2020; Ferreira, Manuela/AAQ-5446-2020; Nogueira, Leandro A. Calazans/I-5563-2017	Beckenkamp, Paula/0000-0003-3986-6111; Ferreira, Manuela/0000-0002-3479-0683; Nogueira, Leandro A. Calazans/0000-0002-0177-9816; Blyth, Fiona/0000-0003-1128-6756; Pozzobon, Daniel/0000-0002-2796-4235	Australia's National Health and Medical Research Council [APP1003608]	Australia's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research is supported by the Australia's National Health and Medical Research Council (application ID APP1003608). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533; Armstrong T, 2000, PHYS ACTIVITY PATTER; Australian Institute of Health and Welfare, 2018, PHYS ACT LIF STAG; Bertuzzi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106581; Buchbinder R, 2013, BEST PRACT RES CL RH, V27, P575, DOI 10.1016/j.berh.2013.10.007; Caspersen CJ, 1974, PUBLIC HLTH REPORTS, P100; Castro PC, 2014, REV SAUDE PUBL, V48, P63, DOI 10.1590/S0034-8910.2014048004783; Craig CL, 2003, MED SCI SPORTS EXERC, P35, DOI [10.1371/JOURNAL.PONE.0106581, DOI 10.1371/JOURNAL.PONE.0106581]; de Vet HCW, 2002, SPINE, V27, P2409, DOI 10.1097/00007632-200211010-00016; Dyrstad SM, 2014, MED SCI SPORT EXER, V46, P99, DOI 10.1249/MSS.0b013e3182a0595f; German Medical Association National Association of Statutory Health Insurance Physicians Association of Scientific Medical Societies, 2011, NAT DIS MAN GUID LOW; Gomes JL, 2015, EUR SPINE J, V24, P452, DOI 10.1007/s00586-015-3763-y; Heesch KC, 2011, J SCI MED SPORT, V14, P233, DOI 10.1016/j.jsams.2010.11.004; Hendrick P, 2011, EUR SPINE J, V20, P464, DOI 10.1007/s00586-010-1616-2; Heneweer H, 2011, EUR SPINE J, V20, P826, DOI 10.1007/s00586-010-1680-7; Heneweer H, 2009, PAIN, V143, P21, DOI 10.1016/j.pain.2008.12.033; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; IPAQ Research Comittee, 2005, GUIDELINES DATA PROC; Linton SJ, 2003, CLIN J PAIN, V19, P80, DOI 10.1097/00002508-200303000-00002; Maher C, 2017, LANCET, V389, P736, DOI 10.1016/S0140-6736(16)30970-9; Myers J, 2015, PROG CARDIOVASC DIS, V57, P306, DOI 10.1016/j.pcad.2014.09.011; Shiri R, 2007, EUR SPINE J, V16, P2043, DOI 10.1007/s00586-007-0362-6; Shiri S, 2017, 2017 IEEE-NIH HEALTHCARE INNOVATIONS AND POINT OF CARE TECHNOLOGIES (HI-POCT), P36; Smuck M, 2014, SPINE J, V14, P209, DOI 10.1016/j.spinee.2013.11.010; Steffens D, 2015, ARTHRIT CARE RES, V67, P403, DOI 10.1002/acr.22533; Steffens D, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-7; Verbunt JA, 2010, PAIN, V149, P428, DOI 10.1016/j.pain.2010.01.020; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219556	10.1371/journal.pone.0219556	http://dx.doi.org/10.1371/journal.pone.0219556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291377	gold, Green Published, Green Submitted			2022-12-26	WOS:000484947800114
J	Wang, DQ; Karvonen-Gutierrez, CA; Jackson, EA; Elliott, MR; Appelhans, BM; Barinas-Mitchell, E; Bielak, LF; Baylin, A				Wang, Dongqing; Karvonen-Gutierrez, Carrie A.; Jackson, Elizabeth A.; Elliott, Michael R.; Appelhans, Bradley M.; Barinas-Mitchell, Emma; Bielak, Lawrence F.; Baylin, Ana			Prospective associations between beverage intake during the midlife and subclinical carotid atherosclerosis: The Study of Women's Health Across the Nation	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE RISK; ALCOHOL-CONSUMPTION; COFFEE CONSUMPTION; DECAFFEINATED COFFEE; SWEETENED BEVERAGES; CHLOROGENIC ACID; TEA CONSUMPTION; DIETARY; FLAVONOIDS	Background The potential impacts of beverage intake during the midlife on future subclinical atherosclerosis among women are unclear. The aim of this study was to evaluate the prospective associations between the intakes of eight beverage groups and subclinical carotid atherosclerosis in midlife women. Methods Data came from the Study of Women's Health Across the Nation, a multicenter, multiethnic, and prospective cohort study. A total of 1,235 midlife women had measures of subclinical carotid atherosclerosis and repeatedly beverage intake data collected using a validated food frequency questionnaire. Beverages were aggregated into eight groups, including coffee, tea, sugar-sweetened beverages, artificially sweetened beverages, fruit juices, whole milk, milk with lower fat content, and alcoholic beverages. The associations of beverage intake with common carotid artery intima-media thickness (CCA-IMT) and adventitial diameter (CCA-AD) were estimated using linear models; the associations with carotid plaque were estimated using log-binomial models. Results Coffee intake was associated with CCA-IMT in an inverted J-shaped pattern. After adjusting for covariates, women with > 0 to < 1 cup/day and 1 to < 2 cups/day of coffee intake had a 0.031 mm (95% CI: 0.012, 0.051) and a 0.027 mm (95% CI: 0.005, 0.049) larger CCA-IMT, respectively, than coffee non-drinkers. Women who consumed >= 2 cups/day of coffee did not have significantly different CCA-IMT than non-drinkers. There was an inverse linear association between moderate alcoholic beverages intake and CCA-IMT (P-trend = 0.014). Whole milk intake had inverted U-shaped associations with CCA-IMT and carotid plaque. No significant associations were found between other beverage groups and subclinical atherosclerosis. Conclusions In midlife women, occasional coffee intake may be associated with more subclinical atherosclerosis while moderate alcoholic beverages intake may be associated with less subclinical atherosclerosis. Future work should focus on the determination of the optimal beverage intake profile for maximum cardiovascular benefits in midlife women.	[Wang, Dongqing; Karvonen-Gutierrez, Carrie A.; Bielak, Lawrence F.; Baylin, Ana] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Jackson, Elizabeth A.] Univ Alabama Birmingham, Sch Med, Div Cardiovasc Med, Birmingham, AL USA; [Elliott, Michael R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Elliott, Michael R.] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI USA; [Appelhans, Bradley M.] Rush Univ, Med Ctr, Dept Prevent Med, Chicago, IL 60612 USA; [Appelhans, Bradley M.] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA; [Barinas-Mitchell, Emma] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Baylin, Ana] Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rush University; Rush University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan	Baylin, A (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.; Baylin, A (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, Ann Arbor, MI 48109 USA.	abaylin@umich.edu	Wang, Dongqing/X-2777-2019	Wang, Dongqing/0000-0003-3369-5972; Barinas-Mitchell, Emma/0000-0002-7280-7781	National Institutes of Health (NIH), DHHS, through the National Institute on Aging (NIA); National Institute of Nursing Research (NINR); NIH Office of Research on Women's Health (ORWH) [U01NR004061, U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495]; NATIONAL INSTITUTE OF NURSING RESEARCH [U01NR004061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG012539, U01AG012553, U01AG012554, U01AG012505, U01AG012531, U01AG012495, U01AG012546, U01AG012535] Funding Source: NIH RePORTER	National Institutes of Health (NIH), DHHS, through the National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Nursing Research (NINR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NIH Office of Research on Women's Health (ORWH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Study of Women's Health Across the Nation (SWAN) has grant support from the National Institutes of Health (NIH), DHHS, through the National Institute on Aging (NIA), the National Institute of Nursing Research (NINR) and the NIH Office of Research on Women's Health (ORWH) (Grants U01NR004061, U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, and U01AG012495). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIA, NINR, ORWH or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLOCK G, 1992, J AM DIET ASSOC, V92, P686; Choi Y, 2015, HEART, V101, P686, DOI 10.1136/heartjnl-2014-306663; Davidson MH, 2009, AM J CARDIOL, V104, P936, DOI 10.1016/j.amjcard.2009.05.037; Debette S, 2008, ARTERIOSCL THROM VAS, V28, P353, DOI 10.1161/ATVBAHA.107.151928; DEMIROVIC J, 1993, CIRCULATION, V88, P2787, DOI 10.1161/01.CIR.88.6.2787; DEWHALLEY CV, 1990, BIOCHEM PHARMACOL, V39, P1743, DOI 10.1016/0006-2952(90)90120-A; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; El Khoudary SR, 2013, MENOPAUSE, V20, P8, DOI 10.1097/gme.0b013e3182611787; Franklin RM, 2009, METABOLISM, V58, P311, DOI 10.1016/j.metabol.2008.09.030; Geleijnse JM, 1999, ARCH INTERN MED, V159, P2170, DOI 10.1001/archinte.159.18.2170; Greendale GA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124865; Hall MH, 2009, SLEEP, V32, P73; Huang MH, 2002, MENOPAUSE, V9, P309, DOI 10.1097/00042192-200209000-00003; Ivey KL, 2011, AM J CLIN NUTR, V94, P234, DOI 10.3945/ajcn.111.014159; Johnson RK, 2018, CIRCULATION, V138, pE126, DOI 10.1161/CIR.0000000000000569; Kang WS, 1999, THROMB RES, V96, P229, DOI 10.1016/S0049-3848(99)00104-8; Kiechl S, 1998, STROKE, V29, P900, DOI 10.1161/01.STR.29.5.900; LAUGHTON MJ, 1991, BIOCHEM PHARMACOL, V42, P1673, DOI 10.1016/0006-2952(91)90501-U; Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8; Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Matthews KA, 2017, STROKE, V48, P70, DOI 10.1161/STROKEAHA.116.014743; Matthews KA, 2009, J AM COLL CARDIOL, V54, P2366, DOI 10.1016/j.jacc.2009.10.009; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Miller PE, 2017, AM J MED, V130, P188, DOI 10.1016/j.amjmed.2016.08.038; Miranda AM, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007155; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Mukamal KJ, 2003, ARTERIOSCL THROM VAS, V23, P2252, DOI 10.1161/01.ATV.0000101183.58453.39; Natella F, 2007, AM J CLIN NUTR, V86, P604, DOI 10.1093/ajcn/86.3.604; Ollberding NJ, 2011, J AM DIET ASSOC, V111, pS47, DOI 10.1016/j.jada.2011.03.009; Olthof MR, 2001, AM J CLIN NUTR, V73, P532; Onakpoya IJ, 2015, J HUM HYPERTENS, V29, P77, DOI 10.1038/jhh.2014.46; Patel YR, 2017, CLIN NUTR ESPEN, V17, P18, DOI 10.1016/j.clnesp.2016.12.003; Recio-Rodriguez JI, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-37; Reis JP, 2010, ARTERIOSCL THROM VAS, V30, P2059, DOI 10.1161/ATVBAHA.110.208280; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Schminke U, 2005, STROKE, V36, P1746, DOI 10.1161/01.STR.0000173159.65228.68; Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098; Smiath S, 2000, CIRCULATION, V101, P111, DOI DOI 10.1161/01.CIR.101.1.111; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; SOWERS MF, 2000, MENOPAUSE BIOL PATHO; Spungen J, 2005, BOWES CHURCHS FOOD V, V18th; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Sternfeld B, 1999, PREV MED, V28, P313, DOI 10.1006/pmed.1998.0470; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Sutton-Tyrrell K, 2002, ATHEROSCLEROSIS, V160, P407, DOI 10.1016/S0021-9150(01)00591-3; Thurston RC, 2018, MENOPAUSE, V25, P849, DOI 10.1097/GME.0000000000001143; Thurston RC, 2014, STROKE, V45, P2246, DOI 10.1161/STROKEAHA.114.005928; Tofferi JK, 2004, AM HEART J, V148, P803, DOI 10.1016/j.ahj.2004.05.023; Toth PP, 2008, INT J CLIN PRACT, V62, P1246, DOI 10.1111/j.1742-1241.2008.01804.x; Toth PP, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00299; Urgert R, 1997, ANNU REV NUTR, V17, P305, DOI 10.1146/annurev.nutr.17.1.305; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; van der Schouw YT, 2000, NUTR METAB CARDIOVAS, V10, P154; van Woudenbergh GJ, 2008, ARTERIOSCL THROM VAS, V28, P1018, DOI 10.1161/ATVBAHA.107.160457; Verhoef P, 2002, AM J CLIN NUTR, V76, P1244, DOI 10.1093/ajcn/76.6.1244; Wang DQ, 2018, J AM HEART ASSOC, V7, DOI [10.1161/JAHA.118.010405, 10.1161/jaha.118.010405]; Wildman RP, 2004, J AM COLL CARDIOL, V44, P579, DOI 10.1016/j.jacc.2004.03.078; Wolf A, 2008, OBES REV, V9, P151, DOI 10.1111/j.1467-789X.2007.00389.x; Xie X, 2012, EUR J PREV CARDIOL, V19, P314, DOI 10.1177/1741826711404501; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; Zureik M, 2004, STROKE, V35, P2770, DOI 10.1161/01.STR.0000147968.48379.c3; Zyriax BC, 2010, EUR J CLIN NUTR, V64, P1199, DOI 10.1038/ejcn.2010.144	66	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219301	10.1371/journal.pone.0219301	http://dx.doi.org/10.1371/journal.pone.0219301			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291324	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800070
J	Ceinos, RM; Chivite, M; Lopez-Patino, MA; Naderi, F; Soengas, JL; Foulkes, NS; Miguez, JM				Ceinos, Rosa M.; Chivite, Mauro; Lopez-Patino, Marcos A.; Naderi, Fatemeh; Soengas, Jose L.; Foulkes, Nicholas S.; Miguez, Jesus M.			Differential circadian and light-driven rhythmicity of clock gene expression and behaviour in the turbot, Scophthalmus maximus	PLOS ONE			English	Article							FEEDING ENTRAINMENT; PERIPHERAL-TISSUES; SENEGALESE SOLE; RAINBOW-TROUT; FOOD; ZEBRAFISH; PERIOD2; TRANSCRIPTS; ENDOCRINE; PACEMAKER	In fish, the circadian clock represents a key regulator of many aspects of biology and is controlled by combinations of abiotic and biotic factors. These environmental factors are frequently manipulated in fish farms as part of strategies designed to maximize productivity. The flatfish turbot, Scophthalmus maximus, represents one of the most important species within the aquaculture sector in Asia and Europe. Despite the strategic importance of this species, the function and regulation of the turbot circadian system remains poorly understood. Here, we have characterized the core circadian clock genes, clock1, per1, per2 and cry1 in turbot and have studied their daily expression in various tissues under a range of lighting conditions and feeding regimes. We have also explored the influence of light and feeding time on locomotor activity. Rhythmic expression of the four core clock genes was observed in all tissues studied under light dark (LD) cycle conditions. Rhythmicity of clock gene expression persisted upon transfer to artificial free running, constant conditions confirming their endogenous circadian clock control. Furthermore, turbot showed daily cycles of locomotor activity and food anticipatory activity (FAA) under LD and scheduled-feeding, with the activity phase as well as FAA coinciding with and being dependent upon exposure to light. Thus, while FAA was absent under constant dark (DD) conditions, it was still detected in constant light (LL). In contrast, general locomotor activity was arrhythmic in both constant darkness and constant light, pointing to a major contribution of light, in concert with the circadian clock, in timing locomotor activity in this species. Our data represents an important contribution to our understanding of the circadian timing system in the turbot and thereby the optimization of rearing protocols and the improvement of the well-being of turbot within fish farming environments.	[Ceinos, Rosa M.; Chivite, Mauro; Lopez-Patino, Marcos A.; Naderi, Fatemeh; Soengas, Jose L.; Miguez, Jesus M.] Univ Vigo, Fac Bioloxia, Dept Bioloxia Func & Ciencias Saude, Lab Fisioloxia Anim, Vigo, Pontevedra, Spain; [Ceinos, Rosa M.; Chivite, Mauro; Lopez-Patino, Marcos A.; Naderi, Fatemeh; Soengas, Jose L.; Miguez, Jesus M.] Univ Vigo, Ctr Invest Marina, Vigo, Pontevedra, Spain; [Foulkes, Nicholas S.] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany	Universidade de Vigo; Universidade de Vigo; CIM UVIGO; Helmholtz Association; Karlsruhe Institute of Technology	Ceinos, RM (corresponding author), Univ Vigo, Fac Bioloxia, Dept Bioloxia Func & Ciencias Saude, Lab Fisioloxia Anim, Vigo, Pontevedra, Spain.; Ceinos, RM (corresponding author), Univ Vigo, Ctr Invest Marina, Vigo, Pontevedra, Spain.	rosaceinos@uvigo.es	Ceinos, Rosa RM/F-1683-2016; Chivite, Mauro/CAF-5846-2022; Miguez, J.M./M-3705-2014; Soengas, José L/M-1898-2014	Ceinos, Rosa RM/0000-0002-3321-2961; Chivite, Mauro/0000-0003-1917-1523; Miguez, J.M./0000-0002-3474-2139; Soengas, José L/0000-0002-6847-3993; Naderi, Fatemeh/0000-0003-1968-410X; Lopez-Patino, Marcos A./0000-0002-1038-7419	Xunta de Galicia (Spain) [P.P 0000421S140.08]; Spanish Ministry of Economy, Industry and Competitiveness [BES-2017-079708]; Helmholtz Association funding programme BIF-TM; Spanish Agnecia EStatal de Investigacion [AGL2016-74857-C3-1-R]; European Fund of Regional Development (FEDER) [AGL2016-74857-C3-1-R]	Xunta de Galicia (Spain)(Xunta de Galicia); Spanish Ministry of Economy, Industry and Competitiveness; Helmholtz Association funding programme BIF-TM; Spanish Agnecia EStatal de Investigacion; European Fund of Regional Development (FEDER)(European Commission)	R.M.C. was supported under a contract (programme I2C) by Xunta de Galicia (Spain) cofound by European Social Fund (ESF) P. P. 0000421S140.08 (https://www.xunta.gal/dog/Publicados/2014/20140317/AnuncioG0164-120314-0001_es.html); M.C. was granted by the Spanish Ministry of Economy, Industry and Competitiveness (BES-2017-079708) (http://www.ciencia.gob.es/stfls/eSede/Ficheros/2018/TEXTO_PRP_PREDOC_2017_COMPLETO_firmado.pdf); N.S.F was supported through the Helmholtz Association funding programme BIF-TM; this study was founded by a grant from Spanish Agnecia EStatal de Investigacion and European Fund of Regional Development (FEDER) to J.L.S. and J.M.M. (AGL2016-74857-C3-1-R) (https://sede.micinn.gob.es/stfls/eSede/Ficheros/2016/Anexo1_Preseleccionados_PRP_Proyectos_Retos_2016-F.pdf).	Batty RS, 1995, J FISH BIOL, V47, P931, DOI 10.1111/j.1095-8649.1995.tb06019.x; Bayarri MJ, 2004, PHYSIOL BEHAV, V81, P577, DOI 10.1016/j.physbeh.2004.02.001; Bolliet V, 2001, PHYSIOL BEHAV, V73, P625, DOI 10.1016/S0031-9384(01)00505-4; Cahill GM, 2002, CELL TISSUE RES, V309, P27, DOI 10.1007/s00441-002-0570-7; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Champalbert G, 1998, J SEA RES, V40, P333, DOI 10.1016/S1385-1101(98)00031-8; Costa LS, 2016, J COMP PHYSIOL B, V186, P775, DOI 10.1007/s00360-016-0989-x; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; FALCON J, 1992, NATO ADV SCI INST SE, V236, P167; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Lopez-Olmeda JF, 2010, BIOLOGICAL CLOCK IN FISH, P155; Figueras A, 2016, DNA RES, V23, P181, DOI 10.1093/dnares/dsw007; Gibson RN, 2015, FLATFISHES: BIOLOGY AND EXPLOITATION, 2ND EDITION, P314; HOLMES RA, 1983, ANIM BEHAV, V31, P1244, DOI 10.1016/S0003-3472(83)80031-1; HOLMES RA, 1986, J FISH BIOL, V29, P49, DOI 10.1111/j.1095-8649.1986.tb04998.x; Imsland AK, 1995, NETH J SEA RES, V34, P149, DOI 10.1016/0077-7579(95)90023-3; Isorna E, 2017, J ENDOCRINOL, V232, pR141, DOI 10.1530/JOE-16-0330; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Patino MAL, 2011, CHRONOBIOL INT, V28, P381, DOI 10.3109/07420528.2011.566398; Lopez-Olmeda JF, 2010, CHRONOBIOL INT, V27, P1380, DOI 10.3109/07420528.2010.501926; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Ceinos RM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27080-2; Martin-Robles AJ, 2012, J COMP PHYSIOL B, V182, P673, DOI 10.1007/s00360-012-0653-z; Montoya A, 2010, AQUACULTURE, V306, P315, DOI 10.1016/j.aquaculture.2010.06.023; Mracek P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051278; Oliveira CCV, 2013, FISH PHYSIOL BIOCHEM, V39, P479, DOI 10.1007/s10695-012-9713-2; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Velarde E, 2009, J BIOL RHYTHM, V24, P104, DOI 10.1177/0748730408329901; Vera LM, 2013, CHRONOBIOL INT, V30, P649, DOI 10.3109/07420528.2013.775143; Wang H, 2008, J MOL EVOL, V67, P29, DOI 10.1007/s00239-008-9121-5; Wang MY, 2015, J BIOL CHEM, V290, P4367, DOI 10.1074/jbc.M114.605022; Watanabe N, 2012, GEN COMP ENDOCR, V178, P400, DOI 10.1016/j.ygcen.2012.06.012; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; DG	37	7	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219153	10.1371/journal.pone.0219153	http://dx.doi.org/10.1371/journal.pone.0219153			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276539	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300042
J	Dolz, G; Chaves, A; Gutierrez-Espeleta, GA; Ortiz-Malavasi, E; Bernal-Valle, S; Herrero, MV				Dolz, Gaby; Chaves, Andrea; Gutierrez-Espeleta, Gustavo A.; Ortiz-Malavasi, Edgar; Bernal-Valle, Sofia; Vinicio Herrero, Marco			Detection of antibodies against flavivirus over time in wild non-human primates from the lowlands of Costa Rica	PLOS ONE			English	Article							WEST-NILE-VIRUS; RAPID DETECTION; ENCEPHALITIS; SAMPLES	Two-hundred-nine free ranging non-human primates from 31 locations throughout Costa Rica were captured and released between 1993 and 2012, and blood samples, sera or plasma were collected, to detect antigens and antibodies, and so assess the distribution of active and passive flavivirus infections over time. A competitive enzyme-linked immunoassay for the detection of antibodies was used to determine the distribution of past flavivirus infections over time, while Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) was used to detect active West Nile Virus (WNV) and Dengue virus (DENV) infections. The first serological evidence of flavivirus in these animals was determined in 1993, at the same time when DENV re-emerged in humans from Costa Rica. An increase in the number of seropositive wild monkeys to flavivirus was determined over time in the country (11.3% seropositivity in 1993-1996, 20.7% in 2001-2008, and finally 52.9% in 2010-2012). Furthermore, the presence of DENV2 was detected in samples from four howler monkeys collected in 2001-2002, whereas DENV2, DENV3, and DENV4 were found in samples from four white-faced monkeys, and WNV in three howler monkeys living in the Pacific coast of Costa Rica during 2010-2012. The habitat where the positive PCR individuals lived were characterized as fragmented forests, having temperatures ranging from 26 degrees C to 28 degrees C, altitudes below 250 meters above sea level, high precipitation during 7 to 9 months (1500-4000 mm), and a marked dry season of 3 to 5 months. All these animals were living near mangroves; however, they did not show clinical signs of illness at the time of sampling. Results obtained show that the number of seropositive wild non-human primates to flavivirus were increasing during time in the country, longitudinal studies are needed to investigate their role as sentinels of these viruses and to determine if flavivirus infections can affect these species.	[Dolz, Gaby; Chaves, Andrea; Bernal-Valle, Sofia; Vinicio Herrero, Marco] Univ Nacl, Escuela Med Vet, Programa Invest Med Poblac, Lab Entomol, Heredia, Costa Rica; [Chaves, Andrea; Gutierrez-Espeleta, Gustavo A.] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; [Ortiz-Malavasi, Edgar] Inst Tecnol Costa Rica, Escuela Forestales, Cartago, Costa Rica	Universidad Nacional Costa Rica; Universidad Costa Rica; Instituto Tecnologico de Costa Rica	Dolz, G (corresponding author), Univ Nacl, Escuela Med Vet, Programa Invest Med Poblac, Lab Entomol, Heredia, Costa Rica.	gaby.dolz.wiedner@una.ac.cr		Dolz, Gaby/0000-0002-9566-5130; BERNAL VALLE, SOFIA/0000-0002-8689-3983	FEES-CONARE; Vicerrectoria de Investigacion, Universidad Nacional	FEES-CONARE; Vicerrectoria de Investigacion, Universidad Nacional	Research was sponsored by FEES-CONARE and Vicerrectoria de Investigacion, Universidad Nacional. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was conducted in the framework of the project "Estudios epidemiologicos (Malaria, Dengue, Virus del Oeste del Nilo, Encefalitis Equina Venezolana), geneticos, etologicos, poblacionales y de habitat en monos de Costa Rica" sponsored by FEES-CONARE, and with participation of UNA-ITCR-UCR-UNED.	Bosch I, 2007, EMERG INFECT DIS, V13, P651, DOI 10.3201/eid1304.061383; Catenacci LS, 2018, ECOHEALTH, V15, P777, DOI 10.1007/s10393-018-1361-2; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1129; Cruz L, 2005, AM J TROP MED HYG, V72, P612, DOI 10.4269/ajtmh.2005.72.612; De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16; Endy TP, 2002, CURR TOP MICROBIOL, V267, P11; Gutiérrez Albenda David Alberto, 2018, Rev. costarric. salud pública, V27, P35; Hayes CG, 1989, ARBOVIRUSES EPIDEMIO, VV, P59; Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703; Jimenez C, 2016, INT J INFECT DIS, V53, P153, DOI 10.1016/j.ijid.2016.11.375; Komar N, 2006, REV PANAM SALUD PUBL, V19, P112, DOI 10.1590/S1020-49892006000200006; Komar Nicholas, 2003, Adv Virus Res, V61, P185; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019; Martin DA, 2002, CLIN DIAGN LAB IMMUN, V9, P544, DOI 10.1128/CDLI.9.3.544-549.2002; Mattar S, 2005, EMERG INFECT DIS, V11, P1497, DOI 10.3201/eid1109.050426; Morice Trejos A., 2010, SALUD PUBLICA COSTA, P197; PORTER KR, 1993, AM J TROP MED HYG, V48, P440, DOI 10.4269/ajtmh.1993.48.440; Ratterree MS, 2003, EMERG INFECT DIS, V9, P1388, DOI 10.3201/eid0911.030226; West G, 2007, ZOO ANIMAL WILDLIFE, P718, DOI 10.1002/9780470376478; Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062	23	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219271	10.1371/journal.pone.0219271	http://dx.doi.org/10.1371/journal.pone.0219271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276532	gold, Green Submitted, Green Published			2022-12-26	WOS:000484936300055
J	Rahman, MS; Mushfiquee, M; Masud, MS; Howlader, T				Rahman, M. Shafiqur; Mushfiquee, Muntaha; Masud, Mohammad Shahed; Howlader, Tamanna			Association between malnutrition and anemia in under-five children and women of reproductive age: Evidence from Bangladesh Demographic and Health Survey 2011	PLOS ONE			English	Article							IRON-DEFICIENCY; NONPREGNANT WOMEN; MATERNAL ANEMIA; RISK-FACTORS; PREVALENCE; GROUNDWATER; DETERMINANTS; POPULATION; INFECTIONS; HEMOGLOBIN	Background Bangladesh is one of the most anemia prone countries in South Asia. Children of age under five years and women of reproductive age are particularly vulnerable in this region. Although several studies have investigated the risk factors of anemia, only few have explored its association with malnutrition, despite its high prevalence in the same group. The objective of this paper is to investigate the association of malnutrition with anemia by conducting separate analyses for under-five children and women of reproductive age using data from the nationally representative 2011 Bangladesh Demographic and Health Survey. Methods Two binary outcome variables are considered separately: presence of anemia in children under five years of age (Hb<11.0 g/dl) and presence of anemia in women of childbearing age (Hb<12.0 g/dl). The exposures of interest corresponding to these two outcomes are stunting (low height-for-age) and low BMI (<18.5 kg/m(2)), respectively. Preliminary analysis involves estimating the association between exposure and outcome while controlling for a single confounder by computing adjusted odds ratios (adjOR) using the Cochran-Mantel-Haenszel approach in stratified analysis. Later, associations between the exposures and outcomes are estimated separately for under-five children and women of reproductive age by fitting multivariable regression models that adjust simultaneously for several confounders. Results The prevalence of anemia is found to be higher among both the stunted children and women with low BMI compared to their healthy counterparts (Children: 56% vs 48%; women: 50% vs 43%). Furthermore, stunted children and women with low BMI have significantly increased odds of developing anemia, as reflected by the adjusted ORs of 1.76 (95% CI: 1.10-2.83) and 1.81 (95% CI: 1.11-3.48), respectively. The association of stunting with anemia in children was modified by their age and socio-economic condition, where risk of being anemic decreases with increasing age but with a lower rate for stunted children from richest family. In addition, stunted children of anemic mothers are at greater risk of being anemic compared to non-stunted children of anemic or non-anemic mothers. Again the association between BMI and anemia in women is modified by the level of education, with risk of anemia being lowest among women with low BMI and higher education. Conclusion Evidence-based policies targeting the vulnerable groups are required to combat anemia and nutritional deficiencies simultaneously under the same program.	[Rahman, M. Shafiqur; Mushfiquee, Muntaha; Masud, Mohammad Shahed; Howlader, Tamanna] Univ Dhaka, Inst Stat Res & Training, Dhaka, Bangladesh	University of Dhaka	Rahman, MS (corresponding author), Univ Dhaka, Inst Stat Res & Training, Dhaka, Bangladesh.	shafiq@isrt.ac.bd		Masud, Mohammad/0000-0003-3939-1021				Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Ahmed F, 2000, PUBLIC HEALTH NUTR, V3, P385, DOI 10.1017/S1368980000000446; Ahmed T, 2012, J HEALTH POPUL NUTR, V30, P1; Akash G. M. B., 2015, NO IRON DEFICIENCY B; [Anonymous], 2008, WORLDWIDE PREVALENCE; Arnold DL, 2009, J OBSTET GYNAECOL RE, V35, P446, DOI 10.1111/j.1447-0756.2008.00980.x; Ayoya MA, 2012, PUBLIC HEALTH NUTR, V15, P916, DOI 10.1017/S1368980011002424; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Bangladesh Bureau of Statistics UNICEF, 2004, AN PREV SURV URB BAN; Center for Disease Control and Prevention (CDC), 1998, REC PREV CONTR IR DE; Chaparro C., 2014, 360FANTA FHI; Dhar B, 2002, J HEALTH POPUL NUTR, V20, P36; GED, 2015, MILL DEV GOALS BANGL; Ghose B, 2016, PEERJ, V4, DOI 10.7717/peerj.1945; Gosdin L, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12597; GRANTHAMMCGREGOR S, 1995, J NUTR, V125, pS2233; Haque SMR, 2015, PUBLIC HLTH RES, V5, P184; Helen Keller International, 2006, NUTR SURV PROJ B; icddrb  UNICEF  Global Alliance for Improved Nutrition, 2013, NAT MICR STAT SURV 2; K4Health, 2006, AN PREV CAUS CONS; Kamruzzaman M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0211-4; Khan JR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-015-0536-z; Khanam R, 2011, J BIOSOC SCI, V43, P437, DOI 10.1017/S0021932011000149; Kuziga F, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0782-3; Legason Ismail Dragon, 2017, BMC Hematol, V17, P10, DOI 10.1186/s12878-017-0081-0; Merrill RD, 2012, INT J VITAM NUTR RES, V82, P5, DOI 10.1024/0300-9831/a000089; Merrill RD, 2011, J NUTR, V141, P944, DOI 10.3945/jn.111.138628; Mohammed SH, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0436-4; Muchie K.F., 2016, BMC NUTR, V2, P51, DOI [DOI 10.1186/s40795-016-0093-3, DOI 10.1186/S40795-016-0093-3]; Ndyomugyenyi R, 2008, T ROY SOC TROP MED H, V102, P130, DOI 10.1016/j.trstmh.2007.09.015; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Pala K, 2008, INDIAN J MED RES, V128, P282; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Rahman MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157814; Rahman S, 2016, PUBLIC HEALTH NUTR, V19, P1862, DOI 10.1017/S1368980015003651; Rakic L, 2013, HIPPOKRATIA, V17, P47; Rashid M, 2010, BANGLADESH MED J, V39; Rawat R, 2014, BRIT J NUTR, V111, P172, DOI 10.1017/S0007114513001852; Sanghvi TG, 2010, FOOD NUTR BULL, V31, pS100, DOI 10.1177/15648265100312S202; Save the Children, 2015, MALN BANGL HARN SOC; SCHOLL TO, 1992, AM J CLIN NUTR, V55, P985, DOI 10.1093/ajcn/55.5.985; Smagulova I. E., 2013, Voprosy Pitaniya, V82, P58; Soliman Ashraf T, 2014, Indian J Endocrinol Metab, V18, pS1, DOI 10.4103/2230-8210.145038; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Woodruff BA, 2018, FOOD NUTR BULL, V39, P39, DOI 10.1177/0379572117743004; World Health Organization, 2015, GLOB PREV AN 2011; Zhang QY, 2009, INT J EPIDEMIOL, V38, P1380, DOI 10.1093/ije/dyp243	47	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219170	10.1371/journal.pone.0219170	http://dx.doi.org/10.1371/journal.pone.0219170			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269082	Green Published, Green Submitted, gold			2022-12-26	WOS:000484927300049
J	Suzuki, S; Hashizume, N; Kanzaki, Y; Maruyama, T; Kozuka, A; Yahikozawa, K				Suzuki, Sho; Hashizume, Naoto; Kanzaki, Yusuke; Maruyama, Takuya; Kozuka, Ayako; Yahikozawa, Kumiko			Prognostic significance of serum albumin in patients with stable coronary artery disease treated by percutaneous coronary intervention	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; HEART-DISEASE; INFLAMMATION; ASSOCIATION; FAILURE; RISK; ATHEROSCLEROSIS; MECHANISMS; MORTALITY	Background Stable coronary artery disease (CAD) is known to have an increased risk of cardiovascular events. Serum albumin (Alb) is reported as a useful risk-stratification tool in cardiovascular diseases such as acute coronary syndrome or heart failure. However, the association between Alb and stable CAD is unclear. Thus, we aimed to investigate the prognostic significance of Alb in patients with stable CAD. Methods and results We analyzed the data of all patients admitted to Shinonoi General Hospital between October 2014 and October 2017 for newly diagnosed stable CAD, treated via elective percutaneous coronary intervention, with the exception of old myocardial infarction. We collected data, including Alb, at admission. The primary endpoint was major adverse cardiac events (MACE; defined as all-cause death, non-fatal myocardial infarction, non-fatal stroke). In 204 enrolled patients (median age, 73 years), during a median follow-up of 783 days, 28 experienced MACE. Alb was significantly lower in patients with MACE than in those without (p<0.001). In Kaplan-Meier analysis, low Alb predicted worse prognosis in MACE (p<0.001). In multivariate Cox regression analysis, low Alb levels independently predicted MACE (p<0.001) after adjusting for age and sex (HR 4.128 [95% CI 1.632-10.440], p = 0.003), or, age and C-reactive protein (HR 3.373 [95% CI 1.289-8.828], p = 0.013). Conclusions Low Alb levels predicted MACE in patients with stable CAD.	[Suzuki, Sho; Hashizume, Naoto; Kanzaki, Yusuke; Maruyama, Takuya; Kozuka, Ayako; Yahikozawa, Kumiko] Shinonoi Gen Hosp, Minaminagano Med Ctr, Dept Cardiovasc Med, Nagano, Japan		Suzuki, S (corresponding author), Shinonoi Gen Hosp, Minaminagano Med Ctr, Dept Cardiovasc Med, Nagano, Japan.	jersey0042@gmail.com		Suzuki, Sho/0000-0001-9058-9258				Aikawa M, 2001, CIRCULATION, V103, P276; Anand IS, 2005, CIRCULATION, V112, P1428, DOI 10.1161/CIRCULATIONAHA.104.508465; Aukrust P, 1998, CIRCULATION, V97, P1136, DOI 10.1161/01.CIR.97.12.1136; Bustos C, 1998, J AM COLL CARDIOL, V32, P2057, DOI 10.1016/S0735-1097(98)00487-2; Chien SC, 2017, INT J CARDIOL, V241, P1, DOI 10.1016/j.ijcard.2017.04.003; Cinar T, 2019, SCAND CARDIOVASC J, V53, P83, DOI 10.1080/14017431.2019.1590628; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Deswal A, 2001, CIRCULATION, V103, P2055; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Fuhrman P, 2004, J AM DIET ASSOC, V104, P1258, DOI 10.1016/j.jada.2004.05.213; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GILLUM RF, 1992, AM HEART J, V123, P507, DOI 10.1016/0002-8703(92)90667-K; Gonzalez-Pacheco H, 2017, AM J CARDIOL, V119, P951, DOI 10.1016/j.amjcard.2016.11.054; Gopal DM, 2010, AM HEART J, V160, P279, DOI 10.1016/j.ahj.2010.05.022; Hemingway H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000286; Horwich TB, 2008, AM HEART J, V155, P883, DOI 10.1016/j.ahj.2007.11.043; Jiang P, 2019, CARDIOL J, V26, P138, DOI 10.5603/CJ.a2018.0071; Karabag Y, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/jcla.22457; Kitai Y, 2013, INT J CARDIOL, V168, P5221, DOI 10.1016/j.ijcard.2013.08.029; KULLER LH, 1991, AM J EPIDEMIOL, V134, P1266, DOI 10.1093/oxfordjournals.aje.a116030; Kurtul A, 2016, ANGIOLOGY, V67, P34, DOI 10.1177/0003319715575220; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Oduncu V, 2013, CORONARY ARTERY DIS, V24, P88, DOI 10.1097/MCA.0b013e32835c46fd; PHILLIPS A, 1989, LANCET, V2, P1434; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schalk BWM, 2006, AM J EPIDEMIOL, V164, P969, DOI 10.1093/aje/kwj312; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Vavik V, 2018, AM J CARDIOL, V122, P1142, DOI 10.1016/j.amjcard.2018.06.027	31	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219044	10.1371/journal.pone.0219044	http://dx.doi.org/10.1371/journal.pone.0219044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269058	gold, Green Submitted, Green Published			2022-12-26	WOS:000484927300039
J	Poor, EE; Jati, VIM; Imron, MA; Kelly, MJ				Poor, Erin E.; Jati, Virta I. M.; Imron, Muhammad Ali; Kelly, Marcella J.			The road to deforestation: Edge effects in an endemic ecosystem in Sumatra, Indonesia	PLOS ONE			English	Article							RAIN-FOREST ROADS; SMALL MAMMALS; HABITAT; FRAGMENTATION; BIODIVERSITY; IMPACTS; CONSERVATION; RESPONSES; FROGS	Worldwide, roads are a main driver of deforestation and degradation as they increase forest access along the forest edge. In many tropical areas, unofficial roads go unreported and unrecorded, resulting in inaccurate estimates of intact forested areas. This is the case in central Sumatra, which boasts populations of critically endangered Sumatran elephants (Elephas maximus sumatrensis), tigers (Panthera tigris sumatrae) and other endemic flora and fauna that make the area globally unique. However, maps do not reflect the reality of forest loss in the area. Here we present new maps from 2002 and 2016 of digitized and ground-truthed roads in one of Sumatra's unique lowland tropical protected areas, Tesso Nilo National Park. Using our newly created roads dataset, we examine the distribution of forest with respect to distance to roads. Our data show >2,400 km of roads within the national park in 2016 -nearly a 10-fold increase from roads known in 2002. Most forest (82-99%) within Tesso Nilo falls within 100 m, 500 m, and 1000 m of road edges. Length of road increased 157% and road density increased from 1.06 km/km(2) to 2.63 km/km(2) from 2002-2016. Our results suggest that this endemic ecosystem is facing substantial threat from roads and their associated impacts. Without swift management action, such as road closures and increased enforcements by park management, this ecosystem, and its endemic wildlife, could be lost. It is imperative that protected areas worldwide more rigorously consider roads and road effects on ecosystem fragmentation in their conservation plans.	[Poor, Erin E.; Kelly, Marcella J.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA; [Jati, Virta I. M.] World Wildlife Fund, Pekanbaru, Riau, Indonesia; [Imron, Muhammad Ali] Univ Gadjah Mada, Dept Forest Resources Conservat, Yogyakarta, Indonesia	Virginia Polytechnic Institute & State University; Gadjah Mada University	Poor, EE (corresponding author), Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA.	erinpoor@vt.edu	Kelly, Marcella/B-4891-2011; Imron, Muhammad Ali/GSN-5793-2022	Kelly, Marcella/0000-0001-9044-3873; Imron, Muhammad Ali/0000-0003-2371-7795; Poor, Erin/0000-0002-8799-3193	National Science Foundation [1536323]; Cleveland Zoo; Philadelphia Zoo; Riverbanks Zoo; US Student Fulbright Program; Ideawild; Virginia Tech; World Wildlife Fund; Indonesian Ministry of Research, Technology and Higher Education; Ministry of Forestry and Environment	National Science Foundation(National Science Foundation (NSF)); Cleveland Zoo; Philadelphia Zoo; Riverbanks Zoo; US Student Fulbright Program; Ideawild; Virginia Tech; World Wildlife Fund; Indonesian Ministry of Research, Technology and Higher Education(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Ministry of Forestry and Environment	This work was supported through grants from the National Science Foundation (nsf.gov), Doctoral Dissertation Improvement Grant, number 1536323, the Cleveland Zoo, the Philadelphia Zoo, the Riverbanks Zoo, the US Student Fulbright Program, Ideawild, Virginia Tech and the World Wildlife Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Indonesian Ministry of Research, Technology and Higher Education and the Ministry of Forestry and Environment, FA Widodo and Sunarto for their support and advice, and Zulfahmi and Jerry Irawan for their critical help in the field. We also thank the anonymous reviewers that helped improve our manuscript. This work was completed with the support of the World Wildlife Fund, the Philadelphia Zoo, the National Science Foundation [Grant Number 1536323], the Cleveland Zoo, the Riverbanks Zoo, Ideawild, the US Student Fulbright Program and Virginia Tech.	[Anonymous], TROPICAL FOREST REMN; Blake S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003546; Brodie JF, 2015, MAMM BIOL, V80, P7, DOI 10.1016/j.mambio.2014.06.001; Clements GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115376; Danielsen F, 2009, CONSERV BIOL, V23, P348, DOI 10.1111/j.1523-1739.2008.01096.x; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; ESRI, 2017, ARCGIS DESKT REL 10; Fahrig L, 2009, ECOL SOC, V14; FULLER TK, 1989, WILDLIFE MONOGR, P1; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Goosem M, 2000, WILDLIFE RES, V27, P151, DOI 10.1071/WR98091; Goosem M, 2002, WILDLIFE RES, V29, P277, DOI 10.1071/WR01058; Goosem M, 2007, CURR SCI INDIA, V93, P1587; GRIFFITHS M, 1993, CONSERV BIOL, V7, P623, DOI 10.1046/j.1523-1739.1993.07030623.x; Harbi J, 2018, FOREST POLICY ECON, V94, P1, DOI 10.1016/j.forpol.2018.05.011; HARPER L H, 1989, Acta Amazonica, V19, P249; Hoskin CJ, 2010, ECOL SOC, V15, DOI 10.5751/es-03272-150315; Hughes AC, 2018, BIOL CONSERV, V223, P129, DOI 10.1016/j.biocon.2018.04.029; Imron MA, 2011, ENVIRON MANAGE, V48, P276, DOI 10.1007/s00267-010-9577-0; Jedrzejewski W, 2002, J WILDLIFE MANAGE, V66, P1235; Kinnaird M, 2010, CONSERV BIOL, V17, P245; Land Resources Department/ Bina program, 1990, LAND RES IND NAT OV; Laumonier Y, 2010, BIODIVERS CONSERV, V19, P1153, DOI 10.1007/s10531-010-9784-2; Laurance SGW, 2004, ECOL APPL, V14, P1344, DOI 10.1890/03-5194; Laurance WF, 1996, BIOL CONSERV, V77, P203, DOI 10.1016/0006-3207(95)00142-5; Laurance WF, 1998, ECOLOGY, V79, P2032, DOI 10.1890/0012-9658(1998)079[2032:RFFATD]2.0.CO;2; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; LAURANCE WF, 1991, BIOL CONSERV, V55, P77, DOI 10.1016/0006-3207(91)90006-U; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2008, CONSERV BIOL, V22, P721, DOI 10.1111/j.1523-1739.2008.00917.x; Laurance WF, 2014, NATURE, V513, P229, DOI 10.1038/nature13717; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Linkie M, 2014, CONSERV BIOL, V28, P1023, DOI 10.1111/cobi.12255; Lovejoy T.E., 1986, P257; Luskin MS, 2014, HUM ECOL, V42, P35, DOI 10.1007/s10745-013-9606-8; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Mace RD, 1996, J APPL ECOL, V33, P1395, DOI 10.2307/2404779; Margono BA, 2014, NAT CLIM CHANGE, V4, P730, DOI [10.1038/nclimate2277, 10.1038/NCLIMATE2277]; Maynard RJ, 2016, TROP CONSERV SCI, V9, P264, DOI 10.1177/194008291600900114; MECH LD, 1988, WILDLIFE SOC B, V16, P85; Mohd-Azlan J, 2018, NAT CONSERV RES, V3, P36, DOI 10.24189/ncr.2018.028; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newmark WD, 1996, AFR J ECOL, V34, P15, DOI 10.1111/j.1365-2028.1996.tb00590.x; Pohlman CL, 2007, BIOTROPICA, V39, P62, DOI 10.1111/j.1744-7429.2006.00238.x; Poor EE, 2019, J ENVIRON MANAGE, V231, P397, DOI 10.1016/j.jenvman.2018.10.065; Porej D, 2004, BIOL CONSERV, V120, P399, DOI 10.1016/j.biocon.2004.03.015; Pratt C, 2007, ENVIRON GEOL, V52, P437, DOI 10.1007/s00254-006-0471-2; Sanderson E., 2006, SETTING PRIORITIES C; Shah P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124872; Sunarto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030859; VANDYKE FG, 1986, J WILDLIFE MANAGE, V50, P102; Yaap B, 2016, TROP CONSERV SCI, V9, DOI 10.1177/1940082916683523	53	15	16	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0217540	10.1371/journal.pone.0217540	http://dx.doi.org/10.1371/journal.pone.0217540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260478	Green Published, gold, Green Submitted			2022-12-26	WOS:000484918700010
J	Waasdorp, M; Florquin, S; Duitman, J; Spek, CA				Waasdorp, Maaike; Florquin, Sandrine; Duitman, JanWillem; Spek, C. Arnold			Pharmacological PAR-1 inhibition reduces blood glucose levels but does not improve kidney function in experimental type 2 diabetic nephropathy	FASEB JOURNAL			English	Article						vorapaxar; BTBRob; ob type 2 diabetes; mesangial expansion; protease-activated receptor	RECEPTOR ANTAGONIST; VORAPAXAR; MODEL; RISK	Vorapaxar-dependent protease-activated receptor (PAR)-1 inhibition diminishes diabetic nephropathy in experimental type 1 diabetes. As most patients with diabetic nephropathy suffer from type 2 diabetes, the aim of this study was to investigate whether PAR-1 inhibition also limits diabetic nephropathy in experimental type 2 diabetes. Consequently, leptin-deficient black and tan brachyuric (BTBRob/ob) mice were randomly assigned to vorapaxar (1.75 mg/kg; twice weekly via oral gavage) or vehicle treatment, whereas matched wild-type (WT) BTBR (BTBRWT) mice served as nondiabetic controls. Weight and (nonfasting) blood glucose levels were monitored for up to 18 wk, after which kidney function and histologic damage was evaluated postmortem. We show that blood glucose levels and body weight increased in diabetic BTBRob/ob mice compared with nondiabetic BTBRWT controls. Vorapaxar-dependent PAR-1 inhibition reduced but did not normalize blood glucose levels in BTBRob/ob mice, whereas it potentiated the increase in body weight. Vorapaxar did not, however, preserve kidney function, whereas it only minimally reduced histopathological signs of kidney injury. Overall, we thus show that PAR-1 inhibition reduces blood glucose levels during the progression of diabetic nephropathy in experimental type 2 diabetes but does not improve renal function. This is in contrast to the therapeutic potential of vorapaxar in type 1 diabetes-induced nephropathy, highlighting the importance of disease-dependent treatment modalities.-Waasdorp, M., Florquin, S., Duitman, J., Spek, C. A. Pharmacological PAR-1 inhibition reduces blood glucose levels but does not improve kidney function in experimental type 2 diabetic nephropathy.	[Waasdorp, Maaike; Duitman, JanWillem; Spek, C. Arnold] Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Amsterdam Infect & Immun Inst, Ctr Expt & Mol Med, Amsterdam, Netherlands; [Florquin, Sandrine] Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Amsterdam Infect & Immun Inst, Dept Pathol, Amsterdam, Netherlands; [Waasdorp, Maaike] Vrije Univ Amsterdam, Amsterdam Infect & Immun Inst, Amsterdam UMC, Mol Cell Biol & Immunol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Waasdorp, M (corresponding author), Vrije Univ Amsterdam, Amsterdam UMC, Mol Cell Biol & Immunol, De Boelelaan 1117, NL-1081 HZ Amsterdam, Netherlands.	m.waasdorp@vumc.nl	Duitman, JanWillem/AFX-7298-2022; Spek, Arnold/AAC-5866-2019	Duitman, JanWillem/0000-0003-4254-3380; Spek, Arnold/0000-0002-2149-4068; Florquin, Sandrine/0000-0002-9676-1722; Waasdorp, Maaike/0000-0002-1103-7875	Dutch Diabetes Foundation [2012.00.1471]	Dutch Diabetes Foundation	The authors thank Joost Daalhuisen and Marieke ten Brink (Center for Molecular and Experimental Medicine, Amsterdam University Medical Center) for their technical assistance during the animal experiments. This work was supported by the Dutch Diabetes Foundation (2012.00.1471). The authors declare no conflicts of interest.	Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Fiseha T, 2016, INT J NEPHROL, V2016, DOI 10.1155/2016/4647685; Gryka RJ, 2017, DRUGS R&D, V17, P65, DOI 10.1007/s40268-016-0158-4; Guan Y, 2017, J PHARMACOL SCI, V135, P81, DOI 10.1016/j.jphs.2017.09.002; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Kopec AK, 2017, J CLIN INVEST, V127, P3152, DOI [10.1172/JCI92744, 10.1172/jci92744]; Mihara M, 2010, ENDOCRINOLOGY, V151, P513, DOI 10.1210/en.2009-0661; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; Neuman JC, 2017, DIABETES, V66, P1572, DOI 10.2337/db16-1362; Ruggenenti P, 2000, NEPHROL DIAL TRANSPL, V15, P1900, DOI 10.1093/ndt/15.12.1900; Sharma R, 2017, J AM SOC NEPHROL, V28, P2619, DOI 10.1681/ASN.2016070789; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Waasdorp Maaike, 2018, Oncotarget, V9, P21655, DOI 10.18632/oncotarget.25069; Waasdorp M, 2017, AM J TRANSL RES, V9, P4512; Waasdorp Maaike, 2017, Biochem Biophys Rep, V10, P152, DOI 10.1016/j.bbrep.2017.03.009; Waasdorp M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33030; Wang H, 2011, BLOOD, V117, P5231, DOI 10.1182/blood-2010-10-314773	17	5	5	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10966	10972		10.1096/fj.201900516R	http://dx.doi.org/10.1096/fj.201900516R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31287960				2022-12-26	WOS:000489166300032
J	Yoo, JY; Jung, NC; Lee, JH; Choi, SY; Choi, HJ; Park, SY; Jang, JS; Byun, SH; Hwang, SU; Noh, KE; Park, Y; Lee, J; Song, JY; Seo, HG; Lee, HS; Lim, DS				Yoo, Ji-Young; Jung, Nam-Chul; Lee, Jun-Ho; Choi, So-Yeon; Choi, Hyun-Ji; Park, Soo-Yeoun; Jang, Ji-Su; Byun, Sei-Hee; Hwang, Sung-Uk; Noh, Kyung-Eun; Park, Yunok; Lee, Jongwon; Song, Jie-Young; Seo, Han Geuk; Lee, Hyun Soo; Lim, Dae-Seog			Pdlim4 is essential for CCR7-JNK-mediated dendritic cell migration and F-actin-related dendrite formation	FASEB JOURNAL			English	Article						DCs; DC maturation; DC marker	T-CELL; ANTIGEN PRESENTATION; PROTEIN RIL; PDZ; CYTOSKELETON; ACTIVATION; MECHANISMS; EXPRESSION; DYNAMICS; DOMAIN	Dendritic cells (DCs) are the most potent professional antigen (Ag)-presenting cells and inducers of T cell-mediated immunity. A previous microarray analysis identified PDZ and LIM domain protein 4 (Pdlim4) as a candidate marker for DC maturation. The aim of this study was to investigate whether Pdlim4 influences DC migration and maturation. Mouse bone marrow-derived DCs were transduced lentivirally with Pdlim4 short hairpin RNA and examined by confocal microscopy, flow cytometry, ELISA, and Western blotting. Pdlim4 was highly induced in LPS-stimulated mature DCs (mDCs). Pdlim4-knockdown mDCs showed reduced expression of molecules associated with Ag presentation and T-cell costimulation, reduced cytokine production, and functional defects in their ability to activate T cells. Moreover, Pdlim4 was necessary for mDC migration via C-C chemokine receptor type 7 (CCR7)-JNK in in vitro Transwell assays. The importance of Pdlim4 in DC migration was confirmed with an in vivo migration model in which C57BL/6 mice were injected with fluorescently labeled DCs in the footpad and migration to the popliteal lymph nodes was assessed by flow cytometry. Moreover, dendrite formation in mDCs was remarkably attenuated under Pdlim4 knockdown. Taken together, these results demonstrate that Pdlim4 is necessary for DC migration via CCR7-JNK, dendrite formation, and subsequent development of functional T-cell responses.-Yoo, J.-Y., Jung, N.-C., Lee, J.-H., Choi, S.-Y., Choi, H.-J., Park, S.-Y., Jang, J.-S., Byun, S.-H., Hwang, S.-U., Noh, K.-E., Park, Y., Lee, J., Song, J.-Y., Seo, H. G., Lee, H. S., Lim, D.-S. Pdlim4 is essential for CCR7-JNK-mediated dendritic cell migration and F-actin-related dendrite formation.	[Yoo, Ji-Young; Jung, Nam-Chul; Choi, So-Yeon; Jang, Ji-Su; Noh, Kyung-Eun; Park, Yunok; Lee, Jongwon; Lim, Dae-Seog] CHA Univ, Dept Biotechnol, 335 Pangyo Ro, Seongnam 13488, South Korea; [Jung, Nam-Chul; Lee, Jun-Ho; Hwang, Sung-Uk; Lee, Hyun Soo] Pharos Vaccine, Seongnam, South Korea; [Choi, Hyun-Ji] JW CreaGene Co, Seongnam, South Korea; [Park, Soo-Yeoun; Byun, Sei-Hee] Aprogen, Seongnam, South Korea; [Song, Jie-Young] Korea Inst Radiol & Med Sci, Dept Radiat Canc Sci, Seoul, South Korea; [Seo, Han Geuk] Konkuk Univ, Sanghuh Coll Life Sci, Dept Food Sci & Biotechnol Anim Resources, Seoul, South Korea	Pochon Cha University; Korea Institute of Radiological & Medical Sciences; Konkuk University	Lim, DS (corresponding author), CHA Univ, Dept Biotechnol, 335 Pangyo Ro, Seongnam 13488, South Korea.	dslim@cha.ac.kr	Song, Jie-Young/AAH-1254-2019; Song, Jie-Young/AAG-6684-2019	Song, Jie-Young/0000-0002-5769-3886	Bio and Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, Information and Communications Technology (ICT), and Future Planning (MSIP) of the Korean government [NRF-2017M3A9C8062622]	Bio and Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, Information and Communications Technology (ICT), and Future Planning (MSIP) of the Korean government	This research was supported by the Bio and Medical Technology Development Program of the National Research Foundation (NRF), funded by the Ministry of Science, Information and Communications Technology (ICT), and Future Planning (MSIP) of the Korean government (NRF-2017M3A9C8062622). The authors declare no conflicts of interest.	Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; An H, 2016, EXP NEUROBIOL, V25, P48, DOI 10.5607/en.2016.25.1.48; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blom M, 2017, EXP CELL RES, V352, P255, DOI 10.1016/j.yexcr.2017.02.013; Boumber YA, 2007, CANCER RES, V67, P1997, DOI 10.1158/0008-5472.CAN-06-3093; Byun SH, 2016, BIOCHEM PHARMACOL, V115, P85, DOI 10.1016/j.bcp.2016.05.009; Choo EH, 2017, CIRCULATION, V135, P1444, DOI 10.1161/CIRCULATIONAHA.116.023106; Cuppen E, 2000, EUR J CELL BIOL, V79, P283, DOI 10.1078/S0171-9335(04)70031-X; Davis DM, 2009, NAT REV IMMUNOL, V9, P543, DOI 10.1038/nri2602; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Granucci F, 1999, MICROBES INFECT, V1, P1079, DOI 10.1016/S1286-4579(99)00209-9; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guy PM, 1999, MOL BIOL CELL, V10, P1973, DOI 10.1091/mbc.10.6.1973; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lee EG, 2016, AUTOIMMUNITY, V49, P90, DOI 10.3109/08916934.2015.1124424; Liechtenstein T., 2012, J CLIN CELL IMMUNOL; Liechtenstein T, 2013, VIRUS RES, V176, P1, DOI 10.1016/j.virusres.2013.05.007; Manjunath N, 2009, ADV DRUG DELIVER REV, V61, P732, DOI 10.1016/j.addr.2009.03.004; Ocana-Morgner C, 2009, BLOOD, V113, P1474, DOI 10.1182/blood-2008-04-152587; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Shurin GV, 2005, J IMMUNOL, V174, P3394, DOI 10.4049/jimmunol.174.6.3394; Steinman RM, 2007, EUR J IMMUNOL, V37, pS53, DOI 10.1002/eji.200737400; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Swetman CA, 2002, EUR J IMMUNOL, V32, P2074, DOI 10.1002/1521-4141(200207)32:7<2074::AID-IMMU2074>3.0.CO;2-S; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Vallenius T, 2004, EXP CELL RES, V293, P117, DOI 10.1016/j.yexcr.2003.09.004; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; Vallenius T, 2002, J CELL SCI, V115, P2067; van den Berk LCJ, 2004, MOL BIOL REP, V31, P203; Vargas P, 2016, NAT CELL BIOL, V18, P43, DOI 10.1038/ncb3284; Verdijk P, 2004, EUR J IMMUNOL, V34, P156, DOI 10.1002/eji.200324241; Vicente-Manzanares M, 2002, INT REV CYTOL, V216, P233; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Xu Y, 2014, J IMMUNOL, V192, P3559, DOI 10.4049/jimmunol.1300695	43	8	8	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11035	11044		10.1096/fj.201901031	http://dx.doi.org/10.1096/fj.201901031			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31287961				2022-12-26	WOS:000489166300039
J	Zhuang, CL; Ma, Q; Zhuang, CS; Ye, J; Zhang, FT; Gui, YT				Zhuang, Chengle; Ma, Qian; Zhuang, Changshui; Ye, Jing; Zhang, Fangting; Gui, Yaoting			LncRNA GClnc1 promotes proliferation and invasion of bladder cancer through activation of MYC	FASEB JOURNAL			English	Article						LIN28B; let-7a; migration	LONG NONCODING RNA; LIN28/LET-7 AXIS; IMPRINTED H19; PROGRESSION; TRANSACTIVATION; RECURRENCE; EXPRESSION; CARCINOMA; PROSTATE; GENE	Various studies demonstrate that long noncoding RNAs (lncRNAs) act as oncogenes or tumor suppressors in cancer. However, the function of lncRNAs in bladder cancer still remains largely unknown. In this study, we identified an lncRNA, gastric cancer-associated lncRNA1 (GClnc1), which was in high abundance in bladder cancer tissues and its expression was related to poor survival rates in patients with bladder cancer. In vitro and in vivo assays showed that GClnc1 significantly promoted cell proliferation, metastasis, and invasiveness in bladder cancer. Mechanistically, we first found that GClnc1 bound to LIN28B and promoted the expression of myelocytomatosis proto-oncogene (MYC) through the LIN28B/let-7a/MYC pathway. In short, GClnc1 is clinically, functionally, and mechanistically oncogenic in bladder cancer. GClnc1 may be a potential target for treating patients with bladder cancer.-Zhuang, C., Ma, Q., Zhuang, C., Ye, J., Zhang, F., Gui, Y. LncRNA GClnc1 promotes proliferation and invasion of bladder cancer through activation of MYC.	[Zhuang, Chengle; Ma, Qian; Zhuang, Changshui; Ye, Jing; Zhang, Fangting; Gui, Yaoting] Peking Univ, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol, Shenzhen Hosp, Shenzhen 518000, Peoples R China; [Zhuang, Chengle; Ma, Qian; Zhuang, Changshui; Ye, Jing; Zhang, Fangting; Gui, Yaoting] Peking Univ, Shenzhen 518000, Peoples R China; [Zhuang, Chengle; Ma, Qian; Zhuang, Changshui; Ye, Jing; Zhang, Fangting; Gui, Yaoting] Hong Kong Univ Sci & Technol, Med Ctr, Shenzhen 518000, Peoples R China	Peking University; Peking University; Hong Kong University of Science & Technology	Zhang, FT; Gui, YT (corresponding author), Peking Univ, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol, Shenzhen Hosp, Shenzhen 518000, Peoples R China.; Zhang, FT; Gui, YT (corresponding author), Peking Univ, Shenzhen 518000, Peoples R China.; Zhang, FT; Gui, YT (corresponding author), Hong Kong Univ Sci & Technol, Med Ctr, Shenzhen 518000, Peoples R China.	fangtingzhang@126.com; guiyaoting2007@aliyun.com	gui, yaoting/GLT-3684-2022		Guangdong Key Laboratory of Male Reproductive Medicine and Genetics [2017B030314074]; Shenzhen Project of Science and Technology [JCYJ20170413100245260]; "San-ming" Project of Medicine in Shenzhen [SZSM201612066]	Guangdong Key Laboratory of Male Reproductive Medicine and Genetics; Shenzhen Project of Science and Technology; "San-ming" Project of Medicine in Shenzhen	This work was supported by grants from the Guangdong Key Laboratory of Male Reproductive Medicine and Genetics (2017B030314074), the Shenzhen Project of Science and Technology (JCYJ20170413100245260), and the "San-ming" Project of Medicine in Shenzhen (SZSM201612066). The authors thank all researchers whose names were not included in the author list, but who participated in this program. The authors declare no conflicts of interest.	Albino D, 2016, CANCER RES, V76, P3629, DOI 10.1158/0008-5472.CAN-15-2665; Allione A, 2018, CARCINOGENESIS, V39, P1254, DOI 10.1093/carcin/bgy098; Ariel I, 2000, J CLIN PATHOL-MOL PA, V53, P320, DOI 10.1136/mp.53.6.320; Balzeau J, 2017, FRONT GENET, V8, P1, DOI 10.3389/fgene.2017.00031; Bellucci M, 2011, NAT METHODS, V8, P444, DOI 10.1038/nmeth.1611; Blondeau JJC, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0047-7; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Calle AS, 2018, CANCER SCI, V109, P2093, DOI 10.1111/cas.13642; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen H, 2012, CANCER LETT, V320, P40, DOI 10.1016/j.canlet.2012.01.027; Chen JB, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-015-0282-y; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; ELKIN M, 1995, FEBS LETT, V374, P57, DOI 10.1016/0014-5793(95)01074-O; Fernandez-Gomez J, 2009, J UROLOGY, V182, P2195, DOI 10.1016/j.juro.2009.07.016; Guo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022387; Han YH, 2013, J SURG ONCOL, V107, P555, DOI 10.1002/jso.23264; Han YH, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2012.08.044; Holdt LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12429; Huang GQ, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0794-3; Lan T., 2019, CANC RES; Li GL, 2017, PAIN, V158, P2042, DOI 10.1097/j.pain.0000000000001013; Mahe M, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708163; Martens-Uzunova ES, 2014, EUR UROL, V65, P1140, DOI 10.1016/j.eururo.2013.12.003; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Muys B. R., 2019, CANC RES; Park SJ, 2016, ONCOGENE, V35, P1292, DOI 10.1038/onc.2015.187; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sun TT, 2016, CANCER DISCOV, V6, P784, DOI 10.1158/2159-8290.CD-15-0921; Sun X, 2016, J CELL MOL MED, V20, P1779, DOI 10.1111/jcmm.12861; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Wang F, 2008, FEBS LETT, V582, P1919, DOI 10.1016/j.febslet.2008.05.012; Wang J, 2018, NEOPLASMA, V65, P769, DOI 10.4149/neo_2018_171204N794; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wang XX, 2016, MATER TODAY CHEM, V1-2, P7, DOI 10.1016/j.mtchem.2016.10.005; Wang ZH, 2018, CANCER CELL, V33, P706, DOI 10.1016/j.ccell.2018.03.006; Wu D, 2018, CANCER LETT, V438, P116, DOI 10.1016/j.canlet.2018.09.016; Yarmishyn AA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S9-S7; Zhang X, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201706523; Zhong ZY, 2017, CANCER LETT, V403, P305, DOI 10.1016/j.canlet.2017.06.027; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhuang CL, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0626-x	42	53	54	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11045	11059		10.1096/fj.201900078RR	http://dx.doi.org/10.1096/fj.201900078RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31298933				2022-12-26	WOS:000489166300040
J	Jagessar, KL; Mchaourab, HS; Claxton, DP				Jagessar, Kevin L.; Mchaourab, Hassane S.; Claxton, Derek P.			The N-terminal domain of an archaeal multidrug and toxin extrusion (MATE) transporter mediates proton coupling required for prokaryotic drug resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug resistance; transporter; cell growth; protein expression; fluorescence; allostery; ion-coupled substrate transport; multidrug and toxin extrusion (MATE)	EFFLUX PUMP; EVOLUTIONARY CONSERVATION; STAPHYLOCOCCUS-AUREUS; MOLECULAR-MECHANISMS; ESCHERICHIA-COLI; STRUCTURAL BASIS; FAMILY; CLONING; NORM	As a contributor to multidrug resistance, the family of multidrug and toxin extrusion (MATE) transporters couples the efflux of chemically dissimilar compounds to electrochemical ion gradients. Although divergent transport mechanisms have been proposed for these transporters, previous structural and functional analyses of members of the MATE subfamily DinF suggest that the N-terminal domain (NTD) supports substrate and ion binding. In this report, we investigated the relationship of ligand binding within the NTD to the drug resistance mechanism of the H+-dependent MATE from the hyperthermophilic archaeon Pyrococcus furiosus (PfMATE). To facilitate this study, we developed a cell growth assay in Escherichia coli to characterize the resistance conferred by PfMATE to toxic concentrations of the antimicrobial compound rhodamine 6G. Expression of WT PfMATE promoted cell growth in the presence of drug, but amino acid substitutions of conserved NTD residues compromised drug resistance. Steady-state binding analysis with purified PfMATE indicated that substrate affinity was unperturbed in these NTD variants. However, exploiting Trp fluorescence as an intrinsic reporter of conformational changes, we found that these variants impaired formation of a unique H+-stabilized structural intermediate. These results imply that disruption of H+ coupling is the origin of compromised toxin resistance in PfMATE variants. These findings support a model mechanism wherein the NTD mediates allosteric coupling to ion gradients through conformational changes to drive substrate transport in PfMATE. Furthermore, the results provide evidence for diverging transport mechanisms within a prokaryotic MATE subfamily.	[Jagessar, Kevin L.; Mchaourab, Hassane S.; Claxton, Derek P.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Claxton, DP (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	derek.p.claxton@vanderbilt.edu		JAGESSAR, KEVIN/0000-0003-1475-2513; Claxton, Derek P/0000-0002-1374-7176	NIGMS, National Institutes of Health [R01 GM077659]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077659] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01 GM077659 (to H.S.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alibert S, 2017, EXPERT OPIN DRUG MET, V13, P301, DOI 10.1080/17425255.2017.1251581; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Chen J, 2002, J BACTERIOL, V184, P572, DOI 10.1128/JB.184.2.572-576.2002; Chen ZL, 2016, CANCER LETT, V370, P153, DOI 10.1016/j.canlet.2015.10.010; Claxton DP, 2018, P NATL ACAD SCI USA, V115, pE6182, DOI 10.1073/pnas.1802417115; Du DJ, 2015, CURR OPIN STRUC BIOL, V33, P76, DOI 10.1016/j.sbi.2015.07.015; Ficici E, 2018, P NATL ACAD SCI USA, V115, pE6172, DOI 10.1073/pnas.1802080115; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Huda MN, 2003, MICROBIOL IMMUNOL, V47, P419, DOI 10.1111/j.1348-0421.2003.tb03379.x; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaatz GW, 2005, ANTIMICROB AGENTS CH, V49, P1857, DOI 10.1128/AAC.49.5.1857-1864.2005; Kozachkov L, 2011, P NATL ACAD SCI USA, V108, P15769, DOI 10.1073/pnas.1109256108; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Kusakizako T, 2019, STRUCTURE, V27, P293, DOI 10.1016/j.str.2018.10.004; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Long F, 2008, ANTIMICROB AGENTS CH, V52, P3052, DOI 10.1128/AAC.00475-08; Lu M, 2016, CHANNELS, V10, P88, DOI 10.1080/19336950.2015.1106654; Lu M, 2013, NAT STRUCT MOL BIOL, V20, P1310, DOI 10.1038/nsmb.2687; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; McAleese F, 2005, ANTIMICROB AGENTS CH, V49, P1865, DOI 10.1128/AAC.49.5.1865-1871.2005; MITCHELL P, 1967, ADV ENZYMOL RAMB, V29, P33; Miyauchi H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01541-0; Mousa JJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.9, 10.1038/nmicrobiol.2015.9]; Nishima W, 2016, BIOPHYS J, V110, P1346, DOI 10.1016/j.bpj.2016.01.027; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Radchenko M, 2016, J BIOL CHEM, V291, P9818, DOI 10.1074/jbc.M116.715227; Radchenko M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8995; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Smirnova I, 2009, P NATL ACAD SCI USA, V106, P21561, DOI 10.1073/pnas.0911434106; Smriti, 2009, J BIOL CHEM, V284, P13904, DOI 10.1074/jbc.M900837200; Steed PR, 2013, BIOCHEMISTRY-US, V52, P5790, DOI 10.1021/bi4008935; Su XZ, 2005, ANTIMICROB AGENTS CH, V49, P4362, DOI 10.1128/AAC.49.10.4362-4364.2005; Tal N, 2009, P NATL ACAD SCI USA, V106, P9051, DOI 10.1073/pnas.0902400106; Tanaka Y, 2017, STRUCTURE, V25, P1455, DOI 10.1016/j.str.2017.07.009; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08; Yilmaz C, 2017, BIOCHEM PHARMACOL, V133, P43, DOI 10.1016/j.bcp.2016.10.005; Yonezawa A, 2011, BRIT J PHARMACOL, V164, P1817, DOI 10.1111/j.1476-5381.2011.01394.x; Yu EW, 2003, J BACTERIOL, V185, P5657, DOI 10.1128/JB.185.19.5657-5664.2003	42	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12807	12814		10.1074/jbc.RA119.009195	http://dx.doi.org/10.1074/jbc.RA119.009195			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31289123	hybrid, Green Published			2022-12-26	WOS:000484414600021
J	Dold, L; Nielsen, MJ; Praktiknjo, M; Schwarze-Zander, C; Boesecke, C; Schierwagen, R; Mohr, R; Wasmuth, JC; Jansen, C; Bischoff, J; Rockstroh, JK; Karsdal, MA; Spengler, U; Trebicka, J; Leeming, DJ				Dold, Leona; Nielsen, Mette J.; Praktiknjo, Michael; Schwarze-Zander, Carolynne; Boesecke, Christoph; Schierwagen, Robert; Mohr, Raphael; Wasmuth, Jan-Christian; Jansen, Christian; Bischoff, Jenny; Rockstroh, Jurgen Kurt; Karsdal, Morten A.; Spengler, Ulrich; Trebicka, Jonel; Leeming, Diana J.			Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART	PLOS ONE			English	Article							HEPATITIS-C VIRUS; ATTENUATION PARAMETER CAP; ANTIRETROVIRAL THERAPY; TRANSIENT ELASTOGRAPHY; PREVALENCE; MORTALITY; INFECTION; CIRRHOSIS; BIOPSY	Background and aims Although combined antiretroviral treatment (cART) has improved overall survival of HIV infected patients, liver fibrosis and liver related-mortality still constitute major challenges in HIV positive patients. Collagen accumulates in the liver during fibrogenesis. Recent studies showed that circulating levels of extracellular matrix (ECM) fragments might reflect degree of portal hypertension and fibrosis stage in liver disease. In this study, we analyzed the correlation between liver fibrosis assessed by Fibroscan and levels of the formation and degradation markers of type III and IV collagen in HIV positive patients receiving cART. Methods 116 HIV positive patients (82.7% male, median age 47 years) were enrolled into the study. Liver stiffness and liver fat content were determined using a Fibroscan with integrated CAP function. We quantified ECM formation and degradation fragments of collagen III and IV: PRO-C3, PRO-C4, C3M and C4M. These fragments were measured in peripheral serum by using specific ELISAs. Results Fifteen (12.9%) out of the 116 HIV positive patients had relevant fibrosis with a liver stiffness >= 7.1 kPa, and 79 patients had relevant steatosis with a CAP value > 248 dB/m. Circulating PRO-C3 levels significantly correlated with increasing degree of liver fibrosis assessed by Fibroscan (p = 0.0005), as well as with APRI score (p = 0.015). Interestingly, circulating PRO-C3 levels were significantly correlated with bilirubin (p = 0.022), reduced platelet count (p = 0.0008) and low albumin levels (p = 0.001), suggesting the association of type III collagen deposition with impaired liver function. None of the other measured ECM components significantly correlated with fibrosis or steatosis. Conclusion The formation marker of type III collagen, PRO-C3 not only reflects liver fibrosis, but might also mirror liver dysfunction in HIV positive patients receiving cART. Therefore, the circulating levels of PRO-C3 might be suitable to monitor progression of liver fibrosis and deterioration of liver function in HIV positive patients receiving cART.	[Dold, Leona; Praktiknjo, Michael; Schwarze-Zander, Carolynne; Boesecke, Christoph; Schierwagen, Robert; Mohr, Raphael; Wasmuth, Jan-Christian; Jansen, Christian; Bischoff, Jenny; Rockstroh, Jurgen Kurt; Spengler, Ulrich; Trebicka, Jonel] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Dold, Leona; Schwarze-Zander, Carolynne; Boesecke, Christoph; Wasmuth, Jan-Christian; Rockstroh, Jurgen Kurt; Spengler, Ulrich] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Bonn, Germany; [Nielsen, Mette J.; Karsdal, Morten A.; Leeming, Diana J.] Nord Biosci Fibrosis Biol & Biomarkers, Herlev, Denmark; [Schierwagen, Robert; Trebicka, Jonel] Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany; [Trebicka, Jonel] European Fdn Study Chron Liver Failure EF CLIF, Barcelona, Spain; [Trebicka, Jonel] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark	University of Bonn; German Center for Infection Research; Nordic Bioscience; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Southern Denmark	Dold, L (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.; Dold, L (corresponding author), German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Bonn, Germany.	Leona.Dold@ukbonn.de	Nielsen, Mette Juul/AAP-1647-2020; Schierwagen, Robert/AAE-6305-2019; Bischoff, Jenny/AAO-9674-2021	Schierwagen, Robert/0000-0002-2195-3666; Bischoff, Jenny/0000-0002-7700-2915; Mohr, Raphael/0000-0003-2403-4275; Karsdal, Morten/0000-0001-5026-8740	German center for infection research (DZIF); Nordic bioscience; DZIF	German center for infection research (DZIF); Nordic bioscience; DZIF	The study was supported by a grant from the German center for infection research (DZIF). The ELISAs for ECM measurement were conducted by Nordic Bioscience. The funder Nordic bioscience provided support in the form of salaries for authors [MAK, DJL, MJN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (DZIF) provided financial support for research materials for JKR and US, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anadol E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191118; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Chou CC, 2014, J MICROBIOL IMMUNOL; Crum-Cianflone N, 2010, CLIN GASTROENTEROL H, V8, P183, DOI 10.1016/j.cgh.2009.09.025; Eisenberg E, 2003, ANESTH ANALG, V96, P1392, DOI 10.1213/01.ANE.0000060453.74744.17; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Funderburg NT, 2016, CURR HIV-AIDS REP, V13, P218, DOI 10.1007/s11904-016-0321-0; Gao SC, 2010, HEPATOL RES, V40, P287, DOI 10.1111/j.1872-034X.2009.00608.x; Jansen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108544; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022; Karlas T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091987; Leeming DJ, 2014, AIDS, V28, P2081, DOI 10.1097/QAD.0000000000000388; Leeming DJ, 2012, HEPATOL RES, V42, P482, DOI 10.1111/j.1872-034X.2011.00946.x; Lehmann J, 2019, LIVER INT, V39, P885, DOI 10.1111/liv.14070; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; Masaki N, 2006, HEPATOL RES, V35, P135, DOI 10.1016/j.hepres.2006.02.006; Mohr R, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000010462, 10.1097/md.0000000000010462]; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Nielsen MJ, 2015, LIVER INT, V35, P429, DOI 10.1111/liv.12700; Nielsen MJ, 2013, AM J TRANSL RES, V5, P303; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Praktiknjo M, 2018, HEPATOL COMMUN, V2, P211, DOI 10.1002/hep4.1135; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Rosenthal E, 2007, J VIRAL HEPATITIS, V14, P183, DOI 10.1111/j.1365-2893.2006.00791.x; Sand JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084934; Sasso M, 2012, CLIN RES HEPATOL GAS, V36, P13, DOI 10.1016/j.clinre.2011.08.001; Schierwagen R, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00195; Tural C, 2003, J VIRAL HEPATITIS, V10, P118, DOI 10.1046/j.1365-2893.2003.00413.x; Vassiliadis E, 2011, BIOMARK INSIGHTS, V6, P49, DOI 10.4137/BMI.S6347; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346	32	6	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219526	10.1371/journal.pone.0219526	http://dx.doi.org/10.1371/journal.pone.0219526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295293	Green Published, Green Submitted, gold			2022-12-26	WOS:000484951800040
J	Kong, JJ; Wang, T; Shen, S; Zhang, ZF; Wang, WT				Kong, Junjie; Wang, Tao; Shen, Shu; Zhang, Zifei; Wang, Wentao			A nomogram predicting the prognosis of young adult patients diagnosed with hepatocellular carcinoma: A population-based analysis	PLOS ONE			English	Article							CLINICOPATHOLOGICAL FEATURES; LIVER-TRANSPLANTATION; CANCER STATISTICS; TUMOR SIZE; SURVIVAL; RESECTION; METASTASIS; RECURRENCE; OUTCOMES; POORER	Background Few studies have reported the clinical characteristics and outcomes of young adult patients diagnosed with hepatocellular carcinoma (HCC). This study aimed to formulate a nomogram to predict the prognosis of young adult HCC patients. Methods Young adult patients diagnosed with HCC from 2004 to 2015 were screened from the Surveillance, Epidemiology, and End Results (SEER) database. Based on the multivariate analysis results, a nomogram was constructed. The concordance index (c-index) and calibration were used to assess the predictive performance of the nomogram. The clinical benefit was measured by using decision curve analysis (DCA). Results The mean follow-up time of the patients was 25.0 +/- 34.0 months. Gender, race, AFP level, Edmondson-Steiner classification, treatment and TNM stage were selected as independent prognostic factors and integrated into the nomogram. The c-indexes of the two sets were 0.786 and 0.775, respectively. The calibration curves showed good agreement between the nomogram-predicted probability and the actual observations. Furthermore, the DCA indicated that the nomogram had positive net benefits compared with the conventional staging system. Conclusions The nomogram could accurately predict the prognosis of young adult HCC patients.	[Kong, Junjie; Wang, Tao; Shen, Shu; Zhang, Zifei; Wang, Wentao] Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Sichuan, Peoples R China; [Kong, Junjie; Wang, Tao; Shen, Shu; Zhang, Zifei; Wang, Wentao] Sichuan Univ, West China Hosp, Liver Transplantat Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Wang, WT (corresponding author), Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Sichuan, Peoples R China.	wwtdoctor02@163.com		/0000-0002-6966-2665	National Natural Science Foundation of China [81770566]; Department of Science and Technology of Sichuan Province [19ZDYF1682]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Sichuan Province	This research was funded by the National Natural Science Foundation of China (No. 81770566) and the Department of Science and Technology of Sichuan Province (No. 19ZDYF1682).	Burkhart RA, 2017, CANCER CONTROL, V24, DOI 10.1177/1073274817729235; Chang PE, 2008, J GASTROENTEROL, V43, P881, DOI 10.1007/s00535-008-2238-x; Chen CH, 2006, LIVER INT, V26, P774, DOI 10.1111/j.1478-3231.2006.01307.x; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cho CS, 2008, J AM COLL SURGEONS, V206, P281, DOI 10.1016/j.jamcollsurg.2007.07.031; Cho SJ, 2007, J GASTROEN HEPATOL, V22, P1226, DOI 10.1111/j.1440-1746.2007.04914.x; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fu YP, 2016, BRIT J CANCER, V114, P767, DOI 10.1038/bjc.2016.47; Goh BKP, 2016, J SURG ONCOL, V113, P89, DOI 10.1002/jso.24099; Ha SY, 2015, ONCOTARGET, V6, P18664, DOI 10.18632/oncotarget.4330; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hu Z, 2018, CLIN TRANSL ONCOL, V20, P729, DOI 10.1007/s12094-017-1779-y; Hwang S, 2015, J GASTROINTEST SURG, V19, P1281, DOI 10.1007/s11605-015-2849-5; Kattan MW, 2007, NAT CLIN PRACT UROL, V4, P638, DOI 10.1038/ncpuro0968; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; Lam CM, 2004, ALIMENT PHARM THER, V19, P771, DOI 10.1111/j.1365-2036.2004.01912.x; Lee CR, 2012, J GASTROINTEST SURG, V16, P1736, DOI 10.1007/s11605-012-1966-7; Lee JI, 2014, CLIN EXP METASTAS, V31, P475, DOI 10.1007/s10585-014-9641-x; Li J, 2014, BRIT J CANCER, V110, P1110, DOI 10.1038/bjc.2014.19; Li ZH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004224; Liang WH, 2015, J CLIN ONCOL, V33, P861, DOI 10.1200/JCO.2014.56.6661; Liu C, 2013, WORLD J GASTROENTERO, V19, P1811, DOI 10.3748/wjg.v19.i11.1811; Ma WJ, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-212; Mao K, 2018, CANCER MED-US, V7, P4475, DOI 10.1002/cam4.1738; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Niederle IM, 2012, J CLIN GASTROENTEROL, V46, P775, DOI 10.1097/MCG.0b013e31826102cc; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Su CH, 2013, ASIAN PAC J CANCER P, V14, P4953, DOI 10.7314/APJCP.2013.14.9.4953; Subramaniam S, 2013, CHIN CLIN ONCOL, V2, DOI 10.3978/j.issn.2304-3865.2013.07.05; Takeishi K, 2011, WORLD J SURG, V35, P1063, DOI 10.1007/s00268-011-1017-7; Tateishi R, 2008, HEPATOL INT, V2, P17, DOI 10.1007/s12072-007-9038-x; Thomas SM, 2017, J ADOLESC YOUNG ADUL, V6, P286, DOI 10.1089/jayao.2016.0048; Wang YZ, 2013, J CLIN ONCOL, V31, P1188, DOI 10.1200/JCO.2012.41.5984; Wu HY, 2015, J SURG ONCOL, V112, P372, DOI 10.1002/jso.23994; Yang DY, 2014, CANCER-AM CANCER SOC, V120, P3707, DOI 10.1002/cncr.28912; Zahran Asmaa M, 2018, Egypt J Immunol, V25, P45; Zhang W, 2017, ONCOTARGET, V8, P106393, DOI 10.18632/oncotarget.18192; Zhang XF, 2018, J GASTROEN HEPATOL, V33, P347, DOI 10.1111/jgh.13843; Zheng SS, 2008, TRANSPLANTATION, V85, P1726, DOI 10.1097/TP.0b013e31816b67e4	39	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219654	10.1371/journal.pone.0219654	http://dx.doi.org/10.1371/journal.pone.0219654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295310	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800058
J	Bastin, JF; Clark, E; Elliott, T; Hart, S; van den Hoogen, J; Hordijk, I; Ma, HZ; Majumder, S; Manoli, G; Maschler, J; Mo, LD; Routh, D; Yu, KL; Zohner, CM; Crowther, TW				Bastin, Jean-Francois; Clark, Emily; Elliott, Thomas; Hart, Simon; van den Hoogen, Johan; Hordijk, Iris; Ma, Haozhi; Majumder, Sabiha; Manoli, Gabriele; Maschler, Julia; Mo, Lidong; Routh, Devin; Yu, Kailiang; Zohner, Constantin M.; Crowther, Thomas W.			Understanding climate change from a global analysis of city analogues	PLOS ONE			English	Article							IMPACTS; SCIENCE; MODEL	Combating climate change requires unified action across all sectors of society. However, this collective action is precluded by the 'consensus gap' between scientific knowledge and public opinion. Here, we test the extent to which the iconic cities around the world are likely to shift in response to climate change. By analyzing city pairs for 520 major cities of the world, we test if their climate in 2050 will resemble more closely to their own current climate conditions or to the current conditions of other cities in different bioclimatic regions. Even under an optimistic climate scenario (RCP 4.5), we found that 77% of future cities are very likely to experience a climate that is closer to that of another existing city than to its own current climate. In addition, 22% of cities will experience climate conditions that are not currently experienced by any existing major cities. As a general trend, we found that all the cities tend to shift towards the sub-tropics, with cities from the Northern hemisphere shifting to warmer conditions, on average similar to 1000 km south (velocity similar to 20 km. year(-1)), and cities from the tropics shifting to drier conditions. We notably predict that Madrid's climate in 2050 will resemble Marrakech's climate today, Stockholm will resemble Budapest, London to Barcelona, Moscow to Sofia, Seattle to San Francisco, Tokyo to Changsha. Our approach illustrates how complex climate data can be packaged to provide tangible information. The global assessment of city analogues can facilitate the understanding of climate change at a global level but also help land managers and city planners to visualize the climate futures of their respective cities, which can facilitate effective decision-making in response to on-going climate change.	[Bastin, Jean-Francois; Clark, Emily; Elliott, Thomas; van den Hoogen, Johan; Hordijk, Iris; Ma, Haozhi; Majumder, Sabiha; Maschler, Julia; Mo, Lidong; Routh, Devin; Yu, Kailiang; Zohner, Constantin M.; Crowther, Thomas W.] Swiss Fed Inst Technol, Inst Integrat Biol, Dept Environm Syst Sci, Crowther Lab, Zurich, Switzerland; [Hart, Simon] Swiss Fed Inst Technol, Dept Environm Syst Sci, Plant Ecol, Inst Integrat Biol, Zurich, Switzerland; [Manoli, Gabriele] Swiss Fed Inst Technol, Inst Environm Engn, Dept Civil Environm & Geomat Engn, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bastin, JF (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Dept Environm Syst Sci, Crowther Lab, Zurich, Switzerland.	bastin.jf@gmail.com	Hart, Simon/AAT-8532-2020; Clark, Emily/GVR-7159-2022	Hart, Simon/0000-0001-7957-8689; van den Hoogen, Johan/0000-0001-6624-8461; Manoli, Gabriele/0000-0002-9245-2877; Crowther, Thomas/0000-0001-5674-8913; Bastin, Jean-Francois/0000-0003-2602-7247; Ma, Haozhi/0000-0003-0709-1438; Routh, Devin/0000-0002-5910-8847	DOB Ecology; Plant-for-the-Planet; German Federal Ministry for Economic Cooperation and Development	DOB Ecology; Plant-for-the-Planet; German Federal Ministry for Economic Cooperation and Development	Author TWC is supported by grant from DOB Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work.; This work was supported by grants to T.W.C. from DOB Ecology, Plant-for-the-Planet and the German Federal Ministry for Economic Cooperation and Development. Images of cities were obtained on Pixabay, and openly shared under CC0 common creative license.	[Anonymous], 2018, VOX; [Anonymous], 2018, WORLD URB PROSP 2018; [Anonymous], 2018, CENTRAL C SUMMER TEM; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Beniston M, 2014, INT J CLIMATOL, V34, P1838, DOI 10.1002/joc.3804; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bright E. A., 2017, LANDSCAN 2016 HIGH R; Cormack RM, 2006, NUMERICAL ECOLOGY BI, V40, P280, DOI [10.2307/2530779, DOI 10.2307/2530779]; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fitzpatrick MC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08540-3; Fowler HJ, 2007, INT J CLIMATOL, V27, P1547, DOI 10.1002/joc.1556; Grenier P, 2013, J APPL METEOROL CLIM, V52, P733, DOI 10.1175/JAMC-D-12-0170.1; Haines A, 2019, NEW ENGL J MED, V380, P263, DOI 10.1056/NEJMra1807873; Hallegatte S, 2007, CLIMATIC CHANGE, V82, P47, DOI 10.1007/s10584-006-9161-z; Hurrell JW, 2013, B AM METEOROL SOC, V94, P1339, DOI 10.1175/BAMS-D-12-00121.1; Kahan DM, 2015, POLIT PSYCHOL, V36, P1, DOI 10.1111/pops.12244; Kopf S, 2008, NAT HAZARD EARTH SYS, V8, P905, DOI 10.5194/nhess-8-905-2008; London M, 2018, LOND ENV STRAT, DOI [10.1016/j.bbabio.2006.11.011, DOI 10.1016/J.BBABIO.2006.11.011]; Lu J, 2014, NAT GEOSCI, V7, P250, DOI 10.1038/ngeo2124; Mahony CR, 2017, GLOBAL CHANGE BIOL, V23, P3934, DOI 10.1111/gcb.13645; Martin GM, 2011, GEOSCI MODEL DEV, V4, P723, DOI 10.5194/gmd-4-723-2011; Marx SM, 2007, GLOBAL ENVIRON CHANG, V17, P47, DOI 10.1016/j.gloenvcha.2006.10.004; Masson-Delmotte V., 2018, IPCC 2018 GLOBAL WAR; Nisbet EC, 2015, ANN AM ACAD POLIT SS, V658, P36, DOI 10.1177/0002716214555474; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ramirez Villegas J., 2010, 1 CIAT; Rohat G, 2018, INT J CLIM CHANG STR, V10, P428, DOI 10.1108/IJCCSM-05-2017-0108; Rohat G, 2017, MITIG ADAPT STRAT GL, V22, P929, DOI 10.1007/s11027-016-9708-x; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Sheppard SRJ, 2012, VISUALIZING CLIMATE, DOI [10.4324/9781849776882, DOI 10.4324/9781849776882]; Smid M, 2018, INT J URBAN SCI, V22, P277, DOI 10.1080/12265934.2017.1409132; Thomson AM, 2011, CLIMATIC CHANGE, V109, P77, DOI 10.1007/s10584-011-0151-4; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Woldemeskel FM, 2016, J GEOPHYS RES-ATMOS, V121, P3, DOI 10.1002/2015JD023719; Zaval L, 2017, EUR J EDUC, V52, P477, DOI 10.1111/ejed.12252; Zhao L, 2014, NATURE, V511, P216, DOI 10.1038/nature13462	36	56	57	8	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0217592	10.1371/journal.pone.0217592	http://dx.doi.org/10.1371/journal.pone.0217592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291249	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800013
J	McGirr, JA; Martin, CH				McGirr, Joseph A.; Martin, Christopher H.			Hybrid gene misregulation in multiple developing tissues within a recent adaptive radiation of Cyprinodon pupfishes	PLOS ONE			English	Article							REMARKABLE SPECIES FLOCK; SAN-SALVADOR ISLAND; REPRODUCTIVE ISOLATION; REGULATORY DIVERGENCE; EXPRESSION DIVERGENCE; INTERSPECIFIC HYBRIDS; EVOLUTION; CIS; SPECIATION; INSIGHTS	Genetic incompatibilities constitute the final stages of reproductive isolation and speciation, but little is known about incompatibilities that occur within recent adaptive radiations among closely related diverging populations. Crossing divergent species to form hybrids can break up coadapted variation, resulting in genetic incompatibilities within developmental networks shaping divergent adaptive traits. We crossed two closely related sympatric Cyprinodon pupfish species-a dietary generalist and a specialized molluscivore-and measured expression levels in their F1 hybrids to identify regulatory variation underlying the novel craniofacial morphology found in this recent microendemic adaptive radiation. We extracted mRNA from eight day old whole-larvae tissue and from craniofacial tissues dissected from 17-20 day old larvae to compare gene expression between a total of seven F1 hybrids and 24 individuals from parental species populations. We found 3.9% of genes differentially expressed between generalists and molluscivores in whole-larvae tissues and 0.6% of genes differentially expressed in craniofacial tissue. We found that 2.1% of genes were misregulated in whole-larvae hybrids whereas 19.1% of genes were misregulated in hybrid craniofacial tissues, after correcting for sequencing biases. We also measured allele specific expression across 15,429 heterozygous sites to identify putative compensatory regulatory mechanisms underlying differential expression between generalists and molluscivores. Together, our results highlight the importance of considering misregulation as an early indicator of genetic incompatibilities in the context of rapidly diverging adaptive radiations and suggests that compensatory regulatory divergence drives hybrid gene misregulation in developing tissues that give rise to novel craniofacial traits.	[McGirr, Joseph A.; Martin, Christopher H.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Martin, Christopher H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Martin, Christopher H.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Berkeley; University of California System; University of California Berkeley	McGirr, JA (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	jmcgirr@email.unc.edu	McGirr, Joseph/AAG-7088-2020; NAME, NO/AAA-3691-2021	Martin, Christopher/0000-0001-7989-9124; McGirr, Joseph/0000-0003-3942-4372	University of North Carolina at Chapel Hill; Miller Institute for Basic Research in the Sciences; National Science Foundation [NSF CAREER 1749764]; National Institutes of Health [NIH/NIDCR R01 DE027052]; NSF CAREER [1749764]; NIH/NIDCR [R01 DE027052]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE027052] Funding Source: NIH RePORTER	University of North Carolina at Chapel Hill; Miller Institute for Basic Research in the Sciences; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded by the University of North Carolina at Chapel Hill, the Miller Institute for Basic Research in the Sciences, the National Science Foundation (NSF CAREER 1749764) and the National Institutes of Health (NIH/NIDCR R01 DE027052) to CHM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was funded by the University of North Carolina at Chapel Hill, the Miller Institute for Basic Research in the Sciences, NSF CAREER 1749764, and NIH/NIDCR R01 DE027052 to CHM. We thank Daniel Matute, Emilie Richards, Michelle St. John, and Sara Suzuki for valuable discussions and computational assistance; Emilie Richards for photographs of specimens in Fig 1; The Vincent J. Coates Genomics Sequencing Laboratory at the University of California, Berkeley and the High-Throughout Sequencing Facility at the University of North Carolina, Chapel Hill for performing RNA library prep and Illumina sequencing; the Gerace Research Centre for accommodation; and the Bahamian government BEST Commission for permission to conduct this research.	Alberti A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-912; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bedford T, 2009, P NATL ACAD SCI USA, V106, P1133, DOI 10.1073/pnas.0812009106; Bell GDM, 2013, GENOME BIOL EVOL, V5, P1309, DOI 10.1093/gbe/evt072; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernatchez L, 2010, PHILOS T R SOC B, V365, P1783, DOI 10.1098/rstb.2009.0274; Biosystems K., 2014, TECHN DAT SHEET KAPA, P1; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Coolon JD, 2014, GENOME RES, V24, P797, DOI 10.1101/gr.163014.113; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Coyne J.A., 2004, SPECIATION; Davidson JH, 2016, G3-GENES GENOM GENET, V6, P1357, DOI 10.1534/g3.116.027946; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Fang S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002795; Goncalves A, 2012, GENOME RES, V22, P2376, DOI 10.1101/gr.142281.112; Haerty W, 2006, MOL BIOL EVOL, V23, P1707, DOI 10.1093/molbev/msl033; Hernandez LP, 2018, J ANAT, V232, P173, DOI 10.1111/joa.12742; Hodgins-Davis A, 2015, MOL BIOL EVOL, V32, P2130, DOI 10.1093/molbev/msv094; Holtmeier CL, 2001, EVOLUTION, V55, P330; Hughes KA, 2006, GENETICS, V173, P1347, DOI 10.1534/genetics.105.051474; HUMPHRIES JM, 1981, COPEIA, P52, DOI 10.2307/1444040; Indjeian VB, 2016, CELL, V164, P45, DOI 10.1016/j.cell.2015.12.007; Landry CR, 2007, HEREDITY, V99, P483, DOI 10.1038/sj.hdy.6801045; Landry CR, 2005, GENETICS, V171, P1813, DOI 10.1534/genetics.105.047449; Lencer ES, 2017, BMC GENOMICS, P1, DOI [10.1186/s12864-016-3406-7, DOI 10.1186/S12864-016-3406-7]; Lencer ES, 2016, J MORPHOL, V277, P935, DOI 10.1002/jmor.20547; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mack KL, 2017, TRENDS GENET, V33, P68, DOI 10.1016/j.tig.2016.11.003; Mack KL, 2016, GENOME RES, V26, P451, DOI 10.1101/gr.195743.115; Malone JH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-82; Martin CH, 2016, EVOLUTION, V70, P1265, DOI 10.1111/evo.12932; Martin CH, 2014, MOL ECOL, V23, P1846, DOI 10.1111/mec.12658; Martin CH, 2013, B PEABODY MUS NAT HI, V54, P231; Martin CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071164; Martin CH, 2013, SCIENCE, V339, P208, DOI 10.1126/science.1227710; Martin CH, 2011, EVOLUTION, V65, P2197, DOI 10.1111/j.1558-5646.2011.01294.x; Mayba O, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0405-3; McGirr JA, 2018, EVOL LETT, V2, P62, DOI 10.1002/evl3.41; McGirr JA, 2017, MOL BIOL EVOL, V34, P873, DOI 10.1093/molbev/msw286; McManus CJ, 2010, GENOME RES, V20, P816, DOI 10.1101/gr.102491.109; Michalak P, 2004, J MOL EVOL, V59, P277, DOI 10.1007/s00239-004-2622-y; Mylroie J. E, 1995, TERRESTRIAL SHALLOW, P77; Ortiz-Barrientos D, 2007, GENETICA, V129, P71, DOI 10.1007/s10709-006-0034-1; Parekh S, 2016, SCI REP, V6, P1, DOI DOI 10.1038/S41598-016-0001-8; Presgraves DC, 2003, GENETICS, V163, P955; Ranz JM, 2004, GENOME RES, V14, P373, DOI 10.1101/gr.2019804; Renaut S, 2011, HEREDITY, V106, P1003, DOI 10.1038/hdy.2010.149; Renaut S, 2009, MOL BIOL EVOL, V26, P925, DOI 10.1093/molbev/msp017; Roberge C, 2008, MOL ECOL, V17, P314, DOI 10.1111/j.1365-294X.2007.03438.x; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Romero IG, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-42; Rottscheidt R, 2007, GENETICS, V177, P1553, DOI 10.1534/genetics.107.076190; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schumer M, 2014, ELIFE, V2014, P1; Signor SA, 2018, TRENDS GENET, P1; Strecker U, 2006, MOL PHYLOGENET EVOL, V39, P865, DOI 10.1016/j.ympev.2006.01.008; Sweigart AL, 2006, GENETICS, V172, P2465, DOI 10.1534/genetics.105.053686; Takahasi KR, 2011, P NATL ACAD SCI USA, V108, P15276, DOI 10.1073/pnas.1105814108; True JR, 2001, EVOL DEV, V3, P109, DOI 10.1046/j.1525-142x.2001.003002109.x; Turner BJ, 2008, BIOL J LINN SOC, V95, P566, DOI 10.1111/j.1095-8312.2008.01079.x; van Dijk EL, 2014, EXP CELL RES, V322, P12, DOI 10.1016/j.yexcr.2014.01.008; WAINWRIGHT PC, 1995, ENVIRON BIOL FISH, V44, P97, DOI 10.1007/BF00005909; Wang LG, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0922-z; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; West RJD, 2015, ETHOLOGY, V121, P793, DOI 10.1111/eth.12394; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wolf JBW, 2010, PHILOS T R SOC B, V365, P1717, DOI 10.1098/rstb.2010.0023	71	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218899	10.1371/journal.pone.0218899	http://dx.doi.org/10.1371/journal.pone.0218899			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291291	Green Submitted, Green Published, gold			2022-12-26	WOS:000484947800040
J	Lee, YY				Lee, Yiu-Yin			The effect of large amplitude vibration on the pressure-dependent absorption of a structure multiple cavity system	PLOS ONE			English	Article							MICRO-PERFORATED PANEL; FINITE-ELEMENT-METHOD; SOUND-ABSORPTION; NONLINEAR VIBRATION; ABSORBER; MODEL; RADIATION; IMPEDANCE; DESIGN; PLATES	This study addresses the effects of large-amplitude vibration on the pressure-dependent absorption of a structure multiple-cavity system. It is the first study to consider the effects of large-amplitude vibration and pressure-dependent absorption. Previous studies considered only one of these two factors in the absorption calculation of a perforated panel absorber. Nonlinear differential equations, which represent the structural vibration of a perforated panel absorber, are coupled with the wave equation, which represents the acoustic pressures induced within the cavities. The coupled nonlinear differential equations are solved with the proposed harmonic balance method, which has recently been adopted to solve nonlinear beam problems and other nonlinear structural-acoustic problems. Its main advantage is that when compared with the classical harmonic balance method, the proposed method generates fewer nonlinear algebraic equations during the solution process. In addition, the solution form of the nonlinear differential equations from this classical method can be expressed in terms of a set of symbolic parameters with various physical meanings. If a numerical method is used, there is no analytic solution form, and the final solution is a set of numerical values. The effects of the excitation magnitude, cavity depth, perforation ratio, and hole diameter on the sound absorption of a panel absorber are investigated, and mode and solution convergence studies are also performed. The solutions from the proposed harmonic balance method and a numerical integration method are compared. The numerical results show that the present harmonic balance solutions agree reasonably well with those obtained with the numerical integration method. Several important observations can be made. First, perforation nonlinearity is a very important factor in the absorption of a panel absorber at the off structural resonant frequency range. The settings of the hole diameter, perforation ratio, and cavity depth for optimal absorption differ greatly with consideration of perforation nonlinearity. Second, the "jump up phenomenon," which does not occur in the case of linear perforation, is observed when perforation nonlinearity is considered. Third, one or more absorption troughs, which worsen the average absorption performance, may exist in cases with multiple cavities.	[Lee, Yiu-Yin] City Univ Hong Kong, Dept Architecture & Civil Engn, Kowloon Tong, Kowloon, Hong Kong, Peoples R China	City University of Hong Kong	Lee, YY (corresponding author), City Univ Hong Kong, Dept Architecture & Civil Engn, Kowloon Tong, Kowloon, Hong Kong, Peoples R China.	bcraylee@cityu.edu.hk						Bavo AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154517; Chen MX, 2014, SHOCK VIB, V2014, DOI 10.1155/2014/954253; Chen SH, 2007, J SOUND VIB, V306, P1, DOI 10.1016/j.jsv.2007.05.038; Chiang YK, 2018, J ACOUST SOC AM, V143, P538, DOI 10.1121/1.5021334; Cui XY, 2017, COMPUT METHOD APPL M, V317, P1122, DOI 10.1016/j.cma.2017.01.022; Fahy F., 2000, SOUND STRUCTURAL VIB; Guo ZJ, 2014, SCI CHINA PHYS MECH, V57, P1581, DOI 10.1007/s11433-013-5317-9; Hasan AMZ, 2016, J VIB CONTROL, V22, P3218, DOI 10.1177/1077546314562225; Huang JL, 2009, COMPUT STRUCT, V87, P1624, DOI 10.1016/j.compstruc.2009.09.005; Hui CK, 2011, THIN WALL STRUCT, V49, P1191, DOI 10.1016/j.tws.2011.03.002; Kang J, 1999, J SOUND VIB, V220, P905, DOI 10.1006/jsvi.1998.1997; Kim HS, 2018, J SOUND VIB, V430, P75, DOI 10.1016/j.jsv.2018.05.036; Lee SH, 2007, J SOUND VIB, V303, P741, DOI 10.1016/j.jsv.2007.02.001; Lee YY, 2007, INT J MECH SCI, V49, P925, DOI 10.1016/j.ijmecsci.2007.01.008; Lee YY, 2009, J SOUND VIB, V324, P1003, DOI 10.1016/j.jsv.2009.02.042; Lee YY, 2016, THIN WALL STRUCT, V98, P332, DOI 10.1016/j.tws.2015.10.006; Lee YY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199159; Lee YY, 2016, INT J MECH SCI, V107, P242, DOI 10.1016/j.ijmecsci.2016.01.019; Lee YY, 2005, J SOUND VIB, V287, P227, DOI 10.1016/j.jsv.2004.11.024; Lee YY, 1998, J SOUND VIB, V217, P239, DOI 10.1006/jsvi.1998.1748; Leung A, 2011, INT J BIFURCAT CHAOS, V21, P1783, DOI 10.1142/S0218127411029434; Maa D.Y., 1994, P 1994 INT C NOIS CO, P1511; MAA DY, 1975, SCI SINICA, V18, P55; Maa DY, 1998, J ACOUST SOC AM, V104, P2861, DOI 10.1121/1.423870; Mangussi F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162365; Mao WB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184729; Nehete DV, 2015, MECH SYST SIGNAL PR, V50-51, P362, DOI 10.1016/j.ymssp.2014.05.028; Pan J, 1999, J SOUND VIB, V223, P543, DOI 10.1006/jsvi.1998.2133; Park SH, 2013, J SOUND VIB, V332, P521, DOI 10.1016/j.jsv.2012.09.015; Sakagami K, 2010, APPL ACOUST, V71, P411, DOI 10.1016/j.apacoust.2009.11.014; Toyoda M, 2005, J SOUND VIB, V286, P601, DOI 10.1016/j.jsv.2004.10.011; Wang F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123860; Wang G, 2015, ENG ANAL BOUND ELEM, V61, P207, DOI 10.1016/j.enganabound.2015.07.017; Wang Y, 2014, SHOCK VIB, V2014, DOI 10.1155/2014/872963; Xu L, 2010, P I MECH ENG C-J MEC, V224, P1383, DOI 10.1243/09544062JMES1620; Xu L, 2009, NONLINEAR ANAL-THEOR, V71, pE827, DOI 10.1016/j.na.2008.12.001; Yao LY, 2010, APPL ACOUST, V71, P743, DOI 10.1016/j.apacoust.2010.03.006; Younesian D, 2014, NONLINEAR DYNAM, V76, P1867, DOI 10.1007/s11071-014-1254-z	38	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219257	10.1371/journal.pone.0219257	http://dx.doi.org/10.1371/journal.pone.0219257			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287827	Green Published, Green Submitted, gold			2022-12-26	WOS:000482328300013
J	Nord, H; Dennhag, N; Tydinger, H; von Hofsten, J				Nord, Hanna; Dennhag, Nils; Tydinger, Hanna; von Hofsten, Jonas			The zebrafish HGF receptor met controls migration of myogenic progenitor cells in appendicular development	PLOS ONE			English	Article							MUSCLE PRECURSOR CELLS; C-MET; HYPAXIAL MUSCLE; LIMB; EXPRESSION; PAX-3; GENE; SF/HGF; CXCR4; LBX1	The hepatocyte growth factor receptor C-met plays an important role in cellular migration, which is crucial for many developmental processes as well as for cancer cell metastasis. Cmet has been linked to the development of mammalian appendicular muscle, which are derived from migrating muscle progenitor cells (MMPs) from within the somite. Mammalian limbs are homologous to the teleost pectoral and pelvic fins. In this study we used Crispr/Cas9 to mutate the zebrafish met gene and found that the MMP derived musculature of the paired appendages was severely affected. The mutation resulted in a reduced muscle fibre number, in particular in the pectoral abductor, and in a disturbed pectoral fin function. Other MMP derived muscles, such as the sternohyoid muscle and posterior hypaxial muscle were also affected in met mutants. This indicates that the role of met in MMP function and appendicular myogenesis is conserved within vertebrates.	[Nord, Hanna; Dennhag, Nils; Tydinger, Hanna; von Hofsten, Jonas] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [von Hofsten, Jonas] Umea Univ, Umea Ctr Mol Med, Umea, Sweden	Umea University; Umea University	von Hofsten, J (corresponding author), Umea Univ, Dept Integrat Med Biol, Umea, Sweden.; von Hofsten, J (corresponding author), Umea Univ, Umea Ctr Mol Med, Umea, Sweden.	Jonas.von.hofsten@umu.se		von Hofsten, Jonas/0000-0003-3730-1790; Dennhag, Nils/0000-0003-0885-6586	Cancerfonden (Sweden) [170710]	Cancerfonden (Sweden)(Swedish Cancer Society)	This work was supported by Cancerfonden (Sweden) grant 170710, www.cancerfonden.se (JVH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BOBER E, 1994, DEVELOPMENT, V120, P603; Bouldin CM, 2010, P NATL ACAD SCI USA, V107, P5489, DOI 10.1073/pnas.0912818107; BrandSaberi B, 1996, DEV BIOL, V179, P303, DOI 10.1006/dbio.1996.0260; Brohmann H, 2000, DEVELOPMENT, V127, P437; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Christ B, 2002, INT J DEV BIOL, V46, P905; Cole NJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001168; Daston G, 1996, DEVELOPMENT, V122, P1017; Dietrich S, 1999, DEVELOPMENT, V126, P1621; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Gross MK, 2000, DEVELOPMENT, V127, P413; Haines L, 2004, DEVELOPMENT, V131, P4857, DOI 10.1242/dev.01374; Heymann S, 1996, DEV BIOL, V180, P566, DOI 10.1006/dbio.1996.0329; Hirasawa T, 2018, ZOOL LETT, V4, DOI 10.1186/s40851-018-0110-2; Huang AH, 2017, DEV BIOL, V429, P420, DOI 10.1016/j.ydbio.2017.03.028; Hunger C, 2012, EXP CELL RES, V318, P2178, DOI 10.1016/j.yexcr.2012.06.020; Kardon G, 2002, DEV CELL, V3, P533, DOI 10.1016/S1534-5807(02)00291-5; Logan M, 1998, DEVELOPMENT, V125, P2825; Lours-Calet C, 2014, DEV BIOL, V390, P231, DOI 10.1016/j.ydbio.2014.03.003; Mackenzie S, 1998, DEV DYNAM, V213, P349, DOI 10.1002/(SICI)1097-0177(199812)213:4<349::AID-AJA1>3.3.CO;2-Y; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; Masselink W, 2017, DEV BIOL, V430, P302, DOI 10.1016/j.ydbio.2017.08.025; Minchin JEN, 2013, DEVELOPMENT, V140, P2972, DOI 10.1242/dev.090050; Neyt C, 2000, NATURE, V408, P82, DOI 10.1038/35040549; NODEN DM, 1983, AM J ANAT, V168, P257, DOI 10.1002/aja.1001680302; ORDAHL CP, 1992, DEVELOPMENT, V114, P339; Schafer K, 1999, NAT GENET, V23, P213, DOI 10.1038/13843; Seger C, 2011, DEV DYNAM, V240, P2440, DOI 10.1002/dvdy.22745; Shin J, 2016, ELIFE, P5; Spielmann M, 2012, AM J HUM GENET, V91, P629, DOI 10.1016/j.ajhg.2012.08.014; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Thisse B, 2004, METHOD CELL BIOL, V77, P505; THISSE C, 1993, DEVELOPMENT, V119, P1203; Thorsen DH, 2004, J EXP BIOL, V207, P4175, DOI 10.1242/jeb.01285; Tremblay P, 1998, DEV BIOL, V203, P49, DOI 10.1006/dbio.1998.9041; Varshney GK, 2016, NAT PROTOC, V11, P2357, DOI 10.1038/nprot.2016.141; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; Vasyutina E, 2006, ANAT EMBRYOL, V211, pS37, DOI 10.1007/s00429-006-0118-9; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; WILLIAMS BA, 1994, J CELL BIOCHEM, P485; Windner SE, 2011, DEV GENES EVOL, V221, P167, DOI 10.1007/s00427-011-0369-1; Yang XM, 1996, DEVELOPMENT, V122, P2163; Yusuf F, 2006, DEV DYNAM, V235, P3007, DOI 10.1002/dvdy.20951	47	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219259	10.1371/journal.pone.0219259	http://dx.doi.org/10.1371/journal.pone.0219259			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287821	Green Published, gold, Green Submitted			2022-12-26	WOS:000482328300014
J	Lawandi, A; Cheng, MP; Lee, TC				Lawandi, Alexander; Cheng, Matthew P.; Lee, Todd C.			Hepatitis B testing practices at a tertiary care centre and their associated costs: A retrospective analysis	PLOS ONE			English	Article							MANAGEMENT; VIRUS; GUIDELINES	Background Hepatitis B is a viral infection requiring specific serologic testing to diagnose the stage of the disease. There are many tests which can be ordered in a variety of combinations. This study aimed to assess routine Hepatitis B screening practices in a tertiary care centre and determine the diagnostic and economic benefits of protocolized ordering. Methods We evaluated all measurements of Hepatitis B total core antibodies, core IgM antibodies, surface antibodies and surface antigens performed at our institution between January 1, 2015 and December 31, 2015. We also recorded secondary testing (envelope antigens and antibodies, and viral DNA). Costs were estimated using provincial insurance reimbursement values. Using the subset of patients who received complete testing, we developed a reflexive screening protocol to minimize costs while simultaneously improving diagnostic utility. Results 30,335 hepatitis B tests were performed at an estimated total cost of $584,683. 53.9% of patients were screened with a single test. 29% of patients who received secondary testing had no evidence of exposure on primary testing. Using the protocol of initial testing of total core antibody and surface antibody with reflexive testing, we would save an estimated $181,632 (95% CI $154,201.90 $208,910.50) per year while providing more complete information. Interpretation Screening practices for Hepatitis B are frequently inadequate to diagnose and stage the infection and often included unnecessary testing. Protocolization of Hepatitis B testing could limit this practice while resulting in significantly lower costs.	[Lawandi, Alexander; Cheng, Matthew P.; Lee, Todd C.] McGill Univ, Dept Med, Div Infect Dis, Montreal, PQ, Canada; [Lee, Todd C.] McGill Univ, Hlth Ctr, Dept Med, Clin Practice Assessment Unit, Montreal, PQ, Canada	McGill University; McGill University	Lawandi, A (corresponding author), McGill Univ, Dept Med, Div Infect Dis, Montreal, PQ, Canada.	alexander.lawandi@mail.mcgill.ca	Lawandi, Alexander/AAA-8505-2022; Cheng, Matthew P./AAO-7051-2020	Lawandi, Alexander/0000-0001-7948-3161; Lee, Todd/0000-0002-2267-4239				Al-Mekhaizeem KA, 2001, CAN MED ASSOC J, V165, P1063; Coffin CS, 2012, CAN J GASTROENTEROL, V26, P917, DOI 10.1155/2012/506819; Gupta S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-53; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; HOOFNAGLE JH, 1991, SEMIN LIVER DIS, V11, P73, DOI 10.1055/s-2008-1040426; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Terrault NA, 2018, HEPATOLOGY, V67, P1560, DOI 10.1002/hep.29800; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882	13	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219347	10.1371/journal.pone.0219347	http://dx.doi.org/10.1371/journal.pone.0219347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283801	gold, Green Published, Green Submitted			2022-12-26	WOS:000484939800030
J	Weber, L; Smejkai, M; Barton, D; Rulik, M				Weber, Lukas; Smejkai, Marek; Barton, Daniel; Rulik, Martin			Testing the applicability of tagging the Great crested newt (Triturus cristatus) using passive integrated transponders	PLOS ONE			English	Article							PIT TAG DETECTION; SURGICAL IMPLANTATION; RADIO TRANSMITTERS; RETENTION RATES; BODY CONDITION; SURVIVAL; HABITAT; SALAMANDERS; POPULATION; MOVEMENT	Tracking individual animals with small-sized passive integrated transponder tags (PIT tags) has become a popular and widespread method, one which can be used for investigating life history traits, including dispersal patterns of small protected animals such as newts. In this study, we tested the applicability of PIT tag usage for individual marking with the Great crested newt (Triturus cristatus) as a model amphibian species, and to test the detection of the newts in nature using a passive telemetry system. Clove oil was used as an anaesthetic before surgery. We implanted PIT tags under the skin of 140 newts. The survival rate of newts was 98.57%. X-ray images were taken to check the exact positions of the PIT tags. Since approximately 15.71% of the newts were capable of expelling the tag from their bodies, tag loss has to be accounted for in future behavioural studies dealing with newts and other amphibians potentially capable of frequent tag expulsion. Lastly, we detected by passive telemetry 97 individuals out of 100 released into a natural breeding pond. Males had higher activity (13 detected males vs 7 females per hour) than females, thus males could be detected if present with more certainty. The result of the movement behaviour showed that e.g. the male of T. cristatus in a breeding pond can travel up to 20 m in 78 seconds. In summary, this promising method could allow the automatic data collection of marked newts in aquatic as well as in terrestrial biotopes, providing data on their dispersal, diurnal activity and movement behaviour.	[Weber, Lukas; Rulik, Martin] Palacky Univ, Fac Sci, Dept Ecol & Environm Sci, Olomouc, Czech Republic; [Smejkai, Marek; Barton, Daniel] Czech Acad Sci, Inst Hydrobiol, Biol Ctr, Ceske Budejovice, Czech Republic	Palacky University Olomouc; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Weber, L (corresponding author), Palacky Univ, Fac Sci, Dept Ecol & Environm Sci, Olomouc, Czech Republic.	lukas.weber01@upol.cz	Šmejkal, Marek/E-1269-2017	Šmejkal, Marek/0000-0002-7887-6411	Univerzita Palackeho v Olomouci [IGA_PrF_2017_015]; Czech Academy of Sciences	Univerzita Palackeho v Olomouci; Czech Academy of Sciences(Czech Academy of Sciences)	Funding was provided by Univerzita Palackeho v Olomouci, award number IGA_PrF_2017_015 to LW and by Czech Academy of Sciences (ROZE project, Strategy AV 21 to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NS, 1998, CAN J FISH AQUAT SCI, V55, P781, DOI 10.1139/cjfas-55-4-781; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2009, AMPHIBIAN ECOLOGY CO; ARG UK, 2010, ADV NOT 5 GREAT CRES; Arntzen JW, 1999, J HERPETOL, V33, P567, DOI 10.2307/1565573; Arntzen JW, 2009, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK, DOI 10.2305/IUCN.UK]; Atkinson-Adams Matthew R., 2016, Herpetological Review, V47, P198; Bateman DS, 2006, N AM J FISH MANAGE, V26, P545, DOI 10.1577/M05-111.1; Bateman DS, 2009, N AM J FISH MANAGE, V29, P653, DOI 10.1577/M07-169.1; Becker PH, 2008, P NATL ACAD SCI USA, V105, P12349, DOI 10.1073/pnas.0804179105; Becker PH, 1997, CONDOR, V99, P534, DOI 10.2307/1369963; Beebee T. J. C., 2000, AMPHIBIANS REPTILES; Bonter DN, 2011, J FIELD ORNITHOL, V82, P1, DOI 10.1111/j.1557-9263.2010.00302.x; Bubb DH, 2002, HYDROBIOLOGIA, V483, P225, DOI 10.1023/A:1021352217332; Cayuela H, 2019, J ANIM ECOL, V88, P164, DOI 10.1111/1365-2656.12906; Clarke J, 1998, J FIELD ORNITHOL, V69, P149; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Connette GM, 2012, WILDLIFE RES, V39, P1, DOI 10.1071/WR11055; Cooke S.J., 2013, ANIMAL BIOTELEMETRY, V1, P1, DOI DOI 10.1186/2050-3385-1-5; Cucherousset J, 2010, J FISH BIOL, V76, P1039, DOI 10.1111/j.1095-8649.2010.02543.x; Dervo B, 2010, AMPHIBIA-REPTILIA, V31, P229, DOI 10.1163/156853810791069128; Dieterman DJ, 2009, N AM J FISH MANAGE, V29, P109, DOI 10.1577/M07-223.1; DOLMEN D, 1983, J HERPETOL, V17, P23, DOI 10.2307/1563776; Drechsler A, 2015, ECOL EVOL, V5, P141, DOI 10.1002/ece3.1340; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; FOLDVIK A, 2018, ANIM BIOTELEM, V6, DOI DOI 10.1186/S40317-018-0147-1; Gibbons JW, 2004, BIOSCIENCE, V54, P447, DOI 10.1641/0006-3568(2004)054[0447:PTSTAI]2.0.CO;2; Gonzalez-Solis J, 1999, ANIM BEHAV, V58, P1123, DOI 10.1006/anbe.1999.1235; Goulet F, 2010, J AM ASSOC LAB ANIM, V49, P460; Gvozdik L, 2006, EVOLUTION, V60, P2110; Hamed M. Kevin, 2008, Herpetological Review, V39, P303; Heyer W.R., 1994, MEASURING MONITORING; Hill MS, 2006, FISH RES, V77, P102, DOI 10.1016/j.fishres.2005.08.001; HIMSTEDT W, 1971, OECOLOGIA, V8, P194, DOI 10.1007/BF00345813; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Hutchens SJ, 2009, WILDLIFE BIOL, V15, P113, DOI 10.2981/08-024; Jehle R, 1998, HERPETOL J, V8, P181; Jehle R, 2000, HERPETOL J, V10, P137; Jehle R., 2011, CRESTED NEWT DWINDLI; Jepsen N, 2002, HYDROBIOLOGIA, V483, P239, DOI 10.1023/A:1021356302311; Johnson JR, 2006, LAB ANIMAL, V35, P29, DOI 10.1038/laban0206-29; Langton T., 2001, GREAT CRESTED NEWT C; Le Chevalier H, 2017, ACTA HERPETOL, V12, P79, DOI 10.13128/Acta_Herpetol-19158; Lebl K, 2010, ECOL RES, V25, P251, DOI 10.1007/s11284-009-0629-y; Linnansaari T, 2007, HYDROBIOLOGIA, V582, P281, DOI 10.1007/s10750-006-0546-9; Madison DM, 1998, COPEIA, P402; Mamer ERJM, 2016, N AM J FISH MANAGE, V36, P1119, DOI 10.1080/02755947.2016.1198288; Marcec R, 2016, J ZOO WILDLIFE MED, V47, P187, DOI 10.1638/2015-0044.1; McDonough C, 2007, J WILDLIFE MANAGE, V71, P1163, DOI 10.2193/2006-380; Mettouris O, 2016, ECOL RES, V31, P483, DOI 10.1007/s11284-016-1346-y; Meyer KA, 2011, N AM J FISH MANAGE, V31, P236, DOI 10.1080/02755947.2011.572799; Mitchell MA, 2009, J EXOT PET MED, V18, P40, DOI 10.1053/j.jepm.2008.11.006; Naef-Daenzer B, 2005, J EXP BIOL, V208, P4063, DOI 10.1242/jeb.01870; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; OLDERS JHJ, 1985, NETH J ZOOL, V35, P479; Ousterhout BH, 2014, BEHAV ECOL SOCIOBIOL, V68, P343, DOI 10.1007/s00265-013-1656-9; Paukert CP, 2001, T AM FISH SOC, V130, P975, DOI 10.1577/1548-8659(2001)130&lt;0975:EOITSA&gt;2.0.CO;2; Pearson KN, 2016, FISH RES, V183, P263, DOI 10.1016/j.fishres.2016.06.014; Perret N, 2002, HERPETOLOGICA, V58, P131, DOI 10.1655/0018-0831(2002)058[0131:IOTAPO]2.0.CO;2; Peterman WE, 2008, FRESHWATER BIOL, V53, P347, DOI 10.1111/j.1365-2427.2007.01900.x; Pojman John A. Sr., 2014, Herpetological Review, V45, P25; Pojman John A. Sr., 2011, Herpetological Review, V42, P362; Quanbeck AR, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-44; Ratnayake CP, 2014, ORNIS FENNICA, V91, P244; Richards S. J., 1994, MEASURING MONITORING, P155; Rittenhouse TAG, 2006, BIOL CONSERV, V131, P14, DOI 10.1016/j.biocon.2006.01.024; Ryan KJ, 2014, HERPETOL CONSERV BIO, V9, P97; Schmidt BR, 2005, CONSERV BIOL, V19, P1149, DOI 10.1111/j.1523-1739.2005.00164.x; Semiatsch Raymond D., 2007, Herpetological Review, V38, P399; Skov C, 2005, J FISH BIOL, V67, P1195, DOI 10.1111/j.1095-8649.2005.00814.x; Stokes W. S., 2002, ILAR J, V43, P31; Thomson RL, 2013, BEHAV ECOL SOCIOBIOL, V67, P905, DOI 10.1007/s00265-013-1513-x; Trochet A, 2017, HERPETOLOGICA, V73, P1; Vojar J, 2007, OCHRANA OBOJZIVELNIK; Ward D. L., 2006, Journal of the Arizona-Nevada Academy of Science, V38, P74, DOI 10.2181/1533-6085(2006)38[74:EOPTLA]2.0.CO;2; Wedemeyer G.A., 1990, P451; Wilkin TA, 2009, J AVIAN BIOL, V40, P135, DOI 10.1111/j.1600-048X.2009.04362.x; Winandy L, 2011, BEHAV RES METHODS, V43, P568, DOI 10.3758/s13428-011-0058-z; Wright KM., 2001, AMPHIBIAN MED CAPTIV; Zakes Z, 2017, AQUAC RES, V48, P5791, DOI 10.1111/are.13402; Zangmeister JL, 2009, J FIELD ORNITHOL, V80, P373, DOI 10.1111/j.1557-9263.2009.00243.x	81	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219069	10.1371/journal.pone.0219069	http://dx.doi.org/10.1371/journal.pone.0219069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283761	Green Submitted, gold, Green Published			2022-12-26	WOS:000484939800017
J	Ghosh, R; Spindler, H; Morgan, MC; Cohen, SR; Begum, N; Gore, A; Mahapatra, T; Walker, DM				Ghosh, Rakesh; Spindler, Hilary; Morgan, Melissa C.; Cohen, Susanna R.; Begum, Nilophor; Gore, Aboli; Mahapatra, Tanmay; Walker, Dilys M.			Diagnosis and management of postpartum hemorrhage and intrapartum asphyxia in a quality improvement initiative using nurse-mentoring and simulation in Bihar, India	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; NEONATAL-MORTALITY; BIRTH ASPHYXIA; RESUSCITATION; PROGRAM; IMPACT; EPIDEMIOLOGY; INFERENCE; INCREASE; DEATHS	Background In the state of Bihar, India a multi-faceted quality improvement nurse-mentoring program was implemented to improve provider skills in normal and complicated deliveries. The objective of this analysis was to examine changes in diagnosis and management of postpartum hemorrhage (PPH) of the mother and intrapartum asphyxia of the infant in primary care facilities in Bihar, during the program. Methods During the program, mentor pairs visited each facility for one week, covering four facilities over a four-week period and returned for subsequent week-long visits once every month for seven to nine consecutive months. Between-and within-facility comparisons were made using a quasi-experimental and a longitudinal design over time, respectively, to measure change due to the intervention. The proportions of PPH and intrapartum asphyxia among all births as well as the proportions of PPH and intrapartum asphyxia cases that were effectively managed were examined. Zero-inflated negative binomial models and marginal structural methodology were used to assess change in diagnosis and management of complications after accounting for clustering of deliveries within facilities as well as time varying confounding. Results This analysis included 55,938 deliveries from 320 facilities. About 2% of all deliveries, were complicated with PPH and 3% with intrapartum asphyxia. Between-facility comparisons across phases demonstrated diagnosis was always higher in the final week of intervention (PPH: 2.5-5.4%, intrapartum asphyxia: 4.2-5.6%) relative to the first week (PPH: 1.22.1%, intrapartum asphyxia: 0.7-3.3%). Within-facility comparisons showed PPH diagnosis increased from week 1 through 5 (from 1.6% to 4.4%), after which it decreased through week 7 (3.1%). A similar trend was observed for intrapartum asphyxia. For both outcomes, the proportion of diagnosed cases where selected evidence-based practices were used for management either remained stable or increased over time. Conclusions The nurse-mentoring program appears to have built providers' capacity to identify PPH and intrapartum asphyxia cases but diagnosis levels are still not on par with levels observed in Southeast Asia and globally.	[Ghosh, Rakesh; Spindler, Hilary; Morgan, Melissa C.; Walker, Dilys M.] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Morgan, Melissa C.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Morgan, Melissa C.] London Sch Hyg & Trop Med, Maternal Adolescent Reprod & Child Hlth Ctr, London, England; [Cohen, Susanna R.] Univ Utah, Coll Nursing, Salt Lake City, UT USA; [Begum, Nilophor; Gore, Aboli; Mahapatra, Tanmay] CARE India, Patna, Bihar, India; [Walker, Dilys M.] Univ Calif San Francisco, Dept Obstet & Gynecol & Reprod Serv, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of London; London School of Hygiene & Tropical Medicine; Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco	Ghosh, R (corresponding author), Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA.	Rakesh.Ghosh@ucsf.edu		Medvedev, Melissa/0000-0003-3457-8452; Ghosh, Rakesh/0000-0002-7839-4148	Bill and Melinda Gates Foundation [OPP1112431]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was funded by the Bill and Melinda Gates Foundation (OPP1112431) to DW.; The authors would like to thank the Database Management System development team of CARE India and the staff members of the PRONTO office in Patna, India. We also thank all of the mentors, mentees, facility in charge, Regional Clinical Capacity Building Specialists for their tireless efforts in implementing the AMANAT program throughout the state of Bihar as well as the CMAI management. Additionally, we are thankful to the CARE India team for their active support and engagement in integrating simulation and team training into the AMANAT program. Finally, we would like to thank the countless women in Bihar for their participation in this program.	Ashish KC, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-0117; Bang A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1141-3; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Carroli G, 2008, BEST PRACT RES CL OB, V22, P999, DOI 10.1016/j.bpobgyn.2008.08.004; Centre for Health Informatics. MoHFW Government of India, POSTP HAEM; Chauhan Monika, 2016, Indian J Public Health, V60, P341, DOI 10.4103/0019-557X.195863; Dandona R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002363; Das A, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1452-z; Das A, 2016, BIRTH-ISS PERINAT C, V43, P328, DOI 10.1111/birt.12239; Davidoff F, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3152; Dehury RK, 2016, J CLIN DIAGN RES, V10, pIE1, DOI 10.7860/JCDR/2016/19079.8404; Dol Justine, 2018, JBI Database System Rev Implement Rep, V16, P701, DOI 10.11124/JBISRIR-2017-003535; Egenberg S, 2017, J CLIN NURS, V26, P3174, DOI 10.1111/jocn.13666; Endrich O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170691; Ghosh R, 2019, ARCH DIS CHILDHOOD; Government of India, 2014, RUR HLTH STAT; Hutcheon J.A., 2010, BMJ-BRIT MED J, V340, P1402, DOI DOI 10.1136/BMJ.C2289; Joseph KS, 2007, BJOG-INT J OBSTET GY, V114, P751, DOI 10.1111/j.1471-0528.2007.01316.x; Kamath-Rayne BD, 2015, MATERN CHILD HLTH J, V19, P1853, DOI 10.1007/s10995-015-1699-9; Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2; Kong MY, 2015, COMPUT STAT DATA AN, V85, P54, DOI 10.1016/j.csda.2014.11.014; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lee ACC, 2008, PEDIATRICS, V121, pE1381, DOI 10.1542/peds.2007-1966; Lee ACC, 2013, PEDIATR RES, V74, P50, DOI 10.1038/pr.2013.206; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S12; Lee ACC, 2009, ARCH PEDIAT ADOL MED, V163, P616, DOI 10.1001/archpediatrics.2009.75; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Mduma E, 2015, RESUSCITATION, V93, P1, DOI 10.1016/j.resuscitation.2015.04.019; Ministry of Health and Family Welfare, 2014, INAP IND NEWB ACT PL; Nathan LM, 2016, INT J GYNECOL OBSTET, V134, P350, DOI 10.1016/j.ijgo.2016.01.021; Nelissen E, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1481-7; Nelissen E, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0612-2; Patel A, 2017, EUR J INTEGR MED, V14, P1, DOI 10.1016/j.eujim.2017.08.003; Rajbhandari S, 2010, INT J GYNECOL OBSTET, V108, P282, DOI 10.1016/j.ijgo.2009.11.006; Rakshasbhuvankar AA, 2014, RESUSCITATION, V85, P1320, DOI 10.1016/j.resuscitation.2014.07.005; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Sankar MJ, 2016, J PERINATOL, V36, pS3, DOI 10.1038/jp.2016.183; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Semrau KEA, 2017, NEW ENGL J MED, V377, P2313, DOI 10.1056/NEJMoa1701075; Stead K, 2009, MED J AUSTRALIA, V190, pS128; Tabangin ME, 2018, INT HEALTH, V10, P163, DOI 10.1093/inthealth/ihy017; UN, 2015, MILLENNIUM DEV GOALS; UNICEF, 2017, DESP ACC REC PROGR M; Vail B, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1254-0; Vail B, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1434-1; Walker D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0367-1; Wyckoff MH, 2015, PEDIATRICS, V136, pS196, DOI 10.1542/peds.2015-3373G	50	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0216654	10.1371/journal.pone.0216654	http://dx.doi.org/10.1371/journal.pone.0216654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276503	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000484936300009
J	Hamed, FN; Astrand, A; Bertolini, M; Rossi, A; Maleki-Dizaji, A; Messenger, AG; McDonagh, AJG; Tazi-Ahnini, R				Hamed, Fatma N.; Astrand, Annika; Bertolini, Marta; Rossi, Alfredo; Maleki-Dizaji, Afsaneh; Messenger, Andrew G.; McDonagh, Andrew J. G.; Tazi-Ahnini, Rachid			Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCR beta-chain, which highlights the immunopathological aspect of the disease	PLOS ONE			English	Article							TH17 CELLS; CD39; EXPRESSION; RECOMBINATION; EPIDEMIOLOGY; BIOMARKER; IMBALANCE; CD73	Alopecia areata (AA) is a hair loss disorder resulting from an autoimmune reaction against hair follicles. T-helper 1 cells are a major contributor to this disorder, but little is known about the role of T-regulatory cells (Tregs) in AA. Here, we analysed the distribution of circulating Treg subsets in twenty AA patients with active hair loss and fifteen healthy subjects by flow cytometry. The Treg suppressor HLA-DR+ subpopulation was significantly reduced in the patients (P< 0.001) and there were significantly fewer cells expressing CD39 among the CD4+CD25+Foxp3+ Treg subpopulation in patients (P = 0.001). FOXP3 CD39 Treg cells were also reduced in hair follicles; by 75% in non-lesional skin and 90% in lesional skin, when compared to control healthy skin. To further characterise Treg cells in AA; Tregs (CD4+CD25+FOXP3+) were investigated for their TCR beta sequence. PCR products analysed by Next Generation Sequencing techniques, showed that all frequent public clonotypes in AA Tregs were also present in controls at relatively similar frequencies, excepting two public clonotypes: CATSRDEGGLDEKLFF (V15 D1 J1-4) and CASRDGTGPSNYGYTF (V2 D1 J1-2), which were exclusively present in controls. This suggests that these Treg clonotypes may have a protective effect and that they may be an exciting subject for future therapeutic applications.	[Hamed, Fatma N.; Tazi-Ahnini, Rachid] Univ Sheffield, Sch Med, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England; [Astrand, Annika] AstraZeneca, Resp Inflammat & Autoimmun IMED Biotech Unit, Gothenburg, Sweden; [Bertolini, Marta] Univ Munster, Dept Dermatol, Lab Hair Res & Regenerat Med, Munster, Germany; [Rossi, Alfredo] Univ Manchester, Salford Royal NHS Fdn Trust, Dermatol Ctr, Salford, Lancs, England; [Maleki-Dizaji, Afsaneh; McDonagh, Andrew J. G.] Sheffield Teaching Hosp, Dept Dermatol, Sheffield, S Yorkshire, England; [Messenger, Andrew G.] Royal Hallamshire Hosp, Dept Dermatol, Sheffield, S Yorkshire, England	University of Sheffield; AstraZeneca; University of Munster; Salford Royal NHS Foundation Trust; University of Manchester; University of Sheffield; University of Sheffield	Tazi-Ahnini, R (corresponding author), Univ Sheffield, Sch Med, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England.	r.taziahnini@shef.ac.uk	Messenger, Andrew/J-1240-2019; Rossi, Alfredo/K-1725-2018	Messenger, Andrew/0000-0003-1424-8069; Rossi, Alfredo/0000-0002-7442-3423	AstraZeneca [X/009300]; University of Sheffield [X/009300]; Libyan Ministry of Education [313821 MED]	AstraZeneca(AstraZeneca); University of Sheffield; Libyan Ministry of Education	Financial support was provided under the Contract Research Organization agreement between AstraZeneca and University of Sheffield (no. X/009300 to RT-A). FNH was awarded a studentship (no. 313821 MED) from the Libyan Ministry of Education. Discussion between author AA, AstraZeneca, and author RT-A from University of Sheffield lead to the hypothesis that Tregs, and especially CD39 & CD73, were altered in AA patients. AstraZeneca was thus involved in the design of the study and sponsored with a oneoff payment to cover approximately 50% of consumables associated with the experiments. The funders had no additional role in data collection and analysis, decision to publish, or preparation of the manuscript. Author AA receives salary from AstraZeneca. Authors AM-D receives salary from AF ChemPharm Ltd, author RT-A receives salary from University of Sheffield and authors AGM and AJGM from National Health Services (NHS)/Sheffield Teaching Hospital (STH). The specific roles of these authors are articulated in the 'author contributions.	Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Arden Bernhard, 1995, Immunogenetics, V42, P455; Biran R, 2015, J DERMATOL SCI, V78, P11, DOI 10.1016/j.jdermsci.2015.01.004; Castela E, 2014, JAMA DERMATOL, V150, P748, DOI 10.1001/jamadermatol.2014.504; Chia JSJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/320495; Dainichi T, 2017, J DERMATOL SCI, V86, P3, DOI 10.1016/j.jdermsci.2016.10.004; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Deliyanti D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00751-w; Dwyer KM, 2007, PURINERG SIGNAL, V3, P171, DOI 10.1007/s11302-006-9050-y; Faas MM, 2017, MOL ASPECTS MED, V55, P9, DOI 10.1016/j.mam.2017.01.002; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Grant CR, 2014, HEPATOLOGY, V59, P1007, DOI 10.1002/hep.26583; Han YM, 2015, J DERMATOL, V42, P981, DOI 10.1111/1346-8138.12978; Hong JW, 2017, ANN DERMATOL, V29, P156, DOI 10.5021/ad.2017.29.2.156; Hou XL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002839; Joachims ML, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85609; Lai LS, 2016, TRANSPL IMMUNOL, V39, P34, DOI 10.1016/j.trim.2016.08.006; Laydon DJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0291; Loza MJ, 2011, CELL IMMUNOL, V271, P110, DOI 10.1016/j.cellimm.2011.06.010; Market E, 2003, PLOS BIOL, V1, P24, DOI 10.1371/journal.pbio.0000016; McDonagh AJG, 2002, CLIN EXP DERMATOL, V27, P409, DOI 10.1046/j.1365-2230.2002.01077.x; Nakachi S, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1309-x; Perera E, 2015, CURR PROBL DERMATOL, V47, P67, DOI 10.1159/000369406; Peres RS, 2015, P NATL ACAD SCI USA, V112, P2509, DOI 10.1073/pnas.1424792112; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; Petukhova Lynn, 2013, J Investig Dermatol Symp Proc, V16, pS16, DOI 10.1038/jidsymp.2013.5; Quigley MF, 2010, P NATL ACAD SCI USA, V107, P19414, DOI 10.1073/pnas.1010586107; Rissiek A, 2015, J AUTOIMMUN, V58, P12, DOI 10.1016/j.jaut.2014.12.007; Bono MR, 2015, FEBS LETT, V589, P3454, DOI 10.1016/j.febslet.2015.07.027; Vincent BG, 2010, J IMMUNOL, V184, P4196, DOI 10.4049/jimmunol.0903931; Wang LL, 2013, MOL MED REP, V8, P1432, DOI 10.3892/mmr.2013.1692; Zhang HY, 2015, CLIN EXP DERMATOL, V40, P182, DOI 10.1111/ced.12497	33	17	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0210308	10.1371/journal.pone.0210308	http://dx.doi.org/10.1371/journal.pone.0210308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31277078	Green Published, Green Accepted, gold			2022-12-26	WOS:000484936300003
J	Hou, J; Shi, WD; Sun, JW				Hou, Jie; Shi, Wendong; Sun, Jingwei			Stock Returns, weather, and air conditioning	PLOS ONE			English	Article							MOOD	This study investigates the relationship between stock returns and local weather through a new channel-the influence of the air-cooling system installed in the New York Stock Exchange (NYSE). To our knowledge, we are the first to employ the use of air conditioning to examine whether and how weather, especially excessively high temperature, and other factors affect stock returns. Using data for 1885-1914, we show that lower Dow Jones Average (DJA) returns were significantly associated with hotness before the NYSE trading rooms were equipped with the cooling system in 1903, whereas this correlation is largely weakened afterward. We also find that before the introduction of the air-cooling system, the negative effect of high temperatures on stock returns was stronger when the precipitation was lower. We obtain consistent results when controlling for the calendar anomalies such as the May-to-October effect, the Monday effect, and the effect of macroeconomic conditions.	[Hou, Jie] Capital Univ Econ & Business, Int Sch Econ & Management, Beijing, Peoples R China; [Shi, Wendong] Renmin Univ China, Sch Econ, Beijing, Peoples R China; [Sun, Jingwei] Cent Univ Finance & Econ, Sch Econ, Beijing, Peoples R China	Capital University of Economics & Business; Renmin University of China; Central University of Finance & Economics	Shi, WD (corresponding author), Renmin Univ China, Sch Econ, Beijing, Peoples R China.	wds@bu.edu		Shi, Wendong/0000-0002-1273-7902	National Natural Science Foundation of China (NSFC) [71703177]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Jingwei Sun received funding for this work from the National Natural Science Foundation of China (NSFC) under Grant #71703177. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CA, 1989, PSYCHOL BULL, V106, P74, DOI 10.1037/0033-2909.106.1.74; ARIEL RA, 1990, J FINANC, V45, P1611, DOI 10.2307/2328753; Bouman S, 2002, AM ECON REV, V92, P1618, DOI 10.1257/000282802762024683; Cadsby CB, 1989, REAPPRAISAL EFFICIEN; Cao M, 2009, J BANK FINANC, V29, P1559; Chan SH, 2004, J BUS, V77, P967, DOI 10.1086/422630; Chen HH, 2003, J FINANC, V58, P685, DOI 10.1111/1540-6261.00541; Connolly M, 2008, J LABOR ECON, V26, P73, DOI 10.1086/522067; Damodaran A, 1989, REV FINANC STUD, V2, P607, DOI 10.1093/rfs/2.4.607; Denissen JJA, 2008, EMOTION, V8, P662, DOI 10.1037/a0013497; Hirshleifer D, 2003, J FINANC, V58, P1009, DOI 10.1111/1540-6261.00556; Hong H, 2009, J FINANC MARK, V12, P672, DOI 10.1016/j.finmar.2009.06.001; Jacobsen B, 2008, J BANK FINANC, V32, P526, DOI 10.1016/j.jbankfin.2007.08.004; JAFFE J, 1985, J FINANC, V40, P433, DOI 10.2307/2327894; Kamstra MJ, 2003, AM ECON REV, V93, P324, DOI 10.1257/000282803321455322; Keef S.P., 2007, APPL FINANC EC, V17, P173, DOI DOI 10.1080/09603100600592745; Keller MC, 2005, PSYCHOL SCI, V16, P724, DOI 10.1111/j.1467-9280.2005.01602.x; LAKONISHOK J, 1990, J FINANC, V45, P231, DOI 10.2307/2328818; Levy T, 2012, J BANK FINANC, V36, P1963, DOI 10.1016/j.jbankfin.2012.03.004; ROGALSKI RJ, 1984, J FINANC, V39, P1603, DOI 10.2307/2327747; ROTTON J, 1985, J PERS SOC PSYCHOL, V49, P1207, DOI 10.1037/0022-3514.49.5.1207; SAUNDERS EM, 1993, AM ECON REV, V83, P1337; Schwert GW, 2003, HDB EC FINANCE; Seppanen O., 2006, 5 INT C COLD CLIM HE; Shi J., 2006, MULTINATIONAL FINANC, V10, P81, DOI [10.17578/10-1/2-3, DOI 10.17578/10-1/2-3]; Theissen E., 2007, APPL FINANCIAL EC, V17, P35, DOI [10.1080/09603100600606172, DOI 10.1080/09603100600606172]; Watson D., 2000, MOOD TEMPERATURE; Williamson SH, 2019, DAILY CLOSING VALUE	28	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219439	10.1371/journal.pone.0219439	http://dx.doi.org/10.1371/journal.pone.0219439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4FP	31276541	Green Submitted, Green Published, gold			2022-12-26	WOS:000484936300079
J	Philip, JL; Xu, XY; Han, M; Akhter, SA; Razzaque, A				Philip, Jennifer L.; Xu, Xianyao; Han, Mei; Akhter, Shahab A.; Razzaque, Abdur			Regulation of cardiac fibroblast-mediated maladaptive ventricular remodeling by beta-arrestins	PLOS ONE			English	Article							COLLAGEN-SYNTHESIS; HEART-FAILURE; MYOFIBROBLAST DIFFERENTIATION; INHIBITION; CARDIOMYOPATHY; ACTIVATION; INFARCTION; TARGET	Cardiac fibroblasts (CF) play a critical role in post-infarction remodeling which can ultimately lead to pathological fibrosis and heart failure. Recent evidence demonstrates that remote (non-infarct) territory fibrosis is a major mechanism for ventricular dysfunction and arrhythmogenesis. beta-arrestins are important signaling molecules involved in beta-adrenergic receptor (beta-AR) desensitization and can also mediate signaling in a G protein independent fashion. Recent work has provided evidence that beta-arrestin signaling in the heart may be beneficial, however, these studies have primarily focused on cardiac myocytes and their role in adult CF biology has not been well studied. In this study, we show that beta-arrestins can regulate CF biology and contribute to pathological fibrosis. Adult male rats underwent LAD ligation to induce infarction and were studied by echocardiography. There was a significant decline in LV function at 2-12 weeks post-MI with increased infarct and remote territory fibrosis by histology consistent with maladaptive remodeling. Collagen synthesis was upregulated 2.9-fold in CF isolated at 8 and 12 weeks post-MI and beta-arrestin expression was significantly increased. beta-adrenergic signaling was uncoupled in the post-MI CF and beta-agonist-mediated inhibition of collagen synthesis was lost. Knockdown of beta-arrestin1 or 2 in the post-MI CF inhibited transformation to myofibroblasts as well as basal and TGF-beta-stimulated collagen synthesis. These data suggest that beta-arrestins can regulate CF biology and that targeted inhibition of these signaling molecules may represent a novel approach to prevent postinfarction pathological fibrosis and the transition to HF.	[Philip, Jennifer L.; Xu, Xianyao; Han, Mei; Akhter, Shahab A.; Razzaque, Abdur] Univ Wisconsin, Dept Surg, Div Cardiothorac Surg, Sch Med & Publ Hlth, 600 Highland Ave, Madison, WI 53706 USA; [Philip, Jennifer L.; Xu, Xianyao; Han, Mei; Akhter, Shahab A.] Univ Chicago, Med Ctr, Dept Surg, Sect Cardiac & Thorac Surg, Chicago, IL 60637 USA; [Akhter, Shahab A.] East Carolina Univ, Dept Cardiovasc Sci, East Carolina Heart Inst, Greenville, NC 27858 USA; [Razzaque, Abdur] Louisiana State Univ, Dept Surg, New Orleans, LA 70112 USA; [Razzaque, Abdur] Louisiana State Univ, Cardiovasc Ctr Excellence, New Orleans, LA 70112 USA	University of Wisconsin System; University of Wisconsin Madison; University of Chicago; University of Chicago Medical Center; University of North Carolina; East Carolina University; Louisiana State University System; Louisiana State University System	Razzaque, A (corresponding author), Univ Wisconsin, Dept Surg, Div Cardiothorac Surg, Sch Med & Publ Hlth, 600 Highland Ave, Madison, WI 53706 USA.; Razzaque, A (corresponding author), Louisiana State Univ, Dept Surg, New Orleans, LA 70112 USA.; Razzaque, A (corresponding author), Louisiana State Univ, Cardiovasc Ctr Excellence, New Orleans, LA 70112 USA.	arazza@lsuhsc.edu		Razzaque, Md Abdur/0000-0002-5932-3432	Howard Hughes Medical Institute Medical Research Fellowship; National Institutes of Health [HL107949]	Howard Hughes Medical Institute Medical Research Fellowship(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in part, by a Howard Hughes Medical Institute Medical Research Fellowship (to JLP) and the National Institutes of Health (HL107949 to SAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bathgate-Siryk A, 2014, HYPERTENSION, V63, P404, DOI 10.1161/HYPERTENSIONAHA.113.02043; BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Cleutjens JPM, 1999, CARDIOVASC RES, V44, P232, DOI 10.1016/S0008-6363(99)00212-6; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Gustafsson AB, 2000, MOL PHARMACOL, V58, P1470, DOI 10.1124/mol.58.6.1470; Imamura T, 2001, J BIOL CHEM, V276, P43663, DOI 10.1074/jbc.M105364200; Katz AM, 1995, EUR HEART J, V16, P110, DOI 10.1093/eurheartj/16.suppl_O.110; Kim IM, 2008, P NATL ACAD SCI USA, V105, P14555, DOI 10.1073/pnas.0804745105; Li JJ, 2014, J MOL CELL CARDIOL, V76, P73, DOI 10.1016/j.yjmcc.2014.08.006; Liu XQ, 2006, MOL PHARMACOL, V70, P1992, DOI 10.1124/mol.106.028951; LOVGREN AK, 2011, SCI TRANSL MED, V3, DOI DOI 10.1016/J.YJMCC.2008.11.015; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Meszaros JG, 2000, AM J PHYSIOL-CELL PH, V278, pC154, DOI 10.1152/ajpcell.2000.278.1.C154; Naugle JE, 2006, AM J PHYSIOL-HEART C, V290, pH323, DOI 10.1152/ajpheart.00321.2005; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Olsen Anne-Marie Schjerning, CIRCULATION, V126, P1955, DOI [10.1161/CIRCULATIONAHA.112.112607, DOI 10.1161/CIRCULATIONAHA.107.653576, DOI 10.1161/CIRCULATI0NAHA.107.187998]; Olson ER, 2005, AM J PHYSIOL-HEART C, V288, pH1131, DOI 10.1152/ajpheart.00763.2004; Pan ZW, 2012, CIRCULATION, V126, P840, DOI 10.1161/CIRCULATIONAHA.112.094524; Patel PA, 2008, CIRC J, V72, P1725, DOI 10.1253/circj.CJ-08-0734; Patel PA, 2009, J MOL CELL CARDIOL, V46, P300, DOI 10.1016/j.yjmcc.2008.11.015; Pleger ST, 2005, MOL THER, V12, P1120, DOI 10.1016/j.ymthe.2005.08.002; Pleger ST, 2007, CIRCULATION, V115, P2506, DOI 10.1161/CIRCULATIONAHA.106.671701; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Swaney JS, 2007, AM J PHYSIOL-HEART C, V293, pH3216, DOI 10.1152/ajpheart.00739.2007; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Theilade J, 2003, BASIC RES CARDIOL, V98, P97, DOI 10.1007/s00395-003-0395-x; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105; Zhao Meng, CIRCULATION, V144, P210, DOI [DOI 10.1161/CIRCULATI0NAHA.107.187998, 10.1161/circulationaha.120.049497, DOI 10.1161/CIRCULATIONAHA.120.049497]	33	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219011	10.1371/journal.pone.0219011	http://dx.doi.org/10.1371/journal.pone.0219011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269046	Green Published, Green Submitted, gold			2022-12-26	WOS:000484927300037
J	Ramenzoni, LL; Russo, G; Moccia, MD; Attin, T; Schmidlin, PR				Ramenzoni, Liza L.; Russo, Giancarlo; Moccia, Maria D.; Attin, Thomas; Schmidlin, Patrick R.			Periodontal bacterial supernatants modify differentiation, migration and inflammatory cytokine expression in human periodontal ligament stem cells	PLOS ONE			English	Article							HUMAN GINGIVAL FIBROBLASTS; PORPHYROMONAS-GINGIVALIS; PROGENITOR CELLS; IMMUNOBIOLOGICAL ACTIVITIES; LIPOPOLYSACCHARIDE; PROTEASE; ACTIVATION; LPS	Periodontal ligament stem cells (PDLSC) play an important role in periodontal tissue homeostasis/turnover and could be applied in cell-based periodontal regenerative therapy. Bacterial supernatants secreted from diverse periodontal bacteria induce the production of cytokines that contribute to local periodontal tissue destruction. However, little is known about the impact of whole bacterial toxins on the biological behavior of PDLSC. Therefore this study investigated whether proliferation, migration, inflammatory cytokines expression and transcriptional profile would be affected by exposure to endotoxins from bacterial species found in the subgingival plaque. PDLSC were cultured with the following bacterial supernatants: S. mutans, S. anginosus, P. intermedia, F. nucleatum, P. gingivalis and T. denticola. These supernatants were prepared in dilutions of 1:1000, 1:500, 1:300 and 1:50. Using quantitative RT-PCR, gene expression of selected inflammatory cytokines (IL-6, IL-8 and IL-1 beta) and cell-surface receptors (TLR2, TLR4) showed upregulation of approximate to 2.0- to 3.0-fold, when exposed to P. intermedia, F. nucleatum, P. gingivalis and T. denticola. However, supernatants did not affect proliferation (MTT) and migration (wound scratch assays) of PDLSC. Next generation RNA sequencing confirmed modified lineage commitment of PDLSC by stimulating chondrogenesis, adipogenesis and inhibition of osteogenesis under P. gingivalis supernatant treatment compared to control. Taken together, this study shows stem cell immunomodulatory response to different periodontal bacteria supernatant and suggests that stem cell transcriptional capacity, migration/proliferation and osteogenesis may differ in the presence of those pathogens. These results bring into question stem cell contribution to periodontal tissue regeneration and onset of inflammation.	[Ramenzoni, Liza L.; Attin, Thomas; Schmidlin, Patrick R.] Univ Zurich, Clin Conservat & Prevent Dent, Ctr Dent Med, Zurich, Switzerland; [Ramenzoni, Liza L.; Schmidlin, Patrick R.] Univ Zurich, Ctr Dent Med, Lab Appl Periodontal & Peri Implantitis Sci, Clin Conservat & Prevent Dent, Zurich, Switzerland; [Russo, Giancarlo; Moccia, Maria D.] Univ Zurich, Funct Genom Ctr Zurich, ETH, Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Schmidlin, PR (corresponding author), Univ Zurich, Clin Conservat & Prevent Dent, Ctr Dent Med, Zurich, Switzerland.; Schmidlin, PR (corresponding author), Univ Zurich, Ctr Dent Med, Lab Appl Periodontal & Peri Implantitis Sci, Clin Conservat & Prevent Dent, Zurich, Switzerland.	patrick.schmidlin@zzm.uzh.ch	Attin, Thomas/ABF-9246-2020; Russo, Giancarlo/GQY-5601-2022	Attin, Thomas/0000-0002-6141-1263; Ramenzoni, Liza L./0000-0002-7732-2118				Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Albiero ML, 2015, J APPL ORAL SCI, V23, P145, DOI 10.1590/1678-775720140334; Andrukhov O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160848; Bandow K, 2010, BIOCHEM BIOPH RES CO, V402, P755, DOI 10.1016/j.bbrc.2010.10.103; Bassir SH, 2016, J CELL PHYSIOL, V231, P50, DOI 10.1002/jcp.25067; Bostanci N, 2007, CYTOKINE, V39, P147, DOI 10.1016/j.cyto.2007.07.002; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Caron MMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033467; Chatzivasileiou K, 2015, J CELL MOL MED, V19, P2067, DOI 10.1111/jcmm.12613; Chatzivasileiou K, 2013, J CELL MOL MED, V17, P766, DOI 10.1111/jcmm.12058; Chen H, 2016, J NEW MAT ELECTR SYS, V19, P7, DOI 10.14447/jnmes.v19i1.340; Choi S, 2013, INT J ORAL SCI, V5, P7, DOI 10.1038/ijos.2013.19; Fagundes JAG, 2011, J PERIODONTOL, V82, P1596, DOI 10.1902/jop.2011.110073; Feng XM, 2013, CELL BIOL INT, V37, P1267, DOI 10.1002/cbin.10141; Graves Dana T, 2011, J Oral Microbiol, V3, DOI 10.3402/jom.v3i0.5304; Hajishengallis G, 2007, J IMMUNOL, V179, P2359, DOI 10.4049/jimmunol.179.4.2359; Holzhausen M, 2010, J DENT RES, V89, P948, DOI 10.1177/0022034510373765; Iwasaki K, 2013, J PERIODONTOL, V84, P1425, DOI 10.1902/jop.2012.120547; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jonsson D, 2011, J PERIODONTAL RES, V46, P153, DOI 10.1111/j.1600-0765.2010.01331.x; Kato H, 2014, ARCH ORAL BIOL, V59, P167, DOI 10.1016/j.archoralbio.2013.11.008; Kimura H, 2013, CELL PHYSIOL BIOCHEM, V32, P899, DOI 10.1159/000354493; Konermann A, 2012, INNATE IMMUN-LONDON, V18, P745, DOI 10.1177/1753425912440598; Kukolj T, 2018, J CELL PHYSIOL, V233, P447, DOI 10.1002/jcp.25904; Li CH, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt456; Liu Y, 2008, STEM CELLS, V26, P1065, DOI 10.1634/stemcells.2007-0734; Lourbakos A, 2001, INFECT IMMUN, V69, P5121, DOI 10.1128/IAI.69.8.5121-5130.2001; Mao JJ, 2012, CELL STEM CELL, V11, P291, DOI 10.1016/j.stem.2012.08.010; MATSUSHITA K, 1994, INFECT IMMUN, V62, P2459, DOI 10.1128/IAI.62.6.2459-2469.1994; Mo IFY, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-52; Nagatomo K, 2006, J PERIODONTAL RES, V41, P303, DOI 10.1111/j.1600-0765.2006.00870.x; OGAWA T, 1991, BIOCHEM BIOPH RES CO, V180, P1335, DOI 10.1016/S0006-291X(05)81342-7; Oido-Mori M, 2001, INFECT IMMUN, V69, P4493, DOI 10.1128/IAI.69.7.4493-4501.2001; Page RC, 1997, PERIODONTOL 2000, V14, P9, DOI 10.1111/j.1600-0757.1997.tb00189.x; Park JH, 2011, INT J MOL MED, V27, P277, DOI 10.3892/ijmm.2010.568; Ramenzoni LL, 2019, MOL CELL BIOCHEM, V452, P17, DOI 10.1007/s11010-018-3408-7; REDDI K, 1995, FEMS IMMUNOL MED MIC, V11, P137, DOI 10.1016/0928-8244(95)00017-2; Rosen G, 1999, INFECT IMMUN, V67, P1180, DOI 10.1128/IAI.67.3.1180-1186.1999; Seo T, 2012, J MICROBIOL, V50, P311, DOI 10.1007/s12275-012-2146-x; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Tang HN, 2016, J CLIN PERIODONTOL, V43, P72, DOI 10.1111/jcpe.12501; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Tsumanuma Y, 2011, BIOMATERIALS, V32, P5819, DOI 10.1016/j.biomaterials.2011.04.071; Wada N, 2009, J CELL PHYSIOL, V219, P667, DOI 10.1002/jcp.21710; Wilson Michael, 1995, Science Progress, V78, P19; Yamanaka T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-228; Yin L, 2010, J ORAL MICROBIOL, V4, P2; Zhu WJ, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/972313	48	14	15	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219181	10.1371/journal.pone.0219181	http://dx.doi.org/10.1371/journal.pone.0219181			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269072	Green Published, Green Submitted, gold			2022-12-26	WOS:000484927300050
J	Hua, ZH; Early, MJ				Hua, Zhihua; Early, Matthew J.			Closing target trimming and CTTdocker programs for discovering hidden superfamily loci in genomes	PLOS ONE			English	Article							GENE FAMILY; EVOLUTION; PROTEIN; DUPLICATION; UBIQUITIN; EXPANSION; PLANTS	The contemporary capacity of genome sequence analysis significantly lags behind the rapidly evolving sequencing technologies. Retrieving biological meaningful information from an ever-increasing amount of genome data would be significantly beneficial for functional genomic studies. For example, the duplication, organization, evolution, and function of superfamily genes are arguably important in many aspects of life. However, the incompleteness of annotations in many sequenced genomes often results in biased conclusions in comparative genomic studies of superfamilies. Here, we present a Perl software, called Closing Target Trimming (CTT), for automatically identifying most, if not all, members of a gene family in any sequenced genomes on CentOS 7 platform. To benefit a broader application on other operating systems, we also created a Docker application package, CTTdocker. Our test data on the F-box gene superfamily showed 78.2 and 79% gene finding accuracies in two well annotated plant genomes, Arabidopsis thaliana and rice, respectively. To further demonstrate the effectiveness of this program, we ran it through 18 plant genomes and five non-plant genomes to compare the expansion of the F-box and the BTB superfamilies. The program discovered that on average 12.7 and 9.3% of the total F-box and BTB members, respectively, are new loci in plant genomes, while it only found a small number of new members in vertebrate genomes. Therefore, different evolutionary and regulatory mechanisms of Cullin-RING ubiquitin ligases may be present in plants and animals. We also annotated and compared the Pkinase family members across a wide range of organisms, including 10 fungi, 10 metazoa, 10 vertebrates, and 10 additional plants, which were randomly selected from the Ensembl database. Our CTT annotation recovered on average 14% more loci, including pseudogenes, of the Pkinase superfamily in these 40 genomes, demonstrating its robust replicability and scalability in annotating superfamiy members in any genomes.	[Hua, Zhihua; Early, Matthew J.] Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA; [Hua, Zhihua] Ohio Univ, Interdisciplinary Program Mol & Cellular Biol, Athens, OH 45701 USA; [Early, Matthew J.] Ohio Univ, Dept Elect Engn & Comp Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Hua, ZH (corresponding author), Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA.; Hua, ZH (corresponding author), Ohio Univ, Interdisciplinary Program Mol & Cellular Biol, Athens, OH 45701 USA.	hua@ohio.edu	Hua, Zhihua/AAD-1146-2021		National Science Foundation CAREER award [MCB1750361]; Ohio University Program to Aid Career Exploration (PACE) fund [ZH9299110]	National Science Foundation CAREER award(National Science Foundation (NSF)); Ohio University Program to Aid Career Exploration (PACE) fund	This work was supported by a National Science Foundation CAREER award (MCB1750361 to ZH) and Ohio University Program to Aid Career Exploration (PACE) fund (ZH9299110 to ZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Behr J, 2010, BMC BIOINFORMATI S10, V11; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Coghlan A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-549; Conant GC, 2014, CURR OPIN PLANT BIOL, V19, P91, DOI 10.1016/j.pbi.2014.05.008; Force A, 1999, GENETICS, V151, P1531; Gingerich DJ, 2007, PLANT CELL, V19, P2329, DOI 10.1105/tpc.107.051300; Guigo R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s2; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hua Z., 2019, PROTOCOLSIO, DOI [10.17504/protocols.io.zf4f3qw, DOI 10.17504/PROTOCOLS.IO.ZF4F3QW]; Hua ZH, 2018, PLANT J, V95, P296, DOI 10.1111/tpj.13951; Hua ZH, 2013, P NATL ACAD SCI USA, V110, P16927, DOI 10.1073/pnas.1316009110; Hua ZH, 2011, ANNU REV PLANT BIOL, V62, P299, DOI 10.1146/annurev-arplant-042809-112256; Hua ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016219; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lewin HA, 2018, P NATL ACAD SCI USA, V115, P4325, DOI 10.1073/pnas.1720115115; Li W.-H., 1983, P14; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li Z, 2016, PLANT CELL, V28, P326, DOI 10.1105/tpc.15.00877; Marone D, 2013, INT J MOL SCI, V14, P7302, DOI 10.3390/ijms14047302; Mathe C, 2002, NUCLEIC ACIDS RES, V30, P4103, DOI 10.1093/nar/gkf543; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Ohno S., 1970, EVOLUTION GENE DUPLI; Panchy N, 2016, PLANT PHYSIOL, V171, P2294, DOI 10.1104/pp.16.00523; Schweikert G, 2009, GENOME RES, V19, P2133, DOI 10.1101/gr.090597.108; Shiu SH, 2005, PLANT PHYSIOL, V139, P18, DOI 10.1104/pp.105.065110; van Dijk EL, 2018, TRENDS GENET, V34, P666, DOI 10.1016/j.tig.2018.05.008; Yang XH, 2008, PLANT PHYSIOL, V148, P1189, DOI 10.1104/pp.108.121921; Zou C, 2009, PLANT PHYSIOL, V151, P3, DOI 10.1104/pp.109.140632	32	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2019	14	7							e0209468	10.1371/journal.pone.0209468	http://dx.doi.org/10.1371/journal.pone.0209468			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3ZV	31265455	Green Published, Green Submitted, gold			2022-12-26	WOS:000484921200001
J	Ying, G; Wang, J; Mallevaey, T; Van Calenbergh, S; Zajonc, DM				Ying, Ge; Wang, Jing; Mallevaey, Thierry; Van Calenbergh, Serge; Zajonc, Dirk M.			Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycolipid; antigen presentation; major histocompatibility complex (MHC); T-cell receptor (TCR); antibody; cellular immune response; 1B1 Fab; immune signaling; natural killer T-cell activation	RECOMBINANT ANTIBODIES; ALPHA-GALACTOSYLCERAMIDE; ANTIGEN PRESENTATION; HUMAN CD1D; RECOGNITION; COMPLEX; GLYCOLIPIDS; SPECIFICITY; TOOLS; POPULATION	Natural killer T (NKT) cells are a subset of T lymphocytes that recognize glycolipid antigens presented by the CD1d molecule (CD1d). They rapidly respond to antigen challenge and can activate both innate and adaptive immune cells. To study the role of antigen presentation in NKT cell activation, previous studies have developed several anti-CD1d antibodies that block CD1d binding to T-cell receptors (TCRs). Antibodies that are specific to both CD1d and the presented antigen can only be used to study the function of only a limited number of antigens. In contrast, antibodies that bind CD1d and block TCR binding regardless of the presented antigen can be widely used to assess the role of TCR-mediated NKT cell activation in various disease models. Here, we report the crystal structure of the widely used anti-mouse CD1d antibody 1B1 bound to CD1d at a resolution of 2.45 angstrom and characterized its binding to CD1d-presented glycolipids. We observed that 1B1 uses a long hydrophobic H3 loop that is inserted deep into the binding groove of CD1d where it makes intimate nonpolar contacts with the lipid backbone of an incorporated spacer lipid. Using an NKT cell agonist that has a modified sphingosine moiety, we further demonstrate that 1B1 in its monovalent form cannot block TCR-mediated NKT cell activation, because 1B1 fails to bind with high affinity to mCD1d. Our results suggest potential limitations of using 1B1 to assess antigen recognition by NKT cells, especially when investigating antigens that do not follow the canonical two alkyl-chain rule.	[Ying, Ge; Wang, Jing; Zajonc, Dirk M.] La Jolla Inst Immunol, Div Immune Regulat, La Jolla, CA 92037 USA; [Mallevaey, Thierry] Univ Toronto, Dept Immunol, Toronto, ON M5S 3G9, Canada; [Mallevaey, Thierry] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Van Calenbergh, Serge] Univ Ghent, Fac Pharmaceut Sci, Lab Med Chem FFW, B-9000 Ghent, Belgium; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; University of Toronto; University of Toronto; Ghent University; Ghent University	Zajonc, DM (corresponding author), Pfizer, Canc Immunol Discovery, San Diego, CA 92121 USA.	Dirk.Zajonc@pfizer.com	Mallevaey, Thierry/AAH-4499-2020	Zajonc, Dirk/0000-0001-7215-1981	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI137230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and National Institutes of Health, NIGMS Grant P41GM103393.	Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Blomqvist M, 2009, EUR J IMMUNOL, V39, P1726, DOI 10.1002/eji.200839001; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brady JL, 2006, J IMMUNOL METHODS, V315, P61, DOI 10.1016/j.jim.2006.07.002; Brossay L, 1997, J IMMUNOL, V159, P1216; Cohen CJ, 2003, J MOL RECOGNIT, V16, P324, DOI 10.1002/jmr.640; Dahan R, 2011, EUR J IMMUNOL, V41, P1465, DOI 10.1002/eji.201041241; Denkberg G, 2008, EUR J IMMUNOL, V38, P829, DOI 10.1002/eji.200737518; Denkberg G, 2006, AUTOIMMUN REV, V5, P252, DOI 10.1016/j.autrev.2005.07.004; Dieude M, 2011, J IMMUNOL, V186, P4771, DOI 10.4049/jimmunol.1000921; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Florence WC, 2009, EMBO J, V28, P3781, DOI 10.1038/emboj.2009.348; Gilliland LK, 1996, TISSUE ANTIGENS, V47, P1, DOI 10.1111/j.1399-0039.1996.tb02509.x; Girardi E, 2016, J BIOL CHEM, V291, P10677, DOI 10.1074/jbc.M115.702118; Girardi E, 2012, IMMUNOL REV, V250, P167, DOI 10.1111/j.1600-065X.2012.01166.x; Girardi E, 2012, NAT IMMUNOL, V13, P851, DOI 10.1038/ni.2371; Girardi E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001189; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Guillaume J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04461-7; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Hava DL, 2005, CURR OPIN IMMUNOL, V17, P88, DOI 10.1016/j.coi.2004.12.003; Ito Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078191; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Le Nours J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10570; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mareeva T, 2008, J BIOL CHEM, V283, P29053, DOI 10.1074/jbc.M804996200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel O, 2012, NAT IMMUNOL, V13, P857, DOI 10.1038/ni.2372; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Stewart-Jones G, 2009, P NATL ACAD SCI USA, V106, P5784, DOI 10.1073/pnas.0901425106; Tatituri RVV, 2013, P NATL ACAD SCI USA, V110, P1827, DOI 10.1073/pnas.1220601110; Uldrich AP, 2011, NAT IMMUNOL, V12, P616, DOI 10.1038/ni.2051; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047989; Wang J, 2010, P NATL ACAD SCI USA, V107, P1535, DOI 10.1073/pnas.0909479107; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Ying G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182296; Yu ED, 2012, J BIOL CHEM, V287, P1269, DOI 10.1074/jbc.M111.308783; Yu KOA, 2007, J IMMUNOL METHODS, V323, P11, DOI 10.1016/j.jim.2007.03.006; Zajonc DM, 2008, J MOL BIOL, V377, P1104, DOI 10.1016/j.jmb.2008.01.061; Zajonc DM, 2016, IMMUNOGENETICS, V68, P561, DOI 10.1007/s00251-016-0931-0; Zajonc DM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00400; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625	58	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12947	12956		10.1074/jbc.RA119.009403	http://dx.doi.org/10.1074/jbc.RA119.009403			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296659	hybrid, Green Published			2022-12-26	WOS:000486416000008
J	Wang, Y; Mack, JA; Maytin, EV				Wang, Yan; Mack, Judith A.; Maytin, Edward, V			CD44 inhibits alpha-SMA gene expression via a novel G-actin/MRTF-mediated pathway that intersects with TGF beta R/p38MAPK signaling in murine skin fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myofibroblast; CD44; actin; myocardin; p38MAPK; transforming growth factor beta (TGF-B); cytoskeleton; TGF beta R; smooth muscle actin; MRTF	HYALURONAN-CD44 INTERACTION; MYOFIBROBLAST DIFFERENTIATION; CELL-ADHESION; NUCLEAR TRANSLOCATION; TRANSCRIPTION FACTOR; UP-REGULATION; MRTF-A; ACTIVATION; GROWTH; RECEPTOR	Well-regulated differentiation of fibroblasts into myofibroblasts (MF) is critical for skin wound healing. Neoexpression of alpha-smooth muscle actin (alpha-SMA), an established marker for MF differentiation, is driven by TGF beta receptor (TGF beta R)-mediated signaling. Hyaluronan (HA) and its receptor CD44 may also participate in this process. To further understand this process, primary mouse skin fibroblasts were isolated and treated in vitro with recombinant TGF-beta 1 (rTGF-beta 1) to induce alpha-SMA expression. CD44 expression was also increased. Paradoxically, CD44 knockdown by RNA interference (RNAi) led to increased alpha-SMA expression and alpha-SMA-containing stress fibers. Removal of extracellular HA or inhibition of HA synthesis had no effect on alpha-SMA levels, suggesting a dispensable role for HA. Exploration of mechanisms linking CD44 knockdown to alpha-SMA induction, using RNAi and chemical inhibitors, revealed a requirement for noncanonical TGF beta R signaling through p38MAPK. Decreased monomeric G-actin but increased filamentous F-actin following CD44 RNAi suggested a possible role for myocardin-related transcription factor (MRTF), a known regulator of alpha-SMA transcription and itself regulated by G-actin binding. CD44 RNAi promoted nuclear accumulation of MRTF and the binding to its transcriptional cofactor SRF. MRTF knockdown abrogated the increased alpha-SMA expression caused by CD44 RNAi, suggesting that MRTF is required for CD44-mediated regulation of alpha-SMA. Finally, chemical inhibition of p38MAPK reversed nuclear MRTF accumulation after rTGF-beta 1 addition or CD44 RNAi, revealing a central involvement of p38MAPK in both cases. We concluded that CD44 regulates alpha-SMA gene expression through cooperation between two intersecting signaling pathways, one mediated by G-actin/MRTF and the other via TGF beta R/p38MAPK.	[Wang, Yan; Mack, Judith A.; Maytin, Edward, V] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Mack, Judith A.; Maytin, Edward, V] Cleveland Clin, Dermatol & Plast Surg Inst, Dept Dermatol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Maytin, EV (corresponding author), Mailstop ND-20,9500 Euclid Ave, Cleveland, OH 44195 USA.	maytine@ccf.org			National Institutes of Health [P01 HL107147, NIH1K12HL141952, S10OD019972]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL141952, P01HL107147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants P01 HL107147, NIH1K12HL141952, and S10OD019972. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afify A, 2009, EXP MOL PATHOL, V86, P95, DOI 10.1016/j.yexmp.2008.12.003; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Andrews JP, 2016, MATRIX BIOL, V51, P37, DOI 10.1016/j.matbio.2016.01.013; Ansorge HL, 2009, J ORTHOP RES, V27, P1386, DOI 10.1002/jor.20891; Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2007, J BIOL CHEM, V282, P1265, DOI 10.1074/jbc.M604672200; Bourguignon LYW, 2006, J INVEST DERMATOL, V126, P1356, DOI 10.1038/sj.jid.5700260; Bourguignon LYW, 2014, AM J PATHOL, V184, P1912, DOI 10.1016/j.ajpath.2014.03.010; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P29654, DOI 10.1074/jbc.M403608200; BROWN TA, 1991, J CELL BIOL, V113, P207, DOI 10.1083/jcb.113.1.207; Busche S, 2008, J CELL SCI, V121, P1025, DOI 10.1242/jcs.014456; Crider BJ, 2011, J INVEST DERMATOL, V131, P2378, DOI 10.1038/jid.2011.219; Ebrahimi Hedyeh, 2016, Middle East J Dig Dis, V8, P166; Evanko SP, 2015, MATRIX BIOL, V42, P74, DOI 10.1016/j.matbio.2014.12.001; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gasparics A, 2018, DEV DYNAM, V247, P396, DOI 10.1002/dvdy.24544; Ghatak S, 2017, J BIOL CHEM, V292, P10465, DOI 10.1074/jbc.M116.752451; Govindaraju P, 2019, MATRIX BIOL, V75-76, P314, DOI 10.1016/j.matbio.2018.06.004; Hinz B, 2016, CURR RES TRANSL MED, V64, P171, DOI 10.1016/j.retram.2016.09.003; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2016, EXP EYE RES, V142, P56, DOI 10.1016/j.exer.2015.07.009; Jordan AR, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00182; Kim SI, 2012, KIDNEY RES CLIN PRAC, V31, P94, DOI 10.1016/j.krcp.2012.04.322; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; Konopka A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155053; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lederer DJ, 2018, NEW ENGL J MED, V378, P1811, DOI 10.1056/NEJMra1705751; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Luchsinger LL, 2011, J BIOL CHEM, V286, P44116, DOI 10.1074/jbc.M111.276931; Mack CP, 2005, J THROMB HAEMOST, V3, P1976, DOI 10.1111/j.1538-7836.2005.01316.x; Maytin EV, 2016, GLYCOBIOLOGY, V26, P553, DOI 10.1093/glycob/cww033; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; MERZAK A, 1994, CANCER RES, V54, P3988; Meyer-ter-Vehn T, 2011, INVEST OPHTH VIS SCI, V52, P9149, DOI 10.1167/iovs.10-6679; Midgley AC, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aao1822; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Molkentin JD, 2017, CIRCULATION, V136, P549, DOI 10.1161/CIRCULATIONAHA.116.026238; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Orian-Rousseau V, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00154; Passi A, 2004, EXP CELL RES, V296, P123, DOI 10.1016/j.yexer.2004.01.031; Penn JW, 2012, INT J BURNS TRAUMA, V2, P18; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Porsch H, 2014, J BIOL CHEM, V289, P19747, DOI 10.1074/jbc.M114.547273; Ronkina N, 2016, SCI REP-UK, V6, DOI 10.1038/srep31219; Roszkowska M, 2016, MOL BIOL CELL, V27, P4055, DOI 10.1091/mbc.E16-06-0423; Schmitt M, 2015, CELL DEATH DIFFER, V22, P677, DOI 10.1038/cdd.2014.156; Sebe A, 2008, FEBS LETT, V582, P291, DOI 10.1016/j.febslet.2007.12.021; Shatirishvili M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.342; SHIMIZU Y, 1989, J IMMUNOL, V143, P2457; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Small EM, 2012, J CARDIOVASC TRANSL, V5, P794, DOI 10.1007/s12265-012-9397-0; Stambe C, 2004, J AM SOC NEPHROL, V15, P326, DOI 10.1097/01.ASN.0000108520.63445.E0; Strauch Arthur Roger, 2013, Biology (Basel), V2, P555, DOI 10.3390/biology2020555; Stunova A, 2018, CYTOKINE GROWTH F R, V39, P137, DOI 10.1016/j.cytogfr.2018.01.003; Tammi RH, 2009, J INVEST DERMATOL, V129, P1858, DOI 10.1038/jid.2009.91; van Caam A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02452; Velasco J, 2011, J BIOL CHEM, V286, P26016, DOI 10.1074/jbc.M110.208694; Velasquez LS, 2013, P NATL ACAD SCI USA, V110, P16850, DOI 10.1073/pnas.1316764110; Wang Y, 2014, J BIOL CHEM, V289, P32253, DOI 10.1074/jbc.M114.578377; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Xu SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126015; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zhang P, 2014, FASEB J, V28, P4591, DOI 10.1096/fj.11-202747; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	75	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12779	12794		10.1074/jbc.RA119.007834	http://dx.doi.org/10.1074/jbc.RA119.007834			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31285260	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000484414600019
J	Zhang, C; Stockwell, SR; Elbanna, M; Ketteler, R; Freeman, J; Al-Lazikani, B; Eccles, S; Brandon, AS; Raynaud, F; Hayes, A; Clarke, PA; Workman, P; Mittnacht, S				Zhang, Chi; Stockwell, Simon R.; Elbanna, May; Ketteler, Robin; Freeman, Jamie; Al-Lazikani, Bissan; Eccles, Suzanne; Brandon, Alexis De Haven; Raynaud, Florence; Hayes, Angela; Clarke, Paul A.; Workman, Paul; Mittnacht, Sibylle			Signalling involving MET and FAK supports cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases	ONCOGENE			English	Article							ACQUIRED-RESISTANCE; DEPENDENT KINASES; CANCER; COMBINATION; INHIBITION; PROTEIN; ARREST; PHOSPHORYLATION; MECHANISMS; RECEPTOR	Deregulation of cyclin-dependent kinases 4 and 6 (CDK4/6) is highly prevalent in cancer; yet, inhibitors against these kinases are currently used only in restricted tumour contexts. The extent to which cancers depend on CDK4/6 and the mechanisms that may undermine such dependency are poorly understood. Here, we report that signalling engaging the MET proto-oncogene receptor tyrosine kinase/focal adhesion kinase (FAK) axis leads to CDK4/6-independent CDK2 activation, involving as critical mechanistic events loss of the CDKI p21(CIP1) and gain of its regulator, the ubiquitin ligase subunit SKP2. Combined inhibition of MET/FAK and CDK4/6 eliminates the proliferation capacity of cancer cells in culture, and enhances tumour growth inhibition in vivo. Activation of the MET/FAK axis is known to arise through cancer extrinsic and intrinsic cues. Our work predicts that such cues support cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases and identifies MET/FAK as a tractable route to broaden the utility of CDK4/6 inhibitor-based therapies in the clinic.	[Zhang, Chi; Stockwell, Simon R.; Elbanna, May; Mittnacht, Sibylle] UCL, UCL Canc Inst, London WC1E 6DD, England; [Zhang, Chi; Al-Lazikani, Bissan; Eccles, Suzanne; Brandon, Alexis De Haven; Raynaud, Florence; Hayes, Angela; Clarke, Paul A.; Workman, Paul] Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SM2 5NG, England; [Ketteler, Robin; Freeman, Jamie] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England	University of London; University College London; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; MRC Laboratory Molecular Biology; University of London; University College London	Mittnacht, S (corresponding author), UCL, UCL Canc Inst, London WC1E 6DD, England.; Workman, P (corresponding author), Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SM2 5NG, England.	paul.workman@icr.ac.uk; s.mittnacht@cancer.ucl.ac.uk	Al-Lazikani, Bissan/AAG-4723-2022; Elbanna, May/ABC-3736-2021; Al-Lazikani, Bissan/AFK-6457-2022	Elbanna, May/0000-0002-9745-9066; Al-Lazikani, Bissan/0000-0003-3367-2519; Raynaud, Florence/0000-0003-0957-6279; Stockwell, Simon/0000-0002-3345-8945; Clarke, Paul/0000-0001-9342-1290; Zhang, Chi/0000-0002-9188-6307	Cancer Research UK [C309/A11566, C309/A8274, C309/A8992, C423/A1421, C423/A15043]; World Cancer Research Fund (WCRF) [12-1280]; Wellcome Trust [094885/Z/10/Z]	Cancer Research UK(Cancer Research UK); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank Nicky Evans for editorial help with writing this paper, and Albert Hallsworth, Melanie Valenti and Gary Box for assisting with the mouse work. We thank the Vogelstein laboratory for providing isogenic TP53<SUP>-/-</SUP> and TP53<SUP>WT</SUP> HCT116 human colorectal cancer cells. Financial support: The work was supported by grants from Cancer Research UK (ref. C309/A11566, ref. C309/A8274 and ref. C309/A8992 (PW), ref. C423/A1421 and ref. C423/A15043 (SM)) and the World Cancer Research Fund (WCRF) (ref. 12-1280). CZ was supported by a Wellcome Trust studentship (ref. 094885/Z/10/Z). PW is a Cancer Research UK Life Fellow. The funders had no role in the design of the study, the collection, analysis and interpretation of the data, the writing of the paper or the decision to submit the paper for publication.	Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Bilgin B, 2017, CURR MED RES OPIN, V33, P1559, DOI 10.1080/03007995.2017.1348344; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Bond M, 2004, J BIOL CHEM, V279, P37304, DOI 10.1074/jbc.M404307200; Bryant P, 2006, MOL CELL BIOL, V26, P4201, DOI 10.1128/MCB.01612-05; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Choi YJ, 2014, ONCOGENE, V33, P1890, DOI 10.1038/onc.2013.137; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dean JL, 2010, ONCOGENE, V29, P4018, DOI 10.1038/onc.2010.154; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Engels B, 2012, SEMIN CANCER BIOL, V22, P41, DOI 10.1016/j.semcancer.2011.12.008; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Franco J, 2014, ONCOTARGET, V5, P6512, DOI 10.18632/oncotarget.2270; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Goel S, 2016, CANCER CELL, V29, P255, DOI 10.1016/j.ccell.2016.02.006; Golubovskaya VM, 2014, FRONT BIOSCI-LANDMRK, V19, P687, DOI 10.2741/4236; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Hamilton E, 2016, CANCER TREAT REV, V45, P129, DOI 10.1016/j.ctrv.2016.03.002; Herrera-Abreu MT, 2016, CANCER RES, V76, P2301, DOI 10.1158/0008-5472.CAN-15-0728; Huang G, 2014, ANTI-CANCER AGENT ME, V14, P9, DOI 10.2174/18715206113139990141; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Knudsen ES, 2017, TRENDS CANCER, V3, P39, DOI 10.1016/j.trecan.2016.11.006; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Leontieva OV, 2013, CELL CYCLE, V12, P3063, DOI 10.4161/cc.26130; Lv PC, 2018, EXPERT OPIN THER PAT, V28, P139, DOI 10.1080/13543776.2018.1414183; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Matsumoto K, 2006, INT J CANCER, V119, P477, DOI 10.1002/ijc.21808; O'Leary B, 2016, NAT REV CLIN ONCOL, V13, P417, DOI 10.1038/nrclinonc.2016.26; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Richardson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031627; Rocca A, 2017, THER ADV MED ONCOL, V9, P83, DOI 10.1177/1758834016677961; Roy-Luzarraga M, 2016, CLIN CANCER RES, V22, P3718, DOI 10.1158/1078-0432.CCR-14-2021; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schettini F, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00608; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; Sherr CJ, 2000, CANCER RES, V60, P3689; Shibue T, 2013, CANCER CELL, V24, P481, DOI 10.1016/j.ccr.2013.08.012; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Verschuren EW, 2007, DEV CELL, V12, P169, DOI 10.1016/j.devcel.2007.01.015; Wang L, 2007, BLOOD, V110, P2075, DOI 10.1182/blood-2007-02-071266; Whittaker SR, 2017, PHARMACOL THERAPEUT, V173, P83, DOI 10.1016/j.pharmthera.2017.02.008; Ye F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S3; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997; 1988, LAB ANIM UK, V22, P195	52	13	14	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 25	2019	38	30					5905	5920		10.1038/s41388-019-0850-2	http://dx.doi.org/10.1038/s41388-019-0850-2			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IT3FY	31296956	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000482739300005
J	Bosnes, I; Nordahl, HM; Stordal, E; Bosnes, O; Myklebust, TA; Almkvist, O				Bosnes, Ingunn; Nordahl, Hans Morten; Stordal, Eystein; Bosnes, Ole; Myklebust, Tor Age; Almkvist, Ove			Lifestyle predictors of successful aging: A 20-year prospective HUNT study	PLOS ONE			English	Article							SOCIAL SUPPORT; OLDER-ADULTS; HEALTHY; PREVALENCE; AGE; DETERMINANTS; TRAJECTORIES; DEFINITIONS; POPULATION; DEPRESSION	Background Lifestyle factors predicting successful aging as a unified concept or as separate components of successful aging are important for understanding healthy aging, interventions and preventions. The main objective was to investigate the effect of midlife predictors on subsequent successful aging 20 years later. Materials and methods Data were from a population-based health survey, the Nord-Trondelag Health Study (HUNT), with an average follow-up of 22.6 years. Individuals free of major disease at baseline in 1984-86 with complete datasets for the successful aging components in HUNT3 in 2006-08, were included (n = 4497; mean age at baseline 52.7, range 45-59, years). Successful aging was defined either as a unified category or as three components: being free of nine specified diseases and depression, having no physical or cognitive impairment, and being actively engaged with life. The midlife predictors (smoking, physical activity, alcohol consumption, obesity and social support) were analysed both as separate predictors and combined into a lifestyle index controlling for sociodemographic variables, using multivariable regression analysis. Results Successful aging as a unified concept was related to all the lifestyle factors in the unadjusted analyses, and all except alcohol consumption in the adjusted analyses. The individual components of successful aging were differently associated with the lifestyle factors; engagement with life was less associated with the lifestyle factors. Non-smoking and good social support were the most powerful predictors for successful aging as a unified concept. When the lifestyle factors were summed into a lifestyle index, there was a trend for more positive lifestyle to be related to higher odds for successful aging. Conclusions Lifestyle factors predicted an overall measure of SA, as well as the individual components, more than 20 years later. Modifiable risk factors in midlife, exemplified by social support, may be used for interventions to promote overall health and specific aspects of health in aging.	[Bosnes, Ingunn; Stordal, Eystein; Bosnes, Ole] Nord Trondelag Hosp Trust, Clin Mental Hlth & Subst Abuse, Namsos, Norway; [Bosnes, Ingunn] Norwegian Univ Sci & Technol NTNU, Dept Psychol, Trondheim, Norway; [Nordahl, Hans Morten; Stordal, Eystein] Norwegian Univ Sci & Technol NTNU, Dept Mental Hlth, Trondheim, Norway; [Nordahl, Hans Morten] St Olavs Hosp, Nidaros DPS, Div Psychiat, Trondheim, Norway; [Myklebust, Tor Age] More & Romsdal Hosp Trust, Dept Res & Innovat, Alesund, Norway; [Almkvist, Ove] Stockholm Univ, Dept Psychol, Stockholm, Sweden; [Almkvist, Ove] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Stockholm University; Karolinska Institutet	Bosnes, I (corresponding author), Nord Trondelag Hosp Trust, Clin Mental Hlth & Subst Abuse, Namsos, Norway.; Bosnes, I (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Psychol, Trondheim, Norway.	Ingunn.Bosnes@hnt.no	Myklebust, Tor Åge/AAQ-1654-2020	Bosnes, Ingunn/0000-0002-8841-3998; Nordahl, Hans M/0000-0001-9275-646X	Liaison Committee	Liaison Committee	This work is funded by a PhD scholarship from the Liaison Committee between the Central Norway Health Authority and the Norwegian University of Science and Technology (NTNU) to IB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atallah N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070854; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bosnes I, 2017, INT PSYCHOGERIATR, V29, P431, DOI 10.1017/S1041610216001861; Bowling A, 2007, INT J AGING HUM DEV, V64, P263, DOI 10.2190/L0K1-87W4-9R01-7127; Britton A, 2008, J AM GERIATR SOC, V56, P1098, DOI 10.1111/j.1532-5415.2008.01740.x; Cosco TD, 2014, INT PSYCHOGERIATR, V26, P373, DOI 10.1017/S1041610213002287; Depp CA, 2006, AM J GERIAT PSYCHIAT, V14, P6, DOI 10.1097/01.JGP.0000192501.03069.bc; Elwood P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081877; Hakulinen C, 2016, J EPIDEMIOL COMMUN H, V70, P710, DOI [10.1136/jech-2015-206165, 10.1136/jech-2015]; Hamid TA, 2012, GERONTOLOGY, V58, P366, DOI 10.1159/000334671; Hank K, 2011, J GERONTOL B-PSYCHOL, V66, P230, DOI 10.1093/geronb/gbq089; Holstein MB, 2003, GERONTOLOGIST, V43, P787, DOI 10.1093/geront/43.6.787; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hsu HC, 2012, GERONTOLOGIST, V52, P843, DOI 10.1093/geront/gns005; Huijg JM, 2016, J GERONTOL B-PSYCHOL, V72, P228; Kahn RL, 2002, GERONTOLOGIST, V42, P725, DOI 10.1093/geront/42.6.725; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Krokstad S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3993-x; Kuh D, 2007, J GERONTOL A-BIOL, V62, P717, DOI 10.1093/gerona/62.7.717; Lafortune L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144405; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Martinson M, 2015, GERONTOLOGIST, V55, P58, DOI 10.1093/geront/gnu037; McLaughlin SJ, 2010, J GERONTOL B-PSYCHOL, V65, P216, DOI 10.1093/geronb/gbp101; Ng TP, 2009, AM J GERIAT PSYCHIAT, V17, P407, DOI 10.1097/JGP.0b013e31819a808e; Peel NM, 2005, AM J PREV MED, V28, P298, DOI 10.1016/j.amepre.2004.12.002; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Rowe JW, 1998, SUCCESSFUL AGING; Sabia S, 2012, CANADIAN MED ASS J; Seeman TE, 2001, HEALTH PSYCHOL, V20, P243, DOI 10.1037//0278-6133.20.4.243; StataCorp, 2017, STAT REL 15 STAT SOF, DOI DOI 10.2307/2234838; Stordal E, 2001, ACTA PSYCHIAT SCAND, V104, P210, DOI 10.1034/j.1600-0447.2001.00130.x; Strawbridge WJ, 1996, AM J EPIDEMIOL, V144, P135, DOI 10.1093/oxfordjournals.aje.a008900; Sun Q, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001090; Urtamo A, 2018, AGING CLIN EXPT RES; Vaillant GE, 2001, AM J PSYCHIAT, V158, P839, DOI 10.1176/appi.ajp.158.6.839; Weir PL, 2010, J HEALTH PSYCHOL, V15, P680, DOI 10.1177/1359105309353648; Willcox BJ, 2006, JAMA-J AM MED ASSOC, V296, P2343, DOI 10.1001/jama.296.19.2343; Word Health Organization, 2014, GLOB STAT REP ALC HL	38	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219200	10.1371/journal.pone.0219200	http://dx.doi.org/10.1371/journal.pone.0219200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4LN	31295289	Green Published, Green Submitted, gold			2022-12-26	WOS:000484951800019
J	Kato, K; Shimada, N; Atsukawa, M; Abe, H; Itokawa, N; Matsumoto, Y; Agata, R; Tsubota, A				Kato, Keizo; Shimada, Noritomo; Atsukawa, Masanori; Abe, Hiroshi; Itokawa, Norio; Matsumoto, Yoshihiro; Agata, Rie; Tsubota, Akihito			Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C	PLOS ONE			English	Article							DOSE REQUIREMENT; GENOTYPE 1B; PHARMACOKINETICS; CYP3A4; CYCLOSPORINE; BMS-650032; MARKERS	Aims Drug-induced liver damage characterized by serum alanine aminotransferase (ALT) elevation often occurs in direct-acting antiviral (DAA) combination therapy for chronic hepatitis C virus (HCV) infection. This study explored single nucleotide polymorphisms (SNPs) at drug metabolism-or transport-related genes that were associated with ALT elevation in asunaprevir plus daclatasvir therapy. Methods Subjects were 185 Japanese patients with chronic HCV genotype 1b infection who received asunaprevir plus daclatasvir therapy. Tag SNPs at possible metabolizing enzyme and transporter genes, which were involved in the pharmacokinetics of asunaprevir and daclatasvir, were selected. Results Among the tag SNPs analyzed, CYP3A4 rs4646437 was significantly associated with ALT elevation (p = 0.013): maximum ALT values in patients with genotype CC were higher than those in patients with genotype non-CC (allele T). The proportion of grades 2-4 in genotype CC patients were significantly greater than those in genotype non-CC patients (p = 0.028). No patients with genotype non-CC showed grade >= 2 ALT elevation. In multivariate analysis, rs4646437 genotype CC and cirrhosis were significant, independent factors associated with grade >= 1 ALT elevation (odds ratio, 2.83 and 1.88; p = 0.040 and 0.045, respectively). In exploratory analyses, although serum concentrations of asunaprevir and daclatasvir were not correlated with maximum ALT values or rs4646437 genotypes, asunaprevir concentrations in patients with grade >= 1 ALT elevation were significantly higher than those in patients with grade <1 ALT elevation (P = 0.023). Conclusions CYP3A4 rs4646437 was found to be significantly and independently associated with ALT elevation in Japanese patients receiving ASV plus DCV therapy. Notably, none of the patients with rs4646437 genotype non-CC ( allele T) had grade >= 2 ALT elevation. SNP genotyping prior to treatment might be useful for carefully monitoring patients to complete treatment safely.	[Kato, Keizo; Tsubota, Akihito] Jikei Univ, Sch Med, Grad Sch Organ Pathol & Therapeut, Liver Dis Control Sci,Minato Ku, Tokyo, Japan; [Kato, Keizo; Abe, Hiroshi] Shinmatsudo Cent Gen Hosp, Div Gastroenterol & Hepatol, Matsudo, Chiba, Japan; [Shimada, Noritomo] Ootakanomori Hosp, Div Gastroenterol & Hepatol, Kashiwa, Chiba, Japan; [Atsukawa, Masanori] Nippon Med Sch, Dept Internal Med, Div Gastroenterol & Hepatol, Bunkyo Ku, Tokyo, Japan; [Itokawa, Norio] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Internal Med, Div Gastroenterol, Chiba, Japan; [Matsumoto, Yoshihiro] Jikei Univ, Sch Med, Kashiwa Hosp, Div Gastroenterol & Hepatol, Chiba, Japan; [Agata, Rie; Tsubota, Akihito] Jikei Univ, Sch Med, Res Ctr Med Sci, Core Res Facil,Minato Ku, Tokyo, Japan	Jikei University; Nippon Medical School; Nippon Medical School; Jikei University; Jikei University	Tsubota, A (corresponding author), Jikei Univ, Sch Med, Grad Sch Organ Pathol & Therapeut, Liver Dis Control Sci,Minato Ku, Tokyo, Japan.; Tsubota, A (corresponding author), Jikei Univ, Sch Med, Res Ctr Med Sci, Core Res Facil,Minato Ku, Tokyo, Japan.	atsubo@jikei.ac.jp			Research Program of Graduate School, The Jikei University School of Medicine [1404-1803]	Research Program of Graduate School, The Jikei University School of Medicine	This study was supported by Research Program of Graduate School, The Jikei University School of Medicine (1404-1803) to KK and AT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2015, J MED VIROL, V88, P506, DOI [10.1002/jmy.24360, DOI 10.1002/JMY.24360]; [Anonymous], ZEP ELB GRAZ TABL OR; [Anonymous], MAV GLEC PIBR TABL O; Bronowicki JP, 2013, ANTIVIR THER, V18, P885, DOI 10.3851/IMP2660; Chau CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126672; Coelho AVC, 2018, BRAZ J INFECT DIS, V22, P392, DOI 10.1016/j.bjid.2018.09.002; Crettol S, 2008, THER DRUG MONIT, V30, P689, DOI 10.1097/FTD.0b013e31818a2a60; de Almeida TB, 2018, J ANTIMICROB CHEMOTH, V73, P2460, DOI 10.1093/jac/dky190; de Velasco G, 2016, EUR UROL FOCUS, V2, P633, DOI 10.1016/j.euf.2016.03.017; Eley T, 2015, CLIN PHARMACOKINET, V54, P1205, DOI 10.1007/s40262-015-0299-6; Eley T, 2015, ANTIVIR THER, V20, P29, DOI 10.3851/IMP2773; Eley T, 2013, CLIN PHARM DRUG DEV, V2, P316, DOI 10.1002/cpdd.52; Gandhi Y, 2018, CLIN PHARMACOKINET, V57, P911, DOI 10.1007/s40262-017-0624-3; Garimella T, 2016, ADV THER, V33, P1867, DOI 10.1007/s12325-016-0407-5; He HR, 2015, EUR J CLIN MICROBIOL, V34, P811, DOI 10.1007/s10096-014-2294-5; Iio E, 2017, J GASTROENTEROL, V52, P94, DOI 10.1007/s00535-016-1225-x; Kiser JJ, 2013, NAT REV GASTRO HEPAT, V10, P596, DOI 10.1038/nrgastro.2013.106; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Li CX, 2014, RECENT PAT ANTI-CANC, V9; Liu MZ, 2017, ACTA PHARMACOL SIN, V38, P415, DOI 10.1038/aps.2016.153; Maekawa S, 2018, J GASTROENTEROL, V53, P780, DOI 10.1007/s00535-017-1405-3; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Morcos PN, 2013, EUR J CLIN PHARMACOL, V69, P1777, DOI 10.1007/s00228-013-1525-5; Mosure KW, 2015, J PHARM SCI-US, V104, P2813, DOI 10.1002/jps.24356; Muir AJ, 2015, JAMA-J AM MED ASSOC, V313, P1736, DOI 10.1001/jama.2015.3868; Poordad F, 2015, JAMA-J AM MED ASSOC, V313, P1728, DOI 10.1001/jama.2015.3860; Schirmer M, 2007, PHARMACOGENOMICS, V8, P443, DOI 10.2217/14622416.8.5.443; Sezaki H, 2017, LIVER INT, V37, P1325, DOI 10.1111/liv.13384; Sharaki O, 2015, MOL BIOL REP, V42, P105, DOI 10.1007/s11033-014-3747-8; Shiozaki T, 2015, INT J CLIN PHARM TH, V53, P292, DOI 10.5414/CP202186; Toyota J, 2017, J GASTROENTEROL, V52, P385, DOI 10.1007/s00535-016-1245-6; U.S. Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases Division of AIDS., 2017, DIV AIDS DAIDS TABL; Uchida Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205600; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669	34	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219022	10.1371/journal.pone.0219022	http://dx.doi.org/10.1371/journal.pone.0219022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291311	Green Submitted, Green Published, gold			2022-12-26	WOS:000484947800045
J	Mitchell, LJ; White, PCL; Arnold, KE				Mitchell, Lucy J.; White, Piran C. L.; Arnold, Kathryn E.			The trade-off between fix rate and tracking duration on estimates of home range size and habitat selection for small vertebrates	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; GREATER SAGE-GROUSE; RESOURCE SELECTION; GPS TELEMETRY; MOVEMENT; BEHAVIOR; SPACE; PERFORMANCE; TECHNOLOGY; TOPOGRAPHY	Despite advances in technology, there are still constraints on the use of some tracking devices for small species when gathering high temporal and spatial resolution data on movement and resource use. For small species, weight limits imposed on GPS loggers and the consequent impacts on battery life, restrict the volume of data that can be collected. Research on home range and habitat selection for these species should therefore incorporate a consideration of how different sampling parameters and methods may affect the structure of the data and the conclusions drawn. However, factors such as these are seldom explicitly considered. We applied two commonly-used methods of home range estimation, Movement-based Kernel Density Estimation (MKDE) and Kernel Density Estimation (KDE) to investigate the influence of fix rate, tracking duration and method on home range size and habitat selection, using GPS tracking data collected at two different fix rates from a small, aerially-insectivorous bird, the European nightjar Caprimulgus europaeus. Effects of tracking parameters varied with home range estimation method. Fix rate and tracking duration most strongly explained change in MKDE and KDE home range size respectively. Total number of fixes and tracking duration had the strongest impact on habitat selection. High between-and within-individual variation strongly influenced outcomes and was most evident when exploring the effects of varying tracking duration. To reduce skew and bias in home range size estimation and especially habitat selection caused by individual variation and estimation method, we recommend tracking animals for the longest period possible even if this results in a reduced fix rate. If accurate movement properties, (e.g. trajectory length and turning angle) and biologically-representative movement occurrence ranges are more important, then a higher fix rate should be used, but priority habitats can still be identified with an infrequent sampling strategy.	[Mitchell, Lucy J.; White, Piran C. L.; Arnold, Kathryn E.] Univ York, Dept Environm & Geog, Wentworth Way, York, N Yorkshire, England	University of York - UK	Mitchell, LJ (corresponding author), Univ York, Dept Environm & Geog, Wentworth Way, York, N Yorkshire, England.	ljr540@york.ac.uk	White, Piran Crawfurd Limond/AAH-6851-2021	White, Piran Crawfurd Limond/0000-0002-7496-5775; Mitchell, Lucy/0000-0003-2162-013X	NERC ACCE Doctoral Training Partnership PhD studentship [NE/L002450/1]	NERC ACCE Doctoral Training Partnership PhD studentship	LJM is funded through a NERC ACCE Doctoral Training Partnership PhD studentship, Grant number: NE/L002450/1, URL: https://nerc.ukri.org/funding/available/postgrad/responsive/dtp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE HDJN, 1991, CAN J ZOOL, V69, P62, DOI 10.1139/z91-010; Alexander I, 1989, IBIS LOND 1859, V132, P568; Arrizabalaga-Escudero A, 2015, BIOL CONSERV, V191, P512, DOI 10.1016/j.biocon.2015.07.043; Balmer D. E., 2013, BIRD ATLAS 2007 1 I; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Baxter JJ, 2017, RANGELAND ECOL MANAG, V70, P493, DOI 10.1016/j.rama.2017.01.007; Benhamou S., 2011, PLOS ONE, V6, P8; Benhamou S, 2012, ECOL MODEL, V227, P112, DOI 10.1016/j.ecolmodel.2011.12.015; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; BERRY R, 1981, BRIT BIRDS, V74, P161; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Blundell GM, 2001, ECOL MONOGR, V71, P469, DOI 10.1890/0012-9615(2001)071[0469:LHREOS]2.0.CO;2; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Boggie MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206222; Boiteau G, 2000, ENVIRON ENTOMOL, V29, P1157, DOI 10.1603/0046-225X-29.6.1157; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; Briscoe DK, 2018, ECOL EVOL, V8, P2788, DOI 10.1002/ece3.3827; Byer NW, 2017, J HERPETOL, V51, P68, DOI 10.1670/15-150; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Cain JW, 2005, WILDLIFE SOC B, V33, P926, DOI 10.2193/0091-7648(2005)33[926:IOTAGF]2.0.CO;2; Calabrese JM, 2016, METHODS ECOL EVOL, V7, P1124, DOI 10.1111/2041-210X.12559; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Calenge C, 2009, ECOL INFORM, V4, P34, DOI 10.1016/j.ecoinf.2008.10.002; Camacho C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104974; Conway G, 2007, BIRD STUDY, V54, P98, DOI 10.1080/00063650709461461; Cramp S., 1985, HDB BIRDS EUROPE MID, VIV; D'Eon RG, 2003, J WILDLIFE MANAGE, V67, P858, DOI 10.2307/3802693; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Dujon AM, 2014, METHODS ECOL EVOL, V5, P1162, DOI 10.1111/2041-210X.12286; Dussault C, 2005, ECOGRAPHY, V28, P619, DOI 10.1111/j.2005.0906-7590.04263.x; Eaton MA, 2015, BR BIRDS, V108, P38; English PA, 2017, LANDSCAPE ECOL, V32, P343, DOI 10.1007/s10980-016-0454-y; Fedy BC, 2014, WILDLIFE MONOGR, V190, P1, DOI 10.1002/wmon.1014; Fischer JW, 2013, CONDOR, V115, P298, DOI 10.1525/cond.2013.110168; Fleming CH, 2015, ECOLOGY, V96, P1182, DOI 10.1890/14-2010.1; Fleming CH, 2017, ECOL INFORM, V40, P8, DOI 10.1016/j.ecoinf.2017.04.008; Fleming CH, 2017, METHODS ECOL EVOL, V8, P571, DOI 10.1111/2041-210X.12673; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Girard I, 2002, J WILDLIFE MANAGE, V66, P1290, DOI 10.2307/3802962; Girard I, 2006, J WILDLIFE MANAGE, V70, P9; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P11; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Guilford TC, 2008, IBIS, V150, P462, DOI 10.1111/j.1474-919X.2008.00805.x; Harrison XA, 2018, PEERJ, V6, DOI 10.7717/peerj.4794; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hemson G, 2005, J ANIM ECOL, V74, P455, DOI 10.1111/j.1365-2656.2005.00944.x; Hinton JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132203; Hofman MPG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216223; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Horne JS, 2006, ECOLOGY, V87, P1146, DOI 10.1890/0012-9658(2006)87[1146:STBHRM]2.0.CO;2; Huck M, 2008, WILDLIFE BIOL, V14, P467, DOI 10.2981/0909-6396-14.4.467; Karelus DL, 2016, SOUTHEAST NAT, V15, P346, DOI 10.1656/058.015.0215; Kelly JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076616; Kie J.G., 2013, ANIM BIOTELEM, V1, P13, DOI [10.1186/2050-3385-1-13, DOI 10.1186/2050-3385-1-13]; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Kochanny CO, 2009, J WILDLIFE MANAGE, V73, P779, DOI 10.2193/2008-394; LAIR H, 1987, ECOLOGY, V68, P1092, DOI 10.2307/1938381; Land ED, 2008, J WILDLIFE MANAGE, V72, P8; Latham ADM, 2015, NEW ZEAL J ECOL, V39, P143; Leclerc M, 2016, OECOLOGIA, V180, P697, DOI 10.1007/s00442-015-3500-6; Lowe A, 2014, AVIAN CONSERV ECOL, V9, DOI 10.5751/ACE-00690-090206; Manly B.F.J., 2002, RESOURCE SELECTION A; McGregor HW, 2016, AUST MAMMAL, V38, P237, DOI 10.1071/AM15034; Merckx T, 2012, J APPL ECOL, V49, P1396, DOI 10.1111/j.1365-2664.2012.02211.x; Merckx T, 2010, AGR ECOSYST ENVIRON, V138, P147, DOI 10.1016/j.agee.2010.04.010; Middleton P., 2017, BREEDING NIGHTJAR SU; Mills KJ, 2006, WILDLIFE SOC B, V34, P1463, DOI 10.2193/0091-7648(2006)34[1463:EOVSFO]2.0.CO;2; MORRIS A, 1994, BIRD STUDY, V41, P181, DOI 10.1080/00063659409477218; Noonan MJ, 2019, ECOL MONOGR, V89, DOI 10.1002/ecm.1344; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; PALMER P, 2002, MOVEMENTS FORAGING N; Papworth SK, 2012, METHODS ECOL EVOL, V3, P584, DOI 10.1111/j.2041-210X.2012.00189.x; Pepin D, 2004, J MAMMAL, V85, P774, DOI 10.1644/BER-022; Rainho A, 2010, J APPL ECOL, V47, P850, DOI 10.1111/j.1365-2664.2010.01820.x; Recio MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028225; Rice MB, 2017, WILDLIFE RES, V44, P407, DOI 10.1071/WR17027; Rowcliffe JM, 2012, METHODS ECOL EVOL, V3, P653, DOI 10.1111/j.2041-210X.2012.00197.x; Schaming TD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149116; Schuler KL, 2014, WILDLIFE BIOL, V20, P259, DOI 10.2981/wlb.12117; SHARPS K, 2013, CONSERVATION ECOLOGY; Stark DJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174891; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; Tomotani BM, 2019, METHODS ECOL EVOL, V10, P70, DOI 10.1111/2041-210X.13112; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; Vickery JA, 2014, IBIS, V156, P1, DOI 10.1111/ibi.12118; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; Walter WD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32937-7; Walter WD, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0039-4; Wikelski M, 2007, J EXP BIOL, V210, P181, DOI 10.1242/jeb.02629; Wilson ADM, 2015, CONSERV BIOL, V29, P1065, DOI 10.1111/cobi.12486; Wilson RP, 2012, MAR ECOL PROG SER, V451, P245, DOI 10.3354/meps09608	94	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219357	10.1371/journal.pone.0219357	http://dx.doi.org/10.1371/journal.pone.0219357			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291318	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000484947800075
J	Nguyen, C; Yamazaki, T; Kovalenko, A; Case, DA; Gilson, MK; Kurtzman, T; Luchko, T				Nguyen, Crystal; Yamazaki, Takeshi; Kovalenko, Andriy; Case, David A.; Gilson, Michael K.; Kurtzman, Tom; Luchko, Tyler			A molecular reconstruction approach to site-based 3D-RISM and comparison to GIST hydration thermodynamic maps in an enzyme active site	PLOS ONE			English	Article							INHOMOGENEOUS FLUID APPROACH; SOLVATION THERMODYNAMICS; FREE-ENERGIES; PARTITION-COEFFICIENT; SPATIAL DECOMPOSITION; INTEGRAL-EQUATION; WATER; ENTROPY; DENSITY; SOLVENT	Computed, high-resolution, spatial distributions of solvation energy and entropy can provide detailed information about the role of water in molecular recognition. While grid inhomogeneous solvation theory (GIST) provides rigorous, detailed thermodynamic information from explicit solvent molecular dynamics simulations, recent developments in the 3D reference interaction site model (3D-RISM) theory allow many of the same quantities to be calculated in a fraction of the time. However, 3D-RISM produces atomic-site, rather than molecular, density distributions, which are difficult to extract physical meaning from. To overcome this difficulty, we introduce a method to reconstruct molecular density distributions from atomic-site density distributions. Furthermore, we assess the quality of the resulting solvation thermodynamics density distributions by analyzing the binding site of coagulation Factor Xa with both GIST and 3D-RISM. We find good qualitative agreement between the methods for oxygen and hydrogen densities as well as direct solute-solvent energetic interactions. However, 3D-RISM predicts lower energetic and entropic penalties for moving water from the bulk to the binding site.	[Nguyen, Crystal; Gilson, Michael K.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Yamazaki, Takeshi] Vancouver Prostate Ctr, Vancouver, BC, Canada; [Kovalenko, Andriy] Natl Res Council Canada, Natl Inst Nanotechnol, Edmonton, AB, Canada; [Kovalenko, Andriy] Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada; [Case, David A.] CUNY, Lehman Coll, Dept Chem, Bronx, NY USA; [Kurtzman, Tom] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Luchko, Tyler] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA; [Yamazaki, Takeshi] 1QB Informat Technol 1QBit, Vancouver, BC, Canada	University of California System; University of California San Diego; National Research Council Canada; University of Alberta; City University of New York (CUNY) System; Lehman College (CUNY); Rutgers State University New Brunswick; California State University System; California State University Northridge	Gilson, MK (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.; Kurtzman, T (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.; Luchko, T (corresponding author), Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA.	mgilson@ucsd.edu; simpleliquid@gmail.com; tluchko@csun.edu	Yamazaki, Takeshi/A-5785-2018	Yamazaki, Takeshi/0000-0002-5714-764X; Luchko, Tyler/0000-0001-6737-6019; Kurtzman, Tom/0000-0003-0900-772X	National Science Foundation (NSF) [1566638]; Research Corporation for Science Advancement (RCSA) Cottrell Scholar Award [23967]; National Institutes of Health (NIH) [GM122086, GM061300, GM100946]	National Science Foundation (NSF)(National Science Foundation (NSF)); Research Corporation for Science Advancement (RCSA) Cottrell Scholar Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This material is based upon work supported by the National Science Foundation (NSF) under Grant No. 1566638 and the Research Corporation for Science Advancement (RCSA) Cottrell Scholar Award #23967 awarded to T. L. Additional support came from National Institutes of Health (NIH) Grant GM122086 (D.A.C.), GM061300 (M.K.G), and GM100946 (M.K.G. and T. K.). The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, NSF, or RCSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel R, 2008, J AM CHEM SOC, V130, P2817, DOI 10.1021/ja0771033; Beglov D, 1997, J PHYS CHEM B, V101, P7821, DOI 10.1021/jp971083h; Case DA, 2012, AMBER 12; Fujita T, 2017, J CHEM PHYS, V147, DOI 10.1063/1.4990502; Giambasu GM, 2014, BIOPHYS J, V106, P883, DOI 10.1016/j.bpj.2014.01.021; Green HS, 1952, THE MOLECULAR THEORY; Gussregen S, 2017, J CHEM INF MODEL, V57, P1652, DOI 10.1021/acs.jcim.6b00765; Haider K, SOLVATION STRUCTURE; Hansen J.-P., 2006, THEORY OF SIMPLE LIQ; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang WJ, 2015, J PHYS CHEM B, V119, P5588, DOI 10.1021/acs.jpcb.5b01291; Huggins DJ, 2014, J CHEM THEORY COMPUT, V10, P3617, DOI 10.1021/ct500415g; Johnson J, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/34/344002; Johnson J, SMALL MOLECULE SOLVA; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4775743; Kast SM, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3041709; Kovalenko A, 2000, J CHEM PHYS, V112, P10391, DOI 10.1063/1.481676; Kovalenko A, 2003, UNDERS CH R, V24, P169; Kovalenko A, 1999, J CHEM PHYS, V110, P10095, DOI 10.1063/1.478883; Kovalenko A, 1999, J COMPUT CHEM, V20, P928, DOI 10.1002/(SICI)1096-987X(19990715)20:9<928::AID-JCC4>3.0.CO;2-X; Kovalenko A, 2000, J CHEM PHYS, V113, P2793, DOI 10.1063/1.1305885; Kovalenko A, 2017, SPRINGER HANDBOOK OF ELECTROCHEMICAL ENERGY, P95; Lazaridis T, 1996, J CHEM PHYS, V105, P4294, DOI 10.1063/1.472247; Lazaridis T, 1998, J PHYS CHEM B, V102, P3531, DOI 10.1021/jp9723574; Lazaridis T, 1998, J PHYS CHEM B, V102, P3542, DOI 10.1021/jp972358w; Li Z, 2012, METHODS MOL BIOL, V819, P393, DOI 10.1007/978-1-61779-465-0_24; Luchko T, 2016, J COMPUT AID MOL DES, V30, P1115, DOI 10.1007/s10822-016-9947-7; Luchko T, 2010, J CHEM THEORY COMPUT, V6, P607, DOI 10.1021/ct900460m; Misin M, 2016, J PHYS CHEM B, V120, P5724, DOI 10.1021/acs.jpcb.6b05352; Misin M, 2016, J PHYS CHEM B, V120, P975, DOI 10.1021/acs.jpcb.5b10809; Misin M, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4914315; MORITA T, 1958, PROG THEOR PHYS, V20, P920, DOI 10.1143/PTP.20.920; NETTLETON RE, 1958, J CHEM PHYS, V29, P1365, DOI 10.1063/1.1744724; Nguyen C, 2011, ARXIV11084876 PHYS Q; Nguyen CN, 2016, J CHEM THEORY COMPUT, V12, P414, DOI 10.1021/acs.jctc.5b00939; Nguyen CN, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4733951; Ornstein LS, 1914, P K AKAD WET-AMSTERD, V17, P793; Palmer DS, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/49/492101; Palmer DS, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3458798; PERKYNS J, 1992, J CHEM PHYS, V97, P7656, DOI 10.1063/1.463485; Ramsey S, 2016, J COMPUT CHEM, V37, P2029, DOI 10.1002/jcc.24417; Ratkova EL, 2010, J PHYS CHEM B, V114, P12068, DOI 10.1021/jp103955r; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Sergiievskyi V, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4935065; Sindhikara DJ, 2013, J PHYS CHEM B, V117, P6718, DOI 10.1021/jp4046116; Singh H., 2003, American Journal of Mathematical and Management Sciences, V23, P301; Stumpe MC, 2011, J PHYS CHEM B, V115, P319, DOI 10.1021/jp102587q; Tielker N, 2016, J COMPUT AID MOL DES, V30, P1035, DOI 10.1007/s10822-016-9939-7; Truchon JF, 2014, J CHEM THEORY COMPUT, V10, P934, DOI 10.1021/ct4009359; Vega C, 2011, PHYS CHEM CHEM PHYS, V13, P19663, DOI 10.1039/c1cp22168j; Wang L, 2009, J CHEM THEORY COMPUT, V5, P1462, DOI 10.1021/ct900078k; Yamazaki T, 2009, J CHEM THEORY COMPUT, V5, P1723, DOI 10.1021/ct9000729; Young T, 2007, P NATL ACAD SCI USA, V104, P808, DOI 10.1073/pnas.0610202104; YU HA, 1990, J CHEM PHYS, V92, P5020, DOI 10.1063/1.458538; Zielkiewicz J, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2018637	57	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219473	10.1371/journal.pone.0219473	http://dx.doi.org/10.1371/journal.pone.0219473			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291328	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800094
J	Greenwald, R; Hayat, MJ; Dons, E; Giles, L; Villar, R; Jakovljevic, DG; Good, N				Greenwald, Roby; Hayat, Matthew J.; Dons, Evi; Giles, Luisa; Villar, Rodrigo; Jakovljevic, Djordje G.; Good, Nicholas			Estimating minute ventilation and air pollution inhaled dose using heart rate, breath frequency, age, sex and forced vital capacity: A pooled-data analysis	PLOS ONE			English	Article							LUNG-FUNCTION; PHYSIOLOGICAL-RESPONSES; PULMONARY-FUNCTION; REFERENCE VALUES; ASTHMA CONTROL; EXPOSURE; PEDESTRIANS; ANXIETY	Air pollution inhaled dose is the product of pollutant concentration and minute ventilation ((V)over dot(E)). Previous studies have parameterized the relationship between (V)over dot(E) and variables such as heart rate (HR) and have observed substantial inter-subject variability. In this paper, we evaluate a method to estimate (V)over dot(E) with easy-to-measure variables in an analysis of pooled-data from eight independent studies. We compiled a large diverse data set that is balanced with respect to age, sex and fitness level. We used linear mixed models to estimate (V)over dot(E) with HR, breath frequency (f(B)), age, sex, height, and forced vital capacity (FVC) as predictors. FVC was estimated using the Global Lung Function Initiative method. We log-transformed the dependent and independent variables to produce a model in the form of a power function and assessed model performance using a ten-fold cross-validation procedure. The best performing model using HR as the only field-measured parameter was (V)over dot(E) = e(-9.59)HR(2.39)age(0.274)sex(-0.204)FVC(0.520) with HR in beats per minute, age in years, sex is 1 for males and 2 for females, FVC in liters, and a median(IQR) cross-validated percent error of 0.664(45.4)%. The best performing model overall was (V)over dot(E) = e(-8.57)HR(1.72)f(B)(0.611)age(0.298)sex(-0.206)FVC(0.614), where f(B) is breaths per minute, and a median(IQR) percent error of 1.20(37.9)%. The performance of these models is substantially better than any previously-published model when evaluated using this large pooled-data set. We did not observe an independent effect of height on (V)over dot(E), nor an effect of race, though this may have been due to insufficient numbers of non-white participants. We did observe an effect of FVC such that these models over- or under-predict (V)over dot(E) in persons whose measured FVC was substantially lower or higher than estimated FVC, respectively. Although additional measurements are necessary to confirm this finding regarding FVC, we recommend using measured FVC when possible.	[Greenwald, Roby] Georgia State Univ, Div Environm Hlth, Sch Publ Hlth, Atlanta, GA 30303 USA; [Hayat, Matthew J.] Georgia State Univ, Div Epidemiol & Biostat, Sch Publ Hlth, Atlanta, GA 30303 USA; [Dons, Evi] Flemish Inst Technol Res VITO, Mol, Belgium; [Dons, Evi] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium; [Giles, Luisa] Douglas Coll, Sport Sci Dept, Vancouver, BC, Canada; [Villar, Rodrigo] Univ Manitoba, Fac Kinesiol & Recreat Management, Winnipeg, MB, Canada; [Jakovljevic, Djordje G.] Newcastle Univ, Inst Cellular Med, Fac Med Sci, Newcastle, England; [Good, Nicholas] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; VITO; Hasselt University; University of Manitoba; Newcastle University - UK; Colorado State University	Greenwald, R (corresponding author), Georgia State Univ, Div Environm Hlth, Sch Publ Hlth, Atlanta, GA 30303 USA.	rgreenwald@gsu.edu	Dons, Evi/H-7913-2019	Dons, Evi/0000-0002-6745-7246; Jakovljevic, Professor Djordje/0000-0003-2686-6542; Greenwald, Roby/0000-0002-1787-8827; Villar, Rodrigo/0000-0001-8568-3346	NIH/NIEHS [K25ES020355, R01ES020017]; Research Foundation Flanders postdoctoral scholarship [12L8818N]; CDC NIOSH grant [T42OH009229]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH009229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020017] Funding Source: NIH RePORTER	NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Research Foundation Flanders postdoctoral scholarship; CDC NIOSH grant(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by NIH/NIEHS grant K25ES020355 (R. Greenwald), Research Foundation Flanders postdoctoral scholarship 12L8818N (E. Dons), NIH/NIEHS grant R01ES020017 (N. Good), and CDC NIOSH grant T42OH009229 (N. Good). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WC, 1993, A033205 CAL AIR RES; Anderson SD, 2009, ASTHMA AND COPD: BASIC MECHANISMS AND CLINICAL MANAGEMENT, 2ND EDITION, P495; Babb TG, 2013, EXERC SPORT SCI REV, V41, P11, DOI 10.1097/JES.0b013e318267c0d2; Barrera-Ramirez J, 2013, APPL PHYSIOL NUTR ME, V38, P1128, DOI 10.1139/apnm-2012-0370; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Bigazzi AY, 2015, TRANSPORT RES REC, P52, DOI 10.3141/2520-07; Bloemsma LD, 2016, ENVIRON RES, V151, P458, DOI 10.1016/j.envres.2016.08.018; Brokamp C, 2016, J EXPO SCI ENV EPID, V26, P428, DOI 10.1038/jes.2016.10; Caiazzo F, 2013, ATMOS ENVIRON, V79, P198, DOI 10.1016/j.atmosenv.2013.05.081; Cozza IC, 2015, SCI TOTAL ENVIRON, V520, P160, DOI 10.1016/j.scitotenv.2015.03.049; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Do Vale ID, 2015, J TRANSP HEALTH, V2, P474, DOI 10.1016/j.jth.2015.07.003; Dons E, 2017, ENVIRON SCI TECHNOL, V51, P1859, DOI 10.1021/acs.est.6b05782; Faria M, 2014, TRANSP RES PROC, V3, P780, DOI 10.1016/j.trpro.2014.10.057; Frye C, 2003, ENVIRON HEALTH PERSP, V111, P383, DOI 10.1289/ehp.5355; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Giles LV, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0434-6; Giles LV, 2014, MED SCI SPORT EXER, V46, P1999, DOI 10.1249/MSS.0000000000000309; Goldman GT, 2012, ATMOS ENVIRON, V57, P101, DOI 10.1016/j.atmosenv.2012.04.045; Gomez P, 2004, INT J PSYCHOPHYSIOL, V53, P91, DOI 10.1016/j.ijpsycho.2004.02.002; Good N, 2018, J EXPO SCI ENV EPID, V1; Greenwald R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147578; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Holguin F, 2007, AM J RESP CRIT CARE, V176, P1236, DOI 10.1164/rccm.200611-1616OC; HUBERT HB, 1982, AM REV RESPIR DIS, V125, P409; Jakovljevic DG, 2012, CLIN PHYSIOL FUNCT I, V32, P388, DOI 10.1111/j.1475-097X.2012.01143.x; Johnson T., 2002, CR827033 EPA RES TRI; Kiyamu M, 2015, AM J PHYS ANTHROPOL, V156, P363, DOI 10.1002/ajpa.22655; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Masaoka Y, 1997, INT J PSYCHOPHYSIOL, V27, P153, DOI 10.1016/S0167-8760(97)00052-4; Masaoka Y, 1999, J APPL PHYSIOL, V86, P1329, DOI 10.1152/jappl.1999.86.4.1329; McArdle WD, 2011, EXERCISE PHYSL; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Mirabelli MC, 2015, EPIDEMIOLOGY, V26, P546, DOI 10.1097/EDE.0000000000000296; National Heart Lung and Blood Institute, 2007, NAT HEART LUNG BLOOD, V08-5846; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Ramos CA, 2015, SCI TOTAL ENVIRON, V527, P111, DOI 10.1016/j.scitotenv.2015.04.120; SATOH T, 1989, Keio Journal of Medicine, V38, P432; Schultz ES, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0709-y; Sharma G, 2006, CLIN INTERV AGING, V1, P253, DOI 10.2147/ciia.2006.1.3.253; Smulyan H, 1998, J AM COLL CARDIOL, V31, P1103, DOI 10.1016/S0735-1097(98)00056-4; Strickland MJ, 2015, J EXPO SCI ENV EPID, V25, P160, DOI 10.1038/jes.2013.16; Villar R, 2015, APPL PHYSIOL NUTR ME, V40, P1019, DOI 10.1139/apnm-2015-0140; Weitz CA, 2016, AM J PHYS ANTHROPOL, V159, P244, DOI 10.1002/ajpa.22873; Wilk JB, 2000, GENET EPIDEMIOL, V19, P81, DOI 10.1002/1098-2272(200007)19:1<81::AID-GEPI6>3.0.CO;2-8; Zora JE, 2013, SCI TOTAL ENVIRON, V448, P56, DOI 10.1016/j.scitotenv.2012.11.067; Zuurbier M, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-48	47	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0218673	10.1371/journal.pone.0218673	http://dx.doi.org/10.1371/journal.pone.0218673			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IS7KI	31287820	Green Published, Green Submitted, gold			2022-12-26	WOS:000482328300005
J	Ibanez-Soria, D; Soria-Frisch, A; Garcia-Ojalvo, J; Ruffini, G				Ibanez-Soria, David; Soria-Frisch, Aureli; Garcia-Ojalvo, Jordi; Ruffini, Giulio			Characterization of the non-stationary nature of steady-state visual evoked potentials using echo state networks	PLOS ONE			English	Article							CANONICAL CORRELATION-ANALYSIS; CROSS-CORRELATION ANALYSIS; RECOGNITION	State Visual Evoked Potentials (SSVEPs) arise from a resonance phenomenon in the visual cortex that is produced by a repetitive visual stimulus. SSVEPs have long been considered a steady-state response resulting from purely oscillatory components phase locked with the stimulation source, matching the stimulation frequency and its harmonics. Here we explore the dynamical character of the SSVEP response by proposing a novel non-stationary methodology for SSVEP detection based on an ensemble of Echo State Networks (ESN). The performance of this dynamical approach is compared to stationary canonical correlation analysis (CCA) for the detection of 6 visual stimulation frequencies ranging from 12 to 22 Hz. ESN-based methodology outperformed CCA, achieving an average information transfer rate of 47 bits/minute when simulating a BCI system of 6 degrees of freedom. However, for some subjects and stimulation frequencies the detection accuracy of CCA exceeds that of ESN. The comparison suggests that each methodology captures different features of the SSVEP response: while CCA captures purely stationary patterns, the ESN-based approach presented here is capable of detecting the non-stationary nature of the SSVEP.	[Ibanez-Soria, David; Soria-Frisch, Aureli; Ruffini, Giulio] Starlab Barcelona SL, Neurosci Res Business Unit, Barcelona, Spain; [Garcia-Ojalvo, Jordi] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Ruffini, Giulio] Neuroelectrics Corp, Cambridge, MA USA	Pompeu Fabra University	Ibanez-Soria, D (corresponding author), Starlab Barcelona SL, Neurosci Res Business Unit, Barcelona, Spain.	david.ibanez@starlab.es	Garcia-Ojalvo, Jordi/A-4574-2009	Garcia-Ojalvo, Jordi/0000-0002-3716-7520; Soria-Frisch, Aureli/0000-0002-4704-927X	European Commission [731827, 247730]; ICREA Academia program; Spanish Ministry of Economy and Competitiveness; FEDER [FIS2015-66503-C3-1-P]; FEDER (Maria de Maeztu Programme for Units of Excellence in RD) [MDM2014-0370]	European Commission(European CommissionEuropean Commission Joint Research Centre); ICREA Academia program(ICREA); Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER(European Commission); FEDER (Maria de Maeztu Programme for Units of Excellence in RD)	This work was partly supported by the European Commission through the STIPED project under the Horizon 2020 Program (H2020, Grant agreement number 731827) and the AsTeRICS project under the 7th Framework Program (FP7, Grant agreement number 247730), the ICREA Academia program and the Spanish Ministry of Economy and Competitiveness and FEDER (project FIS2015-66503-C3-1-P and Maria de Maeztu Programme for Units of Excellence in R&D, MDM2014-0370). The funder, Starlab, provided support in the form of salaries for authors DIS, ASF and GR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section. Co-author GR is employed by Neuroelectrics Corporation. Neuroelectrics Barcelona provided support in the form of salaries for GR but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section.	Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Buchner M, 2006, IEEE T NEURAL NETWOR, V17, P820, DOI 10.1109/TNN.2006.872357; Chen XG, 2014, BRAIN-COMPUT INTERFA, V1, P181, DOI 10.1080/2326263X.2014.944469; Cheng M, 2002, DESIGN IMPLEMENTATIO; Cheron G, 2007, NEUROSCI LETT, V414, P192, DOI 10.1016/j.neulet.2006.12.019; Coone A., 2011, 1 JOINT WIC IEEE S I; Coyle D, 2009, IEEE COMPUT INTELL M, V4, P47, DOI 10.1109/MCI.2009.934560; Dornhege G, 2007, NEURAL INFORM PROCES; Floriano A, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18020615; Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Giles CL, 1997, PROCEEDINGS OF THE IEEE/IAFE 1997 COMPUTATIONAL INTELLIGENCE FOR FINANCIAL ENGINEERING (CIFER), P253, DOI 10.1109/CIFER.1997.618945; Goldstein MR, 2015, SCHIZOPHR RES, V168, P145, DOI 10.1016/j.schres.2015.06.012; Hardoon DR, 2004, NEURAL COMPUT, V16, P2639, DOI 10.1162/0899766042321814; Hohreiter V, 2002, MEAS SCI TECHNOL, V13, P1072, DOI 10.1088/0957-0233/13/7/314; Horwitz A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171859; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; Ibanez-Soria D., 2017, ARXIV171008286; Iscan Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191673; Jaeger H., 2002, SHORT TERM MEMORY EC; Jaeger H., 2002, TUTORIAL TRAINING RE, V5; Jaeger H., 2001, 148 GMD GERM NAT RES; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kanoh S. I., 2017, BIOM ENG INT C BMEIC, P1; Kindermans P.-J., 2010, WORKSH MACH LEARN AS; Kronegg J., 2005, INFORM TRANSFER RATE; KUAN CM, 1995, J APPL ECONOMET, V10, P347, DOI 10.1002/jae.3950100403; Lin ZL, 2007, IEEE T BIO-MED ENG, V54, P1172, DOI 10.1109/TBME.2006.889197; Lukosevicius Mantas, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P659, DOI 10.1007/978-3-642-35289-8_36; Lukosevicius M, 2012, KUNSTL INTELL, V26, P365, DOI 10.1007/s13218-012-0204-5; Macpherson H, 2009, BRAIN COGNITION, V69, P571, DOI 10.1016/j.bandc.2008.12.003; Macpherson HN, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00070; Manjunath G., 2012, THEORY INPUT DRIVEN; Martens James, 2011, P 28 INT C MACH LEAR, P1033, DOI DOI 10.1145/346152.346166; Merkel C, 2014, PROCEDIA COMPUT SCI, V41, P249, DOI 10.1016/j.procs.2014.11.110; Ossmann R, 2012, 4 INT C SOFTW DEV EN, P11; Pei F, 2014, J VISION, V14, DOI 10.1167/14.11.3; PERSON R. S., 1964, MED ELECTRONICS AND BIOL ENGNG, V2, P155, DOI 10.1007/BF02484214; Ruffini G, 2016, LECT NOTES COMPUT SC, V9886, P306, DOI 10.1007/978-3-319-44778-0_36; Martinez JDS, 2012, B ASOC GEOGR ESP, P479; Schrauwen B, 2007, LECT NOTES COMPUT SC, V4668, P471; Sheykhivand S., COMPARISON DIFFERENT; Shih JJ, 2012, MAYO CLIN PROC, V87, P268, DOI 10.1016/j.mayocp.2011.12.008; Soria D., 2018, BIORXIV; Tokovarov M., 2017, EL DEV PROC ENV PROT, P1; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wang Y, 2010, ELECTRON LETT, V46, P1057, DOI 10.1049/el.2010.0923; Williams RJ, 1989, NEURAL COMPUT, V1, P270, DOI 10.1162/neco.1989.1.2.270; Xie SY, 2016, COMPUT INTEL NEUROSC, V2016, DOI 10.1155/2016/6410718; Yildiz IB, 2012, NEURAL NETWORKS, V35, P1, DOI 10.1016/j.neunet.2012.07.005; Zhu Danhua, 2010, Comput Intell Neurosci, P702357, DOI 10.1155/2010/702357	51	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0218771	10.1371/journal.pone.0218771	http://dx.doi.org/10.1371/journal.pone.0218771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276505	Green Published, gold, Green Submitted			2022-12-26	WOS:000484936300021
J	Ortiz-Rodriguez, JM; da Silva, CB; Masot, J; Redondo, E; Gazquez, A; Tapia, JA; Gil, C; Ortega-Ferrusola, C; Pena, FJ				Ortiz-Rodriguez, Jose M.; da Silva, Carolina Balao; Masot, Javier; Redondo, Eloy; Gazquez, Antonio; Tapia, Jose A.; Gil, Cruz; Ortega-Ferrusola, Cristina; Pena, Fernando J.			Rosiglitazone in the thawing medium improves mitochondrial function in stallion spermatozoa through regulating Akt phosphorylation and reduction of caspase 3	PLOS ONE			English	Article							SEMINAL PLASMA ANTIOXIDANTS; ACTIVATED RECEPTOR-GAMMA; FLOW-CYTOMETRY; OXIDATIVE STRESS; MOTION CHARACTERISTICS; MEMBRANE INTEGRITY; LIPID-PEROXIDATION; COOLING RATE; SPERM; CRYOPRESERVATION	Background The population of stallion spermatozoa that survive thawing experience compromised mitochondrial functionality and accelerated senescence, among other changes. It is known that stallion spermatozoa show very active oxidative phosphorylation that may accelerate sperm senescence through increased production of reactive oxygen species. Rosiglitazone has been proven to enhance the glycolytic capability of stallion spermatozoa maintained at ambient temperature. Objectives Thus, we hypothesized that thawed sperm may also benefit from rosiglitazone supplementation. Materials and methods Thawed sperm were washed and resuspended in Tyrodes media, and the samples were divided and supplemented with 0 or 75 mu M rosiglitazone. After one and two hours of incubation, mitochondrial functionality, Akt phosphorylation and caspase 3 activity were evaluated. Additional samples were incubated in the presence of an Akt1/2 inhibitor, compound C (an AMPK inhibitor) or GW9662 (an antagonist of the PPAR. receptor). Results Rosiglitazone maintained Akt phosphorylation and reduced caspase 3 activation (p< 0.01), both of which were prevented by incubation in the presence of the three inhibitors. Rosiglitazone also enhanced mitochondrial functionality (P< 0.01). Conclusion We provide the first evidence that the functionality of frozen stallion spermatozoa can be potentially improved after thawing through the activation of pro survival pathways, providing new clues for improving current sperm biotechnology.	[Ortiz-Rodriguez, Jose M.; Masot, Javier; Redondo, Eloy; Gazquez, Antonio; Tapia, Jose A.; Gil, Cruz; Ortega-Ferrusola, Cristina; Pena, Fernando J.] Univ Extremadura, Vet Teaching Hosp, Lab Equine Reprod & Equine Spermatol, Caceres, Spain; [da Silva, Carolina Balao] Super Agr Sch Elvas, Portalagre Polytech Inst, Elvas, Portugal	Universidad de Extremadura	Pena, FJ (corresponding author), Univ Extremadura, Vet Teaching Hosp, Lab Equine Reprod & Equine Spermatol, Caceres, Spain.	fjuanpvega@unex.es	Ortega-Ferrusola, Cristina/AGI-8478-2022; Peña, Fernando J/D-8450-2012; Ortiz-Rodríguez, Jose Manuel/AAP-2305-2021; Tapia, Jose A./C-5181-2008; Masot, Antonio/J-9845-2017; REDONDO, ELOY/J-9107-2017	Ortega-Ferrusola, Cristina/0000-0002-7698-8735; Peña, Fernando J/0000-0002-1311-2947; Ortiz-Rodríguez, Jose Manuel/0000-0002-3248-6493; Tapia, Jose A./0000-0002-3614-6867; Masot, Antonio/0000-0003-0713-7061; REDONDO, ELOY/0000-0001-7702-5300; Balao da Silva, Carolina Maria/0000-0002-9230-3919	Ministerio de Economia y Competitividad-FEDER, Madrid, Spain [AGL2017-83149-R]; Junta de Extremadura-FEDER [IB16030, GR18008]; IP	Ministerio de Economia y Competitividad-FEDER, Madrid, Spain; Junta de Extremadura-FEDER; IP	This work was supported by Ministerio de Economia y Competitividad-FEDER, Madrid, Spain, grants AGL2017-83149-R, Junta de Extremadura-FEDER (IB16030 and GR18008). IP for the grants FJPV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received financial support for this study from the Ministerio de Economia y Competitividad-FEDER, Madrid, Spain, grants AGL2017-83149-R, Junta de Extremadura-FEDER (IB16030 and GR18008).	Agarwal A, 2018, ANDROLOGIA, V50, DOI 10.1111/and.12796; Agarwal A, 2017, INVESTIG CLIN UROL, V58, P385, DOI 10.4111/icu.2017.58.6.385; Agarwal A, 2017, REPROD BIOMED ONLINE, V34, P48, DOI 10.1016/j.rbmo.2016.10.008; Agarwal A, 2016, THER ADV UROL, V8, P302, DOI 10.1177/1756287216652779; Agarwal A, 2016, FERTIL STERIL, V106, P566, DOI 10.1016/j.fertnstert.2016.05.013; Agarwal A, 2014, REPROD BIOMED ONLINE, V29, P32, DOI 10.1016/j.rbmo.2014.02.013; Ahmad G, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12773; Aitken JB, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.126052; Aitken RJ, 2011, REPRODUCTION, V141, P139, DOI 10.1530/REP-10-0232; Aitken RJ, 2015, ASIAN J ANDROL, V17, P633, DOI 10.4103/1008-682X.153850; Aquila S, 2006, J CELL PHYSIOL, V209, P977, DOI 10.1002/jcp.20807; Bajerski F, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00921; da Silva CMB, 2016, REPROD DOMEST ANIM, V51, P18, DOI 10.1111/rda.12640; da Silva CMB, 2014, REPROD DOMEST ANIM, V49, P1021, DOI 10.1111/rda.12431; BEDFORD SJ, 1995, THERIOGENOLOGY, V43, P955, DOI 10.1016/0093-691X(95)00045-A; Bobe G, 2017, REDOX BIOL, V12, P121, DOI 10.1016/j.redox.2017.02.010; Chester C, 2015, J IMMUNOL, V195, P773, DOI 10.4049/jimmunol.1500633; Cordova A, 2014, CRYOBIOLOGY, V69, P473, DOI 10.1016/j.cryobiol.2014.10.008; Cossarizza A, 2017, EUR J IMMUNOL, V47, P1584, DOI 10.1002/eji.201646632; Darr CR, 2016, THERIOGENOLOGY, V86, P1382, DOI 10.1016/j.theriogenology.2016.04.082; Darr CR, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140707; Engel KM, 2018, ANDROLOGY-US, V6, P335, DOI 10.1111/andr.12467; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Bolanos JMG, 2014, REPROD DOMEST ANIM, V49, P657, DOI 10.1111/rda.12343; Bolanos JMG, 2014, REPRODUCTION, V148, P221, DOI 10.1530/REP-13-0191; Gallon F, 2006, FERTIL STERIL, V86, P1526, DOI 10.1016/j.fertnstert.2006.03.055; Gibb Z, 2013, THERIOGENOLOGY, V79, P1027, DOI 10.1016/j.theriogenology.2013.01.013; Gibb Z, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.116.140509; Gibb Z, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131326; Gibb Z, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118539; Gil MC, 2018, ANIM REPROD SCI, V189, P69, DOI 10.1016/j.anireprosci.2017.12.009; Martin-Moro JG, 2009, J ORAL MAXIL SURG, V67, P1320, DOI 10.1016/j.joms.2008.12.018; Gonzalez-Fernandez L, 2012, THERIOGENOLOGY, V78, P415, DOI 10.1016/j.theriogenology.2012.02.021; Graham JK, 1996, EQUINE PRACT, V12, P131; Gur Y, 2008, MOL CELL ENDOCRINOL, V282, P45, DOI 10.1016/j.mce.2007.11.015; Hall SE, 2017, BIOL REPROD, V96, P107, DOI 10.1095/biolreprod.116.145292; Heiskanen M L, 1987, J Reprod Fertil Suppl, V35, P103; Heitland AV, 1996, EQUINE VET J, V28, P47, DOI 10.1111/j.2042-3306.1996.tb01589.x; HENRY MA, 1993, FERTIL STERIL, V60, P911; Heutelbeck A, 2015, REPROD DOMEST ANIM, V50, P76, DOI 10.1111/rda.12451; Huang FY, 2018, ONCOL LETT, V16, P1975, DOI 10.3892/ol.2018.8833; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kumar P, 2018, LIFE SCI, V209, P24, DOI 10.1016/j.lfs.2018.07.056; Lakpour N, 2012, SYST BIOL REPROD MED, V58, P236, DOI 10.3109/19396368.2012.689923; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lewis SEM, 1997, FERTIL STERIL, V67, P142, DOI 10.1016/S0015-0282(97)81871-7; Li JW, 2018, THERIOGENOLOGY, V107, P27, DOI 10.1016/j.theriogenology.2017.10.035; Macias-Garcia B, 2012, ANIM REPROD SCI, V132, P74, DOI 10.1016/j.anireprosci.2012.03.017; Mair F, 2016, EUR J IMMUNOL, V46, P34, DOI 10.1002/eji.201545774; Malsy M, 2019, EUR J MED RES, V24, DOI 10.1186/s40001-019-0365-x; Munoz PM, 2018, REPROD DOMEST ANIM, V53, P54, DOI 10.1111/rda.13052; Munoz PM, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.139444; Munoz PM, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132878; Mazur P, 2002, BIOL REPROD, V66, P1485, DOI 10.1095/biolreprod66.5.1485; Rodriguez AM, 2012, REPROD DOMEST ANIM, V47, P995, DOI 10.1111/j.1439-0531.2012.02005.x; Morrell JM, 2011, THERIOGENOLOGY, V76, P1424, DOI 10.1016/j.theriogenology.2011.06.011; Mostafa T, 2012, ANDROLOGIA, V44, P66, DOI 10.1111/j.1439-0272.2010.01111.x; Najafi A, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12601; Najafi A, 2016, FERTIL STERIL, V106, P1658, DOI 10.1016/j.fertnstert.2016.09.004; Nakada K, 2006, P NATL ACAD SCI USA, V103, P15148, DOI 10.1073/pnas.0604641103; Neagu VR, 2011, THERIOGENOLOGY, V75, P10, DOI 10.1016/j.theriogenology.2010.07.004; Olaciregui M, 2014, CRYOBIOLOGY, V68, P91, DOI 10.1016/j.cryobiol.2013.12.009; Oldenhof H, 2017, BIOPRESERV BIOBANK, V15, P422, DOI 10.1089/bio.2017.0061; Ferrusola CO, 2017, ANDROLOGY-US, V5, P1174, DOI 10.1111/andr.12419; Ferrusola CO, 2009, BIOL REPROD, V81, P1106, DOI 10.1095/biolreprod.109.078220; Ferrusola CO, 2009, REPRODUCTION, V138, P55, DOI [10.1530/REP-08-0484, 10.1530/RFP-08-0484]; Ortega-Ferrusola C, 2008, J ANDROL, V29, P213, DOI 10.2164/jandrol.107.003640; Ortega-Ferrusola C, 2017, REPROD DOMEST ANIM, V52, P921, DOI 10.1111/rda.13043; Ortega-Ferrusola C, 2017, REPRODUCTION, V153, P293, DOI 10.1530/REP-16-0539; Ortega-Ferrusola C, 2019, BIOL REPROD, V100, P1090, DOI 10.1093/biolre/ioy241; OVERTON WR, 1988, CYTOMETRY, V9, P619, DOI 10.1002/cyto.990090617; Paasch U, 2004, BIOL REPROD, V71, P1828, DOI 10.1095/biolreprod.103.025627; Pena FJ, 2015, REPROD DOMEST ANIM, V50, P529, DOI 10.1111/rda.12551; Pena FJ, 2003, THERIOGENOLOGY, V60, P677, DOI 10.1016/S0093-691X(03)00081-5; Petrunkina AM, 2005, J CELL PHYSIOL, V204, P508, DOI 10.1002/jcp.20317; Davila MP, 2016, REPRODUCTION, V152, P683, DOI 10.1530/REP-16-0409; Davila MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138777; Pujianto DA, 2010, ENDOCRINOLOGY, V151, P1269, DOI 10.1210/en.2009-0964; Ribeiro M, 2014, FREE RADICAL BIO MED, V74, P129, DOI 10.1016/j.freeradbiomed.2014.06.023; Santoro M, 2013, J EXP BIOL, V216, P1085, DOI 10.1242/jeb.079327; Shekhar K, 2014, P NATL ACAD SCI USA, V111, P202, DOI 10.1073/pnas.1321405111; Silva JV, 2015, FERTIL STERIL, V104, P845, DOI 10.1016/j.fertnstert.2015.06.039; Stuhtmann G, 2012, ANIM REPROD SCI, V133, P184, DOI 10.1016/j.anireprosci.2012.06.017; Swegen A, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.142687; Swegen A, 2015, REPRODUCTION, V149, P235, DOI 10.1530/REP-14-0500; Wang M, 2017, PEERJ, V5, DOI 10.7717/peerj.3339	86	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0211994	10.1371/journal.pone.0211994	http://dx.doi.org/10.1371/journal.pone.0211994			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276504	gold, Green Published, Green Submitted			2022-12-26	WOS:000484936300004
J	Kim, DH; Kim, DW; Park, JY; Lee, YJ; Choo, HJ; Ha, TK; Jung, SJ; Park, JS; Moon, SH; Ahn, KJ; Baek, HJ				Kim, Do Hun; Kim, Dong Wook; Park, Jin Young; Lee, Yoo Jin; Choo, Hye Jung; Ha, Tae Kwun; Jung, Soo Jin; Park, Ji Sun; Moon, Sung Ho; Ahn, Ki Jung; Baek, Hye Jin			Ultrasound detection of incidental diffuse parotid disease: A single-center study	PLOS ONE			English	Article							SALIVARY-GLAND ULTRASONOGRAPHY	In this study, we compared ultrasound (US) features between normal parotid parenchyma (NPP) and incidental diffuse parotid disease (DPD). From January 2008 to December 2017, 180 patients underwent neck US before parotid surgery at our hospital. From these, 82 were excluded because of the lack of histopathological data concerning the parotid parenchyma or inadequate US images. A single radiologist blinded to the clinicoserological data and histopathological results, retrospectively investigated all US features and categorizations for the parotid glands using a picture archiving and communication system. Retrospective histopathological analysis of the parotid parenchyma was performed by a single pathologist. On the basis of the histopathological analyses, the 98 patients were divided into NPP (n = 70) and DPD (n = 28) groups. Among US features, parenchymal echogenicity and echotexture showed statistically significant differences between the two groups (p < 0.0001), whereas the gland size, margin, and vascularity showed no significant differences (p > 0.05). The US-based categorization significantly differentiated between NPP and DPD (p < 0.0001), and receiver operating characteristic curve analysis revealed that US categorization based on. 2 abnormal US features showed the best diagnostic performance for detecting DPD. Thus, US can aid in differentiating DPD from NPP.	[Kim, Do Hun] Inje Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Busan Paik Hosp, Busan, South Korea; [Kim, Dong Wook; Park, Jin Young; Lee, Yoo Jin; Choo, Hye Jung] Inje Univ, Coll Med, Busan Paik Hosp, Dept Radiol, Busan, South Korea; [Ha, Tae Kwun] Inje Univ, Coll Med, Busan Paik Hosp, Dept Gen Surg, Busan, South Korea; [Jung, Soo Jin] Inje Univ, Coll Med, Busan Paik Hosp, Dept Pathol, Busan, South Korea; [Park, Ji Sun] Inje Univ, Coll Med, Busan Paik Hosp, Dept Nucl Med, Busan, South Korea; [Moon, Sung Ho] Inje Univ, Coll Med, Busan Paik Hosp, Dept Anesthesiol & Pain Med, Busan, South Korea; [Ahn, Ki Jung] Inje Univ, Coll Med, Busan Paik Hosp, Dept Radiat Oncol, Busan, South Korea; [Baek, Hye Jin] Gyeongsang Natl Univ, Sch Med, Changwon Hosp, Dept Radiol, Chang Won, South Korea	Inje University; Inje University; Inje University; Inje University; Inje University; Inje University; Inje University; Gyeongsang National University	Kim, DW (corresponding author), Inje Univ, Coll Med, Busan Paik Hosp, Dept Radiol, Busan, South Korea.	dwultra@nate.com	Baek, Hye Jin/AAC-7595-2020; Kim, Dong Wook/I-7600-2015	Baek, Hye Jin/0000-0001-7349-2841; TAEKWUN, HA/0000-0001-7980-3700; Kim, Dong Wook/0000-0002-9826-1326; Jung, Soo Jin/0000-0002-9139-701X				Afzelius P, 2016, CLIN PHYSIOL FUNCT I, V36, P1, DOI 10.1111/cpf.12199; Carotti M, 2014, CLIN EXP RHEUMATOL, V32, pS61; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fidelix T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182287; Fujita A, 2018, NEUROIMAG CLIN N AM, V28, P183, DOI 10.1016/j.nic.2018.01.003; Hammenfors DS, 2015, CLIN EXP RHEUMATOL, V33, P56; Kim DW, 2010, AM J NEURORADIOL, V31, P1956, DOI 10.3174/ajnr.A2164; Kim DW, 2015, ENDOCR PRACT, V21, P910, DOI 10.4158/EP15646.OR; Lazarus MN, 2006, RHEUMATOLOGY, V45, P1012, DOI 10.1093/rheumatology/kei281; Milic V, 2012, RHEUMATOLOGY, V51, P1081, DOI 10.1093/rheumatology/ker431; Onkar PM, 2013, ULTRASOUND Q, V29, P313, DOI 10.1097/RUQ.0b013e3182a0abe0; Pedersen OM, 2000, THYROID, V10, P251, DOI 10.1089/thy.2000.10.251; Theander E, 2014, ARTHRIT CARE RES, V66, P1102, DOI 10.1002/acr.22264	13	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219308	10.1371/journal.pone.0219308	http://dx.doi.org/10.1371/journal.pone.0219308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269074	Green Published, gold, Green Submitted			2022-12-26	WOS:000484927300059
J	Surtees, B; Young, S; Hu, YX; Wang, GN; McChesney, E; Kuroki, G; Acree, P; Thomas, S; Blair, T; Rastogi, S; Kraitchman, DL; Weiss, C; Sukumar, S; Harvey, SC; Durr, NJ				Surtees, Bailey; Young, Sean; Hu, Yixin; Wang, Guannan; McChesney, Evelyn; Kuroki, Grace; Acree, Pascal; Thomas, Serena; Blair, Tara; Rastogi, Shivam; Kraitchman, Dara L.; Weiss, Clifford; Sukumar, Saraswati; Harvey, Susan C.; Durr, Nicholas J.			Validation of a low-cost, carbon dioxide-based cryoablation system for percutaneous tumor ablation	PLOS ONE			English	Article							BREAST-CANCER; CRYOTHERAPY; PREVENTION; MANAGEMENT	Breast cancer rates are rising in low- and middle-income countries (LMICs), yet there is a lack of accessible and cost-effective treatment. As a result, the cancer burden and death rates are highest in LMICs. In an effort to meet this need, our work presents the design and feasibility of a low-cost cryoablation system using widely-available carbon dioxide as the only consumable. This system uses an 8-gauge outer-diameter needle and Joule-Thomson expansion to percutaneously necrose tissue with cryoablation. Bench top experiments characterized temperature dynamics in ultrasound gel demonstrated that isotherms greater than 2 cm were formed. Further, this system was applied to mammary tumors in an in vivo rat model and necrosis was verified by histopathology. Finally, freezing capacity under a large heat load was assessed with an in vivo porcine study, where volumes of necrosis greater than 1.5 cm in diameter confirmed by histopathology were induced in a highly perfused liver after two 7-minute freeze cycles. These results demonstrate the feasibility of a carbon-dioxide based cryoablation system for improving solid tumor treatment options in resource-constrained environments.	[Surtees, Bailey; Young, Sean; Hu, Yixin; McChesney, Evelyn; Kuroki, Grace; Acree, Pascal; Thomas, Serena; Blair, Tara; Rastogi, Shivam; Durr, Nicholas J.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Wang, Guannan; Sukumar, Saraswati] Johns Hopkins Med, Dept Oncol, Baltimore, MD USA; [Kraitchman, Dara L.; Weiss, Clifford; Harvey, Susan C.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Kraitchman, Dara L.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Weiss, Clifford; Durr, Nicholas J.] Johns Hopkins Univ, Ctr Bioengn Innovat & Design, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Durr, NJ (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.; Durr, NJ (corresponding author), Johns Hopkins Univ, Ctr Bioengn Innovat & Design, Baltimore, MD 21218 USA.	ndurr@jhu.edu	Wang, Guannan/AAV-2892-2020; Durr, Nicholas/W-5517-2018	Wang, Guannan/0000-0001-6973-2427; Durr, Nicholas/0000-0001-9808-7383; Acree, Pascal/0000-0002-1711-7235	Armour Women's Health & Breast Cancer Innovation Grant through the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Center for Bioengineering Innovation and Design and the Biomedical Engineering Department at Johns Hopkins University	Armour Women's Health & Breast Cancer Innovation Grant through the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Center for Bioengineering Innovation and Design and the Biomedical Engineering Department at Johns Hopkins University	This work was funded by an Under Armour Women's Health & Breast Cancer Innovation Grant through the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and was awarded to ND with grant detailed below: https://ictr.johnshopkins.edu/wp-content/uploads/2017/06/UA-Innovation-RFA-Sept-2017_kws.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Center for Bioengineering Innovation and Design and the Biomedical Engineering Department at Johns Hopkins University for research support, as well as: Monica Rex, Yechan Kang, Nikhil Jois, Alwin Hui, Sonia Trakru, Sarah Lee, Sanjay Elangovan, Ben Lee, Marton Varady, and Sue Lucas.	Anderson BO, 2015, BREAST J, V21, P111, DOI 10.1111/tbj.12357; Beji H, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170500; Callstrom MR, 2008, GASTROENTEROLOGY, V134, P1831, DOI 10.1053/j.gastro.2008.05.022; Erinjeri JP, 2010, J VASC INTERV RADIOL, V21, pS187, DOI 10.1016/j.jvir.2009.12.403; Etheridge ML, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023237; Ferlay J., 2015, INT J CANCER, V136, P5; Hafron J, 2007, NAT CLIN PRACT UROL, V4, P261, DOI 10.1038/ncpuro0802; Laviana AA, 2016, CANCER-AM CANCER SOC, V122, P447, DOI 10.1002/cncr.29743; Littrup PJ, 2009, J VASC INTERV RADIOL, V20, P1329, DOI 10.1016/j.jvir.2009.06.029; Littrup PJ, 2009, J VASC INTERV RADIOL, V20, P1343, DOI 10.1016/j.jvir.2009.05.038; McTaggart RA, 2007, TECH VASC INTERV RAD, V10, P102, DOI 10.1053/j.tvir.2007.09.004; Murata S, 2006, CANCER RES, V66, P638, DOI 10.1158/0008-5472.CAN-05-4329; Niu LZ, 2013, CRYOBIOLOGY, V67, P17, DOI 10.1016/j.cryobiol.2013.04.004; Page David B, 2014, MATCHED T CELL REPER, V2, P138; Pfleiderer SOR, 2002, EUR RADIOL, V12, P3009, DOI 10.1007/s00330-002-1511-2; Pillay AL, 2002, ETHNIC HEALTH, V7, P103, DOI 10.1080/1355785022000038588; Ritch CR, 2009, CURR OPIN UROL, V19, P177, DOI 10.1097/MOU.0b013e32831e16ce; Sabel MS, 2005, BREAST CANCER RES TR, V90, P97, DOI 10.1007/s10549-004-3289-1; Sabel MS, 2004, ANN SURG ONCOL, V11, P542, DOI 10.1245/ASO.2004.08.003; Sankaranarayanan R, 2010, ANN ONCOL, V21, P1935, DOI 10.1093/annonc/mdq049; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Staren ED, 1997, ARCH SURG-CHICAGO, V132, P28; SUKUMAR S, 1983, NATURE, V306, P658, DOI 10.1038/306658a0; Taylor AL., 2016, CARBONATING WORLD MA, DOI 10.13140/RG.2.1.1929.9601; Theodorescu Dan, 2004, Rev Urol, V6 Suppl 4, pS9; Weimar T, 2012, INNOVATIONS, V7, P410, DOI 10.1097/IMI.0b013e31828534e5; Winkler JL, 2010, INT J GYNECOL OBSTET, V111, P73, DOI 10.1016/j.ijgo.2010.04.032; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0207107	10.1371/journal.pone.0207107	http://dx.doi.org/10.1371/journal.pone.0207107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269078	Green Published, Green Submitted, gold			2022-12-26	WOS:000484927300001
J	Nie, YF; Hu, J; Hou, QL; Zheng, WO; Zhang, XH; Yang, T; Ma, LB; Yan, XH				Nie, Yangfan; Hu, Jun; Hou, Qiliang; Zheng, Wenvong; Zhang, Xianghua; Yang, Tao; Ma, Libao; Yan, Xianghua			Lactobacillus frumenti improves antioxidant capacity via nitric oxide synthase 1 in intestinal epithelial cells	FASEB JOURNAL			English	Article						L; frumenti; ROS; NOS1; proteomics	GERM-FREE MICE; GUT MICROBIOTA; OXIDATIVE STRESS; MODEL; BARRIER; INJURY; IRON; PROBIOTICS; PROTEOMICS; ENZYME	Oxidative damages have adverse effects on mammals. Growing studies have focused on exploring new antioxidants. Here, we report that Lactobacillus frumenti increases the total antioxidation capacity activities and decreases the total reactive oxygen species levels in porcine intestinal epithelial cells. Comparative proteomics revealed that expressions of peroxiredoxin 2, isocitrate dehydrogenase 1, NAD(P)H dehydrogenase quinone 1, antioxidant protein 1, and metallothionein-2A, which are associated with antioxidant defense system, were significantly increased with L. frumenti treatment. In germ-free mice, L. frumenti treatment also remarkably improves the intestinal antioxidant capacity. We further illustrated that nitric oxide production-mediated by nitric oxide synthase 1 activation is essential for L. frumenti-induced improvements in intestinal epithelial antioxidant capacity and barrier function. This study suggested that L. frumenti may be a potential probiotic used to prevent oxidative stress-induced aging and diseases in mammals.-Nie, Y., Hu, J., Hou, Q., Zheng, W., Zhang, X., Yang, T., Ma, L., Yan, X. Lactobacillus frumenti improves antioxidant capacity via nitric oxide synthase 1 in intestinal epithelial cells.	[Nie, Yangfan; Hu, Jun; Hou, Qiliang; Zheng, Wenvong; Zhang, Xianghua; Yang, Tao; Ma, Libao; Yan, Xianghua] Huazhong Agr Univ, Coll Anim Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Nie, Yangfan; Hu, Jun; Hou, Qiliang; Zheng, Wenvong; Zhang, Xianghua; Yang, Tao; Ma, Libao; Yan, Xianghua] Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan, Hubei, Peoples R China; [Nie, Yangfan; Hu, Jun; Hou, Qiliang; Zheng, Wenvong; Zhang, Xianghua; Yang, Tao; Ma, Libao; Yan, Xianghua] Hubei Prov Engn Lab Pig Precis Feeding & Feed Saf, Wuhan, Hubei, Peoples R China; [Nie, Yangfan; Hu, Jun; Hou, Qiliang; Zheng, Wenvong; Zhang, Xianghua; Yang, Tao; Ma, Libao; Yan, Xianghua] Natl Ctr Int Res Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Yan, XH (corresponding author), Huazhong Agr Univ, Shizishan St, Wuhan 430070, Hubei, Peoples R China.	xhyan@mail.hzau.edu.cn			National Natural Science Foundation of China [31730090, 31520103915, 31322053]; National Key Research and Development Program of China [2017YFD0500503, 2018YFD0500404]; Hubei Provincial Natural Science Foundation of China [2018CFA020]; Fundamental Research Funds for the Central Universities [2013PY056, 2662015PY111, 2013JQ001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Research funding was provided by the National Natural Science Foundation of China (31730090, 31520103915, and 31322053), the National Key Research and Development Program of China (2017YFD0500503 and 2018YFD0500404), Hubei Provincial Natural Science Foundation of China (2018CFA020), and the Fundamental Research Funds for the Central Universities (2013PY056, 2662015PY111, and 2013JQ001). The authors declare no conflicts of interest.	Al-Asmakh M, 2015, J MICROBIOL BIOTECHN, V25, P1583, DOI 10.4014/jmb.1501.01039; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Bhattarai Y, 2016, METHODS MOL BIOL, V1438, P123, DOI 10.1007/978-1-4939-3661-8_8; Bianchet MA, 2004, METHOD ENZYMOL, V382, P144; Bloodsworth A, 2000, ARTERIOSCL THROM VAS, V20, P1707, DOI 10.1161/01.ATV.20.7.1707; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Cai X, 2013, MOL CELL BIOCHEM, V378, P73, DOI 10.1007/s11010-013-1595-9; Campbell JM, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-19; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Correa-Aragunde N, 2004, PLANTA, V218, P900, DOI 10.1007/s00425-003-1172-7; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Garcia CR, 2012, DALTON T, V41, P6458, DOI 10.1039/c2dt30060e; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Gorbunov NV, 1997, J BIOL CHEM, V272, P12328, DOI 10.1074/jbc.272.19.12328; Grover M, 2014, NEUROGASTROENT MOTIL, V26, P745, DOI 10.1111/nmo.12366; Hatori Y, 2017, IUBMB LIFE, V69, P246, DOI 10.1002/iub.1620; Hu J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03025; Hu J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00897; Hu J, 2017, INT J BIOCHEM CELL B, V89, P42, DOI 10.1016/j.biocel.2017.05.026; Hu J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01727; Huang HY, 2015, J BIOL CHEM, V290, P11119, DOI 10.1074/jbc.M114.608075; Huang Y, 2019, PEST MANAG SCI, V75, P444, DOI 10.1002/ps.5135; Jarry A, 2003, KIDNEY INT, V64, P170, DOI 10.1046/j.1523-1755.2003.00078.x; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Jung M, 2009, TOXICOL APPL PHARM, V234, P236, DOI 10.1016/j.taap.2008.10.014; Kagan VE, 2001, ANTIOXID REDOX SIGN, V3, P189, DOI 10.1089/152308601300185160; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Liu HY, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12355; Maeng O, 2004, BIOCHEM BIOPH RES CO, V317, P558, DOI 10.1016/j.bbrc.2004.03.075; Maxmen A, 2012, NATURE, V486, P453, DOI 10.1038/486453a; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Mishra V, 2015, J AGR FOOD CHEM, V63, P3615, DOI 10.1021/jf506326t; Murakami S, 2014, NEUROTOX RES, V26, P285, DOI 10.1007/s12640-014-9480-1; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Nielsen KL, 2014, AM J CLIN NUTR, V99, P941, DOI 10.3945/ajcn.113.074724; Patlevic P, 2016, INTEGR MED RES, V5, P250, DOI 10.1016/j.imr.2016.07.004; Ramakrishna BS, 2013, J GASTROEN HEPATOL, V28, P9, DOI 10.1111/jgh.12294; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Samoylenko A, 2013, ANTIOXID REDOX SIGN, V19, P2157, DOI 10.1089/ars.2012.4662; Sanchez-Font MF, 2003, CELL MOL LIFE SCI, V60, P1513, DOI 10.1007/s00018-003-3048-1; Shan J, 2007, NITRIC OXIDE-BIOL CH, V17, P25, DOI 10.1016/j.niox.2007.05.001; Sohn SH, 2009, ANN NUTR METAB, V54, P227, DOI 10.1159/000225378; Song DG, 2017, ACS APPL MATER INTER, V9, P14724, DOI 10.1021/acsami.7b03377; Steck N, 2011, GASTROENTEROLOGY, V141, P959, DOI 10.1053/j.gastro.2011.05.035; Tuncer S, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01336; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001; Wang H, 2018, GENE, V677, P119, DOI 10.1016/j.gene.2018.07.059; Wang Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050521; Wen B, 2014, PROTEOMICS, V14, P2280, DOI 10.1002/pmic.201300361; Xu WZ, 2018, CELL MOL NEUROBIOL, V38, P735, DOI 10.1007/s10571-017-0540-y; Yi P, 2012, VET MICROBIOL, V157, P1, DOI 10.1016/j.vetmic.2011.10.024; Yin J, 2014, J ANIM SCI, V92, P612, DOI 10.2527/jas.2013-6986; Zhu MM, 2009, MOL CELL PROTEOMICS, V8, P752, DOI 10.1074/mcp.M800343-MCP200	58	8	8	5	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10705	10716		10.1096/fj.201900253RR	http://dx.doi.org/10.1096/fj.201900253RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31262191	Bronze			2022-12-26	WOS:000489166300011
J	Sani, MA; Zhu, SY; Hofferek, V; Separovic, F				Sani, Marc-Antoine; Zhu, Shiying; Hofferek, Vinzenz; Separovic, Frances			Nitroxide spin-labeled peptides for DNP-NMR in-cell studies	FASEB JOURNAL			English	Article						in-cell NMR; antimicrobial peptides; E; coli bacteria; TOAC	DYNAMIC NUCLEAR-POLARIZATION; MEMBRANE-ACTIVE PEPTIDES; SPECTROSCOPY; MECHANISM	Antimicrobial peptides (AMPs) that target lipid membranes show promise as alternatives to conventional antibiotics. However, the molecular mechanisms of membrane perturbation, as most studies are performed in model systems and in-cell structural studies, have yet to be achieved. Solid-state NMR spectroscopy is a valuable technique to investigate peptide-membrane interactions and to determine the structure of peptides, but the short lifespan of bacteria, especially under magic angle spinning conditions, has not permitted in-cell structural studies. Here, we present the first dynamic nuclear polarization (DNP)-NMR in-cell studies of Escherichia coli bacteria incubated with the AMP maculatin 1.1 (Mac1) in combination with novel nitroxide spin-labeled peptides 2,2,6,6-tetramethylpiperidine-N-oxyl-4-amino-4-carboxylic acid (TOAC)-[F3W]-Mac1 (MacW) and TOAC-TOAC-MacW. The in-cell C-13 and N-15 signal NMR enhancements, and H-1 spin-lattice T-1 relaxation times showed that TOAC-MacW and TOAC-TOAC-MacW performed better than the more hydrophilic biradical AMUPol used for DNP studies. Furthermore, the pores formed by the AMP increased the signal enhancements and decreased T-1 values of specifically C-13- and N-15-labeled Mac1. This approach has a great potential for determining the first in situ structures of AMPs in bacteria.-Sani, M.-A., Zhu, S., Hofferek, V., Separovic, F. Nitroxide spin-labeled peptides for DNP-NMR in-cell studies.	[Sani, Marc-Antoine; Zhu, Shiying; Hofferek, Vinzenz; Separovic, Frances] Univ Melbourne, Sch Chem, Bio21 Inst, Melbourne, Vic 3010, Australia	University of Melbourne	Sani, MA (corresponding author), Univ Melbourne, Sch Chem, Bio21 Inst, Melbourne, Vic 3010, Australia.	msani@unimelb.edu.au		Hofferek, Vinzenz/0000-0002-6150-1453; Sani, Marc-antoine/0000-0003-3284-2176	Australian Research Council (ARC) [DP160100959]; Linkage Infrastructure, Equipment and Facilities (LIEF) Grant [LE160100120]	Australian Research Council (ARC)(Australian Research Council); Linkage Infrastructure, Equipment and Facilities (LIEF) Grant	This research was funded by the Australian Research Council (ARC) Discovery Project Grant DP160100959 (to F.S). and Linkage Infrastructure, Equipment and Facilities (LIEF) Grant LE160100120 (to M.-A.S. and F.S.). The authors declare no conflicts of interest.	Aquila M, 2013, CURR PROTEIN PEPT SC, V14, P607; Fernandez-de-Alba C, 2015, CHEM-EUR J, V21, P4512, DOI 10.1002/chem.201404588; Haney EF, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00043; Hong M, 2011, PROTEIN SCI, V20, P641, DOI 10.1002/pro.600; Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4; Kumar P, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8010004; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; McCoy KM, 2019, J MAGN RESON, V303, P115, DOI 10.1016/j.jmr.2019.04.013; NAKAIE CR, 1981, BRAZ J MED BIOL RES, V14, P173; Ni QZ, 2013, ACCOUNTS CHEM RES, V46, P1933, DOI 10.1021/ar300348n; Overall SA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010181; Porcelli F, 2013, METHODS MOL BIOL, V1063, P159, DOI 10.1007/978-1-62703-583-5_9; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Sani MA, 2015, J MAGN RESON, V253, P138, DOI 10.1016/j.jmr.2014.11.016; Sani MA, 2013, ANTIMICROB AGENTS CH, V57, P3593, DOI 10.1128/AAC.00195-13; Sani MA, 2007, J PEPT SCI, V13, P100, DOI 10.1002/psc.803; Sani MA, 2016, ACCOUNTS CHEM RES, V49, P1130, DOI 10.1021/acs.accounts.6b00074; Sani MA, 2015, J BIOL CHEM, V290, P19853, DOI 10.1074/jbc.M115.643262; Sani MA, 2014, NEW DEV NMR, V3, P287; Sani MA, 2014, EUR BIOPHYS J BIOPHY, V43, P445, DOI 10.1007/s00249-014-0970-0; Sani MA, 2012, BBA-BIOMEMBRANES, V1818, P205, DOI 10.1016/j.bbamem.2011.07.015; Schreier Shirley, 2012, Biophys Rev, V4, P45, DOI 10.1007/s12551-011-0064-5; Sergeyev IV, 2017, P NATL ACAD SCI USA, V114, P5171, DOI 10.1073/pnas.1701484114; Smith AN, 2015, ANGEW CHEM INT EDIT, V54, P1542, DOI 10.1002/anie.201410249; Thankamony ASL, 2017, PROG NUCL MAG RES SP, V102, P120, DOI 10.1016/j.pnmrs.2017.06.002; van der Cruijsen EAW, 2015, CHEM-EUR J, V21, P12971, DOI 10.1002/chem.201501376; Vitzthum V, 2011, CHEMPHYSCHEM, V12, P2929, DOI 10.1002/cphc.201100630; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yamamoto K, 2015, BBA-BIOMEMBRANES, V1848, P342, DOI 10.1016/j.bbamem.2014.07.008; Zagdoun A, 2013, J AM CHEM SOC, V135, P12790, DOI 10.1021/ja405813t	30	22	22	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11021	11027		10.1096/fj.201900931R	http://dx.doi.org/10.1096/fj.201900931R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284743	Bronze			2022-12-26	WOS:000489166300037
J	Reddish, MJ; Guengerich, FP				Reddish, Michael J.; Guengerich, F. Peter			Human cytochrome P450 11B2 produces aldosterone by a processive mechanism due to the lactol form of the intermediate 18-hydroxycorticosterone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; steroid; steroidogenesis; enzyme kinetics; kinetics; pre-steady-state kinetics; conformational change; aldosterone synthesis; corticosterone; CYP11B2; deoxycorticosterone; P450 11B2	CHAIN CLEAVAGE ENZYME; CYP11B2 INHIBITORS; MUTATIONS; POTENT; CORTISOL; EXPRESSION; DISCOVERY; OXIDATION; EXPLORER; PYRIDYL	Human cytochrome P450 (P450) 11B2 catalyzes the formation of aldosterone, the major endogenous human mineralocorticoid. Aldosterone is important for the regulation of electrolyte homeostasis. Mutations and overexpression of P450 11B2 (also known as aldosterone synthase) can lead to hypertension, congestive heart failure, and diabetic nephropathy. The enzyme is therefore a target for drug development to manage these various disorders. P450 11B2 catalyzes aldosterone formation from 11-deoxycorticosterone through three distinct oxidation steps. It is currently unknown to which degree these reactions happen in sequence without the intermediate products dissociating from the enzyme (i.e. processively) or whether these reactions happen solely distributively, in which the intermediate products must first dissociate and then rebind to the enzyme before subsequent oxidation. We present here a comprehensive investigation of processivity in P450 11B2-catalyzed reactions using steady-state, pre-steady-state, pulse-chase, equilibrium-binding titrations, and stopped-flow binding studies. We utilized the data obtained to develop a kinetic model for P450 11B2 and tested this model by enzyme kinetics simulations. We found that although aldosterone is produced processively, the enzyme preferentially utilizes a distributive mechanism that ends with the production of 18-OH corticosterone. This seemingly contradictory observation could be resolved by considering the ability of the intermediate product 18-OH corticosterone to exist as a lactol form, with the equilibrium favoring the ring-closed lactol configuration. In summary, our refined model for P450 11B2 catalysis indicates isomerization of the intermediate to a lactol can explain why P450 11B2 must produce aldosterone through a processive mechanism despite favoring a distributive mechanism.	[Reddish, Michael J.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Reddish, Michael/D-9150-2013	Reddish, Michael/0000-0002-0237-786X	National Institutes of Health [R01 GM118122, T32 ES007028]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM118122 (to F. P. G.) and T32 ES007028 (to F. P. G. for support of M. J. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auchus RJ, 2017, J STEROID BIOCHEM, V165, P71, DOI 10.1016/j.jsbmb.2016.02.002; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Bottner B, 1996, J BIOL CHEM, V271, P8028; Boudi A, 1999, TETRAHEDRON, V55, P5171, DOI 10.1016/S0040-4020(99)00187-8; Chowdhury G, 2012, BIOCHEMISTRY-US, V51, P9995, DOI 10.1021/bi301092c; Chowdhury G, 2010, J BIOL CHEM, V285, P8031, DOI 10.1074/jbc.M109.088039; Curnow KM, 1997, NAT STRUCT BIOL, V4, P32, DOI 10.1038/nsb0197-32; Ferrari P, 2010, BBA-MOL BASIS DIS, V1802, P1178, DOI 10.1016/j.bbadis.2009.10.017; Gobbi S, 2016, J MED CHEM, V59, P2468, DOI 10.1021/acs.jmedchem.5b01609; Gonzalez E, 2017, J BIOL CHEM, V292, P13168, DOI 10.1074/jbc.M117.794917; GOUX WJ, 1985, J AM CHEM SOC, V107, P4320, DOI 10.1021/ja00300a041; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2017, CHEM RES TOXICOL, V30, P2, DOI 10.1021/acs.chemrestox.6b00226; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Hobler A, 2012, J STEROID BIOCHEM, V132, P57, DOI 10.1016/j.jsbmb.2012.03.002; Hoyt SB, 2015, ACS MED CHEM LETT, V6, P861, DOI 10.1021/acsmedchemlett.5b00048; Hu QZ, 2015, J MED CHEM, V58, P2530, DOI 10.1021/acs.jmedchem.5b00079; Hu QZ, 2010, J MED CHEM, V53, P5749, DOI 10.1021/jm100317b; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Imai T, 1998, BIOCHEMISTRY-US, V37, P8097, DOI 10.1021/bi9802768; Johnson KA, 2019, BEILSTEIN J ORG CHEM, V15, P16, DOI 10.3762/bjoc.15.2; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Katsumata N, 2002, J CLIN ENDOCR METAB, V87, P3808, DOI 10.1210/jc.87.8.3808; KEM DC, 1985, J CLIN ENDOCR METAB, V60, P67, DOI 10.1210/jcem-60-1-67; Kim CJ, 2008, J CLIN ENDOCR METAB, V93, P696, DOI 10.1210/jc.2007-2330; Martin RE, 2015, J MED CHEM, V58, P8054, DOI 10.1021/acs.jmedchem.5b00851; Mendieta MAEPB, 2013, J MED CHEM, V56, P6101, DOI 10.1021/jm400484p; Mulatero P, 1998, J CLIN ENDOCR METAB, V83, P3996, DOI 10.1210/jc.83.11.3996; Mulatero P, 2012, J CLIN ENDOCR METAB, V97, P881, DOI 10.1210/jc.2011-2384; OELKERS W, 1988, J CLIN ENDOCR METAB, V66, P181, DOI 10.1210/jcem-66-1-181; OMURA T, 1964, J BIOL CHEM, V239, P2370; Parajes S, 2010, J CLIN ENDOCR METAB, V95, P779, DOI 10.1210/jc.2009-0651; PASCOE L, 1992, P NATL ACAD SCI USA, V89, P4996, DOI 10.1073/pnas.89.11.4996; Peng HM, 2018, J STEROID BIOCHEM, V181, P63, DOI 10.1016/j.jsbmb.2018.03.003; Perrin CL, 2017, J CHEM EDUC, V94, P669, DOI 10.1021/acs.jchemed.6b00629; Portrat-Doyen S, 1998, J CLIN ENDOCR METAB, V83, P4156, DOI 10.1210/jc.83.11.4156; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Schumacher CD, 2013, J HYPERTENS, V31, P2085, DOI 10.1097/HJH.0b013e328363570c; Simpson ER, 2000, J SOC GYNECOL INVEST, V7, pS18, DOI 10.1177/1071557600007001S07; SIMPSON SA, 1954, HELV CHIM ACTA, V37, P1163, DOI 10.1002/hlca.19540370423; SIMPSON SA, 1954, EXPERIENTIA, V10, P132, DOI 10.1007/BF02158515; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; Strushkevich N, 2013, MOL ENDOCRINOL, V27, P315, DOI 10.1210/me.2012-1287; Ulmschneider S, 2005, J MED CHEM, V48, P1563, DOI 10.1021/jm0492397; Wilczynski C, 2015, ENDOCR PRACT, V21, P957, DOI 10.4158/EP14551.RA; Yoshimoto FK, 2016, J AM CHEM SOC, V138, P12124, DOI 10.1021/jacs.6b04437; Young MJ, 2001, J CLIN ENDOCR METAB, V86, P5121, DOI 10.1210/jc.86.11.5121	49	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12975	12991		10.1074/jbc.RA119.009830	http://dx.doi.org/10.1074/jbc.RA119.009830			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296661	hybrid, Green Published			2022-12-26	WOS:000486416000010
J	Ohsug, T; Yamaguchi, K; Zhu, C; Ikenoue, T; Takane, K; Shinozaki, M; Tsurita, G; Yano, H; Furukawa, Y				Ohsug, Tomoyuki; Yamaguchi, Kiyoshi; Zhu, Chi; Ikenoue, Tsuneo; Takane, Kiyoko; Shinozaki, Masaru; Tsurita, Giichiro; Yano, Hideaki; Furukawa, Yoichi			Anti-apoptotic effect by the suppression of IRF1 as a downstream of Wnt/beta-catenin signaling in colorectal cancer cells	ONCOGENE			English	Article							REGULATORY FACTOR-I; TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR; INTERFERON-GAMMA; GROWTH-FACTOR; STEM-CELLS; GENE; UBIQUITINATION; EXPRESSION; COLON	Impaired Wnt signaling pathway plays a crucial role in the development of colorectal cancer through activation of the beta-catenin/TCF7L2 complex. Although genes upregulated by Wnt/beta-catenin signaling have been intensively studied, the roles of downregulated genes are poorly understood. Previously, we reported that interferon-induced proteins with tetratricopeptide repeats 2 (IFIT2) was downregulated by the Wnt/beta-catenin signaling, and that the suppressed expression of IFIT2 conferred antiapoptotic property to colorectal cancer (CRC) cells. However, the mechanisms underlying how Wnt/beta-catenin signaling regulates IFIT2 remain to be elucidated. In this study, we have uncovered that the expression of IFIT2 is induced by IRF1, which is negatively regulated by the Wnt/beta-catenin signaling. In addition, we found that downregulation of IRF1 is mediated by its degradation through the ubiquitination-proteasome pathway, and that decreased activity of a deubiquitinase complex containing USP1 and UAF1 is involved in the degradation of IRF1 by Wnt/beta-catenin signaling. These data should provide better understanding of the Wnt signaling pathway and human carcinogenesis.	[Ohsug, Tomoyuki; Yamaguchi, Kiyoshi; Zhu, Chi; Ikenoue, Tsuneo; Takane, Kiyoko; Furukawa, Yoichi] Univ Tokyo, Adv Clin Res Ctr, Inst Med Sci, Div Clin Genome Res, Tokyo 1088639, Japan; [Shinozaki, Masaru; Tsurita, Giichiro] Univ Tokyo, IMSUT Hosp, Inst Med Sci, Dept Surg, Tokyo 1088639, Japan; [Yano, Hideaki] Natl Ctr Global Hlth & Med, Dept Surg, Ctr Hosp, Tokyo 1628655, Japan	University of Tokyo; University of Tokyo; National Center for Global Health & Medicine - Japan	Furukawa, Y (corresponding author), Univ Tokyo, Adv Clin Res Ctr, Inst Med Sci, Div Clin Genome Res, Tokyo 1088639, Japan.	furukawa@ims.u-tokyo.ac.jp		ZHU, CHI/0000-0001-9529-7000	JSPS KAKENHI [JP17H03575]; Sasakawa Scientific Research Grant from the Japan Science Society [29-435]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sasakawa Scientific Research Grant from the Japan Science Society	This work was supported in part by JSPS KAKENHI Grant numbers JP17H03575 (Y. F.) and the Sasakawa Scientific Research Grant (Grant numbers 29-435, T. O.) from the Japan Science Society.	[Anonymous], 2017, J EXP MED, V214, P3553; Au J Sancea, 2000, ONCOGENE, V19, P3372; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BENECH P, 1987, MOL CELL BIOL, V7, P4498, DOI 10.1128/MCB.7.12.4498; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Chen JJ, 2011, CHEM BIOL, V18, P1390, DOI 10.1016/j.chembiol.2011.08.014; Clarke N, 2004, EMBO J, V23, P3051, DOI 10.1038/sj.emboj.7600302; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Connett JM, 2005, J INTERF CYTOK RES, V25, P587, DOI 10.1089/jir.2005.25.587; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Gao J, 2010, CELL DEATH DIFFER, V17, P699, DOI 10.1038/cdd.2009.156; Giatromanolaki A, 2004, CYTOKINE, V26, P164, DOI 10.1016/j.cyto.2004.03.001; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; HARADA H, 1994, ONCOGENE, V9, P3313; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kano A, 1999, BIOCHEM BIOPH RES CO, V257, P672, DOI 10.1006/bbrc.1999.0276; Kim EJ, 2002, J CELL BIOCHEM, V85, P369, DOI 10.1002/jcb.10142; Kim JH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081604; Kim PKM, 2004, ONCOGENE, V23, P1125, DOI 10.1038/sj.onc.1207023; Kroger A, 2003, ONCOGENE, V22, P1045, DOI 10.1038/sj.onc.1206260; Landre V, 2013, BIOCHEM J, V449, P707, DOI 10.1042/BJ20121076; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Lecona E, 2016, NAT STRUCT MOL BIOL, V23, P270, DOI 10.1038/nsmb.3185; Lee KY, 2010, J BIOL CHEM, V285, P10362, DOI 10.1074/jbc.M109.092544; Li X, 2013, ONCOGENE, V32, P471, DOI 10.1038/onc.2012.66; Liang FS, 2016, CELL REP, V15, P2118, DOI 10.1016/j.celrep.2016.05.007; Lien WH, 2014, GENE DEV, V28, P1517, DOI 10.1101/gad.244772.114; Lowney JK, 1999, ANN SURG ONCOL, V6, P604, DOI 10.1007/s10434-999-0604-4; Mannick EE, 2005, J GASTROEN HEPATOL, V20, P371, DOI 10.1111/j.1440-1746.2005.03573.x; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Mistry H, 2013, MOL CANCER THER, V12, P2651, DOI 10.1158/1535-7163.MCT-13-0103-T; Moretti J, 2012, J BIOL CHEM, V287, P29429, DOI 10.1074/jbc.M112.366807; Moriyama Y, 2001, CLIN CANCER RES, V7, P1293; Murai J, 2011, MOL CELL BIOL, V31, P2462, DOI 10.1128/MCB.05058-11; Murtas D, 2013, BRIT J CANCER, V109, P76, DOI 10.1038/bjc.2013.335; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Narayan V, 2011, J BIOL CHEM, V286, P607, DOI 10.1074/jbc.M110.153122; Nozawa H, 1998, INT J CANCER, V77, P522, DOI 10.1002/(SICI)1097-0215(19980812)77:4<522::AID-IJC8>3.0.CO;2-W; Nozawa H, 1999, GENE DEV, V13, P1240, DOI 10.1101/gad.13.10.1240; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Ohsugi T, 2017, ONCOTARGET, V8, P100176, DOI 10.18632/oncotarget.22122; Palacios J, 1998, CANCER RES, V58, P1344; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Penninger JM, 1997, IMMUNITY, V7, P243, DOI 10.1016/S1074-7613(00)80527-0; Pettersson S, 2009, BIOCHEM J, V418, P575, DOI 10.1042/BJ20082087; Ritorto MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5763; Ruiz-Ruiz C, 2004, J BIOL CHEM, V279, P19712, DOI 10.1074/jbc.M313023200; Sakai T, 2014, PANCREAS, V43, P909, DOI 10.1097/MPA.0000000000000116; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Schwartz JL, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/912102; Tada S, 1998, INT J ONCOL, V13, P1207; Tamura G, 1996, CANCER RES, V56, P612; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; Tan RSP, 1996, CANCER RES, V56, P2417; TANAKA N, 1994, CANCER LETT, V83, P191, DOI 10.1016/0304-3835(94)90318-2; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tomita Y, 2003, INT J CANCER, V104, P400, DOI 10.1002/ijc.10956; van Twest S, 2017, MOL CELL, V65, P247, DOI 10.1016/j.molcel.2016.11.005; Wang Y, 2007, CANCER RES, V67, P2535, DOI 10.1158/0008-5472.CAN-06-3530; Xie D, 2001, CANCER RES, V61, P8917; Yanai H, 2012, ONCOIMMUNOLOGY, V1, P1376, DOI 10.4161/onci.22475; Yin JP, 2015, STRUCTURE, V23, P2043, DOI 10.1016/j.str.2015.08.010; Yuan L, 2015, CANCER LETT, V359, P136, DOI 10.1016/j.canlet.2015.01.003; Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469; Zurawel RH, 1998, CANCER RES, V58, P896	70	15	16	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 8	2019	38	32					6051	6064		10.1038/s41388-019-0856-9	http://dx.doi.org/10.1038/s41388-019-0856-9			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IP8XH	31292489				2022-12-26	WOS:000480329900004
J	Marcus, J; Bejerano-Sagie, M; Patterson, N; Bagchi, S; Verkhusha, VV; Connolly, D; Goldberg, GL; Golden, A; Sharma, VP; Condeelis, J; Montagna, C				Marcus, Jenna; Bejerano-Sagie, Michal; Patterson, Nicole; Bagchi, Susmita; Verkhusha, Vladislav V.; Connolly, Diana; Goldberg, Gary L.; Golden, Aaron; Sharma, Ved P.; Condeelis, John; Montagna, Cristina			Septin 9 isoforms promote tumorigenesis in mammary epithelial cells by increasing migration and ECM degradation through metalloproteinase secretion at focal adhesions	ONCOGENE			English	Article							BREAST-CANCER CELLS; COMPREHENSIVE MOLECULAR PORTRAITS; ALTERNATE READING FRAME; MATRIX-METALLOPROTEINASE; INVADOPODIA FORMATION; NEURALGIC AMYOTROPHY; MAMMALIAN SEPTIN; EXPRESSION; GENE; INVASION	The cytoskeletal interacting protein Septin 9 (SEPT9), a member of the septin gene family, has been proposed to have oncogenic functions. It is a known hot spot of retroviral tagging insertion and a fusion partner of both de novo and therapy-induced mixed lineage leukemia (MLL). Of all septins, SEPT9 holds the strongest link to cancer, especially breast cancer. Murine models of breast cancer frequently exhibit SEPT9 amplification in the form of double minute chromosomes, and about 20% of human breast cancer display genomic amplification and protein over expression at the SEPT9 locus. Yet, a clear mechanism by which SEPT9 elicits tumor-promoting functions is lacking. To obtain unbiased insights on molecular signatures of SEPT9 upregulation in breast tumors, we overexpressed several of its isoforms in breast cancer cell lines. Global transcriptomic profiling supports a role of SEPT9 in invasion. Functional studies reveal that SEPT9 upregulation is sufficient to increase degradation of the extracellular matrix, while SEPT9 downregulation inhibits this process. The degradation pattern is peripheral and associated with focal adhesions (FAs), where it is coupled with increased expression of matrix metalloproteinases (MMPs). SEPT9 overexpression induces MMP upregulation in human tumors and in culture models and promotes MMP3 secretion to the media at FAs. Downregulation of SEPT9 or chemical inhibition of septin filament assembly impairs recruitment of MMP3 to FAs. Our results indicate that SEPT9 promotes upregulation and both trafficking and secretion of MMPs near FAs, thus enhancing migration and invasion of breast cancer cells.	[Marcus, Jenna; Goldberg, Gary L.] Yeshiva Univ, Albert Einstein Coll Med, Dept Obstet & Gynecol, Bronx, NY USA; [Marcus, Jenna; Goldberg, Gary L.] Yeshiva Univ, Albert Einstein Coll Med, Dept Womens Hlth, Bronx, NY USA; [Bejerano-Sagie, Michal; Patterson, Nicole; Bagchi, Susmita; Connolly, Diana; Golden, Aaron; Montagna, Cristina] Yeshiva Univ, Albert Einstein Coll Med, Genet, Bronx, NY 10461 USA; [Verkhusha, Vladislav V.; Golden, Aaron] Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Galway, Ireland; [Sharma, Ved P.; Condeelis, John] Yeshiva Univ, Anat & Struct Biol, Albert Einstein Coll Med, Bronx, NY USA; [Sharma, Ved P.; Condeelis, John] Yeshiva Univ, Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY USA; [Montagna, Cristina] Yeshiva Univ, Albert Einstein Coll Med, Pathol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Ollscoil na Gaillimhe-University of Galway; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Montagna, C (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Genet, Bronx, NY 10461 USA.; Montagna, C (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Pathol, Bronx, NY 10461 USA.	cristina.montagna@einstein.yu.edu	Verkhusha, Vladislav/AAU-7784-2020; Marcus, Jenna/AAK-7334-2021; Marcus, Jenna/GQP-7232-2022	Verkhusha, Vladislav/0000-0002-2083-8121; 	Albert Einstein Cancer Center support grant of the National Institutes of Health [P30CA013330, CA150344]; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA150344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122567] Funding Source: NIH RePORTER	Albert Einstein Cancer Center support grant of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the following shared resources at the Albert Einstein College of Medicine: Molecular Cytogenetic Core, in particular Dr. Jidong Shan; and the Analytical Imaging Facility in particular Dr. Vera DesMarais. Research reported in this publication was supported by the Albert Einstein Cancer Center support grant of the National Institutes of Health under award number P30CA013330 as well as CA150344 to JC.	Akil A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12203; Alvarez ML, 2012, KIDNEY INT, V82, P1024, DOI 10.1038/ki.2012.256; Amir S, 2010, MOL CANCER RES, V8, P643, DOI 10.1158/1541-7786.MCR-09-0497; Amir S, 2009, J BIOL CHEM, V284, P11142, DOI 10.1074/jbc.M808348200; Angelis D, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00122; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Bai XB, 2016, MOL BIOL CELL, V27, P897, DOI 10.1091/mbc.E15-07-0493; Bai XB, 2013, J CELL BIOL, V203, P895, DOI 10.1083/jcb.201308068; Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Beaty BT, 2013, MOL BIOL CELL, V24, P1661, DOI 10.1091/mbc.E12-12-0908; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; BYERS JR, 1971, CAN J ZOOLOG, V49, P1185, DOI 10.1139/z71-179; Cazorla M, 1998, J PATHOL, V186, P144, DOI 10.1002/(SICI)1096-9896(1998100)186:2<144::AID-PATH147>3.0.CO;2-#; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cerveira N, 2011, BIOL CHEM, V392, P713, DOI 10.1515/BC.2011.072; Chacko AD, 2005, J PATHOL, V206, P458, DOI 10.1002/path.1794; Chacko AD, 2012, CELL ONCOL, V35, P85, DOI 10.1007/s13402-011-0066-0; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; Chen QK, 2013, DIFFERENTIATION, V86, P126, DOI 10.1016/j.diff.2013.03.003; Cichon MA, 2015, CANCER INFORM, V14, P1, DOI 10.4137/CIN.S18965; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; Clay L, 2014, ELIFE, V3, DOI 10.7554/eLife.01883; Connolly D, 2014, BIOL CHEM, V395, P157, DOI 10.1515/hsz-2013-0247; Connolly D, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2924; DICKSON SR, 1992, J HISTOCHEM CYTOCHEM, V40, P697, DOI 10.1177/40.5.1315355; Dolat L, 2014, J CELL BIOL, V207, P225, DOI 10.1083/jcb.201405050; Eddy RJ, 2017, TRENDS CELL BIOL, V27, P595, DOI 10.1016/j.tcb.2017.03.003; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Flores-Pliego A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145366; Genna A, 2018, J CELL BIOL, V217, P375, DOI 10.1083/jcb.201702184; Golan M, 2013, CELL CYCLE, V12, P2297, DOI 10.4161/cc.25379; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; Gonzalez ME, 2009, CELL SIGNAL, V21, P477, DOI 10.1016/j.cellsig.2008.11.007; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Heasley LR, 2014, EUKARYOT CELL, V13, P1411, DOI 10.1128/EC.00191-14; Hecht M, 2019, G3-GENES GENOM GENET, V9, P1869, DOI 10.1534/g3.119.400197; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Hoshino D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002964; Hu JL, 2012, CURR BIOL, V22, P1109, DOI 10.1016/j.cub.2012.04.019; Jacob A, 2013, J CELL SCI, V126, P4647, DOI 10.1242/jcs.126573; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Khokha R, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004333; Knauper V, 2002, FEBS LETT, V532, P127, DOI 10.1016/S0014-5793(02)03654-2; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kotepui M, 2016, WSPOLCZESNA ONKOL, V20, P225, DOI 10.5114/wo.2016.61565; Lee Gilho, 2011, Int Neurourol J, V15, P4, DOI 10.5213/inj.2011.15.1.4; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; MAEDA K, 1987, P NATL ACAD SCI USA, V84, P6536, DOI 10.1073/pnas.84.18.6536; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; McDade SS, 2007, HUM MOL GENET, V16, P742, DOI 10.1093/hmg/ddm003; McGowan PM, 2008, ANN ONCOL, V19, P1566, DOI 10.1093/annonc/mdn180; Mehdiani A, 2015, JOVE-J VIS EXP, DOI 10.3791/50974; MONSKY WL, 1993, CANCER RES, V53, P3159; Montagna C, 2003, CANCER RES, V63, P2179; Montagna C, 2015, RES REP BIOCHEM, V5, P59, DOI 10.2147/RRBC.S59060; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Nabeshima K, 2002, PATHOL INT, V52, P255, DOI 10.1046/j.1440-1827.2002.01343.x; Nagano T, 2006, DEVELOPMENT, V133, P4643, DOI 10.1242/dev.02657; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Neubauer K, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00003; Nile AH, 2014, NAT CHEM BIOL, V10, P76, DOI [10.1038/NCHEMBIO.1389, 10.1038/nchembio.1389]; Nistico P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011908; Noordstra Ivar, 2017, F1000Res, V6, P469, DOI 10.12688/f1000research.10729.1; Osaka M, 1999, P NATL ACAD SCI USA, V96, P6428, DOI 10.1073/pnas.96.11.6428; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell SEH, 2000, CANCER RES, V60, P4729; Schmidt K, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-43; Scott M, 2005, ONCOGENE, V24, P4688, DOI 10.1038/sj.onc.1208574; Sellin ME, 2012, MOL BIOL CELL, V23, P4242, DOI 10.1091/mbc.E12-06-0486; Sharma VP, 2013, CURR BIOL, V23, P2079, DOI 10.1016/j.cub.2013.08.044; Sharma VP, 2013, METHODS MOL BIOL, V1046, P343, DOI 10.1007/978-1-62703-538-5_21; Shimoda M, 2017, BBA-MOL CELL RES, V1864, P1989, DOI 10.1016/j.bbamcr.2017.05.027; Simian M, 2001, DEVELOPMENT, V128, P3117; Smith C, 2015, J MOL BIOL, V427, P3273, DOI 10.1016/j.jmb.2015.07.026; Sorensen AB, 2002, GENE, V285, P79, DOI 10.1016/S0378-1119(02)00406-7; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Stehbens SJ, 2014, NAT CELL BIOL, V16, P558, DOI 10.1038/ncb2975; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Sudo K, 2007, HUM MUTAT, V28, P1005, DOI 10.1002/humu.20554; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Team RC, 2016, R LANG ENV STAT COMP; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Tokhtaeva E, 2015, J BIOL CHEM, V290, P5280, DOI 10.1074/jbc.M114.616201; Valenzuela-Iglesias A, 2015, EUR J CELL BIOL, V94, P78, DOI 10.1016/j.ejcb.2014.12.002; Vardi-Oknin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073179; Verdier-Pinard P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44976; Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang Y, 2016, INTRAVITAL, V5; Wang Y, 2012, J CELL BIOL, V196, P375, DOI 10.1083/jcb.201105153; Weidmann MD, 2016, SCI REP-UK, V6, DOI 10.1038/srep36142; Winer A, 2018, MOL CANCER THER, V17, P1147, DOI 10.1158/1535-7163.MCT-17-0646; Winer A, 2016, MOL CANCER THER, V15, P2370, DOI 10.1158/1535-7163.MCT-16-0194; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090; Wolfgang CD, 2000, P NATL ACAD SCI USA, V97, P9437, DOI 10.1073/pnas.160270597; Wolfgang CD, 2001, CANCER RES, V61, P8122; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3; Zhao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017845; Zhou ZN, 2014, ONCOGENE, V33, P3784, DOI 10.1038/onc.2013.363	108	13	13	3	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 25	2019	38	30					5839	5859		10.1038/s41388-019-0844-0	http://dx.doi.org/10.1038/s41388-019-0844-0			21	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IT3FY	31285548	Green Accepted			2022-12-26	WOS:000482739300001
J	Huang, WK; Xue, YH; Wu, Y				Huang, Wenkai; Xue, Yihao; Wu, Yu			A CAD system for pulmonary nodule prediction based on deep three-dimensional convolutional neural networks and ensemble learning	PLOS ONE			English	Article							FALSE-POSITIVE REDUCTION; LUNG NODULES; IMAGES; CLASSIFICATION; MALIGNANCY; DIAGNOSIS	Background Detection of pulmonary nodules is an important aspect of an automatic detection system. Incomputer-aided diagnosis (CAD) systems, the ability to detect pulmonary nodules is highly important, which plays an important role in the diagnosis and early treatment of lung cancer. Currently, the detection of pulmonary nodules depends mainly on doctor experience, which varies. This paper aims to address the challenge of pulmonary nodule detection more effectively. Methods A method for detecting pulmonary nodules based on an improved neural network is presented in this paper. Nodules are clusters of tissue with a diameter of 3 mm to 30 mm in the pulmonary parenchyma. Because pulmonary nodules are similar to other lung structures and have a low density, false positive nodules often occur. Thus, our team proposed an improved convolutional neural network (CNN) framework to detect nodules. First, a non-sharpening mask is used to enhance the nodules in computed tomography (CT) images; then, CT images of 512x512 pixels are segmented into smaller images of 96x96 pixels. Second, in the 96x96 pixel images which contain or exclude pulmonary nodules, the plaques corresponding to positive and negative samples are segmented. Third, CT images segmented into 96x96 pixels are down-sampled to 64x64 and 32x32 size respectively. Fourth, an improved fusion neural network structure is constructed that consists of three three-dimensional convolutional neural networks, designated as CNN-1, CNN-2, and CNN-3, to detect false positive pulmonary nodules. The networks' input sizes are 32x32x32, 64x64x64, and 96x96x96 and include 5, 7, and 9 layers, respectively. Finally, we use the AdaBoost classifier to fuse the results of CNN-1, CNN-2, and CNN-3. We call this new neural network framework the Amalgamated-Convolutional Neural Network (A-CNN) and use it to detect pulmonary nodules. Findings Our team trained A-CNN using the LUNA16 and Ali Tianchi datasets and evaluated its performance using the LUNA16 dataset. We discarded nodules less than 5mm in diameter. When the average number of false positives per scan was 0.125 and 0.25, the sensitivity of A-CNN reached as high as 81.7% and 85.1%, respectively.	[Huang, Wenkai] Guangzhou Univ, Sch Mech & Elect Engn, Ctr Res Leading Technol Special Equipment, Guangzhou, Guangdong, Peoples R China; [Xue, Yihao] Guangzhou Univ, Sch Mech & Elect Engn, Guangzhou, Guangdong, Peoples R China; [Wu, Yu] Guangzhou Univ, Lab Ctr, Guangzhou, Guangdong, Peoples R China	Guangzhou University; Guangzhou University; Guangzhou University	Wu, Y (corresponding author), Guangzhou Univ, Lab Ctr, Guangzhou, Guangdong, Peoples R China.	35452015@qq.com		Wu, Yu/0000-0002-1804-0495; Huang, Wenkai/0000-0003-3111-7511	Social Sciences and Humanities of the Ministry of Education of China [18YJC88002]; Guangdong Provincial Key Platform and Major Scientific Research Projects Featured Innovation Projects [2017GXJK136]; Guangzhou Innovation and Entrepreneurship Education Project [201709P14]	Social Sciences and Humanities of the Ministry of Education of China(Ministry of Education, China); Guangdong Provincial Key Platform and Major Scientific Research Projects Featured Innovation Projects; Guangzhou Innovation and Entrepreneurship Education Project	This work was supported in part by the Social Sciences and Humanities of the Ministry of Education of China under Grant 18YJC88002, in part by the Guangdong Provincial Key Platform and Major Scientific Research Projects Featured Innovation Projects under Grant 2017GXJK136, and in part by the Guangzhou Innovation and Entrepreneurship Education Project under Grant 201709P14.; This work was supported in part by the Social Sciences and Humanities of the Ministry of Education of Chinaunder Grant 18YJC88002, in part by the Guangdong Provincial Key Platform and Major Scientific Research Projects Featured Innovation Projects under Grant 2017GXJK136, and in part by the Guangzhou Innovation and Entrepreneurship Education Project under Grant 201709P14.	Abe Y, 2005, ANTICANCER RES, V25, P483; Arevalo J, 2016, COMPUT METH PROG BIO, V127, P248, DOI 10.1016/j.cmpb.2015.12.014; Cao G, 2014, INT CONF DIGIT SIG, P474, DOI 10.1109/ICDSP.2014.6900710; Dehmeshki H, 2003, IEEE IMAGE PROC, P1085; Dou Q, 2017, IEEE T BIO-MED ENG, V64, P1558, DOI 10.1109/TBME.2016.2613502; Farahani FV, 2018, MATH COMPUT SIMULAT, V149, P48, DOI 10.1016/j.matcom.2018.02.001; Firmino M, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-015-0120-7; Gao XHW, 2017, COMPUT METH PROG BIO, V138, P49, DOI 10.1016/j.cmpb.2016.10.007; Hawkins S, 2016, J THORAC ONCOL, V11, P2120, DOI 10.1016/j.jtho.2016.07.002; Ji SW, 2013, IEEE T PATTERN ANAL, V35, P221, DOI 10.1109/TPAMI.2012.59; Khosravan N, 2018, MED IMAGE COMPUTING; Krishnamurthy S, COMMUNICATIONS COMPU, P343; Kumar D, 2015, 2015 12TH CONFERENCE ON COMPUTER AND ROBOT VISION CRV 2015, P133, DOI 10.1109/CRV.2015.25; Li Q, 2018, CLIN LUNG CANCER, V19, P148, DOI 10.1016/j.cllc.2017.10.002; Mei XY, 2018, J THORAC DIS, V10, P458, DOI 10.21037/jtd.2018.01.88; Nibali A, 2017, INT J COMPUT ASS RAD, V12, P1799, DOI 10.1007/s11548-017-1605-6; Orozco HM, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0003-y; Setio AAA, 2016, IEEE T MED IMAGING, V35, P1160, DOI 10.1109/TMI.2016.2536809; Shen W, 2017, PATTERN RECOGN, V61, P663, DOI 10.1016/j.patcog.2016.05.029; Suzuki K, 2003, MED PHYS, V30, P1602, DOI 10.1118/1.1580485; Tajbakhsh N, 2017, PATTERN RECOGN, V63, P476, DOI 10.1016/j.patcog.2016.09.029; Teramoto A, 2016, MED PHYS, V43, P2821, DOI 10.1118/1.4948498; Vital Daniel Aparecido, 2018, Res. Biomed. Eng., V34, P234, DOI 10.1590/2446-4740.180035; Wu D, 2018, 2018 25TH INTERNATIONAL CONFERENCE ON TELECOMMUNICATIONS (ICT), P181; Xia JF, 2017, COMPUT METH PROG BIO, V147, P37, DOI 10.1016/j.cmpb.2017.06.005; Xie HT, 2019, PATTERN RECOGN, V85, P109, DOI 10.1016/j.patcog.2018.07.031; Zainudin Z, 2018, ADV SCI LETT, V24, P7494, DOI 10.1166/asl.2018.12966; Zhao JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123694; Zhao YY, P SPIE; Zhu W, 2018, MED IMAGE COMPUTING	30	18	19	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2019	14	7							e0219369	10.1371/journal.pone.0219369	http://dx.doi.org/10.1371/journal.pone.0219369			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4NB	31299053	gold, Green Published, Green Submitted			2022-12-26	WOS:000484955800003
J	Hernandez, JM; Pedroza-Gutierrez, C				Hernandez, Juan M.; Pedroza-Gutierrez, Carmen			Estimating the influence of the network topology on the agility of food supply chains	PLOS ONE			English	Article							COMPLEX ADAPTIVE SYSTEMS; RESILIENCE; MIDDLEMEN; MODEL; CAPABILITIES; ANTECEDENTS; DESIGN	Several studies have shown that the performance of a supply chain is heavily influenced by the pattern of relationships among firms. This paper analyzes the structure of relationships (network topology) that leads to the highest agility of a food supply chain when sudden demand changes occur. To do this, a simulation model that represents a supply chain and specific rules to allocate orders is built. The supply chain in the model follows the specific characteristics of trade in the primary sector. The model is fitted to the conditions of a real seafood supply chain in Mexico. Agility is measured through the effect on the order fulfillment of a sudden demand shock and the recovery time of this rate to previous values. The simulation results show that the most suitable structure depends on how product is distributed among suppliers. If product is evenly shared, supply chains with homogeneous topologies are more agile than supply chains with heterogeneous topologies, but the result is the opposite if product is unevenly shared among suppliers. Other previous recommendations, such as having multiple suppliers and horizontal links, are confirmed by the simulations. These findings contribute to the general debate on which is the optimal topology for an agile supply chain.	[Hernandez, Juan M.] Univ Las Palmas Gran Canaria, Dept Quantitat Methods Econ & Management, Las Palmas Gran Canaria, Spain; [Hernandez, Juan M.] Univ Las Palmas Gran Canaria, Inst Tourism & Sustainable Econ Dev TIDES, Las Palmas Gran Canaria, Spain; [Pedroza-Gutierrez, Carmen] Univ Nacl Autonoma Mexico, Escuela Nacl Estudios Super Merida, Jiquilpan, Michoacan, Mexico; [Pedroza-Gutierrez, Carmen] Univ Nacl Autonoma Mexico, Unidad Acad Estudios Reg, Coordinac Humanidades, Jiquilpan, Michoacan, Mexico	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Hernandez, JM (corresponding author), Univ Las Palmas Gran Canaria, Dept Quantitat Methods Econ & Management, Las Palmas Gran Canaria, Spain.; Hernandez, JM (corresponding author), Univ Las Palmas Gran Canaria, Inst Tourism & Sustainable Econ Dev TIDES, Las Palmas Gran Canaria, Spain.	juan.hernandez@ulpgc.es	Pedroza-Gutiérrez, Carmen/D-1267-2017; 穆, 儒/HGC-6534-2022; Hernandez, Juan M./D-7096-2013	Hernandez, Juan M./0000-0001-6897-5179	Universidad Nacional Autonoma de Mexico (UNAM) [PAPIIT IA300215]; Ministry of Economy and Competitiveness of the Government of Spain [ECO2014-59067-P]	Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Ministry of Economy and Competitiveness of the Government of Spain(Spanish Government)	This work was supported by Grant PAPIIT IA300215, Universidad Nacional Autonoma de Mexico (UNAM), https://www.unam.mx/, to CPG; Grant ECO2014-59067-P, Ministry of Economy and Competitiveness of the Government of Spain, http://www.educacionyfp.gob.es/portada.html, to JMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe GK, 2016, J RURAL STUD, V43, P203, DOI 10.1016/j.jrurstud.2015.12.004; Agarwal A, 2006, EUR J OPER RES, V173, P211, DOI 10.1016/j.ejor.2004.12.005; Arya A, 2015, EUR J OPER RES, V240, P393, DOI 10.1016/j.ejor.2014.07.007; Barroso A., 2015, APPL CONT MANAGEMENT, P13, DOI [10.5772/59580, DOI 10.5772/59580]; Beamon BM, 1998, INT J PROD ECON, V55, P281, DOI 10.1016/S0925-5273(98)00079-6; Borgatti SP, 2009, J SUPPLY CHAIN MANAG, V45, P5, DOI 10.1111/j.1745-493X.2009.03166.x; Brintrup A., 2016, LOGIST RES, V9, DOI [10.1007/s12159-015-0128-1, DOI 10.1007/S12159-015-0128-1]; Brintrup A., 2015, IEEE SYST J, V12; Brintrup A, 2018, CHAOS, V28, DOI 10.1063/1.5010766; Cabral I, 2012, INT J PROD RES, V50, P4830, DOI 10.1080/00207543.2012.657970; Carter CR, 2015, J SUPPLY CHAIN MANAG, V51, P89, DOI 10.1111/jscm.12073; Choi TY, 2009, J SUPPLY CHAIN MANAG, V45, P8, DOI 10.1111/j.1745-493X.2009.03151.x; Choi TY, 2002, J OPER MANAG, V20, P469, DOI 10.1016/S0272-6963(02)00025-6; Choi TY, 2001, J OPER MANAG, V19, P351, DOI 10.1016/S0272-6963(00)00068-1; Christopher M., 2004, INT J RETAIL DISTRIB, V32, P367, DOI DOI 10.1108/09590550410546188; Cox A., 2001, J SUPPLY CHAIN MANAG, V37, P28, DOI 10.1111/j.1745- 493X.2001.tb00097.x; Crona B, 2010, MAR POLICY, V34, P761, DOI 10.1016/j.marpol.2010.01.023; Datta P. P., 2007, INT J LOGIST-RES APP, V10, P187, DOI DOI 10.1080/13675560701467144; Gabre-Madhin EZ, 2001, AGR ECON-BLACKWELL, V25, P311, DOI 10.1111/j.1574-0862.2001.tb00211.x; Gligor DM, 2013, J BUS LOGIST, V34, P94, DOI 10.1111/jbl.12012; Gligor DM, 2012, SUPPLY CHAIN MANAG, V17, P438, DOI 10.1108/13598541211246594; Guillaume JL, 2006, PHYSICA A, V371, P795, DOI 10.1016/j.physa.2006.04.047; Hayami Y, 1999, AGR ECON-BLACKWELL, V20, P79, DOI 10.1016/S0169-5150(98)00082-6; Hearnshaw EJS, 2013, INT J OPER PROD MAN, V33, P442, DOI 10.1108/01443571311307343; Helo PT, 2000, INT J PROD RES, V38, P4521, DOI 10.1080/00207540050205271; Jackson M., 2003, Integrated Manufacturing Systems, V14, P482, DOI 10.1108/09576060310491342; Juttner U, 2011, SUPPLY CHAIN MANAG, V16, P246, DOI 10.1108/13598541111139062; Kim W., 2009, JASSS-J ARTIF SOC S, V12, P3; Kim Y, 2015, J OPER MANAG, V33-34, P43, DOI 10.1016/j.jom.2014.10.006; Kim Y, 2011, J OPER MANAG, V29, P194, DOI 10.1016/j.jom.2010.11.001; Kito T., 2014, STRUCTURE TOYOTA SUP; Ledwoch A, 2018, INT J PROD ECON, V197, P13, DOI 10.1016/j.ijpe.2017.12.013; Lee HL, 2004, HARVARD BUS REV, V82, P102; LEVY DL, 1995, J INT BUS STUD, V26, P343, DOI 10.1057/palgrave.jibs.8490177; Li G, 2013, INT J PROD RES, V51, P3894, DOI 10.1080/00207543.2012.754968; Li X, 2009, INT J LOGIST MANAG, V20, P408, DOI 10.1108/09574090911002841; Li X, 2008, INT J LOGIST MANAG, V19, P408, DOI 10.1108/09574090810919224; Mari Sonia Irshad, 2015, International Journal of Logistics Systems and Management, V21, P365; MERLIJN AG, 1989, DEV CHANGE, V20, P683, DOI 10.1111/j.1467-7660.1989.tb00362.x; Nair A, 2011, INT J PROD RES, V49, P1391, DOI 10.1080/00207543.2010.518744; Newman MEJ, 2002, P NATL ACAD SCI USA, V99, P2566, DOI 10.1073/pnas.012582999; Osazuwa OO., 2015, FOOD SUPPLY CHAIN QU; Parhi M, 2005, PAO PRES DRUID WINT; Pedroza C, 2013, MAR POLICY, V39, P135, DOI 10.1016/j.marpol.2012.10.011; Pedroza-Gutierrez C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186063; Pettit TJ, 2010, J BUS LOGIST, V31, P1, DOI 10.1002/j.2158-1592.2010.tb00125.x; Plaganyi EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091833; Raj SA, 2013, INT J PROD RES, V51, P5971, DOI 10.1080/00207543.2013.825381; RUBINSTEIN A, 1987, Q J ECON, V102, P581, DOI 10.2307/1884218; Scholten K, 2015, SUPPLY CHAIN MANAG, V20, P471, DOI 10.1108/SCM-11-2014-0386; Scholten K, 2014, SUPPLY CHAIN MANAG, V19, P211, DOI 10.1108/SCM-06-2013-0191; Sheffi Y, 2005, MIT SLOAN MANAGE REV, V47, P41; Sherehiy B, 2007, INT J IND ERGONOM, V37, P445, DOI 10.1016/j.ergon.2007.01.007; Surana A, 2005, INT J PROD RES, V43, P4235, DOI 10.1080/00207540500142274; Swafford PM, 2006, J OPER MANAG, V24, P170, DOI 10.1016/j.jom.2005.05.002; Tang L, 2016, PHYSICA A, V443, P58, DOI 10.1016/j.physa.2015.09.082; Tsourveloudis NC, 2002, J INTELL ROBOT SYST, V33, P329, DOI 10.1023/A:1015096909316; van Woerkum CMJ, 2007, BRIT FOOD J, V109, P355, DOI 10.1108/00070700710746777; Verdouw CN, 2016, J FOOD ENG, V176, P128, DOI 10.1016/j.jfoodeng.2015.11.009; Vinodh S, 2011, INT J PROD RES, V49, P5263, DOI 10.1080/00207543.2010.524260; Wieland A, 2013, INT J PHYS DISTR LOG, V43, P300, DOI 10.1108/IJPDLM-08-2012-0243; Yusuf YY, 2004, EUR J OPER RES, V159, P379, DOI 10.1016/j.ejor.2003.08.022; Yusuf YY, 1999, INT J PROD ECON, V62, P33, DOI 10.1016/S0925-5273(98)00219-9; Zhao K, 2011, IEEE SYST J, V5, P28, DOI 10.1109/JSYST.2010.2100192	64	4	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218958	10.1371/journal.pone.0218958	http://dx.doi.org/10.1371/journal.pone.0218958			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4JZ	31291283	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800044
J	Reyna, KS				Reyna, Kelly S.			Acute exposure to hyperthermic oscillating temperatures during pre-incubation influences northern bobwhite development, hatching, and survival	PLOS ONE			English	Article							INCUBATION-TEMPERATURE; TRAJECTORIES; EMBRYOS	Temperature extremes alter development, growth, hatching, and survival of eggs of ground-nesting birds, particularly during pre-incubation (egg laying) when eggs are left unattended and exposed to the environment for days or weeks before parental incubation begins. The northern bobwhite quail is a ground-nesting bird whose eggs experience high temperatures (>= 45 degrees C) during pre-incubation. It is known that chronic high temperatures during pre-incubation alter development and reduce hatching and survival of bobwhite eggs, but it is not known if acute doses of high temperatures during pre-incubation have the same effect. In this study, the 12-d pre-incubation period was divided into thirds. Fresh bobwhite eggs were exposed to either a commercial holding temperature for all 12 d (serving as a control), or a high oscillating temperature regimen for 4 d (one third of pre-incubation) either in the early, middle, or late third of pre-incubation, with a low oscillating temperature regimen during the remaining 8 d. The timing of acute exposure to high oscillating temperatures significantly affected bobwhite development. Eggs exposed in the first 2/3 of pre-incubation developed twice as much as eggs exposed late in pre-incubation, even though all eggs received the same amount of heating degree-hours. Thus, a critical window of thermal susceptibility exists for developing northern bobwhites. Acute exposure to high oscillating temperatures resulted in reduced hatchling mass, hatching success, survival, and compromised hatching synchrony. Thus, acute hyperthermic nest temperatures during pre-incubation could result in the observed reductions in the percentage of juveniles in natural populations during hot and droughty years.	[Reyna, Kelly S.] Texas A&M Univ, Coll Agr Sci & Nat Resources, Commerce, TX 75428 USA	Texas A&M University System	Reyna, KS (corresponding author), Texas A&M Univ, Coll Agr Sci & Nat Resources, Commerce, TX 75428 USA.	Kelly.Reyna@tamuc.edu		Reyna, Kelly/0000-0003-3202-2135				Alkan S, 2013, ARC TIERZ, V18, P789; Alsop FM, 1919, ANAT REC, V15, P307; [Anonymous], 2012, NATL QUAIL S PROC; Apanius V., 1998, AVIAN GROWTH DEV EVO; Aristotle, GENERATION ANIMALS; Bridges AS, 2001, J WILDLIFE MANAGE, V65, P10, DOI 10.2307/3803270; Bucknell W., 1839, ECCALEOBION TREATISE; Burggren WW, 2011, RESP PHYSIOL NEUROBI, V178, P13, DOI 10.1016/j.resp.2011.05.001; Christensen VL, 2003, POULTRY SCI, V82, P1869, DOI 10.1093/ps/82.12.1869; Conway CJ, 2000, BEHAV ECOL, V11, P178, DOI 10.1093/beheco/11.2.178; Crosby AD, 2015, BIOL CONSERV, V186, P233, DOI 10.1016/j.biocon.2015.03.018; de Reaumur RAF, 1750, ART HATCHING BRINGIN; DECUYPERE E, 1992, WORLD POULTRY SCI J, V48, P28, DOI 10.1079/WPS19920004; Dozier W, 2010, BOBWHITE QUAIL PRODU; Dzialowski EM, 2002, COMP BIOCHEM PHYS A, V131, P713, DOI 10.1016/S1095-6433(02)00009-0; French NA, 1997, POULTRY SCI, V76, P124, DOI 10.1093/ps/76.1.124; Guthery FS, 2000, NATL QUAIL S P, P198; Guthery FS, 2004, WILDLIFE MONOGR, V159, P1; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HENDRICKX AG, 1965, BIOL BULL-US, V129, P523, DOI 10.2307/1539730; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KOSIN I. L., 1964, World's Poultry Science Journal, V20, P254, DOI 10.1079/WPS19640033; Landauer W., 1961, STORRS AGR EXPT STAT, V1; Loyau T, 2015, ANIMAL, V9, P76, DOI 10.1017/S1751731114001931; MILLER ER, 1975, POULTRY SCI, V54, P901, DOI 10.3382/ps.0540901; Mueller CA, 2015, STURKIE'S AVIAN PHYSIOLOGY, 6TH EDITION, P739; Reyna K, 2012, NATL QUAIL S P, V7, P128; Reyna KS, 2012, POULTRY SCI, V91, P41, DOI 10.3382/ps.2011-01676; Reyna KS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184670; Romanoff A., 1960, THE AVIAN EMBRYO, V1, P429; ROMANOFF ALEXIS L., 1949, AUK, V66, P264; Tazawa Hiroshi, 2000, P617, DOI 10.1016/B978-012747605-6/50025-0; Tomecek JM, 2017, PEERJ, V5, DOI 10.7717/peerj.3709; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Zar JH, 1999, BIOSTATISTICAL ANAL	36	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219368	10.1371/journal.pone.0219368	http://dx.doi.org/10.1371/journal.pone.0219368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291310	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800076
J	Andriollo, T; Gillet, F; Michaux, JR; Ruedi, M				Andriollo, Tommy; Gillet, Francois; Michaux, Johan R.; Ruedi, Manuel			The menu varies with metabarcoding practices: A case study with the bat Plecotus auritus	PLOS ONE			English	Article							DIET; DNA; OVERLAP; PREY; EXTRAPOLATION; RAREFACTION; POPULATION; ECOLOGY; PACKAGE; MYOTIS	Metabarcoding of feces has revolutionized the knowledge of animal diets by providing unprecedented resolution of consumed resources. However, it is still unclear how different methodological approaches influence the ecological conclusions that can be drawn from such data. Here, we propose a critical evaluation of several data treatments on the inferred diet of the bat Plecotus auritus using guano regularly collected from various colonies throughout the entire active season. First and unlike previous claims, our data indicates that DNA extracted from large amounts of fecal material issued from guano accumulates yield broader taxonomic diversity of prey than smaller numbers of pellets would do, provided that extraction buffer volumes are adapted to such increased amounts of material. Second, trophic niche analyses based on prey occurrence data uncover strong seasonality in the bat's diet and major differences among neighboring maternity colonies. Third, while the removal of rare prey items is not always warranted as it introduces biases affecting particularly samples with greater prey species richness. Fourth, examination of distinct taxonomic depths in diet analyses highlights different aspects of food consumption providing a better understanding of the consumer's diet. Finally, the biologically meaningful patterns recovered with presence-absence approaches are virtually lost when attempting to quantify prey consumed using relative read abundances. Even in an ideal situation where reference barcodes are available for most potential prey species, inferring realistic patterns of prey consumption remains relatively challenging. Although best practice in metabarcoding analyses will depend on the aims of the study, several previous methodological recommendations seem unwarranted for studying such diverse diets as that of brown long-eared bats.	[Andriollo, Tommy; Ruedi, Manuel] Nat Hist Museum Geneva, Dept Mammal & Ornithol, Geneva, Switzerland; [Andriollo, Tommy] Univ Geneva, Fac Sci, Sect Biol, Geneva, Switzerland; [Gillet, Francois; Michaux, Johan R.] Univ Liege, Inst Bot B22, Lab Genet Conservat, Liege, Belgium; [Gillet, Francois] INRA, CEFS, Castanet Tolosan, France; [Michaux, Johan R.] CIRAD, Agirs Unit, TA C-22-E Campus Int Baillarguet, Montpellier, France	University of Geneva; University of Liege; INRAE; CIRAD	Ruedi, M (corresponding author), Nat Hist Museum Geneva, Dept Mammal & Ornithol, Geneva, Switzerland.	manuel.ruedi@ville-ge.ch		Andriollo, Tommy/0000-0003-3922-7475	Direction Generale de l'Agriculture et de la Nature de l'Etat de Geneve; Fondation Ernst AMP; Lucie Schmidheiny	Direction Generale de l'Agriculture et de la Nature de l'Etat de Geneve; Fondation Ernst AMP; Lucie Schmidheiny	This study benefitted from the financial support from the Direction Generale de l'Agriculture et de la Nature de l'Etat de Geneve and the Fondation Ernst & Lucie Schmidheiny. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizpurua O, 2018, MOL ECOL, V27, P815, DOI 10.1111/mec.14474; Albaina A, 2016, ECOL EVOL, V6, P1809, DOI 10.1002/ece3.1986; Alberdi A, 2019, MOL ECOL RESOUR, V19, P327, DOI 10.1111/1755-0998.12960; Alberdi A, 2018, METHODS ECOL EVOL, V9, P134, DOI 10.1111/2041-210X.12849; Andre A, 2017, INFECT GENET EVOL, V52, P10, DOI 10.1016/j.meegid.2017.04.011; Andreas M, 2012, ACTA CHIROPTEROL, V14, P335, DOI 10.3161/150811012X661657; Andriollo Tommy, 2019, Entomo Helvetica, V12, P9; Andriollo T, 2018, REV SUISSE ZOOL, V125, P61, DOI 10.5281/zenodo.1196013; Andriollo T, 2018, ECOL EVOL, V8, P12841, DOI 10.1002/ece3.4714; ARLETTAZ R, 1993, MAMMALIA, V57, P519, DOI 10.1515/mamm.1993.57.4.519; Arrizabalaga-Escud, 2018, MOL ECOL, V0027; Ashrafi S, 2011, EUR J WILDLIFE RES, V57, P843, DOI 10.1007/s10344-011-0496-z; Biffi M, 2017, MAMM BIOL, V87, P176, DOI 10.1016/j.mambio.2017.09.001; Bohmann K, 2018, MOL ECOL RESOUR, V18, P1050, DOI 10.1111/1755-0998.12891; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Brown DS, 2014, MOL ECOL, V23, P3695, DOI 10.1111/mec.12445; Burgar JM, 2014, MOL ECOL, V23, P3605, DOI 10.1111/mec.12531; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clare EL, 2011, MOL ECOL, V20, P1772, DOI 10.1111/j.1365-294X.2011.05040.x; Clare EL, 2016, GENOME, V59, P981, DOI 10.1139/gen-2015-0184; Clare EL, 2014, EVOL APPL, V7, P1144, DOI 10.1111/eva.12225; Clare EL, 2014, MOL ECOL, V23, P3633, DOI 10.1111/mec.12519; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Colwell RK, 2013, STATISTICAL ESTIMATI; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Czenze ZJ, 2018, ECOL EVOL, V8, P7599, DOI 10.1002/ece3.4268; Danks HV, 2007, CAN ENTOMOL, V139, P1, DOI 10.4039/n06-048; de Jong Yde, 2014, Biodivers Data J, pe4034, DOI 10.3897/BDJ.2.e4034; Deagle BE, 2019, MOL ECOL, V28, P391, DOI 10.1111/mec.14734; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FECHNEY LR, 1988, NEW ZEAL J MAR FRESH, V22, P163, DOI 10.1080/00288330.1988.9516288; Galan M, 2018, MOL ECOL RESOUR, V18, P474, DOI 10.1111/1755-0998.12749; Gebremedhin B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159133; Guillerault N, 2017, J FISH BIOL, V90, P2214, DOI 10.1111/jfb.13294; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hope PR, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-39; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Huemer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115774; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ibanez C, 2016, MOL ECOL, V25, P5254, DOI 10.1111/mec.13831; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jusino MA, 2019, MOL ECOL RESOUR, V19, P176, DOI 10.1111/1755-0998.12951; Kamenova S, 2018, MOL ECOL RESOUR, V18, P966, DOI 10.1111/1755-0998.12775; Kartzinel TR, 2015, P NATL ACAD SCI USA, V112, P8019, DOI 10.1073/pnas.1503283112; Kerley GIH, 2018, OECOLOGIA, V188, P107, DOI 10.1007/s00442-018-4203-6; Krehenwinkel H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17333-x; KUNZ TH, 1983, CAN J ZOOL, V61, P1317, DOI 10.1139/z83-177; LANGTON RW, 1982, FISH B-NOAA, V80, P745; Leray M, 2015, PEERJ, V3, DOI 10.7717/peerj.1047; Levins R., 1968, EVOLUTION CHANGING E; Mata VA, 2019, MOL ECOL, V28, P165, DOI 10.1111/mec.14779; Mata VA, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0988; Merz B., 2012, LISTE ANNOTE E DES I; Mollot G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093740; Morisita M., 1959, MEMOIRS FS KYUSHU U, V2, P215; Motte G, 2011, THESIS; Nakahara F., 2015, DNA BARCODES, DOI [10.1515/dna-2015-0021, DOI 10.1515/DNA-2015-0021]; Nichols RV, 2018, MOL ECOL RESOUR, V18, P927, DOI 10.1111/1755-0998.12895; Nielsen JM, 2018, METHODS ECOL EVOL, V9, P278, DOI 10.1111/2041-210X.12869; Pianka ER, 1973, ANNU REV ECOL SYST, V4, P53, DOI [DOI 10.1146/ANNUREV.ES.04.110173.000413, 10.1146/annurev.es.04.110173.000413]; Pinol J, 2014, MOL ECOL RESOUR, V14, P18, DOI 10.1111/1755-0998.12156; Pinol J, 2019, MOL ECOL, V28, P407, DOI 10.1111/mec.14776; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Quemere E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058971; R Core Team, 2021, R LANGUAGE ENV STAT; Racey PA, 2000, REPROD BIOL BATS, P510; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Razgour O, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.49; Rostovskaya M. S., 2000, Russian Entomological Journal, V9, P185; Salinas-Ramos VB, 2015, MOL ECOL, V24, P5296, DOI 10.1111/mec.13386; Sato JJ, 2018, J MAMMAL, V99, P952, DOI 10.1093/jmammal/gyy063; Schoeman MC, 2011, OECOLOGIA, V166, P493, DOI 10.1007/s00442-010-1854-3; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; SMITH EP, 1982, ECOLOGY, V63, P1248, DOI 10.2307/1938851; Smith MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014424; Soininen EM, 2017, POLAR BIOL, V40, P2097, DOI 10.1007/s00300-017-2114-3; Srivathsan A, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0150-4; Srivathsan A, 2015, MOL ECOL RESOUR, V15, P250, DOI 10.1111/1755-0998.12302; Sullins DS, 2018, AUK, V135, P583, DOI 10.1642/AUK-17-199.1; Swift JF, 2018, EVOL APPL, V11, P1120, DOI 10.1111/eva.12644; Taberlet P, 2018, ENVIRONMENTAL DNA: FOR BIODIVERSITY RESEARCH AND MONITORING; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Vesterinen EJ, 2018, ECOL EVOL, V8, P10914, DOI 10.1002/ece3.4559; Vesterinen EJ, 2016, MOL ECOL, V25, P1581, DOI 10.1111/mec.13564; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	90	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219135	10.1371/journal.pone.0219135	http://dx.doi.org/10.1371/journal.pone.0219135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276547	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300038
J	Jouglin, M; Blanc, B; de la Cotte, N; Bastian, S; Ortiz, K; Malandrin, L				Jouglin, Maggy; Blanc, Barbara; de la Cotte, Nathalie; Bastian, Suzanne; Ortiz, Katia; Malandrin, Laurence			First detection and molecular identification of the zoonotic Anaplasma capra in deer in France	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; PHYLOGENETIC ANALYSIS; PHAGOCYTOPHILUM; SEQUENCE; DIVERSITY; BACTERIA; CENTRALE; CATTLE; TICKS	Cervids are known to be reservoirs of zoonotic bacteria transmitted by ticks. This study aimed to identify the Anaplasma species carried by captive red deer and swamp deer in a wild fauna reserve in France. Blood from 59 red deer and 7 swamp deer was collected and analyzed over a period of two years. A semi-nested PCR targeting the 23S rRNA was performed to detect and characterize Anaplasma spp. and determine the presence of zoonotic species. Anaplasma phagocytophilum was identified in 14/59 red deer (23.7%) but it was not identified in any of the swamp deer (7 animals). Three sequences could not be assigned to any particular species based on the 23S rRNA sequences. Complementary nested PCR targeting 16S rRNA, gltA and groEL genes and sequencing analysis then identified these sequences as a recently reported zoonotic species, Anaplasma capra; this species was found in 2 red deer (Cervus elaphus) and 1 swamp deer (Rucervus duvaucelii). This is the first report of the tick-borne zoonotic bacterium A. capra in France, a species otherwise described only in China, Japan, Malaysia and South Korea in goats, sheep, deer, cattle and Japanese serows (Capricornis crispus). While this bacterium may have been introduced into the reserve by infected imported animals, its local epidemiological cycle via tick transmission seems possible as locally born deer were found infected. Diagnostic methods, especially molecular ones, should take into account the potential infection of animals and humans with this species.	[Jouglin, Maggy; de la Cotte, Nathalie; Bastian, Suzanne; Malandrin, Laurence] Oniris, INRA, BIOEPAR, Nantes, France; [Blanc, Barbara; Ortiz, Katia] Museum Natl Hist Nat, Reserve Zool Haute Touche, Obterre, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Museum National d'Histoire Naturelle (MNHN)	Malandrin, L (corresponding author), Oniris, INRA, BIOEPAR, Nantes, France.	laurence.malandrin@oniris-nantes.fr						Battilani M, 2017, INFECT GENET EVOL, V49, P195, DOI 10.1016/j.meegid.2017.01.021; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Dahmani M, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2233-2; Dahmani M, 2015, COMP IMMUNOL MICROB, V39, P39, DOI 10.1016/j.cimid.2015.02.002; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Di Domenico M, 2016, TICKS TICK-BORNE DIS, V7, P782, DOI 10.1016/j.ttbdis.2016.03.012; Ebani VV, 2016, COMP IMMUNOL MICROB, V47, P77, DOI 10.1016/j.cimid.2016.06.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia-Perez AL, 2016, TICKS TICK-BORNE DIS, V7, P264, DOI 10.1016/j.ttbdis.2015.10.019; Hornok S, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1403-6; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inokuma H, 2001, CLIN DIAGN LAB IMMUN, V8, P241, DOI 10.1128/CDLI.8.2.241-244.2001; Jouglin M, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2316-0; Kawahara M, 2006, APPL ENVIRON MICROB, V72, P1102, DOI 10.1128/AEM.72.2.1102-1109.2006; Kazimirova M, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3068-1; Koh FX, 2018, VET PARASITOL REG ST, V13, P141, DOI 10.1016/j.vprsr.2018.05.006; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Li H, 2015, LANCET INFECT DIS, V15, P663, DOI 10.1016/S1473-3099(15)70051-4; Lu M, 2017, TICKS TICK-BORNE DIS, V8, P574, DOI 10.1016/j.ttbdis.2017.03.006; Pereira A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1535-0; Ryan MP, 2006, J HOSP INFECT, V62, P278, DOI 10.1016/j.jhin.2005.08.015; Sato M, 2009, J VET MED SCI, V71, P1677, DOI 10.1292/jvms.001677; Seo MG, 2018, VET MICROBIOL, V226, P15, DOI 10.1016/j.vetmic.2018.10.008; Sun XF, 2015, LANCET INFECT DIS, V15, P1263, DOI 10.1016/S1473-3099(15)00377-1; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Yang JF, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0212-0; Yang JF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2182-9; Yang JF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1886-6	32	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219184	10.1371/journal.pone.0219184	http://dx.doi.org/10.1371/journal.pone.0219184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276519	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300047
J	Li, LZ; Shi, M; Salerno, S; Tang, MH; Guo, F; Liu, J; Feng, YH; Fu, M; Huang, QW; Ma, L; Li, Y; Fu, P				Li, Lingzhi; Shi, Min; Salerno, Stephen; Tang, Minghai; Guo, Fan; Liu, Jing; Feng, Yanhuan; Fu, Martina; Huang, Qinwan; Ma, Liang; Li, Yi; Fu, Ping			Microbial and metabolomic remodeling by a formula of Sichuan dark tea improves hyperlipidemia in apoE-deficient mice	PLOS ONE			English	Article							HIGH-FAT DIET; GUT MICROBIOTA; OXIDATIVE STRESS; ANTIOXIDANT ACTIVITY; INSULIN-RESISTANCE; PANCREATIC LIPASE; ALPHA-GLUCOSIDASE; EXTRACT; BACTERIA; ATHEROSCLEROSIS	Medicine-food homology is a long-standing concept in traditional Chinese medicine. YiNian-KangBao (YNKB) tea is a medicine-food formulation based on Sichuan dark tea (Ya'an Tibetan tea), which is traditionally used for its lipid-lowering properties. In this study, we evaluated the effects of YNKB on dyslipidemia and investigated the mechanism underlying its correlation with gut microbiota and serum metabolite regulation. Wild-type mice were fed a normal diet as a control. Male ApoE-/- mice were randomly divided into three high-fat diet (HFD) groups, a model group, and two treated groups (100, 400 mg/kg/d for low, high-dose), and fed by gavage for 12 weeks. Serum lipid levels, composition of gut microbiota, and serum metabolites were then analyzed before treatment with YNKB. We extracted the ingredients of YNKB in boiled water for one hour. YNKB supplementation at a high dose of 400 mg/kg/day reduced bodyweight gains (relative epididymal fat pad and liver weight), and markedly attenuated serum lipid profiles and atherosclerosis index, with no significant differences present between the low-dose treatment and HFD groups. Gut microbiota and serum metabolic analysis indicated that significant differences were observed between normal, HFD, and YNKB treatment groups. These differences in gut microbiota exhibited strong correlations with dyslipidemia- related indexes and serum metabolite levels. Oral administration of high-dose YNKB also showed significant lipid-lowering activity against hyperlipidemia in apoE-deficient mice, which might be associated with composition alterations of the gut microbiota and changes in serum metabolite abundances. These findings highlight that YNKB as a medicine-food formulation derived from Sichuan dark tea could prevent dyslipidemia and improve the understanding of its mechanisms and the pharmacological rationale for preventive use.	[Li, Lingzhi; Shi, Min; Tang, Minghai; Guo, Fan; Liu, Jing; Feng, Yanhuan; Ma, Liang; Fu, Ping] Sichuan Univ, West China Hosp, Kidney Res Inst, Div Nephrol, Chengdu, Sichuan, Peoples R China; [Li, Lingzhi; Shi, Min; Tang, Minghai; Guo, Fan; Liu, Jing; Feng, Yanhuan; Ma, Liang; Fu, Ping] Sichuan Univ, West China Hosp, Kidney Res Inst, Natl Clin Res Ctr Geriatr, Chengdu, Sichuan, Peoples R China; [Salerno, Stephen; Fu, Martina; Li, Yi] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Huang, Qinwan] Chengdu Univ Tradit Chinese Med, Coll Pharm, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; University of Michigan System; University of Michigan; Chengdu University of Traditional Chinese Medicine	Ma, L; Fu, P (corresponding author), Sichuan Univ, West China Hosp, Kidney Res Inst, Div Nephrol, Chengdu, Sichuan, Peoples R China.; Ma, L; Fu, P (corresponding author), Sichuan Univ, West China Hosp, Kidney Res Inst, Natl Clin Res Ctr Geriatr, Chengdu, Sichuan, Peoples R China.	liang_m@scu.edu.cn; fupinghx@scu.edu.cn	Huang, Qinwan/AAA-9740-2019	Huang, Qinwan/0000-0002-6071-051X; Salerno, Stephen/0000-0003-2763-0494; Ma, Liang/0000-0001-8327-7969	National Key R&D Program of China [2016YFC1305403]; Sichuan Province Key RD Program [2018FZ0104]	National Key R&D Program of China; Sichuan Province Key RD Program	The study (Microbial and metabolomic remodeling by a formula of Sichuan dark tea improves hyperlipidemia in apoE-deficient mice) was supported by the National Key R&D Program of China (2016YFC1305403) and the Sichuan Province Key R&D Program (2018FZ0104). The funders provided money for the authors to conduct experiments, collect specimens, and analyze data. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Key R&D Program of China (2016YFC1305403) and the Sichuan Province Key R&D Program (2018FZ0104). We would like to thank Prof. Chuan Li, and the medicine-food tea from Chengdu YiNianKangBao Biological Technology Co., Ltd.	Alcock J, 2014, BIOESSAYS, V36, P940, DOI 10.1002/bies.201400071; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Anhe FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142; Axling U, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-105; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bahado-Singh RO, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.056; Bernini LJ, 2016, NUTRITION, V32, P716, DOI 10.1016/j.nut.2015.11.001; Campbell CL, 2019, DIABET METAB SYND OB, V12, P97, DOI 10.2147/DMSO.S192228; Chen DW, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-386; Chen DL, 2017, ONCOTARGET, V8, P85838, DOI 10.18632/oncotarget.20689; Chen H, 2016, REDOX BIOL, V10, P168, DOI 10.1016/j.redox.2016.09.014; Cho K, 2017, PEDIATR OBES, V12, P93, DOI 10.1111/ijpo.12114; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; Del Chierico F, 2017, HEPATOLOGY, V65, P451, DOI 10.1002/hep.28572; du Souich P, 2017, PHARMACOL THERAPEUT, V175, P1, DOI 10.1016/j.pharmthera.2017.02.029; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Emoto T, 2016, J ATHEROSCLER THROMB, V23, P908, DOI 10.5551/jat.32672; Enkhmaa B, 2005, J NUTR, V135, P729, DOI 10.1093/jn/135.4.729; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fan PX, 2017, SCI REP-UK, V7, DOI 10.1038/srep43412; Galvez J, 2005, MOL NUTR FOOD RES, V49, P601, DOI 10.1002/mnfr.200500013; Garidou L, 2015, CELL METAB, V22, P100, DOI 10.1016/j.cmet.2015.06.001; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gonzalez E, 2012, METABOLOMICS, V8, P997, DOI 10.1007/s11306-011-0329-9; Guo XF, 2017, FOOD FUNCT, V8, P1741, DOI 10.1039/c7fo00183e; Guo Y, 2018, EUR J ENDOCRINOL, V178, P43, DOI [10.1530/EJE-17-0403, 10.1530/eje-17-0403]; Henning SM, 2018, EUR J NUTR, V57, P2759, DOI 10.1007/s00394-017-1542-8; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Hou Y, 2013, FOOD FUNCT, V4, P1727, DOI 10.1039/c3fo60295h; Huang J., 2004, CHIN J CLIN PHARM TH, V09, P1069; Huang QF, 2013, FOOD CHEM TOXICOL, V53, P75, DOI 10.1016/j.fct.2012.11.039; Jiao YK, 2017, J ETHNOPHARMACOL, V199, P119, DOI 10.1016/j.jep.2017.02.003; Kubot K, 2011, NUTR RES, V31, P421, DOI 10.1016/j.nutres.2011.05.004; Kurano M, 2017, J LIPID RES, V58, P433, DOI 10.1194/jlr.P071803; Lee LK, 2013, FOOD RES INT, V53, P619, DOI 10.1016/j.foodres.2013.02.036; Li LZ, 2017, DRUG DES DEV THER, V11, P3531, DOI 10.2147/DDDT.S150825; Li TP, 2014, FOOD CHEM, V145, P335, DOI 10.1016/j.foodchem.2013.08.036; Li XM, 2007, INT J BIOL MACROMOL, V40, P461, DOI 10.1016/j.ijbiomac.2006.11.002; Liao CH, 2013, FOOD CHEM TOXICOL, V58, P416, DOI 10.1016/j.fct.2013.05.018; Lin MC, 2009, J AGR FOOD CHEM, V57, P5925, DOI 10.1021/jf901058a; Liu S, 2013, J ETHNOPHARMACOL, V149, P263, DOI 10.1016/j.jep.2013.06.034; Ono Y, 2006, J ETHNOPHARMACOL, V106, P238, DOI 10.1016/j.jep.2005.12.036; Oresic M, 2012, GENOME MED, V4, DOI 10.1186/gm300; Pauer H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203748; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Pomie C, 2016, MOL METAB, V5, P392, DOI 10.1016/j.molmet.2016.03.004; Reinehr T, 2015, EUR J NUTR, V54, P173, DOI 10.1007/s00394-014-0698-8; Remely M, 2014, GENE, V537, P85, DOI 10.1016/j.gene.2013.11.081; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; Shao YK, 2017, OBES SURG, V27, P295, DOI 10.1007/s11695-016-2297-7; Shi X, 2015, J PROTEOME RES, V14, P1174, DOI 10.1021/pr501121c; Shih CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/597067; Shin HS, 2014, J ETHNOPHARMACOL, V153, P142, DOI 10.1016/j.jep.2014.01.039; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Sugimoto M, 2009, ATHEROSCLEROSIS, V204, P388, DOI 10.1016/j.atherosclerosis.2008.10.021; Tomas J, 2016, P NATL ACAD SCI USA, V113, pE5934, DOI 10.1073/pnas.1612559113; Ursell LK, 2013, BIOESSAYS, V35, P810, DOI 10.1002/bies.201300018; Wang YW, 2017, J SCI FOOD AGR, V97, P5100, DOI 10.1002/jsfa.8387; Ye XL, 2010, J AGR FOOD CHEM, V58, P3132, DOI 10.1021/jf903337f; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27	61	10	10	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219010	10.1371/journal.pone.0219010	http://dx.doi.org/10.1371/journal.pone.0219010			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269076	Green Submitted, gold, Green Published			2022-12-26	WOS:000484927300036
J	Cavuoto, LA; Pajoutan, M; Mehta, RK				Cavuoto, Lora A.; Pajoutan, Mojdeh; Mehta, Ranjana K.			Reliability analyses and values of isometric shoulder flexion and trunk extension strengths stratified by body mass index	PLOS ONE			English	Article							MUSCLE STRENGTH; GRIP STRENGTH; OBESITY; FATIGUE; ASSOCIATION; PERFORMANCE; AGREEMENT; WOMEN; PAIN	The main goal of this study was to investigate the reliability of muscle strength across different levels of obesity. A sample of 142 healthy subjects performed maximum voluntary isometric contractions for shoulder flexion and trunk extension on each of four days. Subjects were recruited into one of three groups, non-obese, overweight, or obese, based on body mass index (BMI). Reliability of the strength measurements within each session and across the four sessions was determined from the intraclass correlation coefficient, coefficient of repeatability, coefficient of variation, and standard error of measurement. For the shoulder flexion measures, the coefficient of variation was < 10% and intraclass correlation coefficient was > 0.75. The absolute reliability of trunk extension strength measurement was rejected due to a high variability across sessions. For both tasks, comparable strengths across the BMI groups were found.	[Cavuoto, Lora A.; Pajoutan, Mojdeh] SUNY Buffalo, Ind & Syst Engn, Buffalo, NY 14260 USA; [Mehta, Ranjana K.] Texas A&M Univ, Ind & Syst Engn, College Stn, TX USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Texas A&M University System; Texas A&M University College Station	Cavuoto, LA (corresponding author), SUNY Buffalo, Ind & Syst Engn, Buffalo, NY 14260 USA.	loracavu@buffalo.edu	Mehta, Ranjana/AAE-3257-2020	Mehta, Ranjana/0000-0002-8254-8365; Cavuoto, Lora/0000-0003-4717-8378	Centers for Disease Control and Prevention [1 R03 OH 010547 01]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The funding was provided by the Centers for Disease Control and Prevention, Grant Number 1 R03 OH 010547 01 (https.//www.cdc.gov/niosh/) to LC. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmoula A, 2012, APPL PHYSIOL NUTR ME, V37, P269, DOI [10.1139/h2012-010, 10.1139/H2012-010]; Akhavanfar MH, 2018, J BIOMECH, V70, P102, DOI 10.1016/j.jbiomech.2017.08.009; ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; BLAKLEY BR, 1994, PERS PSYCHOL, V47, P247, DOI 10.1111/j.1744-6570.1994.tb01724.x; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bohannon RW, 2006, PHYSIOTHERAPY, V92, P11, DOI 10.1016/j.physio.2005.05.003; CALDWELL LS, 1974, AM IND HYG ASSOC J, V35, P201, DOI 10.1080/0002889748507023; Cavuoto LA, 2013, INT J IND ERGONOM, V43, P393, DOI 10.1016/j.ergon.2013.08.001; Cavuoto LA, 2013, APPL ERGON, V44, P254, DOI 10.1016/j.apergo.2012.07.011; Dedering A, 1999, CLIN BIOMECH, V14, P103, DOI 10.1016/S0268-0033(98)00053-9; Edouard P, 2013, J SCI MED SPORT, V16, P162, DOI 10.1016/j.jsams.2012.01.007; Eksioglu M, 2016, APPL ERGON, V52, P8, DOI 10.1016/j.apergo.2015.06.023; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fogelholm M, 2006, INT J OBESITY, V30, P962, DOI 10.1038/sj.ijo.0803243; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hulens M, 2001, INT J OBESITY, V25, P676, DOI 10.1038/sj.ijo.0801560; Karatas GK, 2002, AM J PHYS MED REHAB, V81, P79, DOI 10.1097/00002060-200202000-00001; KITAGAWA K, 1978, EUR J APPL PHYSIOL O, V38, P189, DOI 10.1007/BF00430077; Lafortuna CL, 2005, INT J OBESITY, V29, P833, DOI 10.1038/sj.ijo.0802955; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Looney MA, 2000, MEAS PHYS ED EXERC S, V4, P73, DOI DOI 10.1207/S15327841MPEE0402_3; Ma L, 2009, INT J IND ERGONOM, V39, P211, DOI 10.1016/j.ergon.2008.04.004; Maffiuletti NA, 2007, EUR J APPL PHYSIOL, V101, P51, DOI 10.1007/s00421-007-0471-2; Matter KC, 2007, OBESITY, V15, P2384, DOI 10.1038/oby.2007.283; Mbada Chidozie E., 2010, Journal of Musculoskeletal Research, V13, P13, DOI 10.1142/S0218957710002405; Mehta RK, 2015, INT J OBESITY, V39, P208, DOI 10.1038/ijo.2014.127; Mehta RK, 2016, EUR J APPL PHYSIOL, V116, P319, DOI 10.1007/s00421-015-3283-9; Mehta RK, 2017, HUM FACTORS; Miyatake N, 2000, DIABETES RES CLIN PR, V48, P15, DOI 10.1016/S0168-8227(99)00132-1; OGDEN CL, 2015, NCHS DATA BRIEF, V219, P1, DOI DOI 10.1017/S1368980017000088; Pajoutan M., 2016, ROC HUM FACTORS ERGO, V60, P943, DOI [10.1177/1541931213601217, DOI 10.1177/1541931213601217]; Pajoutan M, 2016, FATIGUE, V4, P115, DOI 10.1080/21641846.2016.1175178; Rahemi H, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0365; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Rechardt M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-165; Rolland Y, 2004, AM J CLIN NUTR, V79, P552; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Spencer SM, 2008, J AM GERIATR SOC, V56, P553, DOI 10.1111/j.1532-5415.2007.01595.x; Strike PW., 2014, STAT METHODS LAB MED; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	44	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219090	10.1371/journal.pone.0219090	http://dx.doi.org/10.1371/journal.pone.0219090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3YW	31260477	Green Published, gold, Green Submitted			2022-12-26	WOS:000484918700032
J	Tonen-Wolyec, S; Batina-Agasa, S; Muwonga, J; Bouassa, RSM; Tshilumba, CK; Belec, L				Tonen-Wolyec, Serge; Batina-Agasa, Salomon; Muwonga, Jeremie; Bouassa, Ralph-Sydney Mboumba; Tshilumba, Charles Kayembe; Belec, Laurent			Acceptability, feasibility, and individual preferences of blood-based HIV self-testing in a population-based sample of adolescents in Kisangani, Democratic Republic of the Congo	PLOS ONE			English	Article								Background Adolescents living in sub-Saharan Africa constitute a vulnerable population at significant risk of HIV infection. This study aims to evaluate the acceptability, feasibility, and accuracy of home-based, supervised HIV self-testing (HIVST) as well as their predictors among adolescents living in Kisangani, Democratic Republic of the Congo (DRC). Methods A cross-sectional, door-to-door survey using a blood-based HIV self-test and a peer-based supervised HIVST approach was conducted from July to August 2018 in Kisangani, DRC. The acceptability and feasibility of HIVST were assessed among adolescents' consenting to use and interpret HIV self-test. The accuracy of HIVST was estimated by the sensibility and specificity of adolescent-interpreted HIV self-test. Factors associated with acceptability and feasibility of HIVST were analyzed with logistic regression. Results A total of 628 adolescents (including 369 [58.8%] females) aged between 15 and 19 years were enrolled. Acceptability of HIVST was high (95.1%); 96.1% of participants correctly used the self-test, and 65.2% asked for verbal instructions. The majority of adolescents (93.5%) correctly interpreted their self-test results. The Cohen's. coefficient between the results read by adolescents and by supervisors was 0.62. The correct interpretation decreased significantly when adolescents had no formal education or attended primary school as compared to those currently attending university (37.0% versus 100%; adjusted OR: 0.01 [95% CI: 0.004-0.03]). In the hands of adolescents at home, the sensitivity of the Exacto Test HIV Self-test was estimated at 100%, while its specificity was 96.0%. The majority of participants (68.0%) affirmed that post-test counseling was essential, and that face-to-face counseling (78.9%) was greatly preferred. Conclusions Home-based, supervised HIVST using a blood-based self-test and peer-based approach can be used with a high degree of acceptability and feasibility by adolescents living in Kisangani, DRC. Misinterpretation of test results is challenging to obtaining good feasibility of HIVST among adolescents with poor educational level. Face-to-face post-test counseling seems to be preferred among Kisangani's adolescents.	[Tonen-Wolyec, Serge; Bouassa, Ralph-Sydney Mboumba] Ecole Doctorale Reg Afrique Cent Infectiol Trop, Franceville, Gabon; [Tonen-Wolyec, Serge] Univ Bunia, Fac Med, Bunia, DEM REP CONGO; [Tonen-Wolyec, Serge; Batina-Agasa, Salomon; Tshilumba, Charles Kayembe] Univ Kisangani, Fac Med Pharm, Kisangani, DEM REP CONGO; [Muwonga, Jeremie] Lab Natl Reference Sida & IST, Kinshasa, DEM REP CONGO; [Muwonga, Jeremie] Programme Natl Lutte VIH SIDA & IST, Kinshasa, DEM REP CONGO; [Belec, Laurent] Hop Europeen Georges Pompidou, Lab Virol, Paris, France; [Belec, Laurent] Univ Paris 05, Paris Sorbonne Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Tonen-Wolyec, S (corresponding author), Ecole Doctorale Reg Afrique Cent Infectiol Trop, Franceville, Gabon.; Tonen-Wolyec, S (corresponding author), Univ Bunia, Fac Med, Bunia, DEM REP CONGO.; Tonen-Wolyec, S (corresponding author), Univ Kisangani, Fac Med Pharm, Kisangani, DEM REP CONGO.	wolyec@gmail.com	Tonen-Wolyec, Serge/ADM-2951-2022	Tonen-Wolyec, Serge/0000-0002-7734-7729				Africaid Zvandiri, 2015, SESS 18 INT C AIDS S; Hernandez MA, 2018, J BIOPHARM STAT, V28, P1090, DOI 10.1080/10543406.2018.1452028; Belza MJ, 2012, SEX TRANSM INFECT, V88, P218, DOI 10.1136/sextrans-2011-050131; Bilardi JE, 2013, AIDS BEHAV, V17, P2093, DOI 10.1007/s10461-012-0395-7; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Gresenguet Gerard, 2017, Open AIDS J, V11, P101, DOI 10.2174/1874613601711010101; Hector J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195391; HIVST.org, POL REG HIVST; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Lee VJ, 2007, JAIDS-J ACQ IMM DEF, V45, P449, DOI 10.1097/QAI.0b013e318095a3f3; MacQueen KM, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.22267; Masters SH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002166; Ministere de la Sante Publique Programme National de la Sante des Adolescents, 2016, PLAN STRAT NAT SANT; Mugo PM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170868; Njau B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-838; Ortblad KF, 2018, JAIDS-J ACQ IMM DEF, V79, pE42, DOI 10.1097/QAI.0000000000001765; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Programme National de Lutte contre le Sida, 2016, GUID PRIS CHARG INT; Sarkar A, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20993; Smith P, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21111; Tonen-Wolyec S, 2018, MED SANTE TROP, V28, P144, DOI 10.1684/mst.2018.0777; Tonen-Wolyec S, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014218; Tonen-Wolyec S, 2018, LANCET HIV, V5, pE341, DOI 10.1016/S2352-3018(18)30141-3; Tonen-Wolyec S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189475; UNAIDS, END AIDS EP AD AD; UNAIDS, NEW HIV INF AD; UNAIDS / UNICEF, 2016, PROGR REP ALL END AD; UNICEF, 2016, AIDS EP CONT TAK STA; WHO, 2015, CONSOLIDATED GUIDELI; WHO, 2016, GUID HIV SELF TEST P; World Bank Document, 2010, REP DEM CONG; World Health Organisation, 2015, HIV AD GUID HIV TEST; World Health Organization, HUM IMM VIR HIV RAP; World Health Organization & UNITAID, 2018, MARK TECHN LANDSC HI; World Health Organization & UNITAID, 2017, HIV RAP DIAGN TESTS; World Health Organization (WHO), 2015, WHO PREQ SAMPL PROD; Zanolini A, 2018, AIDS RES HUM RETROV, V34, P254, DOI [10.1089/aid.2017.0156, 10.1089/AID.2017.0156]	40	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0218795	10.1371/journal.pone.0218795	http://dx.doi.org/10.1371/journal.pone.0218795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IK4PV	31260480	Green Published, Green Submitted, gold			2022-12-26	WOS:000476569700001
J	Nabizadeh, JA; Manthey, HD; Panagides, N; Steyn, FJ; Lee, JD; Li, XX; Akhir, FNM; Chen, WY; Boyle, GM; Taylor, SM; Woodruff, TM; Rolfe, BE				Nabizadeh, Jamileh A.; Manthey, Helga D.; Panagides, Nadya; Steyn, Frederik J.; Lee, John D.; Li, Xaria X.; Akhir, Fazrena N. M.; Chen, Weiyu; Boyle, Glen M.; Taylor, Stephen M.; Woodruff, Trent M.; Rolfe, Barbara E.			C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma	FASEB JOURNAL			English	Article						C5aR1 antagonist; tumor-infiltrating leukocytes	COMPLEMENT ACTIVATION; IMMUNE-RESPONSE; CANCER; CELLS; C5L2; MICROENVIRONMENT; ANAPHYLATOXIN; MODULATOR; BLOCKADE; INNATE	The canonical complement component 5a (C5a) receptor (C5aR) 1 has well-described roles in tumorigenesis but the contribution of the second receptor, C5aR2, is unclear. The present study demonstrates that B16.F0 melanoma cells express mRNA for both C5aR1 and C5aR2 and signal through ERK and p38 MAPKs in response to C5a. Despite this, C5a had no impact on melanoma cell proliferation or migration in vitro. In vivo studies demonstrated that the growth of B16.F0 melanoma tumors was increased in C5aR2(-/-) mice but reduced in C5aR1(-/-) mice and wild-type mice treated with a C5aR1 antagonist. Analysis of tumor-infiltrating leukocyte populations showed no significant differences between wild-type and C5aR2(-/-) mice. Conversely, percentages of myeloid-derived suppressor cells, macrophages, and regulatory T lymphocytes were lower in tumors from C5aR1(-/-) mice, whereas total (CD3(+)) T lymphocytes and CD4(+) subsets were higher. Analysis of cytokine and chemokine levels also showed plasma IFN-gamma was higher and tumor C-C motif chemokine ligand 2 was lower in the absence of C5aR1. The results suggest that C5aR1 signaling supports melanoma growth by promoting infiltration of immunosuppressive leukocyte populations into the tumor microenvironment, whereas C5aR2 has a more restricted but beneficial role in limiting tumor growth. Overall, these data support the potential of C5aR1-inhibitory therapies for melanoma.-Nabizadeh, J. A., Manthey, H. D., Panagides, N., Steyn, F. J., Lee, J. D., Li, X. X., Akhir, F. N. M., Chen, W., Boyle, G. M., Taylor, S. M., Woodruff, T. M., Rolfe, B. E. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.	[Nabizadeh, Jamileh A.; Manthey, Helga D.; Panagides, Nadya; Akhir, Fazrena N. M.; Chen, Weiyu; Rolfe, Barbara E.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Cnr Coll & Cooper Rds, Brisbane, Qld 4072, Australia; [Steyn, Frederik J.] Univ Queensland, Ctr Clin Res, Brisbane, Qld, Australia; [Lee, John D.; Li, Xaria X.; Taylor, Stephen M.; Woodruff, Trent M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Boyle, Glen M.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Akhir, Fazrena N. M.] Univ Teknol Malaysia, MJIIT, Kuala Lumpur, Malaysia; [Chen, Weiyu] Univ Wisconsin, Madison, WI USA	University of Queensland; University of Queensland; University of Queensland; QIMR Berghofer Medical Research Institute; Universiti Teknologi Malaysia; University of Wisconsin System; University of Wisconsin Madison	Rolfe, BE (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Cnr Coll & Cooper Rds, Brisbane, Qld 4072, Australia.; Woodruff, TM (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	b.rolfe@uq.edu.au	Chen, Weiyu/M-5972-2018; Woodruff, Trent M/B-4861-2009; Li, Xaria X/ABG-7342-2020; Woodruff, Trent/AAS-4629-2020; Boyle, Glen/G-1347-2013; Akhir, Fazrena Md/AAD-9120-2019; Steyn, FJ/P-4386-2016; Lee, John/Y-2066-2018	Chen, Weiyu/0000-0003-4436-2743; Woodruff, Trent M/0000-0003-1382-911X; Li, Xaria X/0000-0001-5924-2977; Woodruff, Trent/0000-0003-1382-911X; Boyle, Glen/0000-0002-1385-529X; Akhir, Fazrena Md/0000-0003-4874-8379; Steyn, FJ/0000-0002-4782-3608; Lee, John/0000-0002-9976-7396; Rolfe, Barbara/0000-0002-0468-1371	Australian National Health and Medical Research Council (NHMRC) [APP1103951]; Cancer Council Queensland (CCQ); University of Queensland Collaboration and Industry Fund (CIEF); Motor Neurone Disease Research Institute of Australia Postdoctoral Fellowship [PDF1604]; NHMRC Career Development Fellowship [1105420]; University of Queensland Post-Graduate Research Scholarship; University of Queensland Research Training Scholarship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland (CCQ)(Cancer Council Queensland); University of Queensland Collaboration and Industry Fund (CIEF); Motor Neurone Disease Research Institute of Australia Postdoctoral Fellowship; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland Post-Graduate Research Scholarship(University of Queensland); University of Queensland Research Training Scholarship	The authors thank Dr. Geoff Osborne for advice on flow cytometric analysis and Dr. Darryl Whitehead (both from The University of Queensland) for histological advice. This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC; APP1103951), Cancer Council Queensland (CCQ), and the University of Queensland Collaboration and Industry Fund (CIEF). J.D.L. was supported by a Motor Neurone Disease Research Institute of Australia Postdoctoral Fellowship (PDF1604). T.M.W. was supported by a NHMRC Career Development Fellowship (1105420)., J.A.N. was supported by a University of Queensland Post-Graduate Research Scholarship, and X.X.L. was supported by a University of Queensland Research Training Scholarship. J.A.N. and H.D.M. are equal first authors. T.M.W. and B.E.R. are equal contributing corresponding authors. The authors declare no conflicts of interest.	Ajona D, 2019, SEMIN CELL DEV BIOL, V85, P153, DOI 10.1016/j.semcdb.2017.11.023; Ajona D, 2017, CANCER DISCOV, V7, P694, DOI 10.1158/2159-8290.CD-16-1184; Ajona D, 2013, JNCI-J NATL CANCER I, V105, P1385, DOI 10.1093/jnci/djt205; Aldinucci D, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/292376; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Bonavita E, 2015, CELL, V160, P700, DOI 10.1016/j.cell.2015.01.004; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Callahan MK, 2016, CANCER TREAT RES, V167, P231, DOI 10.1007/978-3-319-22539-5_9; Castro F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00847; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Cho MS, 2014, CELL REP, V6, P1085, DOI 10.1016/j.celrep.2014.02.014; Corrales L, 2012, J IMMUNOL, V189, P4674, DOI 10.4049/jimmunol.1201654; Croker DE, 2016, IMMUNOL CELL BIOL, V94, P787, DOI 10.1038/icb.2016.43; Croker DE, 2014, IMMUNOL CELL BIOL, V92, P631, DOI 10.1038/icb.2014.32; Ellyard JI, 2007, TISSUE ANTIGENS, V70, P1, DOI 10.1111/j.1399-0039.2007.00869.x; Elso CM, 2004, GENES IMMUN, V5, P93, DOI 10.1038/sj.gene.6364042; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gunn L, 2012, J IMMUNOL, V189, P2985, DOI 10.4049/jimmunol.1200846; Hollmann TJ, 2008, MOL IMMUNOL, V45, P1907, DOI 10.1016/j.molimm.2007.10.037; Horst SA, 2015, PATHOGENS, V4, P722, DOI 10.3390/pathogens4040722; Imamura T, 2016, BREAST CANCER-TOKYO, V23, P876, DOI 10.1007/s12282-015-0654-3; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Kaida T, 2016, ONCOTARGET, V7, P84798, DOI 10.18632/oncotarget.12656; Karsten CM, 2017, J IMMUNOL, V199, P3234, DOI 10.4049/jimmunol.1700710; Karsten CM, 2015, J IMMUNOL, V194, P1841, DOI 10.4049/jimmunol.1401401; Klikovits T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16551-7; Klos A, 2013, PHARMACOL REV, V65, P500, DOI 10.1124/pr.111.005223; Lesokhin AM, 2012, CANCER RES, V72, P876, DOI 10.1158/0008-5472.CAN-11-1792; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Li XX, 2019, J IMMUNOL, V202, P3339, DOI 10.4049/jimmunol.1900371; Lv DD, 2013, CELL MOL IMMUNOL, V10, P303, DOI 10.1038/cmi.2012.69; Ma CS, 2016, J EXP MED, V213, P1589, DOI 10.1084/jem.20151467; Makela K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-565; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Mattes J, 2003, J EXP MED, V197, P387, DOI 10.1084/jem.20021683; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Mrowietz U, 1999, BRIT J CANCER, V79, P1025, DOI 10.1038/sj.bjc.6690164; Nagarsheth N, 2017, NAT REV IMMUNOL, V17, P559, DOI 10.1038/nri.2017.49; NICULESCU F, 1992, AM J PATHOL, V140, P1039; Nishimura T, 1999, J EXP MED, V190, P617, DOI 10.1084/jem.190.5.617; Nunez-Cruz S, 2012, NEOPLASIA, V14, P994, DOI 10.1593/neo.121262; Obermajer N, 2011, CANCER RES, V71, P7463, DOI 10.1158/0008-5472.CAN-11-2449; Pandey S., 2019, J BIOL CHEM; Piao CM, 2015, J BIOL CHEM, V290, P10667, DOI 10.1074/jbc.M114.612622; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Reis ES, 2018, NAT REV IMMUNOL, V18, P5, DOI 10.1038/nri.2017.97; Russkamp NF, 2015, FASEB J, V29, P3762, DOI 10.1096/fj.15-271635; Schupp J, 2017, CELL IMMUNOL; Sorensen MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087831; SPANGTHOMSEN M, 1980, EXP CELL BIOL, V48, P138; Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Vadrevu SK, 2014, CANCER RES, V74, P3454, DOI 10.1158/0008-5472.CAN-14-0157; Woodruff TM, 2011, MOL IMMUNOL, V48, P1631, DOI 10.1016/j.molimm.2011.04.014; Yan CG, 2012, J BIOL CHEM, V287, P3217, DOI 10.1074/jbc.M111.280834; Yang JM, 2018, CANCER IMMUNOL RES, V6, P1186, DOI 10.1158/2326-6066.CIR-18-0045; Yoshimura T, 2018, CELL MOL IMMUNOL, V15, P335, DOI 10.1038/cmi.2017.135; Zha HR, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1349587; Zhang J, 2016, ACTA BIOMATER, V41, P264, DOI 10.1016/j.actbio.2016.05.034; Zollo M, 2012, CLIN EXP METASTAS, V29, P585, DOI 10.1007/s10585-012-9473-5	63	15	16	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11060	11071		10.1096/fj.201800980RR	http://dx.doi.org/10.1096/fj.201800980RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31298935				2022-12-26	WOS:000489166300041
J	Sallustio, F; Stasi, A; Curci, C; Divella, C; Picerno, A; Franzin, R; De Palma, G; Rutigliano, M; Lucarelli, G; Battaglia, M; Staffieri, F; Crovace, A; Pertosa, GB; Castellano, G; Gallone, A; Gesualdo, L				Sallustio, Fabio; Stasi, Alessandra; Curci, Claudia; Divella, Chiara; Picerno, Angela; Franzin, Rossana; De Palma, Giuseppe; Rutigliano, Monica; Lucarelli, Giuseppe; Battaglia, Michele; Staffieri, Francesco; Crovace, Antonio; Pertosa, Giovanni Battista; Castellano, Giuseppe; Gallone, Anna; Gesualdo, Loreto			Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides	FASEB JOURNAL			English	Article						endothelial dysfunction; stem cells; antifibrotic effects	INCREASING PROTEIN; MESSENGER-RNA; MECHANISMS; FIBROSIS; SEPSIS; MOUSE; INFLAMMATION; DYSFUNCTION; ACTIVATION; EXPRESSION	Endothelial dysfunction is a hallmark of LPS-induced acute kidney injury (AKI). Endothelial cells (ECs) acquired a fibroblast-like phenotype and contributed to myofibroblast generation through the endothelial-to-mesenchymal transition (EndMT) process. Of note, human adult renal stem/progenitor cells (ARPCs) enhance the tubular regenerative mechanism during AKI but little is known about their effects on ECs. Following LPS exposure, ECs proliferated, decreased EC markers CD31 and vascular endothelial cadherin, and up-regulated myofibroblast markers, collagen I, and vimentin. The coculture with ARPCs normalized the EC proliferation rate and abrogated the LPS-induced EndMT. The gene expression analysis showed that most of the genes modulated in LPS-stimulated ARPCs belong to cell activation and defense response pathways. We showed that the ARPC-specific antifibrotic effect is exerted by the secretion of CXCL6, SAA4, and BPIFA2 produced after the anaphylatoxin stimulation. Next, we investigated the molecular signaling that underlies the ARPC protective mechanism and found that renal progenitors diverge from differentiated tubular cells and ECs in myeloid differentiation primary response 88-independent pathway activation. Finally, in a swine model of LPS-induced AKI, we observed that activated ARPCs secreted CXCL6, SAA4, and BPIFA2 as a defense response. These data open new perspectives on the treatment of both sepsis- and endotoxemia-induced AKI, suggesting an underestimated role of ARPCs in preventing endothelial dysfunction and novel strategies to protect the endothelial compartment and promote kidney repair.-Sallustio, F., Stasi, A., Curci, C., Divella, C., Picerno, A., Franzin, R., De Palma, G., Rutigliano, M., Lucarelli, G., Battaglia, M., Staffieri, F., Crovace, A., Pertosa, G. B., Castellano, G., Gallone, A., Gesualdo, L. Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides.	[Sallustio, Fabio; Curci, Claudia; Gallone, Anna] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Piazza G Cesare 11, I-70124 Bari, Italy; [Sallustio, Fabio; Stasi, Alessandra; Curci, Claudia; Divella, Chiara; Picerno, Angela; Franzin, Rossana; Pertosa, Giovanni Battista; Castellano, Giuseppe; Gallone, Anna; Gesualdo, Loreto] Univ Bari Aldo Moro, Nephrol Dialysis & Transplantat Unit, Dept Emergency & Organ Transplantat, Bari, Italy; [Rutigliano, Monica; Lucarelli, Giuseppe; Battaglia, Michele] Univ Bari Aldo Moro, Urol Androl & Renal Transplantat Unit, Dept Emergency & Organ Transplantat, Bari, Italy; [Staffieri, Francesco; Crovace, Antonio] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Vet Surg Unit, Bari, Italy; [De Palma, Giuseppe] Ist Tumori Giovanni Paolo II, IRCCS, Expt Oncol & Biobank Management Unit, Inst Biobank, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; IRCCS Istituto Tumori Bari Giovanni Paolo II	Sallustio, F (corresponding author), Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Piazza G Cesare 11, I-70124 Bari, Italy.	fabio.sallustio@uniba.it	De Palma, Giuseppe/J-4860-2018; stasi, alessandra/AAO-9506-2020; LUCARELLI, GIUSEPPE/AAX-4148-2020; stasi, alessandra/K-5023-2016; Castellano, Giuseppe/H-1626-2012; Franzin, Rossana/AHH-5631-2022; Sallustio, Fabio/AFP-7212-2022; Franzin, Rossana/AAV-6733-2020; Gesualdo, Loreto/K-7751-2016; Franzin, Rossana/AAO-7099-2021; Gallone, Anna/K-5384-2018; Sallustio, Fabio/D-2326-2011; Curci, Claudia/A-6918-2013; Picerno, Angela/AIC-9957-2022; Staffieri, Francesco/K-4230-2016	De Palma, Giuseppe/0000-0002-6108-096X; stasi, alessandra/0000-0003-3652-3623; LUCARELLI, GIUSEPPE/0000-0001-7807-1229; Castellano, Giuseppe/0000-0002-0153-3795; Franzin, Rossana/0000-0001-7907-7614; Sallustio, Fabio/0000-0002-5132-6532; Gesualdo, Loreto/0000-0002-4861-0911; Gallone, Anna/0000-0002-2252-9584; Sallustio, Fabio/0000-0002-5132-6532; Curci, Claudia/0000-0003-2055-7837; Pertosa, Giovanni Battista/0000-0002-2198-5705; Picerno, Angela/0000-0001-5805-4341; Staffieri, Francesco/0000-0002-2085-376X	University of Bari Aldo Moro; Italian Ministry of Health [GR-2011-02351027]; Regional Strategic Grant, Apulia Region [PSR 094]	University of Bari Aldo Moro; Italian Ministry of Health(Ministry of Health, Italy); Regional Strategic Grant, Apulia Region	This study was supported by University of Bari Aldo Moro, the Italian Ministry of Health (Ricerca Finalizzata 2009 to G.C. and GR-2011-02351027 2011-2012 to G.C.). L.G. was supported by a Regional Strategic Grant, Apulia Region (PSR 094). A.G. and L.G. contributed equally to this work as senior authors. The authors declare no conflicts of interest.	Basile DP, 2011, AM J PHYSIOL-RENAL, V300, pF721, DOI 10.1152/ajprenal.00546.2010; Besnard AG, 2013, J LEUKOCYTE BIOL, V94, P1317, DOI 10.1189/jlb.0313140; Bingle CD, 2002, HUM MOL GENET, V11, P937, DOI 10.1093/hmg/11.8.937; Boca SM, 2018, PEERJ, V6, DOI 10.7717/peerj.6035; Bussolati B, 2015, NAT REV NEPHROL, V11, P695, DOI 10.1038/nrneph.2015.126; Castellano G, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0520-2; Curci C, 2014, NEPHROL DIAL TRANSPL, V29, P799, DOI 10.1093/ndt/gft516; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; Echeverria C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094146; Echeverria C, 2013, J CELL MOL MED, V17, P800, DOI 10.1111/jcmm.12066; Elsbach P, 1998, J LEUKOCYTE BIOL, V64, P14, DOI 10.1002/jlb.64.1.14; Fiorentino M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198269; Gijsbers K, 2005, EXP CELL RES, V303, P331, DOI 10.1016/j.yexcr.2004.09.027; Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052; GORR S, 2015, FASEB J S1, V29; Guerrot D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S15; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; Kizu A, 2009, AM J PATHOL, V175, P1371, DOI 10.2353/ajpath.2009.090698; Kota SK, 2017, J AM SOC NEPHROL, V28, P3473, DOI 10.1681/ASN.2016121265; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; Lazzeri E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03753-4; Lazzeri E, 2015, EXPERT OPIN BIOL TH, V15, P1455, DOI 10.1517/14712598.2015.1067300; Lerolle N, 2010, INTENS CARE MED, V36, P471, DOI 10.1007/s00134-009-1723-x; Li XW, 2003, INFECT IMMUN, V71, P4414, DOI 10.1128/IAI.71.8.4414-4420.2003; Linge HM, 2008, ANTIMICROB AGENTS CH, V52, P2599, DOI 10.1128/AAC.00028-08; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Martin L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00404; MEEK RL, 1989, AM J PATHOL, V135, P411; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Olsen HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076695; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Patschan D, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/828369; Peri F, 2010, BIOCHEM SOC T, V38, P1390, DOI 10.1042/BST0381390; Sallustio F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08474-0; Sallustio F, 2015, BIORESEARCH OPEN ACC, V4, P326, DOI 10.1089/biores.2015.0011; Sallustio F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068296; Sallustio F, 2010, FASEB J, V24, P514, DOI 10.1096/fj.09-136481; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Sipe J, 1999, AMYLOID, V6, P67, DOI 10.3109/13506129908993291; Stasi A, 2017, NEPHROL DIAL TRANSPL, V32, P24, DOI 10.1093/ndt/gfw250; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Tarassishin L, 2013, J NEUROIMMUNE PHARM, V8, P132, DOI 10.1007/s11481-012-9360-5; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Usui M, 1998, BBA-GENE STRUCT EXPR, V1397, P202, DOI 10.1016/S0167-4781(97)00228-5; Vivarelli MS, 2004, J EXP MED, V200, P399, DOI 10.1084/jem.20040446; Wang SC, 1998, J SURG RES, V76, P67, DOI 10.1006/jsre.1998.5290; WEISS J, 1992, J CLIN INVEST, V90, P1122, DOI 10.1172/JCI115930; Wu LP, 2007, J AM SOC NEPHROL, V18, P1807, DOI 10.1681/ASN.2006121402; Zarjou A, 2011, J AM SOC NEPHROL, V22, P999, DOI 10.1681/ASN.2010050484; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	52	17	17	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10753	10766		10.1096/fj.201900351R	http://dx.doi.org/10.1096/fj.201900351R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31268775	Green Submitted, Bronze			2022-12-26	WOS:000489166300015
J	Macias, I; Lain, A; Bernardo-Seisdedos, G; Gil, D; Gonzalez, E; Falcon-Perez, JM; Millet, O				Macias, Iratxe; Lain, Ana; Bernardo-Seisdedos, Ganeko; Gil, David; Gonzalez, Esperanza; Falcon-Perez, Juan M.; Millet, Oscar			Hereditary tyrosinemia type I-associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; protein stability; enzyme mutation; nuclear magnetic resonance (NMR); biophysics; tyrosine; fumaryl acetoacetate hydrolase; rare disease; tyrosinemia type I	UROPORPHYRINOGEN III SYNTHASE; CRYSTAL-STRUCTURE; CATALYTIC MECHANISM; CLINICAL-ASPECTS; GENE; INTERMEDIATE; INHIBITION; SIMULATION	More than 100 mutations in the gene encoding fumarylacetoacetate hydrolase (FAH) cause hereditary tyrosinemia type I (HT1), a metabolic disorder characterized by elevated blood levels of tyrosine. Some of these mutations are known to decrease FAH catalytic activity, but the mechanisms of FAH mutation-induced pathogenicity remain poorly understood. Here, using diffusion ordered NMR spectroscopy, cryo-EM, and CD analyses, along with site-directed mutagenesis, enzymatic assays, and molecular dynamics simulations, we investigated the putative role of thermodynamic and kinetic stability in WT FAH and a representative set of 19 missense mutations identified in individuals with HT1. We found that at physiological temperatures and concentrations, WT FAH is in equilibrium between a catalytically active dimer and a monomeric species, with the latter being inactive and prone to oligomerization and aggregation. We also found that the majority of the deleterious mutations reduce the kinetic stability of the enzyme and always accelerate the FAH aggregation pathway. Depending mainly on the position of the amino acid in the structure, pathogenic mutations either reduced the dimer population or decreased the energy barrier that separates the monomer from the aggregate. The mechanistic insights reported here pave the way for the development of pharmacological chaperones that target FAH to tackle the severe disease HT1.	[Macias, Iratxe; Lain, Ana; Bernardo-Seisdedos, Ganeko; Millet, Oscar] CIC bioGUNE, Prot Stabil & Inherited Dis Lab, Bizkaia Technol Pk,Bldg 800, Derio 48160, Bizkaia, Spain; [Gil, David] CIC bioGUNE, Electron Microscopy Platform, Bizkaia Technol Pk, Derio 48160, Bizkaia, Spain; [Gonzalez, Esperanza; Falcon-Perez, Juan M.] CIC bioGUNE, Exosomes Lab, Bizkaia Technol Pk, Derio 48160, Bizkaia, Spain; [Falcon-Perez, Juan M.] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain	CIC bioGUNE; CIC bioGUNE; CIC bioGUNE; Basque Foundation for Science	Millet, O (corresponding author), CIC bioGUNE, Prot Stabil & Inherited Dis Lab, Bizkaia Technol Pk,Bldg 800, Derio 48160, Bizkaia, Spain.	omillet@cicbiogune.es	González, Esperanza/AAK-4097-2020; Falcon-Perez, Juan M/F-5920-2011; Macias, Iratxe/AAA-7631-2020; Carton, David Gil/M-9332-2019; Millet, Oscar/F-9696-2011; González, Esperanza/H-5450-2015; Bernardo-Seisdedos, Ganeko/C-6923-2016	González, Esperanza/0000-0002-3831-4596; Macias, Iratxe/0000-0003-4900-9949; Carton, David Gil/0000-0003-4241-1302; Millet, Oscar/0000-0001-8748-4105; González, Esperanza/0000-0002-3831-4596; Bernardo-Seisdedos, Ganeko/0000-0002-1372-3844; Lain, Ana/0000-0001-7069-9126; Falcon-Perez, Juan M/0000-0003-3133-0670	Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country Elkartek [BG2015, BG2017]; Agencia Estatal de Investigacion (Spain) [CTQ2015-68756-R]; Severo Ochoa Excellence Accreditation [SEV-2016-0644]	Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country Elkartek; Agencia Estatal de Investigacion (Spain); Severo Ochoa Excellence Accreditation	This work was supported by the Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country Elkartek Grants BG2015 and BG2017, by Agencia Estatal de Investigacion (Spain) for Grant CTQ2015-68756-R, and by Severo Ochoa Excellence Accreditation SEV-2016-0644. The authors declare that they have no conflicts of interest with the contents of this article.	Angileri F, 2015, JIMD REP, V19, P43, DOI 10.1007/8904_2014_363; Angileri F, 2014, CANCERS, V6, P998, DOI 10.3390/cancers6020998; BAIN MD, 1990, EUR J PEDIATR, V149, P637, DOI 10.1007/BF02034752; Bateman RL, 2007, BIOCHEM J, V402, P251, DOI 10.1042/BJ20060961; Bateman RL, 2001, J BIOL CHEM, V276, P15284, DOI 10.1074/jbc.M007621200; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; ben Bdira F, 2014, HUM MOL GENET, V23, P5805, DOI 10.1093/hmg/ddu298; Bergeron A, 2001, J BIOL CHEM, V276, P15225, DOI 10.1074/jbc.M009341200; Blouin JM, 2013, P NATL ACAD SCI USA, V110, P18238, DOI 10.1073/pnas.1314177110; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cao YY, 2012, CHINESE MED J-PEKING, V125, P2132, DOI 10.3760/cma.j.issn.0366-6999.2012.12.010; Chen AD, 1999, ANAL CHEM, V71, p669A, DOI 10.1021/ac9907179; Dursun A, 2011, JIMD REP, V1, P17, DOI 10.1007/8904_2011_10; FernandezCanon JM, 1997, ANAL BIOCHEM, V245, P218, DOI 10.1006/abio.1996.9957; Fortian A, 2011, J BIOL CHEM, V286, P13127, DOI 10.1074/jbc.M110.205849; Fortian A, 2009, BIOCHEMISTRY-US, V48, P454, DOI 10.1021/bi801731q; Geppert J, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0696-z; Harder ME, 2004, PROTEIN SCI, V13, P2207, DOI 10.1110/ps.03229504; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutchesson ACJ, 1996, ARCH DIS CHILD-FETAL, V74, pF191, DOI 10.1136/fn.74.3.F191; Jerschow A, 1998, J MAGN RESON, V134, P17, DOI 10.1006/jmre.1998.1491; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; Manjasetty BA, 2004, BIOL CHEM, V385, P935, DOI 10.1515/BC.2004.122; Medina-Carmona E, 2017, HUM MOL GENET, V26, P3531, DOI 10.1093/hmg/ddx238; Morrow G, 2017, ADV EXP MED BIOL, V959, P9, DOI 10.1007/978-3-319-55780-9_2; Morrow G, 2017, ADV EXP MED BIOL, V959, P25, DOI 10.1007/978-3-319-55780-9_3; Pinto GP, 2015, J CHEM THEORY COMPUT, V11, P2508, DOI 10.1021/acs.jctc.5b00222; Ran TT, 2013, BIOCHEM J, V449, P51, DOI 10.1042/BJ20120913; Rootwelt H, 1996, HUM MUTAT, V7, P239, DOI 10.1002/(SICI)1098-1004(1996)7:3<239::AID-HUMU8>3.3.CO;2-E; Russo PA, 2001, PEDIATR DEVEL PATHOL, V4, P212, DOI 10.1007/s100240010146; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Tanguay RM, 2017, ADV EXP MED BIOL, V959, P49, DOI 10.1007/978-3-319-55780-9_4; Taniguchi Y, 2008, BIOPHYS J, V95, P5296, DOI 10.1529/biophysj.108.141275; Timm DE, 1999, STRUCTURE, V7, P1023, DOI 10.1016/S0969-2126(99)80170-1; Urquiza P, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat7467	36	10	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					13051	13060		10.1074/jbc.RA119.009367	http://dx.doi.org/10.1074/jbc.RA119.009367			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31300554	Green Published, hybrid			2022-12-26	WOS:000486416000016
J	Fujiwara, M; Tian, L; Le, PT; DeMambro, VE; Becker, KA; Rosen, CJ; Guntur, AR				Fujiwara, Makoto; Tian, Li; Le, Phuong T.; DeMambro, Victoria E.; Becker, Kathleen A.; Rosen, Clifford J.; Guntur, Anyonya R.			The mitophagy receptor Bcl-2-like protein 13 stimulates adipogenesis by regulating mitochondrial oxidative phosphorylation and apoptosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						B-cell lymphoma 2 (Bcl-2) family; adipogenesis; mitochondria; apoptosis; mitophagy; adipocyte; bone marrow; mitochondrial metabolism; energy metabolism; Bcl-2-like protein 13 (Bcl2l13); lineage determination; metabolic reprogramming; oxidative phosphorylation	HORMONE-SENSITIVE LIPASE; CHROMOSOMAL INVERSION; BCL-RAMBO; DIFFERENTIATION; CELLS; IDENTIFICATION; AUTOPHAGY; HOMOLOG; DEATH; FAT	Metabolic programming of bone marrow stromal cells (BMSCs) could influence the function of progenitor osteoblasts or adipocytes and hence determine skeletal phenotypes. Adipocytes predominantly utilize oxidative phosphorylation, whereas osteoblasts use glycolysis to meet ATP demand. Here, we compared progenitor differentiation from the marrow of two inbred mouse strains, C3H/HeJ (C3H) and C57BL6J (B6). These strains differ in both skeletal mass and bone marrow adiposity. We hypothesized that genetic regulation of metabolic programs controls skeletal stem cell fate. Our experiments identified Bcl-2-like protein 13 (Bcl2l13), a mitochondrial mitophagy receptor, as being critical for adipogenic differentiation. We also found that Bcl2l13 is differentially expressed in the two mouse strains, with C3H adipocyte progenitor differentiation being accompanied by a >2-fold increase in Bcl2l13 levels relative to B6 marrow adipocytes. Bcl2l13 expression also increased during adipogenic differentiation in mouse ear mesenchymal stem cells (eMSCs) and the murine preadipocyte cell line 3T3-L1. The higher Bcl2l13 expression correlated with increased mitochondrial fusion and biogenesis. Importantly, Bcl2l13 knockdown significantly impaired adipocyte differentiation in both 3T3-L1 cells and eMSCs. Mechanistically, Bcl2l13 knockdown reprogrammed cells to rely more on glycolysis to meet ATP demand in the face of impaired oxidative phosphorylation. Bcl2l13 knockdown in eMSCs increased mitophagy. Moreover, Bcl2l13 prevented apoptosis during adipogenesis. Our findings indicate that the mitochondrial receptor Bcl2l13 promotes adipogenesis by increasing oxidative phosphorylation, suppressing apoptosis, and providing mitochondrial quality control through mitophagy. We conclude that genetic programming of metabolism may be important for lineage determination and cell function within the bone marrow.	[Fujiwara, Makoto; Le, Phuong T.; DeMambro, Victoria E.; Becker, Kathleen A.; Rosen, Clifford J.] Maine Med Ctr, Ctr Clin & Translat Res, Res Inst, Scarborough, ME 04074 USA; [Tian, Li; Rosen, Clifford J.; Guntur, Anyonya R.] Maine Med Ctr, Ctr Mol Med, Res Inst, 81 Res Dr, Scarborough, ME 04074 USA	Maine Medical Center; Maine Medical Center	Guntur, AR (corresponding author), Maine Med Ctr, Ctr Mol Med, Res Inst, 81 Res Dr, Scarborough, ME 04074 USA.	guntua@mmc.org		Guntur, Anyonya/0000-0001-6366-200X	NIGMS, National Institutes of Health (NIH) [U54GM115516-02, 1P20GM121301, P30GM106391]; NIDDK, NIH [R24 DK092759-06]; NIAMS, NIH [R03 AR068095]; Maine Medical Center Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR068095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK092759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121301, P30GM106391, U54GM115516] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Maine Medical Center Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health (NIH), Grants U54GM115516-02, 1P20GM121301, and P30GM106391; NIDDK, NIH, Grant R24 DK092759-06; NIAMS, NIH, Grant R03 AR068095; and start-up research funds from the Maine Medical Center Research Institute (to G. A. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackert-Bicknell CL, 2007, ANN NY ACAD SCI, V1116, P291, DOI 10.1196/annals.1402.010; Akeson EC, 2006, GENOMICS, V87, P311, DOI 10.1016/j.ygeno.2005.09.022; Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Altshuler-Keylin S, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai9248; Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Bonnet N, 2014, BONE, V68, P100, DOI 10.1016/j.bone.2014.07.024; Forni MF, 2016, STEM CELLS, V34, P743, DOI 10.1002/stem.2248; Gawronska-Kozak B, 2007, J CELL BIOCHEM, V102, P122, DOI 10.1002/jcb.21286; Giroud M, 2016, MOL METAB, V5, P615, DOI 10.1016/j.molmet.2016.06.005; Griffin EE, 2006, BBA-MOL CELL RES, V1763, P482, DOI 10.1016/j.bbamcr.2006.02.003; Guntur AR, 2018, J BONE MINER RES, V33, P1052, DOI 10.1002/jbmr.3390; Guntur AR, 2014, ENDOCRINOLOGY, V155, P1589, DOI 10.1210/en.2013-1974; Jensen SA, 2014, P NATL ACAD SCI USA, V111, P5682, DOI 10.1073/pnas.1316700111; Ju LP, 2018, BIOCHEM BIOPH RES CO, V506, P485, DOI 10.1016/j.bbrc.2018.10.034; Kataoka T, 2001, J BIOL CHEM, V276, P19548, DOI 10.1074/jbc.M010520200; Kim JY, 2012, FEBS LETT, V586, P3142, DOI 10.1016/j.febslet.2012.08.015; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Li QQ, 2017, PROTEIN CELL, V8, P439, DOI 10.1007/s13238-017-0385-7; MAGNELLI L, 1994, BIOCHEM BIOPH RES CO, V204, P84, DOI 10.1006/bbrc.1994.2429; Malik AN, 2016, MITOCHONDRION, V29, P59, DOI 10.1016/j.mito.2016.05.003; McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039; Mitterberger MC, 2012, STEM CELL RES, V9, P35, DOI 10.1016/j.scr.2012.04.001; Murakawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8527; Patel R, 2013, J BIOL CHEM, V288, P26834, DOI 10.1074/jbc.M113.482638; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Rojo M, 2002, J CELL SCI, V115, P1663; Rosen CJ, 2004, BONE, V35, P1046, DOI 10.1016/j.bone.2004.07.008; Scheller EL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8808; Shen LJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059070, 10.1371/journal.pone.0077077, 10.1371/journal.pone.0077515]; Shen WJ, 1999, P NATL ACAD SCI USA, V96, P5528, DOI 10.1073/pnas.96.10.5528; Sheng MHC, 2006, CALCIFIED TISSUE INT, V78, P293, DOI 10.1007/s00223-005-0303-5; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smith AJ, 2008, J BIOL CHEM, V283, P33536, DOI 10.1074/jbc.M806732200; Sorisky A, 2000, INT J OBESITY, V24, pS3, DOI 10.1038/sj.ijo.0801491; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Veldhuis-Vlug AG, 2018, J INTERN MED, V283, P121, DOI 10.1111/joim.12718; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	41	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12683	12694		10.1074/jbc.RA119.008630	http://dx.doi.org/10.1074/jbc.RA119.008630			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31266807	hybrid, Green Published			2022-12-26	WOS:000484414600011
J	Hobbs, JK; Pluvinage, B; Robb, M; Smith, SP; Boraston, AB				Hobbs, Joanne K.; Pluvinage, Benjamin; Robb, Melissa; Smith, Steven P.; Boraston, Alisdair B.			Two complementary alpha-fucosidases from Streptococcus pneumoniae promote complete degradation of host-derived carbohydrate antigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Streptococcus; glycoside hydrolase; host-pathogen interaction; structure-function; X-ray crystallography	BETA-GALACTOSIDASE; BIFIDOBACTERIUM-BIFIDUM; MOLECULAR-CLONING; SURFACE-PROTEINS; ENZYMES; IDENTIFICATION; EXPRESSION; GENE; EXOGLYCOSIDASES; LOCALIZATION	An important aspect of the interaction between the opportunistic bacterial pathogen Streptococcus pneumoniae and its human host is its ability to harvest host glycans. The pneumococcus can degrade a variety of complex glycans, including N- and O-linked glycans, glycosaminoglycans, and carbohydrate antigens, an ability that is tightly linked to the virulence of S. pneumoniae. Although S. pneumoniae is known to use a sophisticated enzyme machinery to attack the human glycome, how it copes with fucosylated glycans, which are primarily histo-blood group antigens, is largely unknown. Here, we identified two pneumococcal enzymes, SpGH29(C) and SpGH95(C), that target alpha-(1 -> 3/4) and alpha-(1 -> 2) fucosidic linkages, respectively. X-ray crystallography studies combined with functional assays revealed that SpGH29(C) is specific for the Lewis(A) and Lewis(X) antigen motifs and that SpGH95(C) is specific for the H(O)-antigen motif. Together, these enzymes could defucosylate Lewis(Y) and Lewis(B) antigens in a complementary fashion. In vitro reconstruction of glycan degradation cascades disclosed that the individual or combined activities of these enzymes expose the underlying glycan structure, promoting the complete deconstruction of a glycan that would otherwise be resistant to pneumococcal enzymes. These experiments expand our understanding of the extensive capacity of S. pneumoniae to process host glycans and the likely roles of alpha-fucosidases in this. Overall, given the importance of enzymes that initiate glycan breakdown in pneumococcal virulence, such as the neuraminidase NanA and the mannosidase SpGH92, we anticipate that the alpha-fucosidases identified here will be important factors in developing more refined models of the S. pneumoniae-host interaction.	[Hobbs, Joanne K.; Pluvinage, Benjamin; Robb, Melissa; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8P 5C2, Canada; [Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	University of Victoria; Queens University - Canada	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8P 5C2, Canada.	boraston@uvic.ca		Hobbs, Joanne/0000-0001-5239-8039; Boraston, Alisdair/0000-0001-6417-0592	DOE Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; National Institute of General Medical Sciences; Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank the beamline staff at the Stanford Synchrotron Research Laboratory (SSRL). SSRL is a Directorate of Stanford Linear Accelerator Center (SLAC) National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program (Grant P41RR001209), and the National Institute of General Medical Sciences. Research described in this paper was performed using beamline 08B1-1 at the Canadian Light Source, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research.	Abbott DW, 2010, MOL MICROBIOL, V77, P183, DOI 10.1111/j.1365-2958.2010.07199.x; Afzal M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00158; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Barik S, 1996, Methods Mol Biol, V57, P203; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; BERRY AM, 1994, INFECT IMMUN, V62, P1101, DOI 10.1128/IAI.62.3.1101-1108.1994; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Blomberg C, 2009, J INFECT DIS, V199, P1032, DOI 10.1086/597205; Bongaerts RJM, 2000, INFECT IMMUN, V68, P7141, DOI 10.1128/IAI.68.12.7141-7143.2000; Brockhausen I, 2015, ESSENTIALS GLYCOBIOL; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Buckwalter CM, 2012, TRENDS MICROBIOL, V20, P517, DOI 10.1016/j.tim.2012.08.008; Chen HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002950; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CLARKE VA, 1995, J BIOL CHEM, V270, P8805, DOI 10.1074/jbc.270.15.8805; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; Embry A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-80; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flynn JM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005846; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Greene NG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004996; Gregg KJ, 2011, J BIOL CHEM, V286, P15586, DOI 10.1074/jbc.M111.223172; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Higgins MA, 2014, J MOL BIOL, V426, P1469, DOI 10.1016/j.jmb.2013.12.006; Higgins MA, 2009, J BIOL CHEM, V284, P26161, DOI 10.1074/jbc.M109.024067; Higgins MA, 2009, J MOL BIOL, V388, P299, DOI 10.1016/j.jmb.2009.03.012; Hobbs JK, 2018, FEBS LETT, V592, P3865, DOI 10.1002/1873-3468.13045; HUGHES RC, 1964, BIOCHEMISTRY-US, V3, P1535, DOI 10.1021/bi00898a025; Jeong JK, 2009, J BACTERIOL, V191, P3011, DOI 10.1128/JB.01601-08; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kharat AS, 2003, INFECT IMMUN, V71, P2758, DOI 10.1128/IAI.71.5.2758-2765.2003; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; LACKS S, 1968, GENETICS, V60, P685; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marion C, 2009, INFECT IMMUN, V77, P1389, DOI 10.1128/IAI.01215-08; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLean R, 2015, J BIOL CHEM, V290, P21231, DOI 10.1074/jbc.M115.664847; Muramatsu H, 2001, J BIOCHEM, V129, P923, DOI 10.1093/oxfordjournals.jbchem.a002938; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Paixao L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121042; Perez-Dorado I, 2012, MOL ORAL MICROBIOL, V27, P221, DOI 10.1111/j.2041-1014.2012.00655.x; Pluvinage B, 2011, STRUCTURE, V19, P1603, DOI 10.1016/j.str.2011.08.011; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Robb M, 2017, METHODS MOL BIOL, V1588, P215, DOI 10.1007/978-1-4939-6899-2_17; Robb M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006090; Robb M, 2015, J BIOL CHEM, V290, P30888, DOI 10.1074/jbc.M115.688630; Rosenow C, 1999, GENOME RES, V9, P1189, DOI 10.1101/gr.9.12.1189; Sakurama H, 2012, J BIOL CHEM, V287, P16709, DOI 10.1074/jbc.M111.333781; Schnaar RL, 2015, ESSENTIALS GLYCOBIOL; Seeberger P.H, 2015, ESSENTIALS GLYCOBIOL; Singh AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004364; Stanley P., 2015, ESSENTIALS GLYCOBIOL; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Terra VS, 2010, INFECT IMMUN, V78, P348, DOI 10.1128/IAI.00721-09; Unione L, 2017, CURR MED CHEM, V24, P4057, DOI 10.2174/0929867324666170217093702; Varki A., 1995, SEMIN DEV BIOL, V6, P127, DOI [DOI 10.1016/S1044-5781(06)80022-8, 10.1016/s1044-5781(06)80022-8]; VIJAYAKUMAR MN, 1986, J BACTERIOL, V165, P689, DOI 10.1128/jb.165.3.689-695.1986; Walther T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003223; Weiser JN, 2018, NAT REV MICROBIOL, V16, P354, DOI 10.1038/s41579-018-0001-8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu GG, 2011, J AM CHEM SOC, V133, P1718, DOI 10.1021/ja110733q; Zahner D, 2000, J BACTERIOL, V182, P5919, DOI 10.1128/JB.182.20.5919-5921.2000	74	9	9	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12670	12682		10.1074/jbc.RA119.009368	http://dx.doi.org/10.1074/jbc.RA119.009368			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31266803	hybrid, Green Published			2022-12-26	WOS:000484414600010
J	Hu, QB; Zhang, JX; Chen, Y; Hu, LH; Li, WH; He, ZG				Hu, Qingbin; Zhang, Jiaxun; Chen, Yu; Hu, Lihua; Li, Weihui; He, Zheng-Guo			Cyclic di-GMP co-activates the two-component transcriptional regulator DevR in Mycobacterium smegmatis in response to oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic di-GMP (c-di-GMP); transcription regulation; histidine kinase; Mycobacterium smegmatis; oxidative stress; antioxidant	HISTIDINE PROTEIN-KINASE; BIOFILM FORMATION; GENE-EXPRESSION; TUBERCULOSIS; BINDING; SYSTEM; MATRIX; DOMAIN; IDENTIFICATION; ADAPTATION	Cyclic di-GMP (c-di-GMP) is an important second messenger in bacteria, and its regulatory network has been extensively studied. However, information regarding the activation mechanisms of its receptors remains limited. In this study, we characterized the two-component regulator DevR as a new c-di-GMP receptor and further uncovered a novel co-activation mechanism for effective regulation of DevR in mycobacteria. We show that high c-di-GMP levels induce the expression of the devR operon in Mycobacterium smegmatis and increase mycobacterial survival under oxidative stress. The deletion of either DevR or its two-component kinase DevS significantly weakened the stimulating effect of c-di-GMP on oxidative-stress tolerance of mycobacteria. We also found that DevR senses the c-di-GMP signal through its C-terminal structure and that c-di-GMP alone does not directly affect the DNA-binding activity of DevR. Strikingly, c-di-GMP stimulated DevR phosphorylation by the kinase DevS, thereby activating DevR's DNA-binding affinity. In summary, our results indicated that c-di-GMP triggers a phosphorylation-dependent mechanism that co-activates DevR's transcriptional activity. Our findings suggest a novel paradigm for the cross-talk between c-di-GMP signaling and two-component regulatory systems that activates transcription of stress-response genes in bacteria.	[Hu, Qingbin; Zhang, Jiaxun; Chen, Yu; Hu, Lihua; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China; [Li, Weihui] Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China	Huazhong Agricultural University; Guangxi University	Li, WH (corresponding author), Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China.; He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Hubei, Peoples R China.	lwhlbx@163.com; hezhengguo2019@163.com			National Natural Science Foundation of China [31730005]; National Key R&D Program of China [2017YFD0500300]; NSFC [31670075, 31870036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grant 31730005, National Key R&D Program of China Grant 2017YFD0500300, and NSFC Grants 31670075 and 31870036. The authors declare that they have no conflicts of interest with the contents of this article.	Altamirano-Silva P, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00713-17, 10.1128/iai.00713-17]; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chauhan S, 2008, J BACTERIOL, V190, P4301, DOI 10.1128/JB.01308-07; Colangeli R, 2009, P NATL ACAD SCI USA, V106, P4414, DOI 10.1073/pnas.0810126106; Crepin S, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00168-17; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Fazli M, 2011, MOL MICROBIOL, V82, P327, DOI 10.1111/j.1365-2958.2011.07814.x; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Kariisa AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148478; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; KINGER AK, 1993, GENE, V131, P113, DOI 10.1016/0378-1119(93)90678-V; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Li WH, 2018, NUCLEIC ACIDS RES, V46, P7270, DOI 10.1093/nar/gky611; Li WH, 2018, NUCLEIC ACIDS RES, V46, P3595, DOI 10.1093/nar/gky146; Li WH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9330; Li WH, 2012, NUCLEIC ACIDS RES, V40, P11292, DOI 10.1093/nar/gks923; Li XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134595; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lori C, 2015, NATURE, V523, P236, DOI 10.1038/nature14473; Miller JH., 1972, EXPT MOL GENETICS; Monds RD, 2007, MOL MICROBIOL, V63, P656, DOI 10.1111/j.1365-2958.2006.05539.x; Nde CW, 2011, APPL MICROBIOL BIOT, V90, P277, DOI 10.1007/s00253-010-2931-6; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Petters T, 2012, MOL MICROBIOL, V84, P147, DOI 10.1111/j.1365-2958.2012.08015.x; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Saini DK, 2002, PROTEIN EXPRES PURIF, V25, P203, DOI 10.1006/prep.2002.1628; Stokes RW, 2009, FUTURE MICROBIOL, V4, P1317, DOI [10.2217/fmb.09.94, 10.2217/FMB.09.94]; Strempel N, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02311; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Tao J, 2014, FEMS MICROBIOL LETT, V358, P81, DOI 10.1111/1574-6968.12529; Tschowri N, 2014, CELL, V158, P1136, DOI 10.1016/j.cell.2014.07.022; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Wisedchaisri G, 2005, J MOL BIOL, V354, P630, DOI 10.1016/j.jmb.2005.09.048; Wisedchaisri G, 2008, J MOL BIOL, V378, P227, DOI 10.1016/j.jmb.2008.02.029; Zahringer F, 2011, APPL BIOCHEM BIOTECH, V163, P71, DOI 10.1007/s12010-010-9017-x	45	7	8	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12729	12742		10.1074/jbc.RA119.008252	http://dx.doi.org/10.1074/jbc.RA119.008252			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31270210	hybrid, Green Published			2022-12-26	WOS:000484414600015
J	Inamdar, VV; Reddy, H; Dangelmaier, C; Kostyak, JC; Kunapuli, SP				Inamdar, Vaishali V.; Reddy, Haritha; Dangelmaier, Carol; Kostyak, John C.; Kunapuli, Satya P.			The protein tyrosine phosphatase PTPN7 is a negative regulator of ERK activation and thromboxane generation in platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular signal-regulated kinase (ERK); platelet; thrombosis; hemostasis; aggregation; PTPN7	CYTOSOLIC PHOSPHOLIPASE A(2); P38 MAP KINASE; ADP RECEPTOR; THROMBIN; PHOSPHORYLATION; COLLAGEN; TRANSLOCATION; AGGREGATION; SIGNAL	Protein tyrosine phosphatase nonreceptor type 7 (PTPN7), also called hematopoietic protein tyrosine phosphatase, controls extracellular signal-regulated protein kinase 1/2 (ERK1/2) and p38 mitogen-activated protein kinase in T lymphocytes. Because ERK1/2 plays an important role in regulating thromboxane A(2) (TXA(2)) generation in platelets, we investigated the function of PTPN7 in these cells. Using immunoblot analysis, we detected PTPN7 in both human and mouse platelets but not in PTPN7-null mice. PTPN7 KO mouse platelets exhibited increased platelet functional responses, including aggregation, dense granule secretion, and TXA(2) generation, compared with platelets from WT littermates, upon stimulation with both G protein-coupled receptor (GPCR) and glycoprotein VI (GPVI) agonists. Using the GPCR agonist AYPGKF in the presence of the COX inhibitor indomethacin, we found that PTPN7 KO mouse platelets aggregated and secreted to the same extent as WT platelets, suggesting that elevated TXA(2) is responsible for the potentiation of platelet functional responses in PTPN7-KO platelets. Phosphorylation of ERK1/2 was also elevated in PTPN7 KO platelets. Stimulation of platelets with the GPVI agonist collagen-related peptide along with the COX inhibitor indomethacin did not result in phosphorylation of ERK1/2, indicating that GPVI-mediated ERK phosphorylation occurs through TXA(2). Although bleeding times did not significantly differ between PTPN7-null and WT mice, time to death was significantly faster in PTPN7-null mice than in WT mice in a pulmonary thromboembolism model. We conclude that PTPN7 regulates platelet functional responses downstream of GPCR agonists, but not GPVI agonists, through inhibition of ERK activation and thromboxane generation.	[Inamdar, Vaishali V.; Reddy, Haritha; Dangelmaier, Carol; Kostyak, John C.; Kunapuli, Satya P.] Temple Univ, Sol Sherry Thrombosis Res Ctr, Lewis Katz Sch Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kunapuli, SP (corresponding author), Temple Univ, Rm 403 MRB,3420 N Broad St, Philadelphia, PA 19140 USA.	spk@temple.edu	Inamdar, Vaishali/R-5093-2019	Inamdar, Vaishali/0000-0002-3049-1977	National Institutes of Health [HL137721, HL137207, HL132171, HL93231]; American Heart Association Grant [17SDG33370020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137207, R01HL132171, R01HL137721, R01HL093231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL137721, HL137207, HL132171, and HL93231 ( to S. P. K) and American Heart Association Grant 17SDG33370020 ( to J. C. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badolia R, 2015, BLOOD, V125, P175, DOI 10.1182/blood-2014-05-576306; Borsch-Haubold AG, 1998, J BIOL CHEM, V273, P4449, DOI 10.1074/jbc.273.8.4449; BorschHaubold AG, 1997, EUR J BIOCHEM, V245, P751, DOI 10.1111/j.1432-1033.1997.t01-1-00751.x; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; FITZGERALD DJ, 1986, NEW ENGL J MED, V315, P983, DOI 10.1056/NEJM198610163151602; FITZGERALD GA, 1991, AM J CARDIOL, V68, pB11, DOI 10.1016/0002-9149(91)90379-Y; Garcia A, 2007, BIOCHEM J, V404, P299, DOI 10.1042/BJ20061584; Garcia A, 2010, BIOCHEM J, V429, P369, DOI 10.1042/BJ20100166; Gasparyan AY, 2008, J AM COLL CARDIOL, V51, P1829, DOI 10.1016/j.jacc.2007.11.080; Gronda M, 2001, MOL CELL BIOL, V21, P6851, DOI 10.1128/MCB.21.20.6851-6858.2001; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Karisch R, 2011, CELL, V146, P826, DOI 10.1016/j.cell.2011.07.020; KOUDSTAAL PJ, 1993, STROKE, V24, P219, DOI 10.1161/01.STR.24.2.219; KRAMER RM, 1995, J BIOL CHEM, V270, P27395, DOI 10.1074/jbc.270.46.27395; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Kuliopulos A, 2004, THROMB HAEMOSTASIS, V92, P1387, DOI 10.1160/TH04-03-0187; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; MatijevicAleksic N, 1996, BRIT J HAEMATOL, V92, P212, DOI 10.1046/j.1365-2141.1996.279813.x; McAlees JW, 2009, MOL CELL BIOL, V29, P675, DOI 10.1128/MCB.01466-08; Nadal-Wollbold F, 2002, FEBS LETT, V531, P475, DOI 10.1016/S0014-5793(02)03587-1; PAPKOFF J, 1994, MOL CELL BIOL, V14, P463, DOI 10.1128/MCB.14.1.463; Pettiford SM, 2003, LEUKEMIA, V17, P366, DOI 10.1038/sj.leu.2402767; Roger S, 2004, FEBS LETT, V556, P227, DOI 10.1016/S0014-5793(03)01430-3; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; Saxena M, 1998, J BIOL CHEM, V273, P15340, DOI 10.1074/jbc.273.25.15340; Shankar H, 2006, J THROMB HAEMOST, V4, P638, DOI 10.1111/j.1538-7836.2006.01789.x; Tulasne D, 2002, EUR J BIOCHEM, V269, P1511, DOI 10.1046/j.1432-1033.2002.02798.x; ZANKE B, 1994, LEUKEMIA, V8, P236; ZANKE B, 1992, EUR J IMMUNOL, V22, P235, DOI 10.1002/eji.1830220134	30	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2019	294	33					12547	12554		10.1074/jbc.RA119.007735	http://dx.doi.org/10.1074/jbc.RA119.007735			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6UG	31266805	hybrid, Green Published			2022-12-26	WOS:000484402700024
J	Sasaki, C; Hiraishi, T; Oku, T; Okuma, K; Suzumura, K; Hashimoto, M; Ito, H; Aramori, I; Hirayama, Y				Sasaki, Chiyomi; Hiraishi, Tomoko; Oku, Takuma; Okuma, Kenji; Suzumura, Kenichi; Hashimoto, Motomu; Ito, Hiromu; Aramori, Ichiro; Hirayama, Yoshitaka			Metabolomic approach to the exploration of biomarkers associated with disease activity in rheumatoid arthritis	PLOS ONE			English	Article							WIDE ASSOCIATION; RISK-FACTOR; HOMOARGININE; HISTIDINE; STRESS	We aimed to investigate metabolites associated with the 28-joint disease activity score based on erythrocyte sedimentation rate (DAS28-ESR) in patients with rheumatoid arthritis (RA) using capillary electrophoresis quadrupole time-of-flight mass spectrometry. Plasma and urine samples were collected from 32 patients with active RA (DAS28-ESR >= 3.2) and 17 with inactive RA (DAS28-ESR<3.2). We found 15 metabolites in plasma and 20 metabolites in urine which showed a significant but weak positive or negative correlation with DAS28-ESR. When metabolites between active and inactive patients were compared, 9 metabolites in plasma and 15 in urine were found to be significantly different. Consequently, we selected 11 metabolites in plasma and urine as biomarker candidates which significantly correlated positively or negatively with DAS28-ESR, and significantly differed between active and inactive patients. When a multiple logistic regression model was built to discriminate active and inactive cohorts, three variables-histidine and guanidoacetic acid from plasma and hypotaurine from urine-generated a high area under the receiver operating characteristic (ROC) curve value (AUC = 0.8934). Thus, this metabolomics approach appeared to be useful for investigating biomarkers of RA. Combination of plasma and urine analysis may lead to more precise and reliable understanding of the disease condition. We also considered the pathophysiological significance of the found biomarker candidates.	[Sasaki, Chiyomi; Oku, Takuma; Okuma, Kenji; Aramori, Ichiro; Hirayama, Yoshitaka] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Kyoto, Japan; [Sasaki, Chiyomi; Oku, Takuma; Okuma, Kenji; Aramori, Ichiro; Hirayama, Yoshitaka] Astellas Pharma Inc, Candidate Discovery Sci Labs, Tsukuba, Ibaraki, Japan; [Hiraishi, Tomoko; Suzumura, Kenichi] Astellas Pharma Inc, Anal & Pharmacokinet Res Labs, Tsukuba, Ibaraki, Japan; [Hashimoto, Motomu] Kyoto Univ, Grad Sch Med, Dept Adv Med Rheumat Dis, Kyoto, Kyoto, Japan; [Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Kyoto, Japan	Kyoto University; Astellas Pharmaceuticals; Astellas Pharmaceuticals; Kyoto University; Kyoto University	Hirayama, Y (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Kyoto, Japan.; Hirayama, Y (corresponding author), Astellas Pharma Inc, Candidate Discovery Sci Labs, Tsukuba, Ibaraki, Japan.	yoshitaka.hirayama@astellas.com			Special Coordination Funds for Promoting Science and Technology of the Japanese Government; Astellas Pharma Inc. in the Formation of Innovation Center for Fusion of Advanced Technologies Program	Special Coordination Funds for Promoting Science and Technology of the Japanese Government; Astellas Pharma Inc. in the Formation of Innovation Center for Fusion of Advanced Technologies Program	This work was supported in part by the Special Coordination Funds for Promoting Science and Technology of the Japanese Government and in part by Astellas Pharma Inc. in the Formation of Innovation Center for Fusion of Advanced Technologies Program.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARUOMA OI, 1988, BIOCHEM J, V256, P251, DOI 10.1042/bj2560251; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Cuppen BVJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163087; Davids M, 2012, FEBS LETT, V586, P3653, DOI 10.1016/j.febslet.2012.08.020; Deane KD, 2017, BEST PRACT RES CL RH, V31, P3, DOI 10.1016/j.berh.2017.08.003; Drechsler C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063560; GERBER DA, 1975, J CLIN INVEST, V55, P1164, DOI 10.1172/JCI108033; Hirayama A, 2012, ANALYST, V137, P5026, DOI 10.1039/c2an35492f; Kabil O, 2016, J BIOL CHEM, V291, P16418, DOI 10.1074/jbc.C116.742213; Kami K, 2013, METABOLOMICS, V9, P444, DOI 10.1007/s11306-012-0452-2; Li J, 2018, CLIN RHEUMATOL, V37, P1493, DOI 10.1007/s10067-018-4021-6; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Madsen RK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3243; Malmstrom V, 2017, NAT REV IMMUNOL, V17, P60, DOI 10.1038/nri.2016.124; Muniraj N, 2017, INT J RHEUM DIS, V20, P182, DOI 10.1111/1756-185X.12472; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Pilz S, 2015, AMINO ACIDS, V47, P1703, DOI 10.1007/s00726-015-1993-2; Pilz S, 2011, HEART, V97, P1222, DOI 10.1136/hrt.2010.220731; Pisarenko OI, 1996, CLIN EXP PHARMACOL P, V23, P627, DOI 10.1111/j.1440-1681.1996.tb01748.x; Ramautar R, 2017, ELECTROPHORESIS, V38, P190, DOI 10.1002/elps.201600370; Sbodio JI, 2018, P NATL ACAD SCI USA, V115, P780, DOI 10.1073/pnas.1717877115; Sharma RK, 2017, INFLAMM RES, V66, P97, DOI 10.1007/s00011-016-0998-y; Smolen JS, 2016, LANCET, V388, P1984; Smolen JS, 2015, NAT REV RHEUMATOL, V11, P276, DOI 10.1038/nrrheum.2015.8; Smolenska Z, 2016, BIOMARKERS, V21, P218, DOI 10.3109/1354750X.2015.1130746; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; STIPANUK MH, 1986, ANNU REV NUTR, V6, P179, DOI 10.1146/annurev.nu.06.070186.001143; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Surowiec I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164196; Viatte S, 2016, ARTHRITIS RHEUMATOL, V68, P1603, DOI 10.1002/art.39619; Wade AM, 1998, J NUTR BIOCHEM, V9, P308, DOI 10.1016/S0955-2863(98)00022-9; Watanabe M, 2008, AM J CLIN NUTR, V87, P1860, DOI 10.1093/ajcn/87.6.1860; Zheng KD, 2017, J ORTHOP RES, V35, P1973, DOI 10.1002/jor.23482; Zhou J, 2016, J PHARMACEUT BIOMED, V127, P60, DOI 10.1016/j.jpba.2016.02.004	35	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219400	10.1371/journal.pone.0219400	http://dx.doi.org/10.1371/journal.pone.0219400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295280	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800030
J	Lande, C; Rao, S; Morre, JT; Galindo, G; Kirby, J; Reardon, PN; Bobe, G; Stevens, JF				Lande, Claire; Rao, Sujaya; Morre, Jeffrey T.; Galindo, Gracie; Kirby, Julie; Reardon, Patrick N.; Bobe, Gerd; Stevens, Jan Frederik			Linden (Tilia cordata) associated bumble bee mortality: Metabolomic analysis of nectar and bee muscle	PLOS ONE			English	Article							BOMBUS-TERRESTRIS; FORAGING BUMBLEBEES; POLLEN; FOOD; HONEYBEES; BEHAVIOR; FLOWERS; MEMORY; HYMENOPTERA; POLLINATION	Linden (Tilia spp.), a profusely flowering temperate tree that provides bees with vital pollen and nectar, has been associated with bumble bee (Bombus spp.) mortality in Europe and North America. Bee deaths have been attributed, with inadequate evidence, to toxicity from mannose in nectar or starvation due to low nectar in late blooming linden. Here, we investigated both factors via untargeted metabolomic analyses of nectar from five T. cordata trees beneath which crawling/dead bumble bees (B. vosnesenskii) were observed, and of thoracic muscle of 28 healthy foraging and 29 crawling bees collected from linden trees on cool mornings (< 30 degrees C). Nectar contained the pyridine alkaloid trigonelline, a weak acetylcholinesterase inhibitor, but no mannose. Principal component analysis of muscle metabolites produced distinct clustering of healthy and crawling bees, with significant differences (P<0.05) in 34 of 123 identified metabolites. Of these, TCA (Krebs) cycle intermediates were strongly represented (pathway analysis; P<0.01), suggesting that the central metabolism is affected in crawling bees. Hence, we propose the following explanation: when ambient temperature is low, bees with energy deficit are unable to maintain the thoracic temperature required for flight, and consequently fall, crawl, and ultimately, die. Energy deficit could occur when bees continue to forage on linden despite limited nectar availability either due to loyalty to a previously energy-rich source or trigonelline-triggered memory/learning impairment, documented earlier with other alkaloids. Thus, the combination of low temperature and nectar volume, resource fidelity, and alkaloids in nectar could explain the unique phenomenon of bumble bee mortality associated with linden.	[Lande, Claire; Rao, Sujaya; Galindo, Gracie; Kirby, Julie] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Morre, Jeffrey T.] Oregon State Univ, Dept Chem, Gilbert Hall 153, Corvallis, OR 97331 USA; [Reardon, Patrick N.] Oregon State Univ, NMR Facil, Corvallis, OR 97331 USA; [Bobe, Gerd; Stevens, Jan Frederik] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Bobe, Gerd] Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA; [Stevens, Jan Frederik] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Rao, Sujaya] Univ Minnesota, Dept Entomol, St Paul, MN 55101 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University; Oregon State University; Oregon State University; University of Minnesota System; University of Minnesota Twin Cities	Rao, S (corresponding author), Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA.; Rao, S (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55101 USA.	sujaya@umn.edu		Stevens, Jan Frederik/0000-0002-6348-9347; Reardon, Patrick/0000-0002-6858-0086	United States Department of Agriculture, National Institute of Food and Agriculture [2016-67030-25338]; National Institute of Health [1S10OD018518, S10RR027878, S10RR022589]; M. J. Murdock Charitable Trust [2014162]; USDA National Institute of Food and Agriculture [2016-67030-25338, 1009859]; Oregon State University NMR Facility (NIH) [1S10OD018518]; Oregon State University Mass Spectrometry Center (NIH) [S10RR027878, S10RR022589]; M.J. Murdock Charitable Trust [2014162]	United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. J. Murdock Charitable Trust; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Oregon State University NMR Facility (NIH); Oregon State University Mass Spectrometry Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M.J. Murdock Charitable Trust	Funded by S.R. Exploratory Research Grant 2016-67030-25338, United States Department of Agriculture, National Institute of Food and Agriculture, https://nifa.usda.gov/. J.F.S.Grant 1S10OD018518, S10RR027878 and S10RR022589. National Institute of Health. https://www.nih.gov/. J.F.S.Grant 2014162, M. J. Murdock Charitable Trust. https://murdocktrust.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Exploratory Research Grant 2016-67030-25338/project accession no. 1009859 from the USDA National Institute of Food and Agriculture. We acknowledge the support of the Oregon State University NMR Facility (NIH Grant 1S10OD018518), the Oregon State University Mass Spectrometry Center (NIH Grants S10RR027878 and S10RR022589), and the M.J. Murdock Charitable Trust grant #2014162. We thank Dr. Kevin Ahern and Dr. Robert Durst for the many thoughtful discussions throughout this project, and Dr. Michael Goblirsch and Dr. Tim Kurtti for their insights on early versions of the manuscript.	ALFORD D V, 1969, Journal of Apicultural Research, V8, P37; ALFORD DV., 1978, BUMBLEBEES; [Anonymous], 2012, LIME TREES BASSWOODS; Arinze IJ, 2005, BIOCHEM MOL BIOL EDU, V33, P165, DOI 10.1002/bmb.2005.494033032469; Baal T, 1992, ARBIETSGEMEINSCHAFT, P323; Baracchi D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01980-1; Baracchi David, 2015, F1000Res, V4, P73, DOI 10.12688/f1000research.6262.2; Black S, PESTICIDE CAUSES LAR; Cnaani J, 2006, ETHOLOGY, V112, P278, DOI 10.1111/j.1439-0310.2006.01174.x; CORBET SA, 1979, ECOL ENTOMOL, V4, P9, DOI 10.1111/j.1365-2311.1979.tb00557.x; CRANE E, 1977, BEE WORLD, V58, P129, DOI 10.1080/0005772X.1977.11097662; Donarski JA, 2008, J AGR FOOD CHEM, V56, P5451, DOI 10.1021/jf072402x; Dornhaus A, 2005, BEHAV ECOL, V16, P661, DOI 10.1093/beheco/ari040; Dornhaus A, 2001, BEHAV ECOL SOCIOBIOL, V50, P570, DOI 10.1007/s002650100395; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; Elwes H.J., 1913, TREES GREAT BRITAIN; Gold PE, 2003, NEUROBIOL LEARN MEM, V80, P194, DOI 10.1016/j.nlm.2003.07.003; Goulson Dave, 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P185, DOI 10.1078/1433-8319-00070; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Grote R, 2016, FRONT ECOL ENVIRON, V14, P543, DOI 10.1002/fee.1426; HEINRICH B, 1976, ECOL MONOGR, V46, P105, DOI 10.2307/1942246; HEINRICH B, 1979, ECOLOGY, V60, P245, DOI 10.2307/1937652; Heinrich B., 1979, BUMBLEBEE EC; Illies I, 2007, ENTOMOL GEN, V30, P155; Jacquemart AL, 2018, APIDOLOGIE, V49, P538, DOI 10.1007/s13592-018-0581-3; Jansen JJ, 2009, METABOLOMICS, V5, P150, DOI 10.1007/s11306-008-0124-4; Kearns C. A., 2001, NATURAL HIST BUMBLEB; Kirkwood JS, 2012, J BIOL CHEM, V287, P3833, DOI 10.1074/jbc.M111.316018; Koch H, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0484; Krasenbrink Annette, 1995, Zeitschrift fuer Oekologie und Naturschutz, V3, P237; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; MADEL G, 1977, Bonner Zoologische Beitraege, V28, P149; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Molet M, 2009, NATURWISSENSCHAFTEN, V96, P213, DOI 10.1007/s00114-008-0465-x; Naef R, 2004, CHEM BIODIVERS, V1, P1870, DOI 10.1002/cbdv.200490143; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Nicolson SW, 2011, AFR ZOOL, V46, P197, DOI 10.3377/004.046.0201; Noutsos C, 2015, PLOS ONE, V10; Pawlikowski T, 2010, J APIC SCI, V54, P73; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; PYKE GH, 1979, ANIM BEHAV, V27, P1167, DOI 10.1016/0003-3472(79)90064-2; Raine NE, 2007, ENTOMOL GEN, V29, P179; Rao S, 2019, J APICULT RES, V58, P522, DOI 10.1080/00218839.2019.1584962; SatheeshKumar N, 2010, PHYTOMEDICINE, V17, P292, DOI 10.1016/j.phymed.2009.06.006; SAUNDERS SA, 1969, SCIENCE, V164, P858, DOI 10.1126/science.164.3881.858; Scheper J, 2014, P NATL ACAD SCI USA, V111, P17552, DOI 10.1073/pnas.1412973111; Schievano E, 2015, J AGR FOOD CHEM, V63, P5858, DOI 10.1021/jf506359u; SOLS A, 1960, SCIENCE, V131, P297, DOI 10.1126/science.131.3396.297; Somme L, 2016, URBAN ECOSYST, V19, P1149, DOI 10.1007/s11252-016-0555-z; Stabler D, 2015, J EXP BIOL, V218, P793, DOI 10.1242/jeb.114249; Surholt B., 1992, Apidologie, V23, P335; VANHANDEL E, 1971, COMP BIOCHEM PHYSIOL, V38, P141, DOI 10.1016/0305-0491(71)90293-8; Vaudo AD, 2016, P NATL ACAD SCI USA, V113, pE4035, DOI 10.1073/pnas.1606101113; von Frisch K., 1928, NAT SCI, P307; Wright GA, 2013, SCIENCE, V339, P1202, DOI 10.1126/science.1228806	56	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218406	10.1371/journal.pone.0218406	http://dx.doi.org/10.1371/journal.pone.0218406			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291287	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800020
J	Haanshuus, CG; Morch, K; Blomberg, B; Strom, GEA; Langeland, N; Hanevik, K; Mohn, SC				Haanshuus, Christel Gill; Morch, Kristine; Blomberg, Bjorn; Strom, Gro Elizabeth Ann; Langeland, Nina; Hanevik, Kurt; Mohn, Stein Christian			Assessment of malaria real-time PCR methods and with focus on low-level parasitaemia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTIONS; DNA; SENSITIVITY; DIAGNOSIS; INFANTS; SAMPLES; BLOOD	In epidemiological surveys and surveillance the application of molecular tools is essential in detecting submicroscopic malaria. A genus-specific conventional cytochrome b (cytb) PCR has shown high sensitivity in field studies, detecting 70% submicroscopic malaria. The main objective of this study was to assess the conversion from conventional to real-time PCR testing both SYBR and probe protocols, and including quantitative (q) PCR. The protocols were assessed applying well-defined clinical patient material consisting of 33 positive and 80 negative samples. Sequencing of positive PCR products was performed. In addition, a sensitivity comparison of real-time PCR methods was done by including five relevant assays investigating the effect of amplification target and platform. Sensitivity was further examined using field material consisting of 111 P. falciparum positive samples from Tanzanian children (< 5 years), as well as using related patient data to assess the application of q-PCR with focus on low-level parasitaemia. Both the cytb SYBR and probe PCR protocols showed as high sensitivity and specificity as their conventional counterpart, except missing one P. malariae sample. The SYBR protocol was more sensitive and specific than using probe. Overall, choice of amplification target applied is relevant for achieving ultra-sensitivity, and using intercalating fluorescence dye rather than labelled hydrolysis probes is favourable. Application of q-PCR analysis in field projects is important for the awareness and understanding of low-level parasitaemia. For use in clinical diagnosis and epidemiological studies the highly sensitive and user-friendly cytb SYBR q-PCR method is a relevant tool. The genus-specific method has the advantage that species identification by sequencing can be performed as an alternative to species-specific PCR.	[Haanshuus, Christel Gill; Morch, Kristine; Blomberg, Bjorn; Langeland, Nina; Hanevik, Kurt; Mohn, Stein Christian] Haukeland Hosp, Dept Med, Norwegian Natl Advisory Unit Trop Infect Dis, Bergen, Norway; [Morch, Kristine; Blomberg, Bjorn; Langeland, Nina; Hanevik, Kurt] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Strom, Gro Elizabeth Ann] Haukeland Hosp, Dept Med, Bergen, Norway; [Langeland, Nina] Haraldsplass Deaconess Hosp, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital	Haanshuus, CG (corresponding author), Haukeland Hosp, Dept Med, Norwegian Natl Advisory Unit Trop Infect Dis, Bergen, Norway.	christel.gill.haanshuus@helse-bergen.no	Hanevik, Kurt/I-1159-2012; Blomberg, Bjorn/B-9605-2015	Hanevik, Kurt/0000-0002-1466-2326; Blomberg, Bjorn/0000-0001-5647-4297	Norwegian National Advisory Unit on Tropical Infectious Diseases, Department of Medicine, Haukeland University Hospital, Bergen, Norway; Foundation for Innovative New Diagnostics (FIND)	Norwegian National Advisory Unit on Tropical Infectious Diseases, Department of Medicine, Haukeland University Hospital, Bergen, Norway; Foundation for Innovative New Diagnostics (FIND)	The Norwegian National Advisory Unit on Tropical Infectious Diseases, Department of Medicine, Haukeland University Hospital, Bergen, Norway funded all material used in this study, analysis of data, and writing of the manuscript.; We want to acknowledge the kind donation of reference material of P. falciparum, US 03 F FC27/A3, from the World Health Organization (WHO) Malaria Specimen Bank, hosted by the Centre for Disease Control and Prevention (CDC, Atlanta, USA) with support from the Foundation for Innovative New Diagnostics (FIND).	Abdel-Wahab A, 2002, J INFECT DIS, V185, P1838, DOI 10.1086/340638; Amir A, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2617-y; Bellete B, 2003, J MICROBIOL METH, V55, P213, DOI 10.1016/S0167-7012(03)00141-6; Beshir KB, 2013, J INFECT DIS, V208, P2017, DOI 10.1093/infdis/jit431; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136; Farrugia C, 2011, J CLIN MICROBIOL, V49, P2191, DOI 10.1128/JCM.02156-10; Felger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045542; Gaillard T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1613-y; Haanshuus CG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-26; Haanshuus CG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158816; Hanscheid T, 1999, CLIN LAB HAEMATOL, V21, P235, DOI 10.1046/j.1365-2257.1999.00220.x; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Hofmann N, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001788; Hviid L, 2004, TRENDS PARASITOL, V20, P66, DOI 10.1016/j.pt.2003.11.009; Jerome KR, 2002, J CLIN MICROBIOL, V40, P2609, DOI 10.1128/JCM.40.7.2609-2611.2002; Krungkrai J, 2004, PARASITOLOGY, V129, P511, DOI 10.1017/S0031182004005888; Lefterova MI, 2015, J CLIN MICROBIOL, V53, P2251, DOI 10.1128/JCM.00542-15; Mercereau-Puijalon O, 2002, INT J PARASITOL, V32, P1323, DOI 10.1016/S0020-7519(02)00111-X; Mouillesseaux KP, 2003, J VIROL METHODS, V111, P121, DOI 10.1016/S0166-0934(03)00167-8; Murphy SC, 2012, AM J TROP MED HYG, V86, P383, DOI 10.4269/ajtmh.2012.10-0658; Naeem MA, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2191-y; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Phiri KS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002903; Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; Rantala AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-269; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Rockett RJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-48; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Snow RW, 1998, J INFECT DIS, V177, P819, DOI 10.1086/517818; Strom GEA, 2014, T ROY SOC TROP MED H, V108, P488, DOI 10.1093/trstmh/tru084; Strom GEA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-137; Strom GEA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-228; Tadesse FG, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0821-1; Tajebe A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-411; Wampfler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076316; Wang B, 2014, J CLIN MICROBIOL, V52, P1838, DOI 10.1128/JCM.03615-13; WHO, 2018, WORLD MAL REP 2018; Wiens MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066698; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Wu L, 2015, NATURE, V528, pS86, DOI 10.1038/nature16039; Xu WP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120210	46	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0218982	10.1371/journal.pone.0218982	http://dx.doi.org/10.1371/journal.pone.0218982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276473	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300030
J	Lopez-Maya, E; Olmstead, R; Irwin, MR				Lopez-Maya, Eric; Olmstead, Richard; Irwin, Michael R.			Mindfulness meditation and improvement in depressive symptoms among Spanish- and English speaking adults: A randomized, controlled, comparative efficacy trial	PLOS ONE			English	Article							BREAST-CANCER SURVIVORS; COGNITIVE-BEHAVIORAL THERAPY; LATE-LIFE INSOMNIA; TAI CHI; PSYCHOMETRIC PROPERTIES; INFLAMMATION; STRESS; INVENTORY; ACCULTURATION; AMERICAN	Objective Latino immigrants experience acculturative stress and increased depression risk. Mindfulness meditation improves depressive symptoms, yet the vast majority of research has focused on English speaking populations. Methods In this randomized clinical trial with 2 parallel treatment groups, adults with moderate levels of perceived stress (n = 76) were recruited from the Los Angeles community from October 2015 to March 2016, stratified into Spanish- (n = 36) and English speaking (n = 40) language groups, and randomized for 6 weeks of treatment with standardized mindful awareness practices (MAPs) or health education (HE). Main outcome measure was depressive symptoms, measured by the Beck Depression Inventory. Results Using an intent-to-treat analysis, the primary outcome, depressive symptoms as indexed by the Beck Depression Inventory, showed greater improvement in MAPs vs. HE, with a between-group post-intervention mean difference of -2.2 (95% CI -4.4 - -0.07) and effect size of 0.28; similar effect sizes were found in the the Spanish- (0.29) and English speaking (0.30) groups. MAPs showed significant improvement relative to HE on secondary outcome of mindfulness with between group difference of 10.7 (95% CI4.5-16.9), but not perceived stress. Conclusion The comparable efficacy of Spanish and English formats of mindfulness meditation in improving depressive symptoms suggests that this community based intervention may mitigate depression risk in Latino adults who are experiencing social adversity.	[Lopez-Maya, Eric; Olmstead, Richard; Irwin, Michael R.] Univ Calif Los Angeles, Geffen Sch Med, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav,Mindful Awarene, Los Angeles, CA 90095 USA; [Lopez-Maya, Eric; Olmstead, Richard; Irwin, Michael R.] Univ Calif Los Angeles, Geffen Sch Med, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav,Cousins Ctr Psy, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Irwin, MR (corresponding author), Univ Calif Los Angeles, Geffen Sch Med, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav,Mindful Awarene, Los Angeles, CA 90095 USA.	mirwin1@ucla.edu	Irwin, Michael R./H-4870-2013	Irwin, Michael R./0000-0002-1502-8431; Lopez-Maya, Eric/0000-0003-1978-0302	Petit Foundation; Mindful Awareness Research Center at the UCLA Semel Institute; Mexican National Council for Science and Technology (CONACYT)	Petit Foundation; Mindful Awareness Research Center at the UCLA Semel Institute; Mexican National Council for Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The funding for this study was provided by Petit Foundation to MRI; Mindful Awareness Research Center at the UCLA Semel Institute to MRI; and Mexican National Council for Science and Technology (CONACYT) to EL.	Alegria M, 2007, AM J PUBLIC HEALTH, V97, P68, DOI 10.2105/AJPH.2006.087205; Azocar F, 2001, J CLIN PSYCHOL, V57, P355, DOI 10.1002/jclp.1017; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Berry JW, 2006, INT CUL PSY, P287; Black DS, 2015, JAMA INTERN MED, V175, P494, DOI 10.1001/jamainternmed.2014.8081; Bohlmeijer E, 2011, ASSESSMENT, V18, P308, DOI 10.1177/1073191111408231; Bower JE, 2016, BRAIN BEHAV IMMUN, V51, P1, DOI 10.1016/j.bbi.2015.06.012; Bower JE, 2015, CANCER-AM CANCER SOC, V121, P1231, DOI 10.1002/cncr.29194; Bower JE, 2014, PSYCHONEUROENDOCRINO, V43, P20, DOI 10.1016/j.psyneuen.2014.01.019; BROWN C, 1995, PSYCHOL ASSESSMENT, V7, P59; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; BUMBERRY W, 1978, J CONSULT CLIN PSYCH, V46, P150, DOI 10.1037/0022-006X.46.1.150; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Cobb CL, 2017, CULT DIVERS ETHN MIN, V23, P258, DOI 10.1037/cdp0000118; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Farley Tillman, 2005, J Immigr Health, V7, P213, DOI 10.1007/s10903-005-3678-5; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Franceschi C., 2014, J GERONTOL A BIOL S1, V69, P4, DOI [DOI 10.1093/GER0NA/GLU057, 10.1093/gerona/glu057, DOI 10.1093/GERONA/GLU057]; Fuligni AJ, 2009, BRAIN BEHAV IMMUN, V23, P803, DOI 10.1016/j.bbi.2009.02.021; Fuligni AJ, 2009, PSYCHOSOM MED, V71, P329, DOI 10.1097/PSY.0b013e3181921b1f; Garcia-Campayo J, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01161; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Irwin MR, 2017, J CLIN ONCOL, V35, P2656, DOI 10.1200/JCO.2016.71.0285; Irwin MR, 2015, BIOL PSYCHIAT, V78, P721, DOI 10.1016/j.biopsych.2015.01.010; Irwin Michael R., 2014, Journal of the National Cancer Institute Monographs, P295, DOI 10.1093/jncimonographs/lgu028; Irwin MR, 2014, SLEEP, V37, P1543, DOI 10.5665/sleep.4008; Irwin MR, 2011, NAT REV IMMUNOL, V11, P625, DOI 10.1038/nri3042; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039; Kiecolt-Glaser JK, 2014, J CLIN ONCOL, V32, P1040, DOI 10.1200/JCO.2013.51.8860; Lorenzo-Blanco EI, 2012, J YOUTH ADOLESCENCE, V41, P1350, DOI 10.1007/s10964-012-9774-7; Manotas M, 2014, INT J STRESS MANAGE, V21, P207, DOI 10.1037/a0035150; Mazure CM, 1998, CLIN PSYCHOL-SCI PR, V5, P291, DOI 10.1111/j.1468-2850.1998.tb00151.x; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Morgan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100903; Nair RL, 2018, J YOUTH ADOLESCENCE, V47, P105, DOI 10.1007/s10964-017-0753-x; Proulx J, 2018, MINDFULNESS, V9, P361, DOI 10.1007/s12671-017-0785-z; Raison CL, 2013, JAMA PSYCHIAT, V70, P31, DOI 10.1001/2013.jamapsychiatry.4; Romero A.J., 2017, OXFORD HDB ACCULTURA, P119, DOI [10.1093/oxfordhb/9780190215217.013.8, DOI 10.1093/OXFORDHB/9780190215217.013.8]; Ryan D, 2018, J BEHAV HEALTH SER R, V45, P280, DOI 10.1007/s11414-017-9582-7; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Smalley S.L., 2010, FULLY PRESENT SCI AR; Steiger JH, 2004, PSYCHOL METHODS, V9, P164, DOI 10.1037/1082-989X.9.2.164	43	10	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219425	10.1371/journal.pone.0219425	http://dx.doi.org/10.1371/journal.pone.0219425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4FP	31276540	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300077
J	Zheng, GS; Fan, CY; Di, SK; Wang, XM; Gao, LP; Dzyubenko, N; Chapurin, V; Pang, YZ				Zheng, Guangshun; Fan, Cunying; Di, Shaokang; Wang, Xuemin; Gao, Liping; Dzyubenko, Nikolay; Chapurin, Vladimir; Pang, Yongzhen			Ectopic expression of tea MYB genes alter spatial flavonoid accumulation in alfalfa (Medicago sativa)	PLOS ONE			English	Article							REGULATES PROANTHOCYANIDIN SYNTHESIS; TRANSCRIPTION FACTOR; SEED COAT; BIOSYNTHESIS; ANTHOCYANIN; TRUNCATULA; R2R3-MYB; DIFFERENTIATION; TRANSFORMATION; GRAPEVINE	Flavonoids are one of the largest secondary metabolite groups, which are widely present in plants. Flavonoids include anthocyanins, proanthocyanidins, flavonols and isoflavones. In particular, proanthocyanidins possess beneficial effects for ruminant animals in preventing lethal pasture bloat. As a major legume forage, alfalfa (Medicago sativa) contains little proanthocyanidins in foliage to combat bloat. In an attempt to improve proanthocyanidin content in alfalfa foliage, we over-expressed two MYB transcription factors (CsMYB5-1 and CsMYB5-2) from tea plant that is rich in proanthocyanidins. We showed that, via targeted metabolite and transcript analyses, the transgenic alfalfa plants accumulated higher levels of flavonoids in stems/leaves than the control, in particular anthocyanins and proanthocyanidins. Over-expression of CsMYB5-1 and CsMYB5-2 induced the expression levels of genes involved in flavonoid pathway, especially anthocyanin/proanthocyanidin-specific pathway genes DFR, ANS and ANR in stems/leaves. Both anthocyanin/proanthocyanidin content and the expression levels of several genes were conversely decreased in flowers of the transgenic lines than in control. Our results indicated that CsMYB5-1 and CsMYB5-2 differently regulate anthocyanins/proanthocyanidins in stems/leaves and flowers. Our study provides a guide for increasing anthocyanin/proanthocyanidin accumulation in foliage of legume forage corps by genetic engineering. These results also suggest that it is feasible to cultivate new varieties for forage production to potentially solve pasture bloat, by introducing transcription factors from typical plants with high proanthocyanidin level.	[Zheng, Guangshun; Di, Shaokang; Wang, Xuemin; Pang, Yongzhen] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Zheng, Guangshun; Fan, Cunying] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Zheng, Guangshun; Fan, Cunying] Chinese Acad Sci, Inst Bot, Beijing Bot Garden, Beijing, Peoples R China; [Gao, Liping] Anhui Agr Univ, Sch Life Sci, Hefei, Anhui, Peoples R China; [Dzyubenko, Nikolay; Chapurin, Vladimir] Russian Vavilov Inst Plant Genet Resources, Fed Res Ctr, St Petersburg, Russia	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Anhui Agricultural University; Vavilov All-Russian Institute of Plant Genetic Resources	Pang, YZ (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China.	pangyongzhen@caas.cn		Pang, Yongzhen/0000-0002-2336-7476	Major State Basic Research and Development Program [2014CB138703]; National Nature Science Foundation of China [31670305]	Major State Basic Research and Development Program(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by the Major State Basic Research and Development Program (2014CB138703) to XW; the National Nature Science Foundation of China (31670305) to YP.; This work was supported by the Major State Basic Research and Development Program (2014CB138703), and the National Nature Science Foundation of China (31670305).	Aerts RJ, 1999, AGR ECOSYST ENVIRON, V75, P1, DOI 10.1016/S0167-8809(99)00062-6; Akagi T, 2009, PLANT PHYSIOL, V151, P2028, DOI 10.1104/pp.109.146985; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Bloor SJ, 1997, PHYTOCHEMISTRY, V45, P1399, DOI 10.1016/S0031-9422(97)00129-5; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Broun P, 2005, CURR OPIN PLANT BIOL, V8, P272, DOI 10.1016/j.pbi.2005.03.006; Cosson V, 2006, METH MOL B, V343, P115; Deluc L, 2008, PLANT PHYSIOL, V147, P2041, DOI 10.1104/pp.108.118919; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Hancock KR, 2012, PLANT PHYSIOL, V159, P1204, DOI 10.1104/pp.112.195420; Jiang XL, 2018, PLANT SCI, V270, P209, DOI 10.1016/j.plantsci.2018.02.009; Jiang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062315; Kandil FE, 2002, J AGR FOOD CHEM, V50, P1063, DOI 10.1021/jf011136z; LI JY, 1993, PLANT CELL, V5, P171, DOI 10.1105/tpc.5.2.171; Liu CG, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.182, 10.1038/nplants.2016.182]; Liu CG, 2014, PLANT PHYSIOL, V165, P1424, DOI 10.1104/pp.114.241877; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; MO YY, 1992, P NATL ACAD SCI USA, V89, P7213, DOI 10.1073/pnas.89.15.7213; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Noreen Y, 1998, PLANTA MED, V64, P520, DOI 10.1055/s-2006-957506; Pang YZ, 2008, P NATL ACAD SCI USA, V105, P14210, DOI 10.1073/pnas.0805954105; Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326; Pang YZ, 2009, PLANT PHYSIOL, V151, P1114, DOI 10.1104/pp.109.144022; Passeri V, 2017, PLANTA, V246, P185, DOI 10.1007/s00425-017-2667-y; Pattanaik S, 2010, PLANTA, V231, P1061, DOI 10.1007/s00425-010-1108-y; Peel GJ, 2009, PLANT J, V59, P136, DOI 10.1111/j.1365-313X.2009.03885.x; Permingeat HR, 1998, PLANT MOL BIOL REP, V16, P89, DOI 10.1023/A:1007466522028; Ray H, 2003, PLANT PHYSIOL, V132, P1448, DOI 10.1104/pp.103.025361; Santos-Buelga C, 2000, J SCI FOOD AGR, V80, P1094, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1094::AID-JSFA569&gt;3.0.CO;2-1, 10.1002/(SICI)1097-0010(20000515)80:7<1094::AID-JSFA569>3.3.CO;2-T]; Serafini M, 2003, NATURE, V424, P1013, DOI 10.1038/4241013a; Terrier N, 2009, PLANT PHYSIOL, V149, P1028, DOI 10.1104/pp.108.131862; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Verdier J, 2012, P NATL ACAD SCI USA, V109, P1766, DOI 10.1073/pnas.1120916109; Xiao K, 2005, PLANTA, V222, P27, DOI 10.1007/s00425-005-1511-y; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Yoshida K, 2008, PLANT CELL PHYSIOL, V49, P157, DOI 10.1093/pcp/pcn009; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003; Zhao J, 2010, TRENDS PLANT SCI, V15, P72, DOI 10.1016/j.tplants.2009.11.006; Zhao L, 2013, FUNCT INTEGR GENOMIC, V13, P75, DOI 10.1007/s10142-012-0301-4	40	10	10	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2019	14	7							e0218336	10.1371/journal.pone.0218336	http://dx.doi.org/10.1371/journal.pone.0218336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3ZV	31265465	Green Published, Green Submitted			2022-12-26	WOS:000484921200009
J	Vega, MRLOL; Nigro, ALSA; Luti, SMN; Capitini, LD; Fani, L; Gonnelli, LONRO; Boscaro, RCC; Chiti, FRZO				Vega, Mirella Vivoli; Nigro, Alessia; Luti, Simone; Capitini, Claudia; Fani, Giulia; Gonnelli, Leonardo; Boscaro, Francesca; Chiti, Fabrizio			Isolation and characterization of soluble human full-length TDP-43 associated with neurodegeneration	FASEB JOURNAL			English	Article						protein refolding; neurodegenerative diseases; TDP-43 proteinophaties; stress granules; RNA binding protein	FRONTOTEMPORAL LOBAR DEGENERATION; BINDING PROTEIN 43; N-TERMINAL DOMAIN; DIFFERENTIAL SCANNING FLUOROMETRY; NUCLEIC-ACID BINDING; ESCHERICHIA-COLI; RNA RECOGNITION; DNA; EXPRESSION; MUTATIONS	The involvement of transactivation response (TAR) DNA-binding protein 43 (TDP-43) in neurodegenerative diseases was revealed in 2006, when it was first reported to be the main component of the intracellular inclusions in patients with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration. After 12 yr it is not yet possible to purify to a reasonable yield and in a reproducible manner a stable full-length protein, which has limited so far the characterization of its structure, function, molecular interactors, and pathobiology. Using a novel protocol we have achieved the purification of the full-length TDP-43, with both a short pectate lyase B tag and a glutathione S-transferase tag, which consisted in its expression in bacteria, solubilization from inclusion bodies, purification under denaturing conditions, refolding, and a final size exclusion chromatography (SEC) step. Differential scanning fluorimetry was used to find the best buffers and combination of additives to increase both its solubility and its stability. The protein is pure, as determined with electrophoresis, Western blotting, and mass spectrometry; properly refolded, as revealed by circular dichroism and fluorescence spectroscopies; functional, because it binds to DNA and protein partners; and stable to degradation and aggregation in a physiologic solution. Analyses with dynamic light scattering and SEC revealed that the protein is a dimer.-Vivoli Vega, M., Nigro, A., Luti, S., Capitini, C., Fani, G., Gonnelli, L., Boscaro, F., Chiti, F. Isolation and characterization of soluble human full-length TDP-43 associated with neurodegeneration.	[Vega, Mirella Vivoli; Nigro, Alessia; Luti, Simone; Capitini, Claudia; Fani, Giulia; Chiti, Fabrizio] Univ Florence, Dept Expt & Clin Biomed Sci, Viale Morgagni 50, I-50134 Florence, Italy; [Gonnelli, Leonardo] Univ Florence, Ctr Ric Risonanze Magnet CERM, Florence, Italy; [Boscaro, Francesca] Univ Florence, Mass Spectrometry Ctr, Florence, Italy	University of Florence; University of Florence; University of Florence	Chiti, FRZO (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci, Viale Morgagni 50, I-50134 Florence, Italy.	fabrizio.chiti@unifi.it		Capitini, Claudia/0000-0003-2834-1424; Vivoli Vega, Mirella/0000-0002-1148-5651; Luti, Simone/0000-0001-7050-6590	Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA) [TDP-43 STRUCT]	Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA)	The authors thank the Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA) for funding (Grant TDP-43 STRUCT). M.V.V. acknowledges the financial funding from the backers who have supported the crowdfunding campaign at Experiment. com for the purchase of the fast protein liquid chromatography (FPLC) instrument. The authors declare no conflicts of interest.	Afroz T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00062-0; Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Alibolandi M, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/631607; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Baynes BM, 2005, BIOCHEMISTRY-US, V44, P4919, DOI 10.1021/bi047528r; Belin D, 2004, J MOL BIOL, V335, P437, DOI 10.1016/j.jmb.2003.10.076; Berkmen M, 2012, PROTEIN EXPRES PURIF, V82, P240, DOI 10.1016/j.pep.2011.10.009; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Capitini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086720; Casafont I, 2009, J STRUCT BIOL, V167, P235, DOI 10.1016/j.jsb.2009.06.006; Chang CK, 2012, BIOCHEM BIOPH RES CO, V425, P219, DOI 10.1016/j.bbrc.2012.07.071; Chanson JB, 2010, NEURODEGENER DIS, V7, P260, DOI 10.1159/000273591; Chiang CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21581; Clark EDB, 1998, CURR OPIN BIOTECH, V9, P157; CLELAND JL, 1992, BIO-TECHNOL, V10, P1013, DOI 10.1038/nbt0992-1013; DELATORRE JG, 1981, Q REV BIOPHYS, V14, P81, DOI 10.1017/S0033583500002080; Economou A, 1999, TRENDS MICROBIOL, V7, P315, DOI 10.1016/S0966-842X(99)01555-3; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Georgiou G, 2005, CURR OPIN BIOTECH, V16, P538, DOI 10.1016/j.copbio.2005.07.008; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; HAUN RS, 1992, BIOTECHNIQUES, V13, P515; Hobson EV, 2016, NAT REV NEUROL, V12, P526, DOI 10.1038/nrneurol.2016.111; Hofmann L, 2016, ANAL BIOCHEM, V499, P63, DOI 10.1016/j.ab.2016.01.016; Jiang LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06263-3; Jiang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23928; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Jung JW, 2006, PROTEOMICS, V6, P1110, DOI 10.1002/pmic.200500371; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Khokhlova OV, 2004, MOL BIOL+, V38, P239, DOI 10.1023/B:MBIL.0000023740.66749.b0; Kitamura A, 2018, BIOCHEM BIOPHYS REP, V14, P58, DOI 10.1016/j.bbrep.2018.03.009; Kuo PH, 2014, NUCLEIC ACIDS RES, V42, P4712, DOI 10.1093/nar/gkt1407; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LEE JC, 1981, J BIOL CHEM, V256, P7193; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li W, 2017, J BIOL CHEM, V292, P5089, DOI 10.1074/jbc.M116.753913; Lim LZ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002338; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; Luo Y., 2011, HDB MODERN PHARM ANA, V10, P283; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Mompean M, 2017, J BIOL CHEM, V292, P11992, DOI 10.1074/jbc.M117.775965; Mompean M, 2016, FEBS J, V283, P1242, DOI 10.1111/febs.13651; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Qin HN, 2014, P NATL ACAD SCI USA, V111, P18619, DOI 10.1073/pnas.1413994112; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Rohn TT, 2008, BRAIN RES, V1228, P189, DOI 10.1016/j.brainres.2008.06.094; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Singh CR, 2007, METHOD ENZYMOL, V429, P139, DOI 10.1016/S0076-6879(07)29007-X; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stover CM, 2004, MAMM GENOME, V15, P887, DOI 10.1007/s00335-004-3006-8; Tan RH, 2015, BRAIN, V138, P3110, DOI 10.1093/brain/awv220; Tsai RM, 2016, J NEUROCHEM, V138, P211, DOI 10.1111/jnc.13640; Tsoi PS, 2017, ANGEW CHEM INT EDIT, V56, P12590, DOI 10.1002/anie.201706769; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; Vikis Haris G, 2004, Methods Mol Biol, V261, P175; Vivoli Mirella, 2014, J Vis Exp, P51809, DOI 10.3791/51809; Wang AL, 2018, EMBO J, V37, DOI 10.15252/embj.201797452; Wang YT, 2013, J BIOL CHEM, V288, P9049, DOI 10.1074/jbc.M112.438564; Wei YY, 2016, BIOCHEM BIOPH RES CO, V473, P614, DOI 10.1016/j.bbrc.2016.03.158; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Yoon Sung Ho, 2010, Recent Pat Biotechnol, V4, P23, DOI 10.2174/187220810790069550; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007	74	10	10	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10780	10793		10.1096/fj.201900474R	http://dx.doi.org/10.1096/fj.201900474R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31287959				2022-12-26	WOS:000489166300017
J	Yang, S; Liu, H; Zhu, L; Li, XL; Liu, DQ; Song, XM; Yokota, H; Zhang, P				Yang, Shuang; Liu, Hong; Zhu, Lei; Li, Xinle; Liu, Daquan; Song, Xiaomeng; Yokota, Hiroki; Zhang, Ping			Ankle loading ameliorates bone loss from breast cancer-associated bone metastasis	FASEB JOURNAL			English	Article						mechanical loading; tumor; osteolysis; osteoclast; osteoblast	PHYSICAL-ACTIVITY; TUMOR-GROWTH; PROGRESSION; OSTEOLYSIS; RISK; METAANALYSIS; EXPRESSION; PROTECTS; EXERCISE; EFFICACY	Breast cancer is a serious health problem that preferentially metastasizes to bone. We have previously shown that bone loss can be prevented by mechanical loading, but the efficacy of ankle loading for metastasis-linked bone loss has not been investigated. This study showed that body weight was decreased after inoculation of tumor cells, but ankle loading restored a rapid weight loss. The nonloading group exhibited a decrease in bone volume/tissue volume (BV/TV), trabecular thickness, and trabecular number (all P < 0.01) as well as an increase in trabecular separation (P < 0.001). However, ankle loading improved those changes (all P < 0.05). Furthermore, although the nonloading group increased the tumor bearing as well as expression of IL-8 and matrix metalloproteinase 9, ankle loading decreased them. Induction of tumor in the bone elevated the osteoclast number (P < 0.05) as well as the levels of nuclear factor of activated T-cells cytoplasmic 1, NF-kappa B ligand, cathepsin K, and serum tartrate-resistant acid phosphatase type 5b, but ankle loading reduced osteoclast activity and those levels (all P < 0.05). Tumor bearing was positively correlated with the osteoclast number (P < 0.01) and negatively correlated with BV/TV and the osteoblast number (both P < 0.01). Collectively, these findings demonstrate that ankle loading suppresses tumor growth and osteolysis by inhibiting bone resorption and enhancing bone formation.-Yang, S., Liu, H., Zhu, L., Li, X., Liu, D., Song, X., Yokota, H., Zhang, P. Ankle loading ameliorates bone loss from breast cancer-associated bone metastasis.	[Yang, Shuang; Li, Xinle; Liu, Daquan; Song, Xiaomeng; Zhang, Ping] Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China; [Yang, Shuang; Li, Xinle; Liu, Daquan; Zhang, Ping] Tianjin Med Univ, Key Lab Hormones & Dev, Minist Hlth, Tianjin Key Lab Metab Dis, Tianjin, Peoples R China; [Liu, Hong] Tianjin Med Univ, Key Lab Canc Prevent & Therapy, Minist Educ, Tianjin, Peoples R China; [Zhang, Ping] Tianjin Med Univ, Tianjin Key Lab Spine & Spinal Cord, Tianjin, Peoples R China; [Liu, Hong] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Surg, Tianjin, Peoples R China; [Zhu, Lei] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Mol Imaging & Nucl Med, Tianjin, Peoples R China; [Liu, Hong; Zhu, Lei] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China; [Yokota, Hiroki; Zhang, Ping] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Indiana University System; Indiana University-Purdue University Indianapolis	Zhang, P (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	pizhang@tmu.edu.cn			National Natural Science Foundation of China [81772405, 81572100, 81601863]; Tianjin Science and Technology Program Fund [18PTZWHZ00100]; Science and Technology Development Fund of Tianjin Education Commission for Higher Education [2017KJ223, 2018KJ076]; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR052144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Science and Technology Program Fund; Science and Technology Development Fund of Tianjin Education Commission for Higher Education; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Natural Science Foundation of China (81772405 and 81572100 to P.Z.; 81601863 to X.L.), the Tianjin Science and Technology Program Fund (18PTZWHZ00100 to L.Z.), the Science and Technology Development Fund of Tianjin Education Commission for Higher Education (2017KJ223 to D.L.; 2018KJ076 to X.S.), and U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant AR052144 to H.Y.). The authors declare no conflicts of interest.	Ashcraft KA, 2016, CANCER RES, V76, P4032, DOI 10.1158/0008-5472.CAN-16-0887; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Buenrostro D, 2018, BONE, V113, P77, DOI 10.1016/j.bone.2018.05.008; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; D'Oronzo S, 2017, J BONE ONCOL, V9, P1, DOI 10.1016/j.jbo.2017.09.001; Duong LT, 2014, MOL CANCER THER, V13, P2898, DOI 10.1158/1535-7163.MCT-14-0253; Ell B, 2012, CELL, V151, DOI 10.1016/j.cell.2012.10.005; Erdogan B, 2014, ASIAN PAC J CANCER P, V15, P1503, DOI 10.7314/APJCP.2014.15.4.1503; Hong W, 2014, CANCER LETT, V351, P1, DOI 10.1016/j.canlet.2014.04.007; Jones LW, 2013, ACTA ONCOL, V52, P195, DOI 10.3109/0284186X.2012.742564; Kakhki VRD, 2013, NUCL MED REV, V16, P66, DOI 10.5603/NMR.2013.0037; Kamalakar A, 2014, BONE, V61, P176, DOI 10.1016/j.bone.2014.01.015; Kim Jeongseon, 2013, J Cancer Prev, V18, P193; Kim JY, 2014, BMB REP, V47, P451, DOI 10.5483/BMBRep.2014.47.8.206; Kim Jung Ha, 2014, J Bone Metab, V21, P233, DOI 10.11005/jbm.2014.21.4.233; Kuchuk I, 2013, J BONE ONCOL, V2, P137, DOI 10.1016/j.jbo.2013.09.001; Lahart IM, 2015, ACTA ONCOL, V54, P635, DOI 10.3109/0284186X.2014.998275; Lee JH, 2014, BIOCHEM PHARMACOL, V91, P51, DOI 10.1016/j.bcp.2014.06.005; Li X., 2019, FASEB J; Li XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24668; Liu DQ, 2015, BONE, V81, P620, DOI 10.1016/j.bone.2015.09.012; Loibl S, 2015, BREAST, V24, pS73, DOI 10.1016/j.breast.2015.07.018; Lorenzo J, 2017, J CLIN INVEST, V127, P2530, DOI 10.1172/JCI94606; Luftner D, 2018, BREAST, V37, P28, DOI 10.1016/j.breast.2017.10.007; Lumachi F, 2016, CLIN CHIM ACTA, V460, P227, DOI 10.1016/j.cca.2016.07.005; Luo KW, 2015, ONCOL REP, V34, P477, DOI 10.3892/or.2015.4001; Lynch ME, 2013, J BONE MINER RES, V28, P2357, DOI 10.1002/jbmr.1966; Ma YHV, 2018, J CELL BIOCHEM, V119, P5665, DOI 10.1002/jcb.26745; Merdad A, 2014, ANTICANCER RES, V34, P1355; Pagnotti GM, 2016, BONE, V90, P69, DOI 10.1016/j.bone.2016.05.014; Payne C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008427.pub2; Pedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011; Rollason V, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008455.pub2; Schneeweiss A, 2018, GEBURTSH FRAUENHEILK, V78, P246, DOI 10.1055/s-0044-101614; Selvaduray KR, 2012, GENES NUTR, V7, P53, DOI 10.1007/s12263-011-0223-0; Sheill G, 2018, PM&R, V10, P843, DOI 10.1016/j.pmrj.2018.02.006; Stevens RG, 2014, CA-CANCER J CLIN, V64, P207, DOI 10.3322/caac.21218; Taipaleenmaki H, 2015, CANCER RES, V75, P1433, DOI 10.1158/0008-5472.CAN-14-1026; Tsianakas V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013719; Vagnildhaug OM, 2017, J CACHEXIA SARCOPENI, V8, P789, DOI 10.1002/jcsm.12220; Wang Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0417-0; Wani NA, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3665; Wright LE, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.31; Yee J, 2014, J CANCER SURVIV, V8, P647, DOI 10.1007/s11764-014-0378-y; Zhang HW, 2018, J BONE ONCOL, V11, P38, DOI 10.1016/j.jbo.2018.01.004; Zhang P, 2008, BRIT J SPORT MED, V42, P556, DOI 10.1136/bjsm.2007.042556; Zhang P, 2009, BONE, V44, P989, DOI 10.1016/j.bone.2009.01.367; Zhang P, 2009, EXERC SPORT SCI REV, V37, P52, DOI 10.1097/JES.0b013e31819121c6; Zhang W, 2011, BONE, V48, P1378, DOI 10.1016/j.bone.2011.03.760; Zhong SL, 2014, EUR J EPIDEMIOL, V29, P391, DOI 10.1007/s10654-014-9916-1	50	9	9	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10742	10752		10.1096/fj.201900306RR	http://dx.doi.org/10.1096/fj.201900306RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31266364	Green Published			2022-12-26	WOS:000489166300014
J	Saito, T; Mihira, N; Matsuba, Y; Sasaguri, H; Hashimoto, S; Narasimhan, S; Zhang, B; Murayama, S; Higuchi, M; Lee, VMY; Trojanowski, JQ; Saido, TC				Saito, Takashi; Mihira, Naomi; Matsuba, Yukio; Sasaguri, Hiroki; Hashimoto, Shoko; Narasimhan, Sneha; Zhang, Bin; Murayama, Shigeo; Higuchi, Makoto; Lee, Virginia M. Y.; Trojanowski, John Q.; Saido, Takaomi C.			Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid precursor protein (APP); amyloid-beta (AB); tau protein (tau); tauopathy; dystrophic neurite; humanized mouse model; knock-in; neurodegeneration; tau propagation; dystrophic neurite; plaque deposit	MOUSE MODELS; ALZHEIMERS-DISEASE; PROTEIN-TAU; LOCALIZATION; ACTIVATION; ISOFORMS; CALPAIN; BRAIN; MICE; APP	In cortical regions of brains from individuals with preclinical or clinical Alzheimer's disease (AD), extracellular beta-amyloid (A beta) deposition precedes the aggregation of pathological intracellular tau (the product of the gene microtubule-associated protein tau (MAPT)). To our knowledge, current mouse models of tauopathy reconstitute tau pathology by overexpressing mutant human tau protein. Here, through a homologous recombination approach that replaced the entire murine Mapt gene with the human ortholog, we developed knock-in mice with humanized Mapt to create an in vivo platform for studying human tauopathy. Of note, the humanized Mapt expressed all six tau isoforms present in humans. We next cross-bred the MAPT knock-in mice with single amyloid precursor protein (App) knock-in mice to investigate the A beta-tau axis in AD etiology. The double-knock-in mice exhibited higher tau phosphorylation than did single MAPT knock-in mice but initially lacked apparent tauopathy and neurodegeneration, as observed in the single App knock-in mice. We further observed that tau humanization significantly accelerates cell-to-cell propagation of AD brain-derived pathological tau both in the absence and presence of A beta-amyloidosis. In the presence of A beta-amyloidosis, tau accumulation was intensified and closely associated with dystrophic neurites, consistently showing that A beta-amyloidosis affects tau pathology. Our results also indicated that the pathological human tau interacts better with human tau than with murine tau, suggesting species-specific differences between these orthologous pathogenic proteins. We propose that the MAPT knock-in mice will make it feasible to investigate the behaviors and characteristics of human tau in an animal model.	[Saito, Takashi; Mihira, Naomi; Matsuba, Yukio; Sasaguri, Hiroki; Hashimoto, Shoko; Saido, Takaomi C.] RIKEN, Ctr Brain Sci, Lab Proteolyt Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Saito, Takashi] Nagoya Univ, Res Inst Environm Med, Dept Neurosci & Pathobiol, Nagoya, Aichi 4648601, Japan; [Narasimhan, Sneha; Zhang, Bin; Lee, Virginia M. Y.; Trojanowski, John Q.] Univ Penn, Sch Med, Inst Aging, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Narasimhan, Sneha; Zhang, Bin; Lee, Virginia M. Y.; Trojanowski, John Q.] Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Dept Neuropathol, Itabashi Ku, 35-2 Sakaecho, Tokyo 1730015, Japan; [Higuchi, Makoto] Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Funct Brain Imaging Res, Chiba 2638555, Japan	RIKEN; Nagoya University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Tokyo Metropolitan Institute of Gerontology; National Institutes for Quantum Science & Technology	Saito, T; Saido, TC (corresponding author), RIKEN, Ctr Brain Sci, Lab Proteolyt Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.; Saito, T (corresponding author), Nagoya Univ, Res Inst Environm Med, Dept Neurosci & Pathobiol, Nagoya, Aichi 4648601, Japan.	takashi.saito.aa@riken.jp; saido@brain.riken.jp	Saito, Takashi/G-2563-2015; Saido, Takaomi/N-5472-2015	Saito, Takashi/0000-0002-9659-9251; Saido, Takaomi/0000-0003-1970-6903	RIKEN Center for Brain Science; RIKEN Aging Project; MEXT; Precursory Research for Embryonic Science and Technology from JST; Cell Science Research Foundation; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Japan Agency for Medical Research and Development (AMED) [JP18dm027001]; Astellas Pharma, Inc. JSPS KAKENHI [JP16H06277]; National Institutes of Health [AG10124, AG17586]; NATIONAL INSTITUTE ON AGING [U19AG062418, P30AG010124, P01AG017586] Funding Source: NIH RePORTER	RIKEN Center for Brain Science; RIKEN Aging Project; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Precursory Research for Embryonic Science and Technology from JST; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Astellas Pharma, Inc. JSPS KAKENHI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by research grants from the RIKEN Center for Brain Science, research grants from the RIKEN Aging Project, a Grant-in-Aid-for Scientific Research (B) from MEXT (to T.S.), Precursory Research for Embryonic Science and Technology from JST (to T.S.), the Cell Science Research Foundation (to T.S.), the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Japan Agency for Medical Research and Development (AMED) (Grant JP18dm027001) (to T.C.S.), Astellas Pharma, Inc. JSPS KAKENHI Grant JP16H06277 (to S.M.), and National Institutes of Health Grants AG10124 and AG17586 (to V.M. Y.L. and J.Q.T.). T.S., Y.M., S.H., and T.C.S. serve as advisor, director, researcher, and CEO, respectively, for RIKEN BIO Co. Ltd., which sublicenses animal models, App KI mice, to for-profit organizations, the proceeds from which are used for the identification of disease biomarkers. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Ando K, 2010, BIOCHEM SOC T, V38, P1001, DOI 10.1042/BST0381001; Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Boyko S, 2019, J BIOL CHEM, V294, P11054, DOI 10.1074/jbc.AC119.009198; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chen YX, 2018, BIOCHEM BIOPH RES CO, V496, P1006, DOI 10.1016/j.bbrc.2017.04.153; Enya M, 1999, AM J PATHOL, V154, P271, DOI 10.1016/S0002-9440(10)65273-X; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Goodwin LO, 2019, GENOME RES, V29, P494, DOI 10.1101/gr.233866.117; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Hashimoto S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10278-x; He ZH, 2018, NAT MED, V24, P29, DOI 10.1038/nm.4443; Higuchi M, 2005, J BIOL CHEM, V280, P15229, DOI 10.1074/jbc.M500939200; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Iovino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013947; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Jankowsky JL, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0231-7; Kubo A, 2019, J COMP NEUROL, V527, P985, DOI 10.1002/cne.24577; Kumar H, 2019, BBA-PROTEINS PROTEOM, V1867, P922, DOI 10.1016/j.bbapap.2019.04.004; Lee VMY, 1999, NEURON, V24, P507, DOI 10.1016/S0896-6273(00)81106-X; Luk KC, 2016, CELL REP, V16, P3373, DOI 10.1016/j.celrep.2016.08.053; Narasimhan S, 2017, METHOD CELL BIOL, V141, P287, DOI 10.1016/bs.mcb.2017.06.009; Puig B, 2014, PRION, V8, P11, DOI 10.4161/pri.27892; Robinson JL, 2018, BRAIN, V141, P2181, DOI 10.1093/brain/awy146; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Saito T, 2016, J NEUROSCI, V36, P9933, DOI 10.1523/JNEUROSCI.1907-16.2016; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Sasaguri H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05262-w; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Schoch KM, 2016, NEURON, V90, P941, DOI 10.1016/j.neuron.2016.04.042; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Stefanoska K, 2018, J BIOL CHEM, V293, P3710, DOI 10.1074/jbc.RA118.001784; Vasili E, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00107; Wolfe MS, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/796024; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	44	60	61	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12754	12765		10.1074/jbc.RA119.009487	http://dx.doi.org/10.1074/jbc.RA119.009487			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31273083	hybrid, Green Published			2022-12-26	WOS:000484414600017
J	Yang, CJ; Tsai, SH; Wang, JC; Chang, WC; Lin, CY; Tang, ZC; Hsu, HH				Yang, Chih-Jen; Tsai, Shih-Hung; Wang, Jen-Chun; Chang, Wei-Chou; Lin, Chih-Yuan; Tang, Zun-Cheng; Hsu, Hsian-He			Association between acute aortic dissection and the distribution of aortic calcification	PLOS ONE			English	Article							ARCH CALCIFICATION; VASCULAR CALCIFICATION; INTERNATIONAL REGISTRY; CARDIOVASCULAR EVENTS; RISK-FACTORS; DISEASE; MECHANISMS; MORTALITY; ANEURYSMS; MODEL	Objective Aortic calcification (AC) is associated with increased risks of cardiovascular events and mortality. Numerous studies have explored the association between calcification and abdominal artery aneurysm. However, evidence regarding the association between AC and acute aortic dissection (AAD) is limited. We aimed to evaluate the association between AC-related variables and the development of intimal tear (IT) in patients with AAD. Methods We conducted a retrospective observational study involving 64 patients with type A AAD and 32 patients with type B AAD from February, 2011 to January, 2017 at a tertiary referral medical center in Taiwan. We used the default analysis module "calcification score analysis" to calculate all the calcification variables, including AC scores and volume. Results We identified an association between AC and AAD. Patients with AAD had a greater AC volume in the aortic arch and greater AC scores for both the ascending aorta and the aortic arch than did patients without AAD. However, hypertension and coronary artery disease, rather than AC remained to be the independent risk factor for AAD in multivariate analysis. Patients with type A AAD had greater mean and cumulative AC volumes in the aortic arch, greater cumulative AC volumes in the whole aorta and higher cumulative AC scores in the aortic arch than did patients with type B AAD. ACs were superimposed on ITs in nearly half of the patients with AAD. In patients with type A AAD, AC was more commonly located distal to the IT and farther from the IT. Conclusions We identified the associations between AC-related variables and the location of IT in patients with AAD. However, AC was not an independent risk factor for AAD. The distribution of AC was different between patients with type A and type B AAD.	[Yang, Chih-Jen; Tsai, Shih-Hung; Wang, Jen-Chun] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Emergency Med, Taipei, Taiwan; [Tsai, Shih-Hung] Natl Def Med Ctr, Grad Inst Physiol, Dept Physiol & Biophys, Taipei, Taiwan; [Chang, Wei-Chou; Hsu, Hsian-He] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Radiol, Taipei, Taiwan; [Lin, Chih-Yuan] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan; [Tang, Zun-Cheng] Natl Yang Ming Univ, Dept Biol Imaging & Radiol Sci, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University	Tsai, SH (corresponding author), Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Emergency Med, Taipei, Taiwan.; Tsai, SH (corresponding author), Natl Def Med Ctr, Grad Inst Physiol, Dept Physiol & Biophys, Taipei, Taiwan.; Hsu, HH (corresponding author), Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Radiol, Taipei, Taiwan.	tsaishihung@yahoo.com.tw; hsianhe@yahoo.com.tw		Tsai, Shih-Hung/0000-0003-0215-3193	Tri-Service General Hospital of the National Defense Medical Center in Taipei, Taiwan [TSGH-C107-047]; Ministry of Science and Technology [MOST 106-2314-B-016-031, MOST 106-2314-B-016 -008 -MY3]	Tri-Service General Hospital of the National Defense Medical Center in Taipei, Taiwan; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work received support from the following sources: 1. Tri-Service General Hospital of the National Defense Medical Center in Taipei, Taiwan (TSGH-C107-047); 2. Ministry of Science and Technology (MOST 106-2314-B-016-031 and MOST 106-2314-B-016 -008 -MY3).	Alimohammadi M, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0032-6; Awan Z, 2016, ANGIOLOGY, V67, P157, DOI 10.1177/0003319715583205; Bannas P, 2013, EUR RADIOL, V23, P2652, DOI 10.1007/s00330-013-2877-z; Buijs RVC, 2013, EUR J VASC ENDOVASC, V46, P542, DOI 10.1016/j.ejvs.2013.09.006; Chowienczyk PJ, 2015, CIRCULATION, V131, P1745, DOI 10.1161/CIRCULATIONAHA.115.016377; de Jong PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102036; Demer LL, 2014, ARTERIOSCL THROM VAS, V34, P715, DOI 10.1161/ATVBAHA.113.302070; Evangelista A, 2018, EUR HEART J-ACUTE CA, V7, P602, DOI 10.1177/2048872616682343; FITZGERALD PJ, 1992, CIRCULATION, V86, P64, DOI 10.1161/01.CIR.86.1.64; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; HALLORAN BG, 1995, J SURG RES, V59, P17, DOI 10.1006/jsre.1995.1126; Iijima K, 2010, ATHEROSCLEROSIS, V210, P137, DOI 10.1016/j.atherosclerosis.2009.11.012; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2810, DOI 10.1001/jama.283.21.2810; Kawabori M, 2016, BEST PRACT RES-CLIN, V30, P271, DOI 10.1016/j.bpa.2016.07.001; Khavandgar Z, 2014, J BONE MINER RES, V29, P327, DOI 10.1002/jbmr.2039; Komatsu M, 2014, KIDNEY BLOOD PRESS R, V39, P658, DOI 10.1159/000368476; Leopold JA, 2015, TRENDS CARDIOVAS MED, V25, P267, DOI 10.1016/j.tcm.2014.10.021; Li ZY, 2008, J VASC SURG, V47, P928, DOI 10.1016/j.jvs.2008.01.006; MARSALESE DL, 1990, J AM COLL CARDIOL, V16, P68, DOI 10.1016/0735-1097(90)90458-2; Mitchell RS, 2002, J ENDOVASC THER, V9, P98; Nordon IM, 2011, CARDIOVASC INTER RAD, V34, P890, DOI 10.1007/s00270-010-0028-3; Nosoudi N, 2016, THERANOSTICS, V6, P1975, DOI 10.7150/thno.16547; O'Leary SA, 2015, J MECH BEHAV BIOMED, V42, P154, DOI 10.1016/j.jmbbm.2014.11.005; OGARA PT, 1995, CIRCULATION, V92, P1376, DOI 10.1161/01.CIR.92.6.1376; Raaz U, 2015, CIRCULATION, V131, P1783, DOI 10.1161/CIRCULATIONAHA.114.012377; Ribeiro V., 2007, CT ANGIOGRAPHY THORA, P91; RICHARDSON PD, 1989, LANCET, V2, P941; Sever A, 2016, EMERG RADIOL, V23, P187, DOI 10.1007/s10140-015-1374-x; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Thomas IC, 2018, EUR HEART J-CARD IMG, V19, P1343, DOI 10.1093/ehjci/jey007; Trimarchi S, 2007, J VASC SURG, V46, P913, DOI 10.1016/j.jvs.2007.07.030; Wagenseil JE, 2012, J CARDIOVASC TRANSL, V5, P264, DOI 10.1007/s12265-012-9349-8; Wanga S, 2017, J PATHOL, V243, P294, DOI 10.1002/path.4949; Wen CY, 2010, ANN BIOMED ENG, V38, P391, DOI 10.1007/s10439-009-9835-6; Wu CF, 2017, J FORMOS MED ASSOC, V116, P366, DOI 10.1016/j.jfma.2016.06.006; Yang TL, 2017, ACTA CARDIOL SIN, V33, P241, DOI 10.6515/ACS20160902A; Youssef G, 2015, ACAD RADIOL, V22, P1536, DOI 10.1016/j.acra.2015.08.017; Zhou YB, 2009, EXP BIOL MED, V234, P908, DOI 10.3181/0811-RM-346	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219461	10.1371/journal.pone.0219461	http://dx.doi.org/10.1371/journal.pone.0219461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295298	gold, Green Published, Green Submitted			2022-12-26	WOS:000484951800035
J	Ward, A; Hollister, JR; Choi, YP; Race, B; Williams, K; Shoup, DW; Moore, RA; Priola, SA				Ward, Anne; Hollister, Jason R.; Choi, Young Pyo; Race, Brent; Williams, Katie; Shoup, Daniel W.; Moore, Roger A.; Priola, Suzette A.			Altered distribution, aggregation, and protease resistance of cellular prion protein following intracranial inoculation	PLOS ONE			English	Article							INTRACEREBRAL INOCULATION; ALZHEIMERS-DISEASE; SCRAPIE AGENT; RISK-FACTOR; M CELLS; BRAIN; ACCUMULATION; MICE; INFECTION; SHEEP	Prion protein (PrPC) is a protease-sensitive and soluble cell surface glycoprotein expressed in almost all mammalian cell types. PrPSc, a protease-resistant and insoluble form of PrPC, is the causative agent of prion diseases, fatal and transmissible neurogenerative diseases of mammals. Prion infection is initiated via either ingestion or inoculation of PrPSc or when host PrPC stochastically refolds into PrPSc. In either instance, the early events that occur during prion infection remain poorly understood. We have used transgenic mice expressing mouse PrPC tagged with a unique antibody epitope to monitor the response of host PrPC to prion inoculation. Following intracranial inoculation of either prion-infected or uninfected brain homogenate, we show that host PrPC can accumulate both intra-axonally and within the myelin membrane of axons suggesting that it may play a role in axonal loss following brain injury. Moreover, in response to the inoculation host PrPC exhibits an increased insolubility and protease resistance similar to that of PrPSc, even in the absence of infectious prions. Thus, our results raise the possibility that damage to the brain may be one trigger by which PrPC stochastically refolds into pathogenic PrPSc leading to productive prion infection.	[Ward, Anne; Hollister, Jason R.; Choi, Young Pyo; Race, Brent; Williams, Katie; Shoup, Daniel W.; Moore, Roger A.; Priola, Suzette A.] NIAID, Lab Persistent Viral Dis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Choi, Young Pyo] Korean Brain Res Inst, Res Div, Lab Anim Ctr, Daegu, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Priola, SA (corresponding author), NIAID, Lab Persistent Viral Dis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	spriola@nih.gov			Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Disease [AI000752-23]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000752] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SAP received funding for this study from the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Disease, https://www.niaid.nih.gov/about/dir (AI000752-23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ano Y, 2010, INT J MOL MED, V26, P845, DOI 10.3892/ijmm_00000533; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Beirowski B, 2010, J NEUROPATH EXP NEUR, V69, P455, DOI 10.1097/NEN.0b013e3181da84db; Bencsik AA, 2008, HISTOCHEM CELL BIOL, V129, P643, DOI 10.1007/s00418-008-0382-2; Bergstrom AL, 2006, J COMP PATHOL, V134, P126, DOI 10.1016/j.jcpa.2005.08.002; BORCHELT DR, 1994, J BIOL CHEM, V269, P14711; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Bribian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033872; BRONSON RT, 1992, J NEUROGENET, V8, P71, DOI 10.3109/01677069209084153; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chesebro B, 2015, MBIO, V6, DOI 10.1128/mBio.01419-15; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Chiesa R, 2005, P NATL ACAD SCI USA, V102, P238, DOI 10.1073/pnas.0406173102; Chiesa R, 2008, J NEUROSCI, V28, P13258, DOI 10.1523/JNEUROSCI.3109-08.2008; Christensen HM, 2010, AM J PATHOL, V176, P2695, DOI 10.2353/ajpath.2010.091007; de Monasterio-Schrader P, 2012, CELL MOL LIFE SCI, V69, P2879, DOI 10.1007/s00018-012-0958-9; Esiri MM, 2000, NEUROPATH APPL NEURO, V26, P273, DOI 10.1046/j.1365-2990.2000.00239.x; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Foster N, 2010, J INFECT DIS, V202, P1916, DOI 10.1086/657415; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Gossner A, 2006, VET IMMUNOL IMMUNOP, V109, P267, DOI 10.1016/j.vetimm.2005.08.021; Hamir AN, 2002, CAN J VET RES, V66, P289; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; Jeffrey M, 2017, NEUROPATH APPL NEURO, V43, P215, DOI 10.1111/nan.12302; Jeffrey M, 2012, J COMP PATHOL, V147, P46, DOI 10.1016/j.jcpa.2011.08.011; Jeffrey M, 2009, AM J PATHOL, V175, P1208, DOI 10.2353/ajpath.2009.090125; JENDROSKA K, 1991, NEUROLOGY, V41, P1482, DOI 10.1212/WNL.41.9.1482; Johnson TE, 2010, J VIS EXP; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Knight R, 2017, PROG MOL BIOL TRANSL, V150, P293, DOI 10.1016/bs.pmbts.2017.06.010; Kono J, 2011, MICROBIOL IMMUNOL, V55, P661, DOI 10.1111/j.1348-0421.2011.00359.x; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; Laine J, 2001, EUR J NEUROSCI, V14, P47, DOI 10.1046/j.0953-816x.2001.01621.x; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Li AM, 2007, J NEUROSCI, V27, P852, DOI 10.1523/JNEUROSCI.4244-06.2007; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Medrano AZ, 2008, NEUROBIOL DIS, V31, P20, DOI 10.1016/j.nbd.2008.03.006; MILLSON GC, 1979, VET MICROBIOL, V4, P89, DOI 10.1016/0378-1135(79)90045-2; Mironov A, 2003, J NEUROSCI, V23, P7183, DOI 10.1523/JNEUROSCI.23-18-07183.2003; Mitsios N, 2007, J NEUROSCI RES, V85, P602, DOI 10.1002/jnr.21142; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Nakaoke R, 2000, CELL MOL NEUROBIOL, V20, P717, DOI 10.1023/A:1007054909662; Nemani SK, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0643-9; PICCARDO P, 1990, NEUROLOGY, V40, P518, DOI 10.1212/WNL.40.3_Part_1.518; Priola SA, 2006, MOL BIOTECHNOL, V33, P71; Priola Suzette A, 2018, Handb Clin Neurol, V153, P45, DOI 10.1016/B978-0-444-63945-5.00003-9; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Siso S, 2009, NEUROPATH APPL NEURO, V35, P247, DOI 10.1111/j.1365-2990.2009.01013.x; Takakura I, 2011, AM J PATHOL, V179, P1301, DOI 10.1016/j.ajpath.2011.05.058; Urayama A, 2011, FASEB J, V25, P2792, DOI 10.1096/fj.11-180729; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vorberg I, 2004, J BIOL CHEM, V279, P29218, DOI 10.1074/jbc.M402576200; Weise J, 2004, NEUROSCI LETT, V372, P146, DOI 10.1016/j.neulet.2004.09.030; Yamasaki T, 2014, VIROLOGY, V450, P324, DOI 10.1016/j.virol.2013.11.007	63	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219457	10.1371/journal.pone.0219457	http://dx.doi.org/10.1371/journal.pone.0219457			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291644	Green Submitted, Green Published, gold			2022-12-26	WOS:000484947800087
J	Young, JK; Touzot, L; Brummer, SP				Young, Julie K.; Touzot, Laura; Brummer, Stacey P.			Persistence and conspecific observations improve problem-solving abilities of coyotes	PLOS ONE			English	Article							CANIS-LATRANS; NEOPHOBIA; WILD; BEHAVIOR; TRANSMISSION; INFORMATION; STRATEGIES; IMITATION; DOMINANCE; RESPONSES	Social learning has important ecological and evolutionary consequences but the role of certain factors, such as social rank, neophobia (i.e., avoidance of novel stimuli), persistence, and task-reward association, remain less understood. We examined the role of these factors in social learning by captive coyotes (Canis latrans) via three studies. Study 1 involved individual animals and eliminated object neophobia by familiarizing the subjects to the testing apparatus prior to testing. Studies 2 and 3 used mated pairs to assess social rank, and included object neophobia, but differed in that study 3 decoupled the food reward from the testing apparatus (i.e., altered task-reward association). For all three studies, we compared performance between coyotes that received a demonstration from a conspecific to control animals with no demonstration prior to testing. Coyotes displayed social learning during study 1; coyotes with a demonstrator were faster and more successful at solving the puzzle box but did not necessarily use the same modality as that observed to be successful. In study 2, there was no difference in success between treatment groups but this is likely because only one coyote within each pair was successful so successful coyote results were masked by their unsuccessful mate. In study 3, there was no difference in success between treatment groups; only two coyotes, both dominant, hand-reared males with demonstrators were able to perform the task. However, coyotes with a demonstrator were less neophobic, measured as latency to approach the object, and more persistent, measured as time spent working on the apparatus. Social rank was the best predictor of neophobia and persistence and was also retained in the best model for time to eat inside the apparatus, a post-trial measurement of object neophobia. These results suggest coyotes are capable of social learning for novel tasks but social rank, neophobia, and persistence influence their social-learning capabilities. This study contributes to understanding the mechanisms underlying how animals gain information about their environment.	[Young, Julie K.; Brummer, Stacey P.] USDA, Natl Wildlife Res Ctr, Predator Res Facil, Millville, UT 84326 USA; [Young, Julie K.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Touzot, Laura] Univ Grenoble Alpes, Dept Biol, Grenoble, France; [Touzot, Laura] Univ Lyon, CNRS, Lab Biometrie & Biol Evolut, Villeurbanne, France	United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); VetAgro Sup	Young, JK (corresponding author), USDA, Natl Wildlife Res Ctr, Predator Res Facil, Millville, UT 84326 USA.; Young, JK (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	julie.k.young@usda.gov	Touzot, Laura/ABH-1879-2020	Touzot, Laura/0000-0003-0445-554X	intramural research program of the U.S. Department of Agriculture, National Wildlife Research Center; intramural research program of the U.S. Department of Agriculture, National Wildlife Research Center (NWRC)	intramural research program of the U.S. Department of Agriculture, National Wildlife Research Center; intramural research program of the U.S. Department of Agriculture, National Wildlife Research Center (NWRC)	The authors received no specific funding for this work. Internal funds from the intramural research program of the U.S. Department of Agriculture, National Wildlife Research Center were used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the intramural research program of the U.S. Department of Agriculture, National Wildlife Research Center (NWRC) and approved by the NWRC's Institutional Animal Care and Use Committee (QA-1724 and QA-2581). The findings and conclusions in this publication have not been formally disseminated by the U.S. Department of Agriculture and should not be construed to represent any Agency determination or policy. The datasets generated during the current study are available as supplementary material (S4S7 Tables). They are also archived and available through the USDA-National Wildlife Research Center's archival desk or from the corresponding author. We thank S. Breck for early discussions on study design and review of the manuscript. D. Jolley, E. Stevenson, J. Shultz, N. Floyd, and M. Davis provided assistance with animal care and research logistics at the NWRC Predator Research Facility, Millville, Utah. We thank three anonymous reviewers and the Associate Editor for excellent feedback on the manuscript.	Amy M, 2012, ANIM COGN, V15, P763, DOI 10.1007/s10071-012-0500-3; Aplin LM, 2013, ECOL LETT, V16, P1365, DOI 10.1111/ele.12181; Aplin LM, 2013, ANIM BEHAV, V85, P1225, DOI 10.1016/j.anbehav.2013.03.009; Atwood TC, 2008, ANIM BEHAV, V75, P753, DOI 10.1016/j.anbehav.2007.08.024; Beckers T, 2016, J COMP PSYCHOL, V130, P187, DOI 10.1037/com0000024; Benson-Amram S, 2014, BEHAV PROCESS, V109, P111, DOI 10.1016/j.beproc.2014.09.019; Benson-Amram S, 2013, ANIM BEHAV, V85, P349, DOI 10.1016/j.anbehav.2012.11.003; Benson-Amram S, 2012, P ROY SOC B-BIOL SCI, V279, P4087, DOI 10.1098/rspb.2012.1450; Boyd R., 1985, CULTURE EVOLUTIONARY; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Byrne R.W., 1994, P223; Caldwell CA, 2004, ANIM COGN, V7, P77, DOI 10.1007/s10071-003-0192-9; Chow PKY, 2016, ANIM BEHAV, V112, P273, DOI 10.1016/j.anbehav.2015.11.014; Coelho CG, 2015, ANIM COGN, V18, P911, DOI 10.1007/s10071-015-0861-5; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; D'Aniello B, 2016, ANIM COGN, V19, P565, DOI 10.1007/s10071-016-0958-5; Darrow PA, 2009, APPL ANIM BEHAV SCI, V116, P82, DOI 10.1016/j.applanim.2008.06.013; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; Fawcett TW, 2002, ANIM BEHAV, V64, P547, DOI 10.1006/anbe.2002.3092; Feng LC, 2016, APPL ANIM BEHAV SCI, V181, P34, DOI 10.1016/j.applanim.2016.05.012; Figueroa J, 2013, APPL ANIM BEHAV SCI, V148, P120, DOI 10.1016/j.applanim.2013.06.002; FOX MW, 1972, BEHAVIOUR, V41, P298, DOI 10.1163/156853972X00077; Fredman T, 2008, ANIM COGN, V11, P295, DOI 10.1007/s10071-007-0117-0; Fugazza C, 2016, ANIM COGN, V19, P263, DOI 10.1007/s10071-015-0931-8; Fugazza C, 2014, ANIM COGN, V17, P237, DOI 10.1007/s10071-013-0656-5; Galef BG, 2009, ADV STUD BEHAV, V39, P117, DOI 10.1016/S0065-3454(09)39004-X; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Gese EM, 1996, CAN J ZOOL, V74, P769, DOI 10.1139/z96-089; Greenberg R, 2001, CURR ORNITHOL, V16, P119; Greenberg Russell, 2003, P175; Greggor AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep27764; Griffin AS, 2014, BEHAV PROCESS, V109, P121, DOI 10.1016/j.beproc.2014.08.027; Harris CE, 2001, CAN J ZOOL, V79, P2005, DOI 10.1139/cjz-79-11-2005; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hoppitt W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042044; Horner V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010625; Huber L, 2001, ANIM BEHAV, V62, P945, DOI 10.1006/anbe.2001.1822; JOHNSON WE, 1990, J WILDLIFE MANAGE, V54, P582, DOI 10.2307/3809352; Johnston AM, 2017, DEVELOPMENTAL SCI, V20, DOI 10.1111/desc.12460; Jones TB, 2017, ANIM BEHAV, V129, P93, DOI 10.1016/j.anbehav.2017.05.011; Kendal RL, 2010, LEARN BEHAV, V38, P220, DOI 10.3758/LB.38.3.220; Kendal RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006541; Krueger K, 2014, ANIM COGN, V17, P645, DOI 10.1007/s10071-013-0696-x; Kubinyi E, 2007, COMP COGN BEHAV REV, V2, P26; Kurvers RHJM, 2010, ECOL LETT, V13, P829, DOI 10.1111/j.1461-0248.2010.01473.x; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; Marshall-Pescini S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46636; Mesoudi A, 2016, TRENDS ECOL EVOL, V31, P215, DOI 10.1016/j.tree.2015.12.012; Mettler AE, 2007, APPL ANIM BEHAV SCI, V102, P85, DOI 10.1016/j.applanim.2006.03.012; Mikll J A, TANIM BEHAV EHAV, V70, P1367; Miklosi A, CURR BIOL IOLL, V13, P763; NEL JAJ, 1999, MAMMALIAN SOCIAL LEA, P259; NICOL CJ, 1995, APPL ANIM BEHAV SCI, V44, P79, DOI 10.1016/0168-1591(95)00607-T; Nicol CJ, 1999, ANIM BEHAV, V57, P163, DOI 10.1006/anbe.1998.0920; O'Hara M., 2017, SCI REP, V7, P1, DOI DOI 10.1038/; Reader S.M., 2003, ANIMAL INNOVATION; Reader SM, 2000, ANIM BEHAV, V60, P175, DOI 10.1006/anbe.2000.1450; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Scott JP., 1965, GENETICS SOCIAL BEHA; Seferta A, 2001, ETHOLOGY, V107, P281, DOI 10.1046/j.1439-0310.2001.00658.x; Shivik JA, 2009, J APPL ANIM WELF SCI, V12, P223, DOI 10.1080/10888700902955989; Thornton A, 2012, ANIM BEHAV, V83, P1459, DOI 10.1016/j.anbehav.2012.03.018; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Timm Robert M., 2004, Proceedings of the Vertebrate Pest Conference, V21, P47; Titulaer M, 2012, ANIM BEHAV, V83, P723, DOI 10.1016/j.anbehav.2011.12.020; Turcsan B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195448; Webster SJ, 2001, ANIM BEHAV, V62, P23, DOI 10.1006/anbe.2000.1725; Young JK, 2015, J ETHOL, V33, P137, DOI 10.1007/s10164-015-0422-z; Zentall TR, 2006, ANIM COGN, V9, P335, DOI 10.1007/s10071-006-0039-2	69	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218778	10.1371/journal.pone.0218778	http://dx.doi.org/10.1371/journal.pone.0218778			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4JZ	31291268	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800035
J	Cozzolino, F; Montedori, A; Abraha, I; Eusebi, P; Grisci, C; Heymann, AJ; Lombardo, G; Mengoni, A; Orso, M; Ambrosio, G				Cozzolino, Francesco; Montedori, Alessandro; Abraha, Iosief; Eusebi, Paolo; Grisci, Chiara; Heymann, Anna Julia; Lombardo, Guido; Mengoni, Anna; Orso, Massimiliano; Ambrosio, Giuseppe			A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data Value Project	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; IMPACT; DRUGS	Background Administrative healthcare databases are useful and inexpensive tools that can provide a comprehensive assessment of the burden of diseases in terms of major outcomes, such as mortality, hospital readmissions, and use of healthcare resources. However, a crucial issue is the reliability of information gathered. The aim of this study was to validate ICD-9 codes for several major cardiovascular conditions, i.e., acute myocardial infarction (AMI), atrial fibrillation/flutter (AF), and heart failure (HF), in order to use them for epidemiological, outcome, and health services research. Methods Data from the centralised administrative database of the Umbria Region (890,000 residents, located in Central Italy) were considered. Patients with a first hospital discharge for AMI, AF/flutter, and HF, between 2012 and 2014, were identified using ICD-9-CM codes in primary position. A sample of cases and non-cases was randomly selected, and the corresponding medical charts reviewed by specifically trained investigators. For each disease, case ascertainment was based on all clinical, laboratory, and instrumental examinations available in medical charts. Sensitivity, specificity, and predictive values with 95% confidence intervals (Cis), were calculated. Results We reviewed 458 medical charts, 128 for AMI, 127 for AF/flutter, 127 for HF, and 76 of non cases for each condition. Diagnostic accuracy measures of the original discharge diagnosis were as follows. AMI: sensitivity 98% (95% CI, 94-100%), specificity 91% (95% CI, 8397%), positive predictive value (PPV) 95% (95% CI, 89-98%), negative predictive value (NPV) 97% (95% CI, 91-100%). AF/flutter: sensitivity 95% (95% CI, 90-98%), specificity 95% (95% CI, 87-99%), PPV 97% (95% CI, 92-99%), NPV 92% (95% CI, 84-97%). HF: sensitivity 96% (95% CI, 91-99%), specificity 90% (95% CI, 81-96%), PPV 94% (95% CI, 88-97%), NPV 93% (95% CI, 85-98%). Conclusion The case ascertainment for AMI, AF and flutter, and HF, showed a high level of accuracy (>= 90%). The healthcare administrative database of the Umbria Region can be confidently used for epidemiological, outcome, and health services research.	[Cozzolino, Francesco; Montedori, Alessandro; Abraha, Iosief; Eusebi, Paolo; Orso, Massimiliano] Reg Hlth Author Umbria, Hlth Planning Serv, Perugia, Italy; [Cozzolino, Francesco; Mengoni, Anna; Orso, Massimiliano; Ambrosio, Giuseppe] Univ Perugia, Sch Med, Maria Misericordia Hosp, Div Cardiol, Perugia, Italy; [Abraha, Iosief] Azienda Osped Perugia, Ctr Reg Sangue, Serv Immunotrasfus, Perugia, Italy; [Grisci, Chiara] Univ Perugia, Sect Publ Hlth, Dept Expt Med, Perugia, Italy; [Heymann, Anna Julia] Ist Zooprofilatt Sperimentale Umbria & Marche Tog, Perugia, Italy; [Lombardo, Guido] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy	University of Perugia; University of Perugia; Azienda Ospedaliera di Perugia; University of Perugia; University of Perugia	Abraha, I (corresponding author), Reg Hlth Author Umbria, Hlth Planning Serv, Perugia, Italy.; Abraha, I (corresponding author), Azienda Osped Perugia, Ctr Reg Sangue, Serv Immunotrasfus, Perugia, Italy.	iosief_a@yahoo.it	Orso, Massimiliano/L-1040-2018; Eusebi, Paolo/O-2721-2013; Heymann, Anna Julia/M-1326-2015; Ambrosio, Giuseppe/C-6596-2013; Abraha, Iosief/K-4327-2018	Orso, Massimiliano/0000-0003-0200-1202; Eusebi, Paolo/0000-0002-0715-6396; Heymann, Anna Julia/0000-0002-7317-105X; Ambrosio, Giuseppe/0000-0002-9677-980X; LOMBARDO, Guido/0000-0002-4502-6103; Abraha, Iosief/0000-0002-5440-775X	Regional Health Authority of Umbria [1798]	Regional Health Authority of Umbria	This study was developed within the Data-Value Project ("Progetto Data-Value: valorizzazione del dato sanitario regionale per la Ricerca dei Servizi Sanitari (Health Services Research)" - D.G.R. No 1798 of 29/12/2014) supported by funding from the Regional Health Authority of Umbria. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha I, 2003, EUR J CLIN PHARMACOL, V59, P659, DOI 10.1007/s00228-003-0675-2; ABRAHA I, 2014, J STAT MED RES, V3, P309, DOI DOI 10.6000/1929-6029.2014.03.03.10; Abraha I, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020627; Abraha I, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010547; Abraha I, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010409; Alqaisi F, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-237; Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Camm AJ, 2012, EUR HEART J, V33; Cozzolino F, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020630; Cozzolino F, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013785; Farre N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172745; Gavrielov-Yusim N, 2014, J EPIDEMIOL COMMUN H, V68, P283, DOI 10.1136/jech-2013-202744; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Kavsak PA, 2006, AM HEART J, V152, P118, DOI 10.1016/j.ahj.2005.09.022; Kontos MC, 2003, AM HEART J, V146, P446, DOI 10.1016/S0002-8703(03)00245-X; Lip GYH, 2012, CHEST, V142, P1489, DOI 10.1378/chest.11-2888; McCormick N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135834; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104519; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092286; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Menniti-Ippolito F, 1998, EUR J CLIN PHARMACOL, V54, P393, DOI 10.1007/s002280050481; Metcalfe A, 2013, HEALTH SERV RES, V48, P290, DOI 10.1111/j.1475-6773.2012.01440.x; Montedori A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020628; Montedori A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011776; Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299; Orso M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020631; Quach S, 2010, CAN J CARDIOL, V26, pE306, DOI 10.1016/S0828-282X(10)70438-4; Raschetti R, 2001, JAMA-J AM MED ASSOC, V285, P1840, DOI 10.1001/jama.285.14.1840; Rimland JM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011777; Saczynski JS, 2012, PHARMACOEPIDEM DR S, V21, P129, DOI 10.1002/pds.2313; Salomaa V, 2005, EUR HEART J, V26, P1719, DOI 10.1093/eurheartj/ehi185; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Traversa G, 2003, BMJ-BRIT MED J, V327, P18, DOI 10.1136/bmj.327.7405.18; Varas-Lorenzo C, 2008, PHARMACOEPIDEM DR S, V17, P842, DOI 10.1002/pds.1619; West SL, 2012, PHARMACOEPIDEM DR S, P757; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	38	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0218919	10.1371/journal.pone.0218919	http://dx.doi.org/10.1371/journal.pone.0218919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283787	gold, Green Published			2022-12-26	WOS:000484939800011
J	Beauchamp, MC; Djedid, A; Daupin, K; Clokie, K; Kumar, S; Majewski, J; Jerome-Majewska, LA				Beauchamp, Marie-Claude; Djedid, Anissa; Daupin, Kevin; Clokie, Kayla; Kumar, Shruti; Majewski, Jacek; Jerome-Majewska, Loydie Anne			Loss of function mutation of Eftud2, the gene responsible for mandibulofacial dysostosis with microcephaly (MFDM), leads to pre-implantation arrest in mouse	PLOS ONE			English	Article							HAPLOINSUFFICIENCY; REVEALS; SNU114P; RNA; EXPRESSION; NUMBER; CELLS	Mutations in EFTUD2 are responsible for the autosomal dominant syndrome named MFDM (mandibulofacial dysostosis with microcephaly). However, it is not clear how reduced levels of EFTUD2 cause abnormalities associated with this syndrome. To determine if the mouse can serve as a model for uncovering the etiology of abnormalities found in MFDM patients, we used in situ hybridization to characterize expression of Eftud2 during mouse development, and used CRISPR/ Cas9 to generate a mutant mouse line with deletion of exon 2 of the mouse gene. We found that Eftud2 was expressed throughout embryonic development, though its expression was enriched in the developing head and craniofacial regions. Additionally, Eftud2 heterozygous mutant embryos had reduced EFTUD2 mRNA and protein levels. Moreover, Eftud2 heterozygous embryos were born at the expected Mendelian frequency, and were viable and fertile despite being developmentally delayed. In contrast, Eftud2 homozygous mutant embryos were not found post-implantation but were present at the expected Mendelian frequency at embryonic day (E) 3.5. Furthermore, only wild-type and heterozygous E3.5 embryos survived ex vivo culture. Our data indicate that Eftud2 expression is enriched in the precusor of structures affected in MFDM patients and show that heterozygous mice carrying deletion of exon 2 do not model MFDM. In addition, we uncovered a requirement for normal levels of Eftud2 for survival of pre-implantation zygotes.	[Beauchamp, Marie-Claude; Daupin, Kevin; Clokie, Kayla; Jerome-Majewska, Loydie Anne] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Beauchamp, Marie-Claude; Kumar, Shruti; Majewski, Jacek; Jerome-Majewska, Loydie Anne] McGill Univ Hlth Ctr Glen Site, Montreal, PQ, Canada; [Djedid, Anissa; Kumar, Shruti; Majewski, Jacek; Jerome-Majewska, Loydie Anne] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Jerome-Majewska, Loydie Anne] McGill Univ, Dept Anat & Cell Biol, Strathcona Anat & Dent Bldg, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Jerome-Majewska, LA (corresponding author), McGill Univ, Dept Pediat, Montreal, PQ, Canada.; Jerome-Majewska, LA (corresponding author), McGill Univ Hlth Ctr Glen Site, Montreal, PQ, Canada.; Jerome-Majewska, LA (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; Jerome-Majewska, LA (corresponding author), McGill Univ, Dept Anat & Cell Biol, Strathcona Anat & Dent Bldg, Montreal, PQ, Canada.	loydie.majewska@mcgill.ca		Jerome-Majewska, Loydie/0000-0002-5047-4058	Canadian Institutes of Health Research (MOP) [142452]; FQRS	Canadian Institutes of Health Research (MOP)(Canadian Institutes of Health Research (CIHR)); FQRS	This work was supported by a grant from the Canadian Institutes of Health Research (MOP#142452) given to LJM and JM. LJM and JM are members of the Research Centre of the McGill University Health Centre which is supported in part by FQRS. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We would like to thank Dr Mitra Cowan, Associate Director of the transgenic core facility at McGill University, Goodman Cancer Center, for the micro-injections experiments. This work was supported by a grant from the Canadian Institutes of Health Research (MOP#142452) given to LAM and JM. LJM and JM are members of the Research Centre of the McGill University Health Centre which is supported in part by FQRS. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bartels C, 2002, EMBO REP, V3, P875, DOI 10.1093/embo-reports/kvf172; Brenner TJ, 2005, GENETICS, V170, P1063, DOI 10.1534/genetics.105.042044; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Deml B, 2015, BIRTH DEFECTS RES A, V103, P630, DOI 10.1002/bdra.23397; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Frazer LN, 2008, BIOCHEM SOC T, V36, P551, DOI 10.1042/BST0360551; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; Gordon CT, 2012, J MED GENET, V49, P737, DOI 10.1136/jmedgenet-2012-101173; Hou WY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182995; Huang LJ, 2016, HUM MUTAT, V37, P148, DOI 10.1002/humu.22924; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Lehalle D, 2014, HUM MUTAT, V35, P478, DOI 10.1002/humu.22517; Lei L, 2017, NUCLEIC ACIDS RES, V45, P3422, DOI 10.1093/nar/gkw1043; Lines MA, 2012, AM J HUM GENET, V90, P369, DOI 10.1016/j.ajhg.2011.12.023; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maserati M, 2014, ZYGOTE, V22, P331, DOI 10.1017/S0967199412000561; Matsuo M, 2017, BRAIN DEV-JPN, V39, P177, DOI 10.1016/j.braindev.2016.08.008; Montag M, 2000, BIOL REPROD, V62, P1738, DOI 10.1095/biolreprod62.6.1738; Mudge JM, 2015, MAMM GENOME, V26, P366, DOI 10.1007/s00335-015-9583-x; Niakan KK, 2013, DEV BIOL, V375, P54, DOI 10.1016/j.ydbio.2012.12.008; Revil T, 2013, DEV DYNAM, V242, P281, DOI 10.1002/dvdy.23918; Sarkar A, 2015, AM J MED GENET A, V167, P914, DOI 10.1002/ajmg.a.36948; Shi ZD, 2017, CELL STEM CELL, V20, P675, DOI 10.1016/j.stem.2017.01.001; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venugopalan SR, 2017, ORTHOD CRANIOFAC RES, V20, P50, DOI 10.1111/ocr.12150; Williams LA, 2017, J GENET COUNS, V26, P894, DOI 10.1007/s10897-017-0119-2; Yu KPT, 2018, CLIN DYSMORPHOL, V27, P31, DOI 10.1097/MCD.0000000000000214	33	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219280	10.1371/journal.pone.0219280	http://dx.doi.org/10.1371/journal.pone.0219280			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276534	Green Submitted, Green Published, gold			2022-12-26	WOS:000484936300057
J	Boonprasert, K; Punyapornwithaya, V; Tankaew, P; Angkawanish, T; Sriphiboon, S; Titharam, C; Brown, JL; Somgird, C				Boonprasert, Khajohnpat; Punyapornwithaya, Veerasak; Tankaew, Pallop; Angkawanish, Taweepoke; Sriphiboon, Supaphen; Titharam, Chatchote; Brown, Janine L.; Somgird, Chaleamchat			Survival analysis of confirmed elephant endotheliotropic herpes virus cases in Thailand from 2006-2018	PLOS ONE			English	Article							CAPTIVE ASIAN ELEPHANT; HEMORRHAGIC-DISEASE; VIRAL LOAD; INFECTION; HERPESVIRUSES; MAXIMUS; TIME; EEHV4	The elephant endotheliotropic herpesvirus (EEHV) has been a known cause of death of young elephants in Thailand for over a decade. In this study, we report on the demography, disease characteristics and mortality of 58 elephants with confirmed EEHV hemorrhagic disease between January 2006 and August 2018 using retrospective data subjected to survival analysis. Median age of EEHV presentation was 29 months, and the mortality rate was 68.97% with a median survival time of 36 h. Most EEHV cases occurred in the north of Thailand, the region where most of the country's captive elephants reside. The hazard ratio analysis identified application of medical procedures and antiviral medications as being significant factors correlated to the risk of death. Our results indicate a need to focus EEHV monitoring efforts on young elephants and to follow current protocols that advise starting treatments before clinical signs appear.	[Boonprasert, Khajohnpat; Punyapornwithaya, Veerasak; Tankaew, Pallop; Titharam, Chatchote; Somgird, Chaleamchat] Chiang Mai Univ, Ctr Elephant & Wildlife Res, Chiang Mai, Thailand; [Punyapornwithaya, Veerasak] Chiang Mai Univ, Fac Vet Med, Dept Food Anim Clin, Chiang Mai, Thailand; [Angkawanish, Taweepoke] Forest Ind Org, Natl Elephant Inst, Elephant Hosp, Lampang, Thailand; [Sriphiboon, Supaphen] Kasetsart Univ, Fac Vet Med, Dept Large Anim & Wildlife Clin Sci, Kamphaeng Saen Campus, Nakhon Pathom, Thailand; [Titharam, Chatchote; Somgird, Chaleamchat] Chiang Mai Univ, Fac Vet Med, Dept Compan Anim & Wildlife Clin, Chiang Mai, Thailand; [Brown, Janine L.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA	Chiang Mai University; Chiang Mai University; Kasetsart University; Chiang Mai University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Somgird, C (corresponding author), Chiang Mai Univ, Ctr Elephant & Wildlife Res, Chiang Mai, Thailand.; Somgird, C (corresponding author), Chiang Mai Univ, Fac Vet Med, Dept Compan Anim & Wildlife Clin, Chiang Mai, Thailand.	chaleamchat.s@cmu.ac.th	Punyapornwithaya, Verasak/V-9323-2019; Punyapornwithaya, Veerasak/ABE-5119-2020	Punyapornwithaya, Verasak/0000-0001-9870-7773; 	Chiang Mai University [1/2561]	Chiang Mai University	Financial support was received from Chiang Mai University (1/2561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Chiang Mai University for financial support. We also thank organizations that provided valuable information for this study, including the National Elephant Institute (Thai Elephant Conservation Center and Southern Elephant Hospital, Thailand), the Zoological Park Organization of Thailand, Kasetsart University (Thailand), Chiang Mai University (Thailand), Dr. Thittaya Janyamathakul D. V. M, Pattara Elephant Farm (Thailand), Dr. Channarong Saisaard D. V. M, Elephant Nature Park (Chiang Mai, Thailand), Dr. Pratthana Inthawong D.V.M, Elephant Kingdom, (Surin, Thailand), Dr. Crueahtong Kayan D.V.M, Dr. Panida Muanghong D.V.M, Maetaeng Elephant Park & Clinic (Chiang Mai, Thailand), and veterinarians at the Friends of Asian Elephant Foundation Elephant Hospital (Lampang, Thailand). We are extremely grateful to Dr. Andrew Higgins BVetMed MSc Ph.D. FRSB MRCVS, scientific advisor to Phang Nga Elephant Park (Thailand) for assistance in editing this paper.	Azab W, 2018, ARCH VIROL, V163, P495, DOI 10.1007/s00705-017-3628-2; Barman NN, 2017, VET MICROBIOL, V208, P159, DOI 10.1016/j.vetmic.2017.08.001; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; Boonsri K, 2018, J ZOO WILDLIFE MED, V49, P178, DOI 10.1638/2017-0001R1.1; Bouchard B, 2014, J ZOO WILDLIFE MED, V45, P704, DOI 10.1638/2013-0264R1.1; Bronson E, 2017, J ZOO WILDLIFE MED, V48, P335, DOI [10.1638/2016-0063R.1, 10.1638/2016-0063r.1]; Clark TG, 2003, BRIT J CANCER, V89, P232, DOI 10.1038/sj.bjc.6601118; Cracknell J., 2008, UK ELEPHANT ENDOTHEL, P1; Dastjerdi A, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0806-5; Dudley William N, 2016, J Adv Pract Oncol, V7, P91; Ehlers B, 2001, J GEN VIROL, V82, P475, DOI 10.1099/0022-1317-82-3-475; Ehlers B, 2006, J GEN VIROL, V87, P2781, DOI 10.1099/vir.0.81977-0; Etikan I., 2017, BIOM BIOSTATISTICS I, V5, P55, DOI 10.15406/bbij.2017.05.00128; Fickel J, 2001, VET MICROBIOL, V82, P103, DOI 10.1016/S0378-1135(01)00363-7; Garner MM, 2009, VET PATHOL, V46, P97, DOI 10.1354/vp.46-1-97; Godfrey A., 2009, GAJAH, V30, P13; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Hardman K, 2012, VET REC, V170, P205, DOI 10.1136/vr.100270; Hayward GS, 2012, VET REC, V170, P202, DOI 10.1136/vr.e1212; Howard Lauren Lynn, 2019, P672; Kendall R, 2016, J ZOO WILDLIFE MED, V47, P405, DOI 10.1638/2015-0217.1; Kochagul V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22968-5; Kochakul V, 2018, J VET DIAGN INVEST, V30, P628, DOI 10.1177/1040638718773810; Kotila-Row A., 2015, DETECTION ELEPHANT E; Latimer E, 2011, VET MICROBIOL, V147, P28, DOI 10.1016/j.vetmic.2010.05.042; Li J, 2016, INT J INFECT DIS, V42, P34, DOI 10.1016/j.ijid.2015.10.021; Ling PD, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00091-16; Ling PD, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00081-15; Long SY, 2015, ILAR J, V56, P283, DOI 10.1093/ilar/ilv041; Luz S., 2016, 1 AS EEHV STRAT M WI; McCully RM, 1971, ONDERSTEPOORT J VET, V38; OSSENT P, 1990, VET PATHOL, V27, P131, DOI 10.1177/030098589002700212; Puyati B, 2015, CHIANG MAI VET J, V13, P153, DOI [10.14456/cmvj.2015.2, DOI 10.14456/CMVJ.2015.2]; R Development Core Team, 2017, R LANG ENV STAT COMP; Reid CE, 2006, VET QUART, V28, P61, DOI 10.1080/01652176.2006.9695209; Richman LK, 2014, J VIROL, V88, P13523, DOI 10.1128/JVI.01673-14; Richman LK, 1999, SCIENCE, V283, P1171, DOI 10.1126/science.283.5405.1171; Richman LK, 2000, J WILDLIFE DIS, V36, P1, DOI 10.7589/0090-3558-36.1.1; Richman LK., 2003, THESIS; Schaftenaar W, 2010, J ZOO WILDLIFE MED, V41, P626, DOI 10.1638/2009-0217.1; Schmitt DL, 2000, J ZOO WILDLIFE MED, V31, P518, DOI 10.1638/1042-7260(2000)031[0518:UOFFTT]2.0.CO;2; Seilern-Moy K., 2016, JMM CASE REP, V3, P005005, DOI [10.1099/jmmcr.0.005005, DOI 10.1099/JMMCR.0.005005]; Singh Ritesh, 2011, Perspect Clin Res, V2, P145, DOI 10.4103/2229-3485.86872; Spruance SL, 2004, ANTIMICROB AGENTS CH, V48, P2787, DOI 10.1128/AAC.48.8.2787-2792.2004; Sripiboon S, 2017, J ZOO WILDLIFE MED, V48, P1254, DOI 10.1638/2016-0141r1.1; Sripiboon S, 2016, INFECT GENET EVOL, V44, P487, DOI 10.1016/j.meegid.2016.08.004; Sripiboon S, 2013, J ZOO WILDLIFE MED, V44, P100, DOI 10.1638/1042-7260-44.1.100; Stanton JJ, 2014, J WILDLIFE DIS, V50, P279, DOI 10.7589/2012-09-236; Stanton JJ, 2013, J ZOO WILDLIFE MED, V44, P42, DOI 10.1638/1042-7260-44.1.42; Stanton JJ, 2012, J VIROL METHODS, V186, P73, DOI 10.1016/j.jviromet.2012.07.024; Stanton JJ, 2010, AM J VET RES, V71, P925, DOI 10.2460/ajvr.71.8.925; Waxman M, 2017, LANCET INFECT DIS, V17, P654, DOI 10.1016/S1473-3099(17)30112-3; Weppelmann Thomas A, 2016, Glob Health Res Policy, V1, P5, DOI 10.1186/s41256-016-0005-8; Wiazzane N, 2013, CLIN RES HEPATOL GAS, V37, P614, DOI 10.1016/j.clinre.2013.03.003; Wiedner E, 2012, ZOO WILD ANIMAL MED, V7, P537, DOI [10.1016/C2009-0-63976-3, DOI 10.1016/C2009-0-63976-3]; Wilkie GS, 2014, SCI REP-UK, V4, DOI 10.1038/srep06299; Wilkie GS, 2013, J VIROL, V87, P6700, DOI 10.1128/JVI.00655-13; Zaman Q, 2011, SURVIVAL ANALYSIS IN; Zechariah A, 2013, J WILDLIFE DIS, V49, P381, DOI 10.7589/2012-07-193; Zong J.-C., 2009, P INT EL CONS RES S; Zong JC, 2008, P INT EL CONS RES S; Zong JC, 2016, J VIROL, V90, P3028, DOI 10.1128/JVI.02936-15; Zong JC, 2014, J VIROL, V88, P13547, DOI 10.1128/JVI.01675-14	63	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219288	10.1371/journal.pone.0219288	http://dx.doi.org/10.1371/journal.pone.0219288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276571	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300059
J	Coertse, J; Weyer, J; Nel, LH; Markotter, W				Coertse, Jessica; Weyer, Jacqueline; Nel, Louis H.; Markotter, Wanda			Reverse transcription recombinase polymerase amplification assay for rapid detection of canine associated rabies virus in Africa	PLOS ONE			English	Article							IMMUNOHISTOCHEMICAL TEST; DIAGNOSIS; PCR; EPIDEMIOLOGY; INFECTION	Rabies is a neglected disease mostly affecting the developing world. Accurate and reliable diagnostic and surveillance data forms the foundation for the formulation and monitoring of control strategies. Although various sensitive and specific tests are available for detection of rabies virus, implementation of these tests in low-resource settings are challenging and remains limited. In this study, we describe the developed of a reverse transcription recombinase polymerase amplification assay for the detection of rabies virus. The analytical sensitivity of this assay was determined to be 562 RNA copies and was performed in 20 minutes. The diagnostic sensitivity of the RT-RPA was 100% for detection of rabies virus in field samples. In conclusion, the RT-RPA assay allowed for very quick and sensitive detection of rabies virus and could be adapted for use in low-source settings.	[Coertse, Jessica; Weyer, Jacqueline; Markotter, Wanda] Univ Pretoria, Dept Med Virol, Ctr Viral Zoonoses, Fac Hlth Sci, Pretoria, South Africa; [Weyer, Jacqueline] Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa; [Nel, Louis H.] Univ Pretoria, Fac Nat & Agr Sci, Dept Biochem Genet & Microbiol, Ctr Viral Zoonoses, Pretoria, South Africa	University of Pretoria; National Institute for Communicable Diseases (NICD); University of Pretoria	Coertse, J (corresponding author), Univ Pretoria, Dept Med Virol, Ctr Viral Zoonoses, Fac Hlth Sci, Pretoria, South Africa.	jessica.coertse@up.ac.za	Coertse, Jessica/AAJ-6891-2020; Nel, Louis/F-1001-2012	Coertse, Jessica/0000-0002-8376-6508; Nel, Louis/0000-0001-8963-0153; Markotter, Wanda/0000-0002-7550-0080	South African Research Chair initiative of the Department of Science and Technology; National Research Foundation of South Africa [98339]; Poliomyelitis Research Foundation [16/27]; Centres for Disease Control and Prevention, USA	South African Research Chair initiative of the Department of Science and Technology; National Research Foundation of South Africa(National Research Foundation - South Africa); Poliomyelitis Research Foundation; Centres for Disease Control and Prevention, USA	This work is based on research supported by the South African Research Chair initiative of the Department of Science and Technology and National Research Foundation of South Africa (Grant No 98339, WM) and the Poliomyelitis Research Foundation (Grant No 16/27, JW).; We wish to thank Dr. C. T. Sabeta (Agricultural Research Council-Onderstepoort Veterinary Research) and Dr. U. Eze (University of Nigeria, Nsukka) for the provision of the viral RNA from Nigeria and the Centres for Disease Control and Prevention, USA and the Animal Plant Health Agency, UK for providing lyssavirus isolates. This work is based on research supported by the South African Research Chair initiative of the Department of Science and Technology and National Research Foundation of South Africa (Grant No 98339) and the Poliomyelitis Research Foundation (Grant No 16/27).	Abd El Wahed A, 2015, J CLIN VIROL, V69, P16, DOI 10.1016/j.jcv.2015.05.004; Abd El Wahed A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071642, 10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364]; Amarasinghe GK, 2018, ARCH VIROL, V163, P2283, DOI 10.1007/s00705-018-3814-x; Boldbaatar B, 2009, JPN J INFECT DIS, V62, P187; Boyle DS, 2013, MBIO, V4, DOI 10.1128/mBio.00135-13; Coertse J, 2015, CURRENT LAB TECHNIQU, P63, DOI [10.1016/C2013-0-12670-0, DOI 10.1016/C2013-0-12670-0]; Coertse J, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0948-0; Coertse J, 2010, J CLIN MICROBIOL, V48, P3949, DOI 10.1128/JCM.01256-10; Coetzer A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210018; Coetzer A, 2017, TROP MED INFECT DIS, V2, DOI 10.3390/tropicalmed2030030; Coetzer A, 2017, J S AFR VET ASSOC, V88, DOI 10.4102/jsava.v88i0.1397; Coetzer A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003189; Daher RK, 2016, CLIN CHEM, V62, P947, DOI 10.1373/clinchem.2015.245829; Daher RK, 2015, MOL CELL PROBE, V29, P116, DOI 10.1016/j.mcp.2014.11.005; David D, 2002, VET MICROBIOL, V87, P111, DOI 10.1016/S0378-1135(02)00041-X; Dean D. J., 1996, LAB TECHNIQUES RABIE; Duong V, 2016, INT J INFECT DIS, V46, P107, DOI 10.1016/j.ijid.2016.03.016; Eggerbauer E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004776; Fischer M, 2012, BERL MUNCH TIERARZTL, V125, P264, DOI 10.2376/0005-9366-125-264; Fooks AR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000530; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hayman DTS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001001; Lembo T, 2006, EMERG INFECT DIS, V12, P310; Li J, 2019, ANALYST, V144, P31, DOI 10.1039/c8an01621f; Ma L, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1736-1; Lobato IM, 2018, TRAC-TREND ANAL CHEM, V98, P19, DOI 10.1016/j.trac.2017.10.015; Mallewa M, 2007, EMERG INFECT DIS, V13, P136, DOI 10.3201/eid1301.060810; Markotter W, 2018, REV SCI TECH OIE, V37, P385, DOI 10.20506/rst.37.2.2809; Markotter W, 2006, EMERG INFECT DIS, V12, P1913; Markotter W, 2015, J S AFR VET ASSOC, V86, DOI 10.4102/jsava.v86i1.1220; Muleya W, 2012, VIRUS RES, V163, P160, DOI 10.1016/j.virusres.2011.09.010; Patel P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004953; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Robardet E, 2011, J VIROL METHODS, V177, P15, DOI 10.1016/j.jviromet.2011.06.004; Rupprecht C.E., 2018, LAB TECHNIQUES RABIE; Rupprecht CE, 2018, VET SCI, V5, DOI 10.3390/vetsci5020059; Saitou Y, 2010, J VIROL METHODS, V168, P13, DOI 10.1016/j.jviromet.2010.04.008; Schlottau K, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0853-y; Scott TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058739; Troupin C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006041; Wacharapluesadee S, 2011, J VIROL METHODS, V175, P278, DOI 10.1016/j.jviromet.2011.05.007; WHO, 2013, WHO TECH REP SER, V982, P1; WHO, 2018, ZER 30 GLOB STRAT PL; World Organisation for Animal Health (OIE), 2018, PRINC METH VAL DIAG	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219292	10.1371/journal.pone.0219292	http://dx.doi.org/10.1371/journal.pone.0219292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276479	Green Submitted, Green Published, gold			2022-12-26	WOS:000484936300061
J	Gebreweld, A; Ali, N; Ali, R; Fisha, T				Gebreweld, Angesom; Ali, Neima; Ali, Radiya; Fisha, Temesgen			Prevalence of anemia and its associated factors among children under five years of age attending at Guguftu health center, South Wollo, Northeast Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; IRON-DEFICIENCY; UNDERNUTRITION; INFANTS; OLD	Background Anemia during childhood adversely affects mental, physical and social development of the children. This study is aimed to assess the prevalence of anemia and its associated factors among children less than five years of age in Guguftu, South Wollo, Northeast Ethiopia. Method A cross-sectional health facility based study was conducted among 404 children aged 6 to 59 months. Systematic random sampling technique was used to include the participants. Pretested and structured questionnaires were used to collect socioeconomic and demographic characteristics of the family and child. Data on nutritional status, capillary blood and stool samples were collected from each child. Multivariate logistic regression was used to calculate adjusted odds ratios and the corresponding 95% confidence intervals. Result The overall prevalence of anemia was 41.1% (95% CI; 36.6% - 45.8%). Of the anemic under five children, 112 (67.5%) had mild anemia, 52(31.3%) had moderate anemia, and 2(1.2%) had severe anemia. Children who were in the age group of 6-11(AOR = 4.52; 95% CI: 1.67-12.34) and 12-23 (AOR = 2.79; 95% CI: 1.04-7.51) months, living in an urban (AOR = 1.83; 95% CI: 1.05-3.18), with no formal education mothers (AOR = 7.05; 95% CI: 2.93-17.01) and primary education mothers (AOR = 3.26; 95% CI: 1.29-8.24), with a family monthly income of <750 ETB(AOR = 5.19; 95% CI: 1.24-21.75) and 750-1500 ETB(AOR = 5.89; 95% CI: 1.45-23.98), with early (<6 months) introduction of complementary foods (AOR = 3.53; 95% CI: 1.23-10.18), Underweight (AOR = 2.11; 95% CI: 1.21-3.69) were more likely to become anemic. Conclusion This study has revealed that the prevalence of anemia in children less than five years is high and a severe public health problem in the study area. Therefore, the policymakers should make a strategy that can reduce poverty and increase the awareness of women on breast-feeding, nutrition, and other associated factors to reduce anemia.	[Gebreweld, Angesom; Fisha, Temesgen] Wollo Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Dessie, Ethiopia; [Ali, Neima; Ali, Radiya] Dessie Referral Hosp, Dept Lab, Dessie, Ethiopia	University of Gondar	Gebreweld, A (corresponding author), Wollo Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Dessie, Ethiopia.	afsaha@gmail.com	Gebreweld, Angesom/AAD-5292-2019					Abdi Guled R., 2017, INT J DEV RES, V7, P11189; Adish AA, 1999, PUBLIC HEALTH NUTR, V2, P243, DOI 10.1017/S1368980099000336; Adu-Amankwaah J., 2018, OPEN ACCESS LIB J, V5, P1, DOI DOI 10.4236/OALIB.1104351; Alelign T, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0084-x; Ali D, 2013, J NUTR, V143, P2015, DOI 10.3945/jn.113.175182; Allen L, 2006, GUIDELINES FOOD FORT; [Anonymous], 2008, WORLDWIDE PREVALENCE; Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; Cardoso MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036341; Central Statistical Agency (CSA) Ethiopia ICF, 2017, ETH ICF ETH DEM HLTH; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; Santos Rosemary Ferreira dos, 2011, Rev. Bras. Hematol. Hemoter., V33, P100, DOI 10.5581/1516-8484.20110028; Fosu M. O., 2014, Journal of Biology, Agriculture and Healthcare, V4, P132; Gebreegziabiher G, 2014, ANEMIA, V2014, P1; Getaneh T, 2000, ETHIOPIAN MED J, V38, P77; Grantham-McGregor S., 2010, Annales Nestle, V68, P105, DOI 10.1159/000319670; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Heckman J, 2010, SAMJ S AFR MED J, V100, P445, DOI 10.7196/SAMJ.3579; Janus J, 2010, AM FAM PHYSICIAN, V81, P1462; Joshi S., 2014, MEDICAL J SHREE BIRE, V13, P33; Khan JR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-015-0536-z; Kuziga F, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0782-3; Lanzkowsky P., MANUAL PEDIAT HEMATO, P5; Lopez A, 2016, LANCET, V387, P907, DOI 10.1016/S0140-6736(15)60865-0; Lozoff B, 2007, FOOD NUTR BULL, V28, pS560, DOI 10.1177/15648265070284S409; Malkanthi RLDK, 2010, FOOD NUTR BULL, V31, P475, DOI 10.1177/156482651003100401; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; National Committee for Clinical Laboratory Standards, 2000, HEM VASC ACC CLIN TR, P3; Ngesa O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113756; Novaes Taiane Gonçalves, 2017, Rev. paul. pediatr., V35, P281, DOI 10.1590/1984-0462/;2017;35;3;00008; Oliveira Maria A. A., 2005, J. Pediatr. (Rio J.), V81, P361, DOI [10.2223/JPED.1386, 10.1590/S0021-75572005000600004]; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; Pacifici GM, 2016, INT J PEDIATR-MASSHA, V4, P2256; Parbey P., 2017, J SCI RES REP, V15, P1, DOI [10.9734/JSRR/2017/31465, DOI 10.9734/JSRR/2017/31465]; Shakuntal G, 2016, SCHOLARS J APPL MED, V4, P2020; Simbauranga Rehema H, 2015, BMC Hematol, V15, P13, DOI 10.1186/s12878-015-0033-5; Tolentino K, 2007, AM J TROP MED HYG, V77, P44, DOI 10.4269/ajtmh.2007.77.44; Ughasoro MD, 2015, S AFR J CHILD HEALTH, V9, P14, DOI 10.7196/SAJCH.760; WHO, 2011, WHONMHNHDMNM111; WHO, 2006, WHO CHILD GROWTH STA; Woldie H, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/928632; Xin QQ, 2017, J TROP PEDIATRICS, V63, P36, DOI 10.1093/tropej/fmw049	42	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0218961	10.1371/journal.pone.0218961	http://dx.doi.org/10.1371/journal.pone.0218961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276472	Green Submitted, Green Published, gold			2022-12-26	WOS:000484936300029
J	Shah, N; Bhor, M; Xie, L; Paulose, J; Yuce, H				Shah, Nirmish; Bhor, Menaka; Xie, Lin; Paulose, Jincy; Yuce, Huseyin			Sickle cell disease complications: Prevalence and resource utilization	PLOS ONE			English	Article							CLINICAL COMPLICATIONS; EMERGENCY-DEPARTMENT; PAIN; ADULTS; CARE; LIFE	Objectives This study evaluated the prevalence rate of vaso-occlusive crisis (VOC) episodes, rates of uncomplicated and complicated VOC episodes, and the primary reasons for emergency room (ER) visits and inpatient admissions for sickle cell disease (SCD) patients. Methods The Medicaid Analytic extracts database was used to identify adult SCD patients using claims from 01JUL2009-31DEC2012. The date of the first observed SCD claim was designated as the index date. Patients were required to have continuous medical and pharmacy benefits for >= 6 months baseline and. 12 months follow-up period. Patient demographics, baseline clinical characteristics, the rate of uncomplicated and complicated VOC (VOC with concomitant SCD complications) episodes, and reasons for ER visits and inpatient stays were analyzed descriptively. Results A total of 8,521 patients were included in the analysis, with a median age of 30 years. The average follow-up period was 2.7 years. The rate of VOC episodes anytime in the follow-up was 3.31 in person-years. During the first-year follow-up period, an average of 2.79 VOC episodes were identified per SCD patients, with 1.06 VOC episodes treated in inpatient setting and 0.90 VOC episodes in ER without admission. A total of 76,154 VOC episodes were identified during the entire follow-up period for the overall SCD patients. Most of the VOC episodes (70.3% [n = 53,523]) were uncomplicated episodes, and 29.7% were complicated episodes. Using primary diagnosis claims only, the most frequent complications during the VOC episode were infectious diseases (25.9%), fever (21.8%), and pulmonary disorders (16.2%). Among ER and hospitalizations related to VOC or SCD complication, similar to 85.0% had VOCs as the primary reason for admission; 15.0% had SCD complications as the primary reason. Conclusion In summary, SCD and its related comorbidities and complications result in high acute health care utilization. In addition, VOC remains the primary reason for SCD patients' ER visits and inpatient admissions.	[Shah, Nirmish] Duke Univ, Dept Med, Durham, NC USA; [Bhor, Menaka] Novartis Pharmaceut, US Oncol HEOR, E Hanover, NJ USA; [Xie, Lin] STATinMED Res, Hlth Econ & Outcomes Res, Ann Arbor, MI 48108 USA; [Paulose, Jincy] Novartis Pharmaceut, US Oncol Med, E Hanover, NJ USA; [Yuce, Huseyin] CUNY, New York City Coll Technol, Dept Math, New York, NY 10021 USA	Duke University; Novartis; Optum; Novartis; City University of New York (CUNY) System	Xie, L (corresponding author), STATinMED Res, Hlth Econ & Outcomes Res, Ann Arbor, MI 48108 USA.	lxie@statinmed.com	Xie, Lin/AAX-2889-2020	Yuce, Huseyin/0000-0003-2946-6595	Novartis Pharmaceuticals Corporation	Novartis Pharmaceuticals Corporation(Novartis)	I have read the journal's policy and the authors of this manuscript have the following competing interests: This study was funded by Novartis Pharmaceuticals Corporation which is a commercial company. The funder provided support in the form of salaries for authors JP and MB. The funders also provided consultation fees to STATinMED Research, employer of LX, which is a paid consultant in connection with this study and the development of this manuscript. The funder provided support to NS in the form of research funding, consultant fees, and speaker's fees. HY has nothing to disclose. However, the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no patents, products in development, or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Ballas SK, 2018, CLIN HEMORHEOL MICRO, V68, P105, DOI 10.3233/CH-189002; Ballas SK, 2012, BLOOD, V120, P3647, DOI 10.1182/blood-2012-04-383430; Ballas SK., 1998, SICKLE CELL PAIN PRO, VII; Barriteau CM, 2018, CLIN PEDIATR EMERG M, V19, P103, DOI 10.1016/j.cpem.2018.05.005; Benjamin LJ, 2000, BLOOD, V95, P1130, DOI 10.1182/blood.V95.4.1130.003k03a_1130_1136; Brousseau DC, 2010, JAMA-J AM MED ASSOC, V303, P1288, DOI 10.1001/jama.2010.378; Brousseau DC, 2010, AM J HEMATOL, V85, P77, DOI 10.1002/ajh.21570; Epstein K, 2006, J NATL MED ASSOC, V98, P1109; Habara A, 2016, EXP BIOL MED, V241, P689, DOI 10.1177/1535370216636726; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; Kater A P, 1999, Ned Tijdschr Geneeskd, V143, P2049; Kauf TL, 2009, AM J HEMATOL, V84, P323, DOI 10.1002/ajh.21408; Mann-Jiles V, 2009, J AM ACAD NURSE PRAC, V21, P340, DOI 10.1111/j.1745-7599.2009.00416.x; McClish Donna K, 2005, Health Qual Life Outcomes, V3, P50, DOI 10.1186/1477-7525-3-50; Mehta SR, 2006, AM FAM PHYSICIAN, V74, P303; Paulukonis ST, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26390; Piel FB, 2017, NEW ENGL J MED, V376, P1561, DOI 10.1056/NEJMra1510865; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Sins JWR, 2017, BLOOD ADV, V1, P1598, DOI 10.1182/bloodadvances.2017007211; Smith WR, 2008, ANN INTERN MED, V148, P94, DOI 10.7326/0003-4819-148-2-200801150-00004; Smith WR, 2010, HEMATOL-AM SOC HEMAT, P409, DOI 10.1182/asheducation-2010.1.409; Tripathi A, 2011, PEDIATR BLOOD CANCER, V56, P90, DOI 10.1002/pbc.22822; Yale SH, 2000, AM FAM PHYSICIAN, V61, P1349; Zhang DC, 2016, BLOOD, V127, P801, DOI 10.1182/blood-2015-09-618538	26	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0214355	10.1371/journal.pone.0214355	http://dx.doi.org/10.1371/journal.pone.0214355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276525	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300006
J	Hardie, D; Korsman, S; Ameer, S; Vojnov, L; Hsiao, NY				Hardie, Diana; Korsman, Stephen; Ameer, Sharifa; Vojnov, Lara; Hsiao, Nei-Yuan			Reliability of plasma HIV viral load testing beyond 24 hours: Insights gained from a study in a routine diagnostic laboratory	PLOS ONE			English	Article							BLOOD; STABILITY; ASSAYS; RNA; DNA	Background Viral load testing is key to monitoring response to anti-retroviral therapy (ART). However, in lower and middle income countries with large epidemics, pre-analytical challenges threaten the quality of testing. It is unknown how much delayed processing and adverse storage affects the validity of results. The aim of this study was to determine the impact of delayed testing and warmer storage conditions on HIV RNA stability in diagnostic samples. Methods 1194 samples, collected in EDTA or plasma preparation (PPT) tubes, were studied. Immediately after initial testing, primary tubes were stored for 72, 96 or 168 hours at 4 degrees C, 20 degrees C or 30 degrees C. The viral load was then repeated and the 2 results were compared. Results Viral loads were very stable, with <0.5 log copies/ml median difference noted between paired tests for all storage times and temperatures. The viral load in samples stored for up to a week reliably differentiated between ART-suppressed and failing patients in 98.83% of instances. However, re-centrifugation immediately prior to repeat testing was essential to avoid falsely elevated readings, probably due to contamination of plasma with cell-associated viral nucleic acids. Approximately 20% of samples with initially undetectable viral loads were weakly positive (<100 copies/mL) on repeat. This was not exacerbated by duration or temperature of storage. Conclusion Viral RNA in diagnostic samples is stable well beyond currently recommended limits. However, when testing stored primary samples, contamination of plasma with cellular material easily occurs. Low viral loads (<100copies/mL) in samples stored in this way should be interpreted with caution.	[Hardie, Diana; Korsman, Stephen; Hsiao, Nei-Yuan] Univ Cape Town, Dept Pathol, Div Virol, Cape Town, South Africa; [Hardie, Diana; Korsman, Stephen; Ameer, Sharifa; Hsiao, Nei-Yuan] Natl Hlth Lab Serv, Cape Town, South Africa; [Vojnov, Lara] WHO, Geneva, Switzerland	University of Cape Town; World Health Organization	Hardie, D (corresponding author), Univ Cape Town, Dept Pathol, Div Virol, Cape Town, South Africa.; Hardie, D (corresponding author), Natl Hlth Lab Serv, Cape Town, South Africa.	diana.hardie@uct.ac.za		Korsman, Stephen/0000-0002-1667-4363; Hardie, Diana/0000-0002-0056-7547; Vojnov, Lara/0000-0003-0488-1012	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Aad G, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2014)145; Amellal B, 2008, HIV MED, V9, P790, DOI 10.1111/j.1468-1293.2008.00632.x; [Anonymous], 2018, ANN REP 2017 18, P71; Baca A, 2004, CLIN CHEM, V50, P255, DOI 10.1373/clinchem.2003.027813; Banfi G, 2007, CLIN CHEM LAB MED, V45, P565, DOI 10.1515/CCLM.2007.110; Besson GJ, 2014, CLIN INFECT DIS, V59, P1312, DOI 10.1093/cid/ciu585; Bonner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113813; Ellman TM, 2017, J INT AIDS SOC, V20, P16, DOI 10.1002/jia2.25007; Esber A, 2018, CLIN INFECT DIS, P23, DOI [10.1093/cid/ciy989/5193460, DOI 10.1093/CID/CIY989/5193460]; Giordano M, 2006, J CLIN VIROL, V35, P420, DOI 10.1016/j.jcv.2005.10.011; Goedhals D, 2013, J VIROL METHODS, V187, P248, DOI 10.1016/j.jviromet.2012.11.019; Golob JL, 2018, AIDS, V32, P2113, DOI 10.1097/QAD.0000000000001948; Kraft CS, 2013, J CLIN VIROL, V57, P77, DOI 10.1016/j.jcv.2012.12.015; Kran AMB, 2009, J CLIN MICROBIOL, V47, P2170, DOI 10.1128/JCM.00519-09; Lee TH, 1998, TRANSFUSION, V38, P580, DOI 10.1046/j.1537-2995.1998.38698326338.x; Parkin NT, 2014, AIDS REV, V16, P160; Procop GW, 2017, DIAGN MICR INFEC DIS, V89, P44, DOI 10.1016/j.diagmicrobio.2016.09.003; Sabino EC, 2004, JAIDS-J ACQ IMM DEF, V37, P1432, DOI 10.1097/00126334-200411010-00013; Vandamme AM, 1999, EUR J CLIN INVEST, V29, P445; Wilson Douglas, 2002, HDB HIV MED, P44	20	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219381	10.1371/journal.pone.0219381	http://dx.doi.org/10.1371/journal.pone.0219381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269089	Green Submitted, gold, Green Published			2022-12-26	WOS:000484927300063
J	Hoffmann, CJ; Milovanovic, M; Cichowitz, C; Kinghorn, A; Martinson, NA; Variava, E				Hoffmann, Christopher J.; Milovanovic, Minja; Cichowitz, Cody; Kinghorn, Anthony; Martinson, Neil A.; Variava, Ebrahim			Readmission and death following hospitalization among people with HIV in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INPATIENT MORTALITY; INFECTED ADULTS; OUTCOMES	Background Additional approaches are needed to identify and provide targeted interventions to populations at continued risk for HIV-associated mortality. We sought to describe care utilization and mortality following an index hospitalization for people with HIV in South Africa. Methods We conducted a prospective cohort study among hospitalized patients admitted to medicine wards at a single hospital serving a large catchment area. Participants were followed to 6 months post-discharge. Hospital records were used to describe overall admission numbers and inpatient mortality. Poisson regression was used to assess for associations between readmission or death and independent variables. Results Of 124 enrolled participants, 121 lived to hospital discharge. At the time of discharge the median length of stay of sampled patients was 5.5 days and 105 (87%) participants were referred for follow-up, most within 2 weeks of discharge. By 6 months post-discharge, only 18% of participants had attended the clinic to which they were referred and within the referred timeframe; 64 (53%) had been readmitted at least once and 31 (26%) had died. Self-reported skipping care due to difficulty in access (relative risk 1.3, p = 0.02) and not attending follow-up care on time or at the scheduled clinic or not attending clinic at all (relative risk 1.8 and 2.4, respectively, p = 0.001) were associated with readmission or mortality. Conclusions The post-hospital period is a period of medical vulnerability and high mortality. Improving post-hospital retention in care may reduce post-hospital mortality.	[Hoffmann, Christopher J.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Milovanovic, Minja; Kinghorn, Anthony; Martinson, Neil A.] Perinatal HIV Res Unit, Gauteng, South Africa; [Cichowitz, Cody] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Variava, Ebrahim] Tshepong Hosp, Dept Med, Klerksdorp, South Africa	Johns Hopkins University; Johns Hopkins University	Hoffmann, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA.	choffmann@jhmi.edu	Milovanovic, Minja/J-9832-2017; Variava, Ebrahim/AAO-5717-2020	Milovanovic, Minja/0000-0002-4654-8755; Variava, Ebrahim/0000-0003-2888-789X; Cichowitz, Cody/0000-0002-9029-6508; Hoffmann, Christopher/0000-0002-9422-0519	Johns Hopkins Center for AIDS Research, an NIH [P30AI094189]; Provincial Department of Health in North West; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Johns Hopkins Center for AIDS Research, an NIH; Provincial Department of Health in North West; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Johns Hopkins Center for AIDS Research, an NIH funded program (P30AI094189). CJH was a sub-awardee. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study team acknowledges the time and trust from all the participants that made this study possible, the support from the Provincial Department of Health in North West, the assistance from Tshepong Hospital staff, and the hard work and dedication of the study field team: Nkateko Makwarela, Hilda Mosia, and Tlhompho Gaoshebe.	Akinkuotu A, 2011, INT J STD AIDS, V22, P465, DOI 10.1258/ijsa.2011.011021; [Anonymous], 2015, NAT CONS GUID PREV M; Cichowitz C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208429; Department of Health SA, 2015, NAT HIV COUNS TEST P; Mahlab-Guri K, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006812, 10.1097/md.0000000000006812]; Meintjes G, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002269; Murphy RA, 2010, INT J TUBERC LUNG D, V14, P903; Myer L, 2013, SAMJ S AFR MED J, V103, P28, DOI [10.7196/samj.6285, 10.7196/SAMJ.6285]; Ousley J, 2018, CLIN INFECT DIS, V66, pS126, DOI 10.1093/cid/ciy103; Peck RN, 2016, JAIDS-J ACQ IMM DEF, V73, P522, DOI 10.1097/QAI.000000000001107; Roche S, 2017, SAMJ S AFR MED J, V107, P1110, DOI [10.7196/SAMJ.2017.v107i12.12397, 10.7196/samj.2017.v107i12.12397]; Statistics South Africa (StatsSA), 2017, MORT CAUS DEATH S AF; Stuart-Clark H, 2012, SAMJ S AFR MED J, V102, P549, DOI 10.7196/SAMJ.5615; Wajanga BMK, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0627-9	14	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0218902	10.1371/journal.pone.0218902	http://dx.doi.org/10.1371/journal.pone.0218902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269056	gold, Green Submitted, Green Published			2022-12-26	WOS:000484927300029
J	Juang, CS; Stanley, TA; Kirschbaum, DB				Juang, Caroline S.; Stanley, Thomas A.; Kirschbaum, Dalia B.			Using citizen science to expand the global map of landslides: Introducing the Cooperative Open Online Landslide Repository (COOLR)	PLOS ONE			English	Article							GREAT-BRITAIN; INVENTORY; SUSCEPTIBILITY; HAZARD; DATABASE; EXAMPLE; AREA	Robust inventories are vital for improving assessment of and response to deadly and costly landslide hazards. However, collecting landslide events in inventories is difficult at the global scale due to inconsistencies in or the absence of landslide reporting. Citizen science is a valuable opportunity for addressing some of these challenges. The new Cooperative Open Online Landslide Repository (COOLR) supplements data in a NASA-developed Global Landslide Catalog (GLC) with citizen science reports to build a more robust, publicly available global inventory. This manuscript introduces the COOLR project and its methods, evaluates the initial citizen science results from the first 13 months, and discusses future improvements to increase the global engagement with the project. The COOLR project (https://landslides.nasa.gov) contains Landslide Reporter, the first global citizen science project for landslides, and Landslide Viewer, a portal to visualize data from COOLR and other satellite and model products. From March 2018 to April 2019, 49 citizen scientists contributed 162 new landslide events to COOLR. These events spanned 37 countries in five continents. The initial results demonstrated that both expert and novice participants are contributing via Landslide Reporter. Citizen scientists are filling in data gaps through news sources in 11 different languages, in-person observations, and new landslide events occurring hundreds and thousands of kilometers away from any existing GLC data. The data is of sufficient accuracy to use in NASA susceptibility and hazard models. COOLR continues to expand as an open platform of landslide inventories with new data from citizen scientists, NASA scientists, and other landslide groups. Future work on the COOLR project will seek to increase participation and functionality of the platform as well as move towards collective post-disaster mapping.	[Juang, Caroline S.; Stanley, Thomas A.; Kirschbaum, Dalia B.] NASA, Goddard Space Flight Ctr, Hydrol Sci Lab, Greenbelt, MD 20771 USA; [Juang, Caroline S.] Sci Syst & Applicat Inc, Hydrospher & Biospher Sci, Lanham, MD 20706 USA; [Stanley, Thomas A.] Univ Space Res Assoc, Columbia, MD USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Science Systems and Applications Inc; Universities Space Research Association (USRA)	Juang, CS (corresponding author), NASA, Goddard Space Flight Ctr, Hydrol Sci Lab, Greenbelt, MD 20771 USA.; Juang, CS (corresponding author), Sci Syst & Applicat Inc, Hydrospher & Biospher Sci, Lanham, MD 20706 USA.	cjuang@alumni.harvard.edu	Stanley, Thomas/D-9877-2018; Juang, Caroline/AGJ-9197-2022	Stanley, Thomas/0000-0003-2288-0363; Juang, Caroline/0000-0002-5963-7888	NASA Center for Climate Simulation (NCCS) group; NASA Disasters project; GPM project; Chief Technologists Office at NASA Goddard Space Flight Center; SSAI	NASA Center for Climate Simulation (NCCS) group; NASA Disasters project; GPM project; Chief Technologists Office at NASA Goddard Space Flight Center; SSAI	This work was supported by the NASA Center for Climate Simulation (NCCS) group (https://www.nccs.nasa.gov/), NASA Disasters project (https://disasters.nasa.gov/), GPM project (https://pmm.nasa.gov), and the Chief Technologists Office at NASA Goddard Space Flight Center (https://www.nasa.gov/gsfctechnology). We would like to declare that our first author Caroline Juang has a commercial affiliation with Science Systems and Applications, Inc. (SSAI). Our first author is primarily affiliated with NASA GSFC but as she is not a civil servant on NASA permanent staff, her funding is managed by SSAI. The funder provided support in the form of salary for author C. S. J., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We would like to thank Jim Shute (NASA GSFC/ASRC Federal), Laura Carriere (NASA GSFC/CSC), Dan Duffy (NASA GSFC), and Neh Patel (NASA GSFC/CSC) at the NASA Center for Climate Simulation (NCCS) for generously hosting and maintaining Landslide Reporter and Landslide Viewer. Thank you to our landslides team Robert Emberson (NASA GSFC/USRA), Pukar Amatya (NASA GSFC/USRA), and our interns for your help and support for these citizen science activities. Thank you to Jason Duley (NASA ARC), Ronnie Phillips (NASA ARC), and the Socrata team for developing the initial landslide citizen science system concept. Thank you to Karen Smale (NASA GSFC/ADNET) and the GSFC Science and Exploration Directorate (SED) for giving us the tools to host landslides.nasa.gov on the SED website. Thank you to Jacob Reed (NASA GSFC/TELOPHASE) and the Precipitation Measurement Missions (PMM) team for giving us the tools to host the new landslides. nasa. gov website on the PMM website, and to Jacob for helping publish the new website and for the advice on website-building and social media. Thank you to Marc Kuchner (NASA GSFC) and Kristen Weaver (NASA GSFC/SSAI) for their veteran citizen science project guidance on project creation, outreach, and community building. Thank you to Aries Keck (NASA GSFC) and Katy Mersmann (NASA GSFC/USRA) for their communications guidance for the Landslide Reporter social media accounts and helping lead the social media outreach story. Thank you to the members of the NASA GSFC Citizen Science Group for their continued support of the COOLR project through many iterations of feedback given on how to improve the landslides. nasa. gov website, the web applications, and the citizen science process before and after project launch. Thank you to Amy Kaminski (NASA HQ) and Karen James (NASA HQ/InuTeq) for their guidance and support for our project on an agency level. Thank you to our friends and family, colleagues, and early supporters who have offered guidance on project branding and logo design, beta tested our website and applications, shared our project, and gave valuable feedback. Thank you to Sean McCartney (NASA GSFC/SSAI) for reviewing an early draft of this manuscript. Thank you also to the PLoS ONE editor and the anonymous reviewers for providing important feedback on the manuscript to improve its structure and content. Thank you to all of the networks that have shared our project to the public including but not limited to NASA Earth Observatory, NASA Solve, NASA Education EXPRESS newsletter, the Federal Community of Practice for Crowdsourcing and Citizen Science (FCPCCS), SciStarter, the American Geophysical Union's (AGU) The Landslide Blog, EarthSky, and the United Nations Platform for Space-based Information for Disaster Management and Emergency Response (UN-SPIDER). Last but not least, thank you to our citizen scientists and friends who have contributed landslides to our project, shared our project on their social media feeds, and gave feedback. We are sincerely grateful for all of the minutes and hours of your time contributed to making the COOLR project possible.	[Anonymous], 2018, EARTHSKY VOICES; Barra A, 2016, GEOMAT NAT HAZ RISK, V7, P1874, DOI 10.1080/19475705.2016.1171258; Baum RL, 2014, LANDSLIDE SCI SAFER, V1, P1, DOI [10.1007/978-3-319-04999-1, DOI 10.1007/978-3-319-04999-1]; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Boston C., 2014, P COMP PUBL 17 ACM C, P137, DOI DOI 10.1145/2556420; Bucknam R.C., 2001, 01443 USGS; Choi CE, 2018, LANDSLIDES, V15, P1889, DOI 10.1007/s10346-018-1034-9; Chu HJ, 2018, NAT HAZARDS, V90, P1259, DOI 10.1007/s11069-017-3098-6; Conrad CC, 2011, ENVIRON MONIT ASSESS, V176, P273, DOI 10.1007/s10661-010-1582-5; Cruden D., 1996, LANDSLIDES INVESTIGA, VVolume 247, P36; Cruden D.M., 1991, B ENG GEOL ENVIRON, V43, P27, DOI [10.1007/BF02590167, DOI 10.1007/BF02590167]; Cullen CA, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8100866; Elwood S, 2012, ANN ASSOC AM GEOGR, V102, P571, DOI 10.1080/00045608.2011.595657; Eveleigh A, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P2985, DOI 10.1145/2556288.2557262; Farahmand A, 2013, NAT HAZARD EARTH SYS, V13, P1259, DOI 10.5194/nhess-13-1259-2013; Follett R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143687; Franzoni C, 2014, RES POLICY, V43, P1, DOI 10.1016/j.respol.2013.07.005; Galli M, 2008, GEOMORPHOLOGY, V94, P268, DOI 10.1016/j.geomorph.2006.09.023; Goodchild MF, 2007, GEOJOURNAL, V69, P211, DOI 10.1007/s10708-007-9111-y; Guha-Sapir D., 2015, EM DAT INT DISASTER; Gura Trisha, 2013, Nature, V496, P259; GUZZETTI F, 1994, ENVIRON MANAGE, V18, P623, DOI 10.1007/BF02400865; Guzzetti F, 2012, EARTH-SCI REV, V112, P42, DOI 10.1016/j.earscirev.2012.02.001; Herrera G, 2018, LANDSLIDES, V15, P359, DOI 10.1007/s10346-017-0902-z; Ibsen ML, 1996, GEOMORPHOLOGY, V15, P241, DOI 10.1016/0169-555X(95)00073-E; Juang CS., 2018, SCISTARTER BLOG CITI; Juang CS, 2018, HELP NASA BUILD LARG; Kargel JS, 2016, SCIENCE, V351, DOI 10.1126/science.aac8353; Kirschbaum D, 2018, EARTHS FUTURE, V6, P505, DOI 10.1002/2017EF000715; Kirschbaum D, 2016, LANDSLIDES, V13, P485, DOI 10.1007/s10346-015-0577-2; Kirschbaum D, 2015, GEOMORPHOLOGY, V249, P4, DOI 10.1016/j.geomorph.2015.03.016; Kirschbaum DB, 2010, NAT HAZARDS, V52, P561, DOI 10.1007/s11069-009-9401-4; Kjekstad O, 2009, LANDSLIDES - DISASTER RISK REDUCTION, P573, DOI 10.1007/978-3-540-69970-5_30; Klemann L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188819; Kocaman S., 2018, INT ARCH PHOTOGRAMM, V42, P295, DOI [10.5194/isprs-archives-XLII-3-W4-295-2018, DOI 10.5194/ISPRS-ARCHIVES-XLII-3-W4-295-2018]; Kocaman S, 2019, LANDSLIDES, V16, P611, DOI 10.1007/s10346-018-1101-2; Malamud BD, 2004, EARTH SURF PROC LAND, V29, P687, DOI 10.1002/esp.1064; Marc O, 2018, GLOBAL DATABASE RAIN, P1; Monsieurs E, 2018, LANDSLIDES, V15, P2195, DOI 10.1007/s10346-018-1008-y; Mouillot F, 2014, INT J APPL EARTH OBS, V26, P64, DOI 10.1016/j.jag.2013.05.014; Murthy YVNK, 2014, INT ARCH PHOTOGRAMM, V40-8, P1249, DOI 10.5194/isprsarchives-XL-8-1249-2014; Newman G, 2010, INT J GEOGR INF SCI, V24, P1851, DOI 10.1080/13658816.2010.490532; Patel K., 2018, NASA EARTH OBSERVATO; Patel K, 2018, EARTH MATTERS B 0418; Paul J. D., 2017, WILEY INTERDISCIPLIN, V5, pe1262; Pennington C, 2015, GEOMORPHOLOGY, V249, P44, DOI 10.1016/j.geomorph.2015.03.013; Petley D., 2010, GEOMORPHOLOGICAL HAZ, P63, DOI [DOI 10.1017/CBO9780511807527.006, 10.1017/CBO9780511807527.006]; Petley D, 2012, GEOLOGY, V40, P927, DOI 10.1130/G33217.1; Petley DN, 2018, AGU BLOGOSPHERE LAND; Powell J, 2013, P GEOLOGIST ASSOC, V124, P638, DOI 10.1016/j.pgeola.2012.04.004; Samodra G, 2018, GEOMORPHOLOGY, V306, P306, DOI 10.1016/j.geomorph.2015.07.035; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Stanley T, 2017, NAT HAZARDS, V87, P145, DOI 10.1007/s11069-017-2757-y; Tanyas H, 2017, J GEOPHYS RES-EARTH, V122, P1991, DOI 10.1002/2017JF004236; van Westen CJ, 2006, B ENG GEOL ENVIRON, V65, P167, DOI 10.1007/s10064-005-0023-0; van Westen CJ, 2008, ENG GEOL, V102, P112, DOI 10.1016/j.enggeo.2008.03.010; Wallace, 2012, DIGIT HUMANIT Q, V6; Wang XW, 2018, WATER-SUI, V10, DOI 10.3390/w10050608; West S., 2016, CITIZEN SCI THEORY P, V1, P1, DOI [10.5334/cstp.8, DOI 10.5334/CSTP.8]	59	28	29	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0218657	10.1371/journal.pone.0218657	http://dx.doi.org/10.1371/journal.pone.0218657			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4CE	31269035	Green Submitted, Green Published, gold			2022-12-26	WOS:000484927300021
J	Lago, JC; Puzzi, MB				Lago, Juliana Carvalhaes; Puzzi, Maria Beatriz			The effect of aging in primary human dermal fibroblasts	PLOS ONE			English	Article							OXIDATIVE STRESS; PASSAGE NUMBER; SKIN; SENESCENCE; CULTURE; METALLOPROTEINASE-1; DEGRADATION; EXPOSURE; BEHAVIOR; DAMAGE	Skin aging is a complex process, and alterations in human skin due to aging have distinct characteristic as compared to other organs. The aging of dermal cells and the biological mechanisms involved in this process are key areas to understand skin aging. A large number of biological mechanisms, such as decreasing of protein synthesis of extracellular matrix or increasing of degradation, are known to be altered through skin aging. However, environmental influence can accelerate this characteristic phenotype. In this study, we analyzed primary human dermal fibroblasts in three different in-vitro aging models-UVB irradiation and accelerated proliferation of human dermal fibroblasts from young donors as well as from elderly donors-for the gene expression of COL1A1, COL1A2, COL3A1, COL4A1, COL7A1, MMP1, MMP2, MMP3, MMP7, MMP8, MMP9, MMP10, MMP12, MMP13, MMP14, TIMP1, TIMP2, TIMP3, TIMP4, IL1B, IL1A, IL6, IL8, IL10, PTGS2, TP53, CASP3, LMNA, SIRT1. We compared the gene expression levels with young control. Furthermore, the behavior of skin fibroblasts was also evaluated using cell growth rate. The findings reveal that the gene expression levels in skin fibroblasts was altered in the process of aging in all three in-vitro aging models, and the cell growth rate was reduced, suggesting that these methods can be employed to understand skin aging mechanisms as well as drug discovery screening method.	[Lago, Juliana Carvalhaes; Puzzi, Maria Beatriz] Univ Campinas UNICAMP, Dept Dermatol, Sch Med Sci, Lab Skin Cell Cultures,Pediat Res Ctr, Campinas, SP, Brazil	Universidade Estadual de Campinas	Lago, JC (corresponding author), Univ Campinas UNICAMP, Dept Dermatol, Sch Med Sci, Lab Skin Cell Cultures,Pediat Res Ctr, Campinas, SP, Brazil.	juliana_lago@hotmail.com						Abbas H, 2018, INT J PHARMACEUT, V541, P37, DOI 10.1016/j.ijpharm.2018.01.054; Amar SK, 2015, TOXICOL LETT, V235, P84, DOI 10.1016/j.toxlet.2015.03.008; [Anonymous], 2012, RNEASY MIN HDB; Aoki M, 2014, J INVEST DERMATOL, V134, P818, DOI 10.1038/jid.2013.396; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Bai BX, 2015, J PHOTOCH PHOTOBIO B, V144, P35, DOI 10.1016/j.jphotobiol.2015.02.001; Biran A, 2017, AGING CELL, V16, P661, DOI 10.1111/acel.12592; Boraldi F, 2010, MECH AGEING DEV, V131, P625, DOI 10.1016/j.mad.2010.08.008; BriskeAnderson MJ, 1997, P SOC EXP BIOL MED, V214, P248; ChangLiu CM, 1997, CANCER LETT, V113, P77, DOI 10.1016/S0304-3835(97)04599-0; Chen HY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178969; Chung KW, 2015, J GERONTOL A-BIOL, V70, P959, DOI 10.1093/gerona/glu137; Chung KW, 2013, MOL INSIGHTS SIRT1 P; Cui N, 2017, PROG MOL BIOL TRANSL, V147, P1, DOI 10.1016/bs.pmbts.2017.02.005; de Souza RO, 2018, J PHOTOCH PHOTOBIO B, V178, P53, DOI 10.1016/j.jphotobiol.2017.10.033; DeBoy E, 2017, NUCLEUS-PHILA, V8, P573, DOI 10.1080/19491034.2017.1348449; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Durai Priya Cinna, 2012, Indian J Dermatol, V57, P343, DOI 10.4103/0019-5154.100473; Dyer Joseph M, 2018, J Clin Aesthet Dermatol, V11, P13; Ekanayake-Mudiyanselage S, 2003, J INVEST DERMATOL, V120, P915, DOI 10.1046/j.1523-1747.2003.12233.x; Farage MA, 2009, AM J CLIN DERMATOL, V10, P73, DOI 10.2165/00128071-200910020-00001; Fligiel SEG, 2003, J INVEST DERMATOL, V120, P842, DOI 10.1046/j.1523-1747.2003.12148.x; Gary RK, 2005, ANAL BIOCHEM, V343, P329, DOI 10.1016/j.ab.2005.06.003; GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761; GIAEVER I, 1986, IEEE T BIO-MED ENG, V33, P242, DOI 10.1109/TBME.1986.325896; Hatem S, 2018, CURR DRUG DELIV, V15, P953, DOI 10.2174/1567201815666180214143551; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Ibuki A, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312118756662; Jobeili L, 2017, AGING-US, V9, P2302, DOI 10.18632/aging.101322; Kaisers W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175657; Kilic U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117954; Kostyuk V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044472; Lephart ED, 2018, J COSMET DERMATOL-US, V17, P282, DOI 10.1111/jocd.12508; Li L, 2018, PHOTOCHEM PHOTOBIOL, V94, P725, DOI 10.1111/php.12894; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Souto LRM, 2009, SAO PAULO MED J, V127, P28, DOI 10.1590/S1516-31802009000100007; McKenna T, 2015, J INVEST DERMATOL, V135, P2577, DOI 10.1038/jid.2015.295; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Ming M, 2015, ONCOGENE, V34, P281, DOI 10.1038/onc.2013.583; Na J, 2018, INT J MOL MED, V41, P3090, DOI 10.3892/ijmm.2018.3483; [National Institutes of Health Medicine USNLo], GENETICS HOME REFERE; Pannese E, 2011, BRAIN STRUCT FUNCT, V216, P85, DOI 10.1007/s00429-011-0308-y; Park JT, 2018, EXP GERONTOL, V106, P8, DOI 10.1016/j.exger.2018.02.012; Porcheron A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057985; Quan TH, 2009, J INVEST DERM SYMP P, V14, P20, DOI 10.1038/jidsymp.2009.8; Remoue N, 2013, INT J COSMETIC SCI, V35, P546, DOI 10.1111/ics.12075; Sharma U, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14671; Shoko T, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2112-1; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski AT, 2015, STEROIDS, V103, P72, DOI 10.1016/j.steroids.2015.04.006; Souto Luís Ricardo Martinhão, 2006, Sao Paulo Med. J., V124, P71, DOI 10.1590/S1516-31802006000200005; Straface E, 2007, FEBS LETT, V581, P4342, DOI 10.1016/j.febslet.2007.08.006; Subedi L, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8379539; Takeuchi H, 2013, J INVEST DERMATOL, V133, P1857, DOI 10.1038/jid.2013.71; Tamura E, 2018, SKIN RES TECHNOL, V24, P472, DOI 10.1111/srt.12456; Thiele JJ, 1997, BIOL CHEM, V378, P1299; Tobin DJ, 2017, J TISSUE VIABILITY, V26, P37, DOI 10.1016/j.jtv.2016.03.002; Ulrich D, 2010, J PLAST RECONSTR AES, V63, P1015, DOI 10.1016/j.bjps.2009.04.021; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; Vierkotter A, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.19858; Yang JY, 2011, CELL CYCLE, V10, P144, DOI 10.4161/cc.10.1.14455	61	50	52	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219165	10.1371/journal.pone.0219165	http://dx.doi.org/10.1371/journal.pone.0219165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269075	Green Submitted, gold, Green Published			2022-12-26	WOS:000484927300048
J	Cil, O; Anderson, MO; Yen, R; Kelleher, B; Huynh, TL; Seo, Y; Nilsen, SP; Turner, JR; Verkman, AS				Cil, Onur; Anderson, Marc O.; Yen, Robert; Kelleher, Bryan; Huynh, Tony L.; Seo, Youngho; Nilsen, Steven P.; Turner, Jerrold R.; Verkman, Alan S.			Slowed gastric emptying and improved oral glucose tolerance produced by a nanomolar-potency inhibitor of calcium-activated chloride channel TMEM16A	FASEB JOURNAL			English	Article						transmembrane member 16A; obesity; diabetes mellitus; interstitial cells of Cajal	INTERSTITIAL-CELLS; DUMPING SYNDROME; CAJAL; PROTEIN; KIT; PATHOPHYSIOLOGY; EXPRESSION; DIAGNOSIS; MOTILITY; AGONISTS	Interstitial cells of Cajal, which express the calcium-activated chloride channel transmembrane member 16A (TMEM16A), are an important determinant of gastrointestinal (GI) motility. We previously identified the acylaminocycloalkylthiophene class of TMEM16A inhibitors, which, following medicinal chemistry, gave analog 2-bromodifluoroacetylamino-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylic acid o-tolylamide (TMinh-23) with 30 nM half-maximal inhibitory concentration. Here, we tested the efficacy of TMinh-23 for inhibition of GI motility in mice. In isolated murine gastric antrum, TMinh-23 strongly inhibited spontaneous and carbachol-stimulated rhythmic contractions. Pharmacokinetic analysis showed predicted therapeutic concentrations of TMinh-23 for at least 4 h following a single oral or intraperitoneal dose at 10 mg/kg. Gastric emptying, as assessed following an oral bolus of phenol red or independently by [Tc-99m]-diethylenetriamine pentaacetic acid scintigraphy, was reduced by TMinh-23 by similar to 60% at 20 min. Interestingly, there was little effect of TMinh-23 on baseline whole-gut transit time or time to diarrhea induced by castor oil. Consequent to the delay in gastric emptying, TMinh-23 administration significantly reduced the elevation in blood sugar in mice following an oral but not intraperitoneal glucose load. These results provide pharmacological evidence for involvement of TMEM16A in gastric emptying and suggest the utility of TMEM16A inhibition in disorders of accelerated gastric emptying, such as dumping syndrome, and potentially for improving glucose tolerance in diabetes mellitus/metabolic syndrome and enhancing satiety in obesity.-Cil, O., Anderson, M. O., Yen, R., Kelleher, B., Huynh, T. L., Seo, Y., Nilsen, S. P., Turner, J. R., Verkman, A. S. Slowed gastric emptying and improved oral glucose tolerance produced by a nanomolar-potency inhibitor of calcium-activated chloride channel TMEM16A.	[Cil, Onur; Verkman, Alan S.] Univ Calif San Francisco, Dept Med & Physiol, San Francisco, CA 94158 USA; [Cil, Onur] Univ Calif San Francisco, Dept Pediat, 550 16th St, San Francisco, CA 94158 USA; [Huynh, Tony L.; Seo, Youngho] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94158 USA; [Anderson, Marc O.; Yen, Robert; Kelleher, Bryan] San Francisco State Univ, Dept Chem & Biochem, San Francisco, CA 94132 USA; [Nilsen, Steven P.; Turner, Jerrold R.] Harvard Med Sch, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Nilsen, Steven P.; Turner, Jerrold R.] Harvard Med Sch, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; California State University System; San Francisco State University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cil, O (corresponding author), Univ Calif San Francisco, Dept Pediat, 550 16th St, San Francisco, CA 94158 USA.	onur.cil@ucsf.edu	Seo, Youngho/D-5705-2013; Cil, Onur/AAK-5166-2020	Seo, Youngho/0000-0001-5908-6636; Cil, Onur/0000-0001-5178-0199; Huynh, Tony/0000-0003-2964-1795	American Heart Association [18POST33990365]; Cystic Fibrosis Foundation [VERKMA18G0]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK72517, DK099803, DK101373]; NIH National Eye Institute [EY13574]; NIH National Institute of General Medical Sciences [GM102874]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517, R01DK101373, R24DK099803] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the American Heart Association (18POST33990365), the Cystic Fibrosis Foundation (VERKMA18G0), and grants from the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (DK72517, DK099803, DK101373), NIH National Eye Institute (EY13574), and NIH National Institute of General Medical Sciences (GM102874). The authors declare no conflicts of interest.	Acosta A, 2015, GASTROENTEROLOGY, V148, P537, DOI 10.1053/j.gastro.2014.11.020; Berg P, 2016, DIGEST DIS SCI, V61, P11, DOI 10.1007/s10620-015-3839-x; Bharucha AE, 2015, CLIN GASTROENTEROL H, V13, P466, DOI 10.1016/j.cgh.2014.06.034; Bharucha AE, 2009, CLIN ENDOCRINOL, V70, P415, DOI 10.1111/j.1365-2265.2008.03351.x; Blair PJ, 2014, J NEUROGASTROENTEROL, V20, P294, DOI 10.5056/jnm14060; Camacho S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07919; Chen CQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145556; Cil O, 2016, CELL MOL GASTROENTER, V2, P317, DOI 10.1016/j.jcmgh.2015.12.010; Cipriani G, 2018, GASTROENTEROLOGY, V154, P2122, DOI 10.1053/j.gastro.2018.02.027; Crutzen R, 2016, PFLUG ARCH EUR J PHY, V468, P573, DOI 10.1007/s00424-015-1758-5; Der-Silaphet T, 1998, GASTROENTEROLOGY, V114, P724, DOI 10.1016/S0016-5085(98)70586-4; Galligan JJ, 2017, HANDB EXP PHARMACOL, V239, P363, DOI 10.1007/164_2016_116; Goineau S, 2015, FUND CLIN PHARMACOL, V29, P86, DOI 10.1111/fcp.12086; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Goyal RK, 2019, NEUROGASTROENT MOTIL, V31, DOI 10.1111/nmo.13546; Hayashi Y, 2017, GASTROENTEROLOGY, V153, P521, DOI 10.1053/j.gastro.2017.04.020; Holst JJ, 2016, DIABETES CARE, V39, P884, DOI 10.2337/dc16-0351; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Hwang SJ, 2019, J PHYSIOL-LONDON, V597, P2337, DOI 10.1113/JP277335; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Ishii S, 2009, J GASTROENTEROL, V44, P834, DOI 10.1007/s00535-009-0077-z; Kamaleddin MA, 2018, J CELL PHYSIOL, V233, P787, DOI 10.1002/jcp.25823; Kramer CK, 2014, DIABETES RES CLIN PR, V105, P88, DOI 10.1016/j.diabres.2014.04.023; Lamont BJ, 2008, DIABETES, V57, P190, DOI 10.2337/db07-1202; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Nesher R, 2002, DIABETES, V51, pS53, DOI 10.2337/diabetes.51.2007.S53; Padmanabhan P, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-60; Picollo A, 2015, J MOL BIOL, V427, P94, DOI 10.1016/j.jmb.2014.09.028; Pietra G, 2016, J GEN PHYSIOL, V148, P293, DOI 10.1085/jgp.201611622; Rauniyar N, 2015, INT J MOL SCI, V16, P28566, DOI 10.3390/ijms161226120; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Sanders KM, 2016, PHYSIOLOGY, V31, P316, DOI 10.1152/physiol.00006.2016; Schirra J, 1996, J CLIN INVEST, V97, P92, DOI 10.1172/JCI118411; Seo Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155771; Sharma D, 2018, BIOMED PHARMACOTHER, V108, P952, DOI 10.1016/j.biopha.2018.08.088; Sobczak M, 2014, EUR J PHARMACOL, V736, P63, DOI 10.1016/j.ejphar.2014.04.038; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Sun TY, 2018, AGING-US, V10, P3851, DOI 10.18632/aging.101677; Takaki M, 2010, PROG BIOPHYS MOL BIO, V102, P129, DOI 10.1016/j.pbiomolbio.2010.05.007; Torihashi S, 1999, J AUTONOM NERV SYST, V75, P38, DOI 10.1016/S0165-1838(98)00174-X; Truong EC, 2017, J MED CHEM, V60, P4626, DOI 10.1021/acs.jmedchem.7b00020; Tunaru S, 2012, P NATL ACAD SCI USA, V109, P9179, DOI 10.1073/pnas.1201627109; van Beek AP, 2017, OBES REV, V18, P68, DOI 10.1111/obr.12467; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Yasutomi E, 2018, DIGEST DIS SCI, V63, P881, DOI 10.1007/s10620-017-4905-3; Yin JY, 2006, DIGEST DIS SCI, V51, P1818, DOI 10.1007/s10620-006-9313-z	46	9	9	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11247	11257		10.1096/fj.201900858R	http://dx.doi.org/10.1096/fj.201900858R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31299174	Green Published			2022-12-26	WOS:000489166300055
J	Rong, N; Mistriotis, P; Wang, XY; Tseropoulos, G; Rajabian, N; Zhang, YL; Wang, JM; Liu, S; Andreadis, ST				Rong, Na; Mistriotis, Panagiotis; Wang, Xiaoyan; Tseropoulos, Georgios; Rajabian, Nika; Zhang, Yali; Wang, Jianmin; Liu, Song; Andreadis, Stelios T.			Restoring extracellular matrix synthesis in senescent stem cells	FASEB JOURNAL			English	Article						aging; elasticity; ECM; collagen; NANOG	SMOOTH-MUSCLE-CELLS; EHLERS-DANLOS-SYNDROME; III COLLAGEN; TGF-BETA; NANOG REVERSES; HAIR FOLLICLE; SELF-RENEWAL; DIFFERENTIATION; SMAD3; PROLIFERATION	Collagen type III (COL3) is one of the 3 major collagens in the body, and loss of expression or mutations in the COL3 gene have been associated with the onset of vascular diseases such the Ehlers-Danlos syndrome. Previous work reported a significant reduction of COL3 in tissues such as skin and vessels with aging. In agreement, we found that COL3 was significantly reduced in senescent human mesenchymal stem cells and myofibroblasts derived from patients with Hutchinson-Gilford progeria syndrome, a premature aging syndrome. Most notably, we discovered that ectopic expression of the embryonic transcription factor Nanog homeobox (NANOG) restored COL3 expression by restoring the activity of the TGF-beta pathway that was impaired in senescent cells. RNA sequencing analysis showed that genes associated with the activation of the TGF-beta pathway were up-regulated, whereas negative regulators of the pathway were down-regulated upon NANOG expression. Chromatin immunoprecipitation sequencing and immunoprecipitation experiments revealed that NANOG bound to the mothers against decapentaplegic (SMAD)2 and SMAD3 promoters, in agreement with increased expression and phosphorylation levels of both proteins. Using chemical inhibition, short hairpin RNA knockdown, and gain of function approaches, we established that both SMAD2 and SMAD3 were necessary to mediate the effects of NANOG, but SMAD3 overexpression was also sufficient for COL3 production. In summary, NANOG restored production of COL3, which was impaired by cellular aging, suggesting novel strategies to restore the impaired extracellular matrix production and biomechanical function of aged tissues, with potential implications for regenerative medicine and anti-aging treatments.-Rong, N., Mistriotis, P., Wang, X., Tseropoulos, G., Rajabian, N., Zhang, Y., Wang, J., Liu, S., Andreadis, S. T. Restoring extracellular matrix synthesis in senescent stem cells.	[Rong, Na; Mistriotis, Panagiotis; Wang, Xiaoyan; Tseropoulos, Georgios; Rajabian, Nika; Andreadis, Stelios T.] Univ Buffalo, Dept Chem & Biol Engn, Buffalo, NY USA; [Andreadis, Stelios T.] Univ Buffalo, Dept Biomed Engn, Buffalo, NY USA; [Zhang, Yali; Wang, Jianmin; Liu, Song] Roswell Pk Comprehens Canc Ctr, Dept Biostat & Bioinformat, Buffalo, NY USA; [Andreadis, Stelios T.] Ctr Excellence Bioinformat & Life Sci, Buffalo, NY USA; [Mistriotis, Panagiotis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Johns Hopkins University	Andreadis, ST (corresponding author), Univ Buffalo State Univ New York, Dept Chem & Biol Engn, Bioengn Lab, 908 Furnas Hall,North Campus, Amherst, NY 14260 USA.	sandread@buffalo.edu	Mistriotis, Panagiotis/AAJ-5248-2020; Rajabian, Nika/ABA-6479-2020; wang, jian/GVS-0711-2022	Mistriotis, Panagiotis/0000-0002-8069-3278; 	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01 HL086582]; New York Stem Cell Science (NYSTEM) [C30290GG]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086582] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); New York Stem Cell Science (NYSTEM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (R01 HL086582) and New York Stem Cell Science (NYSTEM; C30290GG) to S.T.A. The authors declare no conflicts of interest.	Alimperti S, 2012, GENE THER, V19, P1123, DOI 10.1038/gt.2011.208; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bajpai VK, 2012, STEM CELL RES, V8, P74, DOI 10.1016/j.scr.2011.07.003; Brassard JA, 2016, BIOGERONTOLOGY, V17, P129, DOI 10.1007/s10522-015-9602-z; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chakravarthy A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06654-8; Cheng W., 2011, AFR J BIOTECHNOL, V10, P13; Davis R, 2012, CELL CYCLE, V11, P109, DOI 10.4161/cc.11.1.18473; de Kroon LMG, 2017, SCI REP-UK, V7, DOI 10.1038/srep43164; Durik M, 2012, CIRCULATION, V126, P468, DOI 10.1161/CIRCULATIONAHA.112.104380; FLEISCHMAJER R, 1990, J STRUCT BIOL, V105, P162, DOI 10.1016/1047-8477(90)90110-X; Gorenne I, 2006, CARDIOVASC RES, V72, P9, DOI 10.1016/j.cardiores.2006.06.004; Gray K, 2015, CIRC RES, V116, P816, DOI 10.1161/CIRCRESAHA.116.304921; Han JH, 2012, STEM CELLS, V30, P2746, DOI 10.1002/stem.1223; Han JH, 2010, CARDIOVASC RES, V87, P147, DOI 10.1093/cvr/cvq024; Hinz B, 2015, MATRIX BIOL, V47, P54, DOI 10.1016/j.matbio.2015.05.006; Horiguchi M, 2012, J BIOCHEM, V152, P321, DOI 10.1093/jb/mvs089; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Manea A, 2008, ARTERIOSCL THROM VAS, V28, P878, DOI 10.1161/ATVBAHA.108.163592; McDonnell NB, 2006, AM J MED GENET A, V140A, P129, DOI 10.1002/ajmg.a.31035; Mistriotis P, 2017, AGEING RES REV, V37, P94, DOI 10.1016/j.arr.2017.05.006; Mistriotis P, 2017, STEM CELLS, V35, P207, DOI 10.1002/stem.2452; Mistriotis P, 2013, TISSUE ENG PART B-RE, V19, P265, DOI [10.1089/ten.teb.2012.0422, 10.1089/ten.TEB.2012.0422]; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Morgan RG, 2013, AM J PHYSIOL-HEART C, V305, pH251, DOI 10.1152/ajpheart.00197.2013; Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052; Okumura N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058000, 10.1371/journal.pone.0075961]; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Plenz GAM, 2003, ATHEROSCLEROSIS, V166, P1, DOI 10.1016/S0021-9150(01)00766-3; Qiu H, 2007, CIRCULATION, V116, P669, DOI 10.1161/CIRCULATIONAHA.107.689208; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; ROBERTS AB, 1992, KIDNEY INT, V41, P557, DOI 10.1038/ki.1992.81; Schwarze U, 2001, AM J HUM GENET, V69, P989, DOI 10.1086/324123; Shahini A, 2017, TISSUE ENG PT A, V23, P535, DOI [10.1089/ten.tea.2016.0494, 10.1089/ten.TEA.2016.0494]; Silver FH, 2001, SKIN RES TECHNOL, V7, P18, DOI 10.1034/j.1600-0846.2001.007001018.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Tsamis A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1004; Ungefroren H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-67; Volk SW, 2014, CALCIFIED TISSUE INT, V94, P621, DOI 10.1007/s00223-014-9843-x; Volk SW, 2011, CELLS TISSUES ORGANS, V194, P25, DOI 10.1159/000322399; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao X, 2008, J BIOL CHEM, V283, P3272, DOI 10.1074/jbc.M708033200; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	50	6	6	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10954	10965		10.1096/fj.201900377R	http://dx.doi.org/10.1096/fj.201900377R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31287964	Green Published			2022-12-26	WOS:000489166300031
J	Barakat, A; Nakao, S; Zandi, S; Sun, DW; Schmidt-Ullrich, R; Hayes, KC; Hafezi-Moghadam, A				Barakat, Aliaa; Nakao, Shintaro; Zandi, Souska; Sun, Dawei; Schmidt-Ullrich, Ruth; Hayes, K. C.; Hafezi-Moghadam, Ali			In contrast to Western diet, a plant-based, high-fat, low-sugar diet does not exacerbate retinal endothelial injury in streptozotocin-induced diabetes	FASEB JOURNAL			English	Article						insulin deficiency; lipoprotein metabolism; leukocyte adhesion; endothelial NF-kappa B signaling; molecular imaging	NF-KAPPA-B; INTERCELLULAR-ADHESION MOLECULE-1; METABOLIC SYNDROME; VASCULAR-PERMEABILITY; INSULIN-RESISTANCE; RETINOPATHY; EXPRESSION; HYPERTRIGLYCERIDEMIA; CHOLESTEROL; LIVER	Controversy remains about how diet affects the vascular endothelial dysfunction associated with disordered insulin-glucose homeostasis. It is postulated that the type and level of certain macronutrients contribute to endothelial dysfunction in vascular diabetes complications. However, it is not well understood how specific macronutrients affect the molecular inflammatory response under conditions of hyperglycemia. Here, we examined retinal microvascular endothelial injury in streptozotocin (STZ)-diabetic rats fed a laboratory Western diet (WD). WD, characterized by its high content of saturated fat, cholesterol, and sugar, significantly increased retinal leukocyte accumulation and endothelial injury in the STZ-diabetic rats. Suppression of endothelial NF-kappa B signaling in the STZ model reduced the WD-induced increase in leukocyte accumulation. To isolate the effect of dietary fat, we generated high-fat diets with varying fatty acid balance and type. These diets contained moderate amounts of carbohydrates but no sugar. We found that neither high levels of saturated or unsaturated fats per se increased retinal leukocyte accumulation and endothelial injury in the STZ-diabetic rat model but that the combination of high levels of dietary cholesterol with specific saturated fatty acids that are abundant in WD exacerbated leukocyte accumulation and endothelial injury in the retinas of STZ-diabetic rats.-Barakat, A., Nakao, S., Zandi, S., Sun, D., Schmidt-Ullrich, R., Hayes, K. C., Hafezi-Moghadam, A. In contrast to Western diet, a plant-based, high-fat, low-sugar diet does not exacerbate retinal endothelial injury in streptozotocin-induced diabetes.	[Barakat, Aliaa; Nakao, Shintaro; Zandi, Souska; Sun, Dawei; Hafezi-Moghadam, Ali] Brigham & Womens Hosp, Mol Biomarkers Nanoimaging Lab, 75 Francis St, Boston, MA 02115 USA; [Barakat, Aliaa; Nakao, Shintaro; Zandi, Souska; Sun, Dawei; Hafezi-Moghadam, Ali] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Nakao, Shintaro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Fukuoka, Japan; [Zandi, Souska] Rotkreuz & Berner Augenklin Lindenhofspital, Swiss Eye Inst, Dept Ophthalmol, Bern, Switzerland; [Sun, Dawei] Harbin Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Harbin, Heilongjiang, Peoples R China; [Schmidt-Ullrich, Ruth] Max Delbruck Ctr Mol Med, Dept Signal Transduct Tumor Cells, Berlin, Germany; [Hayes, K. C.] Brandeis Univ, Foster Biomed Res Lab, Dept Biol, Waltham, MA 02254 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Kyushu University; Harbin Medical University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Brandeis University	Barakat, A; Hafezi-Moghadam, A (corresponding author), Brigham & Womens Hosp, Mol Biomarkers Nanoimaging Lab MBNI, 75 Francis St,Thorn Res Bldg, Boston, MA 02115 USA.	abarakat@bwh.harvard.edu; ahm@bwh.harvard.edu		Zandi, Souska/0000-0001-9351-4278	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Impact Award [DK108238-01]; Juvenile Diabetes Research Foundation (JDRF) Innovation Award	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Impact Award; Juvenile Diabetes Research Foundation (JDRF) Innovation Award	This work was supported by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Impact Award (DK108238-01, to A.H.-M.) and the Juvenile Diabetes Research Foundation (JDRF) Innovation Award (to A.H.-M.). The authors declare no conflicts of interest.	Adamis AP, 2002, BRIT J OPHTHALMOL, V86, P363, DOI 10.1136/bjo.86.4.363; Aurora AB, 2010, BLOOD, V116, P475, DOI 10.1182/blood-2009-07-232132; BAGDADE JD, 1967, NEW ENGL J MED, V276, P427, DOI 10.1056/NEJM196702232760802; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BRUCKDORFER KR, 1971, BIOCHEM J, V123, pP7, DOI 10.1042/bj1230007P; BRUCKDORFER KR, 1972, P NUTR SOC, V31, pA11; Brunner EJ, 2008, AM J CLIN NUTR, V87, P1414, DOI 10.1093/ajcn/87.5.1414; Chaabo F, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-29; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cundiff David K, 2005, MedGenMed, V7, P3; Dow C, 2018, EUR J EPIDEMIOL, V33, P141, DOI 10.1007/s10654-017-0338-8; Frimmel Sonja, 2017, J Ophthalmic Vis Res, V12, P175, DOI 10.4103/jovr.jovr_243_16; Garland RC, 2011, FASEB J, V25, P1284, DOI 10.1096/fj.10-160051; Granado-Casas M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091184; GREENFIELD M, 1980, DIABETOLOGIA, V18, P441; Gustafsson E, 2001, J CELL SCI, V114, P671; Gylling H, 2004, DIABETES, V53, P2217, DOI 10.2337/diabetes.53.9.2217; Henke N, 2007, CIRC RES, V101, P268, DOI 10.1161/CIRCRESAHA.107.150474; Joussen AM, 2002, AM J PATHOL, V160, P501, DOI 10.1016/S0002-9440(10)64869-9; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Lyons TJ, 2004, INVEST OPHTH VIS SCI, V45, P910, DOI 10.1167/iovs.02-0648; MACDONALD I, 1964, CLIN SCI, V27, P23; MACDONALD I, 1972, CLIN SCI, V43, P265, DOI 10.1042/cs0430265; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Miyahara S, 2004, AM J PATHOL, V164, P1697, DOI 10.1016/S0002-9440(10)63728-5; Miyahara S, 2008, FASEB J, V22, P1973, DOI 10.1096/fj.07-096891; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Noda K, 2014, FASEB J, V28, P2038, DOI 10.1096/fj.12-215715; Noda K, 2010, FASEB J, V24, P2443, DOI 10.1096/fj.09-152678; PAWAR SS, 1968, J LIPID RES, V9, P334; RAKIETEN N, 1963, CANCER CHEMOTH REP, P91; REAVEN EP, 1974, J CLIN INVEST, V54, P1167, DOI 10.1172/JCI107860; Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002; REAVEN GM, 1981, DIABETES, V30, P66, DOI 10.2337/diab.30.2.S66; REAVEN GM, 1988, DIABETES METAB REV, V4, P639, DOI 10.1002/dmr.5610040703; REAVEN GM, 1984, HORM METAB RES, V16, P230, DOI 10.1055/s-2007-1014753; Sasaki M, 2015, INVEST OPHTH VIS SCI, V56, P7473, DOI 10.1167/iovs.15-17485; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; SCHRODER S, 1991, AM J PATHOL, V139, P81; Sun DW, 2014, FASEB J, V28, P3942, DOI 10.1096/fj.14-251934; Sun DW, 2010, FASEB J, V24, P1532, DOI 10.1096/fj.09-148981; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Wong MYZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0186582; WOODSIDE WF, 1972, ISRAEL J MED SCI, V8, P309; Xie F, 2010, AM J PATHOL, V177, P39, DOI 10.2353/ajpath.2010.100007; YOUNG NL, 1988, DIABETES, V37, P1151, DOI 10.2337/diabetes.37.8.1151; Zandi S, 2015, CELL REP, V10, P1173, DOI 10.1016/j.celrep.2015.01.050	50	5	4	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10327	10338		10.1096/fj.201900462R	http://dx.doi.org/10.1096/fj.201900462R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31264891	Green Published			2022-12-26	WOS:000482214200049
J	Dupont, L; Du, L; Poulter, M; Choi, S; McIntosh, M; Reeves, MB				Dupont, Liane; Du, Lily; Poulter, Madeleine; Choi, Stephanie; McIntosh, Megan; Reeves, Matthew B.			Src family kinase activity drives cytomegalovirus reactivation by recruiting MOZ histone acetyltransferase activity to the viral promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; herpesvirus; gene expression; histone acetylation; chromatin modification; cytomegalovirus reactivation; epigenetic regulation; hematopoietic cell kinase; lysine acetyltransferase 6A (KAT6A); phosphoproteomics	ENDOGENOUS HUMAN CYTOMEGALOVIRUS; LATENT HUMAN CYTOMEGALOVIRUS; NF-KAPPA-B; GENE-EXPRESSION; DENDRITIC CELLS; PROTEIN; TRANSCRIPTION; DIFFERENTIATION; STIMULATION; INHIBITION	Human cytomegalovirus (HCMV) latency and reactivation rely on a complex interplay between cellular differentiation, cell signaling pathways, and viral gene functions. HCMV reactivation in dendritic cells (DCs) is triggered by IL-6 and extracellular signal-regulated kinase (ERK)-mitogen-activated protein kinase signaling. However, activation of the same pathway fails to reactivate HCMV in other myeloid cell types, despite this signaling axis being active in those cells. We hypothesized that IL-6-induced ERK activation initiates the changes in chromatin structure required for viral reactivation but that a concomitant signal is necessary to complete the changes in chromatin structure required for gene expression to occur. Using a differential phosphoproteomics approach in cells that do or do not support IL-6-induced viral reactivation, we identified the concomitant activation of an Src family kinase (SFK), hematopoietic cell kinase (HCK), specifically in DCs in response to IL-6. Pharmacological and genetic inhibition of HCK activity indicated that HCK is required for HCMV reactivation. Furthermore, the HCK/SFK activity was linked to recruitment of the monocytic leukemia zinc finger protein (MOZ) histone acetyltransferase to the viral promoter, which promoted histone acetylation after ERK-mediated histone phosphorylation. Importantly, pharmacological and genetic inhibition of MOZ activity prevented reactivation. These results provide an explanation for the selective activation of viral gene expression in DCs by IL-6, dependent on concomitant SFK and ERK signaling. They also reveal a previously unreported role for SFK activity in the regulation of chromatin structure at promoters in eukaryotic cells via MOZ histone acetyltransferase activity.	[Dupont, Liane; Du, Lily; Poulter, Madeleine; Choi, Stephanie; McIntosh, Megan; Reeves, Matthew B.] UCL, Royal Free Hosp, Div Infect & Immun, Inst Immun & Transplantat, London NW3 2PF, England; [Dupont, Liane] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0QQ, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Reeves, MB (corresponding author), UCL, Royal Free Hosp, Div Infect & Immun, Inst Immun & Transplantat, London NW3 2PF, England.	matthew.reeves@ucl.ac.uk		Reeves, Matthew/0000-0002-4909-1076; Choi, Stephanie/0000-0002-9155-7407; Dupont, Liane/0000-0002-2124-4069	Medical Research Council Career Development Award Fellowship [G:0900466]; Wellcome Trust [WT/204870/Z/16/Z]; Medical Research Council Research [MR/RO21384/1]; MRC [G0900466, MR/R021384/1] Funding Source: UKRI	Medical Research Council Career Development Award Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Career Development Award Fellowship G:0900466 and a Medical Research Council Research Grant MR/RO21384/1 (to M. B. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Wellcome Trust Grant WT/204870/Z/16/Z. To whom correspondence should be addressed. Tel.: 44-203-1086783; E-mail: matthew.reeves@ucl.ac.uk.	Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Buehler J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005655; Catley MC, 2004, J BIOL CHEM, V279, P18457, DOI 10.1074/jbc.M400765200; Chan EM, 2007, EXP HEMATOL, V35, P1782, DOI 10.1016/j.exphem.2007.07.015; Cheng F, 2015, J VIROL, V89, P9262, DOI 10.1128/JVI.01098-15; Cliffe AR, 2015, CELL HOST MICROBE, V18, P649, DOI 10.1016/j.chom.2015.11.007; Compton T., 2000, METHODS MOL MED CYTO, P53; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Dupont L, 2016, REV MED VIROL, V26, P75, DOI 10.1002/rmv.1862; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Gerhart J, 1999, TERATOLOGY, V60, P226; Goodrum F, 2007, BLOOD, V110, P937, DOI 10.1182/blood-2007-01-070078; Hahn G, 1998, P NATL ACAD SCI USA, V95, P3937, DOI 10.1073/pnas.95.7.3937; Hargett D, 2010, P NATL ACAD SCI USA, V107, P20039, DOI 10.1073/pnas.1014509107; Huang MM, 2012, J VIROL, V86, P8507, DOI 10.1128/JVI.00598-12; Ioudinkova E, 2006, GENE, V384, P120, DOI 10.1016/j.gene.2006.07.021; Keller MJ, 2007, J VIROL, V81, P6669, DOI 10.1128/JVI.01524-06; Kew VG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004195; Keyes LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052827; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Kitabayashi I, 2001, LEUKEMIA, V15, P89, DOI 10.1038/sj.leu.2401983; Krishna BA, 2019, P NATL ACAD SCI USA, V116, P1755, DOI 10.1073/pnas.1816933116; Krishna BA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080445; Krishna BA, 2017, MBIO, V8, DOI 10.1128/mBio.01754-17; Meier JL, 1996, INTERVIROLOGY, V39, P331, DOI 10.1159/000150504; Mendelson M, 1996, J GEN VIROL, V77, P3099, DOI 10.1099/0022-1317-77-12-3099; Murphy JC, 2002, EMBO J, V21, P1112, DOI 10.1093/emboj/21.5.1112; Perez-Campo FM, 2013, IMMUNOLOGY, V139, P161, DOI 10.1111/imm.12072; Poh AR, 2015, ONCOTARGET, V6, P15752, DOI 10.18632/oncotarget.4199; Prosch S, 1999, INTERVIROLOGY, V42, P308, DOI 10.1159/000053965; Reeves MB, 2011, J VIROL, V85, P12750, DOI 10.1128/JVI.05878-11; Reeves MB, 2005, J GEN VIROL, V86, P2949, DOI 10.1099/vir.0.81161-0; Reeves MB, 2005, P NATL ACAD SCI USA, V102, P4140, DOI 10.1073/pnas.0408994102; Sindre H, 1996, BLOOD, V88, P4526, DOI 10.1182/blood.V88.12.4526.bloodjournal88124526; Soderberg-Naucler C, 2001, J VIROL, V75, P7543, DOI 10.1128/JVI.75.16.7543-7554.2001; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; Stanton RJ, 2010, J CLIN INVEST, V120, P3191, DOI 10.1172/JCI42955; TAYLORWIEDEMAN J, 1994, J VIROL, V68, P1597, DOI 10.1128/JVI.68.3.1597-1604.1994; Yuan JX, 2009, J VIROL, V83, P6391, DOI 10.1128/JVI.00061-09	40	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12901	12910		10.1074/jbc.RA119.009667	http://dx.doi.org/10.1074/jbc.RA119.009667			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31273084	Green Published, hybrid			2022-12-26	WOS:000486416000004
J	Yang, XY; Wang, GQ; Cao, T; Zhang, L; Ma, YZ; Jiang, SH; Teng, XC; Sun, XH				Yang, Xiaoying; Wang, Guiqin; Cao, Ting; Zhang, Li; Ma, Yunzhi; Jiang, Shuhui; Teng, Xinchen; Sun, Xiaohui			Large-conductance calcium-activated potassium channels mediate lipopolysaccharide-induced activation of murine microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipopolysaccharide (LPS); microglia; neuroinflammation; NF-kappa B (NF-KB); Toll-like receptor 4 (TLR4); BK channel; cytokine; innate immunity	CA2+-ACTIVATED K+ CHANNELS; BK CHANNELS; SMOOTH-MUSCLE; ION CHANNELS; EXPRESSION; MAXIK; MITOCHONDRIAL; INVOLVEMENT; TRANSIENTS; ADHESION	Large-conductance calcium-activated potassium (BK) channels are ubiquitously expressed in most cell types where they regulate many cellular, organ, and organismal functions. Although BK currents have been recorded specifically in activated murine and human microglia, it is not yet clear whether and how the function of this channel is related to microglia activation. Here, using patch-clamping, Griess reaction, ELISA, immunocytochemistry, and immunoblotting approaches, we show that specific inhibition of the BK channel with paxilline (10 mu M) or siRNA-mediated knockdown of its expression significantly suppresses lipopolysaccharide (LPS)-induced (100 ng/ml) BV-2 and primary mouse microglial cell activation. We found that membrane BK current is activated by LPS at a very early stage through Toll-like receptor 4 (TLR4), leading to nuclear translocation of NF-kappa B and to production of inflammatory cytokines. Furthermore, we noted that BK channels are also expressed intracellularly, and their nuclear expression significantly increases in late stages of LPS-mediated microglia activation, possibly contributing to production of nitric oxide, tumor necrosis factor-alpha, and interleukin-6. Of note, a specific TLR4 inhibitor suppressed BK channel expression, whereas an NF-kappa B inhibitor did not. Taken together, our findings indicate that BK channels participate in both the early and the late stages of LPS-stimulated murine microglia activation involving both membrane-associated and nuclear BK channels.	[Yang, Xiaoying; Wang, Guiqin; Cao, Ting; Zhang, Li; Ma, Yunzhi; Jiang, Shuhui; Teng, Xinchen; Sun, Xiaohui] Soochow Univ, Coll Pharmaceut Sci, Collaborat Innovat Ctr Brain Sci, Jiangsu Key Lab Neuropsychiat Dis, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China	Sun, XH (corresponding author), Soochow Univ, Coll Pharmaceut Sci, Collaborat Innovat Ctr Brain Sci, Jiangsu Key Lab Neuropsychiat Dis, Suzhou 215123, Jiangsu, Peoples R China.	sxh961@hotmail.com	sun, Xiaohui/G-5146-2013	sun, Xiaohui/0000-0003-0294-6855	National Natural Science Foundation of China [31400924, 31401197]; Priority Academic Program Development of the Jiangsu Higher Education Institutes (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of the Jiangsu Higher Education Institutes (PAPD)	This work was supported by National Natural Science Foundation of China Grants 31400924 (to X. S.) and 31401197 (to X. T.) and the Priority Academic Program Development of the Jiangsu Higher Education Institutes (PAPD). The authors declare that they have no conflicts of interest with the contents of this article.	BADER MF, 1994, GLIA, V11, P336, DOI 10.1002/glia.440110406; Balderas E, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00104; Bentzen BH, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00389; Bordey A, 2003, EUR J NEUROSCI, V18, P2893, DOI 10.1111/j.1460-9568.2003.03021.x; Burgazli KM, 2014, EUR REV MED PHARMACO, V18, P646; Cao Q, 2015, DEV CELL, V33, P427, DOI 10.1016/j.devcel.2015.04.010; Chen YJ, 2016, J CEREBR BLOOD F MET, V36, P2146, DOI 10.1177/0271678X15611434; Chen YJ, 2011, J CEREBR BLOOD F MET, V31, P2363, DOI 10.1038/jcbfm.2011.101; Colomar A, 2003, J BIOL CHEM, V278, P30732, DOI 10.1074/jbc.M304534200; Contet C, 2016, INT REV NEUROBIOL, V128, P281, DOI 10.1016/bs.irn.2016.04.001; Duncan PJ, 2016, INT REV NEUROBIOL, V128, P343, DOI 10.1016/bs.irn.2016.03.004; Erdogan A, 2007, ATHEROSCLEROSIS, V190, P100, DOI 10.1016/j.atherosclerosis.2006.02.035; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Gobeil F, 2002, CIRC RES, V90, P682, DOI 10.1161/01.RES.0000013303.17964.7A; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hayashi Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11697; Hayashi Y, 2011, J NEUROSCI, V31, P17370, DOI 10.1523/JNEUROSCI.4152-11.2011; Hoang LM, 1997, NEUROSCI LETT, V231, P25, DOI 10.1016/S0304-3940(97)00519-3; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Jin LW, 2019, ANN CLIN TRANSL NEUR, V6, P723, DOI 10.1002/acn3.754; Kaushal V, 2007, J NEUROSCI, V27, P234, DOI 10.1523/JNEUROSCI.3593-06.2007; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Korvers L, 2016, CELL CALCIUM, V60, P396, DOI 10.1016/j.ceca.2016.09.004; Krabbendam IE, 2018, CELL CALCIUM, V69, P101, DOI 10.1016/j.ceca.2017.07.005; Krishnamoorthy-Natarajan G, 2016, INT REV NEUROBIOL, V128, P401, DOI 10.1016/bs.irn.2016.03.017; Li B, 2016, INT REV NEUROBIOL, V128, P163, DOI 10.1016/bs.irn.2016.03.018; Li BX, 2014, NAT NEUROSCI, V17, P1055, DOI 10.1038/nn.3744; Maezawa Izumi, 2012, Int J Alzheimers Dis, V2012, P868972, DOI 10.1155/2012/868972; Maezawa I, 2011, J BIOL CHEM, V286, P3693, DOI 10.1074/jbc.M110.135244; MCLARNON JG, 1995, BRAIN RES, V693, P8, DOI 10.1016/0006-8993(95)00664-C; McLarnon JG, 1997, NEUROSCIENCE, V78, P1217, DOI 10.1016/S0306-4522(96)00680-X; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; Muller M, 2003, J ENDOTOXIN RES, V9, P181, DOI 10.1179/096805103125001595; Papavlassopoulos M, 2006, J IMMUNOL, V177, P4086, DOI 10.4049/jimmunol.177.6.4086; Price DL, 2002, BRAIN RES, V956, P183, DOI 10.1016/S0006-8993(02)03266-3; Pyott SJ, 2016, INT REV NEUROBIOL, V128, P369, DOI 10.1016/bs.irn.2016.03.016; Ren JD, 2014, IMMUNOLOGY, V141, P345, DOI 10.1111/imm.12193; SAWADA M, 1990, BRAIN RES, V509, P119, DOI 10.1016/0006-8993(90)90317-5; Scheel O, 2006, INFECT IMMUN, V74, P4354, DOI 10.1128/IAI.01783-05; Schilling T, 2004, EUR J NEUROSCI, V19, P1469, DOI 10.1111/j.1460-9568.2004.03265.x; Schilling T, 2007, BRAIN RES, V1186, P21, DOI 10.1016/j.brainres.2007.10.027; Schilling T, 2015, GLIA, V63, P664, DOI 10.1002/glia.22776; Schilling T, 2011, J CELL PHYSIOL, V226, P3295, DOI 10.1002/jcp.22675; Schroeder ME, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01836-8; Seydel U, 2001, J ENDOTOXIN RES, V7, P243, DOI 10.1177/09680519010070030901; Singh H, 2012, J PHYSIOL-LONDON, V590, P5937, DOI 10.1113/jphysiol.2011.215533; SUZUMURA A, 1984, BRAIN RES, V324, P379, DOI 10.1016/0006-8993(84)90054-4; Tao J, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00248; Vanheel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035544; Wang WY, 2017, J CELL BIOL, V216, P1715, DOI 10.1083/jcb.201612123; Yakubovich N, 2001, BBA-BIOMEMBRANES, V1514, P239, DOI 10.1016/S0005-2736(01)00378-9; Yang XY, 2017, BIOPHYS J, V112, p548A, DOI 10.1016/j.bpj.2016.11.2960; Yeh J, 2019, AM J PHYSIOL-RENAL, V316, pF617, DOI 10.1152/ajprenal.00554.2018; Yu M, 2016, ACTA PHARMACOL SIN, V37, P56, DOI 10.1038/aps.2015.139; Zhou Y, 2014, J GEN PHYSIOL, V144, P415, DOI 10.1085/jgp.201411259	56	7	7	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12921	12932		10.1074/jbc.RA118.006425	http://dx.doi.org/10.1074/jbc.RA118.006425			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31296663	hybrid, Green Published			2022-12-26	WOS:000486416000006
J	Gibbons, J; Malouf, R; Spitzberg, B; Martinez, L; Appleyard, B; Thompson, C; Nara, A; Tsou, MH				Gibbons, Joseph; Malouf, Robert; Spitzberg, Brian; Martinez, Lourdes; Appleyard, Bruce; Thompson, Caroline; Nara, Atsushi; Tsou, Ming-Hsiang			Twitter-based measures of neighborhood sentiment as predictors of residential population health	PLOS ONE			English	Article							SOCIAL NETWORKING; HEART-DISEASE; RISK-FACTORS; SEGREGATION; INDICATORS; LANGUAGE; ASSOCIATION; ENVIRONMENT; REGRESSION; HAPPINESS	Several studies have recently applied sentiment-based lexicons to Twitter to gauge local sentiment to understand health behaviors and outcomes for local areas. While this research has demonstrated the vast potential of this approach, lingering questions remain regarding the validity of Twitter mining and surveillance in local health research. First, how well does this approach predict health outcomes at very local scales, such as neighborhoods? Second, how robust are the findings garnered from sentiment signals when accounting for spatial effects? To evaluate these questions, we link 2,076,025 tweets from 66,219 distinct users in the city of San Diego over the period of 2014-12-06 to 2017-05-24 to the 500 Cities Project data and 2010-2014 American Community Survey data. We determine how well sentiment predicts self-rated mental health, sleep quality, and heart disease at a census tract level, controlling for neighborhood characteristics and spatial autocorrelation. We find that sentiment is related to some outcomes on its own, but these relationships are not present when controlling for other neighborhood factors. Evaluating our encoding strategy more closely, we discuss the limitations of existing measures of neighborhood sentiment, calling for more attention to how race/ethnicity and socio-economic status play into inferences drawn from such measures.	[Gibbons, Joseph] San Diego State Univ, Dept Sociol, San Diego, CA 92182 USA; [Malouf, Robert] San Diego State Univ, Dept Linguist & Asian Middle Eastern Languages, San Diego, CA 92182 USA; [Spitzberg, Brian; Martinez, Lourdes] San Diego State Univ, Sch Commun, San Diego, CA 92182 USA; [Appleyard, Bruce] San Diego State Univ, Sch Publ Affairs & Fine Arts, San Diego, CA 92182 USA; [Thompson, Caroline] San Diego State Univ, Sch Publ Hlth, San Diego, CA 92182 USA; [Nara, Atsushi; Tsou, Ming-Hsiang] San Diego State Univ, Dept Geog, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University	Gibbons, J (corresponding author), San Diego State Univ, Dept Sociol, San Diego, CA 92182 USA.	jgibbons@sdsu.edu	Nara, Atsushi/AAY-6024-2020; Tsou, Ming-Hsiang/B-2357-2015	Nara, Atsushi/0000-0003-4173-7773; Thompson, Caroline/0000-0001-9990-9756; Spitzberg, Brian H./0000-0003-3838-6052; Tsou, Ming-Hsiang/0000-0003-3421-486X	National Science Foundation [1416509]; National Institute of Minority Health and Health Disparities [U54MD012397]; National Institute on Minority Health and Health Disparities [U54MD012397] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This material is partially based upon work supported by the National Science Foundation under Grant No. 1416509, IBSS project titled "Spatiotemporal Modeling of Human Dynamics Across Social Media and Social Networks". Funding was also provided by the National Institute of Minority Health and Health Disparities, Grant No. U54MD012397. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Garcia D, 2000, SOC SCI MED, V51, P1143, DOI 10.1016/S0277-9536(00)00016-2; Acevedo-Garcia D, 2001, AM J PUBLIC HEALTH, V91, P734, DOI 10.2105/AJPH.91.5.734; Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 2017, 500 CITIES LOCAL DAT; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L, 1998, STAT TEXTB MONOG, V155, P237; Anselin L, 2003, INT REGIONAL SCI REV, V26, P153, DOI 10.1177/0160017602250972; Baker DA, 2016, CYBERPSYCH BEH SOC N, V19, P638, DOI 10.1089/cyber.2016.0206; Baller RD, 2001, CRIMINOLOGY, V39, P561, DOI 10.1111/j.1745-9125.2001.tb00933.x; Baltagi BH, 2007, J ECONOMETRICS, V140, P5, DOI 10.1016/j.jeconom.2006.09.001; Barrington WE, 2014, HEALTH PLACE, V27, P120, DOI 10.1016/j.healthplace.2014.02.001; Barrington-Leigh C, 2015, P NATL ACAD SCI USA, V112, P8244, DOI 10.1073/pnas.1504033112; Beers Fagersten KA, 2000, DESCRIPTIVE ANAL SOC; Blodgett SL, 2016, P C EMP METH NAT LAN; Blodgett SL, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL), VOL 1, P1415; Boardman JD, 2004, SOC SCI MED, V58, P2473, DOI 10.1016/j.socscimed.2003.09.029; Boillot A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052708, 10.1371/journal.pone.0064417]; Carter B, 2016, JAMA PEDIATR, V170, P1202, DOI 10.1001/jamapediatrics.2016.2341; Cervero R, 1997, TRANSPORT RES D-TR E, V2, P199, DOI 10.1016/S1361-9209(97)00009-6; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Christie C, 2013, J PRAGMATICS, V58, P152, DOI 10.1016/j.pragma.2013.06.009; CLOGG CC, 1995, AM J SOCIOL, V100, P1261, DOI 10.1086/230638; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Dodds PS, 2010, J HAPPINESS STUD, V11, P441, DOI 10.1007/s10902-009-9150-9; Du JC, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0632-8; Dunteman G.H, 1989, PRINCIPAL COMPONENTS, P69; Eichstaedt JC, 2015, PSYCHOL SCI, V26, P159, DOI 10.1177/0956797614557867; Ford MT, 2018, APPL PSYCHOL-HLTH WE, V10, P3, DOI 10.1111/aphw.12123; Gibbons J, 2014, J URBAN HEALTH, V91, P648, DOI 10.1007/s11524-013-9863-2; Gore RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133505; Green L. J, 2002, AFRICAN AM ENGLISH; Guntuku SC, 2017, CURR OPIN BEHAV SCI, V18, P43, DOI 10.1016/j.cobeha.2017.07.005; Hernandez D, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090916; Hill TD, 2005, J HEALTH SOC BEHAV, V46, P170, DOI 10.1177/002214650504600204; Hovy Dirk, 2015, P 53 ANN M ASS COMP; Hutto C. J., 2014, VADER PARSIMONIOUS R, P10; Jashinsky J, 2014, CRISIS, V35, P51, DOI 10.1027/0227-5910/a000234; Jay T., 1992, CURSING AM; Johnson BT, 2017, HEALTH PSYCHOL REV, V11, P280, DOI 10.1080/17437199.2017.1343679; Jones T, 2019, AM SPEECH, V94, P478, DOI 10.1215/00031283-7611213; Jones T, 2015, AM SPEECH, V90, P403, DOI 10.1215/00031283-3442117; Kelejian Harry H, 2010, J Econom, V157, P53; Lee BA, 1997, SOC SCI QUART, V78, P922; Lindquist KA, 2015, CURR DIR PSYCHOL SCI, V24, P99, DOI 10.1177/0963721414553440; Luo QH, 2017, BIOMATER SCI-UK, V5, P295, DOI 10.1039/c6bm00788k; Marshall WE, 2010, TRANSPORT RES REC, P103, DOI 10.3141/2198-12; Matthews SA, 2010, ANN BEHAV MED, V39, P170, DOI 10.1007/s12160-010-9175-7; McIver DJ, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4476; McLaughlin CL, 2017, SCHOOL PSYCHOL INT, V38, P398, DOI 10.1177/0143034317714617; Mednick SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009775; Mowery D, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6895; Nguyen QC, 2017, PUBLIC HEALTH, V148, P120, DOI 10.1016/j.puhe.2017.03.013; Nguyen Quynh C, 2016, JMIR Public Health Surveill, V2, pe158; Nguyen QC, 2016, APPL GEOGR, V73, P77, DOI 10.1016/j.apgeog.2016.06.003; Pang B., 2008, INFORM RETRIEVAL, V2, P1, DOI [DOI 10.1561/1500000011, 10.1561/1500000011)2012, DOI 10.1561/1500000011)2012]; Preotiuc-Pietro D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138717; Rich-Edwards JW, 2005, BMJ-BRIT MED J, V330, P1115, DOI 10.1136/bmj.38434.629630.E0; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; Ross CE, 2009, J HEALTH SOC BEHAV, V50, P49, DOI 10.1177/002214650905000104; Seabrook EM, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9267; SMITH SL, 2019, AM SPEECH, P1, DOI DOI 10.1215/00031283-7706537; South EC, 2015, AM J PUBLIC HLTH AJP; Spears Arthur, 1998, AFRICAN AM ENGLISH S, P226; Spitzberg BH, 2014, COMMUN THEOR, V24, P311, DOI 10.1111/comt.12042; Tsou MH, 2017, LECT NOTES GEOINF CA, P85, DOI 10.1007/978-3-319-57336-6_7; Ueda M, 2017, SOC SCI MED, V189, P158, DOI 10.1016/j.socscimed.2017.06.032; Vogel M, 2016, J RES CRIME DELINQ, V53, P112, DOI 10.1177/0022427815597039; Wang W., 2014, P 17 ACM C COMP SUPP, P415, DOI DOI 10.1145/2531602.2531734; Wang Y, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.170281; Wheeler SM, 2015, J AM PLANN ASSOC, V81, P167, DOI 10.1080/01944363.2015.1081567; Yang C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150881; Yang TC, 2010, HEALTH PLACE, V16, P803, DOI 10.1016/j.healthplace.2010.04.005; Yang W, 2015, APPL GEOGR, V60, P217, DOI 10.1016/j.apgeog.2014.10.016; Zhang XY, 2015, AM J EPIDEMIOL, V182, P127, DOI 10.1093/aje/kwv002	77	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219550	10.1371/journal.pone.0219550	http://dx.doi.org/10.1371/journal.pone.0219550			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4LN	31295294	Green Published, Green Submitted, gold			2022-12-26	WOS:000484951800045
J	Luo, XD				Luo, Xiaodong			Ensemble-based kernel learning for a class of data assimilation problems with imperfect forward simulators	PLOS ONE			English	Article							MODEL ERROR; CALIBRATION; FRAMEWORK	Simulator imperfection, often known as model error, is ubiquitous in practical data assimilation problems. Despite the enormous efforts dedicated to addressing this problem, properly handling simulator imperfection in data assimilation remains to be a challenging task. In this work, we propose an approach to dealing with simulator imperfection from a point of view of functional approximation that can be implemented through a certain machine learning method, such as kernel-based learning adopted in the current work. To this end, we start from considering a class of supervised learning problems, and then identify similarities between supervised learning and variational data assimilation. These similarities found the basis for us to develop an ensemble-based learning framework to tackle supervised learning problems, while achieving various advantages of ensemble-based methods over the variational ones. After establishing the ensemble-based learning framework, we proceed to investigate the integration of ensemble-based learning into an ensemble-based data assimilation framework to handle simulator imperfection. In the course of our investigations, we also develop a strategy to tackle the issue of multi-modality in supervised-learning problems, and transfer this strategy to data assimilation problems to help improve assimilation performance. For demonstration, we apply the ensemble-based learning framework and the integrated, ensemble-based data assimilation framework to a supervised learning problem and a data assimilation problem with an imperfect forward simulator, respectively. The experiment results indicate that both frameworks achieve good performance in relevant case studies, and that functional approximation through machine learning may serve as a viable way to account for simulator imperfection in data assimilation problems.	[Luo, Xiaodong] Norwegian Res Ctr NORCE, Bergen, Norway	Norwegian Research Centre (NORCE)	Luo, XD (corresponding author), Norwegian Res Ctr NORCE, Bergen, Norway.	xluo@norceresearch.no		Luo, Xiaodong/0000-0002-0734-862X	AkerBP ASA [280473]; DEA Norge AS [280473]; EquiNor ASA [280473]; Lundin Norway AS [280473]; Neptune Energy Norge AS [280473]; Var Energi AS [280473]; Research Council of Norway; the "4D Seismic History Matching" project - Research Council of Norway [230303]; ConocoPhillips Skandinavia AS; Halliburton AS; Schlumberger Norge AS; Wintershall Norge AS; DEA Norge AS	AkerBP ASA; DEA Norge AS; EquiNor ASA; Lundin Norway AS; Neptune Energy Norge AS; Var Energi AS; Research Council of Norway(Research Council of Norway); the "4D Seismic History Matching" project - Research Council of Norway; ConocoPhillips Skandinavia AS; Halliburton AS; Schlumberger Norge AS(Schlumberger); Wintershall Norge AS; DEA Norge AS	XL acknowledges financial supports from the following projects: The "DIGIRES" project (RCN no. 280473) funded by industry partners AkerBP ASA (https://www.akerbp.com/), DEA Norge AS (https://dea-norge.com/nb), EquiNor ASA (https://www.equinor.com/), Lundin Norway AS (https://www.lundin-norway.no/), Neptune Energy Norge AS (https://www.neptuneenergy.com/), Petrobras (www.petrobras.com) and Var Energi AS (https://varenergi.no/), as well as the Research Council of Norway (www.forskningsradet.no); and the "4D Seismic History Matching" project (RCN no. 230303) inside the National IOR Centre of Norway (NIORC), which is funded by the Research Council of Norway (www.forskningsradet.no) and the following industry partners: ConocoPhillips Skandinavia AS (www.conocophillips.no), AkerBP ASA (https://www.akerbp.com/), Var Energi AS (https://varenergi.no/), Equinor ASA (https://www.equinor.com/), Neptune Energy Norge AS (https://www.neptuneenergy.com/), Lundin Norway AS (https://www.lundin-norway.no/), Halliburton AS (https://www.halliburton.no), Schlumberger Norge AS (https://www.slb.com), Wintershall Norge AS (https://www.wintershall.no), and DEA Norge AS (https://dea-norge.com/nb).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2009, BIOINFORMATICS, V25, pI313, DOI 10.1093/bioinformatics/btp191; Berry T, 2017, MON WEATHER REV, V145, P2833, DOI 10.1175/MWR-D-16-0428.1; Broomhead DS, 1988, ROYAL SIGNALS RADAR; Carrassi A, 2010, MON WEATHER REV, V138, P3369, DOI 10.1175/2010MWR3192.1; Chen Y, 2013, COMPUTAT GEOSCI, V17, P689, DOI 10.1007/s10596-013-9351-5; Chen Y, 2010, COMPUTAT GEOSCI, V14, P579, DOI 10.1007/s10596-009-9174-6; DEE DP, 1995, MON WEATHER REV, V123, P1128, DOI 10.1175/1520-0493(1995)123<1128:OLEOEC>2.0.CO;2; Elsheikh AH, 2013, J HYDROL, V491, P40, DOI 10.1016/j.jhydrol.2013.03.037; Emerick A, 2011, COMPUTAT GEOSCI, V15, P251, DOI 10.1007/s10596-010-9198-y; Emerick AA, 2013, COMPUT GEOSCI-UK, V55, P3, DOI 10.1016/j.cageo.2012.03.011; Engl H. W., 2000, REGULARIZATION INVER; Evensen G., 2009, DATA ASSIMILATION EN; Evensen G, 2019, COMPUTAT GEOSCI, V23, P761, DOI 10.1007/s10596-019-9819-z; Gao G, 2018, ECMOR; Gao GH, 2017, COMPUTAT GEOSCI, V21, P1325, DOI 10.1007/s10596-017-9657-9; Goodfellow I., 2016, DEEP LEARNING, DOI DOI 10.4258/HIR.2016.22.4.351; Griffith AK, 2000, FLOW TURBUL COMBUST, V65, P469, DOI 10.1023/A:1011454109203; Guo ZY, 2018, SPE J, V23, P367, DOI 10.2118/182660-PA; Haykin S, 2008, CONF REC ASILOMAR C, P3, DOI 10.1109/ACSSC.2008.5074349; Hoteit I, 2012, MON WEATHER REV, V140, P528, DOI 10.1175/2011MWR3640.1; Howes KE, 2017, Q J ROY METEOR SOC, V143, P1227, DOI 10.1002/qj.2996; Kalnay E, 2002, ATMOSPHERIC MODELLIN, DOI [10.1017/CBO9780511802270, DOI 10.1017/CBO9780511802270]; Kopke C, 2018, ADV WATER RESOUR, V116, P195, DOI 10.1016/j.advwatres.2017.11.013; Lin Y., 2007, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2007.383428; Lorentzen R, 2018, ECMOR; Lorentzen RJ, 2019, SPE J, V24, P1452, DOI 10.2118/194205-PA; Lumley DE, 2001, GEOPHYSICS, V66, P50, DOI 10.1190/1.1444921; Luo X, 2010, PHYSICA D, V239, P684, DOI 10.1016/j.physd.2010.01.022; Luo X, 2019, SPE RESERVOIR EVALUA; Luo X, 2019, PETROLEUM GEOSTATIST; Luo X., 2018, WORKSH IOR NORW C; Luo X, 2018, 16 EUR C MATH OIL RE; Luo XD, 2018, SPE J, V23, P396, DOI 10.2118/185936-PA; Luo XD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198586; Luo XD, 2017, SPE J, V22, P985, DOI 10.2118/180025-PA; Luo XD, 2017, COMPUTAT GEOSCI, V21, P205, DOI 10.1007/s10596-016-9605-0; Luo XD, 2015, SPE J, V20, P962, DOI 10.2118/176023-PA; Miyoshi T, 2016, B AM METEOROL SOC, V97, P1347, DOI 10.1175/BAMS-D-15-00144.1; Ren Y, 2016, IEEE COMPUT INTELL M, V11, P41, DOI 10.1109/MCI.2015.2471235; Saeys Y, 2008, LECT NOTES ARTIF INT, V5212, P313, DOI 10.1007/978-3-540-87481-2_21; Sagi O, 2018, WIRES DATA MIN KNOWL, V8, DOI 10.1002/widm.1249; Sakov P, 2018, Q J ROY METEOR SOC, V144, P1297, DOI 10.1002/qj.3213; Silva C, 2010, IEEE T SYST MAN CY C, V40, P287, DOI 10.1109/TSMCC.2009.2038280; Sommer M, 2018, Q J ROY METEOR SOC, V144, P2026, DOI 10.1002/qj.3254; Zhao WB, 2019, 2019 INTERNATIONAL CONFERENCE ON BLOCKCHAIN TECHNOLOGY (ICBCT 2019), P1, DOI [10.1145/3320154.3320162, 10.1109/PESGM40551.2019.8974065]	48	17	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219247	10.1371/journal.pone.0219247	http://dx.doi.org/10.1371/journal.pone.0219247			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295300	Green Published, Green Submitted, gold			2022-12-26	WOS:000484951800021
J	Stevens, M; Rees, T; Steffens, NK; Haslam, SA; Coffee, P; Polman, R				Stevens, Mark; Rees, Tim; Steffens, Niklas K.; Haslam, S. Alexander; Coffee, Pete; Polman, Remco			Leaders' creation of shared identity impacts group members' effort and performance: Evidence from an exercise task	PLOS ONE			English	Article							SOCIAL IDENTITY; GROUP PROTOTYPICALITY; STATISTICAL POWER; ATHLETE LEADERSHIP; TEAM CONFIDENCE; PACING STRATEGY; MODERATING ROLE; DYNAMICS; IDENTIFIABILITY; METAANALYSIS	There is growing evidence that leaders' effectiveness derives in part from their creation of a sense of identity that is shared by members of a group they are attempting to lead (i.e., their identity entrepreneurship). Little is known, however, about the impact of identity entrepreneurship in sport and exercise settings, particularly in relation to its effect on group members' effort and performance. Using a pre-post between subjects experimental design, we examined the effect of leaders' identity entrepreneurship on group members' effort and performance during 5km cycling time trials. Following a baseline session (in which time trials were completed individually), participants (N = 72) were randomly allocated to either a high or low identity entrepreneurship condition, and further randomly divided into groups of five (including a leader who was a confederate). In the subsequent test sessions (which participants attended with their fellow group members), leaders displayed either high or low identity entrepreneurship behaviors. Results indicated that, compared to participants in the low identity entrepreneurship condition, those in the high identity entrepreneurship condition maintained greater effort (maximum heart rate), and demonstrated improved (rather than poorer) performance (average power output in the first 60 seconds of time trials). Examination of pacing showed that the largest increases in participants' average power output occurred in the early stages of their second time trials for those in the high identity entrepreneurship condition only. Results provide causal evidence that leaders who create a shared sense of identity among team members are able to inspire greater participant effort and performance.	[Stevens, Mark; Rees, Tim] Bournemouth Univ, Fac Management, Dept Sport & Phys Act, Poole, Dorset, England; [Steffens, Niklas K.; Haslam, S. Alexander] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Coffee, Pete] Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland; [Polman, Remco] Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld, Australia; [Stevens, Mark] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia	Bournemouth University; University of Queensland; University of Stirling; Queensland University of Technology (QUT); Australian National University	Stevens, M (corresponding author), Bournemouth Univ, Fac Management, Dept Sport & Phys Act, Poole, Dorset, England.; Stevens, M (corresponding author), Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia.	mark.stevens@anu.edu.au	Stevens, Mark/ABA-3037-2020; Haslam, Alex/AAA-2512-2019; Steffens, Niklas/D-3609-2016	Haslam, Alex/0000-0001-9523-7921; Stevens, Mark/0000-0002-7908-3624; Coffee, Pete/0000-0002-1055-0052; Steffens, Niklas/0000-0002-3990-2592				Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Andersen J. A., 2006, J SOCIO-ECON, V35, P1078, DOI DOI 10.1016/J.SOCEC.2005.11.066; Arbuckle J.L., 2014, AMOS; Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Augoustinos M, 2012, EUR J SOC PSYCHOL, V42, P564, DOI 10.1002/ejsp.1868; Barreto NB, 2017, SOC INFLUENCE, V12, P41, DOI 10.1080/15534510.2017.1316771; Bass B.M., 1985, LEADERSHIP PERFORMAN; Bass BM, 2006, TRANSFORMATIONAL LEA, DOI DOI 10.4324/9781410617095; Carey DG, 2009, J STRENGTH COND RES, V23, P2090, DOI 10.1519/JSC.0b013e3181bac5c5; Cicero L, 2007, GROUP DYN-THEOR RES, V11, P165, DOI 10.1037/1089-2699.11.3.165; Cicero L, 2010, BRIT J MANAGE, V21, P411, DOI 10.1111/j.1467-8551.2009.00648.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cotterill ST, 2016, INT REV SPORT EXER P, V9, P116, DOI 10.1080/1750984X.2015.1124443; Ellemers N, 2004, ACAD MANAGE REV, V29, P459, DOI 10.2307/20159054; Estabrooks PA, 2000, GROUP DYN-THEOR RES, V4, P230, DOI DOI 10.1037/1089-2699.4.3.230; EVERETT JJ, 1992, INT J SPORT PSYCHOL, V23, P311; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Field A.P., 2020, DISCOVERING STAT USI, V4th; Fitzmaurice GM., 2012, APPL LONGITUDINAL AN, V2nd; FOSTER C, 1994, SPORTS MED, V17, P77, DOI 10.2165/00007256-199417020-00001; Fox LD, 2000, AM J HEALTH PROMOT, V14, P277, DOI 10.4278/0890-1171-14.5.277; Fransen K, 2018, SCAND J MED SCI SPOR, V28, P725, DOI 10.1111/sms.12950; Fransen K, 2016, SCAND J MED SCI SPOR, V26, P1455, DOI 10.1111/sms.12603; Fransen K, 2015, SOC NETWORKS, V43, P28, DOI 10.1016/j.socnet.2015.04.003; Fransen K, 2015, MED SCI SPORT EXER, V47, P1470, DOI 10.1249/MSS.0000000000000561; Fransen K, 2015, J EXP PSYCHOL-APPL, V21, P89, DOI 10.1037/xap0000033; Fransen K, 2014, SPORT PSYCHOL, V28, P347, DOI 10.1123/tsp.2013-0141; Fransen K, 2014, J SPORT SCI, V32, P1389, DOI 10.1080/02640414.2014.891291; Haslam SA, 2011, NEW PSYCHOLOGY OF LEADERSHIP: IDENTITY, INFLUENCE, AND POWER, P1; Haslam S. A., 2004, PSYCHOL ORG SOCIAL I; Haslam SA, 2007, SOC PSYCHOL QUART, V70, P125, DOI 10.1177/019027250707000204; Haslam SA, 2006, J ORGAN BEHAV, V27, P607, DOI 10.1002/job.370; Haslam SA, 2017, J PERS PSYCHOL, V16, P113, DOI 10.1027/1866-5888/a000176; HOGG MA, 1987, BRIT J SOC PSYCHOL, V26, P325, DOI 10.1111/j.2044-8309.1987.tb00795.x; Hoigaard R., 2006, INT J APPL SPORTS SC, V18, P59; Hoigaard Rune, 2013, IJASS(International Journal of Applied Sports Sciences), V25, P33; KARAU SJ, 1993, J PERS SOC PSYCHOL, V65, P681, DOI 10.1037/0022-3514.65.4.681; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Loughead TM, 2016, J SPORT SCI, V34, P2063, DOI 10.1080/02640414.2016.1150601; Lowe KB, 1996, LEADERSHIP QUART, V7, P385, DOI 10.1016/S1048-9843(96)90027-2; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Maas CJM, 2004, STAT NEERL, V58, P127, DOI 10.1046/j.0039-0402.2003.00252.x; Mattern CO, 2001, INT J SPORTS MED, V22, P350, DOI 10.1055/s-2001-15644; Max Weber, 1946, M WEBER ESSAYS SOCIO, P245; Maxwell S. E., 2017, DESIGNING EXPT ANAL, DOI 10.4324/9781315642956; Ntoumanis N, 2017, SCAND J MED SCI SPOR, V27, P1026, DOI 10.1111/sms.12713; Oakes JM, 2001, EVALUATION REV, V25, P3, DOI 10.1177/0193841X0102500101; Osborne JW., 2004, PRACTICAL ASSESSMENT, V9, P1, DOI [10.7275/QF69-7K43, DOI 10.7275/QF69-7K43, 10.7275/qf69-7k43]; Paustian-Underdahl SC, 2014, J APPL PSYCHOL, V99, P1129, DOI 10.1037/a0036751; Pierro A, 2005, LEADERSHIP QUART, V16, P503, DOI 10.1016/j.leaqua.2005.06.002; Platow MJ, 1997, EUR J SOC PSYCHOL, V27, P465, DOI 10.1002/(SICI)1099-0992(199707)27:4<465::AID-EJSP817>3.0.CO;2-8; Rees T, 2013, J EXP SOC PSYCHOL, V49, P400, DOI 10.1016/j.jesp.2012.12.013; Reicher S, 2005, LEADERSHIP QUART, V16, P547, DOI 10.1016/j.leaqua.2005.06.007; Reicher Stephen D., 2001, SELF NATION CATEGORI; Sarrazin P, 2002, RES Q EXERCISE SPORT, V73, P425, DOI 10.1080/02701367.2002.10609042; Schachter S, 1951, HUM RELAT, V4, P229, DOI 10.1177/001872675100400303; Scherbaum CA, 2009, ORGAN RES METHODS, V12, P347, DOI 10.1177/1094428107308906; Schweizer G, 2016, PSYCHOL SPORT EXERC, V23, P114, DOI 10.1016/j.psychsport.2015.11.005; Slater MJ, 2019, J APPL SPORT PSYCHOL, V31, P65, DOI 10.1080/10413200.2017.1410255; Slater MJ, 2015, QUAL RES SPORT EXERC, V7, P192, DOI 10.1080/2159676X.2014.936030; Steffens N. K., 2017, J OCCUP HEALTH, DOI DOI 10.1037/0CP0000090; Steffens NK, 2014, Z PERSONALFORSCH, V28, P173, DOI 10.1688/ZfP-2014-01-Steffens; Steffens NK, 2014, LEADERSHIP QUART, V25, P1001, DOI 10.1016/j.leaqua.2014.05.002; Steffens NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077952; Stevens M, 2018, SCAND J MED SCI SPOR, V28, P2100, DOI 10.1111/sms.13217; Stevens M, 2020, SPORT EXERC PERFORM, V9, P128, DOI 10.1037/spy0000164; Stevens M, 2019, J SPORT SCI, V37, P221, DOI 10.1080/02640414.2018.1489360; Stevens M, 2017, SPORTS MED, V47, P1911, DOI 10.1007/s40279-017-0720-4; Stogdill RM, 1948, J PSYCHOL, V25, P35, DOI 10.1080/00223980.1948.9917362; Stoter IK, 2016, INT J SPORT PHYSIOL, V11, P337, DOI 10.1123/ijspp.2014-0603; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Teo WP, 2011, J SPORT SCI MED, V10, P600; Turner EE, 1997, J SPORT EXERCISE PSY, V19, P119, DOI 10.1123/jsep.19.2.119; Turner John C., 1991, SOCIAL INFLUENCE; Turner John C., 1982, SOCIAL IDENTITY INTE, P15, DOI DOI 10.1016/J.VACCINE.2011.08.002; Ullrich J, 2009, J APPL PSYCHOL, V94, P235, DOI 10.1037/a0012936; van Knippenberg D, 2011, LEADERSHIP QUART, V22, P1078, DOI 10.1016/j.leaqua.2011.09.004; Wang DN, 2014, J APPL PSYCHOL, V99, P181, DOI 10.1037/a0034531; WIDMEYER WN, 1990, J SPORT EXERCISE PSY, V12, P177, DOI 10.1123/jsep.12.2.177; WILLIAMS K, 1981, J PERS SOC PSYCHOL, V40, P303, DOI 10.1037/0022-3514.40.2.303; Wong L, 2003, LEADERSHIP QUART, V14, P657, DOI 10.1016/j.leaqua.2003.08.001; Worchel S, 1998, BRIT J SOC PSYCHOL, V37, P389, DOI 10.1111/j.2044-8309.1998.tb01181.x; Yukl G., 1998, LEADERSHIP ORG	83	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0218984	10.1371/journal.pone.0218984	http://dx.doi.org/10.1371/journal.pone.0218984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4LN	31295265	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000484951800009
J	van Helvoort, EM; Popov-Celeketic, J; Eijkelkamp, N; Coeleveld, K; Tryfonidou, MA; Wijne, CD; Hack, CE; Lafeber, FPJG; Mastbergen, SC				van Helvoort, E. M.; Popov-Celeketic, J.; Eijkelkamp, N.; Coeleveld, K.; Tryfonidou, M. A.; Wijne, C. D.; Hack, C. E.; Lafeber, F. P. J. G.; Mastbergen, S. C.			Canine IL4-10 fusion protein provides disease modifying activity in a canine model of OA; an exploratory study	PLOS ONE			English	Article							GROOVE MODEL; INTERLEUKIN-4 RECEPTOR; HUMAN CHONDROCYTES; INTRAARTICULAR SPRIFERMIN; CLINICAL-TRIAL; GENE-THERAPY; IN-VITRO; OSTEOARTHRITIS; ARTHRITIS; SAFETY	Objective An ideal disease modifying osteoarthritis drug (DMOAD) has chondroprotective, anti-inflammatory, and analgesic effects. This study describes the production and characterization of a canine IL4-10 fusion protein (IL4-10 FP) and evaluates its in vivo DMOAD activity in a canine model of osteoarthritis (OA). Design The canine Groove model was used as an in vivo model of degenerative knee OA. Six weeks after OA induction dogs were intra-articularly injected weekly, for ten weeks, with either IL4-10 FP or phosphate buffered saline (PBS). In addition to the use of human IL4-10 FP, canine IL4-10 FP was developed and characterized in vitro, and tested in vivo. Force plate analysis (FPA) was performed to analyze joint loading as a proxy measure for pain. After ten weeks dogs were euthanized and cartilage and synovial tissue samples were analyzed by histochemistry (OARSI scores) and biochemistry (cartilage proteoglycan turnover). Results Repetitive intra-articular injections with human IL4-10 FP led to antibody formation, that blocked its functional activity. Therefore, a canine IL4-10 FP was developed, which completely inhibited LPS-induced TNFa production by canine blood cells, and increased proteoglycan synthesis of canine cartilage in vitro (p = 0.043). In vivo, canine IL4-10 FP restored the, by OA impaired, joint loading (p = 0.002) and increased cartilage proteoglycan content (p = 0.029). Conclusions This first study on the potential DMOAD activity upon prolonged repeated treatment with IL4-10 FP demonstrates that a species-specific variant has anti-inflammatory and chondro-protective effects in vitro and chondroprotective and analgesic effects in vivo. These data warrant further research on the DMOAD potential of the IL4-10 FP.	[van Helvoort, E. M.; Popov-Celeketic, J.; Coeleveld, K.; Wijne, C. D.; Lafeber, F. P. J. G.; Mastbergen, S. C.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Eijkelkamp, N.; Hack, C. E.] Univ Utrecht, Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands; [Eijkelkamp, N.] Univ Utrecht, Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands; [Tryfonidou, M. A.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University	van Helvoort, EM (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.	vanHelvoort-3@umcutrecht.nl	Levi, Marcel/AAZ-8559-2020; Tryfonidou, Marianna/O-3114-2017	Tryfonidou, Marianna/0000-0002-2333-7162	Dutch Arthritis Society [NR12-2-202, LLP9, LLP22]	Dutch Arthritis Society	The study was funded by the Dutch Arthritis Society project NR12-2-202 and LLP9. MT is supported by funding from the Dutch Arthritis Society (LLP22).	Alaaeddine N, 1999, ARTHRITIS RHEUM-US, V42, P710, DOI 10.1002/1529-0131(199904)42:4<710::AID-ANR14>3.0.CO;2-4; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Cherian JJ, 2015, OSTEOARTHR CARTILAGE, V23, P2109, DOI 10.1016/j.joca.2015.06.019; Conzemius MG, 2012, JAVMA-J AM VET MED A, V241, P1314, DOI 10.2460/javma.241.10.1314; Cook JL, 2010, OSTEOARTHR CARTILAGE, V18, pS66, DOI 10.1016/j.joca.2010.04.017; de Visser HM, 2017, J ORTHOP RES, V35, P496, DOI 10.1002/jor.23299; DEMAZIERE A, 1992, REV RHUM, V59, P219; Deshmukh V, 2018, OSTEOARTHR CARTILAGE, V26, P18, DOI 10.1016/j.joca.2017.08.015; Eckstein F, 2015, ARTHRITIS RHEUMATOL, V67, P2916, DOI 10.1002/art.39265; Eijkelkamp N, 2016, J NEUROSCI, V36, P7353, DOI 10.1523/JNEUROSCI.0092-16.2016; Forster T, 2004, HUM GENET, V114, P391, DOI 10.1007/s00439-004-1083-0; Guermazi A, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1830-8; Ha CW, 2015, HUM GENE THER CL DEV, V26, P125, DOI 10.1089/humc.2014.145; Ha CW, 2012, CYTOTHERAPY, V14, P247, DOI 10.3109/14653249.2011.629645; Iannone F, 2001, CLIN EXP RHEUMATOL, V19, P139; John T, 2007, CYTOKINE, V40, P226, DOI 10.1016/j.cyto.2007.10.002; Joosten LAB, 1997, ARTHRITIS RHEUM, V40, P249, DOI 10.1002/art.1780400209; Kim MK, 2018, HUM GENE THER CL DEV, V29, P48, DOI 10.1089/humc.2017.249; LAFEBER FPJG, 1993, CONNECT TISSUE RES, V29, P287, DOI 10.3109/03008209309016834; Lee MC, 2015, BONE JOINT J, V97B, P924, DOI 10.1302/0301-620X.97B7.35852; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lohmander LS, 2014, ARTHRITIS RHEUMATOL, V66, P1820, DOI 10.1002/art.38614; Marijnissen ACA, 2002, OSTEOARTHR CARTILAGE, V10, P145, DOI 10.1053/joca.2001.0491; Marijnissen ACA, 2002, OSTEOARTHR CARTILAGE, V10, P282, DOI 10.1053/joca.2001.0507; Mastbergen SC, 2006, OSTEOARTHR CARTILAGE, V14, P39, DOI 10.1016/j.joca.2004.07.009; Millward-Sadler SJ, 2006, OSTEOARTHR CARTILAGE, V14, P991, DOI 10.1016/j.joca.2006.03.013; Moore EE, 2005, OSTEOARTHR CARTILAGE, V13, P623, DOI 10.1016/j.joca.2005.03.003; Popov-Celeketic J, 2018, OSTEOARTHR CARTILAGE, V26, pS292, DOI 10.1016/j.joca.2018.02.587; Prado J, 2018, J VISUALIZED EXPT JO, V11; Reker D, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1356-8; Salter DM, 1996, J RHEUMATOL, V23, P1314; Song SU, 2005, TISSUE ENG, V11, P1516, DOI 10.1089/ten.2005.11.1516; Steen-Louws C, 2018, OSTEOARTHR CARTILAGE, V26, P1127, DOI 10.1016/j.joca.2018.05.005; van Meegeren MER, 2012, OSTEOARTHR CARTILAGE, V20, P764, DOI 10.1016/j.joca.2012.04.002; van Roon JAG, 2001, ARTHRITIS RHEUM-US, V44, P3, DOI 10.1002/1529-0131(200101)44:1<3::AID-ANR2>3.0.CO;2-U; van Vulpen LFD, 2017, J THROMB HAEMOST, V15, P1788, DOI 10.1111/jth.13778; vanRoon JAG, 1996, ARTHRITIS RHEUM, V39, P829, DOI 10.1002/art.1780390516; Yazici Y, 2017, OSTEOARTHR CARTILAGE, V25, P1598, DOI 10.1016/j.joca.2017.07.006	38	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219587	10.1371/journal.pone.0219587	http://dx.doi.org/10.1371/journal.pone.0219587			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295306	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800048
J	Redondo, N; Carroll, A; McNamara, E				Redondo, Natalia; Carroll, Anne; McNamara, Eleanor			Molecular characterization of Campylobacter causing human clinical infection using whole-genome sequencing: Virulence, antimicrobial resistance and phylogeny in Ireland	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; ANTIBIOTIC-RESISTANCE; JEJUNI; GENES; IDENTIFICATION; PREVALENCE; PCR; FLUOROQUINOLONE; EPIDEMIOLOGY; CATTLE	Objectives We characterized clinical isolates of Campylobacter using whole-genome sequencing (WGS) for detection of virulence genes, antimicrobial resistance markers and phylogenetic analysis in order to increase the knowledge on the molecular epidemiology of Campylobacter in Ireland, where there are significant gaps due to the widespread in the use of culture independent methods for the diagnosis of campylobacteriosis. Methods WGS was applied to 122 Campylobacter human isolates collected over a 10-years period, from diarrhoeal stool samples submitted for routine enteric screening. Results Genes associated with cytotoxin production such as cdtA, cdtB and cdtC were found in 88%, 89% and 89% isolates, respectively; adherence, colonization and invasion genes such as cadF, dnaJ, racR, iam, virB11 and ciaB were found in 99%, 99%, 98%, 99%, 1% and 80% isolates, respectively. Genetic markers associated with resistance to quinolones (C257T in gyrA), beta-lactams (bla(oxa-61)) and tetracycline (tet(O)) were present in 43%, 71% and 25% isolates, respectively. The cmeABC operon was present in 94% of isolates. No macrolide or aminoglycoside resistance markers were detected. Phylogenetic analysis showed that 112 isolates were assigned to 29 sequence types grouped into 17 clonal complexes. Four clusters previously unidentified were detected. These results shown the similarity of Irish data compared to what has been described globally. Conclusions WGS has shown a high discriminatory power for cluster detection, demonstrating that its integration in routine laboratory surveillance could improve the detection and management of outbreaks. In addition we were able to demonstrate that virulence genes in clinical Campylobacter infections in Ireland were similar to those known previously. High prevalence of quinolone resistance markers has been found, which has implications for antimicrobial stewardship.	[Redondo, Natalia; Carroll, Anne; McNamara, Eleanor] Dublin Hlth Serv Execut, Publ Hlth Lab, Dublin, Ireland; [Redondo, Natalia] European Ctr Dis Prevent & Control, European Publ Hlth Microbiol Training Programme E, Stockholm, Sweden	European Centre for Disease Prevention & Control	Redondo, N (corresponding author), Dublin Hlth Serv Execut, Publ Hlth Lab, Dublin, Ireland.; Redondo, N (corresponding author), European Ctr Dis Prevent & Control, European Publ Hlth Microbiol Training Programme E, Stockholm, Sweden.	natalia.redondo@hse.ie		REDONDO, NATALIA/0000-0001-9356-8102	European Centre for Disease Prevention and Control	European Centre for Disease Prevention and Control	Dr Natalia Redondo was funded by European Centre for Disease Prevention and Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Madi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156938; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Bacon DJ, 2000, INFECT IMMUN, V68, P4384, DOI 10.1128/IAI.68.8.4384-4390.2000; Bang DD, 2003, J APPL MICROBIOL, V94, P1003, DOI 10.1046/j.1365-2672.2003.01926.x; Biswas D, 2011, INT MICROBIOL, V14, P25, DOI 10.2436/20.1501.01.132; Bolton DJ, 2015, FOOD MICROBIOL, V48, P99, DOI 10.1016/j.fm.2014.11.017; Cody AJ, 2013, J CLIN MICROBIOL, V51, P2526, DOI 10.1128/JCM.00066-13; Datta S, 2003, J MED MICROBIOL, V52, P345, DOI 10.1099/jmm.0.05056-0; de Vries SPW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194481; Dunn SJ, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000227; EFSA, 2017, EUR UN SUMM REP ANT; Ellington MJ, 2017, CLIN MICROBIOL INFEC, V23, P2, DOI 10.1016/j.cmi.2016.11.012; Facciola A, 2017, J Prev Med Hyg, V58, pE79; Findik A, 2011, TROP ANIM HEALTH PRO, V43, P711, DOI 10.1007/s11250-010-9758-0; Ge BL, 2005, ANTIMICROB AGENTS CH, V49, P3347, DOI 10.1128/AAC.49.8.3347-3354.2005; HPSC, 2016, CAMP ANN EP REP; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Lefebure T, 2010, GENOME BIOL EVOL, V2, P646, DOI 10.1093/gbe/evq048; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Linton D, 1996, RES MICROBIOL, V147, P707, DOI 10.1016/S0923-2508(97)85118-2; Llarena AK, 2017, J CLIN MICROBIOL, V55, P1269, DOI [10.1128/jcm.00017-17, 10.1128/JCM.00017-17]; Luangtongkum T, 2008, AVIAN DIS, V52, P487, DOI 10.1637/8181-112807-ResNote.1; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; Moore JE, 2006, MICROBES INFECT, V8, P1955, DOI 10.1016/j.micinf.2005.12.030; Mortensen NP, 2011, APMIS, V119, P626, DOI 10.1111/j.1600-0463.2011.02781.x; O'Mahony E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028490; Payot S, 2006, MICROBES INFECT, V8, P1967, DOI 10.1016/j.micinf.2005.12.032; Qin SS, 2014, J ANTIMICROB CHEMOTH, V69, P964, DOI 10.1093/jac/dkt492; Qin SS, 2012, ANTIMICROB AGENTS CH, V56, P5332, DOI 10.1128/AAC.00809-12; Rokney A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02432; Talukder KA, 2008, J CLIN MICROBIOL, V46, P1485, DOI 10.1128/JCM.01912-07; Wagenaar JA, 2013, CLIN INFECT DIS, V57, P1600, DOI 10.1093/cid/cit555; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhao SH, 2015, J ANTIMICROB CHEMOTH, V70, P1314, DOI 10.1093/jac/dkv001; Zheng J, 2006, J FOOD PROTECT, V69, P768, DOI 10.4315/0362-028X-69.4.768	35	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219088	10.1371/journal.pone.0219088	http://dx.doi.org/10.1371/journal.pone.0219088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291319	gold, Green Published, Green Submitted			2022-12-26	WOS:000484947800049
J	Yee, C; Main, NM; Terry, A; Stevanovski, I; Maczurek, A; Morgan, AJ; Calabro, S; Potter, AJ; Iemma, TL; Bowen, DG; Ahlenstiel, G; Warner, FJ; McCaughan, GW; McLennan, SV; Shackel, NA				Yee, Christine; Main, Nathan M.; Terry, Alexandra; Stevanovski, Igor; Maczurek, Annette; Morgan, Alison J.; Calabro, Sarah; Potter, Alison J.; Iemma, Tina L.; Bowen, David G.; Ahlenstiel, Golo; Warner, Fiona J.; McCaughan, Geoffrey W.; McLennan, Susan V.; Shackel, Nicholas A.			CD147 mediates intrahepatic leukocyte aggregation and determines the extent of liver injury	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MATRIX-METALLOPROTEINASE PRODUCTION; MULTIFUNCTIONAL PROTEINS; FUNCTIONAL-CHARACTERIZATION; EMMPRIN EXPRESSION; INDUCER EMMPRIN; STELLATE CELLS; INFLAMMATION; FIBROGENESIS; CIRRHOSIS	Background Chronic inflammation is the driver of liver injury and results in progressive fibrosis and eventual cirrhosis with consequences including both liver failure and liver cancer. We have previously described increased expression of the highly multifunctional glycoprotein CD147 in liver injury. This work describes a novel role of CD147 in liver inflammation and the importance of leukocyte aggregates in determining the extent of liver injury. Methods Non-diseased, progressive injury, and cirrhotic liver from humans and mice were examined using a mAb targeting CD147. Inflammatory cell subsets were assessed by multiparameter flow cytometry. Results In liver injury, we observe abundant, intrahepatic leukocyte clusters defined as >= 5 adjacent CD45(+) cells which we have termed "leukocyte aggregates". We have shown that these leukocyte aggregates have a significant effect in determining the extent of liver injury. If CD147 is blocked in vivo, these leukocyte aggregates diminish in size and number, together with a marked significant reduction in liver injury including fibrosis. This is accompanied by no change in overall intrahepatic leukocyte numbers. Further, blocking of aggregation formation occurs prior to an appreciable increase in inflammatory markers or fibrosis. Additionally, there were no observed, "off-target" or unpredicted effects in targeting CD147. Conclusion CD147 mediates leukocyte aggregation which is associated with the development of liver injury. This is not a secondary effect, but a cause of injury as aggregate formation proceeds other markers of injury. Leukocyte aggregation has been previously described in inflammation dating back over many decades. Here we demonstrate that leukocyte aggregates determine the extent of liver injury.	[Yee, Christine; Terry, Alexandra; Maczurek, Annette; Morgan, Alison J.; Calabro, Sarah; Potter, Alison J.; Iemma, Tina L.; Bowen, David G.; Warner, Fiona J.; McCaughan, Geoffrey W.; Shackel, Nicholas A.] Univ Sydney, Centenary Inst Canc Med & Cell Biol, Sydney, NSW, Australia; [Yee, Christine; Main, Nathan M.; Terry, Alexandra; Stevanovski, Igor; Shackel, Nicholas A.] Ingham Inst Appl Med Res, Gastroenterol & Liver Lab, Liverpool, Merseyside, England; [Bowen, David G.; McCaughan, Geoffrey W.; Shackel, Nicholas A.] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Camperdown, NSW, Australia; [Ahlenstiel, Golo] Blacktown Hosp, Western Sydney Sch Med, Blacktown, NSW, Australia; [McLennan, Susan V.] Univ Sydney, Royal Prince Alfred Hosp, Dept Med, Dept Endocrinol, Sydney, NSW, Australia; [McLennan, Susan V.] Univ Sydney, Royal Prince Alfred Hosp, Bosch Inst, Sydney, NSW, Australia; [Shackel, Nicholas A.] Liverpool Hosp, Liverpool, Merseyside, England	University of Sydney; Centenary Institute; University of Sydney; Blacktown & Mount Druitt Hospital; University of Sydney; University of Sydney	Shackel, NA (corresponding author), Univ Sydney, Centenary Inst Canc Med & Cell Biol, Sydney, NSW, Australia.; Shackel, NA (corresponding author), Ingham Inst Appl Med Res, Gastroenterol & Liver Lab, Liverpool, Merseyside, England.; Shackel, NA (corresponding author), Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Camperdown, NSW, Australia.; Shackel, NA (corresponding author), Liverpool Hosp, Liverpool, Merseyside, England.	n.shackel@unsw.edu.au	Ahlenstiel, Golo/U-1990-2017	Ahlenstiel, Golo/0000-0003-0026-1457; MCCAUGHAN, GEOFFREY/0000-0002-1483-1636; Yee, Christine/0000-0001-7243-5634; Bowen, David/0000-0002-7965-5581	NMHRC [1063515, 512283]	NMHRC	This work was funded by the NMHRC, Project Grant IDs: 1063515, 512283. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SM, 2011, J NEUROSCI, V31, P669, DOI 10.1523/JNEUROSCI.3659-10.2011; Bao W, 2010, AM J PHYSIOL-CELL PH, V299, pC1212, DOI 10.1152/ajpcell.00228.2010; Bataller R, 2005, HEPATOLOGY, V41, P1046, DOI 10.1002/hep.20665; Berzsenyi MD, 2011, J VIRAL HEPATITIS, V18, P852, DOI 10.1111/j.1365-2893.2010.01390.x; Betsuyaku T, 2003, AM J RESP CELL MOL, V28, P600, DOI 10.1165/rcmb.2002-0059OC; BHATHAL PS, 1983, BRIT J EXP PATHOL, V64, P524; Bowen DG, 2004, J CLIN INVEST, V114, P701, DOI 10.1172/JCI200421593; Calabro SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090571; Chapple CE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8412; Cho JY, 2001, BLOOD, V98, P374, DOI 10.1182/blood.V98.2.374; Choi WG, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0202-6; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Damsker JM, 2009, IMMUNOLOGY, V126, P55, DOI 10.1111/j.1365-2567.2008.02877.x; Fan YQ, 2011, INT J MOL MED, V27, P607, DOI 10.3892/ijmm.2011.621; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Guillot S, 2006, EXP LUNG RES, V32, P81, DOI 10.1080/01902140600710512; Gwinn WM, 2006, J IMMUNOL, V177, P4870, DOI 10.4049/jimmunol.177.7.4870; Hamzavi J, 2008, J CELL MOL MED, V12, P2130, DOI 10.1111/j.1582-4934.2008.00262.x; Hao JL, 2010, CURR CANCER DRUG TAR, V10, P287, DOI 10.2174/156800910791190193; Holz LE, 2010, J AUTOIMMUN, V34, P15, DOI 10.1016/j.jaut.2009.08.005; HOWARD RB, 1967, J CELL BIOL, V35, P675, DOI 10.1083/jcb.35.3.675; Huang LR, 2013, NAT IMMUNOL, V14, P574, DOI 10.1038/ni.2573; Huang ZQ, 2008, BIOCHEM BIOPH RES CO, V374, P517, DOI 10.1016/j.bbrc.2008.07.058; Jeffery CJ, 2003, ANN MED, V35, P28, DOI 10.1080/07853890310004101; Jiang JH, 2010, THESCIENTIFICWORLDJO, V10, P1244, DOI 10.1100/tsw.2010.141; JOSEPH J, 1993, ADV EXP MED BIOL, V342, P389; Kasinrerk W, 1999, IMMUNOLOGY, V96, P184; Kassel R, 2009, HEPATOLOGY, V50, P1625, DOI 10.1002/hep.23173; Khunkaewla P, 2008, MOL IMMUNOL, V45, P1703, DOI 10.1016/j.molimm.2007.09.032; Kim JY, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/821940; KIRSCHNER K, 1976, ANNU REV BIOCHEM, V45, P143, DOI 10.1146/annurev.bi.45.070176.001043; Lim M, 1998, FEBS LETT, V441, P88, DOI 10.1016/S0014-5793(98)01474-4; MACDONALD HR, 1985, J IMMUNOL, V135, P3944; Matsumoto G, 2002, J IMMUNOL, V169, P7087, DOI 10.4049/jimmunol.169.12.7087; Nevzorova YA, 2012, HEPATOLOGY, V56, P1140, DOI 10.1002/hep.25736; Ohteki T, 1999, J IMMUNOL, V162, P3753; Preiss S, 2008, J VIRAL HEPATITIS, V15, P888, DOI 10.1111/j.1365-2893.2008.01001.x; Pushkarsky T, 2001, P NATL ACAD SCI USA, V98, P6360, DOI 10.1073/pnas.111583198; Ravindran S, 2014, EXP CELL RES, V325, P148, DOI 10.1016/j.yexcr.2014.01.018; Riordan SM, 2003, HEPATOLOGY, V37, P1154, DOI 10.1053/jhep.2003.50180; Sancho-Bru P, 2005, J HEPATOL, V43, P272, DOI 10.1016/j.jhep.2005.02.035; Sato T, 2012, INT J ONCOL, V40, P236, DOI 10.3892/ijo.2011.1224; Sato T, 2009, GYNECOL ONCOL, V114, P337, DOI 10.1016/j.ygyno.2009.04.004; Shackel NA, 2003, HEPATOLOGY, V38, P577, DOI 10.1053/jhep.2003.50376; Shackel NA, 2001, GUT, V49, P565, DOI 10.1136/gut.49.4.565; Shackel NA, 2002, AM J PATHOL, V160, P641, DOI 10.1016/S0002-9440(10)64884-5; Testro AG, 2010, J HEPATOL, V52, P199, DOI 10.1016/j.jhep.2009.11.006; Testro AG, 2009, J GASTROEN HEPATOL, V24, P943, DOI 10.1111/j.1440-1746.2009.05854.x; Toole BP, 2003, CURR TOP DEV BIOL, V54, P371, DOI 10.1016/S0070-2153(03)54015-7; Treese C, 2008, CYTOM PART A, V73A, P351, DOI 10.1002/cyto.a.20532; Wang CH, 2011, J CELL MOL MED, V15, P850, DOI 10.1111/j.1582-4934.2010.01084.x; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; Xu Q, 2002, INFLAMM RES, V51, P44, DOI 10.1007/PL00000281; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Yurchenko V, 2010, CLIN EXP IMMUNOL, V160, P305, DOI 10.1111/j.1365-2249.2010.04115.x; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200; Yurchenko V, 2001, BIOCHEM BIOPH RES CO, V288, P786, DOI 10.1006/bbrc.2001.5847; Zhu P, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1899	60	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0215557	10.1371/journal.pone.0215557	http://dx.doi.org/10.1371/journal.pone.0215557			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291257	gold, Green Published, Green Submitted			2022-12-26	WOS:000484947800007
J	Wong, WY; Allie, S; Limesand, KH				Wong, Wen Yu; Allie, Sydney; Limesand, Kirsten H.			PKCB zeta and JNK signaling regulate radiation-induced compensatory proliferation in parotid salivary glands	PLOS ONE			English	Article							N-TERMINAL KINASE; CELL-PROLIFERATION; EPITHELIAL-CELLS; GENE-EXPRESSION; NECK-CANCER; APOPTOSIS; DAMAGE; MODEL; HEAD; SUPPRESSION	Radiotherapy is a common treatment option for head and neck cancer patients; however, the surrounding healthy salivary glands are often incidentally irradiated during the process. As a result, patients often experience persistent xerostomia and hyposalivation, which deceases their quality of life. Clinically, there is currently no standard of care available to restore salivary function. Repair of epithelial wounds involves cellular proliferation and establishment of polarity in order to regenerate the tissue. This process is partially mediated by protein kinase C zeta (PKC zeta), an apical polarity regulator; however, its role following radiation damage is not completely understood. Using an in vivo radiation model, we show a significant decrease in active PKC zeta in irradiated murine parotid glands, which correlates with increased proliferation that is sustained through 30 days post-irradiation. Additionally, salivary glands in PKC zeta null mice show increased basal proliferation which radiation treatment did not further potentiate. Radiation damage also activates Jun N-terminal kinase (JNK), a proliferation-inducing mitogen-activated protein kinase normally inhibited by PKC zeta. In both a PKC zeta null mouse model and in primary salivary gland cell cultures treated with a PKC zeta inhibitor, there was increased JNK activity and production of downstream proliferative transcripts. Collectively, these findings provide a potential molecular link by which PKC zeta suppression following radiation damage promotes JNK activation and radiation-induced compensatory proliferation in the salivary gland.	[Wong, Wen Yu; Limesand, Kirsten H.] Univ Arizona, Canc Biol Grad Interdisciplinary Program, Tucson, AZ 85721 USA; [Allie, Sydney; Limesand, Kirsten H.] Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Limesand, KH (corresponding author), Univ Arizona, Canc Biol Grad Interdisciplinary Program, Tucson, AZ 85721 USA.; Limesand, KH (corresponding author), Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA.	limesank@email.arizona.edu			NIH [R01 DE023534]; Cancer Biology Training Grant [T32CA00921338]; NATIONAL CANCER INSTITUTE [T32CA009213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023534] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Biology Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by NIH R01 DE023534 received by Kirsten Limesand and stipend support for Wen Yu Wong was provided by the Cancer Biology Training Grant, T32CA00921338. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aure MH, 2015, DEV CELL, V33, P231, DOI 10.1016/j.devcel.2015.02.013; Avila JL, 2009, INT J RADIAT ONCOL, V73, P523, DOI 10.1016/j.ijrobp.2008.09.036; BALLAGH RH, 1994, ORAL SURG ORAL MED O, V77, P27, DOI 10.1016/S0030-4220(06)80103-9; Belcher R, 2014, J SURG ONCOL, V110, P551, DOI 10.1002/jso.23724; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chibly AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24678-4; Chibly AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107893; Denaro N, 2016, CLIN EXP OTORHINOLAR, V9, P287, DOI 10.21053/ceo.2015.00976; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Friedrich RE, 2004, IN VIVO, V18, P213; Galvez AS, 2009, MOL CELL BIOL, V29, P104, DOI 10.1128/MCB.01294-08; Grundmann O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-417; Gupta KH, 2017, DEV CELL, V41, P674, DOI 10.1016/j.devcel.2017.05.014; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; Han LC, 2015, RADIAT RES, V183, P693, DOI 10.1667/RR13890.1; HAYNIE JL, 1977, ROUX ARCH DEV BIOL, V183, P85, DOI 10.1007/BF00848779; Hill G., 2014, PLOS ONE, V9, P1; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Lam K, 2001, J CELL PHYSIOL, V189, P79, DOI 10.1002/jcp.1142; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Limesand K, 2007, VITR CELL DEV BIOL A, V39, P170, DOI [10.1007/s11626-003-0012-1, DOI 10.1007/S11626-003-0012-1]; Limesand KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004663; Lin H. Helen, 2018, Critical Reviews in Oncogenesis, V23, P139, DOI 10.1615/CritRevOncog.2018027598; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llado V, 2015, CELL REP, V10, P740, DOI 10.1016/j.celrep.2015.01.007; Lo Nigro C, 2017, CANCER MANAG RES, V9, P363, DOI 10.2147/CMAR.S115761; Lombaert IMA, 2008, STEM CELLS, V26, P2595, DOI 10.1634/stemcells.2007-1034; Lourenco R, 2015, J CELL SCI, V128, DOI [10.1242/jcs.178871, DOI 10.1242/JCS.178871]; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Morgan-Bathke M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113183; Muhvic-Urek M, 2006, PHYSIOL RES, V55, P89, DOI 10.33549/physiolres.930739; Niessen MT, 2013, APKCA CONTROLS EPIDE, P889; Paardekooper GMRM, 1998, INT J RADIAT BIOL, V73, P641, DOI 10.1080/095530098141898; Paul A, PROMOTES BREAST CANC, DOI [10.1038/srep12520, DOI 10.1038/SREP12520]; PETER B, 1994, RADIAT RES, V140, P257, DOI 10.2307/3578910; Radfar L, 2003, ORAL SURG ORAL MED O, V96, P267, DOI 10.1016/S1079-2104(03)00369-X; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Schimizzi GV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159881; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Skwarek LC, 2014, DEVELOPMENT, V141, P2978, DOI 10.1242/dev.109694; Tanos B, 2008, ONCOGENE, V27, P6939, DOI 10.1038/onc.2008.345; Tateishi Y, 2008, BIOCHEM BIOPH RES CO, V366, P301, DOI 10.1016/j.bbrc.2007.11.039; Tensing EK, 2005, RHEUMATOL INT, V25, P28, DOI 10.1007/s00296-003-0386-0; Vorhagen S, 2014, EXP CELL RES, V328, P296, DOI 10.1016/j.yexcr.2014.08.008; Warner SJ, 2010, CURR BIOL, V20, P677, DOI 10.1016/j.cub.2010.03.025; Wong WY, 2018, AM J PHYSIOL-REG I, V315, pR656, DOI 10.1152/ajpregu.00388.2017; Xiao HL, 2013, J CELL PHYSIOL, V228, P416, DOI 10.1002/jcp.24146; Zhao CY, 2014, CANCER RES, V74, P3983, DOI 10.1158/0008-5472.CAN-13-3396	55	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219572	10.1371/journal.pone.0219572	http://dx.doi.org/10.1371/journal.pone.0219572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287841	gold, Green Submitted, Green Published			2022-12-26	WOS:000482328300032
J	Kinikar, A; Chandanwale, A; Kadam, D; Joshi, S; Basavaraj, A; Pardeshi, G; Girish, S; Shelke, S; DeLuca, A; Dhumal, G; Golub, J; Lokhande, N; Gupte, N; Gupta, A; Bollinger, R; Mave, V				Kinikar, Aarti; Chandanwale, Ajay; Kadam, Dileep; Joshi, Samir; Basavaraj, Anita; Pardeshi, Geeta; Girish, Sunita; Shelke, Sangeeta; DeLuca, Andrea; Dhumal, Gauri; Golub, Jonathan; Lokhande, Nilima; Gupte, Nikhil; Gupta, Amita; Bollinger, Robert; Mave, Vidya			High risk for latent tuberculosis infection among medical residents and nursing students in India	PLOS ONE			English	Article							HEALTH-CARE WORKERS; BCG	Defining occupational latent tuberculosis infection (LTBI) risk among healthcare workers is needed to support implementation of prevention guidelines. Prospective cohort study of 200 medical residents and nursing students in India was conducted May 2016-December 2017. Tuberculin skin test (TST) and QuantiFERON TB Gold Test-in-tube (QFT-GIT) were performed at study entry and 12 months. Primary outcome was incident LTBI (>= 10mm TST induration and/or >= 0.351U/mL QFT-GIT) at 12 months; secondary outcomes included baseline LTBI prevalence and risk factors for incident and prevalent LTBI using Poisson regression. Among 200, [90 nursing students and 110 medical residents], LTBI prevalence was 30% (95% Cl, 24-37); LTBI incidence was 26.8 (95% Cl, 18.6-37.2) cases per 100 person years and differed by testing method (28.7 [95% Cl, 20.6-38.9] vs 17.4 [95% Cl, 11.5-25.4] cases per 100 person-years using TST and QFT-GIT, respectively). Medical residents had two-fold greater risk of incident LTBI than nursing students (Relative Risk, 2.16; 95% Cl, 1.05-4.42). During study period 6 (3%) HCWs were diagnosed with active TB disease. Overall, median number of self-reported TB exposures was 5 (Interquartile Range, 1-15). Of 60 participants with prevalent and incident LTBI who were offered free isoniazid preventive therapy (IPT), only 2 participants initiated and completed IPT. High risk for LTBI was noted among medical residents compared to nursing students. Self-reported TB exposure is underreported, and uptake of LTBI prevention therapy remains low. New approaches are needed to identify HCWs at highest risk for LTBI.	[Kinikar, Aarti] BJGMC, JHU Clin Trial Unit, Dept Pediat, Pune, Maharashtra, India; [Chandanwale, Ajay] BJGMC, JHU Clin Trial Unit, Dept Orthoped, Pune, Maharashtra, India; [Kadam, Dileep] Smt Kashibai Navale Med Coll & Gen Hosp, Dept Med, Pune, Maharashtra, India; [Joshi, Samir] BJGMC, JHU Clin Trial Unit, Dept ENT, Pune, Maharashtra, India; [Basavaraj, Anita] Govt Med Coll, Dept Med, Miraj, Maharashtra, India; [Pardeshi, Geeta] Vardhman Mahavir Med Coll & Safdarjung Hosp, Dept Community Med, New Delhi, India; [Girish, Sunita] BJGMC, JHU Clin Trial Unit, Dept Biochem, Pune, Maharashtra, India; [Shelke, Sangeeta] BJGMC, JHU Clin Trial Unit, Dept Community Med, Pune, Maharashtra, India; [DeLuca, Andrea] Johns Hopkins Univ, Dept Environm Hlth & Engn, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Dhumal, Gauri; Lokhande, Nilima; Gupte, Nikhil; Mave, Vidya] BJGMC, JHU Clin Trial Unit, Pune, Maharashtra, India; [Golub, Jonathan] Johns Hopkins Univ, Sch Med, Dept Med Epidemiol & Int Hlth, Baltimore, MD USA; [Golub, Jonathan] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Gupte, Nikhil; Gupta, Amita; Bollinger, Robert; Mave, Vidya] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA	B.J. Govt. Medical College & Sassoon General Hospitals, Pune; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Vardhman Mahavir Medical College & Safdarjung Hospital; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Kinikar, A (corresponding author), BJGMC, JHU Clin Trial Unit, Dept Pediat, Pune, Maharashtra, India.	aarti.kinikar63@gmail.com	Golub, Jonathan/AAM-5928-2021	KINIKAR, AARTI/0000-0001-9466-1130; Bollinger, Robert/0000-0002-6798-6834; Gupta, Amita/0000-0001-7036-2718	National Institutes of Health (NIH) [U01A1069465]; BJGMC JHU HIV TB Program - Fogarty International Center, NIH [D43TW009574]; FOGARTY INTERNATIONAL CENTER [D43TW009574] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BJGMC JHU HIV TB Program - Fogarty International Center, NIH; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the National Institutes of Health (NIH) supplement for BWI Clinical Trials Unit for NIAID Networks (UM1) (P.I. Flexner/Gupta, U01A1069465) and the BJGMC JHU HIV TB Program funded by the Fogarty International Center, NIH) (grant #D43TW009574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Institute of Health (NIH) supplement for BWI Clinical Trials Unit for NIAID Networks (UM1) (P.I. Flexner/Gupta, U01A1069465) and the BJGMC JHU HIV TB Program funded by the Fogarty International Center, NIH) (grant #D43TW009574). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors also acknowledge support from Persistent Systems in kind.	[Anonymous], 2000, Am J Respir Crit Care Med, V161, pS221; [Anonymous], WHOHTMTB2009419; Basavaraj A, DEC 5 2015 46 WORLD; Basavaraj A, 2016, EMERG INFECT DIS, V22, P541, DOI 10.3201/eid2203.151673; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Bjartveit K, 2003, INT J TUBERC LUNG D, V7, P306; Centers for Disease Control and Prevention, 2006, APP B TUB TB RISK AS; Christopher DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010408; Harries AD, 2002, B WORLD HEALTH ORGAN, V80, P526; Hatherill M, 2016, CLIN INFECT DIS, V62, pS262, DOI 10.1093/cid/ciw025; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Lien Luu Thi, 2009, PLoS One, V4, pe6798, DOI 10.1371/journal.pone.0006798; Mathew A, 2013, J CLIN EPIDEMIOL, V66, P67, DOI 10.1016/j.jclinepi.2011.12.010; Ochoa J, 2015, EPIDEMIOL INFECT, V143, P2639, DOI 10.1017/S0950268814003537; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pardeshi Geeta S, 2017, Tuberc Res Treat, V2017, P7514817, DOI 10.1155/2017/7514817; Rafiza S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-19; Raitio M, 2003, INT J TUBERC LUNG D, V7, P556; Singh D, 2001, AM J RESP CRIT CARE, V164, P962, DOI 10.1164/ajrccm.164.6.2102076; Soto A, 2013, BRAZ J INFECT DIS, V17, P383, DOI 10.1016/j.bjid.2012.10.027; Teixeira EG, 2005, INT J TUBERC LUNG D, V9, P841; Tudor C, 2016, CLIN INFECT DIS, V62, pS255, DOI 10.1093/cid/ciw046; Uden L, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx137; van Cutsem G, 2016, CLIN INFECT DIS, V62, pS238, DOI 10.1093/cid/ciw012; Whitty JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058347; World Health Organization, 2009, WHO POL TB INF CONTR	26	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219131	10.1371/journal.pone.0219131	http://dx.doi.org/10.1371/journal.pone.0219131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283794	Green Submitted, gold, Green Published			2022-12-26	WOS:000484939800021
J	Petretto, A; Bruschi, M; Pratesi, F; Croia, C; Candiano, G; Ghiggeri, G; Migliorini, P				Petretto, Andrea; Bruschi, Maurizio; Pratesi, Federico; Croia, Cristina; Candiano, Giovanni; Ghiggeri, Gianmarco; Migliorini, Paola			Neutrophil extracellular traps (NET) induced by different stimuli: A comparative proteomic analysis	PLOS ONE			English	Article							NETTING NEUTROPHILS; NETOSIS; MYELOPEROXIDASE; CONTRIBUTE; TARGETS	Neutrophil extracellular traps (NET) formation is part of the neutrophil response to infections, but excessive or inappropriate NETosis may trigger the production of autoantibodies and cause organ damage in autoimmune disorders. Spontaneously netting neutrophils are not frequent and induction of NET in vitro by selected stimuli is necessary to investigate their structure. In the present work, the protein composition and post-translational modifications of NET produced under different stimuli have been studied by means of proteomic analysis. Neutrophils from healthy donors were stimulated by PMA, A23187, Escherichia coli LPS or untreated; after three hours, cells were washed, treated with DNase and supernatants collected for mass spectrometry. Data were analyzed by unsupervised hierarchical clustering analyses. We identified proteins contained in NETs of any source or exclusive of one stimulus: LPS-induced and spontaneous NET diverge in protein composition, while PMA- and A23187-induced NET appear more similar. Among the post-translational modifications we examined, methionine sulfoxidation is frequent especially in PMA- and LPS-induced NETs. Myeloperoxidase is the protein more extensively modified. Thus, proteomic analysis indicates that NETs induced by different stimuli are heterogeneous in terms of both protein composition and post-translational modifications, suggesting that NET induced in different conditions may have different biological effects.	[Petretto, Andrea] Ist Giannina Gaslini, Core Facil Lab, Core Facil, Prote Lab, Genoa, Italy; [Bruschi, Maurizio; Candiano, Giovanni] Ist Giannina Gaslini, Lab Mol Nephrol, Genoa, Italy; [Pratesi, Federico; Croia, Cristina; Migliorini, Paola] Univ Pisa, Dept Clin & Expt Med, Clin Immunol Unit, Pisa, Italy; [Ghiggeri, Gianmarco] Sci Inst Res & Hlth Care IRCCS, Ist Giannina Gaslini, Div Nephrol Dialysis & Transplantat, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Pisa; University of Genoa; IRCCS Istituto Giannina Gaslini	Migliorini, P (corresponding author), Univ Pisa, Dept Clin & Expt Med, Clin Immunol Unit, Pisa, Italy.	paola.migliorini@med.unipi.it	Croia, Cristina/AAD-5466-2019; Petretto, Andrea/AAA-7342-2020; Migliorini, Paola/P-6176-2015; Bruschi, Maurizio/E-7090-2016; Pratesi, Federico/AAB-3404-2019	Migliorini, Paola/0000-0001-6433-4964; Bruschi, Maurizio/0000-0001-6036-1500; Ghiggeri, Gian Marco/0000-0003-3659-9062; Petretto, Andrea/0000-0001-7811-8517; croia, cristina/0000-0001-7258-383X; PRATESI, FEDERICO/0000-0002-7226-0907				Barnado A, 2016, J LEUKOCYTE BIOL, V99, P265, DOI 10.1189/jlb.5BT0615-234R; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Corsiero E, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00485; Csernok E, 2014, NAT REV RHEUMATOL, V10, P494, DOI 10.1038/nrrheum.2014.78; de Souza CN, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01849; Delgado-Rizo V, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00081; Douda DN, 2015, P NATL ACAD SCI USA, V112, P2817, DOI 10.1073/pnas.1414055112; Dwivedi N, 2014, ANN RHEUM DIS, V73, P483, DOI 10.1136/annrheumdis-2013-203844; ENGLISH D, 1974, J IMMUNOL METHODS, V5, P249, DOI 10.1016/0022-1759(74)90109-4; Fadini GP, 2016, DIABETES, V65, P1061, DOI 10.2337/db15-0863; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hamam HJ, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9010032; Hoppenbrouwers T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176472; Kain R, 2012, J AM SOC NEPHROL, V23, P556, DOI 10.1681/ASN.2011090920; Kenny EF, 2017, ELIFE, V6, DOI [10.7554/elife.24437, 10.7554/eLife.24437]; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Khan MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03257-z; Khan MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41749; Knight JS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00380; Korkmaz B, 2013, SEMIN IMMUNOPATHOL, V35, P411, DOI 10.1007/s00281-013-0362-z; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Liu CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3707; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Naccache PH, 2016, EUR J IMMUNOL, V46, P52, DOI 10.1002/eji.201546022; Neeli I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00038; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pieterse E, 2015, CLIN EXP IMMUNOL, V179, P68, DOI 10.1111/cei.12359; Pieterse E, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00484; Radic M, 2013, SEMIN IMMUNOPATHOL, V35, P465, DOI 10.1007/s00281-013-0376-6; Sollberger G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157454; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Yang H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00302	38	75	78	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0218946	10.1371/journal.pone.0218946	http://dx.doi.org/10.1371/journal.pone.0218946			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283757	gold, Green Published, Green Submitted			2022-12-26	WOS:000484939800015
J	Kulikovskikh, I; Prokhorov, S; Lipic, T; Legovic, T; Smuc, T				Kulikovskikh, Ilona; Prokhorov, Sergej; Lipic, Tomislav; Legovic, Tarzan; Smuc, Tomislav			BioGD: Bio-inspired robust gradient descent	PLOS ONE			English	Article								Recent research in machine learning pointed to the core problem of state-of-the-art models which impedes their widespread adoption in different domains. The models' inability to differentiate between noise and subtle, yet significant variation in data leads to their vulnerability to adversarial perturbations that cause wrong predictions with high confidence. The study is aimed at identifying whether the algorithms inspired by biological evolution may achieve better results in cases where brittle robustness properties are highly sensitive to the slight noise. To answer this question, we introduce the new robust gradient descent inspired by the stability and adaptability of biological systems to unknown and changing environments. The proposed optimization technique involves an open-ended adaptation process with regard to two hyperparameters inherited from the generalized Verhulst population growth equation. The hyperparameters increase robustness to adversarial noise by penalizing the degree to which hardly visible changes in gradients impact prediction. The empirical evidence on synthetic and experimental datasets confirmed the viability of the bio-inspired gradient descent and suggested promising directions for future research. The code used for computational experiments is provided in a repository at https://github.com/yukinoi/bio_gradient_descent.	[Kulikovskikh, Ilona; Prokhorov, Sergej] Samara Natl Res Univ, Dept Informat Syst & Technol, Samara, Russia; [Kulikovskikh, Ilona] Univ Zagreb, Fac Elect Engn & Comp, Zagreb, Croatia; [Kulikovskikh, Ilona; Lipic, Tomislav; Smuc, Tomislav] Rudjer Boskovic Inst, Div Elect, Zagreb, Croatia; [Legovic, Tarzan] Rudjer Boskovic Inst, Div Marine & Environm Res, Zagreb, Croatia	Samara National Research University; University of Zagreb; Rudjer Boskovic Institute; Rudjer Boskovic Institute	Kulikovskikh, I (corresponding author), Samara Natl Res Univ, Dept Informat Syst & Technol, Samara, Russia.; Kulikovskikh, I (corresponding author), Univ Zagreb, Fac Elect Engn & Comp, Zagreb, Croatia.; Kulikovskikh, I (corresponding author), Rudjer Boskovic Inst, Div Elect, Zagreb, Croatia.	ilona@irb.hr	Lipic, Tomislav/J-3641-2017; Kulikovskikh, Ilona/ABD-2156-2020; Kulikovskikh, Ilona/P-2209-2015	Lipic, Tomislav/0000-0002-8037-8198; Kulikovskikh, Ilona/0000-0002-6653-5978; Kulikovskikh, Ilona/0000-0002-6653-5978	Ministry of Science and Higher Education of Russian Federation (Russian Federation) [MK-6218.2018.9]; Russian Foundation for Basic Research [18-37-00219]; Ministry of Education and Science of the Russian Federation [074-U01]; Centre of Excellence project "DATACROSS"; European Union through the European Regional Development Fund-the Competitiveness and Cohesion Operational Programme [KK.01.1.1.01.0009]; Croatian Government	Ministry of Science and Higher Education of Russian Federation (Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Centre of Excellence project "DATACROSS"; European Union through the European Regional Development Fund-the Competitiveness and Cohesion Operational Programme; Croatian Government	This work was supported by the Ministry of Science and Higher Education of Russian Federation (Russian Federation President grant No. MK-6218.2018.9) to IK, the Russian Foundation for Basic Research (grant No. 18-37-00219) to IK, and the Ministry of Education and Science of the Russian Federation (grant No. 074-U01) to IK, and SP. IK, ToL and TS acknowledge the support by the Centre of Excellence project "DATACROSS," cofinanced by the Croatian Government and the European Union through the European Regional Development Fund-the Competitiveness and Cohesion Operational Programme (KK.01.1.1.01.0009). The URLs of the funders are https://minobrnauki.gov.ru, http://www.rfbr.ru/rffi/eng and https://ec.europa.eu/regional_policy/en/funding/erdf/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee WC, 1927, Q REV BIOL, V2, P367, DOI 10.1086/394281; Athalye A, 2018, PR MACH LEARN RES, V80; Barradas-Bautista D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195654; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Biggio B, 2018, PATTERN RECOGN, V84, P317, DOI 10.1016/j.patcog.2018.07.023; Brodbeck L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128444; Carlini N, 2017, P IEEE S SECUR PRIV, P39, DOI 10.1109/SP.2017.49; Chen B, 2019, WORKSH ART INT SAF C; Cherry KM, 2018, NATURE, V559, P370, DOI 10.1038/s41586-018-0289-6; Christian Szegedy, 2014, Arxiv, DOI arXiv:1312.6199; Crandall JW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02597-8; Cully A, 2015, NATURE, V521, P503, DOI 10.1038/nature14422; Dawes J, 2017, NAT HUM BEHAV, V1, P613, DOI 10.1038/s41562-017-0182-6; DRUCKER H, 1992, IEEE T NEURAL NETWOR, V3, P991, DOI 10.1109/72.165600; Floreano D, 2008, INTELLIGENT ROBOTICS; Floreano D, 2015, NATURE, V521, P460, DOI 10.1038/nature14542; Floreano D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000292; FOERSTER HV, 1960, SCIENCE, V132, P1291; Ghodrati M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032357; Goodfellow Ian J, 2015, INT C LEARN REPR ICL; Guo C., 2018, ARXIV, P1; Ilyas A, 2018, ARXIV171209196; Jang BS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31007-2; Kingma DP., 2014, ADAM METHOD STOCHAST; Kurakin A, 2018, ICLR WORKSH; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; LeCun Yann, 2010, MNIST HANDWRITTEN DI; Legovic T, 2016, ECOLOGICAL MODEL TYP; Li Y., 2018, ARXIV180206552; Madry A., 2017, ARXIV170606083; Malthus Th.R., 1798, ESSAY PRINCIPLE POPU; Martinez-Cantin R., 2018, AISTATS, V84, P1722; Maxmen A, 2018, NATURE, V553, P9, DOI 10.1038/d41586-018-00004-w; McDonald J.H, 2014, HDB BIOL STAT, V3rd; Miyato T., 2016, ICLR; Mocanu DC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04316-3; Moosavi-Dezfooli SM, 2017, PROC CVPR IEEE, P86, DOI 10.1109/CVPR.2017.17; Moosavi-Dezfooli SM, 2016, PROC CVPR IEEE, P2574, DOI 10.1109/CVPR.2016.282; Nirschl JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192726; Okun H, 6854 GITH; Palagi S, 2018, NAT REV MATER, V3, P113, DOI 10.1038/s41578-018-0016-9; Papernot N, 2016, 1ST IEEE EUROPEAN SYMPOSIUM ON SECURITY AND PRIVACY, P372, DOI 10.1109/EuroSP.2016.36; Rauber J, 2018, ARXIV 1707 04131; Ros AS, 2018, AAAI CONF ARTIF INTE, P1660; Shariff A, 2017, NAT HUM BEHAV, V1, P694, DOI 10.1038/s41562-017-0202-6; Smilkov D, 2018, ICML, P274; Soudry D, 2018, J MACH LEARN RES, V19; Taddeo M, 2018, NATURE, V556, P296, DOI 10.1038/d41586-018-04602-6; Varga D, 2018, ARXIV171209936; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Webb S, 2018, NATURE, V554, P555, DOI 10.1038/d41586-018-02174-z; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Xu WL, 2018, 25TH ANNUAL NETWORK AND DISTRIBUTED SYSTEM SECURITY SYMPOSIUM (NDSS 2018), DOI 10.14722/ndss.2018.23198; Yao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090695; Yu Fuxun, 2018, ARXIV180509370; Zantedeschi V, 2017, 10 ACM WORKSH ART IN; Zhu XQ, 2004, ARTIF INTELL REV, V22, P177, DOI 10.1007/s10462-004-0751-8	57	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219004	10.1371/journal.pone.0219004	http://dx.doi.org/10.1371/journal.pone.0219004			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276469	Green Submitted, Green Published, gold			2022-12-26	WOS:000484936300031
J	Teo, KK; Rafiq, T; Anand, SS; Schulze, KM; Yusuf, S; McDonald, SD; Wahi, G; Abdalla, N; Desai, D; Atkinson, SA; Morrison, KM				Teo, Koon K.; Rafiq, Talha; Anand, Sonia S.; Schulze, Karleen M.; Yusuf, Salim; McDonald, Sarah D.; Wahi, Gita; Abdalla, Nora; Desai, Dipika; Atkinson, Stephanie A.; Morrison, Katherine M.			Associations of cardiometabolic outcomes with indices of obesity in children aged 5 years and younger	PLOS ONE			English	Article							BODY-MASS INDEX; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; ADOLESCENT OVERWEIGHT; SKINFOLD THICKNESS; HEALTH-RISKS; US CHILDREN; CHILDHOOD; PREVENTION; MESSAGE	Background Childhood obesity is a world-wide concern due to its growing prevalence and association with cardiometabolic risk factors in childhood and subsequent adult cardiovascular disease. In young pre-school children, there is uncertainty regarding which of the commonly used anthropometric measures of childhood obesity is best associated with cardiometabolic risk factors. This study compared the utility of common measures used in identifying obesity in these young children. Methods The four commonly used metrics for identifying obesity in children: body fat percentage >= 90 th percentile, waist circumference >= 90 th percentile, BMI z score > 2 SD and waist-to-height ratio (WHtR) >= 0.5, were measured in a cohort of children born singleton, at full term and followed from birth (n = 761) to 5 years of age (n = 513). The utility of each in identifying cardiometabolic risk factors (fasting lipid profile, fasting blood glucose and blood pressure) was examined. Results At age 5 years, children with percent body fat >= 90 th percentile or waist circumference >= 90 th percentile, were associated with higher levels of triglycerides, glucose, and systolic and diastolic blood pressures than those < 90 th percentile, respectively. Such differences were not obvious at age 3 years or at birth. A BMI z-score > 2 SD was associated with higher levels of triglycerides and systolic and diastolic blood pressure but not glucose at age 5 years. Differences in HDL cholesterol, fasting glucose and systolic blood pressure were observed in children with BMI z score > 2 SD at age 3 years but not with the other indices of obesity. As almost all children had WHtR >= 0.5 at birth, ages 1 and 3 years, this measure could not differentiate increased cardiometabolic risk. At age 5 years, the differences were much more obvious, with significant differences in triglycerides and systolic and diastolic blood pressures between those with WHtR >= 0.5 and those with < 0.5. Conclusion Each of the four commonly used measures of childhood obesity shows moderate associations with cardiometabolic risk factors at 5 years, with no advantage of one measure over the other. These associations were less consistent at 3 years of age or younger. These observations have not been reported previously.	[Teo, Koon K.; Rafiq, Talha; Anand, Sonia S.; Schulze, Karleen M.; Yusuf, Salim; Abdalla, Nora; Desai, Dipika] McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Teo, Koon K.; Anand, Sonia S.; Yusuf, Salim] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Anand, Sonia S.] McMaster Univ, Chanchlani Res Ctr, Hamilton, ON, Canada; [Anand, Sonia S.; McDonald, Sarah D.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Dept Radiol, Hamilton, ON, Canada; [Wahi, Gita; Atkinson, Stephanie A.; Morrison, Katherine M.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Teo, KK (corresponding author), McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.; Teo, KK (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	teok@mcmaster.ca	Morrison, Katherine/AAO-8046-2021; Atkinson, Stephanie/AAS-4146-2021; Rafiq, Talha/AAA-5082-2022; Wahi, Gita/AAS-3312-2021	Morrison, Katherine/0000-0002-1737-256X; Atkinson, Stephanie/0000-0002-5680-7546; Wahi, Gita/0000-0001-5943-9702; Yusuf, Salim/0000-0003-4776-5601; Schulze, Karleen/0000-0002-7481-5697	CIHR [125895]; Heart & Stroke Foundation [7065]; Canadian Institute of Health Research (CIHR); Heart & Stroke Foundation of Canada; Population Health Research Institute, McMaster University	CIHR(Canadian Institutes of Health Research (CIHR)); Heart & Stroke Foundation(Heart & Stroke Foundation of Canada); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Population Health Research Institute, McMaster University	Funded by KT. CIHR: #125895. Heart & Stroke Foundation: #7065. Canadian Institute of Health Research (CIHR). Heart & Stroke Foundation of Canada. http://www.cihr-irsc.gc.ca/e/193.html.http://www.hsf.ca/research/en/grants-aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by research grants from Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada and by funds and in-kind contributions from Population Health Research Institute, McMaster University.	Abbasi A, 2017, J ENDOCR SOC, V1, P524, DOI 10.1210/js.2017-00044; Addo OY, 2010, AM J CLIN NUTR, V91, P635, DOI 10.3945/ajcn.2009.28385; Ahrens W, 2014, INT J OBESITY, V38, pS4, DOI 10.1038/ijo.2014.130; [Anonymous], 1991, ANTHROPOMETRIC STAND; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Bauer KW, 2015, PEDIATR OBES, V10, P329, DOI 10.1111/ijpo.267; Campagnolo PDB, 2011, ANN HUM BIOL, V38, P265, DOI 10.3109/03014460.2010.526147; Brady TM, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00197; Brambilla P, 2013, INT J OBESITY, V37, P943, DOI 10.1038/ijo.2013.32; Centers for Disease Control and Prevention, 2013, GROWTH CHART TRAIN S; Cook Stephen, 2009, J Pediatr, V155, DOI 10.1016/j.jpeds.2009.04.051; Cook S, 2011, PEDIATR CLIN N AM, V58, P1363, DOI 10.1016/j.pcl.2011.09.003; DEURENBERG P, 1990, BRIT J NUTR, V63, P293, DOI 10.1079/BJN19900116; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Elsedfy H, 2014, EGYPT J MED HUM GENE, V15, P249, DOI [10.1016/j.ejmhg.2014.03.002, DOI 10.1016/J.EJMHG.2014.03.002]; Engeland A, 2004, EPIDEMIOLOGY, V15, P79, DOI 10.1097/01.ede.0000100148.40711.59; Field AE, 2005, OBES RES, V13, P163, DOI 10.1038/oby.2005.21; Flegal KM, 2009, AM J CLIN NUTR, V90, P1314, DOI 10.3945/ajcn.2009.28335; Franks PW, 2010, SURV ANESTHESIOL, V54, P237, DOI [10.1097/01.sa.0000388008.28203.4a, DOI 10.1097/01.SA.0000388008.28203.4A]; Freedman DS, 2007, AM J CLIN NUTR, V86, P33, DOI 10.1093/ajcn/86.1.33; Goran MI, 1998, PEDIATRICS, V101, P505; Graves L, 2014, PEDIATR OBES, V9, P327, DOI 10.1111/j.2047-6310.2013.00192.x; Gungor NK, 2014, J CLIN RES PEDIATR E, V6, P129, DOI [10.4274/jcrpe.1471, 10.4274/Jcrpe.1471]; Guo SS, 2002, AM J CLIN NUTR; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Kelishadi R, 2015, J RES MED SCI, V20, P294; Kelly AS, 2013, CIRCULATION, V128, P1689, DOI 10.1161/CIR.0b013e3182a5cfb3; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; Lee JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158818; Li CY, 2006, PEDIATRICS, V118, pE1390, DOI 10.1542/peds.2006-1062; Maffeis C, 2008, J PEDIATR-US, V152, P207, DOI 10.1016/j.jpeds.2007.09.021; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; McCrindle BW, 2015, CAN J CARDIOL, V31, DOI 10.1016/j.cjca.2014.08.017; Mokha JS, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-73; Morrison KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055815; Morrison KM, 2009, AM HEART J, V158, P533, DOI 10.1016/j.ahj.2009.07.005; Shah NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033308; Skinner AC, 2015, NEW ENGL J MED, V373, P1307, DOI 10.1056/NEJMoa1502821; Slaughter MH, 1988, HUM BIOL; Subcommittee on Attention-Deficit/Hyperactivity Disorder Steering Committee on Quality Improvement and Management, 2011, PEDIATRICS; WHO Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA, DOI 10.1093/tropej/fmn002; Xu SM, 2016, EXP THER MED, V11, P15, DOI 10.3892/etm.2015.2853; Zhao M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43686	44	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0218816	10.1371/journal.pone.0218816	http://dx.doi.org/10.1371/journal.pone.0218816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276512	gold, Green Published, Green Submitted			2022-12-26	WOS:000484936300023
J	Grubac, Z; Sutulovic, N; Ademovic, A; Velimirovic, M; Rasic-Markovic, A; Macut, D; Petronijevic, N; Stanojlovic, O; Hrncic, D				Grubac, Zeljko; Sutulovic, Nikola; Ademovic, Anida; Velimirovic, Milica; Rasic-Markovic, Aleksandra; Macut, Djuro; Petronijevic, Natasa; Stanojlovic, Olivera; Hrncic, Dragan			Short-term sleep fragmentation enhances anxiety-related behavior: The role of hormonal alterations	PLOS ONE			English	Article							TESTOSTERONE LEVELS; SEX-DIFFERENCES; COGNITIVE PERFORMANCE; NEUROACTIVE STEROIDS; ANDROGEN TREATMENT; GABA(A) RECEPTOR; WAKE BEHAVIOR; OPEN-FIELD; MALE RATS; PROGESTERONE	Introduction The neuroendocrine background of acute sleep fragmentation in obstructive sleep apnea and sleep fragmentation involvement in psychiatric comorbidities, common in these patients, are still largely unknown. The aim of this study was to determine the effects of short-term experimental sleep fragmentation on anxiety -like behavior and hormonal status in rats. Methods Male rats were adapted to treadmill (ON and OFF mode with belt speed set on 0.02m/s and 0.00m/s) and randomized to: 1) treadmill control (TC, only OFF mode); 2) motion, activity control (AC, 10min ON and 30min OFF mode) and 3) sleep fragmentation (SF, 30s ON and 90s OFF mode) group. Six hours later, the animals were tested in the open field, elevated plus maze and light/dark test (n = 8/group). Testosterone, estradiol, progesterone and corticosterone were determined in separate animal cohort immediately upon sleep fragmentation (n = 6/group). Results SF rats showed decreased rearings number, decreased time spent in the central area and increased thigmotaxic index compared to TC and AC rats in the open field test. Similarly, increased anxiety upon sleep fragmentation was observed in the elevated plus maze and the light/dark test. Significantly lower testosterone, estradiol and progesterone levels were determined in SF in comparison to AC and TC groups, while there was no significant difference in the levels of corticosterone. Conclusion Short term sleep fragmentation enhances anxiety-related behavior in rats, which could be partly mediated by the observed hormonal changes presented in the current study in form of testosterone, estradiol and progesterone depletion.	[Grubac, Zeljko; Sutulovic, Nikola; Ademovic, Anida; Rasic-Markovic, Aleksandra; Stanojlovic, Olivera; Hrncic, Dragan] Univ Belgrade, Inst Med Physiol Richard Burian, Lab Neurophysiol, Fac Med, Belgrade, Serbia; [Velimirovic, Milica; Petronijevic, Natasa] Univ Belgrade, Inst Clin & Med Biochem, Fac Med, Belgrade, Serbia; [Macut, Djuro] Univ Belgrade, CCS, Fac Med, Clin Endocrinol Diabet & Metab Dis, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade	Hrncic, D (corresponding author), Univ Belgrade, Inst Med Physiol Richard Burian, Lab Neurophysiol, Fac Med, Belgrade, Serbia.	drhrncic@yahoo.com	Šutulović, Nikola/AAN-8939-2021; Rasic-Markovic, Aleksandra/AAT-5675-2021; Rasic Markovic, Aleksandra/AAA-9441-2022; Hrncic, Dragan/AAT-2544-2021; Velimirovic, Milica/R-9449-2017	Šutulović, Nikola/0000-0002-9499-3247; Rasic Markovic, Aleksandra/0000-0003-1131-2328; Hrncic, Dragan/0000-0003-0806-444X; Stanojlovic, Olivera/0000-0001-5317-3827; Velimirovic, Milica/0000-0002-0495-0316	Ministry of Education, Science and Technological Development of Serbia [175032]	Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This study has been supported by the Ministry of Education, Science and Technological Development of Serbia (grant #175032) to OS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study has been supported by the Ministry of Education, Science and Technological Development of Serbia (grant #175032).	Aikey JL, 2002, HORM BEHAV, V42, P448, DOI 10.1006/hbeh.2002.1838; Andersen ML, 2005, PROG NEURO-PSYCHOPH, V29, P245, DOI 10.1016/j.pnpbp.2004.11.007; Barrett-Connor E, 2008, J CLIN ENDOCR METAB, V93, P2602, DOI 10.1210/jc.2007-2622; Batterham PJ, 2012, AUST NZ J PSYCHIAT, V46, P1089, DOI 10.1177/0004867412457997; BITRAN D, 1993, HORM BEHAV, V27, P568, DOI 10.1006/hbeh.1993.1041; BOISSY A, 1994, HORM BEHAV, V28, P66, DOI 10.1006/hbeh.1994.1006; Bonnet MH, 2003, SLEEP MED REV, V7, P297, DOI 10.1053/smrv.2001.0245; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Carboni E, 1996, PSYCHOPHARMACOLOGY, V126, P173, DOI 10.1007/BF02246353; Carrier N, 2015, BIOL PSYCHIAT, V78, P259, DOI 10.1016/j.biopsych.2014.12.024; COHEN LS, 1994, J CLIN PSYCHIAT, V55, P284; Colvonen PJ, 2015, J CLIN SLEEP MED, V11, P513, DOI 10.5664/jcsm.4692; COSTALL B, 1989, PHARMACOL BIOCHEM BE, V32, P777, DOI 10.1016/0091-3057(89)90033-6; Cox RC, 2016, J ANXIETY DISORD, V37, P104, DOI 10.1016/j.janxdis.2015.12.001; Datta S, 2007, NEUROSCI BIOBEHAV R, V31, P775, DOI 10.1016/j.neubiorev.2007.02.004; Farr SA, 2000, BRAIN RES, V864, P263, DOI 10.1016/S0006-8993(00)02184-3; Fernandez-Guasti A, 2005, PSYCHONEUROENDOCRINO, V30, P762, DOI 10.1016/j.psyneuen.2005.03.006; Fernandez-Guasti A, 2003, PHARMACOL BIOCHEM BE, V75, P473, DOI 10.1016/S0091-3057(03)00142-4; Filova B, 2015, NEUROSCI BULL, V31, P288, DOI 10.1007/s12264-014-1510-8; Fisher SP, 2012, J BIOL RHYTHM, V27, P48, DOI 10.1177/0748730411431550; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; FRYE CA, 1994, BRAIN RES, V643, P194, DOI 10.1016/0006-8993(94)90025-6; Frye CA, 2000, PHARMACOL BIOCHEM BE, V67, P587, DOI 10.1016/S0091-3057(00)00392-0; Frye CA, 2001, COGN AFFECT BEHAV NE, V1, P371, DOI 10.3758/CABN.1.4.371; Frye CA, 2001, COGN AFFECT BEHAV NE, V1, P172, DOI 10.3758/CABN.1.2.172; Gambineri A, 2003, J ENDOCRINOL INVEST, V26, P493, DOI 10.1007/BF03345209; Gater R, 1998, ARCH GEN PSYCHIAT, V55, P405, DOI 10.1001/archpsyc.55.5.405; Greenwood BN, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00146; Gulinello M, 2002, NEUROPHARMACOLOGY, V43, P701, DOI 10.1016/S0028-3908(02)00171-5; Guzman-Marin R, 2007, NEUROSCIENCE, V148, P325, DOI 10.1016/j.neuroscience.2007.05.030; Han Kuem Sun, 2012, Exp Neurobiol, V21, P141, DOI 10.5607/en.2012.21.4.141; Hirotsu C, 2015, SLEEP SCI, V8, P143, DOI 10.1016/j.slsci.2015.09.002; Horne J, 1999, OCCUP ENVIRON MED, V56, P289, DOI 10.1136/oem.56.5.289; Hoyt BD, 2005, PRIMARY CARE, V32, P535, DOI 10.1016/j.pop.2005.02.013; Hrncic D, 2016, CAN J PHYSIOL PHARM, V94, P1074, DOI 10.1139/cjpp-2015-0581; Hrncic D, 2016, PHYSIOL BEHAV, V155, P188, DOI 10.1016/j.physbeh.2015.12.016; James Stephen M, 2017, Curr Sleep Med Rep, V3, P104, DOI 10.1007/s40675-017-0071-6; Kirbas G, 2007, J INT MED RES, V35, P38, DOI 10.1177/147323000703500103; Le Dantec Y, 2014, NEUROSCIENCE, V274, P357, DOI 10.1016/j.neuroscience.2014.05.050; Le Melledo Jean-Michel, 2004, Expert Rev Neurother, V4, P851, DOI 10.1586/14737175.4.5.851; Lin WC, 2012, CURR PSYCHIAT REP, V14, P503, DOI 10.1007/s11920-012-0307-6; Liu YY, 2019, MED SCI MONITOR, V25, P1806, DOI 10.12659/MSM.913056; Longone Patrizia, 2011, Front Endocrinol (Lausanne), V2, P55, DOI 10.3389/fendo.2011.00055; Lorincz ML, 2017, PROG NEUROBIOL, V151, P237, DOI 10.1016/j.pneurobio.2016.09.003; Luboshitzky R, 2001, J CLIN ENDOCR METAB, V86, P1134, DOI 10.1210/jc.86.3.1134; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Mccoy JG, 2007, SLEEP, V30, P52, DOI 10.1093/sleep/30.1.52; McGuire M, 2008, J PHYSIOL-LONDON, V586, P5215, DOI 10.1113/jphysiol.2008.158121; McHenry J, 2014, FRONT NEUROENDOCRIN, V35, P42, DOI 10.1016/j.yfrne.2013.09.001; McKenna JT, 2007, NEUROSCIENCE, V146, P1462, DOI 10.1016/j.neuroscience.2007.03.009; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Melcangi RC, 2008, CELL MOL LIFE SCI, V65, P777, DOI 10.1007/s00018-007-7403-5; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Morsink LFJ, 2007, PSYCHONEUROENDOCRINO, V32, P874, DOI 10.1016/j.psyneuen.2007.06.009; Nair D, 2011, AM J RESP CRIT CARE, V184, P1305, DOI 10.1164/rccm.201107-1173OC; Neckelmann D, 2007, SLEEP, V30, P873, DOI 10.1093/sleep/30.7.873; Oettel M, 2004, Aging Male, V7, P236; Park DS, 2014, SLEEP BIOL RHYTHMS, V12, P135, DOI 10.1111/sbr.12052; Perry JC, 2008, PROG NEURO-PSYCHOPH, V32, P87, DOI 10.1016/j.pnpbp.2007.07.017; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Reddy DS, 2005, NEUROPHARMACOLOGY, V48, P14, DOI 10.1016/j.neuropharm.2004.09.002; Reul Johannes M H M, 2002, Dialogues Clin Neurosci, V4, P31; Rupprecht R, 2001, INT REV NEUROBIOL, V46, P461; Schmitt K, 2016, ANN MED, V48, P42, DOI 10.3109/07853890.2015.1131327; Sharafkhaneh A, 2005, SLEEP, V28, P1405, DOI 10.1093/sleep/28.11.1405; Sharma S, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/270832; Soderpalm AHV, 2004, PSYCHONEUROENDOCRINO, V29, P339, DOI 10.1016/S0306-4530(03)00033-7; Stepanski EJ, 2002, SLEEP, V25, P268, DOI 10.1093/sleep/25.3.268; Suchecki D, 2002, J NEUROENDOCRINOL, V14, P549, DOI 10.1046/j.1365-2826.2002.00812.x; Suchecki Deborah, 2012, Front Neurol, V3, P41, DOI 10.3389/fneur.2012.00041; Tartar JL, 2009, BEHAV BRAIN RES, V197, P450, DOI 10.1016/j.bbr.2008.08.035; Tufik S, 2009, AN ACAD BRAS CIENC, V81, P521, DOI 10.1590/S0001-37652009000300016; VANDENHEEDE M, 1993, HORM BEHAV, V27, P435, DOI 10.1006/hbeh.1993.1032; Wagner CK, 2006, FRONT NEUROENDOCRIN, V27, P340, DOI 10.1016/j.yfrne.2006.07.003; Ward CP, 2009, BRAIN RES, V1294, P128, DOI 10.1016/j.brainres.2009.07.064; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Yonkers KA, 1997, J CLIN PSYCHIAT, V58, P62	78	7	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0218920	10.1371/journal.pone.0218920	http://dx.doi.org/10.1371/journal.pone.0218920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4CE	31269081	Green Submitted, gold, Green Published			2022-12-26	WOS:000484927300030
J	Ippoliti, C; Candeloro, L; Gilbert, M; Goffredo, M; Mancini, G; Curci, G; Falasca, S; Tora, S; Di Lorenzo, A; Quaglia, M; Conte, A				Ippoliti, Carla; Candeloro, Luca; Gilbert, Marius; Goffredo, Maria; Mancini, Giuseppe; Curci, Gabriele; Falasca, Serena; Tora, Susanna; Di Lorenzo, Alessio; Quaglia, Michela; Conte, Annamaria			Defining ecological regions in Italy based on a multivariate clustering approach: A first step towards a targeted vector borne disease surveillance	PLOS ONE			English	Article							WEST NILE VIRUS; CULICOIDES-IMICOLA; OBSOLETUS-COMPLEX; BLUETONGUE VIRUS; EPIDEMIOLOGY; IDENTIFICATION; VALIDATION; ABUNDANCE; SYSTEM	Ecoregionalization is the process by which a territory is classified in similar areas according to specific environmental and climatic factors. The climate and the environment strongly influence the presence and distribution of vectors responsible for significant human and animal diseases worldwide. In this paper, we developed a map of the eco-climatic regions of Italy adopting a data-driven spatial clustering approach using recent and detailed spatial data on climatic and environmental factors. We selected seven variables, relevant for a broad set of human and animal vector-borne diseases (VBDs): standard deviation of altitude, mean daytime land surface temperature, mean amplitude and peak timing of the annual cycle of land surface temperature, mean and amplitude of the annual cycle of greenness value, and daily mean amount of rainfall. Principal Component Analysis followed by multivariate geographic clustering using the k-medoids technique were used to group the pixels with similar characteristics into different ecoregions, and at different spatial resolutions (250 m, 1 km and 2 km). We showed that the spatial structure of ecoregions is generally maintained at different spatial resolutions and we compared the resulting ecoregion maps with two datasets related to Bluetongue vectors and West Nile Disease (WND) outbreaks in Italy. The known characteristics of Culicoides imicola habitat were well captured by 2/22 specific ecoregions (at 250 m resolution). Culicoides obsoletus/scoticus occupy all sampled ecoregions, according to its known widespread distribution across the peninsula. WND outbreak locations strongly cluster in 4/22 ecoregions, dominated by human influenced landscape, with intense cultivations and complex irrigation network. This approach could be a supportive tool in case of VBDs, defining pixel-based areas that are conducive environment for VBD spread, indicating where surveillance and prevention measures could be prioritized in Italy. Also, ecoregions suitable to specific VBDs vectors could inform entomological surveillance strategies.	[Ippoliti, Carla; Candeloro, Luca; Goffredo, Maria; Mancini, Giuseppe; Tora, Susanna; Di Lorenzo, Alessio; Quaglia, Michela; Conte, Annamaria] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Campo Boario, Teramo, Italy; [Gilbert, Marius] Univ Libre Bruxelles, Spatial Epidemiol Lab SpELL, Brussels, Belgium; [Curci, Gabriele; Falasca, Serena] Univ Aquila, Dept Phys & Chem Sci, Laquila, Italy; [Curci, Gabriele; Falasca, Serena] Univ Aquila, Ctr Excellence Telesensing Environm & Model Predi, Laquila, Italy	IZS Dell'abruzzo E Del Molise Giuseppe Caporale; Universite Libre de Bruxelles; University of L'Aquila; University of L'Aquila	Ippoliti, C (corresponding author), Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Campo Boario, Teramo, Italy.	c.ippoliti@izs.it	Ippoliti, Carla/N-1823-2017; Curci, Gabriele/A-2020-2011; Ippoliti, Carla/AAD-8008-2019; Di Lorenzo, Alessio/I-3374-2016; Quaglia, Michela/D-8353-2016; Candeloro, Luca/ABA-6009-2021; Conte, Annamaria/H-5869-2016; Goffredo, Maria/D-9542-2016; Tora, Susanna/I-3371-2016	Ippoliti, Carla/0000-0001-9030-7329; Curci, Gabriele/0000-0001-9871-5570; Ippoliti, Carla/0000-0001-9030-7329; Di Lorenzo, Alessio/0000-0003-3222-2399; Quaglia, Michela/0000-0002-1593-3749; Candeloro, Luca/0000-0001-8475-3787; Conte, Annamaria/0000-0001-6975-2698; Falasca, Serena/0000-0002-7365-369X; Goffredo, Maria/0000-0002-6831-4167; Tora, Susanna/0000-0001-8801-800X	Italian Ministry of Health [IZSAM_ 05/14_ RC]	Italian Ministry of Health(Ministry of Health, Italy)	Funding was provided by the Italian Ministry of Health -www.salute.gov.it (IZSAM_ 05/14_ RC, Ricerca Corrente 2014 "Identificazione di regioni eco-climatiche in Italia per un sistema di allerta precoce per le malattie trasmesse da vettori"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge Abruzzi Region and the Department of Civil Protection for the access to the DEWETRA database.	Acevedo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014236; Tran A, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-26; Anyamba A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001465; Bailey F, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007092; Bailey R.G., 1996, ECOSYSTEM GEOGRAPHY; Bailey RG, 2004, ENVIRON MANAGE, V34, pS14, DOI 10.1007/s00267-003-0163-6; Bisanzio D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-230; Bivand R.S., 2013, APPL SPATIAL DATA AN, V10; Blagrove MSC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005604; Blasi C, 2014, PLANT BIOSYST, V148, P1255, DOI 10.1080/11263504.2014.985756; Blasi C, 2017, ENVIRON SCI POLICY, V78, P173, DOI 10.1016/j.envsci.2017.09.002; Calistri P, 2013, PREV VET MED, V110, P549, DOI 10.1016/j.prevetmed.2013.02.011; Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029; Calzolari M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140915; Caminade C, 2014, INT J ENV RES PUB HE, V11, P903, DOI 10.3390/ijerph110100903; Cheruvelil KS, 2017, ECOL EVOL, V7, P3046, DOI 10.1002/ece3.2884; Colangeli P, 2011, VET ITAL, V47, P291; Colangeli P, 2011, VET ITAL, V47, P303; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; Conte A, 2004, VETER ITAL SER, V40, P311; Conte Annamaria, 2007, Vet Ital, V43, P571; Conte A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146024; Dijkstra E, 2008, VET REC, V162, P422, DOI 10.1136/vr.162.13.422-a; Eastman J. R., 2009, IDRISI TAIGA GUIDE G; Eastman JR, 2009, INT J REMOTE SENS, V30, P2721, DOI 10.1080/01431160902755338; Estrada-Pena A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-302; European Environment Agency (EEA), 2012, CLC 2012 COP LAND MO; Giovannini A, 2004, VET ITALIANA, V16; Goffredo M, 2004, VETER ITAL SER, V40, P260; Goffredo M, 2013, PREV VET MED, V111, P230, DOI 10.1016/j.prevetmed.2013.05.014; Goffredo M, 2016, VET ITAL, V52, P235, DOI 10.12834/VetIt.35.100.1; Goffredo M, 2015, VET ITAL, V51, P131, DOI 10.12834/VetIt.771.3854.1; Guichard S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112491; Hargrove WW, 2004, ENVIRON MANAGE, V34, pS39, DOI 10.1007/s00267-003-1084-0; Hargrove WW, 1999, COMPUT SCI ENG, V1, P18, DOI 10.1109/5992.774837; Ippoliti C, 2016, VET ITAL, V52, P213, DOI 10.12834/VetIt.1150.6293.1; Ippoliti C, 2013, GEOSPATIAL HEALTH, V8, P267, DOI 10.4081/gh.2013.72; Jamison A, 2015, APPL GEOGR, V63, P418, DOI 10.1016/j.apgeog.2015.08.001; Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116; Kaufman L, 1987, STAT DATA ANAL BASED; Kitron U, 1998, J MED ENTOMOL, V35, P435, DOI 10.1093/jmedent/35.4.435; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Mancini G, 2017, VET ITAL, V53, P97, DOI 10.12834/VetIt.114.933.4764.2; Marcantonio M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121158; McIntyre KM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06948-9; Meiswinkel R, 2007, VET REC, V161, P564, DOI 10.1136/vr.161.16.564; Napoli C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/643439; Nmor JC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-14; Ozdenerol E, 2013, INT J ENV RES PUB HE, V10, P5399, DOI 10.3390/ijerph10115399; Patz J.A., 2003, CLIMATE CHANGE HUMAN, V6, P103; Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543; Penas Merino A., 2011, GLOBAL GEOBOTANY, V1, P1, DOI [DOI 10.5616/GG110001, 10.5616/gg110001]; Pesaresi S, 2017, J MAPS, V13, P955, DOI 10.1080/17445647.2017.1413017; Piani C, 2010, THEOR APPL CLIMATOL, V99, P187, DOI 10.1007/s00704-009-0134-9; Purse BV, 2015, ANNU REV ENTOMOL, V60, P373, DOI 10.1146/annurev-ento-010814-020614; Rebora N, 2015, GEOPH RES ABSTR, V17, P1; Reisen W.R., 2017, ARTHROPOD BORNE DIS, P7, DOI DOI 10.1007/978-3-319-13884-8_2; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419; Rizzo C, 2012, EUROSURVEILLANCE, V17, P7; Rizzo C, 2016, EURO SURVEILL, V21; Roiz D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128112; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150489; Stilianakis NI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161510; Wan ZM, 2014, REMOTE SENS ENVIRON, V140, P36, DOI 10.1016/j.rse.2013.08.027; Wang J, 2003, INT J REMOTE SENS, V24, P2345, DOI 10.1080/01431160210154812; Ward MP, 2009, PREV VET MED, V88, P205, DOI 10.1016/j.prevetmed.2008.10.003	68	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219072	10.1371/journal.pone.0219072	http://dx.doi.org/10.1371/journal.pone.0219072			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269045	gold, Green Published, Green Submitted			2022-12-26	WOS:000484927300040
J	Leal, LLA; Barbosa, GSL; Ferreira, RLU; Avelino, EB; Bezerra, AN; Vale, SHD; Maciel, BLL				Araujo Leal, Leilane Lilian; Lopes Barbosa, Giovanna Stefanne; Urbano Ferreira, Rannapaula Lawrynhuk; Avelino, Erikarla Baracho; Bezerra, Adriana Nunes; de Lima Vale, Sancha Helena; Lima Maciel, Bruna Leal			Cross-validation of prediction equations for estimating body composition in ballet dancers	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; BONE-MINERAL DENSITY; ANTHROPOMETRIC MEASUREMENTS; EATING-DISORDERS; MASS INDEX; FAT; CHILDREN; FATNESS; YOUNG	Introduction In sports related to low body weight, such as classical ballet, the assessment of body composition is important for monitoring performance and health status. This study aimed to cross-validate anthropometry and bioelectrical impedance (BIA) predictive equations for estimating body composition of non-professional classical ballet dancers, using dual-energy-X-ray absorptiometry (DXA) as a reference method. Materials and methods Thirty-seven female non-professional classical dancers (median age of 19 years), at intermediate/advanced level, were evaluated in a cross-sectional study. Body composition was evaluated by DXA, anthropometry and tetrapolar BIA. Twenty different predictive equations of anthropometry (n = 8) and BIA (n = 12) were used to estimate Body Fat (BF) and Fat-Free Mass (FFM), testing their validity against DXA using the Bland-Altman statistics. Results For BF estimated by anthropometry equations, just one equation showed agreement with DXA (r = 0.852, p < 0.0005; p = 0.600 for one sample T-test). According to the Bland-Altman analysis, this equation also showed validity, with the absence of proportional bias. Regarding the predictive BIA equations tested, none were valid for our study group. Conclusion Only one of the anthropometric equations, the one proposed by Durnin and Womerley (1974), but none of the BIA equations analyzed, was valid for the evaluation of body composition of the studied classical dancers. Our results emphasize the importance of previous cross-validation of existing equations or the development of specific equations for body composition assessment in specific populations.	[Araujo Leal, Leilane Lilian; Lima Maciel, Bruna Leal] Univ Fed Rio Grande do Norte, Dept Nutr, Natal, RN, Brazil; [Araujo Leal, Leilane Lilian; Lopes Barbosa, Giovanna Stefanne; Urbano Ferreira, Rannapaula Lawrynhuk; Avelino, Erikarla Baracho; de Lima Vale, Sancha Helena; Lima Maciel, Bruna Leal] Univ Fed Rio Grande do Norte, Postgrad Nutr Program, Natal, RN, Brazil; [Bezerra, Adriana Nunes] Univ Fed Rio Grande do Norte, Dept Endocrinol, Onofre Lopes Univ Hosp, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Maciel, BLL (corresponding author), Univ Fed Rio Grande do Norte, Dept Nutr, Natal, RN, Brazil.; Maciel, BLL (corresponding author), Univ Fed Rio Grande do Norte, Postgrad Nutr Program, Natal, RN, Brazil.	brunalimamaciel@gmail.com	Vale, Sancha H L/K-4003-2012	Vale, Sancha H L/0000-0002-0972-1678; maciel, bruna/0000-0002-0724-1961; avelino, erikarla/0000-0002-6882-8029				Aguirre CA, 2015, EUR J CLIN NUTR, V69, P269, DOI 10.1038/ejcn.2014.144; Amaral R, 2008, REV BRAS NUTR ESPORT, V64, P199; Beck KL, 2015, INT J SPORT NUTR EXE, V25, P335, DOI 10.1123/ijsnem.2014-0089; Bilsborough JC, 2014, J SPORT SCI, V32, P1821, DOI 10.1080/02640414.2014.926380; Bland U., 2015, BIOCHEM MEDICA, V25, P141; Brown MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171998; Buehring B, 2014, J CLIN DENSITOM, V17, P121, DOI 10.1016/j.jocd.2013.02.012; Byrne S, 2001, J SCI MED SPORT, V4, P145, DOI 10.1016/S1440-2440(01)80025-6; Caroline E, 2016, REV ED FISICA, V85, P269; Cavedon V, 2018, PEERJ, V6, DOI 10.7717/peerj.5913; Chumlea WC, 2002, INT J OBESITY, V26, P1596, DOI 10.1038/sj.ijo.0802167; Civil R, 2019, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00136; da Silva CC, 2015, J HUM KINET, V47, P61, DOI 10.1515/hukin-2015-0062; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Eliakim A, 2000, INT J SPORTS MED, V21, P598, DOI 10.1055/s-2000-8489; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Friesen Karlie J, 2011, J Dance Med Sci, V15, P31; Dantas AG, 2018, BODY IMAGE, V25, P40, DOI 10.1016/j.bodyim.2018.02.003; GRAY DS, 1989, AM J CLIN NUTR, V50, P255, DOI 10.1093/ajcn/50.2.255; Grochowska-Niedworok E, 2018, ACTA PAEDIATR, V107, P1077, DOI 10.1111/apa.14208; Guedes D. P, 1985, KINESIS, V1, P183; HERGENROEDER AC, 1993, MED SCI SPORT EXER, V25, P145, DOI 10.1249/00005768-199301000-00020; Hincapie CA, 2010, ARCH PHYS MED REHAB, V91, P1777, DOI 10.1016/j.apmr.2010.07.230; HOUTKOOPER LB, 1992, J APPL PHYSIOL, V72, P366; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; Koutedakis Y, 2004, SPORTS MED, V34, P651, DOI 10.2165/00007256-200434100-00003; Kyle UG, 2001, NUTRITION, V17, P248, DOI 10.1016/S0899-9007(00)00553-0; Lagowska K, 2016, EUR J SPORT SCI, V16, P490, DOI 10.1080/17461391.2015.1034786; Leao C, 2017, SPORTS, V5, DOI 10.3390/sports5010017; LICHTENBELT WDV, 1995, BRIT J NUTR, V74, P439, DOI 10.1079/BJN19950150; Liiv H, 2014, HOMO, V65, P155, DOI 10.1016/j.jchb.2013.09.003; Lim SN, 2015, J EXERC REHABIL, V11, P356, DOI 10.12965/jer.150244; Lopez-Taylor Juan R, 2018, J Sports Med (Hindawi Publ Corp), V2018, P6843792, DOI 10.1155/2018/6843792; LUKASKI HC, 1986, J APPL PHYSIOL, V60, P1327, DOI 10.1152/jappl.1986.60.4.1327; Pederson D, 2000, ANTROPOMETRICA; Petroski E.L., 1995, REV BRAS ATIV FIS SA, V1, P65; POLLOCK ML, 1975, J APPL PHYSIOL, V38, P745, DOI 10.1152/jappl.1975.38.4.745; Ribeiro LG, 2010, INT J SPORTS MED, V31, P283, DOI 10.1055/s-0030-1248241; Roman EP, 2007, DIFERENCAS CRESCIMEN, V25, P227, DOI [10.1590/S0103-05822007000300006, DOI 10.1590/S0103-05822007000300006]; Ross W, 2000, HUMAN ANIMAL SERIES; Sampaio F., 2013, BALLET PASSO PASSO H; Santos DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097846; SEGAL KR, 1988, AM J CLIN NUTR, V47, P7, DOI 10.1093/ajcn/47.1.7; Shepherd JA, 2017, BONE, V104, P101, DOI 10.1016/j.bone.2017.06.010; Silva Cláudia Villela da, 2011, Rev. Bras. Ciênc. Esporte, V33, P495; Siri WE, 1961, TECH MEAS BODY COMPO; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; SLOAN AW, 1962, J APPL PHYSIOL, V17, P967, DOI 10.1152/jappl.1962.17.6.967; Speranza E, 2019, BALLET DANCERS CONST, DOI [10.3390/nu11030502, DOI 10.3390/NU11030502]; Stokic E, 2005, GYNECOL ENDOCRINOL, V20, P195, DOI 10.1080/09513590400027224; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Thibault R, 2012, CLIN NUTR, V31, P435, DOI 10.1016/j.clnu.2011.12.011; Wewege MA, 2018, J SCI MED SPORT, V21, P783, DOI 10.1016/j.jsams.2018.02.006; Wyon M., 2005, J DANC MED SCI, V9; Yannakoulia M, 2000, MED SCI SPORT EXER, V32, P228	58	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2019	14	7							e0219045	10.1371/journal.pone.0219045	http://dx.doi.org/10.1371/journal.pone.0219045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3ZV	31265484	Green Published, gold, Green Submitted			2022-12-26	WOS:000484921200018
J	May, HC; Yu, JJ; Zhang, H; Wang, YF; Cap, AP; Chambers, JP; Guentzel, MN; Arulanandam, BP				May, Holly C.; Yu, Jieh-Juen; Zhang, Hao; Wang, Yufeng; Cap, Andrew P.; Chambers, James P.; Guentzel, M. Neal; Arulanandam, Bernard P.			Thioredoxin-A is a virulence factor and mediator of the type IV pilus system in Acinetobacter baumannii	PLOS ONE			English	Article							INFECTION; RESISTANCE; NEUTROPHILS; EXPRESSION	The Gram-negative pathogen, Acinetobacter baumannii has emerged as a global nosocomial health threat affecting the majority of hospitals in the U.S. and abroad. The redox protein thioredoxin has been shown to play several roles in modulation of cellular functions affecting various virulence factors in Gram-negative pathogens. This study aims to explore the role of thioredoxin-A protein (TrxA) in A. baumannii virulence. We determined that deletion of the TrxA gene did not significantly affect resistance to environmental stressors such as temperature, salt, and pH. However, TrxA was critical for survival in the presence of elevated levels of hydrogen peroxide. Lack of TrxA was associated with decreased expression of type IV pili related genes and an inability to undergo normal twitching motility. Interestingly, the TrxA-null mutant was able to form biofilms better than the wildtype (WT) and was observed to be significantly less virulent than the WT in a pulmonary infection model. These results are supportive of thioredoxin playing a key role in A. baumannii virulence.	[May, Holly C.; Yu, Jieh-Juen; Zhang, Hao; Wang, Yufeng; Chambers, James P.; Guentzel, M. Neal; Arulanandam, Bernard P.] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA; [May, Holly C.; Yu, Jieh-Juen; Zhang, Hao; Wang, Yufeng; Chambers, James P.; Guentzel, M. Neal; Arulanandam, Bernard P.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Cap, Andrew P.] US Army, Coagulat & Blood Res Program, Inst Surg Res, JBSA Ft Sam Houston, San Antonio, TX USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA)	Arulanandam, BP (corresponding author), Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA.; Arulanandam, BP (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.	bernard.arulanandam@utsa.edu	Cap, Andrew Peter/GQZ-4426-2022	Wang, Yufeng/0000-0002-9959-4149	US Department of Defense [W911NF-11-1-0136]; US National Institutes of Health [1R21AI124021]; Jane and Roland Blumberg endowment; NIH [1S10OD021805-01]; CPRIT Core Facility Award [RP160732]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI124021] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021805] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane and Roland Blumberg endowment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT Core Facility Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by US Department of Defense W911NF-11-1-0136 (BPA) and US National Institutes of Health 1R21AI124021 (BPA), and the Jane and Roland Blumberg endowment awarded (BPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Special thanks for Dr. Katrin Mende, Brooke Army Medical Center for her assistance with the antimicrobial susceptibility testing and Dr. Hong Cai for his assistance with the bioinformatics. RNA-seq data were generated in the Genome Sequencing Facility, University of Texas Health Science Center San Antonio, NIH-NCI P30 CA054174 (Cancer Center at University of Texas Health Science Center San Antonio), NIH Shared Instrument grant 1S10OD021805-01 (S10 grant), and CPRIT Core Facility Award (RP160732).	Ainsworth S, 2017, VACCINE, V35, P3387, DOI 10.1016/j.vaccine.2017.05.017; Ambalam P, 2012, FEMS MICROBIOL LETT, V333, P10, DOI 10.1111/j.1574-6968.2012.02590.x; Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Breslow JM, 2011, J NEUROIMMUNE PHARM, V6, P551, DOI 10.1007/s11481-011-9303-6; Breslow JM, 2011, INFECT IMMUN, V79, P3317, DOI 10.1128/IAI.00069-11; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Cheng CY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00287; Clark NM, 2016, CURR OPIN CRIT CARE, V22, P491, DOI 10.1097/MCC.0000000000000337; Dent LL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-196; EMERY JL, 1960, ARCH DIS CHILD, V35, P544, DOI 10.1136/adc.35.184.544; Falagas ME, 2007, CRIT CARE, V11, DOI 10.1186/cc5911; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Haimes J, 2010, THERMO SCI TECH NOTE, V1; Heindorf M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101033; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Ketter P, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00026-14; Ketter PM, 2018, MBIO, V9, DOI 10.1128/mBio.01298-18; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; Krueger F., 2015, TRIM GALORE WRAPPER; Lanka GKK, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv121; Latibeaudiere R, 2015, CLIN INFECT DIS, V60, P415, DOI 10.1093/cid/ciu847; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Leong CG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182139; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005675; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Manchanda V, 2010, J GLOB INFECT DIS, V2, P291, DOI 10.4103/0974-777X.68538; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Miranda-Vizuete A, 1997, J BIOL CHEM, V272, P30841, DOI 10.1074/jbc.272.49.30841; Nielsen TB, 2018, JOVE-J VIS EXP, DOI 10.3791/57672; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Reardon-Robinson ME, 2015, MOL MICROBIOL, V98, P1037, DOI 10.1111/mmi.13172; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Sun DQ, 2016, LIFE SCI, V148, P31, DOI 10.1016/j.lfs.2016.02.015; Tacconelli E, 2017, GLOBAL PRIORITY LIST; Van Faassen H, 2007, INFECT IMMUN, V75, P5597, DOI 10.1128/IAI.00762-07; Vila J, 2008, EXPERT OPIN PHARMACO, V9, P587, DOI 10.1517/14656566.9.4.587; Windle HJ, 2000, J BIOL CHEM, V275, P5081, DOI 10.1074/jbc.275.7.5081; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wood CR, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00442-18; Young LS, 2007, INFECT CONT HOSP EP, V28, P1247, DOI 10.1086/521660	43	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2019	14	7							e0218505	10.1371/journal.pone.0218505	http://dx.doi.org/10.1371/journal.pone.0218505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3ZV	31265467	gold, Green Published, Green Submitted			2022-12-26	WOS:000484921200011
J	Kim, DH; Choi, HI; Park, JS; Kim, CS; Bae, EH; Ma, SK; Kim, SW				Kim, Dong-Hyun; Choi, Hoon-In; Park, Jung Sun; Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan			Src-mediated crosstalk between FXR and YAP protects against renal fibrosis	FASEB JOURNAL			English	Article						kidney disease; hippo pathway; nuclear receptor	HIPPO PATHWAY; CELL-PROLIFERATION; LIPID-METABOLISM; PROMOTES; RECEPTOR; INFLAMMATION; INHIBITION; ACTIVATION; KINASE; LIVER	Renal fibrosis is the common pathway of chronic kidney disease progression. The nuclear receptor farnesoid X receptor [FXR, NR1H4 (nuclear receptor subfamily 1 group member 4)], a multifunctional transcription factor, plays a pivotal role in protecting against fibrosis. However, the mechanisms underlying these antifibrotic actions of FXR in kidney disease are largely unknown. Here, we show that agonist GW4064-mediated FXR activation inhibits the activity of the nonreceptor tyrosine kinase Src (proto-oncogene tyrosine-protein kinase), which is critical for regulation of yes-associated protein (YAP) phosphorylation and nuclear localization in renal fibrosis. Activation of FXR suppressed renal fibrosis and Tyr416-Src phosphorylation in TGF-beta-treated human renal proximal tubule epithelial (HK2) cells. Moreover, GW4064 treatment in HK2 cells increased Ser127 phosphorylation, cytosolic accumulation of YAP, and interaction of the hippo core kinases (Ste20-like kinase 1, large tumor suppressor kinase 1, and salvador homolog 1). Inhibition of Src using PP2 (Src kinase inhibitor) prevented renal fibrosis and increased Ser127 phosphorylation and cytosolic accumulation of YAP. The expression of fibrosis markers, inflammatory genes, and YAP target genes was increased in the kidneys of FXR knockout mice compared with those of wild-type mice. In addition, GW4064 or WAY-362450 (turofexorate isopropyl) treatment protected against unilateral ureteral obstruction-induced renal fibrosis. Collectively, our data support the novel conclusion that Src-mediated crosstalk between FXR and YAP protects against renal fibrosis, making this pathway a possible therapeutic target for chronic kidney disease.-Kim, D.-H., Choi, H.-I., Park, J. S., Kim, C. S., Bae, E. H., Ma, S. K., Kim, S. W. Src-mediated crosstalk between FXR and YAP protects against renal fibrosis.	[Kim, Dong-Hyun; Choi, Hoon-In; Park, Jung Sun; Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Dept Internal Med, Med Sch, 42 Jebongro, Gwangju 61469, South Korea	Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ, Dept Internal Med, Med Sch, 42 Jebongro, Gwangju 61469, South Korea.	skimw@chonnam.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1C1B2007139]; Basic Science Research Program through the NRF - Ministry of Science, Information and Communications Technology (ICT), and Future Planning (MSIP) [2016R1A2B4007870]; Bio and Medical Technology Development Program of the NRF - Korean government, MSIT [2017M3A9E8023001]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Basic Science Research Program through the NRF - Ministry of Science, Information and Communications Technology (ICT), and Future Planning (MSIP); Bio and Medical Technology Development Program of the NRF - Korean government, MSIT	The authors thank Jongsook Kim Kemper (University of Illinois at Urbana-Champaign, Champaign, IL, USA) for kindly providing flag-farnesoid x receptor (FXR) plasmid. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1C1B2007139); the Basic Science Research Program through the NRF funded by the Ministry of Science, Information and Communications Technology (ICT), and Future Planning (MSIP) (2016R1A2B4007870); and the Bio and Medical Technology Development Program of the NRF funded by the Korean government, MSIT (2017M3A9E8023001). The authors declare no conflicts of interest.	Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Chen JC, 2016, J AM SOC NEPHROL, V27, P1689, DOI 10.1681/ASN.2015040415; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653; Gai ZB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10168-6; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Jiang T, 2007, DIABETES, V56, P2485, DOI 10.2337/db06-1642; Kim DH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12179; Kim DH, 2015, EMBO J, V34, P184, DOI 10.15252/embj.201489527; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Levi M, 2011, BBA-MOL BASIS DIS, V1812, P1061, DOI 10.1016/j.bbadis.2011.04.003; Li P, 2016, GENE DEV, V30, P798, DOI 10.1101/gad.274951.115; Liang M, 2017, J AM SOC NEPHROL, V28, P3277, DOI 10.1681/ASN.2015121354; Liu HL, 2016, J LIPID RES, V57, P1831, DOI 10.1194/jlr.M069807; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Modica Salvatore, 2010, Nucl Recept Signal, V8, pe005, DOI 10.1621/nrs.08005; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Peng ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048461; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Seo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31931; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang XXX, 2010, DIABETES, V59, P2916, DOI 10.2337/db10-0019; Wang XX, 2009, AM J PHYSIOL-RENAL, V297, pF1587, DOI 10.1152/ajprenal.00404.2009; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xu J, 2016, CLIN SCI, V130, P349, DOI 10.1042/CS20150385; Yan YL, 2016, KIDNEY INT, V89, P68, DOI 10.1038/ki.2015.293; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao K, 2016, SCI REP-UK, V6, DOI 10.1038/srep37234	42	25	26	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11109	11122		10.1096/fj.201900325R	http://dx.doi.org/10.1096/fj.201900325R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31298930				2022-12-26	WOS:000489166300045
J	Stormberg, T; Stumme-Diers, M; Lyubchenko, YL				Stormberg, Tommy; Stumme-Diers, Micah; Lyubchenko, Yuri L.			Sequence-dependent nucleosome nanoscale structure characterized by atomic force microscopy	FASEB JOURNAL			English	Article						AFM; nucleosome structure; nucleosome interaction; chromatin dynamics	DYNAMICS; DNA	DNA sequence plays an important role in the assembly of nucleosomes, and DNA motifs with high specificity to nucleosomes have been identified. At the same time, important questions such as how the DNA sequence changes DNA wrapping and how the DNA sequence contributes to the interaction between the nucleosomes remain unclear. Here, we addressed these questions by comparing nanoscale properties of nucleosomes assembled on the highest nucleosome positioning sequence, the 601 motif, and essentially random DNA sequences. We used atomic force microscopy to measure the nucleosome positions and the DNA wrapping. The studies showed that nucleosomes assemble on the nonspecific sequence without any preference for position on DNA, but they wrap the same DNA length as DNA of the same length with the 601 sequence. Experiments with longer DNA containing the 601 motif along with nonspecific DNA, capable of forming dinucleosomes, revealed that dinucleosomes assembled on hybrid sequences show a preference for positioning near each other, with one always assembling on the 601 motif. These findings point to the interaction between the nucleosomes and suggest that internucleosomal interactions may play a large role in nucleosome positioning.-Stormberg, T., Stumme-Diers, M., Lyubchenko, Y. L. Sequence-dependent nucleosome nanoscale structure characterized by atomic force microscopy.	[Stormberg, Tommy; Stumme-Diers, Micah; Lyubchenko, Yuri L.] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, 986025 Nebraska Med Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Lyubchenko, YL (corresponding author), Univ Nebraska Med Ctr, Dept Pharmaceut Sci, 986025 Nebraska Med Ctr, Omaha, NE 68198 USA.	ylyubchenko@unmc.edu		Stormberg, Tommy/0000-0001-7526-1318	National Science Foundation [MCB 1515346]; U.S. National Institutes of Health, National Institute of General Medical Sciences [GM096039, GM100156]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096039, R01GM100156] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank G. Warren (University of Nebraska Medical Center) for the assistance in the preparation of nucleosomes and L. Shlyakhtenko (University of Nebraska Medical Center), V. Zhurkin (National Cancer Institute, Bethesda, MD, USA), and K. Zagorski (University of Nebraska Medical Center) for useful insights in the data interpretation. This work was supported by grants to Y.L.L. from the National Science Foundation (MCB 1515346) and the U.S. National Institutes of Health, National Institute of General Medical Sciences (GM096039 and GM100156). The authors declare no conflicts of interest.	Armeev GA, 2019, CURR OPIN STRUC BIOL, V56, P46, DOI 10.1016/j.sbi.2018.11.006; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Eslami-Mossallam B, 2016, ADV COLLOID INTERFAC, V232, P101, DOI 10.1016/j.cis.2016.01.007; Filenko NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016299; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Kan PY, 2007, MOL CELL BIOL, V27, P2084, DOI 10.1128/MCB.02181-06; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lowary PT, 1997, P NATL ACAD SCI USA, V94, P1183, DOI 10.1073/pnas.94.4.1183; Lyubchenko YL, 2004, CELL BIOCHEM BIOPHYS, V41, P75, DOI 10.1385/CBB:41:1:075; Lyubchenko Yuri L, 2014, Biophys Rev, V6, P181, DOI 10.1007/s12551-013-0121-3; Menshikova Irina, 2011, Int J Biochem Mol Biol, V2, P129; Miyagi A, 2011, BIOCHEMISTRY-US, V50, P7901, DOI 10.1021/bi200946z; Pisano S, 2007, J MOL BIOL, V369, P1153, DOI 10.1016/j.jmb.2007.04.027; Pisano S, 2006, BIOPHYS CHEM, V124, P81, DOI 10.1016/j.bpc.2006.05.012; Prunell A, 1998, BIOPHYS J, V74, P2531, DOI 10.1016/S0006-3495(98)77961-5; Sauer PV, 2017, ELIFE, V6, DOI 10.7554/eLife.23474; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Shlyakhtenko LS, 2009, BIOCHEMISTRY-US, V48, P7842, DOI 10.1021/bi900977t; Stumme-Diers MP, 2019, JOVE-J VIS EXP, DOI 10.3791/58820; SUSSMAN JL, 1978, P NATL ACAD SCI USA, V75, P103, DOI 10.1073/pnas.75.1.103; Trifonov EN, 2016, J BIOMOL STRUCT DYN, V34, P1156, DOI 10.1080/07391102.2015.1075158; Trifonov EN, 2011, PHYS LIFE REV, V8, P39, DOI 10.1016/j.plrev.2011.01.004; TRIFONOV EN, 1980, P NATL ACAD SCI-BIOL, V77, P3816, DOI 10.1073/pnas.77.7.3816; Wilson MD, 2017, ACTA CRYSTALLOGR D, V73, P541, DOI 10.1107/S2059798317004430; Yang ZY, 2007, J BIOL CHEM, V282, P7930, DOI 10.1074/jbc.M610584200; Yang Z, 2011, BIOCHEMISTRY-US, V50, P9973, DOI 10.1021/bi201377x; Yodh JG, 2002, BIOCHEMISTRY-US, V41, P3565, DOI 10.1021/bi011612e; Zhou BR, 2018, J MOL BIOL, V430, P3093, DOI 10.1016/j.jmb.2018.06.020; Zhou KD, 2019, NAT STRUCT MOL BIOL, V26, P3, DOI 10.1038/s41594-018-0166-x; Zhurkin VB, 2011, PHYS LIFE REV, V8, P64, DOI 10.1016/j.plrev.2011.02.001	30	5	5	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10916	10923		10.1096/fj.201901094R	http://dx.doi.org/10.1096/fj.201901094R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284760	Green Published, Bronze			2022-12-26	WOS:000489166300027
J	Pinkwart, K; Schneider, F; Lukoseviciute, M; Sauka-Spengler, T; Lyman, E; Eggeling, C; Sezgin, E				Pinkwart, Kerstin; Schneider, Falk; Lukoseviciute, Martyna; Sauka-Spengler, Tatjana; Lyman, Edward; Eggeling, Christian; Sezgin, Erdinc			Nanoscale dynamics of cholesterol in the cell membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; fluorescence correlation spectroscopy (FCS); plasma membrane; membrane biophysics; membrane lipid; membrane structure; Bodipy-cholesterol; diffusion; hindered diffusion; membrane asymmetry; model membranes	FLUORESCENCE CORRELATION SPECTROSCOPY; PLASMA-MEMBRANE; BODIPY-CHOLESTEROL; LIPID ORGANIZATION; PHASE-SEPARATION; DIFFUSION; MODEL; PROTEINS; HEDGEHOG; ANALOGS	Cholesterol constitutes similar to 30-40% of the mammalian plasma membrane, a larger fraction than of any other single component. It is a major player in numerous signaling processes as well as in shaping molecular membrane architecture. However, our knowledge of the dynamics of cholesterol in the plasma membrane is limited, restricting our understanding of the mechanisms regulating its involvement in cell signaling. Here, we applied advanced fluorescence imaging and spectroscopy approaches on in vitro (model membranes) and in vivo (live cells and embryos) membranes as well as in silico analysis to systematically study the nanoscale dynamics of cholesterol in biological membranes. Our results indicate that cholesterol diffuses faster than phospholipids in live membranes, but not in model membranes. Interestingly, a detailed statistical diffusion analysis suggested two-component diffusion for cholesterol in the plasma membrane of live cells. One of these components was similar to a freely diffusing phospholipid analogue, whereas the other one was significantly faster. When a cholesterol analogue was localized to the outer leaflet only, the fast diffusion of cholesterol disappeared, and it diffused similarly to phospholipids. Overall, our results suggest that cholesterol diffusion in the cell membrane is heterogeneous and that this diffusional heterogeneity is due to cholesterol's nanoscale interactions and localization in the membrane.	[Pinkwart, Kerstin; Schneider, Falk; Eggeling, Christian; Sezgin, Erdinc] Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England; [Lukoseviciute, Martyna; Sauka-Spengler, Tatjana] Univ Oxford, Adcliffe Dept Med, MRC Human Immunol Unit, Oxford OX3 9DS, England; [Lyman, Edward] Univ Delaware, Dept Phys, Newark, DE 19716 USA; [Lyman, Edward] Univ Delaware, Dept Astron, Newark, DE 19716 USA; [Lyman, Edward] Univ Delaware, Dept Chem, Newark, DE 19716 USA; [Lyman, Edward] Univ Delaware, Dept Biochem, Newark, DE 19716 USA; [Eggeling, Christian] Friedrich Schiller Univ Jena, Inst Appl Opt & Biophys, Max Wien Pl 4, D-07743 Jena, Germany; [Eggeling, Christian] Leibniz Inst Photon Technol eV, Albert Einstein Str 9, D-07745 Jena, Germany	University of Oxford; University of Oxford; University of Delaware; University of Delaware; University of Delaware; University of Delaware; Friedrich Schiller University of Jena; Leibniz Institut fur Photonische Technologien	Sezgin, E (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England.	erdinc.sezgin@rdm.ox.ac.uk	Sezgin, Erdinc/R-1980-2018	Sezgin, Erdinc/0000-0002-4915-388X; Eggeling, Christian/0000-0002-3698-5599; Sauka-Spengler, Tatjana/0000-0001-9289-0263; Lukoseviciute, Martyna/0000-0002-8915-5249; Schneider, Falk/0000-0003-0502-9139	Wellcome Trust [091911]; United States National Science Foundation [ACI-1548562]; National Institutes of Health [R01GM116961]; BBSRC [BB/P026354/1] Funding Source: UKRI; MRC [MC_UU_00008/9, G0902418, MR/K01577X/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120351, R01GM116961] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); United States National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Wolfson Imaging Centre Oxford and the Micron Advanced Bioimaging Unit supported by Wellcome Trust Strategic Award 091911 for providing microscope facility and financial support. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by United States National Science Foundation Grant ACI-1548562. Anton 2 computer time was provided by the Pittsburgh Supercomputing Center (PSC) through Grant R01GM116961 from the National Institutes of Health. The Anton2 machine at NRBSC/PSC was generously made available by Delaware Shaw Research.	Allender DW, 2019, BIOPHYS J, V116, P2356, DOI 10.1016/j.bpj.2019.03.028; Andrade DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11454; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Bukiya AN, 2017, J LIPID RES, V58, P1044, DOI 10.1194/jlr.R073452; Camley BA, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4932980; Chiantia S, 2011, BIOPHYS J, V100, pLO1, DOI 10.1016/j.bpj.2010.11.051; Clausen MP, 2013, NANO LETT, V13, P2332, DOI 10.1021/nl303151f; Courtney KC, 2018, CELL REP, V24, P1037, DOI 10.1016/j.celrep.2018.06.104; Eggeling C, 2015, ESSAYS BIOCHEM, V57, P69, DOI [10.1042/BSE0570069, 10.1042/bse0570069]; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Endapally S, 2019, CELL, V176, P1040, DOI 10.1016/j.cell.2018.12.042; Fantini J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21907; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Fujimoto T, 2017, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00155; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Garcia-Saez AJ, 2010, METHODS MOL BIOL, V606, P493, DOI 10.1007/978-1-60761-447-0_33; Gimpl G, 2007, BIOSCIENCE REP, V27, P335, DOI 10.1007/s10540-007-9060-1; Gimpl G, 2011, STEROIDS, V76, P216, DOI 10.1016/j.steroids.2010.11.001; Guixa-Gonzalez R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14505; Hiramoto-Yamaki N, 2014, TRAFFIC, V15, P583, DOI 10.1111/tra.12163; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Holtta-Vuori M, 2016, TRAFFIC, V17, P1054, DOI 10.1111/tra.12414; Honigmann A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6412; Honigmann A, 2013, FARADAY DISCUSS, V161, P77, DOI [10.1039/c2fd20107k, 10.1039/C2FD20107K]; Huang PX, 2016, CELL, V166, P1176, DOI 10.1016/j.cell.2016.08.003; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; Javanainen M, 2019, PHYS CHEM CHEM PHYS, V21, P11660, DOI 10.1039/c9cp02022e; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kanerva K, 2013, DEV CELL, V27, P249, DOI 10.1016/j.devcel.2013.09.016; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lagerholm BC, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa519e; Levi V, 2003, BIOCHEM SOC T, V31, P997; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Lin QQ, 2015, BIOPHYS J, V108, P2212, DOI 10.1016/j.bpj.2015.03.056; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; Marks DL, 2008, HISTOCHEM CELL BIOL, V130, P819, DOI 10.1007/s00418-008-0509-5; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Maxfield FR, 2012, METHOD CELL BIOL, V108, P367, DOI 10.1016/B978-0-12-386487-1.00017-1; Mobarak E, 2018, BBA-BIOMEMBRANES, V1860, P2436, DOI 10.1016/j.bbamem.2018.07.003; Mondal M, 2009, MOL BIOL CELL, V20, P581, DOI 10.1091/mbc.E08-07-0785; Mueller V, 2011, BIOPHYS J, V101, P1651, DOI 10.1016/j.bpj.2011.09.006; Ostasov P, 2013, CHEM PHYS LIPIDS, V167, P62, DOI 10.1016/j.chemphyslip.2013.02.006; Plochberger B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15949-7; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Pourmousa M, 2014, J PHYS CHEM B, V118, P7345, DOI 10.1021/jp406883k; Ramirez DMC, 2010, BBA-BIOMEMBRANES, V1798, P558, DOI 10.1016/j.bbamem.2009.12.005; Ramstedt B, 1999, BIOPHYS J, V76, P908, DOI 10.1016/S0006-3495(99)77254-1; Regmi R, 2017, NANO LETT, V17, P6295, DOI 10.1021/acs.nanolett.7b02973; Sankaranarayanan S, 2011, J LIPID RES, V52, P2332, DOI 10.1194/jlr.D018051; Schneider F, 2018, ACS NANO, V12, P8540, DOI 10.1021/acsnano.8b04080; Schneider F, 2017, MOL BIOL CELL, V28, P1507, DOI 10.1091/mbc.E16-07-0536; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sezgin E, 2019, NAT PROTOC, V14, P1054, DOI 10.1038/s41596-019-0127-9; Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16; Sezgin E, 2016, J LIPID RES, V57, P299, DOI 10.1194/jlr.M065326; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Sheng R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2221; Silvius JR, 2003, BBA-BIOMEMBRANES, V1610, P174, DOI 10.1016/S0005-2736(03)00016-6; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sodt AJ, 2014, J AM CHEM SOC, V136, P725, DOI 10.1021/ja4105667; Solanko LM, 2013, BIOPHYS J, V105, P2082, DOI 10.1016/j.bpj.2013.09.031; Thallmair S, 2018, J PHYS CHEM LETT, V9, P5527, DOI 10.1021/acs.jpclett.8b01877; Waithe D, 2018, METHODS, V140, P62, DOI 10.1016/j.ymeth.2017.09.010; Waithe D, 2016, BIOINFORMATICS, V32, P958, DOI 10.1093/bioinformatics/btv687; Weiner MD, 2018, J PHYS CHEM B, V122, P8193, DOI 10.1021/acs.jpcb.8b03949; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Winkler PM, 2018, J PHYS CHEM LETT, V9, P110, DOI 10.1021/acs.jpclett.7b02818; Wustner D, 2016, CHEM PHYS LIPIDS, V194, P12, DOI 10.1016/j.chemphyslip.2015.08.007	75	26	26	6	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12599	12609		10.1074/jbc.RA119.009683	http://dx.doi.org/10.1074/jbc.RA119.009683			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31270209	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000484414600004
J	Kim, SJ; Garcia-Recio, S; Creighton, CJ; Perou, CM; Rosen, JM				Kim, S. J.; Garcia-Recio, S.; Creighton, C. J.; Perou, C. M.; Rosen, J. M.			Alterations in Wnt- and/or STAT3 signaling pathways and the immune microenvironment during metastatic progression	ONCOGENE			English	Article							REGULATORY T-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER CELLS; TUMOR-INITIATING CELLS; STEM-CELLS; WNT/BETA-CATENIN; PROMOTES; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION	Metastatic breast cancer is an extremely complex disease with limited treatment options due to the lack of information about the major characteristics of metastatic disease. There is an urgent need, therefore, to understand the changes in cellular complexity and dynamics that occur during metastatic progression. In the current study, we analyzed the cellular and molecular differences between primary tumors and paired lung metastases using a syngeneic p53-null mammary tumor model of basal-like breast cancer. Distinct subpopulations driven by the Wnt- and/or STAT3 signaling pathways were detected in vivo using a lentiviral Wnt- and STAT3 signaling reporter system. A significant increase in the overlapping populations driven by both the Wnt- and STAT3 signaling pathways was observed in the lung metastases as compared to the primary tumors. Furthermore, the overlapping populations showed a higher metastatic potential relative to the other populations and pharmacological inhibition of both signaling pathways was shown to markedly reduce the metastatic lesions in established lung metastases. An analysis of the unique molecular features of the lung metastases revealed a significant association with immune response signatures. Specifically, Foxp3 gene expression was markedly increased and elevated levels of Foxp3 + Treg cells were detected in close proximity to lung metastases. Collectively, these studies illustrate the importance of analyzing intratumoral heterogeneity, changes in population dynamics, and the immune microenvironment during metastatic progression.	[Kim, S. J.; Rosen, J. M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Garcia-Recio, S.; Perou, C. M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Garcia-Recio, S.; Perou, C. M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Creighton, C. J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Creighton, C. J.] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Baylor College of Medicine	Rosen, JM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	jrosen@bcm.edu	Recio, Susana Garcia/M-4723-2019; Perou, Charles M/H-9934-2014	Recio, Susana Garcia/0000-0003-3820-1679; Perou, Charles M/0000-0001-9827-2247; Rosen, Jeffrey/0000-0002-6637-844X	NIH [RO1 CA148761]; Susan G. Komen [PDF17479425]; Cytometry and Cell Sorting Core [NIH CA125123, RR024574]; NATIONAL CANCER INSTITUTE [P30CA125123, R01CA148761, R01CA195754, R01CA016303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen(Susan G. Komen Breast Cancer Foundation); Cytometry and Cell Sorting Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	;This work was supported by NIH RO1 CA148761 (to JMR and CMP) and by the Susan G. Komen to SGR (PDF17479425). We would like to thank to Dr. Michael T. Lewis for generously providing us with the STAT3-GFP and EFS-GFP reporters. This project was conducted with technical support from the Cytometry and Cell Sorting Core (NIH CA125123 and RR024574) and the expert assistance of Joel M. Sederstrom, the Integrated Microscopy core (NCI CA125123, NIDDK56338, CPRIT RP150578 and John S. Dunn Gulf Coast Consortium for Chemical Genomics), the Lester and Sue Smith Breast Center Pathology Core, and Human Genome Sequencing Center at Baylor College of Medicine. We thank Yiqun Zhang for technical assistance with the gene expression analyses. We would also like to thank to the IHC laboratory at University of Texas MD Anderson Cancer Center for scanning of IHC images. We specially thank Drs. Michael T. Lewis and Kevin P. Roarty for critically reading and editing the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ansari AM, 2016, STEM CELL REV REP, V12, P553, DOI 10.1007/s12015-016-9670-8; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Bockhorn J, 2014, CANCER RES, V74, P7406, DOI 10.1158/0008-5472.CAN-14-1188; Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Celia-Terrassa T, 2016, GENE DEV, V30, P892, DOI 10.1101/gad.277681.116; Chang CH, 2015, STEM CELL REP, V5, P378, DOI 10.1016/j.stemcr.2015.07.009; Chen MW, 2017, CANCER RES, V77, P1955, DOI 10.1158/0008-5472.CAN-16-1115; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Chuang CH, 2017, NAT MED, V23, P291, DOI 10.1038/nm.4285; Dalotto-Moreno T, 2013, CANCER RES, V73, P1107, DOI 10.1158/0008-5472.CAN-12-2418; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dent R, 2009, BREAST CANCER RES TR, V115, P423, DOI 10.1007/s10549-008-0086-2; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Fan C, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-3; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Follenzi A, 2004, BLOOD, V103, P3700, DOI 10.1182/blood-2003-09-3217; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gatza ML, 2014, NAT GENET, V46, P1051, DOI 10.1038/ng.3073; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Gujral TS, 2014, CELL, V159, P844, DOI 10.1016/j.cell.2014.10.032; Halvorsen EC, 2014, CANCER METAST REV, V33, P1025, DOI 10.1007/s10555-014-9529-x; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Jacob LS, 2015, CANCER RES, V75, P3713, DOI 10.1158/0008-5472.CAN-15-0562; Jerry DJ, 2000, ONCOGENE, V19, P1052, DOI 10.1038/sj.onc.1203270; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Jones LM, 2016, CANCER RES, V76, P1416, DOI 10.1158/0008-5472.CAN-15-2770; Jung KH, 2017, CLIN CANCER RES, V23, P5537, DOI 10.1158/1078-0432.CCR-16-2253; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kim MJ, 2014, CANCER LETT, V354, P33, DOI 10.1016/j.canlet.2014.06.023; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Lee-Chang C, 2013, J IMMUNOL, V191, P4141, DOI 10.4049/jimmunol.1300606; Linde N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02481-5; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Medina D, 2002, FASEB J, V16, P881, DOI 10.1096/fj.01-0885fje; Moon SH, 2013, INT J ONCOL, V42, P921, DOI 10.3892/ijo.2013.1765; Mougiakakos D, 2010, ADV CANCER RES, V107, P57, DOI 10.1016/S0065-230X(10)07003-X; Myant KB, 2013, CELL STEM CELL, V12, P761, DOI 10.1016/j.stem.2013.04.006; Naxerova K, 2015, NAT REV CLIN ONCOL, V12, P258, DOI 10.1038/nrclinonc.2014.238; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ranger JJ, 2009, CANCER RES, V69, P6823, DOI 10.1158/0008-5472.CAN-09-1684; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Roarty K, 2017, ONCOGENE, V36, P5958, DOI 10.1038/onc.2017.206; Roarty K, 2015, J CELL BIOL, V208, P351, DOI 10.1083/jcb.201408058; Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schroeder A, 2014, CANCER RES, V74, P1227, DOI 10.1158/0008-5472.CAN-13-0594; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Pereira LMS, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00605; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Thakur R, 2015, SCI REP-UK, V5, DOI 10.1038/srep10194; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang RF, 2008, HUM IMMUNOL, V69, P811, DOI 10.1016/j.humimm.2008.08.276; Wei W, 2014, STEM CELLS, V32, P2571, DOI 10.1002/stem.1752; Williams CB, 2016, NPJ BREAST CANCER, V2, DOI 10.1038/npjbcancer.2015.25; Wu JQ, 2016, CELL REP, V14, P1979, DOI 10.1016/j.celrep.2016.01.074; Xu L, 2010, CLIN IMMUNOL, V135, P466, DOI 10.1016/j.clim.2010.01.014; Xu XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004783; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yan M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2869; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Zhang CH, 2015, ONCOL REP, V33, P1872, DOI 10.3892/or.2015.3783; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107; Zhu L, 2019, BIORXIV, DOI [10.1101/525071, DOI 10.1101/525071]	86	8	8	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 1	2019	38	31					5942	5958		10.1038/s41388-019-0852-0	http://dx.doi.org/10.1038/s41388-019-0852-0			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IT3GE	31289359	Green Accepted			2022-12-26	WOS:000482740000003
J	Ma, QH; Zhang, DJ; Gan, XH				Ma, Qihua; Zhang, Dongjian; Gan, Xuehui			Simulation of the flow field and the chemical reaction coupling of selective catalytic reduction (SCR) system using an orthogonal experiment	PLOS ONE			English	Article							FE; NOX; NH3-SCR; DESIGN	It is difficult to simulate both the flow field and the chemical reaction using, respectively, the flow state and kinetics calculations and actually reflect the influence of the gas flow state on the chemical change in a selective catalytic reduction (SCR) system. In this study, the flow field and the chemical reaction were therefore coupled to simulate a full Cu-Zeolite SCR system and the boundary conditions of the simulation were set by a relevant diesel engine bench test which included the exhaust temperature, the mass flow, and the exhaust pressure. Then, the influence of the gas flow state on the NOx conversion efficiency was investigated. Specifically, an orthogonal experimental design was used to study the influence of the injection parameters (position, angle, and speed) on the NH3 distribution by establishing the NH3 uniformity coefficient. at the SCR catalyst capture surface in the flow field simulation. Then, the velocity capture surface of the SCR catalyst front section was sliced into coupled data transfer interfaces to study the effects of exhaust temperature, ammonia to NOx ratio (ANR), and the NO2/NOx on the NOx conversion efficiency. This was used as guidelines to optimize the SCR system control strategy. The results showed that a 1150 mm injection position, a 45 degrees injection angle, and a 23 m/s injection velocity provided the most uniform NH3 distribution on the SCR catalyst capture surface. For constant injection parameters, the NOx conversion efficiency was the highest when the exhaust temperature was 200 degrees C-400 degrees C, the ANR was 1.1, and NO2/NOx was 0.5.	[Ma, Qihua; Zhang, Dongjian; Gan, Xuehui] Donghua Univ, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai, Peoples R China; [Ma, Qihua; Zhang, Dongjian; Gan, Xuehui] Shanghai Univ Engn Sci, Sch Mech & Automot Engn, Shanghai, Peoples R China; [Ma, Qihua; Gan, Xuehui] Donghua Univ, Key Lab High Performance Fibers & Prod, Minist Educ, Shanghai, Peoples R China; [Zhang, Dongjian; Gan, Xuehui] Donghua Univ, Minist Educ, Key Lab Text Sci & Technol, Shanghai, Peoples R China	Donghua University; Shanghai University of Engineering Science; Donghua University; Donghua University	Gan, XH (corresponding author), Donghua Univ, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai, Peoples R China.; Gan, XH (corresponding author), Donghua Univ, Key Lab High Performance Fibers & Prod, Minist Educ, Shanghai, Peoples R China.; Gan, XH (corresponding author), Donghua Univ, Minist Educ, Key Lab Text Sci & Technol, Shanghai, Peoples R China.	xuehuig@dhu.edu.cn		dongjian, zhang/0000-0001-5528-1151	Shanghai University of Engineering Science (SUES); Key Laboratory of High Performance Fibers and Products, the Ministry of Education, Donghua University [E2-6203-16-09, 2]; State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Donghua University [KF1826]	Shanghai University of Engineering Science (SUES); Key Laboratory of High Performance Fibers and Products, the Ministry of Education, Donghua University; State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Donghua University	This work was supported by the Shanghai University of Engineering Science (SUES); the Key Laboratory of High Performance Fibers and Products, the Ministry of Education, Donghua University (E2-6203-16-09 (2016) NO.2); and the State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Donghua University (KF1826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg A, 2017, CHEM ENG SCI, V161, P167, DOI 10.1016/j.ces.2016.12.024; Aberg A, 2016, TOP CATAL, V59, P945, DOI 10.1007/s11244-016-0573-3; Abidin Z, 2013, 3D SEMI 1D COUPLING; Benjamin S F, 2007, IMECHE C INT COMB EN; Braun J, 2018, MTZ WORLDWIDE, V79, P46; Capetillo A, 2017, COMPUT MATH APPL, V74, P188, DOI 10.1016/j.camwa.2017.01.025; Chen H, 2018, APPL THERM ENG, V137, P584, DOI 10.1016/j.applthermaleng.2018.04.022; Depcik C, 2011, CHEM ENG TECHNOL, V34, P1949, DOI 10.1002/ceat.201100144; [龚金科 Gong Jinke], 2013, [湖南大学学报. 自然科学版, Journal of Hunan University. Natural Sciences], V40, P38; Han Z, 1995, COMBUST SCI TECHNOL, V106, P267, DOI 10.1080/00102209508907782; Huh K. Y., 1991, P INT C MULT FLOWS T, P515; Johnson TV, 2009, INT J ENGINE RES, V10, P275, DOI 10.1243/14680874JER04009; Konstandopoulos AG, 2015, EMISS CONTROL SCI TE, V1, P213, DOI [DOI 10.1007/S40825-015-0020-0, 10.1007/s40825-015-0020-0.]; Liu A B, 1993, 1993 NASASTI, P93; Metkar PS, 2013, CHEM ENG SCI, V87, P51, DOI 10.1016/j.ces.2012.09.008; Metkar PS, 2012, CATAL TODAY, V184, P115, DOI 10.1016/j.cattod.2011.11.032; Metkar PS, 2012, APPL CATAL B-ENVIRON, V111, P67, DOI 10.1016/j.apcatb.2011.09.019; Metkar PS, 2011, CHEM ENG SCI, V66, P5192, DOI 10.1016/j.ces.2011.07.014; Nova I, 2000, CATAL TODAY, V60, P73, DOI 10.1016/S0920-5861(00)00319-9; Pant A, 2011, IND ENG CHEM RES, V50, P5490, DOI 10.1021/ie200060s; Paramadayalan T, 2013, KOREAN J CHEM ENG, V30, P2170, DOI 10.1007/s11814-013-0155-z; Sturgess M P, 2010, POWER TRAINS FUELS L; Tan Piqiang, 2014, J CHEM IND ENG, V65, P4063; Tong Dehui, 2008, T CSICE, P20; Wurzenberger JC, 2005, SAE T, P344; Yuan X., 2015, EMISS CONTROL SCI TE, V1, P121, DOI [10.1007/s40825-015-0013-z, DOI 10.1007/s40825-015-0013-z, DOI 10.1007/S40825-015-0013-Z]; Zhang Lixiong, 2016, SMALL INTERNAL COMBU, V45, P37	27	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2019	14	7							e0216138	10.1371/journal.pone.0216138	http://dx.doi.org/10.1371/journal.pone.0216138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IV5WJ	31299048	gold, Green Published, Green Submitted			2022-12-26	WOS:000484340600001
J	Kitsuka, T; Itoh, M; Amamoto, S; Arai, K; Oyama, J; Node, K; Toda, S; Morita, S; Nishida, T; Nakayama, K				Kitsuka, Takahiro; Itoh, Manabu; Amamoto, Sojiro; Arai, Ken-ichi; Oyama, Junichi; Node, Koichi; Toda, Shuji; Morita, Shigeki; Nishida, Takahiro; Nakayama, Koichi			2-Cl-C center dot OXT-A stimulates contraction through the suppression of phosphodiesterase activity in human induced pluripotent stem cell-derived cardiac organoids	PLOS ONE			English	Article							CARDIOMYOCYTES; ANGIOGENESIS; NUCLEOSIDE	Background 2-Cl-C center dot OXT-A (COA-Cl) is a novel synthesized adenosine analog that activates Sphingosine-1-phosphate 1 receptor (S1P1R) and combines with the adenosine A1 receptor (A1R) in G proteins and was shown to enhance angiogenesis and improve the brain function in rat stroke models. However, the role of COA-Cl in hearts remains unclear. COA-Cl, which has a similar structure to xanthine derivatives, has the potential to suppress phosphodiesterase (PDE), which is an important factor involved in the beating of heart muscle. Methods and results Cardiac organoids with fibroblasts, human induced pluripotent stem cell-derived cardiac myocytes (hiPSC-CMs), and hiPSC-derived endothelial cells (hiPSC-ECs) were cultured until they started beating. The beating and contraction of organoids were observed before and after the application of COA-Cl. COA-Cl significantly increased the beating rate and fractional area change in organoids. To elucidate the mechanism underlying these effects of COA-Cl on cardiac myocytes, pure hiPSC-CM spheroids were evaluated in the presence/absence of Suramin (antagonist of A1R). The effects of COA-Cl, SEW2871 (direct stimulator of S1P1R), two positive inotropes (Isoproterenol [ISO] and Forskolin [FSK]), and negative inotrope (Propranolol [PRP]) on spheroids were assessed based on the beating rates and cAMP levels. COA-Cl stimulated the beating rates about 1.5-fold compared with ISO and FSK, while PRP suppressed the beating rate. However, no marked changes were observed with SEW2871. COA-Cl, ISO, and FSK increased the cAMP level. In contrast, the level of cAMP did not change with PRP or SEW2871 treatment. The results were the same in the presence of Suramin as absence. Furthermore, an enzyme analysis showed that COA-Cl suppressed the PDE activity by half. Conclusions COA-Cl, which has neovascularization effects, suppressed PDE and increased the contraction of cardiac organoids, independent of S1P1R and A1R. These findings suggest that COA-Cl may be useful as an inotropic agent for promoting angiogenesis in the future.	[Kitsuka, Takahiro; Itoh, Manabu; Amamoto, Sojiro; Nishida, Takahiro] Saga Univ, Fac Med, Dept Thorac & Cardiovasc Surg, Saga, Japan; [Arai, Ken-ichi; Nakayama, Koichi] Saga Univ, Fac Med, Dept Regenerat Med & Biomed Engn, Saga, Japan; [Oyama, Junichi; Node, Koichi] Saga Univ, Fac Med, Dept Cardiovasc Med, Saga, Japan; [Toda, Shuji] Saga Univ, Fac Med, Dept Pathol & Microbiol, Saga, Japan; [Morita, Shigeki] Hosp Natl Hosp Org, Kyushu Med Ctr, Dept Cardiovasc Surg, Fukuoka, Fukuoka, Japan	Saga University; Saga University; Saga University; Saga University	Itoh, M (corresponding author), Saga Univ, Fac Med, Dept Thorac & Cardiovasc Surg, Saga, Japan.	itomana@cc.saga-u.ac.jp		Nakayama, Koichi/0000-0002-7324-8862; Arai, Kenichi/0000-0002-2556-4473	JSPS KAKENHI [16H02674, 17H04292, 17K10732]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JSPS KAKENHI Grant Number 16H02674, 17H04292, 17K10732.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; AHN HS, 1986, BIOCHEM PHARMACOL, V35, P1113, DOI 10.1016/0006-2952(86)90147-4; Barnes PJ, 2006, THORAX, V61, P742, DOI 10.1136/thx.2006.061002; Bell CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25187; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Desroches BR, 2012, AM J PHYSIOL-HEART C, V302, pH2031, DOI 10.1152/ajpheart.00743.2011; HALBERT SP, 1971, J EXP MED, V133, P677, DOI 10.1084/jem.133.4.677; Harris K, 2013, TOXICOL SCI, V134, P412, DOI 10.1093/toxsci/kft113; Igarashi J, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12742; Igarashi J, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.68; Itoh M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136681; Keul P, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003393; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; LaMontagne K, 2006, CANCER RES, V66, P221, DOI 10.1158/0008-5472.CAN-05-2001; Li NJ, 2016, FRONT BIOSCI-LANDMRK, V21, P1296, DOI 10.2741/4458; Lochner A, 1998, MOL CELL BIOCHEM, V186, P169, DOI 10.1023/A:1006800205787; Lu F, 2016, J STROKE CEREBROVASC, V25, P2637, DOI 10.1016/j.jstrokecerebrovasdis.2016.07.006; Mattapally S, 2018, AM J PHYSIOL-HEART C, V315, pH327, DOI 10.1152/ajpheart.00688.2017; Mika D, 2013, CARDIOVASC RES, V100, P336, DOI 10.1093/cvr/cvt193; Mukae Y, 2018, TISSUE CELL, V53, P61, DOI 10.1016/j.tice.2018.05.002; Ogihara T, 2017, J TOXICOL SCI, V42, P499, DOI 10.2131/jts.42.499; Richards DJ, 2017, BIOMATERIALS, V142, P112, DOI 10.1016/j.biomaterials.2017.07.021; Sakakibara N, 2017, CHEM PHARM BULL, V65, P504, DOI 10.1248/cpb.c17-00056; Sakakibara N, 2015, CHEM PHARM BULL, V63, P701, DOI 10.1248/cpb.c15-00386; SCHMITZ W, 1989, J CARDIOVASC PHARM, V14, pS11, DOI 10.1097/00005344-198914003-00003; Scott CW, 2013, TOXICOL LETT, V219, P49, DOI 10.1016/j.toxlet.2013.02.020; Simon-Yarza T, 2012, THERANOSTICS, V2, P541, DOI 10.7150/thno.3682; Stover NP, 2008, NEUROTHERAPEUTICS, V5, P252, DOI 10.1016/j.nurt.2008.02.006; Sugiura T, 2016, J CARDIOTHORAC SURG, V11, DOI 10.1186/s13019-016-0559-z; Svystonyuk DA, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00035; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamargo Juan, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P193; Ting DSW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08276-4; Webb S, 2009, NAT REV DRUG DISCOV, V8, P263, DOI 10.1038/nrd2867; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yurie H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171448; Zanella F., 2014, METHOD MOL BIOL, V1353, P147	38	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0213114	10.1371/journal.pone.0213114	http://dx.doi.org/10.1371/journal.pone.0213114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295264	gold, Green Submitted, Green Published			2022-12-26	WOS:000484951800002
J	Krizova, P; Honskus, M				Krizova, Pavla; Honskus, Michal			Genomic surveillance of invasive meningococcal disease in the Czech Republic, 2015-2017	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; SEROGROUP-B; SEQUENCING WGS; VACCINE; VARIANTS; COMPLEX; 4CMENB	Introduction The study presents the results of the genomic surveillance of invasive meningococcal disease (IMD) in the Czech Republic for the period of 2015-2017. Material and methods The study set includes all available IMD isolates recovered in the Czech Republic and referred to the National Reference Laboratory for Meningococcal Infections in 2015-2017, a total of 89 Neissseria meningitidis isolates-from 2015 (n = 20), 2016 (n = 27), and from 2017 (n = 42). All isolates were studied by whole genome sequencing (WGS). Results Serogroup B (MenB) was the most common, followed by serogroups C, W, and Y. Altogether 17 clonal complexes were identified, the most common of which was hypervirulent complex cc11, followed by complexes cc32, cc41/44, cc269, and cc865. Over the three study years, hypervirulent cc11 (MenC) showed an upward trend. The WGS method showed two clearly differentiated clusters of N. meningitidis C: P1.5,2:F3-3:ST-11 (cc11). The first cluster is represented by nine isolates, all of which are from 2017. The second cluster consisted of five isolates from 2016 and eight isolates from 2017. Their genetic discordance is illustrated by the changing nadA allele and subsequently by the variance in BAST type. Clonal complex cc269 (MenB) also increased over the time frame. WGS identified the presence of MenB vaccine antigen genes in all B and non-B isolates of N. meningitidis. Altogether 49 different Bexsero antigen sequence types (BAST) were identified and 10 combinations of these have not been previously described in the PubMLST database. Conclusions The genomic surveillance of IMD in the Czech Republic provides data needed to update immunisation guidelines for this disease. WGS showed a higher discrimination power and	[Krizova, Pavla; Honskus, Michal] Natl Inst Publ Hlth, Ctr Epidemiol & Microbiol, Natl Reference Lab Meningococcal Infect, Prague, Czech Republic	National Institute of Public Health (SZU) - Czech Republic	Krizova, P (corresponding author), Natl Inst Publ Hlth, Ctr Epidemiol & Microbiol, Natl Reference Lab Meningococcal Infect, Prague, Czech Republic.	pavla.krizova@szu.cz		Honskus, Michal/0000-0002-1272-9304; Krizova, Pavla/0000-0002-3993-2994	Ministry of Health of the Czech Republic [15-34887A]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This research was supported by the Ministry of Health of the Czech Republic, grant no. 15-34887A to PK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambini S, 2014, CLIN VACCINE IMMUNOL, V21, P966, DOI 10.1128/CVI.00825-13; Bratcher HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1138; Brehony C, 2016, VACCINE, V34, P4690, DOI 10.1016/j.vaccine.2016.08.015; Eriksson L, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01409-17, 10.1128/jcm.01409-17]; Fazio C, 2019, EUROSURVEILLANCE, V24, P33, DOI 10.2807/1560-7917.ES.2019.24.4.1800183; Hong E, 2018, J INFECTION, V76, P149, DOI 10.1016/j.jinf.2017.10.015; Honskus M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199652; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jolley Keith A, 2018, Wellcome Open Res, V3, P124, DOI 10.12688/wellcomeopenres.14826.1; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kesanopoulos K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209919; Knol MJ, 2017, LANCET PUBLIC HEALTH, V2, pE473, DOI 10.1016/S2468-2667(17)30157-3; Krizova P, 2018, EPIDEMIOL MIKROBI IM, V67, P64; Krizova P, 2018, CEM REPORTS, V27, P16; Lucidarme J, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.45.30395; Lucidarme J, 2017, J INFECTION, V75, P95, DOI 10.1016/j.jinf.2017.05.015; Lucidarme J, 2015, J INFECTION, V71, P544, DOI 10.1016/j.jinf.2015.07.007; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; McNeil LK, 2018, MBIO, V9, DOI 10.1128/mBio.00036-18; Mulhall RM, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00196-18; Muzzi A, 2019, VACCINE, V37, P991, DOI 10.1016/j.vaccine.2018.12.061; Nissen MD, 2013, PEDIATR INFECT DIS J, V32, P364, DOI 10.1097/INF.0b013e31827b0d24; Revez J, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00347; Rodrigues CMC, 2018, EMERG INFECT DIS, V24, P673, DOI 10.3201/eid2404.171480; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; The National Institute of Public Health Czech Republic, 2018, REC CZECH VACC SOC J; Vackova Z, 2017, EPIDEMIOL MIKROBI IM, V66, P50; Vernikos G, 2014, PATHOG GLOB HEALTH, V108, P305, DOI 10.1179/2047773214Y.0000000162; Vogel U, 2000, J CLIN MICROBIOL, V38, P941, DOI 10.1128/JCM.38.2.941-942.2000; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Whittaker R, 2017, VACCINE, V35, P2034, DOI 10.1016/j.vaccine.2017.03.007; Zerbino DR, 2010, CURR PROTOC BIOINFOR, V11, P11	33	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219477	10.1371/journal.pone.0219477	http://dx.doi.org/10.1371/journal.pone.0219477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295279	gold, Green Submitted, Green Published			2022-12-26	WOS:000484951800037
J	Stefanska-Krzaczek, E; Staniaszek-Kik, M; Szczepanska, K; Szymura, TH				Stefanska-Krzaczek, Ewa; Staniaszek-Kik, Monika; Szczepanska, Katarzyna; Szymura, Tomasz H.			Species diversity patterns in managed Scots pine stands in ancient forest sites	PLOS ONE			English	Article							PLANT DIVERSITY; ECOLOGICAL CONTINUITY; UNDERSTORY VEGETATION; BRYOPHYTE COMMUNITIES; EPIPHYTIC BRYOPHYTES; WOODY DEBRIS; RICHNESS; TEMPERATE; BIODIVERSITY; LICHENS	Continuity in forest habitats is crucial for species diversity and richness. Ancient Scots pine forests are usually under forest management, which disturbs vegetation and causes differentiation in terms of tree stand age. To date, vegetation variability in ancient Scots pine forests has not been examined based on tree stand age classes. In the present study the continuity of a large Scots pine forest complex was investigated, and a system of sampling plots established in five tree stand age classes: initiation stands (4-10 years), young stands (20-35 years), middle-aged stands (45-60 years), pre -mature stands (70-85 years) and mature stands (95-110 years). Species composition, including vascular plants, bryophytes and lichens, on soil, tree trunks, and coarse woody debris, was analyzed. Based on existing classifications systems, forest species and ancient forest species groups were distinguished. In the studied ancient Scots pine forests the species pool and richness were relatively low, and the vegetation consisted mostly of generalist species. Cryptogams, which can grow on diverse substrates, were the most abundant species. Moreover, most species could tolerate both forest and non -forest conditions. Age class forests provided different environmental niches for species. Initiation stands were optimal for terrestrial light -demanding species, and in terms of species composition, initiation stands were most specific. Young stands were most preferred by species on coarse woody debris, and at this stage of stand maturation epiphytic species re -appeared. The oldest stands were not rich in forest specialists, i.e. species of closed forest and ancient forest species. Cryptogams of closed forests inhabited different substrates, and they were not associated only with the oldest stands. The low number of forest specialists in the oldest stands may be a general feature of acidophilus pine forests. However, it may also be a result of the lack of species sources in the vicinity of maturing pine stands. In managed forests a frequent diversity pattern is an increase in a species pool and richness after clear-cut logging. In the present study we obtained higher species pools in initiation and young stands, but richness was similar in all tree stand age classes. This resulted from taking into account species of different substrates (terrestrial, epixylous and epiphytic species) which changed their participation in the vegetation of subsequent stages of tree stand development.	[Stefanska-Krzaczek, Ewa] Univ Wroclaw, Bot Garden, Wroclaw, Poland; [Staniaszek-Kik, Monika] Univ Lodz, Fac Biol & Environm Protect, Dept Geobot & Plant Ecol, Lodz, Poland; [Szczepanska, Katarzyna] Wroclaw Univ Environm & Life Sci, Dept Bot & Plant Ecol, Wroclaw, Poland; [Szymura, Tomasz H.] Univ Wroclaw, Dept Ecol Biogeochem & Environm Protect, Wroclaw, Poland	University of Wroclaw; University of Lodz; Wroclaw University of Environmental & Life Sciences; University of Wroclaw	Stefanska-Krzaczek, E (corresponding author), Univ Wroclaw, Bot Garden, Wroclaw, Poland.	ewa.stefanska-krzaczek@uwr.edu.pl		Szymura, Tomasz/0000-0003-4317-4388; Szczepanska, Katarzyna/0000-0002-7752-3024; Staniaszek-Kik, Monika/0000-0001-7969-0312				ANDERSSON LI, 1991, HOLARCTIC ECOL, V14, P121; Ardelean IV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145808; Ares A, 2010, FOREST ECOL MANAG, V260, P1104, DOI 10.1016/j.foreco.2010.06.023; Augusto L, 2003, ANN FOREST SCI, V60, P823, DOI 10.1051/forest:2003077; Aussenac G, 2000, ANN FOR SCI, V57, P287; Baisheva Elvira Z., 2015, Arctoa, V24, P547, DOI 10.15298/arctoa.24.47; Barbier S, 2008, FOREST ECOL MANAG, V254, P1, DOI 10.1016/j.foreco.2007.09.038; Bernes C, 2015, ENVIRON EVID, V4, DOI 10.1186/s13750-014-0030-3; Boudreault C, 2018, CAN J FOREST RES, V48, P821, DOI 10.1139/cjfr-2017-0352; Boudreault C, 2015, CAN J FOREST RES, V45, P595, DOI 10.1139/cjfr-2013-0529; Brakenhielm S, 1998, BIODIVERS CONSERV, V7, P207, DOI 10.1023/A:1008836502640; Cesoniene L, 2018, TURK J AGRIC FOR, V42, P433, DOI 10.3906/tar-1804-71; Chaudhary A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23954; Christensen M, 1996, FOREST ECOL MANAG, V85, P47, DOI 10.1016/S0378-1127(96)03749-8; Coote L, 2012, FOREST ECOL MANAG, V283, P86, DOI 10.1016/j.foreco.2012.07.013; Cornwell WK, 2003, OIKOS, V100, P417, DOI 10.1034/j.1600-0706.2003.11697.x; del Rio M, 2017, FOREST SYST, V26, DOI 10.5424/fs/2017262-11325; Dittrich S, 2013, FLORA, V208, P238, DOI 10.1016/j.flora.2013.03.006; Duguid MC, 2013, FOREST ECOL MANAG, V303, P81, DOI 10.1016/j.foreco.2013.04.009; Ellenberg H., 1992, SCRIPTA GEOBOTANICA, V18, P1; Falinski JB, 1993, PHYTOCOENOSIS 5 SCG, V5, P3; Hermy M, 1999, BIOL CONSERV, V91, P9, DOI 10.1016/S0006-3207(99)00045-2; Hermy M, 2007, ECOL RES, V22, P361, DOI 10.1007/s11284-007-0354-3; Hill MO., 2007, BRYOATT ATTRIBUTES B; Hofmeister J, 2015, ECOL INDIC, V57, P497, DOI 10.1016/j.ecolind.2015.05.015; HOMEIER J, 2017, ECOLOGY CENTRAL EURO, V4, DOI DOI 10.1186/S40663-017-0097-8; Houston Durrant T.H., 2016, EUROPEAN ATLAS FORES, P132, DOI DOI 10.2788/038466; Humphrey JW, 2002, BIOL CONSERV, V107, P165, DOI 10.1016/S0006-3207(02)00057-5; IUSS Working Group WRB, 2014, WORLD REFERENCE BASE, DOI [10.1017/S0014479706394902, DOI 10.1017/S0014479706394902]; Janssen P, 2018, J ECOL, V106, P306, DOI 10.1111/1365-2745.12808; Kacki Zygmunt, 2013, Monographiae Botanicae, V103, P7, DOI 10.5586/mb.2013.001; Kaufmann S, 2017, FOREST ECOL MANAG, V400, P58, DOI 10.1016/j.foreco.2017.05.043; Kelly D. L., 2000, Investigacion Agraria, Sistemas y Recursos Forestales, P15; Klama H., 2006, ANNOTATED CHECKLIST, P83; Kolb A, 2004, J VEG SCI, V15, P199, DOI 10.1111/j.1654-1103.2004.tb02255.x; Kowalska A., 2017, Silva Fennica, V51, P1684; Kruys N, 1999, CAN J FOREST RES, V29, P1295, DOI 10.1139/cjfr-29-8-1295; Kumar P, 2017, J VEG SCI, V28, P389, DOI 10.1111/jvs.12485; Lelli C, 2019, FOREST ECOL MANAG, V432, P707, DOI 10.1016/j.foreco.2018.09.057; Madzule L, 2012, BIODIVERS CONSERV, V21, P437, DOI 10.1007/s10531-011-0192-z; Marcos JA, 2007, FOREST ECOL MANAG, V247, P35, DOI 10.1016/j.foreco.2007.04.022; Marozas V, 2005, SCAND J FOREST RES, V20, P43, DOI 10.1080/14004080510040986; Mason WL, 2000, FOREST SYST, V9, P317, DOI DOI 10.5424/690; Matias L, 2012, FOREST ECOL MANAG, V282, P10, DOI 10.1016/j.foreco.2012.06.053; Matuszkiewicz JM, 2013, FOREST ECOL MANAG, V310, P567, DOI 10.1016/j.foreco.2013.08.060; Matuszkiewicz JM, 2013, ROOEVOLUTION MODELS; Mezaka A, 2012, BIODIVERS CONSERV, V21, P3221, DOI 10.1007/s10531-012-0361-8; Molder A, 2015, ECOL INDIC, V54, P12, DOI 10.1016/j.ecolind.2015.01.044; Muller J, 2019, FOREST ECOL MANAG, V432, P850, DOI 10.1016/j.foreco.2018.10.019; Nelson CR, 2005, CAN J BOT, V83, P610, DOI [10.1139/B05-036, 10.1139/b05-036]; Norden B, 2001, BIODIVERS CONSERV, V10, P779, DOI 10.1023/A:1016675103935; Norden B, 2014, ECOSCIENCE, V21, P34, DOI 10.2980/21-1-3667; Ochyra R., 2003, CENSUS CATALOGUE POL; Odor P, 2013, FOREST ECOL MANAG, V306, P256, DOI 10.1016/j.foreco.2013.07.001; Orczewska A, 2011, POL J ECOL, V59, P75; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Paquette M, 2016, FOREST ECOL MANAG, V359, P99, DOI 10.1016/j.foreco.2015.09.031; Puchniarski TH, 2008, SOSNA ZWYCZAJNA HODO; Pykala J, 2004, APPL VEG SCI, V7, P29, DOI 10.1111/j.1654-109X.2004.tb00592.x; ROBERTS MR, 1995, ECOL APPL, V5, P969, DOI 10.2307/2269348; Schmidt M., 2011, BFN SKRIPTEN; Schmidt M, 2014, FOREST ECOL MANAG, V330, P228, DOI 10.1016/j.foreco.2014.06.043; Smilauer P., 2014, MULTIVARIATE ANAL EC, V5; Spiecker H, 2003, J ENVIRON MANAGE, V67, P55, DOI 10.1016/S0301-4797(02)00188-3; Staniaszek-Kik M, 2018, HERZOGIA, V31, P70, DOI 10.13158/099.031.0104; Statsoft Inc, 2013, EL STAT TXB; Stebel A., 2006, HABILITATION THESIS, V17, P1; Stefanska-Krzaczek E., 2012, Journal of Forest Science (Prague), V58, P345, DOI 10.17221/9/2012-JFS; Stefanska-Krzaczek E, 2016, CRYPTOGAMIE BRYOL, V37, P181, DOI 10.7872/cryb/v37.iss2.2016.181; Stefanska-Krzaczek E, 2016, FOREST ECOL MANAG, V365, P12, DOI 10.1016/j.foreco.2016.01.012; Stefanska-Krzaczek E, 2015, BALT FOR, V21, P233; Stefanska-Krzaczek E, 2013, SYLWAN, V157, P929; Summers RW, 1999, FOREST ECOL MANAG, V119, P231, DOI 10.1016/S0378-1127(98)00515-5; Szymura T. H., 2010, OPERA CORCONTICA S1, V47, P159; Szymura TH, 2018, ACTA SOC BOT POL, V87, DOI 10.5586/asbp.3576; Taborska M, 2017, BIODIVERS CONSERV, V26, P2893, DOI 10.1007/s10531-017-1395-8; Thomas SC, 1999, ECOL APPL, V9, P864, DOI 10.1890/1051-0761(1999)009[0864:PDIMFU]2.0.CO;2; Tichy L, 2010, PROGRAM MANUAL; Tichy L, 2006, USERS MANUAL J VEG S; Tonteri T, 2016, FOREST ECOL MANAG, V381, P115, DOI 10.1016/j.foreco.2016.09.015; Ujhazy K, 2017, FOREST ECOL MANAG, V391, P96, DOI 10.1016/j.foreco.2017.02.010; Vellak K, 1999, BIODIVERS CONSERV, V8, P1595, DOI 10.1023/A:1008927501623; Widenfalk O, 2009, FOREST ECOL MANAG, V257, P1386, DOI 10.1016/j.foreco.2008.12.010; Wolseley P, 2017, BIODIVERS CONSERV, V26, P401, DOI 10.1007/s10531-016-1250-3; Zawadzki S., 1999, GLEBOZNAWSTWO	85	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219620	10.1371/journal.pone.0219620	http://dx.doi.org/10.1371/journal.pone.0219620			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295314	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800056
J	Zhang, RD; Zhou, YF; Yue, ZX; Chen, XF; Cao, X; Ai, XY; Jiang, B; Xing, YF				Zhang, Ruidong; Zhou, Yufei; Yue, Zhongxiao; Chen, Xiaofei; Cao, Xiong; Ai, Xueying; Jiang, Bing; Xing, Yifan			The leaf-air temperature difference reflects the variation in water status and photosynthesis of sorghum under waterlogged conditions	PLOS ONE			English	Article							TOLERANCE; STRESS; LEAVES; COTTON; WHEAT; ROOT; L.; METABOLISM; RESPONSES; TRAITS	Waterlogging stress is one of the most important abiotic stresses limiting sorghum growth and development. Consequently, the responses of sorghum to waterlogging must be monitored and studied. This study investigated changes in the leaf water status, xylem exudation rate, leaf anatomical structure, leaf temperature and photosynthetic performance. Waterlogging-tolerant (Jinuoliang 01, abbreviated JN01) and waterlogging-sensitive (Jinza 31, abbreviated JZ31) sorghum cultivars were planted in pots. The experiment was carried out using a split block design with three replications. Waterlogging stress was imposed at the sorghum five-leaf stage. The leaf free water content (FWC) and relative water content (RWC) decreased under the waterlogged condition. The leaf thickness was thinner under the waterlogged condition, and the main changes occurred in the upper epidermal and mesophyll cells. Gas exchange parameters and the xylem exudation rate were also restrained by waterlogging; however, greater responses of these parameters were observed in JZ31. JZ31 had a higher leaf-air temperature difference (Delta T) than JN01. We found that changes in Delta T were always consistent with changes in the RWC and the gas exchange parameters. Delta T was significantly associated with the leaf RWC, photosynthetic rate (Pn) and transpiration rate (Tr). The results suggest that Delta T may be an indicator reflecting the water status in leaves and can be used to evaluate the tolerance of sorghum to waterlogging.	[Zhang, Ruidong; Zhou, Yufei; Chen, Xiaofei; Ai, Xueying; Jiang, Bing; Xing, Yifan] Shenyang Agr Univ, Coll Agron, Shenyang, Liaoning, Peoples R China; [Zhang, Ruidong; Yue, Zhongxiao; Cao, Xiong] Shanxi Acad Agr Sci, Inst Cash Crops, Taiyuan, Shanxi, Peoples R China	Shenyang Agricultural University; Shanxi Agricultural University	Zhou, YF (corresponding author), Shenyang Agr Univ, Coll Agron, Shenyang, Liaoning, Peoples R China.	zhouyufei2002@aliyun.com		Zhang, Ruidong/0000-0002-8126-9268	China Agriculture Research System [CARS-06]	China Agriculture Research System	This work was financially supported by China Agriculture Research System (CARS-06 to YZ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanullah, 2015, J PLANT NUTR, V38, P1694, DOI 10.1080/01904167.2015.1017051; An YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147202; BLUM A, 1982, FIELD CROP RES, V5, P137, DOI 10.1016/0378-4290(82)90014-4; Dhillon R, 2014, TARIM MAKINALARI BIL, V10, P267; Djanaguiraman M, 2011, CROP SCI, V51, P2125, DOI 10.2135/cropsci2010.10.0571; Du Q, 2019, J INTEGR AGR, V18, P395, DOI [10.1016/s2095-3119(18)61953-7, 10.1016/S2095-3119(18)61953-7]; Egilla JN, 2005, PHOTOSYNTHETICA, V43, P135, DOI 10.1007/s11099-005-5140-2; [冯晓钰 Feng Xiaoyu], 2018, [生态学报, Acta Ecologica Sinica], V38, P177; Gerhards M, 2016, INT J APPL EARTH OBS, V53, P27, DOI 10.1016/j.jag.2016.08.004; Giorio P, 1999, ENVIRON EXP BOT, V42, P95, DOI 10.1016/S0098-8472(99)00023-4; Huang RD, 2018, J INTEGR AGR, V17, P739, DOI [10.1016/S2095-3119(17)61728-3, 10.1016/s2095-3119(17)61728-3]; Johnson R. S., 2005, California Agriculture, V59, P133, DOI 10.3733/ca.v059n02p133; Jumrani K, 2017, PHOTOSYNTH RES, V131, P333, DOI 10.1007/s11120-016-0326-y; Kadam S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00862; Kuai J, 2014, PLANT SCI, V223, P79, DOI 10.1016/j.plantsci.2014.03.010; Kulkarni M, 2010, SCI HORTIC-AMSTERDAM, V124, P316, DOI 10.1016/j.scienta.2010.01.005; Kumutha D, 2008, PLANT SCI, V175, P706, DOI 10.1016/j.plantsci.2008.07.013; Li JinCai, 2006, Acta Agronomica Sinica, V32, P1355; Liu Ya, 2009, Scientia Agricultura Sinica, V42, P2192; Liu YunPeng, 2014, Journal of China Agricultural University, V19, P13; Luan HY, 2018, PLANT GROWTH REGUL, V85, P399, DOI 10.1007/s10725-018-0401-9; Luan Zhong-qi, 2007, Xibei Zhiwu Xuebao, V27, P2323; Mahmud Abdullah-Al, 2016, Indian Journal of Plant Physiology, V21, P56, DOI 10.1007/s40502-015-0202-3; Malik A, 2001, AUST J PLANT PHYSIOL, V28, P1121, DOI 10.1071/PP01089; Min HY, 2018, KOREAN J PLANT RESOU, V31, P124; Mizukami Y, 2006, BIOSYST ENG, V93, P293, DOI 10.1016/j.biosystemseng.2005.12.009; Nelson JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138930; Pang W, 2011, PLANT DIS, V95, P1308, DOI 10.1094/PDIS-01-11-0026; Popescu M., 2014, CURRENT TRENDS NATUR, V3, P74; Prasad PVV, 2011, FUNCT PLANT BIOL, V38, P993, DOI 10.1071/FP11035; Ranathunge K, 2003, PLANTA, V217, P193, DOI 10.1007/s00425-003-0984-9; Ren BaiZhao, 2017, Scientia Agricultura Sinica, V50, P2093; Ren BZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161424; Ren BZ, 2016, AGRON J, V108, P1060, DOI 10.2134/agronj2015.0547; Setter TL, 2009, ANN BOT-LONDON, V103, P221, DOI 10.1093/aob/mcn137; Singh V, 2006, FIELD CROP RES, V96, P199, DOI 10.1016/j.fcr.2005.06.011; Surendar KK, 2013, PLANT GENE TRAIT, V8, P43, DOI [10.5376/pgt.2013.04.0008, DOI 10.5376/PGT.2013.04.0008]; TAKELE A, 1994, TROP AGRIC, V71, P275; Wang J, 2017, PAK J BOT, V49, P1681; [王艺陶 Wang Yitao], 2013, [干旱地区农业研究, Agricultural Research in the Arid Areas], V31, P146; Yamauchi T, 2018, PLANT PHYSIOL, V176, P1118, DOI 10.1104/pp.17.01157; [尹聪 YIN Cong], 2009, [安全与环境学报, Journal of Safety and Environment], V9, P1; Yin DM, 2012, SCI HORTIC-AMSTERDAM, V146, P86, DOI 10.1016/j.scienta.2012.08.019; Zhang L, 2012, EUR J AGRON, V41, P103, DOI 10.1016/j.eja.2012.04.003; Zou Q., 2000, EXPT INSTRUCTION PLA, P18	45	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219209	10.1371/journal.pone.0219209	http://dx.doi.org/10.1371/journal.pone.0219209			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295276	Green Submitted, Green Published, gold			2022-12-26	WOS:000484951800020
J	de Terline, DM; Kane, A; Kramoh, KE; Toure, IA; Mipinda, JB; Diop, IB; Nhavoto, C; Balde, DM; Ferreira, B; Houenassi, MD; Ikama, MS; Kingue, S; Kouam, CK; Takombe, JL; Limbole, E; Kuate, LM; N'guetta, R; Damorou, JM; Sesso, Z; Ali, AS; Perier, MC; Azizi, M; Empana, JP; Jouven, X; Antignac, M				de Terline, Diane Macquart; Kane, Adama; Kramoh, Kouadio Euloge; Toure, Ibrahim Ali; Mipinda, Jean Bruno; Diop, Ibrahima Bara; Nhavoto, Carol; Balde, Dadhi M.; Ferreira, Beatriz; Houenassi, Martin Dedonougbo; Ikama, Meo Stephane; Kingue, Samuel; Kouam, Charles Kouam; Takombe, Jean Laurent; Limbole, Emmanuel; Kuate, Liliane Mfeukeu; N'guetta, Roland; Damorou, Jean Marc; Sesso, Zouwera; Ali, Abdallahi Sidy; Perier, Marie-Cecile; Azizi, Michel; Empana, Jean Philippe; Jouven, Xavier; Antignac, Marie			Factors associated with poor adherence to medication among hypertensive patients in twelve low and middle income Sub-Saharan countries	PLOS ONE			English	Article							BLOOD-PRESSURE; DISEASE; INTERVENTIONS; METAANALYSIS; PREVALENCE; THERAPY; AFRICA; DRUGS	Introduction Over the past few decades, the prevalence of hypertension has dramatically increased in Sub-Saharan Africa. Poor adherence has been identified as a major cause of failure to control hypertension. Scarce data are available in Africa. Aims We assessed adherence to medication and identified socioeconomics, clinical and treatment factors associated with low adherence among hypertensive patients in 12 sub-Saharan African countries. Method We conducted a cross-sectional survey in urban clinics of both low and middle income countries. Data were collected by physicians on demographics, treatment and clinical data among hypertensive patients attending the clinics. Adherence was assessed by questionnaires completed by the patients. Factors associated with low adherence were investigated using logistic regression with a random effect on countries. Results There were 2198 individuals from 12 countries enrolled in the study. Overall, 678 (30.8%), 738 (33.6%), 782 (35.6%) participants had respectively low, medium and high adherence to antihypertensive medication. Multivariate analysis showed that the use of traditional medicine (OR: 2.28, 95% CI [1.79-2.90]) and individual wealth index (low vs. high wealth: OR: 1.86, 95% CI [1.35-2.56] and middle vs. high wealth: OR: 1.42, 95% CI [1.11-1.81]) were significantly and independently associated with poor adherence to medication. In stratified analysis, these differences in adherence to medication according to individual wealth index were observed in low-income countries (p<0.001) but not in middle-income countries (p=0.17). In addition, 26.5% of the patients admitted having stopped their treatment due to financial reasons and this proportion was 4 fold higher in the lowest than highest wealth group (47.8% vs 11.4%) (p<0.001). Conclusion This study revealed the high frequency of poor adherence in African patients and the associated factors. These findings should be useful for tailoring future programs to tackle hypertension in low income countries that are better adapted to patients, with a potential associated enhancement of their effectiveness.	[de Terline, Diane Macquart; Antignac, Marie] St Antoine Hosp, HUEP, AP HP, Dept Pharm, Paris, France; [de Terline, Diane Macquart; Perier, Marie-Cecile; Empana, Jean Philippe; Jouven, Xavier; Antignac, Marie] Hop Europeen Georges Pompidou, Paris Cardiovasc Res Ctr, INSERM, U970, Paris, France; [de Terline, Diane Macquart; Azizi, Michel; Jouven, Xavier] Paris Descartes Univ, Paris, France; [Kane, Adama] Univ Hosp Aristide Le Dantec, Dept Cardiol, Dakar, Senegal; [Kramoh, Kouadio Euloge; N'guetta, Roland] Inst Cardiol Abidjan, Abidjan, Cote Ivoire; [Toure, Ibrahim Ali] Univ Hosp Lamorde, Internal Med & Cardiol Dept, Niamey, Niger; [Mipinda, Jean Bruno] Univ Hosp Libreville, Libreville, Gabon; [Diop, Ibrahima Bara] Univ Hosp Fann, Dept Cardiol, Dakar, Senegal; [Nhavoto, Carol; Ferreira, Beatriz] Inst Coracao ICOR, Maputo, Mozambique; [Balde, Dadhi M.] Univ Hosp Conakry, Dept Cardiol, Conakry, Guinea; [Houenassi, Martin Dedonougbo] Natl Univ Hosp Hubert K MAGA CNHU HKM, Cotonou, Benin; [Ikama, Meo Stephane] Marien NGOUABI Univ, Natl Univ Hosp Brazzaville, Dept Cardiol, Brazzaville, Rep Congo; [Kingue, Samuel] Univ Yaounde, Minist Publ Hlth, Yaounde, Cameroon; [Kouam, Charles Kouam] Reg Hosp, Dept Internal Med, Bafoussam, Cameroon; [Takombe, Jean Laurent] Gen Hosp Kinshasa, Kinshasa, DEM REP CONGO; [Limbole, Emmanuel] Ngaliema Hosp, Dept Internal Med, Dept Internal Med la Gombe CMCG, Kinshasa, DEM REP CONGO; [Kuate, Liliane Mfeukeu] Cent Hosp Yaounde, Yaounde, Cameroon; [Damorou, Jean Marc; Sesso, Zouwera] CH Lome, Dept Cardiol, Lome, Togo; [Ali, Abdallahi Sidy] Cardiol Clin, Nouakchott, Mauritania; [Azizi, Michel] Hop Europeen Georges Pompidou, AP HP, Hypertens Unit, Paris, France; [Azizi, Michel] INSERM, Ctr Invest Clin, Paris, France; [Jouven, Xavier] Hop Europeen Georges Pompidou, AP HP, Dept Cardiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Yaounde I; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	de Terline, DM (corresponding author), St Antoine Hosp, HUEP, AP HP, Dept Pharm, Paris, France.; de Terline, DM (corresponding author), Hop Europeen Georges Pompidou, Paris Cardiovasc Res Ctr, INSERM, U970, Paris, France.; de Terline, DM (corresponding author), Paris Descartes Univ, Paris, France.	diane.macquart-de-terline@aphp.fr	Empana, Jean-Philippe/AAF-6923-2021	Empana, Jean-Philippe/0000-0002-1469-7772	INSERM (Institut national de la Sante et de la Recherche Medicale); AP-HP (Assistance Publique Hopitaux de Paris); Paris Descartes University	INSERM (Institut national de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); AP-HP (Assistance Publique Hopitaux de Paris); Paris Descartes University	This work was supported by: INSERM (Institut national de la Sante et de la Recherche Medicale), AP-HP (Assistance Publique Hopitaux de Paris), Paris Descartes University.	Abegaz TM, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005641; [Anonymous], 2003, ADHERENCE LONG TERM; Antignac M, 2018, HYPERTENSION, V71, P577, DOI 10.1161/HYPERTENSIONAHA.117.10512; Antignac M, 2017, INT J CARDIOL, V243, P523, DOI 10.1016/j.ijcard.2017.04.099; Appiah B, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2334-2; Attaei MW, 2017, LANCET PUBLIC HEALTH, V2, pE411, DOI 10.1016/S2468-2667(17)30141-X; Beaney T, 2018, LANCET GLOB HEALTH, V6, pE736, DOI 10.1016/S2214-109X(18)30259-6; Bodeker G, 2001, BMJ-BRIT MED J, V322, P164, DOI 10.1136/bmj.322.7279.164; Bosworth HB, 2011, AM HEART J, V162, P412, DOI 10.1016/j.ahj.2011.06.007; Bowry ADK, 2011, J GEN INTERN MED, V26, P1479, DOI 10.1007/s11606-011-1825-3; Bramley TJ, 2006, J MANAGE CARE PHARM, V12, P239, DOI 10.18553/jmcp.2006.12.3.239; Chobanian AV, 2009, NEW ARMEN MED J, V3, P60, DOI 10.1056/NEJMsa0903829; Choudhry NK, 2010, CIRC-CARDIOVASC QUAL, V3, P223, DOI 10.1161/CIRCOUTCOMES.110.957142; Chowdhury R, 2013, EUR HEART J, V34, P2940, DOI 10.1093/eurheartj/eht295; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; de Terline DM, 2018, J HYPERTENS, V36, P395, DOI 10.1097/HJH.0000000000001560; Dragomir A, 2010, MED CARE, V48, P418, DOI 10.1097/MLR.0b013e3181d567bd; Gaziano TA, 2005, CIRCULATION, V112, P3547, DOI 10.1161/CIRCULATIONAHA.105.591792; Haynes R B, 2002, Cochrane Database Syst Rev, pCD000011; Hollenberg Daniel, 2008, World Health Popul, V10, P62; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kini V, 2018, JAMA-J AM MED ASSOC, V320, P2461, DOI 10.1001/jama.2018.19271; Korb-Savoldelli V, 2012, J CLIN HYPERTENS, V14, P429, DOI 10.1111/j.1751-7176.2012.00634.x; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Mills E, 2006, INT J STD AIDS, V17, P360, DOI 10.1258/095646206777323382; Nielsen J, 2017, J HUM HYPERTENS, V31, P14, DOI 10.1038/jhh.2016.31; Ojji DB, 2019, COMP DUAL THERAPIES, DOI [10.1056/NEJMoa1901113, DOI 10.1056/NEJMOA1901113]; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pruijm MT, 2008, VASC HEALTH RISK MAN, V4, P1159; Ranque B, 2014, LANCET HAEMATOL, V1, pE64, DOI 10.1016/S2352-3026(14)00007-6; Rockers PC, 2019, LANCET GLOB HEALTH, V7, pE492, DOI 10.1016/S2214-109X(18)30563-1; Ruppar TM, 2017, J HYPERTENS, V35, P1145, DOI 10.1097/HJH.0000000000001260; Shi LZ, 2010, HEALTH QUAL LIFE OUT, V8, P12, DOI 10.1186/1477-7525-8-99; van der Watt ASJ, 2017, QUAL HEALTH RES, V27, P2177, DOI 10.1177/1049732317729342; Wirtz VJ, 2016, CIRCULATION, V133, P2076, DOI 10.1161/CIRCULATIONAHA.115.008722; World Health Organization, 2014, WHO TRADITIONAL MED, DOI 10.3390/biom11101457; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	38	25	25	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219266	10.1371/journal.pone.0219266	http://dx.doi.org/10.1371/journal.pone.0219266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291293	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800062
J	Hage, C; Hoves, S; Ashoff, M; Schandl, V; Hort, S; Rieder, N; Heichinger, C; Berrera, M; Ries, CH; Kiessling, F; Poschinger, T				Hage, Carina; Hoves, Sabine; Ashoff, Mailin; Schandl, Veronika; Hoert, Stefan; Rieder, Natascha; Heichinger, Christian; Berrera, Marco; Ries, Carola H.; Kiessling, Fabian; Poeschinger, Thomas			Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy	PLOS ONE			English	Article							PROGRESSION; TOLERANCE; TUMORS	Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and has a high mortality rate due to limited treatment options. Hence, the response of HCC to different cancer immunotherapies is being intensively investigated in clinical trials. Immune checkpoint blockers (ICB) show promising results, albeit for a minority of HCC patients. Mouse models are commonly used to evaluate new therapeutic agents or regimens. However, to make clinical translation more successful, better characterized preclinical models are required. We therefore extensively investigated two immune-competent orthotopic HCC mouse models, namely transplanted Hep-55.1c and transgenic iAST, with respect to morphological, immunological and genetic traits and evaluated both models' responsiveness to immunotherapies. Hep-55.1c tumors were characterized by rich fibrous stroma, high mutational load and pronounced immune cell infiltrates, all of which are features of immune-responsive tumors. These characteristics were less distinct in iAST tumors, though these were highly vascularized. Cell depletion revealed that CD8(+) T cells from iAST mice do not affect tumor growth and are tumor tolerant. This corresponds to the failure of single and combined ICB targeting PD-1 and CTLA-4. In contrast, combining anti-PD-1 and anti-CTLA-4 showed significant antitumor efficacy in the Hep-55.1c mouse model. Collectively, our data comprehensively characterize two immune-competent HCC mouse models representing ICB responsive and refractory characteristics. Our characterization confirms these models to be suitable for preclinical investigation of novel cancer immunotherapy approaches that aim to either deepen preexisting immune responses or generate de novo immunity against the tumor.	[Hage, Carina; Hoves, Sabine; Ashoff, Mailin; Schandl, Veronika; Hoert, Stefan; Rieder, Natascha; Ries, Carola H.; Poeschinger, Thomas] Roche Innovat Ctr Munich, Roche Pharmaceut Res & Early Dev, Penzberg, Germany; [Hage, Carina; Kiessling, Fabian] Rhein Westfal TH Aachen, Univ Clin, Inst Expt Mol Imaging, Aachen, Germany; [Hage, Carina; Kiessling, Fabian] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Aachen, Germany; [Heichinger, Christian; Berrera, Marco] Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Basel, Switzerland	RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; RWTH Aachen University; Roche Holding	Hage, C; Poschinger, T (corresponding author), Roche Innovat Ctr Munich, Roche Pharmaceut Res & Early Dev, Penzberg, Germany.; Hage, C (corresponding author), Rhein Westfal TH Aachen, Univ Clin, Inst Expt Mol Imaging, Aachen, Germany.; Hage, C (corresponding author), Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Aachen, Germany.	carina.hage@roche.com; thomas.poeschinger@roche.com	Kiessling, Fabian/Y-2417-2019	Kiessling, Fabian/0000-0002-7341-0399; Hage, Carina/0000-0002-5352-0742; Poschinger, Thomas/0000-0003-2581-0424	Roche	Roche(Roche Holding)	This study was sponsored by Roche. The funder provided support in the form of salaries for authors [CH, SH, MA, VS, SH, NR, CH, MB, CHR, TP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ahmed SU, 2013, JOVE-J VIS EXP, DOI 10.3791/50544; Armengol C, 2004, CLIN CANCER RES, V10, P2150, DOI 10.1158/1078-0432.CCR-03-1028; Bagi Cedo M, 2010, Cancers (Basel), V2, P1441, DOI 10.3390/cancers2031441; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Bour G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106675; Broz ML, 2014, CANCER CELL, V26, P938, DOI 10.1016/j.ccell.2014.11.010; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chae YK, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0349-3; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Chung SI, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0423-6; Crissien Ana Maria, 2014, Gastroenterol Hepatol (N Y), V10, P153; Crittenden MR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25482-w; Fasani P, 1999, HEPATOLOGY, V29, P1704, DOI 10.1002/hep.510290604; Finkelmeier F, 2018, EXPERT REV ANTICANC, V18, P1169, DOI 10.1080/14737140.2018.1535315; de Jesus VHF, 2018, J HEPATOCELL CARCINO, V5, P87, DOI 10.2147/JHC.S171396; Friedman D, 2017, HEPATOL RES, V47, P702, DOI 10.1111/hepr.12789; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garnelo M, 2017, GUT, V66, P342, DOI 10.1136/gutjnl-2015-310814; Goodman AM, 2017, MOL CANCER THER, V16, P2598, DOI 10.1158/1535-7163.MCT-17-0386; Hage C, 2019, HEPATOLOGY; Harding JJ, 2018, FUTURE ONCOL, V14, P2293, DOI 10.2217/fon-2018-0008; Harding JJ, 2016, CANCER-AM CANCER SOC, V122, P367, DOI 10.1002/cncr.29769; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Jackson SR, 2014, IMMUNOTHERAPY-UK, V6, P833, DOI [10.2217/imt.14.51, 10.2217/IMT.14.51]; Kim JU, 2016, WORLD J HEPATOL, V8, P471, DOI 10.4254/wjh.v8.i10.471; KRESS S, 1992, MOL CARCINOGEN, V6, P148, DOI 10.1002/mc.2940060210; Kudo M, 2017, ONCOLOGY-BASEL, V93, P147, DOI 10.1159/000481245; Kudo M, 2017, ONCOLOGY-BASEL, V92, P50, DOI 10.1159/000451016; Kunst C, 2016, TRANSL CANCER RES, V5, P632, DOI 10.21037/tcr.2016.11.79; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Makkouk A, 2015, CANCER RES, V75, P5, DOI 10.1158/0008-5472.CAN-14-2538; Mukaida N, 2018, WORLD J GASTROENTERO, V24, P1839, DOI 10.3748/wjg.v24.i17.1839; Novikova MV, 2017, BIOCHEMISTRY-MOSCOW+, V82, P861, DOI 10.1134/S0006297917080016; Olivier Magali, 2004, IARC Sci Publ, P247; Pardee AD, 2012, ONCOIMMUNOLOGY, V1, P48, DOI 10.4161/onci.1.1.18344; Pure E, 2016, CANCER IMMUNOL RES, V4, P269, DOI 10.1158/2326-6066.CIR-16-0011; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Rao Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148263; Reiberger T, 2015, NAT PROTOC, V10, P1264, DOI 10.1038/nprot.2015.080; Roth GS, 2017, EUR J CANCER, V87, P101, DOI 10.1016/j.ejca.2017.10.010; Runge A, 2014, CANCER RES, V74, P4157, DOI 10.1158/0008-5472.CAN-13-2311; Sanduzzi-Zamparelli M, 2018, LIVER TRANSPLANT, P1527; Santos NP, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695923; Severi T, 2010, ACTA PHARMACOL SIN, V31, P1409, DOI 10.1038/aps.2010.142; Stahl S, 2009, IMMUNOL LETT, V123, P31, DOI 10.1016/j.imlet.2009.01.011; Thommen DS, 2018, CANCER CELL, V33, P547, DOI 10.1016/j.ccell.2018.03.012; Uehara T., 2014, CURR PROTOC PHARM, V66, P14; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Xu F, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0777-4; Yi M, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0864-3; Zhang SM, 2008, HEPATOL INT, V2, P237, DOI 10.1007/s12072-008-9052-7	53	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219517	10.1371/journal.pone.0219517	http://dx.doi.org/10.1371/journal.pone.0219517			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291357	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800103
J	Hernandez, PC; Morales, L; Chaparro-Olaya, J; Sarmiento, D; Jaramillo, JF; Ordonez, GA; Cortes, F; Sanchez, LK				Hernandez, Paula C.; Morales, Liliana; Chaparro-Olaya, Jacqueline; Sarmiento, Diana; Felipe Jaramillo, Juan; Ordonez, Gustavo A.; Cortes, Fabian; Sanchez, Lizeth K.			Intestinal parasitic infections and associated factors in children of three rural schools in Colombia. A cross-sectional study	PLOS ONE			English	Article							GIARDIA-DUODENALIS GENOTYPES; ZOONOTIC TRANSMISSION; DOGS; HUMANS; IDENTIFICATION; SCHOOLCHILDREN; ASSEMBLAGES; PREVALENCE; SINALOA; SAMPLES	Rural children are one of the populations that are most vulnerable to gastrointestinal parasite infections. Such diseases decrease the quality of life and result in growth and cognitive delays in the long term. This cross-sectional study was conducted to determine the frequency of intestinal parasite infections among rural schoolchildren in the municipality of Apulo, Colombia. A total of 97 stool samples from children aged between 5 and 15 years were collected and examined via direct light microscopy. Microscopic examination was repeated with sediments obtained using a fecal parasite concentrator, and the Kato-Katz test was performed. Frequency of intestinal parasite infection was 100%. Endolimax nana (77.35%), Blastocystis sp. (71.1%), Giardia intestinalis (39.1%), Entamoeba coli (25.7%), and the Entamoeba histolytica/dispar/moshkovskii complex (9.2%) were the most prevalent protozoa. Trichuris trichiura was the most prevalent helminth (12.3%), followed by Enterobius vermicularis (6.15%) and Ascaris lumbricoides (5.1%). Among the analyzed associated factors, consumption of untreated water increased the risk of acquiring pathogenic intestinal parasites. Finally, because G. intestinalis was the most prevalent pathogenic protozoan, molecular analysis was conducted to establish genetic assemblages and subassemblages of Giardia through sequence-based genotyping of the glutamate dehydrogenase, triose phosphate isomerase, and beta-giardin genes. A total of 14 G. intestinalis-positive samples were genotyped, which revealed the presence of subassemblages AI (n = 1), AII (n = 7), BIII (n = 2), BIV (n = 2), and BIII/BIV (n = 1) as well as a mixed subassemblage AII + BIII (n = 1). Our results indicate that gastrointestinal parasite infections in the tested population were mainly caused by suboptimal water quality. Moreover, molecular typing of G. intestinalis suggested contamination of water by animal-and human-derived cysts.	[Hernandez, Paula C.; Morales, Liliana; Chaparro-Olaya, Jacqueline; Sanchez, Lizeth K.] Univ El Bosque, Lab Parasitol Mol, Vicerrectoria Invest, Bogota, Colombia; [Sarmiento, Diana; Felipe Jaramillo, Juan; Ordonez, Gustavo A.] Univ El Bosque, Inst Salud & Ambiente, Vicerrectoria Invest, Bogota, Colombia; [Cortes, Fabian] Univ El Bosque, Vicerrectoria Invest, Bogota, Colombia; [Sanchez, Lizeth K.] Univ El Bosque, Fac Med, Especializac Pediat, Bogota, Colombia	Universidad El Bosque; Universidad El Bosque; Universidad El Bosque; Universidad El Bosque	Hernandez, PC (corresponding author), Univ El Bosque, Lab Parasitol Mol, Vicerrectoria Invest, Bogota, Colombia.	hernandezpaula@unbosque.edu.co	Morales de la Pava, Liliana/N-6627-2019	Morales de la Pava, Liliana/0000-0002-0906-5383; Chaparro-Olaya, Jacqueline/0000-0001-9815-3459; Jaramillo, Juan Felipe/0000-0001-6417-8578; Cortes-Munoz, Fabian/0000-0001-7043-0493; Hernandez Atehortua, Paula C./0000-0002-2136-7755; Sarmiento, Diana/0000-0002-9959-3226; Ordonez-Sierra, Gustavo Adolfo/0000-0003-2178-5946	Universidad El Bosque [PCI 2016-9045]	Universidad El Bosque	Universidad El Bosque (project PCI 2016-9045) supported this work. The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Lopez Sonia, 2008, Rev. salud pública, V10, P633, DOI 10.1590/S0124-00642008000400013; Al-Delaimy AK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003074; [Anonymous], [No title captured]; Arroyo-Salgado B, 2014, ENFERM INFEC MICR CL, V32, P424, DOI 10.1016/j.eimc.2013.07.016; Barra M, 2016, REV MED CHILE, V144, P886, DOI 10.4067/S0034-98872016000700009; Barreto SM, 2012, INT J EPIDEMIOL, V41, P557, DOI 10.1093/ije/dys017; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Caccio SM, 2008, INT J PARASITOL, V38, P1523, DOI 10.1016/j.ijpara.2008.04.008; Choi B., 2017, PUBLIC HLTH RES PERS, V8, P302, DOI DOI 10.24171/j.phrp.2017.8.5.03; Cifre S, 2018, MED HYPOTHESES, V116, P4, DOI 10.1016/j.mehy.2018.04.006; Ramirez JD, 2015, INFECT GENET EVOL, V32, P208, DOI 10.1016/j.meegid.2015.03.015; Despommier DD., 1995, PARASITIC DIS; Eligio-Garcia L, 2008, VET PARASITOL, V156, P205, DOI 10.1016/j.vetpar.2008.04.029; Faria CP, 2017, INFECT GENET EVOL, V54, P128, DOI 10.1016/j.meegid.2017.06.028; Faria CP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005445; Ferreira Patricia, 2003, Rev. Soc. Bras. Med. Trop., V36, P109; Garcia-Cervantes PC, 2017, J INFECT DEV COUNTR, V11, P180, DOI 10.3855/jidc.8223; Gyang VP, 2019, J MICROBIOL IMMUNOL, V52, P106, DOI 10.1016/j.jmii.2016.09.005; Harold AK, 1989, STAT METHODS EPIDEMI; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lalle M, 2005, INT J PARASITOL, V35, P207, DOI 10.1016/j.ijpara.2004.10.022; Lalle M, 2005, J PARASITOL, V91, P203, DOI 10.1645/GE-293R; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Lebbad M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001262; Minetti C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1059-z; Ministerio de Salud y Protecci?n Social Universidad de Antioquia, 2015, ENC NAC PAR INT POBL; Monis PT, 2003, INFECT GENET EVOL, V3, P233, DOI 10.1016/j.meegid.2003.08.003; Nobre LN, 2013, PATHOG GLOB HEALTH, V107, P103, DOI 10.1179/2047773213Y.0000000075; Osman M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004496; Ostan I, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-342; PAHO, 2009, EP PROF NEGL DIS OTH; PAHO Pan American Health Organization, 2004, GUIA TRAT ENF INF; Pestechian Nader, 2014, Gastroenterol Hepatol Bed Bench, V7, P168; Ponce-Macotela M, 2002, INT J PARASITOL, V32, P1201, DOI 10.1016/S0020-7519(02)00086-3; Quihui-Cota L, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4822-6; Rajamanikam A, 2018, PARASITOL RES, V117, P2585, DOI 10.1007/s00436-018-5948-x; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Rodriguez V, 2014, BIOMEDICA, V34, P271, DOI [10.7705/biomedica.v34i2.1713, 10.1590/S0120-41572014000200013]; Rivero MR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006098; Rose J. B., 2017, GLOB WAT PATH PROJ; Ross Allen G, 2017, Trop Med Infect Dis, V2, DOI 10.3390/tropicalmed2040049; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Sahagun J, 2008, EUR J CLIN MICROBIOL, V27, P81, DOI 10.1007/s10096-007-0404-3; Sanchez Angie, 2017, Front Microbiol, V8, P248, DOI 10.3389/fmicb.2017.00248; Speich B, 2016, LANCET INFECT DIS, V16, P87, DOI 10.1016/S1473-3099(15)00349-7; Suescún Carrero Sandra Helena, 2013, Univ. Salud, V15, P218; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; The World Health Organization (WHO), 2017, INT NEGL TROP DIS GL; Torres-Romero JC, 2014, MEM I OSWALDO CRUZ, V109, P388, DOI 10.1590/0074-0276140507; Traub RJ, 2004, PARASITOLOGY, V128, P253, DOI 10.1017/S0031182003004505; Utzinger J, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13727; Vargas-Sanchez GB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124006; Wegayehu T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0706-7	53	20	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218681	10.1371/journal.pone.0218681	http://dx.doi.org/10.1371/journal.pone.0218681			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291262	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800030
J	Jiang, XD; Shen, W; Bai, XY				Jiang, Xueding; Shen, Wen; Bai, Xiaoyan			Response of net primary productivity to vegetation restoration in Chinese Loess Plateau during 1986-2015	PLOS ONE			English	Article							LAND-COVER CHANGE; CLIMATE-CHANGE; GREEN PROGRAM; ECOLOGICAL RESTORATION; CARBON SEQUESTRATION; TEMPORAL PATTERNS; SOIL; AFFORESTATION; IMPACT; GRAIN	Land use and land cover change induced by large scale ecological restoration programs has a significant impact on the terrestrial ecosystem carbon cycle, especially on the net primary productivity (NPP) in arid and semi-arid regions. This study investigated the change in NPP caused by the large-scale ecological restoration in the Chinese Loess Plateau (LPR) region from 1986 to 2015 based on land cover datasets and NPP calculated using the Carnegie-Ames-Stanford Approach model. The results indicated that the annual total NPP exhibited a significant uptrend (P < 0.01) throughout the whole vegetation restoration region during the last 30 years, with an annual increase of 0.137 Tg C. A significant abrupt change was detected in 2006 for the annual total NPP series. Over half of the restoration region showed an increase in NPP in the past three decades, however, about 30 similar to 40% of the vegetation restoration region exhibited NPP loss before 2006, but subsequently NPP loss was found in only approximately 20% of the study region. Overall, the increase in NPP attributed to the vegetation restoration reached 51.14 Tg C in the past three decades, indicating that these large-scale vegetation restoration programs increased the carbon sequestration capacity of terrestrial ecosystems in the Loess Plateau. The findings of this study improve our understanding of the effects of the green campaign on terrestrial ecosystems.	[Jiang, Xueding] Foshan Univ, Sch Environm & Chem Engn, Foshan, Peoples R China; [Shen, Wen; Bai, Xiaoyan] Guangdong Univ Technol, Sch Environm Sci & Engn, Dept Environm Engn, Guangzhou, Guangdong, Peoples R China	Foshan University; Guangdong University of Technology	Bai, XY (corresponding author), Guangdong Univ Technol, Sch Environm Sci & Engn, Dept Environm Engn, Guangzhou, Guangdong, Peoples R China.	xiaoyanb@gdut.edu.cn			National Natural Science Foundation of China [51509040, 51879107, 51709117, 51579105, 91547202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was funded by the National Natural Science Foundation of China (Grant No. 51509040, 51879107, 51709117, 51579105, 91547202).	Buyantuyev A, 2009, J ARID ENVIRON, V73, P512, DOI 10.1016/j.jaridenv.2008.12.015; Cao SX, 2014, BIOL CONSERV, V180, P270, DOI 10.1016/j.biocon.2014.10.009; Cao SX, 2011, EARTH-SCI REV, V104, P240, DOI 10.1016/j.earscirev.2010.11.002; Chen LD, 2007, PROG PHYS GEOG, V31, P389, DOI 10.1177/0309133307081290; Chen LD, 2010, FOREST ECOL MANAG, V259, P1291, DOI 10.1016/j.foreco.2009.10.025; Chen T, 2013, HYDROL EARTH SYST SC, V17, P3885, DOI 10.5194/hess-17-3885-2013; D'Odorico P, 2013, ADV WATER RESOUR, V51, P326, DOI 10.1016/j.advwatres.2012.01.013; DeFries RS, 1999, GLOBAL BIOGEOCHEM CY, V13, P803, DOI 10.1029/1999GB900037; Deng L, 2014, GLOBAL CHANGE BIOL, V20, P3544, DOI 10.1111/gcb.12508; Don A, 2009, GLOBAL CHANGE BIOL, V15, P1990, DOI 10.1111/j.1365-2486.2009.01873.x; Du S, 2011, AGR FOREST METEOROL, V151, P1, DOI 10.1016/j.agrformet.2010.08.011; Fang JY, 2018, P NATL ACAD SCI USA, V115, P4015, DOI 10.1073/pnas.1700304115; FAO, 2020, GLOBAL FOREST RESOUR; Feng Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep15998; Feng XM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02846; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gao GY, 2016, SCI TOTAL ENVIRON, V557, P331, DOI 10.1016/j.scitotenv.2016.03.019; Guo ZD, 2013, SCI CHINA LIFE SCI, V56, P661, DOI 10.1007/s11427-013-4492-2; He CY, 2017, SCI TOTAL ENVIRON, V576, P660, DOI 10.1016/j.scitotenv.2016.10.107; Imhoff ML, 2004, REMOTE SENS ENVIRON, V89, P434, DOI 10.1016/j.rse.2003.10.015; Jian SQ, 2015, AGR FOREST METEOROL, V206, P85, DOI 10.1016/j.agrformet.2015.03.009; Jiang C, 2015, INT J PLANT PROD, V9, P581; Jiang LL, 2017, SCI TOTAL ENVIRON, V599, P967, DOI 10.1016/j.scitotenv.2017.05.012; Jin T. T., 2011, HYDROL EARTH SYST SC, V8, P653; Lai CG, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10091433; Lai CG, 2016, CATENA, V137, P382, DOI 10.1016/j.catena.2015.10.008; Li J, 2018, SCI TOTAL ENVIRON, V639, P237, DOI 10.1016/j.scitotenv.2018.05.155; Li P, 2016, BIOGEOSCIENCES, V13, P375, DOI 10.5194/bg-13-375-2016; Li P, 2018, SCI TOTAL ENVIRON, V637, P855, DOI 10.1016/j.scitotenv.2018.05.031; Liang W, 2015, AGR FOREST METEOROL, V204, P22, DOI 10.1016/j.agrformet.2015.01.015; Liu D, 2014, LANDSCAPE ECOL, V29, P1675, DOI 10.1007/s10980-014-0081-4; Liu GB, 2014, RESTORATION DEV DEGR; Liu JG, 2008, SCIENCE, V319, P37, DOI 10.1126/science.1150416; Liu JY, 2014, J GEOGR SCI, V24, P195, DOI 10.1007/s11442-014-1082-6; Liu L, 2015, J GEOGR SCI, V25, P19, DOI 10.1007/s11442-015-1150-6; Lu F, 2018, P NATL ACAD SCI USA, V115, P4039, DOI 10.1073/pnas.1700294115; Nasri M, 2009, INT J CLIMATOL, V29, P1430, DOI 10.1002/joc.1805; Normile D, 2007, SCIENCE, V317, P314, DOI 10.1126/science.317.5836.314; Paz-Kagan T, 2014, AGR ECOSYST ENVIRON, V193, P9, DOI 10.1016/j.agee.2014.04.024; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Roxburgh SH, 2005, FUNCT ECOL, V19, P378, DOI 10.1111/j.1365-2435.2005.00983.x; Stone R, 2009, SCIENCE, V325, P556, DOI 10.1126/science.325_556; Sun WY, 2015, AGR FOREST METEOROL, V209, P87, DOI 10.1016/j.agrformet.2015.05.002; Tarnavsky E, 2008, REMOTE SENS ENVIRON, V112, P535, DOI 10.1016/j.rse.2007.05.008; Tian GJ, 2014, ENVIRON POLLUT, V184, P320, DOI 10.1016/j.envpol.2013.09.012; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Vesterdal L, 2002, FOREST ECOL MANAG, V169, P137, DOI 10.1016/S0378-1127(02)00304-3; Wang G., 2007, CHINAS FORESTRY REFO; Wang QX, 2012, GLOBAL PLANET CHANGE, V92-93, P138, DOI 10.1016/j.gloplacha.2012.05.010; Wang XM, 2010, J ARID ENVIRON, V74, P13, DOI 10.1016/j.jaridenv.2009.08.001; Wang XM, 2008, EARTH-SCI REV, V88, P188, DOI 10.1016/j.earscirev.2008.02.001; Wang YQ, 2010, GEODERMA, V159, P99, DOI 10.1016/j.geoderma.2010.07.001; Wang ZL, 2018, GLOB FOOD SECUR-AGR, V16, P138, DOI 10.1016/j.gfs.2018.02.001; Wang ZL, 2017, J HYDROL, V544, P97, DOI 10.1016/j.jhydrol.2016.11.021; Wang ZL, 2017, SCI TOTAL ENVIRON, V579, P314, DOI 10.1016/j.scitotenv.2016.11.098; Wu XC, 2013, GLOBAL CHANGE BIOL, V19, P870, DOI 10.1111/gcb.12086; Wu XS, 2018, J HYDROL, V562, P305, DOI 10.1016/j.jhydrol.2018.05.028; Wu XS, 2017, J HYDROL, V547, P428, DOI 10.1016/j.jhydrol.2017.02.020; Xiao JF, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00394.1; Xiao JF, 2014, J GEOPHYS RES-BIOGEO, V119, P2261, DOI 10.1002/2014JG002820; Xie Chen, 2006, Journal of Environmental Planning and Management, V49, P555, DOI 10.1080/09640560600747554; Xu J.T., 2004, EC REV Q, V4, P139; Xu XG, 2002, CHINESE GEOGR SCI, V12, P1, DOI 10.1007/s11769-002-0063-3; Yang L, 2014, CATENA, V115, P123, DOI 10.1016/j.catena.2013.12.005; Yin RS, 2010, ENVIRON MANAGE, V45, P429, DOI 10.1007/s00267-009-9373-x; Zhang BQ, 2016, SCI TOTAL ENVIRON, V539, P436, DOI 10.1016/j.scitotenv.2015.08.132; Zhang JZ, 2016, LAND USE POLICY, V50, P67, DOI 10.1016/j.landusepol.2015.09.008; Zhang ML, 2016, SCI TOTAL ENVIRON, V553, P184, DOI 10.1016/j.scitotenv.2016.02.106; Zhang T, 2016, SCI TOTAL ENVIRON, V565, P105, DOI 10.1016/j.scitotenv.2016.04.126; Zhang XP, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006711; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590; Zhou DC, 2014, ECOL MODEL, V288, P47, DOI 10.1016/j.ecolmodel.2014.05.016; Zhou WM, 2014, CHINESE GEOGR SCI, V24, P406, DOI 10.1007/s11769-014-0702-5	74	10	10	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219270	10.1371/journal.pone.0219270	http://dx.doi.org/10.1371/journal.pone.0219270			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291307	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800063
J	Rogier, R; Ederveen, THA; Wopereis, H; Hartog, A; Boekhorst, J; van Hijum, SAFT; Knol, J; Garssen, J; Walgreen, B; Helsen, MM; van der Kraan, PM; van Lent, PLEM; van de Loo, FAJ; Abdollahi-Roodsaz, S; Koenders, MI				Rogier, Rebecca; Ederveen, Thomas H. A.; Wopereis, Harm; Hartog, Anita; Boekhorst, Jos; van Hijum, Sacha A. F. T.; Knol, Jan; Garssen, Johan; Walgreen, Birgitte; Helsen, Monique M.; van der Kraan, Peter M.; van Lent, Peter L. E. M.; van de Loo, Fons A. J.; Abdollahi-Roodsaz, Shahla; Koenders, Marije I.			Supplementation of diet with non-digestible oligosaccharides alters the intestinal microbiota, but not arthritis development, in IL-1 receptor antagonist deficient mice	PLOS ONE			English	Article							REGULATORY T-CELLS; RHEUMATOID-ARTHRITIS; TH17 CELLS; CALCIUM-ABSORPTION; ATOPIC-DERMATITIS; GUT MICROBIOTA; IMMUNE-SYSTEM; INFANTS; MIXTURE; FORMULA	The intestinal microbiome is perturbed in patients with new-onset and chronic autoimmune inflammatory arthritis. Recent studies in mouse models suggest that development and progression of autoimmune arthritis is highly affected by the intestinal microbiome. This makes modulation of the intestinal microbiota an interesting novel approach to suppress inflammatory arthritis. Prebiotics, defined as non-digestible carbohydrates that selectively stimulate the growth and activity of beneficial microorganisms, provide a relatively non-invasive approach to modulate the intestinal microbiota. The aim of this study was to assess the therapeutic potential of dietary supplementation with a prebiotic mixture of 90% short-chain galacto-oligosaccharides and 10% long-chain fructo-oligosaccharides (scGOS/IcFOS) in experimental arthritis in mice. We here show that dietary supplementation with scGOS/IcFOS has a pronounced effect on the composition of the fecal microbiota. Interestingly, the genera Enterococcus and Clostridium were markedly decreased by scGOS/IcFOS dietary supplementation. In contrast, the family Lachnospiraceae and the genus Lactobacillus, both associated with healthy microbiota, increased in mice receiving scGOS/IcFOS diet. However, the scGOS/IcFOS induced alterations of the intestinal microbiota did not induce significant effects on the intestinal and systemic T helper cell subsets and were not sufficient to reproducibly suppress arthritis in mice. As expected, we did observe a significant increase in the bone mineral density in mice upon dietary supplementation with scGOS/IcFOS for 8 weeks. Altogether, this study suggests that dietary scGOS/IcFOS supplementation is able to promote presumably healthy gut microbiota and improve bone mineral density, but not inflammation, in arthritis-prone mice.	[Rogier, Rebecca; Walgreen, Birgitte; Helsen, Monique M.; van der Kraan, Peter M.; van Lent, Peter L. E. M.; van de Loo, Fons A. J.; Abdollahi-Roodsaz, Shahla; Koenders, Marije I.] Radboudumc, Expt Rheumatol, Nijmegen, Netherlands; [Ederveen, Thomas H. A.; Boekhorst, Jos; van Hijum, Sacha A. F. T.] Radboudumc, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; [Wopereis, Harm; Knol, Jan] Danone Nutricia Res, Utrecht, Netherlands; [Wopereis, Harm; Knol, Jan] Wageningen Univ, Lab Microbiol, Wageningen, Netherlands; [Hartog, Anita; Boekhorst, Jos] NIZO Food Res, Ede, Netherlands; [Garssen, Johan] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Danone Nutricia; Wageningen University & Research; NIZO Food Research; Utrecht University	Koenders, MI (corresponding author), Radboudumc, Expt Rheumatol, Nijmegen, Netherlands.	Madie.Koenders@Radboucjumc.nl	van der Kraan, Peter M/D-9115-2011; Knol, Jan/A-2178-2010; Ederveen, Thomas HA/G-6294-2016; Knol, Jan/AAL-6487-2020; van de Loo, Fons AJ/A-3425-2014	Knol, Jan/0000-0002-2103-5961; Ederveen, Thomas HA/0000-0003-0068-1275; Knol, Jan/0000-0002-2103-5961; van de Loo, Fons AJ/0000-0002-5851-099X; Boekhorst, Jos/0000-0002-4807-7838	Nutricia research foundation [2013-06, 2014-E1]; ZonMW [114024045]	Nutricia research foundation(Danone Nutricia); ZonMW(Netherlands Organization for Health Research and Development)	This study was financed by the Nutricia research foundation (2013-06 and 2014-E1) and ZonMW (114024045). Nutricia Research provided support in the form of salaries for authors (H.W., A.H., J.K., J.G.). NIZO food research provided support in the form of salaries for authors (A.H., J. B.), but did not have any additional role in the study design, data interpretation, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Bryk G, 2016, EUR J NUTR, V55, P2445, DOI 10.1007/s00394-015-1052-5; Bryk G, 2015, EUR J NUTR, V54, P913, DOI 10.1007/s00394-014-0768-y; Bugatti S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1116-9; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Chen J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0299-7; CHONAN O, 1995, J NUTR SCI VITAMINOL, V41, P95, DOI 10.3177/jnsv.41.95; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaffen Sarah L, 2009, Curr Rheumatol Rep, V11, P365; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Haarman M, 2006, APPL ENVIRON MICROB, V72, P2359, DOI 10.1128/AEM.72.4.2359-2365.2006; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Ikeda S, 2014, J IMMUNOL, V192, P1449, DOI 10.4049/jimmunol.1300387; Kamada N, 2014, GASTROENTEROLOGY, V146, P1477, DOI 10.1053/j.gastro.2014.01.060; Knol J, 2005, ACTA PAEDIATR, V94, P31, DOI 10.1080/08035320510043529; Knol J, 2005, J PEDIATR GASTR NUTR, V40, P36, DOI 10.1097/00005176-200501000-00007; Koenders MI, 2008, ARTHRITIS RHEUM-US, V58, P3461, DOI 10.1002/art.23957; Lee YJ, 2017, J INFECT DIS, V215, P1117, DOI 10.1093/infdis/jix011; Liu XF, 2016, J INTERF CYTOK RES, V36, P706, DOI 10.1089/jir.2016.0057; Liu XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep30594; Liu XF, 2013, CURR MICROBIOL, V67, P170, DOI 10.1007/s00284-013-0338-1; Lodder MC, 2004, ANN RHEUM DIS, V63, P1576, DOI 10.1136/ard.2003.016253; Lubberts E, 2010, SEMIN IMMUNOPATHOL, V32, P43, DOI 10.1007/s00281-009-0189-9; Maeda Y, 2016, ARTHRITIS RHEUMATOL, V68, P2646, DOI 10.1002/art.39783; Marietta EV, 2016, ARTHRITIS RHEUMATOL, V68, P2878, DOI 10.1002/art.39785; Mastaglia SR, 2006, BONE, V39, P837, DOI 10.1016/j.bone.2006.04.015; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; McCabe L, 2015, CURR OSTEOPOROS REP, V13, P363, DOI 10.1007/s11914-015-0292-x; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Moro G, 2006, ARCH DIS CHILD, V91, P814, DOI 10.1136/adc.2006.098251; Moro G, 2002, J PEDIATR GASTR NUTR, V34, P291, DOI 10.1097/00005176-200203000-00014; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Ohta A, 1998, SCAND J GASTROENTERO, V33, P1062, DOI 10.1080/003655298750026769; Picchianti-Diamanti A, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02696; QIIME, 2010, NEW DEF PAR UCL OTU; Reeves AE, 2011, GUT MICROBES, V2, P145, DOI 10.4161/gmic.2.3.16333; Rogier R, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0278-2; Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schouten B, 2012, BRIT J NUTR, V107, P96, DOI 10.1017/S0007114511002637; Schouten B, 2011, PEDIAT ALLERG IMM-UK, V22, P537, DOI 10.1111/j.1399-3038.2010.01132.x; Schouten B, 2010, J NUTR, V140, P835, DOI 10.3945/jn.109.116061; Schouten B, 2009, J NUTR, V139, P1398, DOI 10.3945/jn.109.108514; SciPy.org, 2012, SCIPY OP SOURC SOFTW; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Stanisavljevic S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02005; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; van der Aa LB, 2010, CLIN EXP ALLERGY, V40, P795, DOI 10.1111/j.1365-2222.2010.03465.x; van Hamburg JP, 2011, ARTHRITIS RHEUM-US, V63, P73, DOI 10.1002/art.30093; Vos AP, 2007, INT IMMUNOPHARMACOL, V7, P1582, DOI 10.1016/j.intimp.2007.07.024; Vos AP, 2007, PEDIAT ALLERG IMM-UK, V18, P304, DOI 10.1111/j.1399-3038.2007.00515.x; Wopereis H, 2018, J ALLERGY CLIN IMMUN, V141, P1334, DOI 10.1016/j.jaci.2017.05.054; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914; Zimmerman MA, 2012, AM J PHYSIOL-GASTR L, V302, pG1405, DOI 10.1152/ajpgi.00543.2011	66	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0219366	10.1371/journal.pone.0219366	http://dx.doi.org/10.1371/journal.pone.0219366			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283798	Green Published, gold, Green Submitted			2022-12-26	WOS:000484939800031
J	Huang, BW; Ren, YM; Wang, CH; Lan, ZG; Hui, XH; Liu, WK; Zhang, YK				Huang, Bowen; Ren, Yanming; Wang, Chenghong; Lan, Zhigang; Hui, Xuhui; Liu, Wenke; Zhang, Yuekang			Risk factors for postoperative meningitis after microsurgery for vestibular schwannoma	PLOS ONE			English	Article							ACOUSTIC NEUROMA; TRANEXAMIC ACID; INFECTION; SURGERY; COMPLICATIONS; CRANIOTOMY	Objective Meningitis after microsurgery for vestibular schwannoma (VS) is a severe complication that results in high morbidity. However, few studies have focused on meningitis after VS surgery. The purpose of this study was to identify the risk factors for meningitis after VS surgery. Methods We performed a retrospective analysis of all VS patients who underwent microsurgery and survived for at least 7 days after surgery, between 1 June 2015 and 30 November 2018 at West China Hospital of Sichuan University. Univariate and multivariate analyses were performed to identify the risk factors for postoperative meningitis (POM). Results We enrolled 410 patients, 27 of whom had POM. Through univariate analysis, the factors of hydrocephalus (p = 0.018), Koos grade IV (p = 0.04), operative duration > 3 hours (p = 0.03) and intraoperative bleeding volume >= 400 ml (p = 0. 02) were significantly correlated with POM. The multivariate analysis showed that Koos grade IV (p = 0.04; OR = 3.19; 95% CI 1.032-3.190), operation duration > 3 hours (p = 0.03; OR = 7.927; 95% CI 1.043-60.265), and intraoperative bleeding volume >= 400 ml (p = 0.02; OR = 2.551; 95% CI 1.112-5.850) were the independent influencing factors of POM. Conclusions Koos grade IV, operation duration > 3 hours, and intraoperative blood loss >= 400 ml were identified as independent risk factors for POM after microsurgery for VS. POM also caused a prolonged hospital stay.	[Huang, Bowen; Ren, Yanming; Wang, Chenghong; Lan, Zhigang; Hui, Xuhui; Liu, Wenke; Zhang, Yuekang] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China	Sichuan University	Zhang, YK (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.	2012zykyx@sina.cn	Lan, Zhigang/HGA-7245-2022		Sichuan Province Science and Technology Support Program [2019YFS0397]; Program of Sichuan Science and Technology Department [0040205302272]	Sichuan Province Science and Technology Support Program; Program of Sichuan Science and Technology Department	This work was supported by Sichuan Province Science and Technology Support Program (grant number: 2019YFS0397). and Program of Sichuan Science and Technology Department (grant number: 0040205302272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRYCE GE, 1991, OTOLARYNG HEAD NECK, V104, P81, DOI 10.1177/019459989110400115; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101961; Chen SS, 2018, WORLD NEUROSURG, V111, pE546, DOI 10.1016/j.wneu.2017.12.110; Chouhdari A, 2018, IRAN J NEUROL, V17, P82; Collaborative Study Group for Neonatal Bacterial Meningitis, 2018, Zhonghua Er Ke Za Zhi, V56, P421, DOI 10.3760/cma.j.issn.0578-1310.2018.06.004; Dang YJ, 2018, CAN J GASTROENTEROL, V2018, DOI 10.1155/2018/7940603; Darrouzet V, 2004, LARYNGOSCOPE, V114, P681, DOI 10.1097/00005537-200404000-00016; Draxler DF, 2019, BLOOD ADV, V3, P1598, DOI 10.1182/bloodadvances.2019000092; Druel Benedicte, 1996, Clin Microbiol Infect, V1, P230; Enee V, 2003, Rev Laryngol Otol Rhinol (Bord), V124, P45; Golebiowski A, 2015, ACTA NEUROCHIR, V157, P235, DOI 10.1007/s00701-014-2286-3; Hooda B, 2017, J CLIN NEUROSCI, V41, P132, DOI 10.1016/j.jocn.2017.02.053; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang X, 2016, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V51, P401, DOI 10.3760/cma.j.issn.1673-0860.2016.06.001; Huang X, 2017, WORLD NEUROSURG, V99, P326, DOI 10.1016/j.wneu.2016.12.055; Ishihara H, 2015, INTERV NEURORADIOL, V21, P624, DOI 10.1177/1591019915590537; Moffat DA, 2014, J LARYNGOL OTOL, V128, P406, DOI 10.1017/S0022215114000541; Montaser AS, 2018, WORLD NEUROSURG, V120, P395, DOI 10.1016/j.wneu.2018.08.215; Naidech AM, 2008, NEUROSURGERY, V63, P212, DOI 10.1227/01.NEU.0000320453.61270.0F; Olshan M, 2014, ENT-EAR NOSE THROAT, V93, P304, DOI 10.1177/014556131409300808; Patil H, 2018, WORLD NEUROSURG, V115, pE539, DOI 10.1016/j.wneu.2018.04.091; PATIR R, 1992, ACTA NEUROCHIR, V119, P80, DOI 10.1007/BF01541786; Rahimpour S, 2016, J NEURO-ONCOL, V130, P367, DOI 10.1007/s11060-016-2260-4; Reichert MCF, 2002, AM J INFECT CONTROL, V30, P158, DOI 10.1067/mic.2002.119925; Rezk Essam M, 2017, World Neurosurg, DOI 10.1016/j.wneu.2017.03.025; Shi ZH, 2017, BRIT J NEUROSURG, V31, P5, DOI 10.1080/02688697.2016.1253827; Sluyter S, 2001, J NEUROSURG, V94, P61, DOI 10.3171/jns.2001.94.1.0061; Stangerup SE, 2010, NEUROSURGERY, V67, P1335, DOI 10.1227/NEU.0b013e3181f22660; Wang CH, 2017, CLIN NEUROL NEUROSUR, V162, P25, DOI 10.1016/j.clineuro.2017.06.004; Zhan R, 2014, EUR J CLIN MICROBIOL, V33, P861, DOI 10.1007/s10096-013-2026-2	30	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0217253	10.1371/journal.pone.0217253	http://dx.doi.org/10.1371/journal.pone.0217253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276518	Green Published, gold, Green Submitted			2022-12-26	WOS:000484936300010
J	Rathinam, M; Mishra, P; Vasudevan, M; Budhwar, R; Mahato, A; Prabha, AL; Singh, NK; Rao, U; Sreevathsa, R				Rathinam, Maniraj; Mishra, Pragya; Vasudevan, Madavan; Budhwar, Roli; Mahato, Ajay; Prabha, A. Lakshmi; Singh, Nagendra Kumar; Rao, Uma; Sreevathsa, Rohini			Comparative transcriptome analysis of pigeonpea, Cajanus cajan (L.) and one of its wild relatives Cajanus platycarpus (Benth.) Maesen	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA; POD BORER; GENE; RESISTANCE; CROP; METABOLISM; EXPRESSION; COMPONENTS; PROTEINS; GENOMICS	Pigeonpea is a major source of dietary protein to the vegetarian population of the Indian subcontinent. Crop improvement to mitigate biotic and abiotic stresses for realization of its potential yield and bridging yield gap is the need of the hour. Availability of limited genomic resources in the cultivated germplasm, however, is a serious bottleneck towards successful molecular breeding for the development of superior genotypes in pigeonpea. In view of this, improvement of pigeonpea can be attempted through transgenesis or by exploiting genetic resources from its wild relatives. Pigeonpea wild relatives are known to be bestowed with agronomic traits of importance; discovery and deployment of genes from them can provide a lucrative option for crop improvement. Understanding molecular signatures of wild relatives would not only provide information about the mechanism behind desired traits but also enable us to extrapolate the information to cultivated pigeonpea. The present study deals with the characterization of leaf transcriptomes of Cajanus cajan and one of its wild relatives, Cajanus platycarpus. Illumina sequencing revealed 0.11 million transcripts in both the species with an annotation of 0.09 million (82%) transcripts using BLASTX. Comparative transcriptome analyses on the whole, divulged cues about the wild relative being vigilant and agile. Gene ontology and Mapman analysis depicted higher number of transcripts in the wild relative pertaining to signaling, transcription factors and stress responsive genes. Further, networking between the differentially expressed MapMan bins demonstrated conspicuous interactions between different bins through 535 nodes (512 Genes and 23 Pathways) and 1857 edges. The authenticity of RNA-seq analysis was confirmed by qRT-PCR. The information emanating from this study can provide valuable information and resource for future translational research including genome editing to alleviate varied stresses. Further, this learning can be a platform for in-depth investigations to decipher molecular mechanisms for mitigation of various stresses in the wild relative.	[Rathinam, Maniraj; Mishra, Pragya; Mahato, Ajay; Singh, Nagendra Kumar; Sreevathsa, Rohini] ICAR Res Complex, Natl Inst Plant Biotechnol, Pusa Campus, New Delhi, India; [Rathinam, Maniraj; Prabha, A. Lakshmi] Bharathidasan Univ, Sch Life Sci, Dept Bot, Tiruchirappalli, Tamil Nadu, India; [Vasudevan, Madavan; Budhwar, Roli] Bionivid Technol Private Ltd, Near New Horizon Coll, Bangalore, Karnataka, India; [Rao, Uma] ICAR Res Complex, Indian Agr Res Inst, Div Nematol, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Bharathidasan University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Sreevathsa, R (corresponding author), ICAR Res Complex, Natl Inst Plant Biotechnol, Pusa Campus, New Delhi, India.; Rao, U (corresponding author), ICAR Res Complex, Indian Agr Res Inst, Div Nematol, New Delhi, India.	umanema@gmail.com; rohinisreevathsa@gmail.com		Sreevathsa, Rohini/0000-0003-4171-6956; MAHATO, AJAY KUMAR/0000-0003-1359-6643; Budhwar, Roli/0000-0001-8494-1606	DBT-Indo Swiss Collaboration in Biotechnology [BT/IC-2/ISCB/Phase IV/01/Pigeon Pea/2015]	DBT-Indo Swiss Collaboration in Biotechnology	RS DBT-Indo Swiss Collaboration in Biotechnology (BT/IC-2/ISCB/Phase IV/01/Pigeon Pea/2015). The funder (DBT-ISCB) provided support in the form of salaries for authors [MR, PM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bionivid Technology Private limited performed RNA sequencing followed by the requisite analyses. The specific roles of these authors are articulated in the 'author contributions' section.; The authors acknowledge financial support from DBT-Indo Swiss Collaboration in Biotechnology (BT/IC-2/ISCB/Phase IV/01/Pigeon Pea/2015).	Anders S., 2012, DIFFERENTIAL EXPRESS, DOI DOI 1016/j.jtbi.2009.04.013PMID:19406131; Ayyappan V, 2017, PLANT CELL REP, V36, P129, DOI 10.1007/s00299-016-2065-0; Bankar KG, 2015, GENOM DATA, V5, P352, DOI 10.1016/j.gdata.2015.07.012; Brasileiro ACM, 2015, PLANT MOL BIOL REP, V33, P1876, DOI 10.1007/s11105-015-0882-x; Brozynska M, 2016, PLANT BIOTECHNOL J, V14, P1070, DOI 10.1111/pbi.12454; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Choudhary A. K., 2013, American Journal of Plant Sciences, V4, P372; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Erpen L, 2018, PLANT CELL TISS ORG, V132, P1, DOI 10.1007/s11240-017-1320-6; Evangelistella C, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0828-7; Giraudat J, 2001, CURR OPIN PLANT BIOL, V4, P379, DOI 10.1016/S1369-5266(00)00188-6; Guimaraes PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140937; Guimaraes PM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-387; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; Hanley ME, 2007, PERSPECT PLANT ECOL, V8, P157, DOI 10.1016/j.ppees.2007.01.001; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Henry RJ, 2014, PLANT BIOTECHNOL J, V12, P655, DOI 10.1111/pbi.12215; Hernandez-Garcia CM, 2014, PLANT SCI, V217, P109, DOI 10.1016/j.plantsci.2013.12.007; Hua L, 2015, PLANT CELL, V27, P1875, DOI 10.1105/tpc.15.00260; Hussain ISA, 2016, INDIAN J EXP BIOL, V54, P493; Kassa MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039563; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lewis G.P., 2005, LEGUMES WORLD, P187; Liu JY, 2015, MOL PLANT, V8, P689, DOI 10.1016/j.molp.2015.03.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallikarjuna N, 2006, EUPHYTICA, V149, P161, DOI 10.1007/s10681-005-9063-6; MALLIKARJUNA N, 1995, EUPHYTICA, V83, P43, DOI 10.1007/BF01677859; Mallikarjuna Nalini, 2005, Indian Journal of Genetics & Plant Breeding, V65, P261; Maxted N, 2013, RESOURCE BOOK PREPAR; Mitsuda N, 2009, PLANT CELL PHYSIOL, V50, P1232, DOI 10.1093/pcp/pcp075; Mula M., 2010, LIFTING LEVEL AWAREN; Nagegowda DA, 2010, FEBS LETT, V584, P2965, DOI 10.1016/j.febslet.2010.05.045; Nevo E, 2010, PLANT CELL ENVIRON, V33, P670, DOI 10.1111/j.1365-3040.2009.02107.x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parde V. D., 2012, American Journal of Plant Sciences, V3, P627, DOI 10.4236/ajps.2012.35076; Park CY, 2005, FEBS LETT, V579, P1545, DOI 10.1016/j.febslet.2005.01.057; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pazhamala L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00050; Ramu SV, 2012, J APPL ENTOMOL, V136, P675, DOI 10.1111/j.1439-0418.2011.01703.x; Rhoades D.F., 1976, RECENT ADV PHYTOCHEM, P168, DOI DOI 10.1007/978-1-4684-2646-5_4; Roy S, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1117723; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sankara Rao K, 2008, Physiol Mol Biol Plants, V14, P321, DOI 10.1007/s12298-008-0030-2; Saxena K. B., 1996, International Chickpea and Pigeonpea Newsletter, P51; Saxena K. B., 2008, Tropical Plant Biology, V1, P159, DOI 10.1007/s12042-008-9014-1; Schuman MC, 2016, ANNU REV ENTOMOL, V61, P373, DOI 10.1146/annurev-ento-010715-023851; Sharma HC, 2009, ARTHROPOD-PLANT INTE, V3, P151, DOI 10.1007/s11829-009-9068-5; SHARMA SB, 1995, PLANT DIS, V79, P1033, DOI 10.1094/PD-79-1033; Singh SK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19643-0; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Srivastava R, 2016, SCI REP-UK, V6, DOI 10.1038/srep33616; Sujana G., 2008, International Journal of Tropical Insect Science, V28, P191, DOI 10.1017/S1742758408191822; Swathi M, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00388; Swathi M, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1991-8; Tai APK, 2014, NAT CLIM CHANGE, V4, P817, DOI [10.1038/nclimate2317, 10.1038/NCLIMATE2317]; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Tanksley SD, 1996, THEOR APPL GENET, V92, P213, DOI 10.1007/BF00223378; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P79, DOI 10.4161/psb.2.2.4176; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P79, DOI 10.4161/psb.3.2.5303; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; White C, 2000, ENVIRON ENTOMOL, V29, P773, DOI 10.1603/0046-225X-29.4.773; Xu CX, 2015, SCI REP-UK, V5, DOI 10.1038/srep17706; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang HY, 2017, EVOL APPL, V10, P5, DOI 10.1111/eva.12434; Zhang HJ, 2012, PLANT SIGNAL BEHAV, V7, P1284, DOI 10.4161/psb.21431	71	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0218731	10.1371/journal.pone.0218731	http://dx.doi.org/10.1371/journal.pone.0218731			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269083	Green Submitted, Green Published, gold			2022-12-26	WOS:000484927300025
J	Fumimoto, R; Otsuka, N; Kamiya, H; Sunagawa, T; Tanaka-Taya, K; Kamachi, K; Shibayama, K				Fumimoto, Rei; Otsuka, Nao; Kamiya, Hajime; Sunagawa, Tomimasa; Tanaka-Taya, Keiko; Kamachi, Kazunari; Shibayama, Keigo			Seroprevalence of IgA and IgM antibodies to Bordetella pertussis in healthy Japanese donors: Assessment for the serological diagnosis of pertussis	PLOS ONE			English	Article							TOXIN IGG; EPIDEMIOLOGY; ASSAYS; GENES; AGE	Pertussis is a human respiratory infection caused by the gram-negative bacterium, Bordetella pertussis. To evaluate the pertussis burden and vaccine efficacy, diagnosis and epidemiological surveillance should be based on accurate and valid diagnostic methods. Recently, the serodiagnostic tests Novagnost Bordetella pertussis IgA and IgM were approved in Japan for pertussis diagnostics. Although the anti-pertussis toxin (PT) IgG assay has been used for pertussis diagnosis worldwide, little is known about the anti-B. pertussis IgA and IgM assays. In this study, serum samples from 460 healthy donors were examined to determine the seroprevalence of anti-B. pertussis IgA and IgM in a Japanese population, and its correlation with donor age. Our data demonstrated that anti-B. pertussis IgA and IgM are positively and negatively correlated with age (r = 0.27, r = -0.37; P < 0.001, respectively). Age-specific analysis revealed high titers of anti-B. pertussis IgA in adults (46-50 years), while anti-B. pertussis IgM titers were high in schoolchildren (6-10, 11-15 years). When applying the arbitrary cut-off values for these ages, 17.6% and 39.5% of healthy donors were interpreted as pertussis-positive or indeterminate with anti-B. pertussis IgA (46-50 years) and IgM (11-15 years) titers, respectively. Overall, our findings indicated that the Novagnost Bordetella pertussis IgA and IgM testing could be greatly affected by subject age, limiting its value for pertussis diagnosis.	[Fumimoto, Rei; Otsuka, Nao; Kamachi, Kazunari; Shibayama, Keigo] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Fumimoto, Rei] St Marianna Univ, Dept Pediat, Sch Med, Kawasaki, Kanagawa, Japan; [Kamiya, Hajime; Sunagawa, Tomimasa; Tanaka-Taya, Keiko] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Saint Marianna University; National Institute of Infectious Diseases (NIID)	Otsuka, N (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan.	notsuka@nih.go.jp			Ministry of Health, Labor and Welfare of Japan [10110002]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported by a grant for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare of Japan (No.10110002, NO, https://www.mhlw.go.jp/english/).The funder had no role in study design, data collection and	BARENKAMP SJ, 1992, INFECT IMMUN, V60, P1302, DOI 10.1128/IAI.60.4.1302-1313.1992; Barkoff AM, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv050; Bowden KE, 2014, J CLIN MICROBIOL, V52, P3549, DOI 10.1128/JCM.01189-14; Campbell P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035874; Fumimoto R, 2019, VACCINE, V37, P2463, DOI 10.1016/j.vaccine.2019.03.055; Guiso N, 2011, EUR J CLIN MICROBIOL, V30, P307, DOI 10.1007/s10096-010-1104-y; Hendrikx LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027681; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; May ML, 2017, PATHOLOGY, V49, P770, DOI 10.1016/j.pathol.2017.08.005; May ML, 2013, PATHOLOGY, V45, P172, DOI 10.1097/PAT.0b013e32835c76e2; May ML, 2012, CLIN VACCINE IMMUNOL, V19, P190, DOI 10.1128/CVI.05430-11; Ministry of Health Labour and Welfare, 2019, NAT EP SURV INF DIS; Miyaji Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077165; Moriuchi T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181181; NAGEL J, 1983, J MED MICROBIOL, V16, P417, DOI 10.1099/00222615-16-4-417; National Institute of Infectious Diseases Japan (NIID), 2019, PERT EP NOT SURV UPD; National Institute of Infectious Diseases Japan (NIID), 2013, NESID ANN SURV DAT S; National Institute of Infectious Diseases Japan (NIID), NAT EP SURV VACC PRE; NIBSC, 06140 NIBSC ISWHO; Norman D, 2017, EUR J CLIN MICROBIOL, V36, P2259, DOI 10.1007/s10096-017-3057-x; Otsuka N, 2016, MICROBIOL IMMUNOL, V60, P326, DOI 10.1111/1348-0421.12378; Pawloski LC, 2017, J PEDIATR INFECT DIS, V6, pE15, DOI 10.1093/jpids/piw035; Poynten IM, 2002, EPIDEMIOL INFECT, V128, P161, DOI 10.1017/S0950268801006598; Prince HE, 2012, CLIN VACCINE IMMUNOL, V19, P545, DOI 10.1128/CVI.05725-11; Riffelmann M, 2010, J CLIN MICROBIOL, V48, P4459, DOI 10.1128/JCM.01371-10; Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864; Sealey KL, 2015, J INFECT DIS, V212, P294, DOI 10.1093/infdis/jiu665; Tondella ML, 2009, VACCINE, V27, P803, DOI 10.1016/j.vaccine.2008.11.072; van der Zee A, 2015, CLIN MICROBIOL REV, V28, P1005, DOI 10.1128/CMR.00031-15; van Twillert I, 2017, SCI REP-UK, V7, DOI 10.1038/srep40328; Xing D., 2008, WHOBS082083	31	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219255	10.1371/journal.pone.0219255	http://dx.doi.org/10.1371/journal.pone.0219255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260500	Green Submitted, Green Published, gold			2022-12-26	WOS:000484918700049
J	Spruijt, I; Erkens, C; Suurmond, J; Huisman, E; Koenders, M; Kouw, P; Toumanian, S; Cobelens, F; van den Hof, S				Spruijt, Ineke; Erkens, Connie; Suurmond, Jeanine; Huisman, Erik; Koenders, Marga; Kouw, Peter; Toumanian, Sophie; Cobelens, Frank; van den Hof, Susan			Implementation of latent tuberculosis infection screening and treatment among newly arriving immigrants in the Netherlands: A mixed methods pilot evaluation	PLOS ONE			English	Article							MANAGEMENT	Introduction To reach pre-elimination levels of tuberculosis (TB) incidence in the Netherlands, prevention of TB among immigrants through diagnosis and treatment of latent TB infection (LTBI) is needed. We studied the feasibility of a LTBI screening and treatment program among newly arriving immigrants for national implementation. Methods We used mixed methods to evaluate the implementation of LTBI screening and treatment in five Public Health Services (PHS) among immigrants from countries with a TB incidence >50/100,000 population. We used Poisson regression models with robust variance estimators to assess factors associated with LTBI diagnosis and LTBI treatment initiation and reported reasons for not initiating or completing LTBI treatment. We interviewed five PHS teams using a semi-structured method to identify enhancing and impeding factors for LTBI screening and treatment. Results We screened 566 immigrants; 94 (17%) were diagnosed with LTBI, of whom 49 (52%) initiated and 34 (69%) completed LTBI treatment. LTBI diagnosis was associated with male gender, higher age group, higher TB incidence in the country of origin and lower level of education. Treatment initiation was associated with PHS (ranging from 29% to 86%), lower age group, longer intended duration of stay in the Netherlands, and lower level of education. According to TB physicians, clients and their consulted physicians in the home country lacked awareness about benefits of LTBI treatment. Furthermore, TB physicians questioned the individual and public health benefit of clients who return to their country of origin within the foreseeable future. Conclusions Doubt of physicians in both host country and country of origin about individual and public health benefits of LTBI screening and treatment of immigrants hampered treatment initiation: the high initiation proportion in one PHS shows that if TB physicians are committed, the LTBI treatment uptake can be higher.	[Spruijt, Ineke; Erkens, Connie; van den Hof, Susan] KNCV TB Fdn, The Hague, Netherlands; [Suurmond, Jeanine] Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Publ Hlth, Amsterdam, Netherlands; [Huisman, Erik] Publ Hlth Serv Haaglanden, Dept TB Control, The Hague, Netherlands; [Koenders, Marga] Publ Hlth Serv Gelderland Zuid, Dept TB Control, Nijmegen, Netherlands; [Kouw, Peter] Publ Hlth Serv Amsterdam, Dept TB Control, Amsterdam, Netherlands; [Toumanian, Sophie] Publ Hlth Serv Twente, Dept TB Control, Enschede, Netherlands; [Cobelens, Frank] Univ Amsterdam, Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [Cobelens, Frank] Univ Amsterdam, Med Ctr, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [van den Hof, Susan] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands	KNCV Tuberculosis Foundation; University of Amsterdam; Vrije Universiteit Amsterdam; Public Health Service Amsterdam; University of Amsterdam; University of Amsterdam; Netherlands National Institute for Public Health & the Environment	Spruijt, I (corresponding author), KNCV TB Fdn, The Hague, Netherlands.	ineke.sprujt@kncvtbc.org		Suurmond, Jeanine/0000-0001-6872-2067; Cobelens, Frank/0000-0002-4367-1133	Netherlands Organization for Health Research and Development (ZonMw) [50-53000-98-128]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by the Netherlands Organization for Health Research and Development (ZonMw, grant number 50-53000-98-128, https://www.zonmw.ni/en/). Qiagen provided the QuantiFERON-TB Gold Plus kits free of charge. Qiagen read the final manuscript. Neither ZonMW nor Qiagen had a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babyak M, 2014, PSYCHOSOM MED, V66, P411; Bonvicini F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16010028; Commision Practical Tuberculosis Control, 2015, GUID TREATM LAT TUB; Commission Practical Tuberculosis Control, 2010, GUID INT GAMM REL AS; de Vries Gerard, 2017, J Clin Tuberc Other Mycobact Dis, V7, P40, DOI 10.1016/j.jctube.2017.02.002; de Vries SG, 2017, LANCET INFECT DIS, V17, pE128, DOI 10.1016/S1473-3099(16)30531-X; Ospina JE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-158; Erkens CGM, 2016, EUR RESPIR J, V47, P1492, DOI 10.1183/13993003.01397-2015; European Centre for Disease Prevention and Control, 2018, COST EFF AN PROGR SC; European Centre for Disease Prevention and Control, 2018, MATH MOD PROGR SCREE; Goldberg SV, 2004, INT J TUBERC LUNG D, V8, P76; Goswami ND, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-468; Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981; Gutsfeld C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112681; Hontelez J. A. C., 2018, COST EFFECTIVENESS A; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; KNCV Tuberculosis Foundation, 2017, EV TUB SCREEN IMM NE; Knol MJ, 2012, CAN MED ASSOC J, V184, P895, DOI 10.1503/cmaj.101715; Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; Miles M.B., 2014, QUALITATIVE DATA ANA, V3rd ed.; Riesmeijer R, 2016, NATL PLAN TUBERCULOS; Sandgren A, 2016, EURO SURVEILL, V21; Sandgren A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1550-y; Schreurs-Jonkeren I, 2013, IMPLEMENTATION SCREE; Seedat F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108261; Slump E, 2016, TUBERCULOSIS NETHERL; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; van de Berg S, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00977-2017; WHO, 2014, END TB STRAT; World Health Organisation, 2015, GUID MAN LAT TUB INF	31	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219252	10.1371/journal.pone.0219252	http://dx.doi.org/10.1371/journal.pone.0219252			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260502	Green Published, Green Submitted, gold			2022-12-26	WOS:000484918700048
J	Baroli, B; Loi, E; Solari, P; Kasture, A; Moi, L; Muroni, P; Kasture, S; Setzu, MD; Liscia, A; Zavattari, P				Baroli, Biancamaria; Loi, Eleonora; Solari, Paolo; Kasture, Ameya; Moi, Loredana; Muroni, Patrizia; Kasture, Sanjay; Setzu, Maria Dolores; Liscia, Anna; Zavattari, Patrizia			Evaluation of oxidative stress mechanisms and the effects of phytotherapic extracts on Parkinson's disease Drosophila PINK1(B9) model	FASEB JOURNAL			English	Article						Drosophila melanogaster; PINK1(B9) mutants; phytotherapic preparations; telomere length	AGING-ASSOCIATED ALTERATION; TELOMERE LENGTH; MITOCHONDRIAL DYSFUNCTION; MELANOGASTER; GLUTATHIONE; MUTATIONS; APOPTOSIS; MUTANTS; MUSCLE; RISK	Oxidative stress is commonly observed in both idiopathic and genetic cases of Parkinson's disease (PD). It plays an important role in the degeneration of dopaminergic neurons, and it has been associated with altered telomere length (TL). There is currently no cure for PD, and extracts of antioxidative plant, such as Mucuna pruriens and Withania somnifera, are commonly used in Ayurveda to treat patients with PD. In this study, we evaluated 2 enzymatic markers of oxidative stress, glutathione (GSH) system and superoxide dismutase (SOD), and TL in a Drosophila melanogaster model for PD [phosphatase and tensin homolog-induced putative kinase 1 (PINK1)(B9)]. This evaluation was also performed after treatment with the phytoextracts. PINK1(B9) mutants showed a decrease in GSH amount and SOD activity and unexpected longer telomeres compared with wild-type flies. M. pruriens treatment seemed to have a beneficial effect on the oxidative stress conditions. On the other hand, W. somnifera treatment did not show any improvements in the studied oxidative stress mechanisms and even seemed to favor the selection of flies with longer telomeres. In summary, our study suggests the importance of testing antioxidant phytoextracts in a PINK1(B9) model to identify beneficial effects for PD.-Baroli, B., Loi, E., Solari, P., Kasture, A., Moi, L., Muroni, P., Kasture, S., Setzu, M. D., Liscia, A., Zavattari, P. Evaluation of oxidative stress mechanisms and the effects of phytotherapic extracts on Parkinson's disease Drosophila PINK1(B9) model.	[Baroli, Biancamaria] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Loi, Eleonora; Solari, Paolo; Moi, Loredana; Muroni, Patrizia; Setzu, Maria Dolores; Liscia, Anna; Zavattari, Patrizia] Univ Cagliari, Dept Biomed Sci, Univ Campus,SP 8, I-09042 Cagliari, Italy; [Kasture, Ameya] Univ Vienna, Dept Neurobiol, Vienna, Austria; [Kasture, Sanjay] Pinnacle Biomed Res Inst, Bhopal, India	University of Cagliari; University of Cagliari; University of Vienna	Liscia, A (corresponding author), Univ Cagliari, Dept Biomed Sci, Univ Campus,SP 8, I-09042 Cagliari, Italy.	liscia@unica.it	Loi, Eleonora/Y-2968-2019	Loi, Eleonora/0000-0001-6437-4763; Kasture, Ameya/0000-0002-2947-4803; /0000-0001-8785-1438				Ahmed S, 1998, GENETICS, V150, P643; Alam N, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-175; Alviano DS, 2009, CURR PHARM BIOTECHNO, V10, P106, DOI 10.2174/138920109787048607; Bharath S, 2002, BIOCHEM PHARMACOL, V64, P1037, DOI 10.1016/S0006-2952(02)01174-7; Bjorklund A, 2010, PROG BRAIN RES, V184, P3, DOI 10.1016/S0079-6123(10)84001-4; Cai ZY, 2013, NEUROMOL MED, V15, P25, DOI 10.1007/s12017-012-8207-9; Celotto AM, 2005, MOL INTERV, V5, P292, DOI 10.1124/mi.5.5.9; De Rose F, 2017, SCI REP-UK, V7, DOI 10.1038/srep41059; De Rose F, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/3508073; De Rose F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146140; Degerman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113387; Deocaris CC, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-14; Dutta K, 2018, EXP NEUROL, V309, P193, DOI 10.1016/j.expneurol.2018.08.008; Forero DA, 2016, EXP GERONTOL, V75, P53, DOI 10.1016/j.exger.2016.01.002; Frydrychova RC, 2008, CYTOGENET GENOME RES, V122, P356, DOI 10.1159/000167823; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gonzalez-Ebsen AC, 2017, FRONT BIOSCI-LANDMRK, V22, P117, DOI 10.2741/4475; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; Kasture S, 2013, ORIENTAL PHARM EXP M, V13, P165, DOI 10.1007/s13596-013-0126-2; Keller MF, 2012, HUM MOL GENET, V21, P4996, DOI 10.1093/hmg/dds335; Korandova M, 2018, J INSECT PHYSIOL, V104, P1, DOI 10.1016/j.jinsphys.2017.11.002; Liu ZH, 2011, PHARMACOL RES, V63, P439, DOI 10.1016/j.phrs.2011.01.004; Maeda T, 2012, J NEUROGENET, V26, P245, DOI 10.3109/01677063.2011.651665; Maeda T, 2009, J GERONTOL A-BIOL, V64, P949, DOI 10.1093/gerona/glp070; Manyam BV, 2004, PHYTOTHER RES, V18, P706, DOI 10.1002/ptr.1514; Misra L, 2007, INDIAN J BIOCHEM BIO, V44, P56; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034; Poddighe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110802; Poddighe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073156; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Raffa G D, 2013, Tsitologiia, V55, P204; Raffa GD, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00112; Roberts RO, 2014, MECH AGEING DEV, V141, P64, DOI 10.1016/j.mad.2014.10.002; Salim S, 2017, J PHARMACOL EXP THER, V360, P201, DOI 10.1124/jpet.116.237503; Savage Sharon A, 2018, F1000Res, V7, DOI 10.12688/f1000research.14068.1; Senthil V, 2007, CHEM-BIOL INTERACT, V167, P19, DOI 10.1016/j.cbi.2007.01.004; Solari P, 2018, J INSECT PHYSIOL, V111, P32, DOI 10.1016/j.jinsphys.2018.10.007; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vasantharaja Raguraman, 2016, Advances in Bioscience and Biotechnology, V7, P199, DOI 10.4236/abb.2016.74018; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Walter MF, 2007, CHROMOSOMA, V116, P41, DOI 10.1007/s00412-006-0081-5; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Wu DF, 2018, STAT PUBLIC POLICY, V5, P1, DOI 10.1080/2330443X.2018.1438939; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103	48	7	8	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11028	11034		10.1096/fj.201901010	http://dx.doi.org/10.1096/fj.201901010			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31291788	Green Submitted			2022-12-26	WOS:000489166300038
J	Salizzato, V; Zanin, S; Borgo, C; Lidron, E; Salvi, M; Rizzuto, R; Pallafacchina, G; Donella-Deana, A				Salizzato, Valentina; Zanin, Sofia; Borgo, Christian; Lidron, Elisa; Salvi, Mauro; Rizzuto, Rosario; Pallafacchina, Giorgia; Donella-Deana, Arianna			Protein kinase CK2 subunits exert specific and coordinated functions in skeletal muscle differentiation and fusogenic activity	FASEB JOURNAL			English	Article						myoblast differentiation; myoblast fusion; MyoD expression; muscle development; fusogenic proteins	TRANSCRIPTIONAL MECHANISMS; MYOBLAST FUSION; SATELLITE CELLS; PHOSPHORYLATION; EXPRESSION; COMPLEX; IDENTIFICATION; CAVEOLIN-3; MYOMAKER; PAX3	Casein kinase 2 (CK2) is a tetrameric protein kinase composed of 2 catalytic (alpha and alpha ') and 2 regulatory beta subunits. Our study provides the first molecular and cellular characterization of the different CK2 subunits, highlighting their individual roles in skeletal muscle specification and differentiation. Analysis of C2C12 cell knockout for each CK2 subunit reveals that: 1) CK2 beta is mandatory for the expression of the muscle master regulator myogenic differentiation 1 in proliferating myoblasts, thus controlling both myogenic commitment and subsequent muscle-specific gene expression and myotube formation; 2) CK2 alpha is involved in the activation of the muscle-specific gene program; and 3) CK2 alpha ' activity regulates myoblast fusion by mediating plasma membrane translocation of fusogenic proteins essential for membrane coalescence, like myomixer. Accordingly, CK2 alpha ' overexpression in C2C12 cells and in mouse regenerating muscle is sufficient to increase myofiber size and myonuclei content via enhanced satellite cell fusion. Consistent with these results, pharmacological inhibition of CK2 activity substantially blocks the expression of myogenic markers and muscle cell fusion both in vitro in C2C12 and primary myoblasts and in vivo in mouse regenerating muscle and zebrafish development. Overall, our work describes the specific and coordinated functions of CK2 subunits in orchestrating muscle differentiation and fusogenic activity, highlighting CK2 relevance in the physiopathology of skeletal muscle tissue.-Salizzato, V., Zanin, S., Borgo, C., Lidron, E., Salvi, M., Rizzuto, R., Pallafacchina, G., Donella-Deana, A. Protein kinase CK2 subunits exert specific and coordinated functions in skeletal muscle differentiation and fusogenic activity.	[Salizzato, Valentina; Borgo, Christian; Lidron, Elisa; Salvi, Mauro; Rizzuto, Rosario; Pallafacchina, Giorgia; Donella-Deana, Arianna] Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58-B, I-35131 Padua, Italy; [Zanin, Sofia] Univ Padua, Dept Med, Padua, Italy; [Salizzato, Valentina; Pallafacchina, Giorgia] Italian Natl Res Council CNR, Neurosci Inst, Via Ugo Bassi 58-B, I-35131 Padua, Italy	University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Pallafacchina, G; Donella-Deana, A (corresponding author), Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58-B, I-35131 Padua, Italy.; Pallafacchina, G (corresponding author), Italian Natl Res Council CNR, Neurosci Inst, Via Ugo Bassi 58-B, I-35131 Padua, Italy.	giorgia.pallafacchina@unipd.it; arianna.donella@unipd.it	Pallafacchina, Giorgia/K-4056-2016; Borgo, Christian/AAB-2712-2020; ZANIN, SOFIA/AAJ-5529-2020; Zanin, Sofia/ABA-3509-2021	Pallafacchina, Giorgia/0000-0001-9766-5970; Salvi, Mauro/0000-0003-3448-6048; Rizzuto, Rosario/0000-0001-7044-5097; Salizzato, Valentina/0000-0003-1027-3259; BORGO, CHRISTIAN/0000-0001-9540-8145	University of Padua [PrAt-CPDA130310]; Italian Ministry of Education, University and Research (FIRB); U.S. National Institutes of Health, National Institute on Aging [1P01AG025532-01A1]; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	University of Padua; Italian Ministry of Education, University and Research (FIRB)(Ministry of Education, Universities and Research (MIUR)); U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. D. W. Litchfield (University of Western Ontario, London, ON, Canada) for kindly sharing the pRcCMV2-CK2 alpha'-HA construct, Dr. D. P. Millay (Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA) and Dr. O. Marin (Department of Biomedical Sciences, University of Padua) for kindly providing anti-myomaker antibody and the eIF2 beta(1-22) peptide, respectively. This work was supported by the University of Padua (PrAt-CPDA130310 to A.D.-D.), the Italian Ministry of Education, University and Research (FIRB; to R.R.), and U.S. National Institutes of Health, National Institute on Aging Grant 1P01AG025532-01A1(to R.R.). The authors declare no conflicts of interest.	Battistutta R, 2011, BIOCHEMISTRY-US, V50, P8478, DOI 10.1021/bi2008382; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bi P, 2017, SCIENCE, V356, P323, DOI 10.1126/science.aam9361; Bibby AC, 2005, INT J BIOL SCI, V1, P67; Borgo C, 2017, SCI REP-UK, V7, DOI 10.1038/srep42409; BRAUN T, 1989, EMBO J, V8, P4358; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Brini M, 1997, MOL BIOL CELL, V8, P129, DOI 10.1091/mbc.8.1.129; Brown DM, 2012, J MUSCLE RES CELL M, V32, P383, DOI 10.1007/s10974-011-9267-4; BUCHER EA, 1988, MOL CELL BIOL, V8, P4134, DOI 10.1128/MCB.8.10.4134; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Chen JY, 2015, PLANT CELL, V27, P711, DOI 10.1105/tpc.114.135335; Cheusova T, 2006, GENE DEV, V20, P1800, DOI 10.1101/gad.375206; Cornelison DDW, 2000, DEV BIOL, V224, P122, DOI 10.1006/dbio.2000.9682; Dedieu S, 2002, INT J DEV BIOL, V46, P235; Dick SA, 2015, P NATL ACAD SCI USA, V112, pE5246, DOI 10.1073/pnas.1512869112; Dietz KN, 2011, INT J BIOCHEM CELL B, V43, P936, DOI 10.1016/j.biocel.2011.03.010; Dietz KN, 2009, BIOCHEMISTRY-US, V48, P11786, DOI 10.1021/bi9012947; Filhol O, 2004, EMBO REP, V5, P351, DOI 10.1038/sj.embor.7400115; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Gamage DG, 2017, J BIOL CHEM, V292, P17272, DOI 10.1074/jbc.M117.811372; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Girardi C, 2014, BBA-MOL CELL RES, V1843, P1865, DOI 10.1016/j.bbamcr.2014.04.020; Gotz C, 2017, BIOMED REP, V6, P127, DOI 10.3892/br.2016.829; Goh Q, 2017, ELIFE, V6, DOI 10.7554/eLife.20007; Gonzalez N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154919; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; Iyengar AS, 2012, BIOCHEM BIOPH RES CO, V428, P24, DOI 10.1016/j.bbrc.2012.09.141; Johnson SE, 1996, MOL CELL BIOL, V16, P1604; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054382; Leikina E, 2018, DEV CELL, V46, P767, DOI 10.1016/j.devcel.2018.08.006; Lou DY, 2008, MOL CELL BIOL, V28, P131, DOI 10.1128/MCB.01119-07; LUSCHER B, 1994, EUR J BIOCHEM, V220, P521, DOI 10.1111/j.1432-1033.1994.tb18651.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Messenger MM, 2002, J BIOL CHEM, V277, P23054, DOI 10.1074/jbc.M200111200; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Miller PJ, 2008, PROTEIN SCI, V17, P1979, DOI 10.1110/ps.035956.108; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; O'Brien A, 2014, BIOINFORMATICS, V30, P2673, DOI 10.1093/bioinformatics/btu354; Padilla-Benavides T, 2017, J BIOL CHEM, V292, P18592, DOI 10.1074/jbc.M117.799676; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Peng BW, 2005, BIOCHEM BIOPH RES CO, V338, P1490, DOI 10.1016/j.bbrc.2005.10.111; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Prykhozhij SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138634; Quinn ME, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15665; Ralston E, 1999, EXP CELL RES, V246, P510, DOI 10.1006/excr.1998.4305; Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Salvi M, 2006, FEBS LETT, V580, P3948, DOI 10.1016/j.febslet.2006.06.031; Salvi M, 2009, BBA-MOL CELL RES, V1793, P847, DOI 10.1016/j.bbamcr.2009.01.013; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sarno S, 1996, J BIOL CHEM, V271, P10595, DOI 10.1074/jbc.271.18.10595; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAINBERG A, 1971, DEV BIOL, V25, P1, DOI 10.1016/0012-1606(71)90017-0; Shi J, 2017, P NATL ACAD SCI USA, V114, P11950, DOI 10.1073/pnas.1715229114; Shi XZ, 2012, BIOCHEM J, V446, P349, DOI 10.1042/BJ20120563; Srinivas BP, 2007, NAT GENET, V39, P781, DOI 10.1038/ng2055; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Vilk G, 1999, J BIOL CHEM, V274, P14406, DOI 10.1074/jbc.274.20.14406; WADE R, 1990, DEV BIOL, V142, P270, DOI 10.1016/0012-1606(90)90348-M; Wang C, 2017, EBIOMEDICINE, V16, P212, DOI 10.1016/j.ebiom.2017.01.015; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Winter B, 1997, BIOL CHEM, V378, P1445, DOI 10.1515/bchm.1997.378.12.1445; Xu X, 1999, NAT GENET, V23, P118, DOI 10.1038/12729; ZALIN R, 1972, BIOCHEM J, V130, pP79; Zhang Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15664; Zhang WB, 2017, DEV BIOL, V423, P24, DOI 10.1016/j.ydbio.2017.01.019	72	15	15	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10648	10667		10.1096/fj.201801833RR	http://dx.doi.org/10.1096/fj.201801833RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31268746	Bronze, Green Published			2022-12-26	WOS:000489166300007
J	Tsoi, M; Morin, M; Rico, C; Johnson, RL; Paquet, M; Gevry, N; Boerboom, D				Tsoi, Mayra; Morin, Martin; Rico, Charlene; Johnson, Randy L.; Paquet, Marilene; Gevry, Nicolas; Boerboom, Derek			Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance	FASEB JOURNAL			English	Article						transdifferentiation; Sox9; Bglap; RUNX2; Hippo	YES-ASSOCIATED PROTEIN; HIPPO SIGNALING PATHWAY; BETA-CATENIN; MESENCHYMAL TRANSITION; SERTOLI-CELLS; SIZE-CONTROL; YAP; YAP/TAZ; EXPRESSION; GROWTH	Recent reports suggest that the Hippo signaling pathway influences ovarian follicle development; however, its exact roles remain unknown. Here, we examined the ovarian functions of the Hippo kinases large tumor suppressors (LATS)1 and 2, which serve to inactivate the transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ). Inactivation of Lats1/2 in murine granulosa cells either in vitro or in vivo resulted in a loss of granulosa cell morphology, function, and gene expression. Mutant cells further underwent changes in structure and gene expression suggestive of epithelial-to-mesenchymal transition and transdifferentiation into multiple lineages. In vivo, granulosa cell-specific loss of Lats1/2 caused the ovarian parenchyma to be mostly replaced by bone tissue and seminiferous tubule-like structures. Transdifferentiation into Sertoli-like cells and osteoblasts was attributed in part to the increased recruitment of YAP and TAZ to the promoters of sex-determining region Y box 9 and bone gamma-carboxyglutamate protein, key mediators of male sex determination and osteogenesis, respectively. Together, these results demonstrate for the first time a critical role for Lats1/2 in the maintenance of the granulosa cell genetic program and further highlight the remarkable plasticity of granulosa cells.-Tsoi, M., Morin, M., Rico, C., Johnson, R. L., Paquet, M., Gevry, N., Boerboom, D. Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance.	[Tsoi, Mayra; Rico, Charlene; Boerboom, Derek] Univ Montreal, Fac Med Vet, Ctr Rech Reprod & Fertilite, Dept Biomed Vet, 3200 Sicotte, St Hyacinthe, PQ J25 7C6, Canada; [Paquet, Marilene] Univ Montreal, Fac Med Vet, Ctr Rech Reprod & Fertilite, Dept Pathol & Microbiol, 3200 Sicotte, St Hyacinthe, PQ J25 7C6, Canada; [Morin, Martin; Gevry, Nicolas] Univ Sherbrooke, Fac Sci, Dept Biol, Sherbrooke, PQ, Canada; [Johnson, Randy L.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Universite de Montreal; Universite de Montreal; University of Sherbrooke; University of Texas System; UTMD Anderson Cancer Center	Boerboom, D (corresponding author), Univ Montreal, Fac Med Vet, Ctr Rech Reprod & Fertilite, Dept Biomed Vet, 3200 Sicotte, St Hyacinthe, PQ J25 7C6, Canada.	derek.boerboom@umontreal.ca			Canadian government through Genome Canada; Canadian Institutes of Health Research (CIHR) [MOP-142445]; U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Specialized Cooperative Centers Program in Reproduction Research (SCCPRR) [U54-HD28934]; Fonds de Recherche du Quebec-Sante (FRQS)	Canadian government through Genome Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Specialized Cooperative Centers Program in Reproduction Research (SCCPRR); Fonds de Recherche du Quebec-Sante (FRQS)	The authors thank Claude Paquet, Philippe Godin, and Meggie Girard (all from Universite de Montreal) for technical support. The authors thank Jan Gossen (Osteo-Pharma, Oss, The Netherlands) for CYP19-cre mice. The authors thank McGill University and Genome Quebec Innovation Centre (Montreal, QC, Canada) and the Canadian Center for Computational Genomics (C3G; Montreal, QC, Canada) for generating and analyzing microarray data. C3G is a node of the Canadian Genomic Innovation Network and is supported by the Canadian government through Genome Canada. The authors thank Dagmar Wilhelm (University of Melbourne, Parkville, VIC, Australia) for the FOXL2 antibody. The authors thank the Ligand Assay and Analysis Core at the University of Virginia (Charlottesville, VA, USA) for the hormonal measurements. This work was supported by Canadian Institutes of Health Research (CIHR) operating Grant MOP-142445 (to D.B.). The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Specialized Cooperative Centers Program in Reproduction Research (SCCPRR) Grant U54-HD28934. M.T. was supported by a doctoral research award from the Fonds de Recherche du Quebec-Sante (FRQS). The authors declare no conflicts of interest.	Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Barrionuevo FJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15635; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Boerboom D, 2006, CANCER RES, V66, P1964, DOI 10.1158/0008-5472.CAN-05-3493; Boerboom D, 2005, CANCER RES, V65, P9206, DOI 10.1158/0008-5472.CAN-05-1024; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chen T, 2017, J CELL PHYSIOL, V232, P3261, DOI 10.1002/jcp.25797; Cheng Y, 2015, FASEB J, V29, P2423, DOI 10.1096/fj.14-267856; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Dzafic E, 2013, J ASSIST REPROD GEN, V30, P1255, DOI 10.1007/s10815-013-0068-0; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Fu V, 2017, CURR OPIN CELL BIOL, V49, P99, DOI 10.1016/j.ceb.2017.12.012; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Heath E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-18; Hindley CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23208; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang ZH, 2016, DEVELOPMENT, V143, P2398, DOI 10.1242/dev.130658; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kawamura K, 2013, P NATL ACAD SCI USA, V110, P17474, DOI 10.1073/pnas.1312830110; Kent J, 1996, DEVELOPMENT, V122, P2813; Kossowska-Tomaszczuk K, 2009, STEM CELLS, V27, P210, DOI 10.1634/stemcells.2008-0233; Lee DH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11961; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Levasseur A, 2017, BIOL REPROD, V97, P162, DOI 10.1093/biolre/iox057; Li YQ, 2017, J BIOL CHEM, V292, P17577, DOI 10.1074/jbc.M117.811349; Lindeman RE, 2015, CURR BIOL, V25, P764, DOI 10.1016/j.cub.2015.01.034; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Malik AR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00237; Mattioli M, 2012, THERIOGENOLOGY, V77, P1425, DOI 10.1016/j.theriogenology.2011.11.008; McNeill H, 2017, J AM SOC NEPHROL, V28, P852, DOI 10.1681/ASN.2016060611; Miesfeld JB, 2015, DEVELOPMENT, V142, P3021, DOI 10.1242/dev.119008; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Oki Y, 2012, BIOCHEM J, V447, P239, DOI 10.1042/BJ20120172; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park GS, 2016, ONCOTARGET, V7, P24063, DOI 10.18632/oncotarget.8211; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Poon CLC, 2016, CURR BIOL, V26, P1034, DOI 10.1016/j.cub.2016.02.009; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Nguyen Q, 2015, DIGEST LIVER DIS, V47, P826, DOI 10.1016/j.dld.2015.05.011; Roca H, 2008, NUCLEIC ACIDS RES, V36, P1723, DOI 10.1093/nar/gkn022; Sasaki H, 2017, DEV GROWTH DIFFER, V59, P12, DOI 10.1111/dgd.12335; Sforza C, 2003, EARLY HUM DEV, V74, P27, DOI 10.1016/S0378-3782(03)00081-1; Song SM, 2014, CANCER RES, V74, P4170, DOI 10.1158/0008-5472.CAN-13-3569; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Svotelis A, 2009, METHODS MOL BIOL, V543, P243, DOI 10.1007/978-1-60327-015-1_16; Tang Y, 2016, NAT CELL BIOL, V18, P917, DOI 10.1038/ncb3394; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Varras M, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-36; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vitolol MI, 2007, CANCER BIOL THER, V6, P856, DOI 10.4161/cbt.6.6.4241; Wang R, 2017, ONCOTARGET, V8, P24804, DOI 10.18632/oncotarget.15063; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Zhang H, 2014, J BIOL CHEM, V289, P18681, DOI 10.1074/jbc.M114.554584; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	69	14	14	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10819	10832		10.1096/fj.201900609R	http://dx.doi.org/10.1096/fj.201900609R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31268774	Green Published			2022-12-26	WOS:000489166300020
J	Yuan, YY; Zhao, XY; Wang, P; Mei, F; Zhou, JT; Jin, Y; McNutt, MA; Yin, YX				Yuan, Yuyao; Zhao, Xuyang; Wang, Pan; Mei, Fan; Zhou, Juntuo; Jin, Yan; McNutt, Michael A.; Yin, Yuxin			PTEN alpha regulates endocytosis and modulates olfactory function	FASEB JOURNAL			English	Article						Ap2b1; olfaction; neurodegenerative disease; amphiphysin	PROTEIN-KINASE; AMPHIPHYSIN-I; BAR DOMAIN; CLATHRIN; NEUROGENESIS; DYSFUNCTION; NEURONS; CELLS; BULB; PHOSPHORYLATION	Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) alpha is the first identified isoform of the well-known tumor suppressor PTEN. PTEN alpha has an evolutionarily conserved 173-aa N terminus compared with canonical PTEN. Recently, PTEN alpha has been shown to play roles in multiple biologic processes including learning and memory, cardiac homeostasis, and antiviral immunity. Here, we report that PTEN alpha maintains mitral cells in olfactory bulb (OB), regulates endocytosis in OB neurons, and controls olfactory behaviors in mice. We show that PTEN alpha directly dephosphorylates the endocytic protein amphiphysin and promotes its binding to adaptor-related protein complex 2 subunit beta 1 (Ap2b1). In addition, we identified mutations in the N terminus of PTEN alpha in patients with Parkinson disease and Lewy-body dementia, which are neurodegenerative disorders with early olfactory loss. Overexpression of PTEN alpha mutant H169N in mice OB reduces odor sensitivity. Our data demonstrate a role of PTEN alpha in olfactory function and provide insight into the mechanism of olfactory dysfunction in neurologic disorders.-Yuan, Y., Zhao, X., Wang, P., Mei, F., Zhou, J., Jin, Y., McNutt, M. A., Yin, Y. PTEN alpha regulates endocytosis and modulates olfactory function.	[Yuan, Yuyao; Wang, Pan; Mei, Fan; Zhou, Juntuo; Jin, Yan; McNutt, Michael A.; Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Inst Syst Biomed, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Yuan, Yuyao; Zhao, Xuyang; Wang, Pan; Mei, Fan; Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Beijing, Peoples R China; [Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Peking University; Peking University	Yin, YX (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Inst Syst Biomed, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	yinyuxin@hsc.pku.edu.cn			National Key Research and Development Program of China [2016YFA0500302]; National Natural Science Foundation of China [81430056, 31420103905, 81372491]; Beijing Natural Science Foundation [7161007]; Lam Chung Nin Foundation for Systems Biomedicine; National Natural Scientific Foundation of China [31800849]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Lam Chung Nin Foundation for Systems Biomedicine; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank X. Meng (Peking University Health Science Center) for genomic DNA extraction from blood samples, Jia Liu (Peking University Health Science Center) for neurotransmitter quantification by liquid chromatography with tandem mass spectrometry (LC-MS-MS), and L. Liang (Peking University Health Science Center) for protein expression and purification from Sf9 cells. This work was supported by grants to Y.Y., including the National Key Research and Development Program of China (Grant 2016YFA0500302), the National Natural Science Foundation of China (Grants 81430056, 31420103905, and 81372491), the Beijing Natural Science Foundation (Key Grant 7161007), and the Lam Chung Nin Foundation for Systems Biomedicine. P.W. was supported by the National Natural Scientific Foundation of China (Grant 31800849). The authors declare no conflicts of interest.	Amiri A, 2012, J NEUROSCI, V32, P5880, DOI 10.1523/JNEUROSCI.5462-11.2012; Ayuso-Sacido A, 2010, J NEURO-ONCOL, V97, P323, DOI 10.1007/s11060-009-0035-x; Bear DM, 2016, CURR BIOL, V26, pR1039, DOI 10.1016/j.cub.2016.09.011; Berg DA, 2013, DEVELOPMENT, V140, P2548, DOI 10.1242/dev.088005; Cao YY, 2018, CELL MOL IMMUNOL, V15, P48, DOI 10.1038/cmi.2017.102; Cave JW, 2016, NPJ PARKINSONS DIS, V2, DOI 10.1038/npjparkd.2016.11; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Craft GE, 2008, MOL CELL PROTEOMICS, V7, P1146, DOI 10.1074/mcp.M700351-MCP200; Daynac M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21505; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Doty RL, 2008, ANN NEUROL, V63, P7, DOI 10.1002/ana.21327; Doty RL, 2017, LANCET NEUROL, V16, P478, DOI 10.1016/S1474-4422(17)30123-0; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Fjorback AW, 2009, J MOL NEUROSCI, V37, P191, DOI 10.1007/s12031-008-9092-4; Floyd SR, 2001, J BIOL CHEM, V276, P8104, DOI 10.1074/jbc.M008932200; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hong SY, 2013, CANCER RES, V73, P5266, DOI 10.1158/0008-5472.CAN-12-4441; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Hsiao SJ, 2017, CSH MOL CASE STUD, V3, DOI 10.1101/mcs.a001396; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kawauchi T, 2012, INT J MOL SCI, V13, P4564, DOI 10.3390/ijms13044564; Kobayashi N, 2014, BIOCHEM BIOPH RES CO, V453, P473, DOI 10.1016/j.bbrc.2014.09.108; Kovacs T, 2004, AGEING RES REV, V3, P215, DOI 10.1016/j.arr.2003.10.003; Kreis P, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00023; Li GL, 2018, AUTOPHAGY, V14, P1742, DOI 10.1080/15548627.2018.1489477; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Masson GR, 2016, BIOCHEM J, V473, P135, DOI 10.1042/BJ20150931; Meinecke M, 2013, J BIOL CHEM, V288, P6651, DOI 10.1074/jbc.M112.444869; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Nakai W, 2013, MOL BIOL CELL, V24, P2570, DOI 10.1091/mbc.E13-04-0197; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Rosselli-Murai LK, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208926; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Sekiguchi M, 2013, ARCH BIOCHEM BIOPHYS, V535, P257, DOI 10.1016/j.abb.2013.04.012; Shang WH, 2004, J BIOL CHEM, V279, P40890, DOI 10.1074/jbc.M404527200; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Suetsugu S, 2014, PHYSIOL REV, V94, P1219, DOI 10.1152/physrev.00040.2013; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Tojima T, 2014, J NEUROSCI, V34, P7165, DOI 10.1523/JNEUROSCI.5261-13.2014; Tojima T, 2010, NEURON, V66, P370, DOI 10.1016/j.neuron.2010.04.007; Trempe JF, 2009, MOL CELL, V36, P1034, DOI 10.1016/j.molcel.2009.11.021; Wang LM, 2018, CELL RES, V28, P787, DOI 10.1038/s41422-018-0056-0; Wang P, 2017, CELL REP, V19, P2627, DOI 10.1016/j.celrep.2017.05.088; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Williams MR, 2015, J NEUROSCI, V35, P943, DOI 10.1523/JNEUROSCI.3144-14.2015; Wu YM, 2009, ACTA MED OKAYAMA, V63, P305; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Zhao XN, 2013, P NATL ACAD SCI USA, V110, P11023, DOI 10.1073/pnas.1217727110	53	2	2	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11148	11162		10.1096/fj.201900588RR	http://dx.doi.org/10.1096/fj.201900588RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31291551				2022-12-26	WOS:000489166300048
J	Zhang, SY; Zhang, XB				Zhang, Siyuan; Zhang, Xiaobo			Shrimp miRNA suppresses the stemness of human cancer stem cells via the PIN1 pathway	FASEB JOURNAL			English	Article						shrimp mja-miR-35; cross-species; human PIN1; tumorigenesis	PROLYL-ISOMERASE PIN1; VIRUS-INFECTION; BREAST-CANCER; MICRORNAS; PHOSPHORYLATION; ACTIVATION; MARKER; TARGET; NANOG	A tumor can be regarded as a cell mass with a biologic hierarchy that is orchestrated by cancer stem cells. The specific features of cancer stem cells may result from a series of gene expression regulatory mechanisms. As important regulatory factors of gene expression, microRNAs (miRNAs) have critical roles in the self-renewal, pluripotency, differentiation, and tumorigenicity of cancer stem cells. However, the effects of animal miRNAs on cancer stem cells have not been investigated extensively. Here, we report that miRNA of a shrimp, Marsupenaeus japonicus (mja-miR-35-3p), which possesses antiviral activity in shrimp, could suppress the proliferation of melanoma and breast cancer stem cells, but not cancer nonstem cells, by arresting the cell cycle in the G(1) phase and inducing apoptosis. Shrimp mja-miR-35-3p (named mja-miR-35) targets the human peptidylprolyl cis/trans isomerase, never in mitosis gene a-interacting 1 (PIN1) gene, which is up-regulated in cancer stem cells. The results indicated that PIN1 silencing caused cell cycle arrest in the G(1) phase, induced apoptosis, and decreased the sphere-forming capacity of cancer stem cells, but not cancer nonstem cells, showing that PIN1 had beneficial effects against the stemness of cancer stem cells. The in vivo data revealed that shrimp mja-miR-35 suppressed the stemness of cancer stem cells in mice by inhibiting the PIN1 antiapoptotic-cell cycle pathway. These findings demonstrated that the miRNAs of aquatic animals might be an important source for discovering human antitumor drugs.-Zhang, S., Zhang, X. Shrimp miRNA suppresses the stemness of human cancer stem cells via the PIN1 pathway.	[Zhang, Siyuan; Zhang, Xiaobo] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Siyuan; Zhang, Xiaobo] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Shandong, Peoples R China	Zhejiang University; Qingdao National Laboratory for Marine Science & Technology	Zhang, XB (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	zxb0812@zju.edu.cn		Zhang, Xiaobo/0000-0003-4606-212X	China Ocean Mineral Resources Research and Development Association [DY135-B-04]; Marine Biology and Biotechnology of Qingdao National Laboratory for Marine Science and Technology [MS2018N005]	China Ocean Mineral Resources Research and Development Association; Marine Biology and Biotechnology of Qingdao National Laboratory for Marine Science and Technology	This study was supported by the China Ocean Mineral Resources Research and Development Association (DY135-B-04) and the Marine Biology and Biotechnology of Qingdao National Laboratory for Marine Science and Technology (MS2018N005). The authors declare no conflicts of interest.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berindan-Neagoe I, 2014, CLIN CANCER RES, V20, P6247, DOI 10.1158/1078-0432.CCR-13-2500; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chai S, 2016, HEPATOLOGY, V64, P2062, DOI 10.1002/hep.28821; Chen YL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02071; Cui YL, 2017, MOL THER-NUCL ACIDS, V9, P387, DOI 10.1016/j.omtn.2017.10.016; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; He TL, 2018, ONCOGENE, V37, P5766, DOI 10.1038/s41388-018-0376-z; He YD, 2017, FASEB J, V31, P2854, DOI 10.1096/fj.201601141RR; Huang TZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-159; Imaizumi A, 2016, ANTICANCER RES, V36, P653; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin CY, 2016, ONCOTARGETS THER, V9, P5483, DOI 10.2147/OTT.S102386; Liao P, 2017, MOL CELL, V68, P1134, DOI 10.1016/j.molcel.2017.11.006; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Liu C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14270; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu ZM, 2014, CELL RES, V24, P1033, DOI 10.1038/cr.2014.109; Mohamed A, 2013, AM J PATHOL, V183, P1096, DOI 10.1016/j.ajpath.2013.07.005; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Rustighi A, 2014, EMBO MOL MED, V6, P99, DOI 10.1002/emmm.201302909; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Sun X, 2014, ONCOGENE, V33, P4967, DOI [10.1038/onc.2013.492, 10.1038/onc.2014.224]; Wei S, 2015, NAT MED, V21, P457, DOI 10.1038/nm.3839; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yang F, 2017, CANCER RES, V77, P5543, DOI 10.1158/0008-5472.CAN-17-1375; Zhou XZ, 2016, NAT REV CANCER, V16, P463, DOI 10.1038/nrc.2016.49	35	8	9	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10767	10779		10.1096/fj.201900395RR	http://dx.doi.org/10.1096/fj.201900395RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284761				2022-12-26	WOS:000489166300016
J	Kuatsjah, E; Verstraete, MM; Kobylarz, MJ; Liu, AKN; Murphy, MEP; Eltis, LD				Kuatsjah, Eugene; Verstraete, Meghan M.; Kobylarz, Marek J.; Liu, Alvin K. N.; Murphy, Michael E. P.; Eltis, Lindsay D.			Identification of functionally important residues and structural features in a bacterial lignostilbene dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lignin degradation; metalloenzyme; enzyme mechanism; resveratrol; X-ray crystallography; aromatic compound; bacterial catabolism; carotenoid cleavage oxygenase; lignostilbene; biomass conversion; non-heme iron oxygenase; carotenoid dioxygenase; lignostilbene dioxygenase (LSD)	CAROTENOID CLEAVAGE; BETA-DIOXYGENASE; GENERAL BASE; DOUBLE-BOND; LIGNIN; DEHYDROGENASE; PURIFICATION; MECHANISM; ISOZYMES; ENZYME	Lignostilbene-alpha,beta-dioxygenase A (LsdA) from the bacterium Sphingomonas paucimobilis TMY1009 is a nonheme iron oxygenase that catalyzes the cleavage of lignostilbene, a compound arising in lignin transformation, to two vanillin molecules. To examine LsdA's substrate specificity, we heterologously produced the dimeric enzyme with the help of chaperones. When tested on several substituted stilbenes, LsdA exhibited the greatest specificity for lignostilbene (k(cat)(app) = 1.00 +/- 0.04 x 10(6) M-1 s(-1)). These experiments further indicated that the substrate's 4-hydroxy moiety is required for catalysis and that this moiety cannot be replaced with a methoxy group. Phenylazophenol inhibited the LsdA-catalyzed cleavage of lignostilbene in a reversible, mixed fashion (K-ic = 6 +/- 1 mu M, K-iu = 24 +/- 4 mu M). An X-ray crystal structure of LsdA at 2.3 angstrom resolution revealed a seven-bladed beta-propeller fold with an iron cofactor coordinated by four histidines, in agreement with previous observations on related carotenoid cleavage oxygenases. We noted that residues at the dimer interface are also present in LsdB, another lignostilbene dioxygenase in S. paucimobilis TMY1009, rationalizing LsdA and LsdB homo- and heterodimerization in vivo. A structure of an LsdA center dot phenylazophenol complex identified Phe(59), Tyr(101), and Lys(134) as contacting the 4-hydroxyphenyl moiety of the inhibitor. Phe(59) and Tyr(101) substitutions with His and Phe, respectively, reduced LsdA activity (k(cat)(app)) similar to 15- and 10-fold. The K134M variant did not detectably cleave lignostilbene, indicating that Lys(134) plays a key catalytic role. This study expands our mechanistic understanding of LsdA and related stilbene-cleaving dioxygenases.	[Kuatsjah, Eugene; Eltis, Lindsay D.] Univ British Columbia, Life Sci Inst, Genome Sci & Technol Program, Vancouver, BC V6T 1Z3, Canada; [Verstraete, Meghan M.; Kobylarz, Marek J.; Liu, Alvin K. N.; Murphy, Michael E. P.; Eltis, Lindsay D.] Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Eltis, LD (corresponding author), Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@mail.ubc.ca	Kuatsjah, Eugene/GLN-5085-2022; Eltis, Lindsay/J-8272-2015	Liu, Alvin Ka Nok/0000-0002-5111-3713; Eltis, Lindsay/0000-0002-6774-8158; Verstraete, Meghan/0000-0003-0422-2826; Kuatsjah, Eugene/0000-0002-8793-2331	United States Department of Energy, Office of Science, and Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NSERC; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, and Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Mariko Ikehata assisted with the ICP-MS. Use of the Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory, was supported by the United States Department of Energy, Office of Science, and Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by NIGMS, National Institutes of Health (including Grant P41GM103393). Research described in this paper was performed using beamline 08D1-1 at the Canadian Light Source, which is supported by the NSERC, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bugg TDH, 2015, CURR OPIN CHEM BIOL, V29, P10, DOI 10.1016/j.cbpa.2015.06.009; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chong JL, 2009, PLANT SCI, V177, P143, DOI 10.1016/j.plantsci.2009.05.012; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Crestini C, 2017, GREEN CHEM, V19, P4104, DOI [10.1039/c7gc01812f, 10.1039/C7GC01812F]; dela Sena C, 2014, J BIOL CHEM, V289, P13661, DOI 10.1074/jbc.M114.557710; Diaz-Sanchez V, 2013, EUKARYOT CELL, V12, P1305, DOI 10.1128/EC.00084-13; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Han SY, 2003, J ENZYM INHIB MED CH, V18, P279, DOI 10.1080/1475636031000080207; Han SY, 2002, BIOORG MED CHEM LETT, V12, P1139, DOI 10.1016/S0960-894X(02)00126-9; Harrison PJ, 2014, ARCH BIOCHEM BIOPHYS, V544, P105, DOI 10.1016/j.abb.2013.10.005; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jackson CA, 2017, J APPL MICROBIOL, V122, P940, DOI 10.1111/jam.13401; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kamimura N, 2017, ENV MICROBIOL REP, V9, P679, DOI 10.1111/1758-2229.12597; KAMODA S, 1993, BIOSCI BIOTECH BIOCH, V57, P926, DOI 10.1271/bbb.57.926; Kamoda S, 2003, BIOSCI BIOTECH BIOCH, V67, P1394, DOI 10.1271/bbb.67.1394; Kamoda S, 1997, BIOSCI BIOTECH BIOCH, V61, P1575, DOI 10.1271/bbb.61.1575; KAMODA S, 1993, BIOSCI BIOTECH BIOCH, V57, P931, DOI 10.1271/bbb.57.931; KAMODA S, 1989, AGR BIOL CHEM TOKYO, V53, P2757, DOI 10.1080/00021369.1989.10869724; Kumar VP, 2012, BIOCHEMISTRY-US, V51, P857, DOI [10.1021/bi201808, 10.1021/bi201808u]; Lei Z, 1999, BIOCHEMISTRY-US, V38, P11231, DOI 10.1021/bi990433i; Loewen PC, 2018, BMC BIOCHEM, V19, DOI 10.1186/s12858-018-0098-4; Marasco EK, 2008, CHEMBIOCHEM, V9, P1450, DOI 10.1002/cbic.200700724; McAndrew RP, 2016, P NATL ACAD SCI USA, V113, P14324, DOI 10.1073/pnas.1608917113; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nunes S, 2018, NUTR RES REV, V31, P85, DOI 10.1017/S095442241700021X; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; SEKIMOTO T, 1993, J BIOL CHEM, V268, P27039; Shiel AE, 2012, GEOCHIM COSMOCHIM AC, V76, P175, DOI 10.1016/j.gca.2011.10.005; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Sui XW, 2017, BIOCHEMISTRY-US, V56, P2836, DOI 10.1021/acs.biochem.7b00251; Sui XW, 2016, J BIOL CHEM, V291, P19401, DOI 10.1074/jbc.M116.744912; Sui XW, 2015, J BIOL CHEM, V290, P30212, DOI 10.1074/jbc.M115.696799; Sui XW, 2013, ARCH BIOCHEM BIOPHYS, V539, P203, DOI 10.1016/j.abb.2013.06.012; Takahashi K, 2018, ENVIRON MICROBIOL, V20, P1739, DOI 10.1111/1462-2920.14099; Varman AM, 2016, P NATL ACAD SCI USA, V113, pE5802, DOI 10.1073/pnas.1606043113; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu RQ, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02154-18; ZABINSKI R, 1972, BIOCHEMISTRY-US, V11, P3212, DOI 10.1021/bi00767a012	46	8	8	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2019	294	35					12911	12920		10.1074/jbc.RA119.009428	http://dx.doi.org/10.1074/jbc.RA119.009428			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5FB	31292192	hybrid, Green Published			2022-12-26	WOS:000486416000005
J	Xiaoli, AM; Song, ZY; Yang, FJ				Xiaoli, Alus M.; Song, Ziyi; Yang, Fajun			Lipogenic SREBP-1a/c transcription factors activate expression of the iron regulator hepcidin, revealing cross-talk between lipid and iron metabolisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA transcription; transcription factor; iron metabolism; transcription coregulator; inflammation; lipogenesis; Hamp; hepcidin; LPS; Mediator; SREBP	DE-NOVO LIPOGENESIS; FATTY-ACIDS; MEDIATOR COMPLEX; LIVER; CHOLESTEROL; PROTEINS; PROMOTER; STAT3; HOMEOSTASIS; PATHOLOGY	The sterol regulatory element-binding proteins (SREBPs) are a family of transcription factors best known for stimulating the expression of genes encoding key lipogenic enzymes. However, SREBP functions beyond lipid metabolism are less understood. Here, we show that hepcidin antimicrobial peptide (Hamp), encoding the hormone hepcidin essential for iron homeostasis and regulated by dietary iron and inflammation, is a target gene of the two SREBP isoforms SREBP-1a/c. We found that in tissue culture, mature, active, and nuclear forms of the SREBP-1a/c proteins induce endogenous Hamp gene expression and increase the Hamp promoter activity primarily via three regulatory sequences, including an E-box. Moreover, ChIP experiments revealed that SREBP-1a binds to the Hamp gene promoter. Overexpression of nuclear SREBP-1a under the control of the phosphoenolpyruvate carboxylase-1 (Pck1) promoter in mice increased hepatic Hamp mRNA and blood hepcidin levels, and as expected, caused fatty liver. Consistent with the known effects of Hamp up-regulation, SREBP-1a-overexpressing mice displayed signs of dysregulation in iron metabolism, including reduced serum iron and increased hepatic and splenic iron storage. Conversely, liver-specific depletion of the nuclear forms of SREBPs, as in SREBP cleavage-activating protein knockout mice, impaired lipopolysaccharide-induced up-regulation of hepatic Hamp. Together, these results indicate that the SREBP-1a/c transcription regulators activate hepcidin expression and thereby contribute to the control of mammalian iron metabolism.	Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Yang, FJ (corresponding author), Price Ctr, 1301 Morris Pk Ave,Rm 377, Bronx, NY 10461 USA.	fajun.yang@einstein.yu.edu		SONG, ZIYI/0000-0003-4306-4648	National Institutes of Health [P30 DK041296, DK020541, R01 DK110063, DK098439]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110063, P30DK041296, R01DK098439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants P30 DK041296 and DK020541 and R01 DK110063 and DK098439. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aigner E, 2014, NUTRIENTS, V6, P3587, DOI 10.3390/nu6093587; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Ameer F, 2014, METABOLISM, V63, P895, DOI 10.1016/j.metabol.2014.04.003; Bayele HK, 2006, BLOOD, V108, P4237, DOI 10.1182/blood-2005-07-027037; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Camaschella C, 2018, BRIT J HAEMATOL, V182, P481, DOI 10.1111/bjh.15403; Casanovas G, 2009, J MOL MED, V87, P471, DOI 10.1007/s00109-009-0447-2; Coffey R, 2017, J BIOL CHEM, V292, P12727, DOI 10.1074/jbc.R117.781823; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Engin A, 2017, ADV EXP MED BIOL, V960, P443, DOI 10.1007/978-3-319-48382-5_19; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Feng DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126240; Frazer DM, 2017, AM J CLIN NUTR, V105, P1255, DOI 10.3945/ajcn.117.158188; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Griffin MJ, 2007, J BIOL CHEM, V282, P5453, DOI 10.1074/jbc.M610566200; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Huang H, 2009, BLOOD, V113, P3593, DOI 10.1182/blood-2008-08-173641; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Knutson MD, 2017, J BIOL CHEM, V292, P12735, DOI 10.1074/jbc.R117.786632; Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Means RT, 2013, AM J MED SCI, V345, P57, DOI 10.1097/MAJ.0b013e318253caf1; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Parrow NL, 2014, ANNU REV NUTR, V34, P77, DOI 10.1146/annurev-nutr-071813-105646; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Reichert CO, 2017, ACTA HAEMATOL-BASEL, V137, P220, DOI 10.1159/000471838; Rishi G, 2017, AM J PHYSIOL-GASTR L, V313, pG157, DOI 10.1152/ajpgi.00004.2017; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Song ZY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101383; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Truksa J, 2009, BLOOD, V113, P688, DOI 10.1182/blood-2008-05-160184; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Wong RHF, 2010, CURR OPIN PHARMACOL, V10, P684, DOI 10.1016/j.coph.2010.08.004; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Xiaoli, 2013, TRENDS CARDIOVAS MED, V23, P269, DOI 10.1016/j.tcm.2013.03.002; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; YEN TT, 1976, BIOCHIM BIOPHYS ACTA, V441, P213, DOI 10.1016/0005-2760(76)90164-8; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462	52	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12743	12753		10.1074/jbc.RA119.009644	http://dx.doi.org/10.1074/jbc.RA119.009644			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31270208	hybrid, Green Published			2022-12-26	WOS:000484414600016
J	Shew, AM; Durand-Morat, A; Nalley, LL; Zhou, XG; Rojas, C; Thoma, G				Shew, Aaron M.; Durand-Morat, Alvaro; Nalley, Lawton L.; Zhou, Xin-Gen; Rojas, Clemencia; Thoma, Greg			Warming increases Bacterial Panicle Blight (Burkholderia glumae) occurrences and impacts on USA rice production	PLOS ONE			English	Article							GRAIN ROT; 1ST REPORT; RESISTANCE; EPIDEMIOLOGY; ASSOCIATION; PATHOGEN; GLADIOLI; TRADE	Bacterial Panicle Blight (BPB), caused by Burkholderia glumae, is a bacterial disease in rice (Oryza sativa) that reduces rice yield and quality for producers and consequently creates higher market prices for consumers. BPB is caused by the simultaneous occurrence of high daily minimum temperatures (similar to 22 degrees C) and relative humidity (similar to 77%), which may increase under the current scenario of global warming. This study hypothesized that the economic damage from warming may cause an increase in economic losses, though at a decreasing rate per degree. Thus, this study estimates the yield losses associated with BPB occurrences at the county level in the Mid-South United States (US) for annual rice production in 2003-2013 and under +1-3 degrees C warming scenarios using daily weather information with appropriate thresholds. From the estimated losses, the total production potential of a BPB-resistant rice was quantified using a spatial equilibrium trade model to further estimate market welfare changes with the counterfactual scenario that all US county-level rice production were BPB resistant. Results from the study indicate that the alleviation of BPB would represent a $69 million USD increase in consumer surplus in the US and a concomitant increase in rice production that would feed an additional 1.46 million people annually assuming a global average consumption of 54 Kg per person. Under the 1 degrees C warming scenario, BPB occurrences and production losses would cause price increases for rice and subsequently result in a $112 million USD annual decrease in consumer surplus in the US and a loss of production equivalent to feeding 2.17 million people. Under a 3 degrees C warming scenario, production losses due to BPB cause an annual reduction of $204 million USD in consumer surplus in the US, and a loss in production sufficient to feed 3.98 million people a year. As global warming intensifies, BPB could become a more common and formidable rice disease to combat, and breeding for BPB resistance would be the primary line-of-defense as currently no effective chemical options are available. The results of this study inform agriculturalists, policymakers, and economists about the value of BPB-resistance in the international rice market and also help support efforts to focus future breeding toward climate change impact resilience.	[Shew, Aaron M.] Arkansas State Univ, Coll Agr, Jonesboro, AR USA; [Shew, Aaron M.] Univ Arkansas Syst, Div Agr, Cooperat Extens Serv, Little Rock, AR 72204 USA; [Durand-Morat, Alvaro; Nalley, Lawton L.] Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA; [Zhou, Xin-Gen] Texas A&M AgriLife Res Ctr, Beaumont, TX USA; [Rojas, Clemencia] Univ Arkansas, Dept Plant Pathol, Fayetteville, AR 72701 USA; [Thoma, Greg] Univ Arkansas, Dept Chem Engn, Fayetteville, AR 72701 USA	Arkansas State University; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Nalley, LL (corresponding author), Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA.	llnalley@uark.edu	Nalley, Lawton/AAN-7643-2021	Nalley, Lawton/0000-0002-6718-8189; Shew, Aaron/0000-0003-3788-7891; Thoma, Greg/0000-0001-8757-7635				Boserup E., 2017, CONDITIONS AGR GROWT; Brennan J. P., 1984, Review of Marketing and Agricultural Economics, V52, P175; Brennan JP, 2011, INT RICE RES I CONTR; Cha K.H., 2001, RES PLANT DIS, V7, P150; Chien C. C., 1987, Journal of Agricultural Research of China, V36, P302; Cottyn B, 2001, PHYTOPATHOLOGY, V91, P282, DOI 10.1094/PHYTO.2001.91.3.282; Durand-Morat A, 2010, SP032010 U ARK DEP A; Durand-Morat A, 2018, GLOB FOOD SECUR-AGR, V18, P62, DOI 10.1016/j.gfs.2018.08.004; Duursma RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143346; FAO, 1995, 1981995 FAO; Fischer T, 2014, ACIAR MONOGR SER, V158, P1; Ham JH, 2011, MOL PLANT PATHOL, V12, P329, DOI 10.1111/j.1364-3703.2010.00676.x; HASHIOKA Y., 1969, Riso, V18, P189; Jeong Y, 2003, PLANT DIS, V87, P890, DOI 10.1094/PDIS.2003.87.8.890; Lakkakula P, 2015, AGR ECON-BLACKWELL, V46, P667, DOI 10.1111/agec.12162; Lee YH, 2015, PLANT PATHOLOGY J, V31, P350, DOI 10.5423/PPJ.OA.07.2015.0136; Marasas CN, 2003, AGR ECON, V29, P253, DOI 10.1111/j.1574-0862.2003.tb00162.x; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Mizobuchi R, 2016, RICE, V9, DOI 10.1186/s12284-016-0095-4; MIZUKAMI T, 1969, ANNU REV PHYTOPATHOL, V7, P51, DOI 10.1146/annurev.py.07.090169.000411; Mondal KK, 2015, PLANT DIS, V99, P1268, DOI 10.1094/PDIS-01-15-0094-PDN; Mulaw T., 2018, FIELD RESPONSE ADV R; Muthayya S, 2014, ANN NY ACAD SCI, V1324, P7, DOI 10.1111/nyas.12540; Muthayya S, 2012, FOOD NUTR BULL, V33, P296, DOI 10.1177/156482651203300410; Nalley L, 2017, AGRON J, V109, P193, DOI 10.2134/agronj2016.05.0281; Nalley L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167295; Nandakumar R, 2008, CAN J PLANT PATHOL, V30, P148, DOI 10.1080/07060660809507505; Nandakumar R, 2007, PLANT DIS, V91, P767, DOI 10.1094/PDIS-91-6-0767C; Nandakumar R, 2009, PLANT DIS, V93, P896, DOI 10.1094/PDIS-93-9-0896; Nguyen TLT, 2012, J CLEAN PROD, V28, P168, DOI 10.1016/j.jclepro.2011.08.018; Pinson SRM, 2010, CROP SCI, V50, P1287, DOI 10.2135/cropsci2008.07.0447; PRISM, 2018, PRISM CLIM GROUP DAI; Reynolds M, 2009, J EXP BOT, V60, P1899, DOI 10.1093/jxb/erp016; Riera-Ruiz C, 2014, PLANT DIS, V98, P988, DOI 10.1094/PDIS-10-13-1024-PDN; Rowlandson T, 2015, PLANT DIS, V99, P310, DOI 10.1094/PDIS-05-14-0529-FE; RTWG, 2003, RIC ACR SUMM; Sayre KD, 1997, CROP SCI, V37, P36, DOI 10.2135/cropsci1997.0011183X003700010006x; Schmidt M, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8040312; Shahjahan A., 2000, RICE J, V15, P26; Tsiboe F, 2017, J AGR RESOUR ECON, V42, P215; Tsushima S, 1996, JARQ-JPN AGR RES Q, V30, P85; Tsushima Seiya, 1995, Annals of the Phytopathological Society of Japan, V61, P419, DOI 10.3186/jjphytopath.61.419; Tsushima Seiya, 1995, Annals of the Phytopathological Society of Japan, V61, P109, DOI 10.3186/jjphytopath.61.109; UACES, CROP ENT BUDG ARK FI; USDA-FAS, 2018, USDA FAS PROD SUPPL; Wamishe Y, 2015, BATERIAL PANCILE BLI; Weidema B.P., 2008, JRC SCI TECHNICAL RE; Weidema BP, 2015, J IND ECOL, V19, P20, DOI 10.1111/jiec.12162; Weidema BP, 2009, ECOL ECON, V68, P1591, DOI 10.1016/j.ecolecon.2008.01.019; Zeigler R. S., 1989, Plant Disease, V73, P368, DOI 10.1094/PD-73-0368B; Zhou XG, 2014, PLANT DIS, V98, P566, DOI 10.1094/PDIS-09-13-0913-PDN; Zhou XG, 2011, PHYTOPATHOLOGY, V101, pS205; Zhou Xin-Gen, 2019, INTECHOPEN, DOI [10.5772/intechopen.84882, DOI 10.5772/INTECHOPEN.84882]	53	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219199	10.1371/journal.pone.0219199	http://dx.doi.org/10.1371/journal.pone.0219199			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295286	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800018
J	Chan, YM; Pitchaimuthu, K; Wu, QZ; Carter, OL; Egan, GF; Badcock, DR; McKendrick, AM				Chan, Yu Man; Pitchaimuthu, Kabilan; Wu, Qi-Zhu; Carter, Olivia L.; Egan, Gary F.; Badcock, David R.; McKendrick, Allison M.			Relating excitatory and inhibitory neurochemicals to visual perception: A magnetic resonance study of occipital cortex between migraine events	PLOS ONE			English	Article							BINOCULAR-RIVALRY; PATTERN ADAPTATION; UNITED-STATES; SEROTONIN; GABA; RHYTHMICITY; PREVALENCE; SYSTEM; MOTION	Certain perceptual measures have been proposed as indirect assays of brain neurochemical status in people with migraine. One such measure is binocular rivalry, however, previous studies have not measured rivalry characteristics and brain neurochemistry together in people with migraine. This study compared spectroscopy-measured levels of GABA and Glx ( glutamine and glutamate complex) in visual cortex between 16 people with migraine and 16 non-headache controls, and assessed whether the concentration of these neurochemicals explains, at least partially, inter-individual variability in binocular rivalry perceptual measures. Mean Glx level was significantly reduced in migraineurs relative to controls, whereas mean occipital GABA levels were similar between groups. Neither GABA levels, nor Glx levels correlated with rivalry percept duration. Our results thus suggest that the previously suggested relationship between rivalry percept duration and GABAergic inhibitory neuro-transmitter concentration in visual cortex is not strong enough to enable rivalry percept duration to be reliably assumed to be a surrogate for GABA concentration, at least in the context of healthy individuals and those that experience migraine.	[Chan, Yu Man; Pitchaimuthu, Kabilan; McKendrick, Allison M.] Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic, Australia; [Wu, Qi-Zhu; Egan, Gary F.] Monash Univ, Monash Biomed Imaging, Melbourne, Vic, Australia; [Carter, Olivia L.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Badcock, David R.] Univ Western Australia, Sch Psychol Sci, Perth, WA, Australia; [Pitchaimuthu, Kabilan] Univ Hamburg, Biol Psychol & Neuropsychol, Hamburg, Germany; [Wu, Qi-Zhu] Shenzhen Sinorad Med Elect Inc, Shenzhen, Peoples R China	University of Melbourne; Monash University; University of Melbourne; University of Western Australia; University of Hamburg	McKendrick, AM (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic, Australia.	allisonm@unimelb.edu.au	McKendrick, Allison M/A-2114-2008; Badcock, David R/A-4913-2008	Badcock, David R/0000-0002-4517-435X; Chan, Yu Man/0000-0002-1793-4673; Carter, Olivia/0000-0001-7708-6154; McKendrick, Allison/0000-0003-1972-1222	National Health and Medical Research Council (NHMRC) [APP1081874, GNT1081874]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (NHMRC) Project Grant (APP1081874) (AMM). Author QW is an employee of Shenzhen Sinorad Medical Electronics Inc., Shenzhen, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Health and Medical Research Council (NHMRC) Project Grant (GNT1081874).	Aguila MER, 2015, NMR BIOMED, V28, P890, DOI 10.1002/nbm.3321; ANTHONY M, 1967, ARCH NEUROL-CHICAGO, V16, P544, DOI 10.1001/archneur.1967.00470230096013; Battista J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018211; Battista J, 2010, INVEST OPHTH VIS SCI, V51, P6070, DOI 10.1167/iovs.10-5290; Becerra L, 2016, NEUROIMAGE-CLIN, V11, P588, DOI 10.1016/j.nicl.2016.03.020; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigal ME, 2008, NEUROLOGY, V70, P2078, DOI 10.1212/01.wnl.0000313376.07248.28; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Brascamp JW, 2015, VISION RES, V109, P20, DOI 10.1016/j.visres.2015.02.019; Bridge H, 2015, CEPHALALGIA, V35, P1025, DOI 10.1177/0333102414566860; Burch R, 2018, HEADACHE, V58, P496, DOI 10.1111/head.13281; Carter OL, 2005, NEUROPSYCHOPHARMACOL, V30, P1154, DOI 10.1038/sj.npp.1300621; Carter OL, 2007, PSYCHOPHARMACOLOGY, V195, P415, DOI 10.1007/s00213-007-0930-9; Chronicle EP, 1996, CEPHALALGIA, V16, P525, DOI 10.1046/j.1468-2982.1996.1608525.x; Dichgans M, 2005, NEUROLOGY, V64, P608, DOI 10.1212/01.WNL.0000151855.98318.50; Ditchfield JA, 2006, VISION RES, V46, P141, DOI 10.1016/j.visres.2005.09.014; Edden RAE, 2014, J MAGN RESON IMAGING, V40, P1445, DOI 10.1002/jmri.24478; Einhauser W, 2008, P NATL ACAD SCI USA, V105, P1704, DOI 10.1073/pnas.0707727105; FERRARI MD, 1993, CEPHALALGIA, V13, P151, DOI 10.1046/j.1468-2982.1993.1303151.x; FERRARI MD, 1989, NEUROLOGY, V39, P1239, DOI 10.1212/WNL.39.9.1239; de la Aleja JG, 2013, HEADACHE, V53, P365, DOI 10.1111/head.12030; Hamel E, 2007, CEPHALALGIA, V27, P1295; Harris AD, 2015, J MAGN RESON IMAGING, V42, P1431, DOI 10.1002/jmri.24903; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Marzoli SB, 2017, NEUROL SCI, V38, pS99, DOI 10.1007/s10072-017-2890-0; McKendrick AM, 2018, CEPHALALGIA, V38, P1575, DOI 10.1177/0333102417741130; McKendrick AM, 2011, CEPHALALGIA, V31, P1158, DOI 10.1177/0333102411404715; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Nagamine M, 2008, PSYCHOPHARMACOLOGY, V198, P279, DOI 10.1007/s00213-008-1139-2; Panconesi A, 2008, J HEADACHE PAIN, V9, P267, DOI 10.1007/s10194-008-0058-2; Pitchaimuthu K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14577-5; Prescot A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-34; Purdy RA, 2011, NEUROL SCI, V32, pS89, DOI 10.1007/s10072-011-0541-4; Robertson CE, 2016, CURR BIOL, V26, P80, DOI 10.1016/j.cub.2015.11.019; Shepherd AJ, 2002, SPATIAL VISION, V16, P33, DOI 10.1163/15685680260433896; Shepherd AJ, 2001, BRAIN, V124, P2310, DOI 10.1093/brain/124.11.2310; Siniatchkin M, 2012, CEREB CORTEX, V22, P2207, DOI 10.1093/cercor/bhr248; van Loon AM, 2013, CURR BIOL, V23, P823, DOI 10.1016/j.cub.2013.03.067; Vecchia D, 2012, TRENDS NEUROSCI, V35, P507, DOI 10.1016/j.tins.2012.04.007; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wilkinson F, 2008, CEPHALALGIA, V28, P1327, DOI 10.1111/j.1468-2982.2008.01696.x	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0208666	10.1371/journal.pone.0208666	http://dx.doi.org/10.1371/journal.pone.0208666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291247	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800001
J	Chen, JL; Moss, WN; Spencer, A; Zhang, PY; Childs-Disney, JL; Disney, MD				Chen, Jonathan L.; Moss, Walter N.; Spencer, Adam; Zhang, Peiyuan; Childs-Disney, Jessica L.; Disney, Matthew D.			The RNA encoding the microtubule-associated protein tau has extensive structure that affects its biology	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; FRONTOTEMPORAL DEMENTIA; SPLICING REGULATION; SMALL-MOLECULE; CIS-ELEMENTS; INTRICATE INTERPLAY; SEQUENCE; DESIGN; IDENTIFICATION; EXPRESSION	Tauopathies are neurodegenerative diseases that affect millions of people worldwide including those with Alzheimer's disease. While many efforts have focused on understanding the role of tau protein in neurodegeneration, there has been little done to systematically analyze and study the structures within tau's encoding RNA and their connection to disease pathology. Knowledge of RNA structure can provide insights into disease mechanisms and how to affect protein production for therapeutic benefit. Using computational methods based on thermodynamic stability and evolutionary conservation, we identified structures throughout the tau pre-mRNA, especially at exon-intron junctions and within the 5' and 3' untranslated regions ( UTRs). In particular, structures were identified at twenty exon-intron junctions. The 5' UTR contains one structured region, which lies within a known internal ribosome entry site. The 3' UTR contains eight structured regions, including one that contains a polyadenylation signal. A series of functional experiments were carried out to assess the effects of mutations associated with mis-regulation of alternative splicing of exon 10 and to identify regions of the 3' UTR that contain cis-regulatory elements. These studies defined novel structural regions within the mRNA that affect stability and pre-mRNA splicing and may lead to new therapeutic targets for treating tau-associated diseases.	[Chen, Jonathan L.; Spencer, Adam; Zhang, Peiyuan; Childs-Disney, Jessica L.; Disney, Matthew D.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Moss, Walter N.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA USA	Scripps Research Institute; Iowa State University	Disney, MD (corresponding author), Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA.	Disney@scripps.edu	Moss, Walter/H-8096-2019	Moss, Walter/0000-0001-6419-5570; Disney, Matthew/0000-0001-8486-1796; Zhang, Peiyuan/0000-0003-4086-3436	National Institutes of Health [R01-GM097455-07, DP1-NS096898, P01-NS099114, R00-GM112877]; Tau Consortium and Rainwater Charitable Foundation; Iowa State University College of Agriculture and Life Sciences; Roy J. Carver Charitable Trust; Huntington's Disease Society of America; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097455, R00GM112877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP1NS096898, P01NS099114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tau Consortium and Rainwater Charitable Foundation; Iowa State University College of Agriculture and Life Sciences; Roy J. Carver Charitable Trust; Huntington's Disease Society of America; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (R01-GM097455-07, DP1-NS096898, and P01-NS099114 to M.D.D and R00-GM112877 to W.N.M) and the Tau Consortium and Rainwater Charitable Foundation (to M.D.D.) as well as startup funds from the Iowa State University College of Agriculture and Life Sciences and the Roy J. Carver Charitable Trust (W.N.M.) and the Huntington's Disease Society of America (J.L.C.).	ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Andrews RJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17510-y; Angelbello AJ, 2018, CHEM REV, V118, P1599, DOI 10.1021/acs.chemrev.7b00504; Aronov S, 1999, J MOL NEUROSCI, V12, P131, DOI 10.1007/BF02736927; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Bellaousov S, 2013, NUCLEIC ACIDS RES, V41, pW471, DOI 10.1093/nar/gkt290; Bourdenx M, 2017, PROG NEUROBIOL, V155, P171, DOI 10.1016/j.pneurobio.2015.07.003; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Caillet-Boudin ML, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0025-8; Clote P, 2005, RNA, V11, P578, DOI 10.1261/rna.7220505; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Costales MG, 2017, J AM CHEM SOC, V139, P3446, DOI 10.1021/jacs.6b11273; Crary J, 2013, MICRORNAS SILENCE TA; D'Souza I, 2002, J BIOL CHEM, V277, P26587, DOI 10.1074/jbc.M203794200; Dela-Moss Lumbini I, 2014, BMC Res Notes, V7, P22, DOI 10.1186/1756-0500-7-22; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Dickson JR, 2013, J NEUROCHEM, V127, P739, DOI 10.1111/jnc.12437; Dickson JR, 2013, THESIS; Donahue CP, 2006, J BIOL CHEM, V281, P23302, DOI 10.1074/jbc.C600143200; Fallmann J, 2017, J BIOTECHNOL, V261, P97, DOI 10.1016/j.jbiotec.2017.07.007; Fang R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005668; Freyhult E, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-241; Freyhult EK, 2007, GENOME RES, V17, P117, DOI 10.1101/gr.5890907; Fu YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130200; Garcia-Escudero V, 2017, NEUROSCI LETT, V655, P101, DOI 10.1016/j.neulet.2017.07.007; Gruber AR, 2010, BIOCOMPUT-PAC SYM, P69; Hasegawa M, 1999, FEBS LETT, V443, P93, DOI 10.1016/S0014-5793(98)01696-2; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jiang T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156906; Jiang ZH, 2000, MOL CELL BIOL, V20, P4036, DOI 10.1128/MCB.20.11.4036-4048.2000; Jiang ZH, 2003, J BIOL CHEM, V278, P18997, DOI 10.1074/jbc.M301800200; Juan V, 1999, J MOL BIOL, V289, P935, DOI 10.1006/jmbi.1999.2801; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Li K, 2003, MOL BRAIN RES, V116, P94, DOI 10.1016/S0169-328X(03)00259-6; Lindgreen S, 2006, BIOINFORMATICS, V22, P2988, DOI 10.1093/bioinformatics/btl514; Lisowiec J, 2015, RNA BIOL, V12, P330, DOI 10.1080/15476286.2015.1017214; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Luo YL, 2014, CHEMBIOCHEM, V15, P2041, DOI 10.1002/cbic.201402069; Malkani R, 2006, NEUROBIOL DIS, V22, P401, DOI 10.1016/j.nbd.2005.12.001; Mathews DH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003665; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; McCarthy A, 2015, BRAIN, V138, P3100, DOI 10.1093/brain/awv234; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Moss Walter N, 2018, Noncoding RNA Res, V3, P100, DOI 10.1016/j.ncrna.2018.04.005; Moss WN, 2018, RNA, V24, P273, DOI 10.1261/rna.063933.117; Moss WN, 2014, RNA BIOL, V11, P10, DOI 10.4161/rna.27488; Moss WN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-543; Moss WN, 2012, RNA BIOL, V9, P1305, DOI 10.4161/rna.22343; Moss WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038323; Moss WN, 2011, RNA, V17, P991, DOI 10.1261/rna.2619511; Nemkul N, 2016, THESIS; Ogino S, 2007, J MOL DIAGN, V9, P1, DOI 10.2353/jmoldx.2007.060081; Orr ME, 2017, TRENDS PHARMACOL SCI, V38, P637, DOI 10.1016/j.tips.2017.03.011; Parsch J, 2000, GENETICS, V154, P909; Rivas E, 2017, NAT METHODS, V14, P45, DOI [10.1038/NMETH.4066, 10.1038/nmeth.4066]; Roca X, 2012, GENE DEV, V26, P1098, DOI 10.1101/gad.190173.112; Rzuczek SG, 2017, NAT CHEM BIOL, V13, P188, DOI [10.1038/NCHEMBIO.2251, 10.1038/nchembio.2251]; Santa-Maria I, 2015, J CLIN INVEST, V125, P681, DOI 10.1172/JCI78421; Schoch KM, 2016, NEURON, V90, P941, DOI 10.1016/j.neuron.2016.04.042; Seemann SE, 2017, GENOME RES, V27, P1371, DOI 10.1101/gr.208652.116; Sloma MF, 2016, RNA, V22, P1808, DOI 10.1261/rna.053694.115; Spina S, 2008, BRAIN, V131, P72, DOI 10.1093/brain/awm280; Strobel EJ, 2016, CURR OPIN BIOTECH, V39, P182, DOI 10.1016/j.copbio.2016.03.019; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; van Swieten J, 2007, BRAIN PATHOL, V17, P63, DOI 10.1111/j.1750-3639.2007.00052.x; Velagapudi SP, 2016, P NATL ACAD SCI USA, V113, P5898, DOI 10.1073/pnas.1523975113; Velagapudi SP, 2014, NAT CHEM BIOL, V10, P291, DOI [10.1038/NCHEMBIO.1452, 10.1038/nchembio.1452]; Veo BL, 2012, RNA BIOL, V9, P1344, DOI 10.4161/rna.22181; Wang JN, 2004, J NEUROCHEM, V88, P1078, DOI 10.1046/j.1471-4159.2003.02232.x; Wang JN, 2007, J NEUROCHEM, V100, P437, DOI 10.1111/j.1471-4159.2006.04252.x; Wang Y, 2014, METHODS, V65, P350, DOI 10.1016/j.ymeth.2013.08.019; Wang YZ, 2005, J BIOL CHEM, V280, P14230, DOI 10.1074/jbc.M413846200; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Weingarten-Gabbay S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4939; WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159; Wu JY, 2006, MOL CELL BIOL, V26, P6739, DOI 10.1128/MCB.00739-06; Yao ZZ, 2006, BIOINFORMATICS, V22, P445, DOI 10.1093/bioinformatics/btk008; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	83	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219210	10.1371/journal.pone.0219210	http://dx.doi.org/10.1371/journal.pone.0219210			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291322	Green Published, Green Submitted, gold			2022-12-26	WOS:000484947800057
J	De Schacht, C; Mutaquiha, C; Faria, F; Castro, G; Manaca, N; Manhica, I; Cowan, J				De Schacht, Caroline; Mutaquiha, Claudia; Faria, Felicidade; Castro, Georgina; Manaca, Nelia; Manhica, Ivan; Cowan, James			Barriers to access and adherence to tuberculosis services, as perceived by patients: A qualitative study in Mozambique	PLOS ONE			English	Article							RISK	Introduction Tuberculosis (TB) continues to be a leading cause of death in Sub-Saharan Africa, including Mozambique. While diagnostic methods and total notifications are improving, significant gaps remain between total numbers of TB cases annually, and the number that are notified. The purpose of this study was to elicit Mozambican patients with drug sensitive TB (DS-TB), TB/HIV and Multi drug resistant tuberculosis (MDR-TB) understanding and assessment of the quality of care for DS-TB, HIV/TB and MDR-TB services in Mozambique, along with challenges to effectively preventing, diagnosing and treating TB. Materials and methods Qualitative data was collected via separate focus group discussions consisting of patients with DS-TB, TB/HIV and MDR-TB at four health centers in Sofala and Manica Province, Mozambique, to describe knowledge on TB, HIV and MDR-TB, and identify barriers to access and adherence to services and their recommendations for improvement. A total of 51 patients participated in 11 discussions. Content analysis was done and main themes were identified. Results Focus groups shared a number of prominent themes. Respondents identified numerous challenges including delays in diagnosis, stigma related with diagnosis and treatment, long waits at health facilities, the absence of nutritional support for patients with TB, the absence of a comprehensive psychosocial support program, and the lack of overall knowledge about TB or multi drug resistant TB in the community. Discussion TB patients in central Mozambique identified many challenges to effectively preventing, diagnosing and treating tuberculosis. Awareness strengthening in the community, continuous quality monitoring and in-service training is needed to increase screening, diagnosis and treatment for TB, HIV/TB and MDR-TB.	[De Schacht, Caroline; Faria, Felicidade; Castro, Georgina; Manaca, Nelia; Cowan, James] Hlth Alliance Int, Maputo, Mozambique; [Mutaquiha, Claudia; Manhica, Ivan; Cowan, James] Mozambican Natl TB Program, Maputo, Mozambique; [Cowan, James] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [De Schacht, Caroline] Friends Global Hlth, Maputo, Mozambique	University of Washington; University of Washington Seattle	De Schacht, C (corresponding author), Hlth Alliance Int, Maputo, Mozambique.; De Schacht, C (corresponding author), Friends Global Hlth, Maputo, Mozambique.	carolineds11@gmail.com		De Schacht, Caroline/0000-0001-5384-2410; Cowan, James/0000-0001-8173-6164	Stop TB Partnership's TB REACH initiative - Government of Canada; University of Washington Center for AIDS Research (CFAR), an NIH - NIAID [AI027757]; University of Washington Center for AIDS Research (CFAR), an NIH - NCI [AI027757]; University of Washington Center for AIDS Research (CFAR), an NIH - NIMH [AI027757]; University of Washington Center for AIDS Research (CFAR), an NIH - NIDA [AI027757]; University of Washington Center for AIDS Research (CFAR), an NIH - NICHD [AI027757]; University of Washington Center for AIDS Research (CFAR), an NIH - NHLBI [AI027757]; University of Washington Center for AIDS Research (CFAR), an NIH - NIA [AI027757]; University of Washington Center for AIDS Research (CFAR), an NIH - NIGMS [AI027757]; University of Washington Center for AIDS Research (CFAR), an NIH - NIDDK [AI027757]; National TB program; Ministry of Health	Stop TB Partnership's TB REACH initiative - Government of Canada; University of Washington Center for AIDS Research (CFAR), an NIH - NIAID; University of Washington Center for AIDS Research (CFAR), an NIH - NCI; University of Washington Center for AIDS Research (CFAR), an NIH - NIMH; University of Washington Center for AIDS Research (CFAR), an NIH - NIDA; University of Washington Center for AIDS Research (CFAR), an NIH - NICHD; University of Washington Center for AIDS Research (CFAR), an NIH - NHLBI; University of Washington Center for AIDS Research (CFAR), an NIH - NIA; University of Washington Center for AIDS Research (CFAR), an NIH - NIGMS; University of Washington Center for AIDS Research (CFAR), an NIH - NIDDK; National TB program; Ministry of Health	This research was supported in part by a grant from the Stop TB Partnership's TB REACH initiative which was funded by the Government of Canada. This research was funded in part by a 2015 developmental grant from the University of Washington Center for AIDS Research (CFAR), an NIH funded program under award number AI027757 which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, NIDDK). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Stop TB partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the health facilities, districts, provincial health departments, the National TB program and the Ministry of Health for their support and collaboration with this project. Most importantly we want to thank the patients and the health care providers that participated in this study.	Asres M, 2017, AM J TROP MED HYG, V96, P1071, DOI 10.4269/ajtmh.16-0892; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burtscher D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152283; Cowan J, 2016, INT J TUBERC LUNG D, V20, P335, DOI 10.5588/ijtld.15.0535; Cowan J, 2015, B WORLD HEALTH ORGAN, V93, P125, DOI 10.2471/BLT.14.138560; da Silva RD, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4752-3; Daftary A, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000515; Deshmukh RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135802; INS INE ICF, 2015, INQ IND IMM MAL HIV; Kigozi NG, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4825-3; Kruk ME, 2018, LANCET, V392, P2170, DOI 10.1016/S0140-6736(18)31668-4; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Kyu HH, 2018, LANCET INFECT DIS, V18, P1329, DOI 10.1016/S1473-3099(18)30625-X; MoH-National TB Control Program, 2018, ACT REP 2017; Ngwenya N, 2018, AJAR-AFR J AIDS RES, V17, P72, DOI 10.2989/16085906.2017.1415214; Noe A, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-016-0344-8; Paramasivam Selvam, 2017, J Family Med Prim Care, V6, P643, DOI 10.4103/2249-4863.222052; Saifodine A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-559; Shringarpure KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150849; Skinner D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2054-5; Sullivan BJ, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1290317; Tulloch O, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1523-x; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; World Health Organization, 2013, XPERT MTB RIF ASS DI	24	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219470	10.1371/journal.pone.0219470	http://dx.doi.org/10.1371/journal.pone.0219470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291352	Green Submitted, gold, Green Published			2022-12-26	WOS:000484947800093
J	Skorski, M; Bamunusinghe, D; Liu, QP; Shaffer, E; Kozak, CA				Skorski, Matthew; Bamunusinghe, Devinka; Liu, Qingping; Shaffer, Esther; Kozak, Christine A.			Distribution of endogenous gammaretroviruses and variants of the Fv1 restriction gene in individual mouse strains and strain subgroups	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; HOST-RANGE RESTRICTIONS; FOCUS-FORMING VIRUSES; ECOTROPIC PROVIRUS; XENOTROPIC GAMMARETROVIRUSES; SUBSPECIFIC ORIGIN; LABORATORY MOUSE; INBRED STRAINS; MICE; EXPRESSION	Inbred laboratory mouse strains carry endogenous retroviruses (ERVs) classed as ecotropic, xenotropic or polytropic mouse leukemia viruses (E-, X-or P-MLVs). Some of these MLV ERVs produce infectious virus and/or contribute to the generation of intersubgroup recombinants. Analyses of selected mouse strains have linked the appearance of MLVs and virus-induced disease to the strain complement of MLV E-ERVs and to host genes that restrict MLVs, particularly Fv1. Here we screened inbred strain DNAs and genome assemblies to describe the distribution patterns of 45 MLV ERVs and Fv1 alleles in 58 classical inbred strains grouped in two ways: by common ancestry to describe ERV inheritance patterns, and by incidence of MLV-associated lymphomagenesis. Each strain carries a unique set of ERVs, and individual ERVs are present in 5-96% of the strains, often showing line-age-specific distributions. Two ERVs are alternatively present as full-length proviruses or solo long terminal repeats. High disease incidence strains carry the permissive Fv1(n) allele, tested strains have highly expressed E-ERVs and most have the Bxv1 X-ERV; these three features are not present together in any low-moderate disease strain. The P-ERVs previously implicated in P-MLV generation are not preferentially found in high leukemia strains, but the three Fv1 alleles that restrict inbred strain E-MLVs are found only in low-moderate leukemia strains. This dataset helps define the genetic basis of strain differences in spontaneous lymphomagenesis, describes the distribution of MLV ERVs in strains with shared ancestry, and should help annotate sequenced strain genomes for these insertionally polymorphic and functionally important proviruses.	[Skorski, Matthew; Bamunusinghe, Devinka; Liu, Qingping; Shaffer, Esther; Kozak, Christine A.] NIAID, Mol Microbiol Lab, Bethesda, MD 20892 USA; [Bamunusinghe, Devinka] Qiagen, Germantown, MD USA; [Liu, Qingping] NIAID, Res Technol Branch, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kozak, CA (corresponding author), NIAID, Mol Microbiol Lab, Bethesda, MD 20892 USA.	ckozak@niaid.nih.gov			Intramural Research Program of the National Institute of Allergy and Infectious Diseases, Bethesda, MD [AI000300-37]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000300] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, Bethesda, MD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding to CAK, Grant: AI000300-37, Intramural Research Program of the National Institute of Allergy and Infectious Diseases, Bethesda, MD, https://www.niaid.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Baliji S, 2010, J VIROL, V84, P12841, DOI 10.1128/JVI.01863-10; Bamunusinghe D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080418; Bamunusinghe D, 2017, J VIROL, V91, DOI 10.1128/JVI.00855-17; Bamunusinghe D, 2016, J VIROL, V90, P4186, DOI 10.1128/JVI.03186-15; Bamunusinghe D, 2013, J VIROL, V87, P9845, DOI 10.1128/JVI.01264-13; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BEDIGIAN HG, 1983, J VIROL, V46, P490, DOI 10.1128/JVI.46.2.490-497.1983; Belshaw R, 2007, J VIROL, V81, P9437, DOI 10.1128/JVI.02216-06; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Blake JA, 2017, NUCLEIC ACIDS RES, V45, pD723, DOI 10.1093/nar/gkw1040; Brayton CF, 2012, VET PATHOL, V49, P85, DOI 10.1177/0300985811430696; Bult CJ, 2015, NUCLEIC ACIDS RES, V43, pD818, DOI 10.1093/nar/gku987; Carp RI, 2002, MECH AGEING DEV, V123, P575, DOI 10.1016/S0047-6374(01)00377-3; CHATTOPADHYAY SK, 1982, NATURE, V295, P25, DOI 10.1038/295025a0; CLOYD MW, 1980, J EXP MED, V151, P542, DOI 10.1084/jem.151.3.542; COPELAND NG, 1988, J VIROL, V62, P479, DOI 10.1128/JVI.62.2.479-487.1988; COPELAND NG, 1983, CELL, V33, P379, DOI 10.1016/0092-8674(83)90419-1; EVANS LH, 1986, VIROLOGY, V153, P122, DOI 10.1016/0042-6822(86)90013-9; Festing MF, 1996, GENETIC VARIANTS STR, P1537; FRANKEL WN, 1989, J VIROL, V63, P1763, DOI 10.1128/JVI.63.4.1763-1774.1989; FRANKEL WN, 1990, GENETICS, V124, P221; FREDRICKSON TN, 1984, J NATL CANCER I, V73, P521, DOI 10.1093/jnci/73.2.521; FREED EO, 1987, J VIROL, V61, P2852, DOI 10.1128/JVI.61.9.2852-2856.1987; Gemmell P, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004964; GILBERT DJ, 1993, J VIROL, V67, P2083, DOI 10.1128/JVI.67.4.2083-2090.1993; GROSS L, 1951, P SOC EXP BIOL MED, V76, P27; HARTLEY JW, 1970, J VIROL, V5, P221, DOI 10.1128/JVI.5.2.221-225.1970; HARTLEY JW, 1975, VIROLOGY, V65, P128, DOI 10.1016/0042-6822(75)90013-6; HESTON WE, 1971, INT J CANCER, V7, P141, DOI 10.1002/ijc.2910070116; HOGGAN MD, 1986, J VIROL, V60, P980, DOI 10.1128/JVI.60.3.980-986.1986; HOROWITZ JM, 1985, J VIROL, V56, P798, DOI 10.1128/JVI.56.3.798-806.1985; IHLE JN, 1979, SCIENCE, V204, P71, DOI 10.1126/science.219476; Ikeda H, 2001, J VIROL, V75, P5049, DOI 10.1128/JVI.75.11.5049-5058.2001; Ito K, 2013, J AUTOIMMUN, V43, P10, DOI 10.1016/j.jaut.2013.01.014; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Katzourakis A, 2007, J VIROL, V81, P10712, DOI 10.1128/JVI.00410-07; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KHAN AS, 1982, J VIROL, V44, P625, DOI 10.1128/JVI.44.2.625-636.1982; KIKUTANI H, 1992, ADV IMMUNOL, V51, P285, DOI 10.1016/S0065-2776(08)60490-3; KOZAK CA, 1979, SCIENCE, V204, P69, DOI 10.1126/science.219475; KOZAK CA, 1987, J VIROL, V61, P3082, DOI 10.1128/JVI.61.10.3082-3088.1987; Kozak CA, 1996, VIROLOGY, V225, P300, DOI 10.1006/viro.1996.0604; KOZAK CA, 1985, J VIROL, V55, P281, DOI 10.1128/JVI.55.2.281-285.1985; KOZAK CA, 1982, J EXP MED, V155, P524, DOI 10.1084/jem.155.2.524; KOZAK CA, 1980, J EXP MED, V152, P219, DOI 10.1084/jem.152.1.219; Kozak CA, 2015, VIRUSES-BASEL, V7, P1, DOI 10.3390/v7010001; Kozak CA, 2013, CURR OPIN VIROL, V3, P657, DOI 10.1016/j.coviro.2013.08.001; LEE EJ, 1984, J VIROL, V51, P247, DOI 10.1128/JVI.51.1.247-250.1984; LEVIS R, 1982, CELL, V30, P543, DOI 10.1016/0092-8674(82)90251-3; LILLY F, 1967, SCIENCE, V155, P461, DOI 10.1126/science.155.3761.461; Lilue JT, 2018, NAT GENET, V50, P1574, DOI 10.1038/s41588-018-0223-8; Loeb L., 1907, U PENNSYLVANIA MED B, VXX, P2; LUNG ML, 1983, J VIROL, V45, P275, DOI 10.1128/JVI.45.1.275-290.1983; MacHattie LA, 1977, DNA INSERTION ELEMEN, P219; MORSE HC, 1985, CELL, V41, P439, DOI 10.1016/S0092-8674(85)80017-9; MORSE HC, 1978, ORIGINS INBRED MICE, P1; Murphy ED, 1968, BIOL LAB MOUSE; Nellaker C, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r45; NOWINSKI RC, 1968, VIROLOGY, V34, P617, DOI 10.1016/0042-6822(68)90083-4; OIE HK, 1976, J NATL CANCER I, V56, P423, DOI 10.1093/jnci/56.2.423; PATTENGALE PK, 1983, AM J PATHOL, V113, P235; QUINT W, 1984, J VIROL, V50, P432, DOI 10.1128/JVI.50.2.432-438.1984; ROEDER GS, 1980, SCIENCE, V209, P1375, DOI 10.1126/science.6251544; ROWE WP, 1983, J EXP MED, V158, P353, DOI 10.1084/jem.158.2.353; ROWE WP, 1972, SCIENCE, V178, P860, DOI 10.1126/science.178.4063.860; ROWE WP, 1970, VIROLOGY, V42, P1136, DOI 10.1016/0042-6822(70)90362-4; ROWE WP, 1972, J EXP MED, V136, P1286, DOI 10.1084/jem.136.5.1286; RUDALI G, 1956, CR HEBD ACAD SCI, V242, P837; SHERR CJ, 1974, CELL, V1, P55, DOI 10.1016/0092-8674(74)90155-X; SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195; SPECK NA, 1990, GENE DEV, V4, P233, DOI 10.1101/gad.4.2.233; STEEVES R, 1977, ANNU REV GENET, V11, P277, DOI 10.1146/annurev.ge.11.120177.001425; Stevens A, 2004, J VIROL, V78, P9592, DOI 10.1128/JVI.78.18.9592-9598.2004; STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404; STOYE JP, 1987, J VIROL, V61, P2659, DOI 10.1128/JVI.61.9.2659-2669.1987; STOYE JP, 1991, J VIROL, V65, P1273, DOI 10.1128/JVI.65.3.1273-1285.1991; Taddesse-Heath L, 2000, J VIROL, V74, P6832, DOI 10.1128/JVI.74.15.6832-6837.2000; Tailor CS, 1999, P NATL ACAD SCI USA, V96, P927, DOI 10.1073/pnas.96.3.927; Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X; TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1; Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8; Tanisawa K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-248; Triviai I, 2014, P NATL ACAD SCI USA, V111, P8595, DOI 10.1073/pnas.1401215111; VARMUS HE, 1981, CELL, V25, P23, DOI 10.1016/0092-8674(81)90228-2; Wang JR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S3-S13; Ward JM, 2006, EXP TOXICOL PATHOL, V57, P377, DOI 10.1016/j.etp.2006.01.007; WARE LM, 1972, VIROLOGY, V50, P339, DOI 10.1016/0042-6822(72)90385-6; Yan YH, 2010, J VIROL, V84, P11970, DOI 10.1128/JVI.01549-10; Yan Y, 2009, P NATL ACAD SCI USA, V106, P3259, DOI 10.1073/pnas.0900181106; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; Yap MW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003968; YONEKAWA H, 1988, MOL BIOL EVOL, V5, P63; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	97	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219576	10.1371/journal.pone.0219576	http://dx.doi.org/10.1371/journal.pone.0219576			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291374	gold, Green Published, Green Submitted			2022-12-26	WOS:000484947800120
J	Wang, N; Wang, ZY; Qin, ZZ; Ye, Q; Jia, P; Xu, Z; Xiong, YQ; Xu, F				Wang, Na; Wang, Zhiyong; Qin, Zhenzhen; Ye, Qing; Jia, Peng; Xu, Zhen; Xiong, Yaqing; Xu, Fei			y Residential density was negatively associated with excess body weight among adults in an urban region of China	PLOS ONE			English	Article							BUILT ENVIRONMENT; PHYSICAL-ACTIVITY; NEIGHBORHOOD ENVIRONMENT; RISK-FACTORS; OBESITY; OVERWEIGHT; HEALTH; SPRAWL; COMMUNITIES; PREVALENCE	Background Residential density was found to be associated with excess body weight among adults in Western societies but it remains unclear in China. We aimed to explore the relationship between residential density and excess body weight among adults in China. Methods This cross-sectional study was conducted in 2017 in urban areas of Nanjing, China. A multi-stage sampling method was used to randomly select participants aged 35-74 years from 8 urban neighborhoods in Nanjing. Status of excess body weight was the outcome variable which was categorized as "yes (BMI >= 24)" or "no (BMI<24)" according to specific recommendations for Chinese adults. Residential density was the main explanatory variable which was grouped into tertiles. Odds ratios (OR) and 95% confidence interval (CIs) were calculated to assess the relationship between residential density and excess body weight using mixed-effects regression models after adjusting for age, sex, education, occupation, marital status, redmeat, smoking, physical activity, diabetic status and potential neighborhood-level clustering effect. Results A total of 1551 participants were recruited with a response rate of 98.9% (1551/1568). The mean age (standard deviation) of participants was 54.7 (11.1) years, and 46% of them were men. With adjustment for potential influential factors, participants in neighborhoods with lower (OR = 1.38, 95% CI = 1.06-1.81) and middle (OR = 1.29, 95% CI = 1.01, 1.64) tertile of residential density were at significantly higher risk of gaining excess body weight relative to their counterparts in communities with upper tertile of residential density. Such a negative association between residential density and excess body weight was observed for men only after stratified analysis by gender. Conclusions A negative association between residential density and excess body weight was identified in overall and male urban Chinese adults, and the association was independent of physical activity. Results of our study have important implications in guiding public health policy making regarding prevention of excess body weight at community level via establishment of health-friendly neighborhood environment in China.	[Wang, Na; Wang, Zhiyong; Qin, Zhenzhen; Ye, Qing; Xu, Fei] Nanjing Municipal Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Jia, Peng; Xu, Fei] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, Dept Earth Observat Sci, GeoHlth Initiat, Enschede, Netherlands; [Jia, Peng; Xu, Fei] Int Initiat Spatial Lifecourse Epidemiol ISLE, Enschede, Netherlands; [Xu, Zhen] Nanjing Forestry Univ, Coll Landscape Architecture, Nanjing, Jiangsu, Peoples R China; [Xiong, Yaqing] Jiangsu Prov Official Hosp, Nanjing, Jiangsu, Peoples R China; [Xu, Fei] Nanjing Med Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	University of Twente; Nanjing Forestry University; Nanjing Medical University	Xu, F (corresponding author), Nanjing Municipal Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.; Xu, F (corresponding author), Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, Dept Earth Observat Sci, GeoHlth Initiat, Enschede, Netherlands.; Xu, F (corresponding author), Int Initiat Spatial Lifecourse Epidemiol ISLE, Enschede, Netherlands.; Xiong, YQ (corresponding author), Jiangsu Prov Official Hosp, Nanjing, Jiangsu, Peoples R China.; Xu, F (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China.	xiongyaqingnj@126.com; frankxufei@163.com	Jia, Peng/K-1446-2017	Jia, Peng/0000-0003-0110-3637	Nanjing Medical Science and technique Development Foundation [QRX11038, JSKXKT2018]; Foundation of Jiangsu Province Association of Science and Technology	Nanjing Medical Science and technique Development Foundation; Foundation of Jiangsu Province Association of Science and Technology	The study was supported by Nanjing Medical Science and technique Development Foundation (QRX11038). Prof. Yaqing Xiong was supported by a Program Grant (JSKXKT2018) from Foundation of Jiangsu Province Association of Science and Technology.	ALEXANDER ER, 1993, J ARCHIT PLAN RES, V10, P181; Alexander FE, 1999, EUR J CANCER, V35, P439, DOI 10.1016/S0959-8049(98)00385-2; [Anonymous], 2006, GUID PREV CONTR OV O; [Anonymous], 2002, WORLD HLTH REPORT 20; Booth KM, 2005, J AM DIET ASSOC, V105, pS110, DOI 10.1016/j.jada.2005.02.045; Churchman A., 1999, J PLAN LIT, V13, P389, DOI [10.1177/08854129922092478, DOI 10.1177/08854129922092478]; Doyle S, 2006, J AM PLANN ASSOC, V72, P19, DOI 10.1080/01944360608976721; Ewing R, 2003, AM J HEALTH PROMOT, V18, P47, DOI 10.4278/0890-1171-18.1.47; Ewing R, 2010, J AM PLANN ASSOC, V76, P265, DOI 10.1080/01944361003766766; Forsyth A, 2007, URBAN STUD, V44, P679, DOI 10.1080/00420980601184729; Frank LD, 2000, J PLAN EDUC RES, V20, P6, DOI 10.1177/073945600128992564; Garden FL, 2009, J URBAN HEALTH, V86, P19, DOI 10.1007/s11524-008-9332-5; Hajna S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2082-x; Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; International Physical Activity Prevalence Study, SELF ADM ENV MOD; Kelly-Schwartz AC, 2004, J PLAN EDUC RES, V24, P184, DOI 10.1177/0739456X04267713; Lopez R, 2004, AM J PUBLIC HEALTH, V94, P1574, DOI 10.2105/AJPH.94.9.1574; Lopez RP, 2007, OBESITY, V15, P2111, DOI 10.1038/oby.2007.251; Lopez-Zetina J, 2006, HEALTH PLACE, V12, P656, DOI 10.1016/j.healthplace.2005.09.001; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; *NANJ MUN BUR STAT, STAT YB NANJ; Nanjing Municipal Bureau of Statistics, 2017, STAT YB NANJ; Organization WH, 1998, WELLB MEAS PRIM HLTH; Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009; Pendola R, 2007, HEALTH PLACE, V13, P551, DOI 10.1016/j.healthplace.2006.02.004; Qu Ning-ning, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P265; Rundle A, 2007, AM J HEALTH PROMOT, V10, P19; Rutt CD, 2005, PREV MED, V40, P831, DOI 10.1016/j.ypmed.2004.09.035; Saelens BE, 2012, MED SCI SPORT EXER, V44, P637, DOI 10.1249/MSS.0b013e318237fe18; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Srinivasan S, 2003, AM J PUBLIC HEALTH, V93, P1446, DOI 10.2105/AJPH.93.9.1446; U. S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Van Holle V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-807; Xu F, 2005, PUBLIC HEALTH NUTR, V8, P47, DOI 10.1079/PHN2004653; Xu F, 2007, ASIA-PAC J PUBLIC HE, V19, P3, DOI 10.1177/101053950701900302; Xu F, 2007, ASIA PAC J CLIN NUTR, V16, P240; Xu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088719; Xu F, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2009.094169; Zhao L, 2018, PUBLIC HEALTH, V156, P1, DOI 10.1016/j.puhe.2017.12.003; Zhao WH, 2002, PUBLIC HEALTH NUTR, V5, P829, DOI 10.1079/PHN2002374	43	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219314	10.1371/journal.pone.0219314	http://dx.doi.org/10.1371/journal.pone.0219314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4JZ	31291295	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800072
J	Licata, M; Gennaro, MC; Tuttolomondo, T; Leto, C; La Bella, S				Licata, Mario; Gennaro, Maria Cristina; Tuttolomondo, Teresa; Leto, Claudio; La Bella, Salvatore			Research focusing on plant performance in constructed wetlands and agronomic application of treated wastewater - A set of experimental studies in Sicily (Italy)	PLOS ONE			English	Article							HORIZONTAL SUBSURFACE FLOW; CYPERUS-ALTERNIFOLIUS L.; ARUNDO-DONAX L.; POLLUTANT REMOVAL EFFICIENCY; TYPHA-LATIFOLIA L.; PHRAGMITES-AUSTRALIS; ENERGY CROPS; 2-YEAR TESTS; IRRIGATION; EVAPOTRANSPIRATION	Constructed wetlands are sustainable technologies for the treatment of wastewater. These biological systems have been widely studied throughout the world for more than 30 years; however, most studies have focused on the effects of design and engineering on pollutant removal from wastewater. Undoubtedly, agro-technical aspects have been given too little consideration by research. This paper reports the main results of a set of experiments carried out on two pilot horizontal subsurface flow systems in Sicily (Italy). Festuca, Lolium and Pennisetum spp. in combination and three emergent macrophytes-Arundo donax L., Cyperus alternifolius L. and Typha latifolia L.-alone, were assessed. The aim of the study was to demonstrate that, under predetermined hydraulic and design conditions, the choice of plant species and the management of the vegetation can significantly affect the pollutant removal performance of constructed wetlands. In addition, wastewater (after treatment) can also be used for agricultural purposes leading to increased sustainability in agricultural systems. Arundo and Typha-planted units performed better than Cyperus-planted units in terms of chemical, physical and microbiological contaminant removal. All the species adapted extremely well to wetland conditions. Polyculture systems were found to be more efficient than monocultures in the removal of dissolved organic compounds. The reuse of treated wastewater for the irrigation of open fields and horticultural crops led to significant savings in the use of freshwater and fertilizers. The results of physical-energy characterization of A. donax above-ground plant residues and pellets highlighted the fact that a constructed wetland could also be a potential source of bioenergy.	[Licata, Mario; Gennaro, Maria Cristina; Tuttolomondo, Teresa; Leto, Claudio; La Bella, Salvatore] Univ Palermo, Dept Agr Food & Forest Sci, Palermo, Italy; [Licata, Mario; Tuttolomondo, Teresa; Leto, Claudio; La Bella, Salvatore] Res Consortium Dev Innovat Agroenvironm Syst, Palermo, Italy	University of Palermo	Tuttolomondo, T (corresponding author), Univ Palermo, Dept Agr Food & Forest Sci, Palermo, Italy.; Tuttolomondo, T (corresponding author), Res Consortium Dev Innovat Agroenvironm Syst, Palermo, Italy.	teresa.tuttolomondo@unipa.it			Sicilian Regional Ministry of Food and Agricultural Resources [D71D04000000008]	Sicilian Regional Ministry of Food and Agricultural Resources	Title of the project: Tecnologie innovative per l'impiego di acque "non convenzionali" e prevenzione della desertificazione; this work was funded by Grant numbers: D71D04000000008; Full name of the funder: Sicilian Regional Ministry of Food and Agricultural Resources, URL website: https://caronte.regione.sicilia.it/cms/operations/1866. The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello R, 2007, AGR WATER MANAGE, V93, P65, DOI 10.1016/j.agwat.2007.06.008; Akponikpe PBI, 2011, AGR WATER MANAGE, V98, P834, DOI 10.1016/j.agwat.2010.12.009; Akratos CS, 2007, ECOL ENG, V29, P173, DOI 10.1016/j.ecoleng.2006.06.013; Al-Lahham O, 2003, AGR WATER MANAGE, V61, P51, DOI 10.1016/S0378-3774(02)00173-7; Allen R.G., 1998, FAO IRRIGATION DRAIN, DOI DOI 10.1016/J.EJA.2010.12.001; Angelini LG, 2009, BIOMASS BIOENERG, V33, P635, DOI 10.1016/j.biombioe.2008.10.005; [Anonymous], 151032010 UNI EN; [Anonymous], 149182010 UNI EN; [Anonymous], 1477422010 UNI EN; [Anonymous], 2017, STANDARD METHODS EXA; [Anonymous], 147752010 UNI EN; Avellan CT, 2017, WATER SCI TECHNOL, V75, P2237, DOI 10.2166/wst.2017.106; Ayers RS, 1985, WATER QUALITY AGR; Beebe DA, 2014, ECOL ENG, V71, P394, DOI 10.1016/j.ecoleng.2014.07.052; Bialowiec A, 2014, ECOL ENG, V67, P89, DOI 10.1016/j.ecoleng.2014.03.032; Bialowiec A, 2012, ECOL ENG, V40, P44, DOI 10.1016/j.ecoleng.2011.12.011; Borin M, 2011, ECOL ENG, V37, P721, DOI 10.1016/j.ecoleng.2010.05.003; Calheiros CSC, 2008, BIORESOURCE TECHNOL, V99, P6866, DOI 10.1016/j.biortech.2008.01.043; Castro E, 2011, WATER SCI TECHNOL, V63, P1678, DOI 10.2166/wst.2011.335; Cirelli GL, 2012, AGR WATER MANAGE, V104, P163, DOI 10.1016/j.agwat.2011.12.011; Cirelli GL, 2007, WATER SCI TECHNOL, V56, P183, DOI 10.2166/wst.2007.498; Ciria MP, 2005, BIOSYST ENG, V92, P535, DOI 10.1016/j.biosystemseng.2005.08.007; Cosentino SL, 2006, IND CROP PROD, V23, P212, DOI 10.1016/j.indcrop.2005.06.004; Dahl J., 2004, 2 WORLD C BIOM EN IN, P1265; Evanylo G, 2010, WATER-SUI, V2, P685, DOI 10.3390/w2030685; Gaetani M, 2017, ITAL J AGRON, V12, P110, DOI 10.4081/ija.2017.808; Gatta G, 2015, AGR WATER MANAGE, V149, P33, DOI 10.1016/j.agwat.2014.10.016; Harivandi MA, 2008, ACTA HORTIC, P215, DOI 10.17660/ActaHortic.2008.783.21; Headley TR, 2012, WATER RES, V46, P345, DOI 10.1016/j.watres.2011.10.042; Idris S, 2012, ENVIRON SCI POLLUT R, V19, P1159, DOI 10.1007/s11356-011-0642-x; Italian Environmental Protection Agency and Italian Water Research Institute-National Research Council (APAT and IRSA-CNR), 2004, AN METH WAT; IWA Specialist Group, 2000, CONSTR WETL POLL CON, P41; Jensen M. E., 1990, ASCE MANUALS REPORTS; Jinadasa KBSN, 2008, J ENVIRON SCI HEAL A, V43, P664, DOI 10.1080/10934520801893808; Karathanasis AD, 2003, ECOL ENG, V20, P157, DOI 10.1016/S0925-8574(03)00011-9; La Bella S, 2016, DESALIN WATER TREAT, V57, P22743, DOI 10.1080/19443994.2016.1173384; Laurent A, 2015, RENEW SUST ENERG REV, V46, P41, DOI 10.1016/j.rser.2015.02.023; Leto C, 2008, ACTA HORTIC, P39, DOI 10.17660/ActaHortic.2008.783.3; Leto C, 2004, ACTA HORTIC, P393, DOI 10.17660/ActaHortic.2004.661.54; Leto C, 2013, ECOL ENG, V61, P282, DOI 10.1016/j.ecoleng.2013.09.014; Leto C, 2013, DESALIN WATER TREAT, V51, P7447, DOI 10.1080/19443994.2013.792134; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Liang MQ, 2011, ECOL ENG, V37, P309, DOI 10.1016/j.ecoleng.2010.11.018; Libutti A, 2018, AGR WATER MANAGE, V196, P1, DOI 10.1016/j.agwat.2017.10.015; Licata M, 2017, WATER SCI TECHNOL, V76, P459, DOI 10.2166/wst.2017.221; Licata M, 2017, DESALIN WATER TREAT, V73, P422, DOI 10.5004/dwt.2017.20519; Licata M, 2016, DESALIN WATER TREAT, V57, P23343, DOI 10.1080/19443994.2016.1180479; Liu D, 2012, NAT CLIM CHANGE, V2, P190, DOI 10.1038/NCLIMATE1370; Leiva AM, 2018, ECOL ENG, V120, P116, DOI 10.1016/j.ecoleng.2018.05.023; MCCARTY LB, 2001, BEST GOLF COURSE MAN; Mengel K, 1982, Principles of plant nutrition.; Milani M, 2013, J ENVIRON SCI HEAL A, V48, P568, DOI 10.1080/10934529.2013.730457; Nassi o Di Nasso N., 2011, ITAL J AGRON, V6, P152, DOI DOI 10.4081/IJA.2011.E22; Papaevangelou V, 2016, ENVIRON SCI POLLUT R, V23, P19504, DOI 10.1007/s11356-016-7162-7; Pedescoll A, 2013, ECOL ENG, V58, P335, DOI 10.1016/j.ecoleng.2013.07.007; Pedrero F, 2010, AGR WATER MANAGE, V97, P1233, DOI 10.1016/j.agwat.2010.03.003; Rodriguez M, 2016, ECOL ENG, V91, P302, DOI 10.1016/j.ecoleng.2016.02.047; Rusan MJM, 2007, DESALINATION, V215, P143, DOI 10.1016/j.desal.2006.10.032; Shelef O, 2013, WATER-SUI, V5, P405, DOI 10.3390/w5020405; Stottmeister U, 2003, BIOTECHNOL ADV, V22, P93, DOI 10.1016/j.biotechadv.2003.08.010; Turgeon AJ, 2004, TURFGRASS MANAGEMENT, P59; Tuttolomondo T, 2016, ECOL ENG, V87, P295, DOI 10.1016/j.ecoleng.2015.11.036; Tuttolomondo T, 2015, ECOL ENG, V74, P79, DOI 10.1016/j.ecoleng.2014.10.020; Vymazal J, 2005, ECOL ENG, V25, P606, DOI 10.1016/j.ecoleng.2005.07.005; Vymazal J, 2005, ECOL ENG, V25, P478, DOI 10.1016/j.ecoleng.2005.07.010; Vymazal J, 2013, ECOL ENG, V61, P501, DOI 10.1016/j.ecoleng.2013.10.035; Vymazal J, 2011, HYDROBIOLOGIA, V674, P133, DOI 10.1007/s10750-011-0738-9; Wang YC, 2011, BIOMASS BIOENERG, V35, P50, DOI 10.1016/j.biombioe.2010.08.032; Weerakoon GMPR, 2013, ECOL ENG, V61, P154, DOI 10.1016/j.ecoleng.2013.09.016; Yang ZY, 2016, CLIN COSMET INVESTIG, V8, P1, DOI 10.2147/CCIDE.S95660; Zema DA, 2012, AGR WATER MANAGE, V115, P55, DOI 10.1016/j.agwat.2012.08.009; Zhang DQ, 2014, J ENVIRON MANAGE, V141, P116, DOI 10.1016/j.jenvman.2014.03.015; Zhu SX, 2010, ECOL ENG, V36, P1307, DOI 10.1016/j.ecoleng.2010.06.007	73	27	27	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2019	14	7							e0219445	10.1371/journal.pone.0219445	http://dx.doi.org/10.1371/journal.pone.0219445			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7KI	31287836	Green Published, Green Submitted, gold			2022-12-26	WOS:000482328300021
J	Ma, P; Zhang, ZM; Zhou, XY; Luo, JK; Lu, HM; Wang, Y				Ma, Pan; Zhang, Zhimin; Zhou, Xinyi; Luo, Jiekun; Lu, Hongmei; Wang, Yang			Characterizing semen abnormality male infertility using non-targeted blood plasma metabolomics	PLOS ONE			English	Article							OXIDATIVE STRESS; QUALITY; ACID; MEN; BIOMARKERS; VARICOCELE; DIAGNOSIS; MCT2; TOOL	Semen abnormality (SA) male infertility has become a worldwide reproductive health problem. The invasive tests (e.g., testicular biopsy) and labor-intensive methods of semen collection severely inhibit diagnosis of male infertility. In addition, the pathogenesis and biological interpretation of male infertility are still obscure. In this report, a total of 84 semen abnormality (SA) patients, diagnosed as teratozoospermia (TE, n = 21), asthenozoospermia (AS, n = 23), oligozoospermia (OL, n = 20), azoospermia (AZ, n = 20), and age-matched healthy controls (HC, n = 29) were analyzed by GC-MS for discrimination analysis and discovery of potential biomarkers. Twenty-three biomarkers were obtained by multivariate statistical method (partial least squares-discriminant analysis, PLS-DA) and univariate statistical method (analysis of variance, ANOVA) with comparisons of TE versus HC, AS versus HC, OL versus HC and AZ versus HC. Based on those biomarkers, the most relevant pathways were mainly associated with the metabolism of carbohydrates, amino acids, and lipids. The principal metabolic alternations in SA male infertility included increased levels of energy-related metabolisms, such as tricarboxylic acid cycle, pyruvate metabolism, glyoxylate and dicarboxylate metabolism, glycine, serine, threonine metabolism and saturated fatty acid metabolism. Furthermore, increased levels of glutathione metabolism were related to oxidative stress. Finally, decreased levels of arginine and proline metabolism and inositol phosphate metabolism were observed. In conclusion, blood plasma metabolomics is powerful for characterizing metabolic disturbances in SA male infertility. From metabolic pathway analysis, energy production, oxidation stress and the released enzyme during spermatogenesis take the primary responsibilities for SA male infertility.	[Ma, Pan; Zhang, Zhimin; Zhou, Xinyi; Lu, Hongmei] Cent S Univ, Coll Chem & Chem Engn, Changsha, Hunan, Peoples R China; [Luo, Jiekun; Wang, Yang] Cent S Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, Changsha, Hunan, Peoples R China	Central South University; Central South University	Lu, HM (corresponding author), Cent S Univ, Coll Chem & Chem Engn, Changsha, Hunan, Peoples R China.; Wang, Y (corresponding author), Cent S Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, Changsha, Hunan, Peoples R China.	hongmeilu@csu.edu.cn; wangyang_xy87@163.com			National Natural Science Foundation of China [21675174, 21873116, 81774322]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China. Grant numbers awarded to HM. L includes 21675174 and 21873116. Grant numbers awarded to JK. L includes 81774322. All these funds can be found at website: https://isisn.nsfc.gov.cn/egrantweb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration FA (USFDA), 2001, FED REGISTER, V66, P206; Agarwal A, 2006, FERTIL STERIL, V86, pS180, DOI 10.1016/j.fertnstert.2006.07.477; Attaman JA, 2012, HUM REPROD, V27, P1466, DOI 10.1093/humrep/des065; Aydin S., 1995, International Urology and Nephrology, V27, P199, DOI 10.1007/BF02551320; Callister LC, 2010, MCN-AM J MATERN-CHIL, V35, P174, DOI 10.1097/NMC.0b013e3181d760be; Chen YR, 2015, J CANCER RES CLIN, V141, P705, DOI 10.1007/s00432-014-1846-5; Condorelli RA, 2012, UROLOGY, V79, P1290, DOI 10.1016/j.urology.2012.03.005; Courant F, 2013, J PROTEOME RES, V12, P2914, DOI 10.1021/pr400204q; Deepinder F, 2007, EXPERT REV MOL DIAGN, V7, P351, DOI 10.1586/14737159.7.4.351; Drabovich AP, 2014, NAT REV UROL, V11, P278, DOI 10.1038/nrurol.2014.74; Eslamian G, 2015, FERTIL STERIL, V103, P190, DOI 10.1016/j.fertnstert.2014.10.010; Esteves SC, 2011, CLINICS, V66, P691, DOI 10.1590/S1807-59322011000400026; Ficarra V, 2012, CURR OPIN UROL, V22, P489, DOI 10.1097/MOU.0b013e328358e115; Fraczek M, 2001, Ginekol Pol, V72, P73; Gatta V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-401; Hussein A, 2013, FERTIL STERIL, V100, P88, DOI 10.1016/j.fertnstert.2013.03.022; Imhof M., 2012, e-SPEN Journal, V7, pe50; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kliesch S, 2014, EUR UROL SUPPL, V13, P73, DOI 10.1016/j.eursup.2014.08.002; Kovac JR, 2013, FERTIL STERIL, V99, P998, DOI 10.1016/j.fertnstert.2013.01.111; Lee J, 2014, ASIAN J ANDROL, V16, P694, DOI 10.4103/1008-682X.124561; LENZI A, 1993, HUM REPROD, V8, P1657, DOI 10.1093/oxfordjournals.humrep.a137909; Ma P, 2016, RSC ADV, V6, P113997, DOI 10.1039/c6ra17864b; Mannowetz N, 2012, J CELL PHYSIOL, V227, P2154, DOI 10.1002/jcp.22949; Nallella KP, 2006, FERTIL STERIL, V85, P629, DOI 10.1016/j.fertnstert.2005.08.024; Organization WH, 2010, WHO LAB MAN EX PROC; Phytomed AJ, AM J PHYTOMEDICINE C; PURSEL VG, 1969, J REPROD FERTIL, V18, P176; Schlegel PN, 1997, HUM REPROD, V12, P1688, DOI 10.1093/humrep/12.8.1688; Shamsi MB, 2009, MUTAT RES-FUND MOL M, V665, P29, DOI 10.1016/j.mrfmmm.2009.02.017; Sharma RK, 1996, UROLOGY, V48, P835, DOI 10.1016/S0090-4295(96)00313-5; Sheweita SA, 2005, CURR DRUG METAB, V6, P495, DOI 10.2174/138920005774330594; Silber SJ, 1997, HUM REPROD, V12, P2422, DOI 10.1093/humrep/12.11.2422; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Vriese S.R.D., 2003, MALE FERTILITY LIPID; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Yousef MI, 2003, ANIM REPROD SCI, V76, P99, DOI 10.1016/S0378-4320(02)00226-9; Zhang J, 2014, FERTIL STERIL, V102, P44, DOI 10.1016/j.fertnstert.2014.03.033; Zhang J, 2014, J PROTEOME RES, V13, P3088, DOI 10.1021/pr5003142; Zhou XY, 2016, TALANTA, V147, P82, DOI 10.1016/j.talanta.2015.09.040; Zini A, 2000, FERTIL STERIL, V74, P461, DOI 10.1016/S0015-0282(00)00703-2; Zini A., 2014, SYSTEMS BIOL FREE RA, P2815, DOI [DOI 10.1007/978-3-642-30018-9_180, 10.1007/978-3-642-30018-9_180]	43	13	15	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219179	10.1371/journal.pone.0219179	http://dx.doi.org/10.1371/journal.pone.0219179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276533	Green Submitted, Green Published, gold			2022-12-26	WOS:000484936300046
J	Hamsher, SE; Keepers, KG; Pogoda, CS; Stepanek, JG; Kane, NC; Kociolek, JP				Hamsher, Sarah E.; Keepers, Kyle G.; Pogoda, Cloe S.; Stepanek, Joshua G.; Kane, Nolan C.; Kociolek, J. Patrick			Extensive chloroplast genome rearrangement amongst three closely related Halamphora spp. (Bacillariophyceae), and evidence for rapid evolution as compared to land plants	PLOS ONE			English	Article							PLASTID GENOMES; GREEN-ALGAE; PHAEODACTYLUM-TRICORNUTUM; MITOCHONDRIAL GENOMES; PHYLOGENETIC ANALYSIS; MOLECULAR PHYLOGENY; NUCLEOTIDE-SEQUENCE; PENNATE DIATOM; SIMILARITY; ALIGNMENT	Diatoms are the most diverse lineage of algae, but the diversity of their chloroplast genomes, particularly within a genus, has not been well documented. Herein, we present three chloroplast genomes from the genus Halamphora (H. americana, H. calidilacuna, and H. coffeaeformis), the first pennate diatom genus to be represented by more than one species. Halamphora chloroplast genomes ranged in size from similar to 120 to 150 kb, representing a 24% size difference within the genus. Differences in genome size were due to changes in the length of the inverted repeat region, length of intergenic regions, and the variable presence of ORFs that appear to encode as-yet-undescribed proteins. All three species shared a set of 161 core features but differed in the presence of two genes, serC and tyrC of foreign and unknown origin, respectively. A comparison of these data to three previously published chloroplast genomes in the non-pennate genus Cyclotella (Thalassiosirales) revealed that Halamphora has undergone extensive chloroplast genome rearrangement compared to other genera, as well as containing variation within the genus. Finally, a comparison of Halamphora chloroplast genomes to those of land plants indicates diatom chloroplast genomes within this genus may be evolving at least similar to 4-7 times faster than those of land plants. Studies such as these provide deeper insights into diatom chloroplast evolution and important genetic resources for future analyses.	[Hamsher, Sarah E.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Hamsher, Sarah E.] Grand Valley State Univ, Annis Water Resources Inst, Muskegon, MI 49440 USA; [Keepers, Kyle G.; Pogoda, Cloe S.; Kane, Nolan C.; Kociolek, J. Patrick] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Stepanek, Joshua G.] Colorado Mt Coll, Dept Biol, Edwards, CO USA; [Kociolek, J. Patrick] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA	Grand Valley State University; Grand Valley State University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Hamsher, SE (corresponding author), Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA.; Hamsher, SE (corresponding author), Grand Valley State Univ, Annis Water Resources Inst, Muskegon, MI 49440 USA.	hamshers@gvsu.edu	Facility, BioFrontiers Next Generation Sequencing/AAJ-8616-2020; KANE, NOLAN/B-7652-2016	Keepers, Kyle/0000-0002-2288-8018; Hamsher, Sarah/0000-0002-5748-9770; KANE, NOLAN/0000-0001-9133-6543				Adachi Y, 2012, NUCLEIC ACIDS RES, V40, P3152, DOI 10.1093/nar/gkr1185; [Anonymous], 1998, [No title captured]; Ashworth MP, 2013, J PHYCOL, V49, P1207, DOI 10.1111/jpy.12131; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brembu T, 2014, MAR GENOM, V16, P17, DOI 10.1016/j.margen.2013.12.002; Cavalcante KP, 2014, BRAZ J BIOL, V74, P257, DOI 10.1590/1519-6984.24512; Crowell RM, 2019, J PHYCOL, V55, P352, DOI 10.1111/jpy.12824; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Fabris M, 2012, PLANT J, V70, P1004, DOI 10.1111/j.1365-313X.2012.04941.x; Galachyants YP, 2015, DOKL BIOCHEM BIOPHYS, V461, P84, DOI 10.1134/S1607672915020064; Gargas CB, 2018, PROTIST, V169, P803, DOI 10.1016/j.protis.2018.08.005; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Guisinger MM, 2011, MOL BIOL EVOL, V28, P583, DOI 10.1093/molbev/msq229; Hamsher SE, 2011, PROTIST, V162, P405, DOI 10.1016/j.protis.2010.09.005; HILDEBRAND M, 1991, J BACTERIOL, V173, P5924, DOI 10.1128/jb.173.18.5924-5927.1991; HILDEBRAND M, 1992, PLANT MOL BIOL, V19, P759, DOI 10.1007/BF00027072; Huvet M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-721; Imanian B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010711; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kowallik KV, 1995, PLANT MOL BIOL REP, V13, P336, DOI 10.1007/BF02669188; Lee J, 2018, MOL BIOL EVOL, V35, P1869, DOI 10.1093/molbev/msy081; Letsch MR, 2012, MOL PHYLOGENET EVOL, V64, P524, DOI 10.1016/j.ympev.2012.05.027; Levkov Z., 2009, DIATOMS EUROPE, V5, P5; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lommer M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-718; Mann DG, 2013, J EUKARYOT MICROBIOL, V60, P414, DOI 10.1111/jeu.12047; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Munoz-Gomez SA, 2017, CURR BIOL, V27, P1677, DOI 10.1016/j.cub.2017.04.054; Nakov T, 2018, NEW PHYTOL, V219, P462, DOI 10.1111/nph.15137; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Parks MB, 2018, AM J BOT, V105, P330, DOI 10.1002/ajb2.1056; Pogoda CS, 2019, MITOCHONDRIAL DNA A, V30, P43, DOI 10.1080/24701394.2018.1450397; Rancurel C, 2009, J VIROL, V83, P10719, DOI 10.1128/JVI.00595-09; Rastogi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23106-x; Ravin NV, 2010, CURR GENET, V56, P215, DOI 10.1007/s00294-010-0293-3; Reyes-Prieto A, 2018, ADV BOT RES, V85, P95, DOI 10.1016/bs.abr.2017.11.012; Ruck EC, 2014, GENOME BIOL EVOL, V6, P644, DOI 10.1093/gbe/evu039; Ruck EC, 2011, PROTIST, V162, P723, DOI 10.1016/j.protis.2011.02.003; Sabir JSM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107854; Schrader H. J, 1969, NOVA HEDWIGIA S, V28, p[1, 1]; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Seckbach J, 2011, CELL ORIG LIFE EXTRE, V19, P515, DOI 10.1007/978-94-007-1327-7_23; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Soltis PS, 2002, P NATL ACAD SCI USA, V99, P4430, DOI 10.1073/pnas.032087199; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stepanek Joshua G., 2018, V66; Stepanek JG, 2019, J PHYCOL, V55, P442, DOI 10.1111/jpy.12836; Stepanek JG, 2016, BIOFUELS-UK, V7, P521, DOI 10.1080/17597269.2016.1163216; Stepanek JG, 2014, PROTIST, V165, P177, DOI 10.1016/j.protis.2014.02.002; Struyf E, 2009, SILICON-NETH, V1, P207, DOI 10.1007/s12633-010-9035-x; Tanaka T, 2011, PHOTOSYNTH RES, V109, P223, DOI 10.1007/s11120-011-9622-8; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; Turmel M, 2016, GENOME BIOL EVOL, V8, P2789, DOI 10.1093/gbe/evw190; Van de Vijver B, 2014, PLANT ECOL EVOL, V147, P374, DOI 10.5091/plecevo.2014.979; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu JH, 2015, GENOMICS, V106, P221, DOI 10.1016/j.ygeno.2015.07.004; Yu MJ, 2018, ADV BOT RES, V85, P129, DOI 10.1016/bs.abr.2017.11.009; Zgrundo A, 2013, DIATOM RES, V28, P431, DOI 10.1080/0269249X.2013.833136	64	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0217824	10.1371/journal.pone.0217824	http://dx.doi.org/10.1371/journal.pone.0217824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269054	Green Published, Green Submitted, gold			2022-12-26	WOS:000484927300009
J	Long, XW; Wu, XG; Zhu, SC; Ye, HH; Cheng, YX; Zeng, CS				Long, Xiaowen; Wu, Xugan; Zhu, Shaicheng; Ye, Haihui; Cheng, Yongxu; Zeng, Chaoshu			Salinity can change the lipid composition of adult Chinese mitten crab after long-term salinity adaptation	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; SHRIMP LITOPENAEUS-VANNAMEI; H. MILNE-EDWARDS; ERIOCHEIR-SINENSIS; NA+/K+-ATPASE; MUD CRAB; METABOLISM; GROWTH; CHOLESTEROL; RESPONSES	The Chinese mitten crab (Eriocheir sinensis) is an euryhaline crustacean, whose adults migrate downstream to estuaries for reproduction. Lipids are believed to be involved in salinity adaptation during migration. This study investigated the effects of different salinities (0, 6, 12, and 18 parts per thousand) on the total lipids, neutral lipids, and polar lipids contents, and fatty acid profiles in the gonads, hepatopancreas, and muscles of adult E. sinensis after 40 days of salinity adaptation. The results showed that the males and females from 12 parts per thousand treatment had the highest contents of total lipids and neutral lipids in their hepatopancreas and total lipids in the muscles. Notably, salinity had a greater effect on the fatty acid profiles in the hepatopancreas compared to that in the gonads and muscles. The male hepatopancreas treated with 18 parts per thousand salinity had the highest percentage of total n-6 polyunsaturated fatty acid (Sigma n-6PUFA) in both neutral lipids and polar lipids, while the percentage of total n-3 polyunsaturated fatty acid (Sigma n-3PUFA) in neutral lipids and polar lipids decreased significantly with increasing salinity in males. In females, the 0 parts per thousand treatment had the highest percentages of total saturated fatty acids in neutral lipids and polar lipids in the hepatopancreas, while the highest Sigma n-3PUFA and Sigma n-6PUFA in neutral lipids and polar lipids were detected in the 12 parts per thousand treatment group. In conclusion, brackish water could promote the accumulations of total lipids and neutral lipids in the hepatopancreas and change the fatty acid profiles of adult E. sinensis, particularly in the hepatopancreas after long-term salinity adaptation.	[Long, Xiaowen; Wu, Xugan; Zhu, Shaicheng; Cheng, Yongxu] Shanghai Ocean Univ, Ctr Res Environm Ecol & Fish Nutr, Minist Agr & Rural Affairs, Shanghai, Peoples R China; [Long, Xiaowen; Ye, Haihui; Zeng, Chaoshu] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Fujian, Peoples R China; [Wu, Xugan; Cheng, Yongxu] Shanghai Ocean Univ, Shanghai Engn Res Ctr Aquaculture, Shanghai, Peoples R China; [Wu, Xugan; Cheng, Yongxu] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China; [Zeng, Chaoshu] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Xiamen University; Shanghai Ocean University; Shanghai Ocean University; James Cook University	Wu, XG (corresponding author), Shanghai Ocean Univ, Ctr Res Environm Ecol & Fish Nutr, Minist Agr & Rural Affairs, Shanghai, Peoples R China.; Wu, XG; Zeng, CS (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Fujian, Peoples R China.; Wu, XG (corresponding author), Shanghai Ocean Univ, Shanghai Engn Res Ctr Aquaculture, Shanghai, Peoples R China.; Wu, XG (corresponding author), Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China.; Zeng, CS (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.	xgwu@shou.edu.cn; chaoshu.zeng@jcu.edu.cu	Zhu, Shaicheng/GYU-3901-2022	Zeng, Chaoshu/0000-0001-9022-6588	Natural Science Foundation of China [41876190]; Special Fund of Chinese Agriculture Research System from Ministry of Agriculture of China [CARS-48]; capacity promoting Project of Shanghai Engineering and Technology Center from Shanghai Municipal Science and Technology Commission [19DZ2284300]; Research project for high level university in Shanghai from Shanghai Education Commission [A1-2801-18-1003]; Shanghai Collaborative Innovation Center for Aquatic Animal Genetics and Breeding [A1-2041-18-0003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund of Chinese Agriculture Research System from Ministry of Agriculture of China; capacity promoting Project of Shanghai Engineering and Technology Center from Shanghai Municipal Science and Technology Commission; Research project for high level university in Shanghai from Shanghai Education Commission; Shanghai Collaborative Innovation Center for Aquatic Animal Genetics and Breeding	This study was supported by a general project (no. 41876190) from the Natural Science Foundation of China to YXC, the Special Fund (CARS-48) of Chinese Agriculture Research System from Ministry of Agriculture of China to YXC, the capacity promoting Project of Shanghai Engineering and Technology Center from Shanghai Municipal Science and Technology Commission (No. 19DZ2284300) to YXC. Infrastructure costs were supported by the Supported by Research project for high level university in Shanghai (no. A1-2801-18-1003) from Shanghai Education Commission to YXC, the project (A1-2041-18-0003) of Shanghai Collaborative Innovation Center for Aquatic Animal Genetics and Breeding to YXC.	Benjamini Y, 2001, ANN STAT, V29, P1165; Bentley MG, 2011, INVAD NAT SPRING SER, V6, P107, DOI 10.1007/978-94-007-0591-3_3; Bhoite S, 2013, MAR FRESHW BEHAV PHY, V46, P287, DOI 10.1080/10236244.2013.832525; Carrier JK, 2011, AQUACULTURE, V319, P111, DOI 10.1016/j.aquaculture.2011.06.027; CHAPELLE S, 1976, INT J BIOCHEM, V7, P343, DOI 10.1016/0020-711X(76)90097-5; CHAPELLE S, 1986, COMP BIOCHEM PHYS B, V84, P423, DOI 10.1016/0305-0491(86)90102-1; Chapelle S., 1980, Comparative Biochemistry and Physiology Supplement, P15; CHAPELLE S, 1978, ARCH INT PHYSIOL BIO, V86, P393, DOI 10.3109/13813457809069914; CHAPELLE S, 1986, COMP BIOCHEM PHYS B, V85, P511, DOI 10.1016/0305-0491(86)90039-8; Chapelle S, 1975, ANN I M PACHA, V8, P63; Chen FJ, 2018, ASIA PACIF MICROWAVE, P97, DOI 10.23919/APMC.2018.8617419; Chen K, 2014, J SHELLFISH RES, V33, P825, DOI 10.2983/035.033.0317; Cheng Yong-Xu, 1998, Acta Zoologica Sinica, V44, P420; FOLCH J, 1957, J BIOL CHEM, V226, P497; KIMELBERG HK, 1974, J BIOL CHEM, V249, P1071; Long XW, 2018, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01072; Long XW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179036; Lucu C, 2008, COMP BIOCHEM PHYS A, V149, P362, DOI 10.1016/j.cbpa.2008.01.026; Luvizotto-Santos R, 2003, J EXP ZOOL PART A, V295A, P200, DOI 10.1002/jez.a.10219; Ma Nan, 2017, Journal of Shanghai Ocean University, V26, P872; Palacios E, 2004, AQUACULTURE, V234, P497, DOI 10.1016/j.aquaculture.2003.12.001; Porter RK, 1996, AM J PHYSIOL-REG I, V271, pR1550, DOI 10.1152/ajpregu.1996.271.6.R1550; Romano N, 2014, MAR BIOL RES, V10, P460, DOI 10.1080/17451000.2013.819981; ROMIJN JC, 1972, BIOCHIM BIOPHYS ACTA, V280, P22, DOI 10.1016/0005-2760(72)90209-3; Sheen SS, 2000, AQUACULTURE, V189, P277, DOI 10.1016/S0044-8486(00)00379-3; Shen XW, 1992, APPL CHROMATOGRAPHY; Skipski V.P., 1969, METHOD ENZYMOL, V14, P530; Sui LY, 2009, MAR BIOL, V156, P1573, DOI 10.1007/s00227-009-1193-2; Teng Wei-Ming, 2008, Shanghai Shuichan Daxue Xuebao, V17, P65; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; WADE MG, 1994, BIOL REPROD, V51, P131, DOI 10.1095/biolreprod51.1.131; Wang RF, 2012, CRUSTACEANA, V85, P1431, DOI 10.1163/15685403-00003125; Wang W., 2013, EDUC FORUM, P20; Wu XG, 2007, AQUAC RES, V38, P1459, DOI 10.1111/j.1365-2109.2007.01728.x; Wu X, 2017, CRUSTACEANA, V90, P449, DOI 10.1163/15685403-00003662; Xu Jia-Qian, 2016, Chinese Journal of Zoology, V51, P434, DOI 10.13859/j.cjz.201603011; Ye YF, 2014, J AGR FOOD CHEM, V62, P3496, DOI 10.1021/jf405668a; Zeng CS, 2012, AQUACULTURE: FARMING AQUATIC ANIMALS AND PLANTS, 2ND EDITION, P514; Zhang L.S., 1973, AQUATIC SCI TECHNOLO, V1, P5; Zhang LS, 2002, AQUACULTURE TECHNOLO; Zhang TL, 2001, J FRESHWATER ECOL, V16, P633, DOI 10.1080/02705060.2001.9663855; ZhangK, 2013, OIL GEOPHYSICAL PROS, V48, P409, DOI [10.13810/j.cnki.issn.1000.7210, DOI 10.13810/J.CNKI.ISSN.1000.7210, DOI 10.13859/J.CJZ.2013.04.008]; Zhao Lei, 2016, Chinese Journal of Zoology, V51, P1071, DOI 10.13859/j.cjz.201606015; Zhuang Ping, 2012, Shengtaixue Zazhi, V31, P1997	44	15	17	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2019	14	7							e0219260	10.1371/journal.pone.0219260	http://dx.doi.org/10.1371/journal.pone.0219260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4CE	31269065	Green Accepted, Green Published, gold			2022-12-26	WOS:000484927300058
J	Lee, DJ; Kumarasamy, N; Resch, SC; Sivaramakrishnan, GN; Mayer, KH; Tripathy, S; Paltiel, AD; Freedberg, KA; Reddy, KP				Lee, David J.; Kumarasamy, Nagalingeswaran; Resch, Stephen C.; Sivaramakrishnan, Gomathi N.; Mayer, Kenneth H.; Tripathy, Srikanth; Paltiel, A. David; Freedberg, Kenneth A.; Reddy, Krishna P.			Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector	PLOS ONE			English	Article							XPERT MTB/RIF; ROLL-OUT; IMPACT; MICROSCOPY; INITIATION; SETTINGS; ACCURACY; AFRICA; TESTS; READY	Background Truenat is a novel molecular assay that rapidly detects tuberculosis (TB) and rifampicin-resistance. Due to the portability of its battery-powered testing platform, it may be valuable in peripheral healthcare settings in India. Methods Using a microsimulation model, we compared four TB diagnostic strategies for HIV-negative adults with presumptive TB: (1) sputum smear microscopy in designated microscopy centers (DMCs) (SSM); (2) Xpert MTB/RIF in DMCs (Xpert); (3) Truenat in DMCs (Truenat DMC); and (4) Truenat for point-of-care testing in primary healthcare facilities (Truenat POC). We projected life expectancy, costs, incremental cost-effectiveness ratios (ICERs), and 5-year budget impact of deploying Truenat POC in India's public sector. We defined a strategy "cost-effective" if its ICER was <US$990/year-of-life saved (YLS). Model inputs included: TB prevalence, 15% (among those not previously treated for TB) and 27% (among those previously treated for TB); sensitivity for TB detection, 89% (Xpert) and 86% (Truenat); per test cost, $12.63 (Xpert) and $13.20 (Truenat); and linkage-to-care after diagnosis, 84% (DMC) and 95% (POC). We varied these parameters in sensitivity analyses. Results Compared to SSM, Truenat POC increased life expectancy by 0.39 years and was cost-effective (ICER $210/YLS). Compared to Xpert, Truenat POC increased life expectancy by 0.08 years due to improved linkage-to-care and was cost-effective (ICER $120/YLS). In sensitivity analysis, the cost-effectiveness of Truenat POC, relative to Xpert, depended on the diagnostic sensitivity of Truenat and linkage-to-care with Truenat. Deploying Truenat POC instead of Xpert increased 5-year expenditures by $270 million, due mostly to treatment costs. Limitations of our study include uncertainty in Truenat's sensitivity for TB and not accounting for the "start-up" costs of implementing Truenat in the field. Conclusions Used at the point-of-care in India, Truenat for TB diagnosis should improve linkage-to-care, increase life expectancy, and be cost-effective compared with smear microscopy or Xpert.	[Lee, David J.; Mayer, Kenneth H.; Freedberg, Kenneth A.; Reddy, Krishna P.] Harvard Med Sch, Boston, MA 02115 USA; [Lee, David J.; Freedberg, Kenneth A.; Reddy, Krishna P.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Kumarasamy, Nagalingeswaran] Voluntary Hlth Serv, Chennai Antiviral Res & Treatment Clin Res Site, Chennai, Tamil Nadu, India; [Resch, Stephen C.] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA; [Resch, Stephen C.; Freedberg, Kenneth A.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Sivaramakrishnan, Gomathi N.; Tripathy, Srikanth] Natl Inst Res TB, Chennai, Tamil Nadu, India; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Paltiel, A. David] Yale Sch Publ Hlth, New Haven, CT USA; [Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Reddy, Krishna P.] Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Lee, DJ; Reddy, KP (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Lee, DJ; Reddy, KP (corresponding author), Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA.; Reddy, KP (corresponding author), Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Boston, MA 02114 USA.	lee.david.djl@gmail.com; kpreddy@mgh.harvard.edu	Kumarasasmy, Nagalingeswaran/AAB-7348-2021	Lee, David/0000-0002-0330-1824; Tripathy, Srikanth/0000-0002-8363-2606; Mayer, Kenneth/0000-0001-7460-733X	National Institute on Drug Abuse of the National Institutes of Health [K01 DA042687, R01 DA015612]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R37 AI058736, R37 AI093269]; National Institute of Mental Health of the National Institutes of Health [R01 MH105203]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI093269, R37AI058736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, K01DA042687] Funding Source: NIH RePORTER	National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by awards from the National Institute on Drug Abuse (K01 DA042687 [K.P.R.] and R01 DA015612 [A.D.P.]), the National Institute of Allergy and Infectious Diseases (R37 AI058736 [K.A.F.] and R37 AI093269 [K.P.R.]), and the National Institute of Mental Health (R01 MH105203 [A.D.P.]) of the National Institutes of Health (www.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.	Abdurrahman ST, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.277.3906; Albert H, 2016, EUR RESPIR J, V48, P516, DOI 10.1183/13993003.00543-2016; Andrews JR, 2012, AIDS, V26, P987, DOI 10.1097/QAD.0b013e3283522d47; Ardizzoni E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144656; Baggaley RF, 2017, LANCET HIV, V4, pE465, DOI 10.1016/S2352-3018(17)30123-6; Central TB Division, 2010, REV NAT TB CONTR PRO, P8; Central TB Division, 2017, REV NAT TUB CONTR PR; Central TB Division Ministry of Health and Family Welfare TB India, 2017, TB IND 2017 REV NAT; Clouse K, 2012, SAMJ S AFR MED J, V102, P805, DOI [10.7196/SAMJ.5851, 10.7196/samj.5851]; Davis JL, 2013, LANCET INFECT DIS, V13, P147, DOI 10.1016/S1473-3099(12)70232-3; Denkinger CM, 2015, J INFECT DIS, V211, pS29, DOI 10.1093/infdis/jiu821; Denkinger CM, 2013, EUR RESPIR J, V42, P544, DOI 10.1183/09031936.00081113; Drain PK, 2015, LANCET GLOB HEALTH, V3, pE663, DOI 10.1016/S2214-109X(15)00186-2; Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0; Garcia-Basteiro AL, 2018, PULMONOLOGY, V24, P73, DOI 10.1016/j.rppnen.2017.12.002; Global Drug Facility, 2016, GLOBAL DRUG FACILITY; Goyal V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4779-5; Hanrahan CF, 2015, INT J TUBERC LUNG D, V19, P811, DOI 10.5588/ijtld.15.0013; Hanrahan CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065421; Hsiang E, 2016, INT J TUBERC LUNG D, V20, P1212, DOI 10.5588/ijtld.16.0200; Kendall EA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002472; Khaparde S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184270; Lessells RJ, 2017, AM J RESP CRIT CARE, V196, P901, DOI 10.1164/rccm.201702-0278OC; Nikam C, 2014, INT J MYCOBACT, V3, P205, DOI 10.1016/j.ijmyco.2014.04.003; Nikam C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051121; Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089301; Rupert S, 2017, INT J TUBERC LUNG D, V21, P375, DOI 10.5588/ijtld.16.0496; Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126065; Schnippel K, 2012, TROP MED INT HEALTH, V17, P1142, DOI 10.1111/j.1365-3156.2012.03028.x; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Subbaraman R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002149; Sun AY, 2013, AM J EPIDEMIOL, V178, P1740, DOI 10.1093/aje/kwt210; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Vassall A, 2017, LANCET GLOB HEALTH, V5, pE710, DOI [10.1016/S2214-109X(17)30205-X, 10.1016/s2214-109x(17)30205-x]; Vassall A, 2016, HEALTH ECON, V25, P95, DOI 10.1002/hec.3306; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2008, CHOOSING INT AR COST; World Health Organization, 2014, HIGH PRIOR TARG PROD; Zheng A, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25085	43	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2019	14	7							e0218890	10.1371/journal.pone.0218890	http://dx.doi.org/10.1371/journal.pone.0218890			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3ZV	31265470	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000484921200016
J	Khodarahmi, M; Asghari-Jafarabadi, M; Farhangi, MA				Khodarahmi, Mandieh; Asghari-Jafarabadi, Mohammad; Farhangi, Mandieh Abbasalizad			A structural equation modeling approach for the association of a healthy eating index with metabolic syndrome and cardio-metabolic risk factors among obese individuals	PLOS ONE			English	Article							DIET QUALITY INDEXES; INSULIN-RESISTANCE; RELATIVE VALIDITY; DEPRESSION; HYPERTENSION; METAANALYSIS; ADULTS; TYPE-2; REPRODUCIBILITY; DETERMINANTS	Background Numerous studies have evaluated the association between dietary factors and cardiovascular risk among patients with chronic disease. It is worthwhile to assess these associations in a combination model rather than in an isolated form. In the current study, we aimed to use structural equation modeling (SEM) to assess the association of adherence to a healthy eating index (HEI)-2015 with socio-demographic factors, psychological characteristics, metabolic syndrome (MetS) and other cardio-metabolic risk factors among obese individuals. Methods This cross-sectional study was conducted among 188 healthy obese adults (96 males and 92 females) aged 20-50 years in Tabriz. A validated semi-quantitative food frequency questionnaire (FFQ) was used to record dietary intake and to estimate HEI-2015. Anthropometric parameters, blood pressure and biochemical measurements were evaluated according to standard protocols. Interrelationships among socio-demographic parameters and HEI with cardio-metabolic risk factors were analyzed using SEM. Results The results of SEM analysis revealed that HEI mediated the association between age and several cardio-metabolic risk factors including fat mass (FM), fat free mass (FFM), systolic blood pressure (SBP) and high-density lipoprotein (HDL) (p < 0.05). Moreover, adherence to Dietary Guidelines for Americans (DGA) appears to mediate association between gender and waist circumference (B = -9.78), SBP (B = -4.83), triglyceride (B = -13.01) and HDL (B = 4.31). HEI also mediated indirect negative effects of socioeconomic status on FM (B = -0.56), FFM (B = -0.25), SBP (B = -0.55) and diastolic blood pressure (DBP) (B = -0.3). Additionally, depression and age had indirect unfavorable effects on some insulin resistance indices such as homeostasis model assessment of insulin resistance (B = 0.07; p<0.05, for age) and quantitative insulin sensitivity check index (p<0.05, for age and depression) via HEI. High adherence to HEI was found to be inversely associated with MetS risk (p<0.05). Conclusion Adherence to HEI-2015 seems to mediate the effect of socio-demographic parameters and mental health on cardio-metabolic risk factors as well as MetS risk. Further studies are needed to confirm these findings.	[Khodarahmi, Mandieh] Tabriz Univ Med Sci, Fac Nutr & Food Sci, Nutr Res Ctr, Dept Community Nutr, Tabriz, Iran; [Khodarahmi, Mandieh] Tabriz Univ Med Sci, Fac Nutr & Food Sci, Dept Nutr, Student Res Comm, Tabriz, Iran; [Asghari-Jafarabadi, Mohammad] Tabriz Univ Med Sci, Rd Traff Injury Res Ctr, Tabriz, Iran; [Asghari-Jafarabadi, Mohammad] Tabriz Univ Med Sci, Fac Hlth, Dept Stat & Epidemiol, Tabriz, Iran; [Farhangi, Mandieh Abbasalizad] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran	Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science	Farhangi, MA (corresponding author), Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran.	Abbasalizad_m@yahoo.corn	Farhangi, Mahdieh Abbasalizad/AAC-6758-2019	Abbasalizad Farhangi, Mahdieh/0000-0002-7036-6900	Research Undersecretary of Tabriz University of Medical Sciences [IR.TBZMED.REC.1396.768]	Research Undersecretary of Tabriz University of Medical Sciences	The current work has been granted by Research Undersecretary of Tabriz University of Medical Sciences (Grant No. IR.TBZMED.REC.1396.768) as a Ph.D. thesis of MKH.	Akbaraly TN, 2010, DIABETES CARE, V33, P2339, DOI 10.2337/dc09-2200; [Anonymous], 2004, BEGINNERS GUIDE STRU; Asghari A., 2008, INT J PSYCHOL, V2, P82, DOI DOI 10.1016/J.JAD.2008.01.023; Asghari G, 2017, BRIT J NUTR, V117, P1055, DOI 10.1017/S0007114517000915; Asghari G, 2017, NEPHROL DIAL TRANSPL, V32, P224, DOI 10.1093/ndt/gfw273; Asghari G, 2012, ARCH IRAN MED, V15, P599; Azadbakht L, 2005, ASIA PAC J CLIN NUTR, V14, P163; Azar M., 1980, FOOD COMPOSITION TAB; Beran Tanya N, 2010, BMC Res Notes, V3, P267, DOI 10.1186/1756-0500-3-267; Booth M, 2000, RES Q EXERCISE SPORT, V71, pS114; Brown ES, 2004, BIOL PSYCHIAT, V55, P1, DOI 10.1016/S0006-3223(03)00473-6; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Das K, 2016, BRIEF REV TESTS NORM, DOI [10.11648/j.ajtas.20160501.12, DOI 10.11648/J.AJTAS.20160501.12]; De Koning L, 2011, DIABETES CARE, V34, P1150, DOI 10.2337/dc10-2352; Delavari A, 2009, DIABETES CARE, V32, P1092, DOI 10.2337/dc08-1800; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; Esfahani FH, 2010, J EPIDEMIOL, V20, P150, DOI 10.2188/jea.JE20090083; Fardet A, 2014, ADV NUTR, V5, P430, DOI 10.3945/an.114.006122; Fisher J, INFLUENCE BODY COMPO, P597, DOI [10.1038/oby.2000.77, DOI 10.1038/OBY.2000.77]; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Gao SK, 2008, AM J CLIN NUTR, V88, P64; Giskes K, 2010, OBES REV, V11, P413, DOI 10.1111/j.1467-789X.2009.00658.x; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; Gunn JM, 2012, SOC PSYCH PSYCH EPID, V47, P175, DOI 10.1007/s00127-010-0330-z; Hadaegh F, 2017, DIABETIC MED, V34, P69, DOI 10.1111/dme.13034; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; Jafari-Adli S, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0121-2; Jeffery RW, 2009, APPETITE, V52, P238, DOI 10.1016/j.appet.2008.08.008; Jessri M, 2016, AM J CLIN NUTR, V104, P1378, DOI 10.3945/ajcn.116.132647; Kan C, 2013, DIABETES CARE, V36, P480, DOI 10.2337/dc12-1442; Kelishadi R, 2008, PUBLIC HEALTH NUTR, V11, P246, DOI 10.1017/S1368980007000262; Kline R.B., 2011, PRINCIPLES PRACTICE; Kline R.B., 2016, PRINCIPLES PRACTICE, V4th, pxvii; Koksal E, 2017, ENVIRON HEALTH PREV, V22, DOI 10.1186/s12199-017-0613-z; Krebs-Smith SM, 2018, J ACAD NUTR DIET, V118, P1591, DOI 10.1016/j.jand.2018.05.021; Leng B, 2015, J HYPERTENS, V33, P221, DOI 10.1097/HJH.0000000000000428; Linetzky B, 2013, INT J PUBLIC HEALTH, V58, P277, DOI 10.1007/s00038-012-0371-z; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Mayen AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029; Michels N, 2017, MEDIATION PSYCHOSOCI, DOI [10.1007/s00394-017-1380-8, DOI 10.1007/S00394-017-1380-8]; Mirmiran P, 2010, PUBLIC HEALTH NUTR, V13, P654, DOI 10.1017/S1368980009991698; Moradi G, 2013, INT J PREVENTIVE MED, V4, P671; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; Newton S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177151; Nicklas TA, 2012, J NUTR, V142, P2112, DOI 10.3945/jn.112.164889; Pearson S, 2010, DIABETES CARE, V33, P1128, DOI 10.2337/dc09-1940; Rahmani Asghar, 2015, Acta Med Iran, V53, P596; Rezazadeh A, 2010, NUTRITION, V26, P337, DOI 10.1016/j.nut.2009.06.019; Sadeghi M, 2015, J DIABETES, V7, P633, DOI 10.1111/1753-0407.12236; Sahebi A., 2005, J DEVELOMENTAL PSYCH, V1, P36; Saraf-Bank S, 2017, EUR J CLIN NUTR, V71, P425, DOI 10.1038/ejcn.2016.173; Schwingshackl L, 2018, J ACAD NUTR DIET, V118, P74, DOI 10.1016/j.jand.2017.08.024; Sharma AM, 2005, ACTA DIABETOL, V42, pS3, DOI 10.1007/s00592-005-0175-1; Taverner D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41069-5; Timonen M, 2005, BMJ-BRIT MED J, V330, P17, DOI 10.1136/bmj.38313.513310.F71; Valette M, 2013, INT J OBESITY, V37, P1027, DOI 10.1038/ijo.2012.169; Viego Valentina, 2017, J Public Health Res, V6, P883, DOI 10.4081/jphr.2017.883; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; Wang ZH, 2017, J NUTR, V147, P2102, DOI 10.3945/jn.117.256180; Wardle J, 2011, OBESITY, V19, P771, DOI 10.1038/oby.2010.241; Wiseman TA, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0109-z; World Health Organization, 2019, OB OV	65	24	24	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219193	10.1371/journal.pone.0219193	http://dx.doi.org/10.1371/journal.pone.0219193			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW3YW	31260504	Green Published, gold, Green Submitted			2022-12-26	WOS:000484918700042
J	Tran, P; Wanrooij, PH; Lorenzon, P; Sharma, S; Thelander, L; Nilsson, AK; Olofsson, AK; Medini, P; von Hofsten, J; Stal, P; Chabes, A				Phong Tran; Wanrooij, Paulina H.; Lorenzon, Paolo; Sharma, Sushma; Thelander, Lars; Nilsson, Anna Karin; Olofsson, Anna-Karin; Medini, Paolo; von Hofsten, Jonas; Stal, Per; Chabes, Andrei			De novo dNTP production is essential for normal postnatal murine heart development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nucleoside; nucleotide biosynthesis; nucleoside; nucleotide metabolism; ribonucleotide reductase (RNR); heart development; cardiac muscle; cardiac function; deoxyribonucleoside kinases; desmin; dNTP metabolism; dNTP salvage; cardiomyocyte; dystrophin; laminin	RIBONUCLEOTIDE REDUCTASE; DNA-DAMAGE; REPLICATION; MOUSE; MUTAGENESIS; EXPRESSION; DEOXYRIBONUCLEOTIDE; MECHANISMS; SAMHD1; POOLS	The building blocks of DNA, dNTPs, can be produced de novo or can be salvaged from deoxyribonucleosides. However, to what extent the absence of de novo dNTP production can be compensated for by the salvage pathway is unknown. Here, we eliminated de novo dNTP synthesis in the mouse heart and skeletal muscle by inactivating ribonucleotide reductase (RNR), a key enzyme for the de novo production of dNTPs, at embryonic day 13. All other tissues had normal de novo dNTP synthesis and theoretically could supply heart and skeletal muscle with deoxyribonucleosides needed for dNTP production by salvage. We observed that the dNTP and NTP pools in WT postnatal hearts are unexpectedly asymmetric, with unusually high dGTP and GTP levels compared with those in whole mouse embryos or murine cell cultures. We found that RNR inactivation in heart led to strongly decreased dGTP and increased dCTP, dTTP, and dATP pools; aberrant DNA replication; defective expression of muscle-specific proteins; progressive heart abnormalities; disturbance of the cardiac conduction system; and lethality between the second and fourth weeks after birth. We conclude that dNTP salvage cannot substitute for de novo dNTP synthesis in the heart and that cardiomyocytes and myocytes initiate DNA replication despite an inadequate dNTP supply. We discuss the possible reasons for the observed asymmetry in dNTP and NTP pools in WT hearts.	[Phong Tran; Wanrooij, Paulina H.; Sharma, Sushma; Thelander, Lars; Nilsson, Anna Karin; Chabes, Andrei] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Lorenzon, Paolo; Olofsson, Anna-Karin; Medini, Paolo; von Hofsten, Jonas; Stal, Per] Umea Univ, Dept Integrat Med Biol IMB, S-90187 Umea, Sweden; [von Hofsten, Jonas] Umea Univ, UCMM, S-90187 Umea, Sweden; [Chabes, Andrei] Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Chabes, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.; Chabes, A (corresponding author), Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden.	andrei.chabes@umu.se	Medini, Paolo/GWC-1936-2022; Medini, Paolo/R-7504-2018; Wanrooij, Paulina/R-1509-2019	Wanrooij, Paulina/0000-0002-8607-7564; Chabes, Andrei/0000-0003-1708-8259; von Hofsten, Jonas/0000-0003-3730-1790; Sharma, Sushma/0000-0003-2713-5813; Stal, Per/0000-0002-9340-5298	Swedish Cancer Society; Swedish Research Council; Swedish Society for Medical Research	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research	This work was supported by grants from the Swedish Cancer Society and the Swedish Research Council (to A. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by grants from the Swedish Cancer Society and the Swedish Society for Medical Research.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Alkass K, 2015, CELL, V163, P1026, DOI 10.1016/j.cell.2015.10.035; Alvino GM, 2007, MOL CELL BIOL, V27, P6396, DOI 10.1128/MCB.00719-07; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Cheddad A, 2012, IEEE T MED IMAGING, V31, P1, DOI 10.1109/TMI.2011.2161590; Chimploy K, 2013, J BIOL CHEM, V288, P13145, DOI 10.1074/jbc.M113.461111; Coquel F, 2019, CURR OPIN IMMUNOL, V56, P24, DOI 10.1016/j.coi.2018.09.017; Eriksson AU, 2013, JOVE-J VIS EXP, DOI 10.3791/50238; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Fu Y, 2018, NAT CHEM BIOL, V14, P943, DOI 10.1038/s41589-018-0113-5; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Jia S, 2015, PROCEEDINGS OF THE 18TH ASIA PACIFIC SYMPOSIUM ON INTELLIGENT AND EVOLUTIONARY SYSTEMS, VOL 2, P117, DOI 10.1007/978-3-319-13356-0_10; Karnani N, 2011, GENE DEV, V25, P621, DOI 10.1101/gad.2029711; Kong ZQ, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky203; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Kumar D, 2010, NUCLEIC ACIDS RES, V38, P3975, DOI 10.1093/nar/gkq128; Lindstrom M, 2009, HISTOCHEM CELL BIOL, V132, P141, DOI 10.1007/s00418-009-0606-0; Lmoto Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07009-z; LYONS GE, 1991, DEVELOPMENT, V113, P1017; Mathews CK, 2015, NAT REV CANCER, V15, P528, DOI 10.1038/nrc3981; Noma T, 2001, BIOCHEM J, V358, P225, DOI 10.1042/0264-6021:3580225; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Rentoft M, 2016, P NATL ACAD SCI USA, V113, P4723, DOI 10.1073/pnas.1519128113; Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029; Sambrook J., 2001, MOL CLONING LAB MANU; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102; Thelander L, 2007, NAT GENET, V39, P703, DOI 10.1038/ng0607-703; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Watt DL, 2016, NUCLEIC ACIDS RES, V44, P1669, DOI 10.1093/nar/gkv1298; Wheeler LJ, 2011, J BIOL CHEM, V286, P16992, DOI 10.1074/jbc.M111.236968	34	9	9	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					15889	15897		10.1074/jbc.RA119.009492	http://dx.doi.org/10.1074/jbc.RA119.009492			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31300555	Green Published, hybrid			2022-12-26	WOS:000499478600002
J	Huang, JQ; Zhao, QS; Li, M; Duan, QM; Zhao, Y; Zhang, H				Huang, Jingqiu; Zhao, Qinshuo; Li, Mu; Duan, Qiming; Zhao, Yin; Zhang, Hong			The effects of endothelium-specific CYP2J2 overexpression on the attenuation of retinal ganglion cell apoptosis in a glaucoma rat model	FASEB JOURNAL			English	Article						retinal vasculature; senescence; microRNAs; MMPs	PRIMARY OPEN-ANGLE; COHERENCE TOMOGRAPHY ANGIOGRAPHY; OPTIC-NERVE; BLOOD-FLOW; ISCHEMIA/REPERFUSION INJURY; EPOXYEICOSATRIENOIC ACIDS; CAPILLARY DEGENERATION; INTRAOCULAR-PRESSURE; SECRETORY PHENOTYPE; SENESCENCE	Glaucoma is a leading cause of irreversible blindness worldwide. Vascular factors play a substantial role in the pathogenesis of glaucoma. Expressed in the vascular endothelium, cytochrome P450 (CYP) 2J2 is one of the CYP epoxygenases that metabolize arachidonic acid to produce epoxyeicosatrienoic acids and exert pleiotropic protective effects on the vasculature. In the present study, we investigated whether endothelium-specific overexpression of CYP2J2 (tie2-CYP2J2-Tr) protects against retinal ganglion cell (RGC) loss induced by glaucoma and in what way retinal vessels are involved in this process. We used a glaucoma model of retinal ischemia-reperfusion (I/R) injury in rats and found that endothelium-specific overexpression of CYP2J2 attenuated RGC loss induced by retinal I/R. Moreover, retinal I/R triggered retinal vascular senescence, indicated by up-regulated senescence-related proteins p53, p16, and beta-galactosidase activity. The senescent endothelial cells resulted in pericyte loss and increased endothelial secretion of matrix metallopeptidase 9, which further contributed to RGC loss. CYP2J2 overexpression alleviated vascular senescence, pericyte loss, and matrix metallopeptidase 9 secretion. CYP2J2 suppressed endothelial senescence by down-regulating senescence-associated proteins p53 and p16. These 2 proteins were positively regulated by microRNA-128-3p, which was inhibited by CYP2J2. These results suggest that CYP2J2 protects against endothelial senescence and RGC loss in glaucoma, a discovery that may lead to the development of a potential treatment strategy for glaucoma.-Huang, J., Zhao, Q., Li, M., Duan, Q., Zhao, Y., Zhang, H. The effects of endothelium-specific CYP2J2 overexpression on the attenuation of retinal ganglion cell apoptosis in a glaucoma rat model.	[Huang, Jingqiu; Li, Mu; Zhao, Yin; Zhang, Hong] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Ophthalmol, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Zhao, Qinshuo] Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Hubei, Peoples R China; [Duan, Qiming] Gladstone Inst, San Francisco, CA USA; [Zhao, Yin] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA	Huazhong University of Science & Technology; Wuhan University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Zhao, Y; Zhang, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Ophthalmol, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.	yin.zhao@ucsf.edu; tjyksys@163.com		Duan, Qiming/0000-0002-6204-3028	National Natural Science Foundation of China [81770921, 31800868]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The current studies were supported by funding from the National Natural Science Foundation of China (81770921, 31800868). The authors declare no conflicts of interest.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abraham NG, 2014, HYPERTENSION, V64, P1352, DOI 10.1161/HYPERTENSIONAHA.114.03884; Anwar-mohamed A, 2010, PHARMACOL RES, V61, P410, DOI 10.1016/j.phrs.2009.12.015; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bach MHM, 2005, MECH AGEING DEV, V126, P467, DOI 10.1016/j.mad.2004.10.005; Blau CW, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.035; Bullitt E, 2010, NEUROBIOL AGING, V31, P290, DOI 10.1016/j.neurobiolaging.2008.03.022; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang EI, 2007, CIRCULATION, V116, P2818, DOI 10.1161/CIRCULATIONAHA.107.715847; Chauhan BC, 2004, INVEST OPHTH VIS SCI, V45, P144, DOI 10.1167/iovs.03-0687; Chen HSL, 2017, INVEST OPHTH VIS SCI, V58, P3637, DOI 10.1167/iovs.17-21846; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Chen WS, 2015, CELL PHYSIOL BIOCHEM, V35, P2043, DOI 10.1159/000374011; Chintala SK, 2002, J BIOL CHEM, V277, P47461, DOI 10.1074/jbc.M204824200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Danesh-Meyer HV, 2012, BRAIN, V135, P506, DOI 10.1093/brain/awr338; DeCicco-Skinner KL, 2014, JOVE-J VIS EXP, DOI 10.3791/51312; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Findl O, 2000, AM J OPHTHALMOL, V130, P589, DOI 10.1016/S0002-9394(00)00636-X; Fleming I, 2014, PHARMACOL REV, V66, P1106, DOI 10.1124/pr.113.007781; Gangadhariah MH, 2017, DIABETOLOGIA, V60, P1066, DOI 10.1007/s00125-017-4260-0; Gherghel D, 2005, INVEST OPHTH VIS SCI, V46, P877, DOI 10.1167/iovs.04-0777; Gottanka J, 2005, INVEST OPHTH VIS SCI, V46, P4170, DOI 10.1167/iovs.05-0289; Goyal A, 2014, CURR EYE RES, V39, P823, DOI 10.3109/02713683.2011.556299; Gross GJ, 2005, CARDIOVASC RES, V68, P18, DOI 10.1016/j.cardiores.2005.06.007; Grunwald JE, 1998, INVEST OPHTH VIS SCI, V39, P2329; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; HAMMES HP, 1991, P NATL ACAD SCI USA, V88, P11555, DOI 10.1073/pnas.88.24.11555; Harada C, 2006, AM J PATHOL, V168, P261, DOI 10.2353/ajpath.2006.050765; Harada C, 2010, CELL DEATH DIFFER, V17, P1751, DOI 10.1038/cdd.2010.62; Hughes S, 2006, NEUROBIOL AGING, V27, P1838, DOI 10.1016/j.neurobiolaging.2005.10.021; Imaoka Susumu, 2005, Drug Metab Pharmacokinet, V20, P478, DOI 10.2133/dmpk.20.478; Janota CS, 2015, BRAIN RES, V1620, P153, DOI 10.1016/j.brainres.2015.04.056; Jia J, 2016, EXP NEUROL, V279, P75, DOI 10.1016/j.expneurol.2016.02.016; Jiang TF, 2016, PROG NEUROBIOL, V147, P1, DOI 10.1016/j.pneurobio.2016.07.005; JUCKER M, 1990, NEUROBIOL AGING, V11, P39, DOI 10.1016/0197-4580(90)90060-D; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; Kisler K, 2017, NAT NEUROSCI, V20, P406, DOI 10.1038/nn.4489; Lahteenvuo J, 2012, CIRC RES, V110, P1252, DOI 10.1161/CIRCRESAHA.111.246116; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu Y, 2019, BRAIN RES, V1708, P160, DOI 10.1016/j.brainres.2018.12.023; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Mi XS, 2012, INVEST OPHTH VIS SCI, V53, P4842, DOI 10.1167/iovs.12-9999; Michelson G, 1996, J GLAUCOMA, V5, P91; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Nakazato R, 2017, J NEUROSCI, V37, P10052, DOI 10.1523/JNEUROSCI.3639-16.2017; Navaratna D, 2013, J CLIN INVEST, V123, P3373, DOI 10.1172/JCI65767; Navaratna D, 2011, DIABETES, V60, P1789, DOI 10.2337/db10-1371; Panigrahy D, 2013, P NATL ACAD SCI USA, V110, P13528, DOI 10.1073/pnas.1311565110; Papagiannakopoulos T, 2012, ONCOGENE, V31, P1884, DOI 10.1038/onc.2011.380; Polak K, 2000, BRIT J OPHTHALMOL, V84, P1285, DOI 10.1136/bjo.84.11.1285; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rojas M, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020043; Roy S, 2010, BIOGERONTOLOGY, V11, P447, DOI 10.1007/s10522-010-9263-x; Russo R, 2008, PROG BRAIN RES, V173, P583, DOI 10.1016/S0079-6123(08)01144-8; Sennlaub F, 2003, CIRCULATION, V108, P198, DOI 10.1161/01.CIR.0000080735.93327.00; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; Strokin M, 2003, BRIT J PHARMACOL, V139, P1014, DOI 10.1038/sj.bjp.0705326; Surgucheva Irina, 2010, J Ocul Biol Dis Infor, V3, P41, DOI 10.1007/s12177-010-9054-2; Trivli A, 2019, EXP THER MED, V17, P563, DOI 10.3892/etm.2018.7011; Tual-Chalot S, 2013, JOVE-J VIS EXP, DOI 10.3791/50546; Ungvari Z, 2018, NAT REV CARDIOL, V15, P555, DOI 10.1038/s41569-018-0030-z; Ungvari Z, 2013, J GERONTOL A-BIOL, V68, P1443, DOI 10.1093/gerona/glt057; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Venkataraman ST, 2010, INVEST OPHTH VIS SCI, V51, P2043, DOI 10.1167/iovs.09-3630; Wang YM, 2011, INVEST OPHTH VIS SCI, V52, P840, DOI 10.1167/iovs.10-5985; Wei YH, 2011, FREE RADICAL BIO MED, V51, P216, DOI 10.1016/j.freeradbiomed.2011.04.026; Xu XZ, 2011, ADV DRUG DELIVER REV, V63, P597, DOI 10.1016/j.addr.2011.03.006; Yang BC, 2001, MOL PHARMACOL, V60, P310, DOI 10.1124/mol.60.2.310; Yang C, 2014, INT J BIOCHEM CELL B, V50, P93, DOI 10.1016/j.biocel.2014.02.020; Zhang SH, 2017, AM J OPHTHALMOL, V182, P194, DOI 10.1016/j.ajo.2017.07.024; Zhao QS, 2018, J MOL CELL CARDIOL, V123, P118, DOI 10.1016/j.yjmcc.2018.08.027; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404	77	4	4	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11194	11209		10.1096/fj.201900756R	http://dx.doi.org/10.1096/fj.201900756R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31295013				2022-12-26	WOS:000489166300051
J	Fernandez-Gajardo, R; Matamala, JM; Gutierrez, R; Lozano, P; Cortes-Fuentes, IA; Sotomayor, CG; Bustamante, G; Pasten, JA; Vargas, G; Guerrero, R; Reyes, P; Cavada, G; Feuerhake, W; Rodrigo, R				Fernandez-Gajardo, Rodrigo; Manuel Matamala, Jose; Gutierrez, Rodrigo; Lozano, Prudencio; Cortes-Fuentes, Ignacio A.; Sotomayor, Camilo G.; Bustamante, Gonzalo; Pasten, Juan A.; Vargas, Gabriel; Guerrero, Rodrigo; Reyes, Pablo; Cavada, Gabriel; Feuerhake, Walter; Rodrigo, Ramon			Relationship between infarct size and serum uric acid levels during the acute phase of stroke	PLOS ONE			English	Article							OXIDATIVE STRESS; ISCHEMIC-STROKE; METAANALYSIS; NEURONS	Introduction Uric acid has gained considerable attention as a potential neuroprotective agent in stroke during the last decades, however, its role in the pathophysiology of ischemic stroke remains poorly understood. A serial evaluation of uric acid levels during the acute phase of stroke and its association with infarct size on magnetic resonance imaging is lacking. Methods We present a cohort study of 31 patients with ischemic stroke who were not candidates for thrombolysis according to current criteria at the time. We performed daily measurements of serum uric acid and total antioxidant capacity of plasma during the first week after symptoms onset and 30 days after. Infarct size was determined in the acute phase by a DWI sequence and the final infarct size with a control MRI (FLAIR) at day 30. Results Uric acid significantly decreases between days 2 to 6 compared to day 1, after adjustment by sex, age and DWI at diagnosis, with a nadir value at 72h. A mixed model analysis showed a negative association between DWI at diagnosis and uric acid evolution during the first week after stroke. Moreover, multivariable linear regression of uric acid values during follow up on DWI volumes demonstrated that DWI volume at diagnosis is negatively associated with uric acid levels at day 3 and 4. There were no significant associations between total antioxidant capacity of plasma and DWI at diagnosis, or FLAIR at any point. Discussion Patients with larger infarcts exhibited a significant decrease in serum uric acid levels, accounting for a more prominent reactive oxygen species scavenging activity with subsequent consumption and decay of this antioxidant. The different kinetics of total antioxidant capacity of plasma and serum uric acid levels suggests a specific role of uric acid in the antioxidant response in ischemic stroke.	[Fernandez-Gajardo, Rodrigo; Manuel Matamala, Jose; Bustamante, Gonzalo; Reyes, Pablo; Feuerhake, Walter] Univ Chile, Fac Med, Dept Neurol Sci, Santiago, Chile; [Fernandez-Gajardo, Rodrigo; Manuel Matamala, Jose] Univ Chile, Fac Med, BNI, Santiago, Chile; [Fernandez-Gajardo, Rodrigo; Gutierrez, Rodrigo; Cortes-Fuentes, Ignacio A.; Sotomayor, Camilo G.; Rodrigo, Ramon] Univ Chile, Fac Med, Inst Biomed Sci, Mol & Clin Pharmacol Program, Santiago, Chile; [Manuel Matamala, Jose] Univ Chile, Fac Med, Dept Neurosci, Santiago, Chile; [Lozano, Prudencio; Bustamante, Gonzalo; Pasten, Juan A.; Vargas, Gabriel; Guerrero, Rodrigo; Reyes, Pablo; Feuerhake, Walter] Clin Santa Maria, Dept Neurol, Santiago, Chile; [Cavada, Gabriel] Univ Chile, Sch Publ Hlth, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile	Feuerhake, W (corresponding author), Univ Chile, Fac Med, Dept Neurol Sci, Santiago, Chile.; Rodrigo, R (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Mol & Clin Pharmacol Program, Santiago, Chile.; Feuerhake, W (corresponding author), Clin Santa Maria, Dept Neurol, Santiago, Chile.	wfeuer@gmail.com; rrodrigo@med.uchile.cl	Gutierrez, Rodrigo/AAD-8331-2020; Sotomayor, Camilo G./AAH-9500-2019	Sotomayor, Camilo G./0000-0001-6835-6386; Guerrero, Rodrigo/0000-0002-5634-7535; Matamala, Jose Manuel/0000-0001-9062-5642; Fernandez-Gajardo, Rodrigo/0000-0001-9448-2028	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1120594]; Fondo de Fomento al Desarrollo Cientifico y Tecnologico [ID15I10285]; Clinica Santa Maria	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Fomento al Desarrollo Cientifico y Tecnologico; Clinica Santa Maria	RR received Fondo Nacional de Desarrollo Cientifico y Tecnologico 1120594 and Fondo de Fomento al Desarrollo Cientifico y Tecnologico project ID15I10285. Fondo Nacional de Desarrollo Cientifico y Tecnologico: https://www.conicyt.cl/fondecyt/.Fondo de Fomento al Desarrollo Cientifico y Tecnologico: https://www.conicyt.cl/fondef/.WF received funding for late MR imaging of the patients in the study from Clinica Santa Maria. https://www.clinicasantamaria.cl/ubicacion/portada.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Amaro S, 2007, STROKE, V38, P2173, DOI 10.1161/STROKEAHA.106.480699; Amaro S, 2016, STROKE, V47, P2874, DOI 10.1161/STROKEAHA.116.014672; Amaro S, 2011, STROKE, V42, pS28, DOI 10.1161/STROKEAHA.110.596528; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Chamorro A, 2002, STROKE, V33, P1048, DOI 10.1161/hs0402.105927; Chamorro A, 2014, LANCET NEUROL, V13, P453, DOI 10.1016/S1474-4422(14)70054-7; Cherubini A, 2000, STROKE, V31, P2295, DOI 10.1161/01.STR.31.10.2295; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Li M, 2014, ATHEROSCLEROSIS, V232, P265, DOI 10.1016/j.atherosclerosis.2013.11.051; Liu HX, 2018, NEUROL SCI, V39, P1117, DOI 10.1007/s10072-018-3307-4; Mapoure YN, 2017, STROKE RES TREAT, V2017, DOI 10.1155/2017/1935136; Patel M, 2016, TRENDS PHARMACOL SCI, V37, P768, DOI 10.1016/j.tips.2016.06.007; Rodrigo R, 2013, CNS NEUROL DISORD-DR, V12, P698; Romanos E, 2007, J CEREBR BLOOD F MET, V27, P14, DOI 10.1038/sj.jcbfm.9600312; Saeed SA, 2007, EXP BRAIN RES, V182, P1, DOI 10.1007/s00221-007-1050-9; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Storhaug HM, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-115; Touma L, 2016, JAMA NEUROL, V73, P275, DOI 10.1001/jamaneurol.2015.4441; Vidale S, 2018, J CLIN NEUROL, V14, P407, DOI 10.3988/jcn.2018.14.3.407; Yu ZF, 1998, J NEUROSCI RES, V53, P613, DOI 10.1002/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1	23	6	6	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219402	10.1371/journal.pone.0219402	http://dx.doi.org/10.1371/journal.pone.0219402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295304	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800031
J	Schmidmayer, K; Kumar, P; Lavieille, P; Miscevic, M; Topin, F				Schmidmayer, Kevin; Kumar, Prashant; Lavieille, Pascal; Miscevic, Marc; Topin, Frederic			Heat transfer intensification in an actuated heat exchanger submitted to an imposed pressure drop	PLOS ONE			English	Article							FLUID-FLOW; WAVY-WALL; ENHANCEMENT; CHANNEL; SINKS	This paper is dedicated to the analysis of the improvement of heat transfer and the reduction of the pressure losses induced by the use of an active exchanger of millimeter size in a cooling loop. For pressure conditions imposed at the terminals of such a mini-channel whose upper wall is deformed by a progressive sinusoidal wave and for low Reynolds numbers (Re < 1000), we study the influence of the deformation parameters on the thermo-hydraulic performance of the exchanger (flow, heat transfer). The mechanical power applied to the deformed wall is connected to these parameters as well as to the pressure difference imposed by the external pump. The overall performance increases slightly with the value of the mechanical power up to a critical value for a given wall corrugation. Nevertheless, overall performance is up to 2 orders of magnitude higher than conventional static corrugated channels.	[Schmidmayer, Kevin; Kumar, Prashant; Topin, Frederic] Aix Marseille Univ, Marseille, France; [Lavieille, Pascal; Miscevic, Marc] Univ Toulouse, LAPLACE, Toulouse, France	UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier	Topin, F (corresponding author), Aix Marseille Univ, Marseille, France.	frederic.topin@univ-amu.fr	topin, frederic/AAE-1141-2022	topin, frederic/0000-0001-7987-7179; Schmidmayer, Kevin/0000-0003-0444-3098				Elshafei EAM, 2010, ENERGY, V35, P101, DOI 10.1016/j.energy.2009.08.031; Faghri A., 2010, ADV HEAT MASS TRANSF; Gradeck M, 2005, INT J HEAT MASS TRAN, V48, P1909, DOI 10.1016/j.ijheatmasstransfer.2004.12.026; Islamoglu Y, 2003, APPL THERM ENG, V23, P979, DOI 10.1016/S1359-4311(03)00029-2; Koo J, 2005, INT J HEAT MASS TRAN, V48, P2625, DOI 10.1016/j.ijheatmasstransfer.2005.01.024; Kuppan T., 2000, HEAT EXCHANGER DESIG; Leal L, 2013, INT COMMUN HEAT MASS, V49, P36, DOI 10.1016/j.icheatmasstransfer.2013.10.004; Leal L, 2013, INT J HEAT MASS TRAN, V61, P505, DOI 10.1016/j.ijheatmasstransfer.2013.01.083; Lee PS, 2005, INT J HEAT MASS TRAN, V48, P1688, DOI 10.1016/j.ijheatmasstransfer.2004.11.019; Li HY, 2016, INT J THERM SCI, V110, P26, DOI 10.1016/j.ijthermalsci.2016.06.030; Liu Y, 2011, APPL THERM ENG, V31, P921, DOI 10.1016/j.applthermaleng.2010.11.015; Ma SL, 2015, INT J HEAT MASS TRAN, V90, P454, DOI 10.1016/j.ijheatmasstransfer.2015.03.050; Naphon P, 2008, INT J HEAT MASS TRAN, V51, P3963, DOI 10.1016/j.ijheatmasstransfer.2007.11.050; Naphon P, 2009, INT COMMUN HEAT MASS, V36, P942, DOI 10.1016/j.icheatmasstransfer.2009.05.007; Niceno B, 2001, INT J HEAT FLUID FL, V22, P156, DOI 10.1016/S0142-727X(01)00074-1; NISHIMURA T, 1990, INT J HEAT MASS TRAN, V33, P835, DOI 10.1016/0017-9310(90)90067-5; NISHIMURA T, 1984, J CHEM ENG JPN, V17, P466, DOI 10.1252/jcej.17.466; Phillips R. J., 1987, THESIS; Schmidmayer K, 2017, ENERGY, V128, P713, DOI 10.1016/j.energy.2017.04.048; Wang CC, 2002, INT J HEAT MASS TRAN, V45, P2587, DOI 10.1016/S0017-9310(01)00335-0; Wibulswas P., 1966, THESIS U LONDON	21	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2019	14	7							e0219441	10.1371/journal.pone.0219441	http://dx.doi.org/10.1371/journal.pone.0219441			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4LN	31295283	Green Published, gold, Green Submitted			2022-12-26	WOS:000484951800033
J	Bluhm, C; Butenschoen, O; Maraun, M; Scheu, S				Bluhm, Christian; Butenschoen, Olaf; Maraun, Mark; Scheu, Stefan			Effects of root and leaf litter identity and diversity on oribatid mite abundance, species richness and community composition	PLOS ONE			English	Article							BEECH FAGUS-SYLVATICA; TROPHIC NICHE DIFFERENTIATION; ASH FRAXINUS-EXCELSIOR; MICROBIAL BIOMASS; REPRODUCTIVE MODE; TREE DIVERSITY; CARBON INPUT; FOOD-WEB; SOIL; DECOMPOSITION	Habitat heterogeneity is an important driver of aboveground species diversity but few studies have investigated effects on soil communities. Trees shape their surrounding by both leaf litter and roots generating small scale heterogeneity and potentially governing community patterns of soil organisms. To assess the role of vegetation for the soil fauna, we studied whether tree species (Fagus sylvatica L., Acer pseudoplatanus L., Fraxinus excelsior L., Tilia cordata Mill.), markedly differing in leaf litter quality and root associated mycorrhizal symbionts, affect oribatid mite communities by shaping below- and aboveground resources and habitat complexity and availability. Oribatid mite abundance, species richness, community structure and the proportion of litter living and parthenogenetic individuals were analyzed and related to microbial biomass and the amount of remaining litter mass. Although leaf litter species with higher nutritional values decomposed considerably faster, microbial biomass only slightly differed between leaf litter species. Neither root species nor leaf litter species affected abundance, species richness or community structure of oribatid mites. However, root species had an effect on the proportion of parthenogenetic individuals with increased proportions in the presence of beech roots. Overall, the results suggest that identity and diversity of vegetation via leaf litter or roots are of minor importance for structuring oribatid mite communities of a temperate forest ecosystem.	[Bluhm, Christian; Butenschoen, Olaf; Maraun, Mark; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Scheu, Stefan] Univ Gottingen, Ctr Biodivers & Sustainable Land Use, Gottingen, Germany; [Butenschoen, Olaf] Senckenberg Gesell Nat Forsch, Frankfurt, Germany	University of Gottingen; University of Gottingen; Senckenberg Gesellschaft fur Naturforschung (SGN)	Bluhm, C (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany.	cbluhm@gwdg.de		Bluhm, Christian/0000-0003-4691-2876; Butenschoen, Olaf/0000-0003-1866-9805	German Research Foundation (DFG); Ministry of Science and Culture of Lower Saxony; 'Niedersachsisches Vorab' as part of the Cluster of Excellence 'Functional Biodiversity Research'	German Research Foundation (DFG)(German Research Foundation (DFG)); Ministry of Science and Culture of Lower Saxony; 'Niedersachsisches Vorab' as part of the Cluster of Excellence 'Functional Biodiversity Research'	This project was funded by the German Research Foundation (DFG) and the Ministry of Science and Culture of Lower Saxony and the 'Niedersachsisches Vorab' as part of the Cluster of Excellence 'Functional Biodiversity Research.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; ANDERSON JM, 1978, OECOLOGIA, V32, P341, DOI 10.1007/BF00345112; ANDERSON JM, 1975, J ANIM ECOL, V44, P475, DOI 10.2307/3607; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Aneja MK, 2006, MICROB ECOL, V52, P127, DOI 10.1007/s00248-006-9006-3; Bardgett R. D., 2005, The biology of soil: a community and ecosystem approach; Bardgett RD, 2002, ZOOLOGY, V105, P367, DOI 10.1078/0944-2006-00072; Beck T, 1997, SOIL BIOL BIOCHEM, V29, P1023, DOI 10.1016/S0038-0717(97)00030-8; Castro-Diez P, 2000, OECOLOGIA, V124, P476, DOI 10.1007/PL00008873; Cesarz S, 2013, SOIL BIOL BIOCHEM, V61, P23, DOI 10.1016/j.soilbio.2013.02.003; Chapman SK, 2010, OECOLOGIA, V162, P763, DOI 10.1007/s00442-009-1498-3; Cianciolo JM, 2006, EXP APPL ACAROL, V40, P1, DOI 10.1007/s10493-006-9016-3; Domes K, 2007, PEDOBIOLOGIA, V51, P1, DOI 10.1016/j.pedobi.2006.11.001; Ducarme X, 2004, PEDOBIOLOGIA, V48, P139, DOI 10.1016/j.pedobi.2003.10.002; Eisenhauer N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016055; Eisenhauer N, 2011, SOIL BIOL BIOCHEM, V43, P462, DOI 10.1016/j.soilbio.2010.10.018; Eissfeller V, 2013, SOIL BIOL BIOCHEM, V63, P154, DOI 10.1016/j.soilbio.2013.03.024; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fischer BM, 2010, EXP APPL ACAROL, V52, P221, DOI 10.1007/s10493-010-9366-8; Gilbert KJ, 2014, SOIL BIOL BIOCHEM, V76, P45, DOI 10.1016/j.soilbio.2014.05.005; Giller PS, 1996, BIODIVERS CONSERV, V5, P135, DOI 10.1007/BF00055827; Hansen RA, 1998, APPL SOIL ECOL, V9, P17, DOI 10.1016/S0929-1393(98)00048-1; Hansen RA, 2000, ECOLOGY, V81, P1120, DOI 10.1890/0012-9658(2000)081[1120:EOHCAC]2.0.CO;2; Hogberg MN, 2002, NEW PHYTOL, V154, P791, DOI 10.1046/j.1469-8137.2002.00417.x; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; Irmler U, 2000, PEDOBIOLOGIA, V44, P105, DOI 10.1078/S0031-4056(04)70032-3; Jacob M, 2010, OECOLOGIA, V164, P1083, DOI 10.1007/s00442-010-1699-9; Jacob M, 2009, SOIL BIOL BIOCHEM, V41, P2122, DOI 10.1016/j.soilbio.2009.07.024; Kaneko N, 2005, PEDOBIOLOGIA, V49, P521, DOI 10.1016/j.pedobi.2005.06.004; Kaneko N, 1999, ECOL RES, V14, P131, DOI 10.1046/j.1440-1703.1999.00292.x; Korboulewsky N, 2016, SOIL BIOL BIOCHEM, V94, P94, DOI 10.1016/j.soilbio.2015.11.024; Kubartova A, 2009, MICROB ECOL, V58, P98, DOI 10.1007/s00248-008-9458-8; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Langenbruch C, 2012, PLANT SOIL, V352, P389, DOI 10.1007/s11104-011-1004-7; MACFADYEN A, 1961, J ANIM ECOL, V30, P171, DOI 10.2307/2120; Maraun M, 2000, ECOGRAPHY, V23, P374, DOI 10.1111/j.1600-0587.2000.tb00294.x; Maraun M, 2011, SOIL BIOL BIOCHEM, V43, P877, DOI 10.1016/j.soilbio.2011.01.003; Maraun M, 2003, EUR J SOIL BIOL, V39, P85, DOI 10.1016/S1164-5563(03)00006-2; MARAUN M, 1995, BIOL FERT SOILS, V19, P155, DOI 10.1007/BF00336152; Maraun M, 2012, EVOL ECOL RES, V14, P311; Migge S, 1998, APPL SOIL ECOL, V9, P115, DOI 10.1016/S0929-1393(98)00065-1; Minor MA, 2011, EUR J SOIL BIOL, V47, P122, DOI 10.1016/j.ejsobi.2011.01.003; Nielsen UN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011567; Norton Roy A., 1993, P8; Oksanen J, 2018, PACKAGE VEGAN R PACK; PALMER SC, 1991, EXP APPL ACAROL, V12, P67, DOI 10.1007/BF01204401; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; Pollierer MM, 2012, FUNCT ECOL, V26, P978, DOI 10.1111/j.1365-2435.2012.02005.x; Prescott CE, 2013, FOREST ECOL MANAG, V309, P19, DOI 10.1016/j.foreco.2013.02.034; Remen C, 2008, SOIL BIOL BIOCHEM, V40, P2881, DOI 10.1016/j.soilbio.2008.08.006; Remen C, 2010, SOIL BIOL BIOCHEM, V42, P978, DOI 10.1016/j.soilbio.2010.02.017; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Ruf A, 2006, SOIL BIOL BIOCHEM, V38, P2390, DOI 10.1016/j.soilbio.2006.03.008; Scheu S, 2007, P ROY SOC B-BIOL SCI, V274, P1225, DOI 10.1098/rspb.2007.0040; SCHEU S, 1992, SOIL BIOL BIOCHEM, V24, P1113, DOI 10.1016/0038-0717(92)90061-2; Schneider K, 2005, PEDOBIOLOGIA, V49, P61, DOI 10.1016/j.pedobi.2004.07.010; Schneider K, 2004, SOIL BIOL BIOCHEM, V36, P1769, DOI 10.1016/j.soilbio.2004.04.033; SIEPEL H, 1993, SOIL BIOL BIOCHEM, V25, P1491, DOI 10.1016/0038-0717(93)90004-U; Siira-Pietikainen A, 2001, SOIL BIOL BIOCHEM, V33, P1993, DOI 10.1016/S0038-0717(01)00135-3; Smilauer P., 2014, MULTIVARIATE ANAL EC, V5; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; St John MG, 2006, ECOLOGY, V87, P625, DOI 10.1890/05-0380; Stein A, 2014, ECOL LETT, V17, P866, DOI 10.1111/ele.12277; Sylvain ZA, 2010, PEDOBIOLOGIA, V53, P321, DOI 10.1016/j.pedobi.2010.03.001; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Walter D.E., 2013, MITES ECOLOGY EVOLUT, DOI DOI 10.1007/978-94-007-7164-2; WALTER DE, 1985, PEDOBIOLOGIA, V28, P383; Wardle D., 2002, COMMUNITIES ECOSYSTE; Wardle DA, 2003, OIKOS, V102, P45, DOI 10.1034/j.1600-0706.2003.12481.x; Wardle DA, 2006, SOIL BIOL BIOCHEM, V38, P1052, DOI 10.1016/j.soilbio.2005.09.003; Weigmann G., 2006, DIE TIERWELT DEUTSCH; Weisser WW, 2017, BASIC APPL ECOL, V23, P1, DOI 10.1016/j.baae.2017.06.002; Yang N, 2019, MYCORRHIZA, V29, P85, DOI 10.1007/s00572-018-0876-2; Zaitsev AS, 2006, APPL SOIL ECOL, V34, P230, DOI 10.1016/j.apsoil.2006.01.005; Zieger SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189502	77	4	4	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219166	10.1371/journal.pone.0219166	http://dx.doi.org/10.1371/journal.pone.0219166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291304	Green Submitted, Green Published, gold			2022-12-26	WOS:000484947800054
J	Schonbach, JK; Nusselder, W; Lhachimi, SK				Schoenbach, Johanna-Katharina; Nusselder, Wilma; Lhachimi, Stefan K.			Substituting polyunsaturated fat for saturated fat: A health impact assessment of a fat tax in seven European countries	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; TARGETED FOOD TAXES; CARDIOVASCULAR MORTALITY; DIETARY-FAT; RISK; POLICY; METAANALYSIS; CONSUMPTION; REDUCTIONS; STROKE	There is evidence that replacing saturated fat (SFA) with polyunsaturated fat (PUFA) lowers ischemic heart disease (IHD). In order to improve the population's diet, the World Health Organization has called for the taxation of foods that are high in SFA. We aimed to assess the potential health gains of a European fat tax by applying the SFA intake reduction that has been observed under the Danish fat tax to six other European countries. For each country, we created a fat tax scenario with a decreased SFA intake and a corresponding increase in PUFA. We compared this fat tax scenario to a reference scenario with no change in SFA intake, and to a guideline scenario with a population-wide SFA intake in line with dietary recommendations. We used DYNAMO-HIA to dynamically project the policy-attributable IHD cases of these three scenarios 10 years into the future. A fat tax would reduce prevalent IHD cases by a minimum of 500 and 300 among males and females in Denmark, respectively, up to a maximum of 5,600 and 4,000 among males and females in the UK. Thereby, the prevented IHD cases under a fat tax scenario would correspond to between 11.0% (in females in the Netherlands) and 29.5% (in females in Italy) of the prevented IHD cases under a guideline scenario, which represents the maximum preventable disease burden. Henceforth, our quantification of beneficial health impacts makes the case for the policy debate on fat taxes.	[Schoenbach, Johanna-Katharina; Lhachimi, Stefan K.] Univ Bremen, Inst Publ Hlth & Nursing Res, Bremen, Germany; [Schoenbach, Johanna-Katharina; Lhachimi, Stefan K.] Leibniz Inst Prevent Res & Epidemiol BIPS, Res Grp Evidence Based Publ Hlth, Bremen, Germany; [Nusselder, Wilma] Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands	University of Bremen; Leibniz Institute for Prevention Research & Epidemiology (BIPS); Erasmus University Rotterdam; Erasmus MC	Schonbach, JK (corresponding author), Univ Bremen, Inst Publ Hlth & Nursing Res, Bremen, Germany.; Schonbach, JK (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Res Grp Evidence Based Publ Hlth, Bremen, Germany.	schoenbach@uni-bremen.de	Lhachimi, Stefan K/D-9227-2014	Lhachimi, Stefan K/0000-0001-8597-0935; Schonbach, Johanna-Katharina/0000-0002-4543-6700				Amcoff E, 2012, RIKSMATEN 2010 11 LI; Arnoult MH, 2008, MODELS NUTR DEMAND T; Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Bjorck L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160474; Bodker M, 2015, HEALTH POLICY, V119, P737, DOI 10.1016/j.healthpol.2015.03.003; Boshuizen HC, 2012, DEMOGRAPHY, V49, P1259, DOI 10.1007/s13524-012-0122-z; Briggs MA, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5020029; Clifton PM, 2017, NUTR METAB CARDIOVAS, V27, P1060, DOI 10.1016/j.numecd.2017.10.010; Cobiac LJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002232; de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978; Ellander A, 2015, EUR J LIPID SCI TECH, V117, P1370, DOI 10.1002/ejlt.201400513; Elmadfa I, 2009, ANN NUTR METAB, V55, P3; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Farvid MS, 2014, CIRCULATION, V130, P1568, DOI 10.1161/CIRCULATIONAHA.114.010236; Food and Agricultural Organization of the United Nations, 2010, REPORT EXPERT CONSUL; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Hamley S, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0254-5; Harika RK, 2013, ANN NUTR METAB, V63, P229, DOI 10.1159/000355437; Hooper Lee, 2015, Cochrane Database Syst Rev, pCD011737, DOI 10.1002/14651858.CD011737; Hooper L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002137.pub3; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Jensen JD, 2013, FOOD POLICY, V42, P18, DOI 10.1016/j.foodpol.2013.06.004; Kulik MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032363; Lhachimi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033317; Lhachimi SK, 2010, AM J PREV MED, V38, P78, DOI 10.1016/j.amepre.2009.08.030; Linseisen J, 2009, EUR J CLIN NUTR, V63, pS61, DOI 10.1038/ejcn.2009.75; Lloyd-Williams F, 2008, B WORLD HEALTH ORGAN, V86, P535, DOI 10.2471/BLT.08.053728; Marshall T, 2000, BRIT MED J, V320, P301, DOI 10.1136/bmj.320.7230.301; Martikainen JA, 2011, EUR J CLIN NUTR, V65, P1148, DOI 10.1038/ejcn.2011.78; Mensink RP, 2020, EFFECTS SATURATED FA; Mhurchu CN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128477; Micha R, 2010, LIPIDS, V45, P893, DOI 10.1007/s11745-010-3393-4; Michas G, 2014, ATHEROSCLEROSIS, V234, P320, DOI 10.1016/j.atherosclerosis.2014.03.013; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Mytton O, 2007, J EPIDEMIOL COMMUN H, V61, P689, DOI 10.1136/jech.2006.047746; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Nettleton JA, 2017, ANN NUTR METAB, V70, P26, DOI 10.1159/000455681; Niebylski ML, 2015, NUTRITION, V31, P787, DOI 10.1016/j.nut.2014.12.010; Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214; O'Flaherty M, 2016, INT J CARDIOL, V207, P286, DOI 10.1016/j.ijcard.2016.01.147; O'Flaherty M, 2012, B WORLD HEALTH ORGAN, V90, P522, DOI 10.2471/BLT.11.092643; O'Keeffe C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002837; Orsavova J, 2015, INT J MOL SCI, V16, P12871, DOI 10.3390/ijms160612871; Sahan C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011217; Schwab U, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.25145; Schwingshackl L, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-154; Siri-Tarino PW, 2015, ANNU REV NUTR, V35, P517, DOI 10.1146/annurev-nutr-071714-034449; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Smed S, 2016, EUR J CLIN NUTR, V70, P681, DOI 10.1038/ejcn.2016.6; Smed S, 2012, NUTR BULL, V37, P142, DOI 10.1111/j.1467-3010.2012.01962.x; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; Tiffin R, 2011, EUR J CLIN NUTR, V65, P427, DOI 10.1038/ejcn.2010.281; Virtanen JK, 2018, PROSTAG LEUKOTR ESS, V133, P8, DOI 10.1016/j.plefa.2018.04.002; WHO, 2015, US PRIC POL PROM HEA; Wilkins E., 2017, EUROPEAN CARDIOVASCU; World Health Organization, 2016, FISC POL DIET PREV N	56	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0218464	10.1371/journal.pone.0218464	http://dx.doi.org/10.1371/journal.pone.0218464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4JZ	31291265	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800022
J	Wang, W; Cao, L; Sun, WC; Xin, JL; Zheng, M; Tian, MY; Lu, HJ; Jin, NY				Wang, Wei; Cao, Liang; Sun, Wenchao; Xin, Jialiang; Zheng, Min; Tian, Mingyao; Lu, Huijun; Jin, Ningyi			Sequence and phylogenetic analysis of novel porcine parvovirus 7 isolates from pigs in Guangxi, China	PLOS ONE			English	Article							CIRCOVIRUS TYPE-2; 1ST IDENTIFICATION; VIRUS; ASSOCIATION; PREVALENCE; EXPRESSION; SAMPLES; PCV2; PPV	Parvoviruses are a diverse group of viruses that infect a wide range of animals and humans. In recent years, advances in molecular techniques have resulted in the identification of several novel parvoviruses in swine. In this study, porcine parvovirus 7 (PPV7) isolates from clinical samples collected in Guangxi, China, were examined to understand their molecular epidemiology and co-infection with porcine circovirus type 2 (PCV2). In this study, among the 385 pig serum samples, 105 were positive for PPV7, representing a 27.3% positive detection rate. The co-infection rate of PPV7 and PCV2 was 17.4% (67/385). Compared with the reference strains, we noted 93.9%-97.9% similarity in the NS1 gene and 87.4%-95.0% similarity in the cap gene. Interestingly, compared with the reference strains, sixteen of the PPV7 strains in this study contained an additional 3 to 15 nucleotides in the middle of the cap gene. Therefore, the Cap protein of fourteen strains encoded 474 amino acids, and the Cap protein of the other two strains encoded 470 amino acids. However, the Cap protein of the reference strain PPV7 isolate 42 encodes 469 amino acids. This is the first report of sequence variation within the cap gene, confirming an increase in the number of amino acids in the Cap protein of PPV7. Our findings provide new insight into the prevalence of PPV7 in swine in Guangxi, China, as well as sequence data and phylogenetic analysis of these novel PPV7 isolates.	[Wang, Wei; Xin, Jialiang; Jin, Ningyi] Guangxi Univ, Coll Anim Sci & Technol, Nanning, Peoples R China; [Wang, Wei; Cao, Liang; Sun, Wenchao; Tian, Mingyao; Lu, Huijun; Jin, Ningyi] Acad Mil Med Sci, Inst Mil Vet, Key Lab Jilin Prov Zoonosis Prevent & Control, Changchun, Jilin, Peoples R China; [Cao, Liang; Jin, Ningyi] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China; [Sun, Wenchao; Jin, Ningyi] Wenzhou Univ, Inst Virol, Wenzhou, Peoples R China; [Xin, Jialiang; Zheng, Min] Guangxi Ctr Anim Dis Control & Prevent, Nanning, Peoples R China	Guangxi University; Academy of Military Medical Sciences - China; Jilin Agricultural University; Wenzhou University	Jin, NY (corresponding author), Guangxi Univ, Coll Anim Sci & Technol, Nanning, Peoples R China.; Tian, MY; Lu, HJ; Jin, NY (corresponding author), Acad Mil Med Sci, Inst Mil Vet, Key Lab Jilin Prov Zoonosis Prevent & Control, Changchun, Jilin, Peoples R China.; Jin, NY (corresponding author), Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China.; Jin, NY (corresponding author), Wenzhou Univ, Inst Virol, Wenzhou, Peoples R China.	klwklw@126.com; huijun_lu@126.com; Jinningyi2000@126.com			National Key Research and Development Program of China [2017YFD0500101, 2018YFD0500803, 2018YFD0500104]; National Natural Science Foundation of Zhejiang Province [LQ19C180001]	National Key Research and Development Program of China; National Natural Science Foundation of Zhejiang Province	This work was supported by the following Grants: National Key Research and Development Program of China (Grant numbers 2017YFD0500101, 2018YFD0500803, and 2018YFD0500104), and National Natural Science Foundation of Zhejiang Province (LQ19C180001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 1999, J COMP PATHOL, V121, P1, DOI 10.1053/jcpa.1998.0295; Andersson M, 2011, VET IMMUNOL IMMUNOP, V142, P72, DOI 10.1016/j.vetimm.2011.04.012; Cheung AK, 2010, ARCH VIROL, V155, P801, DOI 10.1007/s00705-010-0646-8; Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1; Csagola A, 2012, ARCH VIROL, V157, P1003, DOI 10.1007/s00705-012-1257-3; Cui J, 2017, TRANSBOUND EMERG DIS, V64, P1945, DOI 10.1111/tbed.12593; Cui J, 2017, VIRUS GENES, V53, P100, DOI 10.1007/s11262-016-1386-y; Glasa M, 2004, J GEN VIROL, V85, P2671, DOI 10.1099/vir.0.80206-0; Heldt CL, 2006, J VIROL METHODS, V135, P56, DOI 10.1016/j.jviromet.2006.01.022; Huang L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-333; MAYR A, 1968, ARCH GES VIRUSFORSCH, V25, P38, DOI 10.1007/BF01243088; Milek D, 2018, RES VET SCI, V120, P28, DOI 10.1016/j.rvsc.2018.08.004; Mira F, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040308; Ni JQ, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0203-2; Oh WT, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080196; Opriessnig T, 2014, VET MICROBIOL, V173, P9, DOI 10.1016/j.vetmic.2014.06.024; Opriessnig T, 2012, VIRUS RES, V164, P20, DOI 10.1016/j.virusres.2011.09.014; Ouh IO, 2018, J VET SCI, V19, P855, DOI 10.4142/jvs.2018.19.6.855; OUYANG T, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11020185; Palinski RM, 2016, VIRUS GENES, V52, P564, DOI 10.1007/s11262-016-1322-1; Ritzmann M, 2005, DEUT TIERARZTL WOCH, V112, P348; Saekhow P, 2015, J VET MED SCI, V77, P1581, DOI 10.1292/jvms.15-0167; Schirtzinger EE, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0401-6; Shackelton LA, 2007, J GEN VIROL, V88, P3294, DOI 10.1099/vir.0.83255-0; Sun JH, 2015, ARCH VIROL, V160, P1339, DOI 10.1007/s00705-015-2373-7; Phan TG, 2015, VIRUS GENES, V50, P134, DOI 10.1007/s11262-014-1123-3; Wang Y, 2019, INFECT GENET EVOL, V71, P31, DOI 10.1016/j.meegid.2019.03.004; Xiao CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065312; Xing XL, 2018, ARCH VIROL, V163, P209, DOI 10.1007/s00705-017-3585-9; Zeng SL, 2011, J GEN VIROL, V92, P784, DOI 10.1099/vir.0.028340-0	30	14	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2019	14	7							e0219560	10.1371/journal.pone.0219560	http://dx.doi.org/10.1371/journal.pone.0219560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4JZ	31291362	Green Published, gold, Green Submitted			2022-12-26	WOS:000484947800115
J	Lopez-Acosta, M; Leynaert, A; Chavaud, L; Amice, E; Bihannic, I; Le Bec, T; Maldonado, M				Lopez-Acosta, Maria; Leynaert, Aude; Chavaud, Laurent; Amice, Erwan; Bihannic, Isabelle; Le Bec, Thierry; Maldonado, Manuel			In situ determination of Si, N, and P utilization by the demosponge Tethya citrina: A benthicchamber approach	PLOS ONE			English	Article							DISSOLVED INORGANIC NITROGEN; TEMPERATE MAERL BEDS; COMMUNITY METABOLISM; MICROBIAL SYMBIONTS; SPONGE; PHOSPHORUS; NITRATE; FLUXES; CARBON; BAY	Sponges consume dissolved silicon (DSi) to build their skeletons. Few studies have attempted to quantify DSi utilization by these organisms and all available determinations come from laboratory measurements. Here we measured DSi consumption rates of the sponge Tethya citrina in its natural habitat, conducting 24h incubations in benthic chambers. Sponges consumed DSi at an average rate of 0.046 +/- 0.018 mu mol h(-1) mL(-1) when DSi availability in its habitat was 8.3 +/- 1.8 mu M. Such DSi consumption rates significantly matched the values predicted by a kinetic model elsewhere developed previously for this species through laboratory incubations. These results support the use of laboratory incubations as a suitable approach to learn about DSi consumption. During the field incubations, utilization of other dissolved inorganic nutrients by this low-microbial-abundance (LMA) sponge was also measured. The sponges were net sources of ammonium (-0.043 +/- 0.031 mu mol h(-1) mL(-1)), nitrate (-0.063 +/- 0.031 mu mol h(-1) mL(-1)), nitrite (-0.007 +/- 0.003 mu mol h(-1) mL(-1)), and phosphate (-0.004 +/- 0.005 mu mol h(-1) mL(-1)), in agreement with the general pattern in other LMA species. The detected effluxes were among the lowest reported for sponges, which agreed with the low respiration rates characterizing this species (0.35 +/- 0.11 mu mol-O-2 h(-1) mL(-1)). Despite relatively low flux, the dense population of T. citrina modifies the availability of dissolved inorganic nutrients in the demersal water of its habitat, contributing up to 14% of nitrate and nitrite stocks. Through these effects, the bottom layer contacting the benthic communities where siliceous LMA sponges abound can be partially depleted in DSi, but can benefit from inputs of N and P dissolved inorganic nutrients that are critical to primary producers.	[Lopez-Acosta, Maria; Maldonado, Manuel] CSIC, CEAB, Dept Marine Ecol, Blanes, Girona, Spain; [Leynaert, Aude; Chavaud, Laurent; Amice, Erwan; Bihannic, Isabelle] Univ Brest, CNRS, LEMAR, Plouzane, France; [Le Bec, Thierry] Univ Bretagne Occidentale, Inst Univ Europeen Mer, Brest, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Lopez-Acosta, M; Maldonado, M (corresponding author), CSIC, CEAB, Dept Marine Ecol, Blanes, Girona, Spain.	marialpezacosta@gmail.com; maldonado@ceab.csic.es	Maldonado, Manuel/J-9331-2012; Leynaert, Aude/A-4211-2010	Maldonado, Manuel/0000-0002-7447-4212; Leynaert, Aude/0000-0001-8226-3733; Lopez-Acosta, Maria/0000-0002-0233-8457	MINECO [CTM2015-67221-R]; Spanish Ministry of Economy and Competitiveness; EC Horizon 2020 Program [BG-01-2015.2]	MINECO(Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); EC Horizon 2020 Program	Funded by (MM) MINECO CTM2015-67221-R. Spanish Ministry of Economy and Competitiveness. MM. EC Horizon 2020 Program. BG-01-2015.2. Action: RIA. Proposal Number 679849-2. European Commission http//www.deepseasponges erg/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SK, 2017, LIMNOL OCEANOGR, V62, P1783, DOI 10.1002/lno.10533; Bayer K, 2008, ENVIRON MICROBIOL, V10, P2942, DOI 10.1111/j.1462-2920.2008.01582.x; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Beucher C, 2004, MAR ECOL PROG SER, V267, P57, DOI 10.3354/meps267057; BISCE P, 2015, PMC, V10, P8502, DOI DOI 10.1007/S00227-009-1344-5; Chu JWF, 2011, MAR ECOL PROG SER, V441, P1, DOI 10.3354/meps09381; CORREDOR JE, 1988, LIMNOL OCEANOGR, V33, P114, DOI 10.4319/lo.1988.33.1.0114; de Goeij JM, 2017, CLIMATE CHANGE OCEAN, P373, DOI [10.1007/978-3-319-59008-0_8, DOI 10.1007/978-3-319-59008-0_8]; Del Amo Y, 1997, MAR ECOL PROG SER, V161, P225, DOI 10.3354/meps161225; Diaz MC, 1997, MAR ECOL PROG SER, V156, P97, DOI 10.3354/meps156097; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Gloeckner V, 2014, BIOL BULL-US, V227, P78, DOI 10.1086/BBLv227n1p78; H, MAR BIOL; HATCHER A, 1994, MAR BIOL, V121, P161, DOI 10.1007/BF00349485; Hoer DR, 2018, LIMNOL OCEANOGR, V63, P2563, DOI 10.1002/lno.10960; HTTPS, PMC, DOI DOI 10.4319/LO.2010.55.5.2001; HTTPS, PMC, DOI DOI 10.1111/J.1462-2920.2008.01582.X; HTTPS, PMC; HTTPS, PMC, DOI DOI 10.1002/LNO.10956; JIME P, 2007, LIMNOL OCEANOGR, V52, P948, DOI DOI 10.1016/B978-0-12-394283-8.00003-5; Keesing JK, 2013, LIMNOL OCEANOGR, V58, P1947, DOI 10.4319/lo.2013.58.6.1947; Leys SP, 2018, LIMNOL OCEANOGR, V63, P187, DOI 10.1002/lno.10623; LOPRIME P, 2018, LIMNOL OCEANOGR, V63, P2508, DOI DOI 10.1002/LNO.10359; LOPRIME P, 2016, LIMNOL OCEANOGR, V61, P2139, DOI DOI 10.1002/LNO.10623; LOPRIME P, 2018, MAR ECOL PROG SER, V605, P111, DOI DOI 10.1002/LNO.10533; Ludeman DA, 2017, J EXP BIOL, V220, P995, DOI 10.1242/jeb.146076; Maldonado M, 2005, LIMNOL OCEANOGR, V50, P799, DOI 10.4319/lo.2005.50.3.0799; MALDONADO M, 2011, PMC, V1, P8, DOI DOI 10.1007/S10750-011-0977-9; Maldonado M, 2012, ADV MAR BIOL, V62, P113, DOI 10.1016/B978-0-12-394283-8.00003-5; Maldonado M, 2012, HYDROBIOLOGIA, V687, P251, DOI 10.1007/s10750-011-0977-9; Maldonado M, 2010, LIMNOL OCEANOGR, V55, P2001, DOI 10.4319/lo.2010.55.5.2001; Martin S, 2007, MAR ECOL PROG SER, V335, P31, DOI 10.3354/meps335031; Martin S, 2007, MAR ECOL PROG SER, V335, P19, DOI 10.3354/meps335019; MOITINHOSILVA L, 2017, PMC, V8, P1222; Morganti T, 2017, LIMNOL OCEANOGR, V62, P1963, DOI 10.1002/lno.10546; Morganti T, 2016, JOVE-J VIS EXP, DOI 10.3791/54221; Moroni Flavio, 2012, J NEURAL TRANSM, V119, P133, DOI [DOI 10.1007/S10750-011-0798-X, 10.1007/s00702-011-0763-x, DOI 10.1007/S00702-011-0763-X]; Osinga R, 1999, MAR BIOTECHNOL, V1, P509, DOI 10.1007/PL00011807; Paytan A, 2007, CHEM REV, V107, P563, DOI 10.1021/cr0503613; PEREABLA P, 2012, HYDROBIOLOGIA, V687, P237, DOI DOI 10.3354/MEPS12752; Pita L, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0428-1; Raimbault P, 2008, BIOGEOSCIENCES, V5, P281, DOI 10.5194/bg-5-281-2008; RAMI P, 2005, ESTUAR COAST SHELF S, V65, P654, DOI DOI 10.1016/J.ECSS.2005.07.012; Reincke T, 1997, MAR BIOL, V129, P591, DOI 10.1007/s002270050200; REISWIG H M, 1981, Marine Ecology, V2, P273, DOI 10.1111/j.1439-0485.1981.tb00271.x; REISWIG HM, 1973, J EXP MAR BIOL ECOL, V14, P231; Ribes M, 2012, ENVIRON MICROBIOL, V14, P1224, DOI 10.1111/j.1462-2920.2012.02701.x; Rivkin RB, 1997, LIMNOL OCEANOGR, V42, P730, DOI 10.4319/lo.1997.42.4.0730; RIX L, 2015, THESIS; SCHLA S, 2010, MAR BIOL, V157, P593, DOI DOI 10.1007/S00227-009-1344-5; SHANMUGAM KT, 1975, P NATL ACAD SCI USA, V72, P136, DOI 10.1073/pnas.72.1.136; Southwell MW, 2008, LIMNOL OCEANOGR, V53, P986, DOI 10.4319/lo.2008.53.3.0986; STRICKLAND JDH, 1972, CANADA, P2; Thiel V, 2007, FEMS MICROBIOL ECOL, V59, P47, DOI 10.1111/j.1574-6941.2006.00217.x; TIKHONOVICH I, 2007, ELSEVIER SCIENCE, P365, DOI DOI 10.1242/JEB.146076; TRE P, 2013, ANNU REV MAR SCI, V5, P477, DOI DOI 10.1146/ANNUREV-MARINE-121211-172346; TREGUER P, 1975, MANUEL DANALYSE DES, P2; Vicente J, 2016, ICES J MAR SCI, V73, P704, DOI 10.1093/icesjms/fsv235; Yahel G, 2005, LIMNOL OCEANOGR-METH, V3, P46, DOI 10.4319/lom.2005.3.46; Yahel G, 2007, LIMNOL OCEANOGR, V52, P428, DOI 10.4319/lo.2007.52.1.0428; Zakem EJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03553-w; Zhang F, 2015, P NATL ACAD SCI USA, V112, P4381, DOI 10.1073/pnas.1423768112	63	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2019	14	7							e0218787	10.1371/journal.pone.0218787	http://dx.doi.org/10.1371/journal.pone.0218787			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4GX	31283799	Green Submitted, Green Published, gold			2022-12-26	WOS:000484939800010
J	Bamford, C; Wignall-Fleming, E; Sreenu, VB; Randall, R; Duprex, P; Rima, B				Bamford, Connor; Wignall-Fleming, Elizabeth; Sreenu, Vattipally B.; Randall, Richard; Duprex, Paul; Rima, Bertus			Unusual, stable replicating viruses generated from mumps virus cDNA clones	PLOS ONE			English	Article							MEASLES-VIRUS; PROTEIN; RESCUE; CELLS; GENE	In reverse genetic experiments we have isolated recombinant mumps viruses (rMuV) that carry large numbers of mutations clustered in small parts of their genome, which are not caused by biased hyper-mutation. In two separate experiments we obtained such recombinant viruses: one virus had 11 mutations in the V/P region of the genome; the other, which also contained an extra transcription unit encoding green fluorescent protein (EGFP), had 32 mutations in the N gene. These specific sets of mutations have not been observed in naturally occurring MuV isolates. Unusually, the vast majority of the mutations (48/51) were synonymous. On passage in Vero cells and human B-LCL cells, a B lymphocyte-like cell line, these mutations appear stable as no reversion occurred to the original consensus sequence, although mutations in other parts of the genome occurred and changed in frequency during passage. Defective interfering RNAs accumulate in passage in Vero cells but not in B-LCL cells. Interestingly, in all passaged samples the level of variation in the EGFP gene is the same as in the viral genes, though it is unlikely that this gene is under any functionality constraint. What mechanism gave rise to these viruses with clustered mutations and their stability remains an open question, which is likely of interest to a wider field than mumps reverse genetics.	[Bamford, Connor; Wignall-Fleming, Elizabeth; Sreenu, Vattipally B.] Glasgow Univ, Ctr Virus Res, Glasgow, Lanark, Scotland; [Bamford, Connor; Rima, Bertus] Queens Univ Belfast, Ctr Expt Med, Belfast, Antrim, North Ireland; [Wignall-Fleming, Elizabeth; Randall, Richard] St Andrews Univ, Sch Biol, St Andrews, Fife, Scotland; [Duprex, Paul] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA	University of Glasgow; Queens University Belfast; University of St Andrews; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rima, B (corresponding author), Queens Univ Belfast, Ctr Expt Med, Belfast, Antrim, North Ireland.	b.rima@qub.ac.uk		Randall, Richard/0000-0002-9304-6678; Wignall-Fleming, Elizabeth B/0000-0002-3626-8768	Wellcome Trust [101788/Z/13/Z]; Queen's University Belfast; University of St Andrews; MRC [MC_UU_12014/12] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Queen's University Belfast; University of St Andrews; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors have acknowledged funding from a Wellcome Trust grant 101788/Z/13/Z to RER and funding from the respective universities for studentships, Queen's University Belfast to CGB, and University of St Andrews to EWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili J, 2013, PHYS WORLD, V26, P42; Bamford CGG, 2014, INVESTIGATING MOL DE; Britton P, 1996, J GEN VIROL, V77, P963, DOI 10.1099/0022-1317-77-5-963; Brown DD, 2005, J GEN VIROL, V86, P1077, DOI 10.1099/vir.0.80804-0; Clarke DK, 2000, J VIROL, V74, P4831, DOI 10.1128/JVI.74.10.4831-4838.2000; Elliott GD, 1988, VIRUS RES S1, V11; Gassen U, 2000, J VIROL, V74, P10737, DOI 10.1128/JVI.74.22.10737-10744.2000; Gutsche I, 2015, SCIENCE, V348, P704, DOI 10.1126/science.aaa5137; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Lemon K, 2007, J VIROL, V81, P8293, DOI 10.1128/JVI.00266-07; Lemon K, 2015, J VIROL, V89, P2849, DOI 10.1128/JVI.03587-14; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Moeller K, 2001, J VIROL, V75, P7612, DOI 10.1128/JVI.75.16.7612-7620.2001; Otani S, 2014, VIROLOGY, V462, P91, DOI 10.1016/j.virol.2014.05.035; Pomeroy LW, 2008, J MOL EVOL, V66, P98, DOI 10.1007/s00239-007-9040-x; Pusuluk O, ARXIV11010073; Rieper E, ARXIV10064053; Rima BK, 2015, J GEN VIROL, V96, P939, DOI 10.1099/vir.0.070789-0; Rota JS, 2013, CLIN VACCINE IMMUNOL, V20, P391, DOI 10.1128/CVI.00660-12; Rubin SA, 1998, J VIROL, V72, P8037, DOI 10.1128/JVI.72.10.8037-8042.1998; Rubin SA, FIELDS VIROLOGY; Santak M, 2015, MICROBES INFECT, V17, P228, DOI 10.1016/j.micinf.2014.11.006; Sauder Christian J, 2011, J Virol, V85, P7059, DOI 10.1128/JVI.00245-11; Sviben D, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1073-9; VANBINNENDIJK RS, 1994, J INFECT DIS, V170, P443, DOI 10.1093/infdis/170.2.443; Wignall-Fleming EB, 2019, J VIROL, V93, DOI 10.1128/JVI.00571-19; Xu P, 2012, J VIROL, V86, P1768, DOI 10.1128/JVI.06019-11	27	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219168	10.1371/journal.pone.0219168	http://dx.doi.org/10.1371/journal.pone.0219168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276568	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000484936300044
J	Britt, EL; Raman, S; Leek, K; Sheehy, CH; Kim, SW; Harada, H				Britt, Erin L.; Raman, Sarina; Leek, Kendall; Sheehy, Casey H.; Kim, Sung W.; Harada, Hisashi			Combination of fenretinide and ABT-263 induces apoptosis through NOXA for head and neck squamous cell carcinoma treatment	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; BCL-2 PROTEIN FAMILY; INHIBITOR; POTENT; MCL-1; FLUOROURACIL; CHEMOTHERAPY; VENETOCLAX; DOCETAXEL; SURVIVAL	The overall survival for recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) remains low, with little progress made over decades. Cisplatin, most frequently used for HNSCC treatment, activates mitochondria-dependent apoptosis through the BCL-2 family proteins. We have previously demonstrated that the pro-apoptotic BH3-only protein, NOXA plays a critical role in this process. NOXA binds and inactivates anti-apoptotic MCL-1, while the BCL-2 inhibitor ABT-263 is capable of inactivating anti-apoptotic BCL-2 and BCL-XL. We hypothesized that combination of NOXA and ABT-263 treatment increases cell death by simultaneously inhibiting anti-apoptotic BCL-2 family proteins in HNSCC cells. Here, we demonstrated that combination of ectopic NOXA expression and ABT-263 enhanced apoptosis in p53-inactive, p53 wild-type, and human papillomavirus (HPV)-positive HNSCC cell lines. Furthermore, a retinoid derivative and an endoplasmic reticulum stress inducer, fenretinide, induced NOXA, and combination of fenretinide and ABT-263 strongly induced apoptosis in HNSCC cells regardless of the HPV or p53 statuses. We also found that MCL-1 and BCL-XL are the primary targets of apoptosis induced by the combinations. These results will develop novel and alternative therapeutic strategies to directly modify the cell death machinery in HNSCC.	[Britt, Erin L.; Raman, Sarina; Leek, Kendall; Sheehy, Casey H.; Kim, Sung W.; Harada, Hisashi] Virginia Commonwealth Univ, Massey Canc Ctr, Sch Dent, Philips Inst Oral Hlth Res, Richmond, VA 23284 USA	Virginia Commonwealth University	Harada, H (corresponding author), Virginia Commonwealth Univ, Massey Canc Ctr, Sch Dent, Philips Inst Oral Hlth Res, Richmond, VA 23284 USA.	hharada@vcu.edu	Harada, Hisashi/H-2815-2019	Harada, Hisashi/0000-0001-5993-1289	Virginia Commonwealth University Presidential Research Quest Fund; National Institutes of Health [P30 CA016059]; VCU Presidential Research Quest Fund; NIH-NCI Cancer Center Support Grant [P30 CA016059]; VCU Massey Cancer Center core laboratories; NATIONAL CANCER INSTITUTE [R03CA235097, P30CA016059] Funding Source: NIH RePORTER	Virginia Commonwealth University Presidential Research Quest Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VCU Presidential Research Quest Fund; NIH-NCI Cancer Center Support Grant; VCU Massey Cancer Center core laboratories; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Virginia Commonwealth University Presidential Research Quest Fund (to HH). National Institutes of Health P30 CA016059 (to VCU Massey Cancer Center core laboratories). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Andrew Yeudall, Yue Sun, and Iain Morgan for cell lines. This work was partly supported by VCU Presidential Research Quest Fund (to HH). Services in support of this project were conducted by the VCU Massey Cancer Center core laboratories, which is supported in part by NIH-NCI Cancer Center Support Grant P30 CA016059.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Armstrong JL, 2007, APOPTOSIS, V12, P613, DOI 10.1007/s10495-006-0020-1; Awan FT, 2014, CLIN CANCER RES, V20, P5869, DOI 10.1158/1078-0432.CCR-14-1889; Bourguignon LYW, 2018, MATRIX BIOL, DOI [10.1016/j.matbio.2018.1007.1008, DOI 10.1016/J.MATBIO.2018.1007.1008]; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cooper JP, 2017, EXP BIOL MED, V242, P1178, DOI 10.1177/1535370217706952; Delbridge ARD, 2015, CELL DEATH DIFFER, V22, P1071, DOI 10.1038/cdd.2015.50; Ehsanian R, 2010, ONCOGENE, V29, P6160, DOI 10.1038/onc.2010.339; Erovic BM, 2005, CLIN CANCER RES, V11, P8632, DOI 10.1158/1078-0432.CCR-05-1170; Faber AC, 2015, P NATL ACAD SCI USA, V112, pE1288, DOI 10.1073/pnas.1411848112; Fang H, 2011, CLIN CANCER RES, V17, P7093, DOI 10.1158/1078-0432.CCR-11-0578; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Leverson JD, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.561; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Moore VD, 2013, CANCER LETT, V332, P202, DOI 10.1016/j.canlet.2011.12.021; Nakajima W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.6; Nakajima W, 2016, ONCOTARGET, V7, P36353, DOI 10.18632/oncotarget.9217; Ng Samuel Y, 2014, Clin Adv Hematol Oncol, V12, P224; Ow Thomas J, 2019, Oncotarget, V10, P494, DOI 10.18632/oncotarget.26563; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Roberts AW, 2016, NEW ENGL J MED, V374, P311, DOI 10.1056/NEJMoa1513257; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Sano D, 2011, CLIN CANCER RES, V17, P6658, DOI 10.1158/1078-0432.CCR-11-0046; Schultz JD, 2010, ONCOL REP, V24, P1213, DOI 10.3892/or_00000974; Sharma K, 2018, MOL ONCOL, V12, P788, DOI 10.1002/1878-0261.12172; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Stilgenbauer S, 2016, LANCET ONCOL, V17, P768, DOI 10.1016/S1470-2045(16)30019-5; Suh Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.548; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Vitale-Cross L, 2009, CANCER PREV RES, V2, P419, DOI 10.1158/1940-6207.CAPR-09-0058; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wong M, 2012, MOL CANCER THER, V11, P1026, DOI 10.1158/1535-7163.MCT-11-0693; Yeudall WA, 1997, MOL CARCINOGEN, V18, P89, DOI 10.1002/(SICI)1098-2744(199702)18:2<89::AID-MC4>3.0.CO;2-L; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	40	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219398	10.1371/journal.pone.0219398	http://dx.doi.org/10.1371/journal.pone.0219398			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276572	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300074
J	Fiori, L; Martinez, E; Orams, MB; Bollard, B				Fiori, Lorenzo; Martinez, Emmanuelle; Orams, Mark B.; Bollard, Barbara			Effects of whale-based tourism in Vava'u, Kingdom of Tonga: Behavioural responses of humpback whales to vessel and swimming tourism activities	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; PORT PHILLIP BAY; MEGAPTERA-NOVAEANGLIAE; EXPOSURE; CETACEANS; VICTORIA; SWIMMERS; HARBOR; MODEL; AREA	Vava'u, Kingdom of Tonga, is a well-established whale-watching destination in the South Pacific. Between July and October, the waters around the archipelago represent one of the most important breeding grounds for Oceania humpback whales (Megaptera novaeangliae). The Tongan government allows tourist swimming activities with whales and tour operators strongly promote the practice of swimming-with-whales, focusing primarily on mother-calf pairs. However, there is increasing evidence, derived from empirical research on swim-with-cetacean tourism, that this kind of interaction affects cetacean behaviour and can lead to negative effects on the cetaceans involved. This study represents the first assessment of humpback whales' behavioural responses to vessel and swimmer approaches in Vava'u. Fifty-six surveys took place during the 2016 and 2017 whale breeding seasons aboard dedicated research and tour vessels. Whale dive time, number of reorientation events, and respiration rates were documented in both the absence and presence of boats and swimmers. Vessel approach type, swimmer placement, and whale avoidance responses were also recorded. Results indicate that the average diving time and the proportion of time spent diving in the presence of swimming activities increased significantly for mother-calf pairs (F-2,F-36 = 18.183, P < 0.001; F-2,F-36 = 5.462, P = 0.009, respectively). Moreover, avoidance responses of whales towards tour vessels were observed for one third of vessel approaches (33.5%) and the avoidance rate was significantly affected by the boat approach type (95% CI: 20.7-69.2%, z = 3.50, P < 0.001). Finally, low levels of compliance to the existing Tongan swim-with-whales regulations were documented, in particular the stipulated whale resting time between interactions with tour operator vessels and swimmers was often not respected (38.4%). Vava'u is an important calving ground for the Oceania humpback whale population and these findings should be carefully considered by stakeholders in Tonga and at other locations where swim-with-whales opportunities are being undertaken. Effective strategies to reduce the risk of detrimental effects on the whales targeted by swimming activities, especially mother-calf pairs, are needed.	[Fiori, Lorenzo; Bollard, Barbara] Auckland Univ Technol, Sch Sci, Inst Appl Ecol New Zealand, Auckland, New Zealand; [Martinez, Emmanuelle] NorthTec, Appl & Environm Sci Dept, Whangarei, New Zealand; [Martinez, Emmanuelle] Marine Res & Technol Inst, TriOceans, Bay Of Isl, New Zealand; [Orams, Mark B.] Auckland Univ Technol, Sch Sport & Recreat, Northcote, New Zealand; [Orams, Mark B.] Univ Sunshine Coast, Sustainabil Res Ctr, Sunshine Coast, Qld, Australia	Auckland University of Technology; University of the Sunshine Coast	Fiori, L (corresponding author), Auckland Univ Technol, Sch Sci, Inst Appl Ecol New Zealand, Auckland, New Zealand.	lfiori@aut.ac.nz		Martinez, Emmanuelle/0000-0001-6492-2643; Bollard, Barbara/0000-0003-2103-8561				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2004, ECOL SOC; [Anonymous], 2016, WAT HUMPB WHAL INT N; [Anonymous], 2013, TONGA WHALE WATCHING, P31; Au WWL, 2000, MAR ENVIRON RES, V49, P469, DOI 10.1016/S0141-1136(99)00086-0; Avila I. C., 2015, Tourism in Marine Environments, V11, P19, DOI 10.3727/154427315X14398263718394; Baker CS, 1998, MAR MAMMAL SCI, V14, P721, DOI 10.1111/j.1748-7692.1998.tb00758.x; BAKER CS, 1989, BEHAV RESPONSES SUMM; Bejder L, 2009, MAR ECOL PROG SER, V395, P177, DOI 10.3354/meps07979; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Bochenski Natalie., 2014, BRISBANE TIMES; Braithwaite JE, 2015, CONSERV PHYSIOL, V3, DOI [10.1093/conphys/cov1001, DOI 10.1093/CONPHYS/COV1001]; Burnham K. P., 1998, MODEL SELECTION INFE; Carlson C, 2013, REV WHALE WATCH GUID; Cartwright R, 2009, BEHAVIOUR, V146, P1573, DOI 10.1163/156853909X458377; CHITTLEBOROUGH R. G., 1958, AUSTRALIAN JOUR MARINE AND FRESHWATER RES, V9, P1; Christensen F, 2018, AQUATIC CONSERVATION; Christiansen F, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1468; Clapham P., 2009, MAR FISH REV, V71, P39; Constantine R, 2008, MARINE WILDLIFE AND TOURISM MANAGEMENT: INSIGHTS FROM THE NATURAL AND SOCIAL SCIENCES, P321, DOI 10.1079/9781845933456.0321; Constantine R, 2001, MAR MAMMAL SCI, V17, P689, DOI 10.1111/j.1748-7692.2001.tb01293.x; Constantine R, 2012, MAR ECOL PROG SER, V453, P249, DOI 10.3354/meps09613; CORKERON PJ, 1995, CAN J ZOOL, V73, P1290, DOI 10.1139/z95-153; Curnock M. I., 2013, Tourism in Marine Environments, V9, P5, DOI 10.3727/154427313X13659574649867; Dawson S, 2008, MAMMAL REV, V38, P19, DOI 10.1111/j.1365-2907.2008.00119.x; Ellison WT, 2012, CONSERV BIOL, V26, P21, DOI 10.1111/j.1523-1739.2011.01803.x; Filby NE, 2014, GLOB ECOL CONSERV, V2, P62, DOI 10.1016/j.gecco.2014.08.006; Fumagalli M, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.172044; Hendrix T., 2014, INT WHAL COMM SCI CO, P6; Higham JES, 2008, ENVIRON CONSERV, V35, P294, DOI 10.1017/S0376892908005249; Higham JES, 2008, CURR ISSUES TOUR, V11, P75, DOI 10.2167/cit345.0; Jackson JA, 2013, SC65ASH07 IWC SCI CO, P31; Kessler M, 2013, MAR POLICY, V39, P314, DOI 10.1016/j.marpol.2012.12.013; Kessler M, 2012, MAR POLICY, V36, P440, DOI 10.1016/j.marpol.2011.08.004; Lundquist D, 2013, MAR MAMMAL SCI, V29, pE24, DOI 10.1111/j.1748-7692.2012.00583.x; Lusseau D, 2003, CONSERV BIOL, V17, P1785, DOI 10.1111/j.1523-1739.2003.00054.x; Lusseau D., 2007, INT J COMP PSYCHOL, V20, P228; Magera AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077908; Mangott Arnold Hubert, 2011, Journal of Ecotourism, V10, P64, DOI 10.1080/14724041003690468; Mann J, 1999, MAR MAMMAL SCI, V15, P102, DOI 10.1111/j.1748-7692.1999.tb00784.x; Martinez E, 2011, TOURISM MARINE ENV, V7, P191, DOI [10.3727/154427311X13195453162895, DOI 10.3727/154427311X13195453162895]; Martinez E, 2010, TOUR REV INT, V14, P99, DOI 10.3727/154427211X13044361606379; Matthews L. H., 1937, Discovery Reports Cambridge, V17, P7; Meissner AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116962; MOBLEY JR, 1985, CAN J ZOOL, V63, P762, DOI 10.1139/z85-111; Noren SR, 2008, FUNCT ECOL, V22, P278, DOI 10.1111/j.1365-2435.2007.01353.x; O'Connor S., 2009, WHALE WATCHING WORLD; Orams MB, 2002, COAST MANAGE, V30, P361, DOI 10.1080/089207502900264; Orams MB, 2014, WHALE WATCHING SUSTA; Peters KJ, 2013, MAR MAMMAL SCI, V29, pE484, DOI 10.1111/mms.12003; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Richter C, 2006, MAR MAMMAL SCI, V22, P46, DOI 10.1111/j.1748-7692.2006.00005.x; Scarpaci C., 2004, Tourism in Marine Environments, V1, P41; Scarpaci C, 2003, ENVIRON MANAGE, V31, P342, DOI 10.1007/s00267-002-2799-z; Schaffar Aline, 2010, Journal of Cetacean Research and Management, V11, P147; Scheidat Meike, 2004, Journal of Cetacean Research and Management, V6, P63; Sprogis K.R., 2017, SWIM WITH WHALE TOUR; Stamation KA, 2010, MAR MAMMAL SCI, V26, P98, DOI 10.1111/j.1748-7692.2009.00320.x; Tougaard J, 2015, MAR POLLUT BULL, V90, P196, DOI 10.1016/j.marpolbul.2014.10.051; Tyack P. L., 1982, BEHAVIOUR, V83, P1; Tyne JA, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160626; Walker K, 2011, TOURIST DESTINATION GOVERNANCE: PRACTICE, THEORY AND ISSUES, P103, DOI 10.1079/9781845937942.0103; WHITEHEAD H, 1983, CAN J ZOOL, V61, P1391, DOI 10.1139/z83-186	63	20	21	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219364	10.1371/journal.pone.0219364	http://dx.doi.org/10.1371/journal.pone.0219364			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276544	Green Published, gold			2022-12-26	WOS:000484936300070
J	Miller, TW; Amason, JD; Garcin, ED; Lamy, L; Dranchak, PK; Macarthur, R; Braisted, J; Rubin, JS; Burgess, TL; Farrell, CL; Roberts, DD; Inglese, J				Miller, Thomas W.; Amason, Joshua D.; Garcin, Elsa D.; Lamy, Laurence; Dranchak, Patricia K.; Macarthur, Ryan; Braisted, John; Rubin, Jeffrey S.; Burgess, Teresa L.; Farrell, Catherine L.; Roberts, David D.; Inglese, James			Quantitative high-throughput screening assays for the discovery and development of SIRP alpha-CD47 interaction inhibitors	PLOS ONE			English	Article							REGULATORY-PROTEIN-ALPHA; RESONANCE ENERGY-TRANSFER; INTERFERENCE COMPOUNDS PAINS; ADVERSE PROGNOSTIC-FACTOR; HEMATOPOIETIC STEM-CELLS; SIRP-ALPHA; THERAPEUTIC TARGET; CD47 EXPRESSION; CANCER; RECEPTOR	CD47 is an immune checkpoint molecule that downregulates key aspects of both the innate and adaptive anti-tumor immune response via its counter receptor SIRP alpha, and it is expressed at high levels in a wide variety of tumor types. This has led to the development of biologics that inhibit SIRP alpha engagement including humanized CD47 antibodies and a soluble SIRP alpha decoy receptor that are currently undergoing clinical trials. Unfortunately, toxicological issues, including anemia related to on-target mechanisms, are barriers to their clinical advancement. Another potential issue with large biologics that bind CD47 is perturbation of CD47 signaling through its high-affinity interaction with the matricellular protein thrombospondin-1 (TSP1). One approach to avoid these shortcomings is to identify and develop small molecule molecular probes and pretherapeutic agents that would (1) selectively target SIRP alpha or TSP1 interactions with CD47, (2) provide a route to optimize pharmacokinetics, reduce on-target toxicity and maximize tissue penetration, and (3) allow more flexible routes of administration. As the first step toward this goal, we report the development of an automated quantitative high-throughput screening (qHTS) assay platform capable of screening large diverse drug-like chemical libraries to discover novel small molecules that inhibit CD47-SIRP alpha interaction. Using time-resolved Forster resonance energy transfer (TR-FRET) and bead-based luminescent oxygen channeling assay formats (AlphaScreen), we developed biochemical assays, optimized their performance, and individually tested them in small-molecule library screening. Based on performance and low false positive rate, the LANCE TR-FRET assay was employed in a similar to 90,000 compound library qHTS, while the AlphaScreen oxygen channeling assay served as a cross-validation orthogonal assay for follow-up characterization. With this multi-assay strategy, we successfully eliminated compounds that interfered with the assays and identified five compounds that inhibit the CD47-SIRP alpha interaction; these compounds will be further characterized and later disclosed. Importantly, our results validate the large library qHTS for antagonists of CD47-SIRP alpha interaction and suggest broad applicability of this approach to screen chemical libraries for other protein-protein interaction modulators.	[Miller, Thomas W.; Amason, Joshua D.; Rubin, Jeffrey S.; Burgess, Teresa L.; Farrell, Catherine L.] Paradigm Shift Therapeut LLC, Rockville, MD 20850 USA; [Miller, Thomas W.; Amason, Joshua D.; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Garcin, Elsa D.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Catonsville, MD USA; [Lamy, Laurence; Dranchak, Patricia K.; Macarthur, Ryan; Braisted, John; Inglese, James] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Amason, Joshua D.] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore County; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Duke University	Miller, TW (corresponding author), Paradigm Shift Therapeut LLC, Rockville, MD 20850 USA.; Miller, TW (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	thomas.miller@pstherx.com	Garcin, Elsa D/C-1556-2013; Miller, Thomas W/G-1215-2011; Roberts, David D./A-9699-2008	Garcin, Elsa D/0000-0003-0501-8421; Miller, Thomas W/0000-0001-8645-2785; Roberts, David D./0000-0002-2481-2981; Dranchak, Patricia/0000-0002-1349-4885	Avon Foundation for Women [02-2015-045, 02-2014-051, 02-2015-095, 02-2017-034]; National Cancer Institute [1U01CA218259-01A1]; Intramural Research Program of NCATS [1ZIATR000053-03]; Intramural Research Program of NCI [ZIASC009172]; Maryland Industrial Partnerships Program (MIPs) [5914]; National Institutes of Health [02921]; DOE Office of Biological and Environmental Research; National Institute of Health project ALS-ENABLE [P30 GM124169]; National Institute of Health High-End Instrumentation Grant [S10OD018483]; NATIONAL CANCER INSTITUTE [U01CA218259, ZIASC009172] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000053] Funding Source: NIH RePORTER	Avon Foundation for Women; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of NCATS; Intramural Research Program of NCI; Maryland Industrial Partnerships Program (MIPs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of Health project ALS-ENABLE; National Institute of Health High-End Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the Avon Foundation for Women (02-2015-045, 02-2014-051, 02-2015-095, 02-2017-034; TWM, TLB, CLF), the National Cancer Institute (1U01CA218259-01A1; TWM, TLB, CLF, JSR) the Intramural Research Programs of NCATS (Project 1ZIATR000053-03, JI) and NCI (Project ZIASC009172, DDR), the Maryland Industrial Partnerships Program (MIPs, #5914; EDG, TWM) and Cooperative Research and Development Agreement 02921 with the National Institutes of Health. This work was also conducted at the Advanced Light Source (ALS), a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy, Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies (IDAT) program, supported by DOE Office of Biological and Environmental Research. Additional support comes from the National Institute of Health project ALS-ENABLE (P30 GM124169) and a High-End Instrumentation Grant S10OD018483. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani R, 2018, NEW ENGL J MED, V379, P1711, DOI 10.1056/NEJMoa1807315; Aldrich C, 2017, J CHEM INF MODEL, V57, P387, DOI 10.1021/acs.jcim.7b00105; Ansell S, 2016, BLOOD, V128; Arkin MR, 2004, ASSAY GUIDANCE MANUA; Avent ND, 2000, BLOOD, V95, P375, DOI 10.1182/blood.V95.2.375; Babaoglu K, 2008, J MED CHEM, V51, P2502, DOI 10.1021/jm701500e; Baccelli I, 2014, ONCOTARGET, V5, P8147, DOI 10.18632/oncotarget.2385; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Baell JB, 2018, ACS CHEM BIOL, V13, P36, DOI 10.1021/acschembio.7b00903; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Basse MJ, 2013, NUCLEIC ACIDS RES, V41, pD824, DOI 10.1093/nar/gks1002; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bourgeas R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009598; CAMPBELL IG, 1992, CANCER RES, V52, P5416; CHILKOTI A, 1995, J AM CHEM SOC, V117, P10622, DOI 10.1021/ja00148a003; Danielsen JMR, 2007, BRIT J HAEMATOL, V138, P756, DOI 10.1111/j.1365-2141.2007.06729.x; Degorce Francois, 2009, Curr Chem Genomics, V3, P22, DOI 10.2174/1875397300903010022; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Du YH, 2013, ASSAY DRUG DEV TECHN, V11, P367, DOI 10.1089/adt.2013.507; Edris B, 2012, P NATL ACAD SCI USA, V109, P6656, DOI 10.1073/pnas.1121629109; Farina MS, 2017, DRUGS, V77, P1077, DOI 10.1007/s40265-017-0748-7; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Fousek K, 2015, CLIN CANCER RES, V21, P3384, DOI 10.1158/1078-0432.CCR-14-2675; Garrido F, 1997, IMMUNOL TODAY, V18, P89, DOI 10.1016/S0167-5699(96)10075-X; Gettinger S, 2016, J CLIN ONCOL, V34, P2980, DOI 10.1200/JCO.2016.66.9929; Gul S, 2014, EXPERT OPIN DRUG DIS, V9, P1393, DOI 10.1517/17460441.2014.954544; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Hdeib Alia, 2015, CNS Oncol, V4, P63, DOI 10.2217/cns.14.54; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoffer L, 2018, J MED CHEM, V61, P5719, DOI 10.1021/acs.jmedchem.8b00653; Hutter G, 2019, P NATL ACAD SCI USA, V116, P997, DOI 10.1073/pnas.1721434116; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Imbert PE, 2007, ASSAY DRUG DEV TECHN, V5, P363, DOI 10.1089/adt.2007.073; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kaur S, 2011, J BIOL CHEM, V286, P14991, DOI 10.1074/jbc.M110.179663; Kenny PW, 2017, J CHEM INF MODEL, V57, P2640, DOI 10.1021/acs.jcim.7b00313; Khandelwal S, 2007, TRANSFUSION, V47, P1725, DOI 10.1111/j.1537-2995.2007.01348.x; Krampitz GW, 2016, P NATL ACAD SCI USA, V113, P4464, DOI 10.1073/pnas.1600007113; Kuriyama T, 2012, BLOOD, V120, P4058, DOI 10.1182/blood-2012-02-408864; Kwong LS, 2014, IMMUNOLOGY, V143, P61, DOI 10.1111/imm.12290; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Liu J, 2015, HAEMATOLOGICA, V100, P36; Liu XJ, 2015, NAT MED, V21, P1209, DOI 10.1038/nm.3931; Lo J, 2015, HEPATOLOGY, V62, P534, DOI 10.1002/hep.27859; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Maxhimer JB, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000139; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Milhas S, 2016, ACS CHEM BIOL, V11, P2140, DOI 10.1021/acschembio.6b00286; Miller TW, 2015, J BIOL CHEM, V290, P24858, DOI 10.1074/jbc.M115.665752; Miller TW, 2013, MATRIX BIOL, V32, P316, DOI 10.1016/j.matbio.2013.02.009; Nishiyama Y, 1997, JPN J CANCER RES, V88, P120, DOI 10.1111/j.1349-7006.1997.tb00356.x; Ogura T, 2004, J BIOL CHEM, V279, P13711, DOI 10.1074/jbc.M310276200; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Pan Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009457; Papke B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11360; Peppard J, 2003, J BIOMOL SCREEN, V8, P149, DOI 10.1177/1087057103252308; Pietsch EC, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.7; Raetz EA, 2006, PEDIATR BLOOD CANCER, V47, P130, DOI 10.1002/pbc.20550; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568; Scarfo I, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0230-9; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; Shoichet BK, 2006, J MED CHEM, V49, P7274, DOI 10.1021/jm061103g; Shukla SJ, 2009, ASSAY DRUG DEV TECHN, V7, P143, DOI 10.1089/adt.2009.193; Sikic BI, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.3019; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Sockolosky JT, 2016, P NATL ACAD SCI USA, V113, pE2646, DOI 10.1073/pnas.1604268113; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Soto-Pantoja DR, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-2434; Soto-Pantoja DR, 2014, CANCER RES, V74, P6771, DOI 10.1158/0008-5472.CAN-14-0037-T; Soto-Pantoja DR, 2012, AUTOPHAGY, V8, P1628, DOI 10.4161/auto.21562; Steinert G, 2014, CANCER RES, V74, P1694, DOI 10.1158/0008-5472.CAN-13-1885; Subramanian S, 2007, J BIOL CHEM, V282, P1805, DOI 10.1074/jbc.M603923200; Suzuki S, 2012, ONCOL REP, V28, P465, DOI 10.3892/or.2012.1831; Tao H, 2017, ONCOL RES, V25, P1579, DOI 10.3727/096504017X14900505020895; THOMAS L, 1982, YALE J BIOL MED, V55, P329; Thorne N, 2010, CURR OPIN CHEM BIOL, V14, P315, DOI 10.1016/j.cbpa.2010.03.020; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; Veloria JR, 2018, BIOTECHNIQUES, V64, P181, DOI 10.2144/btn-2018-2001; Vernon-Wilson EF, 2000, EUR J IMMUNOL, V30, P2130; Vidler LR, 2018, ACS MED CHEM LETT, V9, P792, DOI 10.1021/acsmedchemlett.8b00097; Van VQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041972; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Yasgar A, 2016, METHODS MOL BIOL, V1439, P77, DOI 10.1007/978-1-4939-3673-1_5; Yoshida K, 2015, CANCER MED-US, V4, P1322, DOI 10.1002/cam4.478; Yu H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14932; Yuan J, 2009, NAT CHEM BIOL, V5, P765, DOI 10.1038/nchembio.215; Zhang HM, 2015, P NATL ACAD SCI USA, V112, pE6215, DOI 10.1073/pnas.1520032112; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153550; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	102	15	18	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0218897	10.1371/journal.pone.0218897	http://dx.doi.org/10.1371/journal.pone.0218897			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276567	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300027
J	Platisa, MM; Bojic, T; Mazic, S; Kalauzi, A				Platisa, Mirjana M.; Bojic, Tijana; Mazic, Sanja; Kalauzi, Aleksandar			Generalized Poincare plots analysis of heart period dynamics in different physiological conditions: Trained vs. untrained men	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; EXERCISE; BRADYCARDIA; SINUS	Background Recently we proposed a new method called generalized Poincare plot (gPp) analysis which gave a new insight into the pattern of neurocaridac control. In this study we examined potential of gPp method to reveal changes in cardiac neural control in young athletes during three conditions: supine rest, running and relaxation, with respect to untrained subjects. Methods This method is based on the quantification of Pearson's correlation coefficients r(j, k), between symmetrical (j = k) and asymmetrical summed j previous and k following RR intervals up to the 100th order (j, k <= 100). Results Differences between groups were obtained at all levels of this analysis. The main result is the significant difference of NAI, normalized index of asymmetry, between groups in running, which was originated in different positions of local maxima of r(j, k). Compared with untrained subjects, these findings indicate modified neural control and altered intrinsic heart rate behavior in athletes which are related to some kind of memory mechanism between RR intervals. Conclusion Obtained results provide great potential of gPp method analysis in the recognition of changes in neurocardiac control in healthy subjects. Further studies are needed for identification of altered cardiac regulatory mechanisms whose background may be useful in the evaluation of genesis of athletes neurocardiovascular pathology.	[Platisa, Mirjana M.] Univ Belgrade, Fac Med, Inst Biophys, Belgrade, Serbia; [Bojic, Tijana] Univ Belgrade, Inst Nucl Sci Vinca, Lab Radiobiol & Mol Genet, Belgrade, Serbia; [Mazic, Sanja] Univ Belgrade, Fac Med, Inst Med Physiol, Belgrade, Serbia; [Kalauzi, Aleksandar] Univ Belgrade, Inst Multidisciplinary Res, Dept Life Sci, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade	Platisa, MM (corresponding author), Univ Belgrade, Fac Med, Inst Biophys, Belgrade, Serbia.	mirjana.platisa@gmail.com	Platisa, Mirjana/AAR-4309-2020; Bojić, Tijana/AAF-9042-2019	Platisa, Mirjana/0000-0002-0915-2823; Bojić, Tijana/0000-0003-1149-5697; Kalauzi, Aleksandar/0000-0003-4833-0757; mazic, sanja/0000-0001-7230-6816				Bajic D, 2010, STRESS, V13, P142, DOI 10.3109/10253890903089842; Bosomworth NJ, 2015, CAN FAM PHYSICIAN, V61, P1061; Buchheit M, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00069; Collins HL, 2001, AM J PHYSIOL-HEART C, V280, pH642, DOI 10.1152/ajpheart.2001.280.2.H642; Corrado D, 2007, HEART RHYTHM, V4, P520, DOI 10.1016/j.hrthm.2007.01.002; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; D'Souza A, 2017, CIRC RES, V121, P1058, DOI 10.1161/CIRCRESAHA.117.311607; D'Souza A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4775; Ivanov PC, 2017, SPRINGER PROC PHYS, V191, P145, DOI 10.1007/978-3-319-47810-4_12; Kerfoot EC, 2011, LEARN MEMORY, V18, P405, DOI 10.1101/lm.2108911; Kjaer M, 1998, EUR J APPL PHYSIOL, V77, P195, DOI 10.1007/s004210050321; Kwon O, 2016, CLIN PHYSIOL FUNCT I, V36, P286, DOI 10.1111/cpf.12226; Myrstad M, 2016, CLIN RES CARDIOL, V105, P154, DOI 10.1007/s00392-015-0898-0; Negrao CE, 2013, J APPL PHYSIOL, V114, P1356, DOI 10.1152/japplphysiol.00270.2013; NG AV, 1994, J APPL PHYSIOL, V77, P1366, DOI 10.1152/jappl.1994.77.3.1366; Platisa MM, 2008, PHYSIOL MEAS, V29, P439, DOI 10.1088/0967-3334/29/4/002; Platisa MM, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00038; Rowell LB, HUMAN CARDIOVASCULAR; Rowland T, 2009, PEDIATRICS, V123, P1217, DOI 10.1542/peds.2008-0708; Sagawa K., 1983, HDB PHYSL CARDIOVASC, P453; Sassi R, 2015, EUROPACE, V17, P1341, DOI 10.1093/europace/euv015; Silvani A, 2005, PEDIATR RES, V57, P108, DOI 10.1203/01.PDR.0000148065.32413.B0; Silvani A, 2003, SLEEP, V26, P201, DOI 10.1093/sleep/26.2.201; SMITH ML, 1989, MED SCI SPORT EXER, V21, P40, DOI 10.1249/00005768-198902000-00008; Stanley J, 2015, INT J SPORT PHYSIOL, V10, P528, DOI 10.1123/ijspp.2014-0196; Stein R, 2002, J AM COLL CARDIOL, V39, P1033, DOI 10.1016/S0735-1097(02)01722-9; Varro A, 2010, PFLUG ARCH EUR J PHY, V460, P31, DOI 10.1007/s00424-010-0798-0; Vieluf S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00240; Zoccoli G, 2001, SLEEP, V24, P753	29	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219281	10.1371/journal.pone.0219281	http://dx.doi.org/10.1371/journal.pone.0219281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276529	Green Submitted, Green Published, gold			2022-12-26	WOS:000484936300058
J	Shavit-Stein, E; Aronovich, R; Sylantiev, C; Gofrit, SG; Chapman, J; Dori, A				Shavit-Stein, Efrat; Aronovich, Ramona; Sylantiev, Constantin; Gofrit, Shany Guly; Chapman, Joab; Dori, Amir			The role of thrombin in the pathogenesis of diabetic neuropathy	PLOS ONE			English	Article							SERINE-PROTEASE; DEATH; RAT; CONDUCTION; PHYSIOLOGY; NEURONS; MODEL; MICE; TAIL	Diabetic neuropathy is common and disabling despite glycemic control. Novel neuroprotective approaches are needed. Thrombin and hypercoagulability are associated with diabetes and nerve conduction dysfunction. Our aim was to study the role of thrombin in diabetic neuropathy. We measured thrombin activity by a biochemical assay in streptozotocin (STZ)-induced diabetic neuropathy in male Sprague-Dawley rats. Neuropathy severity was assessed by thermal latency and nerve conduction measures. Thermal latencies were longer in diabetic rats, and improved with the non-specific serine-protease inhibitor Tosyl-Llysine-chloromethyl ketone (TLCK) treatment (p<0.01). The tail nerve of diabetic rats showed slow conduction velocity (p<0.01), and interestingly, increased thrombin activity was noted in the sciatic nerve (p<0.001). Sciatic nodes of Ranvier and the thrombin receptor, protease activated receptor 1 (PAR1) reactivity showed abnormal morphology in diabetic animals by immunofluorescence staining (p<0.0001). Treatment of diabetic animals with either the specific thrombin inhibitor, N-alpha 2 naphtalenesulfonylglycyl alpha-4 amidino-phenylalaninepiperidide (NAPAP) or TLCK preserved normal conduction velocity, (p<0.01 and p = 0.01 respectively), and prevented disruption of morphology (p<0.05 and p<0.03). The results establish for the first time an association between diabetic neuropathy and excessive activation of the thrombin pathway. Treatment of diabetic animals with thrombin inhibitors ameliorates both biochemical, structural and electrophysiological deficits. The thrombin pathway inhibition may be a novel neuroprotective therapeutic target in the diabetic neuropathy pathology.	[Shavit-Stein, Efrat; Sylantiev, Constantin; Gofrit, Shany Guly; Chapman, Joab; Dori, Amir] Sheba Med Ctr, Dept Neurol, Tel Hashomer, Israel; [Shavit-Stein, Efrat; Chapman, Joab; Dori, Amir] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Tel Hashomer, Israel; [Aronovich, Ramona; Chapman, Joab] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Tel Aviv, Israel; [Chapman, Joab; Dori, Amir] Tel Aviv Univ, Sackler Sch Med, Dept Neurol, Tel Aviv, Israel; [Chapman, Joab] Tel Aviv Univ, Sackler Fac Med, Robert & Martha Harden Chair Mental & Neurol Dis, Tel Aviv, Israel; [Dori, Amir] Sheba Med Ctr, Talpiot Med Leadership Program, Tel Hashomer, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Shavit-Stein, E (corresponding author), Sheba Med Ctr, Dept Neurol, Tel Hashomer, Israel.; Shavit-Stein, E (corresponding author), Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Tel Hashomer, Israel.	efrat.shavit.stein@gmail.com	Dori, Amir/E-5623-2013; Chapman, Joab/E-4598-2010	Dori, Amir/0000-0003-4633-1481; Chapman, Joab/0000-0002-2161-9764				Anand R, 1987, Trans Pa Acad Ophthalmol Otolaryngol, V39, P563; Aoki I, 1996, J AM COLL CARDIOL, V27, P560, DOI 10.1016/0735-1097(95)00518-8; Beilin O, 2001, NEUROREPORT, V12, P2347, DOI 10.1097/00001756-200108080-00013; Blaes N, 2012, AM J PHYSIOL-RENAL, V303, pF293, DOI 10.1152/ajprenal.00437.2011; Bushi D, 2015, J NEUROCHEM, V135, P1140, DOI 10.1111/jnc.13372; Bushi D, 2013, J MOL NEUROSCI, V51, P844, DOI 10.1007/s12031-013-0072-y; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Chapman J, 2013, SEMIN THROMB HEMOST, V39, P876, DOI 10.1055/s-0033-1357482; Dugina TN, 2004, B EXP BIOL MED+, V138, P463, DOI 10.1007/s10517-005-0071-2; Dunn EJ, 2006, DIABETOLOGIA, V49, P1071, DOI 10.1007/s00125-006-0197-4; Esmon CT, 2001, THROMB HAEMOSTASIS, V86, P51; Feldman EL, 1999, CURR OPIN NEUROL, V12, P553, DOI 10.1097/00019052-199910000-00009; Festoff BW, 1996, J NEUROBIOL, V30, P255, DOI 10.1002/(SICI)1097-4695(199606)30:2<255::AID-NEU7>3.0.CO;2-4; FORD I, 1992, THROMB HAEMOSTASIS, V68, P628; Gera O, 2016, NEUROSCIENCE, V339, P587, DOI 10.1016/j.neuroscience.2016.10.034; Goyal SN, 2016, CHEM-BIOL INTERACT, V244, P49, DOI 10.1016/j.cbi.2015.11.032; Itzekson Z, 2014, J MOL NEUROSCI, V53, P87, DOI 10.1007/s12031-013-0200-8; Kafri M, 2002, MUSCLE NERVE, V25, P51, DOI 10.1002/mus.10011; KRUPINSKI K, 1989, HAEMOSTASIS, V19, P74; Madan R, 2010, J ASS PHYS INDIA, V58; Maggio N, 2008, J NEUROSCI, V28, P732, DOI 10.1523/JNEUROSCI.3665-07.2008; Maggio N, 2013, EXP NEUROL, V247, P595, DOI 10.1016/j.expneurol.2013.02.011; Malyszko J, 2004, THROMB HAEMOSTASIS, V91, P480, DOI 10.1160/TH03-04-0243; McCutcheon JE, 2009, EUR J NEUROSCI, V29, P997, DOI 10.1111/j.1460-9568.2009.06648.x; Mitsui C, 2001, J NEUROSCI RES, V66, P601, DOI 10.1002/jnr.10008; Obrosova IG, 2009, NEUROTHERAPEUTICS, V6, P638, DOI 10.1016/j.nurt.2009.07.004; Reuther C, 2014, APOPTOSIS, V19, P1545, DOI 10.1007/s10495-014-1027-7; Sakai T, 2009, BIOCHEM BIOPH RES CO, V384, P173, DOI 10.1016/j.bbrc.2009.04.105; Shavit E, 2008, BRAIN, V131, P1113, DOI 10.1093/brain/awn005; Shavit-Stein E, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01139; TZE WJ, 1985, METABOLISM, V34, P721, DOI 10.1016/0026-0495(85)90021-6; Vergnolle N, 2003, TRENDS NEUROSCI, V26, P496, DOI 10.1016/S0166-2236(03)00208-X; Winer N, 2004, J CLIN PHARMACOL, V44, P397, DOI 10.1177/0091270004263017; Xia RH, 2010, MUSCLE NERVE, V41, P850, DOI 10.1002/mus.21588	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219453	10.1371/journal.pone.0219453	http://dx.doi.org/10.1371/journal.pone.0219453			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276565	Green Published, gold, Green Submitted			2022-12-26	WOS:000484936300084
J	Tellier, AP; Archambault, D; Tremblay, KD; Mager, J				Tellier, Adam P.; Archambault, Danielle; Tremblay, Kimberly D.; Mager, Jesse			The elongation factor Elof1 is required for mammalian gastrulation	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION ELONGATION; COMPLEX; MOUSE; ISOFORM; FGFR2; SPT6	Despite having been sequenced over a decade ago, the functional significance of much of the mammalian genome remains unknown. The mouse has become the preeminent mammalian model for identifying endogenous gene function in vivo. Here we characterize the phenotype of a loss-of function allele for the evolutionarily conserved transcription factor, Elongation Factor Homolog 1 (Elof1). Recent work utilizing the yeast homolog, Elf1, has demonstrated that Elf1 associates with the RNA polymerase II complex to promote elongation by relieving the association of the template DNA strand with bound histones. Loss of Elof1 results in developmental delay and morphological defects during early mouse development resulting in peri-gastrulation lethality. Although Elof1 is highly conserved we observe tissue specific expression during gastrulation and in adult murine tissues, suggesting there may be other genes with similar function in diverse tissues or that mElof1 has adopted lineage specific functions. To better understand its function in mammalian transcription, we examined splice variants and find that Elof1 regulates mutually exclusive exon use in vivo. Distinct from what has been demonstrated in yeast, we demonstrate that Elof1 is essential for viability during mammalian gastrulation which may be due to a role mediating tissue specific exclusive exon use, a regulatory function unique to higher eukaryotes.	[Tellier, Adam P.; Archambault, Danielle; Tremblay, Kimberly D.; Mager, Jesse] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Tremblay, KD; Mager, J (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	kdtrembl@umass.edu; jmager@umass.edu		mager, jesse/0000-0002-4123-0633; Tremblay, Kimberly/0000-0002-3059-9910; , Adam/0000-0002-1695-9211	National Institutes of Health [HD083311]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD083311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by National Institutes of Health grant HD083311 to JM.	Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Brewer JR, 2016, GENE DEV, V30, P751, DOI 10.1101/gad.277137.115; Daniels JP, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-24; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Ehara H, 2019, SCIENCE, V363, P744, DOI 10.1126/science.aav8912; Ehara H, 2017, SCIENCE, V357, P921, DOI 10.1126/science.aan8552; Fong N, 2017, MOL CELL, V66, P546, DOI 10.1016/j.molcel.2017.04.016; Griffith GJ, 2011, BIOL REPROD, V84, P654, DOI 10.1095/biolreprod.110.087213; Hou Y, 2017, J BIOINF COMPUT BIOL, V15, DOI 10.1142/S0219720017500032; Hu QW, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005602; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Oqani RK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40358-3; Orlacchio A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201030; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Prather D, 2005, MOL CELL BIOL, V25, P10122, DOI 10.1128/MCB.25.22.10122-10135.2005; Revest JM, 2001, DEV BIOL, V231, P47, DOI 10.1006/dbio.2000.0144; Saldi T, 2016, J MOL BIOL, V428, P2623, DOI 10.1016/j.jmb.2016.04.017; Sanidas I, 2014, MOL CELL, V53, P577, DOI 10.1016/j.molcel.2013.12.018; Tremblay KD, 2000, DEVELOPMENT, V127, P3079; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Xu YG, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1512-3; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; Zhang L, 2008, MOL CELL BIOL, V28, P1393, DOI 10.1128/MCB.01733-07; Zhao JX, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317697546	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219410	10.1371/journal.pone.0219410	http://dx.doi.org/10.1371/journal.pone.0219410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276560	Green Published, gold, Green Submitted			2022-12-26	WOS:000484936300076
J	Weber, B; Mendler, MR; Lackner, I; von Zelewski, A; Hofler, S; Baur, M; Braun, CK; Hummler, H; Schwarz, S; Pressmar, J; Kalbitz, M				Weber, Birte; Mendler, Marc Robin; Lackner, Ina; von Zelewski, Alexander; Hoefler, Severin; Baur, Meike; Braun, Christian Karl; Hummler, Helmut; Schwarz, Stephan; Pressmar, Jochen; Kalbitz, Miriam			Lung injury after asphyxia and hemorrhagic shock in newborn piglets: Analysis of structural and inflammatory changes	PLOS ONE			English	Article							SPONTANEOUS CIRCULATION; PULMONARY INFLAMMATION; RETURN	Objective Asphyxia of newborns is a severe and frequent challenge of the peri-and postnatal period. The purpose of this study was to study early morphological, immunological and structural alterations in lung tissue after asphyxia and hemorrhage (AH). Methods 44 neonatal piglets (age 32 hrs) underwent asphyxia and hemorrhage (AH) and were treated according to the international liaison committee of resuscitation (ILCOR) guidelines. For this study, 15 piglets (blood transfusion (RBC) n = 9; NaCl n = 6, mean age 31 hrs) were randomly picked. 4 hours after ROSC (return of spontaneous circulation), lung tissue and blood samples were collected. Results An elevation of myeloperoxidase (MPO) activity was observed 4 hrs after AH accompanied by an increase of surfactant D after RBC treatment. After AH tight junction proteins Claudin 18 and junctional adhesion molecule 1 (JAM1) were down-regulated, whereas Occludin was increased. Furthermore, after AH and RBC treatment dephosphorylated active form of Connexin 43 was increased. Conclusions AH in neonatal pigs is associated with early lung injury, inflammation and alterations of tight junctions (Claudin, Occludin, JAM-1) and gap junctions (Connexin 43) in lung tissue, which contributes to the development of lung edema and impaired function.	[Weber, Birte; Lackner, Ina; von Zelewski, Alexander; Hoefler, Severin; Baur, Meike; Pressmar, Jochen; Kalbitz, Miriam] Univ Ulm, Ctr Surg, Dept Traumatol Hand Plast & Reconstruct Surg, Ulm, Baden Wurttembe, Germany; [Mendler, Marc Robin; Hummler, Helmut; Schwarz, Stephan] Univ Ulm, Dept Pediat & Adolescent Med, Div Neonatol & Pediat Crit Care, Ulm, Baden Wurttembe, Germany; [Braun, Christian Karl] Univ Hosp Ulm, Inst Clin & Expt Trauma Immunol, Ulm, Baden Wurttembe, Germany; [Hummler, Helmut] Sidra Med, Dept Pediat, Div Neonatol, Doha, Qatar	Ulm University; Ulm University; Ulm University; Sidra Medical & Research Center	Kalbitz, M (corresponding author), Univ Ulm, Ctr Surg, Dept Traumatol Hand Plast & Reconstruct Surg, Ulm, Baden Wurttembe, Germany.	miriam.kalbitz@uniklinik-ulm.de	Hummler, Helmut/AAN-7297-2021; Braun, Christian K/I-5132-2018	Braun, Christian K/0000-0002-9854-3251; Lackner, Ina/0000-0001-6410-9222; Weber, Birte/0000-0001-7779-9816	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [CRC 1149, 251293561]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This work was conducted in the framework of the CRC 1149 funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Project number 251293561. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2001, INTERNAL MED, V40, P159, DOI 10.2169/internalmedicine.40.159; Bosmann M, 2013, FASEB J, V27, P5010, DOI 10.1096/fj.13-236380; BOYER SH, 1975, SCIENCE, V188, P361, DOI 10.1126/science.804182; Cai Xu-xu, 2003, Zhonghua Er Ke Za Zhi, V41, P208; Correale Michele, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P270; Fawke J, 2010, AM J RESP CRIT CARE, V182, P237, DOI 10.1164/rccm.200912-1806OC; Fujinaga T, 2006, TRANSPLANTATION, V82, P1168, DOI 10.1097/01.tp.0000237207.73439.2e; Gillam-Krakauer M., 2017, BIRTH ASPHYXIA; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; Harrington DJ, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.10.877; Hung H Y, 1994, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V35, P36; Jobe AH, 2006, BIOL NEONATE, V89, P298, DOI 10.1159/000092866; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kurt A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011797; LaFemina MJ, 2014, AM J RESP CELL MOL, V51, P550, DOI 10.1165/rcmb.2013-0456OC; Liu MJ, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-94; Liu TG, 2015, INFLAMMATION, V38, P1847, DOI 10.1007/s10753-015-0162-9; MARTINANCEL A, 1995, J PEDIATR-US, V127, P786, DOI 10.1016/S0022-3476(95)70174-5; Mazzon E, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-75; McCarthy EF, 1943, J PHYSIOL-LONDON, V102, P55, DOI 10.1113/jphysiol.1943.sp004014; Mendler MR, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00192; Mendler MR, 2016, NEONATOLOGY, V109, P22, DOI 10.1159/000439020; Mitchell LA, 2015, AM J PATHOL, V185, P372, DOI 10.1016/j.ajpath.2014.10.010; Mustofa J, 2018, RESUSCITATION, V129, P82, DOI 10.1016/j.resuscitation.2018.06.013; Nayak A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00131; O'Donnell JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100931; Parthasarathi K, 2012, AM J PHYSIOL-LUNG C, V303, pL33, DOI 10.1152/ajplung.00219.2011; Rognlien AGW, 2017, NEONATOLOGY, V111, P45, DOI 10.1159/000447322; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sarieddine MZR, 2009, J CELL MOL MED, V13, P4560, DOI 10.1111/j.1582-4934.2008.00654.x; SCHROD L, 1992, EUR J PEDIATR, V151, P688, DOI 10.1007/BF01957575; SCHULMAN I, 1954, AMA AM J DIS CHILD, V87, P167, DOI 10.1001/archpedi.1954.02050090155003; Speer CP, 2006, J PERINATOL, V26, pS57, DOI 10.1038/sj.jp.7211476; Wilson MR, 2005, AM J PHYSIOL-LUNG C, V288, pL599, DOI 10.1152/ajplung.00304.2004; WORTHEN GS, 1987, AM REV RESPIR DIS, V136, P19, DOI 10.1164/ajrccm/136.1.19; Zhang CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114963; Zupan Simunek V, 2008, J Gynecol Obstet Biol Reprod (Paris), V37 Suppl 1, pS7, DOI 10.1016/j.jgyn.2007.11.006	38	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2019	14	7							e0219211	10.1371/journal.pone.0219211	http://dx.doi.org/10.1371/journal.pone.0219211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4FP	31276543	Green Published, Green Submitted, gold			2022-12-26	WOS:000484936300051
J	Vomhof-DeKrey, EE; Lee, J; Lansing, J; Brown, C; Darland, D; Basson, MD				Vomhof-DeKrey, Emilie E.; Lee, Jun; Lansing, Jack; Brown, Chris; Darland, Diane; Basson, Marc D.			Schlafen 3 knockout mice display gender-specific differences in weight gain, food efficiency, and expression of markers of intestinal epithelial differentiation, metabolism, and immune cell function	PLOS ONE			English	Article							PROGENITOR CELLS; GENE-EXPRESSION; CDX2; BINDING; FAMILY; MACROPHAGES; LIPOPROTEIN; ACTIVATION; INDUCTION; MUTATION	Self-renewal and differentiation are essential for intestinal epithelium absorptive functioning and adaptation to pathological states such as short gut syndrome, ulcers, and inflammatory bowel disease. The rodent Slfn3 and its human analog Slfn12 are critical in regulating intestinal epithelial differentiation. We sought to characterize intestinal function in Slfn3 knockout (KO) mice. Male and female pair-fed Slfn3KO mice gained less weight with decreased food efficiency than wild type (WT) mice, with more pronounced effects in females. RNA sequencing performed on intestinal mucosa of Slfn3KO and WT mice showed gene ontology decreases in cell adhesion molecule signaling, tumor necrosis factor receptor binding, and adaptive immune cell proliferation/functioning genes in Slfn3KO mice, with greater effects in females. qPCR analysis of fatty acid metabolism genes, Pla2g4c, Pla2g2f, and Cyp3c55 revealed an increase in Pla2g4c, and a decrease in Pla2g2f in Slfn3KO females. Additionally, adipogenesis genes, Fabp4 and Lpl were decreased and ketogenesis gene Hmgcs2 was increased in female Slfn3KO mice. Sequencing did not reveal significant changes in differentiation markers, so qPCR was utilized. Slfn3KO tended to have decreased expression of intestinal differentiation markers sucrase isomaltase, dipeptidyl peptidase 4, villin 1, and glucose transporter 1 (Glut1) vs. WT males, although these trends did not achieve statistical significance unless data from several markers was pooled. Differentiation markers, Glut2 and sodium-glucose transporter 1 (SGLT1), did show statistically significant sex-dependent differences. Glut2 mRNA was reduced in Slfn3KO females, while SGLT1 increased in Slfn3KO males. Notch2 and Cdx2 were only increased in female Slfn3KO mice. Although Slfn3KO mice gain less weight and decreased food efficiency, their biochemical phenotype is more subtle and suggests a complex interplay between gender effects, Slfn3, and another regulatory pathway yet to be identified that compensates for the chronic loss of Slfn3.	[Vomhof-DeKrey, Emilie E.; Lee, Jun; Lansing, Jack; Brown, Chris; Basson, Marc D.] Univ North Dakota, Sch Med & Hlth Sci, Dept Surg, Grand Forks, ND 58201 USA; [Vomhof-DeKrey, Emilie E.; Lee, Jun; Lansing, Jack; Brown, Chris; Basson, Marc D.] Univ North Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND 58201 USA; [Vomhof-DeKrey, Emilie E.; Lee, Jun; Lansing, Jack; Brown, Chris; Basson, Marc D.] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58201 USA; [Darland, Diane] Univ North Dakota, Sch Med & Hlth Sci, Dept Biol, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks; University of North Dakota Grand Forks; University of North Dakota Grand Forks; University of North Dakota Grand Forks	Basson, MD (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Surg, Grand Forks, ND 58201 USA.; Basson, MD (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND 58201 USA.; Basson, MD (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58201 USA.	marc.basson@med.und.edu		Vomhof-DeKrey, Emilie/0000-0003-3818-5330	National Institutes of Health [NIHRO1DK096137]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health NIHRO1DK096137 (MDB).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Basson MD, 2018, CELL PHYSIOL BIOCHEM, V48, P1274, DOI 10.1159/000492019; BEHR SR, 1986, J EXP MED, V164, P1362, DOI 10.1084/jem.164.4.1362; Bell TA, 2006, GENETICS, V172, P411, DOI 10.1534/genetics.105.047118; BENNETT A, 1981, BRIT J PHARMACOL, V74, P435, DOI 10.1111/j.1476-5381.1981.tb09989.x; Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Bernlohr DA, 1997, ADV EXP MED BIOL, V422, P145; Bevins CL, 2004, CURR OPIN GASTROEN, V20, P572, DOI 10.1097/00001574-200411000-00012; Boyd M, 2010, J BIOL CHEM, V285, P25115, DOI 10.1074/jbc.M109.089516; Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200; Bustos O, 2009, GENE, V447, P1, DOI 10.1016/j.gene.2009.07.006; Chaturvedi L, 2014, BBA-MOL CELL RES, V1843, P3029, DOI 10.1016/j.bbamcr.2014.09.017; Condamine T, 2010, J LEUKOCYTE BIOL, V87, P451, DOI 10.1189/jlb.0609410; Crissey MAS, 2011, GASTROENTEROLOGY, V140, P517, DOI 10.1053/j.gastro.2010.11.033; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donato M, 2013, GENOME RES, V23, P1885, DOI 10.1101/gr.153551.112; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025785; Garin-Shkolnik T, 2014, DIABETES, V63, P900, DOI 10.2337/db13-0436; Gassler Nikolaus, 2017, World J Gastrointest Pathophysiol, V8, P150, DOI 10.4291/wjgp.v8.i4.150; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; Hotamisligil GS, 2015, NAT REV ENDOCRINOL, V11, P592, DOI 10.1038/nrendo.2015.122; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kovalenko PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079745; Kovalenko PL, 2013, JAMA SURG, V148, P1013, DOI 10.1001/jamasurg.2013.3572; Leggett Richard M., 2013, Frontiers in Genetics, V4, P288, DOI 10.3389/fgene.2013.00288; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Liu FR, 2018, CELL BIOL INT, V42, P2, DOI 10.1002/cbin.10778; Liu T, 2007, CARCINOGENESIS, V28, P488, DOI 10.1093/carcin/bgl176; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Michalak A, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00459; Neumann B, 2008, BIOCHEM BIOPH RES CO, V370, P62, DOI 10.1016/j.bbrc.2008.03.032; Patel VB, 2009, BIOCHEM BIOPH RES CO, V388, P752, DOI 10.1016/j.bbrc.2009.08.094; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Sander GR, 2004, J HISTOCHEM CYTOCHEM, V52, P509, DOI 10.1177/002215540405200409; SANDERS KM, 1984, AM J PHYSIOL, V247, pG117, DOI 10.1152/ajpgi.1984.247.2.G117; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Sohn WJ, 2007, MOL IMMUNOL, V44, P3273, DOI 10.1016/j.molimm.2007.03.001; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Syamsunarno MRAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079386; Uesaka T, 2004, J MOL BIOL, V337, P647, DOI 10.1016/j.jmb.2004.01.061; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Vomhof-DeKrey EE, 2012, FREE RADICAL BIO MED, V53, P690, DOI 10.1016/j.freeradbiomed.2012.05.047; Vooijs M, 2011, GASTROENTEROLOGY, V141, P448, DOI 10.1053/j.gastro.2011.06.003; Walsh MF, 2015, J INVEST SURG, V28, P202, DOI 10.3109/08941939.2015.1005780; Walsh MF, 2012, AM J SURG, V204, P598, DOI 10.1016/j.amjsurg.2012.07.004; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang QD, 2017, CELL DEATH DIFFER, V24, P458, DOI 10.1038/cdd.2016.142; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Yoshikawa T, 2011, HISTOCHEM CELL BIOL, V135, P183, DOI 10.1007/s00418-011-0779-1; Yuan LS, 2010, AM J PHYSIOL-GASTR L, V298, pG994, DOI 10.1152/ajpgi.00517.2009	58	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2019	14	7							e0219267	10.1371/journal.pone.0219267	http://dx.doi.org/10.1371/journal.pone.0219267			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW3YW	31260507	Green Published, gold, Green Submitted			2022-12-26	WOS:000484918700050
